PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Kageyama, M; Yokoyama, K; Nagata, S; Kita, S; Nakamura, Y; Kobayashi, S; Solomon, P				Kageyama, Masako; Yokoyama, Keiko; Nagata, Satoko; Kita, Sachiko; Nakamura, Yukako; Kobayashi, Sayaka; Solomon, Phyllis			Rate of Family Violence Among Patients With Schizophrenia in Japan	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						family caregiving; family violence; schizophrenia; severe mental illness; siblings	SEVERE MENTAL-ILLNESS; BEHAVIOR; DISORDERS; PEOPLE	Family violence is a serious concern in the era of deinstitutionalization in Japan. Consequently, we aimed to clarify the rate of family violence among patients with schizophrenia, and differences by sex and relationship to the patient. We asked households belonging to a family group association to complete a self-administered mail survey. Of 350 households that responded, data for 302 were analyzed. The rate of violence toward any family member was 60.9% over the lifetime and 27.2% in the past year. Order of lifetime rates for family members from highest to lowest was 51.0% for mothers, 47.0% for fathers, 30.7% for younger sisters, 23.8% for spouses, 19.5% for younger brothers, 18.2% for older sisters, 17.1% for older brothers, and none for children. Younger sisters were more likely to be victims compared to other siblings. Fathers and older brothers were likely to be victims when patients were male.	[Kageyama, Masako; Nagata, Satoko; Kita, Sachiko] Univ Tokyo, Tokyo 1130033, Japan; [Yokoyama, Keiko] Saitama Prefectural Univ, Saitama, Japan; [Nakamura, Yukako] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kobayashi, Sayaka] Tokyo Womens Med Univ, Tokyo, Japan; [Solomon, Phyllis] Univ Penn, Philadelphia, PA 19104 USA	Kageyama, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Community Hlth Nursing, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kageyama-tky@umin.ac.jp			Uehiro Foundation on Ethics and Education [B-016]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The first author received financial support from the Uehiro Foundation on Ethics and Education (No. B-016, 2014-2015) for the research and publication of this article.	BRODY GH, 1991, AM J MENT RETARD, V95, P527; Angermeyer MC, 2000, ACTA PSYCHIAT SCAND, V102, P63; Schanda H, 2004, ACTA PSYCHIAT SCAND, V110, P98, DOI 10.1111/j.1600-0047.2004.00305.x; Choe JY, 2008, PSYCHIAT SERV, V59, P153, DOI 10.1176/appi.ps.59.2.153; [Anonymous], 2014, DECISION FATHER WHO; Modestin J, 1998, PSYCHIAT CLIN NEUROS, V52, P547, DOI 10.1111/j.1440-1819.1998.tb02699.x; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Solomon PL, 2005, TRAUMA VIOLENCE ABUS, V6, P40, DOI 10.1177/1524838004272464; Vaddadi KS, 2002, INT J SOC PSYCHIATR, V48, P149, DOI 10.1177/002076402128783208; Robbins PC, 2003, LAW HUMAN BEHAV, V27, P561, DOI 10.1023/B:LAHU.0000004886.13268.f2; Corrigan PW, 2005, PSYCHIAT RES, V136, P153, DOI 10.1016/j.psychres.2005.06.005; Walsh E, 2002, BRIT J PSYCHIAT, V180, P490, DOI 10.1192/bjp.180.6.490; Arboleda-Florez J, 1998, INT MED J, V5, P3, DOI [10.1097/YCO.0b013e32832c08fc, DOI 10.1097/YCO.0B013E32832C08FC]; Binder R. L., 1986, J AM ACAD PSYCHIAT L, V14, P131; Chiba Prefecture Family Association of Persons with Mental Disorders, 2009, NEEDS LIF WELF PERS; CICIRELLI VG, 1994, J MARRIAGE FAM, V56, P7, DOI 10.2307/352697; Dalal K, 2012, ASIA-PAC J PUBLIC HE, V24, P265, DOI 10.1177/1010539510384499; DAVIS S, 1991, SOC WORK, V36, P174; Estroff S., 1998, SOC PSYCH PSYCH EPID, V33, P95, DOI 10.1007/s001270050216; Fleischman A, 2014, PSYCHOL MED, V44, P3051, DOI 10.1017/S0033291714000695; Gabrielsen G, 1992, STUDIES CRIME CRIME, V1, P106; Garcia-Moreno C., 2005, WHO MULTICOUNTRY STU; Krug EG, 2002, WORLD REPORT VIOLENC, DOI [10.1136/ip.9.1.93, DOI 10.1136/IP.9.1.93]; Kumagai F, 1981, J COMP FAM STUD, V12, P337; Matsuyama M, 2013, JPN J ADDICT FAM, V29, P50; Research and Training Institute of the Minister of Justice, RES DOM SER CRIM; Shwalb D, 1987, FATHERS ROLE CROSS C, P247; Swan R. W., 1988, J INTERPERS VIOLENCE, V3, P42, DOI 10.1177/088626088003001004; Tokyo Metropolitan Government, CURR LIV COND PEOPL; Wing-Yum Chan B, 2008, INT J FORENSIC MENT, V7, P65	30	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	SEP	2015	27	6					652	660		10.1177/1010539515595069		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ0IQ	WOS:000360279100008		
J	Park, SC; Lee, MS; Shinfuku, N; Sartorius, N; Park, YC				Park, Seon-Cheol; Lee, Min-Soo; Shinfuku, Naotaka; Sartorius, Norman; Park, Yong Chon			Gender differences in depressive symptom profiles and patterns of psychotropic drug usage in Asian patients with depression: Findings from the Research on Asian Psychotropic Prescription Patterns for Antidepressants study	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY			English	Article						Depression; gender; depressive symptom profiles; second-generation antipsychotics; Asian	SEX-DIFFERENCES; TREATMENT GUIDELINE; UNITED-STATES; EAST-ASIA; PREVALENCE; ANXIETY; DISORDERS; HEALTH; KOREA; SCHIZOPHRENIA	Objectives: The purpose of this study was to investigate whether there were gender-specific depressive symptom profiles or gender-specific patterns of psychotropic agent usage in Asian patients with depression. Method: Clinical data from the Research on Asian Psychotropic Prescription Patterns for Antidepressant study (1171 depressed patients) were used to determine gender differences by analysis of covariates for continuous variables and by logistic regression analysis for discrete variables. In addition, a binary logistic regression model was fitted to identify independent clinical correlates of the gender-specific pattern on psychotropic drug usage. Results: Men were more likely than women to have loss of interest (adjusted odds ratio=1.379, p=0.009), fatigue (adjusted odds ratio=1.298, p=0.033) and concurrent substance abuse (adjusted odds ratio=3.793, p=0.008), but gender differences in other symptom profiles and clinical features were not significant. Men were also more likely than women to be prescribed adjunctive therapy with a second-generation antipsychotic (adjusted odds ratio=1.320, p=0.044). However, men were less likely than women to have suicidal thoughts/acts (adjusted odds ratio=0.724, p=0.028). Binary logistic regression models revealed that lower age (odds ratio=0.986, p=0.027) and current hospitalization (odds ratio=3.348, p<0.0001) were independent clinical correlates of use of second-generation antipsychotics as adjunctive therapy for treating depressed Asian men. Conclusion: Unique gender-specific symptom profiles and gender-specific patterns of psychotropic drug usage can be identified in Asian patients with depression. Hence, ethnic and cultural influences on the gender preponderance of depression should be considered in the clinical psychiatry of Asian patients.	[Park, Seon-Cheol] Yong In Mental Hosp, Dept Psychiat, Yongin, South Korea; [Park, Seon-Cheol; Park, Yong Chon] Hanyang Univ, Inst Mental Hlth, Seoul 133791, South Korea; [Lee, Min-Soo] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea; [Shinfuku, Naotaka] Seinan Gakuin Univ, Sch Human Sci, Dept Social Welf, Fukuoka, Japan; [Sartorius, Norman] Assoc Improvement Mental Hlth Programs, Geneva, Switzerland; [Park, Yong Chon] Hanyang Univ, Coll Med, Dept Psychiat, Seoul 133791, South Korea; [Park, Yong Chon] Hanyang Univ, Guri Hosp, Dept Psychiat, Gyomun Dong 471701, Guri, South Korea	Park, YC (reprint author), Hanyang Univ, Guri Hosp, Dept Psychiat, 249-1 Gyomun dong, Gyomun Dong 471701, Guri, South Korea.	hypyc@hanyang.ac.kr					Alexandrino-Silva C, 2013, J AFFECT DISORDERS, V147, P355, DOI 10.1016/j.jad.2012.11.041; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Maier W, 1999, J AFFECT DISORDERS, V53, P241, DOI 10.1016/S0165-0327(98)00131-1; Marcus SM, 2008, COMPR PSYCHIAT, V49, P238, DOI 10.1016/j.comppsych.2007.06.012; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu; Yang SJ, 2011, PSYCHIAT RES, V189, P82, DOI 10.1016/j.psychres.2010.12.027; Uher R, 2012, PSYCHOL MED, V42, P967, DOI 10.1017/S0033291711001905; Azorin JM, 2014, J AFFECT DISORDERS, V167, P85, DOI 10.1016/j.jad.2014.05.058; Marcus SM, 2005, J AFFECT DISORDERS, V87, P141, DOI 10.1016/j.jad.2004.09.008; Canetto SS, 1998, SUICIDE LIFE-THREAT, V28, P1; Silverstein B, 2002, AM J PSYCHIAT, V159, P1051, DOI 10.1176/appi.ajp.159.6.1051; Faravelli C, 2013, PSYCHIAT RES, V210, P1301, DOI 10.1016/j.psychres.2013.09.027; Parker G, 2010, INT REV PSYCHIATR, V22, P429, DOI 10.3109/09540261.2010.492391; Park SC, 2014, J KOREAN MED SCI, V29, P719, DOI 10.3346/jkms.2014.29.5.719; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; Bastiampillai T, 2013, AUST NZ J PSYCHIAT, V47, P299, DOI 10.1177/0004867412471437; Jeon HJ, 2014, INT CLIN PSYCHOPHARM, V29, P150, DOI 10.1097/YIC.0000000000000019; Oquendo MA, 2013, J AFFECT DISORDERS, V150, P1179, DOI 10.1016/j.jad.2013.05.010; Bromberger JT, 2004, AM J PUBLIC HEALTH, V94, P1378, DOI 10.2105/AJPH.94.8.1378; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Bhugra D, 2007, TXB CULTURAL PSYCHIA, P141, DOI 10.1017/CBO9780511543609.013; Cole S, 2000, J CLIN EPIDEMIOL, V53, P59; FRANK E, 1988, AM J PSYCHIAT, V145, P41; Han CS, 2013, J MENT HEALTH, V22, P372, DOI 10.3109/09638237.2013.799265; Jacob JS, 2013, AUSTR NZ J PSYCHIAT, V47, P304; Kanazawa Asako, 2007, Cultur Divers Ethnic Minor Psychol, V13, P35, DOI 10.1037/1099-9809.13.1.35; Leach LS, 2008, J NERV MENT DIS, V196, P128, DOI 10.1097/NMD.0b013e318162aa63; National Institute for Health and Clinical Excellence, 2009, DEPR AD TREATM MAN D; Park SC, 2014, J KOREAN MED SCI, V29, P12, DOI 10.3346/jkms.2014.29.1.12; Park SC, 2013, PSYCHIAT INVEST, V10, P373, DOI 10.4306/pi.2013.10.4.373; Roger B, 2000, PSYCHOL MED, V30, P421; Salokangas RKR, 2002, J AFFECT DISORDERS, V68, P215, DOI 10.1016/S0165-0327(00)00315-3; Schuch JJJ, 2014, J AFFECT DISORDERS, V156, P156, DOI 10.1016/j.jad.2013.12.011; Shinfuku N, 2014, TAIWAN J PSYCHIAT TA, V28, P71; Sim K, 2007, BRIT J CLIN PHARMACO, V63, P431, DOI 10.1111/j.1365-2125.2006.02780.x; Van der Veen DC, 2014, INT PSYCHOGERIATR, V5, P1; Whiteford HA, 2010, LANCET, V382, P1575, DOI DOI 10.1016/S0140-6736(13)61611-6; Wilkowska-Chmielewska J, 2013, J AFFECT DISORDERS, V150, P142, DOI 10.1016/j.jad.2012.12.012; Won E, 2014, J KOREAN MED SCI, V29, P468, DOI 10.3346/jkms.2014.29.4.468; World Health Organization, 1992, ICD 10 CLASS MENT BE; Xiang YT, 2012, AUST NZ J PSYCHIAT, V46, P1159, DOI 10.1177/0004867412453625; Yip PSF, 2008, SUICIDE ASIA CAUSES; YOUNG MA, 1990, J NERV MENT DIS, V178, P200, DOI 10.1097/00005053-199003000-00008	44	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0004-8674	1440-1614		AUST NZ J PSYCHIAT	Aust. N. Z. J. Psych.	SEP	2015	49	9					833	841		10.1177/0004867415579464		9	Psychiatry	Psychiatry	CQ2FE	WOS:000360414000011		
J	Ogura, J; Kuwayama, K; Sasaki, S; Kaneko, C; Koizumi, T; Yabe, K; Tsujimoto, T; Takeno, R; Takaya, A; Kobayashi, M; Yamaguchi, H; Iseki, K				Ogura, Jiro; Kuwayama, Kaori; Sasaki, Shunichi; Kaneko, Chihiro; Koizumi, Takahiro; Yabe, Keisuke; Tsujimoto, Takashi; Takeno, Reiko; Takaya, Atsushi; Kobayashi, Masaki; Yamaguchi, Hiroaki; Iseki, Ken			Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen	BIOCHEMICAL PHARMACOLOGY			English	Article						Hyperuricemia; Aging; Reactive oxygen species; Breast cancer resistance protein; Uric acid excretion	ANION TRANSPORTING POLYPEPTIDES; OXIDATIVE STRESS; TISSUE DISTRIBUTION; URATE; RAT; BCRP/ABCG2; EFFLUX; CELLS; LIVER; GOUT	The prevalence of hyperuricemia/gout increases with aging. However, the effect of aging on function for excretion of uric acid to out of the body has not been clarified. We found that ileal uric acid clearance in middle-aged rats (11-12 months) was decreased compared with that in young rats (2 months). In middle-aged rats, xanthine oxidase (XO) activity in the ileum was significantly higher than that in young rats. Inosine-induced reactive oxygen species (ROS), which are derived from XO, also decreased ileal uric acid clearance. ROS derived from XO decreased the active homodimer level of breast cancer resistance protein (BCRP), which is a uric acid efflux transporter, in the ileum. Pre-administration of allopurinol recovered the BCRP homodimer level, resulting in the recovering ileal uric acid clearance. Moreover, we investigated the effects of ROS derived from XO on BCRP homodimer level directly in Caco-2 cells using hypoxanthine. Treatment with hypoxanthine decreased BCRP homodimer level. Treatment with hypoxanthine induced mitochondrial dysfunction, suggesting that the decreasing BCRP homodimer level might be caused by mitochondrial dysfunction. In conclusion, ROS derived from XO decrease BCRP homodimer level, resulting in suppression of function for uric acid excretion to the ileal lumen. ROS derived from XO may cause the suppression of function of the ileum for the excretion of uric acid with aging. The results of our study provide a new insight into the causes of increasing hyperuricemia/gout prevalence with aging. (C) 2015 Elsevier Inc. All rights reserved.	[Ogura, Jiro; Kuwayama, Kaori; Sasaki, Shunichi; Kaneko, Chihiro; Koizumi, Takahiro; Yabe, Keisuke; Tsujimoto, Takashi; Takeno, Reiko; Takaya, Atsushi; Kobayashi, Masaki; Yamaguchi, Hiroaki; Iseki, Ken] Hokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Lab Clin Pharmaceut &Therapeut,Kita Ku, Sapporo, Hokkaido 0600812, Japan	Iseki, K (reprint author), Hokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Lab Clin Pharmaceut &Therapeut,Kita Ku, Kita-12-Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	ken-i@pharm.hokudai.ac.jp	Ogura, Jiro/F-7260-2012; kobayashi, masaki /B-1638-2015	Ogura, Jiro/0000-0001-5139-137X; 	Japan Society for the Promotion of Science (JSPS) KAKENHI [22890003, 24700819, 26860352]	This work was in part supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers 22890003, 24700819 and 26860352.	Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Enomoto A, 2002, NATURE, V417, P447; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Nuss JE, 2008, BIOCHEM BIOPH RES CO, V365, P355, DOI 10.1016/j.bbrc.2007.10.194; Takada T, 2005, PHARM RES, V22, P458, DOI 10.1007/s11095-004-1884-9; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Anup R, 1999, SURGERY, V125, P560, DOI 10.1067/msy.1999.98045; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; Kage K, 2005, CANCER SCI, V96, P866, DOI 10.1111/j.1349-7006.2005.00126.x; Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X; Yang Y, 2007, P NATL ACAD SCI USA, V104, P10813, DOI 10.1073/pnas.0702027104; Litman T, 2002, BBA-BIOMEMBRANES, V1565, P6, DOI 10.1016/S0005-2736(02)00492-3; Tanaka Y, 2005, BIOCHEM BIOPH RES CO, V326, P181, DOI 10.1016/j.bbrc.2004.11.012; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Uchino H, 2000, BIOCHEM BIOPH RES CO, V270, P254, DOI 10.1006/bbrc.2000.2407; Cencioni C, 2013, INT J MOL SCI, V14, P17643, DOI 10.3390/ijms140917643; Aranda R, 2007, FREE RADICAL RES, V41, P1195, DOI 10.1080/10715760701481461; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BOSS GR, 1979, NEW ENGL J MED, V300, P1459, DOI 10.1056/NEJM197906283002604; DAVIES KJA, 1986, BIOCHEM J, V235, P747; Hayashi M, 1997, ADV DRUG DELIVER REV, V28, P191, DOI 10.1016/S0169-409X(97)00072-0; Hayashi M, 2007, DRUG METAB PHARMACOK, V22, P67, DOI 10.2133/dmpk.22.67; Hosomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030456; HUH K, 1976, JPN J PHARMACOL, V26, P719, DOI 10.1254/jjp.26.719; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Iharada M, 2010, J BIOL CHEM, V285, P26107, DOI 10.1074/jbc.M110.122721; Kaster MP, 2013, PURINERG SIGNAL, V9, P481, DOI 10.1007/s11302-013-9361-8; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lapa FD, 2013, PURINERG SIGNAL, V9, P325, DOI 10.1007/s11302-013-9351-x; Maruyama H, 2013, J PHARM PHARM SCI, V16, P722; Matsuo H., 2009, SCI TRANSL MED, V1; MORIN LG, 1974, CLIN CHEM, V20, P51; Newaz MA, 2006, J CARDIOVASC PHARM, V48, P88, DOI 10.1097/01.fjc.0000245402.62864.0a; Ogura J, 2012, J PHARM PHARM SCI, V15, P295; OSADA Y, 1993, EUR J PHARMACOL, V241, P183, DOI 10.1016/0014-2999(93)90201-R; RADI R, 1990, FREE RADICAL BIO MED, V8, P121, DOI 10.1016/0891-5849(90)90084-V; SORENSEN LEIF B., 1965, ARTHRITIS RHEUM, V8, P694, DOI 10.1002/art.1780080429; STIRPE F, 1965, BIOCHEM J, V94, P309; Takahashi N, 2014, BIOL PHARM BULL, V37, P490; Tsujimoto T, 2013, INT J PHARMACEUT, V458, P262, DOI 10.1016/j.ijpharm.2013.10.013; Vida C, 2011, BIOGERONTOLOGY, V12, P551, DOI 10.1007/s10522-011-9351-6; Yano H, 2014, CLIN EXP NEPHROL, V18, P50, DOI 10.1007/s10157-013-0806-8	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	SEP 1	2015	97	1					89	98		10.1016/j.bcp.2015.06.021		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ2IH	WOS:000360422900008		
J	Maruyama, IN				Maruyama, Ichiro N.			Activation of transmembrane cell-surface receptors via a common mechanism? The "rotation model''	BIOESSAYS			English	Article						cytokine; dimerization; ligand binding; preformed dimer; transmembrane signaling; tyrosine kinase	EPIDERMAL-GROWTH-FACTOR; NATRIURETIC-PEPTIDE RECEPTOR; GREEN FLUORESCENT PROTEIN; INSULIN-RECEPTOR; HORMONE RECEPTOR; LIGAND-BINDING; ASPARTATE RECEPTOR; TYROSINE KINASE; ERYTHROPOIETIN RECEPTOR; EGF RECEPTOR	It has long been thought that transmembrane cell-surface receptors, such as receptor tyrosine kinases and cytokine receptors, among others, are activated by ligand binding through ligand-induced dimerization of the receptors. However, there is growing evidence that prior to ligand binding, various transmembrane receptors have a preformed, yet inactive, dimeric structure on the cell surface. Various studies also demonstrate that during transmembrane signaling, ligand binding to the extracellular domain of receptor dimers induces a rotation of transmembrane domains, followed by rearrangement and/or activation of intracellular domains. The paper here describes transmembrane cell-surface receptors that are known or proposed to exist in dimeric form prior to ligand binding, and discusses how these preformed dimers are activated by ligand binding.	Grad Univ, Okinawa Inst Sci & Technol, Onna, Okinawa, Japan	Maruyama, IN (reprint author), Grad Univ, Okinawa Inst Sci & Technol, Onna, Okinawa, Japan.	ichi@oist.jp			Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan	The author is grateful to Charlotte Fournier and Takashi Yonetani for their invaluable comments on the paper, and Hitomi Ohtaki for assisting in drawing the figure. I also thank my laboratory members for their critical reading of the paper. This work was partly supported by funding to the Information Processing Biology Unit from the Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan.	Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Murayama T, 2013, CURR BIOL, V23, P1007, DOI 10.1016/j.cub.2013.04.052; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Peelman F, 2014, J ENDOCRINOL, V223, pT9, DOI 10.1530/JOE-14-0264; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Ferris HU, 2014, J STRUCT BIOL, V186, P349, DOI 10.1016/j.jsb.2014.03.015; CHUA AO, 1994, J IMMUNOL, V153, P128; Ross RJM, 2001, J CLIN ENDOCR METAB, V86, P1716, DOI 10.1210/jc.86.4.1716; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Kim SH, 2002, P NATL ACAD SCI USA, V99, P11611, DOI 10.1073/pnas.132376499; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Manni S, 2014, STRUCTURE, V22, P1077, DOI 10.1016/j.str.2014.05.010; Schuster B, 2003, FEBS LETT, V538, P113, DOI 10.1016/S0014-5793(03)00154-6; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Puimege L, 2014, CYTOKINE GROWTH F R, V25, P285, DOI 10.1016/j.cytogfr.2014.03.004; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; De Meyts P, 2015, BIOESSAYS, V37, P389, DOI 10.1002/bies.201400190; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Deyev IE, 2011, CELL METAB, V13, P679, DOI 10.1016/j.cmet.2011.03.022; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Garbers C, 2015, CURR OPIN IMMUNOL, V34, P75, DOI 10.1016/j.coi.2015.02.008; Biener E, 2005, BIOL CELL, V97, P905; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; COCHET C, 1988, J BIOL CHEM, V263, P3290; Bush JO, 2012, SEMIN CELL DEV BIOL, V23, P26, DOI 10.1016/j.semcdb.2011.10.018; Munshi S, 2002, J BIOL CHEM, V277, P38797, DOI 10.1074/jbc.M205580200; Bocharov EV, 2010, BIOPHYS J, V98, P881, DOI 10.1016/j.bpj.2009.11.008; BALLOTTI R, 1989, EMBO J, V8, P3303; Bocharov EV, 2008, J BIOL CHEM, V283, P29385, DOI 10.1074/jbc.M803089200; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Brooks AJ, 2008, INT J BIOCHEM CELL B, V40, P1984, DOI 10.1016/j.biocel.2007.07.008; Burke CL, 1998, MOL CELL BIOL, V18, P5371; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4493, DOI 10.1021/bi00133a016; Chavent M, 2014, BIOCHEMISTRY-US, V53, P6641, DOI 10.1021/bi500800x; Cobret L, 2015, BRIT J PHARMACOL, V172, P841, DOI 10.1111/bph.12945; Dietz MS, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-6; Endres NF, 2014, TRENDS BIOCHEM SCI, V39, P437, DOI 10.1016/j.tibs.2014.08.001; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006.0114; Harapin J, 2013, STRUCTURE, V21, P1522, DOI 10.1016/j.str.2013.08.003; Kavran J. M., 2014, ELIFE, V3, P3, DOI DOI 10.7554/ELIFE.03772; Khorchid A, 2005, BIOCHEM J, V385, P255; Langer JA, 2004, CYTOKINE GROWTH F R, V15, P33, DOI 10.1016/j.cytogfr.2003.10.001; Lee J, 2014, J BIOL CHEM, V289, P19769, DOI 10.1074/jbc.M114.578641; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; Liongue C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-120; Ma Xiaoxiao, 2011, Front Biosci (Elite Ed), V3, P22, DOI 10.2741/e216; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Maruyama Ichiro N, 2014, Cells, V3, P304, DOI 10.3390/cells3020304; MARUYAMA IN, 1995, J MOL BIOL, V253, P530, DOI 10.1006/jmbi.1995.0571; MASSAGUE J, 1980, P NATL ACAD SCI-BIOL, V77, P7137, DOI 10.1073/pnas.77.12.7137; Matthews EE, 2011, FASEB J, V25, P2234, DOI 10.1096/fj.10-178673; MILLIGAN DL, 1988, J BIOL CHEM, V263, P6268; MOE GR, 1989, P NATL ACAD SCI USA, V86, P5683, DOI 10.1073/pnas.86.15.5683; Moscatello DK, 1996, ONCOGENE, V13, P85; MOXHAM CP, 1989, J BIOL CHEM, V264, P13238; Nakashima K, 1997, FEBS LETT, V403, P79, DOI 10.1016/S0014-5793(97)00013-6; Parat M, 2010, BIOCHEMISTRY-US, V49, P4601, DOI 10.1021/bi901711w; Poger D, 2010, PROTEINS, V78, P1163, DOI [10.1002/prot.22636, 10.1002/prot.22630]; Renteria ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003667; RIEDEL H, 1986, NATURE, V324, P68, DOI 10.1038/324068a0; RIEDEL H, 1989, EMBO J, V8, P2943; Sarabipour S, 2013, BIOPHYS J, V105, P165, DOI 10.1016/j.bpj.2013.05.053; Sharonov GV, 2014, J BIOL CHEM, V289, P14955, DOI 10.1074/jbc.M114.558783; Shen Jianying, 2012, J Mol Signal, V7, P2, DOI 10.1186/1750-2187-7-2; Shen JY, 2011, FEBS LETT, V585, P295, DOI 10.1016/j.febslet.2010.12.031; SOOS MA, 1989, BIOCHEM J, V263, P553; Whitten AE, 2009, J MOL BIOL, V394, P878, DOI 10.1016/j.jmb.2009.10.011; ZHANG B, 1992, J BIOL CHEM, V267, P18320	102	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0265-9247	1521-1878		BIOESSAYS	Bioessays	SEP	2015	37	9					959	967		10.1002/bies.201500041		9	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	CQ0VI	WOS:000360315400009		
J	Konuma, T; Takahashi, S; Uchida, N; Kuwatsuka, Y; Yamasaki, S; Aoki, J; Onishi, Y; Aotsuka, N; Ohashi, K; Mori, T; Masuko, M; Nakamae, H; Miyamura, K; Kato, K; Atsuta, Y; Kato, S; Asano, S; Takami, A; Miyazaki, Y				Konuma, Takaaki; Takahashi, Satoshi; Uchida, Naoyuki; Kuwatsuka, Yachiyo; Yamasaki, Satoshi; Aoki, Jun; Onishi, Yasushi; Aotsuka, Nobuyuki; Ohashi, Kazuteru; Mori, Takehiko; Masuko, Masayoshi; Nakamae, Hirohisa; Miyamura, Kouichi; Kato, Koji; Atsuta, Yoshiko; Kato, Seiko; Asano, Shigetaka; Takami, Akiyoshi; Miyazaki, Yasushi		Japan Soc Hematopoietic Cell	Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Granulocyte colony-stimulating factor; Conditioning regimen; Cord blood transplantation; Myelodysplastic syndrome; Secondary acute myeloid leukemia	STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CYTARABINE; TOTAL-BODY IRRADIATION; UNRELATED DONORS; ADULT PATIENTS; HEMATOLOGIC MALIGNANCIES; INDUCTION CHEMOTHERAPY; GROWTH-FACTORS; REGIMEN	Granulocyte colony stimulating factor (G-CSF) increases the susceptibility of dormant malignant or nonmalignant hematopoietic cells to cytarabine arabinoside (Ara-C) through the induction of cell cycle entry. Therefore, G-CSF combined conditioning before allogeneic stem cell transplantation might positively contribute to decreased incidences of relapse and graft failure without having to increase the dose of cytotoxic drugs. We conducted a retrospective nationwide study of 336 adult patients with myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia (sAML) after single-unit cord blood transplantation (CBT) who underwent 4 different kinds of conditioning regimens: total body irradiation (TBI) >= 8 Gy + Ara-C/G-CSF + cyclophosphamide (CY) (n = 65), TBI >= 8 Gy + Ara-C + CY (n = 119), TBI >= 8 Gy +other (n = 104), or TBI < 8 Gy or non-TBI (n = 48). The TBI >= 8 Gy + Ara-C/G-CSF + CY regimen showed significantly higher incidence of neutrophil engraftment (hazard ratio, 1.52; 95% confidence interval [CI], 1.10 to 2.08; P = .009) and lower overall mortality (hazard ratio, .46; 95% CI, .26 to .82; P = .008) rates compared with those without a G-CSF regimen. This retrospective study shows that the G-CSF combined conditioning regimen provides better engraftment and survival results. in CBT for adults with MDS and sAML. (C) 2015 American Society for Blood and Marrow Transplantation.	[Konuma, Takaaki; Kato, Seiko] Univ Tokyo, Inst Med Sci, Dept Hematol & Oncol, Tokyo 1088639, Japan; [Takahashi, Satoshi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Mol Therapy, Tokyo 1088639, Japan; [Uchida, Naoyuki] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Kuwatsuka, Yachiyo] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Yamasaki, Satoshi] Natl Hosp Org, Kyushu Med Ctr, Dept Hematol, Fukuoka, Japan; [Yamasaki, Satoshi] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Fukuoka, Japan; [Aoki, Jun] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2410815, Japan; [Onishi, Yasushi] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan; [Aotsuka, Nobuyuki] Japanese Red Cross Soc, Narita Hosp, Div Hematol Oncol, Narita, Japan; [Ohashi, Kazuteru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Mori, Takehiko] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan; [Masuko, Masayoshi] Niigata Univ, Med & Dent Hosp, Div Stem Cell Transplantat, Niigata, Japan; [Nakamae, Hirohisa] Osaka City Univ, Grad Sch Med, Hematol, Osaka 558, Japan; [Miyamura, Kouichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Asano, Shigetaka] Waseda Univ, Sch Adv Sci & Engn, Syst Med Biol Lab, Tokyo, Japan; [Takami, Akiyoshi] Aichi Med Univ, Dept Internal Med, Div Hematol, Nagakute, Aichi, Japan; [Miyazaki, Yasushi] Nagasaki Univ, Atom Bomb Dis Inst, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, Nagasaki 852, Japan	Konuma, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tkonuma@ims.u-tokyo.ac.jp			Chugai Pharmaceuticals	Financial disclosure: S.T. received research grants and honoraria from Chugai Pharmaceuticals. The other authors declare no competing financial interests.	Inamoto Y, 2007, BONE MARROW TRANSPL, V39, P25, DOI 10.1038/sj.bmt.1705543; Pabst T, 2012, BLOOD, V119, P5367, DOI 10.1182/blood-2011-11-389841; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; Malcovati L, 2013, BLOOD, V122, P2943, DOI 10.1182/blood-2013-03-492884; Nakai K, 2005, LEUKEMIA, V19, P396, DOI 10.1038/sj.leu.2403640; Anderson JE, 1997, BLOOD, V89, P2578; Sato A, 2011, BONE MARROW TRANSPL, V46, P257, DOI 10.1038/bmt.2010.91; Konuma T, 2015, LEUKEMIA RES, V39, P625, DOI 10.1016/j.leukres.2015.03.022; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Alessandrino EP, 2013, J CLIN ONCOL, V31, P2761, DOI 10.1200/JCO.2012.48.0525; RIDDELL S, 1988, J CLIN ONCOL, V6, P576; Kanda Y, 2005, BIOL BLOOD MARROW TR, V11, P881, DOI 10.1016/j.bbmt.2005.07.005; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Greenberg P, 1997, BLOOD, V89, P2079; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Mengarelli A, 2002, HAEMATOLOGICA, V87, P52; Ades L, 2014, LANCET, V383, P2239, DOI 10.1016/S0140-6736(13)61901-7; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Atsuta Y, 2013, HAEMATOLOGICA, V98, P814, DOI 10.3324/haematol.2012.076042; Barese C, 2007, STEM CELLS, V25, P1578, DOI 10.1634/stemcells.2006.0808; Buchner T, 2004, NEW ENGL J MED, V350, P2215, DOI 10.1056/NEJM200405203502124; Gao L, 2014, BIOL BLOOD MARROW TR, V20, P1932, DOI [10.1016/j.bbmt.2014.08.001, 10.1016/j.bbmt2014.08.001]; Heuser M, 2011, ANN HEMATOL, V90, P273, DOI 10.1007/s00277-010-1069-z; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Konuma T, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2014.114504; Mardiney M, 1996, BLOOD, V87, P4049; MIYAUCHI J, 1989, BLOOD, V73, P1272; Mori T, 2007, BONE MARROW TRANSPL, V39, P217, DOI 10.1038/sj.bmt.1705578; Okamoto S, 1999, BRIT J HAEMATOL, V104, P569, DOI 10.1046/j.1365-2141.1999.01205.x; Robin M, 2011, LEUKEMIA, V25, P75, DOI 10.1038/leu.2010.219; Scott BL, 2005, BIOL BLOOD MARROW TR, V11, P65, DOI 10.1016/j.bbmt.2004.10.001; Takahashi S, 1998, AM J HEMATOL, V57, P303, DOI 10.1002/(SICI)1096-8652(199804)57:4<303::AID-AJH6>3.0.CO;2-Y; TAKAHASHI S, 1994, BONE MARROW TRANSPL, V13, P239; Wei GQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-46	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	SEP	2015	21	9					1632	1640		10.1016/j.bbmt.2015.05.009		9	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CQ0AB	WOS:000360255900015		
J	Sugita, J; Kawashima, N; Fujisaki, T; Kakihana, K; Ota, S; Matsuo, K; Miyamoto, T; Akashi, K; Taniguchi, S; Harada, M; Teshima, T				Sugita, Junichi; Kawashima, Naomi; Fujisaki, Tomoaki; Kakihana, Kazuhiko; Ota, Shuichi; Matsuo, Keitaro; Miyamoto, Toshihiro; Akashi, Koichi; Taniguchi, Shuichi; Harada, Mine; Teshima, Takanori		Japan Study Grp Cell Therapy	HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						HLA-haploidentical transplantation; Post-transplant cyclophosphamide; Reduced-intensity conditioning; Busulfan	BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; TOTAL-BODY IRRADIATION; HEMATOLOGIC MALIGNANCIES; ACUTE GVHD; ACUTE-LEUKEMIA; RISK; SURVIVAL; OUTCOMES; DONORS	Allogeneic hematopoietic stem cell transplantation (allo-SCT) using post-transplant cyclophosphamide (PTCy) is increasingly performed. We conducted a multicenter phase II study to evaluate the safety and efficacy of PTCy-based HLA-haploidentical peripheral blood stem cell transplantation (PTCy-haploPBSCT) after busulfan-containing reduced-intensity conditioning. Thirty-one patients were enrolled; 61% patients were not in remission and 42% patients had a history of prior allo-SCT Neutrophil engraftment was achieved in 87% patients with a median of 19 days. The cumulative incidence of grades II to IV and III to IV acute graft-versus-host disease (GVHD) and chronic GVHD at 1 year were 23%, 3%, and 15%, respectively. No patients developed severe chronic GVHD. Day 100 nonrelapse mortality (NRM) rate was 19.4%. Overall survival, relapse, and disease-free survival rates were 45%, 45%, and 34%, respectively, at 1 year. Subgroup analysis showed that patients who had a history of prior allo-SCT had lower engraftment, higher NRM, and lower overall survival than those not receiving a prior allo-SCT. Our results suggest that PTCy-haploPBSCT after busulfan-containing reduced-intensity conditioning achieved low incidences of acute and chronic GVHD and NRM and stable donor engraftment and low NRM, particularly in patients without a history of prior allo-SCT. (C) 2015 American Society for Blood and Marrow Transplantation.	[Sugita, Junichi; Teshima, Takanori] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido 0608638, Japan; [Kawashima, Naomi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Fujisaki, Tomoaki] Matsuyama Red Cross Hosp, Dept Hematol, Matsuyama, Ehime, Japan; [Kakihana, Kazuhiko] Komagome Hosp, Div Hematol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Ota, Shuichi] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Miyamoto, Toshihiro; Akashi, Koichi] Kyushu Univ Hosp, Dept Hematol Oncol, Fukuoka 812, Japan; [Taniguchi, Shuichi] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Harada, Mine] Karatsu Higashimatsuura Med Ctr, Karatsu, Japan	Teshima, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Hematol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	teshima@med.hokudai.ac.jp			Regional Medicine Research Foundation (Tochigi, Japan); North Japan Hematology Study Group; Japan Agency for Medical Research and Development (AMED) [15Aek0510012h0001]	Financial disclosure: Supported by grants from Regional Medicine Research Foundation (Tochigi, Japan), North Japan Hematology Study Group, and the Japan Agency for Medical Research and Development (AMED, 15Aek0510012h0001).	Al-Homsi AS, 2015, BIOL BLOOD MARROW TR, V21, P604, DOI 10.1016/j.bbmt.2014.08.014; al-Jurf M, 2005, J CLIN ONCOL, V23, P5074, DOI 10.1200/JCO.2005.09.020; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Colvin GA, 2009, BIOL BLOOD MARROW TR, V15, P421, DOI 10.1016/j.bbmt.2008.12.503; Castagna L, 2014, BIOL BLOOD MARROW TR, V20, P724, DOI 10.1016/j.bbmt.2014.02.001; Ross D, 2013, BIOL BLOOD MARROW TR, V19, P1430, DOI 10.1016/j.bbmt.2013.06.019; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Kasamon YL, 2010, BIOL BLOOD MARROW TR, V16, P482, DOI 10.1016/j.bbmt.2009.11.011; ANASETTI C, 1990, HUM IMMUNOL, V29, P79, DOI 10.1016/0198-8859(90)90071-V; Roberto A, 2015, BLOOD, V125, P2855, DOI 10.1182/blood-2014-11-608406; Raiola AM, 2013, BIOL BLOOD MARROW TR, V19, P117, DOI 10.1016/j.bbmt.2012.08.014; POWLES RL, 1983, LANCET, V1, P612; McCurdy SR, 2015, BLOOD, V125, P3024, DOI 10.1182/blood-2015-01-623991; Mielcarek M, 2012, BLOOD, V119, P2675, DOI 10.1182/blood-2011-12-396275; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; Luznik L, 2002, BIOL BLOOD MARROW TR, V8, P131, DOI 10.1053/bbmt.2002.v8.pm11939602; NOMOTO K, 1992, J IMMUNOL, V149, P2668; Bashey A, 2013, J CLIN ONCOL, V31, P1310, DOI 10.1200/JCO.2012.44.3523; Luznik L, 2001, BLOOD, V98, P3456, DOI 10.1182/blood.V98.12.3456; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; BERENBAUM MC, 1963, NATURE, V200, P84, DOI 10.1038/200084a0; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Armand P, 2014, BLOOD, V123, P3664, DOI 10.1182/blood-2014-01-552984; Aversa F, 2008, BLOOD CELL MOL DIS, V40, P8, DOI 10.1016/j.bcmd.2007.07.004; BEATTY PG, 1985, NEW ENGL J MED, V313, P765, DOI 10.1056/NEJM198509263131301; Bhamidipati PK, 2014, BONE MARROW TRANSPL, V49, P1124, DOI 10.1038/bmt.2014.108; Jagasia M, 2012, BLOOD, V119, P296, DOI 10.1182/blood-2011-06-364265; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Munchel Ashley, 2011, Pediatr Rep, V3 Suppl 2, pe15, DOI 10.4081/pr.2011.s2.e15; Munchel AT, 2011, BEST PRACT RES CL HA, V24, P359, DOI 10.1016/j.beha.2011.05.001; Nakasone H, 2015, BONE MARROW TRANSPL, V50, P559, DOI 10.1038/bmt.2014.293; O'Donnell P, 2015, BIOL BLOOD MARROW TR, V21, P197, DOI 10.1016/j.bbmt.2014.10.008; Raj Kavita, 2014, Biol Blood Marrow Transplant, V20, P890, DOI 10.1016/j.bbmt.2014.03.003; Reagan JL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-150; Solomon SR, 2012, BIOL BLOOD MARROW TR, V18, P1859, DOI 10.1016/j.bbmt.2012.06.019	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	SEP	2015	21	9					1646	1652		10.1016/j.bbmt.2015.06.008		7	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CQ0AB	WOS:000360255900017		
J	Sun, YC; Chai, XY; Inamoto, Y; Pidala, J; Martin, PJ; Flowers, MED; Shen, TT; Lee, SJ; Jagasia, M				Sun, Yi-Chen; Chai, Xiaoyu; Inamoto, Yoshihiro; Pidala, Joseph; Martin, Paul J.; Flowers, Mary E. D.; Shen, Tueng T.; Lee, Stephanie J.; Jagasia, Madan			Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Ocular graft-versus-host disease; Quality of life; Risk factors	STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; DRY EYE; FUNCTIONAL ASSESSMENT; CHRONIC GVHD; VALIDATION; SCALE; CRITERIA; QUESTIONNAIRE; ASSOCIATION	Ocular involvement can be quite symptomatic in patients with chronic graft-versus-host disease (GVHD). The prevalence of and risk factors for ocular GVHD and its impact on quality of life (QOL) in patients with chronic GVHD were studied in a prospective, multicenter, longitudinal, observational study. This study enrolled 342 patients with 1483 follow-up visits after allogeneic hematopoietic cell transplantation. All patients in this analysis were diagnosed with chronic GVHD requiring systemic treatment and enrolled within 3 months of chronic GVHD diagnosis. The symptom burden of ocular GVHD was based on the degree of dry eye symptoms, frequency of artificial tear usage, and impact on activities of daily living. Patients' QOL was measured by self-administered questionnaires. Variables associated with ocular GVHD at enrollment and subsequent new-onset ocular GVHD and the associations with QOL were studied. Of the 284 chronic GVHD patients, 116 (41%) had ocular GVHD within 3 months of chronic GVHD diagnosis ("early ocular GVHD"). Late ocular GVHD (new onset > 3 months after chronic GVHD diagnosis) occurred in 64 patients. Overall cumulative incidence at 2 years was 57%. Female gender (P = .005), higher acute GVHD grade (P = .04), and higher prednisone dose at study entry (P = .04) were associated with early ocular GVHD. For patients who did not have ocular GVHD within 3 months of chronic GVHD diagnosis, presence of prior grades I to IV acute GVHD (HR 1.78, P = .04) was associated with shorter time to late ocular GVHD, whereas female donor male recipient (HR .53, P = .05) was associated with longer time to late ocular GVHD onset. Using all visit data, patients with ocular GVHD had worse QOL, as measured by Functional Assessment of Cancer Therapy Bone Marrow Transplantation (P = .002), and greater chronic GVHD symptom burden, as measured by the Lee symptom overall score excluding the eye component (P < .001), compared with patients without ocular GVHD. In conclusion, this large, multicenter, prospective study shows that ocular GVHD affects 57% of patients within 2 years of chronic GVHD diagnosis. Women, patients on higher doses of prednisone at study entry, and those with a history of acute GVHD were at higher risk for ocular GVHD. Strong evidence suggests that ocular GVHD is associated with worse overall health-related QOL. (C) 2015 American Society for Blood and Marrow Transplantation.	[Sun, Yi-Chen; Shen, Tueng T.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Sun, Yi-Chen] Taipei Tzu Chi Hosp, Dept Ophthalmol, Buddhist Tzu Chi Med Fdn, New Taipei City, Taiwan; [Chai, Xiaoyu; Inamoto, Yoshihiro; Martin, Paul J.; Flowers, Mary E. D.; Lee, Stephanie J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Inamoto, Yoshihiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Pidala, Joseph] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Blood & Marrow Transplantat, Tampa, FL 33682 USA; [Jagasia, Madan] Vanderbilt Univ, Dept Med, Div Hematol Oncol, Stem Cell Transplantat, Nashville, TN 37232 USA	Jagasia, M (reprint author), Vanderbilt Univ, Dept Med, Div Hematol Oncol, Stem Cell Transplantat, 3973 TVC,2220 Pierce Ave,777 PRB, Nashville, TN 37232 USA.	madan.jagasia@vanderbilt.edu			NIH [CA118953, CA163438]; NIH Office of Rare Diseases Research at the National Center for Advancing Translational Science, the National Cancer Institute [U54 CA163438]; FHCRC [U54 CA163438]	Financial disclosure: This work was supported by NIH grants CA118953 and CA163438. The Chronic GVHD Consortium (U54 CA163438) is a part of the NIH Rare Diseases Clinical Research Network, supported through collaboration between the NIH Office of Rare Diseases Research at the National Center for Advancing Translational Science, the National Cancer Institute, and the FHCRC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding organization had no role in the design or conduct of this research.	Inamoto Y, 2012, OPHTHALMOLOGY, V119, P487, DOI 10.1016/j.ophtha.2011.08.040; Pallua S, 2010, BONE MARROW TRANSPL, V45, P1534, DOI 10.1038/bmt.2010.5; [Anonymous], 2007, OCUL SURF, V52, P93; Gratwohl A, 2004, ANN ONCOL, V15, P653, DOI 10.1093/annonc/mdh142; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; McQuellon RP, 1997, BONE MARROW TRANSPL, V19, P357, DOI 10.1038/sj.bmt.1700672; Lee SY, 2003, J IND ENG CHEM, V9, P9; Ogawa Y, 2003, CORNEA, V22, pS19, DOI 10.1097/00003226-200310001-00004; Pidala J, 2011, BLOOD, V117, P4651, DOI 10.1182/blood-2010-11-319509; CELLA DF, 1993, J CLIN ONCOL, V11, P570; Uchino M, 2012, BRIT J OPHTHALMOL, V96, P34, DOI 10.1136/bjophthalmol-2011-300514; Riemens A, 2014, ACTA OPHTHALMOL, V92, P82, DOI 10.1111/aos.12047; DAUGHTON DM, 1982, ARCH PHYS MED REHAB, V63, P620; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Malta JB, 2010, CORNEA, V29, P1392, DOI 10.1097/ICO.0b013e3181e456f0; Bellanti JA, 2014, ALLERGY ASTHMA PROC, V35, P195, DOI 10.2500/aap.2014.34.3763; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Lee SJ, 2002, BIOL BLOOD MARROW TR, V8, P444, DOI 10.1053/bbmt.2002.v8.pm12234170; Tabbara KF, 2009, OPHTHALMOLOGY, V116, P1624, DOI 10.1016/j.ophtha.2009.04.054; Lee SJ, 2006, BONE MARROW TRANSPL, V38, P305, DOI 10.1038/sj.bmt.1705434; Westeneng AC, 2010, CORNEA, V29, P758, DOI 10.1097/ICO.0b013e3181ca321c; Jacobs R, 2012, BONE MARROW TRANSPL, V47, P1470, DOI 10.1038/bmt.2012.56; Appelbaum FR, 2009, THOMAS HEMATOPOIETIC, V4th, P705; Aydin Kurna S, 2014, J OPHTHALMOLOGY, V2014; Chronic GC, 2011, BIOL BLOOD MARROW TR, V17, P1114; FELDMAN F, 1979, CAN J OPHTHALMOL, V14, P257; Herzberg PY, 2010, BIOL BLOOD MARROW TR, V16, P1707, DOI 10.1016/j.bbmt.2010.05.018; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P1343; Li YM, 2014, OPTOMETRY VISION SCI, V91, P278, DOI 10.1097/OPX.0000000000000156; Ogawa Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03419; Rojas B, 2005, EXP EYE RES, V81, P313, DOI 10.1016/j.exer.2005.02.004; Schipper H., 1996, QUALITY LIFE PHARMAC, P11; Tetematsu Y, 2014, SCI REP, V4, P6680; Ware J. E., 1993, SF 36 HLTH SURVEY MA; Ware Jr JE, 1994, SF 36 PHYS MENTAL HL	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	SEP	2015	21	9					1687	1691		10.1016/j.bbmt.2015.05.020		7	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CQ0AB	WOS:000360255900021		
J	Sakurai, K; Ozawa, S; Yamaguchi, T				Sakurai, Kaori; Ozawa, Shimpei; Yamaguchi, Tamayo			Photoaffinity labeling studies of the carbohydrate-binding proteins with different affinities	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Photoaffinity labeling; Photoaffinity probes; Carbohydrate-binding proteins; Carbohydrate-protein interaction; Lectin	TARGET IDENTIFICATION; PROBES; METALLOPROTEASES; MOLECULES; PEPTIDES; LECTIN	Photoaffinity labeling has been used as a promising approach to detection and isolation of carbohydrate-binding proteins, which are typically characterized by low binding affinity and selectivity. When there are several specific binding proteins, it is desirable that a photoaffinity probe is capable of simultaneously crosslinking them and that the crosslinking yields depend on the relative binding affinities. In this study, we describe the design and synthesis of carbohydrate photoaffinity probes and their ability to capture lectins of different binding affinities. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakurai, Kaori; Ozawa, Shimpei; Yamaguchi, Tamayo] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan	Sakurai, K (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Naka Cho 2-24-16, Koganei, Tokyo 1848588, Japan.	sakuraik@cc.tuat.ac.jp			Human Frontier Science Program Foundation; Ajinomoto Scholarship	This work was partly funded by the young investigator Grant from the Human Frontier Science Program Foundation. S.O. was supported by Ajinomoto Scholarship.	Sharma S, 1998, BIOCHEM J, V333, P539; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Hashimoto M, 2008, EUR J ORG CHEM, P2513, DOI 10.1002/ejoc.200701069; Tanaka Y, 2008, MOL BIOSYST, V4, P473, DOI 10.1039/b803218a; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; David A, 2007, ANGEW CHEM INT EDIT, V46, P3275, DOI 10.1002/anie.200604408; Yu SH, 2012, J CARBOHYD CHEM, V31, P325, DOI 10.1080/07328303.2012.676118; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Ziegler S, 2013, ANGEW CHEM INT EDIT, V52, P2744, DOI 10.1002/anie.201208749; Kawatani M, 2014, MEDCHEMCOMM, V5, P277, DOI 10.1039/c3md00276d; Sakurai K, 2014, CHEMBIOCHEM, V15, P1399, DOI 10.1002/cbic.201402051; Bond R. M., 2011, BIOCONJUGATE CHEM, V22, P1811; Cagnoni A. J., 2013, EUR J ORG CHEM, V5, P972; Chan EWS, 2004, J AM CHEM SOC, V126, P14435, DOI 10.1021/ja047044i; Deseke E, 1998, EUR J ORG CHEM, P243; Geurink P. P., 2011, TOP CURR CHEM, V324, P85; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; ONEIL KT, 1989, PROTEINS, V6, P284, DOI 10.1002/prot.340060311; Sakurai K, 2015, ASIAN J ORG CHEM, V4, P116, DOI 10.1002/ajoc.201402209; SIGRIST H, 1990, J PHOTOCH PHOTOBIO B, V7, P277, DOI 10.1016/1011-1344(90)85162-P; Surolia A, 1996, J BIOL CHEM, V271, P17697; Wiegand M, 2006, EUR J ORG CHEM, P4841, DOI 10.1002/ejoc.200600449	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5319	5325		10.1016/j.bmc.2015.07.065		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900008		
J	Sasahara, K; Mashima, A; Yoshida, T; Chuman, H				Sasahara, Katsunori; Mashima, Akira; Yoshida, Tatsusada; Chuman, Hiroshi			Molecular dynamics and density functional studies on the metabolic selectivity of antipsychotic thioridazine by cytochrome P450 2D6: Connection with crystallographic and metabolic results	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Activation energy (E-a); Binding orientation; Compound I (Cpd I); Crystallographic structure; Cytochrome P450 2D6 (CYP2D6); Density functional theory (DFT); Mesoridazine; Molecular dynamics (MD); Sites of metabolism (SOM); Sulforidazine; Thioridazine (THD); Transition state (TS)	RESP MODEL; OXIDATION; MECHANISM; BINDING; SUBSTRATE; ENZYMES; P450; MONOOXYGENASE; CARBAMAZEPINE; HYDROXYLATION	CYP2D6, a cytochrome P450 isoform, significantly contributes to the metabolism of many clinically important drugs. Thioridazine (THD) is one of the phenothiazine-type antipsychotics, which exhibit dopamine D-2 antagonistic activity. THD shows characteristic metabolic profiles compared to other phenothiazine-type antipsychotics such as chlorpromazine. The sulfur atom attached to the phenothiazine ring is preferentially oxidized mainly by CYP2D6, that is, the 2-sulfoxide is a major metabolite, and interestingly this metabolite shows more potent activity against dopamine D-2 receptors than THD. On the other hand, the formation of this metabolite causes many serious problems for its clinical use. Wojcikowski et al. (Drug Metab. Dispos. 2006, 34, 471) reported a kinetic study of THD formed by CYP2D6. Recently, Wang et al. (J. Biol. Chem. 2012, 287, 10834 and J. Biol. Chem. 2015, 290, 5092) revealed the crystallographic structure of THD with CYP2D6. In the current study, the binding and reaction mechanisms at the atomic and electronic levels were computationally examined based on the assumption as to whether or not the different crystallographic binding poses correspond to the different metabolites. The binding and oxidative reaction steps in the whole metabolic process were investigated using molecular dynamics and density functional theory calculations, respectively. The current study demonstrated the essential importance of the orientation of the substrate in the reaction center of CYP2D6 for the metabolic reaction. (C) 2015 Elsevier Ltd. All rights reserved.	[Sasahara, Katsunori; Mashima, Akira; Yoshida, Tatsusada; Chuman, Hiroshi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Tokushima 7708505, Japan; [Sasahara, Katsunori] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Drug Safety Res Ctr, Dept Drug Metab, Tokushima, Japan	Chuman, H (reprint author), Univ Tokushima, Grad Sch, Inst Biomed Sci, 1-78 Shomachi, Tokushima 7708505, Japan.	hchuman@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [15K07888]	This work was supported by Grants-in-Aid for Scientific Research (No. 15K07888) from the Ministry of Education, Culture, Sports, Science, and Technology.	Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Pritchard JF, 2003, NAT REV DRUG DISCOV, V2, P542, DOI 10.1038/nrd.1131; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yuki H, 2012, BIOORGAN MED CHEM, V20, P775, DOI 10.1016/j.bmc.2011.12.004; Llerena A, 2002, J PSYCHOPHARMACOL, V16, P361; Shoji O, 2014, J BIOL INORG CHEM, V19, P529, DOI 10.1007/s00775-014-1106-9; de Visser SP, 2003, J AM CHEM SOC, V125, P7413, DOI 10.1021/ja034142f; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Deeks ED, 2010, DRUGS, V70, P2315, DOI 10.2165/11203800-000000000-00000; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; Li C, 2007, ANGEW CHEM INT EDIT, V46, P8168, DOI 10.1002/anie.200702867; Li CS, 2009, CHEM-EUR J, V15, P8492, DOI 10.1002/chem.200802215; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Seifert A, 2006, PROTEINS, V64, P147, DOI 10.1002/prot.20951; Rydberg P, 2008, J CHEM THEORY COMPUT, V4, P1369, DOI 10.1021/ct800101v; Wojcikowski J, 2006, DRUG METAB DISPOS, V34, P471, DOI 10.1124/dmd.105.006445; Wang A, 2015, J BIOL CHEM, V290, P5092, DOI 10.1074/jbc.M114.627661; Shi RW, 2013, CHINESE J CHEM, V31, P1219, DOI 10.1002/cjoc.201300427; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; BLAKE BL, 1995, XENOBIOTICA, V25, P377; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; BUCKLEY NA, 1995, J TOXICOL-CLIN TOXIC, V33, P199; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Daniel WA, 2000, BRIT J PHARMACOL, V131, P287, DOI 10.1038/sj.bjp.0703540; Dollery C, 1998, THERAPEUTIC DRUGS, pT95; FAEDDA G, 1989, BIOCHEM PHARMACOL, V38, P473, DOI 10.1016/0006-2952(89)90387-0; Frisch M.J., 2009, GAUSSIAN 09; Giammona DA, 1984, THESIS U CALIFORNIA; Hata M, 2008, BIOORGAN MED CHEM, V16, P5134, DOI 10.1016/j.bmc.2008.03.023; Kaiser C, 1970, MEDICINAL CHEMISTR 2, P1410; Kuzmanic A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4220; LIN G, 1993, XENOBIOTICA, V23, P1059; McLaughlin LA, 2005, J BIOL CHEM, V280, P38617, DOI 10.1074/jbc.M505974200; Moors SLC, 2011, J MED CHEM, V54, P6098, DOI 10.1021/jm2006468; NIEDZWIECKI DM, 1984, J PHARMACOL EXP THER, V228, P636; Olah J, 2011, P NATL ACAD SCI USA, V108, P6050, DOI 10.1073/pnas.1010194108; Rydberg P., 2012, CURR INORG CHEM, V2, P292; SVENDSEN CN, 1988, PSYCHIAT RES, V23, P1, DOI 10.1016/0165-1781(88)90029-7; Wen B, 2009, CHEM-BIOL INTERACT, V181, P220, DOI 10.1016/j.cbi.2009.05.014	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5459	5465		10.1016/j.bmc.2015.07.043		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900022		
J	Fudo, S; Yamamoto, N; Nukaga, M; Odagiri, T; Tashiro, M; Neya, S; Hoshino, T				Fudo, Satoshi; Yamamoto, Norio; Nukaga, Michiyoshi; Odagiri, Takato; Tashiro, Masato; Neya, Saburo; Hoshino, Tyuji			Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Influenza virus; Polymerase acidic protein; Endonuclease activity; Inhibitor; Crystal structure analysis; Molecular dynamics simulation	NEURAMINIDASE INHIBITORS; A ENDONUCLEASE; PA SUBUNIT; REVERSE-TRANSCRIPTASE; MOLECULAR-MECHANICS; PROTON CHANNEL; FORCE-FIELD; H ACTIVITY; MODEL; ACID	Seasonal epidemics and occasional pandemics caused by influenza viruses are global threats to humans. Since the efficacy of currently approved drugs is limited by the emerging resistance of the viruses, the development of new antiviral drugs is still demanded. Endonuclease activity, which lies in the influenza polymerase acidic protein N-terminal domain (PAN), is a potent target for novel antiviral agents. Here, we report the identification of some novel inhibitors for PAN endonuclease activity. The binding mode of one of the inhibitory compounds to PAN was investigated in detail by means of X-ray crystal structure analysis and molecular dynamics (MD) simulation. It was observed in the crystal structure that three molecules of the same kind of inhibitor were bound to one PAN. One of the three molecules is located at the active site and makes a chelation to metal ions. Another molecule is positioned at the space adjacent to the metal-chelated site. The other molecule is located at a site slightly apart from the metal-chelated site, causing a conformational change of Arg124. The last binding site was not observed in previous crystallographic studies. Hence, the stability of inhibitor binding was examined by performing 100-ns MD simulation. During the MD simulation, the three inhibitor molecules fluctuated at the respective binding sites at different amplitudes, while all of the molecules maintained interactions with the protein. Molecular mechanics/generalized Born surface area (MM/GBSA) analysis suggested that the molecule in the last binding site has a higher affinity than the others. Structural information obtained in this study will provide a hint for designing and developing novel potent agents against influenza viruses. (C) 2015 Elsevier Ltd. All rights reserved.	[Fudo, Satoshi; Neya, Saburo; Hoshino, Tyuji] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Yamamoto, Norio] Juntendo Univ, Grad Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Yamamoto, Norio; Odagiri, Takato; Tashiro, Masato] Natl Inst Infect Dis, Influenza Virus Res Ctr, Musashimurayama, Tokyo 2080011, Japan; [Nukaga, Michiyoshi] Josai Int Univ, Fac Pharmaceut Sci, Togane Shi, Chiba 2838555, Japan	Yamamoto, N (reprint author), Juntendo Univ, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nyamamo@juntendo.ac.jp; hoshino@chiba-u.jp			Japan Society for the Promotion of Science; Japanese Agency for Medical Research and Development; MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities [S1201013]	Calculations were performed at Research Center for Computational Science, Okazaki, Japan and at Information Technology Center of the University of Tokyo. A part of this work was supported by a Grant for Scientific Research C from Japan Society for the Promotion of Science. This work also supported by a Grant from Japanese Agency for Medical Research and Development and by a Grant-in-Aid (S1201013) from MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2017. This work has been performed under the approval of the Photon Factory Program Advisory Committee (Proposal no. 2012G658, 2014G563). Atomic coordinates have been deposited in the Protein Data Bank as entry 4YYL.	Doan L, 1999, BIOCHEMISTRY-US, V38, P5612, DOI 10.1021/bi9828932; Palamara AT, 2005, J INFECT DIS, V191, P1719, DOI 10.1086/429694; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Sagong HY, 2013, ACS MED CHEM LETT, V4, P547, DOI 10.1021/ml4001112; Parhi AK, 2013, BIOORGAN MED CHEM, V21, P6435, DOI 10.1016/j.bmc.2013.08.053; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; De Vivo M, 2008, J AM CHEM SOC, V130, P10955, DOI 10.1021/ja8005786; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Perez-Jimenez J, 2010, J AGR FOOD CHEM, V58, P4959, DOI 10.1021/jf100128b; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Bauman JD, 2013, ACS CHEM BIOL, V8, P2501, DOI 10.1021/cb400400j; Kim YJ, 2010, ANTIVIR RES, V88, P227, DOI 10.1016/j.antiviral.2010.08.016; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Xiao SY, 2014, J PHYS CHEM B, V118, P873, DOI 10.1021/jp408383g; Parkes KEB, 2003, J MED CHEM, V46, P1153, DOI 10.1021/jm020334u; Stevaert A, 2015, MOL PHARMACOL, V87, P323, DOI 10.1124/mol.114.095588; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Carcelli M, 2014, MOL PHARMACEUT, V11, P304, DOI 10.1021/mp400482a; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Hastings JC, 1996, ANTIMICROB AGENTS CH, V40, P1304; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; FLOCCO MM, 1994, J MOL BIOL, V235, P709, DOI 10.1006/jmbi.1994.1022; Manach C, 2004, AM J CLIN NUTR, V79, P727; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Yanagita H, 2011, BIOORGAN MED CHEM, V19, P816, DOI 10.1016/j.bmc.2010.12.011; Tomassini JE, 1996, ANTIMICROB AGENTS CH, V40, P1189; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Crepin T, 2010, J VIROL, V84, P9096, DOI 10.1128/JVI.00995-10; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Baughman BM, 2012, ACS CHEM BIOL, V7, P526, DOI 10.1021/cb200439z; Haidari M, 2009, PHYTOMEDICINE, V16, P1127, DOI 10.1016/j.phymed.2009.06.002; TOMASSINI J, 1994, ANTIMICROB AGENTS CH, V38, P2827; Beigel H, 2005, NEW ENGL J MED, V353, P1374; Case D. A., 2010, AMBER 11; CDC, 1997, MMWR-MORBID MORTAL W, V46, P1204; Chen E, 2014, ACS MED CHEM LETT, V5, P61, DOI 10.1021/ml4003474; Cianci C, 1996, ANTIVIR CHEM CHEMOTH, V7, P353; DuBois RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002830; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fuji H, 2009, J MED CHEM, V52, P1380, DOI 10.1021/jm801071m; Iwai Y, 2010, BIOORGAN MED CHEM, V18, P5379, DOI 10.1016/j.bmc.2010.05.035; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Kuzuhara T., 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1052; McNicholl IR, 2001, ANN PHARMACOTHER, V35, P57, DOI 10.1345/aph.10118; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sagong HY, 2014, J MED CHEM, V57, P8086, DOI 10.1021/jm500958x; Shoji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066337; Yanagita H, 2012, ACS CHEM BIOL, V7, P552, DOI 10.1021/cb200332k; Yanagita H, 2012, CHEM PHARM BULL, V60, P764	64	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5466	5475		10.1016/j.bmc.2015.07.046		10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900023		
J	Ali, TFS; Iwamaru, K; Ciftci, HI; Koga, R; Matsumoto, M; Oba, Y; Kurosaki, H; Fujita, M; Okamoto, Y; Umezawa, K; Nakao, M; Hide, T; Makino, K; Kuratsu, J; Abdel-Aziz, M; Abuo-Rahma, GEDAA; Beshr, EAM; Otsuka, M				Ali, Taha F. S.; Iwamaru, Kana; Ciftci, Halil Ibrahim; Koga, Ryoko; Matsumoto, Masahiro; Oba, Yasunori; Kurosaki, Hiromasa; Fujita, Mikako; Okamoto, Yoshinari; Umezawa, Kazuo; Nakao, Mitsuyoshi; Hide, Takuichiro; Makino, Keishi; Kuratsu, Jun-ichi; Abdel-Aziz, Mohamed; Abuo-Rahma, Gamal El-Din A. A.; Beshr, Eman A. M.; Otsuka, Masami			Novel metal chelating molecules with anticancer activity. Striking effect of the imidazole substitution of the histidine-pyridine-histidine system	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Histidine-pyridine-histidine; AsPC-1; U87; U251; DNA cleavage	DIOXYGEN-ACTIVATING CAPABILITY; BINDING-SITE; SYNTHETIC MODELS; CARCINOMA-CELLS; BLEOMYCIN; APOPTOSIS; LIGANDS; ANALOGS	Previously we have reported a metal chelating histidine-pyridine-histidine system possessing a trityl group on the histidine imidazole, namely HPH-2Trt, which induces apoptosis in human pancreatic adenocarcinoma AsPC-1 cells. Herein the influence of the imidazole substitution of HPH-2Trt was examined. Five related compounds, HPH-1Trt, HPH-2Bzl, HPH-1Bzl, HPH-2Me, and HPH-1Me were newly synthesized and screened for their activity against AsPC-1 and brain tumor cells U87 and U251. HPH-1Trt and HPH-2Trt were highly active among the tested HPH compounds. In vitro DNA cleavage assay showed both HPH-1Trt and HPH-2Trt completely disintegrate pUC19 DNA. The introduction of trityl group decisively potentiated the activity. (C) 2015 Elsevier Ltd. All rights reserved.	[Ali, Taha F. S.; Iwamaru, Kana; Ciftci, Halil Ibrahim; Koga, Ryoko; Matsumoto, Masahiro; Oba, Yasunori; Okamoto, Yoshinari; Otsuka, Masami] Kumamoto Univ, Fac Life Sci, Dept Bioorgan Med Chem, Chuo Ku, Kumamoto 8620973, Japan; [Kurosaki, Hiromasa] Kinjo Gakuin Univ, Coll Pharm, Moriyama Ku, Nagoya, Aichi 4638521, Japan; [Fujita, Mikako] Kumamoto Univ, Sch Pharm, Res Inst Drug Discovery, Chuo Ku, Kumamoto 8620973, Japan; [Nakao, Mitsuyoshi] Aichi Med Univ, Sch Med, Dept Mol Target Med Screening, Nagakute, Aichi 4801195, Japan; [Umezawa, Kazuo] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8600811, Japan; [Hide, Takuichiro; Makino, Keishi; Kuratsu, Jun-ichi] Kumamoto Univ, Fac Med, Dept Neurosurg, Chuo Ku, Kumamoto 8608556, Japan; [Abdel-Aziz, Mohamed; Abuo-Rahma, Gamal El-Din A. A.; Beshr, Eman A. M.] Menia Univ, Fac Pharm, Dept Med Chem, Menia 61519, Egypt; [Beshr, Eman A. M.] Umm Al Qura Univ, Dept Pharmaceut Chem, Coll Pharm, Mecca 21955, Saudi Arabia	Otsuka, M (reprint author), Kumamoto Univ, Fac Life Sci, Dept Bioorgan Med Chem, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	motsuka@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science [23390028, 19659025]; Egyptian Ministry of Higher Education through a Joint Supervision Channel Program	This work was supported by a Grant-in-Aid for Exploratory Research (B) (23390028) (to M.O.) and a Grant-in-Aid for Scientific Research (C) (19659025) (to M.F.) from the Japan Society for the Promotion of Science. We acknowledge support from the Egyptian Ministry of Higher Education through a Joint Supervision Channel Program (to T.F.S.A.).	Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Lopez-Rodriguez R, 2012, J ORG CHEM, V77, P9915, DOI 10.1021/jo301965v; Zhou YJ, 2010, BIOORGAN MED CHEM, V18, P2165, DOI 10.1016/j.bmc.2010.01.075; COLLMAN JP, 1975, J AM CHEM SOC, V97, P1427, DOI 10.1021/ja00839a026; Boger DL, 1996, BIOORGAN MED CHEM, V4, P179, DOI 10.1016/0968-0896(95)00183-2; Jain R, 2002, BIOORGAN MED CHEM, V10, P189, DOI 10.1016/S0968-0896(01)00265-6; KITTAKA A, 1986, TETRAHEDRON LETT, V27, P3631, DOI 10.1016/S0040-4039(00)84867-4; KITTAKA A, 1988, TETRAHEDRON, V44, P2811; Matsumoto M, 2006, HETEROCYCLES, V69, P311; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nam W, 2007, ACCOUNTS CHEM RES, V40, P522, DOI 10.1021/ar700027f; OHNO M, 1988, International Journal of Experimental and Clinical Chemotherapy, V1, P12; OTSUKA M, 1993, TETRAHEDRON LETT, V34, P8497, DOI 10.1016/S0040-4039(00)61368-0; OTSUKA M, 1995, J MED CHEM, V38, P3264, DOI 10.1021/jm00017a011; Otsuka Masami, 1995, HDB METAL LIGAND INT, P926; Suga A, 1989, SYNLETT, P70; Suginaka R, 1998, JPN J CANCER RES, V89, P947; Umezawa K, 1999, ADV ENZYME REGUL, V39, P145, DOI 10.1016/S0065-2571(98)00022-3	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5476	5482		10.1016/j.bmc.2015.07.044		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900024		
J	Takano, R; Yoshida, M; Inoue, M; Honda, T; Nakashima, R; Matsumoto, K; Yano, T; Ogata, T; Watanabe, N; Hirouchi, M; Kimura, T; Toda, N				Takano, Rieko; Yoshida, Masao; Inoue, Masahiro; Honda, Takeshi; Nakashima, Ryutaro; Matsumoto, Koji; Yano, Tatsuya; Ogata, Tsuneaki; Watanabe, Nobuaki; Hirouchi, Masakazu; Kimura, Takako; Toda, Narihiro			Optimization of 3-aryl-3-ethoxypropanoic acids and discovery of the potent GPR40 agonist DS-1558	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						GPR40; Agonist; Glucose-dependent; Insulin secretagogues; DS-1558	DEPENDENT INSULIN-SECRETION; SMALL-MOLECULE AGONISTS; RECEPTOR AGONISTS; HUMAN ISLETS; FATTY-ACIDS; BETA-CELLS; TAK-875; GLUCOSE; SULFONYLUREAS; FFA1/GPR40	GPR40 agonists stimulate insulin secretion only under the presence of high glucose concentration. Based on this mechanism, GPR40 agonists are believed to be promising novel insulin secretagogues with low risk of hypoglycemia. The optimizations of 3-aryl-3-ethoxypropanoic acids were performed to improve in vitro activity. We discovered compound 29r (DS-1558), (3S)-3-ethoxy-3-(4-{[(1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)propanoic acid, which was confirmed to have an enhancing effect on glucose-dependent insulin secretion after intravenous glucose injection in SD rats. (C) 2015 Elsevier Ltd. All rights reserved.	[Takano, Rieko; Yoshida, Masao] Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Inoue, Masahiro] Daiichi Sankyo Co Ltd, Venture Sci Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Honda, Takeshi; Toda, Narihiro] Daiichi Sankyo Co Ltd, New Modal Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Nakashima, Ryutaro; Matsumoto, Koji; Yano, Tatsuya] Daiichi Sankyo Co Ltd, Cardiovasc Metab Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Ogata, Tsuneaki] Daiichi Sankyo Co Ltd, Global Project Management Dept, Shinagawa Ku, Tokyo 1408710, Japan; [Watanabe, Nobuaki; Hirouchi, Masakazu] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Kimura, Takako] Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Edogawa Ku, Tokyo 1348630, Japan	Takano, R (reprint author), Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	takano.rieko.u2@daiichisankyo.co.jp; toda.narihiro.jw@daiichisankyo.co.jp					Ahren B, 2008, EXPERT OPIN EMERG DR, V13, P593, DOI 10.1517/14728210802584126 ; Amishiro N., [No title captured], Patent No. [WO 200320690 (A1), 200320690A1]; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Houze JB, 2012, BIOORG MED CHEM LETT, V22, P1267, DOI 10.1016/j.bmcl.2011.10.118; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Lorenz M, 2013, BIOORG MED CHEM LETT, V23, P4011, DOI 10.1016/j.bmcl.2013.05.022; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Fujii A, 1996, J AM CHEM SOC, V118, P2521, DOI 10.1021/ja954126l; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Hayashi Y, 2008, ANGEW CHEM INT EDIT, V47, P2082, DOI 10.1002/anie.200704870; McKeown SC, 2007, BIOORG MED CHEM LETT, V17, P1584, DOI 10.1016/j.bmcl.2006.12.084; Maedler K, 2005, J CLIN ENDOCR METAB, V90, P501, DOI 10.1210/jc.2004-0699; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Mizuno CS, 2008, CURR MED CHEM, V15, P61; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Sasaki S, 2011, J MED CHEM, V54, P1365, DOI 10.1021/jm101405t; Christiansen E, 2013, ACS MED CHEM LETT, V4, P441, DOI 10.1021/ml4000673; Del Guerra S, 2005, J DIABETES COMPLICAT, V19, P60, DOI 10.1016/j.jdiacomp.2004.05.001; FERNER RE, 1988, BRIT MED J, V296, P949; Lee HJ, 2004, BIOORG MED CHEM LETT, V14, P463, DOI 10.1016/j.bmcl.2003.10.038; Nakashima R, 2014, EUR J PHARMACOL, V737, P194, DOI 10.1016/j.ejphar.2014.05.014; Takano R, 2014, BIOORG MED CHEM LETT, V24, P2949, DOI 10.1016/j.bmcl.2014.04.065; Takano R, 2015, ACS MED CHEM LETT, V6, P266, DOI 10.1021/ml500391n; Valentine V., 2012, CLIN DIABETES, V30, P151; Watterson K. R., 2014, FRONT ENDOCRINOL, V5, P1	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5546	5565		10.1016/j.bmc.2015.07.028		20	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900032		
J	Hattori, Y; Kobayashi, K; Deguchi, A; Nohara, Y; Akiyama, T; Teruya, K; Sanjoh, A; Nakagawa, A; Yamashita, E; Akaji, K				Hattori, Yasunao; Kobayashi, Kazuya; Deguchi, Ayaka; Nohara, Yukie; Akiyama, Tomomi; Teruya, Kenta; Sanjoh, Akira; Nakagawa, Atsushi; Yamashita, Eiki; Akaji, Kenichi			Evaluation of transition-state mimics in a superior BACE1 cleavage sequence as peptide-mimetic BACE1 inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						BACE 1; Inhibitor; Transition state mimic; Hydroxyethylamine; Hydroxymethylcarbonyl	BETA-SECRETASE INHIBITORS; DESIGN; LIGAND; TOOL; POSITION; MODEL; ACIDS	A superior substrate sequence for BACE1 containing transition-state mimics at the scissile site was evaluated as a protease inhibitor. Hydroxymethylcarbonyl (HMC) and hydroxyethylamine (HEA) isosteres were selected as the transition state mimics, and incorporated into the scissile site of the superior sequence covering the P-4 to P-1' sites (Glu-Ile-Thi-Thi*Nva; *denotes the cleavage site). Isosteres having different absolute configurations of the hydroxyl group were synthesized separately, and the effect of the configuration was evaluated. Configuration of the hydroxyl group of each isostere showed a marked effect on the inhibitory activity; anti-configuration to the scissile site substituent had potent inhibitory activity in an HMC-type inhibitor, whereas anti-configuration of HEA-type inhibitors showed no inhibitory activity. Structural evaluations based on X-ray crystallographic analyses of recombinant BACE1 in complex with each inhibitor provided insights into the protein-ligand interactions, especially at the prime sites. (C) 2015 Elsevier Ltd. All rights reserved.	[Hattori, Yasunao; Kobayashi, Kazuya; Deguchi, Ayaka; Nohara, Yukie; Akiyama, Tomomi; Akaji, Kenichi] Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan; [Teruya, Kenta] Tohoku Univ, Grad Sch Med, Dept Neurochem, Sendai, Miyagi 9808575, Japan; [Sanjoh, Akira] Prot Wave Co, R&D Ctr, Nara 6310006, Japan; [Nakagawa, Atsushi; Yamashita, Eiki] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Akaji, K (reprint author), Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan.	akaji@mb.kyoto-phu.ac.jp	Nakagawa, Atsushi/D-4329-2009	Nakagawa, Atsushi/0000-0002-1700-7861	Ministry of Education, Culture, Sports, Science, and Technology, Japan [25460160]; Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	The authors are grateful to Dr. Taeko Kakizawa for her initial contributions in the preliminary experiments on solid-phase syntheses using commercially available HMC derivatives. The authors are also grateful to Dr. Taku Yoshiya for his useful suggestions regarding the syntheses of HMC derivatives by reduction of the alpha-keto acid derivatives. The authors are also grateful to Saki Goto, Mami Okabe, Natsumi Sato, Kanami Ueno, and Miki Ito for their contribution regarding the syntheses of inhibitors. This work was supported, in part, by a Grant-in-aid for Scientific Research 25460160 to K.A. from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This research is (partially) supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Oehlrich D, 2014, BIOORG MED CHEM LETT, V24, P2033, DOI 10.1016/j.bmcl.2014.03.025; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Hong L, 2004, BIOCHEMISTRY-US, V43, P4689, DOI 10.1021/bi0498252; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Kakizawa T, 2011, BIOORGAN MED CHEM, V19, P2785, DOI 10.1016/j.bmc.2011.03.056; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; CARPINO LA, 1993, J AM CHEM SOC, V115, P4397, DOI 10.1021/ja00063a082; Kimura T, 2006, BIOORG MED CHEM LETT, V16, P2380, DOI 10.1016/j.bmcl.2006.01.108; Ghosh AK, 2014, ORG BIOMOL CHEM, V12, P6842, DOI 10.1039/c4ob00738g; Ghosh AK, 2008, BIOORG MED CHEM LETT, V18, P1031, DOI 10.1016/j.bmcl.2007.12.028; Evans DA, 2002, J AM CHEM SOC, V124, P392, DOI 10.1021/ja0119548; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Yabuuchi T, 2000, J ORG CHEM, V65, P397, DOI 10.1021/jo991218a; Awahara C, 2014, BIOORGAN MED CHEM, V22, P2482, DOI 10.1016/j.bmc.2014.02.050; Butini S, 2013, EUR J MED CHEM, V70, P233, DOI 10.1016/j.ejmech.2013.09.056; FRANCIOTTI M, 1991, TETRAHEDRON LETT, V32, P6783, DOI 10.1016/S0040-4039(00)93602-5; Ghosh AK, 2015, BIOORG MED CHEM LETT, V25, P668, DOI 10.1016/j.bmcl.2014.11.087; Iserloh U, 2008, BIOORG MED CHEM LETT, V18, P414, DOI 10.1016/j.bmcl.2007.10.116; Ju L., 2008, J AM CHEM SOC, V130, P4235; Liu S, 2012, STRUCT BIOL, V12, P21; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osswald H. L., 2014, CHEM SOC REV; Prati F, 2015, ANGEW CHEM INT EDIT, V54, P1578, DOI 10.1002/anie.201410456; SELKOE D, 2001, J PHYSL REV, V81, P741; Suzuki K, 2013, BIOORGAN MED CHEM, V21, P6665, DOI 10.1016/j.bmc.2013.08.016; THAISRIVONGS S, 1987, J MED CHEM, V30, P976, DOI 10.1021/jm00389a004	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5626	5640		10.1016/j.bmc.2015.07.023		15	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900041		
J	Yamamoto, T; Umegawa, Y; Tsuchikawa, H; Matsumori, N; Hanashima, S; Murata, M; Haser, R; Rawlings, BJ; Caffrey, P				Yamamoto, Tomoya; Umegawa, Yuichi; Tsuchikawa, Hiroshi; Matsumori, Nobuaki; Hanashima, Shinya; Murata, Michio; Haser, Resul; Rawlings, Bernard J.; Caffrey, Patrick			Role of polyol moiety of amphotericin B in ion channel formation and sterol selectivity in bilayer membrane	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Amphotericin B; Bioengineered analog; Liposomes; Sterol selectivity; Macrolide	POLYENE ANTIBIOTICS; LIPID-BILAYERS; METHYL-ESTER; ANTIFUNGAL; NYSTATIN; NMR; BIOSYNTHESIS; ORGANIZATION; SIMULATIONS; DERIVATIVES	Amphotericin B (AmB) is a polyene macrolide antibiotic widely used to treat mycotic infections. In this paper, we focus on the role of the polyol moiety of AmB in sterol selectivity using 7-oxo-AmB, 7 alpha-OH-AmB, and 7 beta-OH-AmB. The 7-OH analogs were prepared from 7-oxo-AmB. Their K+ flux activity in liposomes showed that introduction of an additional ketone or hydroxy group on the polyol moiety reduces the original activity. Conformational analyses of these derivatives indicated that intramolecular hydrogen-bonding network possibly influenced the conformational rigidity of the macrolactone ring, and stabilized the active conformation in the membrane. Additionally, the flexible polyol leads to destabilization of the whole macrolactone ring conformation, resulting in a loss of sterol selectivity. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamamoto, Tomoya; Umegawa, Yuichi; Tsuchikawa, Hiroshi; Matsumori, Nobuaki; Hanashima, Shinya; Murata, Michio] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Yamamoto, Tomoya; Umegawa, Yuichi; Murata, Michio] Osaka Univ, Lipid Act Struct Project, ERATO, JST, Toyonaka, Osaka 5600043, Japan; [Haser, Resul; Rawlings, Bernard J.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Caffrey, Patrick] Univ Coll Dublin, Ctr Synth & Chem Biol, Sch Biomol & Biomed Sci, Dublin 2, Ireland	Murata, M (reprint author), Osaka Univ, Grad Sch Sci, Dept Chem, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	murata@chem.sci.osaka-u.ac.jp			MEXT, Japan [25242073, 25750383]; Japan Science and Technology Agency	We are grateful to Dr. Hideki Maki and Yukio Horita of Shionogi & Co., Ltd. for measuring antifungal activity. This work was partly supported by Grant-In-Aids for Scientific Research (A) (No. 25242073) and for Young Scientists (B) (No. 25750383) from MEXT, Japan, and also in part as 'Lipidacting Structure Project (ERATO)' from Japan Science and Technology Agency.	Gruszecki WI, 2009, BIOPHYS CHEM, V143, P95, DOI 10.1016/j.bpc.2009.04.008; Croatt MP, 2011, ORG LETT, V13, P1390, DOI 10.1021/ol2000765; DEKRUIJF.B, 1974, BIOCHIM BIOPHYS ACTA, V339, P57, DOI 10.1016/0005-2736(74)90332-0; Fujii G, 1997, BIOCHEMISTRY-US, V36, P4959, DOI 10.1021/bi962894z; GALLIS HA, 1990, REV INFECT DIS, V12, P308; Brautaset T, 2011, APPL ENVIRON MICROB, V77, P6636, DOI 10.1128/AEM.05780-11; Carmody M, 2005, J BIOL CHEM, V280, P34420, DOI 10.1074/jbc.M506689200; Gagos M, 2001, BBA-BIOMEMBRANES, V1511, P90, DOI 10.1016/S0005-2736(00)00386-2; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Kobayashi Y, 2000, HELV CHIM ACTA, V83, P2562, DOI 10.1002/1522-2675(20000906)83:9<2562::AID-HLCA2562>3.0.CO;2-Z; Palacios DS, 2011, P NATL ACAD SCI USA, V108, P6733, DOI 10.1073/pnas.1015023108; Anderson TM, 2014, NAT CHEM BIOL, V10, P400, DOI 10.1038/nchembio.1496; Tevyashova AN, 2013, ANTIMICROB AGENTS CH, V57, P3815, DOI 10.1128/AAC.00270-13; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Wilcock BC, 2013, J AM CHEM SOC, V135, P8488, DOI 10.1021/ja403255s; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Starzyk J, 2014, J PHYS CHEM B, V118, P13821, DOI 10.1021/jp510245n; Murphy B, 2010, ORG BIOMOL CHEM, V8, P3758, DOI 10.1039/b922074g; Baginski M, 2002, BBA-BIOMEMBRANES, V1567, P63, DOI 10.1016/S0005-2736(02)00581-3; Power P, 2008, CHEM BIOL, V15, P78, DOI 10.1016/j.chembiol.2007.11.008; Lemke A, 2005, APPL MICROBIOL BIOT, V68, P151, DOI 10.1007/s00253-005-1955-9; Caffrey P, 2001, CHEM BIOL, V8, P713, DOI 10.1016/S1074-5521(01)00046-1; Jarzembska KN, 2012, CRYST GROWTH DES, V12, P2336, DOI 10.1021/cg2017227; Resat H, 2002, EUR BIOPHYS J BIOPHY, V31, P294, DOI 10.1007/s00249-002-0214-6; Wasko P, 2012, MOL PHARMACEUT, V9, P1511, DOI 10.1021/mp300143n; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; Nakagawa Y, 2014, BIOCHEMISTRY-US, V53, P3088, DOI 10.1021/bi500122c; ASZALOS A, 1985, J ANTIBIOT, V38, P1699; CHERON M, 1988, BIOCHEM PHARMACOL, V37, P827, DOI 10.1016/0006-2952(88)90168-2; Kolossavary I, 1999, J COMPUT CHEM, V20, P1671; Kristanc L, 2014, BBA-BIOMEMBRANES, V1838, P2635, DOI 10.1016/j.bbamem.2014.05.019; Matsumori N, 2007, J ORG CHEM, V72, P700, DOI 10.1021/jo061309p; Nakagawa Y, 2015, BIOCHEMISTRY-US, V54, P303, DOI 10.1021/bi5012942; Neumann A, 2013, BIOPHYS J, V104, P1485, DOI 10.1016/j.bpj.2013.02.029; Rogers BN, 1997, BIOORG MED CHEM LETT, V7, P3177, DOI 10.1016/S0960-894X(97)10180-9; Szpilman AM, 2009, CHEM-EUR J, V15, P7117, DOI 10.1002/chem.200900231; Szpilman AM, 2008, ANGEW CHEM INT EDIT, V47, P4339, DOI 10.1002/anie.200800590; Takano T, 2009, BIOORGAN MED CHEM, V17, P6301, DOI 10.1016/j.bmc.2009.07.036; Umegawa Y, 2008, BIOCHEMISTRY-US, V47, P13463, DOI 10.1021/bi801875y	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5782	5788		10.1016/j.bmc.2015.07.009		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900057		
J	Tsuji, K; Tanegashima, K; Sato, K; Sakamoto, K; Shigenaga, A; Inokuma, T; Hara, T; Otaka, A				Tsuji, Kohei; Tanegashima, Kosuke; Sato, Kohei; Sakamoto, Ken; Shigenaga, Akira; Inokuma, Tsubasa; Hara, Takahiko; Otaka, Akira			Efficient one-pot synthesis of CXCL14 and its derivative using an N-sulfanylethylanilide peptide as a peptide thioester equivalent and their biological evaluation	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Chemokine; CXCL14; CXCR4; CXCL12; Native Chemical Ligation (NCL)	NATIVE CHEMICAL LIGATION; CHEMOKINE CXCL14; DENDRITIC CELLS; FACTOR-I; BRAK/CXCL14; EXPRESSION; INHIBITOR; MIGRATION; PROTEINS; ANALOGS	CXCL14 is a CXC-type chemokine that exhibits chemotactic activity for immature dendritic cells, activated macrophages, and activated natural killer cells. However, its specific receptor and signaling pathway remain obscure. Recently, it was reported that CXCL14 binds to CXCR4 with high affinity and inhibits CXCL12-mediated chemotaxis. Furthermore, the CXCL14 C-terminal alpha-helical region is important for binding to its receptor. In this context, we chemically synthesized CXCL14 and its derivative with a one-pot method using N-sulfanylethylanilide peptide as a thioester equivalent. The synthetic CXCL14 proteins possessed inhibitory activities to CXCL12-mediated chemotaxis comparable with that of recombinant CXCL14. Moreover, we proved that chemically biotinylated CXCL14 binds to CXCR4 on cells by flow cytometry analysis. (C) 2015 Elsevier Ltd. All rights reserved.	[Tsuji, Kohei; Sato, Kohei; Sakamoto, Ken; Shigenaga, Akira; Inokuma, Tsubasa; Otaka, Akira] Univ Tokushima, Inst Biomed Sci, Tokushima 7708505, Japan; [Tsuji, Kohei; Sato, Kohei; Sakamoto, Ken; Shigenaga, Akira; Inokuma, Tsubasa; Otaka, Akira] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Tanegashima, Kosuke; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Setagaya Ku, Tokyo 1568506, Japan	Hara, T (reprint author), Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Setagaya Ku, Tokyo 1568506, Japan.	hara-tk@igakuken.or.jp; aotaka@tokushima-u.ac.jp			JSPS	This research was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI). K.T. is grateful for JSPS Research Fellowships for Young Scientists.	Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Tessema M, 2010, ONCOGENE, V29, P5159, DOI 10.1038/onc.2010.255; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Ding H, 2011, ORG LETT, V13, P5588, DOI 10.1021/ol202316v; Tanegashima K, 2013, FEBS LETT, V587, P3770, DOI 10.1016/j.febslet.2013.10.017; Shurin GV, 2005, J IMMUNOL, V174, P5490; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Sato K, 2013, ANGEW CHEM INT EDIT, V52, P7855, DOI 10.1002/anie.201303390; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Sato K, 2011, CHEMBIOCHEM, V12, P1840, DOI 10.1002/cbic.201100241; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; Rollins BJ, 1997, BLOOD, V90, P909; Frutos S, 2007, INT J PEPT RES THER, V13, P221, DOI 10.1007/s10989-006-9070-z; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; Starnes T, 2006, EXP HEMATOL, V34, P1101, DOI 10.1016/j.exphem.2006.05.015; Ozawa S, 2006, BIOCHEM BIOPH RES CO, V348, P406, DOI 10.1016/j.bbrc.2006.07.070; Otte M, 2014, FEBS LETT, V588, P4769, DOI 10.1016/j.febslet.2014.11.009; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Tanegashima K, 2013, FEBS LETT, V587, P1731, DOI 10.1016/j.febslet.2013.04.046; Sakamoto K, 2012, J ORG CHEM, V77, P6948, DOI 10.1021/jo3011107; Bang D., 2006, ANGEW CHEM, V118, P4089, DOI 10.1002/ange.200600702; Becker CFW, 2005, MAGN RESON CHEM, V43, pS34, DOI 10.1002/mrc.1688; Dang BB, 2014, ANGEW CHEM INT EDIT, V53, P8970, DOI 10.1002/anie.201404438; Hara T, 2012, J BIOCHEM, V151, P469, DOI 10.1093/jb/mvs030; Huang H, 1999, J PEPT RES, V53, P548, DOI 10.1034/j.1399-3011.1999.00059.x; Lee J, 2011, BIOCONJUGATE CHEM, V22, P1645, DOI 10.1021/bc2002242; Rosa L. D., 2013, MOLECULES, V18, P440; Tanegashima K, 2010, EXP CELL RES, V316, P1263, DOI 10.1016/j.yexcr.2010.01.016; Tsuji K, 2011, BIOORGAN MED CHEM, V19, P4014, DOI 10.1016/j.bmc.2011.05.018	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5909	5914		10.1016/j.bmc.2015.06.064		6	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900069		
J	Busujima, T; Tanaka, H; Shirasaki, Y; Munetomo, E; Saito, M; Kitano, K; Minagawa, T; Yoshida, K; Osaki, N; Sato, N				Busujima, Tsuyoshi; Tanaka, Hiroaki; Shirasaki, Yoshihisa; Munetomo, Eiji; Saito, Masako; Kitano, Kiyokazu; Minagawa, Toshiya; Yoshida, Koji; Osaki, Naoto; Sato, Nagaaki			Identification of 2-[2-(4-tert-butylphenyl)ethyl]-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide (29) as an orally available MGAT2 inhibitor	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Monoacylglycerol acyltransferase; MGAT2; Fat absorption; Oral lipid tolerance test; Tetrahydroisoquinoline	ACYLTRANSFERASE-2; DEFICIENCY; MICE	MGAT2 (monoacylglycerol acyltransferase 2) is expected to be an attractive target for the drug treatment of obesity, diabetes, and other disease. We describe our exploration and structure-activity relationship (SAR) study of 2,3-dihydro-1H-isoindole-5-sulfonamide derivatives. In this study, we identified 29 as an orally available inhibitor of MGAT2 through optimization especially in terms of solubility. This compound exhibited moderate potency in the enzyme inhibitory assay (IC50 = 1522 nM) and significant suppression of fat absorption (57% inhibition) in mice oral lipid tolerance test. (C) 2015 Elsevier Ltd. All rights reserved.	[Busujima, Tsuyoshi; Tanaka, Hiroaki; Shirasaki, Yoshihisa; Sato, Nagaaki] Taisho Pharmaceut Co Ltd, Chem Labs, Kita Ku, Saitama 3319530, Japan; [Munetomo, Eiji; Saito, Masako; Kitano, Kiyokazu] Taisho Pharmaceut Co Ltd, Pharmacol Labs, Kita Ku, Saitama 3319530, Japan; [Minagawa, Toshiya; Yoshida, Koji] Taisho Pharmaceut Co Ltd, Drug Safety & Pharmacokinet Labs, Kita Ku, Saitama 3319530, Japan; [Osaki, Naoto] Taisho Pharmaceut Co Ltd, Pharmaceut Sci Labs, Kita Ku, Saitama 3319530, Japan	Busujima, T (reprint author), Taisho Pharmaceut Co Ltd, Chem Labs, Kita Ku, 1-403 Yoshino Cho, Saitama 3319530, Japan.	t-busujima@so.taisho.co.jp					BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Barlind JG, 2013, BIOORG MED CHEM LETT, V23, P2721, DOI 10.1016/j.bmcl.2013.02.084; Arakawa K, 2010, CHEM ABSTR, Patent No. 2010/095767; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Danilewicz J., 1995, CHEM ABSTR, Patent No. 95/13274; Fernandez M. C., 2013, CHEM ABSTR, Patent No. 2013/112323; Galia E, 1998, PHARMACEUT RES, V15, P698, DOI 10.1023/A:1011910801212; Megash L, 2014, CHEM ABSTR, Patent No. 2014/193884; Nakamura K, 2008, CHEM ABSTR, Patent No. 2008/038768; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Suwa A., 2012, CHEM ABSTR, V2012, Patent No. WO 2012/091010; Turdi H, 2013, CHEM ABSTR, Patent No. 2013/082345; Yen CLE, 2015, J LIPID RES, V56, P489, DOI 10.1194/jlr.R052902	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5922	5931		10.1016/j.bmc.2015.06.065		10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900071		
J	Tamiaki, H; Nagai, T; Tanaka, T; Tatebe, T				Tamiaki, Hitoshi; Nagai, Tomoaki; Tanaka, Takuya; Tatebe, Tomohiro			Synthesis and optical properties of chlorin monomer, dimer and trimer on an amino nitrogen atom	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Chlorophyll; Fluorescence emission data; Light-harvesting antenna; Photosynthesis; Visible absorption spectra	GREEN PHOTOSYNTHETIC BACTERIA; ANTENNA COMPLEXES; ENERGY-TRANSFER; ZINC; AGGREGATION; CHLOROPHYLL; MODELS; BACTERIOCHLORIN; ASSEMBLIES; EMISSION	Naturally occurring chlorophyll-a was chemically modified to methyl 3-aminomethyl-pyropheophorbides- a including primary, secondary, and tertiary amines. Reductive amination of methyl pyropheophorbide-d possessing the 3-formyl group with ammonia efficiently gave a chlorin dimer covalently linked with CH2NHCH2 at the 3-position, which was transformed into a trimer through the substitution at the amino group. Conformational analyses by H-1 NMR spectroscopic observation and molecular modeling estimation indicated that the dimer and trimer were apt to form closely packed structures. Chlorin chromophores in the dimer and trimer were weakly interacted in dichloromethane to shift their Qy absorption bands to longer wavelengths by 4-6 nm than the maxima of the corresponding monomer. In the red-shifted Qy region, the trimer gave an S-shaped circular dichroism band by exciton coupling of composite chlorin units. All the semi-synthetic chlorophyll derivatives were highly fluorescent and no intramolecular quenching was observed even in the trimer. The behaviors would be ascribable to the formation of compact conformers and suppression of intramolecular motion, which are important to construct light-harvesting antenna complexes in phototrophs and their model systems. (C) 2015 Elsevier Ltd. All rights reserved.	[Tamiaki, Hitoshi; Nagai, Tomoaki; Tanaka, Takuya; Tatebe, Tomohiro] Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan	Tamiaki, H (reprint author), Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan.	tamiaki@fc.ritsumei.ac.jp			Japan Society for the Promotion of Science (JSPS) [24107002]	We thank Dr. Shinnosuke Machida of Ritsumeikan University for his experimental assistance and Dr. Shin Ogasawara of Ritsumeikan University for preparation of the manuscript. This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Artificial Photosynthesis (AnApple)' (No. 24107002) from the Japan Society for the Promotion of Science (JSPS).	Kureishi Y, 1998, J PORPHYR PHTHALOCYA, V2, P159, DOI 10.1002/(SICI)1099-1409(199803/04)2:2<159::AID-JPP62>3.0.CO;2-Q; TAMIAKI H, 1994, PHOTOSYNTH RES, V41, P245, DOI 10.1007/BF02184165; Miyatake T, 2010, COORDIN CHEM REV, V254, P2593, DOI 10.1016/j.ccr.2009.12.027; Shinozaki Y, 2014, CRYSTENGCOMM, V16, P9155, DOI 10.1039/c4ce00861h; Tamiaki H, 2014, BIOORG MED CHEM LETT, V24, P1668, DOI 10.1016/j.bmcl.2014.02.062; Pale V, 2013, J MATER CHEM C, V1, P2166, DOI 10.1039/c3tc00499f; Tamiaki H, 1996, PHOTOCHEM PHOTOBIOL, V63, P92, DOI 10.1111/j.1751-1097.1996.tb02997.x; Harada J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00671; Tamiaki H, 1996, TETRAHEDRON, V52, P12421, DOI 10.1016/0040-4020(96)00740-5; Hong YN, 2011, CHEM SOC REV, V40, P5361, DOI 10.1039/c1cs15113d; BEDDARD GS, 1976, NATURE, V260, P366, DOI 10.1038/260366a0; Oba T, 2014, J PORPHYR PHTHALOCYA, V18, P919, DOI 10.1142/S1088424614500710; Tamiaki H, 1996, ANGEW CHEM INT EDIT, V35, P772, DOI 10.1002/anie.199607721; Orf GS, 2013, PHOTOSYNTH RES, V116, P315, DOI 10.1007/s11120-013-9869-3; Biemans HAM, 1998, J AM CHEM SOC, V120, P11054, DOI 10.1021/ja9815632; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; Gunderson VL, 2012, HANDB PORPHYR SCI, V20, P45; Kataoka Y, 2012, BIOORG MED CHEM LETT, V22, P5218, DOI 10.1016/j.bmcl.2012.06.066; Ocakoglu K, 2014, NANOSCALE, V6, P9625, DOI 10.1039/c4nr01661k; Sakakibara K, 2013, BIOMACROMOLECULES, V14, P3223, DOI [10.1021/bm400858v, 10.1021/bm400585v]; Sengupta S, 2013, ACCOUNTS CHEM RES, V46, P2498, DOI 10.1021/ar400017u; Tamiaki H., 2015, J PHOTOCH PHOTOBIO A, DOI [http://dx.doi.org/10.1016/j.jphotochem.2015.05.003, DOI 10.1016/J.JPH0T0CHEM.2015.05.003]; Terazono Y, 2015, J AM CHEM SOC, V137, P245, DOI 10.1021/ja510267c	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					5972	5978		10.1016/j.bmc.2015.06.052		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900075		
J	Nakao, A; Suzuki, H; Ueno, H; Iwasaki, H; Setsuta, T; Kashima, A; Sunada, S				Nakao, Akira; Suzuki, Hiroko; Ueno, Hiroaki; Iwasaki, Hiroshi; Setsuta, Tomofumi; Kashima, Akiko; Sunada, Shinji			Discovery and structural analyses of S-adenosyl-L-homocysteine hydrolase inhibitors based on non-adenosine analogs (vol 23, pg 4952, 2015)	BIOORGANIC & MEDICINAL CHEMISTRY			English	Correction									[Nakao, Akira; Suzuki, Hiroko; Ueno, Hiroaki; Iwasaki, Hiroshi; Setsuta, Tomofumi; Kashima, Akiko; Sunada, Shinji] Mitsubishi Tanabe Pharma Corp, Div Res, Aoba Ku, Yokohama, Kanagawa 2270033, Japan	Nakao, A (reprint author), Mitsubishi Tanabe Pharma Corp, Div Res, 2-2-50 Kawagishi, Toda, Saitama 3358505, Japan.	Nakao.Akira@mc.mt-pharma.co.jp					Nakao A, 2015, BIOORGAN MED CHEM, V23, P4952, DOI 10.1016/j.bmc.2015.05.018	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					6078	6078		10.1016/j.bmc.2015.07.063		1	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900085		
J	Ogiyama, T; Inoue, M; Honda, S; Yamada, H; Watanabe, T; Gotoh, T; Kiso, T; Koakutsu, A; Kakimoto, S; Shishikura, J				Ogiyama, Takashi; Inoue, Makoto; Honda, Shugo; Yamada, Hiroyoshi; Watanabe, Toshihiro; Gotoh, Takayasu; Kiso, Tetsuo; Koakutsu, Akiko; Kakimoto, Shuichiro; Shishikura, Jun-ichi			Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels (vol 22, pg 6899, 2014)	BIOORGANIC & MEDICINAL CHEMISTRY			English	Correction									[Ogiyama, Takashi; Inoue, Makoto; Honda, Shugo; Yamada, Hiroyoshi; Watanabe, Toshihiro; Gotoh, Takayasu; Kiso, Tetsuo; Kakimoto, Shuichiro; Shishikura, Jun-ichi] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; [Koakutsu, Akiko] Astellas Pharma Inc, Drug Discovery Res, Yodogawa Ku, Osaka 5328514, Japan	Ogiyama, T (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	takashi.ogiyama@astellas.com					Ogiyama T, 2014, BIOORGAN MED CHEM, V22, P6899, DOI 10.1016/j.bmc.2014.10.020	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 1	2015	23	17					6079	6079		10.1016/j.bmc.2015.07.033		1	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CQ1IG	WOS:000360349900086		
J	Morganroth, J; Wang, YN; Thorn, M; Kumagai, Y; Harris, S; Stockbridge, N; Kleiman, R; Shah, R				Morganroth, Joel; Wang, Yaning; Thorn, Michael; Kumagai, Yuji; Harris, Stuart; Stockbridge, Norman; Kleiman, Robert; Shah, Rashmi			Moxifloxacin-induced QT(c) interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						Caucasians; ethnicity; Japanese; moxifloxacin; QT(c) interval; thorough QT studies	CARDIAC REPOLARIZATION; GENETIC SUSCEPTIBILITY; ETHNIC-DIFFERENCES; CHANNEL VARIANTS; LIABILITY; QT/QTC; WHITE	AimWe investigated whether moxifloxacin-induced QT(c) prolongations in Japanese and Caucasian healthy male volunteers were significantly different. MethodsA two period, randomized, crossover, ICH-E14-compliant thorough QT (TQT) study compared placebo-corrected changes in QT(c) interval from baseline (QT(c)F) and concentration-effect relationships following administration of placebo and 400 mg moxifloxacin to 40 healthy male volunteers from each ethnic population. The point estimates of QT(c)F for each population, and the difference between the two, were calculated at a geometric mean C-max of moxifloxacin using a linear mixed effects model. The concentration-effect slopes of the two populations were also compared. Equivalence was concluded if the two-sided 90% confidence interval of the difference in QT(c)F was contained within -5 ms to +5 ms limits and the ratio of the slopes was between 0.5 and 2. ResultsThere were no statistically significant differences between the two populations studied, Japanese vs. Caucasians, respectively, for moxifloxacin C-max (3.27 0.6 vs. 2.98 +/- 0.7 mu g ml(-1)), QT(c)F (9.63 +/- 1.15 vs. 11.46 +/- 1.19 ms at C-max of 3.07 mu g ml(-1)) and concentration-response slopes (2.58 +/- 0.62 vs. 2.34 +/- 0.64 ms per mu g ml(-1)). The difference in the two QT(c)F of -1.8 (90% CI -4.6, 0.9) and the ratio of the two slopes (1.1; 90% CI 0.63, 1.82) were within pre-specified equivalence limits. ConclusionsMoxifloxacin-induced QT(c) prolongations did not differ significantly between the Japanese and Caucasian subjects. However, before our findings are more widely generalized, further studies in other populations and with other QT-prolonging drugs are needed to clarify whether inter-ethnic differences in QT sensitivity exist and whether ethnicity of the study population may affect the outcome of a TQT study.	[Morganroth, Joel; Kleiman, Robert] ERes Technol Inc, Philadelphia, PA USA; [Wang, Yaning] US FDA, Div Pharmacometr, Silver Spring, MD USA; [Thorn, Michael] Stat Resources Inc, Chapel Hill, NC USA; [Kumagai, Yuji] Kitasato Univ, East Hosp, Clin Res Ctr, Sagamihara, Kanagawa 228, Japan; [Harris, Stuart] SeaView Res Inc, Miami, FL USA; [Stockbridge, Norman] US FDA, Div Cardiovasc & Renal Prod, Silver Spring, MD USA	Shah, R (reprint author), 8 Birchdale, Gerrards Cross SL9 7JA, Bucks, England.	clinical.safety@hotmail.co.uk					Shah RR, 2012, DRUG SAFETY, V35, P695, DOI 10.2165/11634810-000000000-00000; Mizutani T, 2003, DRUG METAB REV, V35, P99, DOI 10.1081/DMR-120023681; Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479; Sugiyama A, 2014, J CLIN PHARMACOL, V54, P446, DOI 10.1002/jcph.226; Taubel J, 2014, BRIT J CLIN PHARMACO, V77, P170, DOI 10.1111/bcp.12168; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; Florian JA, 2011, J CLIN PHARMACOL, V51, P1152, DOI 10.1177/0091270010381498; Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Stockbridge N, 2013, DRUG SAFETY, V36, P167, DOI 10.1007/s40264-013-0016-z; Yan LHK, 2010, J BIOPHARM STAT, V20, P497, DOI 10.1080/10543400903581945; Chen SG, 2012, PHARMACOTHERAPY, V32, P333, DOI 10.1002/j.1875-9114.2012.01033.x; Shah RR, 2013, BRIT J CLIN PHARMACO, V75, P347, DOI 10.1111/j.1365-2125.2012.04415.x; Shin JG, 2007, BRIT J CLIN PHARMACO, V63, P206, DOI 10.1111/j.1365-2125.2006.02793.x; Kannankeril PJ, 2005, HEART RHYTHM, V2, P134, DOI 10.1016/j.hrthm.2004.10.039; OLATUNDE A, 1982, BRIT J CLIN PHARMACO, V14, P513; Somberg JC, 2012, J CARDIOVASC PHARM T, V17, P86, DOI 10.1177/1074248411406505; Sugiyama A, 2012, BRIT J CLIN PHARMACO, V73, P455, DOI 10.1111/j.1365-2125.2011.04110.x; Sistonen J, 2007, PHARMACOGENET GENOM, V17, P93; Shah RR, 2002, BRIT J CLIN PHARMACO, V54, P188, DOI 10.1046/j.1365-2125.2002.01627.x; Poordad F, 2009, J CLIN PHARMACOL, V49, P1436, DOI 10.1177/0091270009337943; Committee for Medicinal Products for Human Use (CHMP), ICH E14 NOT GUID CLI; Committee for Medicinal Products for Human Use (CHMP), 2012, EMACHMPICH3101332008; Dinh Phillip, 2011, Rev Recent Clin Trials, V6, P220; Efron B, 1998, INTRO BOOTSTRAP; Food and Drug Administration, 2010, GUID IND NON CLIN TR; Food and Drug Administration (FDA), 2014, FDA ACT PLAN ENH COL; ICH E14 Implementation Working Group, 2014, ICH E14 GUID CLIN EV; Lin YL, 2009, PHARMACOEPIDEM DR S, V18, P235, DOI 10.1002/pds.1707; Lowe JS, 2012, CARDIOVASC RES, V95, P300, DOI 10.1093/cvr/cvs160; Moon Seol Ju, 2014, Drugs R D, V14, P63, DOI 10.1007/s40268-014-0040-1; Ono C, 2013, PHARMACOGENOMICS, V14, P1745, DOI 10.2217/pgs.13.171; Ozawa Shogo, 2004, Drug Metab Pharmacokinet, V19, P83, DOI 10.2133/dmpk.19.83; Shah RR, 2015, BRIT J CLIN PHARMACO, V79, P456, DOI 10.1111/bcp.12477; Shah RR, 2007, PHARMACOGENOMICS ADM, P180; Wheeler W, 2011, CLIN PHARMACOL THER, V89, pS42; Zhang J., 2012, 3 DIA CARD SAF WORKS; Zhang WH, 2013, CLIN THER, V35, P1150, DOI 10.1016/j.clinthera.2013.06.009	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-5251	1365-2125		BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	SEP	2015	80	3					446	459		10.1111/bcp.12684		14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ1QA	WOS:000360371900013		
J	Tomohiko, U; Mori, M; Akiyuki, U; Masuda, S; Mutho, M; Masuda, H; Kuwabara, S				Tomohiko, Uchida; Mori, Masahiro; Akiyuki, Uzawa; Masuda, Saeko; Mutho, Mayumi; Masuda, Hiroki; Kuwabara, Satoshi			Change in vital signs after fingolimod initiation in patients with multiple sclerosis: the possible need for 24 h monitoring	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Letter									[Tomohiko, Uchida; Mori, Masahiro; Akiyuki, Uzawa; Masuda, Saeko; Mutho, Mayumi; Masuda, Hiroki; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, Chiba 2608670, Japan	Mori, M (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	morim@faculty.chiba-u.jp					Espinosa PS, 2011, MULT SCLER J, V17, P1387, DOI 10.1177/1352458511410344; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Gilenya-Novartis Pharma, HIGHL PRESCR INF; Kovarik JM, 2004, BRIT J CLIN PHARMACO, V57, P586, DOI 10.1111/j.1365-2125.2003.02065.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-5251	1365-2125		BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	SEP	2015	80	3					607	608		10.1111/bcp.12697		2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ1QA	WOS:000360371900028		
J	Hosoda, Y; Hayashi, H; Kuriyama, S				Hosoda, Yoshikatsu; Hayashi, Hisako; Kuriyama, Shoji			Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt-Koyanagi-Harada disease	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article						Treatment Medical; Inflammation; Retina; Choroid	CORTICOSTEROID-THERAPY; INTRAVITREAL TRIAMCINOLONE; SUBCAPSULAR CATARACTS; RHEUMATOID ARTHRITIS; DIAGNOSTIC-CRITERIA; UVEITIS	Background/aims To investigate the effectiveness of isolated subtenon triamcinolone acetonide injection (STI) as a primary treatment in eyes with acute Vogt-Koyanagi-Harada (VKH) disease. Design Retrospective, observational, cross-sectional study. Methods The data from 27 eyes in 14 patients with acute VKH treated with STI therapy were analysed retrospectively. The time course change in ocular inflammation, best corrected visual acuity (BCVA) and numbers of recurrences were examined. Results STI led to prompt improvement of BCVA within a week after the primary treatment. After completing therapy, patients with VKH had improved BCVA compared with baseline. In six eyes of three patients (22.2%) treated with STI, ocular inflammation was refractory, or VKH was recurrent despite the treatment. There was significant difference between groups with and without recurrences of inflammation in the frequency of headaches before treatment. In the present study, 21 eyes of 11 patients (77.8%) achieved complete resolution of VKH without recurrence after STI therapy alone. Conclusions This study demonstrated that isolated STI therapy is a useful, minimally invasive, primary treatment option for patients with acute VKH without systemic disorders.	[Hosoda, Yoshikatsu; Hayashi, Hisako; Kuriyama, Shoji] Otsu Red Cross Hosp, Dept Ophthalmol, Otsu, Shiga 5200046, Japan	Hosoda, Y (reprint author), Otsu Red Cross Hosp, Dept Ophthalmol, 1-1-35 Nagara, Otsu, Shiga 5200046, Japan.	kubrick@kuhp.kyoto-u.ac.jp					Andrade RE, 2004, AM J OPHTHALMOL, V137, P572, DOI 10.1016/j.ajo.2003.08.035; MOORTHY RS, 1995, SURV OPHTHALMOL, V39, P265, DOI 10.1016/S0039-6257(05)80105-5; HELM CJ, 1995, AM J OPHTHALMOL, V120, P55; BLACK RL, 1960, JAMA-J AM MED ASSOC, V174, P166; Taylor SRJ, 2010, OPHTHALMOLOGICA, V224, P46, DOI 10.1159/000318021; RUBSAMEN PE, 1991, ARCH OPHTHALMOL-CHIC, V109, P682; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; YOSHIKAWA K, 1995, JPN J OPHTHALMOL, V39, P71; BENIZ J, 1991, RETINA-J RET VIT DIS, V11, P275, DOI 10.1097/00006982-199111030-00001; HERSCHLE.J, 1972, AM J OPHTHALMOL, V74, P501; Hosoda Y, 2014, AM J OPHTHALMOL, V157, P1056, DOI 10.1016/j.ajo.2014.01.015; Hsi-Kung Kuo M, 2005, CHANG GUNG MED J, V28, P85; Ishihara K, 2009, OPHTHALMOLOGY, V116, P1799, DOI 10.1016/j.ophtha.2009.04.002; KALINA RE, 1969, ARCH OPHTHALMOL-CHIC, V81, P788; Karacorlu M, 2006, EUR J OPHTHALMOL, V16, P481; LOREDO A, 1972, NEW ENGL J MED, V286, P160; Masuda K, 1969, JPN J CLIN OPHTHAL, V23, P553; Okada AA, 2003, BRIT J OPHTHALMOL, V87, P968, DOI 10.1136/bjo.87.8.968; Perente Irfan, 2009, International Ophthalmology, V29, P33, DOI 10.1007/s10792-007-9159-1; Read RW, 2000, OCUL IMMUNOL INFLAMM, V8, P227, DOI 10.1076/ocii.8.4.227.6457; SASAMOTO Y, 1990, OPHTHALMOLOGICA, V201, P162; SKALKA HW, 1980, ARCH OPHTHALMOL-CHIC, V98, P1773; SPENCER RW, 1965, ARCH OPHTHALMOL-CHIC, V74, P38; Tsujikawa A, 2005, AM J OPHTHALMOL, V139, P670, DOI 10.1016/j.ajo.2004.11.053; WILLIAMS.J, 1969, BRIT J OPHTHALMOL, V53, P361, DOI 10.1136/bjo.53.6.361	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	SEP	2015	99	9					1211	1214		10.1136/bjophthalmol-2014-306244		4	Ophthalmology	Ophthalmology	CQ2VL	WOS:000360460000013		
J	Matsuda, A; Hara, T; Miyata, K; Matsuo, H; Murata, H; Mayama, C; Asaoka, R				Matsuda, Aya; Hara, Takeshi; Miyata, Kazunori; Matsuo, Hiroshi; Murata, Hiroshi; Mayama, Chihiro; Asaoka, Ryo			Do pattern deviation values accurately estimate glaucomatous visual field damage in eyes with glaucoma and cataract?	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article						Glaucoma	OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; AUTOMATED PERIMETRY; PROBABILITY MAPS; EXTRACTION; INDEX; PHACOEMULSIFICATION; DEPRESSION; THRESHOLD; STANDARD	Background/aims To study the efficacy of pattern deviation (PD) values in the estimation of visual field compensating the influence of cataract in eyes with glaucoma. Methods The study subjects comprised of 48 eyes of 37 glaucoma patients. Mean total deviation value (mTDs) on Humphrey Field Analyzer after cataract surgery was compared with mean PD (mPD) before the surgery. Visual field measurements were carried out 6months before (VFpre) and following (VFpost) successful cataract surgery. The difference between the mPD or mTD values in the VFpre and mTD values in the VFpost (denoted as epsilon mPD/mTD) was calculated, and the influence of the extent of true' glaucomatous visual field damage or cataract (as represented by epsilon mPD and mTD, respectively) on this difference was also investigated. Results There was a significant difference between mTD in the VFpre and mTD in the VFpost (p<0.001, repeated measures analysis of variance). There was not a significant difference between mPD in the VFpre and mTD in the VFpost (p=0.06); however, epsilon mPD was significantly correlated with the mTD in VFpost and also mTD (R-2=0.56 and 0.27, p<0.001, Pearson's correlation). The accurate prediction of the mTD in the VFpost can be achieved using the pattern standard deviation (PSD), mTD and also visual acuity before surgery. Conclusions Clinicians should be very careful when reviewing the VF of a patient with glaucoma and cataract since PD values may underestimate glaucomatous VF damage in patients with advanced disease and also overestimate glaucomatous VF damage in patients with early to moderate cataract.	[Matsuda, Aya; Murata, Hiroshi; Mayama, Chihiro; Asaoka, Ryo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo 1138655, Japan; [Hara, Takeshi] Hara Eye Hosp, Otawara, Tochigi, Japan; [Miyata, Kazunori] Miyata Eye Hosp, Miyakonojo, Miyazaki, Japan; [Matsuo, Hiroshi] Matsuo Eye Clin, Tokyo, Japan	Asaoka, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	rasaoka-tky@umin.ac.jp			Japan Science and Technology Agency (JST-CREST); Ministry of Education, Culture, Sports, Science and Technology of Japan [Kakenhi 25861618, Kakenhi 26462679]; Japan National Society for The Prevent of Blind; Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder	Japan Science and Technology Agency (JST-CREST); Ministry of Education, Culture, Sports, Science and Technology of Japan (Kakenhi 25861618, Kakenhi 26462679), Japan National Society for The Prevent of Blind, Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder.	AIRAKSINEN PJ, 1985, ARCH OPHTHALMOL-CHIC, V103, P205; Anderson D. R., 1999, AUTOMATED STATIC PER; Ang GS, 2010, J GLAUCOMA, V19, P275, DOI 10.1097/IJG.0b013e3181b21fb9; Khng C, 2006, J CATARACT REFR SURG, V32, P301, DOI 10.1016/j.jcrs.2005.08.062; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Bengtsson B, 2008, AM J OPHTHALMOL, V145, P343, DOI 10.1016/j.ajo.2007.09.038; CAPRIOLI J, 1987, AM J OPHTHALMOL, V103, P512; ANCTIL JL, 1984, ARCH OPHTHALMOL-CHIC, V102, P363; AIRAKSINEN PJ, 1984, AM J OPHTHALMOL, V98, P566; Kreutzer TC, 2010, J CATARACT REFR SURG, V36, P53, DOI 10.1016/j.jcrs.2009.07.035; Bengtsson B, 1997, ACTA OPHTHALMOL SCAN, V75, P184; BUDENZ DL, 1993, OPHTHALMOLOGY, V100, P511; FUNKHOUSER A, 1992, GRAEF ARCH CLIN EXP, V230, P101, DOI 10.1007/BF00164644; GUTHAUSER U, 1988, AM J OPHTHALMOL, V106, P480; HEIJL A, 1989, ACTA OPHTHALMOL, V67, P353; HEIJL A, 1981, ARCH OPHTHALMOL-CHIC, V99, P832; HEIJL A, 1989, ARCH OPHTHALMOL-CHIC, V107, P204; HEIJL A, 1989, ACTA OPHTHALMOL, V67, P1; HEUER DK, 1988, ARCH OPHTHALMOL-CHIC, V106, P1247; HOTCHKISS ML, 1985, ARCH OPHTHALMOL-CHIC, V103, P397; Japkowicz N., 2011, EVALUATING LEARNING; Langerhorst CT, 1989, INT OPHTHALMOL, V3, P31, DOI 10.1007/BF02028634; Rao HL, 2013, INVEST OPHTH VIS SCI, V54, P307, DOI 10.1167/iovs.12-10836; Rao HL, 2013, J GLAUCOMA, V22, P164, DOI 10.1097/IJG.0b013e31822e8e37; Rehman Siddiqui M A, 2007, J Glaucoma, V16, P205, DOI 10.1097/IJG.0b013e31802dfc35; Smith SD, 1997, ARCH OPHTHALMOL-CHIC, V115, P1515; STEWART WC, 1995, ARCH OPHTHALMOL-CHIC, V113, P875	27	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	SEP	2015	99	9					1240	1244		10.1136/bjophthalmol-2014-306019		5	Ophthalmology	Ophthalmology	CQ2VL	WOS:000360460000019		
J	Koizumi, H; Kano, M; Yamamoto, A; Saito, M; Maruko, I; Sekiryu, T; Okada, AA; Iida, T				Koizumi, Hideki; Kano, Mariko; Yamamoto, Akiko; Saito, Masaaki; Maruko, Ichiro; Sekiryu, Tetsuju; Okada, Annabelle A.; Iida, Tomohiro			Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article						Retina	VERTEPORFIN PHOTODYNAMIC THERAPY; OPTICAL COHERENCE TOMOGRAPHY; VEGF TRAP-EYE; VASCULAR HYPERPERMEABILITY; INTRAVITREAL AFLIBERCEPT; MACULAR DEGENERATION; RANIBIZUMAB THERAPY; THICKNESS; EFFICACY; BEVACIZUMAB	Background/aims To investigate short-term outcomes of intravitreal aflibercept injections (IAIs) for polypoidal choroidal vasculopathy (PCV). Methods 91 eyes of 88 consecutive patients with treatment-naive PCV examined at three university hospitals received IAI monthly for 3months. One month after the third IAI, changes in best-corrected visual acuity (BCVA) and macular morphology were retrospectively evaluated. Additionally, possible baseline characteristics predictive of persistent retinal fluid were analysed. Results The mean BCVA (logarithm of the minimum angle of resolution units) of the 91 eyes improved from 0.31 at baseline to 0.21 at 3months (p<0.0001). The mean central retinal thickness and mean subfoveal choroidal thickness decreased from 323 m and 270m at baseline to 185 m and 232m at 3months, respectively (p<0.0001 for both). Seventy-three eyes (80.2%) achieved a dry macula defined as absence of retinal fluid. Presence of the baseline characteristics of subretinal haemorrhage and greater size of the largest polyp were significantly associated with inability to achieve a dry macula (p=0.008 and 0.03, respectively). However, this association was not found on multivariate logistic regression. Of the 90 eyes that underwent indocyanine green angiography at 3months, 43 eyes (47.8%) showed complete and 28 eyes (31.1%) showed partial resolution of polyps. Twenty-four eyes (24.4%) also showed partial regression of branching choroidal vascular networks. Conclusions IAIs for the treatment of a large number of PCV eyes were found to improve both visual acuity and macular morphology over the short term.	[Koizumi, Hideki; Maruko, Ichiro; Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo 1628666, Japan; [Kano, Mariko; Saito, Masaaki; Sekiryu, Tetsuju] Fukushima Med Univ, Fukushima, Japan; [Yamamoto, Akiko; Okada, Annabelle A.] Kyorin Univ, Sch Med, Tokyo, Japan	Koizumi, H (reprint author), Tokyo Womens Med Univ, Dept Ophthalmol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	koizumi.hideki@twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25670739]	Supported in part by grant no. 25670739 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (HK).	Hirami Y, 2007, RETINA-J RET VIT DIS, V27, P335, DOI 10.1097/01.iae.0000233647.78726.46; Koizumi H, 2013, AM J OPHTHALMOL, V155, P305, DOI 10.1016/j.ajo.2012.07.018; Mori R, 2013, JPN J OPHTHALMOL, V57, P365, DOI 10.1007/s10384-013-0245-9; Stewart MW, 2012, BRIT J OPHTHALMOL, V96, P1157, DOI 10.1136/bjophthalmol-2011-300654; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Koizumi H, 2015, AM J OPHTHALMOL, V159, P627, DOI 10.1016/j.ajo.2014.12.025; Maruko I, 2011, AM J OPHTHALMOL, V151, P594, DOI 10.1016/j.ajo.2010.10.030; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Sasahara M, 2006, AM J OPHTHALMOL, V142, P601, DOI 10.1016/j.ajo.2006.05.051; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Ogasawara Masashi, 2012, Nippon Ganka Gakkai Zasshi, V116, P643; Cho HJ, 2013, AM J OPHTHALMOL, V156, P1192, DOI 10.1016/j.ajo.2013.07.001; Koizumi H, 2011, BRIT J OPHTHALMOL, V95, P1555, DOI 10.1136/bjophthalmol-2011-300285; Yamazaki T, 2012, OPHTHALMOLOGY, V119, P1621, DOI 10.1016/j.ophtha.2012.02.022; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Ikuno Y, 2011, INVEST OPHTH VIS SCI, V52, P5536, DOI 10.1167/iovs.10-6811; Ellabban Abdallah A, 2012, Clin Ophthalmol, V6, P837, DOI 10.2147/OPTH.S30907; Hikichi T, 2010, AM J OPHTHALMOL, V150, P674, DOI 10.1016/j.ajo.2010.05.026; Ijiri S, 2015, GRAEF ARCH CLIN EXP, V253, P351, DOI 10.1007/s00417-014-2707-2; Inoue M, 2014, RETINA-J RET VIT DIS, V34, P2178, DOI 10.1097/IAE.0000000000000229; Sayanagi K, 2007, GRAEF ARCH CLIN EXP, V245, P1569, DOI 10.1007/s00417-007-0582-9; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	26	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	SEP	2015	99	9					1284	1288		10.1136/bjophthalmol-2014-306432		5	Ophthalmology	Ophthalmology	CQ2VL	WOS:000360460000027		
J	Kozuka, C; Sunagawa, S; Ueda, R; Higa, M; Ohshiro, Y; Tanaka, H; Shimizu-Okabe, C; Takayama, C; Matsushita, M; Tsutsui, M; Ishiuchi, S; Nakata, M; Yada, T; Miyazaki, J; Oyadomari, S; Shimabukuro, M; Masuzaki, H				Kozuka, Chisayo; Sunagawa, Sumito; Ueda, Rei; Higa, Moritake; Ohshiro, Yuzuru; Tanaka, Hideaki; Shimizu-Okabe, Chigusa; Takayama, Chitoshi; Matsushita, Masayuki; Tsutsui, Masato; Ishiuchi, Shogo; Nakata, Masanori; Yada, Toshihiko; Miyazaki, Jun-ichi; Oyadomari, Seiichi; Shimabukuro, Michio; Masuzaki, Hiroaki			A novel insulinotropic mechanism of whole grain-derived -oryzanol via the suppression of local dopamine D-2 receptor signalling in mouse islet	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							GLUCAGON-LIKE PEPTIDE-1; PANCREATIC BETA-CELLS; HIGH-FAT DIET; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA EXPRESSION; BROWN RICE; GAMMA-ORYZANOL; CONCISE GUIDE; IN-VIVO; ARRIVE GUIDELINES	Background and Purpose gamma-Oryzanol, derived from unrefined rice, attenuated the preference for dietary fat in mice, by decreasing hypothalamic endoplasmic reticulum stress. However, no peripheral mechanisms, whereby -oryzanol could ameliorate glucose dyshomeostasis were explored. Dopamine D-2 receptor signalling locally attenuates insulin secretion in pancreatic islets, presumably via decreased levels of intracellular cAMP. We therefore hypothesized that -oryzanol would improve high-fat diet (HFD)-induced dysfunction of islets through the suppression of local D-2 receptor signalling. Experimental Approach Glucose metabolism and regulation of molecules involved in D-2 receptor signalling in pancreatic islets were investigated in male C57BL/6J mice, fed HFD and treated with gamma-oryzanol . In isolated murine islets and the beta cell line, MIN6 , the effects of gamma-oryzanol on glucose-stimulated insulin secretion (GSIS) was analysed using siRNA for D-2 receptors and a variety of compounds which alter D-2 receptor signalling. Key Results In islets, -oryzanol enhanced GSIS via the activation of the cAMP/PKA pathway. Expression of molecules involved in D-2 receptor signalling was increased in islets from HFD-fed mice, which were reciprocally decreased by -oryzanol. Experiments with siRNA for D-2 receptors and D-2 receptor ligands in vitro suggest that gamma-oryzanol suppressed D-2 receptor signalling and augmented GSIS. Conclusions and Implications gamma-Oryzanol exhibited unique anti-diabetic properties. The unexpected effects of gamma-oryzanol on D-2 receptor signalling in islets may provide a novel; natural food-based, approach to anti-diabetic therapy.	[Kozuka, Chisayo; Sunagawa, Sumito; Ueda, Rei; Higa, Moritake; Ohshiro, Yuzuru; Tanaka, Hideaki; Masuzaki, Hiroaki] Univ Ryukyus, Grad Sch Med, Div Endocrinol Diabet & Metab, Rheumatol Dept Internal Med 2,Hematol, Okinawa, Japan; [Shimizu-Okabe, Chigusa; Takayama, Chitoshi] Univ Ryukyus, Grad Sch Med, Dept Mol Anat, Okinawa, Japan; [Matsushita, Masayuki] Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Okinawa, Japan; [Tsutsui, Masato] Univ Ryukyus, Grad Sch Med, Dept Pharmacol, Okinawa, Japan; [Ishiuchi, Shogo] Univ Ryukyus, Grad Sch Med, Dept Neurosurg, Okinawa, Japan; [Higa, Moritake] Tomishiro Cent Hosp, Diabet & Life Style Related Dis Ctr, Okinawa, Japan; [Ohshiro, Yuzuru] Okinawa Daiichi Hosp, Okinawa, Japan; [Tanaka, Hideaki] Tanaka Clin, Okinawa, Japan; [Nakata, Masanori; Yada, Toshihiko] Jichi Med Univ, Dept Physiol, Div Integrat Physiol, Sch Med, Shimotsuke, Tochigi, Japan; [Miyazaki, Jun-ichi] Osaka Univ, Sch Med, Div Stem Cell Regulat Res, Osaka, Japan; [Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Shimabukuro, Michio] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Cardiodiabet Med, Tokushima 770, Japan	Masuzaki, H (reprint author), Univ Ryukyus, Grad Sch Med, Div Endocrinol Diabet & Metab Hematol, Rheumatol Dept Internal Med 2, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	hiroaki@med.u-ryukyu.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X	Japan Society for the Promotion of Science (JSPS); Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); Takeda Science Foundation; Society for Woman's Health Science Research [13-A1-001]; Nestle Nutrition Council Japan; Narishige Neuroscience Research Foundation; Lotte Foundation; Metabolic Syndrome Foundation; Leave a Nest Grant; Japan Society for the Promotion of Science (KAKENHI) [24591338, 25.9668]; Technologies for creating next-generation agriculture, forestry and fisheries; Specified Project 'Establishing a research hub toward the development of an intellectual cluster in Okinawa Prefecture'	We thank M. Takaki (University of the Ryukyus, Japan) and F. Y. Wei (Kumamoto University, Japan) for technical help. We are grateful to M. Hirata, I. Asato and C. Noguchi (University of the Ryukyus, Japan) for assistance. The alpha-TC cells were kindly provided by T. Kitamura (Gunma University, Japan). This work was supported in part by Grants-in-Aid from Japan Society for the Promotion of Science (JSPS; KAKENHI Grant Nos. 24591338 and 25.9668), Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), 'Technologies for creating next-generation agriculture, forestry and fisheries', Takeda Science Foundation (Specified Research Grant), Society for Woman's Health Science Research (13-A1-001), the Nestle Nutrition Council Japan, Narishige Neuroscience Research Foundation, Lotte Foundation, Leave a Nest Grants, Metabolic Syndrome Foundation and Specified Project 'Establishing a research hub toward the development of an intellectual cluster in Okinawa Prefecture' (2011-2014). C. K. is a Research Fellow of JSPS.	Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Lerma-Garcia MJ, 2009, FOOD CHEM, V115, P389, DOI 10.1016/j.foodchem.2009.01.063; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Kozuka C, 2012, DIABETES, V61, P3084, DOI 10.2337/db11-1767; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Li YL, 2009, BRAIN RES, V1268, P181, DOI 10.1016/j.brainres.2009.02.075; Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Rayasam GV, 2007, EXPERT OPIN THER TAR, V11, P661, DOI 10.1517/14728222.11.5.661; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Kozuka C, 2015, ENDOCRINOLOGY, V156, P1242, DOI 10.1210/en.2014-1748; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1706, DOI 10.1111/bph.12450; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Missale C, 1998, PHYSIOL REV, V78, P189; Kozuka C, 2013, OBES RES CLIN PRACT, V7, pE165, DOI 10.1016/j.orcp.2013.02.003; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126; Walker JN, 2011, DIABETES OBES METAB, V13, P95, DOI 10.1111/j.1463-1326.2011.01450.x; Vucetic Z, 2012, J NEUROCHEM, V120, P891, DOI 10.1111/j.1471-4159.2012.07649.x; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109; Seino Y, 2010, J DIABETES INVEST, V1, P8, DOI 10.1111/j.2040-1124.2010.00022.x; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Ariyama Y, 2008, METABOLISM, V57, P1625, DOI 10.1016/j.metabol.2008.06.019; Bontempi S, 2007, ENDOCRINOLOGY, V148, P2563, DOI 10.1210/en.2006-1618; FEHMANN HC, 1992, ENDOCRINOLOGY, V130, P159, DOI 10.1210/en.130.1.159; Harris PE, 2008, J MOL MED-JMM, V86, P5, DOI 10.1007/s00109-007-0242-x; Ieiri T, 1982, Nihon Naibunpi Gakkai Zasshi, V58, P1350; MARSDEN CD, 1977, LANCET, V1, P345; Nakata M, 2010, J MOL NEUROSCI, V42, P404, DOI 10.1007/s12031-010-9383-4; Shimabukuro M, 2014, BRIT J NUTR, V111, P310, DOI 10.1017/S0007114513002432; Simpson N, 2012, MOL ENDOCRINOL, V26, P1757, DOI 10.1210/me.2012-1101; SIRTORI CR, 1972, NEW ENGL J MED, V287, P729, DOI 10.1056/NEJM197210122871501; SMITH GP, 1985, AM J PHYSIOL, V249, pR638; Tanaka T, 2007, CELL METAB, V5, P395, DOI 10.1016/j.cmet.2007.04.004; YADA T, 1993, ENDOCRINOLOGY, V133, P1685, DOI 10.1210/en.133.4.1685; Ohishi T, 2012, EXPERT OPIN INV DRUG, V21, P321, DOI 10.1517/13543784.2012.657797; Zmuda EJ, 2011, JOVE-J VIS EXP, V13, P2096, DOI DOI 10.3791/2096	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	SEP	2015	172	18					4519	4534		10.1111/bph.13236		16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ3GT	WOS:000360490800007		
J	Endoh, M				Endoh, Masao			Does levosimendan act as a Ca2+ sensitizer or PDE3 inhibitor?: Commentary on Orstavik etal., Br J Pharmacol 171: 5169-5181	BRITISH JOURNAL OF PHARMACOLOGY			English	Editorial Material						positive inotropic effect; phosphodiesterase inhibitor; Ca2+ sensitizer; amrinone; cilostamide; levosimendan; pimobendan; OR-1896; omecamtiv mecarbil	CANINE VENTRICULAR MYOCARDIUM; TRANSIENTS; CONTRACTILITY; MECHANISM; AGENTS; HEART	LINKED ARTICLE This article is a Commentary on Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GO, Levy FO, Skomedal T, Osnes J-B, and Qvigstad E (2014). PDE3-inhibition by levosimendan is sufficient to account for its inotropic effect in failing human heart.	Yamagata Univ, Dept Pharmacol, Sch Med, Yamagata 9909585, Japan	Endoh, M (reprint author), Yamagata Univ, Dept Pharmacol, Sch Med, Iida Nishi 2-2-2, Yamagata 9909585, Japan.	mendou@med.id.yamagata-u.ac.jp					Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Sato S, 1998, J MOL CELL CARDIOL, V30, P1115, DOI 10.1006/jmcc.1998.0677; SOLARO RJ, 1993, CIRC RES, V73, P981; HAIKALA H, 1995, J MOL CELL CARDIOL, V27, P1859, DOI 10.1016/0022-2828(95)90009-8; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; Endoh M, 2008, CIRC J, V72, P1915, DOI 10.1253/circj.CJ-08-0838; BLINKS JR, 1986, CIRCULATION, V73, P85; ENDOH M, 1986, CIRCULATION, V73, P117; Endoh M, 1998, CIRC RES, V83, P230; Endoh M, 2002, J CARDIOVASC PHARM, V40, P323, DOI 10.1097/01.FJC.0000019207.78822.A8; Orstavik O, 2014, BRIT J PHARMACOL, V171, P5169, DOI 10.1111/bph.12647; Takahashi R, 2002, N-S ARCH PHARMACOL, V366, P440, DOI 10.1007/s00210-002-0627-x; Takahashi R, 2005, BRIT J PHARMACOL, V145, P1143, DOI 10.1038/sj.bjp.0706292	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	SEP	2015	172	18					4594	4596		10.1111/bph.12649		3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ3GT	WOS:000360490800014		
J	Quang, ND; Chai, JC				Quang, Nguyen Duy; Chai, Jin Chun			Permeability of lime- and cement-treated clayey soils	CANADIAN GEOTECHNICAL JOURNAL			English	Article						permeability; clay; soil improvement; lime; cement	BEHAVIOR	The permeability (k) of lime-and cement-treated clayey soils was investigated in the laboratory by flexible-wall permeability tests and oedometer tests. Test results indicate that for the cement-treated soils (with up to 8% cement content by dry weight), the value of k is almost equal to that of untreated soils under identical void ratio (e) conditions, and the k value decreases significantly when the cement content is higher than 8%. For lime-treated soils, the threshold lime content is about 4%. Investigation of the soil microstructure using the mercury intrusion porosimetry (MIP) test and scanning electron microscope (SEM) imaging indicates that when the cementation products formed by the pozzolanic reaction fill mainly the intra-aggregate pores, the value of k is comparable for the treated and untreated samples. When the cementation products begin to fill the interaggregate pores, the value of k of the treated sample becomes smaller than that of the untreated soil sample under the identical e value condition. An indication that the cementation products have filled the interaggregate pores is the rapid increase in strength of the treated soil.	[Quang, Nguyen Duy; Chai, Jin Chun] Saga Univ, Dept Civil Engn & Architecture, Saga 840, Japan	Chai, JC (reprint author), Saga Univ, Dept Civil Engn & Architecture, Saga 840, Japan.	chai@cc.saga-u.ac.jp					Chew SH, 2004, J GEOTECH GEOENVIRON, V130, P696, DOI 10.1061/(ASCE)1090-0241(2004)130:7(696); Locat J, 1996, CAN GEOTECH J, V33, P654; Al-Mukhtar M, 2012, ENG GEOL, V139, P17, DOI 10.1016/j.enggeo.2012.04.004; Anandarajah A, 2003, J GEOTECH GEOENVIRON, V129, P163, DOI 10.1061/(ASCE)1090-0241(2003)129:2(163); DELAGE P, 1984, CAN GEOTECH J, V21, P21; Kang MS, 2003, INT OFFSHORE POLAR E, P385; Mahanta KK, 2012, APPL CLAY SCI, V59-60, P1, DOI 10.1016/j.clay.2012.02.014; McCallister L.D., 1992, ASTM GEOTECH TEST J, V15, P106; Mitchell J. K., 1993, FUNDAMENTALS SOIL BE; Nagaraj T.S., 2001, SOFT CLAY BEHAV ANAL; Schmitz R. M., 2006, GEOTECHNICAL GEOLOGI, V24, DOI 10.1007/s10706-005-3365-2; Tanaka H, 2003, SOILS FOUND, V43, P63; Taylor W.D., 1948, FUNDAMENTAL SOIL MEC; Yamadera A., 1999, THESIS SAGA U JAPAN	14	2	2	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-3674	1208-6010		CAN GEOTECH J	Can. Geotech. J.	SEP	2015	52	9					1221	1227		10.1139/cgj-2014-0134		7	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CQ0OS	WOS:000360296600002		
J	Fukuzawa, T				Fukuzawa, Toshihiko			Ferritin H subunit gene is specifically expressed in melanophore precursor-derived white pigment cells in which reflecting platelets are formed from stage II melanosomes in the periodic albino mutant of Xenopus laevis	CELL AND TISSUE RESEARCH			English	Article						Melanophore; Iridophore; Ferritin H subunit; Periodic albino; Xenopus laevis	NEURAL CREST; PATTERN DEVELOPMENT; MOTILE IRIDOPHORES; DANIO-RERIO; WILD-TYPE; ZEBRAFISH; MELANOCYTES; MELANOGENESIS; EPITHELIUM; MUTATIONS	"White pigment cells" are derived from melanophore precursors and contain both melanophore-specific and iridophore-specific pigment organelles. Whereas melanophores differentiate in the wild type regenerating tail, white pigment cells appear in the regenerating tail in the periodic albino mutant (a (p) /a (p) ) of Xenopus laevis. The localization and density of white pigment cells in the mutant regenerating tail are similar to those of melanophores in the wild type regenerating tail. Here, white pigment cells in the mutant regenerating tail have been compared with melanophores in the wild type regenerating tail in the presence of phenylthiourea (PTU), which inhibits melanosome maturation in melanophores but does not affect reflecting platelet formation in white pigment cells. Ultrastructural analysis shows that reflecting platelet formation in white pigment cells is different from that in iridophores. Reflecting platelets in iridophores are formed from spherical vesicles with electron-dense material, whereas they are formed from stage II melanosomes characteristic of melanophore precursors in white pigment cells. Ultrastructural features of pigment organelles, except reflecting platelets, are similar between mutant melanophores and white pigment cells. In an attempt to identify specific genes in white pigment cells, a subtracted cDNA library enriched for mutant cDNAs has been prepared. Subtracted cDNA fragments have been cloned and selected by whole mount in situ hybridization. Among cDNA fragments examined so far, the ferritin H subunit gene is specifically expressed in white pigment cells, but not in melanophores. Pigment organellogenesis and specific gene expression in white pigment cells are also discussed.	Keio Univ, Dept Biol, Kohoku Ku, Yokohama, Kanagawa 2238521, Japan	Fukuzawa, T (reprint author), Keio Univ, Dept Biol, Kohoku Ku, Hiyoshi 4-1-1, Yokohama, Kanagawa 2238521, Japan.	fukuzawa@fbc.keio.ac.jp			Keio Gijuku Academic Development Fund	This work was supported by Keio Gijuku Academic Development Funds.	Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; Kelsh RN, 2009, SEMIN CELL DEV BIOL, V20, P90, DOI 10.1016/j.semcdb.2008.10.001; Parichy DM, 2000, DEVELOPMENT, V127, P3031; BAGNARA JT, 1979, SCIENCE, V203, P410, DOI 10.1126/science.760198; MATSUNO A, 1989, PIGM CELL RES, V2, P431, DOI 10.1111/j.1600-0749.1989.tb00233.x; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; ROHRLICH ST, 1972, J CELL BIOL, V53, P38, DOI 10.1083/jcb.53.1.38; Ng A, 2009, DEVELOPMENT, V136, P2601, DOI 10.1242/dev.038315; MAYOR R, 1995, DEVELOPMENT, V121, P767; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Parichy DM, 1999, DEVELOPMENT, V126, P3425; NAGAISHI H, 1992, ZOOL SCI, V9, P65; Schiaffino MV, 2010, INT J BIOCHEM CELL B, V42, P1094, DOI 10.1016/j.biocel.2010.03.023; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Parichy DM, 2006, HEREDITY, V97, P200, DOI 10.1038/sj.hdy.6800867; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bagnara J. T., 1973, CHROMATOPHORES COLOR; Bagnara JT, 1979, PIGMENT CELL, V4, P13; Bagnara JT, 1998, PIGMENTARY SYSTEM PH, P9; Behra M, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-6; Colanesi S, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00977.x; Dooly CM, 2012, PIGM CELL MELANOMA R, V26, P205; EPPIG JJ, 1970, J EMBRYOL EXP MORPH, V24, P447; FUKUZAWA T, 1989, PIGM CELL RES, V2, P171, DOI 10.1111/j.1600-0749.1989.tb00183.x; Fukuzawa T, 2010, CELL TISSUE RES, V342, P53, DOI 10.1007/s00441-010-1042-0; FUKUZAWA T, 1988, DEV BIOL, V129, P25, DOI 10.1016/0012-1606(88)90158-3; Fukuzawa T, 2006, HIYOSHI REV NAT SCI, V40, P15; Fukuzawa T, 2004, PIGM CELL RES, V17, P252, DOI 10.1111/j.1600-0749.2004.00135.x; FUKUZAWA T, 1986, J EMBRYOL EXP MORPH, V91, P65; FUKUZAWA T, 1987, PIGM CELL RES, V1, P197, DOI 10.1111/j.1600-0749.1987.tb00413.x; Gruber JV, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/702120; Hall BK, 1988, NEURAL CREST; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Higdon CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067801; HOPERSKAYA OA, 1975, J EMBRYOL EXP MORPH, V34, P253; HOPERSKAYA OA, 1981, DIFFERENTIATION, V20, P104, DOI 10.1111/j.1432-0436.1981.tb01164.x; Hultman KA, 2010, DEV BIOL, V337, P425, DOI 10.1016/j.ydbio.2009.11.019; Hultman KA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000544; JONES KW, 1963, J EMBRYOL EXP MORPH, V11, P135; Kaczara P, 2012, PIGM CELL MELANOMA R, V25, P804, DOI 10.1111/pcmr.12008; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; Le Douarin N, 1999, NEURAL CREST; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Lister JA, 2011, DEV DYNAM, V240, P2529, DOI 10.1002/dvdy.22743; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; MACMILLAN GJ, 1979, J EMBRYOL EXP MORPH, V52, P165; MACMILLAN GJ, 1981, J EMBRYOL EXP MORPH, V64, P333; MACMILLAN GJ, 1981, EXPERIENTIA, V37, P183, DOI 10.1007/BF01963222; MORRISON RL, 1991, J MORPHOL, V209, P229, DOI 10.1002/jmor.1052090209; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PIETZSCHROHRSCHNEIDER I, 1977, CELL TISSUE RES, V178, P279; SELDENRIJK R, 1982, CELL TISSUE RES, V222, P1; Shin Y, 2005, DEV DYNAM, V232, P432, DOI 10.1002/dvdy.20229; SIMS RT, 1962, Q J MICROSC SCI, V103, P439; Sive H.L., 2000, EARLY DEV XENOPUS LA; Smith DR, 2004, EXP CELL RES, V298, P521, DOI 10.1016/j.yexcr.2004.04.033; TAYLOR JD, 1969, GEN COMP ENDOCR, V12, P405, DOI 10.1016/0016-6480(69)90157-9; Wolkow N, 2011, ARCH OPHTHALMOL-CHIC, V129, P1466, DOI 10.1001/archophthalmol.2011.309	63	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	SEP	2015	361	3					733	744		10.1007/s00441-015-2133-8		12	Cell Biology	Cell Biology	CQ0SU	WOS:000360308100007		
J	Ogata, M; Ota, Y; Nanno, M; Suzuki, R; Itoh, T				Ogata, Masaki; Ota, Yuta; Nanno, Masanobu; Suzuki, Ryuji; Itoh, Tsunetoshi			Autocrine DNA fragmentation of intra-epithelial lymphocytes (IELs) in mouse small intestine	CELL AND TISSUE RESEARCH			English	Article						Intraepithelial lymphocyte (IEL); DNA fragmentation; Immunohistology; Small intestine; Mouse (Balb/c)	DELTA-T-CELLS; MURINE SMALL-INTESTINE; GAMMA-DELTA; GRANZYME-B; EPITHELIAL-CELLS; DEFICIENT MICE; PERFORIN; DIFFERENTIATION; CYTOTOXICITY; IDENTIFICATION	Intraepithelial lymphocytes (IELs) are present in the intestinal epithelium. Mechanisms of IELs for the protection of villi from foreign antigens and from infections by micro-organisms have not been sufficiently explained. Although more than 70 % of mouse duodenal and jejunal IELs bear gamma delta TCR (gamma delta IELs), the functions of gamma delta IELs are little investigated. We stimulate gamma delta IELs by anti-CD3 monoclonal antibody (mAb) injection. The mAb activates gamma delta IELs to release Granzyme B (GrB) into the spaces surrounding the gamma delta IELs and intestinal villous epithelial cells (IECs). Released GrB induces DNA fragmentation in IECs independently of Perforin (Pfn). IECs immediately repair their fragmented DNA. Activated IELs reduce their cell size, remain for some time in the epithelium after the activation and are ultimately eliminated without leaving the site. We focus our attention on the response of IELs to the released GrB present in the gap surrounding IELs, after activation, in order to examine whether the released GrB has a similar effect on IELs to that observed on IECs in our previous studies. DNA fragmentation is also induced in IELs together with the repair of fragmented DNA thereafter. The time-kinetics of both events were found to be identical to those observed in IECs. DNA fragmentation in IELs is Pfn-independent. Here, we present Pfn-independent "autocrine DNA fragmentation" in IELs and the repair of fragmented DNA in IELs and discuss their biological significance. Autocrine DNA fragmentation has never been reported to date in vivo.	[Ogata, Masaki; Ota, Yuta; Itoh, Tsunetoshi] Tohoku Univ, Sch Med, Dept Cell Biol, Div Immunol & Embryol, Sendai, Miyagi 9808575, Japan; [Nanno, Masanobu] Yakult Cent Inst Microbiol Res, Div Immunol, Dept Appl Res, Tokyo, Japan; [Suzuki, Ryuji] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Dept Rheumatol & Clin Immunol, Sagamihara, Kanagawa, Japan	Ogata, M (reprint author), Tohoku Univ, Sch Med, Dept Cell Biol, Div Immunol & Embryol, Sendai, Miyagi 9808575, Japan.	ogata@immem.med.tohoku.ac.jp			Ministry of Education, Science and Culture, Japan [20590181, 21590207]; Japan Science and Technology Agency (JST)	This work was in part supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (20590181 to M.O. and 21590207 to T.I.) and the Japan Science and Technology Agency (JST).	GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; CERFBENSUSSAN N, 1987, EUR J IMMUNOL, V17, P1279, DOI 10.1002/eji.1830170910; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; HOUSLEY RM, 1994, J CLIN INVEST, V94, P1764, DOI 10.1172/JCI117524; Kuhla A, 2009, AM J PHYSIOL-GASTR L, V296, pG1069, DOI 10.1152/ajpgi.90689.2008; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Ogata M, 2014, CELL TISSUE RES, V356, P217, DOI 10.1007/s00441-013-1786-4; ISHIKAWA H, 1993, P NATL ACAD SCI USA, V90, P8204, DOI 10.1073/pnas.90.17.8204; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Guerriero JL, 2011, J IMMUNOL, V186, P3517, DOI 10.4049/jimmunol.1003267; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Choy JC, 2005, AM J TRANSPLANT, V5, P494, DOI 10.1111/j.1600-6143.2004.00710.x; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Ogata M, 2013, CELL TISSUE RES, V352, P287, DOI 10.1007/s00441-012-1549-7; Beagley KW, 1998, CRIT REV IMMUNOL, V18, P237; BEAGLEY KW, 1995, J IMMUNOL, V154, P5611; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; GRAMZINSKI RA, 1993, INT IMMUNOL, V5, P145, DOI 10.1093/intimm/5.2.145; GUYGRAND D, 1991, J EXP MED, V173, P1549, DOI 10.1084/jem.173.6.1549; HIROI T, 1995, EUR J IMMUNOL, V25, P2743, DOI 10.1002/eji.1830251005; Hu D, 2011, DEV BIOL, V358, P231, DOI 10.1016/j.ydbio.2011.07.036; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; KILSHAW PJ, 1988, IMMUNOL LETT, V18, P149, DOI 10.1016/0165-2478(88)90056-9; LEFRANCOIS L, 1991, IMMUNOL TODAY, V12, P436, DOI 10.1016/0167-5699(91)90015-L; LEFRANCOIS L, 1995, IMMUNOL TODAY, V16, P16, DOI 10.1016/0167-5699(95)80065-4; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; NAKAMURA M, 1995, ARCH HISTOL CYTOL, V58, P249, DOI 10.1679/aohc.58.249; Ogata M, 2009, CELL TISSUE RES, V335, P371, DOI 10.1007/s00441-008-0727-0; PENNEY L, 1995, IMMUNOLOGY, V86, P212; POUSSIER P, 1994, J EXP MED, V180, P1185, DOI 10.1084/jem.180.4.1185; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; RUSSELL GJ, 1994, EUR J IMMUNOL, V24, P2832, DOI 10.1002/eji.1830241138; Shi LF, 1997, J EXP MED, V185, P855, DOI 10.1084/jem.185.5.855; TAGUCHI T, 1991, J IMMUNOL, V147, P3736; Tamura A, 2003, CELL TISSUE RES, V313, P47, DOI 10.1007/s00441-003-0706-4; Trapani JA, 2000, CURR OPIN IMMUNOL, V12, P323, DOI 10.1016/S0952-7915(00)00094-7; Trapani JA, 2012, CELL DEATH DIFFER, V19, P21, DOI 10.1038/cdd.2011.156; Yaguchi K, 2004, CELL TISSUE RES, V315, P71, DOI 10.1007/s00441-003-0795-0	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	SEP	2015	361	3					799	810		10.1007/s00441-015-2151-6		12	Cell Biology	Cell Biology	CQ0SU	WOS:000360308100013		
J	Gerasimenko, JV; Charlesworth, RM; Sherwood, MW; Ferdek, PE; Mikoshiba, K; Parrington, J; Petersen, OH; Gerasimenko, OV				Gerasimenko, Julia V.; Charlesworth, Richard M.; Sherwood, Mark W.; Ferdek, Pawel E.; Mikoshiba, Katsuhiko; Parrington, John; Petersen, Ole H.; Gerasimenko, Oleg V.			Both RyRs and TPCs are required for NAADP-induced intracellular Ca2+ release	CELL CALCIUM			English	Article						Pancreatic acinar cells; TPC2 knockouts; cADPR; Acidic store; RyR3 knockouts	PANCREATIC-ACINAR-CELLS; ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; INOSITOL TRISPHOSPHATE; RYANODINE RECEPTOR; ENDOPLASMIC-RETICULUM; CALCIUM MOBILIZATION; ZYMOGEN GRANULES; GLAND-CELLS; CHANNELS	Intracellular Ca2+ release is mostly mediated by inositol trisphosphate, but intracellular cyclic-ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) are important messengers in many systems. Whereas cADPR generally activates type 2 ryanodine receptors (RyR2s), the NAADP-activated Ca2+ release mechanism is less clear. Using knockouts and antibodies against RyRs and Two-Pore Channels (TPCs), we have compared their relative importance for NAADP-induced Ca2+ release from two-photon permeabilized pancreatic acinar cells. In these cells, cholecystokinin-elicited Ca2+ release is mediated by NAADP. TPC2-KO reduced NAADP-induced Ca2+ release by 64%, but the combination of TPC2-KO and an antibody against TPC1, significantly reduced Ca2+ release by 86% (64% vs. 86%, p < 0.0002). In RyR3-KO, NAADP-evoked Ca2+ release reduced by similar to 50% but, when combined with antibodies against RyR1, responses were 90% inhibited. Antibodies against RyR2 had practically no effect on NAADP-evoked Ca2+ release, but reduced release in response to cADPR by 55%. Antibodies to RyR1 inhibited NAADP-induced Ca2+ liberation by 81%, but only reduced cADPR responses by 30%. We conclude that full NAADP-mediated Ca2+ release requires both TPCs and RyRs. The sequence of relative importance for NAADP-elicited Ca2+ release from the all stores is RyR1 > TPC2 > RyR3 > TPC1 " RyR2. However, when assessing NAADP-induced Ca2+ release solely from the acidic stores (granules/endosomes/lysosomes), antibodies against TPC2 and TPC1 virtually abolished the Ca2+ liberation as did antibodies against RyR1 and RyR3. Our results indicate that the primary, but very small, NAADP-elicited Ca2+ release via TPCs from endosomes/lysosomes triggers the detectable Ca2+-induced Ca2+ release via RyR1 and RyR3 occurring from the granules and the ER. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[Gerasimenko, Julia V.; Charlesworth, Richard M.; Ferdek, Pawel E.; Petersen, Ole H.; Gerasimenko, Oleg V.] Cardiff Univ, Cardiff Sch Biosci, Med Res Council Grp, Cardiff CF10 3AX, S Glam, Wales; [Sherwood, Mark W.; Mikoshiba, Katsuhiko] Riken Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Mikoshiba, Katsuhiko] ICORP SORST, Ca2 Oscillat Project, JST, Wako, Saitama, Japan; [Parrington, John] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	Gerasimenko, OV (reprint author), Cardiff Univ, Sch Biosci, Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	gerasimenkoov@cardiff.ac.uk	Gerasimenko, Oleg/A-6622-2010		Medical Research Council Programme [MR/J002771/1]; Wellcome Programme [084101/Z/07/Z]	This work was supported by Medical Research Council Programme Grant MR/J002771/1. O.H.P. is a Medical Research Council Professor (G19/22/2). RyR3KO mice were provided by Dr. K. Mikoshiba's Lab [46]. TPC2 KO mice were generated at the Department of Pharmacology, University of Oxford, with funds from a Wellcome Programme grant 084101/Z/07/Z awarded to J.P. and Prof. Antony Galione [26].	Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Nguyen T, 1998, NATURE, V395, P908; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; Futatsugi A, 1999, NEURON, V24, P701, DOI 10.1016/S0896-6273(00)81123-X; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; STREB H, 1984, J MEMBRANE BIOL, V81, P241, DOI 10.1007/BF01868717; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Petersen OH, 2011, CELL CALCIUM, V50, P193, DOI 10.1016/j.ceca.2011.02.010; Yule DI, 1997, J BIOL CHEM, V272, P9093; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rosen D, 2009, J BIOL CHEM, V284, P34930, DOI 10.1074/jbc.M109.016519; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; LAMBRECHT G, 1992, EUR J PHARMACOL, V217, P217, DOI 10.1016/0014-2999(92)90877-7; Gerasimenko JV, 2014, J PHYSIOL-LONDON, V592, P269, DOI 10.1113/jphysiol.2013.261784; Petersen OH, 2009, CELL CALCIUM, V45, P634, DOI 10.1016/j.ceca.2009.02.005; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Billington RA, 2007, CELL CALCIUM, V41, P505, DOI 10.1016/j.ceca.2006.10.002; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Galione A., 2014, CELL CALCIUM; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; Guse AH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002890; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; NIELSEN SP, 1972, J PHYSIOL-LONDON, V223, P685; SCHULZ I, 1989, CELL CALCIUM, V10, P325, DOI 10.1016/0143-4160(89)90058-4; Selinger Z., 1970, BIOCHIM BIOPHYS ACTA, V2013, P326; Singaravelu K, 2006, CELL CALCIUM, V39, P143, DOI 10.1016/j.ceca.2005.10.001; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Vigne P, 1996, BRIT J PHARMACOL, V119, P360; WAKUI M, 1990, CELL, V63, P1025, DOI 10.1016/0092-8674(90)90505-9; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; YOO SH, 1990, J BIOL CHEM, V265, P13446; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; ZIGANSHIN AU, 1993, BRIT J PHARMACOL, V110, P1491	46	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4160	1532-1991		CELL CALCIUM	Cell Calcium	SEP	2015	58	3					237	245		10.1016/j.ceca.2015.05.005		9	Cell Biology	Cell Biology	CP9YS	WOS:000360252400001		
J	Takada, Y; Hirano, M; Kiyonaka, S; Ueda, Y; Yamaguchi, K; Nakahara, K; Mori, MX; Mori, Y				Takada, Yoshinori; Hirano, Mitsuru; Kiyonaka, Shigeki; Ueda, Yoshifumi; Yamaguchi, Kazuma; Nakahara, Keiko; Mori, Masayuki X.; Mori, Yasuo			Rab3 interacting molecule 3 mutations associated with autism alter regulation of voltage-dependent Ca2+ channels	CELL CALCIUM			English	Article						Autism; Calcium; Neurotransmitter release; Rab3 interacting molecule; Voltage-dependent calcium channel	PRESYNAPTIC ACTIVE ZONES; SWISS-MODEL WORKSPACE; CALCIUM-CHANNEL; SPECTRUM DISORDERS; RIM PROTEINS; N-TYPE; NEURONAL DIFFERENTIATION; FUNCTIONAL INTERACTION; EXPRESSION; SYNTAXIN	Autism is a neurodevelopmental psychiatric disorder characterized by impaired reciprocal social interaction, disrupted communication, and restricted and stereotyped patterns of interests. Autism is known to have a strong genetic component. Although mutations in several genes account for only a small proportion of individuals with autism, they provide insight into potential biological mechanisms that underlie autism, such as dysfunction in Ca2+ signaling, synaptic dysfunction, and abnormal brain connectivity. In autism patients, two mutations have been reported in the Rab3 interacting molecule 3 (RIM3) gene. We have previously demonstrated that RIM3 physically and functionally interacts with voltage-dependent Ca2+ channels (VDCCs) expressed in neurons via the beta subunits, and increases neurotransmitter release. Here, by introducing corresponding autism-associated mutations that replace glutamic acid residue 176 with alanine (E176A) and methionine residue 259 with valine (M259V) into the C2B domain of mouse RIM3, we demonstrate that both mutations partly cancel the suppressive RIM3 effect on voltage-dependent inactivation of Ba2+ currents through P/Q-type Ca(V)2.1 recombinantly expressed in HEK293 cells. In recombinant N-type Ca(V)2.2 VDCCs, the attenuation of the suppressive RIM3 effect on voltage-dependent inactivation is conserved for M259V but not El 76A. Slowing of activation speed of P/Q-type Ca(V)2.1 currents by RIM3 is abolished in E176A, while the physical interaction between RIM3 and beta subunits is significantly attenuated in M259V. Moreover, increases by RIM3 in depolarization-induced Ca2+ influx and acetylcholine release are significantly attenuated by El 76A in rat pheochromocytoma PC12 cells. Thus, our data raise the interesting possibility that autism phenotypes are elicited by synaptic dysfunction via altered regulation of presynaptic VDCC function and neurotransmitter release. (C) 2015 Elsevier Ltd. All rights reserved.	[Takada, Yoshinori; Hirano, Mitsuru; Kiyonaka, Shigeki; Ueda, Yoshifumi; Yamaguchi, Kazuma; Nakahara, Keiko; Mori, Masayuki X.; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Mol Biol Lab, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Lab Environm Syst Biol, Dept Technol & Ecol, Kyoto 6158510, Japan	Mori, Y (reprint author), Kyoto Univ, Grad Sch Engn, Mol Biol Lab, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan.	mori@sbchem.lcyoto-u.ac.jp					Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1046/j.1601-183X.2003.00037.x; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alvarez-Baron E, 2013, J NEUROSCI, V33, P824, DOI 10.1523/JNEUROSCI.2229-12.2013; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Guerini FR, 2011, PHARMACOL RES, V64, P283, DOI 10.1016/j.phrs.2011.03.015; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Weidenhofer J, 2006, MOL CELL NEUROSCI, V31, P243, DOI 10.1016/j.mcn.2005.09.013; Meir A, 1999, PHYSIOL REV, V79, P1019; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Arons MH, 2012, J NEUROSCI, V32, P14966, DOI 10.1523/JNEUROSCI.2215-12.2012; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Laumonnier F, 2006, AM J PSYCHIAT, V163, P1622, DOI 10.1176/appi.ajp.163.9.1622; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Autism Developmental Disabilities Monitoring Network Surveillance Year Principal I Centers for Disease C Prevention, 2012, MMWR-MORBID MORTAL W, V61, P1; Billings SE, 2012, NEUROREPORT, V23, P49, DOI 10.1097/WNR.0b013e32834e7deb; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Aamodt S M, 1999, Adv Neurol, V79, P133; Gandini MA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187757; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Guan R, 2007, BIOCHEMISTRY-US, V46, P8988, DOI 10.1021/bi700698a; Kang MG, 2006, P NATL ACAD SCI USA, V103, P5561, DOI 10.1073/pnas.0601289103; Kiyonaka S, 2012, J BIOCHEM, V152, P149, DOI 10.1093/jb/mvs054; Kumar RA, 2010, J MED GENET, V47, P81, DOI 10.1136/jmg.2008.065821; Liang F, 2007, J COMP NEUROL, V503, P501, DOI 10.1002/cne.21403; MILLER RJ, 1988, TRENDS NEUROSCI, V11, P415, DOI 10.1016/0166-2236(88)90191-9; NIIDOME T, 1994, BIOCHEM BIOPH RES CO, V203, P1821, DOI 10.1006/bbrc.1994.2399; Nishida M, 1999, BIOCHEM BIOPH RES CO, V262, P350, DOI 10.1006/bbrc.1999.1218; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; SOLEM M, 1995, J NEUROSCI, V15, P5966; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Stephens GJ, 2001, EUR J NEUROSCI, V13, P1902, DOI 10.1046/j.0953-816x.2001.01566.x; Uriu Y, 2010, J BIOL CHEM, V285, P21750, DOI 10.1074/jbc.M110.101311; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Weidenhofer J, 2008, J PSYCHIATR RES, V43, P282, DOI 10.1016/j.jpsychires.2008.04.001; Wiser O, 1996, EMBO J, V15, P4100; Zhong HJ, 1999, NAT NEUROSCI, V2, P939	65	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4160	1532-1991		CELL CALCIUM	Cell Calcium	SEP	2015	58	3					296	306		10.1016/j.ceca.2015.06.007		11	Cell Biology	Cell Biology	CP9YS	WOS:000360252400007		
J	Takasu, NN; Nakamura, TJ; Tokuda, IT; Todo, T; Block, GD; Nakamura, W				Takasu, Nana N.; Nakamura, Takahiro J.; Tokuda, Isao T.; Todo, Takeshi; Block, Gene D.; Nakamura, Wataru			Recovery from Age-Related Infertility under Environmental Light-Dark Cycles Adjusted to the Intrinsic Circadian Period	CELL REPORTS			English	Article							TIME-SERIES DATA; ESTROUS CYCLICITY; PERMUTATION TEST; CLOCK; OVULATION; RHYTHM; MOUSE; MAINTENANCE; EXPRESSION; PATTERNS	Female reproductive function changes during aging with the estrous cycle becoming more irregular during the transition to menopause. We found that intermittent shifts of the light-dark cycle disrupted regularity of estrous cycles in middle-aged female mice, whose estrous cycles were regular under unperturbed 24-hr light-dark cycles. Although female mice deficient in Cry1 or Cry2, the core components of the molecular circadian clock, exhibited regular estrous cycles during youth, they showed accelerated senescence characterized by irregular and unstable estrous cycles and resultant infertility in middle age. Notably, tuning the period length of the environmental light-dark cycles closely to the endogenous one inherent in the Cry-deficient females restored the regularity of the estrous cycles and, consequently, improved fertility in middle age. These results suggest that reproductive potential can be strongly influenced by age-related changes in the circadian system and normal reproductive functioning can be rescued by the manipulation of environmental timing signals.	[Takasu, Nana N.; Nakamura, Wataru] Osaka Univ, Grad Sch Dent, Lab Oral Chronobiol, Suita, Osaka 5650871, Japan; [Nakamura, Takahiro J.] Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa 2148571, Japan; [Tokuda, Isao T.] Ritsumeikan Univ, Dept Mech Engn, Kusatsu, Shiga 5258577, Japan; [Todo, Takeshi] Osaka Univ, Grad Sch Med, Dept Radiat Biol & Med Genet, Suita, Osaka 5650871, Japan; [Block, Gene D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Nakamura, Wataru] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Block, GD (reprint author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	gblock@conet.ucla.edu; wataru@dent.osaka-u.ac.jp			Japan Science and Technology Agency PRESTO program	We thank Satomi Morita and Hitoshi Uchida for technical assistance. This work was supported by the Japan Science and Technology Agency PRESTO program (to W.N.). N.N.T. is a research fellow of the Japan Society for the Promotion of Science.	ALLEVA JJ, 1971, ENDOCRINOLOGY, V88, P1368; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; de la Iglesia HO, 2006, ENDOCRINOLOGY, V147, P1148, DOI 10.1210/en.2005-1311; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Gillespie JMA, 2003, ENDOCRINOLOGY, V144, P5285, DOI 10.1210/en.2003-0802; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291; Miller BH, 2006, BIOL REPROD, V75, P778, DOI 10.1095/biolreprod.106.052845; van der Horst GTJ, 1999, NATURE, V398, P627; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; EVERETT JW, 1950, ENDOCRINOLOGY, V47, P198; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Ratajczak CK, 2009, ENDOCRINOLOGY, V150, P1879, DOI 10.1210/en.2008-1021; Sellix MT, 2010, TRENDS ENDOCRIN MET, V21, P628, DOI 10.1016/j.tem.2010.06.002; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; BINGEL AS, 1969, J REPROD FERTIL, V19, P223; BROWNGRANT K, 1977, PROC R SOC SER B-BIO, V198, P279, DOI 10.1098/rspb.1977.0098; CARMICHAEL MS, 1981, P NATL ACAD SCI-BIOL, V78, P7830, DOI 10.1073/pnas.78.12.7830; Chandra A., 2013, NATL HLTH STAT REP, V67, P19; Chandra A, 2013, NATL HLTH STAT REPOR, V67, P1; Chappell PE, 2005, J NEUROENDOCRINOL, V17, P119, DOI 10.1111/j.1365.-2826.2005.01270.x; Chappell PE, 2003, J NEUROSCI, V23, P11202; Kopp C, 2006, BEHAV BRAIN RES, V167, P165, DOI 10.1016/j.bbr.2005.09.001; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; ODELL RH, 1975, ANN BIOMED ENG, V3, P160, DOI 10.1007/BF02363068; Pilorz V, 2008, REPRODUCTION, V135, P559, DOI 10.1530/REP-07-0434; Ptitsyn AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S10; Sellix MT, 2010, CURR BIOL, V20, pR266, DOI 10.1016/j.cub.2010.01.045; TAKAHASHI JS, 1980, AM J PHYSIOL, V239, pR497; WISE PM, 1988, P NATL ACAD SCI USA, V85, P5305, DOI 10.1073/pnas.85.14.5305	31	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	SEP 1	2015	12	9					1407	1413		10.1016/j.celrep.2015.07.049		7	Cell Biology	Cell Biology	CQ4KS	WOS:000360574200006		
J	Kondoh, A; Aoki, T; Terada, M				Kondoh, Azusa; Aoki, Takuma; Terada, Masahiro			Synthesis of Phenanthrene Derivatives by Intramolecular Cyclization Utilizing the [1,2]-Phospha-Brook Rearrangement Catalyzed by a Bronsted Base	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						rearrangement; phosphazenes; organocatalysis; cyclization; phenanthrenes	POLYCYCLIC AROMATIC-HYDROCARBONS; PHOSPHA-BROOK REARRANGEMENT; ACYL PHOSPHONATES; PHENANTHROQUINOLIZIDINE ALKALOIDS; 6-EXO-DIG CYCLOISOMERIZATION; SUBSTITUTED PHENANTHRENES; ALKYNES; CONSTRUCTION; METATHESIS; BENZANNULATION	The synthesis of functionalized phenanthrene derivatives was achieved by intramolecular cyclization utilizing the [1,2]-phospha-Brook rearrangement under BrOnsted base catalysis. Treatment of biaryl compounds having an -ketoester moiety and an alkyne moiety at the 2 and 2 positions, respectively, with diisopropyl phosphite in the presence of a catalytic amount of phosphazene base P2-tBu provides 9,10-disubstituted phenanthrene derivatives in high yields. This reaction involves the generation of an ester enolate through an umpolung process, that is, addition of diisopropyl phosphite to a keto moiety followed by the [1,2]-phospha-Brook rearrangement, the intramolecular addition to an alkyne, and the [3,3] rearrangement of the allylic phosphate moiety in a consecutive fashion.	[Kondoh, Azusa; Terada, Masahiro] Tohoku Univ, Res & Analyt Ctr Giant Mol, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Aoki, Takuma; Terada, Masahiro] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	Terada, M (reprint author), Tohoku Univ, Res & Analyt Ctr Giant Mol, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	mterada@m.tohoku.ac.jp			MEXT (Japan); JSPS	This research was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" from MEXT (Japan) and a Grant-in-Aid for Scientific Research from the JSPS.	Demir AS, 2007, J ORG CHEM, V72, P7439, DOI 10.1021/jo0710073; Mamane V, 2004, CHEM-EUR J, V10, P4556, DOI 10.1002/chem.200400220; Matsumoto A, 2011, J AM CHEM SOC, V133, P6557, DOI 10.1021/ja201931e; Larock RC, 1997, J ORG CHEM, V62, P7536, DOI 10.1021/jo9712557; Wei LY, 2006, BIOORGAN MED CHEM, V14, P6560, DOI 10.1016/j.bmc.2006.06.009; Wang CY, 2010, J AM CHEM SOC, V132, P14006, DOI 10.1021/ja106130r; Dubois F, 1998, TETRAHEDRON LETT, V39, P5039, DOI 10.1016/S0040-4039(98)00996-4; Iuliano A, 2004, ORG LETT, V6, P3711, DOI 10.1021/ol048668w; Yao TL, 2004, ORG LETT, V6, P2677, DOI 10.1021/ol049161o; Wang KL, 2009, J ORG CHEM, V74, P935, DOI 10.1021/jo8021633; FLOYD AJ, 1976, CHEM REV, V76, P509, DOI 10.1021/cr60303a001; Liu ZJ, 2007, ANGEW CHEM INT EDIT, V46, P2535, DOI 10.1002/anie.200604969; Hossain ML, 2014, J ORG CHEM, V79, P8689, DOI 10.1021/jo501489c; CANNON JG, 1975, J MED CHEM, V18, P110, DOI 10.1021/jm00235a026; de Koning CB, 1998, TETRAHEDRON LETT, V39, P8725, DOI 10.1016/S0040-4039(98)01919-4; Xia Y, 2012, ANGEW CHEM INT EDIT, V51, P5714, DOI 10.1002/anie.201201374; Chen YF, 2011, ADV SYNTH CATAL, V353, P392, DOI 10.1002/adsc.201000644; Shen HC, 2005, J ORG CHEM, V70, P10113, DOI 10.1021/jo0512599; Kondoh A, 2014, ORG LETT, V16, P3528, DOI 10.1021/ol501479t; Kim YH, 2008, J ORG CHEM, V73, P495, DOI 10.1021/jo702001n; Demir AS, 2009, J ORG CHEM, V74, P2197, DOI 10.1021/jo8026627; Gies AE, 1999, J ORG CHEM, V64, P3650, DOI 10.1021/jo982522r; KATZ TJ, 1985, J AM CHEM SOC, V107, P737, DOI 10.1021/ja00289a054; Kuninobu Y, 2011, J ORG CHEM, V76, P7005, DOI 10.1021/jo200861s; Tovar JD, 2002, J ORGANOMET CHEM, V653, P215, DOI 10.1016/S0022-328X(02)01166-X; Kanno K, 2005, ORG LETT, V7, P5453, DOI 10.1021/ol052214x; Demir AS, 2005, J ORG CHEM, V70, P10584, DOI 10.1021/jo051811u; Kwon Y, 2013, ORG LETT, V15, P920, DOI 10.1021/ol400073s; Corbett MT, 2012, ANGEW CHEM INT EDIT, V51, P4685, DOI 10.1002/anie.201200559; Harrowven DC, 2002, TETRAHEDRON LETT, V43, P3185, DOI 10.1016/S0040-4039(02)00505-1; Furstner A, 2002, J ORG CHEM, V67, P6264, DOI 10.1021/jo025962y; Kondoh A, 2013, ORG LETT, V15, P4568, DOI 10.1021/ol402144q; Murai M, 2014, ORG LETT, V16, P4134, DOI 10.1021/ol5018273; Kwon Y, 2014, ORG LETT, V16, P4936, DOI 10.1021/ol502465e; Mandal AB, 2000, J ORG CHEM, V65, P332, DOI 10.1021/jo991100u; Almeida JF, 2003, ORG LETT, V5, P4939, DOI 10.1021/ol0357954; Hayashi M, 2011, ANGEW CHEM INT EDIT, V50, P2249, DOI 10.1002/anie.201007568; Saifuddin M, 2011, J ORG CHEM, V76, P10122, DOI 10.1021/jo201942r; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; JUNG ME, 1991, TETRAHEDRON LETT, V32, P3025, DOI 10.1016/0040-4039(91)80677-X; Bausch CC, 2005, ADV SYNTH CATAL, V347, P1207, DOI 10.1002/adsc.200505097; Banwell MG, 2006, BIOORG MED CHEM LETT, V16, P181, DOI 10.1016/j.bmcl.2005.09.032; Bera K, 2012, J ORG CHEM, V77, P8780, DOI 10.1021/jo301371n; COLWELL WT, 1972, J MED CHEM, V15, P771, DOI 10.1021/jm00277a018; Corbett M. T., 2012, ANGEW CHEM, V124, P4763; Furstner A, 2003, CHEM COMMUN, P2112, DOI 10.1039/b306880c; El Kaim L, 2005, SYNLETT, P2335, DOI 10.1055/s-2005-872670; Hayashi M., 2011, ANGEW CHEM, V123, P2297; Kraus GA, 2002, TETRAHEDRON LETT, V43, P5319, DOI 10.1016/S0040-4039(02)01026-2; Lewis FD, 1996, J PHYS CHEM-US, V100, P4055, DOI 10.1021/jp9526758; LEWIS FD, 1992, J AM CHEM SOC, V114, P3866, DOI 10.1021/ja00036a039; Li ZG, 2001, SYNTHESIS-STUTTGART, P2365; Liu RH, 1999, MACROMOLECULES, V32, P3957, DOI 10.1021/ma990268e; Liu Z., 2007, ANGEW CHEM, V119, P2587, DOI 10.1002/ange.200604969; Machado AM, 2006, MACROMOLECULES, V39, P3398, DOI 10.1021/ma052315a; Monsieurs K, 2006, SYNLETT, P3225, DOI 10.1055/s-2006-95645; Shu C, 2014, CHEM-ASIAN J, V9, P1525, DOI 10.1002/asia.201400034; Wakabayashi R, 2013, SYNLETT, V24, P2297, DOI 10.1055/s-0033-1339710; WASSMUNDT FW, 1995, J ORG CHEM, V60, P196, DOI 10.1021/jo00106a034; Xia Y., 2012, ANGEW CHEM, V124, P5812	60	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	SEP 1	2015	21	36					12577	12580		10.1002/chem.201501377		4	Chemistry, Multidisciplinary	Chemistry	CQ0UF	WOS:000360312100005		
J	Setsune, J; Toda, M; Yoshida, T; Imamura, K; Watanabe, K				Setsune, Jun-ichiro; Toda, Masayuki; Yoshida, Takafumi; Imamura, Keigo; Watanabe, Keigo			The Synthesis and Dynamic Structures of Multinuclear Complexes of Large Porphyrinoids Expanded by Phenylene and Thienylene Spacers	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						amethyrin; multinuclear complexes; octaphyrin; porphyrinoids; ruthenium; rosarin	X-RAY-STRUCTURE; TRANSITION-METAL-COMPLEXES; FACILE SYNTHESIS; (PI-ALLYL)PALLADIUM COMPLEXES; CRYSTAL-STRUCTURE; HIGHER HOMOLOGS; LIGANDS; HUCKEL; CORE; BENZIPORPHYRINS	1,3-Bis(2-pyrryl)benzene was used to prepare dibenziamethyrin, in which two pyrrole units of [24]amethyrin(1.0.0.1.0.0) are replaced by benzene. 1,4-Bis(2-pyrryl)benzene, 2,5-bis(2-pyrryl)thiophene, and 4,4-bis(2-pyrryl)biphenyl were also used in place of 2,2-bipyrrole to give expanded analogues of [24]rosarin(1.0.1.0.1.0) and [32]octaphyrin(1.0.1.0.1.0.1.0). These large porphyrinoids can incorporate multiple metal units of Rh(CO)(2) and Pd(-allyl) with considerable deviation of the metal atoms from the dipyrrin planes, evidenced by X-ray crystallography. The coordinated Rh(CO)(2) group shuttled between both sides of the macrocycle; the rate was dependent on the spacer, ring size, and number of metal atoms. Variable temperature (HNMR)-H-1 spectroscopy showed that the tris-rhodium complexes of the expanded rosarins with 1,4-phenylene or 2,5-thienylene spacers adopt a C-3v-symmetric form and a C-s-symmetric form as a result of the Rh(CO)(2) groups hopping through the macrocycle cavity. The C-3v-symmetric form has a greater dipole moment and, therefore, is favored in solvents of greater polarity. The Rh(CO)(2) groups in the tris-rhodium complex of the expanded rosarin with 4,4-biphenylene spacers hop so fast that an averaged spectral pattern (D-3h) was seen in the (HNMR)-H-1 spectrum, even at -60 degrees C. Expanded octaphyrins with 1,4-phenylene and 2,5-thienylene spacers bind four Rh(CO)(2) groups outside the macrocycle cavity to form a D-2d-symmetric saddle-shaped structure that did not show any dynamic behavior on the NMR timescale, even at 80 degrees C. This tetranuclear complex is one of the largest porphyrinoid metal complexes characterized by X-ray crystallography to date.	[Setsune, Jun-ichiro; Toda, Masayuki; Yoshida, Takafumi; Imamura, Keigo; Watanabe, Keigo] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan	Setsune, J (reprint author), Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	setsunej@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24550050, 15K05424]	We acknowledge the financial support of the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant-in-Aid for Scientific Research no. 24550050 and no. 15K05424).	ALBINATI A, 1991, ORGANOMETALLICS, V10, P1800, DOI 10.1021/om00052a028; Sessler JL, 1998, INORG CHEM, V37, P2073, DOI 10.1021/ic971018m; Haketa Y, 2011, CHEM-EUR J, V17, P1485, DOI 10.1002/chem.201002748; Stepien M, 2005, ACCOUNTS CHEM RES, V38, P88, DOI 10.1021/ar040189+; Vogel E, 2003, ANGEW CHEM INT EDIT, V42, P2857, DOI 10.1002/anie.200250690; GOGOLL A, 1994, J AM CHEM SOC, V116, P3631, DOI 10.1021/ja00087a072; Shimizu S, 2005, ANGEW CHEM INT EDIT, V44, P2225, DOI 10.1002/anie.200463054; Setsune J, 2009, ANGEW CHEM INT EDIT, V48, P771, DOI 10.1002/anie.200803538; Ikeda C, 2008, ORG LETT, V10, P4601, DOI 10.1021/ol801888d; Takagi J, 2002, TETRAHEDRON LETT, V43, P5649, DOI 10.1016/S0040-4039(02)01135-8; Saito S, 2011, ANGEW CHEM INT EDIT, V50, P4342, DOI 10.1002/anie.201003909; Shimizu S, 2005, ANGEW CHEM INT EDIT, V44, P3726, DOI 10.1002/anie.200500676; Shimizu S, 2006, CHEM-EUR J, V12, P4909, DOI 10.1002/chem.200600158; Chandra B, 2013, ORG LETT, V15, P306, DOI 10.1021/ol3032158; SESSLER JL, 1992, J AM CHEM SOC, V114, P8306, DOI 10.1021/ja00047a061; CARRE FH, 1993, ORGANOMETALLICS, V12, P2478, DOI 10.1021/om00031a018; Werner A, 1999, ANGEW CHEM INT EDIT, V38, P3650, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3650::AID-ANIE3650>3.0.CO;2-F; Sessler JL, 2003, ANGEW CHEM INT EDIT, V42, P5134, DOI 10.1002/anie.200200561; Setsune J, 2006, TETRAHEDRON LETT, V47, P1817, DOI 10.1016/j.tetlet.2006.01.013; Ishiyama T, 2003, ADV SYNTH CATAL, V345, P1103, DOI 10.1002/adsc.200303058; Misra R, 2008, ACCOUNTS CHEM RES, V41, P265, DOI 10.1021/ar700091k; Sessler JL, 2005, CHEM-EUR J, V11, P2001, DOI 10.1002/chem.200400894; Stepien M, 2011, ANGEW CHEM INT EDIT, V50, P4288, DOI 10.1002/anie.201003353; Stepien M, 2007, ANGEW CHEM INT EDIT, V46, P7869, DOI 10.1002/anie.200700555; Stepien M, 2010, J AM CHEM SOC, V132, P3140, DOI 10.1021/ja909913y; Shin JY, 2001, J AM CHEM SOC, V123, P7190, DOI 10.1021/ja0106624; Bui TT, 2012, CHEM-EUR J, V18, P5853, DOI 10.1002/chem.201200196; Bui TT, 2013, J PORPHYR PHTHALOCYA, V17, P27, DOI 10.1142/S1088424612501325; CORRIU RJP, 1991, J CHEM SOC CHEM COMM, P211, DOI 10.1039/c39910000211; Crociani B, 1997, ORGANOMETALLICS, V16, P384, DOI 10.1021/om9608420; Gogoll A, 1997, ORGANOMETALLICS, V16, P1167, DOI 10.1021/om9609527; Hung CH, 2008, CHEM COMMUN, P978, DOI 10.1039/b714412a; Ishimaru Y, 2015, CHEM-ASIAN J, V10, P329, DOI 10.1002/asia.201403126; Kamimura Y, 2007, CHEM-EUR J, V13, P1620, DOI 10.1002/chem.200601304; Kohler T, 2004, CHEM COMMUN, P1060, DOI 10.1039/b400596a; Kumar R, 2006, ORG LETT, V8, P4847, DOI 10.1021/ol0619011; Kumar R, 2007, EUR J ORG CHEM, P4552, DOI 10.1002/ejoe.200700466; Paulus O, 2002, EUR J ORG CHEM, P2565; Rath H, 2006, ORG LETT, V8, P2325, DOI 10.1021/ol060622a; Saito S., 2011, ANGEW CHEM, V50, P4342, DOI DOI 10.1002/ANIE.201003909; Sanchez-Garcia D, 2005, CHEM COMMUN, P2122, DOI 10.1039/b500735f; Sessler J. L., 2003, ANGEW CHEM, V42, P5134, DOI 10.1002/ange.200200561; Sessler J. L., 1994, ANGEW CHEM, V106, P1572, DOI 10.1002/ange.19941061429; Sessler JL, 2001, J HETEROCYCLIC CHEM, V38, P1419; SESSLER JL, 1994, ANGEW CHEM INT EDIT, V33, P1509, DOI 10.1002/anie.199415091; Setsune J, 2006, ORG BIOMOL CHEM, V4, P2247, DOI 10.1039/b518340e; Setsune J, 2000, J AM CHEM SOC, V122, P12405, DOI 10.1021/ja005588o; Setsune J., 2009, ANGEW CHEM, V121, P785; Setsune J, 1999, J AM CHEM SOC, V121, P8957, DOI 10.1021/ja991669c; Setsune JI, 2006, TETRAHEDRON LETT, V47, P7541, DOI 10.1016/j.tetlet.2006.08.098; Setsune JI, 2008, CHEM COMMUN, P1425, DOI 10.1039/b717022j; Shimizu S., 2005, ANGEW CHEM, V117, P3792, DOI 10.1002/ange.200500676; Shimizu S., 2005, ANGEW CHEM, V117, P2265, DOI 10.1002/ange.200463054; Shimizu S, 2008, CHEM-EUR J, V14, P2668, DOI 10.1002/chem.200701909; Soya T, 2015, CHEM-ASIAN J, V10, P231, DOI 10.1002/asia.201402933; Stepien M, 2002, J AM CHEM SOC, V124, P3838, DOI 10.1021/ja017852z; Stepien M., 2007, ANGEW CHEM, V119, P8015, DOI 10.1002/ange.200700555; Stepien M, 2004, J AM CHEM SOC, V126, P4566, DOI 10.1021/ja039384u; Stpien M., 2011, ANGEW CHEM, V723, P4376, DOI DOI 10.1002/ANIE.201003353; Szyszko B, 2014, CHEM-EUR J, V20, P1985, DOI 10.1002/chem.201303676; Takao Y, 2003, ORGANOMETALLICS, V22, P233, DOI 10.1021/om0205593; Tanaka Y, 2008, EUR J ORG CHEM, P1341, DOI 10.1002/ejoc.200701132; Taniguchi R, 2003, TETRAHEDRON LETT, V44, P2505, DOI 10.1016/S0040-4039(03)00328-9; Tyrrell E., 2003, SYNTHESIS-STUTTGART, P0469; Vogel E., 2003, ANGEW CHEM, V115, P2964, DOI 10.1002/ange.200250690; Werner A., 1999, ANGEW CHEM, V111, P3866, DOI 10.1002/(SICI)1521-3757(19991216)111:24<3866::AID-ANGE3866>3.0.CO;2-R; YAO CL, 1987, INORG CHEM, V26, P2725, DOI 10.1021/ic00263a033; Yoneda T., 2014, ANGEW CHEM, V126, P13385, DOI DOI 10.1002/ANGE.201408506; Yoneda T, 2014, ANGEW CHEM INT EDIT, V53, P13169, DOI 10.1002/anie.201408506	69	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	SEP 1	2015	21	36					12715	12727		10.1002/chem.201501570		13	Chemistry, Multidisciplinary	Chemistry	CQ0UF	WOS:000360312100024		
J	Kondo, K; Akita, M; Nakagawa, T; Matsuo, Y; Yoshizawa, M				Kondo, Kei; Akita, Munetaka; Nakagawa, Takafumi; Matsuo, Yutaka; Yoshizawa, Michito			A V-Shaped Polyaromatic Amphiphile: Solubilization of Various Nanocarbons in Water and Enhanced Photostability	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						amphiphiles; anthracene; carbon nanotubes; fullerenes; nanocarbons	WALLED CARBON NANOTUBES; COORDINATION CAGES; AROMATIC-MOLECULES; DISCRETE; C-120; ENCAPSULATION; AGGREGATION; NANOCAPSULE; CAPSULE; SYSTEMS	Nanocarbons are synthetic carbon-rich compounds with polyaromatic frameworks that have lately attracted attention as emerging functional materials. However, their extreme hydrophobicity and aggregation peculiarity, besides their shape and size diversities, precluded their study in solution, especially in green water. More convenient and general solubilizing methods of nanocarbon frameworks are required by using non-covalent supramolecular interactions. Here we report a protocol for solubilizing a wide range of nanocarbons, that is, fullerenes (C-60, C-70, C-84, and C-120), polyarenes (tetracene, pentacene, perylene, coronene, and hexabenzocoronene), and carbon nanotubes (single-walled and multi-walled CNTs), in water through manual grinding with V-shaped polyaromatic amphiphiles. The obtained aqueous nanocomposites are composed of nanocarbons encircled by the polyaromatic frameworks of the amphiphiles through multiple aromatic-aromatic interactions. Notably, the encapsulated photosensitive nanocarbons, such as tetracene, pentacene, and fullerene dimer, exhibit unusual stability toward UV/Vis light.	[Kondo, Kei; Akita, Munetaka; Yoshizawa, Michito] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Nakagawa, Takafumi; Matsuo, Yutaka] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Yoshizawa, M (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	yoshizawa.m.ac@m.titech.ac.jp	Akita, Munetaka/C-5614-2011; Matsuo, Yutaka/C-9897-2011	Akita, Munetaka/0000-0001-7007-9621; Matsuo, Yutaka/0000-0001-9084-9670	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Support for Tokyotech Advanced Researchers (STAR); JSPS	This study was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grants-in-Aid for Scientific Research on Innovative Areas "Soft Molecular Systems" and by "Support for Tokyotech Advanced Researchers (STAR)". We thank Dr. Jeremy K. Klosterman (BGSU) for helpful discussions. K. K. also thanks the JSPS for a Research Fellowship for Young Scientists.	ANDERSSON T, 1992, J CHEM SOC CHEM COMM, P604, DOI 10.1039/c39920000604; Kishi N, 2011, J AM CHEM SOC, V133, P11438, DOI 10.1021/ja2037029; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Leininger S, 2000, CHEM REV, V100, P853, DOI 10.1021/cr9601324; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Oshovsky GV, 2007, ANGEW CHEM INT EDIT, V46, P2366, DOI 10.1002/anie.200602815; Okazawa Y, 2015, J AM CHEM SOC, V137, P98, DOI 10.1021/ja511463k; Klosterman JK, 2009, CHEM SOC REV, V38, P1714, DOI 10.1039/b901261n; Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u; Wang GW, 1997, NATURE, V387, P583; Pluth MD, 2009, ACCOUNTS CHEM RES, V42, P1650, DOI 10.1021/ar900118t; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Suzuki A, 2013, ANGEW CHEM INT EDIT, V52, P8120, DOI 10.1002/anie.201302789; Yoshizawa M, 2005, ANGEW CHEM INT EDIT, V44, P1810, DOI 10.1002/anie.200462171; BENSASSON RV, 1994, J PHYS CHEM-US, V98, P3492, DOI 10.1021/j100064a035; Kaanumalle LS, 2005, J AM CHEM SOC, V127, P3674, DOI 10.1021/ja0425381; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Yoshizawa M, 2014, CHEM SOC REV, V43, P1885, DOI 10.1039/c3cs60315f; Vriezema DM, 2005, CHEM REV, V105, P1445, DOI 10.1021/cr0300688; O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0; Han M, 2014, CHEM SOC REV, V43, P1848, DOI 10.1039/c3cs60473j; Hof F, 2002, ANGEW CHEM INT EDIT, V41, P1488, DOI 10.1002/1521-3773(20020503)41:9<1488::AID-ANIE1488>3.0.CO;2-G; Safont-Sempere MM, 2011, CHEM REV, V111, P5784, DOI 10.1021/cr100357h; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Xu L, 2014, CHEM COMMUN, V50, P5156, DOI 10.1039/c3cc47484d; Yoshizawa M, 2009, ANGEW CHEM INT EDIT, V48, P3418, DOI 10.1002/anie.200805340; Wu JS, 2007, CHEM REV, V107, P718, DOI 10.1021/cr068010r; Anthony JE, 2008, ANGEW CHEM INT EDIT, V47, P452, DOI 10.1002/anie.200604045; Anthony J. E., 2008, ANGEW CHEM, V120, P460, DOI 10.1002/ange.200604045; Castilla AM, 2014, ACCOUNTS CHEM RES, V47, P2063, DOI 10.1021/ar5000924; Englert JM, 2010, CHEM COMMUN, V46, P9194, DOI 10.1039/c0cc03849k; Hashiguchi M, 2013, CARBON, V61, P418, DOI 10.1016/j.carbon.2013.04.101; Hof F., 2002, ANGEW CHEM, V114, P1556, DOI 10.1002/1521-3757(20020503)114:9<1556::AID-ANGE1556>3.0.CO;2-C; Hunter C. A., 2001, PERKIN T, P651; Komatsu K, 1998, J ORG CHEM, V63, P9358, DOI 10.1021/jo981319t; Komatsu K., 1999, J CHEM SOC PERK T, V1, P2963; Kondo K, 2013, ANGEW CHEM INT EDIT, V52, P2308, DOI 10.1002/anie.201208643; Kondo K., 2013, ANGEW CHEM, V125, P2364; Kondo K, 2014, EUR J ORG CHEM, P7389, DOI 10.1002/ejoc.201403136; Martin N., 2012, SUPRAMOLECULAR CHEM; Nakashima N, 2002, CHEM LETT, P638, DOI 10.1246/cl.2002.638; Okazawa Y, 2015, CHEM SCI, V6, P5059, DOI 10.1039/c5sc01545f; Oshovsky G. V., 2007, ANGEW CHEM, V119, P2418, DOI 10.1002/ange.200602815; Steed J. W., 2009, SUPRAMOLECULAR CHEM; Suzuki A., 2013, ANGEW CHEM, V125, P8278; Yamakoshi Y. N., 1994, CHEM COMMUN, P517; Yamashina M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5662; Yoshizawa M., 2005, ANGEW CHEM, V117, P1844, DOI 10.1002/ange.200462171; Yoshizawa M., 2009, ANGEW CHEM, V121, P3470	50	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	SEP 1	2015	21	36					12741	12746		10.1002/chem.201501414		6	Chemistry, Multidisciplinary	Chemistry	CQ0UF	WOS:000360312100027		
J	Lee, JW; Hirota, T; Kumar, A; Kim, NJ; Irle, S; Kay, SA				Lee, Jae Wook; Hirota, Tsuyoshi; Kumar, Anupriya; Kim, Nam-Jung; Irle, Stephan; Kay, Steve A.			Development of Small-Molecule Cryptochrome Stabilizer Derivatives as Modulators of the Circadian Clock	CHEMMEDCHEM			English	Article						3D-QSAR; circadian clock; cryptochrome; protein degradation; small molecule	DEGRADATION; PERIOD; REVEALS; PROTEIN; FBXL3	Small-molecule probes have been playing prominent roles in furthering our understanding of the molecular underpinnings of the circadian clock. We previously discovered a carbazole derivative, KL001 (N-(3-(9H-carbazol-9-yl)-2-hydroxypropyl)-N-(furan-2-ylmethyl)methanesulfonamide), as a stabilizer of the clock protein cryptochrome (CRY). Herein we describe an extensive structure-activity relationship analysis of KL001 derivatives leading to the development of a highly active derivative: 2-(9H-carbazol-9-yl)-N-(2-chloro-6-cyanophenyl)acetamide (KL044). Subsequent 3D-QSAR analysis identified critical features of KL001 derivatives and provided a molecular-level understanding of their interaction with CRY. The electron-rich carbazole, amide/hydroxy linker, sulfonyl group, and electron-withdrawing nitrile moieties contribute to greater biological activity. The hydrogen bonding interactions with Ser394 and His357 as well as stronger CH- interactions with Trp290 make KL044 a better binder than KL001. KL044 lengthened the circadian period, repressed Per2 activity, and stabilized CRY in reporter assays with roughly tenfold higher potency than KL001. Altogether, KL044 is a powerful chemical tool to control the function of the circadian clock through its action on CRY.	[Lee, Jae Wook; Kim, Nam-Jung] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Hirota, Tsuyoshi; Kumar, Anupriya; Irle, Stephan; Kay, Steve A.] Nagoya Univ, Inst Transformat Biomol, Nagoya, Aichi 4648601, Japan; [Lee, Jae Wook] Univ Sci & Technol Republ Korea, Korea Inst Sci & Technol, Dept Biol Chem, Nat Product Res Ctr, Taejon, South Korea; [Hirota, Tsuyoshi; Kay, Steve A.] Univ So Calif, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Hirota, Tsuyoshi] Japan Sci & Technol Agcy, PRESTO, Nagoya, Aichi 4648601, Japan; [Kumar, Anupriya; Irle, Stephan] Nagoya Univ, Grad Sch Sci, Dept Chem, Nagoya, Aichi 4648602, Japan; [Kim, Nam-Jung] Kyung Hee Univ, Coll Pharm, Seoul 130701, South Korea	Hirota, T (reprint author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	thirota@itbm.nagoya-u.ac.jp; anupriya.veerman@gmail.com	Irle, Stephan/E-8984-2011	Irle, Stephan/0000-0003-4995-4991	U.S. National Institutes of Health [R01GM074868]	This research was supported by the U.S. National Institutes of Health (grant R01GM074868 to S.A.K.).	Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; [Anonymous], 2014, ACT MIN FORG VERS 10; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; [Anonymous], 2013, SITEMAP VERS 2 9; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Cheeseright T, 2006, J CHEM INF MODEL, V46, P665, DOI 10.1021/ci050357s; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; [Anonymous], 2014, FORG VERS 10 3 1; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Nangle S., 2013, CELL RES, P1417; Oshima T., 2015, ANGEW CHEM, V127, P7299; Oshima T, 2015, ANGEW CHEM INT EDIT, V54, P7193, DOI 10.1002/anie.201502942	20	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1860-7179	1860-7187		CHEMMEDCHEM	ChemMedChem	SEP	2015	10	9					1489	1497		10.1002/cmdc.201500260		9	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ3JY	WOS:000360499400006		
J	Goto, S; Hasebe, T; Takagi, S				Goto, Shinya; Hasebe, Terumitsu; Takagi, Shu			Platelets: Small in Size But Essential in the Regulation of Vascular Homeostasis - Translation From Basic Science to Clinical Medicine	CIRCULATION JOURNAL			English	Review						Antiplatelet drugs; Aspirin; Coagulation; P2Y(12) inhibitors; Platelets	VON-WILLEBRAND-FACTOR; ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; LOW-DOSE ASPIRIN; NONVALVULAR ATRIAL-FIBRILLATION; THROMBIN-RECEPTOR ANTAGONIST; CARDIOVASCULAR RISK-FACTORS; BLOOD-FLOW CONDITIONS; CONTROLLED PHASE-II; HIGH-SHEAR STRESS	Platelets are small blood cells that adhere to the site of vessel injury where von Willebrand factor (VWF) is expressed. Platelets bind to VWF through interaction with a membrane protein, glycoprotein (GP) Iba. Next, the accumulated platelets are activated to change their morphological and biochemical characteristics. Various vasoactive substances, such as immune-regulatory CD40 ligand, are released locally from activated platelet cells to maintain homeostasis of the vascular system. Major roles played by platelets in the regulation of hemostasis and thrombus formation include local activation of the coagulation cascade. Translocation of negatively charged phospholipids to the surface of activated platelets helps in the formation of prothrombinase complex, which efficiently produces thrombin. Thrombin produces fibrin around the activated platelets and further activates the platelets through thrombin receptor stimulation. Of the various platelet-stimulating receptors and activation signals, cyclooxygenase-1, P2Y12 adenosine 5'-diphosphate receptor, and thrombin receptor (protease activated receptor)-1 blockers are used clinically as antiplatelet agents. In the future, precise understanding of the quantitative contribution of platelet function in hemostasis and pathological thrombus formation should lead to the development of effective antithrombotic agents without increasing the risk of serious bleeding complications.	[Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa 2591193, Japan; [Goto, Shinya] Tokai Univ, Sch Med, Dept Metab Dis, Res Ctr, Isehara, Kanagawa 2591193, Japan; [Hasebe, Terumitsu] Tokai Univ, Sch Med, Dept Radiol, Hachioji Hosp, Tokyo 151, Japan; [Takagi, Shu] Univ Tokyo, Grad Sch Engn, Tokyo, Japan	Goto, S (reprint author), Tokai Univ, Sch Med, Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	sgot03@mac.com			SENSHIN Medical Research Foundation; RIKEN; Strategic Program for Innovational Research Field 1 for Super-computational Life Science;  [24390202]	The authors acknowledge the contribution by Dr Shinichi Goto for correct English grammar. The authors also acknowledge the support from a Grant-in-Aid for Scientific Research in Japan (24390202), a grant from SENSHIN Medical Research Foundation, a grant for the next-generation supercomputer Research and Development program supported by RIKEN, and Strategic Program for Innovational Research Field 1 for Super-computational Life Science.	Alberts MJ, 2011, HEART, V97, P1507, DOI 10.1136/hrt.2010.221788; Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; Alexander JH, 2014, EUR HEART J, V35, P224, DOI 10.1093/eurheartj/eht445; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Goto S, 2008, AM HEART J, V156, P855, DOI 10.1016/j.ahj.2008.06.029; Held C, 2015, EUR HEART J, V36, P1264, DOI 10.1093/eurheartj/ehu463; Chan FKL, 2012, CLIN GASTROENTEROL H, V10, P753, DOI 10.1016/j.cgh.2012.03.027; Goto S, 2008, THROMB HAEMOSTASIS, V100, P611, DOI 10.1160/TH08-06-0388; O'Donoghue ML, 2011, CIRCULATION, V123, P1843, DOI 10.1161/CIRCULATIONAHA.110.000786; Angiolillo DJ, 2010, EUR HEART J, V31, P17, DOI 10.1093/eurheartj/ehp504; Becker RC, 2009, LANCET, V373, P919, DOI 10.1016/S0140-6736(09)60230-0; Uemura N, 2014, J GASTROENTEROL, V49, P814, DOI 10.1007/s00535-013-0839-5; Hori M, 2013, CIRC J, V77, P632, DOI 10.1253/circj.CJ-12-0899; Origasa H, 2011, CARDIOVASC DRUG THER, V25, P551, DOI 10.1007/s10557-011-6328-2; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Hori M, 2014, CIRC J, V78, P1349, DOI 10.1253/circj.CJ-13-1324; Torisu T, 2013, NAT MED, V19, P1281, DOI 10.1038/nm.3288; Andre P, 2003, CIRCULATION, V108, P2697, DOI 10.1161/01.CIR.0000093279.36628.12; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; GOTO S, 1995, J BIOL CHEM, V270, P23352; Goto S, 1997, LANCET, V349, P543, DOI 10.1016/S0140-6736(97)80095-5; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Jackson SP, 2003, NAT REV DRUG DISCOV, V2, P775, DOI 10.1038/nrd1198; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Goto S, 1998, J CLIN INVEST, V101, P479, DOI 10.1172/JCI973; Serebruany V, 2010, EUR HEART J, V31, P227, DOI 10.1093/eurheartj/ehp434; Sato H, 2006, STROKE, V37, P447, DOI 10.1161/01.STR.0000198839.61112.ee; Sugano K, 2014, GUT, V63, P1061, DOI 10.1136/gutjnl-2013-304722; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Gibson CM, 2013, J AM COLL CARDIOL, V62, P286, DOI 10.1016/j.jacc.2013.03.041; Goto S, 2002, CIRCULATION, V105, P2531, DOI 10.1161/01.CIR.0000016703.93845.AF; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Morrow DA, 2013, STROKE, V44, P691, DOI 10.1161/STROKEAHA.111.000433; Freedman JE, 2002, CIRCULATION, V105, P2130, DOI 10.1161/01.CIR.0000017140.26466.F5; TANS G, 1991, BLOOD, V77, P2641; Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3; Goto S, 2010, J ATHEROSCLER THROMB, V17, P156; Goto SY, 2002, CIRCULATION, V106, P266, DOI 10.1161/01.CIR.0000021427.87256.7E; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Goto S, 2010, EUR HEART J, V31, P2601, DOI 10.1093/eurheartj/ehq320; Goto S, 1999, CIRCULATION, V99, P608; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Nakagawa Y, 2009, CIRC J, V73, P145; Li M, 2001, THROMB RES, V104, P15, DOI 10.1016/S0049-3848(01)00343-7; Miyazaki Y, 1996, BLOOD, V88, P3456; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Angiolillo DJ, 2010, CIRC J, V74, P597, DOI 10.1253/circj.CJ-09-0982; Yamazaki T, 2007, CIRC J, V71, P995, DOI 10.1253/circj.71.995; Sakai H, 2000, THROMB HAEMOSTASIS, V84, P204; Goto S, 2009, HAMOSTASEOLOGIE, V29, P321; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Wiviott SD, 2011, CIRCULATION, V123, P1854, DOI 10.1161/CIRCULATIONAHA.110.001404; HARRIS WH, 1977, NEW ENGL J MED, V297, P1246, DOI 10.1056/NEJM197712082972302; Yamashita A, 2006, AM J CARDIOL, V97, P26, DOI 10.1016/j.amjcard.2005.07.105; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; [Anonymous], 1988, LANCET, V2, P349; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; ROSS R, 1976, NEW ENGL J MED, V295, P420, DOI 10.1056/NEJM197608192950805; Hart RG, 2001, STROKE, V32, P803; Antiplatelet Trialists' Collaboration, 1994, BMJ-BRIT MED J, V308, P81; Antiplatelet Trialists' Collaboration, 1994, BRIT MED J, V308, P235; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P71; Collins R, 2009, LANCET, V373, P1849; Baker NC, 2014, CIRCULATION, V130, P1287, DOI 10.1161/CIRCULATIONAHA.114.011471; BERGER G, 1993, BLOOD, V82, P3034; Bonaca MP, 2014, J AM COLL CARDIOL, V64, P2318, DOI 10.1016/j.jacc.2014.07.997; Gent M, 1996, LANCET, V348, P1329; Cavender MA, 2015, CIRCULATION, V131, P1047, DOI 10.1161/CIRCULATIONAHA.114.013774; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Fogelson AL, 2015, ANNU REV FLUID MECH, V47, P377, DOI 10.1146/annurev-fluid-010814-014513; Goto S, 2013, THROMB HAEMOSTASIS, V109, P177, DOI 10.1160/TH12-12-0910; Goto S, 2006, J AM COLL CARDIOL, V47, P155, DOI 10.1016/j.jacc.2005.08.055; Goto S., 2008, PLATELET PROCOAGULAN; GOTO S, 1992, CIRCULATION, V86, P1859; Goto S, 2000, INT ANGIOL, V19, P147; Goto S, 1998, LANCET, V351, P1558, DOI 10.1016/S0140-6736(05)61124-5; Goto Shinya, 2004, Current Vascular Pharmacology, V2, P23, DOI 10.2174/1570161043476456; Goto Shinya, 2008, Rev Neurol Dis, V5 Suppl 1, pS22; Goto S, 2001, Clin Lab, V47, P327; Goto S, 2002, BLOOD, V99, P4645; Goto S, 2001, PLATELETS, V12, P406, DOI 10.1080/09537100120078377; Goto S, 2011, ACUTE CORONARY SYNDR, V10, P103; Goto S, 2014, CLIN CARDIOL, V37, P178, DOI 10.1002/clc.22233; Goto S, 2003, J THROMB HAEMOST, V1, P2022, DOI 10.1046/j.1538-7836.2003.00349.x; Goto S., 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P149, DOI 10.2174/1568016043477233; Goto S, 2004, J AM COLL CARDIOL, V44, P316, DOI 10.1016/j.jacc.2004.02.059; Goto S, 2011, DRUG FUTURE, V36, P101, DOI 10.1358/dof.2011.36.2.1514948; Goto S, 2004, ARTERIOSCL THROM VAS, V24, P2207, DOI 10.1161/01.ATV.0000149144.86175.03; Goto S, 2015, CIRCULATION, V131, P1041, DOI 10.1161/CIRCULATIONAHA.115.015471; Goto S, 2007, THROMB RES, V120, P463, DOI 10.1016/j.thromres.2007.02.003; Goto S, 2002, BLOOD, V99, P4644, DOI 10.1182/blood-2001-12-0284; Goto SI, 2011, HEART ASIA, V3, P93; Hagihara M, 2004, J IMMUNOL, V172, P5297; Hoshiba Y, 2006, J THROMB HAEMOST, V4, P114, DOI 10.1111/j.1538-7836.2005.01701.x; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Ikeda Y, 1997, ANN NY ACAD SCI, V811, P325, DOI 10.1111/j.1749-6632.1997.tb52012.x; Kawai T, 2009, J ATHEROSCLER THROMB, V16, P155; Kawamura Y, 2009, J ATHEROSCLER THROMB, V16, P807; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Khanlou H, 1998, CATHETER CARDIO DIAG, V44, P313, DOI 10.1002/(SICI)1097-0304(199807)44:3<313::AID-CCD14>3.0.CO;2-L; Kikuchi M, 2004, BRIT J RADIOL, V77, P888, DOI 10.1259/bjr/32956594; Levine Glenn N, 2014, Glob Heart, V9, P457, DOI 10.1016/j.gheart.2014.08.001; Levine GN, 2014, NAT REV CARDIOL, V11, P597, DOI 10.1038/nrcardio.2014.104; Matsumoto Y, 2014, PROC IUTAM, V10, P193, DOI 10.1016/j.piutam.2014.01.018; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; O'Donoghue ML, 2012, J THROMB THROMBOLYS, V34, P36, DOI 10.1007/s11239-012-0750-6; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; ROSS R, 1976, NEW ENGL J MED, V295, P369, DOI 10.1056/NEJM197608122950707; Sato Y, 2012, THROMB RES, V130, P278, DOI 10.1016/j.thromres.2012.04.008; Serebruany VL, 2008, EUR HEART J, V29, P2833, DOI 10.1093/eurheartj/ehn494; Shinohara Y, 2012, J STROKE CEREBROVASC, V21, P318, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.005; Shiozaki Seiji, 2012, Journal of Biomechanical Science and Engineering, V7, DOI 10.1299/jbse.7.275; Shiraga M, 2005, J THROMB HAEMOST, V3, P2315, DOI 10.1111/j.1538-7836.2005.01554.x; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Sugimoto M, 1999, INT J HEMATOL, V69, P48; SUZUKI H, 1987, HISTOCHEM J, V19, P125, DOI 10.1007/BF01695137; Takeoka S, 2000, BIOMACROMOLECULES, V1, P290, DOI 10.1021/bm0055293; Tamura N, 2002, THROMB RES, V108, P311, DOI 10.1016/S0049-3848(03)00098-7; Tamura N, 2009, CIRC J, V73, P540; Tobimatsu H, 2015, J ATHEROSCLER THROMB, V22, P1091, DOI 10.5551/jat.28423; Tomasello SD, 2010, EXPERT OPIN INV DRUG, V19, P1557, DOI 10.1517/13543784.2010.521741; Tomita A, 2015, J ATHEROSCLER THROMB, V22, P201, DOI 10.5551/jat.26203; Uchiyama S, 2009, J NEUROL SCI, V287, P45, DOI 10.1016/j.jns.2009.09.011	135	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1871	1881		10.1253/circj.CJ-14-1434		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500003		
J	Yamashita, T; Kasahara, K; Emoto, T; Matsumoto, T; Mizoguchi, T; Kitano, N; Sasaki, N; Hirata, K				Yamashita, Tomoya; Kasahara, Kazuyuki; Emoto, Takuo; Matsumoto, Takuya; Mizoguchi, Taiji; Kitano, Naoki; Sasaki, Naoto; Hirata, Ken-ichi			Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases	CIRCULATION JOURNAL			English	Review						Atherosclerosis; Gut microbiota; Intestinal immunity; Regulatory T cell; Tolerogenic dendritic cell	REGULATORY T-CELLS; RECEPTOR-DEFICIENT MICE; DECREASES ATHEROSCLEROSIS; DENSITY-LIPOPROTEIN; DENDRITIC CELLS; L-CARNITINE; METABOLISM; MECHANISMS; METAGENOME; INDUCTION	Atherosclerosis is considered a chronic inflammatory disease and an intervention targeting the inflammatory process could be a new therapeutic strategy for preventing atherosclerotic cardiovascular diseases (CVD). We hypothesized that the intestine, which is considered the biggest immune organ in the human body, could be a therapeutic target for preventing CVD. We demonstrated that oral administration of anti-CD3 antibody or an active form of vitamin D-3 reduced atherosclerosis in mice via induction of regulatory T cells and tolerogenic dendritic cells in the gut-associated lymphoid tissues. Similar to regulatory immune responses achieved by oral tolerance, our method had systemic effects that ultimately contributed towards atherosclerosis reduction. Recently, we have been interested in the gut microbiota, which have been reported as highly associated with intestinal immunity and systemic metabolic disorders, including obesity and diabetes. Notably, the guts of obese individuals are predominantly colonized by Firmicutes over Bacteroidetes. The association between atherosclerosis and microbiota has been attracting increased attention, and gut microbiota have been shown to participate in the metabolism of a proatherogenic compound called trimethylamine-N-oxide (TMAO) and aggravate CVD. Our investigation of the relationship between susceptibility to CVD and the gut microbiota revealed a characteristic flora type. Here, we discuss the evidence for the relationship between the gut microbiota and cardiometabolic diseases, and consider the gut microbiota as new potential therapeutic targets for treating CVD.	[Yamashita, Tomoya; Kasahara, Kazuyuki; Emoto, Takuo; Matsumoto, Takuya; Mizoguchi, Taiji; Kitano, Naoki; Sasaki, Naoto; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med, Kobe, Hyogo 6500017, Japan	Yamashita, T (reprint author), Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tomoya@med.kobe-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [24591114]; Suzuken Memorial Foundation; Takeda Scientific Foundation; Mochida Memorial Foundation; Senshin Medical Research Foundation; Yakult Bioscience Research Foundation; Uehara Memorial Foundation; Japanese Circulation Society Translational Research Foundation	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant No. 24591114 (T.Y.), Suzuken Memorial Foundation (T.Y. and N.S.), Takeda Scientific Foundation (T.Y. and N.S.), Mochida Memorial Foundation (T.Y.), Senshin Medical Research Foundation (T.Y. and N.S.), Yakult Bioscience Research Foundation (T.Y.), Uehara Memorial Foundation (K.H. and N.S.), and The Japanese Circulation Society Translational Research Foundation (K.H.).	Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Wright SD, 2000, J EXP MED, V191, P1437, DOI 10.1084/jem.191.8.1437; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/nature4441022a; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Stepankova R, 2010, J ATHEROSCLER THROMB, V17, P796; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Hermansson A, 2011, CIRCULATION, V123, P1083, DOI 10.1161/CIRCULATIONAHA.110.973222; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Maron R, 2002, CIRCULATION, V106, P1708, DOI 10.1161/01.CIR.0000029750.99462.30; Takeda M, 2010, ARTERIOSCL THROM VAS, V30, P2495, DOI 10.1161/ATVBAHA.110.215459; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Zhang B, 2013, CIRC J, V77, P2651, DOI 10.1253/circj.CJ-12-1584; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Ishikawa H, 2007, DIABETES, V56, P2103, DOI 10.2337/db06-1632; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Ketelhuth DFJ, 2015, CIRC J, V79, P924, DOI 10.1253/circj.CJ-15-0167; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; De Rosa S, 2014, CIRC J, V78, P567, DOI 10.1253/circj.CJ-14-0086; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Koeth RA, 2014, CELL METAB, V20, P799, DOI 10.1016/j.cmet.2014.10.006; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kasahara K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000719; Kita T, 2014, CARDIOVASC RES, V102, P107, DOI 10.1093/cvr/cvu002; Matsuzawa Y, 2015, CIRC J, V79, P685, DOI 10.1253/circj.CJ-15-0068; Nakajima K, 2011, ARTERIOSCL THROM VAS, V31, P1963, DOI 10.1161/ATVBAHA.111.229443; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ross R, 1999, NEW ENGL J MED, V340, P115	48	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1882	1890		10.1253/circj.CJ-15-0526		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500004		
J	Sonoda, S; Otsuji, Y				Sonoda, Shinjo; Otsuji, Yutaka			Do Two Eyes Really See More Than One? - Intravascular Ultrasound and Optical Coherence Tomography	CIRCULATION JOURNAL			English	Editorial Material							ELECTIVE STENT IMPLANTATION; MYOCARDIAL-INFARCTION; PLAQUE; ELEVATION; IMPACT		[Sonoda, Shinjo; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Dept Internal Med 2, Sch Med, Kitakyushu, Fukuoka 8078555, Japan	Sonoda, S (reprint author), Univ Occupat & Environm Hlth, Dept Internal Med 2, Sch Med, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	s-sonoda@med.uoeh-u.ac.jp					Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Fujii K, 2013, CIRC J, V77, P588, DOI 10.1253/circj.CJ-12-1599; Yonetsu T, 2013, CIRC J, V77, P1933, DOI 10.1253/circj.CJ-13-0643.1; Lee T, 2011, CIRC-CARDIOVASC INTE, V4, P378, DOI 10.1161/CIRCINTERVENTIONS.111.962506; Kimura S, 2009, CIRC-CARDIOVASC INTE, V2, P444, DOI 10.1161/CIRCINTERVENTIONS.108.821124; Twerenbold R, 2012, EUR HEART J, V33, P579, DOI 10.1093/eurheartj/ehr492; Fujii K, 2015, JACC-CARDIOVASC IMAG, V8, P451, DOI 10.1016/j.jcmg.2014.10.015; Hibi K, 2015, CIRC J, V79, P24, DOI 10.1253/circj.CJ-14-1044; Kimura S, 2015, CIRC J, V79, P1944, DOI 10.1253/circj.CJ-14-1375; Lee T, 2011, JACC-CARDIOVASC INTE, V4, P483, DOI 10.1016/j.jcin.2010.12.013; Porto I, 2012, CIRC-CARDIOVASC INTE, V5, pS1; Porto I, 2012, CIRC-CARDIOVASC INTE, V5, P89, DOI 10.1161/CIRCINTERVENTIONS.111.965624; Sakata K, 2015, CIRC J, V79, P513, DOI 10.1253/circj.CJ-15-0103	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1891	1892		10.1253/circj.CJ-15-0811		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500005		
J	Nakagawa, Y; Yasuno, S; Kuwahara, K				Nakagawa, Yasuaki; Yasuno, Shinji; Kuwahara, Koichiro			Differential Relationships Between Anemia and Outcome in Subgroups of Patients With Chronic Heart Failure	CIRCULATION JOURNAL			English	Editorial Material							PRESERVED EJECTION FRACTION; NONCARDIAC COMORBIDITIES; FERRIC CARBOXYMALTOSE; MORTALITY; POPULATION; MORBIDITY; CHART-2; IMPACT; TRIAL; ALPHA		[Nakagawa, Yasuaki; Kuwahara, Koichiro] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Yasuno, Shinji] Kyoto Univ Hosp, Dept EBM Res, Inst Adv Clin & Translat Sci, Kyoto 606, Japan	Nakagawa, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Shogoin, Kyoto 6068507, Japan.	ynakagaw@kuhp.kyoto-u.ac.jp					Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Mentz RJ, 2014, J AM COLL CARDIOL, V64, P2281, DOI 10.1016/j.jacc.2014.08.036; O'Meara E, 2006, CIRCULATION, V113, P986, DOI 10.1161/CIRCULATIONAHA.105.582577; Filippatos G, 2013, EUR J HEART FAIL, V15, P1267, DOI 10.1093/eurjhf/hft099; Nochioka K, 2013, CIRC J, V77, P2318, DOI 10.1253/circj.CJ-13-0127; Maurer MS, 2013, CIRC-HEART FAIL, V6, P254, DOI 10.1161/CIRCHEARTFAILURE.112.969717; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; von Haehling S, 2011, EUR J HEART FAIL, V13, P656, DOI 10.1093/eurjhf/hfr044; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Felker GM, 2006, AM HEART J, V151, P457, DOI 10.1016/j.ahj.2005.03.056; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; Miura M, 2013, CIRC J, V77, P2954, DOI 10.1253/circj.CJ-13-0725; Yamauchi T, 2015, CIRC J, V79, P1984, DOI 10.1253/circj.CJ-15-0174	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1893	1894		10.1253/circj.CJ-15-0852		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500006		
J	Kawamoto, S; Saiki, Y				Kawamoto, Shunsuke; Saiki, Yoshikatsu			Pulsatility During Left Ventricular Assist Device Treatment	CIRCULATION JOURNAL			English	Editorial Material							CONTINUOUS-FLOW; RESPONSES; PRESSURE; SUPPORT		[Kawamoto, Shunsuke; Saiki, Yoshikatsu] Tohoku Univ, Grad Sch Med, Div Cardiovasc Surg, Sendai, Miyagi 9808574, Japan	Kawamoto, S (reprint author), Tohoku Univ, Grad Sch Med, Div Cardiovasc Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan.	shunsukekawamoto@med.tohoku.ac.jp					Akashi H, 2015, CIRC J, V79, P43, DOI 10.1253/circj.CJ-14-1302; Barakat AI, 2003, CELL BIOCHEM BIOPHYS, V38, P323, DOI 10.1385/CBB:38:3:323; Bartoli CR, 2010, ASAIO J, V56, P410, DOI 10.1097/MAT.0b013e3181e7bf3c; Garcia S, 2008, J HEART LUNG TRANSPL, V27, P261, DOI 10.1016/j.healun.2007.12.001; Klotz S, 2004, ANN THORAC SURG, V77, P143, DOI 10.1016/S0003-4975(03)01336-5; Imamura T, 2014, CIRC J, V78, P625, DOI 10.1253/circj.CJ-13-1201; CANTY JM, 1994, CIRCULATION, V89, P375; Cheng Allen, 2014, Ann Cardiothorac Surg, V3, P573, DOI 10.3978/j.issn.2225-319X.2014.08.24; Imamura T, 2015, CIRC J, V79, P1994, DOI 10.1253/circj.CJ-15-0419; Imamura T, 2015, CIRC J, V79, P104, DOI 10.1253/circj.CJ-14-0944; Koenig SC, 2004, ASAIO J, V50, P15, DOI 10.1097/01.MAT.0000104816.50277.EB; Radovancevic B, 2007, J HEART LUNG TRANSPL, V26, P815, DOI 10.1016/j.healun.2007.05.012; Umeki A, 2013, CIRC J, V77, P995, DOI 10.1253/circj.CJ-12-0676	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1895	1896		10.1253/circj.CJ-15-0810		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500007		
J	Higuma, T; Hanada, H; Okumura, K				Higuma, Takumi; Hanada, Hiroyuki; Okumura, Ken			Direct Transfer, Shorter Onset-to-Balloon Time, and Better Clinical Outcome in ST-Segment Elevation Myocardial Infarction	CIRCULATION JOURNAL			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; DOOR; MORTALITY; ANGIOPLASTY; ASSOCIATION; MANAGEMENT		[Higuma, Takumi; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori 0368562, Japan; [Hanada, Hiroyuki] Aomori Prefectural Cent Hosp, Emergency & Crit Care Ctr, Aomori, Japan	Okumura, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Cardiol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	okumura@hirosaki-u.ac.jp					O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019; Berger PB, 1999, CIRCULATION, V100, P14; Daida H, 2013, CIRC J, V77, P934, DOI 10.1253/circj.CJ-13-0174; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Brodie BR, 2010, J AM COLL CARDIOL, V56, P407, DOI 10.1016/j.jacc.2010.04.020; Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065; Chua SK, 2013, CIRC J, V77, P383, DOI 10.1253/circj.CJ-12-0646; Imori Y, 2015, CIRC J, V79, P2000, DOI 10.1253/circj.CJ-14-0678; Shiomi H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3257	11	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1897	1899		10.1253/circj.CJ-15-0803		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500008		
J	Ishii, H; Murohara, T				Ishii, Hideki; Murohara, Toyoaki			How Can We Improve Prognosis in Patients With Acute Myocardial Infarction? - Lesson From Patients Without Primary Percutaneous Coronary Intervention	CIRCULATION JOURNAL			English	Editorial Material							MORTALITY; TRENDS; JAPAN		[Ishii, Hideki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan	Ishii, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	hkishii@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014				Morita Y, 2013, CIRC J, V77, P2778, DOI 10.1253/circj.CJ-13-0251; Nakatani D, 2013, CIRC J, V77, P439, DOI 10.1253/circj.CJ-11-1059; Spoon DB, 2014, CIRCULATION, V129, P1286, DOI 10.1161/CIRCULATIONAHA.113.006518; Takii T, 2010, CIRC J, V74, P93, DOI 10.1253/circj.CJ-09-0619; Hao K, 2015, CIRC J, V79, P2009, DOI 10.1253/circj.CJ-15-0440; Hao K, 2014, CIRC J, V78, P634, DOI 10.1253/circj.CJ-13-1286; Ishihara M, 2012, J CARDIOL, V59, P243, DOI 10.1016/j.jjcc.2011.10.007; Ishii H, 2008, CIRCULATION, V118, P2710, DOI 10.1161/CIRCULATIONAHA.107.748772; Kosuge M, 2009, AM J CARDIOL, V103, P322, DOI 10.1016/j.amjcard.2008.09.079	9	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1900	1901		10.1253/circj.CJ-15-0759		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500009		
J	Adachi, H				Adachi, Hisashi			Trans Fatty Acid and Coronary Artery Disease - Lessons From Seven Countries Study	CIRCULATION JOURNAL			English	Editorial Material							HEART-DISEASE; LINOLEIC-ACID; CHOLESTEROL; MORTALITY		Kurume Univ, Sch Med, Dept Community Med, Kurume, Fukuoka 8300011, Japan	Adachi, H (reprint author), Kurume Univ, Sch Med, Dept Community Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	hadac@med.kurume-u.ac.jp					ABBEY M, 1994, ATHEROSCLEROSIS, V106, P99, DOI 10.1016/0021-9150(94)90086-8; Adachi H, 2005, J EPIDEMIOL, V15, P85, DOI 10.2188/jea.15.85; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; Wei JZ, 2013, CIRC J, V77, P2823, DOI 10.1253/circj.CJ-13-0248; KROMHOUT D, 1995, PREV MED, V24, P308, DOI 10.1006/pmed.1995.1049; Alonso L, 1999, J DAIRY SCI, V82, P878; Keys A, 1967, ACTA MED SCAND S, V460, P1; KEYS A, 1970, Circulation Research Supplement, V41, P1; Kromhout D, 1996, INT J EPIDEMIOL, V25, P753, DOI 10.1093/ije/25.4.753; Mori K, 2015, CIRC J, V79, P2017, DOI 10.1253/circj.CJ-14-0750; Satoh K, 2013, CIRC J, V77, P2702, DOI 10.1253/circj.CJ-13-1155; World Health Organisation, 2003, WHO TECH REP SER, V916, pi	12	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1902	1903		10.1253/circj.CJ-15-0743		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500010		
J	Takahashi, K				Takahashi, Kei			Is the Prevalence of Patent Foramen Ovale in Japanese Truly Low?	CIRCULATION JOURNAL			English	Editorial Material							TRANSCATHETER CLOSURE; STROKE; AUTOPSY		[Takahashi, Kei] Toho Univ, Ohashi Med Ctr, Dept Pathol, Tokyo 1538515, Japan	Takahashi, K (reprint author), Toho Univ, Ohashi Med Ctr, Dept Pathol, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	keitak@oha.toho-u.ac.jp					Shanoudy H, 1998, CHEST, V113, P91, DOI 10.1378/chest.113.1.91; Wilmshurst PT, 2015, DIVING HYPERB MED, V45, P98; Guerin P, 2005, CARDIOVASC INTER RAD, V28, P164, DOI 10.1007/s00270-004-0035-3; Kuramoto J, 2015, CIRC J, V79, P2038, DOI 10.1253/circj.CJ-15-0197; Musto C, 2013, CIRC J, V77, P2922, DOI 10.1253/circj.CJ-13-0565; Handke M, 2007, NEW ENGL J MED, V357, P2262, DOI 10.1056/NEJMoa071422; Takahashi K, 2012, CIRC J, V76, P964, DOI 10.1253/circj.CJ-11-0928; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17; Fisher M, 2015, CIRC J, V79, P271, DOI 10.1253/circj.CJ-14-1342; Kim RJ, 2008, INT J CARDIOL, V129, pE50, DOI 10.1016/j.ijcard.2007.06.116; Klotzsch C, 1996, ARCH NEUROL-CHICAGO, V53, P504; Komar M, 2014, CIRC J, V78, P2415, DOI 10.1253/circj.CJ-14-0456; PENTHER P, 1994, ARCH MAL COEUR VAISS, V87, P15; Schroeckenstein R F, 1972, Minn Med, V55, P11; Seib GA, 1934, AM J ANAT, V55, P511, DOI 10.1002/aja.1000550306; SWEENEY LJ, 1979, AM HEART J, V98, P194, DOI 10.1016/0002-8703(79)90221-7; Sztajzel R, 2002, CEREBROVASC DIS, V13, P102, DOI 10.1159/000047758; The Japanese Society of Pathology, 2013, ANN PATH AUT CAS JAP, P52	18	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1904	1905		10.1253/circj.CJ-15-0824		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500011		
J	Ito, K; Shimokawa, H				Ito, Kenta; Shimokawa, Hiroaki			The Future of Non-Invasive Angiogenic Therapy Using Acoustic Waves	CIRCULATION JOURNAL			English	Editorial Material							PERIPHERAL ARTERY-DISEASE; MYOCARDIAL-INFARCTION; HEART-FAILURE; SHOCK; ISCHEMIA; IMPROVES		Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; Tohoku Univ, Grad Sch Med, Dept Innovat Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Ito, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	ito-kenta@cardio.med.tohoku.ac.jp					Abe Y, 2014, CIRC J, V78, P2915, DOI 10.1253/circj.CJ-14-0230; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; Serizawa F, 2012, CIRC J, V76, P1486, DOI 10.1253/circj.CJ-11-1216; Nakamura T, 2011, ANN BIOMED ENG, V39, P2964, DOI 10.1007/s10439-011-0408-0; Fukumoto Y, 2006, CORONARY ARTERY DIS, V17, P63, DOI 10.1097/00019501-200602000-00011; Ciampa AR, 2005, FEBS LETT, V579, P6839, DOI 10.1016/j.febslet.2005.11.023; Assmus B, 2013, JAMA-J AM MED ASSOC, V309, P1622, DOI 10.1001/jama.2013.3527; Ruiz-Canela M, 2014, CIRC J, V78, P553, DOI 10.1253/circj.CJ-14-0062; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Barzelai S, 2006, ULTRASOUND MED BIOL, V32, P139, DOI 10.1016/j.ultrasmedbio.2005.08.010; Hanawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104863; Nazer B, 2015, CIRC J, V79, P2043, DOI 10.1253/circj.CJ-15-0366; Sheu JJ, 2010, ANN VASC SURG, V24, P809, DOI 10.1016/j.avsg.2010.03.027; Yamaya S, 2014, J NEUROSURG, V121, P1514, DOI 10.3171/2014.8.JNS132562	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1906	1907		10.1253/circj.CJ-15-0809		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500012		
J	Daimon, M				Daimon, Masao			Can We Predict or Prevent Progression of Aortic Stenosis?	CIRCULATION JOURNAL			English	Editorial Material							VALVE STENOSIS		[Daimon, Masao] Tokyo Univ Hosp, Dept Clin Lab, Tokyo 1138655, Japan	Daimon, M (reprint author), Tokyo Univ Hosp, Dept Clin Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	daimon@muf.biglobe.ne.jp					Aksoy O, 2012, J AM COLL CARDIOL, V59, P1452, DOI 10.1016/j.jacc.2012.01.024; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Rajamannan NM, 2009, ARTERIOSCL THROM VAS, V29, P162, DOI 10.1161/ATVBAHA.107.156752; Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162; Ortlepp JR, 2001, HEART, V85, P635, DOI 10.1136/heart.85.6.635; Barasch E, 2014, CIRC J, V78, P232, DOI 10.1253/circj.CJ-13-0821; Bull S, 2015, EUR HEART J-CARD IMG, V16, P834, DOI 10.1093/ehjci/jev043; Nishimura Rick A, 2014, J Am Coll Cardiol, V63, pe57, DOI 10.1016/j.jacc.2014.02.536; Nishizaki Y, 2013, J HEART VALVE DIS, V22, P287; Patel DK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000879; Rashedi Nina, 2015, J Cardiovasc Ultrasound, V23, P59, DOI 10.4250/jcu.2015.23.2.59; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Yamamoto K, 2015, CIRC J, V79, P2050, DOI 10.1253/circj.CJ-15-0499	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1908	1909		10.1253/circj.CJ-15-0805		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500013		
J	Itoh, T				Itoh, Takeo			Roles of Canonical Transient Receptor Potential 6 in Basal [Ca2+]i Regulation in Pulmonary Venous Smooth Muscle Cells Under Chronic Hypoxia-Induced Hypertension	CIRCULATION JOURNAL			English	Editorial Material							OPERATED CA2+ CHANNELS; ARTERIAL-HYPERTENSION		[Itoh, Takeo] Nagoya City Univ, Grad Sch Med Sci, Dept Pharmacol, Nagoya, Aichi 4678601, Japan	Itoh, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Pharmacol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	titoh@med.nagoya-cu.ac.jp					Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Xu SZ, 2001, CIRC RES, V88, P84; Hofmann T, 1999, NATURE, V397, P259; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; McLaughlin VV, 2015, J AM COLL CARDIOL, V65, P1976, DOI 10.1016/j.jacc.2015.03.540; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Elias-Al-Mamun M, 2014, CIRC J, V78, P967; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jaac.2004.02.029; Nergui S, 2014, CIRC J, V78, P1465, DOI 10.1253/circj.CJ-13-1586; Peng GY, 2015, CIRC J, V79, P2058, DOI 10.1253/circj.CJ-15-0067; Yue ZC, 2015, AM J PHYSIOL-HEART C, V308, pH157, DOI 10.1152/ajpheart.00457.2014	12	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1910	1911		10.1253/circj.CJ-15-0770		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500014		
J	Merchant, FM; Salerno-Uriarte, JA; Caravati, F; Falcone, S; Molon, G; Marangoni, D; Raczak, G; Danilowicz-Szymanowicz, L; Pedretti, RFE; Braga, SS; Ikeda, T; Calo, L; Martino, A; Erciyes, D; Piancastelli, M; Maury, P; Cohen, RJ; Armoundas, AA				Merchant, Faisal M.; Salerno-Uriarte, Jorge A.; Caravati, Fabrizio; Falcone, Stefania; Molon, Giulio; Marangoni, Daniele; Raczak, Grzegorz; Danilowicz-Szymanowicz, Ludmila; Pedretti, Roberto F. E.; Braga, Simona Sarzi; Ikeda, Takanori; Calo, Leonardo; Martino, Annamaria; Erciyes, Demet; Piancastelli, Maurizio; Maury, Philippe; Cohen, Richard J.; Armoundas, Antonis A.			Prospective Use of Microvolt T-Wave Alternans Testing to Guide Primary Prevention Implantable Cardioverter Defibrillator Therapy	CIRCULATION JOURNAL			English	Article						Implantable cardioverter defibrillator; Microvolt T wave alternans; Primary prevention; Risk stratification; Sudden cardiac death	SUDDEN CARDIAC DEATH; ISCHEMIC CARDIOMYOPATHY; RISK STRATIFICATION; HEART-FAILURE; MYOCARDIAL-INFARCTION; CLINICAL-USE; FOLLOW-UP; ARRHYTHMIAS; MORTALITY; BENEFIT	Background: We hypothesized that a negative microvolt T-wave alternans (MTWA) test would identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillator (ICD) therapy in a prospective cohort. Methods and Results: Data were pooled from 8 centers where MTWA testing was performed specifically for the purpose of guiding primary prevention ICD implantation. Cohorts were included if the ratio of ICDs implanted in patients who were MTWA "non-negative" to patients who were MTWA negative was >2: 1, indicating that MTWA testing had a significant impact on the decision to implant an ICD. The pooled cohort included 651 patients: 371 MTWA non-negative and 280 MTWA negative. Among non-negative patients, 62% underwent ICD implantation whereas only 13% of MTWA-negative patients received an ICD (P<0.01). Despite a substantially lower prevalence of ICDs, long-term survival (6.9 years) was significantly better among MTWA-negative patients (68.2% non-negative vs. 87.1% negative, P=0.026). Conclusions: MTWA-negative patients had significantly better survival than MTWA non-negative patients, the majority of whom had ICDs. Despite a very low prevalence of ICDs, long-term survival among patients with left ventricular ejection fraction <= 40% and a negative MTWA test was better than in the ICD arm of any study to date that has demonstrated a benefit of ICDs. This provides further evidence that MTWA-negative patients are unlikely to benefit from primary prevention ICD therapy.	[Merchant, Faisal M.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; [Salerno-Uriarte, Jorge A.; Caravati, Fabrizio; Falcone, Stefania] Univ Insubria, Dept Heart Sci, Osped Circolo, Varese, Italy; [Salerno-Uriarte, Jorge A.; Caravati, Fabrizio; Falcone, Stefania] Univ Insubria, Dept Heart Sci, Fdn Macchi, Varese, Italy; [Molon, Giulio; Marangoni, Daniele] S Cuore Hosp, Dept Cardiol, Negrar, Italy; [Raczak, Grzegorz; Danilowicz-Szymanowicz, Ludmila] Med Univ Gdansk, Dept Cardiol & Electrotherapy, Gdansk, Poland; [Pedretti, Roberto F. E.; Braga, Simona Sarzi] Sci Inst Tradate, IRCCS Fdn Salvatore Maugeri, Tradate, Italy; [Ikeda, Takanori] Toho Univ, Div Cardiovasc Med, Fac Med & Med Ctr, Tokyo, Japan; [Calo, Leonardo; Martino, Annamaria] Policlin Casilino, Rome, Italy; [Erciyes, Demet] Florence Nightingale Hosp, Istanbul, Turkey; [Piancastelli, Maurizio] S Maria della Croci, Ravena, Turkey; [Maury, Philippe] Univ Hosp Rangueil Toulouse, Toulouse, France; [Cohen, Richard J.; Armoundas, Antonis A.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Armoundas, Antonis A.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA	Armoundas, AA (reprint author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA.	aarmoundas@partners.org					Chan PS, 2009, CIRC-CARDIOVASC QUAL, V2, P16, DOI 10.1161/CIRCOUTCOMES.108.807123; Chow T, 2008, J AM COLL CARDIOL, V52, P1607, DOI 10.1016/j.jacc.2008.08.018; Bloomfield DM, 2002, J CARDIOVASC ELECTR, V13, P502, DOI 10.1046/j.1540-8167.2002.00502.x; Tung R, 2008, J AM COLL CARDIOL, V52, P1111, DOI 10.1016/j.jacc.2008.05.058; Chow T, 2006, J AM COLL CARDIOL, V47, P1820, DOI 10.1016/j.jacc.2005.11.079; Goldenberg I, 2010, CIRCULATION, V122, P1265, DOI 10.1161/CIRCULATIONAHA.110.940148; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Molon G, 2013, INT J CARDIOL, V168, P3038, DOI 10.1016/j.ijcard.2013.04.133; Reynolds MR, 2006, J AM COLL CARDIOL, V47, P2493, DOI 10.1016/j.jacc.2006.02.049; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Chow T, 2007, J AM COLL CARDIOL, V49, P50, DOI 10.1016/j.jacc.2006.06.079; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Hohnloser SH, 2009, HEART RHYTHM, V6, pS36, DOI 10.1016/j.hrthm.2008.10.011; Hoshida K, 2013, CIRC J, V77, P432, DOI 10.1253/circj.CJ-12-0789; JCS Joint Working Group, 2013, CIRC J, V77, P249; Merchant FM, 2013, AM HEART J, V166, P744, DOI 10.1016/j.ahj.2013.06.023; Merchant FM, 2012, HEART RHYTHM, V9, P1256, DOI 10.1016/j.hrthm.2012.03.014; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; Salerno-Uriarte JA, 2007, J AM COLL CARDIOL, V50, P1896, DOI 10.1016/j.jacc.2007.09.004; Stevenson LW, 2011, AM HEART J, V161, P1007, DOI 10.1016/j.ahj.2011.03.020	22	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1912	1919		10.1253/circj.CJ-15-0253		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500015		
J	Tenma, T; Yokoshiki, H; Mizukami, K; Mitsuyama, H; Watanabe, M; Sasaki, R; Maeno, M; Matsui, Y; Tsutsui, H				Tenma, Taro; Yokoshiki, Hisashi; Mizukami, Kazuya; Mitsuyama, Hirofumi; Watanabe, Masaya; Sasaki, Ryo; Maeno, Motoki; Matsui, Yoshiro; Tsutsui, Hiroyuki			Predictors and Proarrhythmic Consequences of Inappropriate Implantable Cardioverter-Defibrillator Therapy	CIRCULATION JOURNAL			English	Article						Antitachycardia pacing; Implantable cardioverter-defibrillator; Inappropriate shock; Paroxysmal atrial fibrillation; Proarrhythmia	LONG-DETECTION INTERVAL; VENTRICULAR-TACHYCARDIA; DRIVING RESTRICTIONS; SUPRAVENTRICULAR TACHYCARDIA; TACHYARRHYTHMIA DETECTION; DETECTION ALGORITHMS; ISCHEMIC-STROKE; HEART-FAILURE; SHOCKS; SYNCOPE	Background: Despite the benefits of implantable cardioverter-defibrillator (ICD) therapy, inappropriate shocks can lead to multiple adverse effects. The aim of this study was to clarify the predictors of inappropriate ICD shocks and their proarrhythmic consequences. Methods and Results: We retrospectively studied 316 consecutive patients who underwent ICD implantation from December 2000 to December 2011. Of them, 70 (22%) experienced inappropriate ICD shocks without proarrhythmia requiring some intervention; 2 patients (0.6%) had proarrhythmic inappropriate ICD therapy by antitachycardia pacing (ATP), thereby calculated to be 0.18% of patients per year. However, they did not have syncope from this inappropriate ATP. Multivariate analysis identified younger age (<= 56 years: hazard ratio [HR] 1.68, 95% confidence interval [CI] 1.02-2.77, P= 0.043), paroxysmal atrial fibrillation (HR 3.00, 95% CI 1.64-5.31, P= 0.0002), stroke (HR 2.23, 95% CI 1.11-4.47, P= 0.024), and no diuretic use (HR 1.72, 95% CI 1.03-2.93, P= 0.039) as independent predictors of the occurrence of inappropriate ICD shocks. Conclusions: Young age, paroxysmal atrial fibrillation, stroke, and no use of diuretics were independently associated with inappropriate ICD shocks. Proarrhythmic inappropriate ICD therapy was observed with an annual incidence of 0.18% by ATP.	[Tenma, Taro; Yokoshiki, Hisashi; Mizukami, Kazuya; Mitsuyama, Hirofumi; Watanabe, Masaya; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 0608638, Japan; [Matsui, Yoshiro] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Surg, Sapporo, Hokkaido 0608638, Japan; [Sasaki, Ryo; Maeno, Motoki] Hokkaido Univ Hosp, Div Med Engn Ctr, Sapporo, Hokkaido 060, Japan	Yokoshiki, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	yokoshh@med.hokudai.ac.jp					Abello M, 2006, EUR HEART J, V27, P89, DOI 10.1093/eurheartj/ehi500; Nanthakumar K, 2003, J INTERV CARD ELECTR, V8, P215, DOI 10.1023/A:1023973306742; Ruwald ACH, 2013, J CARDIOVASC ELECTR, V24, P672, DOI 10.1111/jce.12099; Simula S, 2014, J STROKE CEREBROVASC, V23, P717, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.032; van Rees JB, 2011, J AM COLL CARDIOL, V57, P556, DOI 10.1016/j.jacc.2010.06.059; Xiong L, 2014, J NEUROL SCI, V337, P141, DOI 10.1016/j.jns.2013.11.036; Vijgen J, 2009, EUROPACE, V11, P1097, DOI 10.1093/europace/eup112; Wilkoff BL, 2004, J CARDIOVASC ELECTR, V15, P1002, DOI 10.1046/j.1540-8167.2004.03625.x; Theuns DAMJ, 2004, J AM COLL CARDIOL, V44, P2362, DOI 10.1016/j.jacc.2004.09.039; Rahmawati A, 2013, CIRC J, V77, P1158, DOI 10.1253/circj.CJ-12-1116; Saeed M, 2014, J CARDIOVASC ELECTR, V25, P52, DOI [10.1111/jce.12239, 10.1111/jce.12273]; Kloppe A, 2014, CIRCULATION, V130, P308, DOI 10.1161/CIRCULATIONAHA.114.009468; Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073; Bansch D, 1998, J AM COLL CARDIOL, V31, P608, DOI 10.1016/S0735-1097(97)00543-3; Etheridge SP, 2001, J CARDIOVASC ELECTR, V12, P1102, DOI 10.1046/j.1540-8167.2001.01102.x; Finsterer J, 2014, J NEUROL SCI, V345, P8, DOI 10.1016/j.jns.2014.07.003; Garcia-Moran E, 2002, EUR HEART J, V23, P901, DOI 10.1053/euhj.2001.3073; Gasparini M, 2013, JAMA-J AM MED ASSOC, V309, P1903, DOI 10.1001/jama.2013.4598; Hreybe H, 2006, AM J CARDIOL, V97, P544, DOI 10.1016/j.amjcard.2005.08.074; HURWITZ JL, 1993, J AM COLL CARDIOL, V21, P895; KOU WH, 1991, ANN INTERN MED, V115, P942; LAUER MR, 1994, AM J CARDIOL, V73, P559, DOI 10.1016/0002-9149(94)90333-6; Link MS, 1997, J AM COLL CARDIOL, V29, P370; Mitsui T, 2003, J ARRHYTHMIA, V19, P502; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Noda T, 2014, CIRC J, V78, P1989, DOI 10.1253/circj.CJ-14-0589; Oginosawa Y, 2010, CIRC J, V74, P2283, DOI 10.1253/circj.CJ-10-0900; Olatidoye AG, 1998, AM J CARDIOL, V82, P1372, DOI 10.1016/S0002-9149(98)00644-4; PINSKI SL, 1995, CIRCULATION, V92, P1651; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Ritter MA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-47; Soundarraj D, 2006, PACE, V29, P810, DOI 10.1111/j.1540-8159.2006.00445.x; Swerdlow CD, 2001, J CARDIOVASC ELECTR, V12, P606, DOI 10.1046/j.1540-8167.2001.00606.x; Swerdlow CD, 2002, J CARDIOVASC ELECTR, V13, P432, DOI 10.1046/j.1540-8167.2002.00432.x; The Japanese Police Agency, ANN REP TRAFF ROAD A; Theuns DAMJ, 2005, AM J CARDIOL, V95, P271, DOI 10.1016/j.amjcard.2004.09.017; Thijssen J, 2011, EUR HEART J, V32, P2678, DOI 10.1093/eurheartj/ehr161; Watanabe T, 2014, CIRC J, V78, P2643, DOI 10.1253/circj.CJ-14-0146; Woo A, 2007, HEART, V93, P1044, DOI 10.1136/hrt.2006.090290	39	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1920	U242		10.1253/circj.CJ-15-0306		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500016		
J	Saito, S; Isshiki, T; Kimura, T; Ogawa, H; Yokoi, H; Nishikawa, M; Miyazaki, S; Tanaka, Y; Nakamura, M				Saito, Shigeru; Isshiki, Takaaki; Kimura, Takeshi; Ogawa, Hisao; Yokoi, Hiroyoshi; Nishikawa, Masakatsu; Miyazaki, Shunichi; Tanaka, Yuko; Nakamura, Masato		PRASFIT ACS; PRASFIT Elective Investigators	Impact of Arterial Access Route on Bleeding Complications in Japanese Patients Undergoing Percutaneous Coronary Intervention - Insight From the PRASFIT Trial	CIRCULATION JOURNAL			English	Article						Arterial access route; Bleeding; Femoral artery; Percutaneous coronary intervention; Radial artery	ST-SEGMENT ELEVATION; PRASUGREL; CLOPIDOGREL; OUTCOMES; ACS	Background: Few large-scale studies have examined the relationship between bleeding events not related to coronary artery bypass grafting (CABG), and the vascular access route used in acute coronary syndrome (ACS) or in elective treatment of coronary artery disease (CAD). Methods and Results: We compared the incidence of bleeding events occurring up to 3 days after percutaneous coronary intervention (PCI) or loading dose of prasugrel or clopidogrel in 2 studies of Japanese patients (PRASFIT-ACS, femoral and radial routes, n= 683 and 531; PRASFIT-Elective, femoral and radial routes, n= 135 and 508). Rates of periprocedural bleeding, bleeding not related to CABG, and puncture site bleeding were consistently lower in the radial access route group than in the femoral access route group in both studies. Risk factors for periprocedural bleeding included sex, body weight, age, and access route in PRASFIT-ACS (femoral access: hazard ratio [HR], 3.739; 95% confidence interval [CI]: 1.727-8.094; radial access: HR, 0.288; 95% CI: 0.128-0.65), and body weight, age, and access route in PRASFIT-Elective (femoral access: HR, 12.32; 95% CI 1.282-> 100; radial access: HR, 0.125; 95% CI: 0.013-1.205). Conclusions: The incidence of periprocedural bleeding is lower with a radial access route than with a femoral access route for PCI in Japanese patients with ACS or those undergoing elective PCI for CAD.	[Saito, Shigeru] Shonan Kamakura Gen Hosp, Div Cardiol, Kamakura, Kanagawa 2478533, Japan; [Isshiki, Takaaki] Ageo Cent Gen Hosp, Ageo, Japan; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Ogawa, Hisao] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Yokoi, Hiroyoshi] Fukuoka Sanno Hosp, Fukuoka, Japan; [Yokoi, Hiroyoshi] Int Univ Hlth & Welf, Ohtawara, Japan; [Nishikawa, Masakatsu] Mie Univ Hosp, Clin Res Support Ctr, Tsu, Mie, Japan; [Miyazaki, Shunichi] Kinki Univ, Fac Med, Dept Med, Div Cardiol, Osakasayama, Japan; [Tanaka, Yuko] Daiichi Sankyo Co Ltd, R&D Div, Clin Data & Biostat Dept, Tokyo, Japan; [Nakamura, Masato] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo, Japan	Saito, S (reprint author), Shonan Kamakura Gen Hosp, Div Cardiol, 1370-1 Okamoto, Kamakura, Kanagawa 2478533, Japan.	transradial@kamakuraheart.org			Daiichi Sankyo (Tokyo, Japan)	The PRASFIT-ACS and PRASFIT-Elective studies were sponsored by Daiichi Sankyo (Tokyo, Japan).	Bernat I, 2014, J AM COLL CARDIOL, V63, P964, DOI 10.1016/j.jacc.2013.08.1651; Lee MS, 2013, JACC-CARDIOVASC INTE, V6, P1149, DOI 10.1016/j.jcin.2013.08.003; Sciahbasi A, 2009, AM J CARDIOL, V103, P796, DOI 10.1016/j.amjcard.2008.11.049; Rao SV, 2012, JACC-CARDIOVASC INTE, V5, P958, DOI 10.1016/j.jcin.2012.05.010; Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017; Mehta SR, 2012, J AM COLL CARDIOL, V60, P2490, DOI 10.1016/j.jacc.2012.07.050; Saito S, 2014, CIRC J, V78, P1684, DOI 10.1253/circj.CJ-13-1482; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Mamas MA, 2012, HEART, V98, P303, DOI 10.1136/heartjnl-2011-300558; Isshiki T, 2014, CIRC J, V78, P2926, DOI 10.1253/circj.CJ-14-0266	11	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1928	1937		10.1253/circj.CJ-15-0276		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500017		
J	Jinnouchi, H; Kuramitsu, S; Shinozaki, T; Kobayashi, Y; Hiromasa, T; Morinaga, T; Mazaki, T; Sakakura, K; Soga, Y; Hyodo, M; Shirai, S; Ando, K				Jinnouchi, Hiroyuki; Kuramitsu, Shoichi; Shinozaki, Tomohiro; Kobayashi, Yohei; Hiromasa, Takashi; Morinaga, Takashi; Mazaki, Toru; Sakakura, Kenichi; Soga, Yoshimitsu; Hyodo, Makoto; Shirai, Shinichi; Ando, Kenji			Two-Year Clinical Outcomes of Newer-Generation Drug-Eluting Stent Implantation Following Rotational Atherectomy for Heavily Calcified Lesions	CIRCULATION JOURNAL			English	Article						Newer-generation drug-eluting stents; Percutaneous coronary intervention; Rotational atherectomy	CORONARY-ARTERY-DISEASE; INTRAVASCULAR ULTRASOUND; POLYMER; TRIAL; DETERMINANTS	Background: Clinical outcomes of implantation of the newer-generation drug-eluting stent (DES) following rotational atherectomy for heavily calcified lesions remain unclear in the real-world setting. Methods and Results: We enrolled 252 consecutive patients (273 lesions) treated with newer-generation DES following rotational atherectomy. The primary endpoint was the cumulative 2-year incidence of major adverse cardiovascular events (MACE), defined as cardiac death, myocardial infarction, clinically-driven target lesion revascularization, and definite stent thrombosis. Complete clinical follow-up information at 2-year was obtained for all patients. The mean age was 73.2+/-9.0 years and 155 patients (61.5%) were male. Cumulative 2-year incidence of MACE (cardiac death, myocardial infarction, clinically-driven target lesion revascularization and definite stent thrombosis) was 20.3% (7.0%, 2.1%, 18.1% and 2.1%, respectively). Predictors of MACE were presenting with acute coronary syndrome (hazard ratio [HR]: 3.80, 95% confidence interval [CI]: 1.29-11.2, P= 0.02), hemodialysis (HR: 1.93, 95% CI: 1.04-3.56, P= 0.04) and previous coronary artery bypass graft (HR: 2.26, 95% CI: 1.02-5.00, P= 0.045). Conclusions: PCI for calcified lesions requiring rotational atherectomy is still challenging even in the era of newer-generation DES.	[Jinnouchi, Hiroyuki; Kuramitsu, Shoichi; Kobayashi, Yohei; Hiromasa, Takashi; Morinaga, Takashi; Mazaki, Toru; Soga, Yoshimitsu; Hyodo, Makoto; Shirai, Shinichi; Ando, Kenji] Kokura Mem Hosp, Div Cardiovasc Med, Kitakyushu 8028555, Japan; [Shinozaki, Tomohiro] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Sakakura, Kenichi] Jichi Med Univ, Div Cardiovasc Med, Saitama Med Ctr, Saitama, Japan	Jinnouchi, H (reprint author), Kokura Mem Hosp, Dept Cardiol, Kokurakita Ku, 3-2-1 Asano, Kitakyushu 8028555, Japan.	hiroyukij0813@hotmail.co.jp					ALFONSO F, 1994, J AM COLL CARDIOL, V23, P879; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Abdel-Wahab M, 2013, CATHETER CARDIO INTE, V81, P285, DOI 10.1002/ccd.24367; Cavusoglu E, 2004, CATHETER CARDIO INTE, V62, P485, DOI 10.1002/ccd.20081; Furuichi S, 2009, EUROINTERVENTION, V5, P370, DOI 10.4244/V5I3A58; Sakakura K, 2012, AM J CARDIOL, V110, P498, DOI 10.1016/j.amjcard.2012.04.021; Smits PC, 2011, J AM COLL CARDIOL, V58, P11, DOI 10.1016/j.jacc.2011.02.023; Rathore S, 2010, CATHETER CARDIO INTE, V75, P919, DOI 10.1002/ccd.22437; Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Abdel-Wahab M, 2013, JACC-CARDIOVASC INTE, V6, P10, DOI 10.1016/j.jcin.2012.07.017; Moussa I, 1997, CIRCULATION, V96, P128; Hoffmann R, 1998, EUR HEART J, V19, P1224, DOI 10.1053/euhj.1998.1028; Hoffmann R, 1998, AM J CARDIOL, V81, P552, DOI 10.1016/S0002-9149(97)00983-1; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Danzi GB, 2014, CIRC J, V78, P1858, DOI 10.1253/circj.CJ-13-1558; Lee Y, 2014, J INVASIVE CARDIOL, V26, P41; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Natsuaki M, 2014, JAMA-J AM MED ASSOC, V311, P2125, DOI 10.1001/jama.2014.3584; SHARMA SK, 1993, AM HEART J, V126, P39, DOI 10.1016/S0002-8703(07)80008-1; Tamekiyo H, 2009, CIRC J, V73, P2042; Yabushita H, 2014, CIRC J, V78, P1867, DOI 10.1253/circj.CJ-13-1426	23	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1938	1943		10.1253/circj.CJ-15-0233		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500018		
J	Kimura, S; Sugiyama, T; Hishikari, K; Yamakami, Y; Sagawa, Y; Kojima, K; Ohtani, H; Hikita, H; Takahashi, A; Isobe, M				Kimura, Shigeki; Sugiyama, Tomoyo; Hishikari, Keiichi; Yamakami, Yosuke; Sagawa, Yuichiro; Kojima, Keisuke; Ohtani, Hirofumi; Hikita, Hiroyuki; Takahashi, Atsushi; Isobe, Mitsuaki			Association of Intravascular Ultrasound- and Optical Coherence Tomography-Assessed Coronary Plaque Morphology With Periprocedural Myocardial Injury in Patients With Stable Angina Pectoris	CIRCULATION JOURNAL			English	Article						Angina; Biomarker; Intravascular ultrasound; Optical coherence tomography; Outcome	CARDIAC TROPONIN ELEVATION; ELECTIVE STENT IMPLANTATION; ATHEROSCLEROTIC PLAQUE; SPOTTY CALCIFICATION; ATTENUATED PLAQUE; ARTERY-DISEASE; HEART-FAILURE; INTERVENTION; INFARCTION; IMPACT	Background: Periprocedural myocardial injury (PMI) is not an uncommon complication and is related to adverse cardiac events after percutaneous coronary intervention (PCI). We investigated the predictors of PMI in patients with stable angina pectoris (SAP) on intravascular imaging. Methods and Results: We enrolled 193 SAP patients who underwent pre-PCI intravascular ultrasound (IVUS) and optical coherence tomography (OCT). Clinical characteristics, lesion morphology, and long-term follow-up data were compared between patients with and without PMI, defined as post-PCI elevation of high-sensitivity cardiac troponin-T. PMI were observed in 79 patients (40.9%). Estimated glomerular filtration rate (odds ratio [OR], 0.973; 95% confidence interval [CI]: 0.950-0.996; P= 0.020), >= 2 stents (OR, 3.100; 95% CI: 1.334-7.205; P= 0.009), final myocardial blush grade 0-2 (OR, 4.077; 95% CI: 1.295-12.839; P= 0.016), and IVUS-identified echo-attenuated plaque (EA; OR, 3.623; 95% CI: 1.700-7.721; P< 0.001) and OCT-derived thin-cap fibroatheroma (OCT-TCFA; OR, 3.406; 95% CI: 1.307-8.872; P= 0.012) were independent predictors of PMI on multivariate logistic regression analysis. A combination of EA and OCT-TCFA had an 82.4% positive predictive value for PMI. On Cox proportional hazards analysis, PMI was an independent predictor of adverse cardiac events during 1-year follow-up (hazard ratio, 2.984; 95% CI: 1.209-7.361; P= 0.018). Conclusions: Plaque morphology assessment using pre-PCI IVUS and OCT may be useful for predicting PMI in SAP patients.	[Kimura, Shigeki; Sugiyama, Tomoyo; Hishikari, Keiichi; Yamakami, Yosuke; Sagawa, Yuichiro; Kojima, Keisuke; Ohtani, Hirofumi; Hikita, Hiroyuki; Takahashi, Atsushi] Yokosuka Kyosai Hosp, Cardiovasc Ctr, Yokosuka, Kanagawa 2388558, Japan; [Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan	Kimura, S (reprint author), Yokosuka Kyosai Hosp, Cardiovasc Ctr, 1-16 Yonegahamadori, Yokosuka, Kanagawa 2388558, Japan.	shigeki55@nifty.com					Watabe H, 2012, J AM COLL CARDIOL, V59, P1881, DOI 10.1016/j.jacc.2012.01.051; van't Hof AWJ, 1998, CIRCULATION, V97, P2302; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Abdelmeguid AE, 1996, CIRCULATION, V94, P1528; Fujii K, 2013, CIRC J, V77, P588, DOI 10.1253/circj.CJ-12-1599; Bruch C, 2007, INT J CARDIOL, V118, P375, DOI 10.1016/j.ijcard.2006.06.066; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Takarada S, 2010, JACC-CARDIOVASC INTE, V3, P766, DOI 10.1016/j.jcin.2010.05.001; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Tanaka A, 2009, EUR HEART J, V30, P1348, DOI 10.1093/eurheartj/ehp122; Lee SY, 2009, JACC-CARDIOVASC INTE, V2, P65, DOI 10.1016/j.jcin.2008.08.022; Maehara A, 2009, CIRC-CARDIOVASC INTE, V2, P482, DOI 10.1161/CIRCINTERVENTIONS.109.868398; Yonetsu T, 2013, CIRC J, V77, P1933, DOI 10.1253/circj.CJ-13-0643.1; Kume T, 2011, EUROINTERVENTION, V6, P768, DOI 10.4244/EIJV6I6A130; Lee T, 2011, CIRC-CARDIOVASC INTE, V4, P378, DOI 10.1161/CIRCINTERVENTIONS.111.962506; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Gibson CM, 1996, CIRCULATION, V93, P879; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Milani RV, 2009, CATHETER CARDIO INTE, V74, P819, DOI 10.1002/ccd.22160; Herrmann J, 2014, CIRC-CARDIOVASC INTE, V7, P533, DOI 10.1161/CIRCINTERVENTIONS.113.000544; Yamada R, 2010, CIRC-CARDIOVASC INTE, V3, P484, DOI 10.1161/CIRCINTERVENTIONS.109.928911; Kimura S, 2009, CIRC-CARDIOVASC INTE, V2, P444, DOI 10.1161/CIRCINTERVENTIONS.108.821124; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Okura H, 2007, CIRC J, V71, P648, DOI 10.1253/circj.71.648; Cuculi F, 2010, HEART, V96, P736, DOI 10.1136/hrt.2009.186189; Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P458, DOI 10.1016/j.jcmg.2008.12.020; Kusumoto A, 2012, J CARDIOL, V59, P202, DOI 10.1016/j.jjcc.2011.11.012; Lee T, 2011, JACC-CARDIOVASC INTE, V4, P483, DOI 10.1016/j.jcin.2010.12.013; Mehran R, 2000, CIRCULATION, V101, P604; Porto I, 2006, CIRCULATION, V114, P662, DOI 10.1161/CIRCULATIONAHA.105.593210; Porto I, 2012, CIRC-CARDIOVASC INTE, V5, P89, DOI 10.1161/CIRCINTERVENTIONS.111.965624; Tardiff BE, 1999, J AM COLL CARDIOL, V33, P88, DOI 10.1016/S0735-1097(98)00551-8; TIMI Study Group, 1985, NEW ENGL J MED, V312, P932; Yamamoto M, 2013, INT J CARDIOL, V168, P2860, DOI 10.1016/j.ijcard.2013.03.134; Yonetsu T, 2012, AM J CARDIOL, V110, P933, DOI 10.1016/j.amjcard.2012.05.027	38	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1944	U270		10.1253/circj.CJ-14-1375		12	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500019		
J	Imamura, T; Kinugawa, K; Nitta, D; Hatano, M; Kinoshita, O; Nawata, K; Kyo, S; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Hatano, Masaru; Kinoshita, Osamu; Nawata, Kan; Kyo, Shunei; Ono, Minoru			Prophylactic Intra-Aortic Balloon Pump Before Ventricular Assist Device Implantation Reduces Perioperative Medical Expenses and Improves Postoperative Clinical Course in INTERMACS Profile 2 Patients	CIRCULATION JOURNAL			English	Article						Cost; Heart failure; Intra-aortic balloon pump; Ventricular assist device	ACUTE MYOCARDIAL-INFARCTION; MAJOR NONCARDIAC SURGERY; D HEART-FAILURE; CARDIOGENIC-SHOCK; CORONARY-PATIENTS; CARDIAC-SURGERY; POOR-PROGNOSIS; COUNTERPULSATION; SUPPORT; MORTALITY	Background: Although intra-aortic balloon pump (IABP) is sometimes used before cardiac surgery to achieve better outcome in high-risk patients, the clinical impact of prophylactic IABP support before left ventricular assist device (LVAD) implantation in patients with worsening hemodynamics was unknown. Methods and Results: We enrolled 22 patients with worsening hemodynamics who had received IABP support before LVAD (IABP group), and also enrolled 22 patients receiving neither IABP nor extracorporeal membrane oxygenation before LVAD, who were selected on propensity score matching (non-IABP group). Although both groups had similar preoperative background, the IABP group had shorter postoperative intensive care unit (ICU) stay, and more improved hemodynamics (P< 0.05 for all). Serum total bilirubin and creatinine decreased significantly in the IABP group compared with the non-IABP group during 1 month after LVAD implantation (P< 0.05 for both). Medical expenses during perioperative ICU stay were significantly lower in the IABP group compared with the non-IABP group, even including the cost of preoperative IABP support (P< 0.05). Conclusions: Prophylactic IABP support in heart failure patients with worsening hemodynamics improves post-LVAD clinical course and reduces perioperative medical expenses.	[Imamura, Teruhiko; Kinugawa, Koichiro; Kyo, Shunei] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo 1138655, Japan; [Nitta, Daisuke; Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Thorac Surg, Tokyo 1138655, Japan	Kinugawa, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kinugawa-tky@umin.ac.jp					SCHEIDT S, 1973, NEW ENGL J MED, V288, P979, DOI 10.1056/NEJM197305102881901; Imamura T, 2014, CIRC J, V78, P1396, DOI 10.1253/circj.CJ-14-0077; Holman WL, 2000, J THORAC CARDIOV SUR, V120, P1112, DOI 10.1067/mtc.2000.110459; Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602; Sawada Y, 1997, MED BIOL ENG COMPUT, V35, P318, DOI 10.1007/BF02534083; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Imamura T, 2014, CIRC J, V78, P2259, DOI 10.1253/circj.CJ-14-0368; Ranucci M, 2013, CRIT CARE MED, V41, P2476, DOI 10.1097/CCM.0b013e3182978dfc; Imamura T, 2013, CIRC J, V77, P96, DOI 10.1253/circj.CJ-12-0686; Kinugawa K, 2011, CIRC J, V75, P2038, DOI 10.1253/circj.CJ-11-0621; Imamura T, 2012, CIRC J, V76, P1895, DOI 10.1253/circj.CJ-12-0182; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Boudoulas Konstantinos Dean, 2014, Acute Card Care, V16, P74, DOI 10.3109/17482941.2014.889311; Christenson JT, 1999, ANN THORAC SURG, V68, P934, DOI 10.1016/S0003-4975(99)00687-6; Christenson JT, 2003, J CARDIAC SURG, V18, P286, DOI 10.1046/j.1540-8191.2003.02030.x; CRESWELL LL, 1992, ANN THORAC SURG, V54, P11; Creswell LL, 1992, ANN THORAC SURG, V54, P18; Dziewierz A, 2014, POSTEP KARDIOL INTER, V10, P175, DOI 10.5114/pwki.2014.45144; Ferrari G, 2001, INT J ARTIF ORGANS, V24, P274; FRYE RL, 1960, J CLIN INVEST, V39, P1043, DOI 10.1172/JCI104119; Imamura T, 2012, J ARTIF ORGANS, V15, P395, DOI 10.1007/s10047-012-0654-4; Imamura T, 2015, J ARTIF ORGANS, V18, P20, DOI 10.1007/s10047-014-0800-2; Joskowiak D, 2011, THORAC CARDIOV SURG, V59, P406, DOI 10.1055/s-0030-1250728; KANTROWI.A, 1968, J AMER MED ASSOC, V203, P113, DOI 10.1001/jama.203.2.113; Loforte A, 2014, ARTIF ORGANS, V38, pE129, DOI 10.1111/aor.12317; London MJ, 2013, JAMA-J AM MED ASSOC, V309, P1704, DOI 10.1001/jama.2013.4135; Mizuno M, 2014, INT J CARDIOL, V176, P1444, DOI 10.1016/j.ijcard.2014.08.154; Nabawi F, 2012, THORAC CARDIOVASC SU, V60, P56; Norkiene Ieva, 2007, Interact Cardiovasc Thorac Surg, V6, P66; Parissis Haralambos, 2007, Hellenic J Cardiol, V48, P346; Pfeiffer S, 2014, CRIT CARE MED, V42, pE728, DOI 10.1097/CCM.0000000000000557; Romeo F, 2013, AM HEART J, V165, P679, DOI 10.1016/j.ahj.2013.02.020; Sloth E, 2008, PERFUSION-UK, V23, P223, DOI 10.1177/0267659108100457; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Yildirim Y, 2014, ARTIF ORGANS, V38, P967, DOI 10.1111/aor.12276	36	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1963	1969		10.1253/circj.CJ-15-0122		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500021		
J	Imamura, T; Kinugawa, K; Nitta, D; Hatano, M; Kinoshita, O; Nawata, K; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Hatano, Masaru; Kinoshita, Osamu; Nawata, Kan; Ono, Minoru			Perioperative Hypoalbuminemia Affects Improvement in Exercise Tolerance After Left Ventricular Assist Device Implantation	CIRCULATION JOURNAL			English	Article						Cardiopulmonary exercise testing; INTERMACS; Peak oxygen consumption; Ventricular assist devices	CHRONIC HEART-FAILURE; CONTINUOUS-FLOW; SERUM-ALBUMIN; SCORING SYSTEM; TRANSPLANTATION; PARAMETERS	Background: Although survival rates have improved for patients receiving implantable continuous flow left ventricular assist devices (I-CF LVAD), postoperative exercise tolerance levels are not necessarily satisfactory. Methods and Results: We enrolled 51 patients who had received an I-CF LVAD and underwent follow-up between 2006 and 2014; all patients underwent cardiopulmonary exercise testing 3 months following surgery: 26 (51%) patients achieved peak oxygen consumption (P(V) over dot O-2) >= 14 ml . kg(-1) . min(-1) and had significantly lower readmission rates for cardiovascular events than those with P(V) over dot O-2 < 14 ml . kg(-1) . min(-1) during 2 years of LVAD treatment (17 vs. 43%, P= 0.033). Uni- and multivariate logistic regression analyses showed that the preoperative serum albumin (S-ALB) level was an independent predictor for P(V) over dot O-2 = 14 ml . kg-1 . min(-1) at 3 months (P= 0.023, odds ratio 6.132). Patients with persistently normal S-ALB levels during the perioperative period had the lowest preoperative serum C-reactive protein level (S-CRP, 0.7+/-0.9 mg/dl), and the majority (77%) showed improved exercise tolerance. Conversely, patients with persistently low S-ALB levels during this period had the highest preoperative S-CRP level (2.8+/-1.2 mg/dl) and did not achieve the test endpoint. Conclusions: Both pre- and postoperative low S-ALB impedes recovery of exercise tolerance after I-CF LVAD surgery, and this may be attributable to inflammatory responses caused by heart failure.	[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo 1138655, Japan; [Nitta, Daisuke; Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo 1138655, Japan	Kinugawa, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kinugawa-tky@umin.ac.jp					Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Harrington D, 1997, J AM COLL CARDIOL, V30, P1758, DOI 10.1016/S0735-1097(97)00381-1; Anker SD, 2002, INT J CARDIOL, V85, P51, DOI 10.1016/S0167-5273(02)00233-4; MANCINI DM, 1991, CIRCULATION, V83, P778; Imamura T, 2014, CIRC J, V78, P2259, DOI 10.1253/circj.CJ-14-0368; Holdy K, 2005, J HEART LUNG TRANSPL, V24, P1690, DOI 10.1016/j.healun.2004.11.047; Caruso R, 2012, CYTOKINE, V59, P138, DOI 10.1016/j.cyto.2012.04.018; Dunlay SM, 2014, J CARD FAIL, V20, P548, DOI 10.1016/j.cardfail.2014.05.008; Kinugawa K, 2011, CIRC J, V75, P2038, DOI 10.1253/circj.CJ-11-0621; Kato TS, 2013, AM J CARDIOL, V112, P1484, DOI 10.1016/j.amjcard.2013.06.023; Imamura T, 2012, CIRC J, V76, P1895, DOI 10.1253/circj.CJ-12-0182; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Imamura T, 2014, CIRC J, V78, P625, DOI 10.1253/circj.CJ-13-1201; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Bouras G, 2014, MED CHEM, V10, P682; Imamura T, 2015, CIRC J, V79, P560, DOI 10.1253/circj.CJ-14-1058; Imamura T, 2015, J ARTIF ORGANS, V18, P120, DOI 10.1007/s10047-015-0816-2; Imamura T, 2015, CIRC J, V79, P104, DOI 10.1253/circj.CJ-14-0944; Kokkinos PF, 2000, AM HEART J, V140, P21, DOI 10.1067/mhj.2000.106916; Rahman A, 2015, J PARENTER ENTERAL N, DOI [10.1177/0148607114566854, DOI 10.1177/0148607114566854]; REDDY HK, 1988, J AM COLL CARDIOL, V12, P353; Saito S, 2014, J HEART LUNG TRANSPL, V33, P599, DOI 10.1016/j.healun.2014.02.015; Vega J D, 1990, ASAIO Trans, V36, pM555	23	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1970	1975		10.1253/circj.CJ-15-0414		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500022		
J	Morimoto, K; Hoashi, T; Kagisaki, K; Yoshimatsu, J; Shiraishi, I; Ichikawa, H; Kobayashi, J; Nakatani, T; Yagihara, T; Kitamura, S; Fujita, T				Morimoto, Kazuki; Hoashi, Takaya; Kagisaki, Koji; Yoshimatsu, Jun; Shiraishi, Isao; Ichikawa, Hajime; Kobayashi, Junjiro; Nakatani, Takeshi; Yagihara, Toshikatsu; Kitamura, Soichiro; Fujita, Tomoyuki			Impact of Ross Operation on Outcome in Young Female Adult Patients Wanting to Have Children	CIRCULATION JOURNAL			English	Article						Aortic valve replacement; Bioprosthesis; Pregnancy; Ross operation	BIOPROSTHETIC VALVE-REPLACEMENT; VALVULAR HEART-DISEASE; AORTIC-VALVE; PREGNANCY OUTCOMES; WOMEN; POPULATION; PROSTHESES	Background: The most appropriate valve substitute at aortic valve replacement (AVR) for young female adult patients wanting to have children is unclear. Methods and Results: Between 1992 and 2013, 12 consecutive female patients aged > 18 (median, 22.5 years; range, 18-34 years) underwent Ross operation (Ross group). Between 1984 and 2013, 9 consecutive female patients aged > 18 (median, 30 years; range, 22-39 years) underwent AVR with bioprosthesis (bioprosthesis group). There was 1 late mortality in the bioprosthesis group, due to prosthetic valve endocarditis (PVE). Freedom from reoperation for aortic valve at 15 years was 90.0% in the Ross group, and 57.1% in the bioprosthesis group (log-rank, P= 0.098). One in the Ross group underwent reoperation for aortic regurgitation (AR), whereas 4 in the bioprosthesis group did so for aortic stenosis (AS) in 2, combined AS and AR in 1, and PVE in 1. Five patients in the Ross group and 3 in the bioprosthesis group had 7 and 4 uneventful pregnancies, respectively. AR progressed during the perinatal period in a total of 7 of 11 pregnancies. No AS was seen at discharge, after 5 years, or during pregnancy in the Ross group. Conclusions: The long-term outcome of Ross operation for female patients wanting to have children is excellent. Although subclinical pulmonary autograft valve regurgitation during pregnancy was often observed, pulmonary autograft stenosis did not occur, therefore it would be an ideal option for patients wanting to have children.	[Morimoto, Kazuki; Hoashi, Takaya; Kagisaki, Koji; Ichikawa, Hajime; Yagihara, Toshikatsu] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, Suita, Osaka 5658565, Japan; [Yoshimatsu, Jun] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol & Gynecol, Suita, Osaka 5658565, Japan; [Shiraishi, Isao] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka 5658565, Japan; [Kobayashi, Junjiro; Kitamura, Soichiro; Fujita, Tomoyuki] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka 5658565, Japan; [Nakatani, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, Suita, Osaka 5658565, Japan; [Yagihara, Toshikatsu] Rinku Gen Med Ctr, Izumisano, Japan; [Kitamura, Soichiro] Sakai City Hosp Org, Sakai, Osaka, Japan	Hoashi, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	thoashi@surg1.med.osaka-u.ac.jp					Amano Jun, 2013, Gen Thorac Cardiovasc Surg, V61, P578, DOI 10.1007/s11748-013-0289-2; Minakata K, 2014, CIRC J, V78, P882, DOI 10.1253/circj.CJ-13-1068; Drenthen W, 2010, EUR HEART J, V31, P2124, DOI 10.1093/eurheartj/ehq200; Siu SC, 2001, CIRCULATION, V104, P515, DOI 10.1161/hc3001.093437; SBAROUNI E, 1994, BRIT HEART J, V71, P196; De Santo LS, 2012, J AM COLL CARDIOL, V59, P1110, DOI 10.1016/j.jacc.2011.10.899; Oosterhof T, 2006, EUR HEART J, V27, P1478, DOI 10.1093/eurheartj/ehl033; Azadani AN, 2009, J HEART VALVE DIS, V18, P367; Elkayam U, 2005, J AM COLL CARDIOL, V46, P403, DOI 10.1016/j.jacc.2005.02.087; Avila WS, 2002, J HEART VALVE DIS, V11, P864; BADDUKE BR, 1991, J THORAC CARDIOV SUR, V102, P179; Berrebi AJ, 2001, ANN THORAC SURG, V71, pS353, DOI 10.1016/S0003-4975(01)02558-9; Chantos EI, 2009, CIRCULATION, V120, P146; Dore A, 1997, EUR HEART J, V18, P1659; Gross C, 1998, ANN THORAC SURG, V66, pS194; El Shaer Fayez, 2005, J Heart Valve Dis, V14, P481; Heuvelman HJ, 2013, AM J CARDIOL, V111, P382, DOI 10.1016/j.amjcard.2012.09.035; Hung L, 2003, CIRCULATION, V107, P1240, DOI 10.1161/01.CIR.0000060806.86686.EC; JAMIESON WRE, 1995, ANN THORAC SURG, V60, pS282; Kawamata K, 2007, CIRC J, V71, P211, DOI 10.1253/circj.71.211; Kitamura S, 2011, SURG TODAY, V41, P500, DOI 10.1007/s00595-010-4459-x; Kuwano Hiroyuki, 2012, Gen Thorac Cardiovasc Surg, V60, P680, DOI 10.1007/s11748-012-0119-y; Matsumoto Y, 2015, CIRC J, V79, P1044, DOI 10.1253/circj.CJ-14-0990; Nishida Takahiro, 2013, Gen Thorac Cardiovasc Surg, V61, P182, DOI 10.1007/s11748-013-0202-z; NUNEZ L, 1983, CHEST, V84, P26, DOI 10.1378/chest.84.1.26; OAKLEY C, 1976, BRIT HEART J, V38, P1140; Ozaki S, 2014, CIRC J, V78, P1144, DOI 10.1253/circj.CJ-13-1335; Salazar E, 1999, AM HEART J, V137, P714, DOI 10.1016/S0002-8703(99)70228-0; Stout KK, 2007, HEART, V93, P552, DOI 10.1136/hrt.2005.067975; Tanaka H, 2014, CIRC J, V78, P878, DOI 10.1253/circj.CJ-13-1178; Uemura H, 2013, THORAC CARDIOVASC SU, V61, P376; Wilbring M, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0341-3; Yap SC, 2007, J HEART VALVE DIS, V16, P398	33	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1976	1983		10.1253/circj.CJ-15-0410		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500023		
J	Yamauchi, T; Sakata, Y; Takada, T; Nochioka, K; Miura, M; Tadaki, S; Ushigome, R; Sato, K; Onose, T; Tsuji, K; Abe, R; Takahashi, J; Miyata, S; Shimokawa, H				Yamauchi, Takeshi; Sakata, Yasuhiko; Takada, Tsuyoshi; Nochioka, Kotaro; Miura, Masanobu; Tadaki, Soichiro; Ushigome, Ryoichi; Sato, Kenjiro; Onose, Takeo; Tsuji, Kanako; Abe, Ruri; Takahashi, Jun; Miyata, Satoshi; Shimokawa, Hiroaki		CHART 2 Investigators	Prognostic Impact of Anemia in Patients With Chronic Heart Failure - With Special Reference to Clinical Background: Report From the CHART-2 Study	CIRCULATION JOURNAL			English	Article						Anemia; Etiology; Heart failure; Left ventricular ejection fraction; Prognosis	EJECTION FRACTION; HEMODIALYSIS-PATIENTS; DARBEPOETIN-ALPHA; MORTALITY; DISEASE; ERYTHROPOIETIN; HEMOGLOBIN; MANAGEMENT; FRAMINGHAM; MORBIDITY	Background: We aimed to elucidate the prognostic impact of anemia with special reference to the clinical background of patients with chronic heart failure (CHF). Methods and Results: We examined 4,646 consecutive patients with Stage C/D CHF registered in the Chronic Heart Failure Analysis and Registry in the Tohoku District-2 (CHART-2) Study (n= 10,219). Among them, 1,627 (35%) had anemia and were characterized by higher age (74 vs. 66 years), lower estimated glomerular filtration rate (52.8 vs. 66.1 ml/min/1.73 m(2)) and higher B-type natriuretic peptide levels (154.5 vs. 81.8 pg/ml) (all P< 0.001) but comparable left ventricular ejection fraction (LVEF; 57.5 vs. 56.7%). Anemic patients were more frequently treated with diuretics (55.1 vs. 42.3%) but less often treated with beta-blockers (45.4 vs. 51.1%) (both P< 0.001). During a median follow-up of 3.8 years, 371 and 272 patients died with and without anemia, respectively (22.8 vs. 9.0%, adjusted hazard ratio 1.40; 95% confidence interval 1.15-1.71, P= 0.001). Subgroup analysis revealed that the prognostic impact of anemia was comparable in terms of age, sex, renal function and double product, but differed by LVEF level and CHF etiology (both, P for interaction < 0.001). In particular, a difference in the prognostic impact of LVEF level was noted in patients with ischemic heart disease. Conclusions: These results indicate that the prognostic impact of anemia is evident in CHF patients with preserved EF and it differs by CHF etiology.	[Yamauchi, Takeshi; Sakata, Yasuhiko; Takada, Tsuyoshi; Nochioka, Kotaro; Miura, Masanobu; Tadaki, Soichiro; Ushigome, Ryoichi; Sato, Kenjiro; Onose, Takeo; Tsuji, Kanako; Abe, Ruri; Takahashi, Jun; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; [Miyata, Satoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Evidenced Based Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Sakata, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	sakatayk@cardio.med.tohoku.ac.jp			Ministry of Health, Labour, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology, Japan	We thank all the members of the Tohoku Heart Failure Society and the staff of the Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine for their contributions (Appendix S1). This study was supported in part by Grants-in Aid from the Ministry of Health, Labour, and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ghali JK, 2008, CIRCULATION, V117, P526, DOI 10.1161/CIRCULATIONAHA.107.698514; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Cromie N, 2002, HEART, V87, P377, DOI 10.1136/heart.87.4.377; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONHA.105.577577; O'Meara E, 2006, CIRCULATION, V113, P986, DOI 10.1161/CIRCULATIONAHA.105.582577; Sakata Y, 2014, CIRC J, V78, P428, DOI 10.1253/circj.CJ-13-1009; Nochioka K, 2013, CIRC J, V77, P2318, DOI 10.1253/circj.CJ-13-0127; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; [Anonymous], 2011, NAT HLTH NUTR SURV J; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; GOBEL FL, 1978, CIRCULATION, V57, P549; Latado AL, 2006, AM J CARDIOL, V98, P1631, DOI 10.1016/j.amjcard.2006.07.045; Silverberg D, 2003, NEPHROL DIAL TRANSPL, V18, P7, DOI [10.1093/ndt//gfg1084, 10.1093/ndt/gfg1056]; Mozaffarian D, 2003, J AM COLL CARDIOL, V41, P1933, DOI 10.1016/S0735-1097(03)00425-X; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Westenbrink BD, 2010, EUR J HEART FAIL, V12, P676, DOI 10.1093/eurjhf/hfq061; Anand IS, 2005, CIRCULATION, V112, P1121, DOI 10.1161/CIRCULATIONAHA.104.512988; Felker GM, 2006, AM HEART J, V151, P457, DOI 10.1016/j.ahj.2005.03.056; Albitar S, 1998, NEPHROL DIAL TRANSPL, V13, P1206, DOI 10.1093/ndt/13.5.1206; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; Miura M, 2012, EUR J HEART FAIL, V14, P367, DOI 10.1093/eurjhf/hfs001; Ezelowitz JA, 2003, CIRCULATION, V107, P223; Goicoechea M, 1998, KIDNEY INT, V54, P1337, DOI 10.1046/j.1523-1755.1998.00084.x; Miura M, 2013, CIRC J, V77, P2954, DOI 10.1253/circj.CJ-13-0725; R Core Team, 2014, R LANG ENV STAT COMP; Roig E, 2005, REV ESP CARDIOL, V58, P10, DOI 10.1157/13070502; World Health Organization, 1968, WHO TECH REP SER, V405, P3	29	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1984	U314		10.1253/circj.CJ-15-0174		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500024		
J	Imamura, T; Kinugawa, K; Nitta, D; Hatano, M; Kinoshita, O; Nawata, K; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Hatano, Masaru; Kinoshita, Osamu; Nawata, Kan; Ono, Minoru			Advantage of Pulsatility in Left Ventricular Reverse Remodeling and Aortic Insufficiency Prevention During Left Ventricular Assist Device Treatment	CIRCULATION JOURNAL			English	Article						Heart failure; INTERMACS; Pulsatile flow; Ventricular assist devices	MECHANICAL CIRCULATORY SUPPORT; CONTINUOUS-FLOW; HEART-FAILURE; TIME-COURSE; RECOVERY; IMPLANTATION; HEMODYNAMICS; RESPONSES; PRESSURE; SYSTEM	Background: A continuous flow (CF) left ventricular assist device (LVAD) has various advantages over a pulsatile flow (PF) LVAD, but the extent of preventing aortic insufficiency (AI) by each type of LVAD remains controversial. Methods and Results: Of 86 patients with non-ischemic cardiomyopathy who underwent LVAD implantation between 2006 and 2015, 20 propensity score-matched patients with PF LVADs and 20 with CF LVADs were enrolled in this study. There were no significant differences in the baseline variables of both groups. During the 6-month LVAD treatment, the LV ejection fraction of the PF group was significantly higher than that of the CF group; the PF group also had a wider pulse pressure and less enlargement of the aortic root (P< 0.05 for all). Patients in the PF group experienced more frequent opening of the native aortic valve and less AI than those in the CF group (P< 0.05 for both). The PF LVAD was explanted in 5 patients (25%), and a CF LVAD was explanted in 1 patient (5%). Conclusions: Compared with CF LVADs, PF LVADs seem to have an advantage in improving LV reverse remodeling and preventing AI. It may be best to incorporate pulsatility into current CF LVADs while retaining their existing benefits.	[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo 1138655, Japan; [Nitta, Daisuke; Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo 1138655, Japan	Kinugawa, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kinugawa-tky@umin.ac.jp					Pak SW, 2010, J HEART LUNG TRANSPL, V29, P1172, DOI 10.1016/j.healun.2010.05.018; Farrar DJ, 2007, ASAIO J, V53, P310, DOI 10.1097/MAT.0b013e3180536694; Imamura T, 2014, J ARTIF ORGANS, V17, P23, DOI 10.1007/s10047-013-0748-7; Hatano M, 2011, CIRC J, V75, P1147, DOI 10.1253/circj.CJ-10-1106; LaRose JA, 2010, ASAIO J, V56, P285, DOI 10.1097/MAT.0b013e3181dfbab5; Ootaki Y, 2005, EUR J CARDIO-THORAC, V28, P711, DOI 10.1016/j.ejcts.2005.08.008; Haft J, 2007, CIRCULATION, V116, pI8, DOI 10.1161/CIRCULATIONAHA.106.677898; Krabatsch T, 2011, ANN THORAC SURG, V91, P1335, DOI 10.1016/j.athoracsur.2011.01.027; Kato TS, 2011, CIRC-HEART FAIL, V4, P546, DOI 10.1161/CIRCHEARTFAILURE.111.962142; Bartoli CR, 2010, ASAIO J, V56, P410, DOI 10.1097/MAT.0b013e3181e7bf3c; Maybaum S, 2007, CIRCULATION, V115, P2497, DOI 10.1161/CIRCULATIONAHA.106.633180; Loebe M, 2001, ASAIO J, V47, P272, DOI 10.1097/00002480-200105000-00023; Kinugawa K, 2011, CIRC J, V75, P2038, DOI 10.1253/circj.CJ-11-0621; Drakos SG, 2013, J AM COLL CARDIOL, V61, P1985, DOI 10.1016/j.jacc.2013.01.072; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Klotz S, 2004, ANN THORAC SURG, V77, P143, DOI 10.1016/S0003-4975(03)01336-5; Westaby S, 2007, J THORAC CARDIOV SUR, V133, P575, DOI 10.1016/j.jtcvs.2006.10.014; Imamura T, 2014, CIRC J, V78, P625, DOI 10.1253/circj.CJ-13-1201; Baric D, 2014, CROAT MED J, V55, P609, DOI 10.3325/cmj.2014.55.609; Connelly JH, 2003, J HEART LUNG TRANSPL, V22, P1291, DOI 10.1016/S1053-2498(03)00028-7; Guglin Maya, 2012, Curr Treat Options Cardiovasc Med, V14, P370, DOI 10.1007/s11936-012-0190-9; Imamura T, 2015, CIRC J, V79, P560, DOI 10.1253/circj.CJ-14-1058; Imamura T, 2015, CIRC J, V79, P104, DOI 10.1253/circj.CJ-14-0944; Karmonik C, 2014, ARTIF ORGANS, V38, P142, DOI 10.1111/aor.12132; Kinoshita M, 1988, ASAIO Trans, V34, P208; Klotz S, 2004, ANN THORAC SURG, V77, P9; Madigan JD, 2001, J THORAC CARDIOV SUR, V121, P902, DOI 10.1067/mtc.2001.112632; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; Muranaka H, 2010, J THORAC CARDIOV SUR, V140, P916, DOI 10.1016/j.jtcvs.2010.02.006; Simon MA, 2010, J CARD FAIL, V16, P99, DOI 10.1016/j.cardfail.2009.10.018; Simon MA, 2005, CIRCULATION, V112, pI32, DOI 10.1161/CIRCULATIONAHA.104.524124; Slaughter MS, 2010, J HEART LUNG TRANSPL, V29, pS1, DOI 10.1016/j.healun.2010.01.011; Thohan V, 2005, J HEART LUNG TRANSPL, V24, P566, DOI 10.1016/j.healun.2004.02.017	33	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					1994	1999		10.1253/circj.CJ-15-0419		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500025		
J	Imori, Y; Akasaka, T; Shishido, K; Ochiai, T; Tobita, K; Yamanaka, F; Mizuno, S; Saito, S				Imori, Yoichi; Akasaka, Takeshi; Shishido, Koki; Ochiai, Tomoki; Tobita, Kazuki; Yamanaka, Futoshi; Mizuno, Shingo; Saito, Shigeru			Prehospital Transfer Pathway and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention	CIRCULATION JOURNAL			English	Article						Direct transfer; Onset-to-balloon time; Prehospital transfer; Primary percutaneous coronary intervention; ST-segment elevation myocardial infarction	ACUTE MYOCARDIAL-INFARCTION; TO-BALLOON TIME; ASSOCIATION TASK-FORCE; PRIMARY ANGIOPLASTY; PRACTICE GUIDELINES; CLINICAL-TRIALS; OUTCOMES; JAPAN; REPERFUSION; THERAPY	Background: It is recommended that not only door-to-balloon time but also prehospital delay for primary percutaneous coronary intervention (PCI) should be improved. We investigated the effect of prehospital transfer pathway on onset-to-balloon time and prognosis in patients with ST-segment elevation myocardial infarction (STEMI) in Japan. Methods and Results: We analyzed data from 540 consecutive patients with primary PCI for STEMI. Patient clinical data and mortality were compared between patients who visited the family physician or non-PCI-capable hospitals and were then transferred to PCI-capable centers (indirect transfer patients), and those who directly visited PCI-capable centers (direct transfer patients). Onset-to-balloon time was longer in indirect transfer patients than in direct transfer patients (mean, 270 min; range, 180-480 min vs. 180 min, 120-240 min; P< 0.001). In addition, patient prognosis was evaluated on Cox proportional regression analysis. Cardiac death and all-cause death were significantly higher in indirect transfer patients (odds ratios [OR], 2.17; 95% confidence intervals [95% CI]: 1.17-4.01, P= 0.01; OR, 1.71; 95% CI: 1.09-2.68, P= 0.02). These results were confirmed using propensity score matching for adjusted analyses. Conclusions: Patients with indirect transfer to regional emergency departments of PCI centers had longer onset-to-balloon time and worse prognosis than those with direct transfer.	[Imori, Yoichi; Akasaka, Takeshi; Shishido, Koki; Ochiai, Tomoki; Tobita, Kazuki; Yamanaka, Futoshi; Mizuno, Shingo; Saito, Shigeru] Shonan Kamakura Gen Hosp, Dept Cardiovasc Med, Kamakura, Kanagawa 2478543, Japan	Imori, Y (reprint author), Shonan Kamakura Gen Hosp, Dept Cardiovasc Med, 1370-1 Okamoto, Kamakura, Kanagawa 2478543, Japan.	yoichiimori@me.com					Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019; LOWEL H, 1991, DEUT MED WOCHENSCHR, V116, P729, DOI 10.1055/s-2008-1063671; [Anonymous], 2009, J AM COLL CARDIOL, DOI DOI 10.1016/J.JACC.2008.10.005; Le May MR, 2012, J AM COLL CARDIOL, V60, P1223, DOI 10.1016/j.jacc.2012.07.008; Kojima S, 2013, CIRC J, V77, P2841, DOI 10.1253/circj.CJ-13-1011; Kasanuki H, 2005, AM HEART J, V150, P411, DOI 10.1016/j.ahj.2004.10.001; Berger PB, 1999, CIRCULATION, V100, P14; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Aquaro GD, 2007, AM J CARDIOL, V100, P28, DOI 10.1016/j.amjcard.2007.02.050; Ali A, 2006, J AM COLL CARDIOL, V48, P244, DOI 10.1016/j.jacc.2006.03.044; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Nallamothu BK, 2003, AM J CARDIOL, V92, P824, DOI 10.1016/S0002-9149(03)00891-9; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015; van Diepen S, 2012, CIRC-CARDIOVASC QUAL, V5, P437, DOI 10.1161/CIRCOUTCOMES.112.965160; Toyota T, 2013, CIRC J, V77, P1508, DOI 10.1253/circj.CJ-12-1161; Gibson CM, 2001, CIRCULATION, V104, P2632; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Patel M, 2012, J AM COLL CARDIOL, V60, P806, DOI 10.1016/j.jacc.2012.03.071; GERSH BJ, 1993, CIRCULATION, V88, P296; Le May MR, 2008, NEW ENGL J MED, V358, P231, DOI 10.1056/NEJMoa073102; Brodie BR, 2010, J AM COLL CARDIOL, V56, P407, DOI 10.1016/j.jacc.2010.04.020; Juliard JM, 2003, AM J CARDIOL, V91, P1401, DOI 10.1016/S0002-9149(03)00388-6; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Matsui K, 2007, CIRC J, V71, P1841, DOI 10.1253/circj.71.1841; Nakayama N, 2009, CIRC J, V73, P484; Obeidat O, 2004, AM J CARDIOL, V94, P1278, DOI 10.1016/j.amjcard.2004.07.112; Rathore SS, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1807; Sakurai K, 2003, CIRC J, V67, P209; Savonitto S, 2002, J AM COLL CARDIOL, V39, P22, DOI 10.1016/S0735-1097(01)01706-5; Shiomi H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3257; Ui S, 2005, CIRC J, V69, P95, DOI 10.1253/circj.69.95; Zhou Hua, 2014, World J Emerg Med, V5, P96, DOI 10.5847/wjem.j.1920-8642.2014.02.003; Zijlstra F., 2002, European Heart Journal, V23, P550, DOI 10.1053/euhj.2001.2901	39	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					2000	U330		10.1253/circj.CJ-14-0678		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500026		
J	Hao, K; Takahashi, J; Ito, K; Miyata, S; Nihei, T; Nishimiya, K; Tsuburaya, R; Matsumoto, Y; Sakata, Y; Yasuda, S; Shimokawa, H				Hao, Kiyotaka; Takahashi, Jun; Ito, Kenta; Miyata, Satoshi; Nihei, Taro; Nishimiya, Kensuke; Tsuburaya, Ryuji; Matsumoto, Yasuharu; Sakata, Yasuhiko; Yasuda, Satoshi; Shimokawa, Hiroaki		Miyagi-Ami Registry Study	Clinical Characteristics of Patients With Acute Myocardial Infarction Who Did Not Undergo Primary Percutaneous Coronary Intervention - Report From the MIYAGI-AMI Registry Study	CIRCULATION JOURNAL			English	Article						Acute myocardial infarction; Percutaneous coronary intervention; Sex differences	ST-SEGMENT ELEVATION; REPERFUSION THERAPY; NATIONAL-REGISTRY; THROMBOLYTIC THERAPY; HEART-FAILURE; FIBRINOLYTIC THERAPY; PRIMARY ANGIOPLASTY; HOSPITAL MORTALITY; RANDOMIZED-TRIALS; JAPAN	Background: In the current era of primary percutaneous coronary intervention (PCI), some patients with acute myocardial infarction (AMI) still do not undergo primary PCI. Methods and Results: To examine the clinical characteristics of AMI patients who did not undergo primary PCI, we analyzed patients enrolled between 2002 and 2010 in the MIYAGI-AMI Registry Study, in which all AMI patients in the Miyagi prefecture have been prospectively registered. Among a total of 8,640 patients, 1,879 (21.7%) did not undergo primary PCI and their in-hospital mortality was significantly worse compared with those who did (21.4% vs. 6.4%, P< 0.01). Multivariate analysis demonstrated that female sex was significantly associated with non-performance of primary PCI [odds ratio (95% confidence interval): 1.40 (1.22-1.61), P< 0.001], along with age [1.01 (1.01-1.02), P< 0.001] and heart failure on admission [2.69 (2.29-3.16), P< 0.001]. When dividing by age, the non-performance rate of primary PCI in females showed a U-shaped prevalence, whereas it simply increased with aging in males. Importantly, female patients aged < 80 years had a significantly higher non-performance rate of primary PCI compared with male patients, regardless of the severity of AMI. Conclusions: These results indicate that in the current PCI era, various factors, including aging, heart failure on admission and sex differences, are associated with non-performance of primary PCI, which remain to be resolved in order to further improve critical care of AMI.	[Hao, Kiyotaka; Takahashi, Jun; Ito, Kenta; Miyata, Satoshi; Nihei, Taro; Nishimiya, Kensuke; Tsuburaya, Ryuji; Matsumoto, Yasuharu; Sakata, Yasuhiko; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808574, Japan; [Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan	Shimokawa, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, Seiryo Machi, Sendai, Miyagi 9808574, Japan.	shimo@cardio.med.tohoku.ac.jp			Miyagi Prefecture; Miyagi Medical Association, Japan	This study was supported in part by the grants-in-aid from the Miyagi Prefecture and the Miyagi Medical Association, Japan. We thank all the collaborators in the MIYAGI-AMI Registry Study (Appendix). We also thank Yuki Kobayashi for excellent secretarial assistance.	Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Okura N, 2012, INT J CARDIOL, V159, P205, DOI 10.1016/j.ijcard.2011.02.072; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019; Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Hao K, 2012, CIRC J, V76, P1136, DOI 10.1253/circj.CJ-11-1233; Barron HV, 1998, CIRCULATION, V97, P1150; Spencer FA, 2002, CIRCULATION, V105, P2605, DOI 10.1161/01.CIR.0000017861.00991.2F; Ong P, 2008, J AM COLL CARDIOL, V52, P523, DOI 10.1016/j.jacc.2008.04.050; Steg PG, 2004, CIRCULATION, V109, P494, DOI 10.1161/01.CIR.0000109691.16944.DA; Daida H, 2013, CIRC J, V77, P934, DOI 10.1253/circj.CJ-13-0174; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Koeth O, 2009, AM J CARDIOL, V104, P1074, DOI 10.1016/j.amjcard.2009.05.054; Jneid H, 2008, CIRCULATION, V117, P2502, DOI 10.1161/CIRCULATIONAHA.107.752113; Anderson RD, 2007, CIRCULATION, V115, P823, DOI 10.1161/CIRCULATIONAHA.106.685859; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; Eagle KA, 2008, EUR HEART J, V29, P609, DOI 10.1093/eurheartj/ehn069; Takii T, 2010, CIRC J, V74, P93, DOI 10.1253/circj.CJ-09-0619; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Balzi D, 2008, INTERN EMERG MED, V3, P109, DOI 10.1007/s11739-008-0090-x; Cohen M, 2005, J THROMB THROMBOLYS, V19, P155, DOI 10.1007/s11239-005-1524-1; Hao K, 2014, CIRC J, V78, P634, DOI 10.1253/circj.CJ-13-1286; MICHELS KB, 1995, CIRCULATION, V91, P476; Parker AB, 2006, CAN J CARDIOL, V22, P131; Sakurai K, 2003, CIRC J, V67, P209; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583; Ui S, 2005, CIRC J, V69, P95, DOI 10.1253/circj.69.95; Watanabe J, 2001, JPN CIRC J, V65, P941, DOI 10.1253/jcj.65.941; APPLEBY P, 1994, LANCET, V343, P311	32	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					2009	U340		10.1253/circj.CJ-15-0440		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500027		
J	Mori, K; Ishida, T; Yasuda, T; Hasokawa, M; Monguchi, T; Sasaki, M; Kondo, K; Nakajima, H; Shinohara, M; Shinke, T; Irino, Y; Toh, R; Nishimura, K; Hirata, KI				Mori, Kenta; Ishida, Tatsuro; Yasuda, Tomoyuki; Hasokawa, Minoru; Monguchi, Tomoko; Sasaki, Maki; Kondo, Kensuke; Nakajima, Hideto; Shinohara, Masakazu; Shinke, Toshiro; Irino, Yasuhiro; Toh, Ryuji; Nishimura, Kunihiro; Hirata, Ken-ichi			Serum Trans-Fatty Acid Concentration Is Elevated in Young Patients With Coronary Artery Disease in Japan	CIRCULATION JOURNAL			English	Article						Coronary artery disease; Elaidic acid; Hyperlipidemia; Metabolic syndrome; Trans-fatty acid	SUDDEN CARDIAC DEATH; HEART-DISEASE; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION; DIAGNOSTIC-CRITERIA; APOLIPOPROTEIN B48; HDL CHOLESTEROL; RISK; ADULTS; WOMEN	Background: Adverse effects of dietary intake of trans-fatty acids (TFA) on the incidence of coronary artery disease (CAD) are well recognized in Western countries. The risk of TFA, however, has not been well clarified in Japan. We investigated the association of serum TFA concentration with serum lipid profile, coronary risk factors, and prevalence of CAD. Methods and Results: A total of 902 patients, who were hospitalized at Kobe University Hospital from July 2008 to March 2012 and gave written informed consent, were enrolled in this study. Among them, 463 patients had CAD, and 318 patients had metabolic syndrome (MetS). Serum TFA, elaidic acid (trans-9-C18: 1) and linolelaidic acid (trans-9, 12-C18:2), were measured on gas chromatography/mass spectrometry. Serum TFA level had a positive correlation with body mass index, waist circumference, low-density lipoprotein cholesterol, triglycerides, and apolipoprotein B48, and an inverse correlation with age and high-density lipoprotein cholesterol. Fasting serum TFA, by age quartile in the young generation with CAD and/or MetS, was higher than that in patients without CAD and/or MetS. On multivariate logistic regression, TFA was identified as a CAD risk after adjustment for classical risk factors. Conclusions: Serum TFA concentration was elevated in young patients with CAD and/or MetS. Diet-derived TFA may cause a serious health problem, particularly in the young generation in Japan.	[Mori, Kenta; Ishida, Tatsuro; Yasuda, Tomoyuki; Hasokawa, Minoru; Monguchi, Tomoko; Sasaki, Maki; Kondo, Kensuke; Nakajima, Hideto; Shinohara, Masakazu; Shinke, Toshiro; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Irino, Yasuhiro; Toh, Ryuji] Kobe Univ, Grad Sch Med, Div Evidence Based Lab Med, Kobe, Hyogo 657, Japan; [Nishimura, Kunihiro] Natl Cerebral & Cardiovasc Ctr, Off Evidence Based Med & Risk Anal, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan	Ishida, T (reprint author), Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ishida@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Cabinet Office Food Safety Commission of Japan	This work was supported by Grants-In-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Grants-in-Aid from the Cabinet Office Food Safety Commission of Japan.	Adiels M, 2012, ATHEROSCLEROSIS, V222, P222, DOI 10.1016/j.atherosclerosis.2012.02.001; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Yamada M, 2010, J EPIDEMIOL, V20, P119, DOI 10.2188/jea.JE20090080; Gebauer SK, 2007, LIPIDS, V42, P787, DOI 10.1007/s11745-007-3095-8; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; Soares-Miranda L, 2012, CIRC-ARRHYTHMIA ELEC, V5, P728, DOI 10.1161/CIRCEP.111.966259; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Hunter JE, 2006, LIPIDS, V41, P967, DOI 10.1007/s11745-006-5049-y; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; Yamada M, 2009, ASIA PAC J CLIN NUTR, V18, P359; Kuhnt K, 2011, EUR J LIPID SCI TECH, V113, P1281, DOI 10.1002/ejlt.201100037; ASCHERIO A, 1994, CIRCULATION, V89, P94; Estadella D, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/137579; KATAN MB, 1995, ANNU REV NUTR, V15, P473, DOI 10.1146/annurev.nutr.15.1.473; de Roos NM, 2001, ARTERIOSCL THROM VAS, V21, P1233, DOI 10.1161/hq0701.092161; Matsuzawa Y, 2005, J ATHEROSCLER THROMB, V12, P301; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155; KROMHOUT D, 1995, PREV MED, V24, P308, DOI 10.1006/pmed.1995.1049; Mozaffarian D, 2006, ATHEROSCLEROSIS SUPP, V7, P29, DOI 10.1016/j.atherosclerosissup.2006.04.007; Lopez-Garcia E, 2005, J NUTR, V135, P562; Maruyama K, 2013, NUTR METAB CARDIOVAS, V23, P519, DOI 10.1016/j.numecd.2011.10.007; Ogawa H, 2013, CIRC J, V77, P231, DOI 10.1253/circj.CJ-66-0053; Mori K, 2013, CLIN CHIM ACTA, V421, P51, DOI 10.1016/j.cca.2013.02.005; Smith D, 1999, EUR J CLIN INVEST, V29, P204; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146; Cabinet of Japan Food Safety Committee, 2007, EV REP TRANS FATT AC; Gillman MW, 1997, EPIDEMIOLOGY, V8, P144, DOI 10.1097/00001648-199703000-00004; Hanada H, 2012, CLIN CHIM ACTA, V413, P160, DOI 10.1016/j.cca.2011.09.013; Harris WS, 2007, AM J CARDIOL, V99, P154, DOI 10.1016/j.amjcard.2006.08.013; Katz AM, 2002, CIRCULATION, V105, P669, DOI 10.1161/hc0602.104287; Kondo K, 2015, MOL NUTR FOOD RES, V59, P729, DOI 10.1002/mnfr.201400537; Nakamura M, 2014, JPN J CARDIOVASC DIS, V49, P12; Nazari B, 2012, J RES MED SCI, V17, P952; Research Program for Risk Assessment Study on Food Safety, 2010, EX SUMM EFF DIET TRA; Research Program for Risk Assessment Study on Food Safety, 2012, RISK ASS REP TRANS F; Sbrana F, 2013, J CARDIOL, V61, P132, DOI 10.1016/j.jjcc.2012.09.005; Tajika K, 2012, CIRC J, V76, P2211, DOI 10.1253/circj.CJ-12-0183; Uematsu M, 2014, CIRC J, V78, P151, DOI 10.1253/circj.CJ-13-0783; World Health Organization, 2003, WHO TECH REP SER, V916, P1	39	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					2017	U352		10.1253/circj.CJ-14-0750		12	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500028		
J	Itoh, H; Dochi, K; Shimizu, W; Denjoy, I; Ohno, S; Aiba, T; Kimura, H; Kato, K; Fukuyama, M; Hasagawa, K; Schulze-Bahr, E; Guicheney, P; Horie, M				Itoh, Hideki; Dochi, Kenichi; Shimizu, Wataru; Denjoy, Isabelle; Ohno, Seiko; Aiba, Takeshi; Kimura, Hiromi; Kato, Koichi; Fukuyama, Megumi; Hasagawa, Kanae; Schulze-Bahr, Eric; Guicheney, Pascale; Horie, Minoru			A Common Mutation of Long QT Syndrome Type 1 in Japan	CIRCULATION JOURNAL			English	Article						KCNQ1; Long QT syndrome; Mutations	SUDDEN CARDIAC DEATH; COMPOUND MUTATIONS; KCNQ1 GENE; CHANNEL; ARRHYTHMIAS; PREVALENCE; RISK; MULTICENTER; MANAGEMENT; KVLQT1	Background: Previous studies of long QT syndrome (LQTS) have revealed the presence of country-specific hot spots in KCNQ1 mutations, and the purpose of this study was to evaluate the influence of a common mutation on clinical phenotypes in Japanese LQT1 patients. Methods and Results: We retrospectively studied the frequency of each mutation in 190 LQT1 Japanese probands and evaluated the clinical severity of LQT1 among carriers with a common mutation. We also compared it with that of carriers with other mutations. In the Japanese cohort, the most common mutation was p. A344spl (c.1032 G> A), comprising a substitution of a guanine for an adenine at the last base of exon 7, and it was found in 17 probands (8.9%). Regarding the clinical characteristics of A344spl carriers, the mean age-of-onset was 10+/-4 years, > 40% were symptomatic, and the mean corrected QT interval was 461+/-30 ms. The prognosis for carriers of the A344spl mutation (n= 31) was intermediate between that for the A341V mutation reported to be associated with severe phenotypes (n= 24) and other mutations (n= 290). Conclusions: The A344spl mutation was a frequent LQTS genotype in Japan, which indicates that the influence of country-specific hot spots should be considered when studying LQT1 clinical phenotypes.	[Itoh, Hideki; Dochi, Kenichi; Ohno, Seiko; Kimura, Hiromi; Kato, Koichi; Fukuyama, Megumi; Hasagawa, Kanae; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 5202192, Japan; [Itoh, Hideki; Guicheney, Pascale] Univ Paris 04, Inst Rech Malad Cardiovasc Metab & Nutr, Paris, France; [Itoh, Hideki; Guicheney, Pascale] Inst Cardiometab & Nutr ICAN, Paris, France; [Shimizu, Wataru] Nippon Med Sch, Dept Internal Med, Div Cardiol, Tokyo 113, Japan; [Shimizu, Wataru; Aiba, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Div Arrhythmia & Electrophysiol, Suita, Osaka, Japan; [Denjoy, Isabelle] Univ Paris 07, Ctr Reference Malad Cardiaques Hereditaires, Serv Cardiol, Hopital Bichat,AP HP, Paris, France; [Schulze-Bahr, Eric] Univ Hosp Munster, Inst Genet Heart Dis IfGH, Dept Cardiovasc Med, Munster, Germany; [Schulze-Bahr, Eric] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany	Horie, M (reprint author), Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 5202192, Japan.	horie@belle.shiga-med.ac.jp			Japan Society for the Promotion of Science (JSPS); Japan Circulation Society; Ministry of Health, Labor, and Welfare of Japan; JSPS; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), by a Translational Research Grant from the Japan Circulation Society, by a Grant-in-Aid for Clinical Research on Measures for Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan (M.H.), a Grant-in-Aid for Scientific Research (C) from JSPS and Grant-in-Aid for Scientific Research on Innovative Areas from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) (H.I.).	Brink PA, 2009, HEART RHYTHM, V6, pS25, DOI 10.1016/j.hrthm.2009.08.036; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Splawski I, 1998, GENOMICS, V51, P86, DOI 10.1006/geno.1998.5361; Shimizu W, 2013, CIRC J, V77, P2867, DOI 10.1253/circj.CJ-13-1217; Westenskow P, 2004, CIRCULATION, V109, P1834, DOI 10.1161/01.CIR.0000125524.34234.13; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Itoh H, 2010, HEART RHYTHM, V7, P1411, DOI 10.1016/j.hrthm.2010.06.013; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Schwartz PJ, 2013, J AM COLL CARDIOL, V62, P169, DOI 10.1016/j.jacc.2013.04.044; Crotti L, 2007, CIRCULATION, V116, P2366, DOI 10.1161/CIRCULATIONAHA.107.726950; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Barsheshet A, 2012, CIRCULATION, V125, P1988, DOI 10.1161/CIRCULATIONAHA.111.048041; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Mizusawa Y, 2014, CIRC J, V78, P2827, DOI 10.1253/circj.CJ-14-0905; Murray A, 1999, CIRCULATION, V100, P1077; Piippo K, 2001, J AM COLL CARDIOL, V37, P562, DOI 10.1016/S0735-1097(00)01124-4; Schwartz PJ, 2011, CIRCULATION, V124, P2181, DOI 10.1161/CIRCULATIONAHA.111.062182; Shimizu W, 2004, J AM COLL CARDIOL, V44, P117, DOI 10.1016/j.jacc.2004.03.043; Takahashi K, 2014, CIRC J, V78, P1974, DOI 10.1253/circj.CJ-13-1516; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Tsuji K, 2007, J MOL CELL CARDIOL, V42, P662, DOI 10.1016/j.yjmcc.2006.12.015; Tsuji-Wakisaka Keiko, 2011, Biochim Biophys Acta, V1812, P1452, DOI 10.1016/j.bbadis.2011.07.011; Winbo A, 2011, HEART RHYTHM, V8, P541, DOI 10.1016/j.hrthm.2010.11.043; Winbo A, 2009, CIRC-CARDIOVASC GENE, V2, P558, DOI 10.1161/CIRCGENETICS.108.825547	26	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					2026	2030		10.1253/circj.CJ-15-0342		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500029		
J	Kuramoto, J; Kawamura, A; Dembo, T; Kimura, T; Fukuda, K; Okada, Y				Kuramoto, Junko; Kawamura, Akio; Dembo, Tomohisa; Kimura, Tokuhiro; Fukuda, Keiichi; Okada, Yasunori			Prevalence of Patent Foramen Ovale in the Japanese Population - Autopsy Study	CIRCULATION JOURNAL			English	Article						Atrial septal aneurysm; Cryptogenic stroke; Ethnicity; Patent foramen ovale	ATRIAL SEPTAL ANEURYSM; TRANSCATHETER CLOSURE; PARADOXICAL EMBOLISM; OUTCOMES; ANATOMY; STROKE; EXPERIENCE; FREQUENCY	Background: Patent foramen ovale (PFO) can cause ischemic stroke because of paradoxical embolism. Autopsy studies have shown that the prevalence of PFO is 25% in whites or blacks. However, there is a paucity of data on the prevalence of PFO in Asians. The aim of this study was to clarify the prevalence of PFO in the Japanese population. Methods and Results: We reviewed 52,717 autopsy reports, which were collected and edited by the Japanese Society of Pathology from 2009 to 2012. Next, we inspected consecutive 103 formalin-fixed specimens that had already been examined by certified pathologists from 2009 to 2013 to find PFO and atrial septal aneurysm (ASA). ASA was defined as >= 10 mm protrusion of the septum into the left or the right atrium. In the database of the Japanese Society of Pathology, the incidence of PFO was 0.08% (43/52,717). Inspection of heart specimens disclosed that the prevalence of PFO was 13.6% (14/103). None of the PFO cases was reported at the original autopsy. PFO was more frequently found in the subjects with ASA (50%) than in those without ASA (9.7%) (P= 0.004). Conclusions: PFO is under-reported in autopsy reports. Re-evaluation of heart specimens disclosed that the prevalence of PFO was 13.6%. The prevalence was lower than reported in the past.	[Kuramoto, Junko; Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Kawamura, Akio; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kawamura, Akio] Natl Def Med Coll, Dept Cardiovasc Med, Tokorozawa, Saitama 3590042, Japan; [Dembo, Tomohisa] Kyorin Univ, Sch Med, Dept Internal Med & Neurol, Mitaka, Tokyo 181, Japan; [Kimura, Tokuhiro] Yamaguchi Univ, Grad Sch Med, Dept Pathol, Ube, Yamaguchi 755, Japan	Kawamura, A (reprint author), Natl Def Med Coll, Dept Cardiovasc Med, 3-2 Namiki, Tokorozawa, Saitama 3590042, Japan.	kawamra@cpnet.med.keio.ac.jp					Agmon Y, 1999, CIRCULATION, V99, P1942; Calvert PA, 2011, NAT REV CARDIOL, V8, P148, DOI 10.1038/nrcardio.2010.224; Musto C, 2013, CIRC J, V77, P2922, DOI 10.1253/circj.CJ-13-0565; Inglessis I, 2013, JACC-CARDIOVASC INTE, V6, P1176, DOI 10.1016/j.jcin.2013.06.013; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17; Windecker S, 2004, J AM COLL CARDIOL, V44, P750, DOI 10.1016/j.jacc.2004.05.044; Fawcett E, 1900, J ANAT PHYSIOL, V35, P67; Fisher M, 2015, CIRC J, V79, P271, DOI 10.1253/circj.CJ-14-1342; Khairy P, 2003, ANN INTERN MED, V139, P753; Lehmann R, 2014, J CARDIOL, V64, P113, DOI 10.1016/j.jjcc.2013.11.020; Parsons F G, 1897, J Anat Physiol, V32, P164; PENTHER P, 1994, ARCH MAL COEUR VAISS, V87, P15; Rodriguez CJ, 2003, STROKE, V34, P2097, DOI 10.1161/01.STR.0000085828.67563.42; Salmasi AM, 2010, ANGIOLOGY, V61, P205, DOI 10.1177/0003319709339590; Schroeckenstein R F, 1972, Minn Med, V55, P11; Seib GA, 1934, AM J ANAT, V55, P511, DOI 10.1002/aja.1000550306; SWEENEY LJ, 1979, AM HEART J, V98, P194, DOI 10.1016/0002-8703(79)90221-7; The Japanese Society of Pathology, 2013, ANN PATH AUT CAS JAP, P52; Thompson T, 1930, Q J MED, V23, P135; WRIGHT RR, 1948, ANAT REC, V100, P331, DOI 10.1002/ar.1091000305; Zhang CJ, 2011, CIRC J, V75, P1867, DOI 10.1253/circj.CJ-11-0068	21	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					2038	2042		10.1253/circj.CJ-15-0197		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500031		
J	Yamamoto, K; Yamamoto, H; Takeuchi, M; Kisanuki, A; Akasaka, T; Ohte, N; Hirano, Y; Yoshida, K; Nakatani, S; Takeda, Y; Sozu, T; Masuyama, T				Yamamoto, Kazuhiro; Yamamoto, Hideya; Takeuchi, Masaaki; Kisanuki, Akira; Akasaka, Takashi; Ohte, Nobuyuki; Hirano, Yutaka; Yoshida, Kiyoshi; Nakatani, Satoshi; Takeda, Yasuharu; Sozu, Takashi; Masuyama, Tohru			Risk Factors for Progression of Degenerative Aortic Valve Disease in the Japanese - The Japanese Aortic Stenosis Study (JASS) Prospective Analysis	CIRCULATION JOURNAL			English	Article						Angiotensin-converting enzyme inhibitor; Angiotensin-receptor blocker; Aortic valve; Degeneration; Warfarin	ANGIOTENSIN-CONVERTING ENZYME; INTRALEAFLET HEMORRHAGE; ATRIAL-FIBRILLATION; RAPID PROGRESSION; PROGNOSTIC VALUE; CLINICAL FACTORS; UNITED-STATES; REPLACEMENT; TRANSCATHETER; ASSOCIATION	Background: Because of ethnic difference in the risk of degenerative aortic valve disease (DAVD), risk factors should be clarified in each race to establish prophylactic strategies for severe aortic valve stenosis (AS). Methods and Results: This study prospectively followed 359 Japanese subjects with DAVD and age >= 50 years for 3 years. As both patients with peak aortic transvalvular flow velocity >= 2 m/s and < 2 m/s were enrolled, subgroup analysis was also conducted. Most patients were under treatment for their comorbidities. The use of warfarin, but none of the traditional risk factors for atherosclerosis, was related to greater reduction in aortic valve area indexed to body surface area (iAVA). In patients with peak aortic transvalvular flow velocity < 2 m/s, the use of an angiotensin-receptor blocker (ARB) was associated with less decrease in iAVA. In patients with peak velocity >= 2 m/s, changes in iAVA were not related to any baseline characteristics, but peak velocity was less increased under treatment with an angiotensin-converting enzyme inhibitor (ACEI). Conclusions: In Japanese, the use of warfarin may exacerbate DAVD, and augmented management of atherosclerotic risk factors beyond the recommendations in the current guidelines is unlikely to exert additional benefit. The prescription of ARB for DAVD patients before the development of AS or ACEI after the development of AS may be useful.	[Yamamoto, Kazuhiro] Tottori Univ, Div Cardiovasc Med Endocrinol & Metab, Dept Mol Med & Therapeut, Fac Med, Yonago, Tottori 6838503, Japan; [Yamamoto, Kazuhiro; Takeda, Yasuharu] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka, Japan; [Yamamoto, Hideya] Hiroshima Univ, Dept Cardiovasc Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Takeuchi, Masaaki] Univ Occupat & Environm Hlth, Sch Med, Dept Lab & Transfus Med, Kitakyushu, Fukuoka 807, Japan; [Kisanuki, Akira] Kagoshima Univ, Sch Hlth Sci, Kagoshima 890, Japan; [Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama, Japan; [Ohte, Nobuyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, Nagoya, Aichi, Japan; [Hirano, Yutaka] Kinki Univ Hosp, Div Cent Clin Lab, Osakasayama, Japan; [Yoshida, Kiyoshi] Kawasaki Med Univ, Dept Cardiol, Kurashiki, Okayama, Japan; [Nakatani, Satoshi] Osaka Univ, Div Funct Diagnost, Dept Hlth Sci, Grad Sch Med, Suita, Osaka, Japan; [Sozu, Takashi] Tokyo Univ Sci, Fac Engn, Dept Management Sci, Tokyo 162, Japan; [Masuyama, Tohru] Hyogo Coll Med, Dept Internal Med, Cardiovasc Div, Nishinomiya, Hyogo 6638501, Japan	Yamamoto, K (reprint author), Tottori Univ, Div Cardiovasc Med Endocrinol & Metab, Dept Mol Med & Therapeut, Fac Med, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	ykazuhiro@med.tottori-u.ac.jp			Ministry of Health, Labour and Welfare (Tokyo, Japan); Japan Heart Foundation (Tokyo, Japan)	This study was supported by grants from the Ministry of Health, Labour and Welfare (Tokyo, Japan), and the Japan Heart Foundation (Tokyo, Japan).	Akahori H, 2011, EUR HEART J, V32, P888, DOI 10.1093/eurheartj/ehq479; Akahori H, 2013, INT J CARDIOL, V167, P514, DOI 10.1016/j.ijcard.2012.01.053; Aronow WS, 2001, AM J CARDIOL, V88, P693, DOI 10.1016/S0002-9149(01)01821-5; O'Brien KD, 2005, ARCH INTERN MED, V165, P858, DOI 10.1001/archinte.165.8.858; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Helske S, 2004, J AM COLL CARDIOL, V44, P1859, DOI 10.1016/j.jacc.2004.07.054; Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; Novaro GM, 2007, J AM COLL CARDIOL, V50, P1992, DOI 10.1016/j.jacc.2007.07.064; Nadir MA, 2011, J AM COLL CARDIOL, V58, P570, DOI 10.1016/j.jacc.2011.01.063; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014; Thanassoulis G, 2010, J AM COLL CARDIOL, V55, P2491, DOI 10.1016/j.jacc.2010.03.019; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Maeda K, 2013, CIRC J, V77, P359, DOI 10.1253/circj.CJ-12-0650; Monin JL, 2009, CIRCULATION, V120, P69, DOI 10.1161/CIRCULATIONAHA.108.808857; Weijs B, 2011, EUR HEART J, V32, P2555, DOI 10.1093/eurheartj/ehr226; Wakabayashi K, 2011, HEART VESSELS, V26, P252, DOI 10.1007/s00380-010-0052-x; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630; O'Brien KD, 2002, CIRCULATION, V106, P2224, DOI 10.1161/01.CIR.0000035655.45453.D2; Faggiano P, 2003, AM J CARDIOL, V91, P99, DOI 10.1016/S0002-9149(02)03011-4; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Goldbarg SH, 2007, J AM COLL CARDIOL, V50, P1205, DOI 10.1016/j.jacc.2007.06.024; VERMEER C, 1990, BIOCHEM J, V266, P625; Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043; Cosmi JE, 2002, ARCH INTERN MED, V162, P2345, DOI 10.1001/archinte.162.20.2345; Yamamoto K, 2010, HYPERTENS RES, V33, P269, DOI 10.1038/hr.2009.225; Lerner RG, 2009, J THROMB HAEMOST, V7, P2023, DOI 10.1111/j.1538-7836.2009.03630.x; Rosenhek R, 2004, CIRCULATION, V110, P1291, DOI 10.1161/01.CIR.0000140723.15274.53; Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162; O'Brien KD, 2006, ARTERIOSCL THROM VAS, V26, P1721, DOI 10.1161/01.ATV.0000227513.13697.ac; Bahler RC, 1999, AM J CARDIOL, V84, P1044, DOI 10.1016/S0002-9149(99)00496-8; Barreto JA, 2013, JAMA-J AM MED ASSOC, V310, P2078, DOI 10.1001/jama.2013.282437; Danielsen R, 2014, INT J CARDIOL, V176, P916, DOI 10.1016/j.ijcard.2014.08.053; Dicht W, 2008, AM J CARDIOL, V102, P743, DOI 10.1016/j.amjcard.2008.04.060; Gaibazzi N, 2015, JACC-CARDIOVASC IMAG, V8, P389, DOI 10.1016/j.jcmg.2014.10.014; Helske S, 2007, EUR HEART J, V28, P1894, DOI 10.1093/eurheartj/ehm129; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022; Marincheva-Savcheva G, 2011, J AM COLL CARDIOL, V57, P2507, DOI 10.1016/j.jacc.2010.12.046; Martinsson A, 2015, CIRCULATION, V131, P988, DOI 10.1161/CIRCULATIONAHA.114.012906; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Otto CM, 1997, CIRCULATION, V95, P2262; Patel DK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000879; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sato K, 2014, CIRC J, V78, P2750, DOI 10.1253/circj.CJ-14-0726; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510	47	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					2050	2057		10.1253/circj.CJ-15-0499		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500033		
J	Yasui, H; Takahama, H; Kanzaki, H; Ishibashi-Ueda, H; Morita, N; Sugano, Y; Hasegawa, T; Ohara, T; Amaki, M; Funada, A; Yoshikawa, Y; Yasuda, S; Ogawa, H; Anzai, T				Yasui, Hiroki; Takahama, Hiroyuki; Kanzaki, Hideaki; Ishibashi-Ueda, Hatsue; Morita, Naomi; Sugano, Yasuo; Hasegawa, Takuya; Ohara, Takahiro; Amaki, Makoto; Funada, Akira; Yoshikawa, Yasushi; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa			Time-Course Changes of Cardiac-Specific Inflammation in a Patient With Left Ventricular Calcified Amorphous Tumor	CIRCULATION JOURNAL			English	Editorial Material							OSTEOPONTIN EXPRESSION; CARDIOMYOPATHY; HEART; CARVEDILOL; CAT		[Yasui, Hiroki; Takahama, Hiroyuki; Kanzaki, Hideaki; Sugano, Yasuo; Hasegawa, Takuya; Ohara, Takahiro; Amaki, Makoto; Funada, Akira; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka 5658565, Japan; [Morita, Naomi] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka 5658565, Japan; [Yasui, Hiroki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Yoshikawa, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan	Takahama, H (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan.	takahama@ncvc.go.jp	Anzai, Toshihisa/J-2179-2015	Anzai, Toshihisa/0000-0003-3319-4967			Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Nakamura K, 2002, CIRCULATION, V105, P2867, DOI 10.1161/01.CIR.0000018605.14470.DD; Reynolds C, 1997, HUM PATHOL, V28, P601, DOI 10.1016/S0046-8177(97)90083-6; Le DE, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0384-7; Miyagawa M, 2014, CIRC J, V78, P1302, DOI 10.1253/circj.CJ-14-0250; Fealey ME, 2007, CARDIOVASC PATHOL, V16, P115, DOI 10.1016/j.carpath.2006.09.002; Juergens KU, 2000, J COMPUT ASSIST TOMO, V24, P688, DOI 10.1097/00004728-200009000-00004; Kouzu H, 2014, CIRC J, V78, P1006, DOI 10.1253/circj.CJ-13-1291; Stawowy P, 2002, EUR J HEART FAIL, V4, P139, DOI 10.1016/S1388-9842(01)00237-9; WILLIAMS EB, 1995, CIRCULATION, V92, P705	10	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					2069	2071		10.1253/circj.CJ-15-0136		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500035		
J	Hakuno, D; Isobe, S; Masaki, N; Adachi, T				Hakuno, Daihiko; Isobe, Sarasa; Masaki, Nobuyuki; Adachi, Takeshi			Right Ventricular Wall Dissection With Ventricular Septal Rupture Following Myocardial Infarction Visualized on 3-Dimensional Transthoracic Echocardiography	CIRCULATION JOURNAL			English	Editorial Material							ERA		[Hakuno, Daihiko; Isobe, Sarasa; Masaki, Nobuyuki; Adachi, Takeshi] Natl Def Med Coll, Dept Internal Med 1, Div Cardiol, Tokorozawa, Saitama 3590042, Japan	Hakuno, D (reprint author), Natl Def Med Coll, Dept Internal Med 1, Div Cardiol, 3-2 Namiki, Tokorozawa, Saitama 3590042, Japan.	daihiko@dg8.so-net.ne.jp					Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Brandt Roland R, 2007, Heart, V93, P551, DOI 10.1136/hrt.2006.095737; Kuga K, 2014, CIRC J, V78, P2483, DOI 10.1253/circj.CJ-14-0301; Marques JS, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jer002; Nozoe M, 2014, J CARDIOL, V63, P14, DOI 10.1016/j.jjcc.2013.06.012; de Morais GP, 2012, ECHOCARDIOGR-J CARD, V29, pE112, DOI 10.1111/j.1540-8175.2011.01636.x; Puri T, 2004, ECHOCARDIOGR-J CARD, V21, P279, DOI 10.1111/j.0742-2822.2004.03085.x; Schram G, 2010, J AM SOC ECHOCARDIOG, V23, DOI 10.1016/j.echo.2009.11.020; Vengala S, 2004, ECHOCARDIOGR-J CARD, V21, P745, DOI 10.1111/j.0742-2822.2004.04063.x	9	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	SEP	2015	79	9					2072	2074		10.1253/circj.CJ-14-1246		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP7SX	WOS:000360089500036		
J	Oshika, M; Tachibana, Y; Nakamura, T				Oshika, Miki; Tachibana, Yoshihiro; Nakamura, Tetsu			Impact of the winter North Atlantic Oscillation (NAO) on the Western Pacific (WP) pattern in the following winter through Arctic sea ice and ENSO: part I-observational evidence	CLIMATE DYNAMICS			English	Article						Arctic sea ice; ENSO; Long-term prediction; NAO; WP	EL-NINO; ATMOSPHERIC CIRCULATION; SURFACE TEMPERATURE; HEMISPHERE WINTER; WIND BURSTS; CLIMATE; TELECONNECTIONS; VARIABILITY; REANALYSIS; EVENTS	On the basis of a 51-year statistical analysis of reanalysis data, we propose for the first time that the positive phase of the Western Pacific (WP) pattern in the winter is linked to the negative phase of the North Atlantic Oscillation (NAO) in the previous winter, and vice versa. We show that there are two possible mechanisms responsible for this interannual remote linkage. One is an Arctic mechanism. Extensive Arctic sea ice in the summer after a negative NAO acts as a bridge to the positive phase of the WP in the next winter. The other mechanism involves the tropics. An El Nio occurrence after a negative winter NAO acts as another bridge to the positive phase of the WP in the following winter. The timescale of the Arctic route is nearly decadal, whereas that of the tropical route is about 3-5 years. The tropical mechanism indicates that the NAO remotely excites an El Nio in the second half of the following year. A process perhaps responsible for the El Nio occurrence was investigated statistically. A negative NAO in the winter increases Eurasian snow cover. This anomalous snow cover then intensifies the cold air outbreak from Asia to the western tropical Pacific. This outbreak can intensify the westerly wind burst and excite El Nio in the following year. We suggest that the phase of the NAO in the winter could be a predictor of the WP in the following year.	[Oshika, Miki; Tachibana, Yoshihiro] Mie Univ, Grad Sch Bioresources, Climate & Ecosyst Dynam Div, Tsu, Mie 514, Japan; [Tachibana, Yoshihiro] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Nakamura, Tetsu] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Nakamura, Tetsu] Natl Inst Polar Res, Tokyo, Japan	Tachibana, Y (reprint author), Mie Univ, Grad Sch Bioresources, Climate & Ecosyst Dynam Div, Tsu, Mie 514, Japan.	tachi@bio.mie-u.ac.jp			Green Network of Excellence Program (GRENE Program) Arctic Climate Change Research Project; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [2205]	We extend grateful thanks to K. Kodera; his enormous support and insightful comments were invaluable during the course of this study. We are also grateful to the reviewer's valuable comments that improved the manuscript. This study was supported by the Green Network of Excellence Program (GRENE Program) Arctic Climate Change Research Project and the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research in Innovative Areas 2205.	Hori ME, 2011, SOLA, V7, DOI 10.2151/sola.2011-007; Nakamura T, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031220; Nakamura T, 2006, GEOPHYS RES LETT, V33, DOI [10.1029/2006GL025719, 10.1029/2006GL026318]; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; Yu LA, 1998, GEOPHYS RES LETT, V25, P3537, DOI 10.1029/98GL02628; Kodera K, 1998, J METEOROL SOC JPN, V76, P347; Chen SF, 2014, CLIM DYNAM, V42, P973, DOI 10.1007/s00382-012-1654-z; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; Hori ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018103; Gong DY, 2001, GEOPHYS RES LETT, V28, P2073, DOI 10.1029/2000GL012311; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Takano Y, 2008, SOLA, V4, P113, DOI 10.2151/sola.2008-029; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Yu LS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001498; WOHLLEBEN TMH, 1995, CLIM DYNAM, V11, P459, DOI 10.1007/BF00207195; HOREL JD, 1981, MON WEATHER REV, V109, P813, DOI 10.1175/1520-0493(1981)109<0813:PSAPAW>2.0.CO;2; Takaya K, 2001, J ATMOS SCI, V58, P608, DOI 10.1175/1520-0469(2001)058<0608:AFOAPI>2.0.CO;2; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; Kwok R, 1999, J GEOPHYS RES-OCEANS, V104, P5177, DOI 10.1029/1998JC900103; MO KC, 1986, MON WEATHER REV, V114, P2488, DOI 10.1175/1520-0493(1986)114<2488:TEGHTD>2.0.CO;2; Clark MP, 1999, INT J CLIMATOL, V19, P27, DOI 10.1002/(SICI)1097-0088(199901)19:1<27::AID-JOC346>3.0.CO;2-N; Honda M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037079; Meehl G.A., 2007, CLIMATE CHANGE 2007, P748; Nakamura T, 2014, IMPACT WINTER UNPUB; Ogi M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017280; PHILANDER SGH, 1985, J ATMOS SCI, V42, P2652, DOI 10.1175/1520-0469(1985)042<2652:ENALN>2.0.CO;2; Randall DA, 2007, CLIMATE CHANGE 2007, P590; Sando AB, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005884; Schlichtholz P, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045894; Zhang ZY, 2009, J GEOGR SCI, V19, P471, DOI 10.1007/s11442-009-0471-8	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	SEP	2015	45	5-6					1355	1366		10.1007/s00382-014-2384-1		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CQ3MZ	WOS:000360507700012		
J	Inoue, K; Takano, H				Inoue, K.; Takano, H.			Epidemiology of asthma exacerbations and their relation with environmental factors in the Basque Country	CLINICAL AND EXPERIMENTAL ALLERGY			English	Letter									[Inoue, K.] Univ Shizuoka, Sch Nursing, Suruga Ku, Shizuoka 4228526, Japan; [Takano, H.] Kyoto Univ, Grad Sch Engn, Kyoto, Japan	Inoue, K (reprint author), Univ Shizuoka, Sch Nursing, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	inoue-k@u-shizuoka-ken.ac.jp					Altzibar JM, 2015, CLIN EXP ALLERGY, V45, P1099, DOI 10.1111/cea.12419; Olson DA, 2008, ATMOS ENVIRON, V42, P1742, DOI 10.1016/j.atmosenv.2007.11.035; Farina F, 2011, TOXICOL LETT, V202, P209, DOI 10.1016/j.toxlet.2011.01.031; Happo MS, 2010, INHAL TOXICOL, V22, P17, DOI 10.3109/08958370902862426	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-7894	1365-2222		CLIN EXP ALLERGY	Clin. Exp. Allergy	SEP	2015	45	9					1475	1475		10.1111/cea.12586		1	Allergy; Immunology	Allergy; Immunology	CQ0VZ	WOS:000360317200013		
J	Abe, K; Narumi, S; Suwanai, AS; Hamajima, T; Hasegawa, T				Abe, Kiyomi; Narumi, Satoshi; Suwanai, Ayuko S.; Hamajima, Takashi; Hasegawa, Tomonobu			Pseudodominant inheritance in a family with nonautoimmune hypothyroidism due to biallelic DUOX2 mutations	CLINICAL ENDOCRINOLOGY			English	Article							CONGENITAL HYPOTHYROIDISM; JAPANESE PATIENTS; DYSHORMONOGENESIS; DEFECTS; GENE	ObjectivesMutations in the dual oxidase 2 gene (DUOX2) is the most common genetic cause of congenital hypothyroidism (CH) in Japan. All previously described DUOX2 mutation-carrying families have followed autosomal recessive inheritance. We report a nonconsanguineous Japanese family harbouring biallelic DUOX2 mutations, which presented an apparently dominant inheritance of nonautoimmune hypothyroidism. Design and methodsThe proband and her two sisters had been diagnosed as having CH on newborn screening and were treated with levothyroxine. Their mother had subclinical hypothyroidism. We sequenced DUOX2 in the proband and her family members. Pathogenicity of the identified novel mutation (p.Y1347C) was verified in vitro. ResultsWe found that the proband and her sisters were compound heterozygous for a novel DUOX2 mutation p.Y1347C and a previously reported functional variant p.H678R. Unexpectedly, we found that the mother was homozygous for p.H678R. Expression experiments showed that the p.Y1347C mutant had reduced H2O2-producing activity, although there was no significant difference in the level of protein expression or localization, between wild type and p.Y1347C. ConclusionsWe report a DUOX2 mutation-carrying pedigree presenting pseudodominant inheritance of nonautoimmune hypothyroidism. We speculate that the relatively high frequency of DUOX2 mutations could lead to pseudodominant inheritance in Japan.	[Abe, Kiyomi; Narumi, Satoshi; Suwanai, Ayuko S.; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Hamajima, Takashi] Aichi Childerens Hlth & Med Ctr, Div Endocrinol & Metab, Aichi, Japan	Narumi, S (reprint author), Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	sat_naru@hotmail.com			Japan Society for the Promotion of Science [24791088, 23591517]	We are grateful to Prof. Takao Takahashi for the fruitful discussion. This work was supported by a Grant-in-Aid for young Scientists (B) (24791088) and a Grant-in-Aid for Scientific Research (C) (23591517) from the Japan Society for the Promotion of Science.	Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Narumi S, 2010, J CLIN ENDOCR METAB, V95, P1981, DOI 10.1210/jc.2009-2373; Grasberger H, 2010, MOL CELL ENDOCRINOL, V322, P99, DOI 10.1016/j.mce.2010.01.029; Park SM, 2005, J MED GENET, V42, P379, DOI 10.1136/jmg.2004.024158; Narumi S, 2011, J CLIN ENDOCR METAB, V96, pE1838, DOI 10.1210/jc.2011-1573; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Bakker B, 2000, J CLIN ENDOCR METAB, V85, P3708, DOI 10.1210/jc.85.10.3708; Deladoeey J, 2008, J CLIN ENDOCR METAB, V93, P627, DOI 10.1210/jc.2007-2276; DesDeken X., 2000, J BIOL CHEM, V275, P23227; Grasberger H, 2011, CURR OPIN PEDIATR, V23, P421, DOI 10.1097/MOP.0b013e32834726a4; Grasberger H, 2007, MOL ENDOCRINOL, V21, P1408, DOI 10.1210/me.2007-0018; Nagasaki K., 2013, INT J PEDIAT ENDO S1, V2013, pO55; Narumi S, 2009, J CLIN ENDOCR METAB, V94, P1317, DOI 10.1210/jc.2008-1767; Scott D. A., 2011, NELSON TXB PEDIAT, P383; TOUBLANC JE, 1992, HORM RES, V38, P230, DOI 10.1159/000182549; Vulsma T., 2013, THYROID FUNDAMENTAL, P535; Yasumoto M, 2004, J CLIN ULTRASOUND, V32, P82, DOI 10.1002/jcu.10234	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	SEP	2015	83	3					394	398		10.1111/cen.12622		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ2VH	WOS:000360459600018		
J	Rokutan, H				Rokutan, Hirofumi			Time to Investigate the Gap between Symptomatic Response and Histologic/Immunohistochemical Parameters	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Letter							EOSINOPHILIC ESOPHAGITIS; DIAGNOSIS		Univ Tokyo, Dept Pathol, Tokyo, Japan	Rokutan, H (reprint author), Univ Tokyo, Dept Pathol, Tokyo, Japan.						Nielsen JA, 2014, AM J GASTROENTEROL, V109, P515, DOI 10.1038/ajg.2013.463; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P2015, DOI 10.1016/j.cgh.2014.06.019; Alexander JA, 2012, CLIN GASTROENTEROL H, V10, P742, DOI 10.1016/j.cgh.2012.03.018; Hirano I, 2012, CLIN GASTROENTEROL H, V10, P750, DOI 10.1016/j.cgh.2012.02.009; Dellon ES, 2015, MODERN PATHOL, V28, P383, DOI 10.1038/modpathol.2014.110; Wolf WA, 2015, CLIN GASTROENTEROL H, V13, P452, DOI 10.1016/j.cgh.2014.07.034	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	SEP	2015	13	9					1701	1702		10.1016/j.cgh.2015.02.001		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP7TG	WOS:000360090400032		
J	Oikawa, T; Ohira, T; Matsubayashi, J; Konaka, C; Ikeda, N				Oikawa, Takefumi; Ohira, Tatsuo; Matsubayashi, Jun; Konaka, Chimori; Ikeda, Norihiko			Factors Influencing the Diagnostic Accuracy of Identifying the Histologic Type of Non-Small-Lung Cancer With Small Samples	CLINICAL LUNG CANCER			English	Article						Large tumor size; Poor differentiation grade; Postoperative diagnosis; Preoperative diagnosis; Risk factor	CISPLATIN PLUS GEMCITABINE; FACTOR RECEPTOR MUTATIONS; PHASE-III; CELL; BEVACIZUMAB; CARBOPLATIN; PACLITAXEL; TRIAL	The pathologic diagnosis of the histologic type is critical to decision-making regarding the treatment options for lung cancer. However, a greater risk of misdiagnosis exists with smaller tissue samples. We found that the nonesmall-cell lung cancer tumor differentiation grade and tumor diameter were associated with the diagnostic accuracy of the preoperative transbronchoscopic examination findings. Background: The pathologic diagnosis has become a greater consideration in decision-making regarding the treatment options for lung cancer. Therefore, the accurate diagnosis of the tumor histologic type is essential, even when only small biopsy or cytology samples are available. However, the risk of a misdiagnosis with smaller biopsy samples is greater. The factors underlying the increased risk of a misdiagnosis in small samples are unknown. The aim of the present study was to identify the clinical and pathologic factors (other than immunohistochemical staining) that influence the pathologic diagnostic accuracy in small biopsy and cytological lung samples obtained by bronchoscopy. Patients and Methods: We performed transbronchial lung biopsy or brushing and lavage to determine the preoperative diagnosis of 126 of 299 surgically resected lung cancer specimens. We assessed the diagnostic accuracy of the preoperative transbronchoscopic examination findings against that of the surgically resected lung specimens. Results: On univariate analysis, the mean pathologic tumor size in the noncorresponding cases was larger than that in corresponding cases. Vascular invasion was also more prevalent in the noncorresponding cases. The tumor differentiation grade in the noncorresponding cases was poorer than in the corresponding cases. The noncorresponding cases were at a more progressed stage. On multivariate analysis, the pathologic tumor size and tumor differentiation grade were associated with the noncorresponding cases. Conclusion: We found a larger tumor size and poor differentiation grade were indicative of lung cancer tissue with a greater content of heterogeneous cells. Therefore, a possibility exists of a false diagnosis using only these factors. Thus, treatment decisions should be made considering the pathologic diagnosis and other relevant factors.	[Oikawa, Takefumi; Konaka, Chimori] Kaken Hosp, Chemotherapy Res Inst, Div Thorac Surg, Ichikawa, Chiba 2720827, Japan; [Ohira, Tatsuo; Ikeda, Norihiko] Tokyo Med Univ, Div Thorac Surg, Tokyo 1608402, Japan; [Matsubayashi, Jun] Tokyo Med Univ, Div Anat Pathol, Tokyo 1608402, Japan	Oikawa, T (reprint author), Kaken Hosp, Chemotherapy Res Inst, Div Thorac Surg, Kounodai 6-1-14, Ichikawa, Chiba 2720827, Japan.	take.oikawa@gmail.com					Kang SM, 2007, CANCER, V109, P581, DOI 10.1002/cncr.22413; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Hirsch FR, 2008, J THORAC ONCOL, V3, P1468, DOI 10.1097/JTO.0b013e318189f551; Loo PS, 2010, J THORAC ONCOL, V5, P442, DOI 10.1097/JTO.0b013e3181d40fac; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Edwards SL, 2000, J CLIN PATHOL, V53, P537, DOI 10.1136/jcp.53.7.537; Ettinger DS, 2014, J NATL COMPR CANC NE, V12, P1738	13	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1525-7304	1938-0690		CLIN LUNG CANCER	Clin. Lung Cancer	SEP	2015	16	5					374	378		10.1016/j.cllc.2015.03.007		5	Oncology	Oncology	CP8YY	WOS:000360182100018		
J	Kitazono, S; Fujiwara, Y; Tsuta, K; Utsumi, H; Kanda, S; Horinouchi, H; Nokihara, H; Yamamoto, N; Sasda, S; Watanabe, S; Asamura, H; Tamura, T; Ohe, Y				Kitazono, Satoru; Fujiwara, Yutaka; Tsuta, Koji; Utsumi, Hirofumi; Kanda, Shintaro; Horinouchi, Hidehito; Nokihara, Hiroshi; Yamamoto, Noboru; Sasda, Shinji; Watanabe, Shun-ichi; Asamura, Hisao; Tamura, Tomohide; Ohe, Yuichiro			Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non-Small-Cell Lung Cancer	CLINICAL LUNG CANCER			English	Article						Concordance rate; Immunohistochemistry; Operative; Surgical procedures	1ST-LINE TREATMENT; B7 FAMILY; PD-1; B7-H1; CHEMOTHERAPY; ACTIVATION; EGFR; CLASSIFICATION; CRIZOTINIB; PATHWAY	Expression of programmed death-ligand 1 (PD-L1) in nonesmall-cell lung cancer (NSCLC) has mainly been examined using surgically resected specimens. We retrospectively evaluated the expression of PD-L1 using immunohistochemistry in 79 paired small biopsy and resected specimens of NSCLC. The concordance between the samples was good, with a concordance rate of 92.4% and k value of 0.8366. Background: Several studies have assessed the expression of programmed death-ligand 1 (PD-L1) in resected surgical specimens of non-small-cell lung cancer (NSCLC). However, the expression of PD-L1 in smaller biopsy samples of advanced NSCLC has not been reported. Patients and Methods: A total of 79 patients with NSCLC at our institution with available biopsy samples and resected specimens were retrospectively enrolled in the present study. PD-L1 expression was assessed by immunohistochemistry and scored using the hybrid scoring method. The concordance rates for the expression of PD-L1 between the 2 samples were analyzed. Results: The pathologic stage of the patients (51 men, 28 women; median age, 68 years) was stage I in 37, stage II in 18, and stage III in 24. The diagnostic procedures included transbronchial biopsy in 59, transbronchial needle aspiration biopsy in 14, and computed tomography (CT)-guided needle biopsy in 6. The positivity rate of PD-L1 in these samples was 38.0% (27 transbronchial biopsies, 6 transbronchial needle aspiration biopsies, 3 CT-guided needle biopsies) versus 35.4% in the resected specimens. The median hybrid score was 0 (range, 0-170), and the mean score was 28.7 +/- 43.4. Comparing the biopsy samples and resected specimens with a score of >= 1 as positive for PD-L1 staining, 6 tumors were discordant for PD-L1 expression and 73 were concordant, for a concordance rate of 92.4% and kappa value of 0.8366. Conclusion: PD-L1 status showed good concordance between the biopsy samples and resected specimens. These small samples, even those derived from transbronchial needle aspiration biopsies, appear adequate for the assessment of PD-L1 expression. (C) 2015 Elsevier Inc. All rights reserved.	[Kitazono, Satoru; Fujiwara, Yutaka; Utsumi, Hirofumi; Kanda, Shintaro; Horinouchi, Hidehito; Nokihara, Hiroshi; Yamamoto, Noboru; Tamura, Tomohide; Ohe, Yuichiro] Natl Canc Ctr, Dept Thorac Oncol, Tokyo 1040045, Japan; [Kitazono, Satoru] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Med Oncol, Tokyo, Japan; [Fujiwara, Yutaka; Yamamoto, Noboru] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Dept Expt Therapeut, Tokyo, Japan; [Tsuta, Koji] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Sasda, Shinji] Natl Canc Ctr, Dept Endoscopy, Resp Endoscopy Div, Tokyo, Japan; [Watanabe, Shun-ichi; Asamura, Hisao] Natl Canc Ctr, Dept Thorac Surg, Tokyo, Japan	Fujiwara, Y (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	yutakafu@ncc.go.jp; yutakafu@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-30]	We greatly appreciate all patients who participated in our study and their families. We also wish to thank Shigehiro Yagishita, Hidenori Mizugaki, and Kuniko Sunami for the assistance of the staff of the Department of Thoracic Oncology, National Cancer Center Hospital. This work was supported in part by the National Cancer Center Research and Development Fund (grant 23-A-30). The study sponsor had no involvement in the study design, collection, analysis, or interpretation of data, writing the report, or in the decision to submit the report for publication.	Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; Scagliotti G, 2012, EUR J CANCER, V48, P961, DOI 10.1016/j.ejca.2012.02.001; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Travis WD, 2011, SEMIN RESP CRIT CARE, V32, P22, DOI 10.1055/s-0031-1272866; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Boland JM, 2013, CLIN LUNG CANCER, V14, P157, DOI 10.1016/j.cllc.2012.05.006; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Quinton Cindy, 2011, Cancers (Basel), V3, P3506, DOI 10.3390/cancers3033506; Taube JM, 2012, SCI TRANSL MED, V4, P127, DOI DOI 10.1126/SCITRANSLMED.3003689; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	26	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1525-7304	1938-0690		CLIN LUNG CANCER	Clin. Lung Cancer	SEP	2015	16	5					385	390		10.1016/j.cllc.2015.03.008		6	Oncology	Oncology	CP8YY	WOS:000360182100020		
J	Shintani, T; Masago, K; Takayama, K; Ueki, K; Kimino, G; Ueki, N; Kosaka, Y; Imagumbai, T; Katakami, N; Kokubo, M				Shintani, Takashi; Masago, Katsuhiro; Takayama, Kenji; Ueki, Kazuhito; Kimino, Genki; Ueki, Nami; Kosaka, Yasuhiro; Imagumbai, Toshiyuki; Katakami, Nobuyuki; Kokubo, Masaki			Stereotactic Body Radiotherapy for Synchronous Primary Lung Cancer: Clinical Outcome of 18 Cases	CLINICAL LUNG CANCER			English	Article						Multiple primary lung cancer; Non-small-cell lung cancer; Stereotactic ablative radiotherapy; Stereotactic body radiotherapy; Synchronous primary lung cancer	RADIATION-THERAPY; POOLED ANALYSIS; ABLATIVE RADIOTHERAPY; SURGICAL-TREATMENT; EXPERIENCE; PROGNOSIS; SURVIVAL; TUMORS	For patients with synchronous primary lung cancer (SPLC), definitive surgical treatment is considered to be standard treatment. The clinical course after stereotactic body radiotherapy (SBRT) with or without surgery for these patients is not clear. This retrospective study showed SBRT yielded an excellent overall survival rate with limited toxicity. SBRT could be a good treatment option for frail patients with SPLC. Background: Previous reports have shown that curative surgical approaches for synchronous primary lung cancer (SPLC) yielded excellent treatment outcomes. However, patients with SPLC are often unsuitable for such surgery as a result of poor general condition or other medical comorbidities. The effectiveness and feasibility of stereotactic body radiotherapy (SBRT) as a definitive treatment for SPLC are not well understood. Patients and Methods: We retrospectively reviewed the records of the patients who received lung SBRT between July 2007 and December 2012 at our institution and identified patients with SPLC. The clinical outcome was analyzed for each patient. The first progression site was classified as local, regional, distant, or new primary lung cancer. Results: A total of 18 patients were eligible. Fifteen patients received SBRT for both lesions, and 3 patients received surgery for one tumor and SBRT for the other. The median follow-up time was 34.3 months (range, 12.2-64.7 months). The median overall and progression-free survival was 45.6 months (95% confidence interval [CI] 21.0-60.6) and 25.3 months (95% CI, 13.1-50.6 months), respectively. The 3-year overall survival and progression-free survival rates were 69.1% (95% CI, 40.7-85.9) and 43.2% (95% CI, 20.2-64.4), respectively. Eleven patients (61%) experienced disease progression. The first progression site was local in 4 (22%), regional in 5 (28%), distant in 3 (17%), and new primary lung cancer in 2 patients (11%). Grade 3 radiation pneumonitis was observed in 2 patients (11%). Conclusion: SBRT for SPLC is a highly effective local treatment with limited toxicity, although the progression rate seems relatively high. (C) 2015 Elsevier Inc. All rights reserved.	[Shintani, Takashi; Takayama, Kenji; Ueki, Kazuhito; Kimino, Genki; Ueki, Nami; Kosaka, Yasuhiro; Imagumbai, Toshiyuki; Kokubo, Masaki] Inst Biomed Res & Innovat, Div Radiat Oncol, Kobe, Hyogo 6500047, Japan; [Masago, Katsuhiro; Katakami, Nobuyuki] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo 6500047, Japan; [Ueki, Nami] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan	Shintani, T (reprint author), Inst Biomed Res & Innovat, Div Radiat Oncol, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takashishintanikchp@yahoo.co.jp					Chang JY, 2013, CANCER-AM CANCER SOC, V119, P3402, DOI 10.1002/cncr.28217; Warth A, 2012, EUR RESPIR J, V39, P1437, DOI 10.1183/09031936.00105911; Chang YL, 2007, J THORAC CARDIOV SUR, V134, P630, DOI 10.1016/j.jtcvs.2007.06.001; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Senthi S, 2012, LANCET ONCOL, V13, P802, DOI 10.1016/S1470-2045(12)70242-5; Fruh M, 2008, J CLIN ONCOL, V26, P3573, DOI 10.1200/JCO.2008.16.2727; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Wang JB, 2012, CLIN LUNG CANCER, V13, P81, DOI 10.1016/j.cllc.2011.08.002; Creach KM, 2012, RADIOTHER ONCOL, V104, P19, DOI 10.1016/j.radonc.2011.12.005; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Shimizu S, 2000, CLIN CANCER RES, V6, P3994; Wang XY, 2009, J NATL CANCER I, V101, P560, DOI 10.1093/jnci/djp054; Finley DJ, 2010, J THORAC ONCOL, V5, P197, DOI 10.1097/JTO.0b013e3181c814c5; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Nagata Y, 2005, INT J RADIAT ONCOL, V63, P1427, DOI 10.1016/j.ijrobp.2005.05.034; Onishi H, 2004, CANCER-AM CANCER SOC, V101, P1623, DOI 10.1002/cncr.20539; Girard N, 2009, CLIN CANCER RES, V15, P5184, DOI 10.1158/1078-0432.CCR-09-0594; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Onishi H, 2011, INT J RADIAT ONCOL, V81, P1352, DOI 10.1016/j.ijrobp.2009.07.1751; Trousse D, 2007, J THORAC CARDIOV SUR, V133, P1193, DOI 10.1016/j.jtcvs.2007.01.012; Dominguez-Ventura A, 2007, EUR J CARDIO-THORAC, V32, P370, DOI 10.1016/j.ejcts.2007.04.002; Griffioen GHMJ, 2013, RADIOTHER ONCOL, V107, P403, DOI 10.1016/j.radonc.2013.04.026; KEOGAN MT, 1993, CLIN RADIOL, V48, P94, DOI 10.1016/S0009-9260(05)81079-7; Matthiesen C, 2012, J MED IMAG RADIAT ON, V56, P561, DOI 10.1111/j.1754-9485.2012.02393.x; Riquet M, 2008, ANN THORAC SURG, V86, P921, DOI 10.1016/j.athoracsur.2008.05.041; Sinha B, 2006, INT J RADIAT ONCOL, V66, P1120, DOI 10.1016/j.ijropb.2006.06.042; Tanvetyanon T, 2013, ANN ONCOL, V24, P889, DOI 10.1093/annonc/mds495	28	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1525-7304	1938-0690		CLIN LUNG CANCER	Clin. Lung Cancer	SEP	2015	16	5					E91	E96		10.1016/j.cllc.2014.12.011		6	Oncology	Oncology	CP8YY	WOS:000360182100008		
J	Muraki, S; Akune, T; Nagata, K; Ishimoto, Y; Yoshida, M; Tokimura, F; Tanaka, S; Kawaguchi, H; Nakamura, K; Oka, H; Yoshimura, N				Muraki, Shigeyuki; Akune, Toru; Nagata, Keiji; Ishimoto, Yuyu; Yoshida, Munehito; Tokimura, Fumiaki; Tanaka, Sakae; Kawaguchi, Hiroshi; Nakamura, Kozo; Oka, Hiroyuki; Yoshimura, Noriko			Does osteophytosis at the knee predict health-related quality of life decline? A 3-year follow-up of the ROAD study	CLINICAL RHEUMATOLOGY			English	Article						Epidemiology; Longitudinal Studies; Osteoarthritis; Pain; WOMAC	INDIVIDUAL RADIOGRAPHIC FEATURES; OSTEOARTHRITIS INDEX; PATELLOFEMORAL JOINT; HIP OSTEOARTHRITIS; UNITED-STATES; ASSOCIATION; PREVALENCE; COHORT; POPULATION; ARTHRITIS	The objective of the present longitudinal study was to clarify whether osteophytosis and joint space narrowing predict quality of life (QOL) decline using a longitudinal population-based cohort of the Research on Osteoarthritis/osteoporosis Against Disability (ROAD) study. The present study analyzed 1,525 participants who completed the radiographic examination at baseline and questionnaires regarding QOL at a 3-year follow-up (546 men and 979 women; mean age, 67.0 +/- 11.0 years). This study examined the associations of osteophyte area (OPA) and minimum joint space width (mJSW) in the medial compartment of the knee at baseline with pain and physical functional disability measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). OPA and mJSW in the medial compartment of the knee were measured using a knee osteoarthritis (OA) computer-aided diagnosis system. Overall, OPA independently predicted physical functional disability after 3 years of follow-up. When analyzed in men and women separately, OPA, rather than mJSW, was an independent predictor for pain and physical functional disability after 3 years of follow-up in men. OPA, rather than mJSW, also predicted worsening of pain in men during the 3-year follow-up, whereas in women, mJSW, rather than OPA, predicted worsening of pain. In conclusion, the present longitudinal study using a large-scale population from the ROAD study found gender differences in the association of osteophytosis and joint space narrowing with pain and physical functional disability.	[Muraki, Shigeyuki; Akune, Toru] Univ Tokyo, Fac Med, Century Med & Res Ctr 22, Dept Clin Motor Syst Med,Bunkyo Ku, Tokyo 1138655, Japan; [Nagata, Keiji; Ishimoto, Yuyu; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama, Japan; [Tokimura, Fumiaki] Tokyo Metropolitan Geriatr Med Ctr, Dept Orthopaed Surg, Tokyo, Japan; [Tanaka, Sakae; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Nakamura, Kozo] Natl Rehabil Ctr Persons Disabil, Saitama, Japan; [Oka, Hiroyuki; Yoshimura, Noriko] Univ Tokyo, Fac Med, Dept Joint Dis Res, Century Med & Res Ctr 22, Tokyo 113, Japan	Muraki, S (reprint author), Univ Tokyo, Fac Med, Century Med & Res Ctr 22, Dept Clin Motor Syst Med,Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	murakis-ort@h.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [S19109007, B20390182, C20591737, C20591774, A18689031, 19659305]; Ministry of Health, Labor and Welfare [H17-Men-eki-009, H18-Choujyu-037, H20-Choujyu-009, H21-Chouju-Wakate-011, H22-Chouju-Wakate-007]; Japanese Orthopaedic Association [2006-1]; Japan Orthopaedics and Traumatology Foundation [166]	This work was supported by Grants-in-Aid for Scientific Research (S19109007, B20390182, C20591737, C20591774), for Young Scientists (A18689031), and for Exploratory Research (19659305) from the Japanese Ministry of Education, Culture, Sports, Science and Technology; grants (H17-Men-eki-009, H18-Choujyu-037, H20-Choujyu-009, H21-Chouju-Wakate-011, and H22-Chouju-Wakate-007) from the Ministry of Health, Labor and Welfare, a Research Aid from the Japanese Orthopaedic Association (JOA-Subsidized Science Project Research 2006-1) and Grant No. 166 from the Japan Orthopaedics and Traumatology Foundation are also acknowledged.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; CROFT P, 1990, AM J EPIDEMIOL, V132, P514; Woo J, 2004, J RHEUMATOL, V31, P2433; Inoue K, 2000, RHEUMATOLOGY, V39, P745, DOI 10.1093/rheumatology/39.7.745; Duncan R, 2007, ANN RHEUM DIS, V66, P86, DOI 10.1136/ard.2006.052548; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; SPECTOR TD, 1993, ANN RHEUM DIS, V52, P790, DOI 10.1136/ard.52.11.790; Jordan JM, 2007, J RHEUMATOL, V34, P172, DOI 10.3899/jrheum.080677; Van den Berg WB, 1999, OSTEOARTHR CARTILAGE, V7, P333, DOI 10.1053/joca.1998.0186; ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Thumboo J, 2001, OSTEOARTHR CARTILAGE, V9, P440, DOI 10.1053/joca.2000.0410; Yoshida S, 2002, J RHEUMATOL, V29, P1454; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Muraki S, 2011, ARTHRITIS RHEUM-US, V63, P3859, DOI 10.1002/art.30641; Oka H, 2008, OSTEOARTHR CARTILAGE, V16, P1300, DOI 10.1016/j.joca.2008.03.011; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Brazier JE, 1999, RHEUMATOLOGY, V38, P870, DOI 10.1093/rheumatology/38.9.870; Linaker CH, 1999, BEST PRACT RES CL RH, V13, P197, DOI 10.1053/berh.1999.0016; Hannan MT, 2000, J RHEUMATOL, V27, P1513; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Sayer AA, 2006, AGE AGEING, V35, P409, DOI 10.1093/ageing/afl024; BARR S, 1994, J RHEUMATOL, V21, P2106; Chang CB, 2007, J BONE JOINT SURG BR, V89B, P1324, DOI 10.1302/0301-620X.89B10.19120; Hashimoto Hideki, 2003, J Orthop Sci, V8, P288, DOI 10.1007/s10776-002-0629-0; Hill CL, 1999, J RHEUMATOL, V26, P2029; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772; Kellgren JH, 1963, EPIDEMIOLOGY CHRONIC; Kijowski R, 2006, SKELETAL RADIOL, V35, P895, DOI 10.1007/s00256-006-0111-7; Ministry of Health Labour and Welfare, 2007, OUTL RES NAT LIV SUR; Muraki S, 2011, OSTEOARTHR CARTILAGE, V19, P840, DOI 10.1016/j.joca.2011.03.008; Neogi T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2844; Oka H, 2010, J ORTHOP SCI, V15, P781, DOI 10.1007/s00776-010-1545-2; Sharma L., 2007, OSTEOARTHRITIS DIAGN, P3; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409	39	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0770-3198	1434-9949		CLIN RHEUMATOL	Clin. Rheumatol.	SEP	2015	34	9					1589	1597		10.1007/s10067-014-2687-y		9	Rheumatology	Rheumatology	CQ0LZ	WOS:000360288800014		
J	Chen, ZY; Hu, W; Wang, Y; Guo, ZW; Sun, LY; Kuwana, M				Chen, Zhiyong; Hu, Wei; Wang, Yan; Guo, Ziwei; Sun, Lingyun; Kuwana, Masataka			Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis/dermatomyositis	CLINICAL RHEUMATOLOGY			English	Article						Autoantibodies < Tissues or models; Myositis < Rheumatic diseases	CLINICALLY AMYOPATHIC DERMATOMYOSITIS; IDIOPATHIC INFLAMMATORY MYOPATHY; INTERSTITIAL LUNG-DISEASE; GENE 5; ASSOCIATION; POPULATION; ANTIBODIES; ALLELES	The study aims to comprehensively assess the profiles of myositis-specific autoantibodies (MSAs) in Chinese patients with polymyositis (PM)/dermatomyositis (DM) and compare them with a Japanese cohort. One hundred forty-five Chinese patients (68 classic DM, 25 clinically amyopathic DM [CADM], and 52 PM) and 165 Japanese patients (56 classic DM, 52 CADM, and 57 PM) were recruited. MSAs were measured with immunoprecipitation, enzyme-linked immunosorbent assay, or immunoprecipitation-immunoblotting. MSA frequencies were compared. The overall frequency of anti-melanoma differentiation-associated gene 5 (MDA5) antibodies was significantly higher in the Chinese patients than in the Japanese cohort (36.6 % [53/145] versus 15.8 % [26/165], respectively, P<0.001), whereas the frequencies of anti-signal recognition particle (SRP) antibodies (1.4 % [2/145] versus 7.9 % [13/165], respectively, P=0.008) and anti-aminoacyl-transfer RNA synthetase (anti-ARS) antibodies (27.6 % [40/145] versus 40 % [66/165], respectively, P=0.02,) were significantly lower. The significantly lower frequency of anti-ARS antibodies and significantly higher frequency of anti-MDA5 antibodies in the Chinese patients were observed in the classic DM subset (14.7 % [10/68] versus 46.4 % [26/56], respectively, P<0.001, and 45.6 % [31/68] versus 5.4 % [3/56], respectively, P<0.001) and CADM subset (8.0 % [2/25] versus 28.8 % [15/52], respectively, P=0.04, and 88.0 % [22/25] versus 44.2 % [23/52], respectively, P=0.0002), but not in the PM subset. The first detailed profile of MSAs in Chinese patients with PM/DM was established. The differences in MSA frequencies in the Chinese cohort and Japanese cohort suggest underlying genetic and/or environmental differences between these two populations. Key Messages A significantly higher frequency of anti-melanoma differentiation-associated gene 5 (MDA5) antibodies was observed in Chinese patients with polymyositis/dermatomyositis (PM/DM) than in Japanese patients. Our findings suggest that distinct genetic and/or local environmental factors affect Chinese and Japanese patients with PM/DM, who have been considered a "homogeneous" population in previous studies.	[Chen, Zhiyong; Wang, Yan; Guo, Ziwei; Sun, Lingyun] Nanjing Univ, Dept Rheumatol & Immunol, Affiliated Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Hu, Wei] Nanjing Univ, Dept Clin Lab, Affiliated Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Kuwana, Masataka] Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138603, Japan	Sun, LY (reprint author), Nanjing Univ, Dept Rheumatol & Immunol, Affiliated Drum Tower Hosp, Sch Med, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	lingyunsun2001@yahoo.com.cn; kuwanam@nms.ac.jp			Nanjing Medical Science and Technique Development Foundation; National Natural Science Foundation of China [81302556]; Jiangsu Province Kejiao Xingwei Program Foundation; Japanese Ministry of Health, Labour, and Welfare	We thank Yuka Okazaki for her excellent technical assistance. This study was supported, in part, by the Nanjing Medical Science and Technique Development Foundation (Z.C.), the National Natural Science Foundation of China (Z.C., no. 81302556), and the Jiangsu Province Kejiao Xingwei Program Foundation (L.S.), and a research grant for intractable diseases from the Japanese Ministry of Health, Labour, and Welfare (M.K.).	Gono T, 2012, ARTHRITIS RHEUM-US, V64, P3736, DOI 10.1002/art.34657; Chen ZY, 2013, ARTHRIT CARE RES, V65, P1316, DOI 10.1002/acr.21985; Chinoy H, 2012, ANN RHEUM DIS, V71, P961, DOI 10.1136/annrheumdis-2011-200182; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sato S, 2010, CURR OPIN RHEUMATOL, V22, P639, DOI 10.1097/BOR.0b013e32833f1987; Arnett FC, 1996, ARTHRITIS RHEUM, V39, P1507, DOI 10.1002/art.1780390910; Chinoy H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3327; Furuya T, 2004, J RHEUMATOL, V31, P1768; Ikeda N, 2011, J DERMATOL, V38, P973, DOI 10.1111/j.1346-8138.2011.01262.x; Kang EH, 2014, MOD RHEUMATOL, V24, P945, DOI 10.3109/14397595.2014.896494; Labrador-Horrillo M, 2014, J IMMUNOL RES, DOI 10.1155/2014/290797; Mammen AL, 2010, ANN NY ACAD SCI, V1184, P134, DOI 10.1111/j.1749-6632.2009.05119.x; Mimori T, 2007, CURR OPIN RHEUMATOL, V19, P523, DOI 10.1097/BOR.0b013e3282f01a8c; Muro Y, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3547; Nakajima F, 2001, MHC, V8, P1; Qin PQ, 2011, INT J IMMUNOGENET, V38, P475, DOI 10.1111/j.1744-313X.2011.01029.x; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sontheimer RD, 2010, ARCH DERMATOL, V146, P76, DOI 10.1001/archdermatol.2009.323	18	0	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0770-3198	1434-9949		CLIN RHEUMATOL	Clin. Rheumatol.	SEP	2015	34	9					1627	1631		10.1007/s10067-015-2935-9		5	Rheumatology	Rheumatology	CQ0LZ	WOS:000360288800019		
J	Umentani, N; Igarashi, T; Mitra, NJ				Umentani, Nobuyuki; Igarashi, Takeo; Mitra, Niloy J.			Guided Exploration of Physically Valid Shapes for Furniture Design	COMMUNICATIONS OF THE ACM			English	Article							OPTIMIZATION	It is common to use computers to design shapes of physical objects such as furniture, but geometric modeling and the physical validity of shapes are conventionally considered independently. This makes creating aesthetically pleasing yet physically valid models challenging. In this paper, we propose an interactive design framework for the efficient and intuitive exploration of geometrically and physically valid shapes. During any geometric editing operation, the system continuously allows visualization of the valid range of the parameters being edited. When one or more constraints are violated following an operation, the system generates multiple suggestions involving both discrete and continuous changes to restore validity. Each suggestion is accompanied by an editing mode, which simultaneously adjusts multiple parameters in a coordinated manner to maintain validity. Thus, while the user focuses on the aesthetics of the design, our computational design framework helps to achieve physical realizability by providing active guidance to the user. We demonstrate our framework on plank-based furniture designs with nail-joints and frictional constraints. We use our system to design a range of examples, conduct a user study, and also fabricate a physical prototype to test its validity and usefulness.	[Umentani, Nobuyuki; Igarashi, Takeo] Univ Tokyo, Japan Sci & Technol Agcy JST, Grad Sch Informat Sci & Technol, Exploratory Res Adv Technol ERATO,Dept Comp Sci, Tokyo, Japan; [Mitra, Niloy J.] UCL, Dept Comp Sci, London, England	Umentani, N (reprint author), Univ Tokyo, Japan Sci & Technol Agcy JST, Grad Sch Informat Sci & Technol, Exploratory Res Adv Technol ERATO,Dept Comp Sci, Tokyo, Japan.				KAUST visiting student grant; Marie Curie Career Integration Grant [303541]; ERC Starting grant SmartGeometry [StG-2013-335373]; JST; JSPS	We thank Lars Hesselgren, Helmut Pottmann, Anthony Steed, and Michael Wand for their comments and useful suggestions. The work was supported in part by a KAUST visiting student grant, the Marie Curie Career Integration Grant 303541, the ERC Starting grant SmartGeometry (StG-2013-335373), JST, and JSPS.	Alexa M., 2010, ACM T GRAPHIC, V29, P1; Shapira L, 2009, COMPUT GRAPH FORUM, V28, P629, DOI 10.1111/j.1467-8659.2009.01403.x; Chaudhuri S, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1866158.1866205; Yu LF, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964981; Funkhouser T, 2004, ACM T GRAPHIC, V23, P652, DOI 10.1145/1015706.1015775; Bergman R., 2010, WOOD HDB WOOD ENG MA; Bickel B, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778800; Gal R, 2009, ACM T GRAPHIC, V28; Igarashi T., 2001, UIST, P173; Kerr W.B., 2010, ACM T GRAPHIC, V29, P35; Merrell P., 2011, ACM T GRAPHIC, DOI 10.1145/2010324.1964982; Mitra N. J., 2009, ACM T GRAPHIC, V28, p[5, 156]; Ovsjanikov M., 2011, ACM T GRAPHIC, V30; Paczkowski P., 2011, ACM TOG SIGG ASIA, V30; Parker H., 1997, SIMPLIFIED DESIGN WO; POPOVIC J, 2000, ANN C SERIES, P209; Smith J, 2002, ACM T GRAPHIC, V21, P295; Talton J. O., 2009, ACM T GRAPHIC, V28; Twigg C.D., 2008, ACM TOG SIGG, V7, P25; Umetani N., 2012, ACM T GRAPHIC, V31, P1; Umetani N., 2011, ACM T GRAPHICS SIGGR, V30, P90; Whiting E., 2009, ACM T GRAPHIC, V28, P5; Yang Y.-L., 2011, ACM T GRAPHIC, V30, P124	23	0	0	ASSOC COMPUTING MACHINERY	NEW YORK	2 PENN PLAZA, STE 701, NEW YORK, NY 10121-0701 USA	0001-0782	1557-7317		COMMUN ACM	Commun. ACM	SEP	2015	58	9					116	124		10.1145/2801945		9	Computer Science, Hardware & Architecture; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CP9KW	WOS:000360214000026		
J	Yoshimoto, T; Fujita, T; Kajiya, M; Matsuda, S; Ouhara, K; Shiba, H; Kurihara, H				Yoshimoto, Tetsuya; Fujita, Tsuyoshi; Kajiya, Mikihito; Matsuda, Shinji; Ouhara, Kazuhisa; Shiba, Hideki; Kurihara, Hidemi			Involvement of smad2 and Erk/Akt cascade in TGF-beta 1-induced apoptosis in human gingival epithelial cells	CYTOKINE			English	Article						TGF-beta 1; Human gingival epithelial cells; Apoptosis; Smad2; Erk/Akt cascade	BETA-INDUCED APOPTOSIS; GROWTH-FACTOR-BETA; TGF-BETA; PORPHYROMONAS-GINGIVALIS; CREVICULAR FLUID; UP-REGULATION; PATHWAYS; BIM; PROLIFERATION; FIBROBLASTS	Periodontitis is the most prevalent infectious disease caused by periodontopathic bacteria and is also a chronic inflammatory disease. Gingival crevicular fluid (GCF) is an inflammatory exudate that seeps into the gingival crevices or periodontal pockets around teeth with inflamed gingiva, and contains various materials including leukocytes and cytokines. Since gingival epithelial cells, which form a barrier against bacterial challenges, are affected by GCF, cytokines or other materials contained within GCF are engaged in the maintenance and disruption of the epithelial barrier. Accordingly, its compositional pattern has been employed as a reliable objective index of local inflammation. Transforming growth factor in (TGF-beta 1) levels in GCF were previously shown to be markedly higher in patients with periodontitis than in healthy subject. However, it currently remains unclear how TGF-beta 1 affects gingival epithelial cell growth or apoptosis; therefore, elucidating the mechanism responsible may lead to a deeper understanding of pathogenic periodontitis. In the present study, the human gingival epithelial cell line, OBA9 cells were stimulated with recombinant TGF-beta 1. Apoptosis-related protein levels were determined by Western blotting. Caspase-3/7 activity was measured with a Caspase-Glo assay kit. Surviving and apoptotic cells were detected using an MTS assay and TUNEL staining, respectively. TGF-beta RI siRNA and smad2 siRNA were transfected into cells using the lipofectamine RNAiMAX reagent. TGF-beta 1 elevated caspase-3 activity and the number of TUNEL-positive apoptotic cells in OBA9 cells. Furthermore, while the levels of the pro-apoptotic proteins Bax, Bak, Bim, and Bad were increased in OBA9 cells stimulated with TGF-beta 1, the TGF-131 treatment also decreased the levels of anti-apoptotic proteins such as Bcl-2 and Bcl-xL in a time-dependent manner. Additionally, TGF-beta 1 up-regulated the protein levels of cleaved caspase-9. These results indicated that TGF-beta 1-induced apoptosis was involved in a mitochondria-related intrinsic pathway. TGF-beta 1 phosphorylated smad2 in OBA9 cells and this phosphorylation was clearly reduced by SB431542 (a TGF-beta type 1 receptor inhibitor). Consistent with this result, SB431542 or smad2 siRNA-induced reductions in smad2 protein expression levels attenuated TGF-beta 1-induced apoptosis. On the other hand, the ligation of TGF-beta 1 on its receptor also stimulated the phosphorylation of Erk and Akt, which are smad2-independent pathways. However, the inhibition of Erk/Akt signaling pathways by U0126, a MEK-Erk inhibitor and LY294002, a PI3Kinase-Akt inhibitor, augmented TGF-beta 1-induced apoptosis in OBA9 cells. Taken together, the results of present study demonstrated that TGF-beta 1 activated both the smad2 and Erk/Akt cascades via its receptor on gingival epithelial cells, even though these two pathways have opposite roles in cell death and survival, and the culmination of these signaling events induced mitochondria-dependent apoptosis in gingival epithelial cells. Based on the results of the present study, we herein proposed for the first time, that TGF-beta 1 is a novel target cytokine for monitoring the progression of periodontal disease. (C) 2015 Elsevier Ltd. All rights reserved.	[Yoshimoto, Tetsuya; Fujita, Tsuyoshi; Kajiya, Mikihito; Matsuda, Shinji; Ouhara, Kazuhisa; Shiba, Hideki; Kurihara, Hidemi] Hiroshima Univ, Inst Biomed & Hlth Sci, Div Appl Life Sci, Dept Periodontal Med,Minami Ku, Hiroshima 7348553, Japan	Fujita, T (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Div Appl Life Sci, Dept Periodontal Med,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	tfuji@hiroshima-u.ac.jp			Japan Society for the Promotion of Science, Japan [24593123]	We thank Professor Shinya Murakami (Osaka University) for providing OBA9 cells. This study was supported by a Grant-inAid for Scientific Research (C) (No. 24593123) from the Japan Society for the Promotion of Science, Japan.	Abuhussein H, 2013, J PERIODONTOL; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; FINE A, 1987, J BIOL CHEM, V262, P3897; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Khalaf H, 2014, CYTOKINE, V67, P29, DOI 10.1016/j.cyto.2014.02.007; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Kajiya M, 2009, J CELL PHYSIOL, V221, P696, DOI 10.1002/jcp.21909; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Kato S, 2000, J MED MICROBIOL, V49, P739; Kinane JA, 2012, CELL MICROBIOL, V14, P1085, DOI 10.1111/j.1462-5822.2012.01780.x; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Bhattacharya R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089475; Das R, 2014, AM J PHYSIOL-RENAL, V306, pF155, DOI 10.1152/ajprenal.00438.2013; Fujita T, 2012, ARCH ORAL BIOL, V57, P1567, DOI 10.1016/j.archoralbio.2012.08.011; Gabbiani C, 2010, ANTI-CANCER AGENT ME, V10, P324; Gfirkan A, 2006, ARCH ORAL BIOL, V51, P906; Lee JH, 2002, CURR EYE RES, V25, P147, DOI 10.1076/ceyr.25.3.147.13475; Mithani SK, 2004, J SURG RES, V117, P296, DOI 10.1016/S0022-4804(03)00335-4; Skaleric U, 1997, EUR J ORAL SCI, V105, P136, DOI 10.1111/j.1600-0722.1997.tb00192.x; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Wright HJ, 2003, ORAL DIS, V9, P88, DOI 10.1034/j.1601-0825.2003.02895.x; Yang JY, 2009, CANCER RES, V69, P2185, DOI 10.1158/0008-5472.CAN-08-3961; Yoshimoto T, 2014, J DENT RES	29	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	SEP	2015	75	1					165	173		10.1016/j.cyto.2015.03.011		9	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CQ3NZ	WOS:000360510600019		
J	Sakashita, M; Yamada, T; Imoto, Y; Hirota, T; Tamari, M; Ito, Y; Kubo, S; Osawa, Y; Takahashi, N; Fujieda, S				Sakashita, Masafumi; Yamada, Takechiyo; Imoto, Yoshimasa; Hirota, Tomomitsu; Tamari, Mayumi; Ito, Yumi; Kubo, Seita; Osawa, Yoko; Takahashi, Noboru; Fujieda, Shigeharu			Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a	CYTOKINE			English	Article						Sublingual immunotherapy; IL-17A; C3a; Seasonal allergic rhinitis	EXPERIMENTAL ALLERGIC-ASTHMA; T-CELLS; RHINITIS; INTERLEUKIN-17; ANAPHYLATOXINS; ACTIVATION; GUIDELINE; SEVERITY; EXTRACT; PRODUCE	Allergen-specific immunotherapy is the only treatment that can alter the natural course of allergic disease. We performed long-term sublingual immunotherapy (SLIT) for patients with seasonal allergic rhinitis caused by Japanese cedar pollen (SAR-JCP), screened molecules as candidate biomarkers, and investigated serum IL-17A and complement components 3a (C3a) and C5a in order to evaluate whether these molecules show changes correlated to symptom scores. In this study, we found that the long-term SLIT reduced the serum levels of IL-17A and C3a and C5a. The levels of C3a in the patients significantly decreased from year 1 compared with those at the baseline, and their levels of IL-17A significantly decreased from year 2 compared with those at baseline. The levels of IL-17A, C3a, and C5a at year 4 of SLIT were significantly lower than not only those at baseline, but also those at year 1. A significant positive correlation was found between the symptom medication scores and the levels of IL-17A at year 4. The symptom medication scores in the group in which IL-17A levels decreased at year 4 were significantly lower than those in the group without such a decrease. The serum level of IL-17A might prove useful as a biological parameter to ascertain the effectiveness of SLIT for patients with SAR-JCP. It is necessary to produce new therapeutics for non-responders in whom serum IL-17A levels are still higher against long-term SLIT. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakashita, Masafumi; Yamada, Takechiyo; Imoto, Yoshimasa; Hirota, Tomomitsu; Tamari, Mayumi; Ito, Yumi; Kubo, Seita; Osawa, Yoko; Takahashi, Noboru; Fujieda, Shigeharu] Univ Fukui, Dept Otorhinolaryngol, Yoshida, Fukui 9101193, Japan; [Hirota, Tomomitsu; Tamari, Mayumi] RIKEN, Ctr Genom Med, Lab Resp & Allerg Dis, Yokohama, Kanagawa, Japan	Yamada, T (reprint author), Univ Fukui, Dept Otorhinolaryngol, 23-3 Matsuoka Shimoaizuki, Yoshida, Fukui 9101193, Japan.	ymdtkcy@gmail.com	Tamari, Mayumi/N-5378-2015		Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI-25293348, 22591896, 20390441, 20591998, 17591782, 17390458, 15591803]	We thank M. Imamura, H. Tsuchiya, M. Masuyama, Y. Ishikawa, and M. Shirasaki for excellent technical assistance. This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was supported by grants KAKENHI-25293348, 22591896, 20390441, 20591998, 17591782, 17390458, and 15591803 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Fujieda S, 2012, AURIS NASUS LARYNX, V39, P553, DOI 10.1016/j.anl.2011.12.006; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Ciprandi G, 2009, ALLERGY, V64, P1375, DOI 10.1111/j.1398-9995.2009.02010.x; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Ibrahim ARN, 2010, INT ARCH ALLERGY IMM, V152, P207, DOI 10.1159/000283026; Zhang X, 2010, J IMMUNOL, V185, P6741, DOI 10.4049/jimmunol.1000892; Hidvegi T, 1995, IMMUNOL LETT, V48, P65, DOI 10.1016/0165-2478(95)02445-X; Mizutani N, 2012, J IMMUNOL, V188, P5694, DOI 10.4049/jimmunol.1103176; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Marogna M, 2010, J ALLERGY CLIN IMMUN, V126, P969, DOI 10.1016/j.jaci.2010.08.030; Locksley RM, 2008, IMMUNITY, V28, P437, DOI 10.1016/j.immuni.2008.03.009; Liu T, 2011, CLIN EXP IMMUNOL, V163, P59, DOI 10.1111/j.1365-2249.2010.04278.x; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint. 11-RAI-0334, 10.2332/allergolint.11-RAI-0334]; Ciprandi G, 2008, J ALLERGY CLIN IMMUN, V122, P650, DOI 10.1016/j.jaci.2008.06.005; De Blay F, 2007, ANN ALLERG ASTHMA IM, V99, P453; ANDERSSON M, 1994, ALLERGY, V49, P242, DOI 10.1111/j.1398-9995.1994.tb02656.x; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84; Engelke C, 2014, J IMMUNOL, V193, P5387, DOI 10.4049/jimmunol.1400080; Frew AJ, 2008, NEW ENGL J MED, V358, P2259, DOI 10.1056/NEJMct0708337; Grailer JJ, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00387; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Kawai T, 2009, CLIN EXP ALLERGY, V39, P1508, DOI 10.1111/j.1365-2222.2009.03316.x; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Sakashita M, 2009, INT ARCH ALLERGY IMM, V151, P255; Wills-Karp M, 2007, CURR OPIN PHARMACOL, V7, P283; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002	30	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	SEP	2015	75	1					181	185		10.1016/j.cyto.2015.03.019		5	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CQ3NZ	WOS:000360510600021		
J	Sato, C				Sato, Chizuko			Migration and National Identity in South Africa, 1860-2010	DEVELOPING ECONOMIES			English	Book Review									[Sato, Chizuko] JETRO, Inst Developing Econ, Chiba, Japan	Sato, C (reprint author), JETRO, Inst Developing Econ, Chiba, Japan.						Klotz A, 2013, MIGRATION AND NATIONAL IDENTITY IN SOUTH AFRICA, 1860-2010, P1, DOI 10.1017/CBO9781139208741; Peberdy Sally, 2009, SELECTING IMMIGRANTS; Segatti A, 2011, AFR DEV FORUM, P1, DOI 10.1596/978-0-8213-8767-2	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1533	1746-1049		DEV ECON	Dev. Econ.	SEP	2015	53	3					232	235		10.1111/deve.12079		4	Economics; Planning & Development	Business & Economics; Public Administration	CP7OL	WOS:000360077400004		
J	Cerasi, E; Seino, S				Cerasi, E.; Seino, S.			Donald F. Steiner: great scientist, close friend, real "Mensch' in memoriam	DIABETES OBESITY & METABOLISM			English	Biographical-Item									[Cerasi, E.] Hebrew Univ Jerusalem, Dept Med, Hadassah Med Ctr, Endocrinol & Metab Serv, IL-91120 Jerusalem, Israel; [Seino, S.] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Mol & Metab Med, Kobe, Hyogo 6500017, Japan	Cerasi, E (reprint author), Hebrew Univ Jerusalem, Dept Med, Hadassah Med Ctr, Endocrinol & Metab Serv, POB 12000, IL-91120 Jerusalem, Israel.	erol.cerasi@mail.huji.ac.il; seino@med.kobe-u.ac.jp					Steiner DF, 2011, J BIOL CHEM, V286, P17399, DOI 10.1074/jbc.X111.244764; Philipson LH, 2015, P NATL ACAD SCI USA, V112, P940, DOI 10.1073/pnas.1423774112	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	SEP	2015	17			1			1	2		10.1111/dom.12530		2	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7GF	WOS:000360770300001		
J	Thorens, B; Accili, D; Ahren, B; Cerasi, E; Seino, S; Boitard, C				Thorens, B.; Accili, D.; Ahren, B.; Cerasi, E.; Seino, S.; Boitard, C.			The Islet and Metabolism Keep Time	DIABETES OBESITY & METABOLISM			English	Editorial Material									[Thorens, B.] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Accili, D.] Columbia Univ, Coll Phys & Surg, Dept Med, Naomi Berrie Diabet Ctr, New York, NY USA; [Ahren, B.] Lund Univ, Div Med, Dept Clin Sci, Lund, Sweden; [Cerasi, E.] Hebrew Univ Jerusalem, Med Ctr, Dept Med, Endocrinol & Metab Serv, Jerusalem, Israel; [Seino, S.] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Mol & Metab Med, Kobe, Hyogo 657, Japan; [Boitard, C.] Univ Paris 05, Cochin Hosp, INSERM, U1016, Paris, France	Thorens, B (reprint author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	Bernard.Thorens@unil.ch; Christian.Boitard@htd.aphp.fr					Accili D, 2014, DIABETES OBES METAB, V16, P1, DOI 10.1111/dom.12353; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	SEP	2015	17			1			3	5		10.1111/dom.12547		3	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7GF	WOS:000360770300002		
J	Ode, KL; Ueda, HR				Ode, K. L.; Ueda, H. R.			Seeing the forest and trees: whole-body and whole-brain imaging for circadian biology	DIABETES OBESITY & METABOLISM			English	Review						light-sheet microscope; single-cell resolution; tissue clearing	SINGLE-CELL RESOLUTION; SUPRACHIASMATIC NUCLEUS; DROSOPHILA-MELANOGASTER; ACTIVITY RHYTHM; NEUROMEDIN-S; MOUSE-BRAIN; CLOCK; TISSUE; RATS; EXPRESSION	Recent advances in methods for making mammalian organs translucent have made possible whole-body fluorescent imaging with single-cell resolution. Because organ-clearing methods can be used to image the heterogeneous nature of cell populations, they are powerful tools to investigate the hierarchical organization of the cellular circadian clock, and how the clock synchronizes a variety of physiological activities. In particular, methods compatible with genetically encoded fluorescent reporters have the potential to detect circadian activity in different brain regions and the circadian-phase distribution across the whole body. In this review, we summarize the current methods and strategy for making organs translucent (removal of lipids, decolourization of haemoglobin and adjusting the refractive index of the specimen). We then discuss possible applications to circadian biology. For example, the coupling of circadian rhythms among different brain regions, brain activity in sleep-wake cycles and the role of migrating cells such as immune cells and cancer cells in chronopharmacology.	[Ode, K. L.; Ueda, H. R.] Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Tokyo 1130033, Japan; [Ode, K. L.; Ueda, H. R.] RIKEN, Quantitat Biol Ctr, Osaka, Japan	Ueda, HR (reprint author), Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	uedah-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT/Japan Society for the Promotion of Science (JSPS) [25221004, 23115006, 26-1180]; Strategic Programs for R&D (President's discretionary fund) of RIKEN; RIKEN Center for Developmental Biology; RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); Japan Foundation for Applied Enzymology; Shimabara Science Promotion Foundation; RIKEN Foreign Postdoctoral Researcher Program	We thank all members in the department of systems pharmacology at UTokyo and cell design core in the Quantitative Biology Center, RIKEN for their continual discussion, especially Dr Arthur Millius for critical reading and proof of this manuscript, and Drs Kazuki Tainaka and Etsuo A. Susaki, and Mr. Shimpei I. Kubota for helping us to make figures. Some of the results presented in this manuscript were obtained with the support of the following grants: Program for Innovative Cell Biology by Innovative Technology and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, a Grant-in-Aid for Scientific Research (S) (grant no. 25221004), a Grant-in-Aid for Scientific Research on Innovative Areas (grant no. 23115006), and a Grant-in-Aid for JSPS Fellows (grant no. 26-1180) from MEXT/Japan Society for the Promotion of Science (JSPS), the Strategic Programs for R&D (President's discretionary fund) of RIKEN, an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology and RIKEN Quantitative Biology Center, a grant from Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), a Grant-in-Aid from Japan Foundation for Applied Enzymology, a Grant-in-Aid from the Shimabara Science Promotion Foundation, and by the RIKEN Foreign Postdoctoral Researcher Program.	An S, 2013, P NATL ACAD SCI USA, V110, pE4355, DOI 10.1073/pnas.1307088110; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Kobayashi Y, 2015, NEURON, V86, P264, DOI 10.1016/j.neuron.2015.02.036; Mori K, 2005, EMBO J, V24, P325, DOI 10.1038/sj.emboj.7600526; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Nadjar A, 2013, GLIA, V61, P724, DOI 10.1002/glia.22465; Yamaguchi Y, 2013, SCIENCE, V342, P85, DOI 10.1126/science.1238599; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Levi F, 2010, ANNU REV PHARMACOL, V50, P377, DOI 10.1146/annurev.pharmtox.48.113006.094626; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Morin LP, 2013, EXP NEUROL, V243, P4, DOI 10.1016/j.expneurol.2012.06.026; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; HONMA KI, 1986, PHYSIOL BEHAV, V38, P687, DOI 10.1016/0031-9384(86)90265-9; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Aoyagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116280; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; HONMA K, 1987, PHYSIOL BEHAV, V40, P767, DOI 10.1016/0031-9384(87)90281-2; Hughes ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002835; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Kawashima T, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00037; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Keller PJ, 2015, NEURON, V85, P462, DOI 10.1016/j.neuron.2014.12.039; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee IT, 2015, NEURON, V85, P1086, DOI 10.1016/j.neuron.2015.02.006; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Natsubori A, 2014, EUR J NEUROSCI, V39, P229, DOI 10.1111/ejn.12400; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; REDDY P, 1984, CELL, V38, P701, DOI 10.1016/0092-8674(84)90265-4; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tsuchiya Y, 2003, GENES CELLS, V8, P713, DOI 10.1046/j.1365-2443.2003.00669.x; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P11227, DOI 10.1073/pnas.0401882101; Vollmers C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003457; Zhang Z, 2015, NAT NEUROSCI, V18, P553, DOI 10.1038/nn.3957	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	SEP	2015	17			1			47	54		10.1111/dom.12511		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7GF	WOS:000360770300009		
J	Neoh, KB; Bong, LJ; Muhammad, A; Itoh, M; Kozan, O; Takematsu, Y; Yoshimura, T				Neoh, Kok-Boon; Bong, Lee-Jin; Muhammad, Ahmad; Itoh, Masayuki; Kozan, Osamu; Takematsu, Yoko; Yoshimura, Tsuyoshi			Understanding the impact of fire on termites in degraded tropical peatlands and the mechanisms for their ecological success: current knowledge and research needs	ECOLOGICAL RESEARCH			English	Article						Forest fire; Peatland rehabilitation; Biodiversity; Savanna; Termite survival strategy	SOUTH-AFRICAN SAVANNA; FORMOSAN SUBTERRANEAN TERMITE; COPTOTERMES-GESTROI ISOPTERA; LACTEUS FROGGATT ISOPTERA; ANNUAL PRESCRIBED FIRE; ANT COMMUNITIES; RETICULITERMES-FLAVIPES; FUNCTIONAL DIVERSITY; SPECIES RICHNESS; DOMINANT ANTS	Peatlands have experienced large scale changes due to extensive deforestation for logging, conversion to agro-industrial plantations, and frequent peat fires. The adverse effects of peat fires can lead to long-term impacts on invertebrate biodiversity in the peatland ecosystem. Although the impact of fire on termite diversity in tropical grasslands and savannas has been the focus of increased attention in recent years, little is known about the effects of peat fires on termite assemblages. In this review, we present available information about the impact of human use of peatlands on termite assemblages in the Indo-Malayan region. By synthesizing the currently available studies conducted in temperate and tropical savanna systems, we highlight the need for studies of the relationship between termites and fire-impacted tropical peatlands. We consider the ecological and biological scenarios in fire-impacted peatland that are likely to shape termite assemblages, and we discuss traits of the surviving genera (i.e., Coptotermes, Schedorhinotermes, and Parrhinotermes) that may contribute to their success in the harsh post-fire peatland environment (e.g., colony fusion, colony breeding structure, subsidiary nests, and colony migration). Knowledge of these strategies is crucial for understanding the evolutionary adaptation process of termites. This review also aims to stimulate further research in using termite ecosystem services to restore the fertility of degraded fire-impacted peatlands.	[Neoh, Kok-Boon; Bong, Lee-Jin; Yoshimura, Tsuyoshi] Kyoto Univ, Lab Innovat Humanohabitabil, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan; [Muhammad, Ahmad] Riau Univ, Dept Biol, Fac Math & Nat Sci, Pekanbaru 28293, Indonesia; [Itoh, Masayuki; Kozan, Osamu] Kyoto Univ, Ctr Southeast Asian Studies, Sakyo Ku, Kyoto 6068501, Japan; [Takematsu, Yoko] Yamaguchi Univ, Fac Agr, Yamaguchi 7538515, Japan	Neoh, KB (reprint author), Kyoto Univ, Lab Innovat Humanohabitabil, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan.	neohkokboon@yahoo.com	Neoh, Kok-Boon/A-4070-2011	Neoh, Kok-Boon/0000-0002-8462-6662	Large-Scale Research Program 'Promoting the Study of Sustainable Humanosphere in Southeast Asia' - Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	We thank Michael Lenz and Janette Lenz and two anonymous reviewers whose comments greatly improved the manuscript. K.-B.N. is an international research fellow of the Japan Society for the Promotion of Science, and L.-J.B. is a mission researcher for the Research Institute for Sustainable Humanosphere, Kyoto University. This study was supported in part by the Large-Scale Research Program 'Promoting the Study of Sustainable Humanosphere in Southeast Asia' funded by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT), 2011-2016.	Abensperg-Traun Max, 1996, Pacific Conservation Biology, V2, P279; Ainuddin Nuruddin A, 2006, J APPL SCI, V6, P2517; Jones DT, 2003, J APPL ECOL, V40, P380, DOI 10.1046/j.1365-2664.2003.00794.x; Joseph GS, 2011, LANDSCAPE ECOL, V26, P439, DOI 10.1007/s10980-011-9572-8; Gathorne-Hardy FJ, 2006, J TROP ECOL, V22, P605, DOI 10.1017/S0266467406003373; Sherwood JH, 2013, HYDROL PROCESS, V27, P1866, DOI 10.1002/hyp.9820; Malmstrom A, 2008, PEDOBIOLOGIA, V51, P419, DOI 10.1016/j.pedobi.2008.01.001; DeSouza O, 2003, SOCIOBIOLOGY, V42, P639; Davies AB, 2013, ECOSYSTEMS, V16, P866, DOI 10.1007/s10021-013-9657-0; Gathorne-Hardy F, 2001, J TROP ECOL, V17, P379, DOI 10.1017/S0266467401001262; Davies RG, 1997, J TROP ECOL, V13, P153; Joseph GS, 2013, LANDSCAPE ECOL, V28, P1505, DOI 10.1007/s10980-013-9897-6; ABENSPERGTRAUN M, 1995, AUST J ECOL, V20, P413, DOI 10.1111/j.1442-9993.1995.tb00557.x; Bruhl CA, 2010, BIODIVERS CONSERV, V19, P519, DOI 10.1007/s10531-009-9596-4; Jones DT, 2000, J APPL ECOL, V37, P191, DOI 10.1046/j.1365-2664.2000.00464.x; Hanula JL, 2012, FORESTS, V3, P317, DOI 10.3390/f3020317; Davies AB, 2010, AUSTRAL ECOL, V35, P482, DOI 10.1111/j.1442-9993.2010.02124.x; Joseph GS, 2014, ECOSYSTEMS, V17, P808, DOI 10.1007/s10021-014-9761-9; Vaessen T, 2011, J TROP FOR SCI, V23, P196; Yule CM, 2010, BIODIVERS CONSERV, V19, P393, DOI 10.1007/s10531-008-9510-5; Moranz RA, 2013, J INSECT CONSERV, V17, P699, DOI 10.1007/s10841-013-9554-z; LENZ M, 1988, SOCIOBIOLOGY, V14, P245; Langner A, 2009, GLOBAL CHANGE BIOL, V15, P48, DOI 10.1111/j.1365-2486.2008.01828.x; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; Philpott SM, 2004, OECOLOGIA, V140, P140, DOI 10.1007/s00442-004-1561-z; Arnan X, 2013, ECOGRAPHY, V36, P1182, DOI 10.1111/j.1600-0587.2013.00155.x; LENZ M, 1993, INSECT SOC, V40, P439, DOI 10.1007/BF01253906; Lo N, 2004, INSECT SOC, V51, P365, DOI 10.1007/s00040-004-0759-8; Davies RG, 1999, J APPL ECOL, V36, P946, DOI 10.1046/j.1365-2664.1999.00450.x; Vasconcelos HL, 2008, AUSTRAL ECOL, V33, P221, DOI 10.1111/j.1442-9993.2007.01811.x; Underwood EC, 2010, J INSECT CONSERV, V14, P359, DOI 10.1007/s10841-010-9265-7; Rein G, 2008, CATENA, V74, P304, DOI 10.1016/j.catena.2008.05.008; Davies AB, 2012, J APPL ECOL, V49, P422, DOI 10.1111/j.1365-2664.2012.02107.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Takematsu Y, 2012, J NAT HIST, V46, P1079, DOI 10.1080/00222933.2011.651653; Beaumont KP, 2012, FOREST ECOL MANAG, V271, P147, DOI 10.1016/j.foreco.2012.02.007; BENZIE JAH, 1986, OECOLOGIA, V70, P559, DOI 10.1007/BF00379904; Bong MCF, 2012, J ENTOMOL, V9, P68; Bos MM, 2008, BIOL INVASIONS, V10, P1399, DOI 10.1007/s10530-008-9215-4; Bourguignon T, 2011, ZOOKEYS, P55, DOI 10.3897/zookeys.148.1826; Costa-Leonardo AM, 2004, SOCIOBIOLOGY, V44, P123; Deheer CJ, 2004, MOL ECOL, V13, P431, DOI 10.1046/j.1365-294X.2003.02065.x; Dosso K, 2010, J TROP ECOL, V26, P323, DOI 10.1017/S0266467410000015; Drescher J, 2011, BIOTROPICA, V43, P93, DOI 10.1111/j.1744-7429.2010.00662.x; Eggleton Paul, 1998, Ecotropica, V3, P119; Eggleton P, 1999, PHILOS T R SOC B, V354, P1791, DOI 10.1098/rstb.1999.0521; Evans TA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1257; FERRAR P, 1982, OECOLOGIA, V52, P139, DOI 10.1007/BF00349023; Guaraldo AC, 2009, SOCIOBIOLOGY, V53, P767; Husseneder C, 1998, MOL ECOL, V7, P983, DOI 10.1046/j.1365-294x.1998.00416.x; Jones DT, 2000, J TROP ECOL, V16, P271, DOI 10.1017/S0266467400001401; Jones DT, 1998, RAFFLES B ZOOL, V46, P79; Jones DT, 2002, RAFFLES B ZOOL, V50, P117; Kaneko N, 1990, T 14 INT C SOIL SCI, V7, P312; Kinnaird MF, 1998, CONSERV BIOL, V12, P954, DOI 10.1046/j.1523-1739.1998.012005954.x; Kon Thian-Woei, 2012, Pakistan Journal of Biological Sciences, V15, P108, DOI 10.3923/pjbs.2012.108.120; Korb J, 2004, BEHAV ECOL, V15, P390, DOI 10.1093/beheco/arh033; Lenz Michael, 1994, P159; Lim KH, 2001, P 2001 PIPOC INT PAL, P355; MARIAU D, 1992, OLEAGINEUX, V47, P561; MATSUMOTO T, 1979, OECOLOGIA, V38, P261, DOI 10.1007/BF00345187; Mertl Amy L., 2012, Psyche (Cambridge), V2012, P1; Messenger MT, 2005, FLA ENTOMOL, V88, P99, DOI 10.1653/0015-4040(2005)088[0099:NFDRFC]2.0.CO;2; Miettinen J, 2010, LAND DEGRAD DEV, V21, P285, DOI 10.1002/ldr.976; Miller LR, 1994, AUST J ENTOMOL, V33, P317, DOI 10.1111/j.1440-6055.1994.tb01236.x; Minarti Y, 2012, RIAU BIOSPECIES, V5, P21; Neoh KB, 2012, INSECT SOC, V59, P223, DOI 10.1007/s00040-011-0207-5; Parr CL, 2002, AFR ENTOMOL, V10, P101; Parr CL, 2008, J ANIM ECOL, V77, P1191, DOI 10.1111/j.1365-2656.2008.01450.x; Perdereau E, 2010, INSECT SOC, V57, P393, DOI 10.1007/s00040-010-0096-z; Relys V, 2002, J ARACHNOL, V30, P416, DOI 10.1636/0161-8202(2002)030[0416:ADASTI]2.0.CO;2; ROISIN Y, 1988, SOCIOBIOLOGY, V14, P21; Seymour CL, 2014, SOIL BIOL BIOCHEM, V68, P105; Silveira JM, 2013, BIODIVERS CONSERV, V22, P513, DOI 10.1007/s10531-012-0426-8; Teixeira MC, 2005, SOCIOBIOLOGY, V45, P631; Traore S, 2008, INSECT SOC, V55, P183, DOI 10.1007/s00040-008-0998-1; Traore S, 2008, FOREST ECOL MANAG, V255, P2337, DOI 10.1016/j.foreco.2007.12.045; TRAPNELL CG, 1976, J ECOL, V64, P577, DOI 10.2307/2258774; TSAI PH, 1982, ACTA ENTOMOL SINICA, V25, P306; Usup A, 2004, TROPICS, V14, P1, DOI DOI 10.3759/TROPICS.14.1; Vargo EL, 2003, MOL ECOL, V12, P2599, DOI 10.1046/j.1365-294X.2003.01938.x; Vargo EL, 2006, ENVIRON ENTOMOL, V35, P151; Yulianti N., 2012, GLOBAL ENV RES, V16, P105; Yuliati I, 2010, WORKSH JSPS INT TRAI	84	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	SEP	2015	30	5					759	769		10.1007/s11284-015-1289-8		11	Ecology	Environmental Sciences & Ecology	CQ0TE	WOS:000360309300001		
J	Johns, RC; Tobita, H; Hara, H; Ozaki, K				Johns, Rob C.; Tobita, Hiroyuki; Hara, Hideho; Ozaki, Kenichi			Adaptive advantages of dietary mixing different-aged foliage within conifers for a generalist defoliator	ECOLOGICAL RESEARCH			English	Article						Polyphagy; Complementary diet; Ontogeny; Phenology; Lymantria dispar	MOTH LYMANTRIA-DISPAR; YOUNG BALSAM FIR; GYPSY-MOTH; INSECT HERBIVORES; HOST-PLANT; FEEDING-BEHAVIOR; TOXIN DILUTION; SECONDARY HOST; GROWTH; CATERPILLAR	Few herbivores are well adapted to feeding on all foliage age classes available and most have evolved traits that are attuned to the characteristics of either developing or mature foliage; however, recent evidence has shown a number of insect herbivores that may mix different-aged foliage as a means of enhancing fitness. We carried out a series of laboratory and field experiments to investigate whether larvae of Asian gypsy moth [L. umbrosa (Butler) = L. dispar hokkaidoensis Goldschmidt] (Lepidoptera: Lymantriidae) engage in and benefit from foliage-age dietary mixing in common conifer species that naturally occur in its native range of Hokkaido, Japan. In a laboratory experiment, early instar larvae were observed on both developing and mature foliage when both age classes were available; however, larval survival and weight were highest on hosts with developing foliage available (larch, fir, and pine), whereas all larvae died on spruce where only mature foliage was available. In contrast, laboratory and field experiments indicated that late-instar larvae often consumed both developing and mature foliage on all conifer species studied, although there was general preference bias towards mature foliage. Field bioassays indicated that late-instar larvae provided both foliage age classes (a 'mixed' diet) had similar performance to those provided only developing or mature foliage. Results of this study indicate that larvae obtain limited performance benefits from mixing different foliage age-classes into their diet, other than perhaps the benefits accrued from having a broader resource pool available on a single host tree.	[Johns, Rob C.; Tobita, Hiroyuki; Ozaki, Kenichi] Hokkaido Res Ctr, Forestry & Forest Prod Res Inst, Sapporo, Hokkaido 0628516, Japan; [Hara, Hideho] Hokkaido Forestry Res Inst, Bibai, Hokkaido 0790198, Japan	Johns, RC (reprint author), Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, 1350 Regent St,POB 4000, Fredericton, NB E3B 5P7, Canada.	rjohns@nrcan.gc.ca			Japanese Society for the Promotion of Science; JSPS Postdoctoral Fellowship for Foreign Researchers [25252030, 19.07779]	We thank A. Komatsu for processing foliage for chemical analyses. We are also grateful to T. Yamaguchi for allowing us to use his Japanese larch stand for manipulative experiments, and to D. Carleton, E. Moise, D. Quiring, C. Simpson, J. Sweeney, Z. Sylvain, and several anonymous reviewers for comments on earlier versions of the manuscript. Financial support was provided through the Japanese Society for the Promotion of Science and from a JSPS Postdoctoral Fellowship for Foreign Researchers (25252030 and 19.07779).	Hagele BF, 1999, OECOLOGIA, V119, P521, DOI 10.1007/s004420050815; LINDROTH RL, 1990, J CHEM ECOL, V16, P2533, DOI 10.1007/BF01017476; STAMP NE, 1990, ECOLOGY, V71, P1031, DOI 10.2307/1937371; Lazarevic J, 2002, ENTOMOL EXP APPL, V102, P75, DOI 10.1046/j.1570-7458.2002.00926.x; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; BARBOSA P, 1987, AM NAT, V130, P53, DOI 10.1086/284697; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; BATESMITH EC, 1977, PHYTOCHEMISTRY, V16, P1421, DOI 10.1016/S0031-9422(00)88795-6; CATES RG, 1980, OECOLOGIA, V46, P22, DOI 10.1007/BF00346961; ALBERT PJ, 1994, ENVIRON ENTOMOL, V23, P645; Singer MS, 2002, ANIM BEHAV, V64, P629, DOI 10.1006/anbe.2002.3082; Gerson EA, 1998, J CHEM ECOL, V24, P815, DOI 10.1023/A:1022369416745; Moreau G, 2003, OECOLOGIA, V135, P391, DOI 10.1007/s00442-003-1213-8; Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; Baranchikov Y. N., 1989, P LYM COMP FEAT NEW, P319; Baranchikov YN, 1994, NE188 USDA FOR SERV, P4; BARBOSA P, 1986, ECOL ENTOMOL, V11, P1, DOI 10.1111/j.1365-2311.1986.tb00273.x; Carroll AL, 1999, CAN ENTOMOL, V131, P659; Geri Claude, 1993, P173; Hajek Ann E., 2009, V6, P71; Hochuli DF, 2001, AUSTRAL ECOL, V26, P563, DOI 10.1046/j.1442-9993.2001.01135.x; HUNTER AF, 1992, OECOLOGIA, V89, P316; Johns R, 2009, ECOL ENTOMOL, V34, P624, DOI 10.1111/j.1365-2311.2009.01110.x; Johns R, 2010, ANIM BEHAV, V80, P659, DOI 10.1016/j.anbehav.2010.06.027; Johns R, 2012, ANIM BEHAV, V84, P1393, DOI 10.1016/j.anbehav.2012.09.003; Johns Rob C., 2006, Journal of the Acadian Entomological Society, V2, P1; JOSEPH G, 1994, ENVIRON ENTOMOL, V23, P396; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; Karban R., 1997, INDUCED RESPONSES HE; Kishida Y, 2011, STANDARD MOTHS JAPAN, V2, P139; KULMAN HM, 1971, ANNU REV ENTOMOL, V16, P289, DOI 10.1146/annurev.en.16.010171.001445; Leonard DE, 1981, USDA TECHNICAL B, P9; Liebhold A., 1995, NE211 USDA FOR SERV; Matsuki M, 2001, AGR FOREST ENTOMOL, V3, P305, DOI 10.1046/j.1461-9555.2001.00119.x; OHIGASHI H, 1981, J CHEM ECOL, V7, P599, DOI 10.1007/BF00987708; Onodera K, 2010, KOSHUNAIKIHOU, V158, P6; Parsons K, 2003, FOREST ECOL MANAG, V184, P33, DOI 10.1016/S0378-1127(03)00145-2; Piene H., 1991, Northern Journal of Applied Forestry, V8, P168; PIENE H, 1980, FOREST SCI, V26, P665; Pinault L, 2009, CAN ENTOMOL, V141, P136, DOI 10.4039/n08-052; Pogue MG, 2007, REV SELECTED SPECIES; RAUPP MJ, 1988, ENVIRON ENTOMOL, V17, P316; ROSSITER M, 1987, ECOLOGY, V68, P857, DOI 10.2307/1938357; SAS Institute Inc, 1999, SAS SYST VERS 8 WIND; SHEPPARD CA, 1990, ENTOMOL EXP APPL, V55, P247; Shields VDC, 2006, NATURWISSENSCHAFTEN, V93, P127, DOI 10.1007/s00114-005-0070-1; STOYENOFF JL, 1994, OECOLOGIA, V97, P143, DOI 10.1007/BF00323144	47	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	SEP	2015	30	5					793	802		10.1007/s11284-015-1280-4		10	Ecology	Environmental Sciences & Ecology	CQ0TE	WOS:000360309300003		
J	Suchewaboripont, V; Ando, M; Iimura, Y; Yoshitake, S; Ohtsuka, T				Suchewaboripont, Vilanee; Ando, Masaki; Iimura, Yasuo; Yoshitake, Shinpei; Ohtsuka, Toshiyuki			The effect of canopy structure on soil respiration in an old-growth beech-oak forest in central Japan	ECOLOGICAL RESEARCH			English	Article						Soil respiration; Spatial variation; Gap/canopy structure; Fine root; Old-growth forest	AGE-RELATED DECLINE; CO2 EFFLUX; DECIDUOUS FOREST; SPATIAL VARIABILITY; STAND-STRUCTURE; CARBON STORAGE; TEMPERATURE; GAPS; PARAMETERS; DEPENDENCE	Soil respiration (R (s) ) is a key component in the estimation of the net ecosystem production (NEP) of old-growth forests, which are generally thought to have ceased carbon accumulation. The objectives of the present study were to characterize the spatial and temporal patterns of R (s) , and to identify the determinants of the spatial and temporal variability of R (s,) using general linear mixed models (GLMM), in an old-growth beech-oak forest. GLMM analyses identified monthly effect as a significant explanatory variable for temporal variation, as well as gap/canopy and soil water content (SWC) as explanatory variables for spatial variation, in R (s) . The complexity of vertical structure in the forest was reflected in the spatial pattern of R (s) , which was higher in canopy areas than in gap areas during the growing season, except in November. This spatial pattern was not affected by soil temperature. Moreover, SWC did not differ between gap and canopy areas, although SWC partially explained the spatial heterogeneity in R (s) . The carbon:nitrogen ratios of soil organic matter in canopy areas were significantly higher than those in gap areas. Fine root biomass was 1.7-fold greater in canopy areas than in gap areas, likely because of the higher R (s) in canopy areas, and root respiration made a much large contribution to R (s) than heterotrophic respiration. The different patterns of fine root biomass between gap and canopy areas mainly control the spatial heterogeneity in R (s) ; thus, it is worth considering the gap/canopy variability in R (s) when evaluating annual efflux in old-growth forests.	[Suchewaboripont, Vilanee; Ohtsuka, Toshiyuki] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Suchewaboripont, Vilanee; Yoshitake, Shinpei; Ohtsuka, Toshiyuki] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan; [Ando, Masaki] Gifu Univ, Fac Appl Biol Sci, Lab Forest Ecol, Gifu 5011193, Japan; [Iimura, Yasuo] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga 5228533, Japan	Suchewaboripont, V (reprint author), Gifu Univ, River Basin Res Ctr, 1-1 Yanagido, Gifu 5011193, Japan.	vilanee.s@hotmail.com					Adachi M, 2006, APPL SOIL ECOL, V34, P258, DOI 10.1016/j.apsoil.2006.01.006; Ngao J, 2012, AGR FOREST METEOROL, V154, P136, DOI 10.1016/j.agrformet.2011.11.003; Hardiman BS, 2011, ECOLOGY, V92, P1818, DOI 10.1890/10-2192.1; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Irvine J, 2002, GLOBAL CHANGE BIOL, V8, P1183, DOI 10.1046/j.1365-2486.2002.00544.x; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00987.x; Gough CM, 2008, BIOSCIENCE, V58, P609, DOI 10.1641/B580708; Bauhus J, 1996, CAN J FOREST RES, V26, P2153, DOI 10.1139/x26-244; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Binkley D, 2002, ECOSYSTEMS, V5, P58, DOI 10.1007/s10021-001-0055-7; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; RUNKLE JR, 1981, ECOLOGY, V62, P1041, DOI 10.2307/1937003; Sulzman EW, 2005, BIOGEOCHEMISTRY, V73, P231, DOI 10.1007/s10533-004-7314-6; Fekete I, 2014, SOIL BIOL BIOCHEM, V74, P106, DOI 10.1016/j.soilbio.2014.03.006; Epron D, 1999, ANN FOR SCI, V56, P221, DOI 10.1051/forest:19990304; Saiz G, 2006, PLANT SOIL, V287, P161, DOI 10.1007/s11104-006-9052-0; Soe ARB, 2005, TREE PHYSIOL, V25, P1427; Hardiman BS, 2013, FOREST ECOL MANAG, V298, P111, DOI 10.1016/j.foreco.2013.02.031; Keith H, 2006, SOIL BIOL BIOCHEM, V38, P1121, DOI 10.1016/j.soilbio.2005.09.012; Scott-Denton LE, 2003, SOIL BIOL BIOCHEM, V35, P525, DOI 10.1016/S0038-0717(03)00007-5; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Vincent G, 2006, SOIL BIOL BIOCHEM, V38, P2527, DOI 10.1016/j.soilbio.2006.03.009; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Bates D., 2014, LME4 LINEAR MIXED EF; BRUMME R, 1995, PLANT SOIL, V168, P593, DOI 10.1007/BF00029373; Burnham K. P., 2002, MODEL SELECTION MULT; Davidson Eric A., 2009, P187, DOI 10.1007/978-1-4419-0026-5_8; Development Core Team R, 2014, R LANG ENV STAT COMP; Hashimoto T, 2009, J FOREST RES-JPN, V14, P44, DOI 10.1007/s10310-008-0096-2; Hirota Mitsuru, 2011, Bulletin of the Institute of Nature Education in Shiga Heights Shinshu University, P9; Hojjati Seyed Mohammd, 2010, Journal of Forestry Research (Harbin), V21, P461, DOI 10.1007/s11676-010-0098-8; Iimura Y, 2013, J GEOGR, V122, P723; Jia Shugang, 2003, Japanese Journal of Ecology (Otsu), V53, P13; Joo SJ, 2012, SCI TOTAL ENVIRON, V416, P400, DOI 10.1016/j.scitotenv.2011.11.025; Jordan A, 2009, BIOGEOSCI DISCUSS, V6, P9977; Kato Shogo, 1999, Japanese Journal of Ecology (Tokyo), V49, P1; Knohl A, 2008, PLANT SOIL, V302, P189, DOI 10.1007/s11104-007-9467-2; NAKASHIZUKA T, 1982, Japanese Journal of Ecology, V32, P57; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Ohtsuka T, 2010, J PLANT RES, V123, P393, DOI 10.1007/s10265-009-0274-0; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Schatz JD, 2012, ECOSYSTEMS, V15, P616, DOI 10.1007/s10021-012-9535-1; Suchewaboripont V, 2015, JPN J FOR ENV, V57; Wirth C, 2009, ECOL STUD-ANAL SYNTH, V207, P11, DOI 10.1007/978-3-540-92706-8_2	45	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	SEP	2015	30	5					867	877		10.1007/s11284-015-1286-y		11	Ecology	Environmental Sciences & Ecology	CQ0TE	WOS:000360309300010		
J	Van Do, T; Sato, T; Saito, S; Kozan, O				Tran Van Do; Sato, Tamotsu; Saito, Satoshi; Kozan, Osamu			Fine-root production and litterfall: main contributions to net primary production in an old-growth evergreen broad-leaved forest in southwestern Japan	ECOLOGICAL RESEARCH			English	Article						Continuous inflow method; Decision matrix; Fine-root decomposition; Litter dynamics; Old-growth forest	GROUND CARBON ALLOCATION; MOUNT-KINABALU; ECOSYSTEMS; BIOMASS; DYNAMICS; TURNOVER; NITROGEN; BORNEO; LENGTH; TREES	Net primary production (NPP) is an important index for evaluating the patterns, processes, and dynamics of carbon cycling in forest ecosystems. In this study, we estimated the NPP in a warm-temperate old-growth evergreen broad-leaved forest in southwestern Japan. The estimation was based on four compartments: aboveground stand increment (Delta M), aboveground litterfall (Lf), fine-root production (Fr), and coarse root increment (Delta Cr). The data for Delta M and Delta Cr were collected from a permanent 200 x 200 m(2) plot over a 4-year interval, while Lf and Fr were collected over a 1-year interval. The NPP was 4.65 g m(-2) day(-1), of which Delta M accounted for 25.2 %, Lf accounted for 38.7 %, Fr accounted for 33.4 %, and the remaining 2.7 % was attributed to Delta Cr. There was a significant regression between aboveground litterfall and fine-root production (R (2) = 0.65, P < 0.05). Fine-root decomposition (0.66 g m(-2) day(-1)) accounted for 14.2 % of the NPP, leading to a higher belowground NPP in the present study compared with that in other forests. We conclude that an estimation of the decomposition of dead fine-roots by the continuous inflow method must be included to improve the accuracy of NPP estimations for forest ecosystems.	[Tran Van Do; Sato, Tamotsu] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 305, Japan; [Tran Van Do; Kozan, Osamu] Kyoto Univ, Ctr Southeast Asian Studies, Sakyo Ku, Kyoto 6068501, Japan; [Tran Van Do] Vietnamese Acad Forest Sci, Silviculture Res Inst, Hanoi, Vietnam; [Saito, Satoshi] Forestry & Forest Prod Res Inst, Dept Plant Ecol, Tsukuba, Ibaraki 305, Japan	Van Do, T (reprint author), Kyoto Univ, Ctr Southeast Asian Studies, Sakyo Ku, 46 Shi Moadachi Cho, Kyoto 6068501, Japan.	dotranvan@hotmail.com			Global Environmental Research Account for National Institute, Ministry of the Environment Japan (MOEJ); Ministry of Agriculture, Forestry and Fisheries of Japan; MOEJ; Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106-NN.06-2013.01]	This research is co-funded by Long-term monitoring of forest carbon dynamics in East Asia [EA-FDPN Phase II]'' from the Global Environmental Research Account for National Institute, Ministry of the Environment Japan (MOEJ), "Evaluation, Adaptation and Mitigation of Global Warming in Agriculture, Forestry and Fisheries: Research and Development'', Ministry of Agriculture, Forestry and Fisheries of Japan, "Monitoring-site 1000 Project'' MOEJ, and Vietnam National Foundation for Science and Technology Development (NAFOSTED) under Grant number 106-NN.06-2013.01.	KIRA T, 1991, ECOL RES, V6, P185, DOI 10.1007/BF02347161; Vogt KA, 1996, PLANT SOIL, V187, P159; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Luo TX, 2002, ECOL APPL, V12, P980, DOI 10.2307/3061031; NADELHOFFER KJ, 1992, ECOLOGY, V73, P1139, DOI 10.2307/1940664; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Noguchi K, 2007, J FOREST RES-JPN, V12, P83, DOI 10.1007/s10310-006-0262-3; Majdi H, 2005, PLANT SOIL, V276, P1, DOI 10.1007/s11104-005-3104-8; Chambers JQ, 2001, FOREST ECOL MANAG, V152, P73, DOI 10.1016/S0378-1127(00)00591-0; Osawa A, 2012, PLANT SOIL, V355, P167, DOI 10.1007/s11104-011-1090-6; Aiba S, 1999, PLANT ECOL, V140, P139, DOI 10.1023/A:1009710618040; Baishya R, 2011, ANN FOREST SCI, V68, P727, DOI 10.1007/s13595-011-0089-8; Wang SQ, 2011, J ENVIRON MANAGE, V92, P1651, DOI 10.1016/j.jenvman.2011.01.024; Metcalfe DB, 2007, PLANT SOIL, V301, P279, DOI 10.1007/s11104-007-9447-6; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; Shvidenko AZ, 2008, DOKL EARTH SCI, V421, P1009, DOI 10.1134/S1028334X08060330; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432; Tateno R, 2004, FOREST ECOL MANAG, V193, P297, DOI 10.1016/j.foreco.2003.11.011; Clark DA, 2001, ECOL APPL, V11, P356; Slik JWF, 2013, GLOBAL ECOL BIOGEOGR, V22, P1261, DOI 10.1111/geb.12092; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; Bernier PY, 2004, PLANT SOIL, V265, P165, DOI 10.1007/s11104-005-0056-y; Davidson EA, 2002, AGR FOREST METEOROL, V113, P39, DOI 10.1016/S0168-1923(02)00101-6; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Chen WJ, 2002, CAN J FOREST RES, V32, P833, DOI 10.1139/X01-165; Dannoura M., 2008, Plant Root, V2, P14, DOI 10.3117/plantroot.2.14; Fairley R.I., 1985, ECOLOGICAL INTERACTI, V4, P37; HENDRICK RL, 1993, CAN J FOREST RES, V23, P2507, DOI 10.1139/x93-312; Hishi T, 2005, NEW PHYTOL, V167, P509, DOI 10.1111/j.1469-8137.2005.01418.x; Kajimoto T, 1999, TREE PHYSIOL, V19, P15; Kimura M, 1960, MISCELLANEOUS REPORT, V52-53, P36; Kira T, 1978, BIOL PRODUCTION WARM, P131; Kira T, 1977, PRIMARY PRODUCTIVITY, P101; Kubota Y, 2003, OCCASIONAL PAPERS KA, V38, P47; Kumamoto Regional Forestry Office, 1963, SOIL SURV REP, V21; Melillo J. M., 1995, CLIMATE CHANGE 1995, P445; Mooney HA, 1996, FUNCTIONAL ROLES BIO; Nakagawa M, 2006, SCI REP KYOTO PREFEC, V58, P51; Nitta I, 1997, PLANT ECOL, V130, P71, DOI 10.1023/A:1009735709258; Ohnuki Y, 1998, JPN J FOR ENV, V40, P67; Ohtsuka T, 2013, ECOL RES, V28, P855, DOI 10.1007/s11284-013-1067-4; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Saito S, 2002, J FOR RES, V7, P137, DOI DOI 10.1007/BF02762602; Sasse J, 1998, THE FORESTS OF JAPAN; Sato T, 2010, PLANT ECOL, V208, P187, DOI 10.1007/s11258-009-9697-x; Sato T, 1999, B KITAKYUSHU MUS NAT, V18, P57; Tada M, 2006, SCI REP KYOTO PREFEC, V58, P41; Tadaki Y., 1995, B NAGOYA U FOR, V14, P1; TADAKI Y, 1968, Journal of the Japanese Forestry Society, V50, P60; TANOUCHI H, 1995, VEGETATIO, V117, P51, DOI 10.1007/BF00033258; Yashiro Y, 2010, J PLANT RES, V123, P463, DOI 10.1007/s10265-010-0323-8	51	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	SEP	2015	30	5					921	930		10.1007/s11284-015-1295-x		10	Ecology	Environmental Sciences & Ecology	CQ0TE	WOS:000360309300015		
J	Kido, R; Ueno, K; Iwata, K; Kitazawa, Y; Imaizumi, S; Mandai, T; Dokko, K; Watanabe, M				Kido, Ryosuke; Ueno, Kazuhide; Iwata, Kaori; Kitazawa, Yuzo; Imaizumi, Satoru; Mandai, Toshihiko; Dokko, Kaoru; Watanabe, Masayoshi			Li+ Ion Transport in Polymer Electrolytes Based on a Glyme-Li Salt Solvate Ionic Liquid	ELECTROCHIMICA ACTA			English	Article						solvate ionic liquid; polymer electrolyte; polymer-in-salt; ionicity; glyme	ROOM-TEMPERATURE; PHYSICOCHEMICAL PROPERTIES; SOLID ELECTROLYTES; GLASS-TRANSITION; MOLECULAR-WEIGHT; VINYL MONOMERS; CONDUCTIVITY; COMPLEXES; BATTERIES; ENHANCEMENT	Polymer electrolytes (PEs) have served as the focus of intensive research as new ion-conducting materials, especially for lithium battery applications. A new strategy to develop fast lithium-conducting PEs is reported here. The thermal, ionic transport, and electrochemical properties of polymer solutions in a glyme-Li salt solvate ionic liquid, [Li(G4)(1)][TFSA], composed of an equimolar mixture of lithium bis (trifluoromethanesulfonyl) amide (Li[TFSA]) and tetraglyme (G4), were characterized. Poly(ethylene oxide) (PEO), poly(methyl methacrylate) (PMMA), and poly(butyl acrylate) (PBA) were combined with [Li(G4)(1)][TFSA] in order to explore the effects of polymer structure on the properties. The self-diffusion coefficient ratio of the glyme and Li+ ions (D-G/D-Li) was investigated to evaluate the stability of the complex (solvate) cations. The D-G/D-Li values suggested that the [Li(G4)(1)](+) complex cations underwent a ligand exchange reaction between G4 and PEO in the PEO-based solution, whereas the cations remained stable (D-G/D-Li = 1) in the PMMA-and PBA-based solutions. The robustness of the [Li(G4)(1)](+) complex cations in the PMMA-and PBA-based solutions was reflected in high weight-loss temperature, greater Li transference number, and high oxidative stability. Owing to the lower glass transition temperature and low affinity towards Li+ ions, the PBA-based solutions yielded superior lithium transport properties (ionic conductivity of 10(-4)similar to 10(-3) Scm(-1) and Li transference number as high as 0.5) among the investigated polymer solutions. (C) 2015 Elsevier Ltd. All rights reserved.	[Kido, Ryosuke; Ueno, Kazuhide; Iwata, Kaori; Kitazawa, Yuzo; Imaizumi, Satoru; Mandai, Toshihiko; Dokko, Kaoru; Watanabe, Masayoshi] Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Watanabe, M (reprint author), Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	mwatanab@ynu.ac.jp	Dokko, Kaoru/A-4005-2013	Dokko, Kaoru/0000-0002-9622-4345	Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST); Technology Research Grant Program of the New Energy and Industrial Technology Development Organization (NEDO) of Japan; Japan Society for the Promotion of Science [13J00192]	This study was supported in part by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST) and by the Technology Research Grant Program of the New Energy and Industrial Technology Development Organization (NEDO) of Japan. Y. K. acknowledges a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists (No. 13J00192).	Noda A, 2000, ELECTROCHIM ACTA, V45, P1265, DOI 10.1016/S0013-4686(99)00330-8; Buriez O, 2000, J POWER SOURCES, V89, P149, DOI 10.1016/S0378-7753(00)00423-7; Sirisopanaporn C, 2009, J POWER SOURCES, V186, P490, DOI 10.1016/j.jpowsour.2008.10.036; Miran MS, 2011, CHEM COMMUN, V47, P12676, DOI 10.1039/c1cc14817f; Yoshida K, 2011, J PHYS CHEM C, V115, P18384, DOI 10.1021/jp206881t; Ueno K, 2014, LANGMUIR, V30, P3228, DOI 10.1021/la404797g; Angell CA, 2012, FARADAY DISCUSS, V154, P9, DOI 10.1039/c1fd00112d; Agapov AL, 2011, MACROMOLECULES, V44, P4410, DOI 10.1021/ma2001096; Song JY, 1999, J POWER SOURCES, V77, P183, DOI 10.1016/S0378-7753(98)00193-1; VENNEMANN N, 1987, POLYMER, V28, P1738, DOI 10.1016/0032-3861(87)90018-8; Shin JH, 2005, J ELECTROCHEM SOC, V152, pA978, DOI 10.1149/1.1890701; Ueno K, 2012, J PHYS CHEM B, V116, P11323, DOI 10.1021/jp307378j; Susan MA, 2005, J AM CHEM SOC, V127, P4976, DOI 10.1021/ja045155b; BOHMER R, 1993, J CHEM PHYS, V99, P4201; Rikukawa M, 2000, PROG POLYM SCI, V25, P1463, DOI 10.1016/S0079-6700(00)00032-0; Kitazawa Y, 2014, MACROMOLECULES, V47, P6009, DOI 10.1021/ma501296m; Qin Q, 2006, J NON-CRYST SOLIDS, V352, P2977, DOI 10.1016/j.jnoncrysol.2006.04.014; Saito Y, 2014, J PHYS CHEM C, V118, P6064, DOI 10.1021/jp412611a; Croce F, 1998, NATURE, V394, P456; GORDON M, 1952, J APPL CHEM, V2, P493; Tokuda H, 2006, J PHYS CHEM B, V110, P19593, DOI 10.1021/jp064159v; Zugmann S, 2011, ELECTROCHIM ACTA, V56, P3926, DOI 10.1016/j.electacta.2011.02.025; FIORETTO D, 1994, J PHYS-CONDENS MAT, V6, P5295, DOI 10.1088/0953-8984/6/28/007; Ye YS, 2013, J MATER CHEM A, V1, P2719, DOI 10.1039/c2ta00126h; Pappenfus TM, 2004, J ELECTROCHEM SOC, V151, pA209, DOI 10.1149/1.1635384; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r; Hayamizu K, 2004, J PHYS CHEM B, V108, P19527, DOI 10.1021/jp0476601; Kofu M, 2012, SOFT MATTER, V8, P7888, DOI 10.1039/c2sm25348h; ANGELL CA, 1993, NATURE, V362, P137, DOI 10.1038/362137a0; ARMAND M, 1983, SOLID STATE IONICS, V9-10, P745, DOI 10.1016/0167-2738(83)90083-8; SHI J, 1993, SOLID STATE IONICS, V60, P11, DOI 10.1016/0167-2738(93)90268-8; Ueki T, 2008, MACROMOLECULES, V41, P3739, DOI 10.1021/ma800171k; Quartarone E, 2011, CHEM SOC REV, V40, P2525, DOI 10.1039/c0cs00081g; Tamura T, 2010, CHEM LETT, V39, P753, DOI 10.1246/cl.2010.753; Nishimoto A, 1998, ELECTROCHIM ACTA, V43, P1177, DOI 10.1016/S0013-4686(97)10017-2; Seki S, 2005, J PHYS CHEM B, V109, P3886, DOI 10.1021/jp045328j; Zhang SP, 2011, MACROMOLECULES, V44, P940, DOI 10.1021/ma102435a; Baumgartel M, 1996, RHEOL ACTA, V35, P168, DOI 10.1007/BF00396044; BRUCE PG, 1993, J CHEM SOC FARADAY T, V89, P3187, DOI 10.1039/ft9938903187; Fox T. G., 1956, B AM PHYS SOC, V1, P123; Fujii K, 2012, SOFT MATTER, V8, P1756, DOI 10.1039/c2sm07119c; Gotoh Y, 2000, POLYM J, V32, P838, DOI 10.1295/polymj.32.838; Imaizumi S., 2011, MACROMOLECULES, V45, P401; Isard JO, 1999, J NON-CRYST SOLIDS, V246, P16, DOI 10.1016/S0022-3093(99)00036-8; KANNO H, 1981, J NON-CRYST SOLIDS, V44, P409, DOI 10.1016/0022-3093(81)90047-8; KELLY IE, 1985, J POWER SOURCES, V14, P13, DOI 10.1016/0378-7753(85)88004-6; MASHITA K, 1995, POLYMER, V36, P2983, DOI 10.1016/0032-3861(95)94348-W; Matyjaszewski K., 2001, J CHEM REV, V101, P2921; NAGASUBRAMANIAN G, 1990, J ELECTROCHEM SOC, V137, P3830, DOI 10.1149/1.2086309; Park MJ, 2013, J APPL POLYM SCI, V129, P2363, DOI 10.1002/app.39064; Shobukawa H, 2005, ELECTROCHIM ACTA, V50, P3872, DOI 10.1016/j.electacta.2005.02.043; TSVETANOV CB, 1990, J SOLUTION CHEM, V19, P425, DOI 10.1007/BF00650375; Wang Y. Y., 2012, PHYS REV LETT, V108; WATANABE M, 1993, J CHEM SOC CHEM COMM, P929, DOI 10.1039/c39930000929; Xu W, 2003, ELECTROCHIM ACTA, V48, P2037, DOI 10.1016/S0013-4686(03)00183-X; Ye H, 2007, J ELECTROCHEM SOC, V154, pA1048, DOI 10.1149/1.2779962	56	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	SEP 1	2015	175						5	12		10.1016/j.electacta.2015.01.067		8	Electrochemistry	Electrochemistry	CP8XP	WOS:000360178600002		
J	Tsurumaki, A; Tajima, S; Iwata, T; Scrosati, B; Ohno, H				Tsurumaki, Akiko; Tajima, Saori; Iwata, Takuya; Scrosati, Bruno; Ohno, Hiroyuki			Antistatic effects of ionic liquids for polyether-based polyurethanes	ELECTROCHIMICA ACTA			English	Article						Ionic liquid; Antistatic; Polyurethane; Ionic conductivity; Polyether	SOLVENT-SOLUTE INTERACTIONS; POLYPROPYLENE; PERFORMANCE; BLENDS	Mobility of component anions of ionic liquids (ILs) was found to be a most effective factor to enhance antistatic properties of polyether-based polyurethanes (PUs). Then, the antistatic effects were discussed with Kamlet-Taft parameters (hydrogen bond acidity: a and basicity: beta) of the added ILs. A strong correlation was found between b value and surface resistivity (Rs) of the PUs containing the ILs. On the contrary, a value was found to have a weak influence on the Rs. Since there was a weaker interaction between polyether chains and anions than cations, antistatic effects of the ILs were weaken by fixing the component anions into the PUs. This strongly suggests that effective antistatic effects are supported by the anion migration of ILs. (C) 2015 Elsevier Ltd. All rights reserved.	[Tsurumaki, Akiko; Tajima, Saori; Iwata, Takuya; Scrosati, Bruno; Ohno, Hiroyuki] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan; [Tsurumaki, Akiko; Tajima, Saori; Iwata, Takuya; Ohno, Hiroyuki] Tokyo Univ Agr & Technol, Grad Sch Engn, Funct Ion Liquid Labs, Koganei, Tokyo 1848588, Japan; [Iwata, Takuya] Iwata & Co Ltd, Nagoya, Aichi 4600003, Japan; [Scrosati, Bruno] Ist Italiano Tecnol, I-16163 Genoa, Italy	Ohno, H (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	50012831205@st.tuat.ac.jp; 50013641210@st.tuat.ac.jp; t.iwata@iwata-cc.co.jp; scrosati@cc.tuat.ac.jp; ohnoh@cc.tuat.ac.jp	Ohno, Hiroyuki/F-6459-2012	Ohno, Hiroyuki/0000-0001-9716-3495	Japans Society for the Promotion of Science	This study was supported by a Grant-in-Aid for Scientific Research from Japans Society for the Promotion of Science. The authors sincerely thank to Mr. Atsuhiko Umezawa, Auto Chemical Ind. Co., Ltd. for preparation of the PU films. We would like to dedicate this article to celebrate the 20th anniversary of the Department of Biotechnology and Life Science at Tokyo University of Agriculture and Technology.	Kodama K, 2011, POLYM J, V43, P242, DOI 10.1038/pj.2010.140; Oprea S, 2011, J MATER SCI, V46, P2251, DOI 10.1007/s10853-010-5064-5; Wu YS, 2008, J PHYS CHEM B, V112, P7530, DOI 10.1021/jp800957c; [Anonymous], 1994, EL DISCH CONTR HDB P; Crowhurst L, 2003, PHYS CHEM CHEM PHYS, V5, P2790, DOI 10.1039/b303095d; Iwata T, 2014, POLYMER, V55, P2501, DOI 10.1016/j.polymer.2014.03.028; Fukaya Y, 2008, GREEN CHEM, V10, P44, DOI 10.1039/b713289a; Tsurumaki A, 2011, POLYM ADVAN TECHNOL, V22, P1223, DOI 10.1002/pat.1931; Chattopadhyay DK, 2007, PROG POLYM SCI, V32, P352, DOI 10.1016/j.progpolymsci.2006.05.003; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; [Anonymous], 2008, S5412008 ANSIESD; Abe M, 2010, GREEN CHEM, V12, P1274, DOI 10.1039/c003976d; Zheng AN, 2012, APPL SURF SCI, V258, P8861, DOI 10.1016/j.apsusc.2012.05.105; Li CS, 2004, COMPOS SCI TECHNOL, V64, P2089, DOI 10.1016/j.compscitech.2004.03.010; Chen K, 2009, POLYM COMPOSITE, V30, P226, DOI 10.1002/pc.20679; Iwata T, 2014, MACROMOL MATER ENG, V299, P794, DOI 10.1002/mame.201300333; Kobayashi T, 2006, J ELECTROSTAT, V64, P377, DOI 10.1016/j.elstat.2005.09.004; Kobayashi T, 2012, J APPL POLYM SCI, V123, P1056, DOI 10.1002/app.34571; Markarian J, 2008, PLASTICS ADDITIVES C, V10, P22, DOI 10.1016/S1464-391X(08)70225-3; Muldoon MJ, 2001, J CHEM SOC PERK T 2, P433, DOI 10.1039/b101449h; Xie F., 2013, ADV MAT RES, V704, P289	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	SEP 1	2015	175						13	17		10.1016/j.electacta.2014.12.128		5	Electrochemistry	Electrochemistry	CP8XP	WOS:000360178600003		
J	Kimura, K; Matsumoto, H; Hassoun, J; Panero, S; Scrosati, B; Tominaga, Y				Kimura, Kento; Matsumoto, Hidetoshi; Hassoun, Jusef; Panero, Stefania; Scrosati, Bruno; Tominaga, Yoichi			A QuaternaryPoly(ethylene carbonate)-Lithium Bis (trifluoromethanesulfonyl)imide-Ionic Liquid-Silica Fiber Composite Polymer Electrolyte for Lithium Batteries	ELECTROCHIMICA ACTA			English	Article						Solid polymer electrolyte; Poly(ethylene carbonate); Ionic liquid; Electrospinning; Lithium; battery	CARBON-DIOXIDE; COPOLYMERIZATION; EPOXIDES; CO2; CHALLENGES; CATALYSTS; ETHERS; SALTS	Poly(ethylene carbonate) (PEC) is known as an alternating copolymer derived from carbon dioxide (CO2) and an epoxide as monomers. Here, we describe a new quaternary PEC-based composite electrolyte containing lithium bis(trifluoromethanesulfonyl) imide (LiTFSI) salt, N-n-butyl-N-methylpyrrolidinium bis(trifluoromethanesulfonyl) imide (Pyr(14)TFSI) ionic liquid, and an electrospun silica (SiO2) fiber (SiF) with a submicron diameter in view of its possible applications in solid-state Li polymer batteries. A freestanding electrolyte membrane is prepared by a solvent casting method. The Pyr(14)TFSI ionic liquid enhances the ionic conductivity of the electrolyte as a result of its plasticizing effect. The electrochemical properties, such as ionic conductivity and Li transference number (t(Li+)), as well as mechanical strength of the electrolyte, are further improved by the SiF. We show that the quaternary electrolyte has a conductivity of the order of 10(-7) S cm(-1) at ambient temperature and a high t(Li+) value of 0.36 with an excellent flexibility. A prototype Li polymer cell using LiFePO4 as a cathode material is assembled and tested. We demonstrate that this battery delivers a reversible charge-discharge capacity close to 100 mAh g(-1) at 75 degrees C and C/15 rate. We believe that this work may pave the road to utilize CO2 as a carbon source for highly-demanded, functional battery materials in future. (C) 2015 Elsevier Ltd. All rights reserved.	[Kimura, Kento; Tominaga, Yoichi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo 1848588, Japan; [Matsumoto, Hidetoshi] Tokyo Inst Technol, Dept Organ & Polymer Mat, Tokyo 1528522, Japan; [Hassoun, Jusef; Panero, Stefania] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy; [Scrosati, Bruno] Italian Inst Technol, I-16163 Genoa, Italy; [Scrosati, Bruno] Tokyo Univ Agr & Technol, Global Innovat Res Org, Tokyo 1848588, Japan	Tominaga, Y (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo 1848588, Japan.	ytominag@cc.tuat.ac.jp	Matsumoto, Hidetoshi/C-6863-2011; Tominaga, Yoichi/D-6400-2012; 	Matsumoto, Hidetoshi/0000-0002-4949-1184; Tominaga, Yoichi/0000-0001-5098-8537; Hassoun, Jusef/0000-0002-8218-5680	JSPS KAKENHI, Japan [25288095]; Italian Institute of Technology (IIT), Italy, within the Regione Lazio project	This work was supported by a Grant-in-Aid for Scientific Research (B) of JSPS KAKENHI (No. 25288095), Japan. JH acknowledges the Italian Institute of Technology (IIT), Italy, within the Regione Lazio project.	Bouchet R, 2013, NAT MATER, V12, P452, DOI [10.1038/nmat3602, 10.1038/NMAT3602]; Appetecchi GB, 2011, J POWER SOURCES, V196, P6703, DOI 10.1016/j.jpowsour.2010.11.070; Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719; Niitani T, 2005, J POWER SOURCES, V146, P386, DOI 10.1016/j.jpowsour.2005.03.102; Wei XY, 1998, CHEM MATER, V10, P2307, DOI 10.1021/cm980170z; Scrosati B, 2001, J POWER SOURCES, V100, P93, DOI 10.1016/S0378-7753(01)00886-2; Lu XB, 2012, ACCOUNTS CHEM RES, V45, P1721, DOI 10.1021/ar300035z; Tominaga Y, 2010, POLYMER, V51, P4295, DOI 10.1016/j.polymer.2010.07.037; Darensbourg DJ, 2007, CHEM REV, V107, P2388, DOI 10.1021/cr068363q; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Nakamura M, 2011, ELECTROCHIM ACTA, V57, P36, DOI 10.1016/j.electacta.2011.03.003; Meyer WH, 1998, ADV MATER, V10, P439, DOI 10.1002/(SICI)1521-4095(199804)10:6<439::AID-ADMA439>3.0.CO;2-I; Croce F, 1998, NATURE, V394, P456; Matsumoto M, 2013, IONICS, V19, P615, DOI 10.1007/s11581-012-0796-7; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; RATNER MA, 1988, CHEM REV, V88, P109, DOI 10.1021/cr00083a006; Hassoun J, 2010, ADV MATER, V22, P5198, DOI 10.1002/adma.201002584; Wetjen M, 2013, CHEMSUSCHEM, V6, P1037, DOI 10.1002/cssc.201300105; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Scrosati B, 2010, J POWER SOURCES, V195, P2419, DOI 10.1016/j.jpowsour.2009.11.048; MacFarlane DR, 1999, J PHYS CHEM B, V103, P4164, DOI 10.1021/jp984145s; Sugimoto H, 2004, J POLYM SCI POL CHEM, V42, P5561, DOI 10.1002/pola.20319; Klaus S, 2011, COORDIN CHEM REV, V255, P1460, DOI 10.1016/j.ccr.2010.12.002; Sun B, 2014, SOLID STATE IONICS, V262, P738, DOI 10.1016/j.ssi.2013.08.014; WESTON JE, 1982, SOLID STATE IONICS, V7, P75, DOI 10.1016/0167-2738(82)90072-8; Appetecchi G.B., 2012, ELECTROCHIM ACTA, V54, P1325; Balaish B., 2015, ANGEW CHEM INT EDIT, V54, P436; Coates GW, 2004, ANGEW CHEM INT EDIT, V43, P6618, DOI 10.1002/anie.200460442; EVANS J, 1987, POLYMER, V28, P2324, DOI 10.1016/0032-3861(87)90394-6; Hayamizu K, 2002, J CHEM PHYS, V117, P5929, DOI 10.1063/1.1501279; INOUE S, 1969, J POLYM SCI POL LETT, V7, P287, DOI 10.1002/pol.1969.110070408; Ishibe S, 2014, REACT FUNCT POLYM, V81, P40, DOI 10.1016/j.reactfunctpolym.2014.04.004; Zhang H, 2014, ELECTROCHIM ACTA, V133, P529, DOI 10.1016/j.electacta.2014.04.099; Matsumoto H., 2012, JP, V494, P3355; Okumura T, 2014, SOLID STATE IONICS, V267, P68, DOI 10.1016/j.ssi.2014.09.011; PELED E, 1995, ELECTROCHIM ACTA, V40, P2197, DOI 10.1016/0013-4686(95)00163-9; Tominaga Y, 2012, POLYM J, V44, P1155, DOI 10.1038/pj.2012.97; Tominaga Y., 2014, CHEM COMMUN, V50, P648	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	SEP 1	2015	175						134	140		10.1016/j.electacta.2015.03.117		7	Electrochemistry	Electrochemistry	CP8XP	WOS:000360178600018		
J	Suematsu, M; Yoshizawa-Fujita, M; Zhu, HJ; Forsyth, M; Takeoka, Y; Rikukawa, M				Suematsu, Mitsutake; Yoshizawa-Fujita, Masahiro; Zhu, Haijin; Forsyth, Maria; Takeoka, Yuko; Rikukawa, Masahiro			Effect of zwitterions on electrochemical properties of oligoether-based electrolytes	ELECTROCHIMICA ACTA			English	Article						Polymer electrolyte; Zwitterion; Oligoether; Electrochemical window; Lithium-ion battery	SOLID POLYMER ELECTROLYTE; LITHIUM BATTERY ELECTROLYTES; IONIC LIQUIDS; SALT; TEMPERATURE; STABILITY; CONDUCTIVITY; VISCOSITY; DEPENDENCE; ADDITIVES	Solid polymer electrolytes show great potential in electrochemical devices. Poly(ethylene oxide) (PEO) has been studied as a matrix for solid polymer electrolytes because it has relatively high ionic conductivity. In order to investigate the effect of zwitterions on the electrochemical properties of poly (ethylene glycol) dimethyl ether (G5)/lithium bis(fluorosulfonyl) amide (LiFSA) electrolytes, a liquid zwitterion (ImZ2) was added to the G5-based electrolytes. In this study, G5, which is a small oligomer, was used as a model compound for PEO matrices. The thermal properties, ionic conductivity, and electrochemical stability of the electrolytes with ImZ2 were evaluated. The thermal stabilities of all the G5-based electrolytes with ImZ2 were above 150 degrees C, and the ionic conductivity values were in the range of 0.8-3.0 mS cm(-1) at room temperature. When the electrolytes contained less than 5.5 wt% ImZ2, the ionic conductivity values were almost the same as that of the electrolyte without ImZ2. The electrochemical properties were improved with the incorporation of ImZ2. The anodic limit of the electrolyte with 5.5 wt% ImZ2 was 5.3 V vs. Li/Li+, which was over 1 V higher than that of G5/LiFSA. (C) 2014 Elsevier Ltd. All rights reserved.	[Suematsu, Mitsutake; Yoshizawa-Fujita, Masahiro; Takeoka, Yuko; Rikukawa, Masahiro] Sophia Univ, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1028554, Japan; [Zhu, Haijin; Forsyth, Maria] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3216, Australia; [Zhu, Haijin; Forsyth, Maria] Deakin Univ, ARC Ctr Excellence Electromat Sci, Geelong, Vic 3216, Australia	Yoshizawa-Fujita, M (reprint author), Sophia Univ, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.	masahi-f@sophia.ac.jp			Japan Society for the Promotion of Science (JSPS) [26410140]	This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 26410140) from Japan Society for the Promotion of Science (JSPS).	Prosini PP, 2001, EUR POLYM J, V37, P65, DOI 10.1016/S0014-3057(00)00077-X; Nguyen DQ, 2007, ELECTROCHEM COMMUN, V9, P109, DOI 10.1016/j.elecom.2006.08.045; Ueno K, 2010, PHYS CHEM CHEM PHYS, V12, P1649, DOI 10.1039/b921462n; Bruce PG, 2008, ANGEW CHEM INT EDIT, V47, P2930, DOI 10.1002/anie.200702505; Bayley PM, 2011, CHEMPHYSCHEM, V12, P823, DOI 10.1002/cphc.201000909; Appetecchi GB, 2009, J POWER SOURCES, V192, P599, DOI 10.1016/j.jpowsour.2008.12.095; Seki S, 2008, J PHYS CHEM C, V112, P16708, DOI 10.1021/jp805403e; Scrosati B, 2001, J POWER SOURCES, V100, P93, DOI 10.1016/S0378-7753(01)00886-2; FAUTEUX D, 1995, ELECTROCHIM ACTA, V40, P2185, DOI 10.1016/0013-4686(95)00161-7; Hayamizu K, 1999, J PHYS CHEM B, V103, P519, DOI 10.1021/jp9825664; LASCAUD S, 1994, MACROMOLECULES, V27, P7469, DOI 10.1021/ma00103a034; Matsumoto H, 2006, J POWER SOURCES, V160, P1308, DOI 10.1016/j.jpowsour.2006.02.018; Kang YK, 2001, J POWER SOURCES, V92, P255, DOI 10.1016/S0378-7753(00)00546-2; Biso M, 2008, ELECTROCHIM ACTA, V53, P7967, DOI 10.1016/j.electacta.2008.06.008; Kato Y, 2002, SOLID STATE IONICS, V150, P355, DOI 10.1016/S0167-2738(02)00450-2; Xia YY, 2001, J POWER SOURCES, V92, P234, DOI 10.1016/S0378-7753(00)00533-4; Murata K, 2000, ELECTROCHIM ACTA, V45, P1501, DOI 10.1016/S0013-4686(99)00365-5; Shin JH, 2004, ELECTROCHIM ACTA, V49, P1605, DOI 10.1016/j.electacta.2003.11.022; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Fulcher GS, 1925, J AM CERAM SOC, V8, P339, DOI 10.1111/j.1151-2916.1925.tb16731.x; Di Noto V, 2011, ELECTROCHIM ACTA, V57, P4, DOI 10.1016/j.electacta.2011.08.048; Vogel H, 1921, PHYS Z, V22, P645; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r; Byrne N, 2005, ADV MATER, V17, P2497, DOI 10.1002/adma.200500595; Li B, 2012, ELECTROCHEM COMMUN, V17, P92, DOI 10.1016/j.elecom.2012.02.016; Li Q, 2002, J POWER SOURCES, V110, P38, DOI 10.1016/S0378-7753(02)00215-X; Tamura T, 2010, CHEM LETT, V39, P753, DOI 10.1246/cl.2010.753; Suematsu M, 2015, INT J ELECTROCHEM SC, V10, P248; GAUTHIER M, 1995, J POWER SOURCES, V54, P163, DOI 10.1016/0378-7753(94)02060-G; Gray FM, 1997, RSC MAT MONOGRAPHS; Johansson P, 2010, J POWER SOURCES, V195, P2074, DOI 10.1016/j.jpowsour.2009.10.029; Li ZH, 2010, ELECTROCHIM ACTA, V56, P804, DOI 10.1016/j.electacta.2010.09.068; Zhang H, 2014, ELECTROCHIM ACTA, V133, P529, DOI 10.1016/j.electacta.2014.04.099; Nguyen DQ, 2008, J POWER SOURCES, V183, P303, DOI 10.1016/j.jpowsour.2008.04.047; Tammann G., 1926, Z ANORG ALLG CHEM, V156, P245, DOI DOI 10.1002/ZAAC.19261560121; Tiyapiboonchaiya C, 2004, NAT MATER, V3, P29, DOI 10.1038/nmat1044; Yoshizawa-Fujita M., 2011, CHEM COMMUN, P2345	37	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	SEP 1	2015	175						209	213		10.1016/j.electacta.2014.12.067		5	Electrochemistry	Electrochemistry	CP8XP	WOS:000360178600027		
J	Tsujii, Y; Nishida, T; Nishiyama, O; Yamamoto, K; Kawai, N; Yamaguchi, S; Yamada, T; Yoshio, T; Kitamura, S; Nakamura, T; Nishihara, A; Ogiyama, H; Nakahara, M; Komori, M; Kato, M; Hayashi, Y; Shinzaki, S; Iijima, H; Michida, T; Tsujii, M; Takehara, T				Tsujii, Yoshiki; Nishida, Tsutomu; Nishiyama, Osamu; Yamamoto, Katsumi; Kawai, Naoki; Yamaguchi, Shinjiro; Yamada, Takuya; Yoshio, Toshiyuki; Kitamura, Shinji; Nakamura, Takeshi; Nishihara, Akihiro; Ogiyama, Hideharu; Nakahara, Masanori; Komori, Masato; Kato, Motohiko; Hayashi, Yoshito; Shinzaki, Shinichiro; Iijima, Hideki; Michida, Tomoki; Tsujii, Masahiko; Takehara, Tetsuo			Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study	ENDOSCOPY			English	Article							SQUAMOUS-CELL CARCINOMA; LEARNING-CURVE; NECK REGION; RESECTION; CANCER; STRICTURE; RISK; HEAD	Background and study aims: The safety and efficacy of endoscopic submucosal dissection (ESD) for superficial esophageal neoplasms (SENs) have not been evaluated in a multicenter survey. The aim of this study was to investigate the clinical outcomes in a multicenter study that included municipal hospitals. Patients and methods: Of 312 consecutive patients with 373 esophageal lesions treated by ESD at 11 hospitals from May 2005 to December 2012, a total of 368 SENs in 307 patients were retrospectively analyzed. Results: The median tumor size was 18 mm (range 2-85 mm). The median procedure time was 90 minutes (range 12-450 minutes). The en bloc resection and complete resection rates were 96.7% (95% confidence interval [CI] 94.4%-98.1 %) and 84.5% (95 % CI 80.5%-87.8 %), respectively. Perforation (including mediastinal emphysema), postoperative pneumonia, bleeding, and esophageal stricture, occurred in 5.2% (95 % CI 3.3%-7.9 %), 1.6% (95 % CI 0.7%-3.5 %), 0%, and 7.1% (95 % CI 4.9%-10.2 %) of patients, respectively. All of these complications were cured conservatively. No procedure-related mortality occurred. Early treatment periods (odds ratio [OR]= 4.04; P<0.01) and low volume institutions (OR= 3.03; P=0.045) were significantly independent risk factors for perforation. The circumference of the lesion was significantly associated with postoperative stricture (OR=32.3; P<0.01). The procedure times significantly decreased in the later period of the study (P<0.01). Follow-up data (median 35 months; range 4-98 months) showed significant differences in overall survival (P=0.03) and recurrence-free survival (P<0.01) rates between patients with curative and non-curative resections. Conclusions: Esophageal ESD has become feasible with acceptable complication risks and favorable long term outcomes.	[Tsujii, Yoshiki; Nishida, Tsutomu; Kato, Motohiko; Hayashi, Yoshito; Shinzaki, Shinichiro; Iijima, Hideki; Tsujii, Masahiko; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Nishiyama, Osamu] Osaka Gen Med Ctr, Dept Gastroenterol, Osaka, Japan; [Yamamoto, Katsumi] Toyonaka City Hosp, Dept Gastroenterol, Toyonaka, Osaka, Japan; [Kawai, Naoki; Yamaguchi, Shinjiro] Osaka Police Hosp, Dept Gastroenterol, Osaka, Japan; [Yamada, Takuya; Yoshio, Toshiyuki] Natl Hosp Org, Osaka Natl Hosp, Dept Gastroenterol, Osaka, Japan; [Kitamura, Shinji] Sakai Municipal Hosp, Dept Gastroenterol, Sakai, Osaka, Japan; [Nakamura, Takeshi] Kansai Rosai Hosp, Dept Gastroenterol, Amagasaki, Hyogo, Japan; [Nishihara, Akihiro] Minoh City Hosp, Dept Gastroenterol, Mino, Japan; [Ogiyama, Hideharu] Itami City Hosp, Dept Gastroenterol, Itami, Hyogo, Japan; [Nakahara, Masanori] Ikeda Municipal Hosp, Dept Gastroenterol, Ikeda, Osaka, Japan; [Komori, Masato] Osaka Rosai Hosp, Dept Gastroenterol, Sakai, Osaka, Japan; [Michida, Tomoki] Osaka Kosei Nenkin Hosp, Dept Gastroenterol, Osaka, Japan	Takehara, T (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp		Nishida, Tsutomu/0000-0003-4037-9003			Yamashina T, 2013, AM J GASTROENTEROL, V108, P544, DOI 10.1038/ajg.2013.8; [Anonymous], 2010, GASTROINTEST ENDOSC, DOI [DOI 10.1016/J.GIE.2010.02.040, DOI 10.1016/J.GIE.2010.02.040]]; Akutsu Y, 2013, ANN SURG, V257, P1032, DOI 10.1097/SLA.0b013e31827017fc; Takeuchi Y, 2010, AM J GASTROENTEROL, V105, P314, DOI 10.1038/ajg.2009.547; Atkins BZ, 2004, ANN THORAC SURG, V78, P1170, DOI 10.1016/j.athoracsur.2004.02.034; Kato M, 2013, GUT, V62, P1425, DOI 10.1136/gutjnl-2011-301647; Akahoshi K, 2008, GASTROINTEST ENDOSC, V67, P1128, DOI 10.1016/j.gie.2007.12.007; Katada C, 2012, LARYNGOSCOPE, V122, P1291, DOI 10.1002/lary.23249; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Maeda Y, 2012, ENDOSCOPY, V44, P565, DOI 10.1055/s-0031-1291664; Akahoshi K, 2013, ENDOSCOPY, V45, P1035, DOI 10.1055/s-0033-1344863; Fujishiro M, 2009, DIGEST ENDOSC, V21, P109, DOI 10.1111/j.1443-1661.2009.00837.x; Hanaoka N, 2012, ENDOSCOPY, V44, P1007, DOI 10.1055/s-0032-1310107; Ishihara R, 2008, GASTROINTEST ENDOSC, V68, P1066, DOI 10.1016/j.gie.2008.03.1114; Mizuta H, 2009, DIS ESOPHAGUS, V22, P626, DOI 10.1111/j.1442-2050.2009.00954.x; Yano T, 2013, ENDOSCOPY, V45, P316, DOI 10.1055/s-0032-1326016; Oda I, 2013, DIGEST ENDOSC, V25, P71, DOI 10.1111/j.1443-1661.2012.01376.x; Yamaguchi N, 2011, GASTROINTEST ENDOSC, V73, P1115, DOI 10.1016/j.gie.2011.02.005; Akasaka T, 2011, DIGEST ENDOSC, V23, P73, DOI 10.1111/j.1443-1661.2010.01062.x; Shimizu Y, 2002, GASTROINTEST ENDOSC, V56, P387, DOI 10.1067/mge.2002.127100; Takahashi H, 2011, ENDOSCOPY, V43, P184, DOI 10.1055/s-0030-1256109; Ono S, 2009, GASTROINTEST ENDOSC, V70, P860, DOI 10.1016/j.gie.2009.04.044; Kato M, 2013, SURG ENDOSC, V27, P154, DOI 10.1007/s00464-012-2402-5; Fujinami H, 2014, DIS ESOPHAGUS, V27, P50, DOI 10.1111/dote.12039; Iseli Tim A, 2012, Ear Nose Throat J, V91, pE1; Ishihara R, 2008, GASTROINTEST ENDOSC, V67, P799, DOI 10.1016/j.gie.2007.08.018; Nonaka Kouichi, 2010, World J Gastrointest Endosc, V2, P69, DOI 10.4253/wjge.v2.i2.69; Oda I, 2012, DIGEST ENDOSC, V24, P129, DOI 10.1111/j.1443-1661.2012.01265.x; Oyama Tsuneo, 2005, Clin Gastroenterol Hepatol, V3, pS67, DOI 10.1016/S1542-3565(05)00291-0; Tamiya Y, 2010, ENDOSCOPY, V42, P8, DOI 10.1055/s-0029-1215215	30	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	SEP	2015	47	9					775	783		10.1055/s-0034-1391844		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CQ0GM	WOS:000360273400003		
J	Kume, K; Sakai, N; Goto, T				Kume, Keiichiro; Sakai, Nobuo; Goto, Takaaki			Development of a novel endoscopic manipulation system: the Endoscopic Operation Robot ver.3	ENDOSCOPY			English	Article								Background and aims: The next generation of flexible endoscopy platforms such as The Master and Slave Transluminal Endoscopic Robot (MASTER) is primarily for remote control manipulation of forceps, but manipulation of the flexible endoscope itself still depends on conventional techniques. We have developed the Endoscopic Operation Robot (EOR) ver.3, which incorporates haptic feedback to provide complete remote control flexible-endoscope manipulation. The present study aimed to evaluate the performance of the EOR ver.3. Method: A colonoscopy training model was used with scope insertion to the cecum. Force during insertion and insertion time (seconds) to the cecum were evaluated. The data were compared by colon zone and experience level (trainee or expert). Results: The mean insertion time into the cecum was 118.54 +/- 89.42 seconds. Stronger force and torque were required for deeper insertion of the scope. Expert and trainee endoscopists differed in the insertion time to the cecum, maximum counterclockwise torque, mean clockwise torque, and mean counterclockwise torque. Conclusion: The EOR ver.3 has operability with which endoscopists can easily familiarize themselves.	[Kume, Keiichiro] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 3, Kitakyushu 8078555, Japan; [Sakai, Nobuo; Goto, Takaaki] Kyushu Inst Technol, Fac Engn, Dept Appl Sci Integrated Syst Engn, Kitakyushu, Japan	Kume, K (reprint author), Univ Occupat & Environm Hlth, Japan Sch Med, Dept Internal Med 3, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu 8078555, Japan.	k-kume@med.uoeh-u.ac.jp			MEXT KAKENHI [23500573, 263500554]; Princess Takamatsu Cancer Research Fund [13-24505]	This work was supported by Grant-in Aid for Scientific Research (MEXT KAKENHI: 23500573 and 263500554) and Grant of the Princess Takamatsu Cancer Research Fund (13-24505).	Phee SJ, 2012, CLIN GASTROENTEROL H, V10, P1117, DOI 10.1016/j.cgh.2012.05.019; Spaun GO, 2009, SURG ENDOSC, V23, P2720, DOI 10.1007/s00464-009-0476-5; Ho KY, 2010, GASTROINTEST ENDOSC, V72, P593, DOI 10.1016/j.gie.2010.04.009; Phee SJ, 2010, SURG ENDOSC, V24, P2293, DOI 10.1007/s00464-010-0955-8; Thompson CC, 2009, GASTROINTEST ENDOSC, V70, P121, DOI 10.1016/j.gie.2008.11.007; Ikeda K, 2011, GASTROINTEST ENDOSC, V73, P117, DOI 10.1016/j.gie.2010.09.016; Klibansky D, 2012, CURR OPIN GASTROEN, V28, P477, DOI 10.1097/MOG.0b013e328356ac5e; Korman LY, 2012, GASTROINTEST ENDOSC, V76, P867, DOI 10.1016/j.gie.2012.05.030; Kume K, 2012, Endoscopy, V44 Suppl 2 UCTN, pE399, DOI 10.1055/s-0032-1310251; Kume K, 2015, HEPATOGASTR IN PRESS; Kume Keiichiro, 2011, World J Gastrointest Endosc, V3, P145, DOI 10.4253/wjge.v3.i7.145; Phee SJ, 2009, IEEE ENG MED BIO, P1192, DOI 10.1109/IEMBS.2009.5333413; Swanstrom LL, 2011, GASTROENTEROLOGY, V140, P1150, DOI 10.1053/j.gastro.2011.02.031; Yeung BP, 2012, INT J SURG, V10, P45	14	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	SEP	2015	47	9					815	819		10.1055/s-0034-1391973		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CQ0GM	WOS:000360273400008		
J	Nakadate, R; Nakamura, S; Moriyama, T; Kenmotsu, H; Oguri, S; Arata, J; Uemura, M; Ohuchida, K; Akahoshi, T; Ikeda, T; Hashizume, M				Nakadate, Ryu; Nakamura, Shotaro; Moriyama, Tomohiko; Kenmotsu, Hajime; Oguri, Susumu; Arata, Jumpei; Uemura, Munenori; Ohuchida, Kenoki; Akahoshi, Tomohiko; Ikeda, Tetsuo; Hashizume, Makoto			Gastric endoscopic submucosal dissection using novel 2.6-mm articulating devices: an ex vivo comparative and in vivo feasibility study	ENDOSCOPY			English	Article							LESIONS	Background and study aims: The conventional procedure of endoscopic submucosal dissection (ESD) is technically demanding. This study investigated the efficiency of novel articulating devices (maximum diameter 2.6mm), which can be used with commercially available, standard endoscopes. Patients and methods: In an ex vivo comparative study, eight endoscopists were divided into novices and experienced operators, and performed ESD using new devices and the conventional setup. An in vivo animal experiment was performed by two experts. Procedure times for incision and dissection were recorded, and unit times for circumferential length and area of specimens were calculated. Results: All procedures were successfully completed with en bloc resection. In the ex vivo study, the unit procedure times for incision and dissection by novices were significantly shorter using the new system (P<0.01 and P<0.05), whereas there was no significant difference for experienced endoscopists. Perforation occurred during one procedure in which the new system was used. The in vivo experiments were successfully completed without adverse events. Conclusions: ESD using novel articulating devices was feasible. These devices were able to reduce the procedure time for novices.	[Nakadate, Ryu; Nakamura, Shotaro; Kenmotsu, Hajime; Arata, Jumpei; Hashizume, Makoto] Kyushu Univ, Ctr Adv Med Innovat, Dept Res & Dev Surg Support Syst, Fukuoka 8128582, Japan; [Nakamura, Shotaro; Moriyama, Tomohiko] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Oguri, Susumu; Uemura, Munenori; Akahoshi, Tomohiko; Ikeda, Tetsuo; Hashizume, Makoto] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Fukuoka 8128582, Japan; [Ohuchida, Kenoki] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan	Hashizume, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	mhashi@dem.med.kyushu-u.ac.jp			Hogy Medical Co. Ltd., Japan	Drs. Nakadate, Nakamura, Arata, Ohuchida, and Hashizume have received research funding from Hogy Medical Co. Ltd., Japan.	Akahoshi K, 2010, ENDOSCOPY, V42, P419, DOI 10.1055/s-0029-1243973; Dallemagne B, 2010, MINIM INVASIV THER, V19, P257, DOI 10.3109/13645706.2010.514741; Wang Z, 2012, ENDOSCOPY, V44, P690, DOI 10.1055/s-0032-1309404; Thompson CC, 2009, GASTROINTEST ENDOSC, V70, P121, DOI 10.1016/j.gie.2008.11.007; Gotoda T, 1999, GASTROINTEST ENDOSC, V50, P560, DOI 10.1016/S0016-5107(99)70084-2; Fuchs KH, 2012, SURG ENDOSC, V26, P2281, DOI 10.1007/s00464-012-2173-z; Deprez PH, 2010, ENDOSCOPY, V42, P854, DOI 10.1055/s-0030-1255563; Fukami N, 2013, GASTROINTEST ENDOSC, V78, P274, DOI 10.1016/j.gie.2013.04.192; Homma K, 2012, DIGEST ENDOSC, V24, P419; Nakadate R, 2014, INT J CARS, V9, pS181; Sakurazawa N, 2009, ENDOSCOPY, V41, P929, DOI 10.1055/s-0029-1215191; Yahagi N, 2004, DIGEST ENDOSC, V16, P34, DOI 10.1111/j.1443-1661.2004.00313.x	12	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	SEP	2015	47	9					820	824		10.1055/s-0034-1391438		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CQ0GM	WOS:000360273400009		
J	Sato, H; Takeuchi, M; Takahashi, K; Sato, Y; Hashimoto, S; Mizuno, K; Suzuki, K; Kobayashi, M; Honma, T; Inoue, H; Terai, S				Sato, Hiroki; Takeuchi, Manabu; Takahashi, Kazuya; Sato, Yuichi; Hashimoto, Satoru; Mizuno, Kenichi; Suzuki, Kenji; Kobayashi, Masaaki; Honma, Terasu; Inoue, Haruhiro; Terai, Shuji			Nutcracker and jackhammer esophagus treatment: a three-case survey, including two novel cases of eosinophilic infiltration into the muscularis propria	ENDOSCOPY			English	Article							PERORAL ENDOSCOPIC MYOTOMY; MOTILITY DISORDERS	Nutcracker esophagus and jackhammer esophagus are largely unknown motility disorders, also sometimes called hypertensive and hypercontractile peristalsis, respectively. There is currently no standardized diagnostic or management plan for these diseases. Here, we report on three patients with jackhammer/nutcracker esophagus who were treated with either peroral endoscopic myotomy or a systemic steroid regimen, focusing particularly on two novel presentations of nutcracker and jackhammer esophagus involving eosinophilic infiltration into the muscularis propria, and their responses to both interventions.	[Sato, Hiroki; Takeuchi, Manabu; Sato, Yuichi; Hashimoto, Satoru; Mizuno, Kenichi; Suzuki, Kenji; Kobayashi, Masaaki; Terai, Shuji] Niigata Univ, Med & Dent Hosp, Div Gastroenterol & Hepatol, Niigata, Niigata 9518510, Japan; [Takahashi, Kazuya; Honma, Terasu] Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata, Japan; [Inoue, Haruhiro] Showa Univ, Ctr Digest Dis, Koto Toyosu Hosp, Tokyo, Japan	Sato, H (reprint author), Niigata Univ, Div Gastroenterol, Med & Dent Hosp, Chuo Ku, 757-1 Asahimachidori, Niigata, Niigata 9518510, Japan.	pyloki@yahoo.co.jp					Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Vanuytsel T, 2013, CLIN GASTROENTEROL H, V11, P1115, DOI 10.1016/j.cgh.2013.03.021; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Dellon ES, 2013, AM J GASTROENTEROL, V108, P679, DOI 10.1038/ajg.2013.71; TALLEY NJ, 1990, GUT, V31, P54, DOI 10.1136/gut.31.1.54; CATTAU EL, 1991, AM J GASTROENTEROL, V86, P272; Khashab MA, 2014, ENDOSCOPY, V46, P298, DOI 10.1055/s-0033-1359024; Philpott H, 2014, PHARMACOL THERAPEUT, DOI DOI 10.1016/J.PHARM-THERA.2014.09.001; Roman S, 2012, NEUROGASTROENT MOTIL, V24, P32, DOI 10.1111/j.1365-2982.2011.01837.x; Sato H, 2015, CLIN GASTROENTEROL H, V13, pE33, DOI 10.1016/j.cgh.2014.11.005	10	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	SEP	2015	47	9					855	857		10.1055/s-0034-1391985		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CQ0GM	WOS:000360273400012		
J	Inadera, H; Tanabe, T				Inadera, Hidekuni; Tanabe, Tsuyoshi			Greetings from the new Editor-in-Chief	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Editorial Material									[Inadera, Hidekuni] Toyama Univ, Dept Publ Hlth, Fac Med, Toyama 9300194, Japan; [Tanabe, Tsuyoshi] Yamaguchi Univ, Dept Publ Hlth, Grad Sch Med, Ube, Yamaguchi 7558505, Japan	Inadera, H (reprint author), Toyama Univ, Dept Publ Hlth, Fac Med, 2630 Sugitani, Toyama 9300194, Japan.	inadera@med.u-toyama.ac.jp; tanabe@yamaguchi-u.ac.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	SEP	2015	20	5					317	317		10.1007/s12199-015-0487-x		1	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ0TP	WOS:000360310400001		
J	Lu, X; Yamano, Y; Takahashi, H; Koda, M; Fujiwara, Y; Hisada, A; Miyazaki, W; Katoh, T				Lu, Xi; Yamano, Yuko; Takahashi, Hiroyuki; Koda, Masahide; Fujiwara, Yuki; Hisada, Aya; Miyazaki, Wataru; Katoh, Takahiko			Associations between estrogen receptor genetic polymorphisms, smoking status, and prostate cancer risk: a case-control study in Japanese men	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Prostate cancer; Estrogen receptor; Polymorphism; Genetic association studies; Smoke	BETA-GENE; ALPHA; EXPRESSION; CARCINOMA; DIETHYLSTILBESTROL; INDUCTION; APOPTOSIS; VARIANTS; COHORT; CELLS	Prostate cancer (PCa) is one of the major causes of death among men. Our study investigated the association of ESR1 and ESR2 genotypes with susceptibility to PCa in relation to smoking status in Japanese. A case-control study was performed with 750 Japanese prostate cancer patients and 870 healthy controls. After age-matching in case-controls, 352 controls and 352 cases were enrolled in this study. By using logistic regression analysis, the different genotypes from ESR1 and ESR2 were analyzed according to case/control status. ESR2 rs4986938 AG and AG + AA genotypes were associated with significantly decreased risk of PCa (AG: OR = 0.68, 95 % CI 0.47-0.97, P < 0.05 and AG + AA: OR = 0.67, 95 % CI 0.47-0.94, P < 0.05). However, there was no significant association between ESR1 rs2234693 and PCa risk. When patients were grouped according to smoking status, the ESR2 rs1256049 AA genotype (OR = 0.48, 95 % CI 0.25-0.95, P < 0.05) and ESR2 rs4986938 AG + AA genotype (OR = 0.64, 95 % CI 0.41-1.00, P < 0.05) showed significantly decreased PCa risk in the ever-smoker group. Our results suggest that the estrogen receptor ESR2 has a very important function to predict PCa and that different SNPs have different predictive values. Smoking may influence estrogenic activity and may influence PCa together with the estrogen receptor.	[Lu, Xi; Koda, Masahide; Fujiwara, Yuki; Hisada, Aya; Miyazaki, Wataru; Katoh, Takahiko] Kumamoto Univ, Dept Publ Hlth, Fac Life Sci, Chuo Ku, Kumamoto 8608556, Japan; [Yamano, Yuko] Showa Univ, Sch Med, Dept Hyg & Prevent Med, Tokyo 142, Japan; [Takahashi, Hiroyuki] Jikei Univ, Dept Pathol, Sch Med, Tokyo 105, Japan	Lu, X (reprint author), Kumamoto Univ, Dept Publ Hlth, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	lucyk1984@hotmail.com					Kuiper GGJM, 1997, FEBS LETT, V410, P87, DOI 10.1016/S0014-5793(97)00413-4; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; Hankey BF, 1999, J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Latil A, 2001, CANCER RES, V61, P1919; MISHINA T, 1985, PROSTATE, V6, P423, DOI 10.1002/pros.2990060411; Imamov O, 2004, P NATL ACAD SCI USA, V101, P9375, DOI 10.1073/pnas.0403041101; Alessio AM, 2007, THROMB RES, V120, P639, DOI 10.1016/j.thromres.2006.10.019; Bonkhoff H, 1999, AM J PATHOL, V155, P641, DOI 10.1016/S0002-9440(10)65160-7; Rosenkranz K, 1998, J CLIN ENDOCR METAB, V83, P4524, DOI 10.1210/jc.83.12.4524; DAI WS, 1988, AM J EPIDEMIOL, V128, P796; Hedelin M, 2006, PROSTATE, V66, P1512, DOI 10.1002/pros.20487; Huncharek M, 2010, AM J PUBLIC HEALTH, V100, P693, DOI 10.2105/AJPH.2008.150508; Allen NE, 2004, CANCER CAUSE CONTROL, V15, P911, DOI 10.1007/s10552-004-1683-y; Suzuki K, 2003, CANCER, V98, P1411, DOI 10.1002/cncr.11639; Horvath LG, 2001, CANCER RES, V61, P5331; Robertson CN, 1996, J NATL CANCER I, V88, P908, DOI 10.1093/jnci/88.13.908; Taylor AH, 2000, J MOL ENDOCRINOL, V24, P145, DOI 10.1677/jme.0.0240145; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; Bergner CC, 2007, ANTICANCER RES, V27, P2071; BOSLAND MC, 1995, CARCINOGENESIS, V16, P1311, DOI 10.1093/carcin/16.6.1311; Bosland MC., 2000, J NATL CANC I MONOGR, V27, P39; Chen YC, 2007, CANCER EPIDEM BIOMAR, V16, P1973, DOI 10.1158/1055-9965.EPI-07-0431; Ehara H, 1995, PROSTATE, V27, P304, DOI 10.1002/pros.2990270603; Furuya Y, 1998, Int J Urol, V5, P134, DOI 10.1111/j.1442-2042.1998.tb00261.x; Hotoribe S., 2008, YOUR MED BOOK PROSTA; Nakata S, 1993, HINYOKIKA KIYO, V39, P1024; Nakata S, 1993, Hinyokika Kiyo, V39, P1017; National Cancer Institute, 2014, PROST CANC TREATM PD; OISHI K, 1989, PROSTATE, V14, P117, DOI 10.1002/pros.2990140205; Risbridger G, 2001, DEV BIOL, V229, P432, DOI 10.1006/dbio.2000.9994; Safarinejad MR, 2012, MOL CARCINOG, V51, P104; Takamura-Enya T, 2003, FOOD CHEM TOXICOL, V41, P543, DOI 10.1016/S0278-6915(02)00305-8; Tanaka Y, 2003, MOL CARCINOGEN, V37, P202, DOI 10.1002/mc.10138; Thellenberg-Karlsson C, 2006, CLIN CANCER RES, V12, P1936, DOI 10.1158/1078-0432.CCR-05-0269; Wang YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066999	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	SEP	2015	20	5					332	337		10.1007/s12199-015-0471-5		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ0TP	WOS:000360310400004		
J	Tanaka, K; Ogata, S; Tanaka, H; Omura, K; Honda, C; Hayakawa, K				Tanaka, Kentaro; Ogata, Soshiro; Tanaka, Haruka; Omura, Kayoko; Honda, Chika; Hayakawa, Kazuo		Osaka Twin Res Grp	The relationship between body mass index and uric acid: a study on Japanese adult twins	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Twin study; Genetics; Environment; Uric acid; Body mass index	ISCHEMIC-HEART-DISEASE; EAST-ASIAN POPULATIONS; BLOOD-PRESSURE; URATE EXCRETION; OBESE SUBJECTS; RISK-FACTORS; HYPERURICEMIA; METAANALYSIS; ASSOCIATION; METABOLISM	The present study aimed to investigate the association between body mass index (BMI) and uric acid (UA) using the twin study methodology to adjust for genetic factors. The association between BMI and UA was investigated in a cross-sectional study using data from both monozygotic and dizygotic twins registered at the Osaka University Center for Twin Research and the Osaka University Graduate School of Medicine. From January 2011 to March 2014, 422 individuals participated in the health examination. We measured height, weight, age, BMI, lifestyle habits (Breslow's Health Practice Index), serum UA, and serum creatinine. To investigate the association between UA and BMI with adjustment for the clustering of a twin within a pair, individual-level analyses were performed using generalized linear mixed models (GLMMs). To investigate an association with adjustment for genetic and family environmental factors, twin-pair difference values analyses were performed. In all analysis, BMI was associated with UA in men and women. Using the GLMMs, standardized regression coefficients were 0.194 (95 % confidence interval: 0.016-0.373) in men and 0.186 (95 % confidence interval: 0.071-0.302) in women. Considering twin-pair difference value analyses, standardized regression coefficients were 0.333 (95 % confidence interval: 0.072-0.594) in men and 0.314 (95 % confidence interval: 0.151-0.477) in women. The present study shows that BMI was significantly associated with UA, after adjusting for both genetic and familial environment factors in both men and women.	[Tanaka, Kentaro] Gifu Univ, Dept Community Hlth Nursing, Sch Med, Gifu, Gifu 5011194, Japan; [Ogata, Soshiro; Tanaka, Haruka] Osaka Univ, Grad Sch Med, Dept Hlth Promot Sci, Osaka, Japan; [Tanaka, Haruka; Omura, Kayoko; Hayakawa, Kazuo] Mie Prefectural Coll Nursing, Tsu, Mie, Japan; [Honda, Chika] Osaka Univ, Ctr Twin Res, Grad Sch Med, Osaka, Japan	Tanaka, K (reprint author), Gifu Univ, Dept Community Hlth Nursing, Sch Med, 1-1 Yanagido, Gifu, Gifu 5011194, Japan.	ktanaka@gifu-u.ac.jp			University Grants from Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT KAKENHI [262931510]	We would like to thank all the twin pair participants who were included in the study. This work was supported by University Grants from Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) and MEXT KAKENHI Grant Number 262931510. Laboratory tests in this research were performed courtesy of Beckman Coulter, Inc.	Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; BRAND FN, 1985, AM J EPIDEMIOL, V121, P11; Purcell S, 2005, BEHAV GENET, V35, P491, DOI 10.1007/s10519-004-1484-9; Choi HK, 2004, ARTHRIT RHEUM-ARTHR, V51, P1023, DOI 10.1002/art.20821; Nan C, 2012, EUR J EPIDEMIOL, V27, P247, DOI 10.1007/s10654-012-9678-6; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Liu L, 2013, CLIN RHEUMATOL, V32, P233, DOI 10.1007/s10067-012-2108-z; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637; Krenke BE, 2002, J FORENSIC SCI, V47, P773; Yamagata S, 2013, DEVELOPMENTAL SCI, V16, P249, DOI 10.1111/desc.12021; Choi HK, 2010, CURR OPIN RHEUMATOL, V22, P165, DOI 10.1097/BOR.0b013e328335ef38; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oka R, 2009, DIABETES RES CLIN PR, V83, P100, DOI 10.1016/j.diabres.2008.10.001; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; YAMASHITA S, 1986, INT J OBESITY, V10, P255; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; KALOUSDIAN S, 1987, GENET EPIDEMIOL, V4, P1, DOI 10.1002/gepi.1370040102; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Krishnan E, 2009, CIRC-HEART FAIL, V2, P556, DOI 10.1161/CIRCHEARTFAILURE.108.797662; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Matsuura F, 1998, METABOLISM, V47, P929, DOI 10.1016/S0026-0495(98)90346-8; Ogura T, 2004, METABOLISM, V53, P448, DOI 10.1016/j.metabol.2003.11.017; Jin YL, 2013, INT J CARDIOL, V168, P2238, DOI 10.1016/j.ijcard.2013.01.214; Bates D., 2014, J STAT SOFTWAR UNPUB, DOI DOI 10.1016/J.JSPS.2012.11.002; Belloc N B, 1972, Prev Med, V1, P409, DOI 10.1016/0091-7435(72)90014-X; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.2307/2290687; Christensen K, 2001, J EPIDEMIOL COMMUN H, V55, P583, DOI 10.1136/jech.55.8.583; de Oliveira EP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-11; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; FABREGAT I, 1987, BIOCHEM BIOPH RES CO, V146, P920, DOI 10.1016/0006-291X(87)90618-8; FOX IH, 1981, METABOLISM, V30, P616, DOI 10.1016/0026-0495(81)90142-6; GLYNN RJ, 1983, ARTHRITIS RHEUM, V26, P87, DOI 10.1002/art.1780260115; Hayakawa K, 2013, TWIN RES HUM GENET, V16, P217, DOI 10.1017/thg.2012.141; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Ministry of Health L and W, 2007, NAT HLTH NUTR SURV J; Palmer TM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4262; Quirk JT, 2001, J EPIDEMIOL COMMUN H, V55, P746, DOI 10.1136/jech.55.10.746; R Core Team, 2014, R LANG ENV STAT COMP; Rathmann W, 2007, EUR J EPIDEMIOL, V22, P439, DOI 10.1007/s10654-007-9132-3; Remedios C, 2012, OBES SURG, V22, P945, DOI 10.1007/s11695-012-0655-7; Schretlen DJ, 2007, NEUROLOGY, V69, P1418, DOI 10.1212/01.wnl.0000277468.10236.f1; Smith T, 2006, POTENTIAL PARTICIPAT, P1; Kumari N. S., 2011, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V2, P1; Matsuzawa Y, 2002, CIRC J, V66, P987; Wada T, 2009, INTERNAL MED, V48, P647, DOI 10.2169/internalmedicine.48.1824; Yatsuya H, 2010, CIRC-CARDIOVASC QUAL, V3, P498, DOI 10.1161/CIRCOUTCOMES.109.908517	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	SEP	2015	20	5					347	353		10.1007/s12199-015-0473-3		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ0TP	WOS:000360310400006		
J	Nanayakkara, S; Senevirathna, STMLD; Parahitiyawa, NB; Abeysekera, T; Chandrajith, R; Ratnatunga, N; Hitomi, T; Kobayashi, H; Harada, KH; Koizumi, A				Nanayakkara, Shanika; Senevirathna, S. T. M. L. D.; Parahitiyawa, Nipuna B.; Abeysekera, Tilak; Chandrajith, Rohana; Ratnatunga, Neelakanthi; Hitomi, Toshiaki; Kobayashi, Hatasu; Harada, Kouji H.; Koizumi, Akio			Whole-exome sequencing reveals genetic variants associated with chronic kidney disease characterized by tubulointerstitial damages in North Central Region, Sri Lanka	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Chronic kidney disease; Sri Lanka; KCNA10; LAMB2; Genetic susceptibility	PUBLIC-HEALTH PROBLEM; CHRONIC-RENAL-FAILURE; CENTRAL PROVINCE; NEPHROTIC SYNDROME; BLOOD-PRESSURE; MUTATIONS; CHANNEL; LOCI; PODOCYTES; ETIOLOGY	The familial clustering observed in chronic kidney disease of uncertain etiology (CKDu) characterized by tubulointerstitial damages in the North Central Region of Sri Lanka strongly suggests the involvement of genetic factors in its pathogenesis. The objective of the present study is to use whole-exome sequencing to identify the genetic variants associated with CKDu. Whole-exome sequencing of eight CKDu cases and eight controls was performed, followed by direct sequencing of candidate loci in 301 CKDu cases and 276 controls. Association study revealed rs34970857 (c.658G > A/p.V220M) located in the KCNA10 gene encoding a voltage-gated K channel as the most promising SNP with the highest odds ratio of 1.74. Four rare variants were identified in gene encoding Laminin beta2 (LAMB2) which is known to cause congenital nephrotic syndrome. Three out of four variants in LAMB2 were novel variants found exclusively in cases. Genetic investigations provide strong evidence on the presence of genetic susceptibility for CKDu. Possibility of presence of several rare variants associated with CKDu in this population is also suggested.	[Nanayakkara, Shanika] Univ Sydney, Inst Dent Res, Fac Dent, Sydney, NSW 2006, Australia; [Senevirathna, S. T. M. L. D.] Univ Western Sydney, Sch Comp Engn & Math, Sydney, NSW, Australia; [Parahitiyawa, Nipuna B.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Abeysekera, Tilak] Univ Peradeniya, Fac Med, Dept Pharmacol, Peradeniya, Sri Lanka; [Chandrajith, Rohana] Univ Peradeniya, Dept Geol, Fac Sci, Peradeniya, Sri Lanka; [Ratnatunga, Neelakanthi] Univ Peradeniya, Dept Pathol, Fac Med, Peradeniya, Sri Lanka; [Hitomi, Toshiaki; Kobayashi, Hatasu; Harada, Kouji H.; Koizumi, Akio] Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto, Japan	Nanayakkara, S (reprint author), Univ Sydney, Inst Dent Res, Fac Dent, Sydney, NSW 2006, Australia.	shanika.nanayakkara@sydney.edu.au			Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology in Japan	The authors would like to acknowledge the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Matejas V, 2010, HUM MUTAT, V31, P992, DOI 10.1002/humu.21304; Abid A, 2012, GENE, V502, P133, DOI 10.1016/j.gene.2012.04.063; Chen YM, 2013, J AM SOC NEPHROL, V24, P1223, DOI 10.1681/ASN.2012121149; Athuraliya NTC, 2011, KIDNEY INT, V80, P1212, DOI 10.1038/ki.2011.258; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Simino J, 2011, AM J HYPERTENS, V24, P1227, DOI 10.1038/ajh.2011.140; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Thilo F, 2012, NEPHROL DIAL TRANSPL, V27, P921, DOI 10.1093/ndt/gfr457; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Wanigasuriya KP, 2007, T ROY SOC TROP MED H, V101, P1013, DOI 10.1016/j.trstmh.2007.05.006; Bandara JM, 2012, TOXICOL LETT, V198, P33; Bisceglia L, 2010, MOL GENET METAB, V99, P42, DOI 10.1016/j.ymgme.2009.09.001; Bostrom MA, 2012, AM J NEPHROL, V36, P252, DOI 10.1159/000342205; Casto AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001266; Chandrajith R, 2011, ENVIRON GEOCHEM HLTH, V33, P267, DOI 10.1007/s10653-010-9339-1; Chen YM, 2009, J AM SOC NEPHROL, V22, P849; Chen YM, 2011, J AM SOC NEPHROL, V22, P849, DOI 10.1681/ASN.2010060632; Dai B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044161; Grand T, 2011, HUM MUTAT, V32, P476, DOI 10.1002/humu.21467; Ileperuma OA, 2009, J NATL SCI FOUND SRI, V37, P219; Jayatilake N, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-180; Kohler R, 2010, PFLUG ARCH EUR J PHY, V459, P969, DOI 10.1007/s00424-010-0819-z; Lang R, 2000, AM J PHYSIOL-RENAL, V278, pF1013; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Mallela J, 2009, INT J BIOCHEM CELL B, V41, P477, DOI [10.1016/j.biocel.2008.02.022, 10.1010/j.biocel.2008.02.022]; Monnens L, 2008, NEPHROL DIAL TRANSPL, V23, P2719, DOI 10.1093/ndt/gfn373; Nanayakkara S, 2014, J OCCUP HEALTH, V56, P28; Nanayakkara Shanika, 2012, Environmental Health and Preventive Medicine, V17, P109, DOI 10.1007/s12199-011-0224-z; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Senevirathna L, 2011, ENV HLTH PREV MED, V17, P191; Servais A, 2008, CLIN J AM SOC NEPHRO, V3, P27, DOI 10.2215/CJN.01740407; Wickremasinghe A. R., 2011, Ceylon Medical Journal, V56, P143, DOI 10.4038/cmj.v56i4.3891; Wimalawansa SJ, 2014, ENVIRON HEALTH PREV, V19, P375, DOI 10.1007/s12199-014-0395-5; Yao XQ, 2002, J AM SOC NEPHROL, V13, P2831, DOI 10.1097/01.ASN.0000036866.37886.C5	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	SEP	2015	20	5					354	359		10.1007/s12199-015-0475-1		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ0TP	WOS:000360310400007		
J	Yamada, G; Imanaka, Y				Yamada, Go; Imanaka, Yuichi			Input-output analysis on the economic impact of medical care in Japan	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Input-output analysis; Econometrics; Policy evaluation; Healthcare reform; Monte Carlo simulation		Since the Cabinet's decision concerning the Basic Policies 2005, the Japanese government has implemented specific measures to suppress increases in national medical care expenditure. However, we believe that the economic significance of medical care should be quantified in terms of its economic impact on national medical care expenditure. No one has examined the economic impact of all medical institutions in Japan using data from a statement of profits and losses. We used an input-output analysis to quantitatively estimate economic impact of medical care and examined its estimation range with a probabilistic sensitivity analysis. To estimate the economic impact and economic impact multipliers of all medical institutions in Japan, an input-output analysis model was developed using an input-output table, statement of profits and losses, margin rates, employee income rates, consumption propensity and an equilibrium output model. Probabilistic sensitivity analysis was conducted using a Monte Carlo simulation. Economic impact of medical care in all medical institutions was Ayen72,107.4 billion ($661.5 billion). This impact yielded a 2.78-fold return of medical care expenditure with a 95 % confidence interval ranging from 2.74 to 2.90. Economic impact of medical care in Japan was two to three times the medical care expenditure (per unit). Production inducement of medical care is comparable to other industrial sectors that are highly influential toward the economy. The contribution to medical care should be evaluated more explicitly in national medical care expenditure policies.	[Yamada, Go; Imanaka, Yuichi] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Healthcare Econ & Qual Management,Sakyo Ku, Kyoto 6068501, Japan	Imanaka, Y (reprint author), Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Healthcare Econ & Qual Management,Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	damayag-sph@umin.ac.jp; imanaka-y@umin.net					Cabinet Office, 2013, BAS POL EC FISC MAN; Central Social Insurance Medical Council, MED EC SURV 1997 200; Crystal Ball&REG;, 2000, PROF ED COMP PROGR V; Doeksen GA, 2003, RURAL REMOTE HEALTH, V3, P1; Doeksen GA, 1997, MEASURING EC IMPORTA; Doi E, 2001, EC REV SHIZUOKA U, V6, P1; Evans J. R., 1998, INTRO SIMULATION RIS; House DR, 2004, J AM DENT ASSOC, V135, P347; Leontief W., 1986, INPUT OUTPUT EC; Leontief W. W., 1966, INPUT OUTPUT EC; LICHTY RW, 1986, MED CARE, V24, P350, DOI 10.1097/00005650-198604000-00006; Matsuda S, 1997, JPN J HLTH EC POLICY, V4, P51; Ministry of Health Labour and Welfare, 2008, EST NAT MED CAR EXP; Ministry of Health Labour and Welfare, 2013, ANN REP HLTH WELF 19; Ministry of Internal Affairs and Communications, 2013, ANN REP FAM INC EXP; Ministry of Internal Affairs and Communications, 2013, POL EV REP SCREEN SY; Ministry of Internal Affairs and Communications, 2000 I O TABL EMPL T; Ministry of Internal Affairs and Communications, 2004, 2000 INP OUTP TABL J; Ministry of Internal Affairs and Communications, 2005, 2000 INP OUTP TABL J; Miyazawa K., 2000, JPN J HLTH EC POLICY, V8, P51; Murata Y, 2005, INTRO EC FORECASTING, V3rd; Scorsone EA, 2001, EC IMPACT KNOX COUNT; Tsukahara Y., 1996, JPN J HLTH EC POLICY, V3, P39; Yasuda H., 2001, FINANCE REGION, V5, P185; Yasuda H., 2005, INPUT OUTPUT ANAL IN, V13, P57; Yasuda H., 2005, INPUT OUTPUT ANAL IN, V13, P67; Yasuda H., 2005, INPUT OUTPUT ANAL IN, V13, P66	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	SEP	2015	20	5					379	387		10.1007/s12199-015-0478-y		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ0TP	WOS:000360310400010		
J	Saito, T; Miyatake, N; Nishii, K				Saito, Takeshi; Miyatake, Nobuyuki; Nishii, Kenji			Relationship between cigarette smoking and one leg with eyes closed balance in Japanese men	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Cigarette smoking; One leg with eyes closed balance; Exercise habit; Balance; Japanese men	RELIABILITY	To investigate the link between cigarette smoking and one leg with eyes closed balance in Japanese men. We used data from 4224 Japanese men, aged 43.3 +/- A 13.9 years, in this cross-sectional study. Balance, such as one leg with eyes closed balance was measured. In addition, cigarette smoking habits were obtained by well-trained medical staff. The effect of cigarette smoking on one leg with eye closed balance was evaluated. A total of 1613 men (38.2 %) had smoking habit and 1471 men (34.8 %) regularly exercised. Age-related changes in one leg with eyes closed balance were noted. One leg with eyes closed balance in subjects with cigarette smoking (30.9 +/- A 31.8 s) was significantly lower than those in subjects without cigarette smoking (32.4 +/- A 33.5 s) even after adjusting for confounding factors i.e. age, body weight and exercise habits. Cigarette smoking might be associated with one leg with eyes closed balance in Japanese men.	[Saito, Takeshi] Okayama Southern Inst Hlth, Okayama Hlth Fdn, Okayama 7000952, Japan; [Saito, Takeshi; Miyatake, Nobuyuki] Kagawa Univ, Fac Med, Dept Hyg, Kagawa 7610793, Japan; [Nishii, Kenji] Okayama Hlth Fdn Hosp, Okayama Hlth Fdn, Okayama 7000952, Japan	Miyatake, N (reprint author), Kagawa Univ, Fac Med, Dept Hyg, Kagawa 7610793, Japan.	miyarin@med.kagawa-u.ac.jp			Ministry of Health, Labor, and Welfare, Japan	This research was supported in part by Research Grants from the Ministry of Health, Labor, and Welfare, Japan. We thank Dr. Takeyuki Numata at Okayama Southern Institute of Health, Okayama Health Foundation for his kind contribution to this study.	Szulc P, 2004, AM J CLIN NUTR, V80, P496; Franchignoni F, 1998, AGING-CLIN EXP RES, V10, P26; Michikawa T, 2009, J ORTHOP SCI, V14, P675, DOI 10.1007/s00776-009-1371-6; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Bishop MD, 2009, ARCH PHYS MED REHAB, V90, P1613, DOI 10.1016/j.apmr.2009.02.025; Giorgetti M M, 1998, Physiother Res Int, V3, P274, DOI 10.1002/pri.150; Miyatake N, 2014, ENVIRON HEALTH PREV, V19, P200, DOI 10.1007/s12199-013-0375-1; Miyatake N, 2009, ACTA MED OKAYAMA, V63, P151; Miyatake Nobuyuki, 2011, Environmental Health and Preventive Medicine, V16, P185, DOI 10.1007/s12199-010-0178-6; Miyatake N, 2010, ENV HLTH PREV MED, V15, P274; Oda K, 2012, HEALTH, V9, P570; PETO R, 1994, BRIT MED J, V309, P937; Ricci NA, 2011, ARCH GERONTOL GERIAT, V52, P79, DOI 10.1016/j.archger.2010.02.004; Saito Takeshi, 2012, J Prev Med Public Health, V45, P381, DOI 10.3961/jpmph.2012.45.6.381; Wolf B, 2001, CLIN REHABIL, V15, P624, DOI 10.1191/0269215501cr456oa	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	SEP	2015	20	5					388	391		10.1007/s12199-015-0457-3		4	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ0TP	WOS:000360310400011		
J	Islam, MS; Ahmed, MK; Habibullah-Al-Mamun, M; Raknuzzaman, M				Islam, Md. Saiful; Ahmed, Md. Kawser; Habibullah-Al-Mamun, Md.; Raknuzzaman, Mohammad			Trace elements in different land use soils of Bangladesh and potential ecological risk	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						Ecological risk; Trace elements; Urban soils; Bangladesh	HEAVY-METAL CONTAMINATION; HEALTH-RISK; SURFACE SEDIMENTS; HAZARDOUS ELEMENTS; INDUSTRIAL-AREA; SANTA-CATARINA; CHINA; POLLUTION; VEGETABLES; WATER	Bogra city is highly susceptible to environmental pollution due to overpopulation, rapid industrialization, and urbanization during the last decades. The levels of six trace elements (chromium, nickel, copper, arsenic, cadmium, and lead) in seven different land use soils in Bangladesh were assessed. The ranges of Cr, Ni, Cu, As, Cd, and Pb in studied soils were 6.3-256, 8.3-271, 13-279, 7.5-87, 0.09-29, and 5.3-624 mg/kg, respectively. The pollution load index (PLI) values for all land uses were higher than 1, indicating the progressive deterioration of soil due to trace elements contamination. In view of the potential ecological risk (PER), soils from all land uses showed moderate to very high potential ecological risk. Among the elements, As and Cd showed a higher potential ecological risk than the others.	[Islam, Md. Saiful] Patuakhali Sci & Technol Univ, Dept Soil Sci, Dumki 8602, Patuakhali, Bangladesh; [Habibullah-Al-Mamun, Md.; Raknuzzaman, Mohammad] Yokohama Natl Univ, Fac Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Habibullah-Al-Mamun, Md.; Raknuzzaman, Mohammad] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Ahmed, Md. Kawser] Univ Dhaka, Dept Oceanog, Earth & Environm Sci Fac, Dhaka 1000, Bangladesh; [Habibullah-Al-Mamun, Md.; Raknuzzaman, Mohammad] Univ Dhaka, Dept Fisheries, Dhaka 1000, Bangladesh	Islam, MS (reprint author), Patuakhali Sci & Technol Univ, Dept Soil Sci, Dumki 8602, Patuakhali, Bangladesh.	msaifulpstu@yahoo.com; kawser@univdhaka.edu; almamunhabib@gmail.com; mohammad-raknuzzaman-jc@ynu.jp					Ahmed MK, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4576-5; Amuno SA, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1435-2; Schwartz C, 2003, PLANT SOIL, V249, P27, DOI 10.1023/A:1022584220411; Karim Z, 2014, ECOL INDIC, V42, P20, DOI 10.1016/j.ecolind.2013.07.020; Dias CL, 2014, INT J COAL GEOL, V122, P50, DOI 10.1016/j.coal.2013.12.011; Han FXX, 2002, NATURWISSENSCHAFTEN, V89, P497, DOI 10.1007/s00114-002-0373-4; Papa S, 2010, ENVIRON MONIT ASSESS, V165, P193, DOI 10.1007/s10661-009-0938-1; Cerqueira B, 2012, SCI TOTAL ENVIRON, V421, P220, DOI 10.1016/j.scitotenv.2012.01.055; Ahmed MK, 2015, CHEMOSPHERE, V128, P284, DOI 10.1016/j.chemosphere.2015.02.016; Zhang WG, 2009, ENVIRON POLLUT, V157, P1533, DOI 10.1016/j.envpol.2009.01.007; Zheng N, 2008, ENVIRON POLLUT, V154, P135, DOI 10.1016/j.envpol.2008.01.001; Sayadi MH, 2011, ENVIRON EARTH SCI, V63, P1179, DOI 10.1007/s12665-010-0792-z; Arenas-Lago D, 2013, MICROCHEM J, V110, P681, DOI 10.1016/j.microc.2013.08.003; Bhuiyan MAH, 2011, ENVIRON MONIT ASSESS, V175, P633, DOI 10.1007/s10661-010-1557-6; Martinello K, 2014, SCI TOTAL ENVIRON, V470, P444, DOI 10.1016/j.scitotenv.2013.10.007; Islam MS, 2014, ENVIRON MONIT ASSESS, V186, P8727, DOI 10.1007/s10661-014-4040-y; Luo W, 2007, ENVIRON GEOCHEM HLTH, V29, P459, DOI 10.1007/s10653-007-9115-z; Huang LL, 2013, CHEMOSPHERE, V93, P1957, DOI 10.1016/j.chemosphere.2013.06.080; Polizzotto ML, 2013, ENVIRON POLLUT, V179, P210, DOI 10.1016/j.envpol.2013.04.025; Alam MGM, 2003, SCI TOTAL ENVIRON, V308, P83, DOI 10.1016/S0048-9697(02)00651-4; Guo WH, 2010, PROCEDIA ENVIRON SCI, V2, P729, DOI 10.1016/j.proenv.2010.10.084; Bai JH, 2011, ENVIRON POLLUT, V159, P817, DOI 10.1016/j.envpol.2010.11.004; Islam MS, 2015, ECOL INDIC, V48, P282, DOI 10.1016/j.ecolind.2014.08.016; Atafar Z, 2010, ENVIRON MONIT ASSESS, V160, P83, DOI 10.1007/s10661-008-0659-x; Li JH, 2009, ENVIRON MONIT ASSESS, V153, P365, DOI 10.1007/s10661-008-0363-x; Silva LFO, 2011, INT J COAL GEOL, V85, P237, DOI 10.1016/j.coal.2010.12.002; Wei BG, 2010, MICROCHEM J, V94, P99, DOI 10.1016/j.microc.2009.09.014; Yuan GL, 2014, J GEOCHEM EXPLOR, V136, P40, DOI 10.1016/j.gexplo.2013.10.002; Kashem MA, 1999, WATER AIR SOIL POLL, V115, P347, DOI 10.1023/A:1005193207319; Martin JAR, 2014, SCI TOTAL ENVIRON, V473, P518, DOI 10.1016/j.scitotenv.2013.12.075; Neumann RB, 2010, NAT GEOSCI, V3, P46, DOI 10.1038/NGEO685; Quispe D, 2012, FUEL, V94, P495, DOI 10.1016/j.fuel.2011.09.034; Li XP, 2012, ATMOS ENVIRON, V47, P58, DOI 10.1016/j.atmosenv.2011.11.041; Yadav S, 2006, ATMOS ENVIRON, V40, P698, DOI 10.1016/j.atmosenv.2005.10.005; Ahmad JU, 2010, ENVIRON MONIT ASSESS, V166, P347, DOI 10.1007/s10661-009-1006-6; Yu J, 2012, ENVIRON EARTH SCI, V65, P29, DOI 10.1007/s12665-011-1062-4; Chen X, 2010, J HAZARD MATER, V181, P640, DOI 10.1016/j.jhazmat.2010.05.060; Arenas-Lago D, 2014, ENVIRON SCI POLLUT R, V21, P10997, DOI 10.1007/s11356-014-3084-4; Liu GN, 2014, ECOL INDIC, V47, P210, DOI 10.1016/j.ecolind.2014.04.040; Cerqueira B, 2011, J HAZARD MATER, V195, P422, DOI 10.1016/j.jhazmat.2011.08.059; Rashed MN, 2010, J HAZARD MATER, V178, P739, DOI 10.1016/j.jhazmat.2010.01.147; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; [Anonymous], 2007, CULTURAL SURVEY REPO, P10; Cui YJ, 2004, ENVIRON INT, V30, P785, DOI 10.1016/j.envint.2004.01.003; Hower JC, 2013, INT J COAL GEOL, V116, P63, DOI 10.1016/j.coal.2013.06.007; Krishna AK, 2007, ENVIRON MONIT ASSESS, V124, P263, DOI 10.1007/s10661-006-9224-7; Martin JAR, 2013, GEODERMA, V200, P180, DOI 10.1016/j.geoderma.2013.02.014; Olawoyin R, 2012, ECOTOX ENVIRON SAFE, V85, P120, DOI 10.1016/j.ecoenv.2012.08.004; Bhuiyan MAH, 2010, J HAZARD MATER, V173, P384, DOI 10.1016/j.jhazmat.2009.08.085; CCME, 2003, CAN ENV QUAL GUID; DEP (Department of Environmental Protection), 2003, ASS LEV SOIL SED WAT; Islam MS, 2014, J AGR FOOD CHEM, V62, P10828, DOI 10.1021/jf502486q; Islam MS, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4533-3; Islam MS, 2015, ENVIRON EARTH SCI, V73, P1837, DOI 10.1007/s12665-014-3538-5; Kheir RB, 2010, ENVIRON POLLUT, V158, P520, DOI 10.1016/j.envpol.2009.08.009; Luoma SN, 2008, METAL CONTAMINATION IN AQUATIC ENVIRONMENTS: SCIENCE AND LATERAL MANAGEMENT, P1; Rahman SH, 2012, APPL SCI-BASEL, V2, P584, DOI 10.3390/app2030584; Saikia BK, 2014, INT J COAL GEOL, V121, P26, DOI 10.1016/j.coal.2013.11.007; Schottler SP, 2006, J PALEOLIMNOL, V36, P19, DOI 10.1007/s10933-006-0007-5; Srinivasa G.S., 2010, J HAZARD MATER, V174, P113, DOI DOI 10.1016/J.JHAZMAT.2009.09.024; Vare L., 2006, GEOPH RES ABSTR, V8; VROM, 2000, CIRC TARG VAL INT VA; [徐争启 Xu Zhengqi], 2008, [环境科学与技术, Enuivonmental Science and Technology], V31, P112	63	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	SEP	2015	187	9								10.1007/s10661-015-4803-0		11	Environmental Sciences	Environmental Sciences & Ecology	CQ0UN	WOS:000360313000041		
J	Li, ZL; Liu, ZH; Chen, RJ; Li, XJ; Tai, PD; Gong, ZQ; Jia, CY; Liu, W				Li, Zhaoling; Liu, Zhihong; Chen, Ruijuan; Li, Xiaojun; Tai, Peidong; Gong, Zongqiang; Jia, Chunyun; Liu, Wan			DNA damage and genetic methylation changes caused by Cd in Arabidopsis thaliana seedlings	ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY			English	Article						Amplified fragment length polymorphism; Methylation-sensitive amplification polymorphism; DNA damage; Genetic methylation; Cadmium	AFLP MARKERS; AUXIN TRANSPORT; GENOMIC DNA; CADMIUM; DIVERSITY; PROTEIN; PLANTS; POLYMORPHISM; EXPOSURE; ENCODES	Amplified fragment length polymorphism (AFLP) and methylation-sensitive amplification polymorphism (MASP) techniques are sensitive to deoxyribonucleic acid (DNA) damage and genetic methylation, respectively. Using these 2 techniques, Arabidopsis thaliana cultured with 0mg/L (control), 0.5mg/L, 1.5mg/L, and 5.0mg/L Cd2+ for 16d was used to analyze the DNA damage and methylation changes as a result of cadmium (Cd). The DNA was amplified by 14 AFLP primer pairs and 13 MSAP primer combinations. In the AFLP experiment, 62 polymorphic sites were found in the patterns of 11 primer combinations and a total of 1116 fragments were obtained in these patterns. There were no polymorphic bands in the remaining 3 pairs. The proportions of polymorphic sites in the 0.5-mg/L Cd2+ and 5.0-mg/L Cd2+ treatments were significantly different. Seven polymorphic fragments were then separated and successfully sequenced, yielding 6 nucleobase substitutions and 1 nucleobase deletion. Similarly, in the MSAP experiment, the MSAP% and number of demethylated-type bands were unchanged after Cd treatment, but the number of methylated-type bands was increased significantly in the 5.0-mg/L Cd2+ treatment group, a finding that may be associated with the AFLP results. The polymorphic bands were also sequenced and the functions of their homologous genes were determined. The DNA damage and methylation changes may be the primary cause of certain pathology changes as a result of Cd uptake in plants. Environ Toxicol Chem 2015;34:2095-2103. (c) 2015 SETAC	[Li, Zhaoling; Liu, Zhihong; Chen, Ruijuan; Li, Xiaojun; Tai, Peidong; Gong, Zongqiang; Jia, Chunyun; Liu, Wan] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Liaoning, Peoples R China; [Li, Zhaoling; Chen, Ruijuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Zhaoling] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Liu, Zhihong] Deakin Univ, Sch Life & Environm, Warrnambool, Vic, Australia	Liu, W (reprint author), Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Liaoning, Peoples R China.	liuwan63@hotmail.com			National Science Foundation of China [21347007, 41201310, 41101295]	The present study was supported by National Science Foundation of China (grants 21347007, 41201310, and 41101295).	Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Polanco C, 2002, PLANT SCI, V162, P817, DOI 10.1016/S0168-9452(02)00029-8; Leung KT, 2004, FEMS MICROBIOL ECOL, V47, P111, DOI [10.1016/S0168-6496(03)00254-X, 10.1016/S0168-9496(03)00254-X]; Koike M, 2002, BIOCHEM BIOPH RES CO, V298, P46, DOI 10.1016/S0006-291X(02)02391-4; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; di Toppi LS, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Castano A, 2004, MUTAT RES-FUND MOL M, V552, P141, DOI 10.1016/j.mrfmmm.2004.06.010; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Cambier S, 2010, ECOTOX ENVIRON SAFE, V73, P312, DOI 10.1016/j.ecoenv.2009.10.012; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Arasimowicz-Jelonek M, 2012, PLANT PHYSIOL BIOCH, V58, P124, DOI 10.1016/j.plaphy.2012.06.018; Bello MJ, 2004, MUTAT RES-FUND MOL M, V554, P23, DOI 10.1016/j.mrfmmm.2004.02.011; Black MC, 1996, ENVIRON TOXICOL CHEM, V15, P802, DOI 10.1897/1551-5028(1996)015<0802:DSBIFM>2.3.CO;2; Breyne P, 1999, MOL GEN GENET, V261, P627; Ellis RP, 1997, MOL BREEDING, V3, P359, DOI 10.1023/A:1009602321815; Filipic M, 2004, MUTAT RES-FUND MOL M, V546, P81, DOI 10.1016/j.mrfmmm.2003.11.006; [葛才林 Ge Cailin], 2002, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V28, P363; Hartmann M, 1998, CARCINOGENESIS, V19, P617, DOI 10.1093/carcin/19.4.617; Hoda A, 2012, ARCH BIOL SCI, V64, P799, DOI 10.2298/ABS1202799H; Huang JC, 2000, BIOTECHNIQUES, V28, P432; Juana G, 2006, J PLANT PHYSL, V163, P452; KING GJ, 1995, J HORTIC SCI, V70, P333; Kuiper MTR, 1998, METH MOL B, V82, P157; Lin RC, 2005, PLANT PHYSIOL, V138, P949, DOI 10.1104/pp105.061572; Liu W, 2012, CHEMOSPHERE, V89, P1048, DOI 10.1016/j.chemosphere.2012.05.068; Miyashita NT, 1999, GENETICS, V152, P1723; Paz EY, 2012, CROP BREED APPL BIOT, V12, P104, DOI 10.1590/S1984-70332012000200002; Rosa EVC, 2003, ENVIRON TOXICOL CHEM, V22, P645, DOI 10.1897/1551-5028(2003)022<0645:BGMIAA>2.0.CO;2; Ruiz-Garcia L, 2005, PLANTA, V222, P301, DOI 10.1007/s00425-005-1524-6; Singh KP, 2004, J CARCINOG, V3, P4, DOI 10.1186/1477-3163-3-4; Wong A, 2001, GENOME, V44, P677, DOI 10.1139/gen-44-4-677; Yabana N, 1996, MOL CELL BIOL, V16, P3420; Yu HC, 2011, RADIAT RES, V175, P599, DOI 10.1667/RR2209.1; Zhang Y, 2008, CHINESE SCI BULL, V53, P58, DOI 10.1007/s11434-008-0049-3	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-7268	1552-8618		ENVIRON TOXICOL CHEM	Environ. Toxicol. Chem.	SEP	2015	34	9					2095	2103		10.1002/etc.3033		9	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CQ3KJ	WOS:000360500600024		
J	Tajiri, J; Maruta, T; Hamada, K; Mizokami, T; Higashi, K				Tajiri, Junichi; Maruta, Tetsushi; Hamada, Katsuhiko; Mizokami, Tetsuya; Higashi, Kiichiro			Radioiodine for patients with autonomously functioning thyroid nodules with a normal TSH level	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION			English	Letter									[Tajiri, Junichi; Maruta, Tetsushi; Hamada, Katsuhiko; Mizokami, Tetsuya; Higashi, Kiichiro] Tajiri Thyroid Clin, Kumamoto 8620950, Japan	Tajiri, J (reprint author), Tajiri Thyroid Clin, Chuo Ku, 2-6-3 Suizenji, Kumamoto 8620950, Japan.	kojosen@j-tajiri.or.jp					Treglia G, 2015, EUR J CLIN INVEST, V45, P739, DOI 10.1111/eci.12456; Ianni F, 2013, J ENDOCRINOL INVEST, V36, P233, DOI 10.3275/8471; Chami R, 2014, EUR J ENDOCRINOL, V170, P593, DOI 10.1530/EJE-13-1003	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2972	1365-2362		EUR J CLIN INVEST	Eur. J. Clin. Invest.	SEP	2015	45	9					1003	1003		10.1111/eci.12497		1	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CP9NI	WOS:000360220700016		
J	Kumagai, S; Ishida, T; Tachibana, H; Ito, Y; Ito, A; Hashimoto, T				Kumagai, S.; Ishida, T.; Tachibana, H.; Ito, Y.; Ito, A.; Hashimoto, T.			Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CARE-ASSOCIATED PNEUMONIA; RESPIRATORY-TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; HOSPITALIZED-PATIENTS; PSEUDOMONAS-AERUGINOSA; RESISTANT PATHOGENS; ANTIBIOTIC-THERAPY; RISK	The aim of this study was to investigate the influence of bacterial coinfection on patients with pneumococcal pneumonia. We retrospectively analyzed the incidence, clinical features, microbial distributions, and outcomes of patients with bacterial coinfection in a cohort of 433 hospitalized patients with pneumococcal pneumonia. Eighty-five patients (19.6 %) were diagnosed with bacterial coinfection; the most frequent pathogens were Haemophilus influenzae (25 patients, 33.3 %), methicillin-susceptible Staphylococcus aureus (MSSA) (15 patients, 20.0 %), and Moraxella catarrhalis (13 patients, 17.3 %). The CURB-65 score and pneumonia severity index (PSI) were significantly higher in patients with bacterial coinfection (both P < 0.001). In addition, the proportion of patients with bacterial coinfection who met the Infectious Disease Society of America (IDSA)/American Thoracic Society (ATS) severe pneumonia criteria was significantly higher (P < 0.001). Multivariate logistic regression analysis identified three risk factors for bacterial coinfection in patients with pneumococcal pneumonia: alcoholism (odds ratio [OR], 5.12; 95 % confidence interval (95 % CI), 1.60-16.4; P = 0.006), hospitalization for 2 days or more within 90 days preceding admission (OR, 2.02; 95 % CI, 1.03-3.98; P = 0.041), and residence in a nursing home or extended care facility (OR, 3.22; 95 % CI, 1.48-6.97; P = 0.003). Multivariate analysis for 30-day mortality showed that bacterial coinfection was a significant adverse prognostic factor (OR, 2.50; 95 % CI, 1.13-5.53; P = 0.023), independent of IDSA/ATS severe pneumonia, PSI, or healthcare-associated pneumonia. In conclusion, bacterial coinfection may have an adverse impact on severity and outcomes of pneumococcal pneumonia.	[Kumagai, S.; Ishida, T.; Tachibana, H.; Ito, Y.; Ito, A.; Hashimoto, T.] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama 7100052, Japan	Kumagai, S (reprint author), Kurashiki Cent Hosp, Dept Resp Med, 1-1-1 Miwa, Kurashiki, Okayama 7100052, Japan.	skumagai1212@gmail.com					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Perez AC, 2014, PATHOG DIS, V70, P280, DOI 10.1111/2049-632X.12129; Chalmers JD, 2011, CLIN INFECT DIS, V53, P107, DOI 10.1093/cid/cir274; Ehara N, 2008, J MED MICROBIOL, V57, P820, DOI 10.1099/jmm.0.47793-0; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Shorr AF, 2012, CLIN INFECT DIS, V54, P193, DOI 10.1093/cid/cir813; FERNANDEZSOLA J, 1995, ARCH INTERN MED, V155, P1649, DOI 10.1001/archinte.155.15.1649; Weimer KED, 2011, J INFECT DIS, V203, P549, DOI 10.1093/infdis/jiq087; Tikhomirova A, 2013, PATHOG DIS, V69, P114, DOI 10.1111/2049-632X.12073; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Lieberman D, 1996, THORAX, V51, P179, DOI 10.1136/thx.51.2.179; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Polverino E, 2013, THORAX, V68, P1007, DOI 10.1136/thoraxjnl-2013-203828; Arancibia F, 2002, ARCH INTERN MED, V162, P1849, DOI 10.1001/archinte.162.16.1849; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mehta AJ, 2013, AM J RESP CRIT CARE, V188, P716, DOI 10.1164/rccm.201301-0061OC; von Baum H, 2010, EUR RESPIR J, V35, P598, DOI 10.1183/09031936.00091809; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Aliberti S, 2012, CLIN INFECT DIS, V54, P470, DOI 10.1093/cid/cir840; Cilloniz C, 2011, THORAX, V66, P340, DOI 10.1136/thx.2010.143982; Cilloniz C, 2011, CRIT CARE, V15, DOI 10.1186/cc10444; Craven DE, 2006, CURR OPIN INFECT DIS, V19, P153; de Roux A, 2006, EUR RESPIR J, V27, P795, DOI 10.1183/0903193606.00058605; FANG GD, 1990, MEDICINE, V69, P307; Gutierrez F, 2005, EUR J CLIN MICROBIOL, V24, P377, DOI 10.1007/s10096-005-1346-2; Margolis E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-59; Minagawa Shunsuke, 2008, Nihon Kokyuki Gakkai Zasshi, V46, P278; Nagaoka K, 2014, INFECT IMMUN, V82, P587, DOI 10.1128/IAI.00943-13; Riquelme R, 2011, EUR RESPIR J, V38, P106, DOI 10.1183/09031936.00125910; Steinhoff D, 1996, CLIN INFECT DIS, V22, P958; von Baum H, 2011, EUR RESPIR J, V37, P1151, DOI 10.1183/09031936.00037410; WHO, GLOB HLTH OBS GHO CA	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0934-9723	1435-4373		EUR J CLIN MICROBIOL	Eur. J. Clin. Microbiol. Infect. Dis.	SEP	2015	34	9					1839	1847		10.1007/s10096-015-2421-y		9	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	CP9OH	WOS:000360223400016		
J	Takamoto, K; Bito, I; Urakawa, S; Sakai, S; Kigawa, M; Ono, T; Nishijo, H				Takamoto, K.; Bito, I.; Urakawa, S.; Sakai, S.; Kigawa, M.; Ono, T.; Nishijo, H.			Effects of compression at myofascial trigger points in patients with acute low back pain: A randomized controlled trial	EUROPEAN JOURNAL OF PAIN			English	Article							ISCHEMIC COMPRESSION; HEALTHY-SUBJECTS; CLINICAL-TRIAL; PRIMARY-CARE; MASSAGE; THERAPY; ACUPUNCTURE; GUIDELINES; RELIABILITY; SENSITIVITY	BackgroundAlthough there is some evidence that massage therapy, especially compression at myofascial trigger points (MTrPs), is effective for sub-acute and chronic low back pain, the effectiveness of massage therapy with compression at MTrPs for acute low back pain has not been studied. MethodsTo evaluate the effectiveness of compression at MTrPs for acute low back pain, 63 patients with acute low back pain were randomly assigned to one of three groups: the MTrP group who received compression at MTrPs (N=23), the non-MTrP group who received compression at non-trigger points (N=21), and the effleurage massage group who received superficial massage (N=19). The patients received the assigned treatment 3 times/week for 2weeks. The subjective pain intensity in static and dynamic conditions and disability caused by low back pain were measured by the visual analogue scale (VAS) and Roland-Morris questionnaire (RMQ), respectively; along with the range of motion (ROM) at the lumbar region and pressure pain threshold (PPT) at trigger points before treatment (baseline), 1week after the start of treatment, and 1month after the end of treatment (follow-up). ResultsStatic and dynamic VAS score, PPT and ROM were significantly improved in the MTrP group compared with those in the non-MTrP and effleurage groups. ConclusionsThese results indicate that compression at MTrPs is effective to treat acute low back pain compared with compression at non-MTrPs and superficial massage. For this article, a commentary is available at the Wiley Online Library.	[Takamoto, K.; Urakawa, S.; Sakai, S.; Ono, T.] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Judo Neurophysiotherapy, Toyama, Japan; [Bito, I.; Nishijo, H.] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Syst Emot Sci, Toyama, Japan; [Kigawa, M.] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Publ Hlth, Toyama, Japan	Nishijo, H (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Judo Neurophysiotherapy, Toyama, Japan.	nishijo@med.u-toyama.ac.jp			Japan Judo Therapist Association	Supported by the Japan Judo Therapist Association.	Aguilera FJM, 2009, J MANIP PHYSIOL THER, V32, P515, DOI 10.1016/j.jmpt.2009.08.001; Albright J, 2001, PHYS THER, V81, P1641; Andersson Gunnar B. J., 1997, P93; Nakamura M, 2003, SPINE, V28, P2414, DOI 10.1097/01.BRS.0000085425.90995.09; Pengel LHM, 2003, BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; REEVES JL, 1986, PAIN, V24, P313, DOI 10.1016/0304-3959(86)90117-X; Hains G, 2010, J MANIP PHYSIOL THER, V33, P362, DOI 10.1016/j.jmpt.2010.05.003; Hou CR, 2002, ARCH PHYS MED REHAB, V83, P1406, DOI 10.1053/apmr.2002.34834; CAREY TS, 1995, NEW ENGL J MED, V333, P913, DOI 10.1056/NEJM199510053331406; Gerwin RD, 1997, PAIN, V69, P65, DOI 10.1016/S0304-3959(96)03248-4; Takamoto K, 2010, BRAIN TOPOGR, V23, P279, DOI 10.1007/s10548-010-0148-8; Hsieh LLC, 2006, BRIT MED J, V332, P696, DOI 10.1136/bmj.38744.672616.AE; Shah JP, 2008, ARCH PHYS MED REHAB, V89, P16, DOI 10.1016/j.apmr.2007.10.018; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Simons DG, 2004, J ELECTROMYOGR KINES, V14, P95, DOI 10.1016/j.jelekin.2003.09.018; MELZACK R, 1977, PAIN, V3, P3, DOI 10.1016/0304-3959(77)90032-X; Itoh K, 2007, COMPLEMENT THER MED, V15, P172, DOI 10.1016/j.ctim.2006.05.003; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Aoki Y, 2012, PAIN RES TREAT, V2012, P680, DOI 10.1155/2012/680496; CAFARELLI E, 1992, SPORTS MED, V14, P1, DOI 10.2165/00007256-199214010-00001; Cagnie B, 2013, J MANIP PHYSIOL THER, V36, P482, DOI 10.1016/j.jmpt.2013.07.001; Chatchawan U, 2005, J BODYWORK MOV THER, V9, P298, DOI 10.1016/j.jbmt.2005.02.001; Delaney JPA, 2002, J ADV NURS, V37, P364, DOI 10.1046/j.1365-2648.2002.02103.x; Franke A, 2000, FORSCH KOMP KLAS NAT, V7, P286, DOI 10.1159/000057176; Furlan A. D., 2008, COCHRANE DETABASE SY, V8, P1; Gatchel RJ, 2003, J OCCUP REHABIL, V13, P1, DOI 10.1023/A:1021823505774; Gerwin Robert D, 2004, Curr Pain Headache Rep, V8, P468, DOI 10.1007/s11916-004-0069-x; GOATS GC, 1994, BRIT J SPORT MED, V28, P149; Grieve Rob, 2011, J Bodyw Mov Ther, V15, P42, DOI 10.1016/j.jbmt.2010.02.005; Gulick Dawn T, 2011, J Bodyw Mov Ther, V15, P319, DOI 10.1016/j.jbmt.2010.06.007; Hains G, 2002, J CAN CHIROPR ASS, V46, P257; Hains G, 2000, J MANIP PHYSIOL THER, V23, P225; Hains G., 2002, J CAN CHIROPR ASS, V46, P192; Hains G, 2010, CLIN CHIROPRACTIC, V13, P201; Hong CZ, 2004, J MUSCULOSKELET PAIN, V12, P37, DOI 10.1300/J094v12n03_06; Hong Chang-Zern, 2006, Curr Pain Headache Rep, V10, P345, DOI 10.1007/s11916-006-0058-3; Itoh Kazunori, 2004, Acupunct Med, V22, P170; Kinkade S, 2007, AM FAM PHYSICIAN, V75, P1181; Koes B. W., 2001, SPINE, V26, P2513; Mense S., 2001, ADULT SPINE PRINCIPL; Mori H, 2004, MED SCI MONITOR, V10, pCR173; Patrick D. W., 1984, TXB PAIN, P691; Rachlin I, 1994, MYOFASCIAL PAIN FIBR, P455; Simons DG, 1999, MYOFASCIAL PAIN DYSF, V1, P2; Simons DG, 1996, J MUSCULOSKELET PAIN, V4, P93, DOI 10.1300/J094v04n01_07; SIMONS DG, 1983, POSTGRAD MED, V73, P66; SIMONS DG, 1984, ARCH PHYS MED REHAB, V65, P561; Suzukamo Yoshimi, 2003, J Orthop Sci, V8, P543, DOI 10.1007/s00776-003-0679-x; Takamoto K, 2009, J PHYSIOL SCI, V59, P191, DOI 10.1007/s12576-009-0025-y; vansTulder M, 2006, EUR SPINE J S, V15, pS169	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1090-3801	1532-2149		EUR J PAIN	Eur. J. Pain	SEP	2015	19	8					1186	1196		10.1002/ejp.694		11	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	CP8YG	WOS:000360180300017		
J	Nakamura, T; Okada, T; Endo, M; Nakamura, T; Oike, Y; Mizuta, H				Nakamura, Takayuki; Okada, Tatsuya; Endo, Motoyoshi; Nakamura, Takafumi; Oike, Yuichi; Mizuta, Hiroshi			Angiopoietin-like protein 2 promotes inflammatory conditions in the ligamentum flavum in the pathogenesis of lumbar spinal canal stenosis by activating interleukin-6 expression	EUROPEAN SPINE JOURNAL			English	Article						Angiopoietin-like protein 2; IL-6; Lumbar spinal canal stenosis; Ligamentum flavum; Fibroblasts	MATRIX METALLOPROTEINASES; SYSTEMIC-SCLEROSIS; COLLAGEN-SYNTHESIS; CELLS; HYPERTROPHY; METASTASIS; ANGPTL2; CARCINOGENESIS; PATHOMECHANISM; PROGRESSION	Chronic inflammation is thought to cause ligamentum flavum (LF) degeneration and hypertrophy in lumbar spinal canal stenosis (LSCS). Angiopoietin-like protein 2 (Angptl2) is highly expressed in hypertrophied LF. Because Angptl2 regulates interleukin-6 (IL-6) expression in various tissues, we investigated whether IL-6 is expressed in hypertrophied LF and, if so, does Angptl2 induce IL-6 expression in LF fibroblasts. LF tissue was obtained from LSCS patients and non-LSCS patients. Polymerase chain reaction (PCR) for Angptl2 and IL-6 genes and immunohistochemistry for IL-6 protein were performed in LF tissue. Fibroblasts from LF tissue were used for in vitro experiments. Expression of integrin alpha 5 beta 1 (an Angptl2 receptor) and Angptl2 binding to receptors on LF fibroblasts were examined by fluorescence-activated cell sorter analysis and cell adhesion assays. After Angptl2 recombinant protein treatment, NF-kappa B activation and IL-6 expression in LF fibroblasts were investigated by immunocytochemistry, PCR, and enzyme-linked immunosorbent assay. IL-6 mRNA expression was increased in hypertrophied LF tissue from LSCS patients and positively correlated with LF thickness and Angptl2 mRNA expression. IL-6 protein was highly expressed in LF fibroblasts in hypertrophied LF tissue. In vitro experiments demonstrated integrin alpha 5 beta 1 expression on LF fibroblasts and Angptl2 binding to cells via receptors. Angptl2 stimulation promoted NF-kappa B nuclear translocation and induced IL-6 expression and secretion in LF fibroblasts. Angptl2 promotes inflammation in LF tissue by activating IL-6 expression, leading to LF degeneration and hypertrophy.	[Nakamura, Takayuki; Okada, Tatsuya; Mizuta, Hiroshi] Kumamoto Univ, Dept Orthopaed Surg, Fac Life Sci, Chuo Ku, Kumamoto 8608556, Japan; [Nakamura, Takayuki; Endo, Motoyoshi; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Chuo Ku, Kumamoto 8608556, Japan; [Nakamura, Takafumi] Nakamura Orthopaed Clin, Kita Ku, Kumamoto 8600082, Japan; [Oike, Yuichi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Nakamura, T (reprint author), Kumamoto Univ, Dept Orthopaed Surg, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	110r5135@st.kumamoto-u.ac.jp					Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Knight DA, 2003, PHARMACOL THERAPEUT, V99, P327, DOI 10.1016/S0163-7258(03)00095-0; Hasegawa M, 1999, RHEUMATOLOGY, V38, P612, DOI 10.1093/rheumatology/38.7.612; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Kong MH, 2009, SPINE, V34, P2537, DOI 10.1097/BRS.0b013e3181b353ea; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Ogata A, 2012, BIOCHEM BIOPH RES CO, V418, P494, DOI 10.1016/j.bbrc.2012.01.052; Schrader PK, 1999, EUR SPINE J, V8, P323, DOI 10.1007/s005860050181; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Aoi J, 2014, MOL CANCER RES, V12, P239, DOI 10.1158/1541-7786.MCR-13-0336; Border W, 1994, NEW ENGL J MED, V11, P1286, DOI DOI 10.1056/NEJM199411103311907; Chen YT, 2011, SPINE, V36, pE1193, DOI 10.1097/BRS.0b013e3182053f58; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Kawaguchi Y, 1999, J CLIN INVEST, V103, P1253, DOI 10.1172/JCI4304; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Moon HJ, 2012, SPINE, V37, pE147, DOI 10.1097/BRS.0b013e3182269b19; Nakamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085542; Nakatani T, 2002, J ORTHOPAED RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Park J B, 2001, Spine (Phila Pa 1976), V26, pE492, DOI 10.1097/00007632-200111010-00007; Park JO, 2013, J SPINAL DISORD TECH, V26, pE6, DOI 10.1097/BSD.0b013e3182698501; Sairyo K, 2005, SPINE, V30, P2649, DOI 10.1097/01.brs.0000188117.77657.ee; Sairyo K, 2007, SPINE, V32, pE340, DOI 10.1097/01.brs.0000263407.25009.6e	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	SEP	2015	24	9					2001	2009		10.1007/s00586-015-3835-z		9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CQ0US	WOS:000360313600016		
J	Sato, M; Inage, K; Sakuma, Y; Sato, J; Orita, S; Yamauchi, K; Eguchi, Y; Ochiai, N; Kuniyoshi, K; Aoki, Y; Nakamura, J; Miyagi, M; Suzuki, M; Kubota, G; Sainoh, T; Fujimoto, K; Shiga, Y; Abe, K; Kanamoto, H; Inoue, G; Takahashi, K; Ohtori, S				Sato, Masashi; Inage, Kazuhide; Sakuma, Yoshihiro; Sato, Jun; Orita, Sumihisa; Yamauchi, Kazuyo; Eguchi, Yawara; Ochiai, Nobuyasu; Kuniyoshi, Kazuki; Aoki, Yasuchika; Nakamura, Junichi; Miyagi, Masayuki; Suzuki, Miyako; Kubota, Gou; Sainoh, Takeshi; Fujimoto, Kazuki; Shiga, Yasuhiro; Abe, Koki; Kanamoto, Hiroto; Inoue, Gen; Takahashi, Kazuhisa; Ohtori, Seiji			Anti-RANKL antibodies decrease CGRP expression in dorsal root ganglion neurons innervating injured lumbar intervertebral discs in rats	EUROPEAN SPINE JOURNAL			English	Article						Pain; Nerve; Intervertebral disc; RANKL; CGRP	NECROSIS-FACTOR-ALPHA; EARLY POSTMENOPAUSAL WOMEN; SENSORY NERVE-FIBERS; LOW-BACK-PAIN; SUBSTANCE-P; KAPPA-B; BONE-RESORPTION; PORTION; MODEL; INTERLEUKIN-1	Nuclear factor-kappa B (NF-kappa B), receptor activator of NF-kappa B (RANK), and RANK ligand (RANKL) are transcriptional regulators of inflammatory cytokines. RANKL expression in dorsal root ganglion (DRG) neurons is elevated in animal models of pain or intervertebral disc herniation. We sought to evaluate the effect of anti-RANKL antibodies on sensory nerves innervating injured intervertebral discs. We labeled DRG neurons innervating L5-6 discs with FluoroGold (FG). The L5-6 discs of 36 rats were punctured using a 23-gage needle and 18 rats underwent sham surgery without disc puncture. The puncture group was evenly subdivided into a group in which 10 mu l saline was administered to the injured disc and a group in which 10 mu l of anti-RANKL antibody was administered. Seven and 14 days postsurgery, DRGs at L2 level were harvested, sectioned, and immunostained for calcitonin gene-related peptide (CGRP). The proportion of CGRP-immunoreactive (IR) DRG neurons of all FG-positive neurons was determined. Amount of tumor necrosis factor (TNF)-alpha and interleukin(IL)-6 was measured within the intervertebral discs in each group at 7 and 14 days after surgery using an enzyme-linked immunosorbent assay (ELISA). The proportion of CGRP-IR DRG neurons to total FG-labeled neurons innervating injured intervertebral discs and amount of TNF-alpha and IL-6 in the injured discs in the saline control group was significantly increased compared with that found in rats from the sham surgery group (P < 0.05). However, application of anti-RANKL antibody to the injured discs significantly decreased the proportion of CGRP-IR DRG neurons to total FG-labeled neurons and amount of TNF-alpha and IL-6 in the injured discs (P < 0.05). TNF-alpha and IL-6 in the injured discs increased and CGRP expression increased in DRG neurons innervating injured discs, and antibodies to RANKL could suppress this increased TNF-alpha, IL-6, and CGRP expression. RANKL may be a therapeutic target for pain control in patients with lumbar disc degeneration.	[Sato, Masashi; Inage, Kazuhide; Sakuma, Yoshihiro; Sato, Jun; Orita, Sumihisa; Yamauchi, Kazuyo; Eguchi, Yawara; Ochiai, Nobuyasu; Kuniyoshi, Kazuki; Aoki, Yasuchika; Nakamura, Junichi; Miyagi, Masayuki; Suzuki, Miyako; Kubota, Gou; Sainoh, Takeshi; Fujimoto, Kazuki; Shiga, Yasuhiro; Abe, Koki; Kanamoto, Hiroto; Inoue, Gen; Takahashi, Kazuhisa; Ohtori, Seiji] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Chiba 2608670, Japan	Ohtori, S (reprint author), Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	sohtori@faculty.chiba-u.jp					Lotz JC, 2006, J BONE JOINT SURG AM, V88A, P76, DOI 10.2106/JBJS.E.01448; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathol.3.12.1806.151431; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3; Ohtori S, 2012, SPINE, V37, P439, DOI 10.1097/BRS.0b013e318238af83; MCCARTHY PW, 1991, SPINE, V16, P653, DOI 10.1097/00007632-199106000-00010; Opree A, 2000, J NEUROSCI, V20, P6289; Ohtori S, 2001, SPINE, V26, P946, DOI 10.1097/00007632-200104150-00020; Moen MD, 2011, DRUG AGING, V28, P63, DOI 10.2165/11203300-000000000-00000; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Inoue G, 2006, SPINE, V31, P2904, DOI 10.1097/01.brs.0000248424.46652.67; Hua XY, 1996, J NEUROSCI, V16, P4742; Ozawa T, 2006, SPINE, V31, P2418, DOI 10.1097/01.brs.0000239159.74211.9c; Ohtori S, 2012, EUR SPINE J, V21, P2079, DOI 10.1007/s00586-012-2183-5; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Fulfaro F, 1998, PAIN, V78, P157, DOI 10.1016/S0304-3959(98)00135-3; ASHTON IK, 1994, ACTA ORTHOP SCAND, V65, P635, DOI 10.3109/17453679408994620; Miyagi M, 2014, SPINE, V39, P1345, DOI 10.1097/BRS.0000000000000334; Charatcharoenwitthaya N, 2007, J BONE MINER RES, V22, P724, DOI 10.1359/JBMR.070207; DING MZ, 1995, J NEUROBIOL, V28, P445, DOI 10.1002/neu.480280405; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Horii M, 2011, SPINE, V36, pE80, DOI 10.1097/BRS.0b013e3181d4be3c; Ma Weiya, 1998, Brain Research, V797, P243, DOI 10.1016/S0006-8993(98)00380-1; Matsuyama Yoshiyuki, 2014, Asian Spine J, V8, P557, DOI 10.4184/asj.2014.8.5.557; Nachemson A, 2004, LUMBAR SPINE, P3; Nakamura S, 1996, SPINE, V21, P917, DOI 10.1097/00007632-199604150-00003; Ohtori S, 1999, SPINE, V24, P2295, DOI 10.1097/00007632-199911150-00002; Ohtori S, 2010, J ORTHOP SCI, V15, P731, DOI 10.1007/s00776-010-1538-1; Ohtori S, 2014, SPINE J; Ohtori S, 2002, ANN ANAT, V184, P235, DOI 10.1016/S0940-9602(02)80113-3; Onda A, 2004, SPINE, V29, P1857, DOI 10.1097/01.brs.0000137054.08788.b2; Ozawa T, 2003, NEUROSCI LETT, V344, P65, DOI 10.1016/S0304-3940(03)00416-6; Sakurai H, 1997, BBA-MOL BASIS DIS, V1362, P252, DOI 10.1016/S0925-4439(97)00068-9; Smith HS, 2014, AM J THER, V21, P106, DOI 10.1097/MJT.0b013e3182456dff; Suzuki M, 2009, EUR SPINE J, V18, P1001, DOI 10.1007/s00586-009-0940-x; Van Offel JF, 2001, CLIN EXP RHEUMATOL, V19, P13	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	SEP	2015	24	9					2017	2022		10.1007/s00586-015-4058-z		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CQ0US	WOS:000360313600018		
J	Fukui, D; Kawakami, M; Yoshida, M; Nakao, S; Matsuoka, T; Yamada, H				Fukui, Daisuke; Kawakami, Mamoru; Yoshida, Munehito; Nakao, Shin-ichi; Matsuoka, Toshiko; Yamada, Hiroshi			Gait abnormality due to spinal instability after lumbar facetectomy in the rat	EUROPEAN SPINE JOURNAL			English	Article						Lumbar facetectomy; Spinal instability; Low back pain; CatWalk method	PAIN BEHAVIOR; MODEL; INJURY; ALLODYNIA; PUNCTURE; FLEXION; SYSTEM	Spinal instability of the lumbar spine causes various clinical symptoms. Among them, spinal instability is thought to contribute to low back pain, but the pathophysiological mechanisms are controversial. Although experimental animal models of spinal instability have been reported, it is unknown whether these models produce pain and whether spinal instability affects walking ability. We used the CatWalk system to investigate whether lumbar facetectomy causes gait abnormalities and low back pain. Thirty male Sprague-Dawley rats were divided into three experimental groups. In the sham group, only the bilateral L4-L5 facet joints were exposed. In the experimental group, rats underwent complete resection of the bilateral L4-L5 facet joints without neural tissue injury. The control group comprised na < ve rats. The CatWalk system was used to analyze gait in postoperative weeks 3, 4.5, 6, and 7. Radiological and histological analyses were also performed. At 7 weeks postoperatively, the rats in the experimental group showed the gait abnormalities seen in low back pain and neuropathic pain models. Radiological examination of the same rats revealed spinal instability with histological evidence of intervertebral disc degeneration. These results suggest that spinal instability and/or intervertebral disc degeneration induce gait abnormalities and low back pain. This experimental model may be useful for elucidating the mechanisms underlying clinical symptoms, such as low back pain, in patients with spinal instability.	[Fukui, Daisuke; Kawakami, Mamoru; Nakao, Shin-ichi; Matsuoka, Toshiko] Wakayama Med Univ, Kihoku Hosp, Spine Care Ctr, Katsuragicho, Wakayama, Japan; [Yoshida, Munehito; Yamada, Hiroshi] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama, Wakayama, Japan	Fukui, D (reprint author), Wakayama Med Univ, Kihoku Hosp, Spine Care Ctr, 219 Myouji, Katsuragicho, Wakayama, Japan.	yumeka18@ares.eonet.ne.jp			Japan Ministry of Education, Science, Sports, and Culture [2259164]	Part of this study was supported by a grant from the Japan Ministry of Education, Science, Sports, and Culture, Grand-in-aid for scientific research No. 2259164, 2010, 2011, and 2012.	Angeby-Möller Kristina, 2008, J Neurosci Methods, V174, P1, DOI 10.1016/j.jneumeth.2008.06.017; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Miyagi M, 2013, SPINE, V38, P1459, DOI 10.1097/BRS.0b013e318299536a; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Olmarker K, 2002, SPINE, V27, P1312, DOI 10.1097/00007632-200206150-00013; Gabriel AF, 2007, J NEUROSCI METH, V163, P9, DOI 10.1016/j.jneumeth.2007.02.003; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; [Anonymous], 1982, CLIN ORTHOPAEDICS; Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Vogelaar CF, 2004, BRAIN RES, V1027, P67, DOI 10.1016/j.brainres.2004.08.036; Gillespie KA, 2004, SPINE, V29, P1208, DOI 10.1097/00007632-200406010-00010; Miyagi M, 2011, SPINE, V36, P1760, DOI 10.1097/BRS.0b013e3182269732; Ferreira-Gomes J, 2008, J PAIN, V9, P945, DOI 10.1016/j.jpain.2008.05.012; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hadjipavlou AG, 1998, J SPINAL DISORD, V11, P312; Ian A, 1989, SPINE, V14, P68; KAIGLE AM, 1995, SPINE, V20, P421, DOI 10.1097/00007632-199502001-00004; Kawchuk GN, 2001, SPINE, V26, P1348, DOI 10.1097/00007632-200106150-00018; Lee KE, 2004, J NEUROSCI METH, V137, P151, DOI 10.1016/j.jneumeth.2004.02.021; NACHEMSON A, 1985, SPINE, V10, P290, DOI 10.1097/00007632-198504000-00019; Nakamae T, 2011, SPINE, V36, pE232, DOI 10.1097/BRS.0b013e3181d8bef3; Olmarker K, 2008, SPINE, V33, P850, DOI 10.1097/BRS.0b013e31816b46ca; PINTAR FA, 1992, SPINE, V17, P804, DOI 10.1097/00007632-199207000-00013	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	SEP	2015	24	9					2085	2094		10.1007/s00586-014-3537-y		10	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CQ0US	WOS:000360313600026		
J	Yamamichi, M; Miner, BE				Yamamichi, Masato; Miner, Brooks E.			Indirect evolutionary rescue: prey adapts, predator avoids extinction	EVOLUTIONARY APPLICATIONS			English	Article						climate change; community evolutionary rescue; contemporary evolution; eco-evolutionary dynamics; eco-evolutionary feedback; environmental change; phenotypic plasticity; rapid evolution	INDUCIBLE DEFENSES; ANTIBIOTIC-RESISTANCE; ENVIRONMENTAL-CHANGE; COMPETITIVE ABILITY; PREVENT EXTINCTION; NATURAL-SELECTION; RAPID EVOLUTION; CLIMATE-CHANGE; TRADE-OFF; DYNAMICS	Recent studies have increasingly recognized evolutionary rescue (adaptive evolution that prevents extinction following environmental change) as an important process in evolutionary biology and conservation science. Researchers have concentrated on single species living in isolation, but populations in nature exist within communities of interacting species, so evolutionary rescue should also be investigated in a multispecies context. We argue that the persistence or extinction of a focal species can be determined solely by evolutionary change in an interacting species. We demonstrate that prey adaptive evolution can prevent predator extinction in two-species predator-prey models, and we derive the conditions under which this indirect evolutionary interaction is essential to prevent extinction following environmental change. A nonevolving predator can be rescued from extinction by adaptive evolution of its prey due to a trade-off for the prey between defense against predation and population growth rate. As prey typically have larger populations and shorter generations than their predators, prey evolution can be rapid and have profound effects on predator population dynamics. We suggest that this process, which we term indirect evolutionary rescue', has the potential to be critically important to the ecological and evolutionary responses of populations and communities to dramatic environmental change.	[Yamamichi, Masato; Miner, Brooks E.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Yamamichi, M (reprint author), Kyoto Univ, Hakubi Ctr Adv Res, Ctr Ecol Res, Sakyo Ku, Kyoto 6068501, Japan.	my287@cornell.edu			Japan Society for the Promotion of Science [24-869]; U.S. National Science Foundation [DBI-1103619]	We thank N.G. Hairston Jr., S. P. Ellner, and T. Yoshida for helpful discussions and comments. M. Y. was supported by a Postdoctoral Fellowship for Research Abroad (24-869) from the Japan Society for the Promotion of Science. B.E.M. was supported by a Postdoctoral Research Fellowship in Biology (DBI-1103619) from the U.S. National Science Foundation.	Abrams PA, 2009, J THEOR BIOL, V261, P294, DOI 10.1016/j.jtbi.2009.07.026; Alexander HK, 2014, EVOL APPL, V7, P1161, DOI 10.1111/eva.12221; Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Fussmann GF, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0036; Shuster SM, 2006, EVOLUTION, V60, P991, DOI 10.1554/05-121.1; Becks L, 2010, ECOL LETT, V13, P989, DOI 10.1111/j.1461-0248.2010.01490.x; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.2307/2407703; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Abrams PA, 2001, ECOL LETT, V4, P166, DOI 10.1046/j.1461-0248.2001.00199.x; Norberg J, 2012, NAT CLIM CHANGE, V2, P747, DOI [10.1038/nclimate1588, 10.1038/NCLIMATE1588]; Vos M, 2004, OIKOS, V105, P471, DOI 10.1111/j.0030-1299.2004.12930.x; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Abrams PA, 2005, CAN J FISH AQUAT SCI, V62, P758, DOI 10.1139/F05-051; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; HAIRSTON NG, 1984, AM NAT, V123, P733; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; Gonzalez A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0404; Fine PVA, 2006, ECOLOGY, V87, pS150; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Yoshida T, 2004, P ROY SOC B-BIOL SCI, V271, P1947, DOI 10.1098/rspb.2004.2818; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.2307/2410305; Lindsey HA, 2013, NATURE, V494, P463, DOI 10.1038/nature11879; Agashe D, 2011, EVOLUTION, V65, P2481, DOI 10.1111/j.1558-5646.2011.01307.x; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Carlson SM, 2014, TRENDS ECOL EVOL, V29, P521, DOI 10.1016/j.tree.2014.06.005; Osmond MM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0085; ABRAMS PA, 1993, EVOL ECOL, V7, P465, DOI 10.1007/BF01237642; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Ellner SP, 2013, FUNCT ECOL, V27, P1087, DOI 10.1111/1365-2435.12174; Harvell C. D., 1999, ECOLOGY EVOLUTION IN; Hiltunen T, 2014, ECOL LETT, V17, P915, DOI 10.1111/ele.12291; Jones AG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-119; Kasada M, 2014, P NATL ACAD SCI USA, V111, P16035, DOI 10.1073/pnas.1406357111; Kovach-Orr C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0084; Leishman MR, 2014, J ECOL, V102, P1451, DOI 10.1111/1365-2745.12318; Matsuda H, 1996, EVOL ECOL, V10, P13, DOI 10.1007/BF01239343; Mougi A, 2013, THEOR ECOL-NETH, V6, P165, DOI 10.1007/s12080-012-0168-y; Northfield TD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001685; Ramos-Jiliberto R, 2003, THEOR POPUL BIOL, V64, P221, DOI 10.1016/S0040-5809(03)00073-X; Schroder A, 2014, TRENDS ECOL EVOL, V29, P614, DOI 10.1016/j.tree.2014.08.006; Taylor P, 1997, EVOL ECOL, V11, P579, DOI 10.1007/s10682-997-1513-2; Tien RJ, 2012, ECOL MONOGR, V82, P491, DOI 10.1890/11-2168.1; Verschoor AM, 2004, ECOL LETT, V7, P1143, DOI 10.1111/j.1461-0248.2004.00675.x; Yamamichi M, 2011, AM NAT, V178, P287, DOI 10.1086/661241	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-4571			EVOL APPL	Evol. Appl.	SEP	2015	8	8					787	795		10.1111/eva.12295		9	Evolutionary Biology	Evolutionary Biology	CQ0UI	WOS:000360312400003		
J	Arima, H; Hayashi, Y; Higashi, T; Motoyama, K				Arima, Hidetoshi; Hayashi, Yuya; Higashi, Taishi; Motoyama, Keiichi			Recent advances in cyclodextrin delivery techniques	EXPERT OPINION ON DRUG DELIVERY			English	Review						active pharmaceutical ingredient; cyclodextrin; drug delivery system; excipient non-viral vector; supramolecule	METHYL-BETA-CYCLODEXTRIN; MESOPOROUS SILICA NANOPARTICLES; FAMILIAL AMYLOIDOTIC POLYNEUROPATHY; SUSTAINED-RELEASE SYSTEM; NEURONAL SIRNA DELIVERY; INTERFERING RNA SIRNA; IN-VITRO; GENE DELIVERY; DRUG-DELIVERY; AMPHIPHILIC CYCLODEXTRINS	Introduction: Active pharmaceutical ingredients(APIs) are evolving from low-molecular-weight drugs to peptide-, protein-, gene-, oligonucleotide and cell-based drugs. Therefore, advanced pharmaceutical technologies are required to achieve manifestation of the drug efficacy, side effect reduction and the adequate dosage form design. Areas covered: In this review, the authors highlight the recent advances in drug delivery techniques utilizing cyclodextrins (CyDs), and cyclic oligosaccharides consisting of alpha-1,4-linkeda alpha-D-glucopyranoseunits, for various drugs described above. Especially, drug delivery system consisting of combination systems of CyDs and functional materials such as dendrinner, liposome and PEG are introduced. Furthermore, the utilities of CyDs as APIs have been also described. Expert opinion: To achieve the controlled release and/or targeting of lowmolecular-weight drugs in systemic administration, the construction of novel CyDs and CyD the supramolecular system should be a useful approach because of the stable complexation of drugs with CyDs. In addition, the combination systems of CyDs and various carriers have the potential as advanced drug delivery systems for proteins and nucleic acids. Furthermore, CyDs have great potential as APIs for various diseases with few side effects, although the detailed mechanism, especially cellular uptake of CyDs, should be clarified.	[Arima, Hidetoshi; Hayashi, Yuya; Higashi, Taishi; Motoyama, Keiichi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan; [Arima, Hidetoshi] Kumamoto Univ, Program Leading Grad Sch, HIGO Hlth life Sci Interdisciplinary & Glocal Ori, Kumamoto 8620973, Japan; [Hayashi, Yuya] Japan Soc Promot Sci, Kumamoto 8620973, Japan	Arima, H (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	arimah@gpo.kumamoto-u.ac.jp					Abu II H., 2010, INT J PHARMACEUT, V392, P83; Agarwal A, 2008, CURR TOP MED CHEM, V8, P311; Akao C, 2014, J CONTROL RELEASE, V193, P35, DOI 10.1016/j.jconrel.2014.07.004; ANDERSSON T, 1992, J CHEM SOC CHEM COMM, P604, DOI 10.1039/c39920000604; Li N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04164; Perret F, 2013, EUR J PHARM BIOPHARM, V83, P25, DOI 10.1016/j.ejpb.2012.09.013; Adam JM, 2002, J MED CHEM, V45, P1806, DOI 10.1021/jm011107f; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Tamura A, 2013, BIOMATERIALS, V34, P2480, DOI 10.1016/j.biomaterials.2012.12.006; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Shen JL, 2014, THERANOSTICS, V4, P487, DOI 10.7150/thno.8263; Godinho BMDC, 2013, MOL PHARMACEUT, V10, P640, DOI 10.1021/mp3003946; Arima H, 2011, EUR J PHARM SCI, V44, P375, DOI 10.1016/j.ejps.2011.08.019; Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444; Okamatsu A, 2013, BIOCONJUGATE CHEM, V24, P724, DOI 10.1021/bc400015r; Kulkarni A, 2012, J AM CHEM SOC, V134, P7596, DOI 10.1021/ja300690j; Grosse PY, 1998, BRIT J CANCER, V78, P1165, DOI 10.1038/bjc.1998.648; Tsutsumi T, 2007, J CONTROL RELEASE, V119, P349, DOI 10.1016/j.jconrel.2007.03.013; Arima H, 2006, J DRUG TARGET, V14, P225, DOI 10.1080/1061180600711136; Stella VJ, 1999, ADV DRUG DELIVER REV, V36, P3, DOI 10.1016/S0169-409X(98)00052-0; Rodriguez-Lavado J, 2014, ORG BIOMOL CHEM, V12, P2289, DOI 10.1039/c3ob42530d; Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Motoyama K, 2009, EUR J PHARM SCI, V38, P249, DOI 10.1016/j.ejps.2009.07.010; Hirayama F, 1999, ADV DRUG DELIVER REV, V36, P125, DOI 10.1016/S0169-409X(98)00058-1; Nakagata N, 2000, MAMM GENOME, V11, P572, DOI 10.1007/s003350010109; Pfeifer A, 2001, ANNU REV GENOM HUM G, V2, P177, DOI 10.1146/annurev.genom.2.1.177; Choi YH, 1998, BIOL REPROD, V59, P1328, DOI 10.1095/biolreprod59.6.1328; Hayashi Y, 2012, AMYLOID, V19, P47, DOI 10.3109/13506129.2012.674581; Sun B, 2009, NANOMEDICINE-UK, V4, P431, DOI [10.2217/nnm.09.17, 10.2217/NNM.09.17]; Nagase Y, 2001, INT J PHARM, V229, P163, DOI 10.1016/S0378-5173(01)00851-1; Okamatsu A, 2013, BIOMACROMOLECULES, V14, P4420, DOI 10.1021/bm401340g; Hatakeyama H, 2004, INT J PHARM, V281, P25, DOI 10.1016/j.ijpharm.2004.05.025; Chen J, 2014, EXPERT OPIN DRUG DEL, V11, P565, DOI 10.1517/17425247.2014.884557; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Sato A, 2007, BIOMATERIALS, V28, P1434, DOI 10.1016/j.biomaterials.2006.11.010; Arima H, 2012, MOL PHARMACEUT, V9, P2591, DOI 10.1021/mp300188f; Higashi T, 2008, BIOMATERIALS, V29, P3866, DOI 10.1016/j.biomaterials.2008.06.019; Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y; Li J, 2008, ADV DRUG DELIVER REV, V60, P1000, DOI 10.1016/j.addr.2008.02.011; Plazzo AP, 2012, CHEM PHYS LIPIDS, V165, P505, DOI 10.1016/j.chemphyslip.2012.03.007; Bae Y, 2009, ADV DRUG DELIVER REV, V61, P768, DOI 10.1016/j.addr.2009.04.016; Tavornvipas S, 2006, J PHARM SCI-US, V95, P2722, DOI 10.1002/jps.20715; Trotta F, 2009, COMPOS INTERFACE, V16, P39, DOI 10.1163/156955408X379388; Peng K, 2010, CHEM COMMUN, V46, P4094, DOI 10.1039/c002565h; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Zhao MX, 2011, CHEM-EUR J, V17, P5171, DOI 10.1002/chem.201003523; McMahon A, 2012, J PHARM PHARMACOL, V64, P1063, DOI 10.1111/j.2042-7158.2012.01497.x; Masotti A, 2009, MINI-REV MED CHEM, V9, P463; SCHWARTZ AL, 1981, J BIOL CHEM, V256, P8878; Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X; McCarthy J, 2013, J CONTROL RELEASE, V168, P28, DOI 10.1016/j.jconrel.2013.03.004; Guo JF, 2012, BIOMATERIALS, V33, P7775, DOI 10.1016/j.biomaterials.2012.07.012; GO KJ, 1985, BIOL REPROD, V32, P145, DOI 10.1095/biolreprod32.1.145; Diaz-Moscoso A, 2011, BIOMATERIALS, V32, P7263, DOI 10.1016/j.biomaterials.2011.06.025; Motoyama K, 2011, J INCL PHENOM MACRO, V70, P333, DOI 10.1007/s10847-010-9842-0; Mondjinou YA, 2013, BIOMACROMOLECULES, V14, P4189, DOI 10.1021/bm400922a; Harada A, 2009, CHEM REV, V109, P5974, DOI 10.1021/cr9000622; CAMILLERI P, 1994, FEBS LETT, V341, P256, DOI 10.1016/0014-5793(94)80467-2; Villari V, 2013, BIOMACROMOLECULES, V14, P811, DOI 10.1021/bm3018609; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; ROSS JF, 1994, CANCER, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; HARADA A, 1995, MACROMOLECULES, V28, P8406, DOI 10.1021/ma00128a060; Arima H, 2012, CANCER GENE THER, V19, P358, DOI 10.1038/cgt.2012.9; Minami K, 1998, J PHARM SCI, V87, P715, DOI 10.1021/js9704339; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Ye YJ, 2013, INT J PHARMACEUT, V458, P110, DOI 10.1016/j.ijpharm.2013.10.005; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Dong HQ, 2008, ANGEW CHEM INT EDIT, V47, P5573, DOI 10.1002/anie.200800952; Kim IY, 2009, J CONTROL RELEASE, V140, P55, DOI 10.1016/j.jconrel.2009.07.005; Li JJ, 2011, APPL MICROBIOL BIOT, V90, P427, DOI 10.1007/s00253-010-3037-x; Arima H, 2013, ADV DRUG DELIVER REV, V65, P1204, DOI 10.1016/j.addr.2013.04.001; Meng HA, 2010, J AM CHEM SOC, V132, P12690, DOI 10.1021/ja104501a; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Mazzaglia A, 2013, BIOMACROMOLECULES, V14, P3820, DOI 10.1021/bm400849n; Matsuo M, 2013, MOL GENET METAB, V108, P76, DOI 10.1016/j.ymgme.2012.11.005; Chen H, 2009, MOL CANCER THER, V8, P1955, DOI 10.1158/1535-7163.MCT-09-0045; Kiss T, 2010, EUR J PHARM SCI, V40, P376, DOI 10.1016/j.ejps.2010.04.014; Gomes-da-Silva LC, 2012, ACCOUNTS CHEM RES, V45, P1163, DOI 10.1021/ar300048p; Nagao G, 2011, COLLOID SURFACE B, V84, P317, DOI 10.1016/j.colsurfb.2011.01.018; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Zhao J, 2014, BIOMATERIALS, V35, P3340, DOI 10.1016/j.biomaterials.2014.01.003; Bienvenu C, 2012, ORG BIOMOL CHEM, V10, P5570, DOI 10.1039/c2ob25786f; Silva OF, 2008, LANGMUIR, V24, P3718, DOI 10.1021/la702962f; Bom A, 2002, ANGEW CHEM INT EDIT, V41, P266; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Sztein JM, 2000, BIOL REPROD, V63, P1774, DOI 10.1095/biolreprod63.6.1774; Kawakami S, 2000, BBA-GEN SUBJECTS, V1524, P258, DOI 10.1016/S0304-4165(00)00163-X; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Arima H, 2010, J CONTROL RELEASE, V146, P106, DOI 10.1016/j.jconrel.2010.05.030; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Reischl D, 2009, NANOMED-NANOTECHNOL, V5, P8, DOI 10.1016/j.nano.2008.06.001; Hayashi Y, 2012, MOL PHARMACEUT, V9, P1645, DOI 10.1021/mp200654g; Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179; O'Mahony AM, 2013, PHARM RES-DORDR, V30, P1086, DOI 10.1007/s11095-012-0945-8; Leamon CP, 2001, DRUG DISCOV TODAY, V6, P44, DOI 10.1016/S1359-6446(00)01594-4; Zhang HH, 2012, J BIOMED MATER RES A, V100A, P2441, DOI 10.1002/jbm.a.34169; Kulkarni A, 2013, MOL PHARMACEUT, V10, P1299, DOI 10.1021/mp300449t; Yano H, 2002, J CONTROL RELEASE, V79, P103, DOI 10.1016/S0168-3659(01)00532-6; Uekama K, 2004, CHEM PHARM BULL, V52, P900, DOI 10.1248/cpb.52.900; Kim C, 2011, MOL PHARMACEUT, V8, P1955, DOI 10.1021/mp100460h; Rahman MA, 2012, J CONTROL RELEASE, V159, P384, DOI 10.1016/j.jconrel.2012.01.045; Yu J, 2014, ACS APPL MATER INTER, V6, P19544, DOI 10.1021/am505649q; Clemens DL, 2012, ANTIMICROB AGENTS CH, V56, P2535, DOI 10.1128/AAC.06049-11; Yunomae K, 2003, FEBS LETT, V536, P225, DOI 10.1016/S0014-5793(03)00059-0; Park C, 2007, ANGEW CHEM INT EDIT, V46, P1455, DOI 10.1002/anie.200603404; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Tai WY, 2010, J CONTROL RELEASE, V146, P264, DOI 10.1016/j.jconrel.2010.04.009; Schiffelers RM, 2003, J CONTROL RELEASE, V91, P115, DOI 10.1016/S0168-3659(03)00240-2; Kumar LD, 2007, ADV DRUG DELIVER REV, V59, P87, DOI 10.1016/j.addr.2007.03.009; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Irie T, 1997, J PHARM SCI, V86, P147, DOI 10.1021/js960213f; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Galanzha EI, 2009, J BIOPHOTONICS, V2, P725, DOI 10.1002/jbio.200910078; Arima Hidetoshi, 2011, Pharmaceuticals (Basel), V5, P61, DOI 10.3390/ph5010061; Arimoa H, 2001, J PHARMACOL EXP THER, V297, P547; Arima H, 2014, CURR TOP MED CHEM, V14, P465; Arima Hidetoshi, 2012, Pharmaceutics, V4, P130, DOI 10.3390/pharmaceutics4010130; Arima H, 2009, SENSORS-BASEL, V9, P6346, DOI 10.3390/s90806346; Arima H, 2005, BIOCHEM PHARMACOL, V70, P1506, DOI 10.1016/j.bcp.2005.08.021; Jiang HL, 2008, J CONTROL RELEASE, V131, P150, DOI 10.1016/j.jconrel.2008.07.029; Diaz-Moscoso A, 2010, J CONTROL RELEASE, V143, P318, DOI 10.1016/j.jconrel.2010.01.016; Diebold Sandra S., 2002, Somatic Cell and Molecular Genetics, V27, P65, DOI 10.1023/A:1022975705406; Egawa Y, 2013, YAKUGAKU ZASSHI, V133, P1287; Fissell WH, 2003, J AM SOC NEPHROL, V14, P454, DOI 10.1097/01.ASN.0000045046.94575.96; Fundueanu G, 2004, BIOMATERIALS, V25, P159, DOI 10.1016/S0142-9612(03)00477-0; Godinho BMDC, 2014, INT J PHARMACEUT, V473, P105, DOI 10.1016/j.ijpharm.2014.06.054; HARADA A, 1990, J CHEM SOC CHEM COMM, P1322, DOI 10.1039/c39900001322; Hibbitts A, 2014, J AEROSOL MED PULM D, V27, P466, DOI 10.1089/jamp.2013.1045; Higashi T, 2012, J PHARM SCI-US, V101, P2891, DOI 10.1002/jps.23232; Higuchi Y, 2007, BIOMATERIALS, V28, P532, DOI 10.1016/j.biomaterials.2006.08.045; Hirayama F, 2000, J PHARM SCI, V89, P1486, DOI 10.1002/1520-6017(200011)89:11<1486::AID-JPS11>3.3.CO;2-4; Huang Y, 2012, J INCL PHENOM MACRO, V72, P55, DOI 10.1007/s10847-011-9938-1; Iohara D, 2011, MOL PHARMACEUT, V8, P1276, DOI 10.1021/mp200204v; Iohara D, 2009, CHEM LETT, V38, P1104, DOI 10.1246/cl.2009.1104; Iohara D, 2012, J PHARM SCI-US, V101, P3390, DOI 10.1002/jps.23045; IRIE T, 1982, J PHARMACOBIO-DYNAM, V5, P741; Jerry N, 2001, DRUG DELIV, V8, P19; Jono H, 2011, BIOCHEM J, V437, P35, DOI 10.1042/BJ20110041; Kaneko K, 2003, XENOBIOTICA, V33, P323, DOI 10.1080/0049825021000058097; Kitagishi H, 2015, CHEM COMMUN, V51, P2421, DOI 10.1039/c4cc09042j; Kulkarni A, 2013, INTEGR BIOL-UK, V5, P115, DOI 10.1039/c2ib20107k; Landel CP, 2005, LAB ANIMAL, V34, P50, DOI 10.1038/laban0405-50; Leamon CP, 2011, J PHARMACOL EXP THER, V336, P336, DOI 10.1124/jpet.110.175109; LI J, 2013, INT J NANOMED, V8, P8; Matsubara K, 1997, PHARMACEUT RES, V14, P1401, DOI 10.1023/A:1012120705408; Miyajima Y, 2006, BIOCONJUGATE CHEM, V17, P1314, DOI 10.1021/bc060064k; Motoyama K, 2014, J DRUG TARGET, V22, P211, DOI 10.3109/1061186X.2013.856012; Motoyama K, 2006, J INCL PHENOM MACRO, V56, P75, DOI 10.1007/s10847-006-9064-7; Mukthavaram R, 2009, BIOMATERIALS, V30, P2369, DOI 10.1016/j.biomaterials.2008.12.074; Nagase Y, 2003, J PHARM SCI-US, V92, P2466, DOI 10.1002/jps.10517; Nakagata N, 1993, Jikken Dobutsu, V42, P317; Nakamura K, 2013, CHEM PHARM BULL, V61, P1188; Namgung R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4702; O' Neill MJ, 2011, INT J PHARMACEUT, V413, P174, DOI 10.1016/j.ijpharm.2011.04.021; Oda Y, 2008, MED CHEM, V4, P244, DOI 10.2174/157340608784325098; O'Mahony AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066413; O'Mahony AM, 2012, EUR J PHARM SCI, V47, P896, DOI 10.1016/j.ejps.2012.08.020; Onodera R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04417; Onodera R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01104; Onodera R, 2013, SCI REP, V4, P4417; Opanasopit P, 2001, J DRUG TARGET, V9, P341; Otero-Espinar FJ, 2010, MINI-REV MED CHEM, V10, P715; Patel Ashaben, 2014, Ther Deliv, V5, P337, DOI 10.4155/tde.14.5; Peng HX, 2015, MAT SCI ENG C-MATER, V46, P253, DOI 10.1016/j.msec.2014.10.022; Ping Y, 2011, BIOMATERIALS, V32, P8328, DOI 10.1016/j.biomaterials.2011.07.038; Ramos P, 2014, ONCOGENE IN PRESS; Salmaso S, 2007, J DRUG TARGET, V15, P379, DOI 10.1080/10611860701349752; Saraswathy M, 2015, COLLOIDS B IN PRESS; Shi Y, 2013, INORG CHEM, V52, P9418, DOI 10.1021/ic400989v; Shinohara K, 2014, CHEM PHARM BULL, V62, P962; Songsasen N, 1997, CRYOBIOLOGY, V35, P240, DOI 10.1006/cryo.1997.2048; Sun L, 2014, INT J PHARMACEUT, V478, P308; Swaminathan S, 2010, EUR J PHARM BIOPHARM, V74, P193; Symens N, 2012, BIOCONJUGATE CHEM, V23, P1276, DOI 10.1021/bc3001003; Szejtli J, 2005, J INCL PHENOM MACRO, V52, P1, DOI 10.1007/s10847-004-7161-z; Tamura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02252; Tamura A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04356; Tavornvipas S, 2004, PHARM RES, V21, P2369, DOI 10.1007/s11095-004-7691-5; Tokihiro K, 1997, CHEM PHARM BULL, V45, P525; Vaishya R, 2015, EXPERT OPIN DRUG DEL, V12, P415, DOI 10.1517/17425247.2015.961420; Van Laethem F., 2002, Current Molecular Medicine (Hilversum), V2, P557; Vanier MT, 2011, ORPHANET J RARE DIS, V5, P16; Wang MS, 2009, BIOCHEM BIOPH RES CO, V386, P526, DOI 10.1016/j.bbrc.2009.06.077; Wang T, 2011, LANGMUIR, V27, P91, DOI 10.1021/la103288j; Wang ZQ, 2004, J MED CHEM, V47, P3329, DOI 10.1021/jm034224e; Welliver Mark, 2006, AANA J, V74, P357; Yameogo JB, 2014, CURR TOP MED CHEM, V14, P526; Yang T, 2014, SOFT MATTER, V10, P2671, DOI 10.1039/c3sm53059k; Yoshida H, 1994, ANGEW CHEM INT EDIT, V33, P1597; Yu WY, 2009, CURR PHARM DESIGN, V15, P3826	196	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1742-5247	1744-7593		EXPERT OPIN DRUG DEL	Expert Opin. Drug Deliv.	SEP	2015	12	9					1425	1441		10.1517/17425247.2015.1026893		17	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CP8ZV	WOS:000360184400004		
J	Kanazawa, K; Koike, Y; Metz, A; Pitonyak, D				Kanazawa, Koichi; Koike, Yuji; Metz, Andreas; Pitonyak, Daniel			New Collinear Twist-3 Analysis of Transverse SSA: Toward a Solution for the Sign-Mismatch Problem	FEW-BODY SYSTEMS			English	Article							SPIN PRODUCTION ASYMMETRIES; HADRONIC PION-PRODUCTION; CHIRAL-ODD CONTRIBUTION; QUANTUM CHROMODYNAMICS; HARD-SCATTERING; FRAGMENTATION; DISTRIBUTIONS; COLLISIONS	We present a new collinear twist-3 analysis of the transverse SSA A (N) at RHIC. We use the TMD Sivers/Collins function to fix some of the relevant collinear twist-3 functions and perform a fit of the RHIC data with other parameterized twist-3 functions. This allows us to keep the consistency among descriptions in pp collision, SIDIS, and e (+) e (-) annihilation and thus could provide a unified description of the spin asymmetries in the low- and high-P (T) processes. By taking into account the twist-3 fragmentation contribution, we show for the first time this contribution could be the main source of A (N) in and its inclusion could provide a solution for the sign-mismatch problem.	[Kanazawa, Koichi; Metz, Andreas] Temple Univ, Dept Phys, Philadelphia, PA 19122 USA; [Koike, Yuji] Niigata Univ, Dept Phys, Niigata 9502181, Japan; [Pitonyak, Daniel] Brookhaven Natl Lab, RIKEN BNL Res Ctr, Upton, NY 11973 USA	Kanazawa, K (reprint author), Temple Univ, Dept Phys, Barton Hall, Philadelphia, PA 19122 USA.	koichi.kanazawa@temple.edu					Adamczyk L, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.051101; Adare A., 2013, ARXIV13121995; Kang ZB, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.074008; Adams J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.171801; Kang ZB, 2010, PHYS LETT B, V691, P243, DOI 10.1016/j.physletb.2010.07.003; Alekseev M, 2009, PHYS LETT B, V673, P127, DOI 10.1016/j.physletb.2009.01.060; Anselmino M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.094019; KANE GL, 1978, PHYS REV LETT, V41, P1689, DOI 10.1103/PhysRevLett.41.1689; COLLINS J, 1993, NUCL PHYS B, V396, P161, DOI 10.1016/0550-3213(93)90262-N; de Florian D, 2007, PHYS REV D, V75, DOI [10.1103/PhysRevD.75.114010, 10.1103/PhysRevD.114010]; SIVERS D, 1991, PHYS REV D, V43, P261, DOI 10.1103/PhysRevD.43.261; Meissner S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.172003; Anselmino M, 2009, EUR PHYS J A, V39, P89, DOI 10.1140/epja/i2008-10697-y; Eguchi H, 2006, NUCL PHYS B, V752, P1, DOI 10.1016/j.nuclphysb.2006.05.036; Airapetian A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.152002; Koike Y, 2009, PHYS LETT B, V675, P181, DOI 10.1016/j.physletb.2009.04.017; Anselmino M, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.054023; Koike Y, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.014026; Lee JH, 2007, AIP CONF PROC, V915, P533, DOI 10.1063/1.2750837; Kanazawa Y, 2000, PHYS LETT B, V478, P121, DOI 10.1016/S0370-2693(00)00261-6; Airapetian A, 2010, PHYS LETT B, V682, P351, DOI 10.1016/j.physletb.2009.11.041; Schafer A, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.077903; Kang ZB, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.094001; Abelev BI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.222001; Kanazawa Y, 2000, PHYS LETT B, V490, P99, DOI 10.1016/S0370-2693(00)00969-2; EFREMOV AV, 1982, SOV J NUCL PHYS+, V36, P140; EFREMOV AV, 1985, PHYS LETT B, V150, P383, DOI 10.1016/0370-2693(85)90999-2; Gluck M, 1998, EUR PHYS J C, V5, P461, DOI 10.1007/s100529800978; QIU JW, 1992, NUCL PHYS B, V378, P52, DOI 10.1016/0550-3213(92)90003-T; SIVERS D, 1990, PHYS REV D, V41, P83, DOI 10.1103/PhysRevD.41.83; Metz A, 2013, PHYS LETT B, V723, P365, DOI 10.1016/j.physletb.2013.05.043; Kanazawa K, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.111501; Gamberg L, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.074012; Gamberg LP, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.071503; Heppelmann S., 2013, POS DIS, V240; Kanazawa K, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.114024; Kanazawa K, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.074022; Kanazawa K, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.034009; Katich J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.022502; Koike Y, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.011502; Kouvaris C, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.114013; Meissner S, 2010, PHYS LETT B, V690, P296, DOI 10.1016/j.physletb.2010.05.037; Metz A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.094039; Qiu JW, 1999, PHYS REV D, V59	44	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0177-7963	1432-5411		FEW-BODY SYST	Few-Body Syst.	SEP	2015	56	6-9					343	348		10.1007/s00601-014-0913-4		6	Physics, Multidisciplinary	Physics	CQ2MV	WOS:000360435800016		
J	Terasawa, Y; Kurosaki, Y; Ibata, Y; Moriguchi, Y; Umeda, S				Terasawa, Yuri; Kurosaki, Yoshiko; Ibata, Yukio; Moriguchi, Yoshiya; Umeda, Satoshi			Attenuated sensitivity to the emotions of others by insular lesion	FRONTIERS IN PSYCHOLOGY			English	Article						insula; interoceptive accuracy; facial expression; arousal level; heartbeat perception task	INTEROCEPTIVE AWARENESS; SUBJECTIVE EXPERIENCE; PREFRONTAL CORTEX; NEURAL SYSTEMS; BRAIN-INJURY; RECOGNITION; HEART; FMRI; NEUROPSYCHOLOGY; PERCEPTION	The insular cortex has been considered to be the neural base of visceral sensation for many years. Previous studies in psychology and cognitive neuroscience have accumulated evidence indicating that interoception is an essential factor in the subjective feeling of emotion. Recent neuroimaging studies have demonstrated that anterior insular cortex activation is associated with accessing interoceptive information and underpinning the subjective experience of emotional state. Only a small number of studies have focused on the influence of insular damage on emotion processing and interoceptive awareness. Moreover, disparate hypotheses have been proposed for the alteration of emotion processing by insular lesions. Some studies show that insular lesions yield an inability for understanding and representing disgust exclusively, but other studies suggest that such lesions modulate arousal and valence judgments for both positive and negative emotions. In this study, we examined the alteration in emotion recognition in three right insular and adjacent area damaged cases with well-preserved higher cognitive function. Participants performed an experimental task using morphed photos that ranged between neutral and emotional facial expressions (i.e., anger, sadness, disgust, and happiness). Recognition rates of particular emotions were calculated to measure emotional sensitivity. In addition, they performed heartbeat perception task for measuring interoceptive accuracy. The cases identified emotions that have high arousal level (e.g., anger) as less aroused emotions (e.g., sadness) and a case showed remarkably low interoceptive accuracy. The current results show that insular lesions lead to attenuated emotional sensitivity across emotions, rather than category-specific impairments such as to disgust. Despite the small number of cases, our findings suggest that the insular cortex modulates recognition of emotional saliency and mediates interoceptive and emotional awareness.	[Terasawa, Yuri; Umeda, Satoshi] Keio Univ, Dept Psychol, Tokyo 2238521, Japan; [Kurosaki, Yoshiko] Hlth Sci Univ Hokkaido, Dept Commun Disorders, Sapporo, Hokkaido, Japan; [Ibata, Yukio] Nasu Red Cross Hosp, Dept Neurosurg, Otawara, Tochigi, Japan; [Moriguchi, Yoshiya] Natl Ctr Neurol & Psychiat, NIMH, Dept Psychophysiol, Tokyo, Japan	Terasawa, Y (reprint author), Keio Univ, Dept Psychol, Kohoku Ku, 4-1-1 Hiyoshi, Tokyo 2238521, Japan.	terasawa@flet.keio.ac.jp			Japan Society for the Promotion of Science; KAKENHI by the Ministry of Education, Culture, Sports, Science and Technology of Japan [26350990]	This work was supported by the Japan Society for the Promotion of Science and the KAKENHI Grant No. 26350990 by the Ministry of Education, Culture, Sports, Science and Technology of Japan. We are grateful to the three patients who participated in this study.	Evans KC, 2002, J NEUROPHYSIOL, V88, P1500, DOI 10.1152/jn.00957.2001; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Ronchi R, 2015, NEUROPSYCHOLOGIA, V70, P11, DOI 10.1016/j.neuropsychologia.2015.02.010; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Iaria G, 2008, HUM BRAIN MAPP, V29, P363, DOI 10.1002/hbm.20393; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Kuppens P, 2013, PSYCHOL BULL, V139, P917, DOI 10.1037/a0030811; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Werner NS, 2009, PSYCHOPHYSIOLOGY, V46, P1123, DOI 10.1111/j.1469-8986.2009.00855.x; Terasawa Y, 2013, SOC COGN AFFECT NEUR, V8, P259, DOI 10.1093/scan/nss108; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; Couto B, 2013, CORTEX, V49, P1420, DOI 10.1016/j.cortex.2012.08.006; Adolphs R, 2000, J NEUROSCI, V20, P2683; EHLERS A, 1992, J ABNORM PSYCHOL, V101, P371, DOI 10.1037//0021-843X.101.3.371; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Cameron OG, 2001, PSYCHOSOM MED, V63, P697; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.200510031; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Berntson GG, 2011, PSYCHOL SCI, V22, P80, DOI 10.1177/0956797610391097; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Terasawa Y, 2013, HUM BRAIN MAPP, V34, P598, DOI 10.1002/hbm.21458; Farb NAS, 2013, CEREB CORTEX, V23, P114, DOI 10.1093/cercor/bhr385; Moriguchi Y, 2014, SOC COGN AFFECT NEUR, V9, P591, DOI 10.1093/scan/nst030; Borg C, 2013, NEUROCASE, V19, P592, DOI 10.1080/13554794.2012.713491; Boucher O, 2015, NEUROPSYCHOLOGIA, V71, P1, DOI 10.1016/j.neuropsychologia.2015.03.008; Couto B, 2014, SOC COGN AFFECT NEUR, V9, P1253, DOI 10.1093/scan/nst108; Damasio A., 2012, CEREB CORTEX, V23, P833, DOI [10.1093/cercor/bhs077, DOI 10.1093/CERC0R/BHS077]; Hamaguchi T, 2004, NEUROGASTROENT MOTIL, V16, P299, DOI 10.1111/j.1365-2982.2004.00498.x; Herbert BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036646; James W., 1884, MIND, V9, P188, DOI DOI 10.1093/MIND/OS-IX.34.188; Jenkins LM, 2014, PSYCHIAT RES-NEUROIM, V224, P192, DOI 10.1016/j.pscychresns.2014.08.007; Lanes RD, 2008, PSYCHOSOM MED, V70, P214, DOI 10.1097/PSY.0b013e3181647e44; Lange C. G., 1885, EMOTIONS PSYCHOPHYSI; Lee KH, 2012, SOC COGN AFFECT NEUR, V7, P521, DOI 10.1093/scan/nsp001; MANDLER G, 1958, J ABNORM SOC PSYCH, V56, P367, DOI 10.1037/h0048083; Mehling WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048230; Porges S.W., 1993, BODY PERCEPTION QUES; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sherrington C. S., 1906, INTEGRATIVE ACTION N; Terasawa Y, 2014, COGNITION EMOTION, V28, P1435, DOI 10.1080/02699931.2014.888988	56	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	SEP 1	2015	6								1314	10.3389/fpsyg.2015.01314		10	Psychology, Multidisciplinary	Psychology	CQ3VE	WOS:000360531100003		
J	Ogura, T; Sano, T; Takagi, W; Onda, S; Masuda, D; Imoto, A; Higuchi, K				Ogura, Takeshi; Sano, Tatsushi; Takagi, Wataru; Onda, Saori; Masuda, Daisuke; Imoto, Akira; Higuchi, Kazuhide			Same-Session Balloon Dilation of Tight Esophageal Stenosis and Pseudocyst Drainage Using a Forward-Viewing Echoendoscope	GASTROENTEROLOGY			English	Editorial Material									[Ogura, Takeshi; Sano, Tatsushi; Takagi, Wataru; Onda, Saori; Masuda, Daisuke; Imoto, Akira; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 5698686, Japan	Ogura, T (reprint author), Osaka Med Coll, Dept Internal Med 2, 2-7 Daigakuchou, Takatsuki, Osaka 5698686, Japan.	oguratakeshi0411@yahoo.co.jp					Yasuda I, 2009, DIGEST ENDOSC, V21, pS82, DOI 10.1111/j.1443-1661.2009.00875.x; Fuccio L, 2015, J HEPATO-BIL-PAN SCI, V22, P27, DOI 10.1002/jhbp.181; Iwashita T, 2011, J GASTROEN HEPATOL, V27, P362	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	SEP	2015	149	3					541	543		10.1053/j.gastro.2015.03.055		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ0FE	WOS:000360269800019		
J	Inoue, M; Itoh, Y; Rii, T; Kita, Y; Hirota, K; Kunita, D; Hirakata, A				Inoue, Makoto; Itoh, Yuji; Rii, Tosho; Kita, Yoshiyuki; Hirota, Kazunari; Kunita, Daisuke; Hirakata, Akito			Macular retinoschisis associated with glaucomatous optic neuropathy in eyes with normal intraocular pressure	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Foveal detachment; Glaucomatous optic neuropathy; Retinoschisis; Retinal nerve fiber layer; Normal tension glaucoma; Vitrectomy	DISC PIT MACULOPATHY; COHERENCE TOMOGRAPHY; NERVE HEAD; PERIPAPILLARY RETINOSCHISIS; CONGENITAL PITS; LASER TREATMENT; GAS TAMPONADE; DETACHMENT; VITRECTOMY; SCHISIS	The purpose of this study was to evaluate the clinical features, optical coherence tomography (OCT) findings, and surgical outcomes of eyes with macular retinoschisis associated with glaucomatous optic neuropathy and normal intraocular pressure (IOP). In this retrospective interventional observational study, 11 eyes of 11 patients who underwent pars plana vitrectomy for macular retinoschisis and glaucomatous optic neuropathy were studied. All eyes had a vertical cup-to-disc ratio of a parts per thousand yen0.7 and retinal nerve fiber layer (RNFL) defects. Intraocular pressure (IOP) was < 21 mmHg in all eyes, and there was no presence of congenital optic disc pits or high myopia in any eyes. The best-corrected visual acuity (BCVA) and the appearance of the fundus and OCT images were evaluated. The retinoschisis extended from the optic disc to the macula in all 11 eyes, and foveal detachment was present in 10 eyes. OCT showed vitreous adhesions near the RNFL defects and over the retinal vessels. The retinoschisis in the RNFL resolved immediately after the vitrectomy, and the BCVA improved significantly (p = 0.004). Macular retinoschisis resolved or decreased in all cases, although it required an average of 11 +/- 3 months. The optic disc cup and RNFL defects were more clearly visible after resolution of the retinoschisis. Macular retinoschisis can develop from vitreous traction near the RNFL defect in eyes with glaucomatous optic neuropathy and normal IOP. We suggest that the traction on the structurally fragile RNFL contributed to the retinoschisis.	[Inoue, Makoto; Itoh, Yuji; Rii, Tosho; Kita, Yoshiyuki; Hirota, Kazunari; Kunita, Daisuke; Hirakata, Akito] Kyorin Univ, Sch Med, Kyorin Eye Ctr, Mitaka, Tokyo 1818611, Japan; [Rii, Tosho] Shin Kong Wu Ho Mem Hosp, Dept Ophthalmol, Taipei, Taiwan	Inoue, M (reprint author), Kyorin Univ, Sch Med, Kyorin Eye Ctr, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	inoue@eye-center.org					Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; Shukla D, 2012, RETINA-J RET VIT DIS, V32, P1337, DOI 10.1097/IAE.0b013e318235d8fc; GASS JDM, 1969, AM J OPHTHALMOL, V67, P821; LINCOFF H, 1988, ARCH OPHTHALMOL-CHIC, V106, P61; SNEAD MP, 1991, BRIT J OPHTHALMOL, V75, P381, DOI 10.1136/bjo.75.6.381; Giarelli L, 2003, ARCH PATHOL LAB MED, V127, P1314; Garcia-Arumi J, 2004, GRAEF ARCH CLIN EXP, V242, P819, DOI 10.1007/s00417-004-0897-8; Hirakata A, 2012, OPHTHALMOLOGY, V119, P810, DOI 10.1016/j.ophtha.2011.09.026; Tantri A, 2004, SURV OPHTHALMOL, V49, P214, DOI 10.1016/j.survophthal.2003.12.007; Hirakata A, 2005, OPHTHALMOLOGY, V112, P1430, DOI 10.1016/j.ophtha.2005.02.013; Ugurlu S, 1998, AM J OPHTHALMOL, V125, P457, DOI 10.1016/S0002-9394(99)80185-8; Lincoff H, 1998, BRIT J OPHTHALMOL, V82, P367, DOI 10.1136/bjo.82.4.367; BROWN GC, 1980, OPHTHALMOLOGY, V87, P51; Theodossiadis PG, 2007, GRAEF ARCH CLIN EXP, V245, P1311, DOI 10.1007/s00417-007-0534-4; BARTZSCHMIDT KU, 1995, INT OPHTHALMOL, V19, P35, DOI 10.1007/BF00156417; Christoforidis John B, 2012, Clin Ophthalmol, V6, P1169, DOI 10.2147/OPTH.S34706; COLL GE, 1995, GRAEF ARCH CLIN EXP, V233, P441, DOI 10.1007/BF00180949; Farjad H, 2010, OPTOMETRY VISION SCI, V87, P205; Hasegawa T, 1997, JPN J OPHTHALMOL, V41, P324, DOI 10.1016/S0021-5155(97)00057-9; Hiraoka T, 2010, CLIN EXP OPHTHALMOL, V38, P669, DOI 10.1111/j.1442-9071.2010.02311.x; Ho TC, 2012, RETINA-J RET VIT DIS, V32, P631, DOI 10.1097/IAE.0B013E31824D0A4B; Hollander DA, 2005, ARCH OPHTHALMOL-CHIC, V123, P270, DOI 10.1001/archopht.123.2.270; Honkanen RA, 2007, AM J OPHTHALMOL, V143, P788, DOI 10.1016/j.ajo.2007.01.029; Hubschman JP, 2010, OPHTHAL SURG LAS IM, DOI [10.3928/15428877-20100215-60, DOI 10.3928/15428877-20100215-60]; Hwang YH, 2014, BRIT J OPHTHALMOL, V98, P669, DOI 10.1136/bjophthalmol-2013-303931; Kahook MY, 2007, AM J OPHTHALMOL, V143, P697, DOI 10.1016/j.ajo.2006.10.054; Laud K, 2007, RETINA-J RET VIT DIS, V27, P116, DOI 10.1097/01.iae.0000247168.07776.6f; Mavrikakis E, 2011, ACTA OPHTHALMOL, V89, P95, DOI 10.1111/j.1755-3768.2009.01553.x; Meirelles RL, 2005, GRAEF ARCH CLIN EXP, V243, P76, DOI 10.1007/s00417-004-0956-1; SCHATZ H, 1988, OPHTHALMOLOGY, V95, P178; Shimada N, 2012, AM J OPHTHALMOL, V154, P693, DOI 10.1016/j.ajo.2012.04.013; Song In Seok, 2011, Korean J Ophthalmol, V25, P455, DOI 10.3341/kjo.2011.25.6.455; Spaide RF, 2003, RETINA-J RET VIT DIS, V23, P238, DOI 10.1097/00006982-200304000-00017; SUGAR HS, 1962, AM J OPHTHALMOL, V53, P307; Yoshikawa Tadanobu, 2013, International Ophthalmology, V33, P425, DOI 10.1007/s10792-012-9673-7; Zhao M, 2011, GRAEF ARCH CLIN EXP, V249, P1255, DOI 10.1007/s00417-011-1668-y; Zumbro DS, 2007, AM J OPHTHALMOL, V144, P70, DOI 10.1016/j.ajo.2007.03.027	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	SEP	2015	253	9					1447	1456		10.1007/s00417-014-2830-0		10	Ophthalmology	Ophthalmology	CQ0MQ	WOS:000360290700004		
J	Hashimoto, Y; Saito, W; Saito, M; Hirooka, K; Mori, S; Noda, K; Ishida, S				Hashimoto, Yuki; Saito, Wataru; Saito, Michiyuki; Hirooka, Kiriko; Mori, Shohei; Noda, Kousuke; Ishida, Susumu			Decreased choroidal blood flow velocity in the pathogenesis of multiple evanescent white dot syndrome	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Choroidal circulation; Laser speckle flowgraphy; Mean blur rate; Multiple evanescent white dot syndrome		On the basis of angiographic features, it is suggested that choroidal circulation disturbance may be involved in the pathogenesis of multiple evanescent white dot syndrome (MEWDS). The aim of this study is to quantitatively evaluate changes in choroidal circulation hemodynamics using laser speckle flowgraphy (LSFG) in patients with MEWDS. Twelve eyes of 12 patients with MEWDS and 12 unaffected fellow eyes as controls were included. The macular mean blur rate (MBR), a quantitative index of relative blood flow velocity in the choroid, was measured by LSFG. Sequential changes in the average MBR values at the macula with granular changes and the lesion area with white dots were analysed. Moreover, correlations between the MRR changing rate and initial visual functions were examined. Visual functions significantly improved 3 months after initial visit with accompanying improvements in outer retinal morphology. When compared with the baseline measurements, the MBR significantly increased at the macula of the affected eyes by 20.2 % and 13.0 % at 1 and 3 months respectively (P < 0.01 for both), while no significant change was detected in fellow eyes. Similarly, the MBR increased at the lesion area by 17.8 % and 12.0 % at 1 and 3 months respectively (P < 0.05 for both). Notably, the macular MBR elevation at 1 month was negatively correlated with both initial best-corrected visual acuity and the average threshold at the macula on Humphrey perimetry at baseline (R = -0.76, P = 0.003; R = -0.60, P = 0.03, respectively), suggesting a close link between initially reduced choroidal blood flow and functional abnormalities at the onset of MEWDS. These results, in concert with angiographic findings, are likely to reinforce the concept of choroidal circulation impairment as a predisposing factor for MEWDS.	[Hashimoto, Yuki; Saito, Wataru; Saito, Michiyuki; Hirooka, Kiriko; Mori, Shohei; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido 0608638, Japan; [Saito, Wataru; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Saito, W (reprint author), Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Kita Ku, Nishi 7,Kita 15, Sapporo, Hokkaido 0608638, Japan.	wsaito@med.hokudai.ac.jp					Aizawa Naoko, 2011, Clin Ophthalmol, V5, P1171, DOI 10.2147/OPTH.S22093; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Li DJ, 2009, OPHTHALMOLOGY, V116, P762, DOI 10.1016/j.ophtha.2008.12.060; Obana A, 1996, RETINA-J RET VIT DIS, V16, P97; JAMPOL LM, 1984, ARCH OPHTHALMOL-CHIC, V102, P671; Hangai M, 2009, ARCH OPHTHALMOL-CHIC, V127, P1307, DOI 10.1001/archophthalmol.2009.250; Hirose S, 2008, ACTA OPHTHALMOL, V86, P902, DOI 10.1111/j.1755-3768.2008.01384.x; Nagahara M, 2011, INVEST OPHTH VIS SCI, V52, P87, DOI 10.1167/iovs.09-4422; Nguyen MHT, 2007, RETINA-J RET VIT DIS, V27, P414, DOI 10.1097/01.iae.0000246676.88033.25; Hashimoto Yuki, 2012, Clin Ophthalmol, V6, P1645, DOI 10.2147/OPTH.S35854; IE D, 1994, AM J OPHTHALMOL, V117, P7; Saito M, 2012, GRAEF ARCH CLIN EXP, V250, P239, DOI 10.1007/s00417-011-1843-1	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	SEP	2015	253	9					1457	1464		10.1007/s00417-014-2831-z		8	Ophthalmology	Ophthalmology	CQ0MQ	WOS:000360290700005		
J	Kawashima, Y; Oishi, A; Tsujikawa, A; Yamashiro, K; Miyake, M; Ueda-Arakawa, N; Yoshikawa, M; Takahashi, A; Yoshimura, N				Kawashima, Yu; Oishi, Akio; Tsujikawa, Akitaka; Yamashiro, Kenji; Miyake, Masahiro; Ueda-Arakawa, Naoko; Yoshikawa, Munemitsu; Takahashi, Ayako; Yoshimura, Nagahisa			Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Age-related macular degeneration; Polypoidal choroidal vasculopathy; Aflibercept; Optical coherence tomography; Genotype	COMPLEMENT FACTOR-H; INTRAVITREAL AFLIBERCEPT; VEGF TRAP; BEVACIZUMAB; TACHYPHYLAXIS; VERTEPORFIN; LOC387715; THERAPY; LAPTOP; FLUID	To evaluate visual and anatomic outcomes in response to the conversion of treatment in patients with neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) refractory to previous treatment. We also investigated the effect of genetic factors. We recruited patients with AMD or PCV refractory to ranibizumab and initiated aflibercept treatment. Changes in the logarithm of minimum angle of resolution (logMAR) and central retinal thickness (CRT) measured using optical coherence tomography (OCT) 6 months after the conversion were compared between the AMD and PCV groups. We also genotyped each patient for the ARMS2 A69S, CFH Y402H, and I62V alleles, and investigated the association between genotype and treatment response. Mean age of the participants was 75.6 +/- 8.0 years. There were 15 patients with AMD and 26 patients with PCV. While PCV patients gained about 1 line of vision (0.40 +/- 0.37 to 0.31 +/- 0.40, P = 0.003), AMD patients did not show significant improvement (0.41 +/- 0.37 to 0.42 +/- 0.39, P = 0.699) despite the decrease in CRT (202.1 +/- 113.7 to 131.2 +/- 55.7 mu m, P = 0.003). The prevalence of dry retina after treatment was higher among PCV patients (80.8 vs 46.7 %, P = 0.024). There was no significant difference between patients with risk and non-risk alleles for ARMS2 A69S, CFH Y402H, and I62V. In AMD or PCV patients refractory to ranibizumab, switching to aflibercept is generally effective regardless of patient genotype. PCV patients may benefit more significantly than AMD patients.	[Kawashima, Yu; Oishi, Akio; Tsujikawa, Akitaka; Yamashiro, Kenji; Miyake, Masahiro; Ueda-Arakawa, Naoko; Yoshikawa, Munemitsu; Takahashi, Ayako; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan	Oishi, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, 54 Shougoin Kawahara Cho, Kyoto 6068507, Japan.	aquio@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [21592256]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This research was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (No. 21592256) and the Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Schachat AP, 2013, AM J OPHTHALMOL, V156, P1, DOI 10.1016/j.ajo.2013.04.009; Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Kokame GT, 2012, RETINA-J RET VIT DIS, V32, P1446, DOI 10.1097/IAE.0b013e3182695bf8; Chang AA, 2014, OPHTHALMOLOGY, V121, P188, DOI 10.1016/j.ophtha.2013.08.035; Abedi F, 2013, OPHTHALMOLOGY, V120, P1641, DOI 10.1016/j.ophtha.2013.01.014; Gasperini JL, 2012, BRIT J OPHTHALMOL, V96, P14, DOI 10.1136/bjo.2011.204685; Schaal S, 2008, OPHTHALMOLOGY, V115, P2199, DOI 10.1016/j.ophtha.2008.07.007; Stangos AN, 2010, AM J OPHTHALMOL, V150, P666, DOI 10.1016/j.ajo.2010.05.035; Kumar N, 2013, RETINA-J RET VIT DIS, V33, P1605, DOI 10.1097/IAE.0b013e31828e8551; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Forooghian F, 2009, RETINA-J RET VIT DIS, V29, P723, DOI 10.1097/IAE.0b013e3181a2c1c3; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Oishi A, 2014, OPHTHALMOLOGY, V121, P1151, DOI 10.1016/j.ophtha.2013.12.037; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Oishi A, 2011, EUR J OPHTHALMOL, V21, P777, DOI 10.5301/EJO.2011.7430; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Stewart MW, 2008, BRIT J OPHTHALMOL, V92, P667, DOI 10.1136/bjo.2007.134874; Cho M, 2009, AM J OPHTHALMOL, V148, P70, DOI 10.1016/j.ajo.2009.02.012; Hatz K, 2014, BRIT J OPHTHALMOL, V98, P188, DOI 10.1136/bjophthalmol-2013-303444; Yamashiro K, 2012, AM J OPHTHALMOL, V154, P125, DOI 10.1016/j.ajo.2012.01.010; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Eghoj MS, 2012, BRIT J OPHTHALMOL, V96, P21, DOI 10.1136/bjo.2011.203893; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Cho H, 2013, BRIT J OPHTHALMOL, V97, P1032, DOI 10.1136/bjophthalmol-2013-303344; Hikichi T, 2013, BRIT J OPHTHALMOL, V97, P617, DOI 10.1136/bjophthalmol-2012-302652; Bakall B, 2013, AM J OPHTHALMOL, V156, pe11; Heussen FM, 2013, GRAEFES ARCH CLIN EX, V252, P909; Klein R, 2013, JAMA OPHTHALMOL, V131, P383, DOI 10.1001/jamaophthalmol.2013.713; Nakata I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019108; Patel KH, 2013, EYE, V27, P668; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Yonekawa Y, 2013, AM J OPHTHALMOL, V156, pe22	34	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	SEP	2015	253	9					1471	1477		10.1007/s00417-014-2838-5		7	Ophthalmology	Ophthalmology	CQ0MQ	WOS:000360290700007		
J	Cano, J; Garcia, A; Hurtado, F; Sakai, T; Tejel, J; Urrutia, J				Cano, Javier; Garcia, Alfredo; Hurtado, Ferran; Sakai, Toshinori; Tejel, Javier; Urrutia, Jorge			Blocking the -Holes of Point Sets in the Plane	GRAPHS AND COMBINATORICS			English	Article						k-holes; Piercing; Blocking	ERDOS-SZEKERES THEOREM; EMPTY; TRIANGLES; NUMBER	Let be a set of points in the plane in general position. A subset of consisting of elements that are the vertices of a convex polygon is called a -hole of , if there is no element of in the interior of its convex hull. A set of points in the plane blocks the -holes of if any -hole of contains at least one element of in the interior of its convex hull. In this paper we establish upper and lower bounds on the sizes of -hole blocking sets, with emphasis in the case .	[Cano, Javier; Urrutia, Jorge] Univ Nacl Autonoma Mexico, Inst Matemat, Mexico City, DF, Mexico; [Garcia, Alfredo; Tejel, Javier] Univ Zaragoza, IUMA, Dept Metodos Estadist, Zaragoza, Spain; [Hurtado, Ferran] UPC, Dept Matemat Aplicada 2, Barcelona, Spain; [Sakai, Toshinori] Tokai Univ, Res Inst Educ Dev, Tokyo 151, Japan	Cano, J (reprint author), Univ Nacl Autonoma Mexico, Inst Matemat, Mexico City, DF, Mexico.	j_cano@uxmcc2.iimas.unam.mx; olaverri@unizar.es; Ferran.Hurtado@upc.edu; sakai@tokai-u.co.jp; jtejel@unizar.es; urrutia@matem.unam.mx			MICINN [MTM2009-07242]; MINECO [MTM2012-30951]; ESF EUROCORES programme EuroGIGA, CRP ComPoSe: MICINN [EUI-EURC-2011-4306]; SEP-CONACYT of Mexico [80268];  [E58 (ESF)-DGA];  [MTM2006-03909]	A. Garcia, Ferran Hurtado and J. Tejel were partially supported by projects E58 (ESF)-DGA, MICINN MTM2009-07242, MINECO MTM2012-30951, and ESF EUROCORES programme EuroGIGA, CRP ComPoSe: MICINN Project EUI-EURC-2011-4306 J. Urrutia was partially supported by projects MTM2006-03909 (Spain), and SEP-CONACYT of Mexico, Proyecto 80268.	Aichholzer O, 2009, COMP GEOM-THEOR APPL, V42, P934, DOI 10.1016/j.comgeo.2009.04.002; Araujo G, 2005, COMP GEOM-THEOR APPL, V32, P59, DOI 10.1016/j.comgeo.2004.10.003; Barany I, 2004, STUD SCI MATH HUNG, V41, P243, DOI 10.1556/SScMath.41.2004.2.4; Czyzowicz J., 2000, 12 CAN C COMP GEOM 1, P47; Dehnhardt K., 1987, THESIS TU BRAUNSCHWE; Devillers O, 2003, COMP GEOM-THEOR APPL, V26, P193, DOI 10.1016/S0925-7721(03)00013-0; Dujmovic V., 2011, THICKNESS ANTI UNPUB; Erdos P., 1978, AUSTR MATH SOC GAZ, V5, P52; Fabila-Monroy R., 2011, P 14 SPAN M COMP GEO; Gerken T, 2008, DISCRETE COMPUT GEOM, V39, P239, DOI 10.1007/s00454-007-9018-x; Harborth H, 1978, ELEM MATH, V33, P116; HORTON JD, 1983, CAN MATH BULL, V26, P482, DOI 10.4153/CMB-1983-077-8; Karolyi G, 2001, STUD SCI MATH HUNG, V38, P245, DOI 10.1556/SScMath.38.2001.1-4.17; KATCHALSKI M, 1988, ACTA MATH HUNG, V51, P323, DOI 10.1007/BF01903339; Nicolas CM, 2007, DISCRETE COMPUT GEOM, V38, P389, DOI 10.1007/s00454-007-1343-6; Pach J., 2008, GEOMETRY GAMES GRAPH, P195; Por A., 2010, J COMPUT GEOM, V1, P29; Purdy G.B., 1982, AMS ABSTR, V3, P318; Sakai T, 2007, GRAPH COMBINATOR, V23, P343, DOI 10.1007/s00373-007-0717-0; Szekeres G., 1935, COMPOS MATH, V2, P463; Vogtenhuber B., 2011, THESIS GRAZ U TECHNO	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	SEP	2015	31	5					1271	1287		10.1007/s00373-014-1488-z		17	Mathematics	Mathematics	CP9DA	WOS:000360192700013		
J	Furuya, M; Kamada, M; Ozeki, K				Furuya, Michitaka; Kamada, Masaru; Ozeki, Kenta			The Existence of Semi-colorings in a Graph	GRAPHS AND COMBINATORICS			English	Article						Semi-coloring; 2-factor; Almost regular graph		A semi-coloring is a fractional-type edge coloring of graphs. Daniely and Linial (J Graph Theory 69:426-440, 2012) conjectured that every graph has a semi-coloring. In this paper, we give an affirmative answer to this conjecture by considering a -factor in almost regular graphs.	[Furuya, Michitaka; Kamada, Masaru] Tokyo Univ Sci, Dept Math Informat Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Ozeki, Kenta] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Ozeki, Kenta] JST, ERATO, Kawarabayashi Large Graph Project, Tokyo, Japan	Furuya, M (reprint author), Tokyo Univ Sci, Dept Math Informat Sci, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	michitaka.furuya@gmail.com; masarukamada1101@gmail.com; ozeki@nii.ac.jp			JSPS KAKENHI [25871053]	This work was supported by JSPS KAKENHI Grant number 25871053 (K. Ozeki).	Daniely A, 2012, J GRAPH THEOR, V69, P426, DOI 10.1002/jgt.20593; Diestel R., 2010, GRADUATE TEXTS MATH, V173; KANO M, 1990, DISCRETE MATH, V80, P159, DOI 10.1016/0012-365X(90)90116-Y; Wu BYDR, 2013, GRAPH COMBINATOR, V29, P1135, DOI 10.1007/s00373-012-1171-1	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	SEP	2015	31	5					1397	1401		10.1007/s00373-014-1445-x		5	Mathematics	Mathematics	CP9DA	WOS:000360192700022		
J	Kondo, T; Toyoda, T				Kondo, Takefumi; Toyoda, Tetsu			Uniform Estimates of Nonlinear Spectral Gaps	GRAPHS AND COMBINATORICS			English	Article						Nonlinear spectral gap; Path method	FIXED-POINT PROPERTY; HARMONIC MAPS; CAT(0) SPACES	By generalizing the path method, we show that nonlinear spectral gaps of a finite connected graph are uniformly bounded from below by a positive constant which is independent of the target metric space. We apply our result to an -ball in the -regular tree, and observe that the asymptotic behavior of nonlinear spectral gaps of as does not depend on the target metric space, which is in contrast to the case of a sequence of expanders. We also apply our result to the -dimensional Hamming cube and obtain an estimate of its nonlinear spectral gap with respect to an arbitrary metric space, which is asymptotically sharp as .	[Kondo, Takefumi] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Toyoda, Tetsu] Suzuka Natl Coll Technol, Suzuka, Mie 5100294, Japan	Toyoda, T (reprint author), Suzuka Natl Coll Technol, Shiroko Cho, Suzuka, Mie 5100294, Japan.	kondo.takefumi@math.nagoya-u.ac.jp; toyoda@genl.suzuka-ct.ac.jp			JST, CREST	The authors would like to thank Professor Hiroyasu Izeki for valuable discussions concerning Proposition 2.2. We are also grateful to the anonymous referee for their careful reading of this paper and many helpful suggestions. The first author was supported by JST, CREST, "A mathematical challenge to a new phase of material sciences".	Izeki H, 2005, GEOMETRIAE DEDICATA, V114, P147, DOI 10.1007/s10711-004-1843-y; Naor A, 2011, COMPOS MATH, V147, P1546, DOI 10.1112/S0010437X11005343; Gromov M, 2003, GEOM FUNCT ANAL, V13, P73; BOURGAIN J, 1986, ISRAEL J MATH, V56, P222, DOI 10.1007/BF02766125; BOURGAIN J, 1985, ISRAEL J MATH, V52, P46, DOI 10.1007/BF02776078; Diaconis P., 1993, ANN APPL PROBAB, V3, P696, DOI 10.1214/aoap/1177005359; Diaconis P., 1991, ANN APPL PROBAB, V1, P36, DOI 10.1214/aoap/1177005980; Fujiwara K, 2012, P AM MATH SOC, V140, P1023; Gromov M., 2004, J MATH SCI N Y, V119, P178, DOI 10.1023/B:JOTH.0000008756.15786.0f; Izeki H, 2012, GROUP GEOM DYNAM, V6, P701, DOI 10.4171/GGD/171; Izeki H, 2009, ANN GLOB ANAL GEOM, V35, P363, DOI 10.1007/s10455-008-9139-3; JERRUM M, 1989, SIAM J COMPUT, V18, P1149, DOI 10.1137/0218077; Kondo T., SYMMETRY OPTIM UNPUB; Kondo T, 2012, MATH Z, V271, P343, DOI 10.1007/s00209-011-0866-y; Mendel M, 2014, PUBL MATH-PARIS, P1, DOI 10.1007/s10240-013-0053-2; Mendel M, 2010, PROC APPL MATH, V135, P236; Pansu P., 2008, SUPERRIGIDITE GEOMET, V18, P373; QUASTEL J, 1992, COMMUN PUR APPL MATH, V45, P623, DOI 10.1002/cpa.3160450602; SALOFF-COSTE L., 1997, LECT NOTES MATH, V1665, P301, DOI 10.1007/BFb0092621; Toyoda T, 2010, KODAI MATH J, V33, P398; Toyoda T., 2010, PREPRINT; Wang MT, 2000, COMMUN ANAL GEOM, V8, P545	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	SEP	2015	31	5					1517	1530		10.1007/s00373-014-1457-6		14	Mathematics	Mathematics	CP9DA	WOS:000360192700032		
J	Ozeki, K; Sugiyama, T				Ozeki, Kenta; Sugiyama, Takeshi			Spanning k-Forests with Large Components in K-1,K-k+1-Free Graphs	GRAPHS AND COMBINATORICS			English	Article						k-trees; k-forests; Star-free graphs; Degree sum	CLAW-FREE-GRAPHS; SUFFICIENT CONDITION; MAXIMUM DEGREE; CYCLES; TREES; PATHS	For an integer with , a -tree (resp. a -forest) is a tree (resp. forest) with maximum degree at most . In this paper, we show that for any integer with , any connected -free graph has a spanning -tree or a spanning -forest with only large components.	[Ozeki, Kenta] Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Ozeki, Kenta] Kawarabayashi Large Graph Project, JST, ERATO, Tokyo, Japan; [Sugiyama, Takeshi] Fukushima Natl Coll Technol, Dept Commun & Informat Sci, Fukushima 9708034, Japan	Sugiyama, T (reprint author), Fukushima Natl Coll Technol, Dept Commun & Informat Sci, 30 Nagao Kamiarakawa Taira Iwaki, Fukushima 9708034, Japan.	ozeki@nii.ac.jp; sugiyama@fukushima-nct.ac.jp			JSPS KAKENHI [25871053]	This work was supported by JSPS KAKENHI Grant number 25871053.	Akiyama J., 1980, TRU MATH, V16, P97; Ando K, 2002, DISCRETE MATH, V243, P195, DOI 10.1016/S0012-365X(01)00214-X; Aung M, 1998, GRAPH COMBINATOR, V14, P209, DOI 10.1007/s003730050027; Bermond J. C., 1976, C NUMER, V15, P41; Bondy J.A., 1995, HDB COMBINATORICS, VI, P5; BROERSMA HJ, 1993, GRAPH COMBINATOR, V9, P3, DOI 10.1007/BF01195323; CARO Y, 1991, J GRAPH THEOR, V15, P7, DOI 10.1002/jgt.3190150103; Diestel R.:, 2000, GRADUATE TEXTS MATH, V173; Dirac G. A., 1952, P LONDON MATH SOC  3, Vs3-2, P69; EGAWA Y, 1989, J COMB THEORY B, V46, P356, DOI 10.1016/0095-8956(89)90055-5; Faudree R, 1997, DISCRETE MATH, V164, P87, DOI 10.1016/S0012-365X(96)00045-3; FAUDREE RJ, 1987, J GRAPH THEOR, V11, P555, DOI 10.1002/jgt.3190110413; Flandrin E., 1989, ANN DISCRETE MATH, V41, P131; Fujisawa J, 2010, GRAPH COMBINATOR, V26, P695, DOI 10.1007/s00373-010-0941-x; Jackson B., 1990, AUSTRALASIAN J COMBI, V2, P135; JACKSON B, 1995, J COMB THEORY B, V63, P163, DOI 10.1006/jctb.1995.1013; Kaneko A, 2003, J COMB THEORY B, V88, P195, DOI 10.1016/S0095-8956(03)00027-3; Kyaw A, 2001, GRAPH COMBINATOR, V17, P113, DOI 10.1007/s003730170059; LI H, 1995, J GRAPH THEOR, V20, P447, DOI 10.1002/jgt.3190200408; LINIAL N, 1976, DISCRETE MATH, V15, P297, DOI 10.1016/0012-365X(76)90031-5; MATTHEWS MM, 1985, J GRAPH THEOR, V9, P269, DOI 10.1002/jgt.3190090208; Ore O., 1960, AM MATH MONTHLY, V67, P55, DOI 10.2307/2308928; Rivera-Campo E., 1992, C NUMER, V90, P19; Voss H.-J., 1991, E EUROPEAN SERIES, V49; Win S, 1975, ABH MATH SEM HAMBURG, V43, P263, DOI DOI 10.1007/BF02995957	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	SEP	2015	31	5					1659	1677		10.1007/s00373-014-1434-0		19	Mathematics	Mathematics	CP9DA	WOS:000360192700042		
J	Ozeki, K				Ozeki, Kenta			A Toughness Condition for a Spanning Tree With Bounded Total Excesses	GRAPHS AND COMBINATORICS			English	Article						Spanning k-trees; Toughness; Total excess	GRAPH	Let be an integer with . In terms of the toughness of a graph, Win gave a sufficient condition for the existence of a spanning -tree, that is, a spanning tree in which the maximum degree is at most . For a spanning tree of a graph , we define the total excess of from as , where is the vertex set of and is the degree of a vertex in . Enomoto, Ohnishi and Ota extended Win's result by giving a condition that guarantees the existence of a spanning tree with a bounded total excess. Here we further extend the result as follows. Let be the number of components of a graph . Let be integers with , let be nonnegative integers, and let be a connected graph. If satisfies that for every and every , then has a spanning tree such that for every .	Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Ozeki, Kenta] JST, Kawarabayashi Large Graph Project, ERATO, Tokyo, Japan	Ozeki, K (reprint author), Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan.	ozeki@nii.ac.jp			JSPS KAKENHI [25871053]	This work was supported by JSPS KAKENHI Grant number 25871053.	Ellingham MN, 2002, J GRAPH THEOR, V39, P62, DOI 10.1002/jgt.10019; Bauer D, 2006, GRAPH COMBINATOR, V22, P1, DOI 10.1007/s00373-006-0649-0; Bauer D, 2000, DISCRETE APPL MATH, V99, P317, DOI 10.1016/S0166-218X(99)00141-9; Chvatal V., 1973, Discrete Mathematics, V5, DOI 10.1016/0012-365X(73)90138-6; Ellingham MN, 2000, J GRAPH THEOR, V33, P125, DOI 10.1002/(SICI)1097-0118(200003)33:3<125::AID-JGT1>3.0.CO;2-X; Enomoto H, 2011, ARS COMBINATORIA, V102, P289; Ohnishi Y., CONNECTED FACT UNPUB; WIN S, 1989, GRAPH COMBINATOR, V5, P201, DOI 10.1007/BF01788671	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	SEP	2015	31	5					1679	1688		10.1007/s00373-014-1487-0		10	Mathematics	Mathematics	CP9DA	WOS:000360192700043		
J	Sugano, K; Tack, J; Kuipers, EJ; Graham, DY; El-Omar, EM; Miura, S; Haruma, K; Asaka, M; Uemura, N; Malfertheiner, P				Sugano, Kentaro; Tack, Jan; Kuipers, Ernst J.; Graham, David Y.; El-Omar, Emad M.; Miura, Soichiro; Haruma, Ken; Asaka, Masahiro; Uemura, Naomi; Malfertheiner, Peter		Kyoto Global Consensus Conference	Kyoto global consensus report on Helicobacter pylori gastritis	GUT			English	Article							IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIFE-STYLE FACTORS; INTESTINAL METAPLASIA; FUNCTIONAL DYSPEPSIA; ACID-SECRETION; ATROPHIC GASTRITIS; NONULCER DYSPEPSIA; PEPTIC-ULCER; CANCER-RISK; MAGNIFYING ENDOSCOPY	Objective To present results of the Kyoto Global Consensus Meeting, which was convened to develop global consensus on (1) classification of chronic gastritis and duodenitis, (2) clinical distinction of dyspepsia caused by Helicobacter pylori from functional dyspepsia, (3) appropriate diagnostic assessment of gastritis and (4) when, whom and how to treat H. pylori gastritis. Design Twenty-three clinical questions addressing the above-mentioned four domains were drafted for which expert panels were asked to formulate relevant statements. A Delphi method using an anonymous electronic system was adopted to develop the consensus, the level of which was predefined as >= 80%. Final modifications of clinical questions and consensus were achieved at the face-to-face meeting in Kyoto. Results All 24 statements for 22 clinical questions after extensive modifications and omission of one clinical question were achieved with a consensus level of >80%. To better organise classification of gastritis and duodenitis based on aetiology, a new classification of gastritis and duodenitis is recommended for the 11th international classification. A new category of H. pylori-associated dyspepsia together with a diagnostic algorithm was proposed. The adoption of grading systems for gastric cancer risk stratification, and modern image-enhancing endoscopy for the diagnosis of gastritis, were recommended. Treatment to eradicate H. pylori infection before preneoplastic changes develop, if feasible, was recommended to minimise the risk of more serious complications of the infection. Conclusions A global consensus for gastritis was developed for the first time, which will be the basis for an international classification system and for further research on the subject.	[Sugano, Kentaro] Jichi Med Univ, Dept Med, Shimotsuke, Tochigi 3290498, Japan; [Tack, Jan] Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Leuven, Belgium; [Kuipers, Ernst J.] Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Graham, David Y.] Baylor Coll Med, Michael E DeBakery VA Med Ctr, Dept Med, Houston, TX 77030 USA; [El-Omar, Emad M.] Univ Aberdeen, Inst Med Sci, Div Appl Med, Aberdeen, Scotland; [Miura, Soichiro] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan; [Haruma, Ken] Kawasaki Med Univ, Dept Gastroenterol, Kurashiki, Okayama, Japan; [Asaka, Masahiro] Hokkaido Univ, Dept Canc Prevent Med, Sapporo, Hokkaido, Japan; [Uemura, Naomi] Natl Ctr Global Hlth & Med, Kohnodai Hosp, Ichikawa, Japan; [Malfertheiner, Peter] Univ Magdeburg, Dept Gastroenterol, D-39106 Magdeburg, Germany	Sugano, K (reprint author), Jichi Med Univ, Dept Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	sugano@jichi.ac.jp			Japanese Society of Gastroenterology (JSGE)	We thank the Japanese Society of Gastroenterology (JSGE) for providing financial support, enabling this global consensus meeting. Technical support by Omura Publishing Co Ltd and Mr Osamu Iimura of the JSGE is greatly appreciated. We also thank Japan Convention Service Co Ltd for their excellent management of the conference.	Anagnostopoulos GK, 2007, ENDOSCOPY, V39, P202, DOI 10.1055/s-2006-945056; Ang TL, 2006, J GASTROENTEROL, V41, P647, DOI 10.1007/s00535-006-1818-x; Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625; Atkins D, 2004, BRIT MED J, V328, P1490; Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108; Rugge M, 2008, DIGEST LIVER DIS, V40, P650, DOI 10.1016/j.dld.2008.02.030; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Mazzoleni LE, 2011, ARCH INTERN MED, V171, P1929, DOI 10.1001/archinternmed.2011.533; Sonnenberg A, 2010, GASTROENTEROLOGY, V139, P1894, DOI 10.1053/j.gastro.2010.08.018; Uedo N, 2006, ENDOSCOPY, V38, P819, DOI 10.1055/s-2006-944632; Dinis-Ribeiro M, 2004, J MED SCREEN, V11, P141, DOI 10.1258/0969141041732184; Rugge M, 2005, HUM PATHOL, V36, P228, DOI 10.1016/j.humpath.2004.12.008; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Suzuki H, 2009, GUT LIVER, V3, P81, DOI 10.5009/gnl.2009.3.2.81; Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Gonen C, 2009, HELICOBACTER, V14, P12, DOI 10.1111/j.1523-5378.2009.00650.x; Tahara T, 2009, GASTROINTEST ENDOSC, V70, P246, DOI 10.1016/j.gie.2008.11.046; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Tack J, 2010, AM J GASTROENTEROL, V105, P757, DOI 10.1038/ajg.2010.66; Yagi K, 2002, ENDOSCOPY, V34, P376, DOI 10.1055/s-2002-25281; Suzuki H, 2013, NAT REV GASTRO HEPAT, V10, P168, DOI 10.1038/nrgastro.2013.9; Naylor GM, 2006, GUT, V55, P1545, DOI 10.1136/gut.2005.080358; Kikuste I, 2014, EUR J GASTROEN HEPAT, V26, P704, DOI 10.1097/MEG.0000000000000108; Lau JYW, 2013, LANCET, V381, P2033, DOI 10.1016/S0140-6736(13)60596-6; Correa P, 2013, GASTROENTEROL CLIN N, V42, P211, DOI 10.1016/j.gtc.2013.01.002; de Vries AC, 2009, AM J GASTROENTEROL, V104, P1342, DOI [10.1038/ajg.2008.15, 10.1038/ajg.2009.15]; Capelle LG, 2010, GASTROINTEST ENDOSC, V71, P1150, DOI 10.1016/j.gie.2009.12.029; de Vries AC, 2010, HELICOBACTER, V15, P259, DOI 10.1111/j.1523-5378.2010.00760.x; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Yeomans ND, 2008, ALIMENT PHARM THERAP, V27, P465, DOI 10.1111/j.1365-2036.2008.03610.x; Miehlke S, 1998, BRIT J CANCER, V78, P263, DOI 10.1038/bjc.1998.475; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Franchini M, 2007, J ANTIMICROB CHEMOTH, V60, P237, DOI 10.1093/jac/dkm195; Vergara M, 2005, ALIMENT PHARM THERAP, V21, P1411, DOI 10.1111/j.1365-2036.2005.02444.x; Iijima K, 2000, GUT, V46, P20, DOI 10.1136/gut.46.1.20; Graham DY, 2014, CLIN GASTROENTEROL H, V12, P177, DOI 10.1016/j.cgh.2013.05.028; Fock KM, 2013, NAT REV GASTRO HEPAT, V10, P495, DOI 10.1038/nrgastro.2013.96; Okubo M, 2011, DIGESTION, V83, P161, DOI 10.1159/000321799; MARSHALL BJ, 1984, LANCET, V1, P1311; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Megraud F, 2005, J PEDIATR-US, V146, P198, DOI 10.1016/j.jpeds.2004.10.044; Wu JY, 2014, EXPERT REV GASTROENT, V8, P21, DOI 10.1586/17474124.2014.859522; Sugano K, 2011, J NEUROGASTROENTEROL, V17, P366, DOI 10.5056/jnm.2011.17.4.366; Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Miki K, 2011, P JPN ACAD B-PHYS, V87, P405, DOI 10.2183/pjab.87.405; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Pimentel-Nunes P, 2012, ENDOSCOPY, V44, P236, DOI 10.1055/s-0031-1291537; Moayyedi P, 2000, AM J GASTROENTEROL, V95, P1448; Malfertheiner P, 2011, DIGEST DIS, V29, P459, DOI 10.1159/000332213; TALLEY NJ, 1988, ANN INTERN MED, V108, P865; den Hoed CM, 2013, ENDOSCOPY, V45, P249, DOI 10.1055/s-0032-1326379; Graham DY, 2004, GUT, V53, P1235, DOI 10.1136/gut.2003.037499; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Nordenstedt H, 2013, AM J GASTROENTEROL, V108, P65, DOI 10.1038/ajg.2012.372; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Suzuki H, 2011, J GASTROEN HEPATOL, V26, P42, DOI 10.1111/j.1440-1746.2011.06629.x; Capelle LG, 2010, DIGEST DIS SCI, V55, P3442, DOI 10.1007/s10620-010-1189-2; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Camilleri M, 2013, NAT REV GASTRO HEPAT, V10, P187, DOI 10.1038/nrgastro.2013.11; Toljamo K, 2011, HELICOBACTER, V16, P444, DOI 10.1111/j.1523-5378.2011.00871.x; Lee YC, 2013, GUT, V62, P676, DOI 10.1136/gutjnl-2012-302240; Nandurkar S, 1998, ARCH INTERN MED, V158, P1427, DOI 10.1001/archinte.158.13.1427; Shiotani A, 2013, SEMIN CANCER BIOL, V23, P492, DOI 10.1016/j.semcancer.2013.07.004; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; Hawkey CJ, 2002, GUT, V51, P344, DOI 10.1136/gut.51.3.344; Kim JJ, 2002, GASTROENTEROLOGY, V123, P542, DOI 10.1053/gast.2002.34751; Matsueda S, 2014, WORLD J GASTROENTERO, V20, P1657, DOI 10.3748/wjg.v20.i7.1657; Agreus L, 2012, SCAND J GASTROENTERO, V47, P136, DOI 10.3109/00365521.2011.645501; Dinis-Ribeiro M, 2004, NEOPLASIA, V6, P449, DOI 10.1593/neo.03505; Kato M, 2010, GASTROINTEST ENDOSC, V72, P523, DOI 10.1016/j.gie.2010.04.041; Rugge M, 2011, WORLD J GASTROENTERO, V17, P4596, DOI 10.3748/wjg.v17.i41.4596; Take S, 2007, J GASTROENTEROL, V42, P21, DOI 10.1007/s00535-006-1924-9; Graham DY, 2005, GUT, V54, P735, DOI 10.1136/gut.2004.056549; Satoh K, 1998, AM J GASTROENTEROL, V93, P569; El-Zimaity HMT, 1999, HUM PATHOL, V30, P72, DOI 10.1016/S0046-8177(99)90303-9; de Vries AC, 2008, GASTROENTEROLOGY, V134, P945, DOI 10.1053/j.gastro.2008.01.071; Kimura K, 1996, Scand J Gastroenterol Suppl, V214, P17; Bode G, 2002, J INTERN MED, V252, P41, DOI 10.1046/j.1365-2796.2002.01000.x; Broutet N, 2003, BRIT J CANCER, V88, P1239, DOI 10.1038/sj.bjc.6600877; BUCKLEY M, 1995, ALIMENT PHARM THERAP, V9, P53; Chen HN, 2015, GASTRIC CANCER, DOI [10.1007/410120-015-0462-7, DOI 10.1007/S10120-015-0462-7]; CLARK EG, 1964, MED CLIN N AM, V48, P613; Delaney B, 2009, COCHRANE DB SYST REV, V7; Dinis-Ribeiro M, 2003, GASTROINTEST ENDOSC, V57, P498, DOI 10.1067/mge.2003.145; Dorer MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000544; Du MQ, 2000, J PATHOL, V192, P488; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; van Zanten SJOV, 2000, CAN MED ASSOC J, V162, pS3; Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Franchini M, 2012, SEMIN THROMB HEMOST, V38, P463, DOI 10.1055/s-0032-1305781; Furuta T, 2010, GASTROENTEROL CLIN N, V39, P465, DOI 10.1016/j.gtc.2010.08.007; GENTA RM, 1993, MODERN PATHOL, V6, P281; Gisbert JP, 2004, COCHRANE DB SYST REV; Graham DY, 2012, GASTROENTEROLOGY, V143, P10, DOI 10.1053/j.gastro.2012.05.012; Graham DY, 1996, GASTROENTEROLOGY, V110, P1647, DOI 10.1053/gast.1996.v110.agast961647; Graham DY, 2006, GASTROINTEST ENDOSC, V64, P686, DOI 10.1016/j.gie.2006.03.013; Gutierrez O, 1997, SCAND J GASTROENTERO, V32, P664, DOI 10.3109/00365529708996515; Hart J, 2009, ALIMENT PHARM THER, V31, P143, DOI 10.1111/j.1365-2036.2009.04133.x; Haruma K, 1999, ALIMENT PHARM THERAP, V13, P155; Harvey RF, 2010, ALIMENT PHARM THER, V32, P394, DOI 10.1111/j.1365-2036.2010.04363.x; International Agency for Research on Cancer, 2014, IARC WORK GROUP REP, V8; Jones DJ, 2012, ANN INTERN MED, V156, P809, DOI 10.7326/0003-4819-156-11-201206050-00008; JONSSON KA, 1989, SCAND J GASTROENTERO, V24, P385, DOI 10.3109/00365528909093064; Kato M, 2013, DIGEST ENDOSC, V25, P264, DOI 10.1111/j.1443-1661.2012.01385.x; Kimura K, 1969, ENDOSCOPY, V3, P87, DOI DOI 10.1055/S-0028-1098086; Kuipers EJ, 2003, EUR J GASTROEN HEPAT, V15, P877, DOI 10.1097/01.meg.0000059171.46867.9e; LAMBERT JR, 1993, GASTROENTEROL CLIN N, V22, P141; LANZA FL, 1991, AM J GASTROENTEROL, V86, P735; Lim JH, 2013, GUT LIVER, V7, P41, DOI 10.5009/gnl.2013.7.1.41; Makris N, 2003, INT J TECHNOL ASSESS, V19, P446; Malfertheiner P, 2003, ALIMENT PHARM THERAP, V18, P615, DOI 10.1046/j.1365-2036.2003.01695.x; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436; Meining A, 1998, VIRCHOWS ARCH, V432, P311, DOI 10.1007/s004280050171; Meining A, 1997, VIRCHOWS ARCH, V431, P11, DOI 10.1007/s004280050063; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Miwa H, 2012, J GASTROEN HEPATOL, V27, P626, DOI 10.1111/j.1440-1746.2011.07037.x; Moayyedi P, 2011, COCHRANE DB SYST REV, V16; MORRIS A, 1987, AM J GASTROENTEROL, V82, P192; Nishizawa T, 2013, INT J MOL SCI, V14, P9487, DOI 10.3390/ijms14059487; Ohkusa T, 1998, ANN INTERN MED, V129, P712; Okuda M, 2004, J PEDIATR-US, V144, P196, DOI 10.1016/j.jpeds.2003.10.057; Okuda M, 2005, CLIN DIAGN LAB IMMUN, V12, P1280, DOI 10.1128/CDLI.12.11.1280-1284.2005; Osawa H, 2014, VIDEO J ENCY GI ENDO, V1, P607; PRICE AB, 1991, J GASTROEN HEPATOL, V6, P209, DOI 10.1111/j.1440-1746.1991.tb01468.x; Quaseem A, 2010, ANN INTERN MED, V153, P194; Rosenstock S, 1997, GUT, V41, P169; Rugge M, 2010, ALIMENT PHARM THER, V31, P1104, DOI 10.1111/j.1365-2036.2010.04277.x; Rugge M, 2008, INT J SURG PATHOL, V16, P150, DOI 10.1177/1066896907307238; Schindler R, 1939, Bull N Y Acad Med, V15, P322; Shin CM, 2011, HELICOBACTER, V16, P179, DOI 10.1111/j.1523-5378.2011.00838.x; Sipponen M, 1992, J CLIN PATHOL, V45, P319; Strickland R G, 1975, Front Gastrointest Res, V1, P12; Tack J, 2006, ROME 3 FUNCTIONAL GA, P419; TALLEY NJ, 1993, GASTROENTEROL CLIN N, V22, P153; Tanaka A, 2011, PATHOL RES PRACT, V207, P354, DOI 10.1016/j.prp.2011.03.001; Wildner-Christensen Mette, 2006, Scand J Gastroenterol, V41, P149, DOI 10.1080/00365520510024070; Yagi K, 2002, J GASTROEN HEPATOL, V17, P39, DOI 10.1046/j.1440-1746.2002.02665.x; YASUNAGA Y, 1994, GUT, V35, P1571, DOI 10.1136/gut.35.11.1571; Zabaleta Jovanny, 2012, Frontiers in Genetics, V3, P294, DOI 10.3389/fgene.2012.00294; Zhang YY, 2009, ALIMENT PHARM THER, V29, P145, DOI 10.1111/j.1365-2036.2008.03873.x	142	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	SEP	2015	64	9					1353	1367		10.1136/gutjnl-2015-309252		15	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ1WB	WOS:000360389800004		
J	Hayashi, K; An, Y; Nagashima, M; Hiroshima, K; Ohe, M; Makihara, Y; Yamashita, K; Yamazato, S; Fukunaga, M; Sonoda, K; Ando, K; Goya, M				Hayashi, Kentaro; An, Yoshimori; Nagashima, Michio; Hiroshima, Kenichi; Ohe, Masatsugu; Makihara, Yu; Yamashita, Kennosuke; Yamazato, Schoichiro; Fukunaga, Masato; Sonoda, Koichiro; Ando, Kenji; Goya, Masahiko			Importance of nonpulmonary vein foci in catheter ablation for paroxysmal atrial fibrillation	HEART RHYTHM			English	Article						Catheter ablation; Atrial fibrillation; Pulmonary vein isolation; Mapping; Nonpulmonary vein foci	PULMONARY VEINS; OUTCOMES; SUBSTRATE; STRATEGY; ECTOPY	BACKGROUND Pulmonary vein (PV) isolation is an established treatment strategy for paroxysmal atrial fibrillation (PAF). However, the recurrence rate of PAP is 8% to 37%, despite repeated procedures, and the catheter ablation strategy for PAF with non-PV foci is unclear. OBJECTIVE The purpose of this study was to assess the PAF ablation strategy for non-PV foci. METHODS The study included 304 consecutive patients undergoing PAF ablation (209 males, age 63.0 +/- 10.4 years) divided into 3 groups: group 1 (245 patients) with no inducible non-PV foci; group 2 (34 patients) with atrial fibrillation (AF) originating from non-PV foci and all the foci successfully ablated; and group 3 (25 patients) with AF originating from non-PV triggers, but without all foci being ablated or with persistently inducible AF. RESULTS Mean follow-up period was 26.9 +/- 11.8 months, and AF recurrence rates since the last procedure were 9.8%, 8.8%, and 68.0% in groups 1, 2, and 3, respectively. There was no statistically significant difference in recurrence rate between groups 1 and 2 (P = .89); however, there were statistically significant differences between groups 3 and 1 (P < .0001) and groups 3 and 2 (P < .0001). The patients in group 2 had an AF-free outcome to equivalent to those who had PV foci in group 1 (P = .83). CONCLUSION Success rates can be improved for PAF ablation if non-PV foci are detected and eliminated.	[Hayashi, Kentaro; An, Yoshimori; Nagashima, Michio; Hiroshima, Kenichi; Ohe, Masatsugu; Makihara, Yu; Yamashita, Kennosuke; Yamazato, Schoichiro; Fukunaga, Masato; Sonoda, Koichiro; Ando, Kenji; Goya, Masahiko] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan	Hayashi, K (reprint author), Kokura Mem Hosp, Dept Cardiol, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka, Japan.	sg-kentaro@kf6.so-net.ne.jp					Tilz RR, 2012, J AM COLL CARDIOL, V60, P1921, DOI 10.1016/j.jacc.2012.04.060; Shah D, 2003, PACE, V26, P1631, DOI 10.1046/j.1460-9592.2003.t01-1-00243.x; Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027; Chang HY, 2013, J CARDIOVASC ELECTR, V24, P250, DOI 10.1111/jce.12036; Nademanee K, 2008, J AM COLL CARDIOL, V51, P843, DOI 10.1016/j.jacc.2007.10.044; Vogt J, 2013, J AM COLL CARDIOL, V61, P1707, DOI 10.1016/j.jacc.2012.09.033; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Elayi CS, 2013, J CARDIOVASC ELECTR, V24, P1199, DOI 10.1111/jce.12252; Yamaguchi T, 2010, EUROPACE, V12, P1698, DOI 10.1093/europace/euq326; Bhargava M, 2009, HEART RHYTHM, V6, P1403, DOI 10.1016/j.hrthm.2009.06.014; Elayi CS, 2011, J CARDIOVASC ELECTR, V22, P1199, DOI 10.1111/j.1540-8167.2011.02122.x; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Nanthakumar K, 2004, CIRCULATION, V109, P1226, DOI 10.1161/01.CIR.0000121423.78120.49; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Cheng XC, 2015, INT J CARDIOL, V181, P297, DOI 10.1016/j.ijcard.2014.12.002; Feld GK, 2009, HEART RHYTHM, V6, pS23, DOI 10.1016/j.hrthm.2009.03.002; Goya M, 2002, CIRCULATION, V106, P1317, DOI 10.1161/01.CIR.0000033115.92612.F4; Murakawa Y, 2014, CIRC J, V78, P1091, DOI 10.1253/circj.CJ-14-0099	19	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	SEP	2015	12	9					1918	1924		10.1016/j.hrthm.2015.05.003		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CQ1LK	WOS:000360359000015		
J	Nagao, T; Inden, Y; Yanagisawa, S; Kato, H; Ishikawa, S; Okumura, S; Mizutani, Y; Ito, T; Yamamoto, T; Yoshida, N; Hirai, M; Murohara, T				Nagao, Tomoyuki; Inden, Yasuya; Yanagisawa, Satoshi; Kato, Hiroyuki; Ishikawa, Shinji; Okumura, Satoshi; Mizutani, Yoshiaki; Ito, Tadahiro; Yamamoto, Toshihiko; Yoshida, Naoki; Hirai, Makoto; Murohara, Toyoaki			Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation	HEART RHYTHM			English	Article						Activated clotting time; Atrial fibrillation; Catheter ablation; New oral anticoagulant	RADIOFREQUENCY CATHETER ABLATION; BLEEDING COMPLICATIONS; RANDOMIZED-TRIAL; WARFARIN; DABIGATRAN; RIVAROXABAN; SAFETY; STROKE; THROMBOEMBOLISM; METAANALYSIS	BACKGROUND Close monitoring of intraoperative activated dotting time (ACT) is crucial to prevent complications during the periprocedural period of atrial fibrillation (AF) ablation. However, little is known about the ACT in patients receiving new oral anticoagulant agents (NOACs). OBJECTIVE The purpose of this study was to evaluate change in the ACT among anticoagulant agents used during the periprocedural period of AF ablation. METHODS We examined 869 consecutive patients who underwent AF ablation between April 2012 and August 2014 and received NOACs (n = 499), including dabigatran, rivaroxaban, and apixaban, or warfarin (n = 370) for uninterrupted periprocedural anticoagulation. Changes in intraprocedural ACT were investigated among the anticoagulant agents. Furthermore, the incidence of periprocedural events was estimated. RESULTS The average time in minutes required for achieving a target ACT > 300 seconds was significantly longer in the dabigatran group (DG) and apixaban group (AG) than in the warfarin group (WG) and rivaroxaban group (RG) (60 and 70 minutes vs 8 and 9 minutes, respectively; P <.001). In addition, the proportion of patients who achieved the target ACT after initial heparin bolus was significantly lower in the DG and AG than in the WG and RG (36% and 26 /a vs 84% and 78%, respectively; P <.001). Furthermore, the incidence of periprocedurat complications was equivalent among the groups. CONCLUSION The average time required to reach the target ACT was longer in the DG and AG than in the WG and RG.	[Nagao, Tomoyuki; Inden, Yasuya; Yanagisawa, Satoshi; Kato, Hiroyuki; Ishikawa, Shinji; Okumura, Satoshi; Mizutani, Yoshiaki; Ito, Tadahiro; Yamamoto, Toshihiko; Yoshida, Naoki; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Inden, Yasuya; Hirai, Makoto] Nagoya Univ, Grad Sch Hlth Sci, Nagoya, Aichi 4668550, Japan	Inden, Y (reprint author), Nagoya Univ, Dept Cardiol, Grad Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	inden@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Yanagisawa, Satoshi/Q-1723-2015				Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Haissaguerre M, 2005, J CARDIOVASC ELECTR, V16, P1125, DOI 10.1111/j.1540-8167.2005.00307.x; Providencia R, 2014, HEART, V100, P324, DOI 10.1136/heartjnl-2013-304386; Di Biase L, 2014, CIRCULATION, V129, P2638, DOI 10.1161/CIRCULATIONAHA.113.006426; Tada H, 2001, J AM COLL CARDIOL, V38, P750, DOI 10.1016/S0735-1097(01)01425-5; Konduru SV, 2012, J INTERV CARD ELECTR, V35, P277, DOI 10.1007/s10840-012-9719-9; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Yamaguchi T, 2000, STROKE, V31, P817; Hussein AA, 2009, HEART RHYTHM, V6, P1425, DOI 10.1016/j.hrthm.2009.07.007; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Di Biase L, 2010, CIRCULATION, V121, P2550, DOI 10.1161/CIRCULATIONAHA.109.921320; Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE; Oral H, 2007, CIRCULATION, V115, P2606, DOI 10.1161/CIRCULATIONAHA.107.691386; Gaita F, 2010, CIRCULATION, V122, P1667, DOI 10.1161/CIRCULATIONAHA.110.937953; Bassiouny M, 2013, CIRC-ARRHYTHMIA ELEC, V6, P460, DOI 10.1161/CIRCEP.113.000320; Aryal MR, 2014, AM J CARDIOL, V114, P577, DOI 10.1016/j.amjcard.2014.05.038; Gautam S, 2011, J CARDIOVASC ELECTR, V22, P248, DOI 10.1111/j.1540-8167.2010.01894.x; Bassiouny M, 2013, CIRC-ARRHYTHMIA ELEC, V6, pe79; BinAbdulhak AA, 2013, EUROPACE, V15, P1412; Calkins H, 2015, AM J CARDIOL, V115, P154, DOI 10.1016/j.amjcard.2014.10.002; Connolly SJ, 2010, NEW ENGL J MED, V363, P1877; Naccarelli GV, 2014, J INTERV CARD ELECTR, V41, P107, DOI 10.1007/s10840-014-9924-9; Crawford T, 2009, HEART RHYTHM, V6, pE12, DOI 10.1016/j.hrthm.2009.07.026	24	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	SEP	2015	12	9					1972	1978		10.1016/j.hrthm.2015.04.016		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CQ1LK	WOS:000360359000023		
J	Tung, R; Vaseghi, M; Frankel, DS; Vergara, P; Di Biase, L; Nagashima, K; Yu, R; Vangala, S; Tseng, CH; Choi, EK; Khurshid, S; Patel, M; Mathuria, N; Nakahara, S; Tzou, WS; Sauer, WH; Vakil, K; Tedrow, U; Burkhardt, JD; Tholakanahalli, VN; Saliaris, A; Dickfeld, T; Weiss, JP; Bunch, TJ; Reddy, M; Kanmanthareddy, A; Callans, DJ; Lakkireddy, D; Natale, A; Marchlinski, F; Stevenson, WG; Della Bella, P; Shivkumar, K				Tung, Roderick; Vaseghi, Marmar; Frankel, David S.; Vergara, Pasquale; Di Biase, Luigi; Nagashima, Koichi; Yu, Ricky; Vangala, Sitaram; Tseng, Chi-Hong; Choi, Eue-Keun; Khurshid, Shaan; Patel, Mehul; Mathuria, Nilesh; Nakahara, Shiro; Tzou, Wendy S.; Sauer, William H.; Vakil, Kairav; Tedrow, Usha; Burkhardt, J. David; Tholakanahalli, Venkatakrishna N.; Saliaris, Anastasios; Dickfeld, Timm; Weiss, J. Peter; Bunch, T. Jared; Reddy, Madhu; Kanmanthareddy, Arun; Callans, David J.; Lakkireddy, Dhanunjaya; Natale, Andrea; Marchlinski, Francis; Stevenson, William G.; Della Bella, Paolo; Shivkumar, Kalyanam			Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study	HEART RHYTHM			English	Article						Ablation; Ventricular tachycardia	MYOCARDIAL-INFARCTION; DEFIBRILLATOR IMPLANTATION; NONISCHEMIC CARDIOMYOPATHY; CARDIOVERTER-DEFIBRILLATOR; SINUS RHYTHM; END-POINT; SUBSTRATE; SCAR; ARRHYTHMIAS; OUTCOMES	BACKGROUND The impact of catheter ablation of ventricular tachycardia (VT) on all-cause mortality remains unknown. OBJECTIVE The purpose of this study was to examine the association between VT recurrence after ablation and survival in patients with scar-related VT. METHODS Analysis of 2061 patients with structural heart disease referred for catheter ablation of scar-related VT from 12 international centers was performed. Data on clinical and procedural variables, VT recurrence, and mortality were analyzed. Kaplan-Meier analysis was used to estimate freedom from recurrent VT, transplant, and death. Cox proportional hazards frailty models were used to analyze the effect of risk factors on VT recurrence and mortality. RESULTS One-year freedom from VT recurrence was 70% (72% in ischemic and 68% in nonischemic cardiomyopathy). Fifty-seven patients (3%) underwent cardiac transplantation, and 216 (10%) died during follow-up. At 1 year, the estimated rate of transplant and/or mortality was 15% (same for ischemic and nonischemic cardiomyopathy). Transplant-free survival was significantly higher in patients without VT recurrence than in those with recurrence (90% vs 71%, P <.001). In multivariable analysis, recurrence of VT after ablation showed the highest risk for transplant and/or mortality [hazard ratio 6.9 (95% CI 5.3-9.0), P <.001]. In patients with ejection fraction <30% and across all New York Heart Association functional classes, improved transplant-free survival was seen in those without VT recurrence. CONCLUSION Catheter ablation of VT in patients with structural heart disease results in 70% freedom from VT recurrence, with an overall transplant and/or mortality rate of 150/0 at 1 year. Freedom from VT recurrence is associated with improved transplant-free survival, independent of heart failure severity.	[Tung, Roderick; Vaseghi, Marmar; Yu, Ricky; Shivkumar, Kalyanam] UCLA Hlth Syst, UCLA Cardiac Arrhythmia Ctr, Los Angeles, CA USA; [Frankel, David S.; Khurshid, Shaan; Callans, David J.; Marchlinski, Francis] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Vergara, Pasquale; Della Bella, Paolo] Hosp San Raffaele, I-20132 Milan, Italy; [Di Biase, Luigi; Burkhardt, J. David; Natale, Andrea] St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, Austin, TX USA; [Nagashima, Koichi; Choi, Eue-Keun; Tedrow, Usha; Stevenson, William G.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Vangala, Sitaram; Tseng, Chi-Hong] UCLA Dept Med Stat Core, Los Angeles, CA USA; [Patel, Mehul; Mathuria, Nilesh] Texas Heart Inst, Baylor St Lukes Med Ctr, Houston, TX 77025 USA; [Nakahara, Shiro] Dokkyo Med Univ, Koshigaya Hosp, Saitama, Japan; [Tzou, Wendy S.; Sauer, William H.] Univ Colorado, Aurora, CO USA; [Vakil, Kairav; Tholakanahalli, Venkatakrishna N.] Univ Minnesota, Med Ctr, Minneapolis VA Med Ctr, Minneapolis, MN 55455 USA; [Saliaris, Anastasios; Dickfeld, Timm] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; [Weiss, J. Peter; Bunch, T. Jared] Intermt Med Ctr, Intermt Heart Inst, Murray, UT USA; [Reddy, Madhu; Kanmanthareddy, Arun; Lakkireddy, Dhanunjaya] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	Shivkumar, K (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Cardiac Arrhythmia Ctr, UCLA Hlth Syst, 100 UCLA Med Plaza,Suite 660, Los Angeles, CA 90095 USA.	kshivkumar@mednet.ucla.edu			National Heart, Lung, and Blood Institute [R01HL084261]; Medtronic Japan Fellowship; Biosense Webster; St. Jude Medical	The following authors contributed equally to this manuscript: Drs. Tung and Vaseghi; Drs. Frankel, Vergara, and DiBiase; and Drs. Natale, Marchlinski, Stevenson, Della Bella, and Shivkumar. The study was an unfunded, investigator-initiated collaborative study. Dr. Shivkumar was supported by National Heart, Lung, and Blood Institute Grant R01HL084261. Dr. Di Biase is a consultant to Biosense Webster, St. Jude Medical, and Stereotaxis. Dr. Nagashima is the recipient of a Medtronic Japan Fellowship. Dr. Tedrow has received honoraria from Medtronic, Boston Scientific, and St. Jude Medical; and research grants from Biosense Webster and St. Jude Medical. Dr. Burkhardt is a consultant to Biosense Webster. Dr. Tholakanahalli has no disclosures relevant to the study. Dr. Dickfeld has received a research grant from, and is a consultant to, Biosense Webster. Dr. Weiss is a consultant to Stereotaxis. Dr. Bunch is a consultant to Boston Scientific. Dr. Stevenson is the recipient of a patent for needle ablation consigned to Brigham and Women's Hospital. Dr. Della Bella is a consultant to St. Jude Medical; and has received honoraria for lectures from Biosense Webster, St. Jude Medical, and Biotronik.	STEVENSON WG, 1995, J AM COLL CARDIOL, V26, P481, DOI 10.1016/0735-1097(95)80026-D; van Taxis CFV, 2013, JACC-CARDIOVASC IMAG, V6, P42, DOI 10.1016/j.jcmg.2012.05.016; Stevenson WG, 1997, J AM COLL CARDIOL, V29, P1180; Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Cesario DA, 2006, HEART RHYTHM, V3, P1, DOI 10.1016/j.hrthm.2005.10.015; Sacher F, 2010, J AM COLL CARDIOL, V55, P2366, DOI 10.1016/j.jacc.2009.10.084; Stevenson WG, 2008, CIRCULATION, V118, P2773, DOI 10.1161/CIRCULATIONAHA.108.788604; Di Biase L, 2012, J AM COLL CARDIOL, V60, P132, DOI 10.1016/j.jacc.2012.03.044; Soejima K, 2004, CIRCULATION, V110, P1197, DOI 10.1161/01.CIR.0000140725.42845.90; Sacher F, 2008, CIRC-ARRHYTHMIA ELEC, V1, P153, DOI 10.1161/CIRCEP.108.769471; Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216; Carbucicchio C, 2008, CIRCULATION, V117, P462, DOI 10.1161/CIRCULATIONAHA.106.686534; Marchlinski FE, 2000, CIRCULATION, V101, P1288; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; Vergara P, 2012, J CARDIOVASC ELECTR, V23, P621, DOI 10.1111/j.1540-8167.2011.02246.x; Soejima K, 2001, CIRCULATION, V104, P664, DOI 10.1161/hc3101.093764; Tung R, 2013, HEART RHYTHM, V10, P490, DOI 10.1016/j.hrthm.2012.12.013; Tung R, 2012, CIRC-ARRHYTHMIA ELEC, V5, P264, DOI 10.1161/CIRCEP.111.967976; Tokuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000072; Tanner H, 2010, J CARDIOVASC ELECTR, V21, P47, DOI 10.1111/j.1540-8167.2009.01563.x; Ghanbari H, 2014, CIRC-ARRHYTHMIA ELEC, V7, P677, DOI 10.1161/CIRCEP.113.001404; Nakahara S, 2010, J AM COLL CARDIOL, V55, P2355, DOI 10.1016/j.jacc.2010.01.041; Della Bella P, 2013, CIRCULATION, V127, P1359, DOI 10.1161/CIRCULATIONAHA.112.000872; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P288, DOI 10.1016/j.jacc.2007.08.058; Tung R, 2010, J CARDIOVASC ELECTR, V21, P799, DOI 10.1111/j.1540-8167.2009.01705.x; Arenal A, 2003, J AM COLL CARDIOL, V41, P81, DOI 10.1016/S0735-1097(02)02623-2; Aliot EM, 2009, HEART RHYTHM, V6, P886, DOI 10.1016/j.hrthm.2009.04.030; Bunch TJ, 2014, HEART RHYTHM, V11, P533, DOI 10.1016/j.hrthm.2013.12.014; Della Bella P, 2004, EUR HEART J, V25, P1127, DOI 10.1016/j.ehj.2004.01.021; MCPHERSON CA, 1985, AM J CARDIOL, V55, P689, DOI 10.1016/0002-9149(85)90138-9; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457; Sosa E, 1996, J CARDIOVASC ELECTR, V7, P531, DOI 10.1111/j.1540-8167.1996.tb00559.x	35	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	SEP	2015	12	9					1997	2007		10.1016/j.hrthm.2015.05.036		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CQ1LK	WOS:000360359000027		
J	Miyazaki, S; Takagi, T; Matsuda, J; Iesaka, Y				Miyazaki, Shinsuke; Takagi, Takamitsu; Matsuda, Junji; Iesaka, Yoshito			Perimitral atrial tachycardia passing through a completely blocked mitral isthmus line?	HEART RHYTHM			English	Editorial Material						Differential pacing; Mitrat isthmus; Perimitral flutter; Linear block	ABLATION; CONDUCTION		[Miyazaki, Shinsuke; Takagi, Takamitsu; Matsuda, Junji; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Ctr Cardiovasc, Tsuchiura, Ibaraki 3000053, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Ctr Cardiovasc, Div Cardiol, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58; Shah D, 2000, CIRCULATION, V102, P1517; Miyazaki S, 2015, HEART RHYTHM, V12, P104, DOI 10.1016/j.hrthm.2014.09.055; Shah AJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P957, DOI 10.1161/CIRCEP.112.971259	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	SEP	2015	12	9					2038	2040		10.1016/j.hrthm.2015.05.002		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CQ1LK	WOS:000360359000033		
J	Hoki, T; Miyanishi, K; Tanaka, S; Takada, K; Kawano, Y; Sakurada, A; Sato, M; Kubo, T; Sato, T; Sato, Y; Takimoto, R; Kobune, M; Kato, J				Hoki, Toshifumi; Miyanishi, Koji; Tanaka, Shingo; Takada, Kohichi; Kawano, Yutaka; Sakurada, Akira; Sato, Masanori; Kubo, Tomohiro; Sato, Tsutomu; Sato, Yasushi; Takimoto, Rishu; Kobune, Masayoshi; Kato, Junji			Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis	HEPATOLOGY			English	Article							FATTY LIVER-DISEASE; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; MESSENGER-RNA; JAPANESE PATIENTS; OXIDATIVE DAMAGE; ION TRANSPORTER; HEPCIDIN; PHLEBOTOMY; OVERLOAD	Increased hepatic iron accumulation is thought to be involved in the pathogenesis of nonalcoholic steatohepatitis (NASH). Hepatic iron accumulation, as well as oxidative DNA damage, is significantly increased in NASH livers. However, the precise mechanism of iron accumulation in the NASH liver remains unclear. In this study, 40 cases with a diagnosis of NASH (n=25) or simple steatosis (SS; n=15) by liver biopsy were enrolled. An oral iron absorption test (OIAT) was used, in which 100 mg of sodium ferrous citrate was administered to each individual. The OIAT showed that absorption of iron from the gastrointestinal (GI) tract was increased significantly in NASH patients, compared to SS and control subjects. Iron reduction therapy was effective in patients with NASH, who exhibited iron deposition in the liver and no alanine aminotransferase improvement after other therapies (n=9). Serum hepcidin concentration and messenger RNA (mRNA) levels of divalent metal transporter 1 (DMT1) also were significantly elevated in patients with NASH. OIAT results were correlated with grade of liver iron accumulation and DMT1 mRNA levels. Then, we demonstrated that DMT1 mRNA levels increased significantly in Caco-2/TC7 cell monolayers cultured in transwells with serum from NASH patients. An electrophoresis mobility shift assay showed activation of iron regulatory protein (IRP) in those cells, and IRP1 small interfering RNA clearly inhibited the increase of DMT1 mRNA levels. Conclusion: In spite of elevation of serum hepcidin, iron absorption from the GI tract increased through up-regulation of DMT1 by IRP1 activation by humoral factor(s) in sera of patients with NASH. (Hepatology 2015) Hepatology 2015;62:751-761)	[Hoki, Toshifumi; Miyanishi, Koji; Tanaka, Shingo; Takada, Kohichi; Kawano, Yutaka; Sakurada, Akira; Sato, Masanori; Kubo, Tomohiro; Sato, Tsutomu; Sato, Yasushi; Takimoto, Rishu; Kobune, Masayoshi; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido 0608543, Japan	Kato, J (reprint author), Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	miyako@sapmed.ac.jp; jkato@sapmed.ac.jp			JSPS KAKENHI [20590787]	Supported, in part, by JSPS KAKENHI (grant no.: 20590787).	Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Fujita N, 2009, CANCER EPIDEM BIOMAR, V18, P424, DOI 10.1158/1055-9965.EPI-08-0725; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Tanaka S, 2013, J GASTROENTEROL, V48, P1249, DOI 10.1007/s00535-012-0739-0; Sumida Y, 2003, J HEPATOL, V38, P32, DOI 10.1016/S0168-8278(02)00331-8; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Beaton MD, 2013, ALIMENT PHARM THER, V37, P720, DOI 10.1111/apt.12255; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-2; Aigner E, 2008, AM J CLIN NUTR, V87, P1374; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Kato J, 2007, J GASTROENTEROL, V42, P830, DOI 10.1007/s00535-007-2095-z; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Sohda T, 1999, BIOCHEM GENET, V37, P63, DOI 10.1023/A:1018718101579; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Barisani D, 2008, J HEPATOL, V49, P123, DOI 10.1016/j.jhep.2008.03.011; Canonne-Hergaux F, 1999, BLOOD, V93, P4406; Kato J, 2001, CANCER RES, V61, P8697; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Poli G, 1997, FREE RADICAL BIO MED, V22, P287, DOI 10.1016/S0891-5849(96)00327-9; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Fargion S, 2001, AM J GASTROENTEROL, V96, P2448; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUTTERIDGE JMC, 1985, CLIN SCI, V68, P463; Kato J, 2001, AM J HUM GENET, V69, P191, DOI 10.1086/321261; Kijima H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-167; Kobune M, 2011, INT J HEMATOL, V93, P715, DOI 10.1007/s12185-011-0878-8; Lee PL, 1998, BLOOD CELL MOL DIS, V24, P199, DOI 10.1006/bcmd.1998.0186; Miyanishi K, 2001, GASTROENTEROLOGY, V121, P865, DOI 10.1053/gast.2001.27982; ROWE JW, 1977, MEDICINE, V56, P197; Sumida Y, 2006, HEPATOL RES, V36, P315, DOI 10.1016/j.hepres.2006.08.003; Trombini P, 2011, LIVER INT, V31, P994, DOI 10.1111/j.1478-3231.2011.02520.x; Yamauchi N, 2004, J GASTROENTEROL, V39, P654, DOI 10.1007/s00535-003-1361-y	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	SEP	2015	62	3					751	761		10.1002/hep.27774		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ1RB	WOS:000360375100013		
J	Ji, JF; Zheng, X; Forgues, M; Yamashita, T; Wauthier, EL; Reid, LM; Wen, XY; Song, Y; Wei, JS; Khan, J; Thorgeirsson, SS; Wang, XW				Ji, Junfang; Zheng, Xin; Forgues, Marshonna; Yamashita, Taro; Wauthier, Eliane L.; Reid, Lola M.; Wen, Xinyu; Song, Young; Wei, Jun S.; Khan, Javed; Thorgeirsson, Snorri S.; Wang, Xin Wei			Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma	HEPATOLOGY			English	Article							CANCER STEM-CELLS; HEPATIC PROGENITOR CELLS; LIVER-CANCER; CYTOKERATIN-19 EXPRESSION; MESENCHYMAL TRANSITION; TGF-BETA; EPCAM; PROGRESSION; METASTASIS; SURVIVAL	Therapies that target cancer stem cells (CSCs) hold promise in eliminating cancer burden. However, normal stem cells are likely to be targeted owing to their similarities to CSCs. It is established that epithelial cell adhesion molecule (EpCAM) is a biomarker for normal hepatic stem cells (HpSCs), and EpCAM(+)AFP(+) hepatocellular carcinoma (HCC) cells have enriched hepatic CSCs. We sought to determine whether specific microRNAs (miRNAs) exist in hepatic CSCs that are not expressed in normal HpSCs. We performed a pair-wise comparison of the miRNA transcriptome of EpCAM(+) and corresponding EpCAM(-) cells isolated from two primary HCC specimens, as well as from two fetal livers and three healthy adult liver donors by small RNA deep sequencing. We found that miR-150, miR-155, and miR-223 were preferentially highly expressed in EpCAM(+) HCC cells, which was further validated. Their gene surrogates, identified using miRNA and messenger RNA profiling in a cohort of 292 HCC patients, were associated with patient prognosis. We further demonstrated that miR-155 was highly expressed in EpCAM(+) HCC cells, compared to corresponding EpCAM(-) HCC cells, fetal livers with enriched normal hepatic progenitors, and normal adult livers with enriched mature hepatocytes. Suppressing miR-155 resulted in a decreased EpCAM(+) fraction in HCC cells and reduced HCC cell colony formation, migration, and invasion in vitro. The reduced levels of identified miR-155 targets predicted the shortened overall survival and time to recurrence of HCC patients. Conclusion: miR-155 is highly elevated in EpCAM(+) HCC cells and might serve as a molecular target to eradicate the EpCAM(+) CSC population in human HCCs. (Hepatology 2015;62:829-840)	[Ji, Junfang] Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Ji, Junfang] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA; [Zheng, Xin] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Ji, Junfang; Forgues, Marshonna; Wang, Xin Wei] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Yamashita, Taro] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Wauthier, Eliane L.; Reid, Lola M.] UNC Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Wauthier, Eliane L.; Reid, Lola M.] UNC Sch Med, Program Mol Biol & Biotechnol, Chapel Hill, NC USA; [Wen, Xinyu; Song, Young; Wei, Jun S.; Khan, Javed] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Thorgeirsson, Snorri S.] NCI, Expt Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	Wang, XW (reprint author), NCI, 37 Convent Dr,MSC 4258, Bethesda, MD 20892 USA.	jji@cc.hawaii.edu; xw3u@nih.gov	Khan, Javed/P-9157-2014; Wang, Xin/B-6162-2009	Khan, Javed/0000-0002-5858-0488; 	center for cancer research, the U.S. National Cancer Institute [Z01-BC 010313, Z01-BC010876]; UNC School of Medicine (Chapel Hill, NC) - SRA from Vesta Therapeutics (Bethesda, MD); National Institutes of Health (NIH) [R21CA182322]; NIH [P30DK34987]; National Institute of Diabetes and Digestive and Kidney Diseases [DK34987]; Cancer Center grant [CA016086]	This work was supported by the intramural research program of the center for cancer research, the U.S. National Cancer Institute (Z01-BC 010313 and Z01-BC010876), collaborators at the UNC School of Medicine (Chapel Hill, NC) funded by an SRA from Vesta Therapeutics (Bethesda, MD), by a National Institutes of Health (NIH) grant (R21CA182322), and with core services support from several center grants: NIH (P30DK34987); National Institute of Diabetes and Digestive and Kidney Diseases (DK34987); and a Cancer Center grant (CA016086).	Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Durnez A, 2006, HISTOPATHOLOGY, V49, P138, DOI 10.1111/j.1365-2559.2006.02468.x; Uenishi T, 2003, CANCER SCI, V94, P851, DOI 10.1111/j.1349-7006.2003.tb01366.x; Johansson J, 2013, ONCOGENE, V32, P5614, DOI 10.1038/onc.2013.322; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Yin QY, 2010, J VIROL, V84, P6318, DOI 10.1128/JVI.00635-10; Budhu A, 2013, GASTROENTEROLOGY, V144, P1066, DOI 10.1053/j.gastro.2013.01.054; Gupta PB, 2009, NAT MED, V15, P1010, DOI [10.1038/nm0909-1010, 10.1038/nm.2032]; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Cavard C, 2008, FUTURE ONCOL, V4, P647, DOI 10.2217/14796694.4.5.647; Oishi N, 2012, HEPATOLOGY, V56, P1792, DOI 10.1002/hep.25890; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; STROM SC, 1982, J NATL CANCER I, V68, P771; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Weber M, 2014, AM J PHYSIOL-HEART C, V306, pH1192, DOI 10.1152/ajpheart.00521.2013; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Ji Junfang, 2009, Cancer Biol Ther, V8, P1686; Ji JF, 2011, CELL BIOSCI, V1, DOI [10.1186/2045-3701-1-4, 10.1186/045-3701-1-4]; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Turner WS, 2008, STEM CELLS, V26, P1547, DOI 10.1634/stemcells.2007-0863	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	SEP	2015	62	3					829	840		10.1002/hep.27886		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ1RB	WOS:000360375100020		
J	Yao, KY; Khandelwal, S; Sammoura, F; Kazama, A; Hu, CM; Lin, LW				Yao, Kaiyuan; Khandelwal, Sourabh; Sammoura, Firas; Kazama, Atsushi; Hu, Chenming; Lin, Liwei			Piezoelectricity-Induced Schottky Barrier Height Variations in AlGaN/GaN High Electron Mobility Transistors	IEEE ELECTRON DEVICE LETTERS			English	Article						GaN HEMT; Schottky barrier; piezoelectricity	ELASTIC PROPERTIES; HEMT DEVICES; GAN; POLARIZATION; HETEROSTRUCTURES; GASES; MODEL; ALN	Drain current of AlGaN/GaN high electron mobility transistors (HEMTs) is measured to decrease/increase with in-plane tensile/compressive external strain. Such a trend is opposite to the conventional theory of direct piezoelectric effect on 2-D electron gas (2DEG). The reason is found to be the dependence of nickel gate barrier height on external strain, which strongly affects HEMTs' threshold voltage and 2DEG concentration. The Ni/AlGaN interface states are proposed to be responsible for strain-induced gate barrier variations, which are important for device performances and sensor applications.	[Yao, Kaiyuan; Sammoura, Firas; Lin, Liwei] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Khandelwal, Sourabh; Hu, Chenming] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Kazama, Atsushi] Hitachi Ltd, Res & Dev Grp, Ibaraki 3191414, Japan	Yao, KY (reprint author), Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.	kyyao@berkeley.edu			Berkeley Sensor and Actuator Center; National Science Foundation/Industry/University Cooperative Research Center	This work was supported in part by the Berkeley Sensor and Actuator Center, a National Science Foundation/Industry/University Cooperative Research Center. The review of this letter was arranged by Editor T. Egawa.	Bermudez VM, 1999, J APPL PHYS, V86, P1170, DOI 10.1063/1.370861; Khandelwal S, 2011, IEEE T ELECTRON DEV, V58, P3622, DOI 10.1109/TED.2011.2161314; Chu SNG, 2005, MAT SCI ENG A-STRUCT, V409, P340, DOI 10.1016/j.msea.2005.05.119; Mamor M, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/33/335802; Eickhoff M, 2001, J APPL PHYS, V90, P3383, DOI 10.1063/1.1398602; Ambacher O, 2000, J APPL PHYS, V87, P334, DOI 10.1063/1.371866; Wright AF, 1997, J APPL PHYS, V82, P2833, DOI 10.1063/1.366114; Pearton SJ, 2004, J PHYS-CONDENS MAT, V16, pR961, DOI 10.1088/0953-8984/16/29/R02; Khandelwal S, 2012, SOLID STATE ELECTRON, V76, P60, DOI 10.1016/j.sse.2012.05.054; Shimada K, 1998, J APPL PHYS, V84, P4951, DOI 10.1063/1.368739; Bernardini F, 1997, PHYS REV B, V56, P10024; Chang CT, 2009, IEEE ELECTR DEVICE L, V30, P213, DOI 10.1109/LED.2009.2012447; Ghosh S, 2015, IEEE T ELECTRON DEV, V62, P443, DOI 10.1109/TED.2014.2360420; Iucolano F, 2008, J APPL PHYS, V104, DOI 10.1063/1.3006133; Koehler AD, 2010, IEEE ELECTR DEVICE L, V31, P665, DOI 10.1109/LED.2010.2048195; Schroder D. K., 2006, SEMICONDUCTOR MAT DE; Takagi Y, 1996, PHYSICA B, V219-20, P547, DOI 10.1016/0921-4526(95)00807-1; Timoshenko S. P., 1930, STRENGTH MAT; Tsubouchi K., 1981, P IEEE ULTR S, P375	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	SEP	2015	36	9					902	904		10.1109/LED.2015.2456178		3	Engineering, Electrical & Electronic	Engineering	CQ0GR	WOS:000360273900010		
J	Wang, T; Sawada, R; Lee, C				Wang, Tao; Sawada, Renshi; Lee, Chengkuo			A Piezoelectric Micromachined Ultrasonic Transducer Using Piston-Like Membrane Motion	IEEE ELECTRON DEVICE LETTERS			English	Article						Piezoelectric micromachined ultrasonic transducer (pMUT); MEMS; Piezoelectric; Ultrasound		Piezoelectric micromachined ultrasonic transducer (pMUT) is a promising candidate for the next-generation 3-D diagnostic ultrasonic imaging. However, the transmitting sensitivity of reported pMUT is not satisfied so far. Enhancement of the transmitting sensitivity hence is always desirable. In this letter, we report a piston-like pMUT. With the help of etching holes in the membrane, the mode shape becomes from Gaussian-like to piston-like, which enables higher transmitted acoustic pressure. In addition, frequency of such pMUT does not decrease after etching holes are fabricated, but slightly increases. Higher frequency for ultrasonic imaging thus is practical, and the frequency can be predicted by well-established methods. Sensitivity of 73 nm/V at 2.31 MHz is achieved for the piston-like pMUT with three rows of etching holes. Benefited from the piston-like membrane motion, the space pressure level is 5.3 dB higher than the classical pMUT.	[Wang, Tao; Lee, Chengkuo] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117576, Singapore; [Sawada, Renshi] Kyushu Univ, Dept Mech Engn, Fukuoka 8190395, Japan	Wang, T (reprint author), Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117576, Singapore.	elelc@nus.edu.sg			Science and Engineering Research Council, Agency for Science, Technology and Research, Singapore [1220103064]; Competitive Research Program through National Research Foundation, Singapore [NRF-CRP001-057, R-263-000-A27-281]	This work was supported in part by the Science and Engineering Research Council, Agency for Science, Technology and Research, Singapore, under Grant 1220103064 and in part by the NRF-CRP001-057 Competitive Research Program through the National Research Foundation, Singapore, under Grant R-263-000-A27-281. The review of this letter was arranged by Editor M. Rais-Zadeh.	Wang T, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905441; Bernstein JJ, 1997, IEEE T ULTRASON FERR, V44, P960, DOI 10.1109/58.655620; Muralt P, 2005, IEEE T ULTRASON FERR, V52, P2276, DOI 10.1109/TUFFC.2005.1563270; Sammoura F, 2013, IEEE INT ULTRA SYM, P275, DOI 10.1109/ULTSYM.2013.0071; Khuri-Yakub BT, 2009, IEEE SPECTRUM, V46, P44, DOI 10.1109/MSPEC.2009.4907385; Guedes A., 2011, P 16 INT SOL STAT SE, P2062; Huang YL, 2009, IEEE T ULTRASON FERR, V56, P136, DOI 10.1109/TUFFC.2009.1013; LU YP, 2015, J MICROELECTROMECH S, V24, P904, DOI DOI 10.1109/JMEMS.2014.2358991; LU YP, 2015, J MICROELECTROMECH S, V24, P1142, DOI DOI 10.1109/JMEMS.2014.2387154; Shelton S., 2009, P 2009 IEEE INT ULTR, P402; Wang T, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/7/075002	11	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	SEP	2015	36	9					957	959		10.1109/LED.2015.2459075		3	Engineering, Electrical & Electronic	Engineering	CQ0GR	WOS:000360273900028		
J	Adachi, S; Yoshida, Y; Nojiri, T; Kurata, Y; Kato, T; Watanabe, S; Yoshida, M				Adachi, Shuichiro; Yoshida, Yutaka; Nojiri, Takeshi; Kurata, Yasushi; Kato, Takahiko; Watanabe, Seiichi; Yoshida, Masato			Effect of Glass Frits Amount on Atmospheric Sintering Behavior and Characteristics of Electrode Produced by Copper-Phosphorus Alloy	IEEE JOURNAL OF PHOTOVOLTAICS			English	Article						Atmospheric sintering; copper-phosphorus (Cu-P) alloy; electrode; glass frit; silicon (Si) solar cells	SOLAR-CELLS; BIBO3; CONTACTS; SYSTEM	In this study, we evaluate the atmospheric sintering behavior and characteristics of electrodes produced by copper-phosphorus (Cu-P) alloy paste containing various amounts of B2O3-Bi2O3-SiO2 glass frits. We demonstrate the need for a certain extent of glass frits to expand the applicable temperature for use of Cu-P alloy paste shifted to the higher temperature side, where commercial pastes for crystalline silicon (Si) photovoltaics are sintered, although the minimum electrical resistivity of the Cu-P alloy electrode increased by increasing the amount of glass frits. Based on the characteristics of the Cu-P alloy electrode, the need to expand the Cu crystal network and prevent the oxidization of generated Cu has emerged to reduce electrical resistivity. A crystalline BiPO4 was formed in the sintered Cu-P alloy electrode, which suggests a reaction between partially crystallized glass frits and P2O5 generated from Cu-P-O glass derived from the Cu-P alloy that has occurred. Subsequently, the sintering behavior of Cu-P alloy paste, including the glass frits, was discussed based on the results of X-ray diffraction, transmission electron microscopy, scanning transmission electron microscopy energy-dispersive X-ray spectroscopy, and electron energy loss spectroscopy.	[Adachi, Shuichiro; Nojiri, Takeshi; Kurata, Yasushi; Yoshida, Masato] Hitachi Chem Co Ltd, Tsukuba Res Lab, Tsukuba, Ibaraki 3004247, Japan; [Yoshida, Masato] Kitami Inst Technol, Kitami, Hokkaido 0908507, Japan; [Kato, Takahiko] Hitachi Ltd, Ctr Technol Innovat Mat, Res & Dev Grp, Ibaraki 3191292, Japan; [Kato, Takahiko; Watanabe, Seiichi] Hokkaido Univ, Fac Engn, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0608628, Japan	Adachi, S (reprint author), Hitachi Chem Co Ltd, Tsukuba Res Lab, Tsukuba, Ibaraki 3004247, Japan.	s-adachi@hitachi-chem.co.jp; yyoshida@mail.kitami-it.ac.jp; t-nojiri@hitachi-chem.co.jp; y-kurata@hitachi-chem.co.jp; takahiko.kato.ts@hitachi.com; sw004@eng.hokudai.ac.jp; masa-yoshida@hitachi-chem.co.jp			"Nanotechnology Platform" Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was conducted in part at Hokkaido University and was supported by "Nanotechnology Platform" Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Adachi S, 2013, IEEE J PHOTOVOLT, V3, P1178, DOI 10.1109/JPHOTOV.2013.2270353; Adachi S., ATMOSPHERICALLY SINT; Schubert G, 2006, SOL ENERG MAT SOL C, V90, P3399, DOI 10.1016/j.solmat.2006.03.040; Ballif C, 2003, APPL PHYS LETT, V82, P1878, DOI 10.1063/1.1562338; Ihara R, 2004, OPT MATER, V27, P403, DOI 10.1016/j.optmat.2004.07.002; Bajaj A, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/035112; Iordanova RS, 2011, BULG CHEM COMMUN, V43, P254; Kato T, 2012, IEEE J PHOTOVOLT, V2, P499, DOI 10.1109/JPHOTOV.2012.2188018; Kim D, 2009, J KOREAN PHYS SOC, V55, P1046; MEY SA, 1990, CALPHAD, V14, P265; Neuhaus D.-H., 2007, ADV OPTOELECTRON, V2007, P1, DOI DOI 10.1155/2007/24521; POTTIER MJ, 1974, B PSYCHONOMIC SOC, V83, P235; Russell R., 2012, 27 EUR PHOT SOL EN C; Schubert G., 2004, P 19 EUR PHOT SOL EN, P813; Schubert G., 2002, P PHOT EUR C ROM, P343; Sopori B., 2007, 17 WORKSH CRYST SIL; Yoshida Manabu, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Zhang W., 2012, PV MAG, P66	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	SEP	2015	5	5					1325	1334		10.1109/JPHOTOV.2015.2449655		10	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CQ2ND	WOS:000360436800009		
J	Yamazato, T; Kinoshita, M; Arai, S; Souke, E; Yendo, T; Fujii, T; Kamakura, K; Okada, H				Yamazato, Takaya; Kinoshita, Masayuki; Arai, Shintaro; Souke, Eisho; Yendo, Tomohiro; Fujii, Toshiaki; Kamakura, Koji; Okada, Hiraku			Vehicle Motion and Pixel Illumination Modeling for Image Sensor Based Visible Light Communication	IEEE JOURNAL ON SELECTED AREAS IN COMMUNICATIONS			English	Article						Visible light communication (VLC); image sensor; outdoor mobile channel modeling; infrastructure to vehicle VLC (I2V-VLC); vehicle to infrastructure VLC (V2I-VLC); vehicle to vehicle VLC (V2V-VLC); vehicle motion model; optical flow; pinhole camera model; pixel illumination model; DC gain	TRACKING; CAMERA; SYSTEM	Channel modeling is critical for the design and performance evaluation of visible light communication (VLC). Although a considerable amount of research has focused on indoor VLC systems using single-element photodiodes, there remains a need for channel modeling of VLC systems for outdoor mobile environments. In this paper, we describe and provide results for modeling image sensor based VLC for automotive applications. In particular, we examine the channel model for mobile movements in the image plane as well as channel decay according to the distance between the transmitter and the receiver. Optical flow measurements were conducted for three VLC situations for automotive use: infrastructure to vehicle VLC (I2V-VLC); vehicle to infrastructure VLC (V2I-VLC); and vehicle to vehicle VLC (V2V-VLC). We describe vehicle motion by optical flow with sub-pixel accuracy using phase-only correlation (POC) analysis and show that a single-pinhole camera model successfully describes these three VLC cases. In addition, the luminance of the central pixel from the projected LED area versus the distance between the LED and the camera was measured. Our key findings are twofold. First, a single-pinhole camera model can be applied to vehicle motion modeling of a I2V-VLC, V2I-VLC, and V2V-VLC. Second, the DC gain at a pixel remains constant as long as the projected image of the transmitter LED occupies several pixels. In other words, if we choose a pixel with highest luminance among the projected image of transmitter LED, the value remains constant, and the signal-to-noise ratio does not change according to the distance.	[Yamazato, Takaya; Kinoshita, Masayuki; Fujii, Toshiaki; Okada, Hiraku] Nagoya Univ, Nagoya, Aichi 4648603, Japan; [Arai, Shintaro; Souke, Eisho] Kagawa Coll, Natl Inst Technol, Toshima, Kagawa 7691192, Japan; [Yendo, Tomohiro] Nagaoka Univ Technol, Nagaoka, Niigata 4648063, Japan; [Kamakura, Koji] Chiba Inst Technol, Chiba 2750016, Japan	Yamazato, T (reprint author), Nagoya Univ, Nagoya, Aichi 4648603, Japan.	yamazato@ieee.org			Toyota Central RD Labs., Inc.	This work was partially supported by Toyota Central R&D Labs., Inc.	Agostinacchio M., 2014, EUR TRANSP RES REV, V6, P267; Alonso JD, 2008, IEEE T VEH TECHNOL, V57, P2736, DOI 10.1109/TVT.2008.917220; Amano Y, 2013, GLOB TELECOMM CONF, P2430, DOI 10.1109/GLOCOM.2013.6831438; Wong KYK, 2003, IEEE T PATTERN ANAL, V25, P147, DOI 10.1109/TPAMI.2003.1177148; Takita K, 2003, IEICE T FUND ELECTR, VE86A, P1925; Lee K, 2011, IEEE COMMUN LETT, V15, P217, DOI 10.1109/LCOMM.2011.010411.101945; Nishimoto S, 2012, IEEE GLOBE WORK, P1234, DOI 10.1109/GLOCOMW.2012.6477757; Yamazato T, 2014, IEEE COMMUN MAG, V52, P88, DOI 10.1109/MCOM.2014.6852088; Sun WC, 2013, IEEE T CONTR SYST T, V21, P2417, DOI 10.1109/TCST.2012.2237174; Komine T, 2009, IEEE T WIREL COMMUN, V8, P2892, DOI 10.1109/TWC.2009.060258; Avidan S, 2004, IEEE T PATTERN ANAL, V26, P1064, DOI 10.1109/TPAMI.2004.53; Gancarz J, 2013, IEEE COMMUN MAG, V51, P34, DOI 10.1109/MCOM.2013.6685755; Takai I, 2013, IEEE PHOTONICS J, V5, DOI 10.1109/JPHOT.2013.2277881; Baker S., 2007, P IEEE INT C COMP VI, P1, DOI DOI 10.1109/ICCV.2007.4408903; Bergstrom A. L. Lars, 2014, NOBEL PRIZE PHYS 201; Faugeras O., 1993, 3 DIMENSIONAL COMPUT; Ghassemlooy Z., 2013, J ELECT COMPUT INNOV, V1, P1; GRIFFIN MJ, 1978, APPL ERGON, V9, P15, DOI 10.1016/0003-6870(78)90214-4; Haigh P. A., 2011, P 12 ANN POSTGR S CO, P190; He Y., 2013, OPT PHOTON J, V3, P153; Kahn JM, 1997, P IEEE, V85, P265, DOI 10.1109/5.554222; Kamijo S., 2000, IEEE Transactions on Intelligent Transportation Systems, V1, DOI 10.1109/6979.880968; Kinoshita M., 2014, P GC WKSHPS DEC, P450; Schmidt C., 2013, SPIE NEWSROOM; Siegmann P, 2008, IEEE T INSTRUM MEAS, V57, P607, DOI 10.1109/TIM.2007.911643; Sun ZH, 2004, ITSC 2004: 7TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, PROCEEDINGS, P585; Urabe H., 2012, OPT ENG, V51; Wright M., 2013, LEDS MAGAZINE    MAR, P35; Yamazato T., 2014, IEICE T COMMUN, p[E97, 1759]	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8716	1558-0008		IEEE J SEL AREA COMM	IEEE J. Sel. Areas Commun.	SEP	2015	33	9					1793	1805		10.1109/JSAC.2015.2432511		13	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CQ2CU	WOS:000360407800007		
J	Palma, G; Falconi, C; Nazabal, V; Yano, T; Kishi, T; Kumagai, T; Ferrari, M; Prudenzano, F				Palma, G.; Falconi, C.; Nazabal, V.; Yano, T.; Kishi, T.; Kumagai, T.; Ferrari, M.; Prudenzano, F.			Modeling of Whispering Gallery Modes for Rare Earth Spectroscopic Characterization	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Modeling; optical fibers; optical resonators; optical spectroscopy; optical waveguide theory	AMPLIFIERS; GLASSES; DESIGN	A refined model of a mid-IR amplifier, constituted by a tapered chalcogenide fiber coupled to an erbium-doped chalcogenide microsphere, is integrated with a global solution search procedure based on particle swarm optimization approach. It is implemented in a computer code in order to obtain an inversion algorithm useful to evaluate the spectroscopic parameters of rare-earth-doped glass microspheres. The rare earth parameters can be recovered by means of the optical gain measurement. The error in evaluation of the erbium lifetime tau(41) is <3.5%. It is <0.5% for the other lifetimes and ion-ion interaction parameters. These excellent results are obtained since whispering gallery mode electromagnetic field interacts with rare earth for long effective distances.	[Palma, G.; Falconi, C.; Prudenzano, F.] Politecn Bari, Dept Elect & Informat Engn, I-70125 Bari, Italy; [Nazabal, V.] Univ Rennes 1, CNRS, UMR 6226, Inst Sci Chim Rennes, F-35042 Rennes, France; [Yano, T.; Kishi, T.; Kumagai, T.] Tokyo Inst Technol, Dept Chem & Mat Sci, Tokyo 1528550, Japan; [Ferrari, M.] CNR, CSMFO Lab, Ist Foton & Nanotecnol, I-38123 Trento, Italy	Palma, G (reprint author), Politecn Bari, Dept Elect & Informat Engn, I-70125 Bari, Italy.	giuseppe.palma@poliba.it; falconia@tiscali.it; virginie.nazabal@univ-rennes1.fr; tetsuji@ceram.titech.ac.jp; tkishi@ceram.titech.ac.jp; kumagai.t.af@m.titech.ac.jp; mferrari@science.unitn.it; francesco.prudenzano@poliba.it	Ferrari, Maurizio/H-3362-2011	Ferrari, Maurizio/0000-0003-3723-5957			Moizan V, 2008, OPT MATER, V31, P39, DOI 10.1016/j.optmat.2008.01.005; Elliott GR, 2007, OPT EXPRESS, V15, P17542, DOI 10.1364/OE.15.017542; Mescia L, 2012, OPT EXPRESS, V20, P7616, DOI 10.1364/OE.20.007616; Girard S, 2013, J LIGHTWAVE TECHNOL, V31, P1247, DOI 10.1109/JLT.2013.2245304; Grillet C., 2008, APPL PHYS LETT, V92; Kadono K, 2003, J NON-CRYST SOLIDS, V331, P79, DOI 10.1016/j.jnoncrysol.2003.08.087; Mescia L, 2013, IEEE PHOTONICS J, V5, DOI 10.1109/JPHOT.2013.2277052; Mescia L, 2011, J NON-CRYST SOLIDS, V357, P1851, DOI 10.1016/j.jnoncrysol.2010.12.049; Palma G., 2013, OPT ENG, V53	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	SEP 1	2015	27	17					1861	1863		10.1109/LPT.2015.2443915		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CQ1RC	WOS:000360375300002		
J	Bai, EW; Ishii, H; Tempo, R				Bai, Er-Wei; Ishii, Hideaki; Tempo, Roberto			A Markov Chain Monte Carlo Approach to Nonlinear Parametric System Identification	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article						Monte Carlo; parameter estimation; system identification	SET-MEMBERSHIP IDENTIFICATION; NOISE; COMPLEXITY	Nonlinear system identification is discussed in a mixed set-membership and statistical setting. A Markov chain Monte Carlo (MCMC) approach is proposed that estimates the feasible parameter set, the minimum volume outer-bounding ellipsoid and the minimum variance estimate. The proposed algorithm is proved to be convergent and enjoys some desirable properties. Further, its computational complexity and numerical accuracy are studied.	[Bai, Er-Wei] Univ Iowa, Dept Elect & Comp Engn, Iowa City, IA 52242 USA; [Bai, Er-Wei] Queens Univ, Sch Elect, Elect Engn, Belfast BT9 6AZ, Antrim, North Ireland; [Ishii, Hideaki] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268503, Japan; [Tempo, Roberto] Politecn Torino, IEIIT CNR, I-10129 Turin, Italy	Bai, EW (reprint author), Univ Iowa, Dept Elect & Comp Engn, Iowa City, IA 52242 USA.	er-wei-bai@uiowa.edu; ishii@dis.titech.ac.jp; roberto.tempo@polito.it			NSF [CNS-1329057]; European Union Seventh Framework Programme under Network of Excellence [257462 HYCON2]	This work was supported in part by the NSF CNS-1329057 and by the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement 257462 HYCON2 Network of Excellence. Recommended by Associate Editor S. Anderson.	Alamo T., 2015, AUTOMATICA, V51; Alamo T., 2010, PERSPECTIVES MATH SY, P34; TIERNEY L, 1994, ANN STAT, V22, P1701, DOI 10.1214/aos/1176325750; Milanese M, 2005, AUTOMATICA, V41, P2019, DOI 10.1016/j.automatica.2005.07.007; Ozay N, 2012, IEEE T AUTOMAT CONTR, V57, P634, DOI 10.1109/TAC.2011.2166295; Granvilliers L, 2006, ACM T MATH SOFTWARE, V32, P138, DOI 10.1145/1132973.1132980; Kumar P, 2005, J OPTIMIZ THEORY APP, V126, P1, DOI 10.1007/s10957-005-2653-6; FOGEL E, 1982, AUTOMATICA, V18, P229, DOI 10.1016/0005-1098(82)90110-8; Ninness B, 2010, AUTOMATICA, V46, P40, DOI 10.1016/j.automatica.2009.10.015; Bai EW, 1999, IEEE T AUTOMAT CONTR, V44, P1107, DOI 10.1109/9.769366; BAI EW, 1995, IEEE T CIRCUITS-I, V42, P266; Bai EW, 1996, AUTOMATICA, V32, P985, DOI 10.1016/0005-1098(96)00040-4; Boyd S, 2004, CONVEX OPTIMIZATION; Cerone V, 2012, P AMER CONTR CONF, P3421; Dabbene F., 2010, P IEEE MULT SYST CON, P1564; Dabbene F, 2014, IEEE T AUTOMAT CONTR, V59, P2113, DOI 10.1109/TAC.2014.2318092; Deller JR, 2002, CIRC SYST SIGNAL PR, V21, P69, DOI 10.1007/BF01211652; Meyn S.P., 1996, MARKOV CHAINS STOCHA; Ninness B., 2007, INT J ADAPT CONTROL, V9, P107; Spall J., 2003, INTRO STOCHASTIC SEA; SZEPTYCKI P, 1982, P AM MATH SOC, V85, P27, DOI 10.2307/2043275; Sznaier M, 2009, AUTOMATICA, V45, P701, DOI 10.1016/j.automatica.2008.09.026; Tempo R, 2012, RANDOMIZED ALGORITHM; Tjarnstrom F, 2002, IEEE DECIS CONTR P, P3422	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9286	1558-2523		IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	SEP	2015	60	9					2542	2546		10.1109/TAC.2014.2380997		5	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CQ3KU	WOS:000360501800031		
J	Aoki, H; Kobayashi, H				Aoki, Hitoshi; Kobayashi, Haruo			Self-Heat Characterizations and Modeling of Multifinger nMOSFETs for RF-CMOS Applications	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Modeling; multifinger; RF-CMOS; self-heating; shallow trench isolation (STI)	SOI MOSFETS; PARAMETERS; RESISTANCE	The purpose of this paper is to characterize and model the self-heating effect (SHE) of multifinger n-channel MOSFETs (nMOSFETs). The amount of SHE is small enough not to be analyzed for single-finger bulk CMOS devices. However, SHE should be considered for multifinger nMOSFETs that are mainly used for RF-CMOS applications. The SHE mechanism was analyzed based on a 2-D device simulator. SHE model equations are derived and implemented in the BSIM6 model with Verilog-A language used in a SPICE simulator. The model improves speed and accuracy of multifinger nMOSFETs simulations. To extract thermal resistance and capacitance, an advanced ac conductance method using a vector network analyzer is developed to obtain Ids-Vds measurement without increasing temperatures with the proposed model and extracted parameters, excellent agreement has been obtained between measurements and simulations in dc and S-parameter domain, whereas the original BSIM6 shows inconsistency between the static dc and the small signal ac simulations due to the lack of SHE. Unlike the widely used subcircuits-based SHE models, including Silicon-On-Insulator MOSFET and power MOSFET models, the proposed SHE model can converge in large-scale circuits even for transient simulations.	[Aoki, Hitoshi; Kobayashi, Haruo] Gunma Univ, Div Elect & Informat, Kiryu, Gumma 3768515, Japan; [Aoki, Hitoshi] MoDeCH Inc, Tokyo 1920081, Japan	Aoki, H (reprint author), Gunma Univ, Div Elect & Informat, Kiryu, Gumma 3768515, Japan.	h.aoki@oak.gunma-u.ac.jp; k_haruo@el.gunma-u.ac.jp					Jin W, 2001, IEEE T ELECTRON DEV, V48, P730; TU RH, 1995, IEEE ELECTR DEVICE L, V16, P67, DOI 10.1109/55.386025; MCDAID LJ, 1989, ELECTRON LETT, V25, P827, DOI 10.1049/el:19890557; Anghel C, 2004, IEEE ELECTR DEVICE L, V25, P141, DOI 10.1109/LED.2003.821669; Rinaldi N, 2001, IEEE T ELECTRON DEV, V48, P323, DOI 10.1109/16.902734; Aoki H., 2014, P IEEE RAD FREQ INT, P119; Caviglia AL, 1999, IEEE T ELECTRON DEV, V46, P762, DOI 10.1109/16.753711; Chauhan Y. S., 2013, BSIM6 0 MOSFET COMPA; Cheng YH, 1996, IEEE T ELECTRON DEV, V43, P1291, DOI 10.1109/16.506782; Chuang MY, 1997, IEEE T ELECTRON DEV, V44, P1567; Ming H., 1998, P 5 INT C SOL STAT I, P472; MUNRO PC, 1991, IEEE J SOLID-ST CIRC, V26, P1321, DOI 10.1109/4.84951; SU LT, 1994, IEEE ELECTR DEVICE L, V15, P374, DOI 10.1109/55.320972; Wei CJ, 1996, IEEE T MICROW THEORY, V44, P2641, DOI 10.1109/22.554615	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	SEP	2015	62	9					2704	2709		10.1109/TED.2015.2446498		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CQ2AK	WOS:000360401500001		
J	Ning, SY; Iwasaki, TO; Shimomura, K; Johguchi, K; Yanagizawa, E; Rosendale, G; Manning, M; Viviani, D; Rueckes, T; Takeuchi, K				Ning, Sheyang; Iwasaki, Tomoko Ogura; Shimomura, Kazuya; Johguchi, Koh; Yanagizawa, Eisuke; Rosendale, Glen; Manning, Monte; Viviani, Darlene; Rueckes, Thomas; Takeuchi, Ken			Investigation and Improvement of Verify-Program in Carbon Nanotube-Based Nonvolatile Memory	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Carbon nanotube (CNT); nonvolatile memory; resistance switching; verify-program		Carbon nanotube (CNT)-based random access memory (NRAM) cells are measured to investigate cell program at different set current compliances and temperatures. Then, a physical model is proposed to explain the mechanism of cell resistance switching. Specifically, the changes in the NRAM cell tunneling current and resistance can be attributed to the variation of the distance between CNTs. An attraction force (Fattraction), generated by electrical induction, reduces the distance, whereas a repulsion force (Frepulsion), generated by phonon-induced temperature, increases the distance. It is proposed that the dominance of these two forces is reversed during set and reset programs, possibly due to the reduction of Frepulsion in set program. Finally, two verify-reset schemes are proposed to improve the NRAM cell verify-program performance. The first proposal, multiple-pulse reset demonstrates 23% program time reduction by skipping a cell resistance read between two successive reset pulses. The second proposal, gate-pulse reset is calculated to decrease more than 40% program energy by reducing bitline charge energy in array program.	[Ning, Sheyang; Iwasaki, Tomoko Ogura; Shimomura, Kazuya; Johguchi, Koh; Yanagizawa, Eisuke; Takeuchi, Ken] Chuo Univ, Dept Elect Elect & Commun Engn, Tokyo 1128551, Japan; [Ning, Sheyang] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan; [Rosendale, Glen; Manning, Monte; Viviani, Darlene; Rueckes, Thomas] Nantero Inc, Woburn, MA 01801 USA	Ning, SY (reprint author), Chuo Univ, Dept Elect Elect & Commun Engn, Tokyo 1128551, Japan.	ning@takeuchi-lab.org; iwasaki@takeuchi-lab.org; shimomura@takeuchi-lab.org; johguchi@takeuchi-lab.org; yanagizawa@takeuchi-lab.org; glen@nantero.com; monte@nantero.com; darlene@nantero.com; thomas@nantero.com; takeuchi@takeuchi-lab.org					Aitkaliyeva A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02774; Bandaru PR, 2007, J NANOSCI NANOTECHNO, V7, P1239, DOI 10.1166/jnn.2007.307; Iwasaki TO, 2013, 2013 5TH IEEE INTERNATIONAL MEMORY WORKSHOP (IMW), P44, DOI 10.1109/IMW.2013.6582094; Suhr J, 2007, NAT NANOTECHNOL, V2, P417, DOI 10.1038/nnano.2007.186; Deshpande VV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.105501; [Anonymous], 2013, INT TECHNOLOGY ROADM; Osman MA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125413; Sasago Y, 2009, 2009 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P24; Deshpande VV, 2006, NANO LETT, V6, P1092, DOI 10.1021/nl052513f; Di Bartolomeo A, 2010, NANOSCALE RES LETT, V5, P1852, DOI 10.1007/s11671-010-9727-6; Iwasaki T. O., 2013, JPN J APPL PHYS, V52; Johguchi K., 2013, P IEEE INT REL PHYS; Kianian S., 2010, P EUR SOL STAT DEV R, P404; Kumar S., 2009, J APPL PHYS, V106; Mashreghi A, 2011, COMP MATER SCI, V50, P2814, DOI 10.1016/j.commatsci.2011.04.035; Ning S., 2014, S VLSI TECHN JUN, P1; Rosendale G., 2014, P IEEE 6 INT MEM WOR, P1; Rueckes T., 2011, P FLASH MEM SUMM AUG, P1; Shi L., 2009, J APPL PHYS, V105; Smith R. F., 2007, P AER C, P1; Sun C, 2014, IEEE T CIRCUITS-I, V61, P2360, DOI 10.1109/TCSI.2014.2309780; Tsai C.-L., 2011, APPL PHYS LETT, V99; Wong HS, 2009, 2009 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P92	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	SEP	2015	62	9					2837	2844		10.1109/TED.2015.2450219		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CQ2AK	WOS:000360401500020		
J	Jamison, PC; Tsunoda, T; Vo, TA; Li, JT; Jagannathan, H; Shinde, SR; Paruchuri, VK; Gall, D				Jamison, Paul C.; Tsunoda, Takaaki; Tuan Anh Vo; Li, Juntao; Jagannathan, Hemanth; Shinde, Sanjay R.; Paruchuri, Vamsi K.; Gall, Daniel			SiO2 Free HfO2 Gate Dielectrics by Physical Vapor Deposition	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						HfO2; high-k dielectrics; interface scavenging; MOSFET; physical vapor deposition (PVD); SiO2 interlayer	ATOMIC LAYER DEPOSITION; SILICON; SURFACE; GROWTH; FILMS	HfO2 layers, 25-angstrom thick, were grown by cyclic Hf sputter deposition and room temperature oxidation steps on chemically oxidized Si(001). Subsequent in situ annealing and TiN deposition yield a high-kappa gate-stack for which the original 8-angstrom-thick SiO2 layer is eliminated, as confirmed by transmission electron microscopy. Transistors fabricated with this gate-stack achieve an equivalent oxide thickness in inversion T-inv = 9.7 angstrom, with a gate leakage J(g) = 0.8 A/cm(2). Devices fabricated without in situ annealing of the HfO2 layer yield a T-inv which increases from 10.8 to 11.2 angstrom as the oxidation time during each HfO2 growth cycle increases from 10 to 120 s, also causing a decrease in J(g) from 0.95 to 0.60 A/cm(2), and an increase in the transistor threshold voltage from 272 to 294 mV. The annealing step reduces Tinv by 1.5 angstrom (10%) but also increases the gate leakage by 0.1 A/cm(2) (30%), and causes a 61 mV reduction in V-t. These effects are primarily attributed to the oxygen-deficiency of the as-deposited HfO2, which facilitates both the reduction of an interfacial SiO2 layer and a partial phase transition to a high-kappa cubic or tetragonal HfO2 phase.	[Jamison, Paul C.; Li, Juntao; Jagannathan, Hemanth; Paruchuri, Vamsi K.] Albany Nanotech, IBM Res, Albany, NY 12203 USA; [Jamison, Paul C.; Gall, Daniel] Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA; [Tsunoda, Takaaki] Canon Anelva Corp, Yokohama, Kanagawa 2158550, Japan; [Tuan Anh Vo] SUNY Polytech Inst, Albany, NY 12203 USA; [Shinde, Sanjay R.] Canon USA Inc, Ind Prod Div, San Jose, CA 95134 USA	Jamison, PC (reprint author), Albany Nanotech, IBM Res, Albany, NY 12203 USA.	pjamison@us.ibm.com; tsunoda.takaaki@canonanelva.co.jp; tvo@sunycnse.com; juntaoli@us.ibm.com; jhemanth@us.ibm.com; sshinde@cusa.canon.com; paruchur@us.ibm.com; galld@rpi.edu	Gall, Daniel/B-1060-2008	Gall, Daniel/0000-0002-5762-9307	Division of Materials Research through the U.S. National Science Foundation [1309490]	This work was supported by the Division of Materials Research through the U.S. National Science Foundation under Grant 1309490. The review of this paper was arranged by Editor J. Huang.	Ando T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3373914; Tan RQ, 2004, APPL SURF SCI, V222, P346, DOI 10.1016/j.apsusc.2003.09.003; Morita Y, 2013, SOLID STATE ELECTRON, V84, P58, DOI 10.1016/j.sse.2013.02.020; CABRERA N, 1948, REP PROG PHYS, V12, P163; Li FM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3601487; Guha S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196101; Tomida K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2355471; Triyoso DH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208558; Park BK, 2002, APPL PHYS LETT, V80, P2368, DOI 10.1063/1.1466534; Zhao XY, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.233106; Kim H, 2004, J APPL PHYS, V96, P3467, DOI 10.1063/1.1776636; Chung KB, 2007, J VAC SCI TECHNOL A, V25, P141, DOI 10.1116/1.2402155; Clark RD, 2008, ECS TRANSACTIONS, V16, P291, DOI 10.1149/1.2980004; Doris B., 2003, IEDM; Filatova EO, 2010, J ELECTRON SPECTROSC, V181, P206, DOI 10.1016/j.elspec.2010.04.005; Kang LG, 2000, INTERNATIONAL ELECTRON DEVICES MEETING 2000, TECHNICAL DIGEST, P35, DOI 10.1109/IEDM.2000.904253; Kukli K, 2007, MICROELECTRON ENG, V84, P2010, DOI 10.1016/j.mee.2007.04.035; Lee BH, 2000, INTERNATIONAL ELECTRON DEVICES MEETING 2000, TECHNICAL DIGEST, P39; Lee SJ, 2000, INTERNATIONAL ELECTRON DEVICES MEETING 2000, TECHNICAL DIGEST, P31, DOI 10.1109/IEDM.2000.904252; Lysaght PS, 2002, J NON-CRYST SOLIDS, V303, P54, DOI 10.1016/S0022-3093(02)00964-X; Migita S, 2008, 2008 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P152, DOI 10.1109/VLSIT.2008.4588599; Nakajima Y, 2010, ECS TRANSACTIONS, V28, P203, DOI 10.1149/1.3372576; Sokolov AA, 2010, TECH PHYS+, V55, P1045, DOI 10.1134/S1063784210070200; Sun Z., 2012, HIGH K GATE DIELECTR; Tan RQ, 2005, APPL SURF SCI, V241, P135, DOI 10.1016/j.apsusc.2004.09.030	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	SEP	2015	62	9					2878	2882		10.1109/TED.2015.2454953		5	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CQ2AK	WOS:000360401500026		
J	Banno, N; Tada, M; Sakamoto, T; Miyamura, M; Okamoto, K; Iguchi, N; Hada, H				Banno, Naoki; Tada, Munehiro; Sakamoto, Toshitsugu; Miyamura, Makoto; Okamoto, Koichiro; Iguchi, Noriyuki; Hada, Hiromitsu			Cu Atom Switch With Steep Time-to-ON-State Versus Switching Voltage Using Cu Ionization Control	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Atom switch; electrochemical reaction; field-programmable gate array (FPGA); nonvolatile memory; polymer; reconfigurable logic; solid electrolyte	SOLID-ELECTROLYTE; PERFORMANCE; FILMS	To break the tradeoff relationship between fast and low-voltage programming of a Cu atom switch, the effect of the composition in the AlTi oxide buffer layer placed on a Cu electrode is investigated. To improve the voltage dependence of time-to-ON-state, namely, switching slope (SS), the Cu ionization rate is increased by changing the composition ratio of the AlTi oxide buffer. An Al0.5Ti0.5Oy buffer leads to an extremely steep SS of 56 mV/decade by eliminating metallic Al residue on the Cu electrode. This buffer enables fast (10 ns) and low-voltage (similar to 2 V) programming, as demonstrated in a 1-Mbit array. Cycle endurance (>10(3) cycles) with a high ON/OFF resistance ratio (>10(4)) was also confirmed. The steep SS technology is indispensable for conducting bridges used in a low-power nonvolatile field-programmable gate array.	[Banno, Naoki; Tada, Munehiro; Sakamoto, Toshitsugu; Miyamura, Makoto; Okamoto, Koichiro; Iguchi, Noriyuki; Hada, Hiromitsu] Low Power Elect Assoc & Project, Tsukuba, Ibaraki 3058569, Japan	Banno, N (reprint author), Low Power Elect Assoc & Project, Tsukuba, Ibaraki 3058569, Japan.	banno@bu.jp.nec.com; m-tada@bl.jp.nec.com; t-sakamoto@dp.jp.nec.com; m-miyamura@aj.jp.nec.com; k-okamoto@fb.jp.nec.com; iguchi@aj.jp.nec.com; h-hada@bp.jp.nec.com			Ministry of Economy, Trade and Industry through the Ultra-Low Voltage Device Project; New Energy and Industrial Technology Development Organization	This work was supported in part by the Ministry of Economy, Trade and Industry through the Ultra-Low Voltage Device Project and in part by the New Energy and Industrial Technology Development Organization. The review of this paper was arranged by Editor R. Huang.	SanchezBajo F, 1997, J APPL CRYSTALLOGR, V30, P427, DOI 10.1107/S0021889896015464; HIROSE Y, 1976, J APPL PHYS, V47, P2767, DOI 10.1063/1.322942; Tada M, 2011, IEEE T ELECTRON DEV, V58, P4398, DOI 10.1109/TED.2011.2169070; Banno N, 2008, IEEE T ELECTRON DEV, V55, P3283, DOI 10.1109/TED.2008.2004246; Xia QF, 2009, NANO LETT, V9, P3640, DOI 10.1021/nl901874j; Tada M, 2010, IEEE T ELECTRON DEV, V57, P1987, DOI 10.1109/TED.2010.2051191; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Tada M, 2012, IEEE T ELECTRON DEV, V59, P2357, DOI 10.1109/TED.2012.2204263; Nardi F, 2012, IEEE T ELECTRON DEV, V59, P2461, DOI 10.1109/TED.2012.2202319; Banno N., 2012, P S VLSI TECHN, P39; Banno N, 2014, IEEE T ELECTRON DEV, V61, P3827, DOI 10.1109/TED.2014.2355830; Banno N., 2012, INT C SOL STAT DEV M, P616; Banno N., 2014, S VLSI S TECHN JUN, P1; Gouttebaron R, 2000, SURF INTERFACE ANAL, V30, P527, DOI 10.1002/1096-9918(200008)30:1<527::AID-SIA834>3.0.CO;2-Z; Goux L, 2013, ECS TRANSACTIONS, V58, P175, DOI 10.1149/05807.0175ecst; Kozicki M. N., 2002, SIL NAN WORKSH, P51; Miyamura M, 2014, INT SYM QUAL ELECT, P330; Miyamura M., 2012, P IEEE IEDM DEC, P247; Muralidhar R., 2014, P IEEE INT REL PHYS, pBD31; ROSE J, 1993, P IEEE, V81, P1013, DOI 10.1109/5.231340; Sills S., 2014, S VLSI, P1; Tada M., 2010, P IEEE IEDM DEC, P1651; Tada M., 2012, P IEEE IEDM DEC, P2981; Tada M., 2011, P IEEE IEDM DEC, P3021; Watanabe H, 2006, JPN J APPL PHYS 1, V45, P2933, DOI 10.1143/JJAP.45.2933	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	SEP	2015	62	9					2966	2971		10.1109/TED.2015.2443120		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CQ2AK	WOS:000360401500041		
J	Tada, M; Okamoto, K; Sakamoto, T; Hada, H				Tada, Munehiro; Okamoto, Koichiro; Sakamoto, Toshitsugu; Hada, Hiromitsu			ON-State Reliability of Cu Atom Switch Under Current-Temperature Stress	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Atom switch; field-programmable gate array; nonvolatile memory; programmable logic device; polymer; reconfigurable logic; solid electrolyte	DUAL-DAMASCENE INTERCONNECTS; THIN-FILM LINES; SOLID-ELECTROLYTE; ELECTROMIGRATION; VOLTAGE	The dc current-stress tolerance of the ON-state Cu atom switch is evaluated at elevated temperature. It is revealed that the reset-direction current stress causes time-dependent failures, which originate from the E-field-driven diffusion of Cu in the conducting bridge. A new empirical lifetime estimation model, including the Joule heating effect, gives an allowable maximum current per atom switch of I-max = 115 mu A, which is large enough to satisfy the requirements for signal routing under currents that are average (18 mu A) and peak (63 mu A) in the reconfigurable switch block operated at 500 MHz at 125 degrees C.	[Tada, Munehiro; Okamoto, Koichiro; Sakamoto, Toshitsugu; Hada, Hiromitsu] NEC Corp Ltd, Tsukuba, Ibaraki 3058501, Japan	Tada, M (reprint author), NEC Corp Ltd, Tsukuba, Ibaraki 3058501, Japan.	m-tada@bl.jp.nec.com; k-okamoto@fb.jp.nec.com; t-sakamoto@dp.jp.nec.com; h-hada@bp.jp.nec.com			Ministry of Economy, Trade and Industry through the Ultralow Voltage Device Project; New Energy and Industrial Technology Development Organization	This work was supported in part by the Ministry of Economy, Trade and Industry through the Ultralow Voltage Device Project and in part by the New Energy and Industrial Technology Development Organization. The review of this paper was arranged by Editor E. Rosenbaum.	[Anonymous], 2011, INT TECHNOLOGY ROADM; Sakamoto T, 2012, IEEE T ELECTRON DEV, V59, P3574, DOI 10.1109/TED.2012.2219051; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Ogawa ET, 2001, INT REL PHY, P341; Tada M, 2011, IEEE T ELECTRON DEV, V58, P4398, DOI 10.1109/TED.2011.2169070; Hu CK, 1999, APPL PHYS LETT, V74, P2945, DOI 10.1063/1.123974; Schindler C, 2007, IEEE T ELECTRON DEV, V54, P2762, DOI 10.1109/TED.2007.904402; Sakamoto T, 2003, APPL PHYS LETT, V82, P3032, DOI 10.1063/1.1572964; Arnaud L, 2003, J APPL PHYS, V93, P192, DOI 10.1063/1.1527711; Tada M, 2004, IEEE T ELECTRON DEV, V51, P1867, DOI 10.1109/TED.2004.837375; Lee KD, 2001, APPL PHYS LETT, V79, P3236, DOI 10.1063/1.1418034; Hu CK, 2006, MICROELECTRON RELIAB, V46, P213, DOI 10.1016/j.microrel.2005.05.015; Tada M, 2010, IEEE T ELECTRON DEV, V57, P1987, DOI 10.1109/TED.2010.2051191; Kozicki MN, 1999, ELEC SOC S, V99, P298; Terabe K, 2002, J APPL PHYS, V91, P10110, DOI 10.1063/1.1481775; Tada M, 2013, IEEE T ELECTRON DEV, V60, P3534, DOI 10.1109/TED.2013.2275188; Tada M, 2007, IEEE T ELECTRON DEV, V54, P1867, DOI 10.1109/TED.2007.901265; Tada M, 2012, IEEE T ELECTRON DEV, V59, P2357, DOI 10.1109/TED.2012.2204263; Banno N, 2014, IEEE T ELECTRON DEV, V61, P3827, DOI 10.1109/TED.2014.2355830; Banno N., 2014, P S VLSI TECHN HAW H, P250; BLACK JR, 1969, IEEE T ELECTRON DEV, VED16, P338, DOI 10.1109/T-ED.1969.16754; HU CK, 1995, IBM J RES DEV, V39, P465; Miyamura M., 2011, INT SOLID STATE CIRC, V11, P228; Miyamura M, 2014, INT SYM QUAL ELECT, P330; Miyamura M., 2012, P IEEE IEDM DEC, P247; Parikh S, 2001, PROCEEDINGS OF THE IEEE 2001 INTERNATIONAL INTERCONNECT TECHNOLOGY CONFERENCE, P183, DOI 10.1109/IITC.2001.930054; Rosenberg R., 1971, J VAC SCI TECHNOL, V9, P263; Sakamoto T., 2007, APPL PHYS LETT, V91; Tada M, 2006, Proceedings of the IEEE 2006 International Interconnect Technology Conference, P89; Tsai MH, 2001, PROCEEDINGS OF THE IEEE 2001 INTERNATIONAL INTERCONNECT TECHNOLOGY CONFERENCE, P266, DOI 10.1109/IITC.2001.930080; Vianello E, 2012, 2012 IEEE INTERNATIONAL ELECTRON DEVICES MEETING (IEDM), DOI 10.1109/IEDM.2012.6479145; Waser R., 2009, ADV MATER, V21, P2632, DOI DOI 10.1002/ADMA.200900375	32	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	SEP	2015	62	9					2992	2997		10.1109/TED.2015.2451139		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CQ2AK	WOS:000360401500045		
J	Kim, T; Wang, YB; Sahinoglu, Z; Wada, T; Hara, S; Qiao, W				Kim, Taesic; Wang, Yebin; Sahinoglu, Zafer; Wada, Toshihiro; Hara, Satoshi; Qiao, Wei			A Rayleigh Quotient-Based Recursive Total-Least-Squares Online Maximum Capacity Estimation for Lithium-Ion Batteries	IEEE TRANSACTIONS ON ENERGY CONVERSION			English	Article						Lithium-ion battery; online capacity estimation; Rayleigh quotient; recursive total least squares; state of health	EXTENDED KALMAN FILTER; SLIDING-MODE OBSERVER; MANAGEMENT-SYSTEMS; HEALTH DETERMINATION; PARAMETER-ESTIMATION; PART 2; STATE; IDENTIFICATION; ALGORITHM; MATRIX	The maximum capacity, the amount of maximal electric charge that a battery can store, not only indicates the state of health, but also is required in numerous methods for state-of-charge estimation. This paper proposes an alternative approach to perform online estimation of the maximum capacity by solving the recursive total-least-squares (RTLS) problem. Different from prior art, the proposed approach poses and solves the RTLS as a Rayleigh quotient optimization problem. The Rayleigh quotient-based approach can be readily generalized to other parameter estimation problems including impedance estimation. Compared with other capacity estimation methods, the proposed algorithm enjoys the advantages of existing RTLS-based algorithms for instance, low computation, simple implementation, and high accuracy, and thus is suitable for use in real-time embedded battery management systems. The proposed method is compared with existing methods via simulations and experiments.	[Kim, Taesic; Wang, Yebin; Sahinoglu, Zafer] Mitsubishi Elect Res Labs, Cambridge, MA 02139 USA; [Wada, Toshihiro] Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan; [Qiao, Wei] Univ Nebraska, Dept Elect & Comp Engn, Lincoln, NE 68588 USA	Kim, T (reprint author), Univ Nebraska, Dept Comp Sci & Engn, Lincoln, NE 68588 USA.	taesickim@huskers.unl.edu; yebinwang@ieee.org; zafer@merl.com; Wada.Toshihiro@bx.MitsubishiElectric.co.jp; Hara.Satoshi@cb.MitsubishiElectric.co.jp; wqiao@engr.unl.edu					Lee S, 2008, J POWER SOURCES, V185, P1367, DOI 10.1016/j.jpowsour.2008.08.103; Markovsky I, 2007, SIGNAL PROCESS, V87, P2283, DOI 10.1016/j.sigpro.2007.04.004; [Anonymous], 2008, THEOR IMPL IMP TRACK; Kim IS, 2010, IEEE T POWER ELECTR, V25, P1013, DOI 10.1109/TPEL.2009.2034966; Hu C, 2012, APPL ENERG, V92, P694, DOI 10.1016/j.apenergy.2011.08.002; Wang YB, 2015, IEEE T CONTR SYST T, V23, P948, DOI 10.1109/TCST.2014.2356503; Hussein AA, 2013, IEEE ENER CONV, P677, DOI 10.1109/ECCE.2013.6646767; Nishi Y, 2001, J POWER SOURCES, V100, P101, DOI 10.1016/S0378-7753(01)00887-4; Einhorn M, 2012, IEEE T IND APPL, V48, P736, DOI 10.1109/TIA.2011.2180689; Zhang YC, 2011, J POWER SOURCES, V196, P1513, DOI 10.1016/j.jpowsour.2010.08.070; Plett GL, 2004, J POWER SOURCES, V134, P262, DOI 10.1016/j.jpowsour.2004.02.032; Andre D, 2013, ENG APPL ARTIF INTEL, V26, P951, DOI 10.1016/j.engappai.2012.09.013; Plett GL, 2006, J POWER SOURCES, V161, P1369, DOI 10.1016/j.jpowsour.2006.06.004; Kim T, 2011, IEEE T ENERGY CONVER, V26, P1172, DOI 10.1109/TEC.2011.2167014; GOLUB GH, 1973, SIAM REV, V15, P318, DOI 10.1137/1015032; Gould CR, 2009, IEEE T VEH TECHNOL, V58, P3905, DOI 10.1109/TVT.2009.2028348; Chaturvedi NA, 2010, IEEE CONTR SYST MAG, V30, P49, DOI 10.1109/MCS.2010.936293; Chen XS, 2012, TAIWAN J MATH, V16, P179; DAVILA CE, 1994, IEEE T SIGNAL PROCES, V42, P268, DOI 10.1109/78.275601; Eddahech A, 2012, 2012 IEEE ENERGY CONVERSION CONGRESS AND EXPOSITION (ECCE), P4501, DOI 10.1109/ECCE.2012.6342209; Edelman A, 1996, BIT, V36, P494, DOI 10.1007/BF01731929; Erdinc O., 2009, P 2009 INT C CLEAN E, P383; Feng DZ, 2004, IEEE T SIGNAL PROCES, V52, P2729, DOI 10.1109/TSP.2004.834260; Gadsden S. A., 2011, ISRN SIGNAL PROC, V2011; Goodwin G. C., 1984, ADAPTIVE FILTERING P; Hammad N., 2010, 2010010028 SAE; Kim T, 2013, IEEE ENER CONV, P292; Kim T, 2014, P AMER CONTR CONF, P4410; Kim T., 2014, P IEEE INN SMART GRI, P132; Liu J., 2010, ADV KNOWLEDGE DISCOV, V1, P1; Plett G. L., 2011, U. S. Patent, Patent No. [8 041 522, 8041522]; Plett GL, 2011, J POWER SOURCES, V196, P2319, DOI 10.1016/j.jpowsour.2010.09.048; Rahimi Hossein, 2013, Proceedings of the 2013 IEEE Symposium on Computational Intelligence in Cyber Security (CICS), DOI 10.1109/CICYBS.2013.6597198; Saha B., 2009, P ANN C PROGN HLTH M, P1; Stewart G. W., 1990, SVD SIGNAL PROCESSIN; Tang XD, 2011, P AMER CONTR CONF, P947	36	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-8969	1558-0059		IEEE T ENERGY CONVER	IEEE Trans. Energy Convers.	SEP	2015	30	3					842	851		10.1109/TEC.2015.2424673		10	Energy & Fuels; Engineering, Electrical & Electronic	Energy & Fuels; Engineering	CQ2NZ	WOS:000360439300003		
J	Takiguchi, M; Sugimoto, H; Kurihara, N; Chiba, A				Takiguchi, Masaki; Sugimoto, Hiroya; Kurihara, Noboru; Chiba, Akira			Acoustic Noise and Vibration Reduction of SRM by Elimination of Third Harmonic Component in Sum of Radial Forces	IEEE TRANSACTIONS ON ENERGY CONVERSION			English	Article						Acoustic noise; current regulation; switched reluctance motor (SRM)	SWITCHED RELUCTANCE MOTOR; ELECTRIC VEHICLES; DRIVES	A novel method to reduce an acoustic noise and the vibration of a switched reluctance motor has been proposed. In this method, driving current is a sum of dc, fundamental, the second- and the third-harmonic components. This driving current is determined to eliminate the third harmonic component in the sum of radial forces of the stator teeth. Consequently, an acoustic noise and a vibration are reduced. The effectiveness of the proposed method is confirmed by means of finite-element method and test machine experiments.	[Takiguchi, Masaki; Sugimoto, Hiroya; Kurihara, Noboru; Chiba, Akira] Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1528550, Japan	Takiguchi, M (reprint author), Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1528550, Japan.	takiguchi.m@belm.ee.titech.ac.jp; sugimoto@belm.ee.titech.ac.jp; yabu.n@belm.ee.titech.ac.jp; chiba@ee.titech.ac.jp					Ahn JW, 2004, IEEE T IND ELECTRON, V51, P374, DOI 10.1109/TIE.2004.825227; Takeno M, 2012, IEEE T IND APPL, V48, P1327, DOI 10.1109/TIA.2012.2199952; Kim SI, 2013, IEEE T IND APPL, V49, P2516, DOI 10.1109/TIA.2013.2264651; Zhu ZQ, 2011, IEEE T ENERGY CONVER, V26, P36, DOI 10.1109/TEC.2010.2087336; Fiedler JO, 2010, IEEE T IND ELECTRON, V57, P2939, DOI 10.1109/TIE.2010.2046573; Chai JY, 2006, IEE P-ELECT POW APPL, V153, P348, DOI 10.1049/ip-epa:20050340; CAMERON DE, 1992, IEEE T IND APPL, V28, P1250, DOI 10.1109/28.175275; Divandari M., 2010, P IEEE IAS 9 INT C I, P1; Dorrell DG, 2010, IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS (ISIE 2010), P3728; Higuchi T., 2010, P IPEC, P2175; Hofmann A, 2013, 2013 IEEE INTERNATIONAL ELECTRIC MACHINES & DRIVES CONFERENCE (IEMDC), P1009; Kasper K. A., 2006, P VEH POW PROP C, P1; Koeing A. C., 2007, P ADV POW EL C, P383; Lin CJ, 2014, IEEE T ENERGY CONVER, V29, P250, DOI 10.1109/TEC.2013.2291702; Nakao N, 2013, 2013 IEEE ECCE ASIA DOWNUNDER (ECCE ASIA), P1111, DOI 10.1109/ECCE-Asia.2013.6579247; Nakata K., 2002, POW CONV C 2002 PCC, V3, P971, DOI 10.1109/PCC.2002.998100; Paradkar M, 2012, IEEE IND ELEC, P4099, DOI 10.1109/IECON.2012.6389234; Sanada M, 2011, IEEE T ENERGY CONVER, V26, P904, DOI 10.1109/TEC.2011.2142185; Widmer J. D., 2011, P IEEE IEMDC MAY, P1183; WU CY, 1995, IEEE T IND APPL, V31, P91	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-8969	1558-0059		IEEE T ENERGY CONVER	IEEE Trans. Energy Convers.	SEP	2015	30	3					883	891		10.1109/TEC.2015.2401398		9	Energy & Fuels; Engineering, Electrical & Electronic	Energy & Fuels; Engineering	CQ2NZ	WOS:000360439300007		
J	Cahaya, AB; Tretiakov, OA; Bauer, GEW				Cahaya, Adam B.; Tretiakov, Oleg A.; Bauer, G. E. W.			Spin Seebeck Power Conversion	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Spin caloritronics; spin Seebeck; thermoelectricity	MAGNETIC TUNNEL-JUNCTIONS; THERMOELECTRIC FIGURE; TRANSPORT; MERIT	Spin caloritronics is the science and technology to control spin, charge, and heat currents in magnetic nanostructures. The spin degree of freedom provides new strategies for thermoelectric power generation that have not yet been fully explored. After an elementary introduction into conventional thermoelectrics and spintronics, we give a brief review of the physics of spin caloritronics. We discuss spin-dependent thermoelectrics based on the two-current model in metallic magnets as well as the spin Seebeck and Peltier effects that are based on spin wave excitations in ferromagnets. We derive expressions for the efficiency and figure of merit ZT of several spin caloritronic devices.	[Cahaya, Adam B.; Tretiakov, Oleg A.; Bauer, G. E. W.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Bauer, G. E. W.] Tohoku Univ, Adv Inst Mat Res, World Premier Inst, Sendai, Miyagi 9808577, Japan; [Bauer, G. E. W.] Delft Univ Technol, Kavli Inst NanoSci, NL-2628 CJ Delft, Netherlands	Cahaya, AB (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	adam.b.cahaya@imr.tohoku.ac.jp	Bauer, Gerrit/F-8273-2010; Tretiakov, Oleg/A-2795-2009	Bauer, Gerrit/0000-0002-3615-8673; Tretiakov, Oleg/0000-0001-7283-6884	EU-STREP InSpin; DAAD SpinNet; Dutch FOM/NWO; German Research Foundation [SPP 1538]; Japan Society for the Promotion of Science Fellowship for Young Scientists;  [25800184];  [25220910];  [15H01009];  [25247056]	The authors would like to thank E. Saitoh, K. Uchida, J. Flipse, and J. Xiao for their insightful discussions. This work was supported in part by EU-STREP InSpin, in part by DAAD SpinNet, in part by the Dutch FOM/NWO, in part by the German Research Foundation through SPP 1538 Spin Caloric Transport, and in part by the Grants-in-Aid for Scientific Research under Grant 25800184, Grant 25220910, Grant 15H01009, and Grant 25247056. The work of A. B. Cahaya was supported by the Japan Society for the Promotion of Science Fellowship for Young Scientists.	Chen YT, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.144411; Walter M, 2011, NAT MATER, V10, P742, DOI [10.1038/nmat3076, 10.1038/NMAT3076]; Adachi H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.094410; CUTLER M, 1969, PHYS REV, V181, P1336, DOI 10.1103/PhysRev.181.1336; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Hatami M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.174426; Qu D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067206; Uchida K, 2012, J APPL PHYS, V111, DOI 10.1063/1.4716012; Uchida K, 2010, NAT MATER, V9, P894, DOI [10.1038/nmat2856, 10.1038/NMAT2856]; Avery AD, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.196602; Weiler M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.176601; HICKS LD, 1993, PHYS REV B, V47, P16631, DOI 10.1103/PhysRevB.47.16631; Uchida K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507386; Giazotto F, 2006, REV MOD PHYS, V78, P217, DOI 10.1103/RevModPhys.78.217; Brataas A, 2006, PHYS REP, V427, P157, DOI 10.1016/j.physrep.2006.01.001; MOLENKAMP LW, 1992, PHYS REV LETT, V68, P3765, DOI 10.1103/PhysRevLett.68.3765; Takahashi S, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/014105; Dubi Y, 2011, REV MOD PHYS, V83, P131, DOI 10.1103/RevModPhys.83.131; Kirihara A, 2012, NAT MATER, V11, P686, DOI [10.1038/nmat3360, 10.1038/NMAT3360]; Bauer GEW, 2012, NAT MATER, V11, P391, DOI [10.1038/nmat3301, 10.1038/NMAT3301]; Tserkovnyak Y, 2005, REV MOD PHYS, V77, P1375, DOI 10.1103/RevModPhys.77.1375; Tretiakov OA, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3637055; Xiao JA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.099904; Hoffmann A, 2013, IEEE T MAGN, V49, P5172, DOI 10.1109/TMAG.2013.2262947; Foros J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.016601; Uchida K, 2008, NATURE, V455, P778, DOI 10.1038/nature07321; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; Jaworski CM, 2010, NAT MATER, V9, P898, DOI [10.1038/nmat2860, 10.1038/NMAT2860]; Adachi H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/3/036501; Huang SY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.107204; Mojumder NN, 2012, IEEE T MAGN, V48, P2016, DOI 10.1109/TMAG.2011.2179982; Hatami M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.066603; Schmid M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.187201; Jia XT, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/17005; Vining CB, 2009, NAT MATER, V8, P83, DOI 10.1038/nmat2361; Heremans JP, 2013, NAT NANOTECHNOL, V8, P471, DOI 10.1038/nnano.2013.129; Schreier M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.094410; Bosu S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.224401; Dejene FK, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.100404; JOHNSON M, 1987, PHYS REV B, V35, P4959, DOI 10.1103/PhysRevB.35.4959; Flipse J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.027601; Xiao J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214418; Agrawal M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.107204; Burrowes C, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3690918; Cahaya AB, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863084; de Groot S. R., 1952, THERMODYNAMICS IRREV; Dejene FK, 2013, NAT PHYS, V9, P635, DOI 10.1038/NPHYS2743; FERT A, 1995, J MAGN MAGN MATER, V140, P1, DOI 10.1016/0304-8853(94)00880-9; GOLDSMID HJ, 1988, J PHYS D APPL PHYS, V21, P344, DOI 10.1088/0022-3727/21/2/015; Hamrle J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.094402; Heikkila TT, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.100408; Hoffman S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.064408; Hu SJ, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.74; Jiang JH, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042126; Lee K.- D., 2015, THERMOELECTRIC SIGNA; Lin WW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1748; Mizuguchi M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.093002; POLLACK GL, 1969, REV MOD PHYS, V41, P48, DOI 10.1103/RevModPhys.41.48; Ramos R., 2015, OBSERVATION HUGE THE; Rezende SM, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.014416; Rowe D., 1994, CRC HDB THERMOELECTR; Saiga Yuta, 2014, Applied Physics Express, V7, DOI 10.7567/APEX.7.093001; SANDERS DJ, 1977, PHYS REV B, V15, P1489, DOI 10.1103/PhysRevB.15.1489; Schreier M, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/2/025001; Sugihara A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.065204; Tikhonov K. S., 2013, NATURE COMMUN, V4; Tretiakov OA, 2012, J APPL PHYS, V111, DOI 10.1063/1.3672847; Tretiakov OA, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3481382; Villamor E, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.020403; Xiao J., IN PRESS; Xiao J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.174415; Yang XH, 2012, J APPL PHYS, V111, DOI 10.1063/1.3679569; Zhang J., 2015, THERMAL TRANSPORT NO	73	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	SEP	2015	51	9							0800414	10.1109/TMAG.2015.2436362		14	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CQ2BU	WOS:000360405200001		
J	Konishi, T; Kubo, T; Watanabe, K; Ikeda, K				Konishi, Takuya; Kubo, Takatomi; Watanabe, Kazuho; Ikeda, Kazushi			Variational Bayesian Inference Algorithms for Infinite Relational Model of Network Data	IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS			English	Article						Bayesian nonparametrics; infinite relational model (IRM); network data; variational Bayesian (VB) inference		Network data show the relationship among one kind of objects, such as social networks and hyperlinks on the Web. Many statistical models have been proposed for analyzing these data. For modeling cluster structures of networks, the infinite relational model (IRM) was proposed as a Bayesian nonparametric extension of the stochastic block model. In this brief, we derive the inference algorithms for the IRM of network data based on the variational Bayesian (VB) inference methods. After showing the standard VB inference, we derive the collapsed VB (CVB) inference and its variant called the zeroth-order CVB inference. We compared the performances of the inference algorithms using six real network datasets. The CVB inference outperformed the VB inference in most of the datasets, and the differences were especially larger in dense networks.	[Konishi, Takuya; Kubo, Takatomi; Ikeda, Kazushi] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan; [Watanabe, Kazuho] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi 4418580, Japan	Konishi, T (reprint author), Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan.	takuya-ko@is.naist.jp; takatomi-k@is.naist.jp; wkazuho@cs.tut.ac.jp; kazushi@is.naist.jp					FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Globerson A, 2007, J MACH LEARN RES, V8, P2265; SETHURAMAN J, 1994, STAT SINICA, V4, P639; Sato M, 2001, NEURAL COMPUT, V13, P1649, DOI 10.1162/089976601750265045; Hoffman MD, 2013, J MACH LEARN RES, V14, P1303; Nowicki K, 2001, J AM STAT ASSOC, V96, P1077, DOI 10.1198/016214501753208735; Blei DM, 2006, BAYESIAN ANAL, V1, P121; Asuncion A., 2009, 25 C UNC ART INT MON; Attias H., 1999, ADV NEURAL INFORM PR; Beal M., 2003, THESIS U COLL LONDON; Blundell C., 2012, ADV NEURAL INFORM PR; Ishiguro K., 2010, ADV NEURAL INFORM PR; Ishiguro K., 2012, P 15 INT C ART INT S, P547; Jain S, 2004, J COMPUT GRAPH STAT, V13, P158, DOI 10.1198/1061860043001; KEMP C., 2006, P NAT C ART INT, V21, P381; Kurihara K, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2796; Leskovec J., 2007, ACM T KNOWL DISCOV D, V1, P2, DOI DOI 10.1145/1217299.1217301; Meeds E., 2007, ADV NEURAL INFORM PR; Miller K. T., 2009, ADV NEURAL INFORM PR; Minka T.P., 2000, ESTIMATING DIRICHLET; Morup M., 2010, ADV NEURAL INFORM PR; Palla K., 2012, P 29 INT C MACH LEAR, P1607; Sato I., 2012, P 29 INT C MACH LEAR, P999; Teh Y. W., 2007, ADV NEURAL INFORM PR; Wang P., 2013, P 16 INT C ART INT S, P599	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2162-237X	2162-2388		IEEE T NEUR NET LEAR	IEEE Trans. Neural Netw. Learn. Syst.	SEP	2015	26	9					2176	2181		10.1109/TNNLS.2014.2362012		6	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CQ2NH	WOS:000360437300026		
J	Ozawa, T; Ishihara, S; Nishikawa, T; Tanaka, T; Tanaka, J; Kiyomatsu, T; Hata, K; Kawai, K; Nozawa, H; Kazama, S; Yamaguchi, H; Sunami, E; Kitayama, J; Watanabe, T				Ozawa, Tsuyoshi; Ishihara, Soichiro; Nishikawa, Takeshi; Tanaka, Toshiaki; Tanaka, Junichiro; Kiyomatsu, Tomomichi; Hata, Keisuke; Kawai, Kazushige; Nozawa, Hiroaki; Kazama, Shinsuke; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki			The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Platelet to lymphocyte ratio; Platelet; Lymphocyte; Colorectal cancer; Stage II	COLON-CANCER; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; POOR-PROGNOSIS; TUMOR-CELLS; FLUOROURACIL; INFLAMMATION; NEUTROPHIL; RECURRENCE; SIGNATURE	The platelet to lymphocyte ratio (PLR) is a potential prognostic marker in a number of different cancers. The aim of this study was to evaluate the prognostic impact of the PLR in patients with stage II colorectal cancer (CRC) who have undergone curative resection but not adjuvant chemotherapy. A retrospective review was performed on 234 patients with stage II CRC who underwent curative resection, but not adjuvant chemotherapy, in our institute. The patients were divided into low and high PLR groups, and patient survival as well as several clinicopathological factors were compared between the groups. Disease-free survival (DFS) and cancer-specific survival (CSS) were analyzed by using the Kaplan-Meier method, and multivariate analysis was performed by using the Cox proportional hazard model. The cutoff value of the PLR determined by using a receiver-operating characteristic curve analysis was 25.4. DFS and CSS were significantly better in patients with a low PLR compared to patients with a high PLR (P = 0.002 and P = 0.011, respectively). On multivariate analysis, we identified the PLR as an independent prognostic factor for DFS and CSS, with a hazard ratio of 2.65 (95 % confidence interval [CI], 1.26-5.45; P = 0.011) and 3.61 (95 % CI, 1.08-12.64; P = 0.038, respectively). The PLR is a good prognostic indicator in patients with stage II CRC who have undergone curative surgery but not adjuvant chemotherapy.	[Ozawa, Tsuyoshi; Ishihara, Soichiro; Nishikawa, Takeshi; Tanaka, Toshiaki; Tanaka, Junichiro; Kiyomatsu, Tomomichi; Hata, Keisuke; Kawai, Kazushige; Nozawa, Hiroaki; Kazama, Shinsuke; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo 1138655, Japan	Ozawa, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg Oncol, 7-3-1 Hongo Bunkyo Ku, Tokyo 1138655, Japan.	tsu443@hotmail.com					Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Galizia G, 2013, J GASTROINTEST SURG, V17, P1809, DOI 10.1007/s11605-013-2258-6; Canna K, 2005, BRIT J CANCER, V92, P651, DOI 10.1038/sj.bjc.6602419; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Zhang JX, 2013, LANCET ONCOL, V14, P1295, DOI 10.1016/S1470-2045(13)70491-1; Szkandera J, 2014, AM J SURG, V208, P210, DOI 10.1016/j.amjsurg.2013.10.030; Smith RA, 2009, AM J SURG, V197, P466, DOI 10.1016/j.amjsurg.2007.12.057; Son HJ, 2013, ANN SURG ONCOL, V20, P2908, DOI 10.1245/s10434-013-2968-8; Maak M, 2013, ANN SURG, V257, P1053, DOI 10.1097/SLA.0b013e31827c1180; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; O'Connor ES, 2011, J CLIN ONCOL, V29, P3381, DOI 10.1200/JCO.2010.34.3426; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Baranyai Z, 2014, THROMB HAEMOSTASIS, V111, P483, DOI 10.1160/TH13-08-0632; Raungkaewmanee S, 2012, J GYNECOL ONCOL, V23, P265, DOI 10.3802/jgo.2012.23.4.265; Ropponen KM, 1997, J PATHOL, V182, P318, DOI 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6; Ceze N, 2011, CANCER CHEMOTH PHARM, V68, P1305, DOI 10.1007/s00280-011-1610-3; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Benson AB, 2013, J NATL COMPR CANC NE, V11, P519; Bae Sung Joon, 2014, Ann Coloproctol, V30, P266, DOI 10.3393/ac.2014.30.6.266; LABIANCA R, 1995, LANCET, V345, P939; Kawai K, 2014, SURG TODAY, V44, P797, DOI 10.1007/s00595-013-0606-5; Kitayama J, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-47; Kumar A, 2014, CANCER; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Neofytou K, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0239-6; Gray R, 2007, LANCET, V370, P2020; Rodriguez-Moranta F, 2006, J CLIN ONCOL, V24, P386, DOI 10.1200/JCO.2005.02.0826; Sasaki K, 2012, WORLD J SURG, V36, P192, DOI 10.1007/s00268-011-1329-7; Trousseau A, 1865, LECT CLIN MED DEL HO, V5; Xie X, 2014, DIS ESOPHAGUS; Ying HQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0305-0	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	SEP	2015	30	9					1165	1171		10.1007/s00384-015-2276-9		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CQ3YY	WOS:000360542000003		
J	Nosaka, M; Ishida, Y; Kimura, A; Hama, M; Kawaguchi, T; Yamamoto, H; Kuninaka, Y; Shimada, E; Kondo, T				Nosaka, Mizuho; Ishida, Yuko; Kimura, Akihiko; Hama, Mizuki; Kawaguchi, Takashi; Yamamoto, Hiroki; Kuninaka, Yumi; Shimada, Emi; Kondo, Toshikazu			Immunohistochemical detection of intrathrombotic IL-6 and its application to thrombus age estimation	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Forensic pathology; Thrombus age estimation; Immunohistochemistry; IL-6; Macrophages	WOUND-HEALING PROCESS; ESSENTIAL INVOLVEMENT; IFN-GAMMA; MICE; INTERLEUKIN-6; CYTOKINES; THROMBOEMBOLISM; COAGULATION; RECEPTOR; MODEL	We immunohistochemically examined intrathrombotic IL-6 expression using a murine model of deep vein thrombosis induced by the ligation of the inferior vena cava (IVC) and discussed the availability of intrathrombotic IL-6 for thrombus age estimation. IL-6(+) cells could be first detected at 1 day after IVC ligation in three of five samples, and all samples with postligation intervals of 3 days or more had intrathrombotic IL-6(+) cells. Thereafter, the numbers of IL-6(+) cells were elevated with the increase of postligation intervals. Double-color immunofluorescence analyses demonstrated that IL-6 was mainly expressed by intrathrombotic macrophages. In all samples with postligation intervals of 5 days or less, the IL-6/macrophage ratio (IL-6/MI center dot) was < 0.5. In contrast, the IL-6/MI center dot was greater than 0.5 at a parts per thousand yen7 days after the IVC ligation. These observations implied that IL-6/MI center dot ratios of > 0.5 would strongly indicate thrombus ages of a parts per thousand yen7 days. Reciprocally, the ratios of less than 0.5 would suggest thrombus ages of a parts per thousand currency sign5 days. The present study demonstrated that the immunohistochemical detection of IL-6 was suitable to estimate the age of venous thrombi.	[Nosaka, Mizuho; Ishida, Yuko; Kimura, Akihiko; Hama, Mizuki; Kawaguchi, Takashi; Yamamoto, Hiroki; Kuninaka, Yumi; Shimada, Emi; Kondo, Toshikazu] Wakayama Med Univ, Dept Forens Med, Wakayama 6418509, Japan	Kondo, T (reprint author), Wakayama Med Univ, Dept Forens Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	kondot@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government	We thank Ms. Mariko Kawaguchi for her excellent assistance in the preparation of this manuscript. This study was financially supported in part by Grants-in-Aid for Scientific Research (A) and (C) from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government.	AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Fineschi V, 2009, FORENSIC SCI INT, V186, P22, DOI 10.1016/j.forsciint.2009.01.006; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Kondo Toshikazu, 2007, Legal Medicine, V9, P109, DOI 10.1016/j.legalmed.2006.11.009; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Nosaka M, 2010, FORENSIC SCI INT, V195, P143, DOI 10.1016/j.forsciint.2009.12.008; Nosaka M, 2011, J CLIN INVEST, V121, P2911, DOI 10.1172/JCI40782; Stouthard JML, 1996, THROMB HAEMOSTASIS, V76, P738; Cecchi R, 2010, INT J LEGAL MED, V124, P523, DOI 10.1007/s00414-010-0505-x; Ishida Y, 2012, INT J LEGAL MED, V126, P435, DOI 10.1007/s00414-012-0685-7; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Wojcik BM, 2011, ANN VASC SURG, V25, P229, DOI 10.1016/j.avsg.2010.09.003; POLI V, 1994, EMBO J, V13, P1189; Ma WX, 2011, INT J LEGAL MED, V125, P549, DOI 10.1007/s00414-011-0567-4; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Ishida Y, 2004, J IMMUNOL, V172, P1848; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com; Cecchi R, 2012, INT J LEGAL MED, V126, P477, DOI 10.1007/s00414-012-0670-1; IRNIGER W, 1963, VIRCHOWS ARCH A, V336, P220, DOI 10.1007/BF00957911; Kothari P, 2013, J IMMUNOL, V192, P349; LEU AJ, 1989, PATHOLOGE, V10, P87; Nosaka M, 2013, INT J LEGAL MED, V127, P937, DOI 10.1007/s00414-013-0873-0; Nosaka M, 2010, INT J LEGAL MED, V124, P439, DOI 10.1007/s00414-010-0484-y; Nosaka M, 2009, INT J LEGAL MED, V123, P235, DOI 10.1007/s00414-009-0324-0; Nosaka M, 2012, INT J LEGAL MED, V126, P421, DOI 10.1007/s00414-012-0680-z; Sun JH, 2012, INT J LEGAL MED, V126, P113, DOI 10.1007/s00414-011-0604-3	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2015	129	5					1021	1025		10.1007/s00414-015-1147-9		5	Medicine, Legal	Legal Medicine	CQ0VM	WOS:000360315900013		
J	Ishida, Y; Kuninaka, Y; Nosaka, M; Kimura, A; Kawaguchi, T; Hama, M; Sakamoto, S; Shinozaki, K; Eisenmenger, W; Kondo, T				Ishida, Yuko; Kuninaka, Yumi; Nosaka, Mizuho; Kimura, Akihiko; Kawaguchi, Takashi; Hama, Mizuki; Sakamoto, Shoichi; Shinozaki, Kouhei; Eisenmenger, Wolfgang; Kondo, Toshikazu			Immunohistochemical analysis on MMP-2 and MMP-9 for wound age determination	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Forensic pathology; MMP-2; MMP-9; Wound age determination; Immunohistochemistry	MATRIX METALLOPROTEINASE-2 AND-9; HUMAN SKIN WOUNDS; HEALING-PROCESS; KERATINOCYTE MIGRATION; ESSENTIAL INVOLVEMENT; TISSUE INHIBITOR; TGF-BETA; EXPRESSION; REPAIR; FIBROBLASTS	We performed immunohistochemical study combined with morphometrical analyses in order to examine the expression of matrix metalloproteinase-2 (MMP-2) and MMP-9 using 55 human skin wounds of different ages: group I, 0-3 days (n = 16); II, 4-7 days (n = 11); III, 9-14 days (n = 16); and IV, 17-21 days (n = 12). Immunopositive reactions for MMP-2 were observed in all human skin specimens including uninjured skin as control. The number of MMP-2(+) macrophages was significantly increased in accordance with wound ages. In contrast to MMP-2, no MMP-9(+) signals were detected in uninjured and wound specimens aged less than 1 day. However, the number of MMP-9(+) macrophages profoundly appeared in groups II and III. Morphometrically, in all of wound samples aged 9-12 days, MMP-2(+) cell number was more than 20. On the contrary, most of the remaining samples had < 20 positive cells. However, only one sample (a 7-day-old wound) showed 21 positive cells. Thus, with regard to practical applicability with forensic safety, MMP-2(+) macrophages of > 20 would indicate a wound age of 7-12 days. Additionally, 10 out of 12 wound specimens aged 9-12 days showed the MMP-2(+) cell number of > 25, implying that MMP-2(+) cell number of > 25 would indicate the wound age of 9-12 days. On the contrary, all wound samples aged 3-14 days except for only one sample had MMP-9(+) cell number of > 30, indicating that MMP-9(+) cell number of > 30 would indicate the wound age of 3-14 days. Collectively, MMP-2 seemed to be more distinct marker, compared with MMP-9.	[Ishida, Yuko; Kuninaka, Yumi; Nosaka, Mizuho; Kimura, Akihiko; Kawaguchi, Takashi; Hama, Mizuki; Sakamoto, Shoichi; Shinozaki, Kouhei; Kondo, Toshikazu] Wakayama Med Univ, Dept Forens Med, Wakayama 6418509, Japan; [Eisenmenger, Wolfgang] Univ Munich, Inst Legal Med, D-80336 Munich, Germany	Kondo, T (reprint author), Wakayama Med Univ, Dept Forens Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	kondot@wakayama-med.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	This study was financially supported by Grants in-Aid for Scientific Research (A), Young Scientists (A), and Exploratory Research from the Ministry of Education, Science, Sports and Culture of Japan. We sincerely thank Ms. Mariko Kawaguchi for her excellent assistance in preparing this manuscript.	An JL, 2010, INT J LEGAL MED, V124, P99, DOI 10.1007/s00414-009-0375-2; An JL, 2011, INT J LEGAL MED, V125, P59, DOI 10.1007/s00414-010-0523-8; Bonnema DD, 2007, J CARD FAIL, V13, P530, DOI 10.1016/j.cardfail.2007.04.010; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Yoshida C, 2011, INT J LEGAL MED, V125, P11, DOI 10.1007/s00414-009-0374-3; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; AGREN MS, 1994, BRIT J DERMATOL, V131, P634, DOI 10.1111/j.1365-2133.1994.tb04974.x; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Kondo Toshikazu, 2007, Legal Medicine, V9, P109, DOI 10.1016/j.legalmed.2006.11.009; Kondo T, 2002, INT J LEGAL MED, V116, P87, DOI 10.1007/s004140100260; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Ishida Y, 2008, J IMMUNOL, V180, P569; Inkinen K, 2000, APMIS, V108, P318, DOI 10.1034/j.1600-0463.2000.d01-63.x; Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x; Nowinski D, 2004, J INVEST DERMATOL, V122, P216, DOI 10.1046/j.0022-202X.2003.22112.x; Vihinen P, 2005, CURR CANCER DRUG TAR, V5, P203, DOI 10.2174/1568009053765799; Kondo T, 1999, INT J LEGAL MED, V112, P249, DOI 10.1007/s004140050244; Cecchi R, 2010, INT J LEGAL MED, V124, P523, DOI 10.1007/s00414-010-0505-x; Ishida Y, 2012, INT J LEGAL MED, V126, P435, DOI 10.1007/s00414-012-0685-7; Gillard JA, 2004, WOUND REPAIR REGEN, V12, P295, DOI 10.1111/j.1067-1927.2004.012314.x; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Ishida Y, 2006, J IMMUNOL, V176, P5598; WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Sawicki G, 2005, MOL CELL BIOCHEM, V269, P209, DOI 10.1007/s11010-005-3178-x; Ravanti L, 2000, INT J MOL MED, V6, P391; Ma WX, 2011, INT J LEGAL MED, V125, P549, DOI 10.1007/s00414-011-0567-4; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Ishida Y, 2004, J IMMUNOL, V172, P1848; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Ashcroft GS, 1997, CELL TISSUE RES, V290, P581, DOI 10.1007/s004410050963; Ishida Y, 2009, INT J LEGAL MED, V123, P299, DOI 10.1007/s00414-009-0320-4; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; BETZ P, 1994, INT J LEGAL MED, V107, P60, DOI 10.1007/BF01225491; Bohnert M, 2010, INT J LEGAL MED, V124, P583, DOI 10.1007/s00414-010-0437-5; Fracasso T, 2011, INT J LEGAL MED, V125, P377, DOI 10.1007/s00414-010-0512-y; Hayashi T, 2004, INT J LEGAL MED, V118, P320, DOI 10.1007/s00414-004-0468-x; Ishida Y, 2008, INT J LEGAL MED, V122, P409, DOI 10.1007/s00414-008-0255-1; Kondo T, 2002, INT J LEGAL MED, V116, P267, DOI 10.1007/s00414-002-0322-y; Manuel JA, 2006, MATRIX BIOL, V25, P505, DOI 10.1016/j.matbio.2006.07.008; Nosaka M, 2010, INT J LEGAL MED, V124, P439, DOI 10.1007/s00414-010-0484-y; Nosaka M, 2009, INT J LEGAL MED, V123, P235, DOI 10.1007/s00414-009-0324-0; Oelusarz A, 2013, PHYSL REP, V1, DOI [10.1002/phy2.90, DOI 10.1002/PHY2.90]; Santos MCLG, 2001, BRIT J DERMATOL, V145, P854, DOI 10.1046/j.1365-2133.2001.04502.x; Seah CC, 2005, J INVEST DERMATOL, V124, P466, DOI 10.1111/j.0022-202X.2004.23557.x; Soo C, 2000, PLAST RECONSTR SURG, V105, P638, DOI 10.1097/00006534-200002000-00024; Tandara AA, 2011, J PLAST RECONSTR AES, V64, P108, DOI 10.1016/j.bjps.2010.03.051; Tanriverdi-Akhisaroglu S, 2009, CELL BIOCHEM FUNCT, V27, P81, DOI 10.1002/cbf.1537; Wysocki A B, 1992, J ET Nurs, V19, P166; Yu TY, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-2	58	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2015	129	5					1043	1048		10.1007/s00414-015-1167-5		6	Medicine, Legal	Legal Medicine	CQ0VM	WOS:000360315900016		
J	Ishida, Y; Kimura, A; Nosaka, M; Kuninaka, Y; Shimada, E; Yamamoto, H; Nishiyama, K; Inaka, S; Takayasu, T; Eisenmenger, W; Kondo, T				Ishida, Yuko; Kimura, Akihiko; Nosaka, Mizuho; Kuninaka, Yumi; Shimada, Emi; Yamamoto, Hiroki; Nishiyama, Kosuke; Inaka, Shogo; Takayasu, Tatsunori; Eisenmenger, Wolfgang; Kondo, Toshikazu			Detection of endothelial progenitor cells in human skin wounds and its application for wound age determination	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Forensic pathology; Wound age determination; Endothelial progenitor cells; Immunohistochemistry	TRAUMATIC BRAIN-INJURY; MOLECULAR PATHOLOGY; TEMPORAL EXPRESSION; STEM-CELLS; REGENERATION; FIBROCYTES; DIAGNOSIS; VITALITY; VASCULARIZATION; MYOFIBROBLASTS	Endothelial progenitor cells (EPCs), a newly identified cell type, are bone marrow-derived progenitor cells that co-express stem cell markers and vascular endothelial growth factor (VEGF) receptor (Flk-1). In this study, a double-color immunofluorescence analysis was carried out using anti-CD34 and anti-Flk-1 antibodies to examine the time-dependent appearance of EPCs, using 52 human skin wounds with different wound ages (Group I, 0-1 days; Group II, 2-6 days; Group III, 7-14 days; and Group IV, 17-21 days). In wound specimens with an age of less than one day, CD34(+)/Flk-1(+) EPCs were not detected. EPCs were initially observed in wounds aged two days, and their number was increased in lesions with advances in wound age. In morphometrical analysis, the average number of EPCs was the highest in the wounds of Group III. Especially, 20 out of 21 wounds aged 7-12 days had > 20 EPCs, and all wound samples with postinfliction intervals of 14-21 days had < 15 EPCs. These observations at least showed that > 20 EPCs would indicate a wound age of 7-12 days. Taken together, our observations indicate the detection of EPCs would be useful for wound age determination.	[Ishida, Yuko; Kimura, Akihiko; Nosaka, Mizuho; Kuninaka, Yumi; Shimada, Emi; Yamamoto, Hiroki; Nishiyama, Kosuke; Inaka, Shogo; Kondo, Toshikazu] Wakayama Med Univ, Dept Forens Med, Wakayama 6418509, Japan; [Takayasu, Tatsunori] Kanazawa Univ, Grad Sch Med Sci, Dept Forens & Social Environm Med, Kanazawa, Ishikawa 9208640, Japan; [Eisenmenger, Wolfgang] Univ Munich, Inst Legal Med, D-80336 Munich, Germany	Kondo, T (reprint author), Wakayama Med Univ, Dept Forens Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	kondot@wakayama-med.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	This study was financially supported by Grants-in-Aid for Scientific Research (A), Young Scientists (A), and Exploratory Research from the Ministry of Education, Science, Sports and Culture of Japan. We sincerely thank Ms. Mariko Kawaguchi for her excellent assistance in preparing this manuscript.	Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Patschan D, 2006, AM J PHYSIOL-RENAL, V291, pF176, DOI 10.1152/ajprenal.00454.2005; Betz P, 1996, INT J LEGAL MED, V108, P262, DOI 10.1007/BF01369823; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; Inokuma D, 2006, STEM CELLS, V24, P2810, DOI 10.1634/stemcells.2006-0264; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gomperts BN, 2007, J LEUKOCYTE BIOL, V82, P449, DOI 10.1189/jlb.0906587; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Sasaki M, 2008, J IMMUNOL, V180, P2581; Maeda H, 2014, LEGAL MED-TOKYO, V16, P61, DOI 10.1016/j.legalmed.2014.01.002; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Sato Y, 2000, INT J LEGAL MED, V113, P140, DOI 10.1007/s004140050285; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Kondo Toshikazu, 2007, Legal Medicine, V9, P109, DOI 10.1016/j.legalmed.2006.11.009; Kondo T, 2002, INT J LEGAL MED, V116, P87, DOI 10.1007/s004140100260; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Matsumoto T, 2008, BONE, V43, P434, DOI 10.1016/j.bone.2008.05.001; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Wu YJ, 2007, WOUND REPAIR REGEN, V15, pS18, DOI 10.1111/j.1524-475X.2007.00221.x; Kawamoto A, 2001, CIRCULATION, V103, P634; Kubo H, 2014, LEGAL MED-TOKYO, V16, P128, DOI 10.1016/j.legalmed.2014.01.008; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Abe R, 2001, J IMMUNOL, V166, P7556; Kondo T, 1999, INT J LEGAL MED, V112, P249, DOI 10.1007/s004140050244; Cecchi R, 2010, INT J LEGAL MED, V124, P523, DOI 10.1007/s00414-010-0505-x; Ishida Y, 2012, INT J LEGAL MED, V126, P435, DOI 10.1007/s00414-012-0685-7; Schmidt M, 2003, J IMMUNOL, V171, P380; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com; Ohshima T, 2000, FORENSIC SCI INT, V113, P153, DOI 10.1016/S0379-0738(00)00269-3; Ishida Y, 2009, INT J LEGAL MED, V123, P299, DOI 10.1007/s00414-009-0320-4; BETZ P, 1992, INT J LEGAL MED, V105, P99, DOI 10.1007/BF02340832; Cecchi R, 2014, INT J LEGAL MED, V128, P117, DOI 10.1007/s00414-013-0876-x; Chen JH, 2012, LEGAL MED-TOKYO, V14, P177, DOI 10.1016/j.legalmed.2012.01.015; Dressler J, 1999, INT J LEGAL MED, V112, P159, DOI 10.1007/s004140050223; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Dressler J, 1999, Int J Legal Med, V112, P39; Gauchotte G, 2013, INT J LEGAL MED, V127, P957, DOI 10.1007/s00414-013-0880-1; Grieb G, 2012, ADV WOUND CARE, V1, P36; Hayashi T, 2004, INT J LEGAL MED, V118, P320, DOI 10.1007/s00414-004-0468-x; Hernandez-Cueto C, 2000, AM J FOREN MED PATH, V21, P21, DOI 10.1097/00000433-200003000-00004; Ishida Y, 2008, INT J LEGAL MED, V122, P409, DOI 10.1007/s00414-008-0255-1; Kondo T, 2000, HISTOCHEM J, V32, P509, DOI 10.1023/A:1004164905041; Kondo T, 2002, INT J LEGAL MED, V116, P267, DOI 10.1007/s00414-002-0322-y; Kubo H, 2014, LEGAL MED-TOKYO, V16, P8, DOI 10.1016/j.legalmed.2013.10.002; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Oehmichen M, 2004, FORENSIC SCI INT, V144, P221, DOI 10.1016/j.forsciint.2004.04.057; Roomans Godfried M, 2010, Eur Cell Mater, V19, P284; Sakurada M, 2013, INT J LEGAL MED, V127, P783, DOI 10.1007/s00414-012-0806-3; Sivan-Loukianova E, 2003, J VASC RES, V40, P368, DOI 10.1159/000072701; Wang Q, 2013, INT J LEGAL MED, V127, P881, DOI 10.1007/s00414-013-0868-x; Xu J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00167	57	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2015	129	5					1049	1054		10.1007/s00414-015-1181-7		6	Medicine, Legal	Legal Medicine	CQ0VM	WOS:000360315900017		
J	Hayashi, T; Ago, K; Nakamae, T; Higo, E; Ogata, M				Hayashi, Takahito; Ago, Kazutoshi; Nakamae, Takuma; Higo, Eri; Ogata, Mamoru			Two different immunostaining patterns of beta-amyloid precursor protein (APP) may distinguish traumatic from nontraumatic axonal injury	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Traumatic axonal injury; Beta-amyloid precursor protein (APP); Hypoxia; Immunostaining patterns	CLOSED-HEAD INJURY; BRAIN-INJURY; DAMAGE; IMMUNOHISTOCHEMISTRY; DIAGNOSIS; MARKER; ADULTS	Immunostaining for beta-amyloid precursor protein (APP) is recognized as an effective tool for detecting traumatic axonal injury, but it also detects axonal injury due to ischemic or other metabolic causes. Previously, we reported two different patterns of APP staining: labeled axons oriented along with white matter bundles (pattern 1) and labeled axons scattered irregularly (pattern 2) (Hayashi et al. (Leg Med (Tokyo) 11:S171-173, 2009). In this study, we investigated whether these two patterns are consistent with patterns of trauma and hypoxic brain damage, respectively. Sections of the corpus callosum from 44 cases of blunt head injury and equivalent control tissue were immunostained for APP. APP was detected in injured axons such as axonal bulbs and varicose axons in 24 of the 44 cases of head injuries that also survived for three or more hours after injury. In 21 of the 24 APP-positive cases, pattern 1 alone was observed in 14 cases, pattern 2 alone was not observed in any cases, and both patterns 1 and 2 were detected in 7 cases. APP-labeled injured axons were detected in 3 of the 44 control cases, all of which were pattern 2. These results suggest that pattern 1 indicates traumatic axonal injury, while pattern 2 results from hypoxic insult. These patterns may be useful to differentiate between traumatic and nontraumatic axonal injuries.	[Hayashi, Takahito; Ago, Kazutoshi; Nakamae, Takuma; Higo, Eri; Ogata, Mamoru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, Kagoshima 8908544, Japan	Hayashi, T (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	takahito@m2.kufm.kagoshima-u.ac.jp			Ministry of Education, Culture, Science, and Technology of Japan [19590677, 22790599]	This study was financially supported by Grants-in-Aids for Scientific Research (C) (grant no. 19590677 to M. Ogata) and for Young Scientists (B) (grant no. 22790599 to T. Hayashi) from the Ministry of Education, Culture, Science, and Technology of Japan.	SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Kaur B, 1999, J CLIN PATHOL, V52, P203; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Davceva N, 2012, J FORENSIC LEG MED, V19, P413, DOI 10.1016/j.jflm.2012.04.011; Field AS, 2003, AM J NEURORADIOL, V24, P1461; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Harrington D, 2000, J CLIN FORENSIC MED, V7, P19, DOI 10.1054/jcfm.2000.0359; Hayashi Takahito, 2009, Leg Med (Tokyo), V11 Suppl 1, pS171, DOI 10.1016/j.legalmed.2009.01.076; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Oehmichen Manfred, 2003, Leg Med (Tokyo), V5, P190, DOI 10.1016/S1344-6223(03)00077-4; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Ogata Mamoru, 2007, Legal Medicine, V9, P105, DOI 10.1016/j.legalmed.2006.11.013; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2015	129	5					1085	1090		10.1007/s00414-015-1245-8		6	Medicine, Legal	Legal Medicine	CQ0VM	WOS:000360315900021		
J	Hishmat, AM; Michiue, T; Sogawa, N; Oritani, S; Ishikawa, T; Fawzy, IA; Hashem, MAM; Maeda, H				Hishmat, Asmaa Mohammed; Michiue, Tomomi; Sogawa, Nozomi; Oritani, Shigeki; Ishikawa, Takaki; Fawzy, Irene Atef; Hashem, Mohamed Abdel Mohsen; Maeda, Hitoshi			Virtual CT morphometry of lower limb long bones for estimation of the sex and stature using postmortem Japanese adult data in forensic identification	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Forensic radiology; Identification; Sex estimation; Stature estimation; Lower limb long bone; Japanese population	MULTIDETECTOR COMPUTED-TOMOGRAPHY; HEIGHT ESTIMATION; LENGTH; POPULATION; WHITES; IMAGES; FEMUR; FOOT	The application of computed tomography (CT) is useful for the documentation of whole-body anatomical data on routine autopsy, virtual reconstruction of skeletal structure, objective measurements, and reassessment by repetitive analyses. In addition, CT data processing facilitates volumetric and radiographic density analyses. Furthermore, a recently developed automated analysis system markedly improved the performance and accuracy of three-dimensional (3D) reconstruction. The present study investigated virtual CT morphometry of lower limb long bones, including the femur, tibia, fibula, and first metatarsus, to estimate the sex and stature using postmortem CT data of forensic autopsy cases of Japanese over 19 years of age (total n = 259, 150 males and 109 females). Bone mass volumes, lengths, and total CT attenuation values of bilateral femurs, tibias, and fibulas correlated with the stature; however, the mean CT attenuation (HU) values showed age-dependent decreases. Correlations with the stature were similar for the lengths and mass volumes of the femur, tibia, and fibula (r = 0.77-0.85) but were higher for the mass volume of the first metatarsus (r = 0.77 for right and r = 0.58 for left). In addition, the ratio of the bone volume to the length of each bone showed the most significant sex-related differences (males > females with accuracy of 75.8-98.1 %). These findings indicate the usefulness of virtual CT morphometry of individual lower limb long bones, including volumetry, to estimate the sex and stature in identification.	[Hishmat, Asmaa Mohammed; Michiue, Tomomi; Sogawa, Nozomi; Oritani, Shigeki; Ishikawa, Takaki; Maeda, Hitoshi] Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Osaka 5458585, Japan; [Hishmat, Asmaa Mohammed; Fawzy, Irene Atef; Hashem, Mohamed Abdel Mohsen] Menia Univ, Fac Med, Dept Forens Med & Clin Toxicol, Al Minya, Egypt; [Michiue, Tomomi; Sogawa, Nozomi; Ishikawa, Takaki; Maeda, Hitoshi] Osaka City Univ, Sch Med, Medicolegal Consultat & Postmortem Invest Support, Abeno Ku, Osaka 5458585, Japan	Michiue, T (reprint author), Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Asahi Machi 1-4-3, Osaka 5458585, Japan.	michi.leg@med.osaka-cu.ac.jp					ALLBROOK DAVID, 1961, JOUR FORENSIC MED, V8, P15; Andou M, 1923, KOKKA IGAKU ZASSHI, V434, P101; Saini V, 2012, J FORENSIC SCI, V57, P434, DOI 10.1111/j.1556-4029.2011.01966.x; ALDEGHERI R, 1993, J BONE JOINT SURG BR, V75, P86; Trotter M, 1952, AM J PHYS ANTHROP-NE, V10, P463, DOI 10.1002/ajpa.1330100407; GILES E, 1991, J FORENSIC SCI, V36, P1134; [Anonymous], 2001, 8 IEEE INT C COMP VI; Scheuer L, 2002, CLIN ANAT, V15, P297, DOI 10.1002/ca.10028; Ozaslan A, 2003, FORENSIC SCI INT, V132, P40, DOI 10.1016/S0379-0738(02)00425-5; Duyar I, 2003, AM J PHYS ANTHROPOL, V122, P23, DOI 10.1002/ajpa.10257; BLACK TK, 1978, AM J PHYS ANTHROPOL, V48, P227, DOI 10.1002/ajpa.1330480217; Khosla S, 2008, ENDOCR REV, V29, P441, DOI 10.1210/er.2008-0002; Bellucci S., 2006, Supersymmetric Mechanics-Vol.1 Supersymmetry, Noncommutativity and Matrix Models; Bhavna NS, 2009, INTERNET J BIOL ANTH, V2, P86; Cordeiro C, 2009, FORENSIC SCI INT, V193, pe1; Dayal MR, 2008, S AFR J SCI, V104, P124; Fujii A, 1960, B SCH PHYS ED JUNTEN, V3, P49; Giurazza F, 2012, FORENSIC SCI INT, V222, pe1; Hasegawa Iwao, 2009, Legal Medicine, V11, P260, DOI 10.1016/j.legalmed.2009.07.004; Hishmat AM, 2014, LEGAL MED-TOKYO, V16, P114, DOI 10.1016/j.legalmed.2014.01.004; Humphrey LT, 1998, AM J PHYS ANTHROPOL, V105, P57, DOI 10.1002/(SICI)1096-8644(199801)105:1<57::AID-AJPA6>3.0.CO;2-A; Jacob M, 2013, INDIAN J RES, V2, P185; Jamaiyah H, 2010, Med J Malaysia, V65 Suppl A, P131; Krishan K, 2012, J FORENSIC LEG MED, V19, P211, DOI 10.1016/j.jflm.2011.12.024; Leopold D, 1985, Gegenbaurs Morphol Jahrb, V131, P277; Lorkiewicz-Muszynska D, 2013, INT J LEGAL MED, V127, P653, DOI 10.1007/s00414-012-0805-4; Mountrakis C, 2010, FORENSIC SCI INT, V200; O'Donnell C, 2011, FORENSIC SCI INT, V205, P15, DOI 10.1016/j.forsciint.2010.05.026; Pandya A, 2011, NATL J MED RES, V1, P67; Petrovecki V, 2007, J FORENSIC SCI, V52, P547, DOI 10.1111/j.1556-4029.2007.00419.x; Pureepatpong N., 2012, SIRIRAJ MED J, V64, P22; Rainio J, 2001, Leg Med (Tokyo), V3, P34, DOI 10.1016/S1344-6223(01)00009-8; Rodriguez S, 2014, LEGAL MED-TOKYO, V16, P252, DOI 10.1016/j.legalmed.2014.05.006; Schmeling A, 2003, LEGAL MED, V5, P367, DOI 10.1016/S1344-6223(02)00134-7; Singh S, 2013, J INDIAN ACAD FORENS, V35; Soni G, 2010, J ANAT SOC INDIA, V59, P216; Stull KE, 2014, FORENSIC SCI INT, V238, P133, DOI 10.1016/j.forsciint.2014.03.005; Taik MM, 1972, J LIFE SCI, V5, P127; Tatarek NE, 2007, FORENSIC MED LOWER E, P71; Torimitsu S, 2014, LEGAL MED-TOKYO, V16, P181, DOI 10.1016/j.legalmed.2014.03.001; Torimitsu S, 2014, LEGAL MED-TOKYO, V16, P14, DOI 10.1016/j.legalmed.2013.10.003; Ubelaker DH, 1999, HUMAN SKELETAL REMAI, P60; Vedapriya KA, 2013, INT J BIOL MED RES, V4, P3199; Watanabe Satoshi, 2006, Legal Medicine, V8, P156, DOI 10.1016/j.legalmed.2006.01.001; Wilson RJ, 2010, J FORENSIC SCI, V55, P684, DOI 10.1111/j.1556-4029.2010.01343.x; Yonhao W, 1979, ACTA ANAT SINICA, V10, P1; Yoshino M, 1986, REP NATL RES I POLIC, V39, P201; Zaher JF, 2011, EGYPT J FOR SCI, V1, P103; Zeybek G, 2008, FORENSIC SCI INT, V181	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2015	129	5					1173	1182		10.1007/s00414-015-1228-9		10	Medicine, Legal	Legal Medicine	CQ0VM	WOS:000360315900034		
J	Yasuda, M				Yasuda, Masaya			Ramification of the Kummer extension generated from torsion points of elliptic curves	INTERNATIONAL JOURNAL OF NUMBER THEORY			English	Article						Torsion points of elliptic curves; ramification; Kummer generators		For a prime p, let zeta(p) denote a fixed primitive pth root of unity. Let E be an elliptic curve over a number field k with a p-torsion point. Then the p-torsion subgroup of E gives a Kummer extension over k(zeta(p)). In this paper, for p = 5 and 7, we study the ramification of such Kummer extensions using explicit Kummer generators directly computed by Verdure in 2006.	Fujitsu Labs Ltd, Nakahara Ku, Kawasaki, Kanagawa 2118588, Japan	Yasuda, M (reprint author), Fujitsu Labs Ltd, Nakahara Ku, 4-1-1 Kamikodanaka, Kawasaki, Kanagawa 2118588, Japan.	yasuda.masaya@jp.fujitsu.com					Cassels J.W.S., 1967, ALGEBRAIC NUMBER THE; Fisher T. A., 2000, THESIS U CAMBRIDGE; GREITHER C, 1989, MANUSCRIPTA MATH, V64, P261, DOI 10.1007/BF01165823; Kubert D. S., 1976, P LOND MATH SOC, V3, P253; Saito S., 1997, NUMBER THEORY; Silverman J., 1986, GRADUATE TEXTS MATH, V106; Silverman Joseph H., 1994, GRADUATE TEXTS MATH, V151; Verdure H., 2006, INT J PURE APPL MATH, V33, P75; Washington L.C., 1982, GRADUATE TEXTS MATH, V83; Yasuda M, 2013, INT J NUMBER THEORY, V9, P1743, DOI 10.1142/S1793042113500541; Yasuda M., 2012, COMMENT MATH U ST PA, V61, P1; Yasuda M, 2013, B KOREAN MATH SOC, V50, P83, DOI 10.4134/BKMS.2013.50.1.083	12	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-0421	1793-7310		INT J NUMBER THEORY	Int. J. Number Theory	SEP	2015	11	6					1725	1734		10.1142/S1793042115500736		10	Mathematics	Mathematics	CQ3HD	WOS:000360491800001		
J	Miyashita, H; Shiba, H; Kawana, H; Nakahara, T				Miyashita, H.; Shiba, H.; Kawana, H.; Nakahara, T.			Clinical utility of three-dimensional SPECT/CT imaging as a guide for the resection of medication-related osteonecrosis of the jaw	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						medication-related osteonecrosis of the jaw; three-dimensional SPECT/CT; two-stage operation; dental implantation; quality of life	BISPHOSPHONATE-RELATED OSTEONECROSIS; BONE-SCINTIGRAPHY; FLAP	In recent years, proactive surgical treatment has been reported to be effective for medication-related osteonecrosis of the jaw (MRONJ). However, an uncertain resection entails the risk of recurrence, whereas an extensive surgical procedure may lead to a marked reduction in quality of life as a result of reduced masticatory function and poor cosmesis. Therefore, radiological assessment can be helpful to accurately localize MRONJ before surgery. The integrated single-photon emission computed tomography and computed tomography system (SPECT/CT) allows oral and maxillofacial surgeons to identify an area of MRONJ, especially when three-dimensional (3D) SPECT and CT fusion images are offered. A patient for whom 3D SPECT and CT image fusion (as developed in the radiology department of the study institution) contributed to determining the extent of the lesion, thereby leading to a favourable patient prognosis, is reported herein. There was exact correlation between the histological and radiological results.	[Miyashita, H.; Shiba, H.; Kawana, H.] Keio Univ, Sch Med, Div Oral & Maxillofacial Surg, Dept Dent & Oral Surg, Tokyo 1608582, Japan; [Nakahara, T.] Keio Univ, Sch Med, Dept Radiol, Shinjuku Ku, Tokyo 1608582, Japan	Nakahara, T (reprint author), Keio Univ, Sch Med, Dept Radiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	n-tadaki0909@poem.ocn.ne.jp					Ferrari S, 2008, J ORAL MAXIL SURG, V66, P999, DOI 10.1016/j.joms.2007.06.631; Bedogni A, 2008, ORAL SURG ORAL MED O, V105, P358, DOI 10.1016/j.tripleo.2007.08.040; Pautke C, 2011, ORAL ONCOL, V47, P425, DOI 10.1016/j.oraloncology.2011.03.022; O'Ryan FS, 2009, J ORAL MAXIL SURG, V67, P1363, DOI 10.1016/j.joms.2009.03.005; Dore F, 2009, J NUCL MED, V50, P30, DOI 10.2967/jnumed.107.048785; Guggenberger R, 2013, AM J NEURORADIOL, V34, P1242, DOI 10.3174/ajnr.A3355; Naito M, 2004, J DENT HLTH, V54, P110; Nakahara T, 2013, J NUCL MED S2, V54; Nakahara T., 2013, J NUCL MED S2, V54, P622; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031	10	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	SEP	2015	44	9					1106	1109		10.1016/j.ijom.2015.05.002		4	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CQ2GV	WOS:000360419000008		
J	Takatsuji, H; Kobayashi, T; Kojima, T; Hasebe, D; Izumi, N; Saito, I; Saito, C				Takatsuji, H.; Kobayashi, T.; Kojima, T.; Hasebe, D.; Izumi, N.; Saito, I.; Saito, C.			Effects of orthognathic surgery on psychological status of patients with jaw deformities	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						jaw deformity; orthognathic surgery; psychological status; Minnesota Multiphasic Personality Inventory (MMPI)	DENTOFACIAL DEFORMITY; MOTIVATION; SATISFACTION; PERCEPTIONS; PROFILE; IMPACT	The purpose of this study was to determine the effect of orthognathic surgery on psychological status. The subjects were 119 patients (38 males and 81 females, mean age 25.5 +/- 9.4 years) who underwent orthognathic surgery. They were divided into class III (84 patients), class II (20 patients), and class I (15 patients) groups according to the anteroposterior skeletal pattern, and they were also divided into an asymmetry group (51 patients) and a symmetry group (68 patients). We assessed psychological status using the Minnesota Multiphasic Personality Inventory (MMPI) before surgery and at more than 6 months after surgery. The MMPI scores for the depression, hysteria, psychasthenia, and social introversion scales were significantly higher than standard values before surgery, and the hypomania scale significantly lower. The cannot say scale, depression scale, and hysteria scale decreased significantly after surgery. A comparison of MMPI scores among the groups showed the depression scale in the class III group to be higher than those in the class I and II groups; there was no significant difference between the asymmetry and symmetry groups. In conclusion, orthognathic surgery has a positive influence on the psychological status of patients with jaw deformities, especially patients with skeletal class III malocclusion.	[Takatsuji, H.; Kobayashi, T.; Kojima, T.; Hasebe, D.; Saito, C.] Niigata Univ, Grad Sch Med & Dent Sci, Div Reconstruct Surg Oral & Maxillofacial Reg, Dept Tissue Regenerat & Reconstruct, Niigata 9518514, Japan; [Izumi, N.] Kashiwazaki Gen Hosp & Med Ctr, Dept Dent & Oral Surg, Kashiwazaki, Niigata, Japan; [Saito, I.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Orthodont, Niigata 9518514, Japan; [Saito, C.] Tokyo Dent Coll, Suidobashi Hosp, Dept Oral & Maxillofacial Surg, Tokyo, Japan	Takatsuji, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Reconstruct Surg Oral & Maxillofacial Reg, Dept Tissue Regenerat & Reconstruct, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	takatsuji@dent.niigata-u.ac.jp					Alanko OME, 2010, ACTA ODONTOL SCAND, V68, P249, DOI 10.3109/00016357.2010.494618; Kim SJ, 2009, ORAL SURG ORAL MED O, V108, P828, DOI 10.1016/j.tripleo.2009.07.044; Hunt OT, 2001, AM J ORTHOD DENTOFAC, V120, P490, DOI 10.1067/mod.2001.118402; GARVILL J, 1992, J CRANIO MAXILL SURG, V20, P28, DOI 10.1016/S1010-5182(05)80193-3; Ryan FS, 2012, AM J ORTHOD DENTOFAC, V141, P734, DOI 10.1016/j.ajodo.2011.12.026; LAUFER D, 1976, ORAL SURG ORAL MED O, V41, P309, DOI 10.1016/0030-4220(76)90143-2; Soh CL, 2013, INT J ORAL MAX SURG, V42, P974, DOI 10.1016/j.ijom.2013.03.023; BELL R, 1985, AM J ORTHOD DENTOFAC, V88, P323, DOI 10.1016/0002-9416(85)90132-0; Nurminen L, 1999, EUR J ORTHODONT, V21, P79, DOI 10.1093/ejo/21.1.79; KIYAK HA, 1981, J ORAL SURG, V39, P757; Hatch JP, 1999, AM J ORTHOD DENTOFAC, V115, P536, DOI 10.1016/S0889-5406(99)70276-3; Chen Bo, 2002, Int J Adult Orthodon Orthognath Surg, V17, P217; Cunningham SJ, 2000, EUR J ORTHODONT, V22, P195, DOI 10.1093/ejo/22.2.195; Cunningham S J, 1995, Int J Adult Orthodon Orthognath Surg, V10, P159; FINLAY PM, 1995, BRIT J ORAL MAX SURG, V33, P9, DOI 10.1016/0266-4356(95)90078-0; FLANARY CM, 1990, AM J ORTHOD DENTOFAC, V98, P313, DOI 10.1016/S0889-5406(05)81488-X; Gerzanic Lucia, 2002, Int J Adult Orthodon Orthognath Surg, V17, P75; Hatch J P, 1998, Int J Adult Orthodon Orthognath Surg, V13, P67; HELDT L, 1982, AM J ORTHOD DENTOFAC, V82, P318, DOI 10.1016/0002-9416(82)90466-3; Ito A, 2007, JPN J JAW DEFORM, V17, P229; KIYAK HA, 1988, J ORAL MAXIL SURG, V46, P365; KIYAK HA, 1982, J ORAL MAXIL SURG, V40, P150, DOI 10.1016/0278-2391(82)90046-5; Kobayashi T, 2006, JPN J JAW DEFORM, V16, P153; MAXWELL R, 1991, International Journal of Adult Orthodontics and Orthognathic Surgery, V6, P123; McKiernan E X, 1992, Int J Adult Orthodon Orthognath Surg, V7, P187; Nakamura H, 1987, JPN J ORAL MAXILLOFA, V31, P2685; PETERSON LJ, 1976, J ORAL SURG, V34, P157; Phillips C, 2004, J ORAL MAXIL SURG, V62, P535, DOI 10.1016/j.joms.2003.08.025; Phillips C, 1998, ANGLE ORTHOD, V68, P547; Phillips C, 2001, Int J Adult Orthodon Orthognath Surg, V16, P87; Pogrel M A, 1994, Int J Adult Orthodon Orthognath Surg, V9, P105; Shiotani T, 1997, STANDARDIZATION NEW, P130; Stirling J, 2007, J Orthod, V34, P113, DOI 10.1179/146531207225022023; Tanaka F, 1993, VOLUME MMPI NEW JAPA, V1st, P1; Vulink NCC, 2008, INT J ORAL MAX SURG, V37, P985, DOI 10.1016/j.ijom.2008.06.005; WICTORIN L, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P138; WILMOT JJ, 1993, ANGLE ORTHOD, V63, P283	37	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	SEP	2015	44	9					1125	1130		10.1016/j.ijom.2015.02.003		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CQ2GV	WOS:000360419000011		
J	Uchida, Y; Goto, M; Danjo, A; Yamashita, Y; Shibata, K; Kuraoka, A				Uchida, Y.; Goto, M.; Danjo, A.; Yamashita, Y.; Shibata, K.; Kuraoka, A.			Anatomical relationship between the sublingual fossa and the lateral lingual foramen	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						sublingual fosssa; lateral lingual foramen; perforation; submental artery; bleeding	LIFE-THREATENING HEMORRHAGE; IMPLANT PLACEMENT; MOUTH; FLOOR	This study investigated the locational relationship between the sublingual fossa (SF) and the lateral lingual foramen (LLF) in order to gain useful knowledge so that perforation of the lingual cortical bone and damage to the adjacent blood vessels can be avoided when placing an endosseous implant (implant) in the mandibular interforaminal region. The deepest point of the SF (SFP) and the LLF were identified in 38 Japanese cadaver mandibles (20 edentulous and 18 dentate) by computed tomography (CT) and physical measurement. Their locations were measured. In the edentulous cases, the SFP was located approximately 15 mm vertically from the alveolar crest in the direction of the mandibular lower margin in the canine and premolar regions, and the LLF was located within a 5 mm radius from the SFP. Thus, significant attention to the locational relationship between the SFP and the LLF, as seen on preoperative CT, is required when placing an implant >= 3.75 mm in diameter and >= 15 mm in length in this region.	[Uchida, Y.; Goto, M.; Danjo, A.; Yamashita, Y.] Saga Med Sch, Dept Oral & Maxillofacial Surg, Saga, Japan; [Uchida, Y.] Uchida Dent Clin, Higashi Ku, Fukuoka 8130044, Japan; [Shibata, K.; Kuraoka, A.] Saga Med Sch, Dept Anat, Saga, Japan	Uchida, Y (reprint author), Uchida Dent Clin, Higashi Ku, 2-27-5 Chihaya, Fukuoka 8130044, Japan.	1672219701@jcom.home.ne.jp					GREEN RM, 1987, ORAL SURG ORAL MED O, V63, P287, DOI 10.1016/0030-4220(87)90191-5; Uchida Y, 2012, INT J ORAL MAX SURG, V41, P1571, DOI 10.1016/j.ijom.2012.03.015; Givol N, 2000, J PERIODONTOL, V71, P1893, DOI 10.1902/jop.2000.71.12.1893; Kalpidis Christos D, 2005, Implant Dent, V14, P117, DOI 10.1097/01.id.0000165028.89434.99; Kamijo Y, 1982, ANATOMY PERMANENT TE; Katsumi Y, 2013, CLIN ORAL IMPLAN RES, V24, P434, DOI 10.1111/j.1600-0501.2011.02348.x; Mardinger O, 2007, INT J ORAL MAX IMPL, V22, P127; MASON ME, 1990, J ORAL MAXIL SURG, V48, P201; Mordenfeld A, 1997, INT J ORAL MAX IMPL, V12, P558; Nakajima K, 2014, OR SURG OR MED OR PA, V117, pE32, DOI 10.1016/j.oooo.2012.03.032; Ratschew C, 1994, DTSCH ZAHNARZTL Z, V49, P65; Trikeriotis D, 2008, DENTOMAXILLOFAC RAD, V37, P125, DOI 10.1259/dmfr/24407623	12	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	SEP	2015	44	9					1146	1151		10.1016/j.ijom.2015.04.004		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CQ2GV	WOS:000360419000014		
J	Kishimoto, I; Moroto, S; Fujiwara, K; Harada, H; Kikuchi, M; Suehiro, A; Shinohara, S; Naito, Y				Kishimoto, Ippei; Moroto, Saburo; Fujiwara, Keizo; Harada, Hiroyuki; Kikuchi, Masahiro; Suehiro, Atsushi; Shinohara, Shogo; Naito, Yasushi			Bilateral duplication of the internal auditory canal: A case with successful cochlear implantation	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Duplicated internal auditory canal; Inner ear malformation; Vestibular aqueduct; Temporal bone CT; Cochlear implant; Gusher	HEARING-LOSS	We report a case of bilateral duplication of the internal auditory canal (IAC). An 11-month-old girl with congenital profound hearing loss was referred to our hospital. Imaging evaluations revealed bilateral IAC duplication, which contained the facial and cochleovestibular nerves in one canal, but no nerves in the other. She underwent cochlear implantation. At 5 months after surgery her hearing thresholds with the cochlear implant are 40 and 45 dB at 2000 and 4000 Hz, respectively. Bilateral duplicated IAC is extremely rare, with seven cases reported in the literature. This case represents a previously unreported type of IAC duplication, and is the first case in which cochlear implantation was successfully performed. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kishimoto, Ippei; Moroto, Saburo; Fujiwara, Keizo; Harada, Hiroyuki; Kikuchi, Masahiro; Suehiro, Atsushi; Shinohara, Shogo; Naito, Yasushi] Kobe City Med Ctr, Gen Hosp, Dept Otolaryngol, Kobe, Hyogo, Japan	Naito, Y (reprint author), Kobe City Med Ctr, Gen Hosp, Dept Otolaryngol, Kobe, Hyogo, Japan.	naito@kcho.jp			JSPS KAKENHI [26462574]; Health and Labor Sciences Research Grant for intractable auditory system disorders	The first and corresponding authors were supported by JSPS KAKENHI Grant Number 26462574, and Health and Labor Sciences Research Grant for intractable auditory system disorders. The corresponding author is grateful to Dr. Levent Sennaroglu for valuable discussion on this case.	Sennaroglu L, 2002, LARYNGOSCOPE, V112, P2230, DOI 10.1097/00005537-200212000-00019; CURTIN H, 1986, AM J OTOL, V7, P275; Demir OI, 2005, PEDIATR RADIOL, V35, P1220, DOI 10.1007/s00247-005-1547-y; Bakar TG, 2008, EUR ARCH OTO-RHINO-L, V265, P999, DOI 10.1007/s00405-007-0564-x; Gray RF, 1998, J LARYNGOL OTOL, V112, P646; Jensen J., 1968, ACTA RADIOL DIAGN ST, V286, P1; Kono T, 2009, ARCH OTOLARYNGOL, V135, P1048, DOI 10.1001/archoto.2009.137; Saylisoy S, 2014, J COMPUT ASSIST TOMO, V38, P20, DOI 10.1097/RCT.0b013e3182a0d05f; WEISSMAN JL, 1991, AM J NEURORADIOL, V12, P867; Weon YC, 2007, PEDIATR RADIOL, V37, P1047, DOI 10.1007/s00247-007-0570-6	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	SEP	2015	79	9					1595	1598		10.1016/j.ijporl.2015.07.004		4	Otorhinolaryngology; Pediatrics	Otorhinolaryngology; Pediatrics	CP9YC	WOS:000360250800043		
J	Takano, W; Nakamura, Y				Takano, Wataru; Nakamura, Yoshihiko			Statistical mutual conversion between whole body motion primitives and linguistic sentences for human motions	INTERNATIONAL JOURNAL OF ROBOTICS RESEARCH			English	Article						Motion; natural language; sentence from motion; motion from sentence	IMITATION	This paper describes a novel approach to linguistic mutual inference, which enables robots not only to linguistically interpret the motion patterns in the form of sentences but also to generate the motions from the sentences. The inference can be established based on two modules, the motion language model and the natural language model. The motion language model stochastically represents an association structure between symbols of motion patterns and the words in sentences assigned to the motion. This is a statistical model with a three layered structure of motion symbols, latent states and words. The natural language model statistically represents a structure of sentences based on word bigrams. The motion language model and the natural language model correspond to semantics and syntax respectively. An approach to the integration of motion language model with the natural language model allows the linguistic mutual inference for the robots. The two kinds of inference can be made by solving search problems, search for a sequence of words corresponding to a motion and search for a symbol of motion pattern corresponding to a sentence. The proposed approach to interpretation of motion patterns as sentences and generation of motion patterns from the sentences through the integration of motion language model with the natural language model is validated by an experiment on the human behavioral data.	[Takano, Wataru; Nakamura, Yoshihiko] Univ Tokyo, Mechanoinformat, Tokyo 1138656, Japan	Takano, W (reprint author), Univ Tokyo, Mechanoinformat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	takano@ynl.t.u-tokyo.ac.jp			Japan Society for the Promotion of Science [26700021]	This research was supported by Grant-in-Aid for Young Scientists (A) (26700021), Japan Society for the Promotion of Science.	Inamura T, 2004, INT J ROBOT RES, V23, P363, DOI 10.1177/0278364904042199; Takano W, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P1232, DOI 10.1109/ICRA.2012.6225331; Sugita Y, 2005, ADAPT BEHAV, V13, P33, DOI 10.1177/105971230501300102; Rose C, 1998, IEEE COMPUT GRAPH, V18, P32, DOI 10.1109/38.708559; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Tani J, 2003, IEEE T SYST MAN CY A, V33, P481, DOI 10.1109/TSMCA.2003.809171; Billard AG, 2006, ROBOT AUTON SYST, V54, P370, DOI 10.1016/j.robot.2006.01.007; Arikan O, 2003, ACM T GRAPHIC, V22, P402, DOI 10.1145/882262.882284; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Asfour T, 2006, P IEEE RAS INT C HUM, P40; Deacon T. W., 1997, SYMBOLIC SPECIES COE; Ijspeert A. J., 2003, ADV NEURAL INFORM PR, V15, P1547; KADABA MP, 1990, J ORTHOPAED RES, V8, P383, DOI 10.1002/jor.1100080310; Kadone H, 2005, P 2005 IEEE RSJ INT, P2900; Kudo T., 2004, P 2004 C EMP METH NA, V2004, P230; Kulic D, 2009, IEEE T ROBOT, V25, P1158, DOI 10.1109/TRO.2009.2026508; Nakamura T, 2011, P IEEE INT C ROB AUT, P6233; Nakamura T, 2007, P IEEE RSJ INT C INT, P2415; Nakaoka S, 2010, INT J ROBOT RES, V26, P829; Ogata T, 2007, P IEEE RSJ INT C INT, P1858; Okada M., 2002, Proceedings 2002 IEEE International Conference on Robotics and Automation (Cat. No.02CH37292), DOI 10.1109/ROBOT.2002.1014741; Ott C, 2008, P IEEE RAS INT C HUM, P399; Rabiner L. R., 1993, PRENTICE HALL SIGNAL; Saussure F. D., 1966, COURSE GEN LINGUISTI; Sugiura K, 2010, IEEE INT C INT ROBOT, P1774; Takano W, 2010, IEEE INT CONF ROBOT, P2404, DOI 10.1109/ROBOT.2010.5509532; Takano W, 2007, IEEE INT CONF ROBOT, P3092, DOI 10.1109/ROBOT.2007.363942; Takano W, 2009, P IEEE INT C ROB AUT, P646; Takano W, 2007, P IEEE RSJ INT C INT, P1416; Takeuchi K, 1995, P 10 PAC AS C LANG I, P163; Yamane K, 2010, P IEEE RAS INT C HUM, P504	31	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0278-3649	1741-3176		INT J ROBOT RES	Int. J. Robot. Res.	SEP	2015	34	10					1314	1328		10.1177/0278364915587923		15	Robotics	Robotics	CQ1WY	WOS:000360392200004		
J	Yan, YE; Turale, S; Stone, T; Petrini, M				Yan, Y. E.; Turale, S.; Stone, T.; Petrini, M.			Disaster nursing skills, knowledge and attitudes required in earthquake relief: Implications for nursing education	INTERNATIONAL NURSING REVIEW			English	Article						China; Disaster; Disaster Nursing; Disaster Preparedness; Disaster Training; Emergency Nursing; Nursing Education	NURSES; PREPAREDNESS	BackgroundGlobally, nurses becoming more aware of getting better prepared for disaster relief, but in China, disaster nursing knowledge, courses and research are still limited. IntroductionChina has long been prone to disasters, but disaster nursing education and training is in its infancy. AimThis study explored the skills, knowledge and attitudes required by registered nurses from across China who worked in the aftermath of three large earthquakes to try to determine future disaster nursing education requirements. MethodThe Questionnaire ofNurses'DisasterNursingSkills atEarthquakeSites, assessing nursing skills, knowledge and attitudes, was distributed to 139 registered nurses in 38 hospitals in 13 provinces across China who had worked in one or more earthquake disaster zones. Descriptive statistics were used for quantitative data, and content analysis for qualitative data. ResultsEighty-nine questionnaires were returned, a response rate of 68.3%. No respondent had ever received specific disaster nursing training prior to their post-earthquake nursing. Skills most often used by respondents were haemostasis bandaging, fixation, manual handling, observation and monitoring, debridement and dressing, and mass casualty transportation. Respondents identified that the most important groups of skills required were cardiopulmonary resuscitation; haemostasis, bandaging, fixation, and manual handling; and emergency management. They emphasized the need for psychological care of victims as well as that of fellow health workers. ConclusionNo respondent had ever received disaster nursing training prior to engagement at the earthquake disaster sites. All believed that there were important gaps in their knowledge and skills, and supported disaster nursing courses in the future. Implications for nursing and health policyChina urgently needs to develop disaster nursing courses, with the support of nurse leaders, educationalists and government, to implement training using an all hazards approach in accordance with international best practice and trainees' background clinical experience and knowledge.	[Yan, Y. E.; Petrini, M.] Wuhan Univ, HOPE Sch Nursing, Wuhan 430072, Hubei, Peoples R China; [Turale, S.] Ewha Womans Univ, Dept Global Hlth & Nursing, Div Nursing, Seoul 120750, South Korea; [Stone, T.] Yamaguchi Univ, Fac Hlth Sci, Int Nursing, Ube, Yamaguchi 755, Japan	Turale, S (reprint author), Ewha Womans Univ, Dept Global Hlth & Nursing, Div Nursing, Gil 52, Seoul 120750, South Korea.	turale@ewha.ac.kr					Yang YN, 2010, INT NURS REV, V57, P217, DOI 10.1111/j.1466-7657.2009.00795.x; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Fung OWM, 2008, J ADV NURS, V62, P698, DOI 10.1111/j.1365-2648.2008.04655.x; Arbon P, 2006, AUSTRALASIAN EMERGEN, V9, P171, DOI 10.1016/j.aenj.2006.05.003; Ashkenazi Itamar, 2005, Prehosp Disaster Med, V20, P122; Baack S, 2013, J NURS SCHOLARSHIP, V45, P281, DOI 10.1111/jnu.12029; Dewolfe D. J., 2000, FIELD MANUAL MENTAL; Fritsch K., 2009, SE ASIAN J TROPICAL, V40, P71; Hilton Carla, 2004, J Contin Educ Nurs, V35, P59; Holloway I, 2013, QUALITATIVE RES NURS; International Council of Nurses (ICN), 2009, ICN FRAM DIS NURS CO; International Council of Nurses (ICN), 2006, POS STAT NURS DIS PR; Jennings-Sanders Andrea, 2005, Disaster Manag Response, V3, P80, DOI 10.1016/j.dmr.2005.04.001; Johnstone MJ, 2014, NURS HEALTH SCI, V16, P67, DOI 10.1111/nhs.12130; Littleton-Kearney Marguerite T, 2008, Crit Care Nurs Clin North Am, V20, P103, DOI 10.1016/j.ccell.2007.10.008; Mayner L, 2010, AUSTRALASIAN EMERGEN, V14, P75; Norris F, 2001, 50000 DISASTER VICTI; Petrini MA, 2014, NURS HEALTH SCI, V16, P1, DOI 10.1111/nhs.12132; Qiu X, 2008, MED ETHICS, V3rd; Schmidt Cheryl K, 2011, Nurs Educ Perspect, V32, P380; Turale S, 2014, INT NURS REV, V61, P3, DOI 10.1111/inr.12093; Veenema Tener Goodwin, 2006, Nurs Educ Perspect, V27, P93; Weiner Elizabeth, 2005, Nurs Educ Perspect, V26, P334; World Health Organization, 2007, RISK RED EM PREP WHO; Yang T, 2008, CHINESE ED J, P1002; Yin H. H., 2011, J ADV NURS, V67, P2230; Zhang Q., 2009, CHINESE NURSING RES, V23, P923; Zhang WeiDong, 2009, China Tropical Medicine, V9, P1111; Zhou WJ, 2015, NURSE EDUC PRACT, V15, P75, DOI 10.1016/j.nepr.2014.06.011	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-8132	1466-7657		INT NURS REV	Int. Nurs. Rev.	SEP	2015	62	3					351	359		10.1111/inr.12175		9	Nursing	Nursing	CP9MK	WOS:000360218200020		
J	Baba, T; Homma, Y; Ochi, H; Kobayashi, H; Matsumoto, M; Sakamoto, Y; Kuwahara, H; Maeda, K; Kaneko, K				Baba, Tomonori; Homma, Yasuhiro; Ochi, Hironori; Kobayashi, Hideo; Matsumoto, Mikio; Sakamoto, Yuko; Kuwahara, Hirotomo; Maeda, Kouichi; Kaneko, Kazuo			Higher reliability and validity of Baba classification with computerised tomography imaging and implant information for periprosthetic femoral fractures	INTERNATIONAL ORTHOPAEDICS			English	Article						Periprosthetic femoral fracture; Vancouver classification; Baba classification; Implant design	TOTAL HIP-ARTHROPLASTY; VANCOUVER CLASSIFICATION; FOLLOW-UP; COMPONENT; REPLACEMENT; SYSTEM; FEMUR; KNEE	Purpose Baba classification for periprosthetic femoral fracture focuses on the positional relationship between the implant design and fracture site. The objective of this study was to investigate whether the addition of CT images and implant information to plain radiograms increases the reliability of Baba classification to a level higher than that of Vancouver classification. Methods Twenty patients were randomly selected from 61 patients with periprosthetic femoral fracture between 2009 and 2014. After Vancouver and Baba classifications were fully explained to six orthopedic surgeons (three experts and three non-experts), plain radiograms, CT imaging and implant information at the time of injury were presented, and the inter- and intra-observer reliability based on the Vancouver and Baba classifications and accuracy rates of stem stability were investigated. Results When interobserver reliability was made based on only radiograms, the mean kappa value of Baba classification-based judgments made by the experts was 0.76, and those of Vancouver classification-based judgments made by the experts was 0.41. When interobserver reliability was made based on the radiograms and CT images and implant information, the mean kappa value of Baba classification-based judgments made by the experts was 0.94, and those of Vancouver classification-based judgments were 0.48. Intra-observer reliability of Baba classification was 0.81 in the experts. Validity analysis showed 95.0 % agreement within all subgroups. Conclusions Reliability and validity of Baba classification was improved when additional information was given. We believe that this new classification is useful to establish a therapeutic strategy for femoral fractures around the stem.	[Baba, Tomonori; Homma, Yasuhiro; Ochi, Hironori; Kobayashi, Hideo; Matsumoto, Mikio; Kaneko, Kazuo] Juntendo Univ, Sch Med, Dept Orthoped Surg, Bunkyo Ku, Tokyo 113, Japan; [Sakamoto, Yuko; Kuwahara, Hirotomo; Maeda, Kouichi] Juntendo Univ, Nerima Hosp, Dept Orthoped Surg, Nerima Ku, Tokyo 113, Japan	Baba, T (reprint author), Juntendo Univ, Sch Med, Dept Orthoped Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 113, Japan.	tobaba@juntendo.ac.jp					Rayan F, 2008, J BONE JOINT SURG BR, V90B, P1576, DOI 10.1302/0301-620X.90B12.20681; Naqvi GA, 2012, J ARTHROPLASTY, V27, P1047, DOI 10.1016/j.arth.2011.11.021; Corten K, 2009, J BONE JOINT SURG BR, V91B, P1424, DOI 10.1302/0301-620X.91B11.22292; Wood GCA, 2011, J ARTHROPLASTY, V26, P886, DOI 10.1016/j.arth.2010.07.002; Brady OH, 2000, J ARTHROPLASTY, V15, P59, DOI 10.1016/S0883-5403(00)91181-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; [Anonymous], 2004, CLIN ORTHOP RELA MAR, DOI 10.1097/00003086-200403000-00012; Haidukewych GJ, 2013, J BONE JOINT SURG AM, V95A, P368; Neumann D, 2012, INT ORTHOP, V36, P1045, DOI 10.1007/s00264-011-1371-y; Laurer HL, 2011, ARCH ORTHOP TRAUM SU, V131, P983, DOI 10.1007/s00402-011-1272-y; Schmitz MWJL, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-37; Duncan CP, 2014, BONE JOINT J, V96B, P713, DOI 10.1302/0301-620X.96B6.34040; Baba T, 2015, INT ORTHOP, V39, P1, DOI 10.1007/s00264-014-2476-x; Baba Tomonori, 2013, Eur J Orthop Surg Traumatol, V23, P437, DOI 10.1007/s00590-012-1005-0; Duncan CP, 1995, AAOS INSTR COURS LEC, V44, P293; Goto E, 2014, J ORTHOP SCI, V19, P959, DOI 10.1007/s00776-014-0619-y; HARRIS WH, 1986, J BONE JOINT SURG AM, V68A, P1064; Lindahl H, 2006, J BONE JOINT SURG AM, V88A, P1215, DOI 10.2106/JBJS.E.00457; LOUDON JR, 1989, J BONE JOINT SURG BR, V71, P624; Moloney GB, 2014, ARCH ORTHOP TRAUM SU, V134, P9, DOI 10.1007/s00402-013-1883-6; Shah RP, 2014, J AM ACAD ORTHOP SUR, V22, P482, DOI 10.5435/JAAOS-22-08-482	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	SEP	2015	39	9					1695	1699		10.1007/s00264-015-2674-1		5	Orthopedics	Orthopedics	CQ2MY	WOS:000360436200005		
J	Inoue, D; Kabata, T; Maeda, T; Kajino, Y; Yamamoto, T; Takagi, T; Oomori, T; Tsuchiya, H				Inoue, Daisuke; Kabata, Tamon; Maeda, Toru; Kajino, Yoshitomo; Yamamoto, Takashi; Takagi, Tomoharu; Oomori, Takaaki; Tsuchiya, Hiroyuki			The value of bulk femoral head allograft in acetabular reconstruction using Kerboull-type plate	INTERNATIONAL ORTHOPAEDICS			English	Article						Total hip arthroplasty; Acetabular reconstruction; Kerboull-type plate; Bulk allograft	TOTAL HIP-ARTHROPLASTY; REINFORCEMENT DEVICE; FOLLOW-UP; REVISION; GRAFT	Purpose This study investigated the mid- and long-term results of acetabular reconstruction using a KT plate with an allograft and showed the utility of filling the bony defect with bulk femoral head allograft rather than morselised allograft. Methods We retrospectively investigated a consecutive series of 31 hips in 30 patients who underwent primary THA or revision THA between March 2002 and March 2012. Bulk grafts from femoral head allografts were used in 16 hips and morselised grafts were used in 15 hips. The mean follow-up period was 7.2 years (3-13 years). The acetabular bone defects were classified according to the American Academy of Orthopedic Surgeons grading system. Type II defects were present in five hips; 26 hips were type III. Results Radiological failure, defined as absolute error of the inclination of the KT plate > 3A degrees, breakage of the KT plate or screw, and/or absolute error of the vertical or horizontal migration of the femoral head > 3 mm was found in 12 cases. All these complications appeared in the morselized group; there were no complications in the bulk group. The eight-year survival rate of morselised grafts was 52.5 % and that of bulk grafts was 100 %, using radiological loosening as an end point. Conclusions We conclude that using bulk graft from femoral head allografts is necessary to achieve mechanically stable reconstruction for large acetabular bone defects.	[Inoue, Daisuke; Kabata, Tamon; Maeda, Toru; Kajino, Yoshitomo; Yamamoto, Takashi; Takagi, Tomoharu; Oomori, Takaaki; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan	Kabata, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.	tamonkabata@yahoo.co.jp					Hori J, 2012, INT ORTHOP, V36, P23, DOI 10.1007/s00264-011-1248-0; Kerboull M, 2000, CLIN ORTHOP RELAT R, P155; Kosashvili Y, 2011, J ARTHROPLASTY, V26, P1170, DOI 10.1016/j.arth.2011.04.022; Tanaka C, 2003, J ARTHROPLASTY, V18, P719, DOI 10.1054/S0883-5403(03)00149-9; Schreurs BW, 2004, J BONE JOINT SURG AM, V86A, P2385; Akiyama H, 2011, J BONE JOINT SURG BR, V93B, P1194, DOI 10.1302/0301-620X.93B9.26598; Okano K, 2010, J ARTHROPLASTY, V25, P594, DOI 10.1016/j.arth.2009.04.003; Kawanabe K, 2007, J BONE JOINT SURG BR, V89B, P26, DOI 10.1302/0301-620X.89B1.18037; Kawanabe K, 2011, J ARTHROPLASTY, V26, P1061, DOI 10.1016/j.arth.2011.04.019; Zehntner M K, 1994, J Arthroplasty, V9, P469, DOI 10.1016/0883-5403(94)90092-2; Lunn JV, 2005, ACTA ORTHOP, V76, P296, DOI 10.1080/00016470510030733; Abolghasemian M, 2013, BONE JOINT J, V95B, P166, DOI 10.1302/0301-620X.95B2.30608; Garbuz D, 1996, J BONE JOINT SURG AM, V78A, P693; Baba T, 2010, INT ORTHOP, V34, P341, DOI 10.1007/s00264-009-0789-y; DANTONIO JA, 1989, CLIN ORTHOP RELAT R, P126; Ito H, 2010, J ARTHROPLASTY, V25, P1307, DOI 10.1016/j.arth.2009.10.012; JASTY M, 1990, J BONE JOINT SURG BR, V72, P63; Kaku N, 2014, EUR J ORTHOP SURG TR, V25, P321; Shima Y, 1971, J JPN ORTHOP ASSOC, V45, P813; Tägil M, 2000, Acta Orthop Scand Suppl, V290, P1	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	SEP	2015	39	9					1839	1844		10.1007/s00264-015-2857-9		6	Orthopedics	Orthopedics	CQ2MY	WOS:000360436200026		
J	Koie, T; Ohyama, C; Hosogoe, S; Yamamoto, H; Imai, A; Hatakeyama, S; Yoneyama, T; Hashimoto, Y; Yoneyama, T; Tobisawa, Y; Mori, K				Koie, Takuya; Ohyama, Chikara; Hosogoe, Shogo; Yamamoto, Hayato; Imai, Atsushi; Hatakeyama, Shingo; Yoneyama, Takahiro; Hashimoto, Yasuhiro; Yoneyama, Tohru; Tobisawa, Yuki; Mori, Kazuyuki			Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Article						Non-muscle-invasive bladder cancer; Transurethral resection; Second TUR; Cancer recurrence; Cancer progression	TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; 7 EORTC; PROGRESSION; RECURRENCE; RISK; TRIALS	A second transurethral resection (TUR) has been recommended by guidelines for high-grade non-muscle-invasive bladder cancer (NMIBC). However, the impact of surgical quality and post-TUR intra-vesical instillation therapy on oncologic outcome still remains unclear for newly diagnosed NMIBC. We conducted a retrospective cohort study for the patients who underwent extensive TUR followed by appropriate intra-vesical therapy for newly diagnosed NMIBC to assess their oncological outcomes. We treated a cohort of 150 patients with NMIBC by our single but extensive TUR protocol at Hirosaki University Hospital between January 2005 and May 2012. The extensive TUR procedure comprised complete resection of all visible tumors including the muscle layer with a separate cold cup-biopsy of the marginal bottom. After visible tumors resection, additional resection for 5 mm wider area around the first surgical margin was performed. TUR was conducted by three expert urologists who had common agreement with the extensive TUR. All patients received 50 mg of epirubicin instillation immediately after TUR. Out of 150 patients, 74 patients who had multiple tumors or high-grade T1 disease received 40 mg of bacillus Calmette-Gu,rin Tokyo 172 strain once a week for six consecutive weeks. Patients who received second TUR were not included. The endpoints in this study were the recurrence-, progression-free, cancer-specific, and overall survivals. The 5-year recurrence- and progression-free survival rates were 77.2 and 98.0 %, respectively. The 5-year cancer-specific and overall survival rates were 98.0 and 92.6 %, respectively. The 5-year recurrence- and progression-free survival rates in high-grade T1 disease were 77.1 and 97.6 %, respectively, which were not significantly different from those in the cohort with Ta or low-grade BC. Cystoscopy revealed that 93 % of the patients were tumor-free, at the first cystoscopy, and four patients (3 %) showed progression to stage T2 or higher disease during the first year. While the present study has several limitations, including single-arm and retrospective nature, a single but extensive TUR combined with adjuvant intravesical treatment may have acceptable oncological outcomes in NMIBC patients.	[Koie, Takuya; Ohyama, Chikara; Hosogoe, Shogo; Yamamoto, Hayato; Imai, Atsushi; Hatakeyama, Shingo; Yoneyama, Takahiro; Hashimoto, Yasuhiro; Yoneyama, Tohru; Tobisawa, Yuki; Mori, Kazuyuki] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan	Koie, T (reprint author), Hirosaki Univ, Grad Sch Med, Dept Urol, 5 Zaifucho, Hirosaki, Aomori 0368562, Japan.	goodwin@hirosaki-u.ac.jp					AKAZA H, 1995, CANCER, V75, P552, DOI 10.1002/1097-0142(19950115)75:2<552::AID-CNCR2820750219>3.0.CO;2-H; Babjuk M, 2010, EUR UROL, V58, P191, DOI 10.1016/j.eururo.2010.04.019; Brausi M, 2002, EUR UROL, V41, P523, DOI 10.1016/S0302-2838(02)00068-4; Herr HW, 2007, J UROLOGY, V177, P75, DOI 10.1016/j.juro.2006.08.070; Kulkarni GS, 2010, EUR UROL, V57, P60, DOI 10.1016/j.eururo.2009.08.024; Divrik RT, 2010, EUR UROL, V58, P185, DOI 10.1016/j.eururo.2010.03.007; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Cookson MS, 1997, J UROLOGY, V158, P62, DOI 10.1097/00005392-199707000-00017; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1097/01.ju.0000034450.80198.1c; Witjes JA, 2008, EUR UROL, V53, P45, DOI 10.1016/j.eururo.2007.08.015; COOKSON MS, 1992, J UROLOGY, V148, P797; Edge SB, 2010, AJCC CANC STAGING MA, P497; Grimm MO, 2003, J UROLOGY, V170, P433, DOI 10.1097/01.ju.0000070437.14275.e0; Herr HW, 2011, THESCIENTIFICWORLDJO, V11, P283, DOI 10.1100/tsw.2011.29; Holmang S, 2013, SCAND J UROL, V47, P363, DOI 10.3109/21681805.2013.769461; Mostafid H, 2012, BJU INT, V109, P1579, DOI 10.1111/j.1464-410X.2011.10638.x; Oosterlinck W, 2001, EUR UROL, V40, P515, DOI 10.1159/000049828; Shelley MD, 2000, COCHRANE DB SYST REV; Yoneyama T, 2008, UROLOGY, V71, P1161, DOI 10.1016/j.urology.2007.11.080; Zurkirchen MA, 2004, UROL INT, V72, P99, DOI 10.1159/000075961	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	SEP	2015	47	9					1509	1514		10.1007/s11255-015-1048-3		6	Urology & Nephrology	Urology & Nephrology	CP9MV	WOS:000360219300010		
J	Ikuma, Y; Ogoe, S; Mitsugi, M; Niwa, K; Anandan, S; Yamauchi, E; Tajiri, H; Sakata, O				Ikuma, Yasuro; Ogoe, Seiya; Mitsugi, Masahiro; Niwa, Koichi; Anandan, Srinivasan; Yamauchi, Eiji; Tajiri, Hiroo; Sakata, Osami			Surface X-ray diffraction study and photocatalytic activity of HF-treated single crystal rutile TiO2(001) surface	IONICS			English	Article						Surface structure; Titanium oxide (001) single crystal; Photocatalyst; Surface X-ray diffraction; Decomposition reaction; Low-energy electron diffraction	RECONSTRUCTION	The photocatalytic activity of a hydrogen fluoride (HF)-treated rutile TiO2(001) surface for the decomposition reaction of linoleic acid was lower than that of an as-received (polished) rutile TiO2(001) surface. The surfaces of as-received TiO2(001) and HF-treated TiO2(001) were investigated using low-energy electron diffraction (LEED) and surface X-ray diffraction (SXRD) to elucidate differences in their photocatalytic activities. The as-received (polished) surface did not yield good LEED patterns, which implied that the surface was not well-ordered and was thus not examined using SXRD. In contrast, the HF-treated surface produced good LEED patterns with a 1 x 1 structure and was thus studied using SXRD. The analysis of crystal truncation rods indicated that all atoms in the four layers of the surface moved toward the bulk and that the HF-treated surface was (101)-faceted with terraces. On average, the facet was found to be four layers deep. The difference in the condition of the surface influences the photocatalytic activity of the surface.	[Ikuma, Yasuro; Ogoe, Seiya; Mitsugi, Masahiro; Niwa, Koichi; Yamauchi, Eiji] Kanagawa Inst Technol, Atsugi, Kanagawa 2430292, Japan; [Anandan, Srinivasan] Int Adv Res Ctr Powder Met & New Mat ARCI, Hyderabad 500005, Andhra Pradesh, India; [Tajiri, Hiroo; Sakata, Osami] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan	Ikuma, Y (reprint author), Kanagawa Inst Technol, Atsugi, Kanagawa 2430292, Japan.	ikuma@chem.kanagawa-it.ac.jp			Japan Society for the Promotion of Science (JSPS) [23560807]	The authors gratefully acknowledge support from the Japan Synchrotron Radiation Research Institute (Proposal Nos. 2008B1393, 2008B2208, 2009B1445, and 2010A1258) for providing the BL13XU beamline facilities at SPring-8 to conduct synchrotron experiments. This work was financially supported in part by a Grant-in-Aid for Scientific Research (C) (No. 23560807) from the Japan Society for the Promotion of Science (JSPS).	ROBINSON IK, 1992, REP PROG PHYS, V55, P599, DOI 10.1088/0034-4885/55/5/002; Perron H, 2007, THEOR CHEM ACC, V117, P565, DOI 10.1007/s00214-006-0189-y; TAIT RH, 1979, PHYS REV B, V20, P5178, DOI 10.1103/PhysRevB.20.5178; Wilson JN, 2003, J CATAL, V214, P46, DOI 10.1016/S0021-9517(02)00172-0; Liu G, 2014, CHEM REV, V114, P9559, DOI 10.1021/cr400621z; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Charlton G, 1997, PHYS REV LETT, V78, P495, DOI 10.1103/PhysRevLett.78.495; Diebold D, 2003, SURF SCI REP, V48, P53; FIRMENT LE, 1982, SURF SCI, V116, P205, DOI 10.1016/0039-6028(82)90428-9; Fukui K, 2001, JPN J APPL PHYS 1, V40, P4331, DOI 10.1143/JJAP.40.4331; Ikuma Y, 2011, T MAT RES SOC JPN, V36; Ikuma Y, 2013, J CERAM SOC JPN, V121, P254, DOI 10.2109/jcersj2.121.254; Ikuma Yasuro, 2014, Key Engineering Materials, V617, DOI 10.4028/www.scientific.net/KEM.617.109; Nowotny J, 2012, GREEN CHEM CHEM ENG, P1; Sakata O, 2003, SURF REV LETT, V10, P543, DOI 10.1142/S0218625X03004809; Wilson JN, 2004, LANGMUIR, V20, P10956, DOI 10.1021/la0484422; Zajonz H, 1998, SURF SCI, V398, P369, DOI 10.1016/S0039-6028(98)80042-3	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0947-7047	1862-0760		IONICS	Ionics	SEP	2015	21	9					2495	2501		10.1007/s11581-015-1452-9		7	Chemistry, Physical; Electrochemistry; Physics, Condensed Matter	Chemistry; Electrochemistry; Physics	CP7SN	WOS:000360088500013		
J	Asama, T; Arima, TH; Gomi, T; Keishi, T; Tani, H; Kimura, Y; Tatefuji, T; Hashimoto, K				Asama, T.; Arima, T. -H.; Gomi, T.; Keishi, T.; Tani, H.; Kimura, Y.; Tatefuji, T.; Hashimoto, K.			Lactobacillus kunkeei YB38 from honeybee products enhances IgA production in healthy adults	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						bee pollen; honeybee products; Immunoglobulin A; Lactobacillus kunkeei; microbiota	LACTIC-ACID BACTERIA; DIFFERENTIATION; CELLS; IDENTIFICATION; PROFILES; STRAINS; POLLEN; PCR; DNA	AimsTo identify lactic acid bacterial isolates, which promote immunoglobulin A (IgA) production in honeybee products and honeybees (Apis mellifera). Methods and ResultsPyrosequencing analysis of the microbiota of honeybee products and honeybees revealed the predominance of Lactobacillus kunkeei in honey, bee pollen, bee bread and royal jelly. Lactobacillus kunkeei was isolated from bee pollen, bee bread and honey stomach, and its effect on IgA production was evaluated invitro. Heat-killed YB38 and YB83 isolates from bee pollen promoted IgA production in mouse Peyer's Patch cells and had little mitogenic activity or effect on IL-2 production in mouse spleen cells in comparison with Listeria monocytogenes, which does exhibit mitogen activity. A pilot study in 11 healthy adults showed that 4-week intake of 1000mgday(-1) heat-killed YB38 increased secretory IgA (SIgA) concentrations and secretion in saliva with no adverse effects. ConclusionHeat-killed Lact.kunkeei YB38 from bee pollen increases IgA production and may safely improve immune responsiveness. Significance and Impact of the StudyThis is the first report of microbiota analysis of royal jelly and the immune efficacy of Lact.kunkeei from honeybee products in humans.	[Asama, T.; Keishi, T.; Tani, H.; Kimura, Y.; Tatefuji, T.; Hashimoto, K.] Yamada Bee Co Inc, Inst Bee Prod & Hlth Sci, Kagamino, Okayama 7080393, Japan; [Arima, T. -H.; Gomi, T.] Prefectural Univ Hiroshima, Dept Life & Environm Sci, Shobara, Hiroshima, Japan	Asama, T (reprint author), Yamada Bee Co Inc, Inst Bee Prod & Hlth Sci, 194 Ichiba, Kagamino, Okayama 7080393, Japan.	ta1022@yamada-bee.com					Abdullah H., 2009, J BAGH COLL DENT, V21, P76; Anderson KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083125; Torriani S, 1999, APPL ENVIRON MICROB, V65, P4351; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Fahlman MM, 2005, MED SCI SPORT EXER, V37, P374, DOI 10.1249/01.MSS.0000155432.67020.88; Ishida Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1652, DOI 10.1271/bbb.69.1652; Kaech SM, 2001, NAT IMMUNOL, V2, P415; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Bishop NC, 2009, FRONT BIOSCI, V14, P4444, DOI 10.2741/3540; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Kopermsub P, 2010, INT J FOOD MICROBIOL, V138, P200, DOI 10.1016/j.ijfoodmicro.2010.01.024; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; NIESSNER M, 1995, CLIN EXP IMMUNOL, V101, P428; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Takenaka T., 1980, Bulletin of the Faculty of Agriculture Tamagawa University, P71; Fukushima Y., 1997, Bioscience and Microflora, V16, P65; Ibarguren C, 2010, J MICROBIOL, V48, P44, DOI 10.1007/s12275-009-0177-8; Izumo T, 2011, J HEALTH SCI, V57, P304, DOI 10.1248/jhs.57.304; Kobayashi N, 2011, INT IMMUNOPHARMACOL, V11, P199, DOI 10.1016/j.intimp.2010.11.019; Kotani Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091857; Manan NA, 2009, AFR J BIOTECHNOL, V8, P3964; Suda W, 2008, MICROBES ENVIRON, V23, P248, DOI 10.1264/jsme2.23.248; Takeda K, 1997, MILCHWISSENSCHAFT, V52, P21	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	SEP	2015	119	3					818	826		10.1111/jam.12889		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CP9RA	WOS:000360231000020		
J	Takahashi, M; Kita, Y; Kusaka, K; Mizuno, A; Goto-Yamamoto, N				Takahashi, M.; Kita, Y.; Kusaka, K.; Mizuno, A.; Goto-Yamamoto, N.			Evaluation of microbial diversity in the pilot-scale beer brewing process by culture-dependent and culture-independent method (vol 118, pg 454, 2015)	JOURNAL OF APPLIED MICROBIOLOGY			English	Correction									[Takahashi, M.; Kita, Y.; Kusaka, K.; Mizuno, A.; Goto-Yamamoto, N.] Natl Res Inst Brewing, Higashihiroshima, Japan	Takahashi, M (reprint author), Natl Res Inst Brewing, Higashihiroshima, Japan.						Haakensen M, 2008, CAN J MICROBIOL, V54, P321, DOI [10.1139/w08-007, 10.1139/W08-007]; Herzog P, 2008, INT J SYST EVOL MICR, V58, P26, DOI 10.1099/ijs.0.65362-0; Takahashi M, 2015, J APPL MICROBIOL, V118, P454, DOI 10.1111/jam.12712	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	SEP	2015	119	3					904	904		10.1111/jam.12900		1	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CP9RA	WOS:000360231000030		
J	Nakano, S; Kitagawa, Y; Miyoshi, D; Sugimoto, N				Nakano, Shu-ichi; Kitagawa, Yuichi; Miyoshi, Daisuke; Sugimoto, Naoki			Effects of background anionic compounds on the activity of the hammerhead ribozyme in Mg2+-unsaturated solutions	JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY			English	Article						Ribozyme; Metal ion binding; Macromolecular crowding; Poly(ethylene glycol)	METAL-IONS; MAGNESIUM-IONS; NUCLEIC-ACIDS; SELF-CLEAVAGE; RNA; CATALYSIS; DNA; EQUILIBRIA; STABILITY; COSOLUTES	Cellular ribozymes exhibit catalytic activity in media containing large numbers of anionic compounds and macromolecules. In this study, the RNA cleavage activity of the hammerhead ribozyme induced by Mg2+ was investigated using the solutions containing background nucleic acids, small phosphate and carboxylic acid compounds, and neutral polymers. Analysis of the substrate cleavage kinetics showed that the anionic compounds do not affect the ribozyme activity in Mg2+-saturated solutions and there is almost no effect of the anion-Mg2+ complexes formed. On the other hand, the rate of substrate cleavage in Mg2+-unsaturated solutions was reduced under conditions of a high background of anionic compounds found in cells. The extent of the reduction was more with a greater net negative charge, caused by decreased amounts of Mg2+ that could be used for the ribozyme reaction. It was remarkable that background DNA and RNA molecules having phosphodiester bonds reduced the cleavage rate as much as adenosine monophosphates having a charge of -2 when the effects of the same amount of phosphate groups were compared. Greater reductions in rates than those expected from the molecular charge were also observed in the background of fatty acids that form micelles. An addition of poly(ethylene glycol) to the solutions partially restored the ribozyme activity, suggesting a possible role of macromolecular crowding in counteracting the inhibitory effects of background anions on the ribozyme reaction. The results have biological and practical implications with respect to the effects of molecular environment on the efficiency of ion binding to RNA.	[Nakano, Shu-ichi; Kitagawa, Yuichi; Miyoshi, Daisuke; Sugimoto, Naoki] Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Dept Nanobiochem, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Sugimoto, Naoki] Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Chuo Ku, Kobe, Hyogo 6500047, Japan	Nakano, S (reprint author), Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Dept Nanobiochem, Chuo Ku, 7-1-20 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	shuichi@center.konan-u.ac.jp			JSPS [24550200]; MEXT	We thank Akiko Matsuyama and Junpei Ueno for technical assistance. This work was supported in part by Grants-in-Aid for Scientific Research from JSPS (No. 24550200), MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2009-2014.	FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Bevilacqua PC, 2004, BIOPOLYMERS, V73, P90, DOI 10.1002/bip.10519; Record MT, 1998, ADV PROTEIN CHEM, V51, P281; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; O'Rear JL, 2001, RNA, V7, P537, DOI 10.1017/S1355838201002461; Nakano S, 2012, J PHYS CHEM B, V116, P7406, DOI 10.1021/jp302170f; Boots JL, 2008, RNA, V14, P2212, DOI 10.1261/rna.1010808; Minton AP, 1998, METHOD ENZYMOL, V295, P127; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; Citti L, 2005, CURR GENE THER, V5, P11; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; Penedo JC, 2004, RNA, V10, P880, DOI 10.1261/rna.5268404; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Lee TS, 2008, J AM CHEM SOC, V130, P3053, DOI 10.1021/ja076529e; Cuervo A, 2014, P NATL ACAD SCI USA, V111, pE3624, DOI 10.1073/pnas.1405702111; Sigel RKO, 2007, CHEM REV, V107, P97, DOI 10.1021/cr0502605; Nakano S, 2001, BIOCHEMISTRY-US, V40, P12022, DOI 10.1021/bi011253n; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Nakano S, 2008, MOL BIOSYST, V4, P579, DOI 10.1039/b718806d; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Nakano S, 2014, CHEM REV, V114, P2733, DOI 10.1021/cr400113m; Misra VK, 1998, BIOPOLYMERS, V48, P113, DOI 10.1002/(SICI)1097-0282(1998)48:2<113::AID-BIP3>3.0.CO;2-Y; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Bourdeau V, 1999, NUCLEIC ACIDS RES, V27, P4457, DOI 10.1093/nar/27.22.4457; Martick M, 2008, CHEM BIOL, V15, P332, DOI 10.1016/j.chembiol.2008.03.010; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; ASAMI K, 1976, J MEMBRANE BIOL, V28, P169, DOI 10.1007/BF01869695; Bassi GS, 1997, EMBO J, V16, P7481, DOI 10.1093/emboj/16.24.7481; Bloomfield V. A., 2000, NUCL ACIDS STRUCTURE; Cantor C.R., 1980, BIOPHYSICAL CHEM; Chi YI, 2008, PLOS BIOL, V6, P2060, DOI 10.1371/journal.pbio.0060234; Dawson R. M. C., 1959, DATA BIOCH RES; Hanna R, 2000, CURR OPIN CHEM BIOL, V4, P166, DOI 10.1016/S1367-5931(99)00071-X; Hsiao C, 2009, COMPLEXES NUCL ACIDS; KUHN A, 1985, J BACTERIOL, V163, P906; Li S, 2008, METHOD MOL BIOL, V405, P113; Martel AE, 1989, CRITICAL STABILITY C; McElroy WD, 1951, PHOSPHORUS METABOLIS; Meyers RA, 2005, REV CELL BIOL MOL ME; Nakano S, 2014, FEBS OPEN BIO, V4, P643, DOI 10.1016/j.fob.2014.06.009; Nakano SI, 2008, CHEM COMMUN, P700, DOI 10.1039/b715647b; Nashimoto M, 2000, EUR J BIOCHEM, V267, P2738, DOI 10.1046/j.1432-1327.2000.01294.x; SANDER C, 1971, J MOL BIOL, V55, P1, DOI 10.1016/0022-2836(71)90276-2; Speight JG, 2005, LANGES HDB CHEM; Tanizaki S, 2008, BIOPHYS J, V94, P747, DOI 10.1529/biophysj.107.116236; WIGGINS PM, 1990, MICROBIOL REV, V54, P432; Woldringh CL, 1999, EUKARYOTIC PERSPECTI; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-8257	1432-1327		J BIOL INORG CHEM	J. Biol. Inorg. Chem.	SEP	2015	20	6					1049	1058		10.1007/s00775-015-1286-y		10	Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear	Biochemistry & Molecular Biology; Chemistry	CP9OM	WOS:000360224000011		
J	Kuriu, T; Kakimoto, Y; Araki, O				Kuriu, Takayuki; Kakimoto, Yuta; Araki, Osamu			Computational simulation: astrocyte-induced depolarization of neighboring neurons mediates synchronous UP states in a neural network	JOURNAL OF BIOLOGICAL PHYSICS			English	Article						Astrocyte; Synchronous UP state; Slow inward current; Release of glutamic acid; Neural network model; Adaptive exponential integrate-and-fire model	SYNAPTIC-TRANSMISSION; GLUTAMATE RELEASE; GLIAL-CELLS; IN-VIVO; MODEL; PLASTICITY; SYNAPSES; COMMUNICATION; OSCILLATIONS; HIPPOCAMPUS	Although recent reports have suggested that synchronous neuronal UP states are mediated by astrocytic activity, the mechanism responsible for this remains unknown. Astrocytic glutamate release synchronously depolarizes adjacent neurons, while synaptic transmissions are blocked. The purpose of this study was to confirm that astrocytic depolarization, propagated through synaptic connections, can lead to synchronous neuronal UP states. We applied astrocytic currents to local neurons in a neural network consisting of model cortical neurons. Our results show that astrocytic depolarization may generate synchronous UP states for hundreds of milliseconds in neurons even if they do not directly receive glutamate release from the activated astrocyte.	[Kuriu, Takayuki; Kakimoto, Yuta; Araki, Osamu] Tokyo Univ Sci, Dept Appl Phys, Katsushika Ku, Tokyo 1258585, Japan	Araki, O (reprint author), Tokyo Univ Sci, Dept Appl Phys, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	brainics@rs.tus.ac.jp					Kumar A, 2008, NEURAL COMPUT, V20, P1, DOI 10.1162/neco.2008.20.1.1; Navarrete M, 2013, CEREB CORTEX, V23, P1240, DOI 10.1093/cercor/bhs122; Fellin T, 2006, J BIOL CHEM, V281, P4274, DOI 10.1074/jbc.M510679200; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Poskanzer KE, 2011, P NATL ACAD SCI USA, V108, P18453, DOI 10.1073/pnas.1112378108; Araque A, 2010, PHILOS T R SOC B, V365, P2375, DOI 10.1098/rstb.2009.0313; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Fellin T, 2009, P NATL ACAD SCI USA, V106, P15037, DOI 10.1073/pnas.0906419106; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Allegrini P, 2009, J BIOL PHYS, V35, P413, DOI 10.1007/s10867-009-9166-8; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Carmignoto G, 2006, J PHYSIOLOGY-PARIS, V99, P98, DOI 10.1016/j.jphysparis.2005.12.008; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Pirttimaki TM, 2011, J NEUROSCI, V31, P7637, DOI 10.1523/JNEUROSCI.5783-10.2011; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Verkhratsky A, 2011, BRAIN RES REV, V66, P133, DOI 10.1016/j.brainresrev.2010.05.002; Cossart R., 2003, NATURE, V423, P13; Destexhe A, 2009, J COMPUT NEUROSCI, V27, P493, DOI 10.1007/s10827-009-0164-4; Di Garbo A, 2009, J BIOL PHYS, V35, P361, DOI 10.1007/s10867-009-9143-2; El Boustani S, 2007, J PHYSIOLOGY-PARIS, V101, P99, DOI 10.1016/j.jphysparis.2007.10.001; Kandel E., 2013, PRINCIPLES NEURAL SC; Rodriguez M, 2013, BRAIN RES BULL, V93, P17, DOI 10.1016/j.brainresbull.2012.09.018; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Tewari SG, 2012, J BIOL PHYS, V38, P465, DOI 10.1007/s10867-012-9267-7; Wade J.J., 2011, PLOS ONE, V6, P1; Wang FS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002334; Zhao J, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-12	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0092-0606	1573-0689		J BIOL PHYS	J. Biol. Phys.	SEP	2015	41	4					377	390		10.1007/s10867-015-9385-0		14	Biophysics	Biophysics	CQ0VQ	WOS:000360316300005		
J	Ueki, S; Niinomi, K; Takashima, Y; Kimura, R; Komai, K; Murakami, K; Fujiwara, C				Ueki, Shingo; Niinomi, Kazuteru; Takashima, Yuko; Kimura, Ryoko; Komai, Kazuyo; Murakami, Kiyotaka; Fujiwara, Chieko			Predictors of maternal state anxiety on arrival at a Japanese hospital outpatient clinic: a cross-sectional study	JOURNAL OF CLINICAL NURSING			English	Article						anxiety; cross-sectional study; family nursing; mother; paediatric nursing; paediatrics	CHILD; FEVER; PARENTS	Aims and objectivesTo identify the factors that predict maternal state anxiety when mothers and their sick children visit the outpatient unit of a paediatric hospital. BackgroundWhile previous studies have focused on predictors of anxiety in mothers with ill children, the existing literature is limited in study design, research timing, respondent characteristics, sample size and data analysis. DesignA cross-sectional design with self-administered questionnaires. MethodsMothers were recruited from the outpatient unit of a Japanese paediatric hospital (N=1077). Participants' state anxiety scores were collected using the Japanese version of Spielberger's State-Trait Anxiety Inventory. The independent variables were the mothers' and sick children's background information. ResultsParticipants were 1077 mothers; 990 provided valid responses. Mothers' mean state anxiety score was 4972. Significant predictors of maternal anxiety were mothers' childrearing anxiety, child age, the sick child having a fever, sick child having siblings, having a person providing childrearing support, the mother's first visit to the hospital, out-of-hours visit and severity of the child's illness. The overall model explained 216% of the variance (multiple regression analysis). ConclusionsAs various factors predicted maternal anxiety, identifying methods to address these factors may reduce maternal state anxiety. Relevance to clinical practiceThere is potential for improved understanding of the predictors of maternal state anxiety to aid in the development of materials that would best measure anxiety. The present findings may also suggest some means of providing appropriate information and support to anxious mothers. Our findings cannot demonstrate causation, however, and teaching methods and supportive practices were not investigated; therefore, a qualitative study on the concrete content of maternal anxiety and an intervention study to create support services for anxious mothers is required. In addition, prospective or longitudinal studies are also important for investigating causation.	[Ueki, Shingo; Niinomi, Kazuteru; Takashima, Yuko; Fujiwara, Chieko] Osaka Univ, Grad Sch Med, Course Hlth Sci, Suita, Osaka, Japan; [Kimura, Ryoko] Toyonaka City Publ Hlth Ctr, Osaka, Japan; [Komai, Kazuyo] NAKANO Childrens Hosp, Osaka, Japan; [Murakami, Kiyotaka] Childrens Hosp, Osaka, Japan	Ueki, S (reprint author), Osaka Univ, Grad Sch Med, Course Hlth Sci, 1-7 Yamadaoka, Suita, Osaka, Japan.	ueki-s@sahs.med.osaka-u.ac.jp			Osaka University, Japan	We are particularly thankful to Dr. Minoru Kino, Director of Nakano Children's Hospital, for providing the investigation site, and we greatly appreciate the efforts of the Osaka University students who assisted with our research. We also thank all of the study's participants. Our study was supported in part by a research grant from Osaka University, Japan.	Al-Nouri L, 2006, J TROP PEDIATRICS, V52, P113, DOI 10.1093/tropej/fmi076; Holm L, 2008, PEDIATR EMERG CARE, V24, P836, DOI 10.1097/PEC.0b013e31818ea04c; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Fleissig A, 1999, PATIENT EDUC COUNS, V38, P69, DOI 10.1016/S0738-3991(98)00124-4; Betz MG, 2006, EUR J EMERG MED, V13, P129, DOI 10.1097/01.mej.0000194401.15335.c7; O'Neill-Murphy K, 2001, PEDIATR EMERG CARE, V17, P47, DOI 10.1097/00006565-200102000-00014; SCHMITT BD, 1980, AM J DIS CHILD, V134, P176; Lester KJ, 2010, J ANXIETY DISORD, V24, P102, DOI 10.1016/j.janxdis.2009.09.004; Betz CL, 1994, FAMILY CTR NURSING C, V2nd; Child Development Institute, 2013, LANG DEV CHILDR; Csaki F, 1973, INF THEOR P 2 INT S, P267; Hamasaki Y, 2010, JAPANESE J PUBLIC HL, V66, P44; Hidano N, 2000, STAI MANUAL; Horita N, 2005, JAPANESE SOC CHILD H, V64, P3; Hosono K, 2006, CLIN THERMOMETRY THE, V24, P40; Hyeon OJ, 2011, J CLIN NURS, V20, P1490; Iimura N, 2011, JAPANESE J CLIN NURS, V34, P1693; Ishihara A, 1997, JAPANESE SOC CHILD H, V6, P56; Japan Council for Quality Health Care, 2012, HOSP ACCR STAND FUNC; Japanese Nursing Association, 2014, CHAR CERT PAED EM NU; Japanese Society for Care and Education in Paediatrics, 2014, FDN PRINC; Kawakami Chifumi, 2004, Fukuoka Acta Medica, V95, P73; Ministry of Health Labour and Welfare, 2013, CHILD ASS CHILD REAR; Ministry of Health Labour and Welfare, 2013, PROJ VIS ALL FAM CHI; MISHEL MH, 1983, NURS RES, V32, P324; Mishina H, 2012, PEDIATR INT, V54, P504, DOI 10.1111/j.1442-200X.2012.03577.x; Mishina H, 2011, JAPANESE SOC CHILD H, V70, P39; Niinomi N, 2007, J CHILD HLTH, V66, P561; Okada N, 2012, JAPAN ACAD COMMUNITY, V15, P119; Shimokai C, 2004, LIFE DESIGN REPORT, V7, P4; Simon K, 1993, J Pediatr Nurs, V8, P298; Spielberger CD, 1966, ANXIETY BEHAV, P3; Tanaka T, 2008, JAPANESE SOC EMERGEN, V7, P318; Yagihashi T, 2011, JAPANESE SOC CHILD H, V70, P298; Zelkowitz Phyllis, 2012, Womens Health (Lond Engl), V8, P205, DOI 10.2217/whe.11.96	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	SEP	2015	24	17-18					2383	2391		10.1111/jocn.12788		9	Nursing	Nursing	CQ2TY	WOS:000360455600005		
J	Miyata, K; Yoshimura, S; Hayashi, Y				Miyata, Kumiko; Yoshimura, Sadako; Hayashi, Yuko			Facilitating patients with disorders of consciousness to sit without trunk support: a qualitative study	JOURNAL OF CLINICAL NURSING			English	Article						Disorders of consciousness; nursing intervention; rehabilitation; sitting; text-mining approach	VEGETATIVE STATE; REHABILITATION; STROKE; FRACTURES; PROGRAM; BALANCE; CARE	Aims and objectivesThis study aimed to clarify why and how clinical nurses facilitate sitting without trunk support among patients with disorders of consciousness. BackgroundRecent attention has focused on encouraging patients with disorders of consciousness to sit without trunk support, but no reports describe this intervention among patients with poor awareness and physical disuse. DesignQualitative research design. MethodsWe enrolled five clinical nurses with interventional experience in rehabilitating patients with disorders of consciousness to sit without trunk support. Participant observation and semi-structured interviews were used to collect data. The data were analysed by text-mining method. ResultsThree reasons for nursing in the sitting position were identified: to raise the patient's body to assess the recovery of activities of daily living, to adjust their circadian rhythm and encourage the will to sit, and to make it easier to breathe. Five practices were identified: moving the patient to the prone position to sit in safety and comfort, developing postural stability by improving the flexibility of the lower limbs, improving the flexibility of the hip joints, developing trunk balance and encouraging hand use for stability, and ensuring safety by terminating the sitting practice when symptoms of respiratory failure, heart failure, or excessive tiredness developed. ConclusionsThe rationale for nursing patients with disorders of consciousness to sit without trunk support was to establish a foundation for independent living. This was achieved by preparing patient's disused body for activity by improving the flexibility of hip joint in the prone position. This represents a new intervention for patients with disorders of consciousness that could facilitate independent living. Relevance to clinical practiceThis study provides empirical and practical evidence from nurses who perform novel clinical interventions that specifically promote independent living. Further accumulation of quantitative clinical results and physiological verification are required.	[Miyata, Kumiko; Hayashi, Yuko] Hokkaido Univ Sci, Dept Nursing, Sapporo, Hokkaido 0068585, Japan; [Yoshimura, Sadako] Hokkaido Univ, Fac Hlth Sci, Dept Nursing, Sapporo, Hokkaido 060, Japan	Miyata, K (reprint author), Hokkaido Univ Sci, Dept Nursing, 7-15-4-1 Maeda, Sapporo, Hokkaido 0068585, Japan.	miyata-k@hus.ac.jp					Puggina ACG, 2012, J NEUROSCI NURS, V44, P260, DOI 10.1097/JNN.0b013e3182666407; JENNETT B, 1972, LANCET, V1, P734; Andrews K, 1996, BRIT MED J, V313, P13; Gosseries O, 2011, FRONT COLLECT, P29, DOI 10.1007/978-3-642-18047-7_2; Oh H, 2003, J CLIN NURS, V12, P394; Spaak J, 2005, J APPL PHYSIOL, V98, P648, DOI 10.1152/japplphysiol.01332.2003; Oppl B, 2014, J BONE MINER RES, V29, P1096, DOI 10.1002/jbmr.2122; Lavrijsen J, 2007, BRAIN INJURY, V21, P993, DOI 10.1080/02699050701528447; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/0962010443000506; SANDIN KJ, 1990, STROKE, V21, P82; Cabanas-Valdes R, 2013, NEUROREHABILITATION, V33, P575, DOI 10.3233/NRE-130996; Feldman R., 2007, TEXT MINING HDB; Geraghty Max, 2005, Nurs Stand, V20, P54; Higuchi K, 2012, KH CODER; Laureys S, 2011, NEUROLOGY CONSCIOUSN; Mazaux JM, 2001, J REHABIL MED, V33, P99; Okubo N, 2011, J NEUROSCI NURS, V43, pE13, DOI 10.1097/JNN.0b013e318214570f; Posner JB, 2007, PLUM POSNERS DIAGNOS; Shumway-Cook A, 2006, MOTOR CONTROL TRANSL, P157; Vollman K., 2010, CRIT CARE NURSE, V30, P3; VonsWild K, 2012, J MED LIFE, V5, P3; Yu C. H., 2011, QUALITATIVE REPORT, V16, P730	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	SEP	2015	24	17-18					2498	2504		10.1111/jocn.12834		7	Nursing	Nursing	CQ2TY	WOS:000360455600017		
J	Prasetyo, AA; Sariyatun, R; Reviono; Sari, Y; Hudiyono; Haryati, S; Adnan, ZA; Hartono; Kageyama, S				Prasetyo, Afiono Agung; Sariyatun, Ratna; Reviono; Sari, Yulia; Hudiyono; Haryati, Sri; Adnan, Zainal Arifin; Hartono; Kageyama, Seiji			The APOBEC3B deletion polymorphism is associated with prevalence of hepatitis B virus, hepatitis C virus, Torque Teno virus, and Toxoplasma gondii co-infection among HIV-infected individuals	JOURNAL OF CLINICAL VIROLOGY			English	Article						APOBEC; HIV; HBV; HCV; TTV; Toxoplasma gondii	CYTIDINE DEAMINASES; HEPATOCELLULAR-CARCINOMA; GENE DELETION; IN-VITRO; SUSCEPTIBILITY; REPLICATION; POPULATION; EXPRESSION; INDONESIA; VIF	Background: Data regarding the influence of the APOBEC3B deletion on infectious diseases remain limited and shown discrepancies. Objectives: To characterize the APOBEC3B deletion polymorphism status and its association with prevalence of co-infection with blood-borne pathogens in Indonesian HIV-infected individuals. Materials and methods: A total of 597 HIV-positive blood samples were tested for the hepatitis B virus (HBV), hepatitis C virus (HCV), Torque Teno virus (TTV), GB virus-C (GBV-C), and Toxoplasma gondii. Nucleic acid was extracted from plasma samples and used for the molecular detection of HIV RNA, HBV DNA, HCV RNA, TTV DNA, and GBV-C RNA, whereas HBsAg, anti-HCV, IgM and IgG anti-T. gondii were detected through serological testing. The APOBEC3B deletion polymorphism was genotyped by polymerase chain reaction (PCR). Results: The deletion genotype was associated with HCV viremia (p < 0.001) as well as elevated IgG antiT. gondii (adjusted OR [aOR] = 3.4). The deletion genotype was also associated with decreased levels of HBsAg (aOR = 0.03), and anti-HCV (aOR = 0.1). D/D was frequently found in HIV-infected individuals with CD4 + T cells < 14% (aOR = 5.8). The intact genotype was associated with a reduced likelihood of a CD4 + T cell count < 200 cells/mu L (aOR = 0.2) but a higher prevalence of TTV co-infection (aOR = 8.6). Conclusions: The APOBEC3B deletion polymorphism was found to be associated with HBV, HCV, TTV, and T. gondii co-infection in Indonesian HIV-infected individuals. (C) 2015 Elsevier B.V. All rights reserved.	[Prasetyo, Afiono Agung; Sariyatun, Ratna; Reviono; Sari, Yulia; Hudiyono; Haryati, Sri; Adnan, Zainal Arifin; Hartono] Sebelas Maret Univ, A IGIC A Infect Genom Immunol & Canc Res Grp, Surakarta 57126, Indonesia; [Prasetyo, Afiono Agung; Sariyatun, Ratna; Sari, Yulia; Hudiyono; Haryati, Sri] Sebelas Maret Univ, Ctr Biotechnol & Biodivers Res & Dev, Surakarta 57126, Indonesia; [Prasetyo, Afiono Agung; Hudiyono] Sebelas Maret Univ, Fac Med, Dept Microbiol, Surakarta 57126, Indonesia; [Reviono] Sebelas Maret Univ, Fac Med, Dept Pulmonol, Surakarta 57126, Indonesia; [Sari, Yulia; Haryati, Sri] Sebelas Maret Univ, Fac Med, Dept Parasitol, Surakarta 57126, Indonesia; [Adnan, Zainal Arifin] Sebelas Maret Univ, Fac Med, Dept Internal Med, Surakarta 57126, Indonesia; [Hartono] Sebelas Maret Univ, Fac Med, Dept Physiol, Surakarta 57126, Indonesia; [Kageyama, Seiji] Tottori Univ, Fac Med, Div Virol, Dept Microbiol & Immunol, Yonago, Tottori 6838503, Japan	Prasetyo, AA (reprint author), Sebelas Maret Univ, Fac Med, Dept Microbiol, Jl Ir Sutami 36A, Surakarta 57126, Indonesia.	afie.agp.la@gmail.com			Indonesian Directorate of Higher Education [322/SP2H/PP/DP2M/VI/2009, 440/SP2H/PP/DP2M/VI/2010, 505/SP2H/PL/Dit.Litabmas/VII/2011, 197/SP2H/PL/Dit.Litabmas/IV/2012, 077/SP2H/PL/Dit.Litabmas/V/2013]; Indonesian Directorate of Higher Education-APBN/DIPA UNS [2342/UN27.16/PN/2012, 159a/UN27.11/PN/2013, 165/UN27.11/PN/2013, 267a/UN27.16/PN/2013, 499/UN27.11/PN/2014, 501/UN27.11/PN/2014, 853/UN27.11/PN/2014, 339/UN27.11/PL/2015]	Grants from the Indonesian Directorate of Higher Education (No. 322/SP2H/PP/DP2M/VI/2009, 440/SP2H/PP/DP2M/VI/2010, No. 505/SP2H/PL/Dit.Litabmas/VII/2011, No. 197/SP2H/PL/Dit.Litabmas/IV/2012, and No. 077/SP2H/PL/Dit.Litabmas/V/2013) and from Indonesian Directorate of Higher Education-APBN/DIPA UNS (No. 2342/UN27.16/PN/2012, No. 159a/UN27.11/PN/2013, No. 165/UN27.11/PN/2013, No. 267a/UN27.16/PN/2013, No. 499/UN27.11/PN/2014, No. 501/UN27.11/PN/2014, 853/UN27.11/PN/2014, and No. 339/UN27.11/PL/2015).	Prasetyo AA, 2014, SE ASIAN J TROP MED, V45, P1032; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; An P, 2009, J INFECT DIS, V200, P1054, DOI 10.1086/605644; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011; Deng Y, 2014, CANCER LETT, V343, P161, DOI 10.1016/j.canlet.2013.09.041; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Jha P, 2012, INFECT GENET EVOL, V12, P142, DOI 10.1016/j.meegid.2011.11.001; Prasetyo AA, 2013, J INFECT DEV COUNTR, V7, P453, DOI 10.3855/jidc.2965; Bonvin M, 2007, J GEN VIROL, V88, P3270, DOI 10.1099/vir.0.83149-0; Abe H, 2009, HEPATOL RES, V39, P1159, DOI 10.1111/j.1872-034X.2009.00566.x; Vieira VC, 2013, BIOMED RES INT, DOI 10.1155/2013/683095; Zhang W, 2008, CELL MICROBIOL, V10, P112, DOI 10.1111/j.1462-5822.2007.01020.x; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Blanco-Melo D, 2012, IMMUNITY, V37, P399, DOI 10.1016/j.immuni.2012.08.013; Bonvin M, 2008, CURR OPIN INFECT DIS, V21, P298, DOI 10.1097/QCO.0b013e3282fe1bb2; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Ezzikouri S, 2013, J VIRAL HEPATITIS, V20, P678, DOI 10.1111/jvh.12042; Giret MTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018407; Imahashi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092861; Irshad M, 2008, WORLD J GASTROENTERO, V14, P6044, DOI 10.3748/wjg.14.6044; Itaya S, 2010, J INFECT DIS, V202, P815, DOI 10.1086/655227; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Netski DM, 2007, J INFECT DIS, V195, P857, DOI 10.1086/511826; Wang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064809	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	SEP	2015	70						67	71		10.1016/j.jcv.2015.07.009		5	Virology	Virology	CP7NO	WOS:000360075100014		
J	Ly, MHP; Takamatsu, Y; Nabeshima, T; Hoai, LLP; Thi, HP; Thi, DD; Nguyen, NL; Thi, TTN; Thi, QML; Buerano, CC; Morita, K; Hasebe, F				Minh Huong Phu Ly; Takamatsu, Yuki; Nabeshima, Takeshi; Linh Ly Pham Hoai; Hang Pham Thi; Dinh Dang Thi; Ngoc Linh Nguyen; Thu Thuy Nguyen Thi; Quynh Mai Le Thi; Buerano, Corazon C.; Morita, Kouichi; Hasebe, Futoshi			Isolation of dengue serotype 3 virus from the cerebrospinal fluid of an encephalitis patient in Hai Phong, Vietnam in 2013	JOURNAL OF CLINICAL VIROLOGY			English	Article						Case report; Dengue encephalitis; Atypical DENV infection; Dengue serotype 3 genotype III; Phylogenetic analysis	CENTRAL-NERVOUS-SYSTEM; NEUROLOGICAL MANIFESTATIONS; INFECTION; FEVER; COMPLICATIONS; CHILDREN	Dengue encephalitis (DE) is characterized as unusual presentation of dengue infection. Despite the reports that DE accounts for only 1-5% of dengue cases, this disease tends to be increasingly reported to threaten global human health throughout dengue endemic areas particularly in Southeast Asia. The molecular information of clinically characterized, neurotropic dengue virus (DENV) in human beings is extremely scarce despite it playing an important role in deciphering the pathogenesis of dengue-related neurological cases. Here we report a case of DE caused by DENV3 genotype III in a male patient with atypical symptoms of DENV infection in Hai Phong, Vietnam in 2013. The virus isolated from the cerebrospinal fluid of this case-patient was closely related to DENV3 genotype III strains isolated from serum of two other patients, who manifested classical dengue in the same year and residing in the same area as the case-patient. It is noteworthy to mention that in 2013, DENV3 genotype III was detected for the first time in Vietnam. (C) 2015 Elsevier B.V. All rights reserved.	[Minh Huong Phu Ly; Takamatsu, Yuki; Nabeshima, Takeshi; Buerano, Corazon C.; Morita, Kouichi; Hasebe, Futoshi] Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki 852, Japan; [Minh Huong Phu Ly] Nagasaki Univ, Grad Sch Biochem Sci, Nagasaki 852, Japan; [Linh Ly Pham Hoai; Hang Pham Thi; Dinh Dang Thi] Nagasaki Univ, NIHE Nagasaki Friendship Lab, Hanoi, Vietnam; [Ngoc Linh Nguyen; Thu Thuy Nguyen Thi; Quynh Mai Le Thi] Natl Inst Hyg & Epidemiol, Dept Virol, Hanoi, Vietnam; [Hasebe, Futoshi] Nagasaki Univ, Ctr Int Collaborat Res, Nagasaki 852, Japan	Hasebe, F (reprint author), 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	rainbow@nagasaki-u.ac.jp			KAKENHI [24659210]; Global Center of Excellence Program, Ministry of Education, Culture, Sports, Science and Technology, Japan; e-Asia Joint Research Program, Japan Science and Technology Agency (JST), Japan; Japan Initiative for Global Research Network on Infectious Diseases; Research on Emerging and Re-emerging Infectious Diseases, JST, Japan [H23-shinkou-ippan-010]; Ministry of Health, Labour and Welfare, Japan	This work was funded by the Grant-in-Aid for Scientific Research (KAKENHI No. 24659210); Global Center of Excellence Program, Ministry of Education, Culture, Sports, Science and Technology, Japan; e-Asia Joint Research Program, Japan Science and Technology Agency (JST), Japan; Japan Initiative for Global Research Network on Infectious Diseases; Research on Emerging and Re-emerging Infectious Diseases, JST, Japan (H23-shinkou-ippan-010); and grant(s) in aid for scientific research by the Ministry of Health, Labour and Welfare, Japan.	Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040; Ramos C, 1998, J NEUROVIROL, V4, P465; Cam BV, 2001, AM J TROP MED HYG, V65, P848; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Faye O, 2014, EMERG INFECT DIS, V20, P456, DOI 10.3201/eid2003.121885; Lum LCS, 1996, AM J TROP MED HYG, V54, P256; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Fatima Z, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-200; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Lam SK, 1996, NEUROL J SE ASIA, V1, P3; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Luo L, 2013, INT J INFECT DIS, V17, pE498, DOI 10.1016/j.ijid.2012.12.017; Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341; Pandey Basu D, 2013, Trop Med Health, V41, P103, DOI 10.2149/tmh.2012-17; Puccioni-Sohler M, 2013, ARQ NEURO-PSIQUIAT, V71, P667, DOI 10.1590/0004-282X20130147; Samanta M, 2012, J TROP PEDIATRICS, V58, P398, DOI 10.1093/tropej/fmr109; Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068; Soares CN, 2010, INT J INFECT DIS, V14, pE150, DOI 10.1016/j.ijid.2009.03.016; Sun J., 2011, EMERGING INFECT DIS, V17; Tahir M, 2006, J CLIN VIROL, V37, P65, DOI 10.1016/j.jcv.2006.05.006; WHO, 2009, DENG GUID DIAGN TREA	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	SEP	2015	70						93	96		10.1016/j.jcv.2015.07.295		4	Virology	Virology	CP7NO	WOS:000360075100019		
J	Aizawa, Y; Yamanaka, T; Watanabe, K; Oishi, T; Saitoh, A				Aizawa, Yuta; Yamanaka, Takayuki; Watanabe, Kanako; Oishi, Tomohiro; Saitoh, Akihiko			Asymptomatic children might transmit human parechovirus type 3 to neonates and young infants	JOURNAL OF CLINICAL VIROLOGY			English	Article						Human parechovirus type 3; Asymptomatic siblings; Transmission; Epidemic; Feces; Neonates	INFECTIONS; ILLNESS; SEPSIS	Background: Human parechovirus type 3 (HPeV3) epidemics occur worldwide and can lead to severe disease in neonates and young infants. Little is known about the source of HPeV3 infection. Objectives: To investigate the source of HPeV3 infection and the role of asymptomatic children in the families of infected children. Study design: During a 2014 HPeV3 epidemic in Niigata, Japan, we analyzed (1) clinical information on sick contacts for 43 neonates and young infants with HPeV3-related disease diagnosed by PCR analysis of serum and/or cerebrospinal fluid and (2) stool samples from symptomatic and asymptomatic siblings/cousins of index patients. To confirm transmission, the P1 (VP0, VP3, and VP1) and 3D(pol) regions of HPeVs were sequenced and analyzed. Results: Sick contact with family members was confirmed for 51% (n = 22) of patients. Among the 30 symptomatic family members, 67% (n = 20) were siblings, 20% (n = 6) were mothers, and 13% (n = 4) were other relatives. Stool samples from symptomatic and asymptomatic siblings/cousins of 4 HPeV3-infected patients yielded positive results for HPeVs on PCR analysis. Furthermore, the P1 and 3Dpol nucleotide sequences of family members were 100% identical to those of the respective index cases. Conclusions: Identification of genetically identical virus from HPeV3-infected patients and asymptomatic children in their families suggests that the latter are a source of infection in neonates and young infants with HPeV3-related diseases. (C) 2015 Elsevier B.V. All rights reserved.	[Aizawa, Yuta; Oishi, Tomohiro; Saitoh, Akihiko] Niigata Univ, Grad Sch Med & Dent Sci, Dept Pediat, Niigata 9518510, Japan; [Yamanaka, Takayuki] Niigata Medicalcare Cooperat Kido Hosp, Dept Pediat, Niigata, Japan; [Watanabe, Kanako] Niigata Univ, Grad Sch Hlth Sci, Dept Med Technol, Niigata 9518510, Japan; [Saitoh, Akihiko] Univ Calif San Diego, Dept Pediat, Div Infect Dis, San Diego, CA 92103 USA	Saitoh, A (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Pediat, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	asaitoh@med.niigata-u.ac.jp			Japan Society for the Promotion of Science [26461569]; Morinaga Foundation for Health Nutrition [AN601269]	This work was supported by grants from the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research 26461569) to AS, and the Morinaga Foundation for Health & Nutrition (AN601269) to YA.	Aizawa Y., 2015, EMERG INFEC IN PRESS; Harvala H, 2008, J CLIN MICROBIOL, V46, P3446, DOI 10.1128/JCM.01207-08; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Shoji K, 2013, PEDIATR INFECT DIS J, V32, P233, DOI 10.1097/INF.0b013e31827b1fd0; Wolthers KC, 2008, CLIN INFECT DIS, V47, P358, DOI 10.1086/589752; Boivin G, 2005, EMERG INFECT DIS, V11, P103; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Esposito S, 2014, J CLIN VIROL, V60, P84, DOI 10.1016/j.jcv.2014.03.003; Sedmak G, 2010, CLIN INFECT DIS, V50, P357, DOI 10.1086/649863; Nix WA, 2008, J CLIN MICROBIOL, V46, P2519, DOI 10.1128/JCM.00277-08; Kolehmainen P, 2012, J CLIN VIROL, V54, P156, DOI 10.1016/j.jcv.2012.02.006; Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1<57::AID-RMV266>3.3.CO;2-8; Levorson RE, 2009, PEDIATR INFECT DIS J, V28, P545, DOI 10.1097/INF.0b013e318194596a; Eis-Hubinger AM, 2013, J CLIN MICROBIOL, V51, P715, DOI 10.1128/JCM.02731-12; Verboon-Maciolek MA, 2008, ANN NEUROL, V64, P266, DOI 10.1002/ana.21445; Calvert J, 2010, J GEN VIROL, V91, P1229, DOI 10.1099/vir.0.018747-0; de Oliveira DMM, 2014, J MED VIROL, V86, P1569, DOI 10.1002/jmv.23791; John Modlin F., 2012, PRINCIPLES PRACTICE, P1172; MATSUURA K, 1983, MICROBIOL IMMUNOL, V27, P359; Mizuta K., 2013, J CLIN VIROL, V58, P188; Vincent Racaniello R., 2013, FIELDS VIROLOGY, V1, P610; Yan L., 2012, PLOS ONE, V7	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	SEP	2015	70						105	108		10.1016/j.jcv.2015.07.300		4	Virology	Virology	CP7NO	WOS:000360075100022		
J	Horiuchi, R; Suszynski, WJ; Carvalho, MS				Horiuchi, R.; Suszynski, W. J.; Carvalho, M. S.			Simultaneous multilayer coating of water-based and alcohol-based solutions	JOURNAL OF COATINGS TECHNOLOGY AND RESEARCH			English	Article; Proceedings Paper	17th Biennial International Coating Science and Technology Symposium (ISCST)	SEP 07-10, 2014	San Diego, CA			Multilayered coating; Slot die; Interlayer; Miscible solution; Dewetting	POLY(VINYL-ALCOHOL) SOLUTIONS; SLOT; FLOW	Multilayer continuous liquid coating is the most efficient way to manufacture films that require more than one layer for optimal performance. Two-layer slot coating is one of the different coating methods largely used to deposit two thin, uniform liquid layers onto a moving substrate. In recent years, the operating conditions and solution properties which are required to avoid various coating defects have been discussed in the literature. However, these past studies have not focused on the problem of top layer dewetting, which may occur at some operating conditions. It is important to include in the operating window of the process, the region of the parameter space at which the top layer dewetting is avoided. In this work, we used water-based and alcohol-based solutions to create two-layer films over a moving substrate using a two-layer slot coating die. The critical operating condition at which top layer dewetting is observed is determined experimentally for different liquid viscosities, surface tensions, and wet thicknesses. A physical mechanism that explains the reported phenomenon is proposed. The results show how dewetting can be avoided by controlling the liquid properties (surface tension and viscosity) and wet thickness of each layer and will certainly help the design of two-layer slot coating processes.	[Horiuchi, R.] Asahi Kasei Corp, Fuji, Shizuoka 4168501, Japan; [Horiuchi, R.; Suszynski, W. J.] Univ Minnesota, Dept Chem Engn & Mat Sci, Coating Proc Fundamentals Program, Minneapolis, MN 55455 USA; [Carvalho, M. S.] Pontificia Univ Catolica Rio de Janeiro, Dept Mech Engn, BR-22453900 Gavea, RJ, Brazil	Carvalho, MS (reprint author), Pontificia Univ Catolica Rio de Janeiro, Dept Mech Engn, Rua Marques de Sao Vicente 225, BR-22453900 Gavea, RJ, Brazil.	msc@puc-rio.br					YIH CS, 1967, J FLUID MECH, V27, P337, DOI 10.1017/S0022112067000357; Cohen D, 1993, THESIS U MINNESOTA; Cohen ED, 1995, COATING DRYING DEFEC; Lin YN, 2005, POLYM ENG SCI, V45, P1590, DOI 10.1002/pen.20454; Lu SY, 2001, POLYM ENG SCI, V41, P1823, DOI 10.1002/pen.10879; Musson LC, 2001, THESIS U MINNESOTA; Nam J, 2010, AICHE J, V56, P2503, DOI 10.1002/aic.12172; Nam J, 2009, J FLUID MECH, V631, P397, DOI 10.1017/S0022112009007022; Sartor L, 1998, US Patent, Patent No. [5,728,430, 5728430]; Taylor SD, 1999, CHEM ENG SCI, V54, P909, DOI 10.1016/S0009-2509(98)00306-6	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1945-9645	1935-3804		J COAT TECHNOL RES	J. Coat. Technol. Res.	SEP	2015	12	5					819	826		10.1007/s11998-015-9689-9		8	Chemistry, Applied; Materials Science, Coatings & Films	Chemistry; Materials Science	CP7RE	WOS:000360084800003		
J	Miura, H; Yamamura, M				Miura, Hidenobu; Yamamura, Masato			Direct thickness measurement of doctor-bladed liquid film on gravure roll surface	JOURNAL OF COATINGS TECHNOLOGY AND RESEARCH			English	Article; Proceedings Paper	17th Biennial International Coating Science and Technology Symposium (ISCST)	SEP 07-10, 2014	San Diego, CA			Reverse kiss gravure coating; Doctoring process; Capillary number; Blade thickness; Coating window	SIMULATION; CELLS	We provide experimental evidence that the liquid film remaining on a doctor-bladed gravure roll surface significantly influences the liquid transfer from the engraved roll surface to a moving substrate. The local free surface profiles of doctor-bladed liquid films were directly measured on both tri-helical grooves and lands (the nongrooved areas between grooves) at different roll speeds and blade thicknesses. The liquid film covered the roll surface with a finite thickness on the lands below the critical capillary number. An increase in the capillary number led to a transition from a fully filled to a starved configuration, in which the liquid barely remained on the lands and partly filled the grooves with a concave surface profile. The liquid transfer ratio monotonically decreased with a decrease in the liquid thickness on the gravure roll surface, obeying a single curve for different blade thicknesses. Furthermore, the decrease in liquid thickness promoted a flow instability transition from unstable dripping though a stable state with a uniform surface to a cascade.	[Miura, Hidenobu; Yamamura, Masato] Kyushu Inst Technol, Dept Appl Chem, Fukuoka 8048550, Japan; [Miura, Hidenobu] Fuji Kikai Kogyo Co Ltd, Dept Res & Dev, Hiroshima 7390146, Japan	Yamamura, M (reprint author), Kyushu Inst Technol, Dept Appl Chem, Fukuoka 8048550, Japan.	yamamura@che.kyutech.ac.jp					Huang WX, 2008, INT J HEAT FLUID FL, V29, P1436, DOI 10.1016/j.ijheatfluidflow.2008.07.002; PULKRABEK WW, 1983, CHEM ENG SCI, V38, P1309, DOI 10.1016/0009-2509(83)80051-7; Kapur N, 2003, CHEM ENG SCI, V58, P2875, DOI 10.1016/S0009-2509(03)00136-2; COYLE DJ, 1990, AICHE J, V36, P161, DOI 10.1002/aic.690360202; Hewson RW, 2006, CHEM ENG SCI, V61, P5487, DOI 10.1016/j.ces.2006.04.021; Sankaran AK, 2012, J NON-NEWTON FLUID, V175, P64, DOI 10.1016/j.jnnfm.2012.03.011; BENKREIRA H, 1993, CHEM ENG SCI, V48, P2329, DOI 10.1016/0009-2509(93)80248-O; Benkreira H, 1998, CHEM ENG SCI, V53, P1223, DOI 10.1016/S0009-2509(97)00446-6; Campana DM, 2014, J FLUID MECH, V747, P545, DOI 10.1017/jfm.2014.175; Chuang HK, 2008, INT POLYM PROC, V23, P216, DOI 10.3139/217.2134; Dodds S, 2009, PHYS FLUIDS, V21; Dontula P, 1998, AICHE J, V44, P1247, DOI 10.1002/aic.690440603; Hanumanthu R, 1999, AICHE J, V45, P2487, DOI 10.1002/aic.690451204; Hewson RW, 2011, CHEM ENG SCI, V66, P3666, DOI 10.1016/j.ces.2011.04.034; Hewson RW, 2009, EUR PHYS J-SPEC TOP, V166, P99, DOI 10.1140/epjst/e2009-00886-x; Hewson RW, 2010, CHEM ENG SCI, V65, P1311, DOI 10.1016/j.ces.2009.09.047; Kumar S, 2008, PHYS FLUIDS, V20; Lee CC, 2012, INT POLYM PROC, V27, P128, DOI 10.3139/217.2483; Lee JA, 2013, J NON-NEWTON FLUID, V199, P1, DOI 10.1016/j.jnnfm.2013.05.005; Powell CA, 2002, INT J NUMER METHOD H, V12, P338, DOI 10.1108/09615530210433251; Yin X, 2006, CHEM ENG SCI, V61, P1146, DOI 10.1016/j.ces.2005.07.039	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1945-9645	1935-3804		J COAT TECHNOL RES	J. Coat. Technol. Res.	SEP	2015	12	5					827	833		10.1007/s11998-015-9714-z		7	Chemistry, Applied; Materials Science, Coatings & Films	Chemistry; Materials Science	CP7RE	WOS:000360084800004		
J	Komoda, Y; Kobayashi, S; Suzuki, H; Hidema, R				Komoda, Yoshiyuki; Kobayashi, Shigeyuki; Suzuki, Hiroshi; Hidema, Ruri			Effect of shear strain in coating on the particle packing of gelled-clay particle dispersions during drying	JOURNAL OF COATINGS TECHNOLOGY AND RESEARCH			English	Article; Proceedings Paper	17th Biennial International Coating Science and Technology Symposium (ISCST)	SEP 07-10, 2014	San Diego, CA			Yielding behavior; Particle aggregates; Void formation; Surface roughness	THIN-FILM; SLURRY; LATEX; FABRICATION; ELECTRODES; SUSPENSION; SCATTERING; DYNAMICS; POLYMER	Particle aggregates formed in a dispersing medium may be destroyed depending on the shear history applied in the coating process. Yielding behavior of gelled-clay particle dispersion can be interpreted as the destruction of particle network structure with the increase in shear strain. In the present study, gelled-clay particle dispersion was coated at different shear strain to control the initial status of particle aggregation of the drying process. The packing behavior of clay particles in the coated film was investigated from the viewpoint of void fraction in the film by the simultaneous measurements of weight loss and thickness decrease. Additionally, the change of surface roughness was researched based on the scattering pattern analysis. As a result, it was found that dispersed particles started to be packed tightly in the constant drying rate period, and that void fraction and surface structure of particle-packed layer scarcely changed in the latter part of the falling drying rate period. In contrast, if clay particle aggregates remained at the beginning of drying, a loosely packed particle layer was formed without changing surface structure in the constant drying rate period. However, the surface roughness was increased continuously in the falling drying rate period in spite of keeping constant film thickness, probably because void in the particle layer was collapsed.	[Komoda, Yoshiyuki; Kobayashi, Shigeyuki; Suzuki, Hiroshi] Kobe Univ, Chem Sci & Engn, Kobe, Hyogo 6578501, Japan; [Hidema, Ruri] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan	Komoda, Y (reprint author), Kobe Univ, Chem Sci & Engn, I-1,Rokkodai cho, Kobe, Hyogo 6578501, Japan.	komoda@kobe-u.ac.jp; 125t435t@stu.kobe-u.ac.jp; hero@kobe-u.ac.jp; hidema@port.kobe-u.ac.jp					Bitsch B, 2014, J POWER SOURCES, V265, P81, DOI 10.1016/j.jpowsour.2014.04.115; Trenque I, 2013, OPT MATER, V35, P661, DOI 10.1016/j.optmat.2012.10.056; Ito S, 2003, SOL ENERG MAT SOL C, V76, P3, DOI 10.1016/S0927-0248(02)00209-X; Keddie JL, 1997, MAT SCI ENG R, V21, P101, DOI 10.1016/S0927-796X(97)00011-9; Tirumkudulu MS, 2005, LANGMUIR, V21, P4938, DOI 10.1021/la048298k; Yamaguchi T, 2005, COLLOID POLYM SCI, V283, P1123, DOI 10.1007/s00396-004-1258-1; Hato MJ, 2011, COLLOID POLYM SCI, V289, P1119, DOI 10.1007/s00396-011-2438-4; de Paiva LB, 2008, APPL CLAY SCI, V42, P8, DOI 10.1016/j.clay.2008.02.006; Brunel L, 2007, OPT EXPRESS, V15, P15250, DOI 10.1364/OE.15.015250; Guo RP, 2011, OPTIK, V122, P1890, DOI 10.1016/j.ijleo.2010.11.019; Kim S, 2013, LANGMUIR, V29, P10059, DOI 10.1021/la401897n; Komoda Y, 2009, J POWER SOURCES, V193, P488, DOI 10.1016/j.jpowsour.2009.04.015; Komoda Y, 2011, DRY TECHNOL, V29, P1037, DOI 10.1080/07373937.2010.551284; Komoda Y, 2015, J CHEM ENG JPN, V48, P87, DOI 10.1252/jcej.14we128; Komoda Y, 2008, ADV POWDER TECHNOL, V19, P507, DOI 10.1163/156855208X368599; Li J, 2007, APPL PHYS A-MATER, V87, P97, DOI 10.1007/s00339-006-3844-1; Matusmoto T, 1974, NIHON RHEOROJI GAKKA, V2, P12; Mewis J., 2012, COLLOIDAL SUSPENSION; Shimokawa Y, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051803; TAKAI N, 1975, OPT COMMUN, V14, P24, DOI 10.1016/0030-4018(75)90050-4; Xu P, 2009, DRY TECHNOL, V27, P636, DOI 10.1080/07373930902820804; Yamamoto T, 2009, KAGAKU KOGAKU RONBUN, V35, P297; Yamamura M, 2012, J CHEM ENG JPN, V45, P441; Yen HJ, 2013, RSC ADV, V3, P17048, DOI 10.1039/c3ra42180e; Yokota M, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.1.015801; Zakharov P, 2010, SOFT MATER, V8, P102, DOI 10.1080/15394451003708549	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1945-9645	1935-3804		J COAT TECHNOL RES	J. Coat. Technol. Res.	SEP	2015	12	5					939	948		10.1007/s11998-015-9719-7		10	Chemistry, Applied; Materials Science, Coatings & Films	Chemistry; Materials Science	CP7RE	WOS:000360084800016		
J	Ejima, A				Ejima, Aki			Pleiotropic actions of the male pheromone cis-vaccenyl acetate in Drosophila melanogaster	JOURNAL OF COMPARATIVE PHYSIOLOGY A-NEUROETHOLOGY SENSORY NEURAL AND BEHAVIORAL PHYSIOLOGY			English	Review						cVA; Pheromone; Courtship; Aggression; Copulation; Aggregation; Concentration; Odor context	CUTICULAR HYDROCARBONS; AGGREGATION PHEROMONE; BEHAVIORAL-RESPONSES; COURTSHIP BEHAVIOR; OLFACTORY NEURONS; SENSITIVE NEURONS; FEMALE DROSOPHILA; RECEPTOR NEURONS; SEX-PHEROMONE; AGGRESSION	The male-specific lipid, cis-vaccenyl acetate (cVA) has multiple functions in intra-species communication in Drosophila melanogaster. The presence of cVA in a male suppresses courtship motivation of other males and averts male-male courtship. Meanwhile, aggression behaviors between males are promoted by a high amount of cVA caused by increased densities of male flies. cVA also works as a modifier of courtship memory, which is suppressed courtship motivation driven by previous unsuccessful courtship experience. Conversely, cVA in the courting male stimulates female reproductive motivation and increases the probability of copulation success. It also works as an aggregation pheromone, attracting both males and females at the gathering spot. Thus, cVA is a unique example of a single molecule leading to different behaviors in response to the social context. However, despite recent advances in understanding the molecular and neural machinery for cVA sensing, it is still largely unknown how cVA triggers a specific behavior as the situation demands. In this review article, I discuss two potential machineries that might determine cVA actions for behavior selection at the sensory level.	[Ejima, Aki] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Ejima, Aki] Univ Tokyo, ERATO Touhara Chemosensory Signal Project, JST, Tokyo 1138657, Japan	Ejima, A (reprint author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aki@mail.ecc.u-tokyo.ac.jp			JSPS KAKENHI [22680026, 23657055, 25115008]; JST, Japan	The author's work is funded by JSPS KAKENHI Grant Numbers 22680026, 23657055, 25115008 and the ERATO Touhara Chemosensory Signal Project from JST, Japan.	SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Zhou C, 2014, NEURON, V83, P149, DOI 10.1016/j.neuron.2014.05.038; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; SHOREY HH, 1973, ANNU REV ENTOMOL, V18, P349, DOI 10.1146/annurev.en.18.010173.002025; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Chertemps T, 2005, BIOCHEM BIOPH RES CO, V333, P1066, DOI 10.1016/j.bbrc.2005.06.015; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Guiraudie-Capraz G, 2007, INTEGR ZOOL, V2, P89, DOI 10.1111/j.1749-4877.2007.00047.x; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Bontonou Gwenaelle, 2014, Insects, V5, P439, DOI 10.3390/insects5020439; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Griffith LC, 2009, ANN NY ACAD SCI, V1170, P394, DOI 10.1111/j.1749-6632.2009.04367.x; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Fernandez MP, 2013, J COMP PHYSIOL A, V199, P1065, DOI 10.1007/s00359-013-0851-5; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Liu WW, 2011, NAT NEUROSCI, V14, P896, DOI 10.1038/nn.2836; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; MANE SD, 1983, SCIENCE, V222, P419, DOI 10.1126/science.222.4622.419; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; Brieger G, 1970, SCIENCE, V80, P167; BUTTERWO.FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Certel Sarah J, 2012, Cold Spring Harb Protoc, V2012, P319, DOI 10.1101/pdb.prot068130; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; COSTA R, 1989, J EVOLUTION BIOL, V2, P395, DOI 10.1046/j.1420-9101.1989.2060395.x; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; Gomez-Diaz C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001546; Mehren JE, 2004, CURR OPIN NEUROBIOL, V14, P745, DOI 10.1016/j.conb.2004.10.012; SCOTT D, 1987, J INSECT PHYSIOL, V33, P363, DOI 10.1016/0022-1910(87)90125-9; Scott D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023645; Sengupta S, 2014, NEUROBIOL CHEM COMMU; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; TOMPKINS L, 1981, Z NATURFORSCH C, V36, P694; Van der Goes van Naters W, 2014, NEUROBIOLOGY CHEM CO; van der Goes van Naters W., 2007, CURR BIOL, V17, P606; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; VENARD R, 1980, EXPERIENTIA, V36, P211, DOI 10.1007/BF01953737; Wertheim B, 2003, OIKOS, V100, P269, DOI 10.1034/j.1600-0706.2003.11579.x; Wertheim B, 2002, ENTOMOL EXP APPL, V103, P61, DOI 10.1023/A:1019832101537; Wyatt TD, 2003, PHEROMONES ANIMAL BE, DOI [10.1007/s00049-003-0253-1, DOI 10.1007/S00049-003-0253-1]; Yamamoto D, 2014, J COMP PHYSIOL A, V200, P251, DOI 10.1007/s00359-014-0891-5; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	58	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7594	1432-1351		J COMP PHYSIOL A	J. Comp. Physiol. A -Neuroethol. Sens. Neural Behav. Physiol.	SEP	2015	201	9			SI		927	932		10.1007/s00359-015-1020-9		6	Behavioral Sciences; Neurosciences; Physiology; Zoology	Behavioral Sciences; Neurosciences & Neurology; Physiology; Zoology	CQ3ND	WOS:000360508100011		
J	Tada, S; Allen, PF; Ikebe, K; Zheng, H; Shintani, A; Maeda, Y				Tada, S.; Allen, P. F.; Ikebe, K.; Zheng, H.; Shintani, A.; Maeda, Y.			The Impact of the Crown-Root Ratio on Survival of Abutment Teeth for Dentures	JOURNAL OF DENTAL RESEARCH			English	Article						removable prosthodontics; clinical outcome; prognosis; decision-making; evidence-based dentistry; health care; prosthetics dentistry; prosthodontics	PERIODONTAL-DISEASE; PERMANENT TEETH; OVERDENTURE; POPULATION; CARIES; SELECTION; HYGIENE	Crown-root ratio (CRR) is commonly recorded when planning prosthodontic procedures. However, there is a lack of longitudinal clinical data evaluating the association between CRR and tooth survival. The aim of this longitudinal practice-based study was to assess the impact of CRR on the survival of abutment teeth for removable partial dentures (RPDs). Data were collected from 147 patients provided with RPDs at a dental hospital in Japan. In total, 236 clasp-retained RPDs and 856 abutment teeth were analyzed. Survival of abutment teeth was assessed using Kaplan-Meier methods and Cox's proportional hazard (PH) regression. The Cox PH regression was used to assess the prognostic significance of initial CRR value with adjustments for clinically relevant factors, including age, sex, frequency of periodontal maintenance programs, occlusal support area, type of abutment tooth, status of endodontic treatment, and probing pocket depth. Abutment teeth were divided into 1 of 5 risk groups according to CRR: A (0.75), B (0.76-1.00), C (1.01-1.25), D (1.26-1.50) and E (1.51). The 7-year survival rate was 89.1% for group A, 85.9% for group B, 86.5% for group C, 76.9% for group D, and 46.7% for group E. The survival curves of groups A, B, and C were illustrated to be quite similar and favorable. The multivariable analysis treating CRR as a continuous variable allowed estimation of the hazard ratio at any specific CRR value. When CRR = 0.80 was set as a reference, the estimated hazard ratio was 0.58 for CRR = 0.50 (95% confidence interval [CI], 0.36-0.91), 1.13 for CRR = 1.00 (95% CI, 0.93-1.37), 1.35 for CRR = 1.25 (95% CI, 1.02-1.80), 1.53 for CRR = 1.50 (95% CI, 1.15-2.08), or 1.95 for CRR = 2.00 (95% CI, 1.44-2.65). These practice-based longitudinal data provide information to improve the evidence-based prognosis of teeth in providing prosthodontic procedures.	[Tada, S.; Ikebe, K.; Maeda, Y.] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 565, Japan; [Allen, P. F.] Natl Univ Ireland Univ Coll Cork, Cork Univ Dent Sch & Hosp, Dept Restorat Dent, Cork, Ireland; [Zheng, H.; Shintani, A.] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Suita, Osaka 565, Japan	Tada, S (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 565, Japan.	sayat617@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [22592149]	This research was supported by a Grant-in-Aid for Scientific Research (No. 22592149) from the Japan Society for the Promotion of Science. We are profoundly grateful to colleagues at the Osaka University Graduate School of Dentistry for their assistance. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Jepson NJA, 2001, BRIT DENT J, V191, P140, DOI 10.1038/sj.bdj.4801122a; Tada S, 2013, J DENT, V41, P1175, DOI 10.1016/j.jdent.2013.07.018; Holtta P, 2004, EUR J ORTHODONT, V26, P491, DOI 10.1093/ejo/26.5.491; Locker D, 1996, COMMUNITY DENT ORAL, V24, P403, DOI 10.1111/j.1600-0528.1996.tb00888.x; Schulte J, 2007, J PROSTHET DENT, V98, P1, DOI 10.1016/S0022-3913(07)60031-6; [Anonymous], 2005, J PROSTHET DENT, V94, P10; BUDTZJORGENSEN E, 1995, J ORAL REHABIL, V22, P3, DOI 10.1111/j.1365-2842.1995.tb00203.x; De Boever J, 2004, OCCLUSION CLIN PRACT, P83; do Amaral BA, 2010, J ORAL REHABIL, V37, P545, DOI 10.1111/j.1365-2842.2010.02069.x; Dykema RW, 1968, J TENN DENT ASS, V43, P309; ERICSSON I, 1982, J CLIN PERIODONTOL, V9, P497, DOI 10.1111/j.1600-051X.1982.tb02111.x; Grossmann Y, 2005, J PROSTHET DENT, V93, P559, DOI 10.1016/j.prosdent.2005.03.006; Haghanifar Sina, 2014, J Dent (Shiraz), V15, P173; Harrel SK, 2003, PERIODONTOL 2000, V32, P111, DOI 10.1046/j.0906-6713.2002.03209.x; Hirotomi T, 2010, J CLIN PERIODONTOL, V37, P494, DOI 10.1111/j.1600-051X.2010.01565.x; LORD JL, 1974, J PROSTHET DENT, V32, P41, DOI 10.1016/0022-3913(74)90097-3; Milward P, 2013, BRIT DENT J, V215, DOI 10.1038/sj.bdj.2013.1095; Nyman S R, 1994, Periodontol 2000, V4, P15, DOI 10.1111/j.1600-0757.1994.tb00002.x; PENNY RE, 1979, J PROSTHET DENT, V42, P34, DOI 10.1016/0022-3913(79)90327-5; RENNER RP, 1984, J PROSTHET DENT, V51, P593, DOI 10.1016/0022-3913(84)90399-8; REYNOLDS JM, 1968, J PROSTHET DENT, V19, P483, DOI 10.1016/0022-3913(68)90064-4; Shillingburg HT, 1997, FUNDAMENTALS FIXED P, V3rd, p[85, 191]; Steele J G, 2001, Gerodontology, V18, P95, DOI 10.1111/j.1741-2358.2001.00095.x; Steele J G, 1997, Gerodontology, V14, P67, DOI 10.1111/j.1741-2358.1997.00067.x; Tan HP, 2014, COMMUNITY DENT ORAL, V42, P435, DOI 10.1111/cdoe.12104; Uehara S, 1979, J JPN ASS PERIODONTO, V21, P72; Wright P S, 1992, Int J Prosthodont, V5, P39; Yun HJ, 2014, J ADV PROSTHODONT, V6, P171, DOI 10.4047/jap.2014.6.3.171	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	SEP	2015	94	9		2			220S	225S		10.1177/0022034515589710		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ0KD	WOS:000360283100015		
J	Tanoue, R; Koi, K; Yamashita, J				Tanoue, R.; Koi, K.; Yamashita, J.			Effect of Alendronate on Bone Formation during Tooth Extraction Wound Healing	JOURNAL OF DENTAL RESEARCH			English	Article						diphosphonates; osteoclasts; osteoblasts; neutrophils; inflammation; lymphatic vessels	RAT; SOCKETS; CELLS; MODEL; ZOLEDRONATE; INHIBIT	Alendronate (ALN) is an antiresorptive agent widely used for the treatment of osteoporosis. Its suppressive effect on osteoclasts has been extensively studied. However, the effect of ALN on bone formation is not as clear as its effect on resorption. The objective was to determine the effect of short-term ALN on bone formation and tooth extraction wound healing. Molar tooth extractions were performed in mice. ALN, parathyroid hormone (PTH), or saline (vehicle control) was administered. PTH was used as the bone anabolic control. Mice were euthanized at 3, 5, 7, 10, and 21 d after extractions. Hard tissue healing was determined histomorphometrically. Neutrophils and lymphatic and blood vessels were quantified to evaluate soft tissue healing. Gene expression in the wounds was assessed at the RNA level. Furthermore, the vossicle bone transplant system was used to verify findings from extraction wound analysis. Alkaline phosphatase (ALP) was visualized in the vossicles to assess osteoblast activity. ALN exhibited no negative effect on bone formation. In intact tibiae, ALN increased bone mass significantly more than PTH did. Consistently, significantly elevated osteoblast numbers were noted. In the extraction sockets, bone fill in the ALN-treated mice was equivalent to the control. Genes associated with bone morphogenetic protein signaling, such as bmp2, nog, and dlx5, were activated in the extraction wounds of the ALN-treated animals. Bone formation in vossicles was significantly enhanced in the ALN versus PTH group. In agreement with this, ALN upregulated ALP activity considerably in vossicles. Neutrophil aggregation and suppressed lymphangiogenesis were evident in the soft tissue at 21 d after extraction, although gross healing of extraction wounds was uneventful. Bone formation was not impeded by short-term ALN treatment. Rather, short-term ALN treatment enhanced bone formation. ALN did not alter bone fill in extraction sockets.	[Tanoue, R.; Koi, K.; Yamashita, J.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Div Prosthodont, Ann Arbor, MI 48109 USA; [Tanoue, R.] Kurume Univ, Sch Med, Dental & Oral Med Ctr, Kurume, Fukuoka 830, Japan	Yamashita, J (reprint author), Univ Michigan, Sch Dent, 1011 North Univ Ave, Ann Arbor, MI 48109 USA.	yamashit@umich.edu			National Institutes of Health/National Institute of Dental and Craniofacial Research [R01DE 023538]	This work was supported by the National Institutes of Health/National Institute of Dental and Craniofacial Research R01DE 023538. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Abtahi J, 2012, J ORAL PATHOL MED, V41, P494, DOI 10.1111/j.1600-0714.2011.01125.x; Aguirre JI, 2010, ORAL DIS, V16, P674, DOI 10.1111/j.1601-0825.2010.01677.x; ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333; Chen PQ, 2005, J BONE MINER RES, V20, P962, DOI 10.1359/JBMR.050105; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Berggreen E, 2013, J DENT RES, V92, P1074, DOI 10.1177/0022034513504589; Kuroshima S, 2014, OSTEOPOROSIS INT, V25, P1141, DOI 10.1007/s00198-013-2570-8; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Kuroshima S, 2013, J DENT RES, V92, P553, DOI 10.1177/0022034513487558; Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; Somford MP, 2009, J BONE MINER RES, V24, P1736, DOI [10.1359/jbmr.090408, 10.1359/JBMR.090408]; Sharma A, 2012, J PERIODONTOL, V83, P11, DOI 10.1902/jop.2011.110091; Pettway Glenda J., 2008, V455, P101, DOI 10.1007/978-1-59745-104-8_7; Duque G, 2007, J BONE MINER RES, V22, P1603, DOI 10.1359/JBMR.070701; Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x; Kim JH, 2011, ORAL DIS, V17, P705, DOI 10.1111/j.1601-0825.2011.01829.x; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Wang CZ, 2010, BIOMATERIALS, V31, P8674, DOI 10.1016/j.biomaterials.2010.07.096; Iwata K, 2006, BONE, V39, P1053, DOI 10.1016/j.bone.2006.05.006; GUGLIELMOTTI MB, 1985, J ORAL MAXIL SURG, V43, P359, DOI 10.1016/0278-2391(85)90257-5; Jee JH, 2010, ORAL SURG ORAL MED O, V110, pE47, DOI 10.1016/j.tripleo.2010.03.025; Kuiper JWP, 2012, BRIT J PHARMACOL, V165, P532, DOI 10.1111/j.1476-5381.2011.01592.x; Lindtner RA, 2014, OSTEOPOROSIS INT, V25, P1151, DOI 10.1007/s00198-013-2494-3; PIETROKO.J, 1971, J PROSTHET DENT, V26, P119, DOI 10.1016/0022-3913(71)90041-2; Smith N, 1974, Aust Dent J, V19, P250; Toker H, 2012, ARCH ORAL BIOL, V57, P1545, DOI 10.1016/j.archoralbio.2012.06.013; Yamashita J, 2008, J BONE MINER RES, V23, P621, DOI 10.1359/JBMR.071211	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	SEP	2015	94	9					1251	1258		10.1177/0022034515592867		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP9BO	WOS:000360188900010		
J	Uruno, A; Usui, A; Inoue, T; Takeda, Y; Kobayashi, M				Uruno, Aya; Usui, Ayaka; Inoue, Tomohiro; Takeda, Yuji; Kobayashi, Masakazu			Crystallographic Characterization of AgGaTe2, AgAlTe2, and Ag(Ga,Al)Te-2 Grown by Closed-Space Sublimation	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Chalcopyrite; Ag(Ga, Al)Te-2; AgGaTe2; AgAlTe2; closed-space sublimation; pole-figure measurements; transmittance measurements	FILM SOLAR-CELLS; THIN-FILM; PHYSICAL-PROPERTIES; SAPPHIRE; LAYERS; CDTE	AgGaTe2, AgAlTe2, and Ag(Ga,Al)Te-2 layers were grown by the closed-space sublimation method on c-plane sapphire substrates. The crystallographic properties of the AgGaTe2 and AgAlTe2 layers were then analyzed by x-ray diffraction (XRD). Very strong 112 diffraction peaks were observed in the XRD spectra of both layers, and it was clear the (112) orientation was predominant in both layers. The orientation and domain structure of the AgAlTe2 layer were carefully analyzed by XRD pole-figure measurement, and the effect of substrate surface atomic arrangement on the crystallinity of the AgAlTe2 layer was investigated. On the basis of the pole-figure image, six types of {112} domain were confirmed in the layer, and [ 10] in one domain was regarded as aligned with the sapphire's a-axis when the layer was formed on the c-plane sapphire substrate surface. In addition to crystallographic characterization, the optical properties of the Ag(Ga,Al)Te-2 layer were evaluated on the basis of transmittance measurements. The optical bandgap, derived from the transmittance spectrum, was approximately 2.0 eV. This value was between the bandgap values of AgGaTe2 and AgAlTe2. These results showed that an alloy of AgGaTe2 and AgAlTe2 had been grown successfully.	[Uruno, Aya; Usui, Ayaka; Inoue, Tomohiro; Takeda, Yuji; Kobayashi, Masakazu] Waseda Univ, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo 1698555, Japan; [Kobayashi, Masakazu] Waseda Univ, Kagami Mem Res Inst Mat Sci & Technol, Shinjuku Ku, Tokyo 1690051, Japan	Uruno, A (reprint author), Waseda Univ, Dept Elect Engn & Biosci, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	a.uruno@fuji.waseda.jp			Waseda University Research Initiatives; Waseda University Grant for Special Research Project; "Early Bird'' Grant for young researcher at Waseda Research Institute for Science and Engineering; TEPCO Memorial Foundation	This work was supported in part by Waseda University Research Initiatives, Waseda University Grant for Special Research Project, and "Early Bird'' Grant for young researcher at Waseda Research Institute for Science and Engineering. One of authors (A.U.) acknowledges the support from TEPCO Memorial Foundation.	Aguirre BA, 2014, J ELECTRON MATER, V43, P2651, DOI 10.1007/s11664-014-3104-7; Rose DH, 1999, PROG PHOTOVOLTAICS, V7, P331, DOI 10.1002/(SICI)1099-159X(199909/10)7:5<331::AID-PIP257>3.0.CO;2-P; Park KC, 1997, THIN SOLID FILMS, V305, P201, DOI 10.1016/S0040-6090(97)00215-0; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; STOLT L, 1993, APPL PHYS LETT, V62, P597, DOI 10.1063/1.108867; TELL B, 1974, PHYS REV B, V9, P5203, DOI 10.1103/PhysRevB.9.5203; Wu XZ, 2004, SOL ENERGY, V77, P803, DOI 10.1016/j.solener.2004.06.006; He YB, 2003, APPL PHYS LETT, V83, P1743, DOI 10.1063/1.1606505; Karaagac H, 2010, J ALLOY COMPD, V503, P468, DOI 10.1016/j.jallcom.2010.05.035; Matsuo H, 2009, PHYS STATUS SOLIDI C, V6, P1070, DOI 10.1002/pssc.200881138; Mise T, 2010, THIN SOLID FILMS, V518, P5604, DOI 10.1016/j.tsf.2010.04.065; Nakasu T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.015502; Okamoto T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC12; Ozaki S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW02; Rashkeev SN, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.165212; Uruno A, 2014, J ELECTRON MATER, V43, P2874, DOI 10.1007/s11664-014-3135-0; Uruno A, 2014, J APPL PHYS, V116, DOI 10.1063/1.4901468; Uruno A, 2014, PHYS STATUS SOLIDI C, V11, P1186, DOI 10.1002/pssc.201300583; Xianfeng Z., 2013, JPN J APPL PHYS, V52	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	SEP	2015	44	9					3013	3017		10.1007/s11664-015-3733-5		5	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CQ0TX	WOS:000360311300009		
J	Saito, I; Hitsumoto, S; Maruyama, K; Nishida, W; Eguchi, E; Kato, T; Kawamura, R; Takata, Y; Onuma, H; Osawa, H; Tanigawa, T				Saito, Isao; Hitsumoto, Shinichi; Maruyama, Koutatsu; Nishida, Wataru; Eguchi, Eri; Kato, Tadahiro; Kawamura, Ryoichi; Takata, Yasunori; Onuma, Hiroshi; Osawa, Haruhiko; Tanigawa, Takeshi			Heart Rate Variability, Insulin Resistance, and Insulin Sensitivity in Japanese Adults: The Toon Health Study	JOURNAL OF EPIDEMIOLOGY			English	Article						heart rate variability; glucose intolerance; insulin sensitivity; epidemiology	CARDIAC AUTONOMIC FUNCTION; FASTING PLASMA-GLUCOSE; METABOLIC SYNDROME; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; PHYSICAL-ACTIVITY; COMMUNITIES; HYPERINSULINEMIA; HYPERTENSION	Background: Although impaired cardiac autonomic function is associated with an increased risk of type 2 diabetes in Caucasians, evidence in Asian populations with a lower body mass index is limited. Methods: Between 2009-2012, the Toon Health Study recruited 1899 individuals aged 30-79 years who were not taking medication for diabetes. A 75-g oral glucose tolerance test was used to diagnose type 2 diabetes, and fasting and 2-h-postload glucose and insulin concentrations were measured. We assessed the homeostasis model assessment index for insulin resistance (HOMA-IR) and Gutt's insulin sensitivity index (ISI). Pulse was recorded for 5 min, and time-domain heart rate variability (HRV) indices were calculated: the standard deviation of normal-to-normal intervals (SDNN) and the root mean square of successive difference (RMSSD). Power spectral analysis provided frequency domain measures of HRV: high frequency (HF) power, low frequency (LF) power, and the LF: HF ratio. Results: Multivariate-adjusted logistic regression models showed decreased SDNN, RMSSD, and HF, and increased LF: HF ratio were associated significantly with increased HOMA-IR and decreased ISI. When stratified by overweight status, the association of RMSSD, HF, and LF: HF ratio with decreased ISI was also apparent in nonoverweight individuals. The interaction between LF: HF ratio and decreased ISI in overweight individuals was significant, with the odds ratio for decreased ISI in the highest quartile of LF: HF ratio in non-overweight individuals being 2.09 (95% confidence interval, 1.41-3.10). Conclusions: Reduced HRV was associated with insulin resistance and lower insulin sensitivity. Decreased ISI was linked with parasympathetic dysfunction, primarily in non-overweight individuals.	[Saito, Isao] Ehime Univ, Grad Sch Med, Dept Community Hlth Syst Nursing, Toon, Ehime 7910295, Japan; [Hitsumoto, Shinichi] Ehime Univ Hosp, Dept Total Med Support Ctr, Toon, Ehime, Japan; [Maruyama, Koutatsu] Univ Grad Sch Med, Dept Basic Med Res & Educ, Toon, Ehime, Japan; [Nishida, Wataru; Kawamura, Ryoichi; Takata, Yasunori; Onuma, Hiroshi; Osawa, Haruhiko] Ehime Univ, Grad Sch Med, Dept Mol & Genet Med, Toon, Ehime 7910295, Japan; [Eguchi, Eri] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Publ Hlth, Okayama, Japan; [Kato, Tadahiro] Ehime Univ, Fac Educ, Ctr Educ & Educ Res, Matsuyama, Ehime, Japan; [Tanigawa, Takeshi] Juntendo Univ, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan	Saito, I (reprint author), Ehime Univ, Grad Sch Med, Dept Community Hlth Syst Nursing, 454 Shitsukawa, Toon, Ehime 7910295, Japan.	saitoi@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22390134, 25293142, 25860443, 25860441]; Health and Labor Sciences Research Grants from the Ministry of Health, Welfare and Labor, Japan (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus) [201021038A]	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid for Research B, no. 22390134 in 2010-2012 and 25293142 from 2013, and Grants-in-Aid for Young Scientists (B), no. 25860443 and 25860441 from 2013) and Health and Labor Sciences Research Grants from the Ministry of Health, Welfare and Labor, Japan (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus, no. 201021038A in 2010-2012).	Singh JP, 1998, HYPERTENSION, V32, P293; Rennie KL, 2003, AM J EPIDEMIOL, V158, P135, DOI 10.1093/aje/kwg120; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Saito I, 2012, CIRC J, V76, P1066, DOI 10.1253/circj.CJ-11-1519; Ishikawa-Takata K, 2011, J EPIDEMIOL, V21, P114, DOI 10.2188/jea.JE20100079; Liao DP, 2002, DIABETES, V51, P3524, DOI 10.2337/diabetes.51.12.3524; Hamer M, 2007, PSYCHOSOM MED, V69, P660, DOI 10.1097/PSY.0b013e318148c4c0; Ribeiro R, 2005, DIABETOLOGIA, V48, P976, DOI 10.1007/s00125-005-1714-6; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Hemingway H, 2005, CIRCULATION, V111, P3071, DOI 10.1161/CIRCULATION.104.497347; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Dekker JM, 2000, CIRCULATION, V102, P1239; Vinik AI, 2011, DIABETIC MED, V28, P643, DOI 10.1111/j.1464-5491.2010.03184.x; Flaa A, 2008, METABOLISM, V57, P1422, DOI 10.1016/j.metabol.2008.05.012; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Tabara Y, 2011, J HYPERTENS, V29, P1948, DOI 10.1097/HJH.0b013e32834abd06; Carnethon MR, 2003, CIRCULATION, V107, P2190, DOI 10.1161/01.CIR.0000066324.74807.95; Boulton AJM, 2010, DIABETES CARE, V33, P207, DOI 10.2337/dc09-1728; Gerritsen J, 2001, DIABETES CARE, V24, P1793, DOI 10.2337/diacare.24.10.1793; Festa A, 2000, DIABETES CARE, V23, P624, DOI 10.2337/diacare.23.5.624; Benthem L, 2000, AM J PHYSIOL-ENDOC M, V279, pE1286; Bergholm R, 2001, J CLIN ENDOCR METAB, V86, P1403, DOI 10.1210/jc.86.3.1403; Berkelaar M, 2013, DIABETOLOGIA, V56, P1436, DOI 10.1007/s00125-013-2848-6; Chang CJ, 2010, AM J MED, V123, P432, DOI 10.1016/j.amjmed.2009.07.031; Cooper TM, 2014, BRAIN BEHAV IMMUN, DOI [10.1016/j.bbi.2014.12.017, DOI 10.1016/J.BBI.2014.12.017]; Gavin JR, 1997, DIABETES CARE, V20, P1183; Laitinen T, 1999, DIABETES, V48, P1295, DOI 10.2337/diabetes.48.6.1295; Lautt WW, 2004, J PHARMACOL SCI, V95, P9, DOI 10.1254/jphs.95.9; Nakamura M, 2009, J ATHEROSCLER THROMB, V16, P756; Schroeder EB, 2005, DIABETES CARE, V28, P668, DOI 10.2337/diacare.28.3.668; Soares-Miranda L, 2012, DIABETES-METAB RES, V28, P363, DOI 10.1002/dmrr.2281; Soonthornpun S, 2003, J CLIN ENDOCR METAB, V88, P1019, DOI 10.1210/jc.2002-021127; Task Force, 1996, EUR HEART J, V17, P354, DOI DOI 10.1093/0XF0RDJ0URNALS.EURHEARTJ.A014868	35	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	SEP	2015	25	9					583	591		10.2188/jea.JE20140254		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ4CI	WOS:000360551400004		
J	Taniguchi, Y; Fujiwara, Y; Nofuji, Y; Nishi, M; Murayama, H; Seino, S; Tajima, R; Matsuyama, Y; Shinkai, S				Taniguchi, Yu; Fujiwara, Yoshinori; Nofuji, Yu; Nishi, Mariko; Murayama, Hiroshi; Seino, Satoshi; Tajima, Rika; Matsuyama, Yutaka; Shinkai, Shoji			Prospective Study of Arterial Stiffness and Subsequent Cognitive Decline Among Community-Dwelling Older Japanese	JOURNAL OF EPIDEMIOLOGY			English	Article						cognitive decline; arterial stiffness; older persons	PULSE-WAVE VELOCITY; BLOOD-PRESSURE; HYPERTENSIVE PATIENTS; GENERAL-POPULATION; APOLIPOPROTEIN-E; RISK-FACTORS; MEMORY LOSS; DEMENTIA; IMPAIRMENT; PERFORMANCE	Background: Brachial-ankle pulse wave velocity (baPWV) is inversely associated with cognitive function. However, it is not known whether baPWV predicts cognitive decline (CD) in later life. We examined whether or not baPWV is an independent risk marker of subsequent CD in a population of older Japanese. Methods: Among 982 adults aged 65 years or older who participated in a baseline survey, 526 cognitively intact adults (Mini-Mental State Examination [MMSE] score >= 24; mean [SD] age, 71.7 [5.6] years; women, 57.8%) were followed for a period of up to 5 years. Pulse wave velocity was determined using an automated waveform analyser. Cognition was assessed by the MMSE, and CD was defined as a decrease of two points or more on the MMSE. Results: During an average follow-up of 3.4 years, 85 participants (16.2%) developed CD. After controlling for important confounders, the odds ratios for CD in the highest and middle tertiles of baPWV, as compared with the lowest tertile, were 2.95 (95% confidence interval, 1.29-6.74) and 2.39 (95% confidence interval, 1.11-5.15), respectively. Conclusions: High baPWV was an independent predictor of CD in a general population of older adults and may be useful in the clinical evaluation of elders.	[Taniguchi, Yu; Fujiwara, Yoshinori; Nofuji, Yu; Nishi, Mariko; Murayama, Hiroshi; Seino, Satoshi; Shinkai, Shoji] Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo 1730015, Japan; [Tajima, Rika; Matsuyama, Yutaka] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan	Taniguchi, Y (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	yu0717@tmig.or.jp			TMIG; Ministry of Education, Culture, Sports, Science and Technology, Japan [20390190, 21390212, 24390173, 24890302]; JST/RISTEX	We are grateful for the collaboration of staff members from the Public Health Center in Kusatsu and that of our colleagues on the Research Team for Social Participation and Community Health, Tokyo Metropolitan Institute of Gerontology (TMIG). This study was supported by the TMIG, JST/RISTEX and Grants-In-Aid for Scientific Research (B) 20390190, (B) 21390212, (B) 24390173 and 24890302 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Andrew MK, 2010, ALZHEIMERS DEMENT, V6, P319, DOI 10.1016/j.jalz.2009.11.001; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Kilander L, 1998, HYPERTENSION, V31, P780; Kao TW, 2011, EUR J CLIN INVEST, V41, P513, DOI 10.1111/j.1365-2362.2010.02438.x; Iadecola C, 2009, STROKE, V40, pS40, DOI 10.1161/STROKEAHA.108.533638; Wilson RS, 2010, NEUROLOGY, V74, P951, DOI 10.1212/WNL.0b013e3181d64786; Kivipelto M, 2001, NEUROLOGY, V56, P1683; Henskens LHG, 2008, HYPERTENSION, V52, P1120, DOI 10.1161/HYPERTENSIONAHA.108.119024; Howieson DB, 2003, NEUROLOGY, V60, P1489; Liao DP, 1999, HYPERTENSION, V34, P201; Scuteri A, 2013, INT J CARDIOL, V169, P371, DOI 10.1016/j.ijcard.2013.09.009; Bathum L, 2006, J AM GERIATR SOC, V54, P654, DOI 10.1111/j.1532-5415.2005.53554.x; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Deary IJ, 2006, NEUROLOGY, V67, P1195, DOI 10.1212/01.wnl.0000238520.06958.6a; Scuteri A, 2007, J HYPERTENS, V25, P1035, DOI 10.1097/HJH.0b013e3280895b55; Ohnishi H, 2003, DIABETES CARE, V26, P437, DOI 10.2337/diacare.26.2.437; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Suzuki E, 2001, DIABETES CARE, V24, P2107, DOI 10.2337/diacare.24.12.2107; ELIAS MF, 1993, AM J EPIDEMIOL, V138, P353; Watson NL, 2011, J GERONTOL A-BIOL, V66, P1336, DOI 10.1093/gerona/glr119; Poels MMF, 2007, STROKE, V38, P888, DOI 10.1161/01.STR.0000257998.33768.87; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Fujiwara Y, 2004, PREV MED, V39, P1135, DOI 10.1016/j.ypmed.2004.04.026; Ueda I, 2008, J HUM HYPERTENS, V22, P699, DOI 10.1038/jhh.2008.57; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Taniguchi Y, 2012, J GERONTOL A-BIOL, V67, P796, DOI 10.1093/gerona/glr243; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Small BJ, 2000, NEUROLOGY, V54, P2082; Bretsky P, 2003, NEUROLOGY, V60, P1077; Hanon O, 2005, STROKE, V36, P2193, DOI 10.1161/01.STR.0000181771.82518.1c; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Saczynski JS, 2006, AM J EPIDEMIOL, V163, P433, DOI 10.1093/aje/kwj061; Yambe M, 2007, J HYPERTENS, V25, P87, DOI 10.1097/01.hjh.0000254375.73241.e2; Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Kearney-Schwartz A, 2009, STROKE, V40, P1229, DOI 10.1161/STROKEAHA.108.532853; Yip AG, 2002, J MED GENET, V39, P639, DOI 10.1136/jmg.39.9.639; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Fujiwara Y, 2005, J GERONTOL A-BIOL, V60, P607; Fukuhara M, 2006, CIRC J, V70, P756, DOI 10.1253/circj.70.756; Heude B, 2003, AM J CLIN NUTR, V77, P803; Hyman BT, 1996, ANN NEUROL, V40, P55, DOI 10.1002/ana.410400111; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; Levi MN, 2013, J HYPERTENS, V31, P1073, DOI DOI 10.1097/HJH.0B013E3283603F53); Nagasaki H, 1996, PERCEPT MOTOR SKILL, V82, P435; Ng TP, 2009, J AM GERIATR SOC, V57, P101, DOI 10.1111/j.1532-5415.2008.02086.x; Nichols W, 2005, MCDONALDS BLOOD FLOW; Nichols W. W., 1998, MCDONALDS BLOOD FLOW; Skoog I, 2002, ANN NY ACAD SCI, V977, P29; Taniguchi Y, 2014, J GERONTOL A-BIOL, V69, P1276, DOI 10.1093/gerona/glt286; World Health Organization, DEM PUBL HLTH PRIOR; Yasuno F, 2012, NEUROBIOL AGING, V33, P2633, DOI 10.1016/j.neurobiolaging.2011.12.028	52	1	1	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	SEP	2015	25	9					592	599		10.2188/jea.JE20140250		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ4CI	WOS:000360551400005		
J	Sata, M; Yamagishi, K; Sairenchi, T; Ikeda, A; Irie, F; Watanabe, H; Iso, H; Ota, H				Sata, Mizuki; Yamagishi, Kazumasa; Sairenchi, Toshimi; Ikeda, Ai; Irie, Fujiko; Watanabe, Hiroshi; Iso, Hiroyasu; Ota, Hitoshi			Impact of Caregiver Type for 3-Year-Old Children on Subsequent Between-Meal Eating Habits and Being Overweight From Childhood to Adulthood: A 20-Year Follow-up of the Ibaraki Children's Cohort (IBACHIL) Study	JOURNAL OF EPIDEMIOLOGY			English	Article						children; eating habits; overweight; cohort study; epidemiology	SNACK FOOD-INTAKE; OBESITY; WEIGHT; BEHAVIORS; GRANDCHILDREN; GRANDPARENTS; FATNESS; FAMILY	Background: Because of the increasing number of mothers who continue to work after childbirth, participation in childcare has diversified. However, the impact of the main caregiver on children's habits has not been determined. We sought to examine the effect of caregiver differences on childhood habituation of between-meal eating and body mass index (BMI). Methods: The Ibaraki Children's Cohort Study involved 4592 Japanese children whose parents answered health questionnaires at age 3. Follow-up questionnaires were distributed to parents when children were 6 and 12 years old and to study subjects directly when they were 22 years old. We compared prevalence of between-meal eating and overweight as well as mean BMI at ages 6, 12, and 22 years, by their main daytime caregiver at age 3. Results: Compared to children cared for by mothers, those cared for by grandparents had a higher prevalence of between-meal eating before dinner for boys and girls at ages 6 and 12 years. At age 22 years, boys cared for by grandparents had a higher prevalence of overweight than those cared for by mothers (18.5% versus 11.2%, P = 0.037), but no such difference was noted in girls. However, both boys and girls cared for by grandparents had higher mean BMI over time than those cared for by mothers (coefficient = 0.47 kg/m(2) for boys and coefficient = 0.35 kg/m(2) for girls). Conclusions: Being cared for by grandparents at age 3 was associated with subsequent between-meal eating habits, being overweight, and increased mean BMI from childhood to adulthood.	[Sata, Mizuki; Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka 5650871, Japan; [Sata, Mizuki; Yamagishi, Kazumasa; Sairenchi, Toshimi; Ota, Hitoshi] Ibaraki Hlth Serv Assoc, Ibaraki Hlth Plaza, Mito, Ibaraki, Japan; [Yamagishi, Kazumasa] Univ Tsukuba, Fac Med, Dept Publ Hlth Med, Tsukuba, Ibaraki, Japan; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Ikeda, Ai] Juntendo Univ, Sch Med, Dept Publ Hlth, Tokyo 113, Japan; [Irie, Fujiko] Ibaraki Prefectural Off, Dept Hlth & Welf, Mito, Ibaraki, Japan; [Watanabe, Hiroshi] Ibaraki Hlth Serv Assoc, Mito, Ibaraki, Japan	Iso, H (reprint author), Osaka Univ, Dept Social & Environm Med, Publ Hlth, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	iso@pbhel.med.osaka-u.ac.jp		Iso, Hiroyasu/0000-0002-9241-7289			Pearce A, 2010, INT J OBESITY, V34, P1160, DOI 10.1038/ijo.2010.15; Ruiz SA, 2007, J SOC ISSUES, V63, P793; KLESGES RC, 1983, J APPL BEHAV ANAL, V16, P371, DOI 10.1901/jaba.1983.16-371; Branen L, 1999, J NUTR EDUC, V31, P304, DOI 10.1016/S0022-3182(99)70483-8; Li B, 2014, INT J BEHAV MED, V21, P700, DOI 10.1007/s12529-013-9333-y; Bailey JA, 2009, DEV PSYCHOL, V45, P1214, DOI 10.1037/a0016129; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Phillips SM, 2004, OBES RES, V12, P461, DOI 10.1038/oby.2004.52; Nicklas TA, 2003, AM J PREV MED, V25, P9, DOI 10.1016/S0749-3797(03)00098-9; Campbell KJ, 2006, INT J OBESITY, V30, P1272, DOI 10.1038/sj.ijo.0803266; [Anonymous], OECD DAT; Field AE, 2004, INT J OBESITY, V28, P1210, DOI 10.1038/sj.ijo.0802762; Higgins MM, 2010, NUTRIENTS, V2, P1188, DOI 10.3390/nu2121188; Kagamimori S, 1999, CHILD CARE HLTH DEV, V25, P235, DOI 10.1046/j.1365-2214.1999.00127.x; Matthiessen J, 2014, ACTA PAEDIATR, V103, P1083, DOI 10.1111/apa.12722; Ministry of Internal Affairs and Communications Bureau of Statistics, 2012, LAB FORC SURV; National Institute of Population and Social Security Research, 2010, ANN POP SOC SEC SURV; Riedel C, 2014, INT J EPIDEMIOL, V43, P1593, DOI 10.1093/ije/dyu150; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj/ijo/801961; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Yuasa Kyoko, 2008, J Med Invest, V55, P71, DOI 10.2152/jmi.55.71	23	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	SEP	2015	25	9					600	607		10.2188/jea.JE20140078		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ4CI	WOS:000360551400006		
J	Nam, DH; Udo, K; Mano, A				Nam, D. H.; Udo, K.; Mano, A.			Future fluvial flood risks in Central Vietnam assessed using global super-high-resolution climate model output	JOURNAL OF FLOOD RISK MANAGEMENT			English	Article						Downscaling; rainfall and flood extremes; super-high-resolution climate model	PRECIPITATION EXTREMES; FREQUENCY ESTIMATION; HEAVY PRECIPITATION; CHANGING CLIMATE; CHANGE IMPACTS; RCM RAINFALL; UK; SIMULATIONS; UNCERTAINTY; TRENDS	Fluvial flood risks are explored at the Vu Gia-Thu Bon River system in Central Vietnam based on a coupled hydrological-hydraulic model combined with design storm hyetographs constructed based on heavy rainfall downscaled from the output of a state-of-the-art super-high-resolution (20-km mesh) global climate model simulated under greenhouse gas emission scenario A1B. The results indicate that intensified rainfall due to future climate changes (2075-2099) will lead to higher flood risks in the fluvial plains, especially in the lower areas of the river system. The potential extent of inundation caused by a 25-year return period flood in future climate patterns will increase by approximately 150% compared with those produced by the most severe flood in the present-day climate (1979-2003). Moreover, the flood risks induced by a 10-year return period flood tend to be slightly more severe than that of the 25-year return period in the present-day climate.	[Nam, D. H.; Udo, K.; Mano, A.] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 9808579, Japan	Nam, DH (reprint author), Tohoku Univ, Int Res Inst Disaster Sci, Aoba 6-6-11, Sendai, Miyagi 9808579, Japan.	nam@potential1.civil.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS); JST/JICA; SATREPS (Science and Technology Research Partnership for Sustainable Development)	This study is financially supported by the Japan Society for the Promotion of Science (JSPS), JST/JICA, and SATREPS (Science and Technology Research Partnership for Sustainable Development). Thanks are due to the Meteorological Research Institute (MRI) of Japan for the providing the AGCM20 simulation data. Special thanks are given to Dr Hosaka M. (MRI) and Dr Asaoka Y. (Tohoku University) for guidance in handling the grid value data.	Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; Fowler HJ, 2005, J HYDROL, V300, P212, DOI 10.1016/j.jhydrol.2004.06.017; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Groisman PY, 2005, J CLIMATE, V18, P1326, DOI 10.1175/JCLI3339.1; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Prudhomme C, 2003, J HYDROL, V277, P1, DOI 10.1016/S0022-1694(03)00065-9; Wilby RL, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004065; Groisman PY, 2001, B AM METEOROL SOC, V82, P219, DOI 10.1175/1520-0477(2001)082<0219:HPAHSI>2.3.CO;2; FOWLER AM, 1995, NAT HAZARDS, V11, P283, DOI 10.1007/BF00613411; Cheng KS, 2001, J AM WATER RESOUR AS, V37, P723, DOI 10.1111/j.1752-1688.2001.tb05506.x; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Kay AL, 2006, J HYDROL, V318, P163, DOI 10.1016/j.jhydrol.2005.06.013; Horritt MS, 2002, J HYDROL, V268, P87, DOI 10.1016/S0022-1694(02)00121-X; Arnell NW, 1999, GLOBAL ENVIRON CHANG, V9, P5, DOI 10.1016/S0959-3780(98)00015-6; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Wilby RL, 2008, HYDROL PROCESS, V22, P2511, DOI 10.1002/hyp.6847; Kay AL, 2009, CLIMATIC CHANGE, V92, P41, DOI 10.1007/s10584-008-9471-4; Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Kusunoki S, 2006, J METEOROL SOC JPN, V84, P581, DOI 10.2151/jmsj.84.581; Cullen H., 2010, WEATHER FUTURE; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Kardhana H, 2007, WIT TRANS ECOL ENVIR, V104, P201, DOI 10.2495/RM070201; Kato H., 2003, P GIS RS HYDROL WATE, V1, P1; Kay AL, 2006, J HYDROL, V318, P151, DOI 10.1016/j.jhydrol.2005.06.012; Keifer C. J., 1957, J HYDRAULICS DIVISIO, V83, P1; Kitoh A., 2009, HYDROLOGICAL RES LET, V3, P49, DOI DOI 10.3178/HRL.3.49; MALMSTROM VH, 1969, J GEOGR, V68, P351, DOI 10.1080/00221346908981131; Mizuta R, 2006, J METEOROL SOC JPN, V84, P165, DOI 10.2151/jmsj.84.165; Nam D.H., 2012, ANN J HYDRAUL ENG JS, V68; Nam DH, 2014, HYDROL PROCESS, V28, P5844, DOI 10.1002/hyp.10084; Nam D.H., 2013, ANN J HYDRAUL ENG JS, V69; Nam D.H., 2011, ANN J HYDRAUL ENG JS, V67, P7, DOI [10.2208/jscejhe.67.I_7, DOI 10.2208/JSCEJHE.67.I_7]; Nam DH, 2013, J WATER CLIM CHANGE, V4, P373, DOI 10.2166/wcc.2013.088; NOAA - National Oceanic and Atmospheric Administration USA, 2007, EV DIFF HYDR MOD SUP; Prudhomme C., 2009, CLIMATIC CHANGE, V93, P97; Sugawara M., 1967, P INT S FLOODS THEIR, P1; Ulbrich U., 2003, Weather, V58, DOI 10.1256/wea.61.03A; Vidal JP, 2008, J HYDROL, V353, P143, DOI 10.1016/j.jhydrol.2008.02.003; Wenzel G.W., 1982, URBAN STORMWATER HYD, V2, P35	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1753-318X			J FLOOD RISK MANAG	J. Flood Risk Manag.	SEP	2015	8	3					276	288		10.1111/jfr3.12096		13	Environmental Sciences; Water Resources	Environmental Sciences & Ecology; Water Resources	CP9PF	WOS:000360226000008		
J	Thirunavukarasu, K; Purushothaman, S; Gowthaman, MK; Nakajima-Kambe, T; Rose, C; Kamini, NR				Thirunavukarasu, K.; Purushothaman, S.; Gowthaman, M. K.; Nakajima-Kambe, T.; Rose, C.; Kamini, N. R.			Utilization of fish meal and fish oil for production of Cryptococcus sp MTCC 5455 lipase and hydrolysis of polyurethane thereof	JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE			English	Article						Cryptococcus sp.; Lipase; Fish meal; Sardine oil; Polyurethane degradation	POLYESTER POLYURETHANE; EXTRACELLULAR LIPASE; BACILLUS-SUBTILIS; RHIZOPUS-ORYZAE; NITROGEN-SOURCE; CANDIDA-RUGOSA; SP S-2; BIODEGRADATION; ENZYME; PURIFICATION	Fish meal has been used as an additional nitrogen source and fish oil as inducer for the growth and production of lipase from Cryptococcus sp. MTCC 5455. A response surface design illustrated that the optimum factors influencing lipase production were fish meal, 1.5 %, w/v, Na2HPO4, 0.2 %, w/v, yeast extract, 0.25 %, w/v and sardine oil, 2.0 %, w/v with an activity of 71.23 U/mL at 96 h and 25 A degrees C, which was 48.39 % higher than the conventional one-factor-at-a-time method. The crude concentrated enzyme hydrolyzed polyurethane (PUR) efficiently and hydrolysis was 94 % at 30 A degrees C and 96 h. The products, diethylene glycol and adipic acid were quantified by HPLC and scanning electron microscopic studies of the degraded polymer showed significant increase in size of the holes from 24 to 72 h of incubation. Hydrolysis of PUR within 96 h makes the lipase novel for disposal of PUR and provides an innovative solution to the problems created by plastic wastes.	[Thirunavukarasu, K.] Sathyabama Univ, Dept Biomed Engn, Chennai 600119, Tamil Nadu, India; [Purushothaman, S.; Gowthaman, M. K.; Rose, C.; Kamini, N. R.] Cent Leather Res Inst, Dept Biotechnol, Chennai 600020, Tamil Nadu, India; [Nakajima-Kambe, T.] Univ Tsukuba, Bioind Sci Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Kamini, NR (reprint author), Cent Leather Res Inst, Dept Biotechnol, Chennai 600020, Tamil Nadu, India.	kaminiganesh@rediffmail.com			Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, New Delhi, India	The authors thank The Director, Central Leather Research Institute, Chennai, India for his kind permission to publish this work. We also acknowledge for the grants from Department of Biotechnology, Government of India and the financial assistance extended by Council of Scientific and Industrial Research, New Delhi, India.	Rowe L, 2002, INT BIODETER BIODEGR, V50, P33, DOI 10.1016/S0964-8305(02)00047-1; Pignede G, 2000, J BACTERIOL, V182, P2802, DOI 10.1128/JB.182.10.2802-2810.2000; Ellouz Y, 2001, BIORESOURCE TECHNOL, V80, P49, DOI 10.1016/S0960-8524(01)00057-8; Gautam R, 2007, INT BIODETER BIODEGR, V60, P245, DOI 10.1016/j.ibiod.2007.03.009; Kamini NR, 2000, PROCESS BIOCHEM, V36, P317, DOI 10.1016/S0032-9592(00)00228-4; NakajimaKambe T, 1997, J FERMENT BIOENG, V83, P456, DOI 10.1016/S0922-338X(97)83000-0; Kamini NR, 2001, PROCESS BIOCHEM, V37, P405, DOI 10.1016/S0032-9592(01)00220-5; Herbst D, 2012, J BIOTECHNOL, V162, P398, DOI 10.1016/j.jbiotec.2012.03.011; CRABBE JR, 1994, INT BIODETER BIODEGR, V33, P103, DOI 10.1016/0964-8305(94)90030-2; Dhake KP, 2011, J BIOTECHNOL, V156, P46, DOI 10.1016/j.jbiotec.2011.08.019; Contesini FJ, 2010, J MOL CATAL B-ENZYM, V67, P163, DOI 10.1016/j.molcatb.2010.07.021; NAKAJIMAKAMBE T, 1995, FEMS MICROBIOL LETT, V129, P39; Gautam R, 2007, APPL BIOCHEM BIOTECH, V141, P85, DOI 10.1007/s12010-007-9212-6; Lou WY, 2006, J BIOTECHNOL, V125, P64, DOI 10.1016/j.jbiotec.2006.01.017; MAKHZOUM A, 1995, FOOD MICROBIOL, V12, P277, DOI 10.1016/S0740-0020(95)80108-1; Masaki K, 2005, APPL ENVIRON MICROB, V71, P7548, DOI 10.1128/AEM.71.11.7548-7550.2005; Awan MS, 2010, AFR J BIOTECHNOL, V9, P2918; Chakraborty K, 2008, FOOD CHEM, V109, P727, DOI 10.1016/j.foodchem.2008.01.026; CHARTRAIN M, 1993, J FERMENT BIOENG, V76, P487, DOI 10.1016/0922-338X(93)90246-5; Chen LC, 1997, INFECT IMMUN, V65, P2599; Esakkiraj P, 2010, APPL BIOCHEM BIOTECH, V160, P1254, DOI 10.1007/s12010-009-8632-x; Garcia-Gomez MJ, 2009, FOOD CHEM, V112, P604, DOI 10.1016/j.foodchem.2008.06.016; Ghorbel S, 2005, WORLD J MICROB BIOT, V21, P33, DOI 10.1007/s11274-004-1556-2; Ghribi D, 2009, EUR J LIPID SCI TECH, V111, P967, DOI 10.1002/ejlt.200900004; Ikemoto M, 1996, J GEN APPL MICROBIOL, V42, P371, DOI 10.2323/jgam.42.371; ISOBE K, 1988, AGR BIOL CHEM TOKYO, V52, P41; Kim YD, 1998, POLYM DEGRAD STABIL, V62, P343, DOI 10.1016/S0141-3910(98)00017-2; Perez-Galvez R, 2012, FOOD BIOPROCESS TECH, V5, P2172, DOI 10.1007/s11947-011-0523-9; Rai AK, 2010, ENZYME MICROB TECH, V46, P9, DOI 10.1016/j.enzmictec.2009.09.007; Ramakrishnan V, 2015, J FOOD SCI TECH MYS, V52, P1328, DOI 10.1007/s13197-013-1141-5; RAO PV, 1993, PROCESS BIOCHEM, V28, P391; Risholm-Sundman M, 2005, HOLZ ROH WERKST, V63, P179, DOI 10.1007/s00107-004-0549-z; Sellami-Kamoun A, 2011, ANN MICROBIOL, V61, P273, DOI 10.1007/s13213-010-0134-0; Souissi N, 2009, AFR J BIOTECHNOL, V8, P451; Thirunavukarasu K, 2008, PROCESS BIOCHEM, V43, P701, DOI 10.1016/j.procbio.2008.02.011	35	1	1	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0022-1155	0975-8402		J FOOD SCI TECH MYS	J. Food Sci. Technol.-Mysore	SEP	2015	52	9					5772	5780		10.1007/s13197-014-1697-8		9	Food Science & Technology	Food Science & Technology	CP7OK	WOS:000360077300037		
J	Isayama, H				Isayama, Hiroyuki			Highlights of the Tokyo Conference of Asian Pancreato-biliary Interventional Endoscopist 2014	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Editorial Material									Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan	Isayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isayama-tky@umin.ac.jp					Moon JH, 2015, J HEPATO-BIL-PAN SCI, V22, P650, DOI 10.1002/jhbp.270; Kawakubo K, 2014, J HEPATO-BIL-PAN SCI, V21, P328, DOI 10.1002/jhbp.27; Kaffes AJ, 2015, J HEPATO-BIL-PAN SCI, V22, P657, DOI 10.1002/jhbp.272; Park DH, 2015, J HEPATO-BIL-PAN SCI, V22, P664, DOI 10.1002/jhbp.271	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	SEP	2015	22	9					647	649		10.1002/jhbp.273		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CP9HS	WOS:000360205400001		
J	Moon, JH; Rerknimitr, R; Kogure, H; Nakai, Y; Isayama, H				Moon, Jong Ho; Rerknimitr, Rungsun; Kogure, Hirofumi; Nakai, Yousuke; Isayama, Hiroyuki			Topic controversies in the endoscopic management of malignant hilar strictures using metal stent: side-by-side versus stent-in-stent techniques	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Biliary stent; Biliary stricture; Endoscopic procedure; Hilar stricture; Self-expandable metal stent	HEPATIC DUCT DRAINAGE; BILIARY OBSTRUCTION; PLACEMENT; CHOLANGIOCARCINOMA; EFFICACY; DEPLOYMENT; TUMORS; TRIAL	Endoscopic management of unresectable hilar malignant biliary stricture (MBS) is currently challenging, and the best approach is still controversial. Liver volume is the key to adequate biliary drainage in hilar MBS and multiple stenting is mandatory to drain over 50% of liver volume in most cases. The self-expandable metallic stent (SEMS) has shown superior patency to plastic stents in recent reports. There are two methods of multiple stenting for hilar MBS: stent-in-stent (SIS) and side-by-side (SBS). Advantages of SIS include multiple SEMS placement in one stent caliber at the common bile duct (CBD), which is considered physiologically ideal. The through-the-mesh (TTM) technique with guidewires and the SEMS delivery system can be technically difficult in SIS, although the recent development of dedicated SEMSs having a loose portion facilitating the TTM technique makes SIS technically feasible both at stent deployment and re-interventions. Conversely, the SBS technique, if placed across the papilla, is technically simple at initial placement and re-intervention at stent occlusion. However, SBS has potential disadvantages of overexpansion of the CBD because of parallel placement of multiple SEMS, which can lead to portal vein thrombosis. Given the limited evidence available, a well-designed randomized controlled trial comparing these two techniques is warranted.	[Moon, Jong Ho] Soonchunhyang Univ, Sch Med, Ctr Digest Dis, Bucheon, South Korea; [Moon, Jong Ho] Soonchunhyang Univ, Sch Med, Res Inst, Dept Internal, Bucheon, South Korea; [Rerknimitr, Rungsun] Chulalongkorn Univ, Dept Med, Div Gastroenterol, Bangkok, Thailand; [Kogure, Hirofumi; Nakai, Yousuke; Isayama, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan	Isayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isayama-tky@umin.ac.jp					Rerknimitr R, 2013, J GASTROEN HEPATOL, V28, P593, DOI 10.1111/jgh.12128; De Palma GD, 2001, GASTROINTEST ENDOSC, V53, P547, DOI 10.1067/mge.2001.113381; Freeman ML, 2003, GASTROINTEST ENDOSC, V58, P41, DOI 10.1067/mge.2003.292; Naitoh I, 2009, J GASTROEN HEPATOL, V24, P552, DOI 10.1111/j.1440-1746.2008.05750.x; Mukai T, 2013, J HEPATO-BIL-PAN SCI, V20, P214, DOI 10.1007/s00534-012-0508-8; Vienne A, 2010, GASTROINTEST ENDOSC, V72, P728, DOI 10.1016/j.gie.2010.06.040; Hintze RE, 2001, GASTROINTEST ENDOSC, V53, P40, DOI 10.1067/mge.2001.111388; Isayama H, 2009, GASTROINTEST ENDOSC, V70, P37, DOI 10.1016/j.gie.2008.09.032; Loew BJ, 2009, GASTROINTEST ENDOSC, V70, P445, DOI 10.1016/j.gie.2008.11.018; WAGNER HJ, 1993, ENDOSCOPY, V25, P213, DOI 10.1055/s-2007-1010295; Sangchan A, 2012, GASTROINTEST ENDOSC, V76, P93, DOI 10.1016/j.gie.2012.02.048; Chang WH, 1998, GASTROINTEST ENDOSC, V47, P354, DOI 10.1016/S0016-5107(98)70218-4; Cheng JLS, 2002, GASTROINTEST ENDOSC, V56, P33, DOI 10.1067/mge.2002.125364; Chennat J, 2010, GASTROINTEST ENDOSC, V72, P632, DOI 10.1016/j.gie.2010.04.037; Dumas R, 2000, GASTROINTEST ENDOSC, V51, P334, DOI 10.1016/S0016-5107(00)70364-6; Dumonceau JM, 2011, ENDOSCOPY, V43, P617, DOI 10.1055/s-0030-1256315; Iwano H, 2011, DIGEST ENDOSC, V23, P43, DOI 10.1111/j.1443-1661.2010.01036.x; Kim KM, 2012, HEPATO-GASTROENTEROL, V59, P341, DOI 10.5754/hge11533; Kogure H, 2010, SURG ENDOSC, V25, P463; Kogure H, 2014, DIGEST ENDOSC, V26, P93, DOI 10.1111/den.12055; Law R, 2013, DIGEST DIS SCI, V58, P2667, DOI 10.1007/s10620-013-2671-4; Lee TH, 2013, ENDOSCOPY, V45, P106, DOI 10.1055/s-0032-1325928; Liberato MJA, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-103; Mukai T, 2011, J HEPATO-BIL-PAN SCI, V18, P646, DOI 10.1007/s00534-011-0406-5; Naitoh I, 2012, DIGEST DIS SCI, V57, P3279, DOI 10.1007/s10620-012-2270-9; Park DH, 2009, GASTROINTEST ENDOSC, V69, P1357, DOI 10.1016/j.gie.2008.12.250	26	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	SEP	2015	22	9					650	656		10.1002/jhbp.270		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CP9HS	WOS:000360205400002		
J	Moriwaki, T; Ishida, H; Araki, M; Endo, S; Yoshida, S; Kobayashi, M; Hamano, Y; Sugaya, A; Shimoyamada, M; Hasegawa, N; Imanishi, M; Ito, Y; Sato, D; Hyodo, I				Moriwaki, Toshikazu; Ishida, Hiroyasu; Araki, Masahiro; Endo, Shinji; Yoshida, Shigemasa; Kobayashi, Mariko; Hamano, Yukako; Sugaya, Akinori; Shimoyamada, Masahiro; Hasegawa, Naoyuki; Imanishi, Mamiko; Ito, Yuka; Sato, Daiki; Hyodo, Ichinosuke			Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Biliary tract cancer; Cholangiocarcinoma; Cisplatin; Gallbladder carcinoma; Gemcitabine; S-1	MONOTHERAPY; CHEMOTHERAPY; TRIAL; MULTICENTER; 5-FLUOROURACIL; CAPECITABINE; OXALIPLATIN; JAPAN; EVERY	BackgroundTo develop a triplet regimen containing gemcitabine, cisplatin, and S-1 (GPS), we assessed the recommended dose for patients with untreated advanced biliary tract cancer in this phase I study. MethodsDose-limiting toxicities (DLTs) were evaluated for the following two dose levels: gemcitabine (1000mg/m(2) for level 1 and 1200mg/m(2) for level 2 on day 1), cisplatin (30mg/m(2) fixed dose on day 1), and S-1 (40-60mg/day fixed dose twice a day for 7days), every 2weeks until progression. DLTs for each level were evaluated in six or more patients during the first twocycles. ResultsA total of 18 patients were enrolled and 16 patients were evaluated. DLTs at level 1 were observed in two of 10 patients. At level 2, a DLT was observed in one of six patients. The main grade 3 or 4 treatment-related adverse events were neutropenia and leukopenia, and a few non-hematological toxicities were observed. Among 14 patients with measurable lesions, the best response rate was 50%. ConclusionsGPS with a relative dose intensity corresponding to 90% of the standard gemcitabine plus cisplatin regimen could be administered safely, and showed preliminary antitumor activity. Survival benefits will be studied subsequently.	[Moriwaki, Toshikazu; Endo, Shinji; Kobayashi, Mariko; Hamano, Yukako; Sugaya, Akinori; Hasegawa, Naoyuki; Imanishi, Mamiko; Hyodo, Ichinosuke] Univ Tsukuba, Div Gastroenterol, Tsukuba, Ibaraki 3058575, Japan; [Ishida, Hiroyasu; Yoshida, Shigemasa; Shimoyamada, Masahiro; Ito, Yuka; Sato, Daiki] Natl Hosp Org, Mito Med Ctr, Dept Gastroenterol, Ibaraki, Japan; [Araki, Masahiro] Ibaraki Prefectural Cent Hosp & Canc Ctr, Div Gastroenterol, Ibaraki, Japan	Moriwaki, T (reprint author), Univ Tsukuba, Div Gastroenterol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tmoriwak@gmail.com			NPO Tsukuba Cancer Clinical Trial Group	This work was supported by the NPO Tsukuba Cancer Clinical Trial Group. We thank all the patients who participated in this study. We thank Miss Mizuki Aida for data management. A portion of this study was presented at the Japanese Biliary Association in September 2013.	Walter T, 2013, EUR J CANCER, V49, P329, DOI 10.1016/j.ejca.2012.08.003; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Furuse J, 2008, CANCER CHEMOTH PHARM, V62, P849, DOI 10.1007/s00280-007-0673-7; Morizane C, 2013, CANCER SCI, V104, P1211, DOI 10.1111/cas.12218; Kanai M, 2015, CANCER CHEMOTH PHARM, V75, P293, DOI 10.1007/s00280-014-2648-9; Kanai M, 2012, CANCER CHEMOTH PHARM, V69, P1181, DOI 10.1007/s00280-011-1818-2; Katayose Y, 2012, HEPATO-GASTROENTEROL, V59, P691, DOI 10.5754/hge11530; Kobayashi S, 2012, JPN J CLIN ONCOL, V42, P800, DOI 10.1093/jjco/hys102; Lassen U, 2011, ACTA ONCOL, V50, P448, DOI 10.3109/0284186X.2010.500300; Matt P, 2011, ONCOLOGIST, V16, P1451, DOI 10.1634/theoncologist.2011-0224; Moriwaki T, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0287-y; Park I, 2009, ONCOLOGY-BASEL, V76, P126, DOI 10.1159/000195538; Sasaki T, 2012, INVEST NEW DRUG, V30, P708, DOI 10.1007/s10637-010-9553-9; Sasaki T, 2009, ONCOLOGY-BASEL, V77, P71, DOI 10.1159/000226214; Sohn BS, 2013, TUMORI, V99, P139, DOI 10.1700/1283.14182; Suzuki E, 2013, CANCER CHEMOTH PHARM, V71, P1141, DOI 10.1007/s00280-013-2106-0; Tan BR, 2008, ANN ONCOL, V19, P1742, DOI 10.1093/annonc/mdn375; Ueno H, 2004, BRIT J CANCER, V91, P1769, DOI 10.1038/sj.bjc.6602208; Uwagawa T, 2015, CANCER CHEMOTH PHARM, V75, P191, DOI 10.1007/s00280-014-2636-0; Yamashita Y, 2010, JPN J CLIN ONCOL, V40, P24, DOI 10.1093/jjco/hyp119	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	SEP	2015	22	9					669	674		10.1002/jhbp.255		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CP9HS	WOS:000360205400005		
J	Shimizu, R; Kanno, K; Sugiyama, A; Ohata, H; Araki, A; Kishikawa, N; Kimura, Y; Yamamoto, H; Kodama, M; Kihira, K; Tazuma, S				Shimizu, Rina; Kanno, Keishi; Sugiyama, Akiko; Ohata, Hiroki; Araki, Anna; Kishikawa, Nobusuke; Kimura, Yasuhiro; Yamamoto, Hiroya; Kodama, Masanobu; Kihira, Kenji; Tazuma, Susumu			Cholangiocyte senescence caused by lysophosphatidylcholine as a potential implication in carcinogenesis	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Carcinogenesis; Cellular senescence; Cholangiocyte; Lysophosphatidylcholine; Senescence-associated secretory phenotype	SCLEROSING CHOLANGITIS; ENRICHMENT ANALYSIS; DNA METHYLATION; CANCER PATIENTS; CHOLANGIOCARCINOMA; PLASMA; CELLS; BILIARY; TUMOR; PROFILES	BackgroundThe incidence of biliary tract cancer in patients with pancreaticobiliary maljunction or intrahepatic cholelithiasis is markedly high with undefined mechanism. In these diseases, biliary lysophosphatidylcholine (LPC) level is reportedly increased. This study investigated the influence of LPC on cholangiocytes focusing on cellular senescence and its potential contribution to carcinogenesis. MethodsCultured MMNK-1, an immortalized human cholangiocyte was treated with LPC in vitro and its effect was evaluated. ResultsLysophosphatidylcholine demonstrated cytotoxicity with generation of intracellular reactive oxygen species. Accordingly, LPC provoked oxidative DNA injury, whereas the gene expressions of DNA repair enzyme (OGG1, MUTYH, MTH1) remained unchanged. Interestingly, LPC caused global DNA hypomethylation, which is frequently observed in cancer tissues. Microarray analysis identified differentially regulated genes in response to LPC, which included the components of senescence-associated secretory phenotype (SASP) including interleukin-8 (IL-8), IL-6, transforming growth factor- and plasminogen activator inhibitor-1. Significant induction of these genes was further confirmed by quantitative real-time polymerase chain reaction. In addition to upregulation of p21 gene expression, senescence-associated beta-galactosidase activity, a widely used marker of cellular senescence was significantly induced by the treatment of LPC. ConclusionsBased on these data, cholangiocyte senescence and SASP caused by LPC are potential pathogenic mechanisms in the development of biliary tract cancer.	[Shimizu, Rina; Ohata, Hiroki; Araki, Anna; Kimura, Yasuhiro; Yamamoto, Hiroya; Kodama, Masanobu; Kihira, Kenji] Hiroshima Univ Hosp, Dept Pharmaceut Serv, Hiroshima 7348551, Japan; [Kanno, Keishi; Sugiyama, Akiko; Kishikawa, Nobusuke; Tazuma, Susumu] Hiroshima Univ Hosp, Dept Gen Internal Med, Minami Ku, Hiroshima 7348551, Japan	Kanno, K (reprint author), Hiroshima Univ Hosp, Dept Gen Internal Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	kkanno@hiroshima-u.ac.jp			Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan	The authors thank Mika Nakashima for technical assistance. This study was conducted and supported by Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan. This work was carried out, in part, at the Analysis Center of Life Science, Hiroshima University.	Fuchs B, 2005, CLIN BIOCHEM, V38, P925, DOI 10.1016/clinbiochem.2005.06.006; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Komichi D, 2005, FREE RADICAL BIO MED, V39, P1418, DOI 10.1016/j.freeradbiomed.2005.07.005; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Jaiswal M, 2000, CANCER RES, V60, P184; Ohtani N, 2013, CANCER SCI, V104, P525, DOI 10.1111/cas.12118; Goeppert B, 2014, HEPATOLOGY, V59, P544, DOI 10.1002/hep.26721; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Cho YH, 2010, ANTICANCER RES, V30, P2489; Okita M, 1997, INT J CANCER, V71, P31, DOI 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4; Gauss A, 2013, WORLD J GASTROENTERO, V19, P5454, DOI 10.3748/wjg.v19.i33.5454; Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993; Bujko M, 2014, INT J HEMATOL, V100, P79, DOI 10.1007/s12185-014-1592-0; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI [10.1146/annurev-pathol-121808-102144, 10.1140/annurev-pathol-121808-102144]; Fujita K, 2014, J HEPATO-BIL-PAN SCI, V21, P212, DOI 10.1002/jhbp.20; Funabiki T, 2009, LANGENBECK ARCH SURG, V394, P159, DOI 10.1007/s00423-008-0336-0; Gales D, 2013, ISRN ONCOL, V2013, DOI DOI 10.1155/2013/859154; Iwase M, 2008, ATHEROSCLEROSIS, V196, P931, DOI 10.1016/j.atherosclerosis.2007.02.012; Kang KA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.149; Maruyama M, 2004, TRANSPLANTATION, V77, P446, DOI 10.1097/01.TP.0000110292.73873.25; MEHTA D, 1990, AM REV RESPIR DIS, V142, P157; Miwa Masanao, 2014, World J Gastrointest Pathophysiol, V5, P570, DOI 10.4291/wjgp.v5.i4.570; Morreall J, 2015, DNA REPAIR, V26, P15, DOI 10.1016/j.dnarep.2014.11.007; Qureshi Kamran, 2014, Curr Gastroenterol Rep, V16, P412, DOI 10.1007/s11894-014-0412-2; RYBORG AK, 1995, BRIT J DERMATOL, V133, P398, DOI 10.1111/j.1365-2133.1995.tb02667.x; SHIMADA K, 1991, HEPATOLOGY, V13, P438, DOI 10.1016/0270-9139(91)90296-8; Shoda J, 1999, HEPATOLOGY, V29, P1026, DOI 10.1002/hep.510290440; Subimerb C, 2014, ASIAN PAC J CANCER P, V15, P4217, DOI 10.7314/APJCP.2014.15.10.4217; Sueoka H, 2014, SURGERY, V155, P640, DOI 10.1016/j.surg.2013.12.037; Suzuki Y, 2014, J HEPATO-BIL-PAN SCI, V21, P617, DOI 10.1002/jhbp.116	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	SEP	2015	22	9					675	682		10.1002/jhbp.256		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CP9HS	WOS:000360205400006		
J	Maeda, S; Morikawa, T; Takadate, T; Suzuki, T; Minowa, T; Hanagata, N; Onogawa, T; Motoi, F; Nishimura, T; Unno, M				Maeda, Shimpei; Morikawa, Takanori; Takadate, Tatsuyuki; Suzuki, Takashi; Minowa, Takashi; Hanagata, Nobutaka; Onogawa, Tohru; Motoi, Fuyuhiko; Nishimura, Toshihide; Unno, Michiaki			Mass spectrometry-based proteomic analysis of formalin-fixed paraffin-embedded extrahepatic cholangiocarcinoma	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Biomarker; Extrahepatic cholangiocarcinoma; Mass spectrometry; Proteomics; Scheduled selected reaction monitoring	ACID-BINDING PROTEIN; NONMETASTATIC LUNG ADENOCARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; GASTRIC-CARCINOMA; BILIARY-TRACT; CANCER; EXPRESSION; SERUM; LIVER; TISSUES	BackgroundExtrahepatic cholangiocarcinoma is very difficult to diagnose at an early stage, and has a poor prognosis. Novel markers for diagnosis and optimal treatment selection are needed. However, there has been very limited data on the proteome profile of extrahepatic cholangiocarcinoma. This study was designed to unravel the proteome profile of this disease and to identify overexpressed proteins using mass spectrometry-based proteomic approaches. MethodsWe analyzed a discovery set of formalin-fixed paraffin-embedded tissues of 14 extrahepatic cholangiocarcinomas using shotgun mass spectrometry, and compared proteome profiles with those of seven controls. Then, selected candidates were verified by quantitative analysis using scheduled selected reaction monitoring-based mass spectrometry. Furthermore, immunohistochemical staining used a validation set of 165 cases. ResultsIn total, 1,992 proteins were identified and 136 proteins were overexpressed. Verification of 58 selected proteins by quantitative analysis revealed 11 overexpressed proteins. Immunohistochemical validation for 10 proteins showed positive rates of S100P (84%), CEAM5 (75%), MUC5A (62%), OLFM4 (60%), OAT (42%), CAD17 (41%), FABPL (38%), AOFA (30%), K1C20 (25%) and CPSM (22%) in extrahepatic cholangiocarcinomas, which were rarely positive in controls. ConclusionsWe identified 10 proteins associated with extrahepatic cholangiocarcinoma using proteomic approaches. These proteins are potential targets for future diagnostic biomarkers and therapy.	[Maeda, Shimpei; Morikawa, Takanori; Takadate, Tatsuyuki; Onogawa, Tohru; Motoi, Fuyuhiko; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Maeda, Shimpei] South Miyagi Med Ctr, Dept Surg, Sendai, Miyagi, Japan; [Suzuki, Takashi] Tohoku Univ, Grad Sch Med, Dept Pathol & Histotechnol, Sendai, Miyagi 9808574, Japan; [Minowa, Takashi; Hanagata, Nobutaka] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Tsukuba, Ibaraki, Japan; [Nishimura, Toshihide] Tokyo Med Univ, Dept Surg 1, Tokyo 1608402, Japan	Unno, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	m_unno@surg1.med.tohoku.ac.jp					Alvaro D, 2009, CURR OPIN GASTROEN, V25, P279, DOI 10.1097/MOG.0b013e328325a894; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Aishima S, 2011, AM J SURG PATHOL, V35, P590, DOI 10.1097/PAS.0b013e31820ffdf1; Kinoshita M, 2002, HEPATOLOGY, V36, P433, DOI 10.1053/jhep.2002.34851; Nishimura T, 2010, J PROTEOMICS, V73, P1100, DOI 10.1016/j.jprot.2009.11.010; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Oue N, 2009, INT J CANCER, V125, P2383, DOI 10.1002/ijc.24624; Welzel TM, 2007, CLIN GASTROENTEROL H, V5, P1221, DOI 10.1016/j.cgh.2007.05-020; Takadate T, 2013, INT J CANCER, V132, P1368, DOI 10.1002/ijc.27797; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Wang X, 2009, EUR J CANCER CARE, V18, P625, DOI 10.1111/j.1365-2354.2008.00965.x; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Shimonishi T, 2000, HISTOPATHOLOGY, V37, P55, DOI 10.1046/j.1365-2559.2000.00932.x; Kobayashi D, 2007, CANCER SCI, V98, P334, DOI 10.1111/j.1349-7006.2007.00397.x; Bonney GK, 2008, LANCET ONCOL, V9, P149, DOI 10.1016/S1470-2045(08)70027-5; Fillatre Y, 2010, RAPID COMMUN MASS SP, V24, P2453, DOI 10.1002/rcm.4649; Liu W, 2007, HISTOPATHOLOGY, V51, P157, DOI 10.1111/j.1365-2559.2007.02763.x; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.500084-MCP200; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Boonla C, 2003, CANCER, V98, P1438, DOI 10.1002/cncr.11652; Hamada S, 2011, CANCER SCI, V102, P150, DOI 10.1111/j.1349-7006.2010.01757.x; Hashimoto T, 2004, PATHOBIOLOGY, V71, P115, DOI 10.1159/000076465; Hodorova I, 2012, MED SCI MONITOR, V18, pBR482; Ishihara S, 2007, DIGEST SURG, V24, P131, DOI 10.1159/000101901; Kawase H, 2009, J PROTEOME RES, V8, P4092, DOI 10.1021/pr900468k; Lachmann RA, 2006, CLIN PHYSIOL FUNCT I, V26, P371, DOI 10.1111/j.1475-097X.2006.00703.x; Lawrie LC, 2004, BRIT J CANCER, V90, P1955, DOI 10.1038/sj.bjc.6601828; Lee HJ, 2010, GASTROENTEROLOGY, V139, DOI DOI 10.1053/J.GASTRO.2010.04.008; LIU TH, 1989, CHINESE MED J-PEKING, V102, P630; Minato H, 1996, HISTOPATHOLOGY, V28, P411, DOI 10.1046/j.1365-2559.1996.343384.x; Miyasaka Y, 2001, BRIT J CANCER, V85, P228, DOI 10.1054/bjoc.2001.1901; Nakanishi Y, 2008, MODERN PATHOL, V21, P807, DOI 10.1038/modpathol.2008.65; Prieto DA, 2005, BIOTECHNIQUES S, V38, P32; Rullier A, 2000, AM J SURG PATHOL, V24, P870, DOI 10.1097/00000478-200006000-00014; Sharaf RN, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-5; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Takamura M, 2010, INT J ONCOL, V36, P245, DOI 10.3892/ijo_00000495; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Wang Q, 2012, ONCOL REP, V28, P303, DOI 10.3892/or.2012.1794	47	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	SEP	2015	22	9					683	691		10.1002/jhbp.262		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CP9HS	WOS:000360205400007		
J	Wada, K; Sano, K; Amano, H; Miura, F; Toyota, N; Ito, H; Shibuya, M; Ikeda, Y; Kainuma, M; Takada, T				Wada, Keita; Sano, Keiji; Amano, Hodaka; Miura, Fumihiko; Toyota, Naoyuki; Ito, Hiromichi; Shibuya, Makoto; Ikeda, Yutaka; Kainuma, Masahiko; Takada, Tadahiro			Biweekly gemcitabine plus S-1 for locally advanced and metastatic pancreatic cancer: a preliminary feasibility study	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Chemotherapy; Gemcitabine; Pancreatic cancer; S-1	PHASE-II TRIAL; SURVIVAL; CHEMOTHERAPY; MULTICENTER; THERAPY	BackgroundChemotherapy for unresectable pancreatic cancer should not only prolong survival but maintain quality of life, considering its limited life expectancy. To achieve these goals, biweekly gemcitabine plus S-1 was assessed in the clinical practice setting. MethodsFifty-two patients with either locally advanced or metastatic pancreatic cancer who received biweekly gemcitabine plus S-1 as a first-line anti-cancer treatment were included in this study. Treatment delivery, toxicity, response, and survival were reviewed to assess the feasibility and efficacy. ResultsThe completion rate of treatment delivery was 95.1%, with relative dose intensity of 97.1% for gemcitabine and 97.3% for S-1. Overall, grade 3 or worse adverse events were rare, with hematologic toxicities occurring in 5.8%. The objective response rate was 30.8%, and more than a 50% reduction of CA19-9 was observed in 77.1%. Surgical conversion was completed with a margin-negative resection in four patients whose tumor had shrunk for at least 6 months. The median progression-free and overall survivals were 10.4 and 18.2 months, respectively. Reduction of CA19-9 was associated with longer survival. ConclusionsBiweekly gemcitabine plus S-1 may be a good alternative to current standard chemotherapies for unresectable pancreatic cancer with less toxicity and less treatment burden without losing efficacy.	[Wada, Keita; Sano, Keiji; Amano, Hodaka; Miura, Fumihiko; Toyota, Naoyuki; Ito, Hiromichi; Shibuya, Makoto; Ikeda, Yutaka; Kainuma, Masahiko; Takada, Tadahiro] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo 1738605, Japan	Wada, K (reprint author), Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	wada@med.teikyo-u.ac.jp					Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Ozaka M, 2012, CANCER CHEMOTH PHARM, V69, P1197, DOI 10.1007/s00280-012-1822-1; Kim MK, 2009, JPN J CLIN ONCOL, V39, P49, DOI 10.1093/jjco/hyn126; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Nakamura K, 2006, BRIT J CANCER, V94, P1575, DOI 10.1038/sj.bjc.6603168; Ueno H, 2005, ONCOLOGY-BASEL, V68, P171, DOI 10.1159/000086771; Haller DG, 2008, J CLIN ONCOL, V26, P2118, DOI 10.1200/JCO.2007.15.2090; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Lee GW, 2009, CANCER CHEMOTH PHARM, V64, P707, DOI 10.1007/s00280-008-0918-0; Sho M, 2015, J GASTROENTEROL, V50, P694, DOI 10.1007/s00535-014-1005-4; Chuah B, 2011, CANCER SCI, V102, P478, DOI 10.1111/j.1349-7006.2010.01793.x; Nakai Y, 2012, BRIT J CANCER, V106, P1934, DOI 10.1038/bjc.2012.183; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Shirasaka T, 2009, JPN J CLIN ONCOL, V39, P2, DOI 10.1093/jjco/hyn127; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S01053-4296(03)00031-6; Murakami Y, 2012, J SURG ONCOL, V106, P174, DOI 10.1002/jso.23068; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Nakai Y, 2009, ONCOLOGY-BASEL, V77, P300, DOI 10.1159/000259616; National Cancer Institute, 2014, SEER CANC STAT REV 1; Satoi S, 2013, J HEPATO-BIL-PAN SCI, V20, P590, DOI 10.1007/s00534-013-0616-0; The Center for Cancer Control and Information Services, 2014, CANC STAT JAP; Yanagimoto H, 2014, J HEPATO-BIL-PAN SCI, V21, P761, DOI 10.1002/jhbp.130	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	SEP	2015	22	9					692	698		10.1002/jhbp.274		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CP9HS	WOS:000360205400008		
J	Minaga, K; Kitano, M; Yamashita, Y				Minaga, Kosuke; Kitano, Masayuki; Yamashita, Yukitaka			Surgically resected needle tract seeding following endoscopic ultrasound-guided fine-needle aspiration in pancreatic cancer	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Endoscopic ultrasound-guided fine-needle aspiration; Needle tract seeding; Pancreatic cancer	FNA		[Minaga, Kosuke; Kitano, Masayuki] Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osakasayama 5898511, Japan; [Minaga, Kosuke; Yamashita, Yukitaka] Wakayama Med Ctr, Japanese Red Cross Soc, Dept Gastroenterol & Hepatol, Wakayama, Japan	Minaga, K (reprint author), Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, 377-2 Ohno Higashi, Osakasayama 5898511, Japan.	kousukeminaga@med.kindai.ac.jp			Japan Society for the Promotion of Science	This study was supported by grants from the Japan Society for the Promotion of Science.	Paquin SC, 2005, GASTROINTEST ENDOSC, V61, P610, DOI 10.1016/S0016-5107(05)00082-9; Shah JN, 2004, GASTROINTEST ENDOSC, V59, P923, DOI 10.1016/S0016-5107(04)00340-2; Chong A, 2011, GASTROINTEST ENDOSC, V74, P933, DOI 10.1016/j.gie.2010.10.020; Jenssen C, 2012, WORLD J GASTROENTERO, V18, P4659, DOI 10.3748/wjg.v18.i34.4659; Anderson B, 2013, DIGEST ENDOSC, V25, P344, DOI 10.1111/den.12057; Katanuma A, 2012, ENDOSCOPY, V44, pE160, DOI 10.1055/s-0031-1291716; Doi S, 2008, GASTROINTEST ENDOSC, V67, P988, DOI 10.1016/j.gie.2007.10.025	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	SEP	2015	22	9					708	709		10.1002/jhbp.269		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CP9HS	WOS:000360205400010		
J	Iwata, H; Witte, M; Samavedam, UKSRL; Gupta, Y; Shimizu, A; Ishiko, A; Schroder, T; Seeger, K; Dahlke, M; Rades, D; Zillikens, D; Ludwig, RJ				Iwata, Hiroaki; Witte, Mareike; Samavedam, Unni Krishna S. R. L.; Gupta, Yask; Shimizu, Atsushi; Ishiko, Akira; Schroeder, Tobias; Seeger, Karsten; Dahlke, Markus; Rades, Dirk; Zillikens, Detlef; Ludwig, Ralf J.			Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita	JOURNAL OF IMMUNOLOGY			English	Article							INDUCED TISSUE-DAMAGE; VII COLLAGEN; MONOCLONAL-ANTIBODIES; PEMPHIGOID DISEASES; SUSCEPTIBILITY; AUTOIMMUNE; AUTOANTIBODIES; MICE; IMMUNOFLUORESCENCE; INDUCTION	Animal models have enhanced our understanding of the pathogenesis of autoimmune diseases. For these models, genetically identical, inbred mice have commonly been used. Different inbred mouse strains, however, show a high variability in disease manifestation. Identifying the factors that influence this disease variability could provide unrecognized insights into pathogenesis. We established a novel Ab transfer-induced model of epidermolysis bullosa acquisita (EBA), an autoimmune disease characterized by (muco)-cutaneous blistering caused by anti-type VII collagen (COL7) autoantibodies. Blistering after anti-COL7 IgG (directed against the von Willebrand factor A like domain 2) transfer showed clear variability among inbred mouse strains, that is, severe cutaneous blistering and inflammation in C57BL/6J and absence of skin lesions in MRL/MpJ mice. The transfer of anti-COL7 IgG into irradiated, EBA-resistant MRL/MpJ mice, rescued by transplantation with bone marrow from EBA-susceptible B6.AK-H2k mice, induced blistering. To the contrary, irradiated EBA-susceptible B6.AK-H2k mice that were rescued using MRL/MpJ bone marrow were devoid of blistering. In vitro, immune complex activation of neutrophils from C57BL/6J or MRL/MpJ mice showed an impaired reactive oxygen species release from the latter, whereas no differences were observed after PMA activation. This finding was paralleled by divergent expression profiles of immune complex activated neutrophils from either C57BL/6J or MRL/MpJ mice. Collectively, we demonstrate that radiosensitive cells determine the varying extent of skin inflammation and blistering in the end-stage effector phase of EBA.	[Iwata, Hiroaki; Zillikens, Detlef; Ludwig, Ralf J.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Witte, Mareike; Samavedam, Unni Krishna S. R. L.; Gupta, Yask; Schroeder, Tobias; Zillikens, Detlef; Ludwig, Ralf J.] Med Univ Lubeck, Lubeck Inst Expt Dermatol, D-23538 Lubeck, Germany; [Shimizu, Atsushi; Ishiko, Akira] Toho Univ, Fac Med, Dept Dermatol 1, Sch Med, Tokyo 1438540, Japan; [Seeger, Karsten] Med Univ Lubeck, Dept Chem, D-23538 Lubeck, Germany; [Dahlke, Markus; Rades, Dirk] Med Univ Lubeck, Dept Radiat Oncol, D-23538 Lubeck, Germany	Ludwig, RJ (reprint author), Med Univ Lubeck, Lubeck Inst Expt Dermatol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	ralf.ludwig@uksh.de	Ludwig, Ralf/A-2629-2008	Ludwig, Ralf/0000-0002-1394-1737	Deutsche Forschungsgemeinschaft [DFG LU877/10-1, GRK 1727/1, GRK 1743/1, EXC 306/2]	This work was supported in part by Deutsche Forschungsgemeinschaft Grants DFG LU877/10-1, GRK 1727/1 (Research Training Group "Modulation of Autoimmunity"), GRK 1743/1 (Research Training Group "Genes, Environment, and Inflammation"), and EXC 306/2 (Excellence Cluster "Inflammation at Interfaces").	BEUTNER EH, 1964, P SOC EXP BIOL MED, V117, P505; LEDBETTER JA, 1980, J EXP MED, V152, P280, DOI 10.1084/jem.152.2.280; Zumelzu C, 2011, J INVEST DERMATOL, V131, P2386, DOI 10.1038/jid.2011.231; Recke A, 2014, J IMMUNOL, V193, P1600, DOI 10.4049/jimmunol.1400160; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Kasperkiewicz M, 2012, J PATHOL, V228, P8, DOI 10.1002/path.4023; Ji H, 2001, J EXP MED, V194, P321, DOI 10.1084/jem.194.3.321; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Sadeghi H, 2015, J IMMUNOL, V194, P3656, DOI 10.4049/jimmunol.1402688; Ludwig RJ, 2013, TRENDS MOL MED, V19, P501, DOI 10.1016/j.molmed.2013.06.003; Buijsrogge JJA, 2011, BRIT J DERMATOL, V165, P92, DOI 10.1111/j.1365-2133.2011.10346.x; Kim JH, 2011, ACTA DERM-VENEREOL, V91, P307, DOI 10.2340/00015555-1065; Chiriac MT, 2007, J PATHOL, V212, P56, DOI 10.1002/path.2157; Ludwig RJ, 2011, J INVEST DERMATOL, V131, P167, DOI 10.1038/jid.2010.248; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Yu XH, 2010, J INVEST DERMATOL, V130, P2841, DOI 10.1038/jid.2010.230; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Xie C, 2004, J IMMUNOL, V172, P5047; Mihai S, 2007, J IMMUNOL, V178, P6514; Leontyev D, 2012, BLOOD, V119, P5261, DOI 10.1182/blood-2012-03-415695; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Hirose M, 2011, J IMMUNOL, V187, P1176, DOI 10.4049/jimmunol.1100596; Hirose M, 2015, J INVEST DERMATOL, V135, P768, DOI 10.1038/jid.2014.453; Iwata H, 2015, J INVEST DERMATOL, V135, P916, DOI 10.1038/jid.2014.451; Iwata H, 2013, J IMMUNOL, V191, P2978, DOI 10.4049/jimmunol.1300310; Kasprick A, 2015, EUR J IMMUNOL, V45, P1462, DOI 10.1002/eji.201444769; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Leineweber S, 2011, FEBS LETT, V585, P1748, DOI 10.1016/j.febslet.2011.04.071; ROCK B, 1989, NEW ENGL J MED, V320, P1463, DOI 10.1056/NEJM198906013202206; ROENIGK HH, 1971, ARCH DERMATOL, V103, P1, DOI 10.1001/archderm.103.1.1; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Srinivas G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3462; Vorobyev A, 2015, J INVEST DERMATOL, V135, P1565, DOI 10.1038/jid.2015.51; WATSON WC, 1985, J EXP MED, V162, P1878, DOI 10.1084/jem.162.6.1878; Wegener H, 2014, J BIOL CHEM, V289, P4861, DOI 10.1074/jbc.M113.531327; Wegener H, 2013, BIOCHEM BIOPH RES CO, V430, P449, DOI 10.1016/j.bbrc.2012.11.119; WOODLEY DT, 1988, J CLIN INVEST, V81, P683, DOI 10.1172/JCI113373; Zillikens D, 1999, J INVEST DERMATOL, V113, P947, DOI 10.1046/j.1523-1747.1999.00808.x; Zillikens Detlef, 1996, Journal of Investigative Dermatology, V106, P1333, DOI 10.1111/1523-1747.ep12349283	40	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	SEP 1	2015	195	5					1945	1954		10.4049/jimmunol.1501003		10	Immunology	Immunology	CP6QY	WOS:000360014200007		
J	Kaneko, Y; Hiruma, K				Kaneko, Yu; Hiruma, Kiyoshi			Allatotropin inhibits juvenile hormone biosynthesis by the corpora allata of adult Bombyx mori	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Bombyx mori; Juvenile hormone; Allatotropin; Short neuropeptide F; Corpora allata	MANDUCA-SEXTA ALLATOTROPIN; ARMYWORM SPODOPTERA-FRUGIPERDA; TOBACCO HORNWORM; NUTRITIONAL REGULATION; PSEUDALETIA-UNIPUNCTA; INSECT METAMORPHOSIS; GRYLLUS-BIMACULATUS; DIPLOPTERA-PUNCTATA; ECDYSTEROID LEVELS; FARNESOIC ACID	Juvenile hormone am synthesis by the corpora allata (CA) does not occur during the pupal stage in both male and female Bombyx mori but begins shortly before adult ecdysis and thereafter only in females. JH biosynthesis in female adults was prevented by allatotropin (AT) through the corpora cardiaca (CC) and the tightly attached oesophagus before adult ecdysis, but after ecdysis, removal of the CC had little effect and only the oesophagus was necessary for AT to prevent JH synthesis. AT could not prevent JH synthesis by the CA alone in either stage. Short neuropeptide F (sNPF) acted directly on the CA, preventing JH biosynthesis without preventing the JH biosynthetic enzymes before adult ecdysis, but had little effect after ecdysis, indicating that the action of AT was not via sNPF. The inhibition of JH synthesis by AT was indirect. Both AT and a factor(s) from the AT-stimulated oesophagus through the CC were necessary for the inhibitory action, which was due to the prevention of some of the JH biosynthetic enzymes. These results clearly show that AT prevents JH synthesis in adult CA in B. mori, although AT stimulates JH biosynthesis by the CA in several insect species. (C) 2015 Elsevier Ltd. All rights reserved.	[Hiruma, Kiyoshi] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; Iwate Univ, Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan	Hiruma, K (reprint author), Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan.	hiruma@hirosaki-u.ac.jp			Japan Society for the Promotion of Science [22380032, 25292195, 24880008]; Hirosaki University	We thank Dr. N. Yamanaka and Dr. H. Kataoka for sNPF and AT. This work was supported by grants from the Japan Society for the Promotion of Science (22380032, 25292195 and 24880008), and a grant for Exploratory Research by Young Scientists from Hirosaki University. Experiments using radioisotope were performed at the Gene Research Center, Hirosaki University.	Abdel-latief M, 2004, REGUL PEPTIDES, V122, P69, DOI 10.1016/j.regpep.2004.05.015; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Ueda H, 2009, J INSECT PHYSIOL, V55, P798, DOI 10.1016/j.jinsphys.2009.04.013; LORENZ MW, 1995, J BIOL CHEM, V270, P21103; Mayoral JG, 2009, INSECT BIOCHEM MOLEC, V39, P31, DOI 10.1016/j.ibmb.2008.09.010; KRAMER SJ, 1991, P NATL ACAD SCI USA, V88, P9458, DOI 10.1073/pnas.88.21.9458; WOODHEAD AP, 1989, P NATL ACAD SCI USA, V86, P5997, DOI 10.1073/pnas.86.15.5997; Gu SH, 1996, J INSECT PHYSIOL, V42, P625, DOI 10.1016/0022-1910(96)00025-X; Stay B, 2007, ANNU REV ENTOMOL, V52, P277, DOI 10.1146/annurev.ento.51.110104.151050; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Koladich PM, 2002, PEPTIDES, V23, P645, DOI 10.1016/S0196-9781(01)00658-1; Weaver RJ, 2009, ANN NY ACAD SCI, V1163, P316, DOI 10.1111/j.1749-6632.2009.04459.x; Nouzova M, 2011, INSECT BIOCHEM MOLEC, V41, P660, DOI 10.1016/j.ibmb.2011.04.008; Duve H, 2003, CELL TISSUE RES, V314, P281, DOI 10.1007/s00441-003-0783-4; Noriega FG, 2004, INSECT BIOCHEM MOLEC, V34, P687, DOI 10.1016/j.ibmb.2004.03.021; Perez-Hedo M, 2013, INSECT BIOCHEM MOLEC, V43, P495, DOI 10.1016/j.ibmb.2013.03.008; GU SH, 1993, EXPERIENTIA, V49, P806, DOI 10.1007/BF01923554; Areiza M, 2014, INSECT BIOCHEM MOLEC, V54, P98, DOI 10.1016/j.ibmb.2014.09.006; Audsley N, 1999, EUR J ENTOMOL, V96, P287; DAI JD, 1991, DEV BIOL, V144, P309, DOI 10.1016/0012-1606(91)90424-2; Dillen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053604; FUKUDA SOICHI, 1944, JOUR FAC SCI IMP UNIV TOKYO SECT IV, V6, P477; Goodman W.G., 2005, COMPREHENSIVE MOL IN, P319; GRANGER NA, 1994, MOL CELL ENDOCRINOL, V103, P73, DOI 10.1016/0303-7207(94)90071-X; Granger NA, 1996, ARCH INSECT BIOCHEM, V32, P449, DOI 10.1002/(SICI)1520-6327(1996)32:3/4<449::AID-ARCH17>3.0.CO;2-C; Hiruma K, 2013, CURR TOP DEV BIOL, V103, P73, DOI 10.1016/B978-0-12-385979-2.00003-4; Kaneko Y, 2011, APPL ENTOMOL ZOOL, V46, P87, DOI 10.1007/s13355-010-0013-y; Kaneko Y, 2014, DEV BIOL, V393, P312, DOI 10.1016/j.ydbio.2014.07.014; Kaneko Y, 2011, MOL CELL ENDOCRINOL, V335, P204, DOI 10.1016/j.mce.2011.01.012; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Li YP, 2004, REGUL PEPTIDES, V118, P175, DOI 10.1016/j.regpep.2003.12.004; LORENZ MW, 1995, REGUL PEPTIDES, V57, P227, DOI 10.1016/0167-0115(95)00036-B; Marchal E, 2013, GEN COMP ENDOCR, V188, P85, DOI 10.1016/j.ygcen.2013.04.018; Nagata S, 2012, PEPTIDES, V34, P98, DOI 10.1016/j.peptides.2012.01.002; NIJHOUT MM, 1974, BIOL BULL, V146, P377, DOI 10.2307/1540412; Nouzova M, 2012, PEPTIDES, V34, P201, DOI 10.1016/j.peptides.2011.07.025; Nyati P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071967; Oeh U, 2000, INSECT BIOCHEM MOLEC, V30, P719, DOI 10.1016/S0965-1748(00)00043-6; PRATT GE, 1989, BIOCHEM BIOPH RES CO, V163, P1243, DOI 10.1016/0006-291X(89)91111-X; RAIKHEL AS, 2005, COMPREHENSIVE MOL IN, V3, P433; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Stay B, 2000, INSECT BIOCHEM MOLEC, V30, P653, DOI 10.1016/S0965-1748(00)00036-9; Swevers L, 1999, INSECT BIOCHEM MOLEC, V29, P955, DOI 10.1016/S0965-1748(99)00059-4; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Truesdell PF, 2000, INSECT BIOCHEM MOLEC, V30, P691, DOI 10.1016/S0965-1748(00)00040-0; TSUCHIDA K, 1987, ARCH INSECT BIOCHEM, V5, P167, DOI 10.1002/arch.940050303; WHISENTON LR, 1987, MOL CELL ENDOCRINOL, V54, P171, DOI 10.1016/0303-7207(87)90154-7; WHISENTON LR, 1985, GEN COMP ENDOCR, V58, P311, DOI 10.1016/0016-6480(85)90347-8; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2	50	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	SEP	2015	80				SI		15	21		10.1016/j.jinsphys.2015.01.005		7	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CQ3OG	WOS:000360511300003		
J	Toyota, K; Miyakawa, H; Hiruta, C; Furuta, K; Ogino, Y; Shinoda, T; Tatarazako, N; Miyagawa, S; Shaw, JR; Iguchi, T				Toyota, Kenji; Miyakawa, Hitoshi; Hiruta, Chizue; Furuta, Kenjiro; Ogino, Yukiko; Shinoda, Tetsuro; Tatarazako, Norihisa; Miyagawa, Shinichi; Shaw, Joseph R.; Iguchi, Taisen			Methyl farnesoate synthesis is necessary for the environmental sex determination in the water flea Daphnia pulex	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Daphnia pulex; Environmental sex determination; Photoperiod; Methyl farnesoate; Juvenile hormone acid O-methyltransferase	ACID-O-METHYLTRANSFERASE; KRUPPEL-HOMOLOG 1; PERFORMANCE LIQUID-CHROMATOGRAPHY; JUVENILE-HORMONE BIOSYNTHESIS; RECEPTOR ANTAGONIST MK-801; BINDING-PROTEIN; GENE-EXPRESSION; BOMBYX-MORI; INSECT METAMORPHOSIS; TRIBOLIUM-CASTANEUM	Sex-determination systems can be divided into two groups: genotypic sex determination (GSD) and environmental sex determination (ESD). ESD is an adaptive life-history strategy that allows control of sex in response to environmental cues in order to optimize fitness. However, the molecular basis of ESD remains largely unknown. The micro crustacean Daphnia pulex exhibits ESD in response to various external stimuli. Although methyl famesoate (MF: putative juvenile hormone, JH, in daphnids) has been reported to induce male production in daphnids, the role of MF as a sex-determining factor remains elusive due to the lack of a suitable model system for its study. Here, we establish such a system for ESD studies in D. pulex. The WTN6 strain switches from producing females to producing males in response to the shortened day condition, while the MFP strain only produces females, irrespective of day-length. To clarify whether MF has a novel physiological role as a sex-determining factor in D. pulex, we demonstrate that a MF/JH biosynthesis inhibitor suppressed male production in WTN6 strain reared under the male-inducible condition, shortened day-length. Moreover, we show that juvenile hormone acid O-methyltransferase (JHAMT), a critical enzyme of MF/JH biosynthesis, displays MF-generating activity by catalyzing famesoic acid. Expression of the JHAMT gene increased significantly just before the MF-sensitive period for male production in the WTN6 strain, but not in the MFP strain, when maintained under male-inducible conditions. These results suggest that MF synthesis regulated by JHAMT is necessary for male offspring production in D. pulex. Our findings provide novel insights into the genetic underpinnings of ESD and they begin to shed light on the physiological function of MF as a male-fate determiner in D. pulex. (C) 2015 Elsevier Ltd. All rights reserved.	[Toyota, Kenji; Ogino, Yukiko; Miyagawa, Shinichi; Iguchi, Taisen] Grad Univ Adv Studies SOKENDAI, Fac Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Toyota, Kenji; Miyakawa, Hitoshi; Hiruta, Chizue; Ogino, Yukiko; Miyagawa, Shinichi; Iguchi, Taisen] Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Toyota, Kenji; Miyakawa, Hitoshi; Hiruta, Chizue; Ogino, Yukiko; Miyagawa, Shinichi; Iguchi, Taisen] Natl Inst Nat Sci, Okazaki, Aichi 4448787, Japan; [Hiruta, Chizue] Iwate Med Univ, Ctr Liberal Arts & Sci, Dept Biol, Yahaba, Iwate 0283694, Japan; [Furuta, Kenjiro] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane 6908504, Japan; [Shinoda, Tetsuro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Tatarazako, Norihisa] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Shaw, Joseph R.] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Shaw, Joseph R.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Iguchi, T (reprint author), Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	taisen@nibb.ac.jp			JSPS Research Fellowship for Young Scientists [12J05579, 12J04065]; Sasakawa Scientific Research Grant from The Japan Science Society; Saito Ho-on Kai Scientific Research Grant from The Saito Gratitude Foundation; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of the Environment of Japan; National Institute for Basic Biology; Research Council of Norway [221455]; Adverse Outcome Pathways for Endocrine Disruption in Daphnia magna; National Institute of Environmental Health Sciences [R01ES019324]	We would like to thank Dr. Eiji Watanabe, Department of Neurobiology, Laboratory of Neurophysiology, National Institute for Basic Biology, Aichi, Japan, for providing the incubator, Dr. John K. Colbourne, Department of Environmental Genomics, School of Bioscience, University of Birmingham, Birmingham, UK, for providing the D. pulex WTN6 strain, and Ms. Michiyo Yoshiyama for technical assistance. D. pulex genomic sequence data was produced by The Center for Genomics and Bioinformatics at Indiana University and distributed via wFleaBase in collaboration with the Daphnia Genomics Consortium (https://wiki.cgb.indiana.edu/display/DGC/Home). We thank members of the Iguchi laboratory for helpful advice and discussion. This work was supported by a JSPS Research Fellowship for Young Scientists to KT (No. 12J05579) and CH (No. 12J04065), a Sasakawa Scientific Research Grant from The Japan Science Society to KT, a Saito Ho-on Kai Scientific Research Grant from The Saito Gratitude Foundation to KT, Grants from the Ministry of Education, Culture, Sports, Science, and Technology (TI), the Ministry of the Environment of Japan (TI), a Grant from the National Institute for Basic Biology (TI), and the Research Council of Norway (project 221455), Adverse Outcome Pathways for Endocrine Disruption in Daphnia magna, a conceptual approach for mechanistically-based risk assessment (TI) and a Grant from the National Institute of Environmental Health Sciences (R01ES019324) to JRS.	Saito K, 2006, INSECT MOL BIOL, V15, P245, DOI 10.1111/j.1365-2583.2006.00612.x; BULL JJ, 1985, EXPERIENTIA, V41, P1285, DOI 10.1007/BF01952071; Shinoda T, 2001, INSECT BIOCHEM MOLEC, V31, P521, DOI 10.1016/S0965-1748(00)00133-8; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Daimon T, 2013, BIOTECHNOL APPL BIOC, V60, P82, DOI 10.1002/bab.1058; Sinev AY, 2011, ZOOTAXA, P45; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Warner RR, 1996, J EXP MAR BIOL ECOL, V204, P155, DOI 10.1016/0022-0981(96)02582-8; Mayoral JG, 2009, INSECT BIOCHEM MOLEC, V39, P31, DOI 10.1016/j.ibmb.2008.09.010; Defelipe LA, 2011, INSECT BIOCHEM MOLEC, V41, P228, DOI 10.1016/j.ibmb.2010.12.008; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; Zarkower D, 2001, NAT REV GENET, V2, P175, DOI 10.1038/35056032; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Olmstead AW, 2002, J EXP ZOOL, V293, P736, DOI 10.1002/jez.10162; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; Miura T, 2005, EVOL DEV, V7, P122, DOI 10.1111/j.1525-142X.2005.05014.x; Arand M, 1999, BIOCHEM J, V344, P273, DOI 10.1042/0264-6021:3440273; Miyakawa H, 2013, J EXP ZOOL PART A, V319, P440, DOI 10.1002/jez.1807; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Hui JHL, 2010, PEPTIDES, V31, P451, DOI 10.1016/j.peptides.2009.10.003; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Merchant-Larios H, 2013, SEX DEV, V7, P95, DOI 10.1159/000341936; Tatarazako N, 2003, CHEMOSPHERE, V53, P827, DOI 10.1016/S0045-6535(03)00761-6; Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Kim K, 2006, P ROY SOC B-BIOL SCI, V273, P141, DOI 10.1098/rspb.2005.3299; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; Oda S, 2011, ENVIRON TOXICOL CHEM, V30, P232, DOI 10.1002/etc.378; Oda S, 2005, CHEMOSPHERE, V61, P1168, DOI 10.1016/j.chemosphere.2005.02.075; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Banta AM, 1929, PHYSIOL ZOOL, V2, P93; Begum M, 2004, J INSECT PHYSIOL, V50, P927, DOI 10.1016/j.jinsphys.2004.07.003; CHANG ES, 1980, P NATL ACAD SCI-BIOL, V77, P4657, DOI 10.1073/pnas.77.8.4657; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; Geister TL, 2008, J EXP BIOL, V211, P1587, DOI 10.1242/jeb.016725; Goodman W., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2-10008-1; GOODMAN WG, 1984, J CHROMATOGR, V294, P447, DOI 10.1016/S0021-9673(01)96161-8; Gotoh H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004098; Guler Y, 2012, MAR BIOL, V159, P2885, DOI 10.1007/s00227-012-2042-2; Hao W, 2013, J INSECT PHYSIOL, V59, P906, DOI 10.1016/j.jinsphys.2013.06.009; HARDIE J, 1981, J INSECT PHYSIOL, V27, P257, DOI 10.1016/0022-1910(81)90059-7; Hobk A., 1990, ECOLOGY, V71, P2255; Ichikawa A, 2007, J CHROMATOGR A, V1161, P252, DOI 10.1016/j.chroma.2007.06.003; Ignace DD, 2011, HYDROBIOLOGIA, V668, P117, DOI 10.1007/s10750-010-0534-y; Ishikawa A, 2012, INSECT MOL BIOL, V21, P49, DOI 10.1111/j.1365-2583.2011.01111.x; Jones D, 2010, GEN COMP ENDOCR, V165, P244, DOI 10.1016/j.ygcen.2009.07.006; Jones G, 2013, GEN COMP ENDOCR, V182, P73, DOI 10.1016/j.ygcen.2012.11.009; Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kuballa AV, 2007, GEN COMP ENDOCR, V150, P48, DOI 10.1016/j.ygcen.2006.07.020; LEES AD, 1973, J INSECT PHYSIOL, V19, P2279, DOI 10.1016/0022-1910(73)90237-0; Li WF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068544; Miyakawa H., 2014, CURR OPIN INSECT SCI, V1, P81; Miyakawa H., 2010, BMC DEV BIOL, V10; Miyakawa H., 2015, PLOS ONE IN PRESS; Miyakawa H., 2013, NAT COMMUN; Nijhout HF, 1994, INSECT HORMONES; Olmstead AW, 2000, ENVIRON TOXICOL CHEM, V19, P2107, DOI 10.1897/1551-5028(2000)019<2107:EOEACO>2.3.CO;2; Smith G, 1915, P R SOC LOND B-CONTA, V88, P418, DOI 10.1098/rspb.1915.0005; Spanier KI, 2010, BMC MOL BIOL, V11, P11; Suzuki R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00133; Tanaka S, 2001, ARCH INSECT BIOCHEM, V47, P139, DOI 10.1002/arch.1045; Toyota K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-239; Vandesompele J., 2002, GENOME BIOL, V18, P3, DOI DOI 10.1186/GB-2002-3-7-RESEARCH0034; Vermunt AMW, 2001, INSECT MOL BIOL, V10, P147, DOI 10.1046/j.1365-2583.2001.00249.x; WARD VK, 1992, INT J BIOCHEM, V24, P1933, DOI 10.1016/0020-711X(92)90289-D; Yanai H., 2011, STATCEL USEFUL ADD I; Zhou XG, 2007, DEVELOPMENT, V134, P601, DOI 10.1242/dev.02755	78	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	SEP	2015	80				SI		22	30		10.1016/j.jinsphys.2015.02.002		9	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CQ3OG	WOS:000360511300004		
J	Matsumoto, H; Ueno, C; Nakamura, Y; Kinjoh, T; Ito, Y; Shimura, S; Noda, H; Imanishi, S; Mita, K; Fujiwara, H; Hiruma, K; Shinoda, T; Kamimura, M				Matsumoto, Hitoshi; Ueno, Chihiro; Nakamura, Yuki; Kinjoh, Terunori; Ito, Yuka; Shimura, Sachiko; Noda, Hiroaki; Imanishi, Shigeo; Mita, Kazuei; Fujiwara, Haruhiko; Hiruma, Kiyoshi; Shinoda, Tetsuro; Kamimura, Manabu			Identification of two juvenile hormone inducible transcription factors from the silkworm, Bombyx mori	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Juvenile hormone; Transcription factor; E75; Enhancer of split; Hemocyte; Ecdysone	KRUPPEL-HOMOLOG 1; ECDYSTEROID-REGULATED GENES; DEVELOPMENTAL EXPRESSION; METHOPRENE-TOLERANT; TOBACCO HORNWORM; NUCLEAR RECEPTOR; MANDUCA-SEXTA; CELL-LINE; GALLERIA-MELLONELLA; INSECT DEVELOPMENT	Juvenile hormone (JH) regulates many physiological processes in insects. However, the signal cascades in which JH is active have not yet been fully elucidated, particularly in comparison to another major hormone ecdysteroid. Here we identified two JH inducible transcription factors as candidate components of JH signaling pathways in the silkworm, Bombyx mori. DNA microarray analysis showed that expression of two transcription factor genes, E75 and Enhancer of split m beta (E(spl)m beta), was induced by juvenile hormone I (JH I) in NIAS-Bm-aff3 cells. Real time RT-PCR analysis confirmed that expression of four E75 isoforms (E75A, E75B, E75C and E75D) and E(spl)m beta was 3-8 times greater after JH I addition. Addition of the protein synthesis inhibitor cycloheximide did not suppress JH-induced expression of the genes, indicating that they were directly induced by JH. JH-induced expression of E75 and E(spl)m beta was also observed in four other B. mori cell lines and in larval hemocytes of final instar larvae. Notably, E75A expression was induced very strongly in larval hemocytes by topical application of the JH analog fenoxycarb; the level of induced expression was comparable to that produced by feeding larvae with 20-hydroxyecdysone. These results suggest that E75 and E(spl)m beta are general and direct target genes of JH and that the transcription factors encoded by these genes play important roles in JH signaling. (C) 2015 Elsevier Ltd. All rights reserved.	[Matsumoto, Hitoshi; Ueno, Chihiro; Nakamura, Yuki; Kinjoh, Terunori; Ito, Yuka; Shimura, Sachiko; Noda, Hiroaki; Imanishi, Shigeo; Mita, Kazuei; Shinoda, Tetsuro; Kamimura, Manabu] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Kinjoh, Terunori; Hiruma, Kiyoshi] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Fujiwara, Haruhiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	Kamimura, M (reprint author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	kamimura@affrc.go.jp			Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), Japan	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), Japan.	Dubrovsky EB, 2014, ADV INSECT PHYSIOL, V46, P305, DOI 10.1016/B978-0-12-417010-0.00004-5; Furuta K, 2013, BIOSCI BIOTECH BIOCH, V77, P988, DOI 10.1271/bbb.120883; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Nakamura Y, 2011, INSECT MOL BIOL, V20, P279, DOI 10.1111/j.1365-2583.2010.01056.x; Zhu JS, 2010, INSECT BIOCHEM MOLEC, V40, P23, DOI 10.1016/j.ibmb.2009.12.004; Gauhar Z, 2009, GENOME RES, V19, P1006, DOI 10.1101/gr.081349.108; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Tanaka H, 2009, MOL BIOTECHNOL, V41, P173, DOI 10.1007/s12033-008-9108-x; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Beckstead RB, 2007, INSECT BIOCHEM MOLEC, V37, P570, DOI 10.1016/j.ibmb.2007.03.001; Bigot L, 2012, INSECT BIOCHEM MOLEC, V42, P22, DOI 10.1016/j.ibmb.2011.10.003; Delidakis Christos, 2014, V110, P217, DOI 10.1016/B978-0-12-405943-6.00006-3; Dubrovskaya VA, 2004, GENE, V340, P171, DOI 10.1016/j.gene.2004.07.022; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; Dubrovsky EB, 2004, DEV BIOL, V268, P258, DOI 10.1016/j.ydbio.2004.01.009; Duncan EJ, 2010, GENOME RES, V20, P917, DOI 10.1101/gr.104794.109; GRENIER S, 1993, ANN APPL BIOL, V122, P369, DOI 10.1111/j.1744-7348.1993.tb04042.x; Imanishi S., 2006, Sanshi Konchuu Biotec (Journal of Insect Biotechnology and Sericology), V75, P45; Imanishi S., 2002, P 2002 C IN VITR BIO, P16; Jennings BH, 1999, MOL CELL BIOL, V19, P4600; JINDRA M, 1994, EUR J BIOCHEM, V221, P665, DOI 10.1111/j.1432-1033.1994.tb18779.x; Jindra M, 1996, DEV GENES EVOL, V206, P305, DOI 10.1007/s004270050057; Kamimura M, 1998, APPL ENTOMOL ZOOL, V33, P333; Kamimura Manabu, 2003, Journal of Insect Biotechnology and Sericology, V72, P197; Kamimura M, 2012, J BIOL CHEM, V287, P16488, DOI 10.1074/jbc.M112.341180; Kamimura M, 2014, APPL ENTOMOL ZOOL, V49, P443, DOI 10.1007/s13355-014-0271-1; Kanamori Y, 2010, J BIOL CHEM, V285, P36933, DOI 10.1074/jbc.M110.180398; Keshan B, 2006, DEV BIOL, V295, P623, DOI 10.1016/j.ydbio.2006.03.049; Lan Q, 1997, INSECT MOL BIOL, V6, P3, DOI 10.1046/j.1365-2583.1997.00151.x; Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021; Mane-Padros D, 2008, DEV BIOL, V315, P147, DOI 10.1016/j.ydbio.2007.12.015; Matsuoka T, 2000, DEV GENES EVOL, V210, P120, DOI 10.1007/s004270050018; MITSUHASHI J, 1984, ZOOL SCI, V1, P415; Palli SR, 1997, DEV GENET, V20, P36, DOI 10.1002/(SICI)1520-6408(1997)20:1<36::AID-DVG5>3.0.CO;2-A; Path S.R., 1995, INSECT BIOCHEM MOLEC, V25, P697; Paul RK, 2006, ZOOL SCI, V23, P1085, DOI 10.2108/zsj.23.1085; Pierceall WE, 1999, MOL CELL ENDOCRINOL, V150, P73, DOI 10.1016/S0303-7207(99)00022-2; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Riddiford L.M., 1985, P37; Riddiford L.M., 1979, TCA (TISSUE CULTURE ASSOCIATION) MANUAL, V5, P975, DOI 10.1007/BF00919715; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Shimomura M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-486; Shirai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049348; Shpigler H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100650; Siaussat D, 2004, EUR J BIOCHEM, V271, P3017, DOI 10.1111/j.1432-1033.2004.04233.x; Soin T, 2008, J INSECT PHYSIOL, V54, P429, DOI 10.1016/j.jinsphys.2007.11.001; Suetsugu Y., 2013, BOMBYX MORI BETHES G, VG3, P1481; Suzuki MG, 2008, MOL CELL BIOL, V28, P333, DOI 10.1128/MCB.01528-07; Swevers L, 2002, INSECT BIOCHEM MOLEC, V32, P1643, DOI 10.1016/S0965-1748(02)00104-2; Takahashi Tadashi, 2006, Journal of Insect Biotechnology and Sericology, V75, P79; Velarde RA, 2009, J INSECT PHYSIOL, V55, P59, DOI 10.1016/j.jinsphys.2008.10.006; Zhou BH, 1998, DEV BIOL, V193, P127, DOI 10.1006/dbio.1997.8798	60	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	SEP	2015	80				SI		31	41		10.1016/j.jinsphys.2015.02.011		11	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CQ3OG	WOS:000360511300005		
J	Ogihara, MH; Hikiba, J; Iga, M; Kataoka, H				Ogihara, Mari H.; Hikiba, Juri; Iga, Masatoshi; Kataoka, Hiroshi			Negative regulation of juvenile hormone analog for ecdysteroidogenic enzymes	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Dauer larvae; Ecdysteroidogenesis; Ecdysteroidogenic enzymes; Fenoxycarb; Juvenile hormone analog	SILKWORM BOMBYX-MORI; TANDEM MASS-SPECTROMETRY; PROTHORACICOTROPIC HORMONE; DROSOPHILA-MELANOGASTER; ECDYSONE BIOSYNTHESIS; DAUER LARVAE; 5TH INSTAR; FENOXYCARB; EXPRESSION; METAMORPHOSIS	Disruption of the appropriate balance between juvenile hormone (JH) and ecdysteroids causes abnormal insect development. The application of a JH analog (JHA) during the early days of the final (fifth) instar induces dauer larvae with low ecdysteroid titers in insects, but the mechanism that underlies the action of JHA remains unclear. In this study, we clarified the negative effects of JHA on ecdysteroidogenic enzymes. JHA application to Bombyx mod larvae during the early stage of the fifth instar suppressed the expression of four enzymes, i.e., neverland (nvd), spook, phantom, and disembodied but not non-molting glossy and shadow. Furthermore, JHA application reduced the amount of 7-dehydrocholesterol, a metabolite produced by Nvd, in both the prothoracic glands and hemolymph, indicating JHA can disrupt ecdysteroidogenic pathway from the first step. Neck ligation resulted in increased nvd expression, whereas JHA application reversed this increase. These results suggest that the endogenous JH represses ecdysteroidogenesis during the early days in final instar larvae. Neck ligation and JHA application had no substantial effects on the expression of a transcription factor, ftz-f1, or a prothoracicotropic hormone receptor, torso; therefore, the inhibitory regulation of JHA may not involve these factors. Further analysis is required to clarify the regulation of JHA in ecdysteroidogenesis, but this study showed that JHA, and probably endogenous JH, can suppress the transcription of four of six ecdysteroidogenic enzymes. This regulation may be essential for maintaining the appropriate balance between JH and ecdysone during insect development. (C) 2015 Elsevier Ltd. All rights reserved.	[Ogihara, Mari H.; Hikiba, Juri; Iga, Masatoshi; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778562, Japan	Ogihara, MH (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Kasiwano Ha 5-1-5, Kashiwa, Chiba 2778562, Japan.	m-h-ogihara@ib.k.u-tokyo.ac.jp; kataoka@k.u-tokyo.ac.jp			Promotion of Basic Research Activities for Innovation Biosciences; Suntory Foundation for Life Sciences	This study was supported partly by Promotion of Basic Research Activities for Innovation Biosciences (to H.K.). This study was also supported partly by a SUNBOR GRANT from the Suntory Foundation for Life Sciences (to M.H.O.).	Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; SAKURAI S, 1989, GEN COMP ENDOCR, V75, P222, DOI 10.1016/0016-6480(89)90074-9; Yamanaka N, 2005, J BIOL CHEM, V280, P14684, DOI 10.1074/jbc.M500308200; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Hikiba J, 2013, J CHROMATOGR B, V915, P52, DOI 10.1016/j.jchromb.2012.12.014; Dedos SG, 1996, GEN COMP ENDOCR, V104, P213, DOI 10.1006/gcen.1996.0164; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Yamanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P2808, DOI 10.1271/bbb.70420; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Xiang YH, 2010, DEV BIOL, V344, P800, DOI 10.1016/j.ydbio.2010.05.510; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; ISHIZAKI H, 1994, INT J DEV BIOL, V38, P301; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Dedos SG, 1999, J INSECT PHYSIOL, V45, P769, DOI 10.1016/S0022-1910(99)00058-X; Dedos SG, 2002, J INSECT PHYSIOL, V48, P857, DOI 10.1016/S0022-1910(02)00155-5; Iga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103239; Igarashi F, 2011, ANAL BIOCHEM, V419, P123, DOI 10.1016/j.ab.2011.08.046; KAJIURA Z, 1992, COMP BIOCHEM PHYS A, V101, P277; Kamimura M, 2002, GEN COMP ENDOCR, V128, P231, DOI 10.1016/S0016-6480(02)00507-5; KAMIMURA M, 1995, APPL ENTOMOL ZOOL, V30, P487; Maeda S, 2008, COMP BIOCHEM PHYS B, V149, P507, DOI 10.1016/j.cbpb.2007.11.015; Niimi S, 1997, J INSECT PHYSIOL, V43, P875, DOI 10.1016/S0022-1910(97)00021-8; Rewitz KF, 2006, MOL CELL ENDOCRINOL, V247, P166, DOI 10.1016/j.mce.2005.12.053; SAKURAI S, 1988, ARCH INSECT BIOCHEM, V8, P219, DOI 10.1002/arch.940080403; Sztal T, 2007, INSECT BIOCHEM MOLEC, V37, P1044, DOI 10.1016/j.ibmb.2007.05.017; Tanaka Y., 2011, ENDOCRINOLOGY, V2, P107; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	SEP	2015	80				SI		42	47		10.1016/j.jinsphys.2015.03.012		6	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CQ3OG	WOS:000360511300006		
J	Minakuchi, C; Ishii, F; Washidu, Y; Ichikawa, A; Tanaka, T; Miura, K; Shinoda, T				Minakuchi, Chieka; Ishii, Fumika; Washidu, Yumiko; Ichikawa, Akio; Tanaka, Toshiharu; Miura, Ken; Shinoda, Tetsuro			Expressional and functional analysis of CYP15A1, a juvenile hormone epoxidase, in the red flour beetle Tribolium castaneum	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Juvenile hormone; Tribolium castaneum; CYP15; Epoxidation	ACID-O-METHYLTRANSFERASE; KEY REGULATORY ENZYME; CORPORA-ALLATA; MANDUCA-SEXTA; LIQUID-CHROMATOGRAPHY; METHOPRENE-TOLERANT; MEVALONATE PATHWAY; TOBACCO HORNWORM; BIOSYNTHESIS; METAMORPHOSIS	Juvenile hormone (JH) is synthesized and secreted by the corpora allata. In the final two steps of JH biosynthesis, farnesoic acid (FA) is converted to JH through methylation by JH acid O-methyltransferase (JHAMT) and epoxidation by the cytochrome P450 enzyme CYP15. In the present study, we identified a homolog of CYP15 from the red flour beetle Tribolium castaneum (TcCYP15A1), and analyzed its expression as well as its role in JH biosynthesis. Quantitative RT-PCR analysis showed that the level of TcCYP15A1 mRNA was high in the embryonic stage as well as in the middle of the final larval instar. In the embryonic stage, the transcript level of TcCYP15A1 started to increase 30 h after egg laying (AEL), peaked 54-60 h AEL, and was followed by an increase of TcJHAMT mRNA, suggesting that JH biosynthesis started at this time point. TcCYP15A1 mRNA was present, but not exclusively so in the larval corpora allata. The recombinant TcCYP15A1 protein epoxidized both FA and methyl farnesoate (MF) in highly stereo-specific manners. These results confirmed that TcCYP15A1 is involved in JH biosynthesis. The RNAi-mediated knockdown of TcCYP15A1 in the pre-final larval instar did not result in precocious metamorphosis to pupa, indicating that MF may exhibit JH-like activity in order to maintain the larval status. The double knockdown of TcJHAMT and TcCYP15A1 resulted in pupae and adults with shorter wings, suggesting that the precursors of JH, JH acid and MF, may be essential for wing expansion. (C) 2015 Elsevier Ltd. All rights reserved.	[Minakuchi, Chieka; Ishii, Fumika; Washidu, Yumiko; Tanaka, Toshiharu; Miura, Ken] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ichikawa, Akio; Shinoda, Tetsuro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	Minakuchi, C (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furocho, Nagoya, Aichi 4648601, Japan.	c_mina@agr.nagoya-u.ac.jp			JSPS KAKENHI [25252059, 23780050]	We thank Dr. A. Miyanoshita (National Food Research Institute, Japan) for providing T. castaneum, and Dr. Takumi Kayukawa and Ms. Michiyo Yoshiyama (National Institute of Agrobiological Sciences) for their technical assistance in cell cultures. Financial support for this research was provided by JSPS KAKENHI Grant Number 25252059 to T.S., and Number 23780050 to C.M.	Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Daimon T, 2013, BIOTECHNOL APPL BIOC, V60, P82, DOI 10.1002/bab.1058; Mayoral JG, 2009, INSECT BIOCHEM MOLEC, V39, P31, DOI 10.1016/j.ibmb.2008.09.010; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Parthasarathy R, 2009, MECH DEVELOP, V126, P563, DOI 10.1016/j.mod.2009.03.005; BOROVSKY D, 1994, INSECT BIOCHEM MOLEC, V24, P437, DOI 10.1016/0965-1748(94)90038-8; Jones G, 2010, J INSECT PHYSIOL, V56, P1456, DOI 10.1016/j.jinsphys.2010.06.001; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; WILLIAMS CM, 1961, BIOL BULL, V121, P572, DOI 10.2307/1539456; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Sheng ZT, 2008, ARCH INSECT BIOCHEM, V69, P143, DOI 10.1002/arch.20268; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; Cerny AC, 2005, DEVELOPMENT, V132, P5353, DOI 10.1242/dev.02154; Harshman LG, 2010, J INSECT PHYSIOL, V56, P1465, DOI 10.1016/j.jinsphys.2010.06.003; Ichikawa A, 2007, J CHROMATOGR A, V1161, P252, DOI 10.1016/j.chroma.2007.06.003; Ichikawa A, 2010, NAT PROD RES, V24, P1800, DOI 10.1080/14786411003752045; JUDY KJ, 1973, P NATL ACAD SCI USA, V70, P1509, DOI 10.1073/pnas.70.5.1509; JUDY KJ, 1975, LIFE SCI, V16, P1059, DOI 10.1016/0024-3205(75)90190-3; KIGUCHI K, 1978, J INSECT PHYSIOL, V24, P673, DOI 10.1016/0022-1910(78)90063-X; Li WF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068544; Reibstein D., 1976, The juvenile hormones., P131; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Schooley D.A., 1985, COMPREHENSIVE INSECT, V7, P363; SPARAGANA SP, 1985, ARCH INSECT BIOCHEM, V2, P191, DOI 10.1002/arch.940020207; Tian L, 2010, ARCH INSECT BIOCHEM, V75, P275, DOI 10.1002/arch.20395; WEIRICH GF, 1979, ARCH BIOCHEM BIOPHYS, V198, P175, DOI 10.1016/0003-9861(79)90408-9; Yokoi Kakeru, 2012, Results Immunol, V2, P72, DOI 10.1016/j.rinim.2012.03.002	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	SEP	2015	80				SI		61	70		10.1016/j.jinsphys.2015.04.008		10	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CQ3OG	WOS:000360511300008		
J	Saito, Y; Kamita, SG; Hammock, BD; Kunimi, Y; Inoue, MN; Nakai, M				Saito, Yasumasa; Kamita, Shizuo G.; Hammock, Bruce D.; Kunimi, Yasuhisa; Inoue, Maki N.; Nakai, Madoka			Juvenile hormone (JH) esterase activity but not JH epoxide hydrolase activity is downregulated in larval Adoxophyes honmai following nucleopolyhedroviruses infection	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Adoxophyes honmai; Juvenile hormone esterase (JHE); JH epoxide hydrolase (JHEH); Baculovirus; Nucleopolyhedrovirus; qRT-PCR	SUMMER FRUIT TORTRIX; SMALLER TEA TORTRIX; BOMBYX-MORI; MOLECULAR-CLONING; GENE-EXPRESSION; BIOLOGICAL CHARACTERIZATION; DEVELOPMENTAL EXPRESSION; HELIOTHIS-VIRESCENS; GRYLLUS-ASSIMILIS; CDNA CLONING	Juvenile hormones (JHs) and ecdysteroids are critical insect developmental hormones. JH esterase (JHE) and JH epoxide hydrolase (JHEH) are JH-selective enzymes that metabolize JH and thus regulate the titer of JH. Baculoviruses are known to alter host endocrine regulation. The nucleopolyhedroviruses, AdhoNPV and AdorNPV, are known to have slow and fast killing activity against Adoxophyes honmai (Lepidoptera: Tortricidae), respectively. Here we found that when penultimate (4th) instar A. honmai are inoculated with AdhoNPV or AdorNPV, the mean survival time is 9.7 and 8.2 days, respectively. The larvae molted once but did not pupate. The AdhoNPV- or AdorNPV-infected larvae did not show a dramatic increase in JHE activity as was found in mock-infected larvae, instead they showed a marked decrease in JHE activity. In contrast, both viral infections had no effect on JHEH activity. In order to further characterize the JHE activity, the JHE-coding sequence of A. honmai (ahjhe) was cloned and confirmed to encode a biologically active JHE. Quantitative real-time PCR analysis of ahjhe expression in 4th and 5th instar A. honmai revealed that AdhoNPV and AdorNPV are able to reduce ahjhe expression levels. (C) 2015 Elsevier Ltd. All rights reserved.	[Saito, Yasumasa; Kunimi, Yasuhisa; Inoue, Maki N.; Nakai, Madoka] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Dept Biol Prod Sci, Fuchu, Tokyo 1838509, Japan; [Saito, Yasumasa; Kamita, Shizuo G.; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Saito, Yasumasa; Kamita, Shizuo G.; Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA	Nakai, M (reprint author), Tokyo Univ Agr & Technol, Inst Agr, Dept Appl Biol Sci, Fuchu, Tokyo 183, Japan.	madoka@cc.tuat.ac.jp			Overseas Intensive Short-term Course fellowship of United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology	This work was partially supported by an Overseas Intensive Short-term Course fellowship (2013) of United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology to Y.S.	ABDELAAL YAI, 1985, INSECT BIOCHEM, V15, P111, DOI 10.1016/0020-1790(85)90051-4; Anand A, 2008, J INSECT PHYSIOL, V54, P1323, DOI 10.1016/j.jinsphys.2008.06.006; Zhang QR, 2005, INSECT BIOCHEM MOLEC, V35, P153, DOI 10.1016/j.ibmb.2004.10.010; Nakai M, 2002, PHYSIOL ENTOMOL, V27, P157, DOI 10.1046/j.1365-3032.2002.00282.x; Ismail SM, 2000, J INSECT PHYSIOL, V46, P59, DOI 10.1016/S0022-1910(99)00102-X; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Li S, 2003, J INSECT PHYSIOL, V49, P1021, DOI 10.1016/S0022-1910(03)00185-9; Kamita SG, 2010, J PESTIC SCI, V35, P265, DOI 10.1584/jpestics.R10-09; Kunimi Y, 1996, J INVERTEBR PATHOL, V68, P310, DOI 10.1006/jipa.1996.0101; Gatehouse HS, 2009, INSECT MOL BIOL, V18, P635, DOI 10.1111/j.1365-2583.2009.00904.x; Mackert A, 2008, COMP BIOCHEM PHYS B, V150, P33, DOI 10.1016/j.cbpb.2008.01.004; Hirai M, 2002, INSECT BIOCHEM MOLEC, V32, P627, DOI 10.1016/S0965-1748(01)00141-2; Ishii T, 2003, J INVERTEBR PATHOL, V83, P206, DOI 10.1016/S0022-2011(03)00087-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Kamita SG, 2003, INSECT BIOCHEM MOLEC, V33, P1261, DOI 10.1016/j.ibmb.2003.08.004; Ishii T, 2002, BIOL CONTROL, V23, P96, DOI 10.1006/bcon.2001.0988; Hajos JP, 1999, INSECT MOL BIOL, V8, P539, DOI 10.1046/j.1365-2583.1999.00150.x; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Kunimi Y, 2007, J INVERTEBR PATHOL, V95, P181, DOI 10.1016/j.jip.2007.03.007; Campbell PM, 2001, INSECT BIOCHEM MOLEC, V31, P513, DOI 10.1016/S0965-1748(01)00035-2; Bai H, 2007, INSECT BIOCHEM MOLEC, V37, P829, DOI 10.1016/j.ibmb.2007.05.010; Crone EJ, 2007, INSECT BIOCHEM MOLEC, V37, P540, DOI 10.1016/j.ibmb.2007.02.010; Crone EJ, 2007, INSECT BIOCHEM MOLEC, V37, P1359, DOI 10.1016/j.ibmb.2007.08.005; Feng QL, 1999, MOL CELL ENDOCRINOL, V148, P95, DOI 10.1016/S0303-7207(98)00228-7; Hammock BD, 1985, COMPREHENSIVE INSECT, P431; HAMMOCK BD, 1977, ANAL BIOCHEM, V82, P573, DOI 10.1016/0003-2697(77)90196-8; HANZLIK TN, 1989, J BIOL CHEM, V264, P12419; HAYAKAWA Y, 1995, J INSECT PHYSIOL, V41, P1, DOI 10.1016/0022-1910(94)00077-T; Hilton S, 2008, J GEN VIROL, V89, P2898, DOI 10.1099/vir.0.2008/002881-0; Hilton S, 2008, J INVERTEBR PATHOL, V97, P298, DOI 10.1016/j.jip.2007.09.011; Hinton AC, 2001, INSECT BIOCHEM MOLEC, V32, P57, DOI 10.1016/S0965-1748(01)00079-0; Hinton AC, 2003, INSECT BIOCHEM MOLEC, V33, P477, DOI 10.1016/S0965-1748(03)00010-9; Hussain M, 2014, J INSECT PHYSIOL, V70, P151, DOI 10.1016/j.jinsphys.2014.08.003; Kamita SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028392; Keiser KCL, 2002, ARCH INSECT BIOCHEM, V50, P191, DOI 10.1002/arch.10044; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Merrington CL, 1999, PRACT APPROACH SER, V202, P101; Munyiri FN, 2007, INSECT BIOCHEM MOLEC, V37, P497, DOI 10.1016/j.ibmb.2007.02.006; Nakai M, 2003, VIROLOGY, V316, P171, DOI 10.1016/S0042-6822(03)00599-3; Nakai M, 2004, VIRUS RES, V101, P185, DOI 10.1016/j.virusres.2004.01.003; Rasband W., 2009, IMAGEJ; Seino A, 2010, BIOSCI BIOTECH BIOCH, V74, P1421, DOI 10.1271/bbb.100104; Shiotsuki T, 2000, BIOSCI BIOTECH BIOCH, V64, P1681, DOI 10.1271/bbb.64.1681; Takahashi M, 2008, BIOL CONTROL, V46, P542, DOI 10.1016/j.biocontrol.2008.06.003; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Tsubota T, 2010, INSECT MOL BIOL, V19, P527, DOI 10.1111/j.1365-2583.2010.01019.x; van Oers MM, 2011, J INVERTEBR PATHOL, V107, pS3, DOI 10.1016/j.jip.2011.05.001; WEYER U, 1990, J GEN VIROL, V71, P1525, DOI 10.1099/0022-1317-71-7-1525	49	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	SEP	2015	80				SI		71	80		10.1016/j.jinsphys.2015.02.005		10	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CQ3OG	WOS:000360511300009		
J	de Vries, PJ; D'Augeres, GB; Belousova, E; Carter, T; Castellana, R; Cottin, V; Crippa, S; Curatolo, P; Ferreira, JC; Fladrowski, C; Feucht, M; Gislimberti, G; Hertzberg, C; Qin, J; Jozwiak, S; Kingswood, JC; Lawson, J; Macaya, A; Nabbout, R; O'Callaghan, F; Benedik, MP; Sander, V; Sauter, M; Takahashi, Y; Touraine, R; Youroukos, S; Ulker, B; Zonnenberg, B; Jansen, A				de Vries, P. J.; D'Augeres, G. B.; Belousova, E.; Carter, T.; Castellana, R.; Cottin, V.; Crippa, S.; Curatolo, P.; Ferreira, J. C.; Fladrowski, C.; Feucht, M.; Gislimberti, G.; Hertzberg, C.; Qin, J.; Jozwiak, S.; Kingswood, J. C.; Lawson, J.; Macaya, A.; Nabbout, R.; O'Callaghan, F.; Benedik, M. P.; Sander, V.; Sauter, M.; Takahashi, Y.; Touraine, R.; Youroukos, S.; Ulker, B.; Zonnenberg, B.; Jansen, A.			TSC-ASSOCIATED NEUROPSYCHIATRIC DISORDERS (TAND): BASELINE DATA FROM THE TOSCA INTERNATIONAL DISEASE REGISTRY	JOURNAL OF INTELLECTUAL DISABILITY RESEARCH			English	Meeting Abstract						intellectual disability; TAND; TOSCA; TSC			[de Vries, P. J.] Univ Cape Town, Div Child & Adolescent Psychiat, ZA-7925 Cape Town, South Africa; [D'Augeres, G. B.] Assoc Sclerose Tubereuse Bourneville, Gradignan, France; [Belousova, E.] Moscow Inst Pediat & Pediat Surg, Moscow, Russia; [Carter, T.] TSA Tuberous Sclerosis Assoc, Nottingham, England; [Castellana, R.] Novartis Farmaceut SA, Barcelona, Spain; [Cottin, V.] Univ Lyon 1, Hop Louis Pradel, F-69365 Lyon, France; [Crippa, S.; Gislimberti, G.] Novartis Farma SpA, Origgio, Italy; [Curatolo, P.] Tor Vergata Univ Hosp, Rome, Italy; [Ferreira, J. C.] Ctr Hosp Lisboa Ocidental, Lisbon, Portugal; [Fladrowski, C.] Assoc Sclerosi Tuberosa ONLUS, Milan, Italy; [Fladrowski, C.] European Tuberous Sclerosis Complex Assoc, Dattein, Germany; [Feucht, M.] Univ Klin Kinder & Jugendheilkunde, Vienna, Austria; [Hertzberg, C.] Vivantes Klinikum Neukolln, Berlin, Germany; [Qin, J.] Peking Univ, Peoples Hosp PKUPH, Dept Pediat, Beijing 100871, Peoples R China; [Jozwiak, S.] Med Univ Warsaw, Dept Child Neurol, Warsaw, Poland; [Kingswood, J. C.] Royal Sussex Cty Hosp, Sussex Kidney Unit, Brighton BN2 5BE, E Sussex, England; [Lawson, J.] Sydney Childrens Hosp, Tuberous Sclerosis Multidisciplinary Management C, Randwick, NSW, Australia; [Macaya, A.] Hosp Univ Vall dHebron, Barcelona, Spain; [Nabbout, R.] Hosp Necker Enfants Malades, Paris, France; [O'Callaghan, F.] UCL, Inst Child Hlth, London, England; [Benedik, M. P.] SPS Pediat Klin, Ljubljana, Slovenia; [Sander, V.] Tallinn Children Hosp, Tallinn, Estonia; [Sauter, M.] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Takahashi, Y.] NHO, Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan; [Touraine, R.] Hop Nord St Etienne, St Etienne, France; [Youroukos, S.] St Sophia Childrens Hosp, Athens, Greece; [Ulker, B.] Novartis Pharma AG, Basel, Switzerland; [Zonnenberg, B.] Univ Med Ctr, Utrecht, Netherlands; [Jansen, A.] UZ Brussel VUB, Pediat Neurol Unit, Brussels, Belgium								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0964-2633	1365-2788		J INTELL DISABIL RES	J. Intell. Disabil. Res.	SEP	2015	59	9					788	789				2	Education, Special; Genetics & Heredity; Clinical Neurology; Psychiatry; Rehabilitation	Education & Educational Research; Genetics & Heredity; Neurosciences & Neurology; Psychiatry; Rehabilitation	CP9KS	WOS:000360213600005		
J	Iijima, K; Fujikubo, M				Iijima, Kazuhiro; Fujikubo, Masahiko			Cumulative collapse of a ship hull girder under a series of extreme wave loads	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						Hull girder; Post-ultimate strength behavior; Cumulative collapse; Extreme wave; Still-water bending moment		This paper addresses the cumulative collapse behavior of a ship hull girder under a series of extreme wave loads. It is a follow-up of the previous work done by the present authors. In the previous work, the post-ultimate strength behavior under a single extreme wave was investigated by using numerical simulations and tank tests. The reduction in the vertical bending moment after reaching the ultimate strength was not reproduced in the scaled model. In the present work, a more realistic hull girder capacity model is employed. We introduce a new type of model whose hull girder bending moment capacity decreases after its ultimate strength. A series of the focused waves with the same time history are generated and applied to the scaled model in the tank tests. It is observed that the still-water bending moment decreases with the development of the plastic deformations. The development rate of collapse per one focused wave becomes smaller under a series of focused waves if the reduction rate of the still-water bending moment is larger than the reduction rate of the bending moment capacity after the ultimate strength.	[Iijima, Kazuhiro; Fujikubo, Masahiko] Osaka Univ, Dept Naval Architecture & Ocean Engn, Suita, Osaka, Japan	Iijima, K (reprint author), Osaka Univ, Dept Naval Architecture & Ocean Engn, Suita, Osaka, Japan.	iijima@naoe.eng.osaka-u.ac.jp			KAKENHI [23656549]	The present work was partially supported by KAKENHI, Grant-in-Aid for Challenging Exploratory Research (23656549), 2012.	Xu WJ, 2012, J MAR SCI TECH-JAPAN, V17, P203, DOI 10.1007/s00773-012-0158-1; Iijima K, 2011, J MAR SCI TECH-JAPAN, V16, P379, DOI 10.1007/s00773-011-0142-1; Jensen JJ, 2006, PROBABILIST ENG MECH, V21, P330, DOI 10.1016/j.probengmech.2005.11.007; Bureau d'Enquetes sur lesve Enements de Mer BEAmer, 2003, PERT TOT SUIT AV COQ; Der Kiureghian A., 2000, PROBALISTIC ENG MECH, V15, P81, DOI 10.1016/S0266-8920(99)00011-9; Fujino M, 1984, J SOC NAV ARCH JPN, V156, P144; IACS, 2005, COMM STRUCT RUL BULK; IACS, 2005, COMM STRUCT RUL DOUB; Kimura K, 2010, P PAAMES 2010 SING, P65; Lehmann E, 2006, P 16 ISSC SOUTH UK, V3, P121; MALTA Maritime Authority, 2000, REP INV LOSS MOT TAN; Wada R, 2010, P PAAMES 2010 SING; Watanebe I, 1998, J MARINE SCI TECHNOL, V3, P171, DOI 10.1007/BF02492932; Xu W, 2011, P 30 INT C OC OFFSH; Xu W, 2011, P MARSTRUCT 2011 HAM, P239; Yao T, 2006, P 16 ISSC SOUTH UK, V1, P356; Yao T., 2009, P 19 INT OFFSH POL E, P706; Yao T, 1998, J MARINE SCI TECHNOL, V3, P181, DOI 10.1007/BF02492933	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	SEP	2015	20	3					530	541		10.1007/s00773-015-0308-3		12	Engineering, Marine; Engineering, Civil	Engineering	CQ3NE	WOS:000360508200012		
J	Aoki, K; Nikolov, K				Aoki, Kosuke; Nikolov, Kalin			Bubbles, banks and financial stability	JOURNAL OF MONETARY ECONOMICS			English	Article						Rational bubbles; Banks; Credit frictions	HOUSING BUBBLES; LIQUIDITY; BUSINESS; RISK	The macroeconomic impact of rational bubbles in a limited commitment economy crucially depends on whether banks or ordinary savers hold the bubble. Banks hold the bubble asset when their leverage is high, when long-term real interest rates are low or when lax supervision allows them to enjoy high deposit insurance subsidies. When banks are the bubble-holders, this amplifies the output boom by reducing loan-deposit rate spreads while the bubble survives but also deepens the recession when the bubble bursts. In contrast, the real impact of bubbles held by ordinary savers is more muted. (C) 2015 Elsevier B.V. All rights reserved.	[Aoki, Kosuke] Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1030033, Japan; [Nikolov, Kalin] European Cent Bank, Frankfurt, Germany	Aoki, K (reprint author), Univ Tokyo, Fac Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1030033, Japan.	kaoki@e.u-tokyo.ac.jp			Center for Advanced Research in Finance (CARF); University of Tokyo; JSPS [25380223]	We are especially grateful to the editor of the Journal, an anonymous referee, and Jaume Ventura whose excellent comments helped us improve the paper a lot. We also thank Sergi Basco, Henrik Borchgrevink, Russell Cooper, Wouter den Haan, Piti Disyatat, Martin Eichenbaum, Philipp Hartmann, Jonathan Heathcote, Xavier Freixas, Roman Inderst, Peter Karadi, Nobu Kiyotaki, Alberto Martin, Tomoyuki Nakajima, Helene Rey, Victor Rios-Rull, Immo Schott, Shigenori Shiratsuka, Javier Suarez, Harald Uhlig, Christopher Waller and Philippe Weil. Aoki thanks financial support from the Center for Advanced Research in Finance (CARF), the University of Tokyo and the JSPS Grant-in-Aid for Scientific Research No. 25380223.	Farhi E, 2012, REV ECON STUD, V79, P678, DOI 10.1093/restud/rdr039; Ventura J, 2012, J ECON THEORY, V147, P738, DOI 10.1016/j.jet.2011.03.016; Miao JJ, 2015, J ECON THEORY, V157, P763, DOI 10.1016/j.jet.2015.02.004; Caballero RJ, 2006, J MONETARY ECON, V53, P35, DOI 10.1016/j.jmoneco.2005.10.005; Gertler M, 2011, J MONETARY ECON, V58, P17, DOI 10.1016/j.jmoneco.2010.10.004; Acharya VV, 2013, J FINANC ECON, V107, P515, DOI 10.1016/j.jfineco.2012.09.004; Eisfeldt AL, 2006, J MONETARY ECON, V53, P369, DOI 10.1016/j.jmoneco.2005.04.006; Gilchrist S, 2012, AM ECON REV, V102, P1692, DOI 10.1257/aer.102.4.1692; Martin A, 2012, AM ECON REV, V102, P3033, DOI 10.1257/aer.102.6.3033; Claessens S, 2012, J INT ECON, V87, P178, DOI 10.1016/j.jinteco.2011.11.008; Aoki K., 2010, 8087 CEPR; Arce O, 2011, AM ECON J-MACROECON, V3, P212, DOI 10.1257/mac.3.1.212; Basco S, 2014, J INT ECON, V92, P78, DOI 10.1016/j.jinteco.2013.10.008; Calomiris CW, 2009, CATO J, V29, P65; Chakraborty I., 2014, DO ASSET PRICE UNPUB; Gertler M. L, 2010, HDB MONETARY EC, V3, P547, DOI 10.1016/B978-0-444-53238-1.00011-9; Haldane A., 2013, COMMUNICATION; Hirano T., 2010, WORKING PAPER; Jorda O., 2012, IMF ECON REV, V59, P340; KEELEY MC, 1990, AM ECON REV, V80, P1183; Kiyotaki Nobuhiro, 1998, JAPANESE EC REV, V49, P18, DOI 10.1111/1468-5876.00069; Kocherlakota N., 2009, WORKING PAPER; Krugman P., 2014, SECULAR STAGNATION F; Laeven L., 2010, WP10146 IMF; Martinez-Miera D., 2014, BANKS ENDOGENO UNPUB; Miao J., 2011, BUBBLES CREDIT UNPUB; Reinhart C., 2014, ANN ECON FINANC, V15, P1065; Repullo R, 2004, J FINANC INTERMED, V13, P496, DOI 10.1016/j.jfi.2004.07.001; Summers L., 2014, SECULAR STAGNATION F; WEIL P, 1987, Q J ECON, V102, P1, DOI 10.2307/1884677	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3932	1873-1295		J MONETARY ECON	J. Monetary Econ.	SEP	2015	74						33	51		10.1016/j.jmoneco.2015.05.002		19	Business, Finance; Economics	Business & Economics	CQ3PU	WOS:000360515800003		
J	Crucini, MJ; Shintani, M; Tsuruga, T				Crucini, Mario J.; Shintani, Mototsugu; Tsuruga, Takayuki			Noisy information, distance and law of one price dynamics across US cities	JOURNAL OF MONETARY ECONOMICS			English	Article						Real exchange rates; Law of one price; Relative prices; Trade costs	STICKY PRICES; TRADE; CONVERGENCE; PERSISTENCE; BORDER; COSTS; LEVEL	US micro price data at the city level suggests that both the volatility and the persistence of law of one price deviations are rising in the distance between US cities. A standard two-city equilibrium model with trade costs can predict the relationship between volatility and distance but not between persistence and distance. We show that if there is imperfect information about the state of nominal aggregate demand, with noisy signals that are asymmetric across cities, then distance and persistence will be positively correlated. Our main results are shown to be robust to the introduction of sticky prices and multiple cities. (C) 2015 Elsevier B.V. All rights reserved.	[Crucini, Mario J.; Shintani, Mototsugu] Vanderbilt Univ, Dept Econ, Nashville, TN 37235 USA; [Shintani, Mototsugu] Univ Tokyo, RCAST, Tokyo 1138654, Japan; [Tsuruga, Takayuki] Kyoto Univ, Grad Sch Econ, Kyoto 6068501, Japan; [Crucini, Mario J.] NBER, Cambridge, MA 02138 USA; [Crucini, Mario J.; Tsuruga, Takayuki] CAMA, Sydney, NSW, Australia	Crucini, MJ (reprint author), Vanderbilt Univ, Dept Econ, 221 Kirkland Hall, Nashville, TN 37235 USA.	mario.crucini@vanderbilt.edu			National Science Foundation [SES-1030164]	We thank Jeff Campbell, Virgiliu Midrigan, Ricardo Reis, two anonymous referees, and seminar participants at Kyoto University, the University of Tokyo, Otaru University of Commerce for helpful comments and discussions. Crucini and Shintani gratefully acknowledge the financial support of National Science Foundation (SES-1030164). Shintani and Tsuruga gratefully acknowledge the financial support of Grant-in-aid for Scientific Research.	Angeletos G.-M., 2009, J MONETARY ECON, V56, P19; Anderson JE, 2004, J ECON LIT, V42, P691, DOI 10.1257/0022051042177649; Parsley DC, 2001, J INT ECON, V55, P87, DOI 10.1016/S0022-1996(01)00096-4; Eaton J, 2002, ECONOMETRICA, V70, P1741, DOI 10.1111/1468-0262.00352; Huang KXD, 2004, AM ECON REV, V94, P836, DOI 10.1257/0002828042002552; Disdier AC, 2008, REV ECON STAT, V90, P37, DOI 10.1162/rest.90.1.37; Crucini MJ, 2008, J MONETARY ECON, V55, P629, DOI 10.1016/j.jmoneco.2007.12.010; Cecchetti SG, 2002, INT ECON REV, V43, P1081, DOI 10.1111/1468-2354.t01-1-00049; Broda C, 2006, Q J ECON, V121, P541, DOI 10.1162/qjec.2006.121.2.541; Carvalho C, 2011, AM ECON REV, V101, P2391, DOI 10.1257/aer.101.6.2391; Choi CY, 2007, J JPN INT ECON, V21, P260, DOI 10.1016/j.jjie.2006.03.002; Crucini MJ, 2010, J INT ECON, V81, P48, DOI 10.1016/j.jinteco.2010.01.003; Crucini MJ, 2010, ECON J, V120, P462, DOI 10.1111/j.1468-0297.2010.02354.x; Crucini MJ, 2013, EUR ECON REV, V62, P58, DOI 10.1016/j.euroecorev.2013.04.007; Engel C, 1996, AM ECON REV, V86, P1112; Fukunaga I, 2007, J MONEY CREDIT BANK, V39, P1711, DOI 10.1111/j.1538-4616.2007.00084.x; Grossman G.M., 1998, REGIONALIZATION WORL, P29; Helpman E, 2008, Q J ECON, V123, P441, DOI 10.1162/qjec.2008.123.2.441; Hummels D.L., 2001, GEOGRAPHY TRAD UNPUB; Kano K, 2013, J INT ECON, V90, P403, DOI 10.1016/j.jinteco.2013.02.002; Kehoe P.J., 2007, 656 FED RES BANK MIN; LUCAS RE, 1972, J ECON THEORY, V4, P103, DOI 10.1016/0022-0531(72)90142-1; Obstfeld M, 1997, J JPN INT ECON, V11, P441, DOI 10.1006/jjie.1997.0385; Parsley DC, 1996, Q J ECON, V111, P1211, DOI 10.2307/2946713; Phelps E.S., 1970, MICROECONOMIC FDN EM, P1; Mankiw NG, 2002, Q J ECON, V117, P1295, DOI 10.1162/003355302320935034; Nakamura E, 2008, Q J ECON, V123, P1415, DOI 10.1162/qjec.2008.123.4.1415; Woodford M, 2003, KNOWLEDGE, INFORMATION, AND EXPECTATION IN MODERN MACROECONOMICS: IN HONOR OF EDMUND S. PHELPS, P25; Yazgan ME, 2011, ECON LETT, V110, P76, DOI 10.1016/j.econlet.2010.10.013	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3932	1873-1295		J MONETARY ECON	J. Monetary Econ.	SEP	2015	74						52	66		10.1016/j.jmoneco.2015.06.003		15	Business, Finance; Economics	Business & Economics	CQ3PU	WOS:000360515800004		
J	Sunakawa, T				Sunakawa, Takeki			Optimal Monetary Policy with Labor Market Frictions: The Role of the Wage Channel	JOURNAL OF MONEY CREDIT AND BANKING			English	Article						Ramsey-optimal monetary policy; right-to-manage bargaining; wage channel; real wage rigidity; wage markups	KEYNESIAN MODEL; UNEMPLOYMENT FLUCTUATIONS; EQUILIBRIUM UNEMPLOYMENT; CYCLICAL BEHAVIOR; BUSINESS-CYCLE; STICKY PRICES; SEARCH; EFFICIENCY; EMPLOYMENT; VACANCIES	This paper introduces right-to-manage bargaining into a labor search model with sticky prices instead of standard efficient bargaining and examines the Ramsey-optimal monetary policy. Without real wage rigidity, even when the steady state is inefficient, price stability is nearly optimal in response to technology or government shocks. Right-to-manage bargaining creates the wage channel to inflation, because there is a direct relationship between real wages and real marginal cost. In the presence of the wage channel, price markups consist of only real marginal cost, and real wages and hours per worker are determined such as in the Walrasian labor market.	Univ Tokyo, Grad Sch Publ Policy, Tokyo 1138654, Japan	Sunakawa, T (reprint author), Univ Tokyo, Grad Sch Publ Policy, Tokyo 1138654, Japan.	sunakawa@pp.u-tokyo.ac.jp					Andolfatto D, 1996, AM ECON REV, V86, P112; Hall RE, 2008, AM ECON REV, V98, P1653, DOI 10.1257/aer.98.4.1653; Merz M, 1995, J MONETARY ECON, V36, P269, DOI 10.1016/0304-3932(95)01216-8; DIXIT AK, 1977, AM ECON REV, V67, P297; Erceg CJ, 2000, J MONETARY ECON, V46, P281, DOI 10.1016/S0304-3932(00)00028-3; Hall RE, 2005, AM ECON REV, V95, P50, DOI 10.1257/0002828053828482; ROTEMBERG JJ, 1982, REV ECON STUD, V49, P517, DOI 10.2307/2297284; Schmitt-Grohe S, 2004, J ECON DYN CONTROL, V28, P755, DOI 10.1016/S0165-1889(03)00043-5; Krause MU, 2007, J MONETARY ECON, V54, P706, DOI 10.1016/j.jmoneco.2005.12.001; Blanchard O, 2007, J MONEY CREDIT BANK, V39, P35, DOI 10.1111/j.1538-4616.2007.00015.x; Thomas C, 2008, J MONETARY ECON, V55, P936, DOI 10.1016/j.jmoneco.2008.03.007; Gertler M, 2009, J POLIT ECON, V117, P38; Shimer R, 2005, AM ECON REV, V95, P25, DOI 10.1257/0002828053828572; Hagedorn M, 2008, AM ECON REV, V98, P1692, DOI 10.1257/aer.98.4.1692; Benigno P, 2012, J ECON THEORY, V147, P1, DOI 10.1016/j.jet.2011.10.012; Blanchard O, 2010, AM ECON J-MACROECON, V2, P1, DOI 10.1257/mac.2.2.1; BARRO RJ, 1977, J MONETARY ECON, V3, P305, DOI 10.1016/0304-3932(77)90024-1; Chari VV, 2007, ECONOMETRICA, V75, P781, DOI 10.1111/j.1468-0262.2007.00768.x; Cheremukhin AA, 2014, EUR ECON REV, V68, P71, DOI 10.1016/j.euroecorev.2014.02.008; Christoffel K, 2010, J MONEY CREDIT BANK, V42, P1435, DOI 10.1111/j.1538-4616.2010.00348.x; Christoffel K, 2008, J MONETARY ECON, V55, P865, DOI 10.1016/j.jmoneco.2009.03.009; Faia E, 2009, J MONETARY ECON, V56, P570, DOI 10.1016/j.jmoneco.2009.03.009; Gali J, 2007, REV ECON STAT, V89, P44, DOI 10.1162/rest.89.1.44; HOSIOS AJ, 1990, REV ECON STUD, V57, P279, DOI 10.2307/2297382; Leontief W, 1946, J POLIT ECON, V54, P76, DOI 10.1086/256311; NICKELL SJ, 1983, OXFORD ECON PAP, V35, P183; Pescatori Andrea, 2011, 1111 FED RES BANK CL; Ravenna F, 2011, AM ECON J-MACROECON, V3, P130, DOI 10.1257/mac.3.2.130; Shimer R, 2010, CREI LECT MACROECON, P1; Sunakawa T, 2012, ECON LETT, V117, P679, DOI 10.1016/j.econlet.2011.12.072; Trigari Antonella, 2006, 304 IGIER BOCC U; Woodford M., 2010, HDB MONETARY EC, V3, P723, DOI 10.1016/B978-0-444-53454-5.00002-5	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-2879	1538-4616		J MONEY CREDIT BANK	J. Money Credit Bank.	SEP	2015	47	6					1119	1147		10.1111/jmcb.12239		29	Business, Finance; Economics	Business & Economics	CP7WI	WOS:000360099400004		
J	Oishi, H; Yamamoto, M; Nonaka, S; Shimizu, T; Yoshida, K; Mitsuhashi, T; Arai, H				Oishi, Hidenori; Yamamoto, Munetaka; Nonaka, Senshu; Shimizu, Takashi; Yoshida, Kensaku; Mitsuhashi, Takashi; Arai, Hajime			Treatment results of endosaccular coil embolization of asymptomatic unruptured intracranial aneurysms in elderly patients	JOURNAL OF NEUROINTERVENTIONAL SURGERY			English	Article						Aneurysm; Intervention	ENDOVASCULAR TREATMENT; SUBARACHNOID HEMORRHAGE; NATURAL-HISTORY; FOLLOW-UP; CEREBRAL ANEURYSMS; TRIAL; AGE; COMPLICATIONS; MANAGEMENT; ISAT	Background and purpose We report the results of endosaccular coil embolization of asymptomatic unruptured intracranial aneurysms (UIAs) in elderly patients (65years). Materials There were 375 elderly patients with 400 asymptomatic UIAs. Patients were divided into two groups: group A included patients aged 65-74 years and group B patients aged 75years. Results Endovascular procedures were completed in 97.8% of patients. Immediate anatomical outcomes showed complete occlusion in 53.7%, residual neck in 18.9%, and residual aneurysm in 27.4%. Anatomical follow-ups (mean 36.328.1months) were unchanged in 55.7%, improved in 22.6%, minor recurrence in 11.5%, and major recurrence in 10.2%. Procedure related complications occurred in 31 patients (8.3%). 15 patients had ischemic and 10 hemorrhagic complications. Retreatments were performed in 16 patients (4.3%). Among 366 patients technically completed, 363 (99.2%) showed a favorable clinical outcome (modified Rankin Scale (mRS) score <1) at 30days. The remaining three patients showed a worsening of mRS >0 at 30days. The latest clinical follow-up outcomes showed: mRS score 0 in 362 patients; mRS score 1 in one; mRS score 3 in one; mRS score 4 in one; and mRS score 5 in one patient. Permanent morbidity and mortality rates were 1.1% and 0%, respectively. There were no statistically significant differences in gender, comorbidities, aneurysm size, neck width, dome-to-neck ratio, immediate anatomical outcomes, anatomical follow-up outcomes, or procedure related complications between the groups. Conclusions Endosaccular coil embolization is safe and feasible for elderly patients with asymptomatic UIAs. Old age itself should not be a contraindication.	[Oishi, Hidenori] Juntendo Univ, Sch Med, Dept Neuroendovasc Therapy, Tokyo 1138421, Japan; [Yamamoto, Munetaka; Arai, Hajime] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 1138421, Japan; [Nonaka, Senshu] Juntendo Urayasu Hosp, Dept Neurosurg, Tokyo, Japan; [Shimizu, Takashi] Juntendo Nerima Hosp, Dept Neurosurg, Tokyo, Japan; [Yoshida, Kensaku] Tokyo Metropolitan Hiroo Gen Hosp, Dept Neurosurg, Tokyo, Japan; [Mitsuhashi, Takashi] Tama Nanbu Chiiki Hosp, Dept Neurosurg, Tokyo, Japan	Oishi, H (reprint author), Juntendo Univ, Sch Med, Dept Neurosurg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ohishi@juntendo.ac.jp					Johansson M, 2004, NEURORADIOLOGY, V46, P385, DOI 10.1007/s00234-004-1170-x; INAGAWA T, 1988, J NEUROSURG, V69, P332, DOI 10.3171/jns.1988.69.3.0332; Hwang SK, 2011, AM J NEURORADIOL, V32, P1087, DOI 10.3174/ajnr.A2458; JUVELA S, 1993, J NEUROSURG, V79, P174, DOI 10.3171/jns.1993.79.2.0174; Barker FG, 2004, NEUROSURGERY, V54, P18, DOI 10.1227/01.NEU.0000097195.48840.C4; Ryttlefors M, 2008, STROKE, V39, P2720, DOI 10.1161/STROKEAHA.107.506030; Roy D, 2001, STROKE, V32, P1998, DOI 10.1161/hs0901.095600; Sturiale CL, 2013, STROKE, V44, P1897, DOI 10.1161/STROKEAHA.113.001524; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Sedat J, 2002, STROKE, V33, P2620, DOI 10.1161/01.STR.0000034788.70971.14; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Khosla A, 2012, AM J NEURORADIOL, V33, P953, DOI 10.3174/ajnr.A2881; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Lubicz B, 2004, AM J NEURORADIOL, V25, P592; Brinjikji W, 2011, STROKE, V42, P1320, DOI 10.1161/STROKEAHA.110.607986; Oishi H, 2012, AM J NEURORADIOL, V33, P958, DOI 10.3174/ajnr.A2858; Thornton J, 2002, NEUROSURGERY, V50, P239, DOI 10.1097/00006123-200202000-00003; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Cai YL, 2005, NEUROSURGERY, V57, P1096, DOI 10.1227/01.NEU.0000185583.25420.DF; Gonzalez NR, 2010, NEUROSURGERY, V66, P714, DOI 10.1227/01.NEU.0000367451.59090.D7; McDougall CG, 2012, J NEUROSURG, V116, P135, DOI 10.3171/2011.8.JNS101767; Mont'alverne F, 2005, NEURORADIOLOGY, V47, P446, DOI 10.1007/s00234-005-1345-0; Morita A, 2012, NEW ENGL J MED, V366, P2474; RANKIN J, 1957, Scott Med J, V2, P200; Stiefel MF, 2010, J NEUROINTERV SURG, V2, P11, DOI 10.1136/jnis.2009.001685; Weir B, 2002, J NEUROSURG, V96, P64, DOI 10.3171/jns.2002.96.1.0064	27	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1759-8478	1759-8486		J NEUROINTERV SURG	J. NeuroInterventional Surg.	SEP	2015	7	9					660	665		10.1136/neurintsurg-2014-011305		6	Neuroimaging; Surgery	Neurosciences & Neurology; Surgery	CQ1ZL	WOS:000360399000010		
J	Nagai, T; Watanabe, N; Yoshinaga, K; Mizobe, H; Kojima, K; Kuroda, L; Odanaka, Y; Saito, T; Beppu, F; Gotoh, N				Nagai, Toshiharu; Watanabe, Natsuko; Yoshinaga, Kazuaki; Mizobe, Hoyo; Kojima, Koichi; Kuroda, Lkuma; Odanaka, Yuki; Saito, Tadao; Beppu, Fumiaki; Gotoh, Naohiro			Abundances of Triacylglycerol Positional Isomers and Enantiomers Comprised of a Dipalmitoylglycerol Backbone and Short- or Medium-chain Fatty Acids in Bovine Milk Fat	JOURNAL OF OLEO SCIENCE			English	Article						chiral separation; enantiomers; milk fat; triacylglycerol	TRIACYL-SN-GLYCEROLS; PERFORMANCE LIQUID-CHROMATOGRAPHY; STEREOSPECIFIC ANALYSIS; TRIGLYCERIDES; SEPARATION; LIPASES; LIPIDS; PHASE	Bovine milk fat (BMF) is composed of triacylglycerols (TAG) rich in palmitic acid (P), oleic acid (0), and short-chain or medium-chain fatty acids (SCFAs or MCFAs). The composition and binding positions of the fatty acids on the glycerol backbone determine their physical and nutritional properties. SCFAs and MCFAs are known to characteristically bind to the sn-3 position of the TAGs in BMF; however, there are very few non-destructive analyses of TAG enantiomers binding the fatty acids at this position. We previously reported a method to resolve the enantiomers of TAGs, binding both long-chain saturated fatty acid and unsaturated fatty acid at the sn-1 and 3 positions, in palm oil, fish oil, and marine mammal oil using chiral HPLC. Here, we further developed a method to resolve several TAG enantiomers containing a dipalmitoyl (PP) glycerol backbone and one SCFA (or MCFA) in BMF. We revealed that the predominant TAG structure in BMF was homochiral, such as 1,2-dipalmitoy1-3-butyroyl-sn-glycerol. This is the first quantitative determination of many TAG enantiomers, which bind to a SCFA or MCFA, in BMF was evaluated simultaneously. Furthermore, the results indicated that the amount ratios of the positional isomers and enantiomers of TAGs consisting of a dipalmitoyl (PP) glycerol backbone and SCFA (or MCFA), resembled the whole TAG structures containing the other diacylglycerol backbones consisting of P, 0, myristic acid, and/or stearic acid in BMF.	[Nagai, Toshiharu; Yoshinaga, Kazuaki; Mizobe, Hoyo; Kojima, Koichi] Tsukishima Foods Ind Co Ltd, Edogawa Ku, Tokyo 1348520, Japan; [Watanabe, Natsuko; Beppu, Fumiaki; Gotoh, Naohiro] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Kuroda, Lkuma] GL Sci Inc, Shinjuku Ku, Tokyo 1631130, Japan; [Odanaka, Yuki] Showa Univ, Sch Pharm, Shinagawa Ku, Tokyo 1428555, Japan; [Saito, Tadao] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	Gotoh, N (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	ngotoh@kaiyodai.ac.jp	GOTOH, Naohiro/O-1975-2014				ANDO Y, 1992, J AM OIL CHEM SOC, V69, P417, DOI 10.1007/BF02540941; NELSON JH, 1977, J DAIRY SCI, V60, P327; ROGALSKA E, 1990, J BIOL CHEM, V265, P20271; Nishio M, 2014, PHYS CHEM CHEM PHYS, V16, P12648, DOI 10.1039/c4cp00099d; Mottram HR, 1996, TETRAHEDRON LETT, V37, P8593, DOI 10.1016/0040-4039(96)01964-8; JENSEN RG, 1990, J DAIRY SCI, V73, P223; PARODI PW, 1982, LIPIDS, V17, P437, DOI 10.1007/BF02535223; Nagai T, 2011, J CHROMATOGR A, V1218, P2880, DOI 10.1016/j.chroma.2011.02.067; Botham K. M., 2012, HARPERS ILLUSTRATED, P229; Botham K. M., 2012, HARPERS ILLUSTRATED, P140; BRACCO U, 1994, AM J CLIN NUTR, V60, p1002S; BRECKENR.WC, 1969, CAN J BIOCHEM CELL B, V47, P761; BRECKENRIDGE W. C, 1968, J LIPID RES, V9, P388; BROCKERH.H, 1966, J LIPID RES, V7, P62; BROCKERH.H, 1966, BIOCHIM BIOPHYS ACTA, V116, P67, DOI 10.1016/0005-2760(66)90092-0; BROCKERH.H, 1965, J LIPID RES, V6, P10; CHRISTIE WW, 1985, J DAIRY RES, V52, P219; CHRISTIE WW, 1982, J SOC DAIRY TECHNOL, V35, P22, DOI 10.1111/j.1471-0307.1982.tb02259.x; Gotoh N, 2012, J OLEO SCI, V61, P173, DOI 10.5650/jos.61.173; ITABASHI Y, 1986, LIPIDS, V21, P413, DOI 10.1007/BF02534938; ITABASHI Y, 1990, J LIPID RES, V31, P2119; ITABASHI Y, 1993, J AM OIL CHEM SOC, V70, P1177, DOI 10.1007/BF02564223; Jensen RG, 2002, J DAIRY SCI, V85, P295; JENSEN RG, 1983, LIPIDS, V18, P239, DOI 10.1007/BF02534556; MARSHALL MO, 1977, EUR J BIOCHEM, V81, P259, DOI 10.1111/j.1432-1033.1977.tb11947.x; Mizobe H, 2013, J AM OIL CHEM SOC, V90, P1809, DOI 10.1007/s11746-013-2339-4; Nagai T, 2011, J OLEO SCI, V60, P345, DOI 10.5650/jos.60.345; Nawar W. W., 1996, FOOD CHEM, P225; PARODI PW, 1970, AUST J DAIRY TECHNOL, V25, P200; TAKAGI T, 1991, LIPIDS, V26, P542, DOI 10.1007/BF02536601; Wada S., 1977, Journal of Japan Oil Chemists' Society [Yukagaku], V26, P95; Yoshinaga K, 2013, J OLEO SCI, V62, P115, DOI 10.5650/jos.62.115	32	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	SEP	2015	64	9					943	952		10.5650/jos.ess15040		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CQ2HT	WOS:000360421400003		
J	Endo, C; Ito, Y; Akabane, C; Kaneko, Y; Sakai, H				Endo, Chika; Ito, Yoshiko; Akabane, Chika; Kaneko, Yukihiro; Sakai, Hideki			Spontaneous Emulsification of Triolein Induced by Mixed Micellar Solutions of Sodium Polyoxyethylene Alkyl Ether Sulfate and Dodecyldimethyl Amine Oxide	JOURNAL OF OLEO SCIENCE			English	Article						spontaneous emulsification; dynamic interfacial tension; interface dilatational elasticity; Marangoni effect	SURFACE DILATATIONAL ELASTICITY; ANIONIC SURFACTANTS; ZWITTERIONIC SURFACTANTS; NONIONIC SURFACTANT; MIXTURES; TENSION; SYSTEMS; SOLUBILIZATION; PREDICTION; PRECIPITATION	A new mechanism of spontaneous emulsification without any salts or co-solvents is described, and is related to the dilatational behavior. Spontaneous emulsification can reduce the time required to remove oily soils from hard surfaces and enhance the detergency, because this type of emulsification requires no external mechanical work. In this paper, we focused on triolein, the main component of food oils and human sebum soil, and tried to induce spontaneous emulsification by using mixed micellar solutions of sodium polyoxyethylene alkyl ether sulfate and N, N-dimethyldodecylamine oxide (AES/DDAO). We characterized the dilatation of the oil/water interface using dynamic interfacial tension and elasticity measurements. This study confirmed that the degree of spontaneous emulsification can be enhanced by controlling the molar ratio of DDAO to AES. This enhancement can be attributed to an increased rate of decrease in the dynamic interfacial tension (i.e., a decreased interface dilatational elasticity), allowing for much greater suppression of the Marangoni effect. Further, we determined that one of the reasons for the decrease in the interface dilatational elasticity is the increasing number of micelles near the oil drop interface, which results from a decrease in the electrostatic repulsion between the micelles and the drop interface. Therefore, controlling the molar ratio of a mixed anionic/amphoteric surfactant solution is an effective way to induce spontaneous emulsification in the absence of salts or co-solvents.	[Endo, Chika; Ito, Yoshiko; Akabane, Chika; Kaneko, Yukihiro] LION CORP, R&D, Funct Mat Sci Res Labs, Edogawa Ku, Tokyo 1320035, Japan; [Sakai, Hideki] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 2788510, Japan	Endo, C (reprint author), LION CORP, R&D, Funct Mat Sci Res Labs, Edogawa Ku, 7-2-1 Hirai, Tokyo 1320035, Japan.	chika-k@lion.co.jp					Alargova RG, 1997, LANGMUIR, V13, P5544, DOI 10.1021/la970399d; Kume G, 2008, J SURFACTANTS DETERG, V11, P1, DOI 10.1007/s11743-007-1047-1; Sohrabi B, 2008, J PHYS CHEM B, V112, P14869, DOI 10.1021/jp803105n; AMANTE JC, 1991, J COLLOID INTERF SCI, V144, P243, DOI 10.1016/0021-9797(91)90255-7; Yamashita Y, 2007, LANGMUIR, V23, P1073, DOI 10.1021/la061991i; MILLER CA, 1993, COLLOID SURFACE A, V74, P169, DOI 10.1016/0927-7757(93)80263-E; Parekh P, 2011, COLLOID SURFACE A, V385, P111, DOI 10.1016/j.colsurfa.2011.05.057; Wang RT, 2014, J SURFACTANTS DETERG, V17, P881, DOI 10.1007/s11743-014-1605-2; ABE M, 1989, J COLLOID INTERF SCI, V127, P328, DOI 10.1016/0021-9797(89)90038-6; ROSEN MJ, 1982, J AM OIL CHEM SOC, V59, P582, DOI 10.1007/BF02636329; Blanca N. L., 2007, [No title captured], Patent No. [WO, 141 067, 141067]; Chen BH, 1997, COLLOID SURFACE A, V128, P129, DOI 10.1016/S0927-7757(96)03920-9; Christov NC, 2004, LANGMUIR, V20, P565, DOI 10.1021/la035717p; Cui ZG, 2000, COLLOID POLYM SCI, V278, P22; Davies J. T., 1963, DISPERSE SYSTEMS ADH, V2<SUP>nd</SUP>, P360; Hansen FK, 2008, LANGMUIR, V24, P189, DOI 10.1021/la7024582; IWASAKI T, 1991, LANGMUIR, V7, P30, DOI 10.1021/la00049a008; Matsuki H, 1997, J COLLOID INTERF SCI, V191, P120, DOI 10.1006/jcis.1997.4924; Mulqueen M, 2000, LANGMUIR, V16, P7640, DOI 10.1021/la000537q; Nan YQ, 2006, J COLLOID INTERF SCI, V293, P464, DOI 10.1016/j.jcis.2005.06.054; Nishida K., 2007, Jpn. Pat., Patent No. [153 956, 153956]; OGINO K, 1976, B CHEM SOC JPN, V49, P1187, DOI 10.1246/bcsj.49.1187; Ohbu K., 1980, U. S. Pat., Patent No. [045 134, 045134]; Rosen M. J., 2004, SURFACTANTS INTERFAC, DOI 10.1002/0471670561; ROSEN MJ, 1991, SURF SOLUT, V11, P315; Shiloach A, 1997, LANGMUIR, V13, P3968, DOI 10.1021/la970160x; Shrestha LK, 2008, J OLEO SCI, V57, P485, DOI 10.5650/jos.57.485; Singh S.K., 2006, J OLEO SCI, V55, P99; Soontravanich S, 2009, J SURFACTANTS DETERG, V12, P145, DOI 10.1007/s11743-009-1106-x; Tadros T.F., 2013, EMULSION FORMATION A, P1; Todorov PD, 2002, LANGMUIR, V18, P7896, DOI 10.1021/la020367c; VALAULIKAR BS, 1985, J COLLOID INTERF SCI, V108, P403, DOI 10.1016/0021-9797(85)90277-2; Zhang H, 2005, J SURFACTANTS DETERG, V8, P99, DOI 10.1007/s11743-005-0337-3	33	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	SEP	2015	64	9					953	962		10.5650/jos.ess15080		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CQ2HT	WOS:000360421400004		
J	Mizuhashi, T; Asakawa, T; Ohta, A				Mizuhashi, Toshinari; Asakawa, Tsuyoshi; Ohta, Akio			Micelle Vesicle Transition by Cleavage of Disulfide Spacer Chain for Gemini Surfactant in Didodecyldimethylammonium Chloride Aqueous Solutions	JOURNAL OF OLEO SCIENCE			English	Article						micelle-vesicle transition; disulfide linked gemini surfactant; cleavage of disulfide spacer chain	MONOMERIC THIOL SURFACTANTS; CATIONIC SURFACTANTS; FLUORESCENCE; MIXTURES; SYSTEMS; PROBE	We examined the "micelle-vesicle transition" through the mixing effect of single tailed thiol surfactants produced by the cleavage of gemini surfactants, [C12H25N(CH3)(2)CH2CH2SSCH2CH2N(CH3)(2)C12H25] 2C1 (C12SSC12), which have a disulfide bond in the spacer chain. Phase diagrams of C12H25N(CH3)(2)CH2CH2SHCl-didodecyldimethylammonium chloride (C12SH-DDAC) and C12SSC12-DDAC were determined by conductivity and pyrene fluorescence probe methods. The aggregate diameters were evaluated by dynamic light scattering (DLS). The critical vesicle concentration (CVC) was confirmed by the abrupt increase in the intensity of light scattering with excitation at 335 nm. Vesicle formation was confined to the DDAC-rich region of the C12SSC12-DDAC system, while the vesicle formation region for the C12SH-DDAC system spread out with the addition of dithiothreitol (DTT) to C12SSC12-DDAC. This implies that single tailed surfactants can induce a more favorable environment for molecular packing of the vesicular surface. The micelle vesicle transition occurs with disulfide spacer chain cleavage of gemini surfactants at a particular specific concentration range.	[Mizuhashi, Toshinari; Asakawa, Tsuyoshi; Ohta, Akio] Kanazawa Univ, Coll Sci & Engn, Sch Chem, Kanazawa, Ishikawa 9201192, Japan	Asakawa, T (reprint author), Kanazawa Univ, Coll Sci & Engn, Sch Chem, Kanazawa, Ishikawa 9201192, Japan.	asakawa@se.kanazawa-u.ac.jp	ASAKAWA, Tsuyoshi/L-3517-2015				ZANA R, 1980, J COLLOID INTERF SCI, V78, P330, DOI 10.1016/0021-9797(80)90571-8; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Sakai H, 2004, COLLOID SURFACE A, V232, P221, DOI 10.1016/j.colsurfa.2003.10.015; Kato M, 2005, B CHEM SOC JPN, V78, P1411, DOI 10.1246/bcsj.78.1411; Tian MZ, 2012, LANGMUIR, V28, P12005, DOI 10.1021/la301762g; Ghosh S, 2011, J COLLOID INTERF SCI, V358, P208, DOI 10.1016/j.jcis.2011.02.054; Aratono M, 2007, J PHYS CHEM B, V111, P107, DOI 10.1021/jp0637328; Kodama T, 2006, COLLOID SURFACE A, V277, P20, DOI 10.1016/j.colsurfa.2005.11.004; Aratono M, 2008, J PHYS CHEM B, V112, P12304, DOI 10.1021/jp803484b; Asakawa T, 2011, J OLEO SCI, V60, P469, DOI 10.5650/jos.60.469; Asakawa T, 2008, J OLEO SCI, V57, P243, DOI 10.5650/jos.57.243; Chung MH, 2003, COLLOID SURFACE B, V29, P75, DOI 10.1016/S0927-7765(02)00183-2; Dong JM, 2013, CHEM-EUR J, V19, P7931, DOI 10.1002/chem.201300526; Fan HM, 2008, J COLLOID INTERF SCI, V321, P227, DOI 10.1016/j.jcis.2008.01.039; KALYANASUNDARAM K, 1988, LANGMUIR, V4, P942, DOI 10.1021/la00082a027; Ohno K., 2003, CHEM LETT, V9, P828; Rio J.M.D., 1995, J COLLOID INTERF SCI, V172, P137; Viseu MI, 2000, LANGMUIR, V16, P4882, DOI 10.1021/la991493s; Zana R, 1997, LANGMUIR, V13, P5552, DOI 10.1021/la970369a	19	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	SEP	2015	64	9					963	969		10.5650/jos.ess15083		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CQ2HT	WOS:000360421400005		
J	Kawase, T; Nakagawa, M; Higuchi, Y; Oida, T				Kawase, Tokuzo; Nakagawa, Mami; Higuchi, Yuuya; Oida, Tatsuo			Novel Synthesis of Anionic Gemini Surfactants from 1, 4-Diol as a Key Block Material	JOURNAL OF OLEO SCIENCE			English	Article						all-hydrocarbon gemini; anionic head groups; 1,4-diol; surface tension; surface pressure-area isotherm	SELF-ASSEMBLING MOLECULES; AIR-WATER-INTERFACE; AQUEOUS-SOLUTION; SEMIFLUOROALKYL GROUP; MONOLAYER BEHAVIOR; ACTIVE PROPERTIES; HYDROPHOBIC GROUP; ACID MONOLAYERS; PERFORMANCE; ALDEHYDES	In this study, a series of all-hydrocarbon anionic gemini surfactants containing COOH (adipic acid-type and suberic acid-type), SO3Na, OSO3Na, and OP=0(OH)(2) functional groups was developed from 1,4-diol and 1,4-diketone as a key block material. The effect of the surfactant head groups on the surface properties was investigated by surface tension and surface pressure-area (pi-A) measurements. We found that the critical micelle concentrations (CMC) of the studied geminis were smaller by one order of magnitude than those of the corresponding 1+1-type surfactants. From pi-A measurements, the limiting areas of COOH-type geminis were less than twofold of the area of the corresponding 1+1-type, which indicates that the gemini structure enabled tighter packing than is possible in surfactants of the 1+1-type. In contrast, the limiting area of the OP=O(OH)(2)-type gemini was larger than those of the COOH-type geminis. Furthermore, the suberic acid-type gemini showed a smaller limiting area than that of adipic acid-type gemini. Therefore, we can conclude that the flexibility of the gemini at the connecting position has a significant effect on formation of the monolayer at the air/water interface.	[Kawase, Tokuzo; Nakagawa, Mami; Higuchi, Yuuya; Oida, Tatsuo] Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan	Kawase, T (reprint author), Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Hashigamicho 1, Kyoto 6068585, Japan.	kawase@kit.ac.jp					AGRAWAL ML, 1988, J COLLOID INTERF SCI, V121, P355, DOI 10.1016/0021-9797(88)90439-0; Aisaka Tsunetomo, 2007, J Oleo Sci, V56, P633; KAJIYAMA T, 1989, CHEM LETT, P1047, DOI 10.1246/cl.1989.1047; Du XG, 2006, COLLOID SURFACE A, V290, P132, DOI 10.1016/j.colsurfa.2006.05.013; Ohno A, 2008, J FLUORINE CHEM, V129, P577, DOI 10.1016/j.jfluchem.2008.03.007; ZHU Y, 1990, J AM OIL CHEM SOC, V67, P459, DOI 10.1007/BF02638962; Kawase T, 2012, TENSIDE SURFACT DET, V49, P498; MENGER FM, 1993, J AM CHEM SOC, V115, P10083, DOI 10.1021/ja00075a025; Tsubone K, 2003, J SURFACTANTS DETERG, V6, P39, DOI 10.1007/s11743-003-0246-5; Takamatsu Y, 2009, J COLLOID INTERF SCI, V338, P229, DOI 10.1016/j.jcis.2009.06.016; Hait SK, 2002, CURR SCI INDIA, V82, P1101; Kumar N, 2014, J DISPER SCI TECHNOL, V35, P205, DOI 10.1080/01932691.2013.780243; Wang YX, 2008, J COLLOID INTERF SCI, V319, P534, DOI 10.1016/j.jcis.2007.11.021; Jenkins HDB, 1999, INORG CHEM, V38, P3609, DOI 10.1021/ic9812961; Kawase T, 2011, J OLEO SCI, V60, P61, DOI 10.5650/jos.60.61; Zana R, 2002, ADV COLLOID INTERFAC, V97, P205, DOI 10.1016/S0001-8686(01)00069-0; Zana R, 1997, LANGMUIR, V13, P402, DOI 10.1021/la9606963; WADSWORTH W, 1961, J AM CHEM SOC, V83, P1733, DOI 10.1021/ja01468a042; Kawase T, 2010, J OLEO SCI, V59, P483, DOI 10.5650/jos.59.483; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Cai MJ, 2010, J DISPER SCI TECHNOL, V31, P1633, DOI 10.1080/01932690903297389; Li X, 2010, J SURFACTANTS DETERG, V13, P353, DOI 10.1007/s11743-010-1188-5; Lin LH, 2012, J SURFACTANTS DETERG, V15, P623, DOI 10.1007/s11743-012-1345-0; Ge YS, 2012, LANGMUIR, V28, P5913, DOI 10.1021/la204212s; CHEN YL, 1986, LANGMUIR, V2, P349, DOI 10.1021/la00069a018; CATUSSE C, 1988, EUR POLYM J, V24, P21, DOI 10.1016/0014-3057(88)90120-6; Chen H, 2014, J SURFACTANTS DETERG, V17, P937, DOI 10.1007/s11743-014-1585-2; Duivenvoorde FL, 1997, LANGMUIR, V13, P3737, DOI 10.1021/la9620420; Hana Y, 2011, PHYS CHEM CHEM PHYS, V13, P1939, DOI [10.1039/c0cp01196g, DOI 10.1039/C0CP01196G]; KAJIYAMA T, 1992, B CHEM SOC JPN, V65, P864, DOI 10.1246/bcsj.65.864; Kawase T, 2011, TENSIDE SURFACT DET, V48, P466; Kawase T, 2015, J SURFACTANTS DETERG, V18, P615, DOI 10.1007/s11743-015-1682-x; Kawase T, 2013, J OLEO SCI, V62, P371, DOI 10.5650/jos.62.371; Li X, 2010, TENSIDE SURFACT DET, V47, P243; Li Z, 2006, TENSIDE SURFACT DET, V43, P151; Liu XP, 2011, J DISPER SCI TECHNOL, V32, P568, DOI 10.1080/01932691003757272; Matsuoka K, 2006, BIOMACROMOLECULES, V7, P2274, DOI 10.1021/bm060368+; Matsuoka K., 2000, GARBOHYDR RES, V329, P765; Menger F. M., 2000, ANGEW CHEM INT EDIT, V39, P1906, DOI DOI 10.1002/1521-3773; MUKAIYAMA T, 1980, CHEM LETT, P255, DOI 10.1246/cl.1980.255; Okahara M, 1988, J JPN OIL CHEM SOC Y, V37, P746; Rosen M. J., 2004, SURFACTANTS INTERFAC; Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P1, DOI 10.1002/9781118228920; Shankar V., 2007, J PHYS CHEM B, V111, P11419, DOI DOI 10.1021/JP0742791; Shankar V., 2008, LANGMUIR, V24, P758, DOI DOI 10.1021/LA701998C; Shukla D, 2007, SURF REV LETT, V14, P991, DOI 10.1142/S0218625X07010500; Shukla D, 2008, TENSIDE SURFACT DET, V45, P72; Sommerdijk NAJM, 1997, J AM CHEM SOC, V119, P4338, DOI 10.1021/ja962303s; STETTER H, 1981, CHEM BER-RECL, V114, P1226, DOI 10.1002/cber.19811140403; Tai SX, 2012, EUR J LIPID SCI TECH, V114, P1062, DOI 10.1002/ejlt.201100431; Tyagi P, 2011, TENSIDE SURFACT DET, V48, P293; van Zon A, 1999, TENSIDE SURFACT DET, V36, P84; Zana R, 2002, J COLLOID INTERF SCI, V248, P203, DOI 10.1006/jcis.2001.8104; Zhu Y.-P., 2004, SURFACTANT SCI SERIE, V117, P277	54	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	SEP	2015	64	9					971	986		10.5650/jos.ess15109		16	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CQ2HT	WOS:000360421400006		
J	Miyazawa, M; Nakashima, Y; Nakahashi, H; Hara, N; Nakagawa, H; Usami, A; Chavasiri, W				Miyazawa, Mitsuo; Nakashima, Yoshimi; Nakahashi, Hiroshi; Hara, Nobuyuki; Nakagawa, Hiroki; Usami, Atsushi; Chavasiri, Warinthorn			Volatile Compounds with Characteristic Odor of Essential Oil from Magnolia obovata Leaves by Hydrodistillation and Solvent-assisted Flavor Evaporation	JOURNAL OF OLEO SCIENCE			English	Article						Magnolia obovata; volatile compounds; hydrodistillation; solvent-assisted flavor evaporation; AEDA	AROMA COMPOUNDS; THUNB; BARK; COMPONENTS; TEA	The present study focuses on the volatile compounds with characteristic odor of essential oil from the leaves of Magnolia obovata by hydrodistillation (HD) and solvent-assisted flavor evaporation (SAFE) method. Eighty-seven compounds, representing 98.0% of the total oil, were identified using HD. The major compounds of HD oil were (E)-beta-caryophyllene (23.7%), alpha-humulene (11.6%), geraniol (9.1%), and borneol (7.0%). In SAFE oil, fifty-eight compounds, representing 99.7% of the total oil, were identified. The main compounds of SAFE oil were (E)-beta-caryophyllene (48.9%), alpha-humulene (15.7%), and bicyclogermacrene (4.2%). In this study, we newly identified eighty-five compounds of the oils from M. obovata leaves. These oils were also subjected to aroma evaluation by gas chromatography-olfactometry (GC-O) and aroma extract dilution analysis (AEDA). As a result, twenty-four (HD) and twenty-five (SAFE) aroma-active compounds were detected. (E)-beta-Caryophyllene, alpha-humulene, linalool, geraniol, 1,8-cineole, and bicyclogermacrene were found to impart the characteristic odor of M. obovata leaves. These results imply that the oils of M. obovata leaves must be investigated further to clarify their potential application in the food and pharmaceutical industries.	[Miyazawa, Mitsuo; Nakashima, Yoshimi; Nakahashi, Hiroshi; Hara, Nobuyuki; Nakagawa, Hiroki; Usami, Atsushi] Kindai Univ, Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan; [Chavasiri, Warinthorn] Chulalongkorn Univ, Fac Sci, Dept Chem, Bangkok 10330, Thailand	Miyazawa, M (reprint author), Kindai Univ, Kinki Univ, Fac Sci & Engn, Dept Appl Chem, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	miyazawa@apch.kindai.ac.jp					Pongsuwan W, 2007, J AGR FOOD CHEM, V55, P231, DOI 10.1021/jf062330u; Takahashi T, 2010, PHYTOCHEM ANALYSIS, V21, P489, DOI 10.1002/pca.1224; KAWAI T, 1994, PLANTA MED, V60, P17, DOI 10.1055/s-2006-959399; Namgung HJ, 2010, J SCI FOOD AGR, V90, P1926, DOI 10.1002/jsfa.4036; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; Nejia H, 2013, NAT PROD RES, V27, P1795, DOI 10.1080/14786419.2012.755680; Czerny M, 2008, EUR FOOD RES TECHNOL, V228, P265, DOI 10.1007/s00217-008-0931-x; Cho IH, 2006, J AGR FOOD CHEM, V54, P4820, DOI 10.1021/jf0601416; Ko BK, 2009, J AGR FOOD CHEM, V57, P6862, DOI 10.1021/jf901454j; Mori M, 1997, HOLZ ROH WERKST, V55, P275, DOI 10.1007/BF02990563; Beleggia R, 2009, J CEREAL SCI, V49, P301, DOI 10.1016/j.jcs.2008.12.002; Zeller A, 2006, J AGR FOOD CHEM, V54, P3686, DOI 10.1021/jf052944j; Mo XL, 2010, J AGR FOOD CHEM, V58, P2462, DOI 10.1021/jf903631w; Engel W, 1999, EUR FOOD RES TECHNOL, V209, P237, DOI 10.1007/s002170050486; Fiehn O, 2006, OMICS, V10, P158, DOI 10.1089/omi.2006.10.158; FUJITA M, 1973, YAKUGAKU ZASSHI, V93, P415; Guth H, 1999, FLAVOR CHEMISTRY, P377; Itokawa H., 1986, GENDAI TOYO IGAKU, V7, P60; Kameoka H., 1994, Journal of Essential Oil Research, V6, P555; Patricio R. L., 2007, J AGR FOOD CHEM, V55, P3018; Prakasia P. P., 2015, CORREA PHARM INNOV J, V3, P50; SASHIDA Y, 1976, YAKUGAKU ZASSHI, V96, P218; Umlauf D, 2004, PHYTOCHEMISTRY, V65, P2463, DOI 10.1016/j.phytochem.2004.08.019	23	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	SEP	2015	64	9					999	1007		10.5650/jos.ess15114		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CQ2HT	WOS:000360421400008		
J	Komba, S; Kotake-Nara, E; Machida, S				Komba, Shiro; Kotake-Nara, Eiichi; Machida, Sachiko			Fucoxanthin Derivatives: Synthesis and their Chemical Properties	JOURNAL OF OLEO SCIENCE			English	Article						fucoxanthin; fucoxanthin derivatives; levulinyl protected lithocholyl fucoxanthin; lithocholyl fucoxanthin	MICROWAVE-ASSISTED EXTRACTION; UNDARIA-PINNATIFIDA; MIXED MICELLES; CACO-2 CELLS; CAROTENOID UPTAKE; ACTIVITY SPECTRA; BROWN SEAWEEDS; BETA-CAROTENE; KOMBU EXTRACT; CANCER CELLS	Novel fucoxanthin derivatives that could change the size of mixed micelles were synthesized. The mixed micelles under consideration consist of a bile acid and some additives. To change the affinity against a bile acid, we designed the synthesis of a fucoxanthin-lithocholic acid complex. Lithocholic acid is one of the bile acids. The 3-OH on lithocholic acid was protected by a levulinyl group, and the protected lithocholic acid was selectively coupled via an ester linkage to the 3-OH on fucoxanthin to obtain levulinyl-protected lithocholyl fucoxanthin (LevLF). The levulinyl group was then selectively deprotected using hydrazine to obtain a lithocholyl fucoxanthin (LF). The average sizes of the micelles that contained these compounds (fucoxanthin, LevLF, and LF) with a bile acid (sodium taurocholate) were measured. The LevLF induced larger micelles than fucoxanthin or LF. Interestingly, the addition of 1-oleoyl-rac-glycerol induced a more efficient change in the micelle size. The large micelles grew larger, and the small micelles became smaller. Triple-mixed micelles with LevLF, sodium taurocholate, and 1-oleoyl-rac-glycerol formed the largest micelle with a diameter of 68 nm. On the other hand, triple-mixed micelles using LF, sodium taurocholate, and 1-oleoyl-rac-glycerol made the smallest micelles with diameters as low as 12 nm. We also investigated the hydrolysis of these compounds with enzymes (esterase from porcine liver, lipase from porcine pancreas, and cholesterol esterase from Pseudonionas sp.). The ester linkage between the lithocholic acid and fucoxanthin of LevLF was hydrolyzed with cholesterol esterase. In addition, the intestinal absorption was examined with Caco-2 cells, and no advantageous change in absorption efficiency was observed by chemically modifying the fucoxanthin unless different micelles sizes and increasing hydrophobicity are induced.	[Komba, Shiro; Machida, Sachiko] NARO, Natl Food Res Inst, Biomol Engn Lab, Tsukuba, Ibaraki 3058642, Japan; [Kotake-Nara, Eiichi] NARO, Natl Food Res Inst, Lipid Lab, Tsukuba, Ibaraki 3058642, Japan	Komba, S (reprint author), NARO, Natl Food Res Inst, Biomol Engn Lab, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	skomba@affrc.go.jp					Filimonov DA, 2014, CHEM HETEROCYCL COM+, V50, P444, DOI 10.1007/s10593-014-1496-1; Heo SJ, 2012, FOOD CHEM TOXICOL, V50, P3336, DOI 10.1016/j.fct.2012.06.025; Xiao XH, 2012, J SEP SCI, V35, P2313, DOI 10.1002/jssc.201200231; Asai A, 2008, BRIT J NUTR, V100, P273, DOI 10.1017/S0007114507895468; Sugawara T, 2006, J AGR FOOD CHEM, V54, P9805, DOI 10.1021/jf062204q; Kotake-Nara E, 2001, J NUTR, V131, P3303; Lagunin A, 2000, BIOINFORMATICS, V16, P747, DOI 10.1093/bioinformatics/16.8.747; Yonekura L, 2006, LIPIDS, V41, P629, DOI 10.1007/s11745-006-5013-x; Kotake-Nara E, 2012, BIOSCI BIOTECH BIOCH, V76, P875, DOI 10.1271/bbb.110777; Lagunin A, 2010, CURR PHARM DESIGN, V16, P1703, DOI 10.2174/138161210791164063; Hosokawa M, 2004, BBA-GEN SUBJECTS, V1675, P113, DOI 10.1016/j.bbagen.2004.08.012; OKAI Y, 1993, MUTAT RES, V303, P63, DOI 10.1016/0165-7992(93)90096-E; Xia S, 2013, MAR DRUGS, V11, P2667, DOI 10.3390/md11072667; Kim SM, 2012, APPL BIOCHEM BIOTECH, V166, P1843, DOI 10.1007/s12010-012-9602-2; Jaswir I, 2013, J LIQ CHROMATOGR R T, V36, P1340, DOI 10.1080/10826076.2012.691435; Das SK, 2005, BBA-GEN SUBJECTS, V1726, P328, DOI 10.1016/j.bbagen.2005.09.007; Kesisoglou F, 2007, ADV DRUG DELIVER REV, V59, P631, DOI 10.1016/j.addr.2007.05.003; Asai A, 2004, DRUG METAB DISPOS, V32, P205, DOI 10.1124/dmd.32.2.205; Brisson L, 2008, CHEM PHYS LIPIDS, V154, P33, DOI 10.1016/j.chemphyslip.2008.04.002; Hashimoto T, 2012, BRIT J NUTR, V107, P1566, DOI 10.1017/S0007114511004879; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Odeberg JM, 2003, EUR J PHARM SCI, V19, P299, DOI 10.1016/S0928-0987(03)00135-0; Kim SM, 2012, J KOREAN SOC APPL BI, V55, P477, DOI 10.1007/s13765-012-2108-3; Stepanchikova A, 2003, CURR MED CHEM, V10, P225; Pasquet V, 2011, PROCESS BIOCHEM, V46, P59, DOI 10.1016/j.procbio.2010.07.009; Teas J, 2013, J APPL PHYCOL, V25, P771, DOI 10.1007/s10811-012-9931-0; Maeda H, 2006, INT J MOL MED, V18, P147; Fung A, 2013, FOOD CHEM, V136, P1055, DOI 10.1016/j.foodchem.2012.09.024; Poroikov V, 2001, SAR QSAR ENVIRON RES, V12, P327, DOI 10.1080/10629360108033242; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; VANBOOM JH, 1976, TETRAHEDRON LETT, P4875; Das SK, 2006, J CLIN BIOCHEM NUTR, V38, P119, DOI 10.3164/jcbn.38.119; ENGLERT G, 1990, MAGN RESON CHEM, V28, P519, DOI 10.1002/mrc.1260280610; FUKUI H, 1987, J PHARMACOBIO-DYNAM, V10, P236; Funahashi H, 1999, JPN J CANCER RES, V90, P922; Funahashi H, 2001, JPN J CANCER RES, V92, P483; Jaswir I, 2012, FOOD SCI TECHNOL RES, V18, P251; Kanazawa K, 2008, FOOD SCI TECHNOL RES, V14, P573, DOI 10.3136/fstr.14.573; Kusumi T., 2004, MAR DRUGS, V2, P63, DOI DOI 10.3390/MD202063; Novotny JA, 2005, J LIPID RES, V46, P1896, DOI 10.1194/jlr.M400504-JLR200; OKUZUMI J, 1993, CANCER LETT, V68, P159, DOI 10.1016/0304-3835(93)90142-V; REYNIER MO, 1985, LIPIDS, V20, P145, DOI 10.1007/BF02534246; Sugawara T, 2001, J NUTR, V131, P2921; WATERHOUS DV, 1985, J LIPID RES, V26, P1068; Zorofchian Moghadamtousi S., 2014, SCI WORLD J, V2014, P10	45	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	SEP	2015	64	9					1009	1018		10.5650/jos.ess15039		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CQ2HT	WOS:000360421400009		
J	Hisama, M; Matsuda, S; Arai, J; Masui, K; Yamamura, H				Hisama, Masayoshi; Matsuda, Sanae; Arai, Junichi; Masui, Katsunobu; Yamamura, Haruo			Synthesis and Characterization of a New Hydroquinone Derivative: Disodium p-Phenylene Diisostearyl Diphosphate	JOURNAL OF OLEO SCIENCE			English	Article						disodium p-phenylene diisostearyl diphosphate; amphiphilic hydroquinone derivative; stable hydroquinone derivative; skin peemeability; skin application	HUMAN SKIN MODELS; SURFACE PH; CUTANEOUS BIOAVAILABILITY; ARBUTIN; PERMEATION; ABSORPTION; MELANOGENESIS; PENETRATION; MECHANISM; CELLS	A novel amphiphilic hydroquinone derivative having a C18 alkyl chain phosphate attached to the hydroquinone (HQ) moiety was chemically synthesized. The thermal stability, distribution between organic and aqueous phases, and in vitro skin permeability were evaluated. This HQ derivative was identified as disodium p-phenylene diisostearyl diphosphate (HQ-2P2IS) by UV, infrared, mass, and nuclear magnetic resonance spectroscopies. Product HQ-2P2IS was obtained in good yield (56%), and it exhibited satisfactory stability in neutral solution, comparable to that of HQ. Its skin permeability was also higher than that of HQ. HQ-2P2IS is susceptible to enzymatic hydrolysis by tissue phosphatase, which releases HQ in the skin tissues. Thus, these characteristics indicate that the novel hydroquinone derivative presented herein, i.e., HQ-2P2IS, may serve as an effective pro-hydroquinone for skin care applications.	[Hisama, Masayoshi; Matsuda, Sanae; Arai, Junichi; Masui, Katsunobu] Toyo Beauty Co Ltd, Cent Res Ctr, Div Res & Dev, Higashinari Ku, Osaka 5370021, Japan; [Yamamura, Haruo] CHARLE CO LTD, Mkt Div, Dept Res & Dev, Suma Ku, Kobe, Hyougo 6540192, Japan	Hisama, M (reprint author), Toyo Beauty Co Ltd, Cent Res Ctr, Div Res & Dev, Higashinari Ku, 3-13-8 Higashinakamoto, Osaka 5370021, Japan.	hisama@toyobeauty.jp					Yosipovitch G, 1998, J INVEST DERMATOL, V110, P20, DOI 10.1046/j.1523-1747.1998.00069.x; Luo LH, 2008, CHEM-BIOL INTERACT, V173, P1, DOI 10.1016/j.cbi.2008.02.002; KHALED N, 1991, BIOTECHNOL LETT, V13, P167, DOI 10.1007/BF01025812; MAAG H, 1984, J AM OIL CHEM SOC, V61, P259, DOI 10.1007/BF02678778; Kitagawa S, 1997, CHEM PHARM BULL, V45, P1354; BAUMANN H, 1988, ANGEW CHEM INT EDIT, V27, P41, DOI 10.1002/anie.198800411; KORTING HC, 1990, ACTA DERM-VENEREOL, V70, P429; Diembeck W, 1999, FOOD CHEM TOXICOL, V37, P191, DOI 10.1016/S0278-6915(98)00114-8; Nihei KI, 2003, BIOORG MED CHEM LETT, V13, P2409, DOI 10.1016/S0960-894X(03)00395-0; Lim YJ, 2009, ARCH PHARM RES, V32, P367, DOI 10.1007/s12272-009-1309-8; Maeda K, 1996, J PHARMACOL EXP THER, V276, P765; PALUMBO A, 1991, BIOCHIM BIOPHYS ACTA, V1073, P85, DOI 10.1016/0304-4165(91)90186-K; Chakraborty AK, 1998, PIGM CELL RES, V11, P206, DOI 10.1111/j.1600-0749.1998.tb00731.x; Bonina FP, 2002, J PHARM SCI, V91, P171, DOI 10.1002/jps.1174; Bronaugh RL, 1995, TOXICOL METHOD, V5, P265, DOI 10.3109/15376519509084030; Dreher F, 2002, SKIN PHARMACOL APPL, V15, P31, DOI 10.1159/000066683; Dreher F, 2002, SKIN PHARMACOL APPL, V15, P40, DOI 10.1159/000066680; Gamrath H. R., 1956, US Pat, Patent No. [2750399 19560612, CAN 51:1932, AN 1957:1932, 2750399]; Joseph P., 1998, BRIT J CANCER, V78, P213; Lotte C, 2002, SKIN PHARMACOL APPL, V15, P18, DOI 10.1159/000066679; Matsuda S, 2008, CHEM PHARM BULL, V56, P292, DOI 10.1248/cpb.56.292; Nordlund JJ, 2006, J EUR ACAD DERMATOL, V20, P781, DOI 10.1111/j.1468-3083.2006.01670.x; Shibayama H., 2005, J OLEO SCI, V54, P601; SMITH CJ, 1988, PIGM CELL RES, V1, P386, DOI 10.1111/j.1600-0749.1988.tb00140.x; ZLOTOGORSKI A, 1987, ARCH DERMATOL RES, V279, P398, DOI 10.1007/BF00412626	25	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	SEP	2015	64	9					1033	1041		10.5650/jos.ess15047		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CQ2HT	WOS:000360421400011		
J	Matsumoto, E; Fujita, Y; Okada, Y; Kauppinen, EI; Kamiya, H; Chiba, K				Matsumoto, Emiko; Fujita, Yuko; Okada, Yohei; Kauppinen, Esko I.; Kamiya, Hidehiro; Chiba, Kazuhiro			Hydrophobic benzyl amines as supports for liquid-phase C-terminal amidated peptide synthesis: application to the preparation of ABT-510	JOURNAL OF PEPTIDE SCIENCE			English	Article						hydrophobic benzyl amine; soluble tag-assisted liquid-phase peptide synthesis; C-terminal amidation; ABT-510; epimerization	EPITHELIAL OVARIAN-CANCER; SOLUBLE POLYMER SUPPORTS; BACKBONE AMIDE LINKER; GROWTH; MODEL; CATALYSTS; PROTEINS	C-terminal amidation is one of the most common modification of peptides and frequently found in bioactive peptides. However, the C-terminal modification must be creative, because current chemical synthetic techniques of peptides are dominated by the use of C-terminal protecting supports. Therefore, it must be carried out after the removal of such supports, complicating reaction work-up and product isolation. In this context, hydrophobic benzyl amines were successfully added to the growing toolbox of soluble tag-assisted liquid-phase peptide synthesis as supports, leading to the total synthesis of ABT-510 (2). Although an ethyl amide-forming type was used in the present work, different types of hydrophobic benzyl amines could also be simply designed and prepared through versatile reductive aminations in one step. The standard acidic treatment used in the final deprotection step for peptide synthesis gave the desired C-terminal secondary amidated peptide with no epimerization. Copyright (c) 2015 European Peptide Society and John Wiley & Sons, Ltd.	[Matsumoto, Emiko; Fujita, Yuko; Chiba, Kazuhiro] Tokyo Univ Agr & Technol, Dept Appl Biol Chem, Fuchu, Tokyo 1838509, Japan; [Okada, Yohei; Kauppinen, Esko I.; Kamiya, Hidehiro] Tokyo Univ Agr & Technol, Dept Chem Engn, Koganei, Tokyo 1848588, Japan; [Kauppinen, Esko I.] Aalto Univ, Sch Sci, Dept Appl Phys, Aalto 00076, Finland	Chiba, K (reprint author), Tokyo Univ Agr & Technol, Dept Appl Biol Chem, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	chiba@cc.tuat.ac.jp	Okada, Yohei/P-8136-2014; Kamiya, Hidehiro/F-8507-2013		Japan Society for the Promotion of Science	This work was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	MUTTER M, 1971, ANGEW CHEM INT EDIT, V10, P811, DOI 10.1002/anie.197108112; Creighton CJ, 1999, J AM CHEM SOC, V121, P6786, DOI 10.1021/ja9913131; Boas U, 2009, CHEM REV, V109, P2092, DOI 10.1021/cr068206r; Hasina R, 2009, CANCER PREV RES, V2, P385, DOI 10.1158/1940-6207.CAPR-08-0211; Chatterjee J, 2013, ANGEW CHEM INT EDIT, V52, P254, DOI 10.1002/anie.201205674; BAYER E, 1972, NATURE, V237, P512, DOI 10.1038/237512a0; Okada Y, 2013, J ORG CHEM, V78, P320, DOI 10.1021/jo302127d; Samaritoni JG, 2014, J ORG CHEM, V79, P3140, DOI 10.1021/jo500273f; Bergbreiter DE, 2009, CHEM REV, V109, P530, DOI 10.1021/cr8004235; Jensen KJ, 1998, J AM CHEM SOC, V120, P5441, DOI 10.1021/ja974116f; BAYER E, 1991, ANGEW CHEM INT EDIT, V30, P113, DOI 10.1002/anie.199101133; Takahashi D, 2012, ORG LETT, V14, P4514, DOI 10.1021/ol302002g; Bergbreiter DE, 2002, CHEM REV, V102, P3345, DOI 10.1021/cr010343v; Campbell NE, 2010, NEOPLASIA, V12, P275, DOI 10.1593/neo.91880; Gravert DJ, 1997, CHEM REV, V97, P489, DOI 10.1021/cr960064l; Dickerson TJ, 2002, CHEM REV, V102, P3325, DOI 10.1021/cr010335e; Alsina J, 1999, CHEM-EUR J, V5, P2787, DOI 10.1002/(SICI)1521-3765(19991001)5:10<2787::AID-CHEM2787>3.0.CO;2-2; Fujita Y, 2013, ORG LETT, V15, P1155, DOI 10.1021/ol4003477; Boojamra CG, 1997, J ORG CHEM, V62, P1240, DOI 10.1021/jo9622845; BOOJAMRA CG, 1995, J ORG CHEM, V60, P5742, DOI 10.1021/jo00123a001; Brink HTT, 2006, J PEPT SCI, V12, P686; GECKELER K, 1981, ADV POLYM SCI, V39, P65; Greenaway J, 2009, MOL CANCER THER, V8, P64, DOI 10.1158/1535-7163.MCT-08-0864; Kitada S, 2011, BIOORG MED CHEM LETT, V21, P4476, DOI 10.1016/j.bmcl.2011.06.004; Kitada S, 2013, TETRAHEDRON, V69, P2555, DOI 10.1016/j.tet.2013.01.068; Nabors LB, 2010, ARCH NEUROL-CHICAGO, V67, P313, DOI 10.1001/archneurol.2010.16; Recouvreux MV, 2012, ENDOCRINOLOGY, V153, P3861, DOI 10.1210/en.2012-1007; Scott WL, 2001, TETRAHEDRON LETT, V42, P2073, DOI 10.1016/S0040-4039(01)00090-9; SHEMYAKI.MM, 1965, TETRAHEDRON LETT, P2323; SPENCER JR, 1993, J ORG CHEM, V58, P1635, DOI 10.1021/jo00058a064; Tana G, 2010, CHEM COMMUN, V46, P8219, DOI 10.1039/c0cc03090b	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	SEP	2015	21	9					691	695		10.1002/psc.2791		5	Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CP9KZ	WOS:000360214300001		
J	Katayama, H				Katayama, Hidekazu			Facile preparation of the N-acetyl-glucosaminylated asparagine derivative with TFA-sensitive protecting groups useful for solid-phase glycopeptide synthesis	JOURNAL OF PEPTIDE SCIENCE			English	Article						N-acetylglucosamine; glycopeptide; insulin-like androgenic gland factor; solid-phase peptide synthesis	CHEMOENZYMATIC SYNTHESIS; ACETYLGLUCOSAMINIDASE; TRANSGLYCOSYLATION; OLIGOSACCHARIDES; GLYCODELIN	In this study, a novel N-acetyl-glucosaminylated asparagine derivative was developed. This derivative carried TFA-sensitive protecting groups and was derived from commercially available compounds only in three steps. It was applicable to the ordinary 9-fluorenylmethoxycarbonyl (Fmoc)-based solid-phase peptide synthesis (SPPS) method, and the protecting groups on the carbohydrate moiety could be removed by a single step of TFA cocktail treatment generally used for the final deprotection step in Fmoc-SPPS. Copyright (c) 2015 European Peptide Society and John Wiley & Sons, Ltd.	Tokai Univ, Dept Appl Biochem, Sch Engn, Hiratsuka, Kanagawa 2591292, Japan	Katayama, H (reprint author), Tokai Univ, Dept Appl Biochem, Sch Engn, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	katay@tokai-u.jp			Naito Foundation; Tokai University Educational System General Research Organization	The author is grateful to Prof. Akemi Suzuki of the Institute of Glycoscience, Tokai University for the help on HRMS measuring. This work was supported in part by grant-in-aid from Naito Foundation, and in part by the Research and Study Program of Tokai University Educational System General Research Organization.	MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Basel Y, 2000, J ORG CHEM, V65, P6368, DOI 10.1021/jo000257f; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Asahina Y, 2013, ORG BIOMOL CHEM, V11, P7199, DOI 10.1039/c3ob41565a; Banzai K, 2011, FISHERIES SCI, V77, P329, DOI 10.1007/s12562-011-0337-8; Hagiwara M, 2011, J ORG CHEM, V76, P5229, DOI 10.1021/jo200149d; Katayama H, 2014, BIOORGAN MED CHEM, V22, P5783, DOI 10.1016/j.bmc.2014.09.031; Katayama H, 2010, BIOCHEMISTRY-US, V49, P1798, DOI 10.1021/bi902100f; Lapid K, 2006, GLYCOBIOLOGY, V16, p39R, DOI 10.1093/glycob/cwj059; MELDAL M, 1990, TETRAHEDRON LETT, V31, P6987, DOI 10.1016/S0040-4039(00)97223-X; Mizuno M, 1999, J AM CHEM SOC, V121, P284, DOI 10.1021/ja9831305; TAKEGAWA K, 1995, J BIOL CHEM, V270, P3094; Takenouchi T, 2014, J PEPT SCI, V20, P55, DOI 10.1002/psc.2592; Yamamoto K., 2013, BIOTECHNOL LETT, V35, P1733; YAMAMOTO KJ, 1994, BIOCHEM BIOPH RES CO, V203, P244, DOI 10.1006/bbrc.1994.2174	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	SEP	2015	21	9					696	699		10.1002/psc.2792		4	Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CP9KZ	WOS:000360214300002		
J	Hayakawa, Y; Matsuno, M; Tanaka, M; Wada, A; Kitamura, K; Takei, O; Sasaki, R; Mizukami, T; Hasegawa, M				Hayakawa, Yumiko; Matsuno, Mitsuhiro; Tanaka, Makoto; Wada, Akihiro; Kitamura, Koichiro; Takei, Osamu; Sasaki, Ryuzo; Mizukami, Tamio; Hasegawa, Makoto			Complementary DNA display selection of high-affinity peptides binding the vacuolating toxin (VacA) of Helicobacter pylori	JOURNAL OF PEPTIDE SCIENCE			English	Article						artificial functional peptide; cDNA display method; Helicobacter pylori; in vitro peptide evolution; vacuolating cytotoxin A	MESSENGER-RNA DISPLAY; IN-VITRO SELECTION; CDNA DISPLAY; BOTULINUM NEUROTOXIN; PHAGE DISPLAY; FUNCTIONAL PROTEINS; EVOLUTION; LIBRARIES; INHIBITORS; APTAMERS	Artificial peptides designed for molecular recognition of a bacterial toxin have been developed. Vacuolating cytotoxin A protein (VacA) is a major virulence factor of Helicobacter pylori, a gram-negative microaerophilic bacterium inhabiting the upper gastrointestinal tract, particularly the stomach. This study attempted to identify specific peptide sequences with high affinity for VacA using systematic directed evolution in vitro, a cDNA display method. A surface plasmon resonance-based biosensor and fluorescence correlation spectroscopy to examine binding of peptides with VacA identified a peptide (GRVNQRL) with high affinity. Cyclization of the peptide by attaching cysteine residues to both termini improved its binding affinity to VacA, with a dissociation constant (K-d) of 58nm. This study describes a new strategy for the development of artificial functional peptides, which are promising materials in biochemical analyses and medical applications. Copyright (c) 2015 European Peptide Society and John Wiley & Sons, Ltd.	[Hayakawa, Yumiko; Matsuno, Mitsuhiro; Tanaka, Makoto; Sasaki, Ryuzo; Mizukami, Tamio; Hasegawa, Makoto] Nagahama Inst Biosci & Technol, Grad Sch Biosci, Nagahama, Shiga 5260829, Japan; [Wada, Akihiro] Nagasaki Univ, Inst Trop Med, Nagasaki 8528523, Japan; [Kitamura, Koichiro] JANUSYS Co Ltd, Kawaguchi, Saitama 3330844, Japan; [Takei, Osamu] Lifetech Co Ltd, Iruma, Saitama 3580014, Japan	Hasegawa, M (reprint author), Nagahama Inst Biosci & Technol, Grad Sch Biosci, Tamura 1266, Nagahama, Shiga 5260829, Japan.	m_hasegawa@nagahama-i-bio.ac.jp					Abdeen SJ, 2010, ACS CHEM BIOL, V5, P1097, DOI 10.1021/cb100209b; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Sato A, 1996, BIOCHEMISTRY-US, V35, P10441, DOI 10.1021/bi960132y; Wada A, 2010, GLYCOBIOLOGY, V20, P668, DOI 10.1093/glycob/cwq014; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; GIEBEL LB, 1995, BIOCHEMISTRY-US, V34, P15430, DOI 10.1021/bi00047a006; Kurz M, 2001, CHEMBIOCHEM, V2, P666, DOI 10.1002/1439-7633(20010903)2:9<666::AID-CBIC666>3.0.CO;2-#; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Tombola F, 1999, BIOPHYS J, V76, P1401; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Ma HZ, 2006, TOXICON, V47, P901, DOI 10.1016/j.toxicon.2006.03.003; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Yahiro K, 1999, J BIOL CHEM, V274, P36693, DOI 10.1074/jbc.274.51.36693; Nishikawa K, 2006, FASEB J, V20, P2597, DOI 10.1096/fj.06-6572fje; Cover TL, 1996, MOL MICROBIOL, V20, P241, DOI 10.1111/j.1365-2958.1996.tb02612.x; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Ueno S, 2012, P NATL ACAD SCI USA, V109, P11121, DOI 10.1073/pnas.1203561109; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Josephson K, 2014, DRUG DISCOV TODAY, V19, P388, DOI 10.1016/j.drudis.2013.10.011; Butz K, 2001, ONCOGENE, V20, P6579, DOI 10.1038/sj.onc.1204805; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Gujraty K, 2005, MOL PHARMACEUT, V2, P367, DOI 10.1021/mp050040f; Hansson M, 1999, IMMUNOTECHNOLOGY, V4, P237, DOI 10.1016/S1380-2933(98)00026-8; Kitamura K, 2009, J MOL BIOL, V387, P1186, DOI [10.1016/j.jmb.2008.12.028, 10.1016/j.imb.2008.12.028]; Millward SW, 2005, J AM CHEM SOC, V127, P14142, DOI 10.1021/ja054373h; Mochizuki Y, 2012, METHODS MOL BIOL, V805, P237, DOI 10.1007/978-1-61779-379-0_13; Nagel-Wolfrum K, 2004, MOL CANCER RES, V2, P170; Naimuddin M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-2; Nemoto N, 2012, BIOCHEM BIOPH RES CO, V421, P129, DOI 10.1016/j.bbrc.2012.03.130; Pack CG, 2000, BIOCHEM BIOPH RES CO, V267, P300, DOI 10.1006/bbrc.1999.1864; Sagane Y, 2013, CURR MICROBIOL, V67, P188, DOI 10.1007/s00284-013-0355-0; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Tabuchi I, 2001, FEBS LETT, V508, P309, DOI 10.1016/S0014-5793(01)03075-7; Tomai E, 2006, J BIOL CHEM, V281, P21345, DOI 10.1074/jbc.M604258200; Ueno S, 2012, METHODS MOL BIOL, V805, P113, DOI 10.1007/978-1-61779-379-0_8; Yamaguchi J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp514; Yiadom KPAB, 2005, BIOCHEM BIOPH RES CO, V335, P1247, DOI 10.1016/j.bbrc.2005.07.196; Zoller F, 2013, ANGEW CHEM INT EDIT, V52, P11760, DOI 10.1002/anie.201304603	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	SEP	2015	21	9					710	716		10.1002/psc.2795		7	Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CP9KZ	WOS:000360214300004		
J	Yamamoto, A; Kawai, M; Iwanaga, K; Matsukura, T; Niwa, F; Hasegawa, T; Heike, T				Yamamoto, A.; Kawai, M.; Iwanaga, K.; Matsukura, T.; Niwa, F.; Hasegawa, T.; Heike, T.			Response to thyrotropin-releasing hormone stimulation tests in preterm infants with transient hypothyroxinemia of prematurity	JOURNAL OF PERINATOLOGY			English	Article							BIRTH-WEIGHT INFANTS; RESPIRATORY-DISTRESS-SYNDROME; THYROID-HORMONE; GESTATIONAL-AGE; THYROXINE SUPPLEMENTATION; BORN; DYSFUNCTION; DEFICIENCY	OBJECTIVE: Whether hormone supplementation is necessary for infants with transient hypothyroxinemia of prematurity (THOP) remains controversial, and further analysis of the hypothalamus-pituitary-thyroid axis of infants with THOP is necessary. STUDY DESIGN: Thyrotropin-releasing hormone (TRH) stimulation tests were performed at 2 weeks of age in 50 infants with a gestational age of 30 weeks or less, and the data were analyzed retrospectively. RESULT: Subjects were divided into three groups; group A consisted of euthyroid infants, group B consisted of infants with THOP and group C consisted of hypothyroid infants. The basal and peak thyroid-stimulating hormone level of group C in response to TRH stimulation tests was significantly higher than the others, but no differences were observed between groups A and B. CONCLUSION: The response of infants with THOP to the TRH stimulation test was not different from that of euthyroid infants, which suggested that their hypothalamic-pituitary-thyroid axis was appropriately regulated in infants with THOP.	[Yamamoto, A.; Kawai, M.; Iwanaga, K.; Matsukura, T.; Niwa, F.; Hasegawa, T.; Heike, T.] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan	Yamamoto, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Kawaramachi, Kyoto 6068507, Japan.	akaney64@kuhp.kyoto-u.ac.jp					Kaptein EM, 2009, J CLIN ENDOCR METAB, V94, P3663, DOI 10.1210/jc.2009-0899; Rapaport R, 2001, J PEDIATR-US, V139, P182, DOI 10.1067/mpd.2001.116934; Kawai M, 2012, PEDIATR INT, V54, P177, DOI 10.1111/j.1442-200X.2011.03518.x; VULSMA T, 1989, NEW ENGL J MED, V321, P13, DOI 10.1056/NEJM198907063210103; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Takizawa F, 2010, PEDIATR INT, V52, pe154, DOI 10.1111/j.1442-200X.2010.03072.x; Yagasaki H, 2010, J PEDIATR ENDOCR MET, V23, P153; vanWassenaer AG, 1997, NEW ENGL J MED, V336, P21, DOI 10.1056/NEJM199701023360104; Ares S, 2011, J PEDIATR ENDOCR MET, V24, P897, DOI 10.1515/JPEM.2011.166; Briet JM, 2001, PEDIATRICS, V107, P712, DOI 10.1542/peds.107.4.712; CUESTAS RA, 1979, J PEDIATR-US, V94, P643, DOI 10.1016/S0022-3476(79)80042-6; DenOuden AL, 1996, PEDIATR RES, V39, P142, DOI 10.1203/00006450-199601000-00021; DEZEGHER F, 1995, J CLIN ENDOCR METAB, V80, P3127, DOI 10.1210/jc.80.11.3127; HADEED AJ, 1981, PEDIATRICS, V68, P494; Osborn DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005945.pub2; KOIVUSALO F, 1981, J CLIN ENDOCR METAB, V53, P734; La Gamma EF, 2009, PEDIATRICS, V124, pE258, DOI 10.1542/peds.2008-2837; Leviton A, 1999, J PEDIATR-US, V134, P706, DOI 10.1016/S0022-3476(99)70285-4; Lucas A, 1996, BRIT MED J, V312, P1133; Lucas A, 1996, BRIT MED J, V312, P1132; MEIJER WJ, 1992, ARCH DIS CHILD, V67, P944; Niwa F, 2012, CLIN ENDOCRINOL, V77, P255, DOI 10.1111/j.1365-2265.2011.04323.x; Okada J, 2011, CLIN ENDOCRINOL, V74, P354, DOI 10.1111/j.1365-2265.2010.03927.x; POLK DH, 1991, AM J PHYSIOL, V260, pE53; RAPAPORT R, 1993, J CLIN ENDOCR METAB, V77, P889, DOI 10.1210/jc.77.4.889; Reuss ML, 1997, AM J PUBLIC HEALTH, V87, P1693, DOI 10.2105/AJPH.87.10.1693; Sureka Bollepalli SRR, 2012, AVERYS DIS NEWBORN, P1307; van Wassenaer-Leemhuis A, 2014, THYROID, V24, P1162, DOI 10.1089/thy.2013.0618; VanWassenaer AG, 1997, PEDIATR RES, V42, P604, DOI 10.1203/00006450-199711000-00009	30	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0743-8346	1476-5543		J PERINATOL	J. Perinatol.	SEP	2015	35	9					725	728		10.1038/jp.2015.67		4	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CQ2DC	WOS:000360408600013		
J	Devadoss, A; Sudhagar, P; Terashima, C; Nakata, K; Fujishima, A				Devadoss, Anitha; Sudhagar, Pitchaimuthu; Terashima, Chiaki; Nakata, Kazuya; Fujishima, Akira			Photoelectrochemical biosensors: New insights into promising photoelectrodes and signal amplification strategies	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY C-PHOTOCHEMISTRY REVIEWS			English	Review						Photoelectrochemical biosensors; Photoelectrodes; Biomolecules; Signal amplification	SENSITIZED SOLAR-CELLS; GRAPHENE-CDS NANOCOMPOSITES; LOCALIZED SURFACE-PLASMON; RESONANCE ENERGY-TRANSFER; TIO2 NANOTUBE ARRAYS; QUANTUM DOTS; ELECTROCHEMICAL SENSORS; PHOTOCURRENT GENERATION; ENHANCED PHOTOELECTROCHEMISTRY; BIOMEDICAL APPLICATIONS	The photoelectrochemical (PEC) process is a promising low-cost approach to convert chemical energy to electricity under light illumination and applied potential. PEC biosensing has attracted huge attention because of its ability to detect biomolecules through the photocurrent generated from biomolecule oxidation. However, important factors in the mechanism of PEC biosensing, particularly photoexcited (charge) carrier generation and separation at nano-bio interfaces, are not well explored. Therefore, with the objective of emphasising the implications of photoexcited (charge) carrier transport, here we review recent efforts indicating the significance of electrode design to enhance the performance of PEC biosensor with semiconductor photocatalytic materials. Besides enzymatic PEC biosensors, the underlying beneficial mechanism of direct oxidisation of biomolecules onto a wide range of semiconductor photocatalyst surfaces by the photogenerated holes is briefly discussed. This review is primarily divided into three parts: materials, signal amplification, and promising device architectures, based on recent advances in PEC biosensors. In addition, this review outlines the strategies used to detect a wide range of bioanalytes. After a summary of PEC sensing architectures, the review concludes with an outlook and the current challenges in fabricating solar-light-driven and self-powered biosensors using nanostructured photocatalytic semiconductors. The PEC biosensing schemes presented in this review provide unambiguous operating guidelines of this subject to facilitate our understanding of the compatibility between semiconductor photocatalysts and bioanalytes. (C) 2015 Elsevier B.V. All rights reserved.	[Devadoss, Anitha; Sudhagar, Pitchaimuthu; Terashima, Chiaki; Nakata, Kazuya; Fujishima, Akira] Tokyo Univ Sci, PIRC, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan	Sudhagar, P (reprint author), Tokyo Univ Sci, PIRC, Res Inst Sci & Technol, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	vedichi@gmail.com; terashima@rs.tus.ac.jp	Nakata, Kazuya/D-7633-2011	Nakata, Kazuya/0000-0002-6648-8534	Japan Society for the Promotion of Science (JSPS) [P13374]	P.S. (ID: P13374) thanks the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship Program for Foreign Researchers for financial assistance.	Liu YX, 2012, CHEM SOC REV, V41, P2283, DOI 10.1039/c1cs15270j; Li YJ, 2012, ANAL CHEM, V84, P10492, DOI 10.1021/ac302853y; Hammel E, 2004, CARBON, V42, P1153, DOI 10.1016/j.carbon.2003.12.043; Zhao WW, 2011, CHEM COMMUN, V47, P10990, DOI 10.1039/c1cc13952e; Guo YS, 2011, CHEM COMMUN, V47, P1595, DOI 10.1039/c0cc03921g; Long YT, 2011, SMALL, V7, P1624, DOI 10.1002/smll.201100427; Tanne J, 2011, ANAL CHEM, V83, P7778, DOI 10.1021/ac201329u; Gao C, 2012, NANOSCALE, V4, P1948, DOI 10.1039/c2nr11757f; Zhang LW, 2012, J PHOTOCH PHOTOBIO C, V13, P263, DOI 10.1016/j.jphotochemrev.2012.07.002; Pardo-Yissar V, 2003, J AM CHEM SOC, V125, P622, DOI 10.1021/ja028922k; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Golub E, 2012, J PHYS CHEM C, V116, P13827, DOI 10.1021/jp303741x; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Chen AC, 2013, CHEM SOC REV, V42, P5425, DOI 10.1039/c3cs35518g; Xie C, 2010, NANO LETT, V10, P4020, DOI 10.1021/nl101950x; Zhang BT, 2012, BIOSENS BIOELECTRON, V37, P112, DOI 10.1016/j.bios.2012.04.051; Ueno K, 2013, J PHOTOCH PHOTOBIO C, V15, P31, DOI 10.1016/j.jphotochemrev.2013.04.001; Devadoss A, 2012, ELECTROCHEM COMMUN, V19, P43, DOI 10.1016/j.elecom.2012.03.003; Tian JP, 2014, SENSOR ACTUAT B-CHEM, V196, P532, DOI 10.1016/j.snb.2014.02.046; Devadoss A, 2013, ANALYST, V138, P5025, DOI 10.1039/c3an00317e; Song SP, 2010, CHEM SOC REV, V39, P4234, DOI 10.1039/c000682n; Zhao WW, 2012, ANAL CHEM, V84, P5892, DOI 10.1021/ac300127s; Zheng ZK, 2011, J MATER CHEM, V21, P9079, DOI 10.1039/c1jm10983a; Zhang XR, 2011, BIOSENS BIOELECTRON, V26, P2737, DOI 10.1016/j.bios.2010.09.051; Zhang XY, 2014, ELECTROCHIM ACTA, V133, P615, DOI 10.1016/j.electacta.2014.04.089; Cosnier S, 2008, ANALYST, V133, P984, DOI 10.1039/b803083a; Shi X, 2013, PHYS CHEM CHEM PHYS, V15, P11717, DOI 10.1039/c3cp50459j; Tang J, 2013, NANO LETT, V13, P5350, DOI 10.1021/nl4028507; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Chen SY, 2012, CHEM MATER, V24, P3659, DOI 10.1021/cm302533s; Wark AW, 2008, ANGEW CHEM INT EDIT, V47, P644, DOI 10.1002/anie.200702450; Freeman R, 2013, ACS APPL MATER INTER, V5, P2815, DOI 10.1021/am303189h; Wang GL, 2009, BIOSENS BIOELECTRON, V24, P2494, DOI 10.1016/j.bios.2008.12.031; Zhao WW, 2015, CHEM SOC REV, V44, P729, DOI 10.1039/c4cs00228h; Kamat PV, 2011, J PHYS CHEM LETT, V2, P242, DOI 10.1021/jz101639v; Chen D, 2010, ANAL CHEM, V82, P2253, DOI 10.1021/ac9021055; Zhang XR, 2012, CHEM-EUR J, V18, P16411, DOI 10.1002/chem.201202213; Kirsch J, 2013, CHEM SOC REV, V42, P8733, DOI 10.1039/c3cs60141b; Tu WW, 2011, CHEM-EUR J, V17, P9440, DOI 10.1002/chem.201100577; Sudhagar P, 2012, J MATER CHEM, V22, P14228, DOI 10.1039/c2jm31599h; Zhang XR, 2010, CHEM COMMUN, V46, P9173, DOI 10.1039/c0cc03595e; Zheng M, 2011, J ELECTROANAL CHEM, V656, P167, DOI 10.1016/j.jelechem.2010.11.036; Da PM, 2014, ANAL CHEM, V86, P6633, DOI 10.1021/ac501406x; Turner APF, 2013, CHEM SOC REV, V42, P3184, DOI 10.1039/c3cs35528d; Li HB, 2014, BIOSENS BIOELECTRON, V54, P317, DOI 10.1016/j.bios.2013.11.024; Sudhagar P, 2009, ELECTROCHEM COMMUN, V11, P2220, DOI 10.1016/j.elecom.2009.09.035; Wang YC, 2014, NANO LETT, V14, P3668, DOI 10.1021/nl5014579; Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873; Rodenas P, 2013, ADV ENERGY MATER, V3, P176, DOI 10.1002/aenm.201200255; Sudhagar P, 2014, PHYS CHEM CHEM PHYS, V16, P17748, DOI 10.1039/c4cp02009j; Hvastkovs EG, 2010, ANALYST, V135, P1817, DOI 10.1039/c0an00113a; Zeng XX, 2013, ANAL CHEM, V85, P11720, DOI 10.1021/ac403408y; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Rasmussen M, 2013, ANAL METHODS-UK, V5, P1140, DOI 10.1039/c3ay26488b; Kongkanand A, 2007, NANO LETT, V7, P676, DOI 10.1021/nl0627238; Kang Q, 2010, ANAL CHEM, V82, P9749, DOI 10.1021/ac101798t; Chan DKL, 2014, BEILSTEIN J NANOTECH, V5, P689, DOI 10.3762/bjnano.5.81; Zhao XM, 2012, CHEM-EUR J, V18, P4974, DOI 10.1002/chem.201102379; Lightcap IV, 2012, J AM CHEM SOC, V134, P7109, DOI 10.1021/ja3012929; Devadoss A, 2014, ACS APPL MATER INTER, V6, P4864, DOI 10.1021/am4058925; Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005; Lee HJ, 2008, J PHYS CHEM C, V112, P11600, DOI 10.1021/jp802572b; Lee YL, 2009, ADV FUNCT MATER, V19, P604, DOI 10.1002/adfm.200800940; Tang J, 2014, NANO LETT, V14, P2702, DOI 10.1021/nl500608w; Nakata K, 2012, J PHOTOCH PHOTOBIO C, V13, P169, DOI 10.1016/j.jphotochemrev.2012.06.001; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Zang Y, 2014, ACS APPL MATER INTER, V6, P15991, DOI 10.1021/am503804g; Hu CG, 2013, ANAL CHEM, V85, P10612, DOI 10.1021/ac4028005; Qing Q, 2014, NAT NANOTECHNOL, V9, P142, DOI [10.1038/nnano.2013.273, 10.1038/NNANO.2013.273]; Dong HF, 2012, ANGEW CHEM INT EDIT, V51, P4607, DOI 10.1002/anie.201108302; Lee HJ, 2009, LANGMUIR, V25, P7602, DOI 10.1021/la900247r; Han H, 2012, ACS NANO, V6, P8308, DOI 10.1021/nn303002u; Atwater HA, 2010, NAT MATER, V9, P865, DOI 10.1038/nmat2866; Guo WX, 2012, J AM CHEM SOC, V134, P4437, DOI 10.1021/ja2120585; Faber MS, 2014, ENERG ENVIRON SCI, V7, P3519, DOI 10.1039/c4ee01760a; Devadoss A, 2011, ANAL CHEM, V83, P2383, DOI 10.1021/ac102697c; Zhang XM, 2013, ELECTROCHIM ACTA, V108, P491, DOI 10.1016/j.electacta.2013.07.064; Rajh T, 2004, NANO LETT, V4, P1017, DOI 10.1021/nl049684p; Shen QM, 2011, J PHYS CHEM C, V115, P17958, DOI 10.1021/jp203868t; Wang Y, 2014, ELECTROCHIM ACTA, V115, P269, DOI 10.1016/j.electacta.2013.09.173; Bakker E, 2006, ANAL CHEM, V78, P3965, DOI 10.1021/ac060637m; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Bai J, 2014, CHEM REV, V114, P10131, DOI 10.1021/cr400625j; He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639; Wang LL, 2012, J MATER CHEM, V22, P18111, DOI 10.1039/c2jm32520a; Borisov SM, 2008, CHEM REV, V108, P423, DOI 10.1021/cr068105t; Tang J, 2014, J MATER CHEM A, V2, P6153, DOI 10.1039/c3ta14173j; Yanagimoto T, 2012, SENSOR ACTUAT B-CHEM, V166, P31, DOI 10.1016/j.snb.2011.11.047; Li C, 2014, J PHOTOCH PHOTOBIO C, V19, P20, DOI 10.1016/j.jphotochemrev.2013.10.005; Zhao XM, 2012, ANALYST, V137, P3697, DOI 10.1039/c2an35658a; Zheng XT, 2013, ACS NANO, V7, P6278, DOI 10.1021/nn4023137; Dong HF, 2010, ANAL CHEM, V82, P5511, DOI 10.1021/ac100852z; Han DM, 2013, ELECTROCHEM COMMUN, V35, P38, DOI 10.1016/j.elecom.2013.07.038; Qian Z, 2010, BIOSENS BIOELECTRON, V25, P2045, DOI 10.1016/j.bios.2010.01.036; Zhao WW, 2014, CHEM REV, V114, P7421, DOI 10.1021/cr500100j; Bonifazi D, 2007, CHEM SOC REV, V36, P390, DOI 10.1039/b604308a; Tu WW, 2010, ANAL CHEM, V82, P8711, DOI 10.1021/ac102070f; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Christopher P, 2012, NAT MATER, V11, P1044, DOI [10.1038/nmat3454, 10.1038/NMAT3454]; Wang GL, 2010, NANOSCALE, V2, P1112, DOI 10.1039/c0nr00084a; Yue Z, 2013, ACS APPL MATER INTER, V5, P2800, DOI 10.1021/am3028662; Zhao WW, 2012, CHEM COMMUN, V48, P9456, DOI 10.1039/c2cc34543a; Forster RJ, 2009, ANNU REV ANAL CHEM, V2, P359, DOI 10.1146/annurev-anchem-060908-155305; Tokudome H, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2135392; Zhang XR, 2013, RSC ADV, V3, P2846, DOI 10.1039/c2ra22238h; Bai S, 2013, CARBON, V60, P157, DOI 10.1016/j.carbon.2013.04.009; Wannier GH, 1937, PHYS REV, V52, P0191, DOI 10.1103/PhysRev.52.191; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Ronkainen NJ, 2010, CHEM SOC REV, V39, P1747, DOI 10.1039/b714449k; Wang WJ, 2012, ANAL CHIM ACTA, V744, P33, DOI 10.1016/j.aca.2012.07.025; Conzuelo F, 2014, CHEMELECTROCHEM, V1, P1854, DOI 10.1002/celc.201402098; Fan GC, 2014, BIOSENS BIOELECTRON, V59, P45, DOI 10.1016/j.bios.2014.03.011; Esteves ACC, 2002, CURR OPIN SOLID ST M, V6, P347, DOI 10.1016/S1359-0286(02)00079-7; Sheeney-Haj-Ichia L, 2002, J PHYS CHEM B, V106, P13094, DOI 10.1021/jp022102c; Parolo C, 2013, CHEM SOC REV, V42, P450, DOI 10.1039/c2cs35255a; Huo KF, 2014, RSC ADV, V4, P17300, DOI 10.1039/c4ra01458h; Bi S, 2009, CHEM-EUR J, V15, P4704, DOI 10.1002/chem.200801722; Han H, 2013, CHEM COMMUN, V49, P2810, DOI 10.1039/c3cc40439k; Sheeney-Haj-Ichia L, 2004, ADV FUNCT MATER, V14, P416, DOI 10.1002/adfm.200305430; Becquerel A. E., 1839, CR HEBD ACAD SCI, V9, P145; Becquerel A.E., 1841, ANN PHYS CHEM, V54, P35; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cao HJ, 2014, CHEM COMMUN, V50, P13315, DOI 10.1039/c4cc06214k; Chen G., 2012, LANGMUIR, V28, P393; Chien FC, 2007, BIOSENS BIOELECTRON, V22, P2737, DOI 10.1016/j.bios.2006.11.021; Curri ML, 2002, MAT SCI ENG C-BIO S, V22, P449, DOI 10.1016/S0928-4931(02)00191-1; Devadoss A, 2014, PHYS CHEM CHEM PHYS, V16, P21237, DOI 10.1039/c4cp03262d; Ding CF, 2010, CHEM COMMUN, V46, P7990, DOI 10.1039/c0cc01507e; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Jiang S., 2013, NAT COMMUN, V4, P1; Kimmel D.W., 2011, ANAL CHEM, V84, P685, DOI DOI 10.1021/AC202878Q; Lee Y.L., 2009, CHEM MATER, V22, P922; Lightcap I.V., 2012, ACCOUNTS CHEM RES, V46, P2235; Matylitsky VV, 2009, J AM CHEM SOC, V131, P2424, DOI 10.1021/ja808084y; Medintz 1. L., 2005, NAT MATER, V4, P435, DOI DOI 10.1038/NMAT1390; Raja R., 2015, CHEM COMMUN, P522; Ren Y., 2012, ANGEW CHEM, V124, P2206; Samantara AK, 2014, J MATER CHEM A, V2, P12677, DOI 10.1039/c4ta01349b; Sekretaryova AN, 2014, ANAL CHEM, V86, P9540, DOI 10.1021/ac501699p; Sheeney-Haj-Ichia L, 2002, ADV MATER, V14, P1323, DOI 10.1002/1521-4095(20020916)14:18<1323::AID-ADMA1323>3.0.CO;2-D; Shen QM, 2014, NANOSCALE, V6, P6315, DOI 10.1039/c4nr00520a; Talapin DV, 2001, NANO LETT, V1, P207, DOI 10.1021/nl0155126; Venkatanarayanan A, 2011, ELECTROCHEM COMMUN, V13, P396, DOI 10.1016/j.elecom.2011.01.031; Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wang YF, 2014, J PHYS CHEM C, V118, P17240, DOI 10.1021/jp5024789; Wang YH, 2013, ANALYST, V138, P7112, DOI 10.1039/c3an01410j; Xuelian Y., 2013, NANOTECHNOLOGY, V24; Yoshida A, 2010, J PHYS CHEM C, V114, P2867, DOI 10.1021/jp9081454; Zhan W, 2010, LANGMUIR, V26, P15671, DOI 10.1021/la102884u; Zhan W, 2008, LANGMUIR, V24, P13258, DOI 10.1021/la802972p; Zhang XM, 2013, CHEM COMMUN, V49, P7091, DOI 10.1039/c3cc42583e; Zhao WW, 2012, CHEM COMMUN, V48, P895, DOI 10.1039/c1cc16775h	154	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-5567	1873-2739		J PHOTOCH PHOTOBIO C	J. Photochem. Photobiol. C-Photochem. Rev.	SEP	2015	24						43	63		10.1016/j.jphotochemrev.2015.06.002		21	Chemistry, Physical	Chemistry	CQ2HL	WOS:000360420600003		
J	Yoshimura, M; Uezono, Y; Ueta, Y				Yoshimura, Mitsuhiro; Uezono, Yasuhito; Ueta, Yoichi			Anorexia in human and experimental animal models: physiological aspects related to neuropeptides	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Review						Hypothalamus; Feeding-regulating neuropeptides; Anorexia; Behavior; Rodents	HORMONE-RELATED PROTEIN; DEHYDRATION-INDUCED ANOREXIA; MELANIN-CONCENTRATING HORMONE; TUMOR-BEARING RATS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; FEEDING-REGULATING PEPTIDES; CISPLATIN-INDUCED ANOREXIA; MESSENGER-RNA LEVELS; CANCER CACHEXIA; FOOD-INTAKE	Anorexia, a loss of appetite for food, can be caused by various physiological and pathophysiological conditions. In this review, firstly, clinical aspects of anorexia nervosa are summarized in brief. Secondly, hypothalamic neuropeptides responsible for feeding regulation in each hypothalamic nucleus are discussed. Finally, three different types of anorexigenic animal models; dehydration-induced anorexia, cisplatin-induced anorexia and cancer anorexia-cachexia, are introduced. In conclusion, hypothalamic neuropeptides may give us novel insight to understand and find effective therapeutics strategy essential for various kinds of anorexia.	[Yoshimura, Mitsuhiro; Ueta, Yoichi] Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Kitakyushu, Fukuoka 8078555, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Tokyo 1040045, Japan	Ueta, Y (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Kitakyushu, Fukuoka 8078555, Japan.	yoichi@med.uoeh-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [25293055]; Ministry of Health Labour and Welfare, Japan; Naito Foundation, Japan	We thank A. Dickie (University of Glasgow) for language editing of the manuscript. This article was supported by a Grant-in-Aid for Scientific Research (B) (no. 25293055) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine from the Ministry of Health Labour and Welfare, Japan; and by The Naito Foundation, Japan.	Harrison A, 2009, CLIN PSYCHOL PSYCHOT, V16, P348, DOI 10.1002/cpp.628; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Fujitsuka N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.25; Alvarez-Salas E, 2012, ENDOCRINOLOGY, V153, P4067, DOI 10.1210/en.2011-2011; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Morgan DG, 1998, DIABETOLOGIA, V41, P1482, DOI 10.1007/s001250051095; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Ramos EJB, 2004, CURR OPIN CLIN NUTR, V7, P427, DOI 10.1097/01.mco.0000134363.53782.cb; MCCARTHY HD, 1993, AM J PHYSIOL, V264, pE638; Primeaux SD, 2011, PEPTIDES, V32, P1270, DOI 10.1016/j.peptides.2011.03.022; Terawaki K, 2014, AM J PHYSIOL-ENDOC M, V306, pE373, DOI 10.1152/ajpendo.00116.2013; Cooper MJ, 2005, CLIN PSYCHOL REV, V25, P511, DOI 10.1016/j.cpr.2005.01.003; Siljee JE, 2013, EUR J ENDOCRINOL, V168, P361, DOI 10.1530/EJE-12-0750; Gull WW, 1997, OBES RES, V5, P498; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Muscaritoli M, 2006, EUR J CANCER, V42, P31, DOI 10.1016/j.ejca.2005.07.026; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Hakansson ML, 1998, NEUROENDOCRINOLOGY, V68, P420, DOI 10.1159/000054392; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Fujiki N, 2006, PEPTIDES, V27, P2326, DOI 10.1016/j.peptides.2006.03.011; Watts AG, 1999, PHYSIOL BEHAV, V65, P871; Irani BG, 2011, EUR J PHARMACOL, V660, P80, DOI 10.1016/j.ejphar.2010.10.101; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; ANAND BK, 1951, P SOC EXP BIOL MED, V77, P323; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Chance WT, 1996, PEPTIDES, V17, P797, DOI 10.1016/0196-9781(96)00108-8; Pearce JMS, 2004, EUR NEUROL, V52, P191, DOI 10.1159/000082033; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Shimada M, 1998, NATURE, V396, P670; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; Bell ME, 2000, J NEUROSCI, V20, P6707; Plata-Salaman CR, 1998, AM J PHYSIOL-REG I, V275, pR566; HOESS RH, 1982, P NATL ACAD SCI-BIOL, V79, P3398, DOI 10.1073/pnas.79.11.3398; Inhoff T, 2008, PEPTIDES, V29, P2159, DOI 10.1016/j.peptides.2008.09.014; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Bing C, 2001, J NEUROCHEM, V79, P1004, DOI 10.1046/j.1471-4159.2001.00639.x; Hashimoto H, 2007, CLIN CANCER RES, V13, P292, DOI 10.1158/1078-0432.CCR-06-1487; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; Wade TD, 2000, AM J PSYCHIAT, V157, P469, DOI 10.1176/appi.ajp.157.3.469; Haque Z, 2013, STRESS, V16, P353, DOI 10.3109/10253890.2012.736047; Watts AG, 2001, ANNU REV NEUROSCI, V24, P357, DOI 10.1146/annurev.neuro.24.1.357; Jureus A, 2000, ENDOCRINOLOGY, V141, P2703, DOI 10.1210/en.141.7.2703; Watts AG, 1995, BEHAV NEUROSCI, V109, P1146, DOI 10.1037//0735-7044.109.6.1146; Iguchi H, 2001, INT J CANCER, V94, P24, DOI 10.1002/ijc.1425; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Laviano A, 2005, NAT CLIN PRACT ONCOL, V2, P158, DOI 10.1038/ncponc0112; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Lugarini F, 2002, AM J PHYSIOL-REG I, V283, pR862, DOI 10.1152/ajpregu.00200.2002; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Yakabi K, 2010, REGUL PEPTIDES, V161, P97, DOI 10.1016/j.regpep.2010.02.003; Stengel A, 2011, ENDOCRINOLOGY, V152, P4033, DOI 10.1210/en.2011-1500; KUKREJA SC, 1988, J CLIN INVEST, V82, P1798, DOI 10.1172/JCI113794; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Lu XY, 2000, HORM BEHAV, V37, P335, DOI 10.1006/hbeh.2000.1584; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Bodnar RJ, 2013, PEPTIDES, V50, P55, DOI 10.1016/j.peptides.2013.10.001; Schoorlemmer GHM, 2002, AM J PHYSIOL-REG I, V283, pR1061, DOI 10.1152/ajpregu.00236.2002; Yakabi K, 2010, ENDOCRINOLOGY, V151, P3773, DOI 10.1210/en.2010-0061; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Vella KR, 2011, CELL METAB, V14, P780, DOI 10.1016/j.cmet.2011.10.009; Watts AG, 2010, PHYSIOL BEHAV, V100, P472, DOI 10.1016/j.physbeh.2010.04.010; Nara-ashizawa N, 2001, METABOLISM, V50, P1213, DOI 10.1053/meta.2001.26706; Chance WT, 1998, REGUL PEPTIDES, V75-6, P347, DOI 10.1016/S0167-0115(98)00087-1; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Watts AG, 1999, J NEUROSCI, V19, P6111; Shimizu H, 2009, PEPTIDES, V30, P995, DOI 10.1016/j.peptides.2009.01.002; Kampe J, 2006, BRAIN RES, V1119, P133, DOI 10.1016/j.brainres.2006.08.055; Ramanjaneya M, 2013, AM J PHYSIOL-ENDOC M, V305, pE1049, DOI 10.1152/ajpendo.00191.2013; Sergeyev V, 2001, MOL BRAIN RES, V90, P93, DOI 10.1016/S0169-328X(01)00088-2; Juszczak M, 2014, J PHYSIOL PHARMACOL, V65, P777; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Fetissov SO, 2005, P NATL ACAD SCI USA, V102, P14865, DOI 10.1073/pnas.0507204102; Attia E, 2010, ANNU REV MED, V61, P425, DOI 10.1146/annurev.med.050208.200745; Boyle CN, 2012, PHYSIOL BEHAV, V105, P305, DOI 10.1016/j.physbeh.2011.08.005; Brambilla F, 2007, INT CLIN PSYCHOPHARM, V22, P197, DOI 10.1097/YIC.0b013e328080ca31; CHRONWALL BM, 1984, NEUROSCI LETT, V52, P213, DOI 10.1016/0304-3940(84)90164-2; Criscione L, 1998, J CLIN INVEST, V102, P2136, DOI 10.1172/JCI4188; DEBONS AF, 1968, AM J PHYSIOL, V214, P652; du Percie Sert N, 2011, CANCER CHEMOTH PHARM, V67, P667; Favaro A, 2006, ARCH GEN PSYCHIAT, V63, P82, DOI 10.1001/archpsyc.63.1.82; Frederich R, 2002, J LAB CLIN MED, V139, P72, DOI 10.1067/mlc.2002.121014; Fujitsuka N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00271; Garcia-Luna C, 2010, REGUL PEPTIDES, V159, P54, DOI 10.1016/j.regpep.2009.09.011; GARNER DM, 1980, PSYCHOL MED, V10, P647; Grill V, 1998, EUR J CANCER, V34, P222, DOI 10.1016/S0959-8049(97)10130-7; HAGEN TC, 1976, NEUROENDOCRINOLOGY, V21, P255, DOI 10.1159/000122530; Halmi KA, 1996, PSYCHIAT RES, V62, P23, DOI 10.1016/0165-1781(96)02986-1; Jaimes-Hoy L, 2008, HORM BEHAV, V53, P366, DOI 10.1016/j.yhbeh.2007.11.003; Jensen PB, 1998, J CLIN INVEST, V101, P503, DOI 10.1172/JCI275; Just N, 2011, NMR BIOMED, V24, P1326, DOI 10.1002/nbm.1694; Kaye WH, 2005, PHYSIOL BEHAV, V85, P73, DOI 10.1016/j.physbeh.2005.04.013; Kim KW, 2008, MOL ENDOCRINOL, V22, P1950, DOI 10.1210/me.2008-0127; KISS JZ, 1985, BRAIN RES, V329, P169, DOI 10.1016/0006-8993(85)90522-0; Kiwaki K, 2004, AM J PHYSIOL-ENDOC M, V286, pE551, DOI 10.1152/ajpendo.00126.2003; KOCSIS F, 1973, Z NATURFORSCH C, VC 28, P131; KOW LM, 1987, EXP BRAIN RES, V67, P93, DOI 10.1007/BF00269457; LIN MT, 1983, NEUROENDOCRINOLOGY, V37, P206, DOI 10.1159/000123544; Lock JD, 2009, BMJ CLIN EVID; Medina F, 1998, PEPTIDES, V19, P1309, DOI 10.1016/S0196-9781(98)00093-X; Merali Z, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00193; Mondello P, 2015, NUTR CANCER, V67, P12, DOI 10.1080/01635581.2015.976318; MORGANE PJ, 1961, NATURE, V191, P672, DOI 10.1038/191672a0; Nakhate KT, 2010, PHARMACOL BIOCHEM BE, V97, P340, DOI 10.1016/j.pbb.2010.09.001; Oh IS, 2006, NATURE, V443, P709, DOI DOI 10.1038/NATURE05162; Onuma E, 2005, INT J CANCER, V116, P471, DOI 10.1002/ijc.21038; Piccinni A, 2015, CURR MED CHEM, V22, P1631; Primeaux SD, 2013, HORM METAB RES, V45, P967, DOI 10.1055/s-0033-1353181; Rinaman L, 2005, AM J PHYSIOL-REG I, V288, pR1791, DOI 10.1152/ajpregu.00860.2004; Sakurai T, 1998, Cell, V92, P696; Shay NF, 2000, J NUTR, V130, p1493S; Solomon A, 2005, NUTR NEUROSCI, V8, P287, DOI 10.1080/10284150500502546; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Steward CA, 2003, NEUROREPORT, V14, P687, DOI 10.1097/01.wnr.0000064982.96259.00; Suzuki M, 2012, SYNAPSE, V66, P747, DOI 10.1002/syn.21559; Ueta Y, 2007, ENDOCR J, V54, P831, DOI 10.1507/endocrj.KR-111; Voigt JP, 2015, BEHAV BRAIN RES, V277, P14, DOI 10.1016/j.bbr.2014.08.065; WEAVER DR, 1995, MOL BRAIN RES, V28, P296, DOI 10.1016/0169-328X(94)00222-Z; Williamson-Hughes PS, 2005, BRAIN RES, V1041, P117, DOI 10.1016/j.brainres.2004.11.066; Xin XG, 1998, NEUROREPORT, V9, P737, DOI 10.1097/00001756-199803090-00032; Yoshimura M, 2013, PEPTIDES, V46, P13, DOI 10.1016/j.peptides.2013.04.019; Yoshimura M, 2014, AM J PHYSIOL-REG I, V307, pR225, DOI 10.1152/ajpregu.00488.2013; Zonnevijlle-Bendek MJS, 2002, EUR CHILD ADOLES PSY, V11, P38	129	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	SEP	2015	65	5					385	395		10.1007/s12576-015-0386-3		11	Physiology	Physiology	CQ1WE	WOS:000360390100001		
J	Yamazaki, F				Yamazaki, Fumio			The cutaneous vasoconstrictor response in lower extremities during whole-body and local skin cooling in young women with a cold constitution	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Cold sensation; Skin blood flow; Norepinephrine; Cold syndrome; Local temperature	BROWN ADIPOSE-TISSUE; NITRIC-OXIDE; HUMANS; DETERMINANTS; TEMPERATURE; CHILLINESS; PERCEPTION; MECHANISM; EXPOSURE; COMFORT	To clarify the characteristics of the thermal control of skin blood flow (SkBF) in individuals with a cold constitution, we examined the cutaneous vasoconstrictor responses in the calf and dorsal foot during whole-body and local skin cooling in young women complaining of chilliness (C group) and young women not suffering from it (N group). During whole-body skin cooling, the vasoconstrictor sensitivity in the dorsal foot, but not in the calf, was greater in the C group than in the N group. The C group also showed greater vasoconstrictor responses in the dorsal foot, but not in the calf, during local skin cooling and the iontophoretic application of norepinephrine. These findings suggest that the C group possesses a specific SkBF controlling system that is characterized by higher adrenergic sensitivity for greater cutaneous vasoconstriction in the distal portion of the lower extremities during cold exposure.	Yamaguchi Prefectural Univ, Fac Nursing & Nutr, Exercise Physiol Lab, Yamaguchi 7530021, Japan	Yamazaki, F (reprint author), Yamaguchi Prefectural Univ, Fac Nursing & Nutr, Exercise Physiol Lab, 6-2-1 Sakurabatake, Yamaguchi 7530021, Japan.	fsone@n.ypu.jp			Japan Society for the Promotion of Science [24500688]	The author thanks the subjects who participated in this experiment. I would also like to thank Mr. Yasuhiro Sogabe, Mr. Kouichi Monji and Ms. Nagisa Yuge for experimental assistance. This study was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (24500688). The management of Grant-in-Aid for Scientific Research and the documents for this study was properly transferred from the University of Occupational and Environmental Health to the Yamaguchi Prefectural University for the movement of the author (Fumio Yamazaki).	AITKEN RCB, 1969, P ROY SOC MED, V62, P989; Alvarez GE, 2006, J APPL PHYSIOL, V100, P2083, DOI 10.1152/japplphysiol.01265.2005; Stephens DP, 2004, AM J PHYSIOL-HEART C, V287, pH1404, DOI 10.1152/ajpheart.00061.2004; Johnson JM, 2014, COMPR PHYSIOL, V4, P33, DOI 10.1002/cphy.c130015; Charkoudian N, 1999, J APPL PHYSIOL, V87, P1719; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Hardy JD, 1938, J NUTR, V15, P461; Hodges GJ, 2006, J PHYSIOL-LONDON, V574, P849, DOI 10.1113/jphysiol.2006.109884; CAMPBELL WI, 1990, ULSTER MED J, V59, P149; Stephens DP, 2002, AM J PHYSIOL-HEART C, V282, pH264; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Stephens DP, 2001, AM J PHYSIOL-HEART C, V280, pH1496; Matsuda-Nakamura M, 2015, J PHYSIOL SCI, V65, P339, DOI 10.1007/s12576-015-0371-x; Nakamura K, 2008, J PHYSIOL-LONDON, V586, P2611, DOI 10.1113/jphysiol.2008.152686; Frank SM, 1999, J APPL PHYSIOL, V86, P1588; Yamazaki F, 2006, J APPL PHYSIOL, V100, P42, DOI 10.1152/japplphysiol.00139.2005; WADA F, 1995, AM J PHYSIOL-REG I, V268, pR583; EKENVALL L, 1988, AM J PHYSIOL, V255, pH1000; FLAVAHAN NA, 1985, AM J PHYSIOL, V249, pH950; Hensel H., 1981, THERMORECEPTION TEMP; Ikeda T, 2013, JPN J MATERNAL HLTH, V53, P487; Kusumi Y, 2009, J JPN ACAD MIDWIF, V23, P241; Miura T, 2001, JAP J MATERNAL HLTH, V42, P784; Nagashima K, 2002, J APPL PHYSIOL, V92, P1029, DOI 10.1152/japplphysiol.00399.2001; Nakamura S, 2010, J JPN ACAD NURS SCI, V30, P62; Okada M, 2005, BIOMED THERMOL, V24, P44; Sadakata Mieko, 2007, Journal of Physiological Anthropology, V26, P449, DOI 10.2114/jpa2.26.449; Sadakata M, 2007, BIOMED THERMOL, V27, P1; Tanaka H, 2005, JPN RED CROSS MED J, V56, P507; Yamada Noriko, 2007, Japanese Journal of Neuropsychopharmacology, V27, P191; Yamada Noriko, 2009, Japanese Journal of Neuropsychopharmacology, V29, P171; Yamato T, 2002, HEP, V29, P878; Yamazaki F, 2011, J APPL PHYSIOL, V111, P170, DOI 10.1152/japplphysiol.00068.2011	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	SEP	2015	65	5					397	405		10.1007/s12576-015-0378-3		9	Physiology	Physiology	CQ1WE	WOS:000360390100002		
J	Kozaki, Y; Umetsu, R; Mizukami, Y; Yamamura, A; Kitamori, K; Tsuchikura, S; Ikeda, K; Yamori, Y				Kozaki, Yasuko; Umetsu, Rena; Mizukami, Yukako; Yamamura, Aya; Kitamori, Kazuya; Tsuchikura, Satoru; Ikeda, Katsumi; Yamori, Yukio			Peripheral gene expression profile of mechanical hyperalgesia induced by repeated cold stress in SHRSP5/Dmcr rats	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Repeated cold stress; Mechanical hyperalgesia; Peripheral pain mechanisms; Pain-related genes	NERVOUS-SYSTEM; CHRONIC PAIN; MICE; BEHAVIOR; RECEPTOR	Repeated cold stress (RCS) is known to transiently induce functional disorders associated with hypotension and hyperalgesia. In this study, we investigated the effects of RCS (24 and 4 A degrees C alternately at 30-min intervals during the day and 4 A degrees C at night for 2 days, followed by 4 A degrees C on the next 2 consecutive nights) on the thresholds for cutaneous mechanical pain responses and on peripheral expression of "pain-related genes" in SHRSP5/Dmcr rats, which are derived from stroke-prone spontaneously hypertensive rats. To define genes peripherally regulated by RCS, we detected changes in the expression of pain-related genes in dorsal root ganglion cells by PCR-based cDNA subtraction analysis or DNA microarray analysis, and confirmed the changes by RT-PCR. We found significantly changed expression in eight pain-related genes (upregulated: Fyn, St8sia1, and Tac 1; downregulated: Ctsb, Fstl1, Itpr1, Npy, S100a10). At least some of these genes may play key roles in hyperalgesia induced by RCS.	[Kozaki, Yasuko; Umetsu, Rena; Mizukami, Yukako; Yamamura, Aya] Kinjo Gakuin Univ, Coll Pharm, Moriyama Ku, Nagoya, Aichi 4638521, Japan; [Kitamori, Kazuya] Kinjo Gakuin Univ, Coll Human Life & Environm, Nagoya, Aichi, Japan; [Tsuchikura, Satoru] Dis Model Cooperat Res Assoc, Kyoto, Japan; [Ikeda, Katsumi] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Yamori, Yukio] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan	Kozaki, Y (reprint author), Kinjo Gakuin Univ, Coll Pharm, Moriyama Ku, 2-1723 Ohmori, Nagoya, Aichi 4638521, Japan.	kozaki@kinjo-u.ac.jp			Ministry of Education, Science, Sports, and Culture, Japan [23590724]	This work was supported in part by a Grant-in-Aid (23590724) for Scientific Research (C) from the Ministry of Education, Science, Sports, and Culture, Japan.	Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Foulkes T, 2006, J NEUROSCI, V26, P10499, DOI 10.1523/JNEUROSCI.1997-06.2006; Nasu T, 2010, EUR J PAIN, V14, P236, DOI 10.1016/j.ejpain.2009.05.009; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Okuda T, 2002, BIOCHEM BIOPH RES CO, V296, P537, DOI 10.1016/S0006-291X(02)00902-6; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Solway B, 2011, P NATL ACAD SCI USA, V108, P7224, DOI 10.1073/pnas.1017719108; HATA T, 1988, J AUTON PHARMACOL, V8, P45, DOI 10.1111/j.1474-8673.1988.tb00168.x; SATOH M, 1992, PAIN, V49, P273, DOI 10.1016/0304-3959(92)90151-Z; Watanabe S, 2011, PAIN, V152, P327, DOI 10.1016/j.pain.2010.10.036; Kawanishi C, 1997, PHYSIOL BEHAV, V62, P849, DOI 10.1016/S0031-9384(97)00248-5; Sun L, 2012, J NEUROSCI, V32, P11330, DOI 10.1523/JNEUROSCI.0677-12.2012; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; Dent MAR, 1996, DEVELOPMENT, V122, P1029; HATA T, 1982, FOLIA PHARMACOL JPN, V79, P335, DOI 10.1254/fpj.79.335; HATA T, 1984, Japanese Journal of Psychosomatic Medicine, V24, P257; Kita T, 1983, SHINSHIN IGAKU, V23, P61; KITA T, 1975, FOLIA PHARMACOL JPN, V71, P195, DOI 10.1254/fpj.71.195; KITA T, 1979, JPN J PHARMACOL, V29, P479, DOI 10.1254/jjp.29.479; Kitamori Kazuya, 2012, Environmental Health and Preventive Medicine, V17, P173, DOI 10.1007/s12199-011-0235-9; Kozaki Y, 2014, J PHYSL SCI S1, V64, pS157; LaCroix-Fralish ML, 2007, PAIN, V131, DOI DOI 10.1016/J.PAIN.2007.04.041; Luo C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001283; OHARA H, 1991, JPN J PHARMACOL, V57, P243, DOI 10.1254/jjp.57.243; Taylor BK, 2001, AM J PHYSIOL-REG I, V280, pR345; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	SEP	2015	65	5					417	425		10.1007/s12576-015-0380-9		9	Physiology	Physiology	CQ1WE	WOS:000360390100004		
J	Tomoto, T; Sugawara, J; Hirasawa, A; Imai, T; Maeda, S; Ogoh, S				Tomoto, Tsubasa; Sugawara, Jun; Hirasawa, Ai; Imai, Tomoko; Maeda, Seiji; Ogoh, Shigehiko			Impact of short-term training camp on arterial stiffness in endurance runners	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Pulse wave velocity; Left ventricular contractility; Endurance training; Ventricular-arterial coupling	PERIPHERAL ARTERIES; AEROBIC CAPACITY; EXERCISE; HEALTHY; AGE	Lack of elasticity in the central artery causes an increase in left ventricular (LV) afterload. Although regular moderate-intensity endurance exercise improves cardiovascular function, including arterial destiffening, little is known about the effect of short-term vigorous exercise on cardiovascular function (i.e., the interaction between cardiac and arterial functions). We measured arterial stiffness [via pulse wave velocity from the heart to ankle (haPWV)] and LV contractility (via systolic interval time) before and after a 1-week training camp in a total of 33 regularly highly-trained collegiate endurance runners. They participated in three training sessions per day which mainly consisted of long-distance running and sprint training. The averaged running distance was a parts per thousand 44 % longer during the camp than the regular training program. After the camp, heart rate at rest and haPWV were significantly increased, whereas blood pressure remained unchanged. Although a ratio of pre-ejection period and LV ejection time (PEP/LVET, an index of blunted LV contractility) was unaltered, presumably due to the large variability of individual response, there was a significant correlation between changes in haPWV and PEP/LVET (r = 0.54, P < 0.01). These results suggest that, in regularly highly-trained endurance athletes, arterial stiffness increases after a training camp characterized by greater training volume (vs. regular training), and that the individual response in arterial stiffness correlates with the corresponding changes in myocardial contractility.	[Tomoto, Tsubasa] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Tomoto, Tsubasa; Sugawara, Jun] Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Hirasawa, Ai; Ogoh, Shigehiko] Toyo Univ, Kawagoe, Saitama, Japan; [Imai, Tomoko] Univ Tsukuba, Sports R&D Core, Tsukuba, Ibaraki, Japan; [Maeda, Seiji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan	Sugawara, J (reprint author), Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	jun.sugawara@aist.go.jp					Kimoto E, 2003, DIABETES, V52, P448; Safar ME, 2000, J HYPERTENS, V18, P1527, DOI 10.1097/00004872-200018110-00001; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456; Sugawara J, 2005, J HUM HYPERTENS, V19, P401, DOI 10.1038/sj.jhh.1001838; Failla M, 1999, J HYPERTENS, V17, P1117, DOI 10.1097/00004872-199917080-00011; Vlachopoulos C, 2010, AM J HYPERTENS, V23, P974, DOI 10.1038/ajh.2010.99; SCHIFF HB, 1978, Q J MED, V47, P463; Pichot V, 2000, MED SCI SPORT EXER, V32, P1729, DOI 10.1097/00005768-200010000-00011; Barnes JN, 2010, J APPL PHYSIOL, V109, P1102, DOI 10.1152/japplphysiol.00548.2010; Pichot V, 2002, MED SCI SPORT EXER, V34, P1660, DOI 10.1249/01.MSS.0000035993.08625.31; BOUTOUYRIE P, 1994, AM J PHYSIOL-HEART C, V267, pH1368; DOUGLAS PS, 1987, CIRCULATION, V76, P1206; Hayashi K, 2005, JPN J PHYSIOL, V55, P235, DOI 10.2170/jjphysiol.S2116; Aslani A, 2009, ECHOCARDIOGR-J CARD, V26, P1036, DOI 10.1111/j.1540-8175.2009.00919.x; Johnson Mary Black, 1992, Journal of Athletic Training, V27, P352; Burr JF, 2014, J SCI MED SPORT, V17, P322, DOI 10.1016/j.jsams.2013.04.018; Kim WJ, 2012, ATHEROSCLEROSIS, V225, P237, DOI 10.1016/j.atherosclerosis.2012.08.034; Lehmann MJ, 1997, J SPORT MED PHYS FIT, V37, P7; Mangoni AA, 1997, HYPERTENSION, V30, P1085; Nichols WW, 2011, MCDONALDS BLOOD FLOW; Otsuki T, 2006, HYPERTENS RES, V29, P759, DOI 10.1291/hypres.29.759; PERRET F, 1989, AM J HYPERTENS, V2, P727; Weissler A M, 1971, Mod Concepts Cardiovasc Dis, V40, P1	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	SEP	2015	65	5					445	449		10.1007/s12576-015-0383-6		5	Physiology	Physiology	CQ1WE	WOS:000360390100007		
J	Imaoka, Y; Kawai, M; Mori, F; Miyata, H				Imaoka, Yoko; Kawai, Minako; Mori, Futoshi; Miyata, Hirofumi			Effect of eccentric contraction on satellite cell activation in human vastus lateralis muscle	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Human muscle fiber; Eccentric contraction; Satellite cell; mRNA	HEPATOCYTE GROWTH-FACTOR; MYOGENIC GENE-EXPRESSION; MOUSE SKELETAL-MUSCLE; LENGTHENING CONTRACTIONS; RESISTANCE EXERCISE; POSSIBLE MECHANISM; NITRIC-OXIDE; IN-VIVO; MYOSTATIN; FIBERS	We compared the time-course of satellite cell (SC) activation between eccentric and concentric contractions in the vastus lateralis (VL) muscle after step exercise. Young adults participated in a 30-min step up/down exercise which mainly involved concentric contractions with the right VL muscle and eccentric contractions with the left VL muscle. The concentric and eccentric contraction phases of the VL muscles were identified by changes in the electromyogram (EMG) and knee joint angle. Biopsy samples were taken from both VL muscles at three time periods: before the exercise and 2 and 5 days after the exercise. We found that the numbers of SCs were significantly increased in the type IIa fibers of the left VL at 2 and 5 days after the exercise. The expression of both hepatocyte growth factor (HGF) and myogenic differentiation 1 (MyoD) mRNA had significantly increased in the left VL at 2 and 5 days after the exercise and in the right VL at 5 days after the exercise. The expression of transient receptor potential canonical (TRPC) 1 mRNA also increased in the left VL at 2 days after exercise. These results indicate that eccentric contraction can effectively activate SC proliferation for up to 5 days after exercise. Similar changes in HGF, MyoD and TRPC1 mRNA expression suggest that HGF/c-Met signal activation through cation influx has a major impact on skeletal muscle SC activation in response to eccentric exercise.	[Imaoka, Yoko; Miyata, Hirofumi] Yamaguchi Univ, Grad Sch Med, Dept Biol Sci, Yamaguchi 7538515, Japan; [Kawai, Minako] Shimane Univ, Sch Med, Dept Neural & Muscular Physiol, Yamaguchi, Japan; [Mori, Futoshi] Hiroshima Prefectural Univ, Dept Occupat Therapy, Mihara, Japan	Miyata, H (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Biol Sci, Yoshida 1677-1, Yamaguchi 7538515, Japan.	hiro@yamaguchi-u.ac.jp			Japanese Ministry of Education, Science and Culture [23650434]	This work was supported in part by a grant from The Japanese Ministry of Education, Science and Culture (No. 23650434).	Hara M, 2012, AM J PHYSIOL-CELL PH, V302, pC1741, DOI 10.1152/ajpcell.00068.2012; Tatsumi R, 2010, ANIM SCI J, V81, P11, DOI 10.1111/j.1740-0929.2009.00712.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Kawai M, 2013, EQUINE VET J, V45, P512, DOI 10.1111/evj.12010; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009; NEWHAM DJ, 1986, MUSCLE NERVE, V9, P59, DOI 10.1002/mus.880090109; Cooper RN, 1999, J CELL SCI, V112, P2895; Tatsumi R, 2004, MUSCLE NERVE, V30, P654, DOI 10.1002/mus.20114; Argiles JM, 2012, DRUG DISCOV TODAY, V17, P702, DOI 10.1016/j.drudis.2012.02.001; FRIDEN J, 1981, EXPERIENTIA, V37, P506, DOI 10.1007/BF01986165; LIEBER RL, 1988, ACTA PHYSIOL SCAND, V133, P587, DOI 10.1111/j.1748-1716.1988.tb08446.x; Zhang BT, 2012, J APPL PHYSIOL, V112, P2077, DOI 10.1152/japplphysiol.00770.2011; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; O'Reilly C, 2008, MUSCLE NERVE, V38, P1434, DOI 10.1002/mus.21146; Roig M, 2009, BRIT J SPORT MED, V43, P556, DOI 10.1136/bjsm.2008.051417; Wozniak AC, 2007, DEV DYNAM, V236, P240, DOI 10.1002/dvdy.21012; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Raue U, 2006, J APPL PHYSIOL, V101, P53, DOI 10.1152/japplphysiol.01616.2005; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Coolican SA, 1997, J BIOL CHEM, V272, P6653; Kurosaka M, 2012, ACTA PHYSIOL, V205, P159, DOI 10.1111/j.1748-1716.2011.02381.x; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Ates K, 2007, FEBS LETT, V581, P2727, DOI 10.1016/j.febslet.2007.05.030; Takekura H, 2001, J PHYSIOL-LONDON, V533, P571, DOI 10.1111/j.1469-7793.2001.0571a.x; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Costa A, 2007, EUR J APPL PHYSIOL, V101, P427, DOI 10.1007/s00421-007-0510-z; Imaoka Y, 2014, JPN J PHYS FIT SPORT, V63, P177; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; LIEBER RL, 1994, J APPL PHYSIOL, V77, P1926; McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; Molinari F, 2006, IEEE T BIO-MED ENG, V53, P1309, DOI 10.1109/TBME.2006.873680; NARDONE A, 1989, J PHYSIOL-LONDON, V409, P451; Okamoto T, 2006, CLIN PHYSIOL FUNCT I, V26, P39, DOI 10.1111/j.1475-097X.2005.00651.x; Suetta C, 2013, J PHYSIOL-LONDON, V591, P3789, DOI 10.1113/jphysiol.2013.257121; Tsuchida K, 2008, CURR OPIN DRUG DISC, V11, P487; Vallejo AF, 2006, AGE AGEING, V35, P291, DOI 10.1093/ageing/afj082; Yamano S, 2005, AM J VET RES, V66, P401, DOI 10.2460/ajvr.2005.66.401	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	SEP	2015	65	5					461	469		10.1007/s12576-015-0385-4		9	Physiology	Physiology	CQ1WE	WOS:000360390100009		
J	Ishii, K; Mitsuhiro, I; Matsukawa, K				Ishii, Kei; Mitsuhiro, Idesako; Matsukawa, Kanji			Differential contribution of aortic and carotid sinus baroreflexes to control of heart rate and renal sympathetic nerve activity	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Aortic and carotid sinus baroreceptors; Renal sympathetic nerve activity; Phenylephrine; Nitroprusside; Precollicular-premammillary decerebrate rat	NUCLEUS-TRACTUS-SOLITARIUS; SPONTANEOUS MOTOR-ACTIVITY; CENTRAL COMMAND; AWAKE CATS; BARORECEPTORS; REFLEX; ONSET; SUMMATION; ARTERIAL; BRADYCARDIA	We examined the roles of aortic and carotid sinus baroreceptors in control of heart rate (HR) and renal sympathetic nerve activity (RSNA) in 17 decerebrate rats. The baroreflex curves between the changes in mean arterial blood pressure (MAP) and HR or RSNA in response to intravenous injection of phenylephrine (10-20 mu g/kg) or nitroprusside (10 mu g/kg) were identified before and following sequential denervation of all four baroafferent nerves. The slope of the MAP-HR curve in the pressor range was decreased (P < 0.05) to 31 +/- A 7 % of the control following denervation of bilateral aortic nerves, whereas it remained substantial (72 +/- A 10 %) following denervation of bilateral carotid sinus nerves. The slope for HR became negligible following complete denervation of all four baroafferent nerves. In contrast, the slope of the MAP-RSNA curve decreased as the sequential baroafferent denervation progressed, irrespective of the denervation order, and it remained well as long as any single baroafferent nerve was intact. The similar influences of sequential baroafferent denervation on the responses of HR and RSNA were observed in the depressor range. Thus, it is likely that aortic and carotid sinus baroreceptors play differential roles in control of HR but they contribute similarly to control of RSNA.	[Ishii, Kei; Mitsuhiro, Idesako; Matsukawa, Kanji] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Integrat Physiol, Minami Ku, Hiroshima 7348551, Japan	Matsukawa, K (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Integrat Physiol, Minami Ku, I-2-3 Kasumi, Hiroshima 7348551, Japan.	matsuk@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	We really appreciate the valuable expert advice of Dr. Minoru Shinohara (Georgia Institute of Technology) in reviewing the manuscript. This study was supported by Grants-in-Aid for Scientific Research (B) and for Exploratory Research from the Japan Society for the Promotion of Science (JSPS) and for JSPS Fellows (K.I.).	ALEXANDER N, 1963, AM J PHYSIOL, V205, P775; Miki K, 2003, J PHYSIOL-LONDON, V548, P313, DOI 10.1113/physiol.2002.033050; MATSUKAWA K, 1993, AM J PHYSIOL, V265, pR792; Pickering AE, 2008, AUTON NEUROSCI-BASIC, V142, P32, DOI 10.1016/j.autneu.2008.03.009; Chan RKW, 2000, NEUROSCIENCE, V101, P165, DOI 10.1016/S0306-4522(00)00332-8; CIRIELLO J, 1981, J AUTONOM NERV SYST, V3, P299, DOI 10.1016/0165-1838(81)90071-0; DONOGHUE S, 1985, J PHYSIOL-LONDON, V360, P261; FERGUSON DW, 1985, J CLIN INVEST, V76, P2265, DOI 10.1172/JCI112236; GUO GB, 1982, CIRC RES, V50, P554; Idesako M, 2014, J PHYSL SCI S1, V64, pS125; Komine H, 2003, AM J PHYSIOL-HEART C, V285, pH516, DOI 10.1152/ajpheart.00013.2003; Matsukawa K, 2014, J PHYSIOL SCI, V64, P291, DOI 10.1007/s12576-014-0318-7; Matsukawa K, 2013, AUTON NEUROSCI-BASIC, V179, P75, DOI 10.1016/j.autneu.2013.07.008; Matsukawa K, 2012, AM J PHYSIOL-HEART C, V303, pH464, DOI 10.1152/ajpheart.01133.2011; MATSUKAWA K, 1989, AM J PHYSIOL, V256, pR371; Murata J, 2004, J APPL PHYSIOL, V97, P1371, DOI 10.1152/japplphysiol.00307.2004; NINOMIYA I, 1969, AM J PHYSIOL, V216, P1330; NINOMIYA I, 1986, AM J PHYSIOL, V251, pH528; NOSAKA S, 1995, J AUTONOM NERV SYST, V55, P69, DOI 10.1016/0165-1838(95)00030-2; Paton JF, 2001, J PHYSL, V427, P553; Paxinos G., 1986, RAT BRAIN STEREOTAXI; Sagawa K., 1983, HDB PHYSL 2, VIII, P453; SAGAWA K, 1965, AM J PHYSIOL, V209, P1278; Segar JL, 1997, AM J PHYSIOL-REG I, V273, pR457; TANABE S, 1989, AM J PHYSIOL, V256, pH1399; THAMES MD, 1984, AM J PHYSIOL, V246, pH851	26	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	SEP	2015	65	5					471	480		10.1007/s12576-015-0387-2		10	Physiology	Physiology	CQ1WE	WOS:000360390100010		
J	Ishii, K; Idesako, M; Matsukawa, K				Ishii, Kei; Idesako, Mitsuhiro; Matsukawa, Kanji			Differential contribution of aortic and carotid sinus baroreflexes to control of heart rate and renal sympathetic nerve activity (vol 65, pg 471, 2015)	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Correction									[Ishii, Kei; Idesako, Mitsuhiro; Matsukawa, Kanji] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Integrat Physiol, Minami Ku, Hiroshima 7348551, Japan	Matsukawa, K (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Integrat Physiol, Minami Ku, I-2-3 Kasumi, Hiroshima 7348551, Japan.	matsuk@hiroshima-u.ac.jp					Ishii K, 2015, J PHYSIOL SCI, V65, P471, DOI 10.1007/s12576-015-0387-2	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	SEP	2015	65	5					481	481		10.1007/s12576-015-0389-0		1	Physiology	Physiology	CQ1WE	WOS:000360390100011		
J	Nishida, K; Kodama, N; Yonemura, S; Hanba, YT				Nishida, Keisuke; Kodama, Naomi; Yonemura, Seiichiro; Hanba, Yuko T.			Rapid response of leaf photosynthesis in two fern species Pteridium aquilinum and Thelypteris dentata to changes in CO2 measured by tunable diode laser absorption spectroscopy	JOURNAL OF PLANT RESEARCH			English	Article						CO2 response; Ferns; Mesophyll conductance; Pteridophytes; Photosynthesis	MESOPHYLL DIFFUSION CONDUCTANCE; CARBON-ISOTOPE DISCRIMINATION; QUANTUM CASCADE LASER; LEAVES; PLANTS; IRRADIANCE; LIGHT; LIMITATIONS; EVOLUTION; STOMATA	We investigated stomatal conductance (g (s)) and mesophyll conductance (g (m)) in response to atmospheric CO2 concentration [CO2] in two primitive land plants, the fern species Pteridium aquilinum and Thelypteris dentata, using the concurrent measurement of leaf gas exchange and carbon isotope discrimination. [CO2] was initially decreased from 400 to 200 mu mol mol(-1), and then increased from 200 to 700 mu mol mol(-1), and finally decreased from 700 to 400 mu mol mol(-1). Analysis by tunable diode laser absorption spectroscopy (TDLAS) revealed a rapid and continuous response in g (m) within a few minutes. In most cases, both ferns showed rapid and significant responses of g (m) to changes in [CO2]. The largest changes (quote % decrease) were obtained when [CO2] was decreased from 400 to 200 mu mol mol(-1). This is in contrast to angiosperms where an increase in g (m) is commonly observed at low [CO2]. Similarly, fern species observed little or no response of g (s) to changes in [CO2] whereas, a concomitant decline of g (m) and g (s) with [CO2] is often reported in angiosperms. Together, these results suggest that regulation of g (m) to [CO2] may differ between angiosperms and ferns.	[Nishida, Keisuke] Kyoto Inst Technol, Grad Sch Sci, Sakyo Ku, Kyoto 6068585, Japan; [Kodama, Naomi; Yonemura, Seiichiro] Natl Inst Agroenvironm Sci, Agrometeorol Div, Tsukuba, Ibaraki 3058604, Japan; [Kodama, Naomi] Swiss Fed Inst Forest Snow & Landscape Res WSL, CH-8903 Birmensdorf, Switzerland; [Hanba, Yuko T.] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan	Nishida, K (reprint author), Kyoto Inst Technol, Grad Sch Sci, Sakyo Ku, Kyoto 6068585, Japan.	nishida-keisuke0725@hotmail.co.jp			New Technology Development Foundation; Japanese Society for the Promotion of Science [26850009]; Solar-Terrestrial Environmental Laboratory	This work was supported by the New Technology Development Foundation (to N. Kodama), a Grant-in-Aid for Scientific Research for Young Researchers from the Japanese Society for the Promotion of Science (Scientific Research No. 26850009 to N. Kodama) and Collaborative Research Funding from the Solar-Terrestrial Environmental Laboratory (to N. Kodama and S. Yonemura). The authors also thank Dr. Yutaka Matsumi for giving technical advice on laser spectroscopy and Dr. Ichiro Terashima and Dr. Ko Noguchi for their insightful advice on the gas exchange system.	Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Doi M, 2008, PLANT PHYSIOL, V147, P922, DOI 10.1104/pp.108.118950; Evans JR, 2013, PLANT CELL ENVIRON, V36, P745, DOI 10.1111/j.1365-3040.2012.02591.x; Tomas M, 2013, J EXP BOT, V64, P2269, DOI 10.1093/jxb/ert086; Pryer KM, 2001, NATURE, V409, P618, DOI 10.1038/35054555; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Sessa EB, 2014, FUNCT ECOL, V28, P108, DOI 10.1111/1365-2435.12150; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Carriqui M, 2015, PLANT CELL ENVIRON, V38, P448, DOI 10.1111/pce.12402; Bice KL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2002PA000778; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Flexas J, 2012, PLANT SCI, V193, P70, DOI 10.1016/j.plantsci.2012.05.009; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; Hanba YT, 2002, PLANT CELL ENVIRON, V25, P1021, DOI 10.1046/j.1365-3040.2002.00881.x; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; Wada R, 2011, ATMOS ENVIRON, V45, P1168, DOI 10.1016/j.atmosenv.2010.10.015; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; Tazoe Y, 2009, J EXP BOT, V60, P2291, DOI 10.1093/jxb/erp035; Der JP, 2009, AM J BOT, V96, P1041, DOI [10.3732/ajb.0800333, 10.3732/ajb.D0800333]; EVANS JR, 1986, AUST J PLANT PHYSIOL, V13, P281; Messinger SM, 2006, PLANT PHYSIOL, V140, P771, DOI 10.1104/pp.105.073676; Volkova L, 2009, FUNCT PLANT BIOL, V36, P1046, DOI 10.1071/FP09098; Hanba YT, 1999, FUNCT ECOL, V13, P632, DOI 10.1046/j.1365-2435.1999.00364.x; Hanba YT, 2001, AUST J PLANT PHYSIOL, V28, P1075, DOI 10.1071/PP00102; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; Vrabl D, 2009, J EXP BOT, V60, P2315, DOI 10.1093/jxb/erp115; Woodward FI, 1998, J EXP BOT, V49, P471, DOI 10.1093/jexbot/49.suppl_1.471; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Tholen D, 2012, PLANT CELL ENVIRON, V35, P2087, DOI 10.1111/j.1365-3040.2012.02538.x; Kawase M, 2013, J PLANT RES, V126, P517, DOI 10.1007/s10265-013-0548-4; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Ethier GJ, 2006, PLANT CELL ENVIRON, V29, P2168, DOI 10.1111/j.1365-3040.2006.01590.x; LORETO F, 1992, PLANT PHYSIOL, V98, P1437, DOI 10.1104/pp.98.4.1437; Mizokami Y, 2015, PLANT CELL ENVIRON, V38, P388, DOI 10.1111/pce.12394; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; Terashima I, 2002, PLANT CELL PHYSIOL, V43, P70, DOI 10.1093/pcp/pcf001; Douthe C, 2011, J EXP BOT, V62, P5335, DOI 10.1093/jxb/err141; Smith AR, 2006, TAXON, V55, P705; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Bunce JA, 2010, PHOTOSYNTHETICA, V48, P507, DOI 10.1007/s11099-010-0067-7; Gago J, 2013, PHYSIOL PLANTARUM, V149, P599, DOI 10.1111/ppl.12073; Gilbert ME, 2011, J EXP BOT, V63, P413; Haworth M, 2011, J EXP BOT, V62, P2419, DOI 10.1093/jxb/err086; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; LAISK A, 1984, PLANT PHYSIOL, V76, P723, DOI 10.1104/pp.76.3.723; Murakami K, 2007, AM FERN J, V97, P186, DOI 10.1640/0002-8444(2007)97[186:NIAREO]2.0.CO;2; Nelson DD, 2008, APPL PHYS B-LASERS O, V90, P301, DOI 10.1007/s00340-007-2894-1; OGREN E, 1993, PLANTA, V189, P182, DOI 10.1007/BF00195075; ROESKE CA, 1984, BIOCHEMISTRY-US, V23, P6275, DOI 10.1021/bi00320a058; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173; Tazoe Y, 2015, PLANT CELL ENVIRON, V38, P385, DOI 10.1111/pce.12437; Tazoe Y, 2011, PLANT CELL ENVIRON, V34, P1; Tuzson B, 2008, INFRARED PHYS TECHN, V51, P198, DOI 10.1016/j.infrared.2007.05.006; Zhang YG, 2013, PHILOS T R SOC A, V371, P1	55	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	SEP	2015	128	5					777	789		10.1007/s10265-015-0736-5		13	Plant Sciences	Plant Sciences	CQ1QH	WOS:000360372700005		
J	Yamaji, F; Ohsawa, TA				Yamaji, Futa; Ohsawa, Takeshi A.			Breaking-bud pollination: a new pollination process in partially opened flowers by small bees	JOURNAL OF PLANT RESEARCH			English	Article						Body size; Lasioglossum japonicum; Lycoris sanguinea var. sanguinea; Pollination mechanism	POLLEN DISPERSAL; FORAGING RANGES; PLANT; SPECIALIZATION; AMARYLLIDACEAE; CLEISTOGAMY; XYRIDACEAE; EVOLUTION; ECOLOGY; SYSTEMS	Plant-pollinator interactions have usually been researched in flowers that have fully opened. However, some pollinators can visit flowers before full opening and contribute to fruit and seed sets. In this paper, we researched the pollination biology of flowers just starting to open in four field experiments. We observed the insect visitors to Lycoris sanguinea var. sanguinea for 3 years at five sites. These observations revealed that only small bees, Lasioglossum japonicum, often entered through tiny spaces between the tepals of 'breaking buds' (i.e. partially opened flowers) and collected pollen. We hypothesized that they can pollinate this species at the breaking-bud stage, when the stigma is located near the anthers. To measure the pollination effect of small bees at the breaking-bud stage, we bagged several breaking buds after small bees had visited them and examined whether these buds were pollinated. In bagging experiments, 30 % of the breaking buds set fruit and seeds. Fruit-set ratios of the breaking buds did not differ significantly from those of the fully opened flowers, which had been visited by several insect species. We also counted the pollen grain numbers on the body of L. japonicum and on the anthers of randomly-selected and manipulated flowers. These experiments revealed that all of the captured bees had some pollen of target plants and that L. japonicum collected most of the pollen grains at the breaking-bud stage. Our results showed that the new pollination process, breaking-bud pollination, happened in breaking buds by L. japonicum, although there is no evidence to reveal that this is the most effective pollination method for L. sanguinea var. sanguinea. In principle, this new pollination process can occur in other flowering plants and our results are a major contribution to studies of plant-pollinator interactions.	[Yamaji, Futa; Ohsawa, Takeshi A.] Chiba Univ, Dept Biol, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan	Yamaji, F (reprint author), Chiba Univ, Dept Biol, Grad Sch Sci, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	futa.yamaji@gmail.com; asakawa@faculty.chiba-u.jp			 [26.11613]	The authors thank O. Tadauchi, Kyushu University, for insect identification. We also thank Y. Watano, Chiba University, T. Takano, The University of Tokyo, L. K. Faulks, Uppsala University, and two anonymous reviewers for their helpful comments on the manuscript. This research was partly supported by Grant-in-Aid for JSPS Fellows (26.11613).	Hermann K, 2013, CURR BIOL, V23, P873, DOI 10.1016/j.cub.2013.03.069; Rosas-Guerrero V, 2014, ECOL LETT, V17, P388, DOI 10.1111/ele.12224; [Anonymous], 2010, BIOL CONSERV, DOI DOI 10.1016/J.BIOCON.2009.12.003; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; THORP RW, 1979, ANN MO BOT GARD, V66, P788, DOI 10.2307/2398919; LORD EM, 1981, BOT REV, V47, P421, DOI 10.1007/BF02860538; Culley TM, 2007, BOT REV, V73, P1, DOI 10.1663/0006-8101(2007)73[1:TCBSAR]2.0.CO;2; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; WALLER DM, 1984, EVOLUTION, V38, P427, DOI 10.2307/2408501; ARROYO J, 1995, NEW PHYTOL, V129, P135, DOI 10.1111/j.1469-8137.1995.tb03017.x; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Thorp RW, 2000, PLANT SYST EVOL, V222, P211, DOI 10.1007/BF00984103; HARDER LD, 1990, ECOLOGY, V71, P1110, DOI 10.2307/1937379; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Boyd RS, 2011, CASTANEA, V76, P255, DOI 10.2179/11-006.1; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Darwin C.R., 1877, DIFFERENT FORMS FLOW; Faegri K., 1979, PRINCIPLES POLLINATI; GALEN C, 1989, AM J BOT, V76, P419, DOI 10.2307/2444612; Hsu Ping-Sheng, 1994, SIDA Contributions to Botany, V16, P301; Kawano S, 2009, PLANT SPEC BIOL, V24, P139, DOI 10.1111/j.1442-1984.2009.00249.x; Kettle CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016111; Ma B, 2001, J JPN SOC HORTIC SCI, V70, P697; Ma B, 2000, SCI REP COLL AGR OSA, V52, P13; NASRALLA.ME, 1974, GENETICS, V76, P45; Proctor M., 1996, NATURAL HIST POLLINA; REDBOTORSTENSSON P, 1995, ACTA BOT NEERL, V44, P247; Tadauchi Osamu, 2001, Esakia, V41, P149; Wall MA, 2002, FLA ENTOMOL, V85, P290, DOI 10.1653/0015-4040(2002)085[0290:FMBLZH]2.0.CO;2; Wang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060449; Willson MF, 2000, SEEDS ECOLOGY REGENE, V2, P85; Wright KM, 2013, CURR BIOL, V23, pR525, DOI 10.1016/j.cub.2013.04.069	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	SEP	2015	128	5					803	811		10.1007/s10265-015-0741-8		9	Plant Sciences	Plant Sciences	CQ1QH	WOS:000360372700007		
J	Oku, H; Inafuku, M; Ishikawa, T; Takamine, T; Ishmael, M; Fukuta, M				Oku, Hirosuke; Inafuku, Masashi; Ishikawa, Takeshi; Takamine, Tnomonori; Ishmael, Mutanda; Fukuta, Masakazu			Molecular cloning and biochemical characterization of isoprene synthases from the tropical trees Ficus virgata, Ficus septica, and Casuarina equisetifolia	JOURNAL OF PLANT RESEARCH			English	Article						Isoprene synthase; Tropical tree; Cloning; Characterization; Docking simulation	APPROXIMATE COMPUTATIONAL METHOD; PROTEIN STRUCTURES; ORBITAL METHOD; POPLAR LEAVES; EMISSION; TEMPERATURE; EXPRESSION; EVOLUTION; FAMILY; PLANTS	Three isoprene synthase (IspS) cDNA clones have been isolated from tropical trees (Ficus septica, F. virgata, and Casuarina equisetifolia), and their enzyme properties have been compared with those of Populus alba IspS. Phylogenetic analysis of the deduced amino acid sequences with known monoterpene synthase resolved IspS from F. septica and F. virgata and other IspSs in a clade together with TPS-b clade I, whereas IspS from C. equisetifolia was within another clade, sister to TPS-b clade II. The optimum reaction temperature was 40 A degrees C for the IspSs isolated from the tropical trees, and 45 A degrees C for P. alba IspS. The optimum pH of the IspSs from the tropical trees peaked between pH 8 and pH10 contrasting with the rather broad optimum pH (7.5-10.5) of P. alba IspS. IspSs from F. septica and F. virgata were activated solely by Mg2+, whereas IspS from C. equisetifolia was dependent more on Mn2+ than on Mg2+. Michaelis constant (Km) values of IspSs from tropical trees were lower than that of P. alba IspS. Analysis of inter fragment interaction energy of IspS-substrate complex model and crystal structure of bornyl diphosphate synthase (1N20) found that the coordination geometry of amino acids with higher attraction force is similar at the active site of C. equisetifolia IspS and bornyl diphosphate synthase. These observations suggest the occurrence of another group of IspSs in TPS-b subfamily and extend the knowledge on biochemical regulatory mechanism of isoprene emission from tropical trees.	[Oku, Hirosuke; Inafuku, Masashi] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan; [Takamine, Tnomonori; Fukuta, Masakazu] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 9030213, Japan; [Ishmael, Mutanda] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan; [Ishikawa, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Oku, Hirosuke] Univ Ryukyus, Mol Biotechnol Grp, Ctr Mol Biosci, Nishihara, Okinawa 9030213, Japan	Oku, H (reprint author), Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan.	okuhiros@comb.u-ryukyu.ac.jp					Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Zurbriggen A, 2012, BIOENERG RES, V5, P814, DOI 10.1007/s12155-012-9192-4; Sasaki K, 2005, FEBS LETT, V579, P2514, DOI 10.1016/j.febslet.2005.03.066; Koksal M, 2010, J MOL BIOL, V402, P363, DOI 10.1016/j.jmb.2010.07.009; Kesselmeier J, 2000, ATMOS ENVIRON, V34, P4063, DOI 10.1016/S1352-2310(00)00186-2; Sharkey TD, 1996, TREE PHYSIOL, V16, P649; Wiberley AE, 2009, PLANT CELL ENVIRON, V32, P939, DOI 10.1111/j.1365-3040.2009.01980.x; Kitaura K, 1999, CHEM PHYS LETT, V312, P319, DOI 10.1016/S0009-2614(99)00937-9; Ishikawa T, 2009, J COMPUT CHEM, V30, P2594, DOI 10.1002/jcc.21265; Lehning A, 1999, PLANT CELL ENVIRON, V22, P495, DOI 10.1046/j.1365-3040.1999.00425.x; Gray DW, 2011, J BIOL CHEM, V286, P20582, DOI 10.1074/jbc.M111.237438; Mayrhofer S, 2005, PLANT PHYSIOL, V139, P474, DOI 10.1104/pp.105.066373; MONSON RK, 1992, PLANT PHYSIOL, V98, P1175, DOI 10.1104/pp.98.3.1175; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.127.4.1781; Schnitzler JP, 2005, PLANTA, V222, P777, DOI 10.1007/s00425-005-0022-1; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Vickers CE, 2009, PLANT CELL ENVIRON, V32, P520, DOI 10.1111/j.1365-3040.2009.01946.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; Aaron JA, 2010, PURE APPL CHEM, V82, P1585, DOI 10.1351/PAC-CON-09-09-37; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Sharkey TD, 2013, EVOLUTION, V67, P1026, DOI 10.1111/evo.12013; Basyuni M, 2006, PHYTOCHEMISTRY, V67, P2517, DOI 10.1016/j.phytochem.2006.09.016; COLOVOS C, 1993, PROTEIN SCI, V2, P1511; Cronquist A., 1988, EVOLUTION CLASSIFICA; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; Fehsenfeld Fred, 1992, Global Biogeochemical Cycles, V6, P389, DOI 10.1029/92GB02125; Guenther A, 1996, J GEOPHYS RES-ATMOS, V101, P25859, DOI 10.1029/96JD02597; Guenther A, 1999, J GEOPHYS RES-ATMOS, V104, P30625, DOI 10.1029/1999JD900391; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Helmig D, 1998, J GEOPHYS RES-ATMOS, V103, P25519, DOI 10.1029/98JD01023; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Oku H, 2008, ATMOS ENVIRON, V42, P8747, DOI 10.1016/j.atmosenv.2008.08.036; Scharer MA, 2011, FEBS LETT, V585, P111, DOI 10.1016/j.febslet.2010.11.013; SILVER GM, 1995, J BIOL CHEM, V270, P13010; Affek HP, 2002, PLANT PHYSIOL, V129, P269, DOI 10.1104/pp.010909	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	SEP	2015	128	5					849	861		10.1007/s10265-015-0740-9		13	Plant Sciences	Plant Sciences	CQ1QH	WOS:000360372700012		
J	Wang, SL; Ito, T; Uehara, M; Naito, S; Takano, J				Wang, Sheliang; Ito, Toshiaki; Uehara, Masataka; Naito, Satoshi; Takano, Junpei			UDP-D-galactose synthesis by UDP-glucose 4-epimerase 4 is required for organization of the trans-Golgi network/early endosome in Arabidopsis thaliana root epidermal cells	JOURNAL OF PLANT RESEARCH			English	Article						Arabidopsis thaliana; UDP-D-galactose; UDP-D-glucose 4-epimerase; Endomembrane organization; TGN/EEs	ENDOMEMBRANE ORGANIZATION; ENDOPLASMIC-RETICULUM; PLANT-CELLS; PROTEINS; TRAFFICKING; COLOCALIZATION; BIOSYNTHESIS; MICROTUBULES; ENDOCYTOSIS; MORPHOLOGY	Endomembrane organization is essential for cell physiology. We previously identified an Arabidopsis thaliana mutant in which a plasma membrane (PM) marker GFP-NIP5;1 and trans-Golgi network/early endosome (TGN/EE) markers were accumulated in intracellular aggregates in epidermal cells of the root elongation zone. The mutant was identified as an allele of UDP-glucose epimerase 4 (UGE4)/root hair defective 1/root epidermal bulgar 1, which was previously described as a mutant with swollen root epidermal cells and has an altered sugar composition in cell wall polysaccharides. Importantly, these defects including aggregate formation were restored by supplementation of d-galactose in the medium. These results suggested that UDP-d-galactose synthesis by UGE4 is important for endomembrane organization in addition to cell wall structure. Here, we further investigated the nature of the aggregates using various markers of endomembrane compartments and BOR1-GFP, which traffics from PM to vacuole in response to high-B supply. The markers of multi-vesicular bodies/late endosomes (MVB/LEs) and BOR1-GFP were strongly accumulated in the intracellular aggregates, while those of the endoplasmic reticulum (ER), the vacuolar membrane, and the Golgi were only slightly affected in the uge4 mutant. The abnormal localizations of these markers in the uge4 mutant differed from the effects of inhibitors of actin and microtubule polymerization, although they also affected endomembrane organization. Furthermore, electron microscopy analysis revealed accumulation of abnormal high-electron-density vesicles in elongating epidermal cells. The abnormal vesicles were often associated or interconnected with TGN/EEs and contained ADP-ribosylation factor 1, which is usually localized to the Golgi and the TGN/EEs. On the other hand, structures of the ER, Golgi apparatus, and MVB/LEs were apparently normal in uge4 cells. Together, our data indicate the importance of UDP-d-galactose synthesis by UGE4 for the organization and function of endomembranes, especially TGN/EEs, which are a sorting station of the secretory and vacuolar pathways.	[Wang, Sheliang; Uehara, Masataka; Takano, Junpei] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Ito, Toshiaki; Naito, Satoshi; Takano, Junpei] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Naito, Satoshi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0608589, Japan; [Uehara, Masataka] Sumika Agrotech Co LTD, Technol Dev Ctr, Sobiraki, Nihama 7920001, Japan	Takano, J (reprint author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan.	jtakano@abs.agr.hokudai.ac.jp			NEXT program from the Japan Society for the Promotion of Science; Human Frontier Science Program	We acknowledge Tomoko Shimizu for technical assistance, Akira Yoshinari for valuable comments, Niko Geldner (Lausanne University), Takashi Ueda (University of Tokyo), and ABRC for providing materials. This work was supported by the NEXT program from the Japan Society for the Promotion of Science and the Young Investigators Grant from the Human Frontier Science Program, to J. T.	Abramoff MD, 2004, J BIOPHOTONICS INT, V11, P36; Petruccelli S, 2006, PLANT BIOTECHNOL J, V4, P511, DOI 10.1111/j.1467-7652.2006.00200.x; Uemura T, 2012, P NATL ACAD SCI USA, V109, P1784, DOI 10.1073/pnas.1115146109; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Viotti C, 2010, PLANT CELL, V22, P1344, DOI 10.1105/tpc.109.072637; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Barber C, 2006, J BIOL CHEM, V281, P17276, DOI 10.1074/jbc.M512727200; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Andeme-Onzighi C, 2002, PLANTA, V215, P949, DOI 10.1007/s00425-002-0836-z; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235; Stierhof YD, 2010, EUR J CELL BIOL, V89, P285, DOI 10.1016/j.ejcb.2009.12.003; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Brandizzi F, 2013, PLANT J, V75, P339, DOI 10.1111/tpj.12227; Seifert GJ, 2002, CURR BIOL, V12, P1840, DOI 10.1016/S0960-9822(02)01260-5; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; BASKIN TI, 1992, AUST J PLANT PHYSIOL, V19, P427; Baum TJ, 2000, J NEMATOL, V32, P166; Chanoca A, 2014, PLANT ENDOSOMES METH, V1209, P63; Rivera-Serrano EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044735; Robinson DG, 2011, PLANT CELL, V23, P846, DOI 10.1105/tpc.110.082099; Takano Junpei, 2010, Proc Natl Acad Sci U S A, V107, P5220, DOI 10.1073/pnas.0910744107; Tamura K, 2005, PLANT CELL, V17, P1764, DOI 10.1105/tpc.105.031930; Uehara M, 2014, PLANT CELL PHYSIOL, V55, P704, DOI 10.1093/pcp/pct191; Uemura T, 2014, CURR OPIN PLANT BIOL, V22, P116, DOI 10.1016/j.pbi.2014.10.002; Yin YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027995	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	SEP	2015	128	5					863	873		10.1007/s10265-015-0737-4		11	Plant Sciences	Plant Sciences	CQ1QH	WOS:000360372700013		
J	Kato, H; Mori, T; Murota, N; Kikuchi, M				Kato, Hideaki; Mori, Takahiro; Murota, Nobuo; Kikuchi, Masaru			Analytical Model for Elastoplastic and Creep-Like Behavior of High-Damping Rubber Bearings	JOURNAL OF STRUCTURAL ENGINEERING			English	Article						Base isolation; Biaxial loads; Wind load; Numerical analysis; Rubber; Creep; Analysis and computation	SEISMIC ISOLATION BEARINGS; HYSTERETIC SYSTEMS; RANDOM VIBRATION	In the present study, a new analytical model of high-damping rubber bearings (HDRBs) for time-history analysis is proposed. The proposed model is used in the evaluation of elastoplastic and creep-like behavior of HDRBs under bidirectional seismic and strong wind loading. The analytical model was developed by reducing the degrees of freedom of a new type of constitutive law that was proposed by the authors for finite-element analysis of seismic isolation bearings. First, the validity of the proposed model for time-history response analysis was examined through various tests of HDRBs under unidirectional and bidirectional loading. The analytical results agreed well with the test results. Next, wind loading tests were conducted and the reproducibility of creep-like behavior of HDRBs under wind loading was evaluated. The effectiveness of the proposed model was verified by the tests, and the limitations of the applicability of the proposed model were determined. (C) 2014 American Society of Civil Engineers.	[Kato, Hideaki; Mori, Takahiro; Murota, Nobuo] Bridgestone Co, Dept Infrastruct Prod Dev, Totsuka Ku, Yokohama, Kanagawa 2448510, Japan; [Kikuchi, Masaru] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Kato, H (reprint author), Bridgestone Co, Dept Infrastruct Prod Dev, Totsuka Ku, 1 Kashio Cho, Yokohama, Kanagawa 2448510, Japan.	hideaki.kato@bridgestone.com; takahiro.mori1@bridgestone.com; nobuo.murota@bridgestone.com; mkiku@eng.hokudai.ac.jp			Ministry of Land, Infrastructures, Transport and Tourism	The bidirectional loading tests were conducted as part of the activities of the subcommittee for HDRBs in the Japan Society of Seismic Isolation (JSSI). The recorded ground motion data used in the seismic response analyses were provided by the National Research Institute for Earthquake Science and Disaster Prevention. The present study was supported in part by a Grant-in-Aid for the Promotion of Architectural Standardization from the Ministry of Land, Infrastructures, Transport and Tourism. Finally, the authors would like to thank Mr. Takenaka and Mr. Kondo for their support and for providing the wind response loading data.	Abe M, 2004, J STRUCT ENG-ASCE, V130, P1119, DOI 10.1061/(ASCE)0733-9445(2004)130:8(1119); Yamamoto M, 2012, EARTHQ ENG STRUCT D, V41, P1845, DOI 10.1002/eqe.2161; Kikuchi M, 1997, EARTHQUAKE ENG STRUC, V26, P215, DOI 10.1002/(SICI)1096-9845(199702)26:2<215::AID-EQE640>3.0.CO;2-9; Grant DN, 2004, J EARTHQ ENG, V8, P161, DOI 10.1142/S136324690400164X; Abe M, 2004, J STRUCT ENG-ASCE, V130, P1133, DOI 10.1061/(ASCE)0733-9445(2004)130:8(1133); WEN YK, 1976, J ENG MECH DIV-ASCE, V102, P249; CONSTANTINOU M, 1990, J STRUCT ENG-ASCE, V116, P455, DOI 10.1061/(ASCE)0733-9445(1990)116:2(455); Haringx J. A., 1948, 3 PHIL RES, P401; Haringx J. A., 1949, 4 PHIL GLOEIL, P49; Iizuka M, 2000, ENG STRUCT, V22, P323, DOI 10.1016/S0141-0296(98)00118-7; Jennings P. C., 1964, J ENG MECH DIV ASCE, V90, P131; Kikuchi M, 2010, EARTHQ ENG STRUCT D, V39, P1513, DOI 10.1002/eqe.1042; KOH CG, 1988, INT J MECH SCI, V30, P933, DOI 10.1016/0020-7403(88)90075-6; MacKnight W. J., 2005, VISCOELASTIC MODELS, P51; Mori T., 2011, P 12 WORLD C SEISM I; Mori T., 2010, J STRUCT CONSTR ENG, V75, P2171, DOI 10.3130/aijs.75.2171; Ogden R. W., 1998, ELASTICITY, P169; PARK YJ, 1986, EARTHQUAKE ENG STRUC, V14, P543, DOI 10.1002/eqe.4290140405; Suzuki M., 2010, P SUMM ANN M AIJ H B, VB2, P277; Wada A., 1989, RES PRACT P STRUCT C; YEOH OH, 1993, RUBBER CHEM TECHNOL, V66, P754, DOI 10.5254/1.3538343	21	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9445	1943-541X		J STRUCT ENG	J. Struct. Eng.	SEP	2015	141	9							04014213	10.1061/(ASCE)ST.1943-541X.0001181		9	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CP5QX	WOS:000359939900006		
J	Sun, Y; Wu, Y; Qiu, Y; Tamura, Y				Sun, Ying; Wu, Yue; Qiu, Ye; Tamura, Yukio			Effects of Free-Stream Turbulence and Reynolds Number on the Aerodynamic Characteristics of a Semicylindrical Roof	JOURNAL OF STRUCTURAL ENGINEERING			English	Article						Cylindrical roof; Power spectra; Reynolds number; Turbulence intensity; Wind pressure and force; Wind effects	CIRCULAR-CYLINDER; FORCES	The influences of free-stream turbulence and Reynolds number on the aerodynamic characteristics of a semicylindrical roof have been investigated experimentally under uniform flow conditions. Grids were used to generate homogeneous turbulent flows with turbulence intensities varying from 5.7 to 12.2%. The diameters, D, of the semicylindrical roof models were 0.2 and 0.6 m. The Reynolds numbers based on D ranged from 6.90 x 10(4) to 8.28 x 10(5) in smooth flow and from approximately 6.06 x 10(4) to 4.79 x 10(5) in grid-generated turbulent flow. Measurements of the surface pressure indicated that, in smooth flow, the mean and RMS pressure distributions became Reynolds number independent when R > 4.14 x 10(5). The introduction of turbulence has caused a premature transition of the separated shear layer from laminar to turbulent. Increasing free-stream turbulence helps to remarkably reduce the mean and fluctuating drag force at lower Reynolds number, R < 1.46 x 10(5). There is also a relatively significant reduction in the mean lift force as the turbulence intensity increases when R > 1.46 x 10(5). The data also suggested that the effects of turbulence essentially depend on the turbulence intensity and the ratio of turbulence length scale to cylinder diameter. The small-scale turbulence was better able to interact with the surface boundary layer before and after separation and thus dramatically increased the pressure fluctuations in both the top and wake regions. (C) 2014 American Society of Civil Engineers.	[Sun, Ying; Wu, Yue; Qiu, Ye] Harbin Inst Technol, Key Lab Struct Dynam Behav & Control, Minist Educ, Harbin 150090, Peoples R China; [Tamura, Yukio] Beijing Jiaotong Univ, Sch Civil Engn, Beijing 100044, Peoples R China; [Tamura, Yukio] Tokyo Polytech Univ, Dept Architectural Engn, Nakano, Kanagawa 2430297, Japan	Qiu, Y (reprint author), Harbin Inst Technol, Key Lab Struct Dynam Behav & Control, Minist Educ, Harbin 150090, Peoples R China.	qiutianyuanye@gmail.com			National Natural Science Foundation of China [91215302, 51278160, 51378147]	This study was financially supported by the National Natural Science Foundation of China under Grant Numbers 91215302, 51278160 and 51378147.	Nishimura H, 2001, J WIND ENG IND AEROD, V89, P713, DOI 10.1016/S0167-6105(01)00067-8; IRWIN HPAH, 1979, J IND AERODYNAM, V5, P93, DOI 10.1016/0167-6105(79)90026-6; BASU RI, 1986, J WIND ENG IND AEROD, V24, P33, DOI 10.1016/0167-6105(86)90071-1; Bradley R. A., 2011, THESIS U WITWATERSRA; Cheng CM, 2010, J WIND ENG IND AEROD, V98, P328, DOI 10.1016/j.jweia.2009.12.002; CHEUNG JCK, 1983, J WIND ENG IND AEROD, V14, P399, DOI 10.1016/0167-6105(83)90041-7; HOXEY RP, 1983, J WIND ENG IND AEROD, V11, P225, DOI 10.1016/0167-6105(83)90102-2; Johnson G. L., 1985, P 5 US NAT C WIND EN; Norberg C., 1987, J FLUIDS STRUCTURES, V1, P337, DOI 10.1016/0889-9746(87)90264-7; Sun Y., 2013, INT J SPACE STRUCT, V28, P87; TOY N, 1988, J WIND ENG IND AEROD, V29, P263, DOI 10.1016/0167-6105(88)90164-X	11	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9445	1943-541X		J STRUCT ENG	J. Struct. Eng.	SEP	2015	141	9							UNSP 04014230	10.1061/(ASCE)ST.1943-541X.0001209		11	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CP5QX	WOS:000359939900023		
J	Shibasaki, K; Ogawa, S; Yamada, S; Iijima, K; Eto, M; Kozaki, K; Toba, K; Ouchi, Y; Akishita, M				Shibasaki, Koji; Ogawa, Sumito; Yamada, Shizuru; Iijima, Katsuya; Eto, Masato; Kozaki, Koichi; Toba, Kenji; Ouchi, Yasuyoshi; Akishita, Masahiro			Favorable Effect of Sympathetic Nervous Activity on Rehabilitation Outcomes in Frail Elderly	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Frailty; Holter monitoring; Functional Independence Measure; rehabilitation	HEART-RATE-VARIABILITY; MUSCLE MASS; SERUM-ALBUMIN; HIP FRACTURE; THERAPEUTIC IMPLICATIONS; STROKE REHABILITATION; FUNCTIONAL OUTCOMES; TOTAL CHOLESTEROL; BODY-COMPOSITION; ISCHEMIC-STROKE	Objectives: Previous studies have suggested the relationship between physical function, mortality, and autonomic nervous activity in frail elderly and that maintaining sympathetic nervous activity might lead to improved physical function and mortality in the elderly population. The aim of this study was to investigate the utility of sympathetic nervous activity measured by heart rate variability in frail elderly patients undergoing inpatient rehabilitation, further focusing the nervous activity on the effect of rehabilitation therapy. Design: Prospective cohort study. Participants: Sixty-one subjects aged 75 years or older were recruited after treatment of acute phase illness. Measurements: Before undergoing rehabilitation, data of 24-hour Holter monitoring and a blood venous sample were obtained. From RR intervals in the electrocardiogram, heart rate and SDs of all NN intervals in all 5-minute segments of the entire recording, power spectral density, low frequency (LF), high frequency (HF), and low frequency/high frequency (LF/HF) were calculated. Functional Independence Measure (FIM) and Barthel index were used to measure physical function. Results: FIM score and Barthel index were 46.8 +/- 25.4 and 32.8 +/- 31.7, respectively. Serum total protein, albumin, hemoglobin, and total cholesterol were all significantly related to FIM score and Barthel index before rehabilitation. Heart rate variability indices did not show a significant relationship with physical function, whereas the high LH/HF group showed significant improvement in physical function compared with the low LH/HF group. Moreover, LF/HF frequency was a predictive factor for improvement of physical function after 2 months of rehabilitation. Conclusion: A favorable effect of preserved LF/HF on rehabilitation outcome was observed in elderly undergoing rehabilitation. Preservation of sympathetic nervous activity may lead to improved physical function in the elderly. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Shibasaki, Koji; Ogawa, Sumito; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; [Yamada, Shizuru] Komagane Kogen Ladies Clin, Komagane, Nagano, Japan; [Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Bunkyo Ku, Tokyo 1138655, Japan; [Eto, Masato] Tokyo Univ Hosp, Gen Educ Ctr, Bunkyo Ku, Tokyo 113, Japan; [Kozaki, Koichi] Kyorin Univ, Sch Med, Dept Geriatr Med, Mitaka, Tokyo 181, Japan; [Toba, Kenji] Natl Ctr Geriatr & Gerontol, Obu City, Aichi, Japan; [Ouchi, Yasuyoshi] Toranomon Gen Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Minato Ku, Tokyo, Japan	Ogawa, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	suogawa-tky@umin.ac.jp			National Center for Geriatrics and Gerontology (NCGG), Japan [25-11]	This study was funded by the Research Funding for Longevity Sciences (25-11) from National Center for Geriatrics and Gerontology (NCGG), Japan.	HUIKURI HV, 1994, CIRCULATION, V90, P121; Schalk BWM, 2004, AGE AGEING, V33, P266, DOI 10.1093/ageing/afh073; Dutsch M, 2007, NEUROLOGY, V69, P2249, DOI 10.1212/01.wnl.0000286946.06639.a7; Varadhan R, 2009, J GERONTOL A-BIOL, V64, P682, DOI 10.1093/gerona/glp013; Chen KD, 2001, MUSCLE NERVE, V24, P211, DOI 10.1002/1097-4598(200102)24:2<211::AID-MUS60>3.3.CO;2-4; Bagg S, 2002, STROKE, V33, P179, DOI 10.1161/hs0102.101224; CARTER WJ, 1994, J GERONTOL, V49, pB162; Kamalakkannan G, 2008, J HEART LUNG TRANSPL, V27, P457, DOI 10.1016/j.healun.2008.01.013; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Muslumanoglu L, 2004, ARCH PHYS MED REHAB, V85, P470, DOI 10.1016/j.apmr.2003.03.009; Pan SL, 2010, ARCH PHYS MED REHAB, V91, P913, DOI 10.1016/j.apmr.2010.02.002; ASTRAND PO, 1964, J APPL PHYSIOL, V19, P268; Ng YS, 2005, ARCH PHYS MED REHAB, V86, P2138, DOI 10.1016/j.apmr.2005.07.289; ALEXANDER MP, 1994, STROKE, V25, P128; Reuben DB, 1999, J AM GERIATR SOC, V47, P402; Hershkovitz A, 2007, ARCH PHYS MED REHAB, V88, P916, DOI 10.1016/j.apmr.2007.03.029; Snyder CK, 2012, J AM GERIATR SOC, V60, P1663, DOI 10.1111/j.1532-5415.2012.04115.x; Fowler EG, 2004, NEUROLOGY, V62, P1006; Koopman R, 2009, CURR OPIN CLIN NUTR, V12, P601, DOI 10.1097/MCO.0b013e3283318a25; Burns J, 2007, CIRCULATION, V115, P1999, DOI 10.1161/CIRCULATIONAHA.106.668863; Oka H, 2007, NEUROLOGY, V69, P1460, DOI 10.1212/01.wnl.0000277450.49788.82; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Visser M, 2005, AM J CLIN NUTR, V82, P531; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Nakamura T, 2005, ARCH PHYS MED REHAB, V86, P436, DOI 10.1016/j.apmr.2004.06.071; Beloosesky Y, 2002, CLIN REHABIL, V16, P321, DOI 10.1191/0269215502cr497oa; CARTER WJ, 1991, METABOLISM, V40, P855, DOI 10.1016/0026-0495(91)90015-O; Lucini D, 2002, CIRCULATION, V106, P2673, DOI 10.1161/01.CIR.0000039106.89299.AB; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jpjysiol.2003.056770; Shibasaki K, 2014, GERIATR GERONTOL INT, V14, P159, DOI 10.1111/ggi.12074; Camillo CA, 2008, LUNG, V186, P393, DOI 10.1007/s00408-008-9105-7; Ryall JG, 2007, J GERONTOL A-BIOL, V62, P813; Oka H, 2007, J NEUROL SCI, V254, P72, DOI 10.1016/j.jns.2007.01.002; Korpelainen JT, 1997, STROKE, V28, P2150; TSUJI H, 1994, CIRCULATION, V90, P878; Masiero S, 2007, CLIN NEUROL NEUROSUR, V109, P763, DOI 10.1016/j.clineuro.2007.07.009; Schalk BWM, 2005, J AM GERIATR SOC, V53, P1331, DOI 10.1111/j.1532-5415.2005.53417.x; Appenzeller O., 1982, AUTONOMIC NERVOUS SY; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Gruson KI, 2002, J ORTHOP TRAUMA, V16, P39, DOI 10.1097/00005131-200201000-00009; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lang TA, 2006, REPORT STAT MED ANNO, P87; MAHONEY F I, 1965, Md State Med J, V14, P61; Ministry of Health Labour and Welfare, HLTH WELF SERV ELD; Peters R, 2010, AGE AGEING, V39, P609, DOI 10.1093/ageing/afq071; Ricart-Firinga C, 2000, AM J PHYSIOL-CELL PH, V278, pC582; Roach ES, 2010, TOOLES CEREBROVASCUL; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Stevens L, 2000, AM J PHYSIOL-CELL PH, V279, pC1558; Camm AJ, 1996, CIRCULATION, V93, P1043	52	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	SEP 1	2015	16	9							799.e7	10.1016/j.jamda.2015.06.007		6	Geriatrics & Gerontology	Geriatrics & Gerontology	CQ0XC	WOS:000360320100021		
J	Ito, T; Inatomi, Y; Nagae, K; Nakano-Nakamura, M; Nakahara, T; Furue, M; Uchi, H				Ito, T.; Inatomi, Y.; Nagae, K.; Nakano-Nakamura, M.; Nakahara, T.; Furue, M.; Uchi, H.			Narrow-margin excision is a safe, reliable treatment for well-defined, primary pigmented basal cell carcinoma: an analysis of 288 lesions in Japan	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article							MANAGEMENT; HEAD; NECK	BackgroundComplete excision is the most promising treatment for basal cell carcinoma (BCC) and a surgical margin of at least 4mm is recommended. However, little is known about the appropriate surgical margin of pigmented BCC. ObjectiveTo investigate the reliability of narrower margin excision of well-defined, pigmented BCC. MethodsWe identified a total of 263 patients with 288 well-defined, primary pigmented BCC at the Department of Dermatology, Kyushu University (Fukuoka, Japan), between January 2006 and December 2013. All lesions were surgically excised with 1-6-mm margins and analysed. For 30 recent lesions out of the 288 lesions, border gaps between dermoscopy and histopathology were assessed. ResultsOf the 288 lesions, 218 (75.7%) were excised with a narrow margin (3mm) and 60 lesions (24.3%) with a wide margin (4mm). Only two lesions (0.7%), which were excised with 2-mm margins, were associated with tumour-positive margins. Narrow-margin excision showed a complete removal rate of 99% (2-mm margins, 95.3%; 3-mm margins, 100%). Dermoscopically determined borders almost exactly corresponded to the histopathological ones; 71.2% of border gaps between dermoscopy and histopathology were within 1mm and there were no cases in which tumours spread beyond 1mm of their dermoscopic borders. ConclusionSurgical excision with a 2-3-mm margin is reliable treatment for well-defined, primary pigmented BCC, with a complete removal rate of 99%.	[Ito, T.; Inatomi, Y.; Nagae, K.; Nakano-Nakamura, M.; Nakahara, T.; Furue, M.; Uchi, H.] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan	Ito, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan.	takamiti@dermatol.med.kyushu-u.ac.jp					Kimyai-Asadi A, 2005, J AM ACAD DERMATOL, V53, P464, DOI 10.1016/j.jaad.2005.03.038; Carducci M, 2011, DERMATOL SURG, V37, P280, DOI 10.1111/j.1524-4725.2010.01870.x; Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x; Caresana G, 2010, J EUR ACAD DERMATOL, V24, P1395, DOI 10.1111/j.1468-3083.2010.03652.x; Betti Roberto, 1998, Journal of Dermatology (Tokyo), V25, P691; Dellon AL, 1985, J SURG ONCOL, V28, P72; EPSTEIN E, 1973, BRIT J DERMATOL, V89, P37, DOI 10.1111/j.1365-2133.1973.tb01915.x; BREUNINGER H, 1991, J DERMATOL SURG ONC, V17, P574; Lalloo MT, 2000, CLIN OTOLARYNGOL, V25, P370, DOI 10.1046/j.1365-2273.2000.00376.x; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P451; MALONEY ME, 1992, J AM ACAD DERMATOL, V27, P74, DOI 10.1016/0190-9622(92)70160-H; NCCN Clinical Practice Guidelines in Oncology, 2012, NCCN CLIN PRACT GUID; Quinn AG, 2012, ROOKS TXB DERMATOLOG, V52, P18; Sussman LAE, 1996, AUST NZ J SURG, V66, P276, DOI 10.1111/j.1445-2197.1996.tb01184.x; Wilson AW, 2004, BRIT J ORAL MAX SURG, V42, P311, DOI 10.1016/j.bjoms.2004.02.030	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	SEP	2015	29	9					1828	1831		10.1111/jdv.12689		4	Dermatology	Dermatology	CP9LL	WOS:000360215700021		
J	Murakami, H; Lee, SK				Murakami, Hidetoshi; Lee, Seong Keon			Unbiasedness and biasedness of the Jonckheere-Terpstra and the Kruskal-Wallis tests	JOURNAL OF THE KOREAN STATISTICAL SOCIETY			English	Article						Jonckheere-Terpstra test; Kruskal Wallis test; Power function; Unbiasedness	RANK-TESTS; EXAMPLE	Finding the unbiasedness and biasedness of test statistics is important in testing a hypothesis. In this study, the unbiasedness/biasedness of the Jonckheere-Terpstra test is investigated for ordered alternatives. Our results show that the one-sided Joncicheere-Terpstra test is unbiased for the location parameter family of distributions and that the non-randomized two-sided Jonckheere-Terpstra test is biased for the shifted location parameter. Additionally, the unbiasedness/biasedness of the Kruskal Wallis test is considered for the general two-sided alternatives. By giving a counter example, our investigation reveals that the Kruskal Wallis test is biased against a shifted location parameter for unequal sample sizes. Our results indicate that we require to consider a bias correction for the nonparametric tests. (C) 2014 The Korean Statistical Society. Published by Elsevier B.V. All rights reserved.	[Murakami, Hidetoshi] Natl Def Acad, Dept Math, Yokosuka, Kanagawa 2398686, Japan; [Lee, Seong Keon] Sungshin Univ, Dept Stat, Seoul 136742, South Korea	Lee, SK (reprint author), Sungshin Univ, Dept Stat, 249-1,Dongseon 3 Ga, Seoul 136742, South Korea.	murakami@gug.math.chuo-u.ac.jp; sklee@sungshin.ac.kr			JSPS; KAKENHI [26730025]	The authors wish to express sincere thanks to the editor, the associated editor and two anonymous referees, whose comments improve the quality of the manuscript. An author, Hidetoshi Murakami, appreciates that this research is supported by the Grant-in-Aid for Young Scientists B of JSPS, KAKENHI Number 26730025.	AMRHEIN P, 1995, ANN I STAT MATH, V47, P167, DOI 10.1007/BF00773420; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.2307/3001968; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.2307/2333011; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583; Chakraborti S, 2010, NONPARAMETRIC STAT I; Jureckova J, 2012, BERNOULLI, V18, P229, DOI 10.3150/10-BEJ326; Lehmann E. L., 1959, TESTING STAT HYPOTHE; Lehmann E. L., 2005, TESTING STAT HYPOTHE; PURI ML, 1965, COMMUN PUR APPL MATH, V18, P51, DOI 10.1002/cpa.3160180108; Sugiura N, 2006, ANN I STAT MATH, V58, P93, DOI 10.1007/s10463-005-0019-3; SUGIURA N, 1965, ANN I STAT MATH, V17, P261, DOI 10.1007/BF02868170; Terpstra TJ, 1952, INDAGATIONES MATHEMA, V14, P327; Tryon V. P., 1973, ANN STAT, V1, P1061	13	0	0	KOREAN STATISTICAL SOC	SEOUL	SCIENCE & TECHNOLOGY, BLDG RM 709, 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1226-3192	1876-4231		J KOREAN STAT SOC	J. Korean Stat. Soc.	SEP	2015	44	3					342	351		10.1016/j.jkss.2014.10.001		10	Statistics & Probability	Mathematics	CP9YU	WOS:000360252600002		
J	Terabayashi, T; Ito, Y; Mizuno, M; Suzuki, Y; Kinashi, H; Sakata, F; Tomita, T; Iguchi, D; Tawada, M; Nishio, R; Maruyama, S; Imai, E; Matsuo, S; Takei, Y				Terabayashi, Takeshi; Ito, Yasuhiko; Mizuno, Masashi; Suzuki, Yasuhiro; Kinashi, Hiroshi; Sakata, Fumiko; Tomita, Takako; Iguchi, Daiki; Tawada, Mitsuhiro; Nishio, Ryosuke; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi; Takei, Yoshifumi			Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury	LABORATORY INVESTIGATION			English	Article							UNILATERAL URETERAL OBSTRUCTION; LYMPHATIC ABSORPTION RATE; DIALYSIS PATIENTS; FACTOR-C; MESOTHELIAL CELLS; SOLUTE TRANSPORT; NODE METASTASIS; CAPD PATIENTS; LYMPHANGIOGENESIS; ICODEXTRIN	Appropriate fluid balance is important for good clinical outcomes and survival in patients on peritoneal dialysis. We recently reported that lymphangiogenesis associated with fibrosis developed in the peritoneal cavity via the transforming growth factor-beta 1-vascular endothelial growth factor-C (VEGF-C) pathway. We investigated whether VEGF receptor-3 (VEGFR-3), the receptor for VEGF-C and -D, might be a new target to improve net ultrafiltration by using adenovirus-expressing soluble VEGFR-3 (Adeno-sVEGFR-3) in rodent models of peritoneal injury induced by methylglyoxal (MGO). We demonstrated that lymphangiogenesis developed in these MGO models, especially in the diaphragm, indicating that lymphangiogenesis is a common feature in the peritoneal cavity with inflammation and fibrosis. In MGO models, VEGF-D was significantly increased in the diaphragm; however, VEGF-C was not significantly upregulated. Adeno-sVEGFR-3, which was detected on day 50 after administration via tail vein injections, successfully suppressed lymphangiogenesis in the diaphragm and parietal peritoneum in mouse MGO models without significant effects on fibrosis, inflammation, or neoangiogenesis. Drained volume in the peritoneal equilibration test using a 7.5% icodextrin peritoneal dialysis solution (the 7.5% icodextrin peritoneal equilibration test) was improved by Adeno-sVEGFR-3 on day 22 (P<0.05) and day 50 after reduction of inflammation (P<0.01), indicating that the 7.5% icodextrin peritoneal equilibration test identifies changes in lymphangiogenesis. The solute transport rate was not affected by suppression of lymphangiogenesis. In human peritoneal dialysis patients, the dialysate to plasma ratio of creatinine positively correlated with the dialysate VEGF-D concentration (P<0.001). VEGF-D mRNA was significantly higher in the peritoneal membranes of patients with ultrafiltration failure, indicating that VEGF-D is involved in the development of lymphangiogenesis in peritoneal dialysis patients. These results indicate that VEGFR-3 is a new target to improve net ultrafiltration by suppressing lymphatic absorption and that the 7.5% icodextrin peritoneal equilibration test is useful for estimation of lymphatic absorption.	[Terabayashi, Takeshi; Ito, Yasuhiko; Mizuno, Masashi; Suzuki, Yasuhiro; Kinashi, Hiroshi; Sakata, Fumiko; Tomita, Takako; Iguchi, Daiki; Tawada, Mitsuhiro; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Nephrol & Renal Replacement Therapy, Nagoya, Aichi 4668550, Japan; [Nishio, Ryosuke] Kyoto Univ Hosp, Dept Emergency Med, Kyoto 606, Japan; [Imai, Enyu] Nakayamadera Imai Clin, Takarazuka, Hyogo, Japan; [Takei, Yoshifumi] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan	Ito, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Nephrol & Renal Replacement Therapy, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	yasuito@med.nagoya-u.ac.jp			Ministry of Education, Science, and Culture, Japan [20590972]; Aichi Kidney Foundation; Japanese Association of Dialysis Physicians; Ministry of Health, Labor and Welfare of Japan	We express our gratitude to Mr Norihiko Suzuki, Ms Naoko Asano, Ms Keiko Higashide, and Ms Yuriko Sawa (Department of Nephrology and Renal Replacement Therapy, Nagoya University, Nagoya, Japan) for their technical assistance. We also thank Dr Makoto Mizutani (Handa Municipal Hospital, Handa, Japan), Dr Isao Ito (Yokkaichi Municipal Hospital, Yokkaichi, Japan), Dr Hirotake Kasuga (Nagoya Kyoritsu Hospital, Nagoya, Japan), Dr Takeyuki Hiramatsu (Kounan-Kousei Hospital, Kounan, Japan), and Dr Masanobu Horie (Daiyukai-Daiichi Hospital, Ichinomiya, Japan) for collecting peritoneum samples from the peritoneal dialysis patients. We also express our gratitude to Professor Kari Alitalo (University of Helsinki, Helsinki, Finland) and Dr Hajime Kubo (Kyoto University, Kyoto, Japan, currently working at Tanabe Mitsubishi Pharma Corporation, Osaka, Japan), and Vegenics Pty Limited (a subisidialy of Circadian Technologies Limited, Australia) for providing Adeno-VEGFR-3, and also Professor Alitalo and Dr Kubo for discussing the Adeno-sVEGFR-3 treatment and this manuscript. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Japan (YI # 20590972), the 2013 research grant from the Aichi Kidney Foundation (T Terabayashi and YI), and the Japanese Association of Dialysis Physicians, Grant 2013-15 (YI). This study was also supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labor and Welfare of Japan.	STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Hirahara I, 2006, PERITON DIALYSIS INT, V26, P380; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Nishimura H, 2008, AM J PHYSIOL-RENAL, V294, pF1084, DOI 10.1152/ajprenal.00565.2007; Yamamoto T, 2010, PERITON DIALYSIS INT, V30, P343, DOI 10.3747/pdi.2008.00273; HEIMBURGER O, 1990, KIDNEY INT, V38, P495, DOI 10.1038/ki.1990.231; Yung S, 2006, PERITON DIALYSIS INT, V26, P162; Honda K, 2008, CLIN J AM SOC NEPHRO, V3, P720, DOI 10.2215/CJN.03630807; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Johnson DW, 2003, NEPHROLOGY, V8, P1, DOI 10.1046/j.1440-1797.2003.00117.x; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077; Hosono K, 2011, ARTERIOSCL THROM VAS, V31, P1049, DOI 10.1161/ATVBAHA.110.222356; Smit W, 2004, PERITON DIALYSIS INT, V24, P562; Kinashi H, 2013, J AM SOC NEPHROL, V24, P1627, DOI 10.1681/ASN.2012030226; Hirahara I, 2009, NEPHROL DIAL TRANSPL, V24, P437, DOI 10.1093/ndt/gfn495; Lee AS, 2013, KIDNEY INT, V83, P50, DOI 10.1038/ki.2012.312; Sakamoto I, 2009, KIDNEY INT, V75, P828, DOI 10.1038/ki.2008.661; Onogawa S, 2004, CANCER SCI, V95, P32, DOI 10.1111/j.1349-7006.2004.tb03167.x; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Nykanen AI, 2010, CIRCULATION, V121, P1413, DOI 10.1161/CIRCULATIONAHA.109.910703; Takei Y, 2004, CANCER RES, V64, P3365, DOI 10.1158/0008-5472.CAN-03-2682; Kim YL, 1999, PERITON DIALYSIS INT, V19, pS384; He YL, 2002, J NATL CANCER I, V94, P819; Sampimon DE, 2011, NEPHROL DIAL TRANSPL, V26, P291, DOI 10.1093/ndt/gfq343; Williams JD, 2002, J AM SOC NEPHROL, V13, P470; Mateijsen MAM, 1999, PERITON DIALYSIS INT, V19, P517; Cui Y, 2014, MOL MED, V20, P120, DOI 10.2119/molmed.2013.00123; Flessner M, 2004, PERITON DIALYSIS INT, V24, P313; Fussholler A, 2002, J AM SOC NEPHROL, V13; Garcia-Lopez E, 2007, PERITON DIALYSIS INT, V27, P415; Kawaguchi Y, 2003, PERITON DIALYSIS INT, V23, pS175; Kitamura M, 2012, CHEM-BIOL INTERACT, V195, P95, DOI 10.1016/j.cbi.2011.11.002; Krediet RT, 2004, PERITON DIALYSIS INT, V24, P309; MACTIER RA, 1987, J CLIN INVEST, V80, P1311, DOI 10.1172/JCI113207; Mizuno M, 2011, CLIN EXP NEPHROL, V15, P727, DOI 10.1007/s10157-011-0471-8; Mizutani M, 2010, AM J PHYSIOL-RENAL, V298, pF721, DOI 10.1152/ajprenal.00368.2009; Moberly JB, 2002, KIDNEY INT, V62, pS23; Pawlaczyk K, 2001, PERITON DIALYSIS INT, V21, pS359; Peritoneal Dialysis Adequacy 2006 Work Group, 2006, AM J KIDNEY DIS S, V48, pS91; TWARDOWSKI ZJ, 1990, SEMIN DIALYSIS, V3, P141, DOI 10.1111/j.1525-139X.1990.tb00029.x; Yang H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-36	44	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	SEP	2015	95	9					1029	1043		10.1038/labinvest.2015.87		15	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CQ2AY	WOS:000360402900006		
J	Suzuki, S; Yasunaga, H; Matsui, H; Fushimi, K; Yamasoba, T				Suzuki, Sayaka; Yasunaga, Hideo; Matsui, Hiroki; Fushimi, Kiyohide; Yamasoba, Tatsuya			Factors associated with severe epiglottitis in adults: Analysis of a Japanese inpatient database	LARYNGOSCOPE			English	Article						Acute epiglottitis; airway intervention; nationwide study; comorbidities at admission; mortality	PROCEDURE-COMBINATION-DATABASE; BODY-MASS INDEX; FAT DISTRIBUTION; RHODE-ISLAND; HONG-KONG; EXPERIENCE; MANAGEMENT; SUPRAGLOTTITIS; DIAGNOSIS; CHILDREN	Objectives/HypothesisThe aim of the study was to evaluate the factors associated with the development of severe epiglottitis in adults to provide information for physicians to make early decisions on airway management. Study DesignRetrospective cohort study. MethodsAdult patients admitted to acute care hospitals with a diagnosis of acute epiglottitis between January 2011 and December 2012 were identified in the Diagnosis Procedure Combination database of Japan. The main outcome measures were: 1) severe epiglottitis requiring airway intervention or resulting in early death within 2 days after admission and 2) 2-day mortality. Multivariable logistic regression analysis was performed to evaluate the association between patient characteristics and development of severe epiglottitis. ResultsA total of 6,072 epiglottitis patients from 599 hospitals were identified. The proportion of developing severe epiglottitis was 9.4%, and 2-day mortality was 0.4%. Factors significantly associated with severe epiglottitis were older age, male sex (adjusted odds ratio [OR] 1.60; 95% confidence interval [CI], 1.28-2.00; P<.001), body mass index (BMI) >25.0 kg/m(2) (OR 1.31; 95% CI, 1.05-1.63; P=.018), diabetes mellitus (OR 1.41; 95% CI, 1.06-1.86; P=.017), epiglottic cyst (OR 2.90; 95% CI, 1.46-5.78; P=.002), pneumonia (OR 2.90; 95% CI, 1.73-4.86; P<.001), and academic hospitals (OR 1.56; 95% CI, 1.21-2.00; P=.001). Epiglottitis-related admission was summer-dominant, but seasonality was not significantly associated with severe epiglottitis. ConclusionDevelopment of severe epiglottitis was significantly associated with older age, BMI >25.0 kg/m(2), diabetes mellitus, epiglottic cyst, or pneumonia at admission. Level of Evidence2b. Laryngoscope, 125:2072-2078, 2015	[Suzuki, Sayaka; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Suzuki, Sayaka; Yamasoba, Tatsuya] Univ Tokyo, Fac Med, Dept Otolaryngol & Head & Neck Surg, Tokyo 1130033, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Suzuki, S (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sayasuzuki-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare of Japan [H26-Policy-011]	This study was funded by a grant-in-aid from the Ministry of Health, Labour and Welfare of Japan (Research on Policy Planning and Evaluation grant number: H26-Policy-011). The authors have no other funding, financial relationships, or conflicts of interest to disclose.	Shah RK, 2004, LARYNGOSCOPE, V114, P557, DOI 10.1097/00005537-200403000-00031; Katori H, 2005, J LARYNGOL OTOL, V119, P967; Yoon TM, 2010, CLIN OTOLARYNGOL, V35, P18, DOI 10.1111/j.1749-4486.2009.02069.x; Sumitani M, 2011, ANESTHESIOLOGY, V114, P84, DOI 10.1097/ALN.0b013e318200197d; FRANTZ TD, 1994, JAMA-J AM MED ASSOC, V272, P1358, DOI 10.1001/jama.272.17.1358; Briem B, 2009, AURIS NASUS LARYNX, V36, P46, DOI 10.1016/j.anl.2008.03.012; Simpson L, 2010, SLEEP, V33, P467; King GG, 2005, EUR RESPIR J, V25, P896, DOI 10.1183/09031936.05.0014504; Whittle AT, 1999, THORAX, V54, P323; Guldfred LA, 2008, J LARYNGOL OTOL, V122, P818, DOI 10.1017/S0022215107000473; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shah RK, 2010, LARYNGOSCOPE, V120, P1256, DOI 10.1002/lary.20921; Barba C, 2004, LANCET, V363, P157; Berg S, 1996, SCAND J INFECT DIS, V28, P261, DOI 10.3109/00365549609027168; Berger G, AM J OTOLARYNGOL, V24, P374; Bizaki AJ, 2011, LARYNGOSCOPE, V121, P2107, DOI 10.1002/lary.22147; CARENFELT C, 1989, CLIN OTOLARYNGOL, V14, P489, DOI 10.1111/j.1365-2273.1989.tb00410.x; Chang YL, 2005, OTOLARYNG HEAD NECK, V132, P689, DOI 10.1016/j.otohns.2005.01.011; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheung CSK, 2009, EUR J EMERG MED, V16, P221, DOI 10.1097/MEJ.0b013e328320ad2f; Glynn Fergal, 2008, Curr Infect Dis Rep, V10, P200, DOI 10.1007/s11908-008-0033-8; Guardiani E, 2010, LARYNGOSCOPE, V120, P2183, DOI 10.1002/lary.21083; Hebert PC, 1998, LARYNGOSCOPE, V108, P64; Kamble VA, 1999, ANESTHESIOLOGY, V91, P872, DOI 10.1097/00000542-199909000-00043; KASS EG, 1993, LARYNGOSCOPE, V103, P841; MAYOSMITH MF, 1995, CHEST, V108, P1640, DOI 10.1378/chest.108.6.1640; MAYOSMITH MF, 1986, NEW ENGL J MED, V314, P1133, DOI 10.1056/NEJM198605013141801; Nakamura H, 2001, J LARYNGOL OTOL, V115, P31; Nakamura M, 2013, EAT WEIGHT DISORD-ST, V18, P437, DOI 10.1007/s40519-013-0051-x; Ng HL, 2008, EMERG MED J, V25, P253, DOI 10.1136/emj.2007.050153; PADFIELD A, 1972, ANAESTHESIA, V27, P84, DOI 10.1111/j.1365-2044.1972.tb08165.x; Park KW, 1998, ANESTHESIOLOGY, V88, P254, DOI 10.1097/00000542-199801000-00034; Pattni V, 2013, BMJ CASE REP; SENIOR BA, 1994, LARYNGOSCOPE, V104, P1314; Solomon P, 1998, J OTOLARYNGOL, V27, P332; Wood N, 2005, INTERN MED J, V35, P530, DOI 10.1111/j.1445-5994.2005.00909.x; WURTELE P, 1990, OTOLARYNG HEAD NECK, V103, P902	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	SEP	2015	125	9					2072	2078		10.1002/lary.25114		7	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CP9RH	WOS:000360231700022		
J	Furukawa, T; Shimotai, Y; Ohta, N; Ishida, A; Kurakami, K; Suzuki, H; Yamakawa, M; Hongo, S; Kakehata, S				Furukawa, Takatoshi; Shimotai, Yoshitaka; Ohta, Nobuo; Ishida, Akihiro; Kurakami, Kazuya; Suzuki, Hitoshi; Yamakawa, Mitsunori; Hongo, Seiji; Kakehata, Seiji			Epstein-Barr virus in the enlarged salivary tissues of patients with IgG4-related disease	LARYNGOSCOPE			English	Article						Epstein-Barr virus; IgG4-related disease; EBER; EBNA	PATHOLOGICAL CHARACTERISTICS; AUTOIMMUNE PANCREATITIS; SCLEROSING PANCREATITIS; HERPESVIRUSES; PERIODONTITIS; SIALADENITIS; ROLES; CELLS; TH2; EBV	ObjectiveImmunoglobulin G4-related disease (IgG4-RD) is a recently recognized disease entity characterized by high-serum IgG4 concentration and IgG4-producing plasma cell production with fibrotic or sclerotic changes in affected organs. We aimed to clarify the roles of Epstein-Barr virus (EBV) in patients with IgG4-RDs. Study Design and SettingA retrospective clinical study at the Yamagata University School of Medicine, Yamagata, Japan. MethodsThe patient group consisted of four males and four females with an average age of 62 years (range: 48-73). Expression of IgG4, latent member protein 1, EBV nuclear antigens-2, and EBV-encoded RNA in affected salivary glands from patients with IgG4-RD was examined by using immunohistochemistry and in situ hybridization. The copy number of EBV DNA in the salivary glands was also investigated by real-time polymerase chain reaction. ResultsAll patients had hard masses in the salivary or lacrimal glands, or both, bilaterally. Serum concentrations of IgG4 were elevated in all cases (mean 589.1, range 129-1750), and IgG4-positive plasmacytes were observed in the involved salivary glands. Four patients developed potentially life-threatening systemic involvement after initial salivary gland swelling. EBV-associated molecules (EBNA and EBER) were overexpressed in the affected salivary glands. The copy number of EBV DNA was significantly higher in patients with potentially life-threatening systemic involvement than in patients without systemic involvement (P<0.05). ConclusionThese results suggest that the copy number of EBV DNA could be useful as diagnostic findings in IgG4-RD to predict potentially life-threatening systemic involvement. Level of Evidence4. Laryngoscope, 125:2079-2084, 2015	[Ohta, Nobuo] Yamagata City Hosp Saiseikan, Dept Otolaryngol, Yamagata, Japan; [Furukawa, Takatoshi; Ohta, Nobuo; Ishida, Akihiro; Kurakami, Kazuya; Kakehata, Seiji] Yamagata City Hosp Saiseikan, Head & Neck Surg, Yamagata, Japan; [Furukawa, Takatoshi; Shimotai, Yoshitaka; Hongo, Seiji] Yamagata Univ, Fac Med, Dept Infect Dis, Yamagata 990, Japan; [Suzuki, Hitoshi; Yamakawa, Mitsunori] Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata 990, Japan	Ohta, N (reprint author), Yamagata City Hosp, Dept Otolaryngol, 1-3-26 Nanokamachi, Yamagata 9908533, Japan.	moohta@saiseikan.jp			Japan Society for the Promotion of Science [25462675]	This work was supported by a Grant-in-Aid for Scientific Research (C) (25462675) from the Japan Society for the Promotion of Science. The authors have no other funding, financial relationships, or conflicts of interest to disclose.	Kamisawa T, 2003, GUT, V52, P683, DOI 10.1136/gut.52.5.683; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Kanari H, 2010, INT ARCH ALLERGY IMM, V152, P47, DOI 10.1159/000312125; Yamamoto M, 2005, AUTOIMMUN REV, V4, P195, DOI 10.1016/j.autrev.2004.10.005; Tao Q, 2006, FRONT BIOSCI, V11, P2672, DOI 10.2741/2000; Chalabi M, 2010, MOL ORAL MICROBIOL, V25, P236, DOI 10.1111/j.2041-1014.2010.00571.x; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Contreras A, 2000, ORAL MICROBIOL IMMUN, V15, P15, DOI 10.1034/j.1399-302x.2000.150103.x; Kamisawa T, 2006, J GASTROENTEROL, V41, P613, DOI 10.1007/s00535-006-1862-6; Zhang JJ, 2014, EUR J NUCL MED MOL I, V41, P1624, DOI 10.1007/s00259-014-2729-3; Ohta N, 2012, LARYNGOSCOPE, V122, P572, DOI 10.1002/lary.22449; Kubar A, 2005, J PERIODONTAL RES, V40, P97, DOI 10.1111/j.1600-0765.2005.00770.x; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Ohta N, 2012, LARYNGOSCOPE, V122, P2169, DOI 10.1002/lary.23429; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Klemenc P, 2005, J CLIN VIROL, V34, P147, DOI 10.1016/j.jcv.2005.03.001; Lacroix A, 2007, J MED VIROL, V79, P1349, DOI 10.1002/jmv.20868; Nakashima H, 2010, CLIN NEPHROL, V73, P385; Ohta N, 2014, ALLERGOL INT, V63, P171, DOI 10.2332/allergolint.13-RAI-0673; Pan SH, 2009, CARCINOGENESIS, V30, P366, DOI 10.1093/carcin/bgn291; Takano K, 2010, AM J OTOLARYNG, V31, P429, DOI 10.1016/j.amjoto.2009.08.002	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	SEP	2015	125	9					2079	2084		10.1002/lary.25153		6	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CP9RH	WOS:000360231700023		
J	Yanagawa, T; Sakagami, H; Sunahara, A; Nagatomo, H				Yanagawa, T.; Sakagami, H.; Sunahara, A.; Nagatomo, H.			Asymmetric implosion of a cone-guided target irradiated by Gekko XII laser	LASER AND PARTICLE BEAMS			English	Article						Asymmetric implosion; Cone-guided target; Hydrodynamic simulation; Inertial confinement fusion	IGNITION; GENERATION; PLASMA	In implosion experiments of a cone-guided target using Gekko XII laser, the lasers on the cone side are not irradiated to avoid the irradiation of the cone. In such condition, the implosion process is done highly asymmetrically. Thus we evaluated the effects of the asymmetric implosion on the compression ratio of the fuel in Gekko XII irradiation orientation by three-dimensional hydro simulations. In this paper, we discuss the degradation of the compression ratio by asymmetric implosion and show that the compression ratio can be enhanced by adjusting the laser intensity between each beam to reduce the asymmetry of the implosion.	[Yanagawa, T.] Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Sakagami, H.] Natl Inst Nat Sci, Natl Inst Fus Sci, Fundamental Phys Simulat Res Div, Toki, Gifu 5095292, Japan; [Sunahara, A.] Inst Laser Technol, Suita, Osaka, Japan; [Nagatomo, H.] Osaka Univ, Inst Laser Engn, Suita, Osaka 565, Japan	Yanagawa, T (reprint author), Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	yanagawa.takumi@nifs.ac.jp		SUNAHARA, ATSUSHI/0000-0001-7543-5226	Institute of Laser Engineering, Osaka University	This work was partially performed under the joint research project of the Institute of Laser Engineering, Osaka University.	Temporal M, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/12/124008; Shay HD, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4751839; Li CK, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.205001; Chaudhuri A, 2011, J COMPUT PHYS, V230, P1731, DOI 10.1016/j.jcp.2010.11.016; Regan SP, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694057; Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638; Sakagami H, 2012, LASER PART BEAMS, V30, P103, DOI 10.1017/S0263034611000735; Casner A, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4737901; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Nagatomo H, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2671124; Theobald W, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3566082; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Hu SX, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3491467; Heya M, 2001, LASER PART BEAMS, V19, P267, DOI 10.1017/S0263034601192177; PESKIN CS, 1972, J COMPUT PHYS, V10, P252, DOI 10.1016/0021-9991(72)90065-4; Kodama R, 2002, NATURE, V418, P933, DOI 10.1038/418933a; Atzeni S., 2004, PHYS INERTIAL FUSION; Azechi H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/10/104024; Hata M, 2013, LASER PART BEAMS, V31, P371, DOI 10.1017/S0263034613000104; Johzaki T, 2007, LASER PART BEAMS, V25, P621, DOI 10.1017/S0263034607000730; Ma TM, 2013, MOL PHYS, V111, P111, DOI 10.1080/00268976.2012.705025; Nagatomo H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075028; Rygg JR, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2892025; SAKAGAMI H, 1990, PHYS REV LETT, V65, P432, DOI 10.1103/PhysRevLett.65.432; Shiraga H, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/12/124029; Stephens RB, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1896952; Sunahara A, 2012, LASER PART BEAMS, V30, P95, DOI 10.1017/S0263034611000723; Thomas V. A., 2012, PHYS REV LETT, V109, DOI [10.1103/PhysRevLett.109.075004, DOI 10.1103/PHYSREVLETT.109.075004]; Yanagawa T, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4826211	29	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	SEP	2015	33	3					367	378		10.1017/S0263034615000427		12	Physics, Applied	Physics	CQ2QM	WOS:000360446200003		
J	Del Sorbo, D; Arikawa, Y; Batani, D; Beg, F; Breil, J; Chen, H; Feugeas, JL; Fujioka, S; Hulin, S; Koga, M; Maclean, H; Morace, A; Namimoto, T; Nazarov, W; Nicolai, P; Nishimura, H; Ozaki, T; Sakaki, T; Santos, JJ; Spindloe, C; Tanaka, KA; Vaisseau, X; Veltcheva, M; Yabuchi, T; Zhang, Z				Del Sorbo, D.; Arikawa, Y.; Batani, D.; Beg, F.; Breil, J.; Chen, H.; Feugeas, J. L.; Fujioka, S.; Hulin, S.; Koga, M.; Maclean, H.; Morace, A.; Namimoto, T.; Nazarov, W.; Nicolai, Ph.; Nishimura, H.; Ozaki, T.; Sakaki, T.; Santos, J. J.; Spindloe, Ch.; Tanaka, K. A.; Vaisseau, X.; Veltcheva, M.; Yabuchi, T.; Zhang, Z.			Approach to the study of fast electron transport in cylindrically imploded targets	LASER AND PARTICLE BEAMS			English	Article						Fast ignition; Inertial confinement fusion; Relativistic electron transport; Warm and dense matter	FAST IGNITION; GAIN; LASERS; MATTER	The transport of relativistic electron beam in compressed cylindrical targets was studied from a numerical and experimental point of view. In the experiment, cylindrical targets were imploded using the Gekko XII laser facility of the Institute of Laser Engineering. Then the fast electron beam was created by shooting the LFEX laser beam. The penetration of fast electrons was studied by observing K emission from tracer layers in the target.	[Del Sorbo, D.; Batani, D.; Breil, J.; Feugeas, J. L.; Hulin, S.; Nicolai, Ph.; Sakaki, T.; Santos, J. J.; Vaisseau, X.; Veltcheva, M.] Univ Bordeaux, CELIA Ctr Lasers Intenses & Applicat, CNRS, CEA,UMR 5107, F-33405 Talence, France; [Arikawa, Y.; Fujioka, S.; Koga, M.; Morace, A.; Namimoto, T.; Nishimura, H.; Zhang, Z.] Osaka Univ, ILE, Osaka, Japan; [Beg, F.] UCSD, La Jolla, CA USA; [Chen, H.; Maclean, H.] LLNL, Livermore, CA USA; [Nazarov, W.] St Andrews Univ, St Andrews, Fife, Scotland; [Ozaki, T.] Natl Inst Fus Sci, Toki, Gifu, Japan; [Spindloe, Ch.] Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; [Tanaka, K. A.; Yabuchi, T.] Osaka Univ, Grad Sch Engn, Osaka, Japan	Batani, D (reprint author), Univ Bordeaux, CELIA Ctr Lasers Intenses & Applicat, CNRS, CEA,UMR 5107, F-33405 Talence, France.	batani@celia.u-bordeaux1.fr	Arikawa, Yasunobu/L-8760-2015	Arikawa, Yasunobu/0000-0002-3142-3060	COST action [MP1208]; ANR-TERRE	The authors want to thank the ILE technical team for the help, the ANR-TERRE for the fundings, Luca Antonelli, Luca Fedeli and Claudio Bellei for interesting discussions about this topic. They also acknowledge the support of the COST action MP1208 "Developing the Physics and the Scientific Community for Inertial Fusion".	Abdallah J, 2007, LASER PART BEAMS, V25, P245, DOI 10.1017/S0263034607000080; Perez F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.065004; Breil J, 2011, COMPUT FLUIDS, V46, P161, DOI 10.1016/j.compfluid.2010.06.017; Robinson APL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.025002; Chawla S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.025001; Stephens RB, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066414; Nicolai P, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016402; Santos JJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.025001; Tabak M, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1871246; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Green JS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.015003; Touati M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/073014; Bell AR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.035003; Atzeni S, 2005, PLASMA PHYS CONTR F, V47, pB769, DOI 10.1088/0741-3335/47/12B/S58; Badziak J, 2006, LASER PART BEAMS, V24, P249, DOI [10.1017/S0263034606060368, 10.1017/S026303460606368]; Batani D, 2002, LASER PART BEAMS, V20, P321, DOI 10.1017/S0263034602202244; Beg FN, 1997, PHYS PLASMAS, V4, P447, DOI 10.1063/1.872103; Chen CD, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2964231; Gu YQ, 2013, LASER PART BEAMS, V31, P579, DOI 10.1017/S026303461300044X; Gus'Kov SY, 2005, LASER PART BEAMS, V23, P255, DOI 10.1017/S0263034605050305; Hallo L, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/1/014001; Legall H., 2005, OPTICS PHOTONICS; Martinolli E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.055402; Martinolli E, 2002, LASER PART BEAMS, V20, P171, DOI 10.1017/S0263034602202037; Morace A, 2010, NUCL INSTRUM METH A, V623, P797, DOI 10.1016/j.nima.2010.02.130; Mulser P, 2004, LASER PART BEAMS, V22, P5, DOI [10.1017/S0263034604221024, 10.1017/S0263034604221204]; Nakamura H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.165001; Ohira S, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752872; Perez F, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124035; Vauzour B, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3578346; Zhou CT, 2010, LASER PART BEAMS, V28, P563, DOI 10.1017/S0263034610000625	31	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	SEP	2015	33	3					525	534		10.1017/S0263034615000592		10	Physics, Applied	Physics	CQ2QM	WOS:000360446200021		
J	Miyata, S; Fukuda, Y; Tojima, H; Matsuzaki, K; Kitanaka, S; Sawada, H				Miyata, Shohei; Fukuda, Yasuaki; Tojima, Haruka; Matsuzaki, Keiichi; Kitanaka, Susumu; Sawada, Hiroshi			Mechanism of the inhibition of leukemia cell growth and induction of apoptosis through the activation of ATR and PTEN by the topoisomerase inhibitor 3EZ, 20Ac-ingenol	LEUKEMIA RESEARCH			English	Review						Topo catalytic inhibitor; PTEN/Akt; ATM/ATR; p53; Inhibition of proliferation; Apoptosis	OVARIAN-CANCER CELLS; I CLEAVAGE COMPLEXES; MEDIATED DNA-DAMAGE; ARSENIC TRIOXIDE; PI3K/AKT PATHWAY; DECATENATION CHECKPOINT; CATALYTIC INHIBITOR; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; HISTONE H2AX	The PI3K/Akt signaling pathway is constitutively activated in various leukemias. In the present study, the topoisomerase inhibitor, 3EZ, 20Ac-ingenol, was more effective in inhibiting the growth of BALL-1 cells than that of normal lymphocyte cells. ATM/ATR protein levels were increased, PTEN protein was upregulated, and p-Akt protein was downregulated at early time points after treatment with 3EZ, 20Ac-ingenol. In further experiments, p53 protein expression was increased, and H2AX phosphorylation and p21 protein expression were induced after treatment with 3EZ, 20Ac-ingenol. Moreover, the activation of caspase 3 followed decrease in the Bcl-2/Bax ratio after treatment with 3EZ, 20Ac-ingenol, and accumulation of sub-G1 phase cells was observed in flow cytometry analyses. These data suggest that 3EZ, 20Ac-ingenol-induced DNA damage downregulates p-Akt and upregulates ATR leading to cell cycle arrest and increased apoptosis in BALL-1 cells. (C) 2015 Elsevier Ltd. All rights reserved.	[Miyata, Shohei; Fukuda, Yasuaki; Tojima, Haruka] Nihon Univ, Coll Humanities & Sci, Dept Chem, Tokyo 1568550, Japan; [Matsuzaki, Keiichi; Kitanaka, Susumu] Nihon Univ, Sch Pharm, Chiba, Japan; [Sawada, Hiroshi] Nihon Univ, Coll Humanities & Sci, Dept Integrated Sci Phys & Biol, Tokyo 1568550, Japan	Miyata, S (reprint author), Nihon Univ, Coll Humanities & Sci, Dept Chem, Tokyo 1568550, Japan.	miyata@chs.nihon-u.ac.jp			Nihon University	This investigation was supported in part by a grant from Nihon University to S. Miyata.	Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Shin SY, 2010, CANCER LETT, V287, P231, DOI 10.1016/j.canlet.2009.06.019; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Andoh T, 1998, BBA-GENE STRUCT EXPR, V1400, P155, DOI 10.1016/S0167-4781(98)00133-X; Park I, 2006, EXP CELL RES, V312, P1996, DOI 10.1016/j.yexcr.2006.02.029; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Bower JJ, 2010, CELL CYCLE, V9, P1617, DOI 10.4161/cc.9.8.11470; Huang FF, 2013, CANCER LETT, V336, P96, DOI 10.1016/j.canlet.2013.04.006; Selvendiran K, 2007, J BIOL CHEM, V282, P28609, DOI 10.1074/jbc.M703796200; Hu YC, 2013, BIOCHEM PHARMACOL, V85, P1018, DOI 10.1016/j.bcp.2013.01.008; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; HARPER JW, 1995, MOL BIOL CELL, V6, P387; Kryeziu K, 2013, MOL CANCER THER, V12, P1073, DOI 10.1158/1535-7163.MCT-13-0065; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/003-042; Nakashio A, 2000, CANCER RES, V60, P5303; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Wu N, 2010, BIOCHEMISTRY-US, V49, P10131, DOI 10.1021/bi1009419; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Zhao ZW, 2012, BIOCHEM J, V444, P291, DOI 10.1042/BJ20111855; Ming M, 2012, CANCER LETT, V319, P125, DOI 10.1016/j.canlet.2012.01.003; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fukuda Y, 2013, ARCH PHARM RES, V36, P1029, DOI 10.1007/s12272-013-0108-4; Hlobilkova A, 2006, ANTICANCER RES, V26, P1015; Kanbe K., 2012, PHARM PHARM, V3, P158; Liu YQ, 2009, CANCER LETT, V274, P47, DOI 10.1016/j.canlet.2008.08.037; Martin SA, 2008, MOL CANCER THER, V7, P2509, DOI 10.1158/1535-7163.MCT-08-0199; Pastor N, 2012, MUTAT RES-FUND MOL M, V738, P45, DOI 10.1016/j.mrfmmm.2012.07.005; Redondo-Munoz J, 2010, CLIN CANCER RES, V16, P4382, DOI 10.1158/1078-0432.CCR-10-0072; Robinson HMR, 2007, CELL CYCLE, V6, P1265, DOI 10.4161/cc.6.10.4225; Sordet O, 2004, J BIOL CHEM, V279, P33968, DOI 10.1074/jbc.M404620200; Sordet O, 2006, MOL CANCER THER, V5, P3139, DOI 10.1158/1535-7163/MCT-06-0463; Wang L, 2007, MUTAT RES-FUND MOL M, V616, P70, DOI 10.1016/j.mrfmmm.2006.11.023; Xu N., 2012, J ONCOL, V2012, P1; Yu HY, 2014, BIOMOL THER, V22, P184, DOI 10.4062/biomolther.2014.026; Zhang XH, 2013, LEUKEMIA RES, V37, P1719, DOI 10.1016/j.leukres.2013.09.019	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126	1873-5835		LEUKEMIA RES	Leuk. Res.	SEP	2015	39	9					927	932		10.1016/j.leukres.2015.06.006		6	Oncology; Hematology	Oncology; Hematology	CP7VL	WOS:000360097100001		
J	Sawai, H; Ogiso, H; Okazaki, T				Sawai, Hirofumi; Ogiso, Hideo; Okazaki, Toshiro			Differential changes in sphingolipids between TNF-induced necroptosis and apoptosis in U937 cells and necroptosis-resistant sublines	LEUKEMIA RESEARCH			English	Article						Necroptosis; Apoptosis; TNF; Sphingolipids; Ceramide; Mass spectrometry	TUMOR-NECROSIS-FACTOR; DEATH PATHWAYS; CERAMIDE; RESPONSES; RECEPTOR; STRESS; KINASE	Differential changes in various sphingolipids between TNF-induced necroptosis and apoptosis were investigated using liquid chromatography-tandem mass spectrometry. A marked increase in d18:1/16:0 ceramide was detected in U937 cells treated with TNF in the presence of Z-VAD-fmk (VAD). The level of d18:1/16:0 ceramide in necroptosis was almost twice as high as that in apoptosis after 4h, while an increase in PI-positive cells was observed only in necroptosis within 4 h. Necroptosis-resistant U937 (UNR) sublines were established to more clearly discriminate between necroptosis and apoptosis. All three UNR sublines were almost completely resistant to the treatment with TNF/VAD, but were as sensitive to TNF-induced apoptosis as parental cells. The expression of RIP3, a pivotal kinase in necroptosis, was lost in all three UNR sublines. In contrast with the large increase in ceramide levels in TNF/VAD-treated parental cells, they were only slightly increased in UNR cells. Although intracellular levels of reactive oxygen species (ROS) were elevated in both necroptosis and apoptosis, the treatment with butylated hydroxyanisole, an antioxidant, significantly inhibited increases in ceramide levels and PI-positive cells only in necroptosis. These results implicate that the ROS-induced large increase in ceramide levels may play a role in plasma membrane permeabilization in TNF-induced necroptosis. (C) 2015 Elsevier Ltd. All rights reserved.	[Sawai, Hirofumi] Osaka Dent Univ, Dept Internal Med, Hirakata, Osaka 5731121, Japan; [Ogiso, Hideo; Okazaki, Toshiro] Kanazawa Med Univ, Hematol & Immunol, Kanazawa, Ishikawa 9200293, Japan	Sawai, H (reprint author), Osaka Dent Univ, Dept Internal Med, 8-1 Kuzuhahanazonocho, Hirakata, Osaka 5731121, Japan.	sawai@cc.osaka-dent.ac.jp			Society for the Promotion of Science [25462941]; Takeda Science Foundation; Shalome Co., Ltd.; ONO Pharmaceutical Co., Ltd.; Strategic Research Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan [S1201004, H2012-16]; SENSHIN Medical Research Foundation; Mizutani Foundation for Glycoscience; Collaborative Research from Kanazawa Medical University [C2012-4, C2013-1]	This work was supported by Grant-in-Aid for Scientific Research (C) (25462941) from Japan Society for the Promotion of Science (to H.S.), the Takeda Science Foundation (2012-), performed the joint research project with Shalome Co., Ltd. (2012-2015) and with ONO Pharmaceutical Co., Ltd. (2012-2014), a grant from Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan (S1201004; H2012-16), SENSHIN Medical Research Foundation, Mizutani Foundation for Glycoscience (2013-14), and the Collaborative Research from Kanazawa Medical University (C2012-4; C2013-1) (to T.O.).	Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Aouali N, 2011, ONCOL REP, V25, P1161, DOI 10.3892/or.2011.1180; Goldkorn T, 1998, J CELL SCI, V111, P3209; Ogiso Hideo, 2014, Metabolites, V4, P98, DOI 10.3390/metabo4010098; Sawai H, 2014, LEUKEMIA RES, V38, P706, DOI 10.1016/j.leukres.2014.02.002; Sawai H, 1999, CHEM PHYS LIPIDS, V102, P141, DOI 10.1016/S0009-3084(99)00082-1; Sawai H, 2005, CURR PHARM DESIGN, V11, P2479, DOI 10.2174/1381612054367463; Thon L, 2005, FASEB J, V19, P1945, DOI 10.1096/fj.05-3726com	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126	1873-5835		LEUKEMIA RES	Leuk. Res.	SEP	2015	39	9					964	970		10.1016/j.leukres.2015.06.002		7	Oncology; Hematology	Oncology; Hematology	CP7VL	WOS:000360097100007		
J	Sakai, T; Masaki, Y; Otsuki, N; Sakamaki, I; Kishi, S; Miyazono, T; Urasaki, Y; Murakami, J; Satoh, T; Nakamura, T; Iwao, H; Nakajima, A; Kawanami, T; Miki, M; Fujita, Y; Tanaka, M; Fukushima, T; Okazaki, T; Ueda, T				Sakai, Tomoyuki; Masaki, Yasufumi; Otsuki, Nozomi; Sakamaki, Ippei; Kishi, Shinji; Miyazono, Takayoshi; Urasaki, Yoshimasa; Murakami, Jun; Satoh, Tomomi; Nakamura, Takuji; Iwao, Haruka; Nakajima, Akio; Kawanami, Takafumi; Miki, Miyuki; Fujita, Yoshimasa; Tanaka, Masao; Fukushima, Toshihiro; Okazaki, Toshiro; Ueda, Takanori			Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group	MEDICAL ONCOLOGY			English	Article						Indolent B cell lymphoma; Mantle cell lymphoma; R-CMD; Toxicity	NON-HODGKINS-LYMPHOMA; UNTREATED FOLLICULAR LYMPHOMA; PHASE-II; REFRACTORY INDOLENT; MITOXANTRONE; FLUDARABINE; DEXAMETHASONE; RITUXIMAB; CYCLOPHOSPHAMIDE; CLADRIBINE	Standardized treatments for indolent B cell lymphoma primarily consisting of follicular lymphoma (FL) and for mantle cell lymphoma (MCL) have yet to be established. Here the Hokuriku Hematology Oncology Study Group conducted a multicenter prospective study to investigate the efficacy and safety of a combination regimen of rituximab, cladribine, mitoxantrone, and dexamethasone (R-CMD) in indolent B cell lymphoma and MCL. A total of 33 CD20-positive patients who received care between January 2008 and August 2011 were investigated. These patients' illnesses were FL (n = 21), nodal marginal zone B cell lymphoma (NMZB, n = 3), MCL (n = 3), splenic marginal zone B cell lymphoma (n = 2), hairy cell leukemia (n = 1), Waldenstrom macroglobulinemia (WM, n = 1), and lymphoplasmacytic lymphoma (LPL, n = 2). Patients received four 21-day cycles of rituximab 375 mg/m(2) (day 1), cladribine 0.10 mg/kg (days 1-3), mitoxantrone 8 mg/m(2) (day 1), and dexamethasone 8 mg/body (days 1-3), with four additional rituximab doses at 4-week intervals. Of the 33 patients, 26 achieved complete response/unconfirmed complete response, and six achieved a partial response (4 with FL, 1 with NMZB, 1 with WM). One had progressive disease (FL), and four relapsed after remission (1 with FL, 2 with MCL, 1 with LPL). R-CMD therapy was relatively convenient and effective in indolent B cell lymphoma and MCL. Nonetheless, to suppress the number and function of both B cells and T cells, comprehensive infection prevention and follow-up are necessary in the future.	[Sakai, Tomoyuki; Masaki, Yasufumi; Satoh, Tomomi; Nakamura, Takuji; Iwao, Haruka; Nakajima, Akio; Kawanami, Takafumi; Miki, Miyuki; Fujita, Yoshimasa; Tanaka, Masao; Fukushima, Toshihiro; Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol & Immunol, Kahoku, Ishikawa 9200293, Japan; [Otsuki, Nozomi] Natl Org Awara Hosp, Div Clin Res, Awara, Fukui 9104272, Japan; [Sakamaki, Ippei; Kishi, Shinji; Ueda, Takanori] Univ Fukui, Fac Med Sci, Div Hematol & Oncol, Yoshidagun, Fukui 9101193, Japan; [Miyazono, Takayoshi; Murakami, Jun] Toyama Univ, Dept Gastroenterol & Hematol, Toyama, Toyama 9300194, Japan; [Urasaki, Yoshimasa] Univ Fukui, Fac Med Sci, Div Transfus Med, Yoshidagun, Fukui 9101193, Japan	Sakai, T (reprint author), Kanazawa Med Univ, Dept Hematol & Immunol, 1-1 Daigaku,Uchinada Machi, Kahoku, Ishikawa 9200293, Japan.	pochi@kanazawa-med.ac.jp					Montoto S, 2008, HAEMATOL-HEMATOL J, V93, P207, DOI 10.3324/haematol.11671; Friedberg JW, 2008, J CLIN ONCOL, V26, P204, DOI 10.1200/JCO.2007.12.5070; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Flinn IW, 2000, BLOOD, V96, P71; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; Fowler N, 2011, J CLIN ONCOL, V29, P3389, DOI 10.1200/JCO.2010.32.1844; Sinha R, 2012, CANCER-AM CANCER SOC, V118, P3538, DOI 10.1002/cncr.26660; Bordonaro R, 2004, LEUKEMIA LYMPHOMA, V45, P93, DOI 10.1080/1042819031000139765; Ibatici A, 2014, BRIT J HAEMATOL, V164, P710, DOI 10.1111/bjh.12695; Keating M J, 1997, Eur J Cancer Care (Engl), V6, P21, DOI 10.1111/j.1365-2354.1997.tb00321.x; Leonard J, 2012, ASCO ANN M, V30, P8000; McLaughlin P, 1996, J CLIN ONCOL, V14, P1262; McLaughlin P, 2003, P AN M AM SOC CLIN, V102, P564; Robak T, 2004, LEUKEMIA LYMPHOMA, V45, P937, DOI 10.1080/1042819032000159825; Robak T, 2007, LEUKEMIA LYMPHOMA, V48, P1092, DOI 10.1080/10428190701361216; Robak T, 1999, LEUKEMIA LYMPHOMA, V32, P359; Rummel MJ, 2002, EUR J CANCER, V38, P1739, DOI 10.1016/S0959-8049(02)00143-0; Srokowski TP, 2011, CANCER-AM CANCER SOC, V117, P5067, DOI 10.1002/cncr.26121; Tobinai K, 2009, CANCER SCI, V100, P158, DOI 10.1111/j.1349-7006.2008.00999.x; Tsimberidou AM, 2002, BLOOD, V100, P4351, DOI 10.1182/blood-2001-12-0269; Tsimberidou AM, 2005, CANCER, V104, P345, DOI 10.1002/cncr.21151; Velasquez WS, 2003, J CLIN ONCOL, V21, P1996, DOI 10.1200/JCO.2003.09.047	22	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1357-0560	1559-131X		MED ONCOL	Med. Oncol.	SEP	2015	32	9							232	10.1007/s12032-015-0677-9		6	Oncology	Oncology	CQ1RO	WOS:000360376500010		
J	Tsuchiya, Y; Ando, D; Takamatsu, K; Goto, K				Tsuchiya, Yoshifumi; Ando, Daisuke; Takamatsu, Kaoru; Goto, Kazushige			Resistance exercise induces a greater irisin response than endurance exercise	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						Irisin; PGC-l alpha; FNDC5; Exercise mode; Time-course change	HUMAN SKELETAL-MUSCLE; CIRCULATING IRISIN; METABOLIC SYNDROME; ADIPOSE-TISSUE; OBESE CHILDREN; WHITE FAT; HUMANS; SERUM; PLASMA; YOUNG	Objective. We determined detailed time-course changes in the irisin response to acute exercise using different exercise modes. Methods. In experiment 1, seven healthy males rested for 12 h (8:00-20:00) to determine the diurnal variation in plasma irisin concentration. In experiment 2, 10 healthy males conducted three exercises to clarify time-course changes in plasma irisin concentration over 6 h, using a randomized crossover design. The resistance exercise (R) trial consisted of eight exercises of 12 repetitions with 3-4 sets at 65% of one repetition maximum (1RM). The endurance exercise (E) trial consisted of 60 mm of pedaling at 65% of maximal oxygen uptake (VO2max). In the combined mode (R + E) trial, 30 min of endurance exercise was preceded by 30 min of resistance exercise. Results. In experiment 1, no significant changes in plasma irisin concentration were observed over 12 h. In experiment 2, the R trial showed a marked increase in plasma irisin concentration 1 h after exercise (P < 0.05), but not in the E or R + E trials. The area under the curve (AUC) for irisin concentrations for 6 h after exercise was significantly higher in the R trial than in the R + E trial (P < 0.05). The AUC for irisin concentrations was significantly correlated with AUC values for blood glucose, lactate, and serum glycerol (r = 0.37, 0.45, 0.45, respectively. P < 0.05). Conclusions. Resistance exercise resulted in significantly greater irisin responses compared with endurance exercise alone, and resistance and endurance exercises combined. (C) 2015 Elsevier Inc. All rights reserved.	[Tsuchiya, Yoshifumi; Goto, Kazushige] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan; [Ando, Daisuke] Univ Yamanashi, Fac Educ & Human Sci, Kofu, Yamanashi 4008510, Japan; [Takamatsu, Kaoru] Univ Tsukuba, Tsukuba, Ibaraki 3058574, Japan	Goto, K (reprint author), Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	kagoto@fc.ritsumei.ac.jp			Japan Society for the Promotion of Science [23300232]; Meiji Yasuda Life Foundation of Health and Welfare	We wish to thank the subjects for commitment to the research. We thank laboratory members for help the experiment and analyses of blood samples. This work was supported by the Japan Society for the Promotion of Science (23300232); Meiji Yasuda Life Foundation of Health and Welfare.	American College of Sports Medicine, 2009, MED SCI SPORTS EXERC, V41, P687, DOI DOI 10.1249/MSS.0B013E3181915670; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Daskalopoulou SS, 2014, EUR J ENDOCRINOL, V171, P343, DOI 10.1530/EJE-14-0204; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011; Brenmoehl J, 2014, INT J BIOL SCI, V10, P338, DOI 10.7150/ijbs.7972; Al-Daghri NM, 2014, CLIN SCI, V126, P837, DOI 10.1042/CS20130426; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Huh JY, 2014, METABOLISM, V63, P918, DOI 10.1016/j.metabol.2014.04.001; Huh JY, 2014, J CLIN ENDOCR METAB, V99, pE2154, DOI 10.1210/jc.2014-1437; Aydin S, 2013, PEPTIDES, V50, P13, DOI 10.1016/j.peptides.2013.09.011; Goto K, 2007, MED SCI SPORT EXER, V39, P308, DOI 10.1249/01.mss.0000246992.33482.cb; Anastasilakis AD, 2014, J CLIN ENDOCR METAB, V99, P3247, DOI 10.1210/jc.2014-1367; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; de la Iglesia R, 2014, CLIN ENDOCRINOL, V81, P306, DOI 10.1111/cen.12383; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Loffler D, 2015, J CLIN ENDOCR METAB, V100, P1289, DOI 10.1210/jc.2014-2932; Aydin S, 2013, PEPTIDES, V47, P66, DOI 10.1016/j.peptides.2013.07.001; Bluher S, 2014, OBESITY, V22, P1701, DOI 10.1002/oby.20739; Elsen M, 2014, J ENDOCRINOL, V222, pR25, DOI 10.1530/JOE-14-0189; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Crujeiras AB, 2015, CLIN ENDOCRINOL, V82, P467, DOI 10.1111/cen.12627; Czarkowska-Paczek B, 2014, J PHYSIOL PHARMACOL, V65, P449; Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Erickson Harold P, 2013, Adipocyte, V2, P289, DOI 10.4161/adip.26082; Gouni-Berthold I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072858; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hew-Butler T, 2015, PHYSL REP, V3; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Novelle MG, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/746281; Park KH, 2014, METABOLISM, V63, P233, DOI 10.1016/j.metabol.2013.10.011; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Reinehr T, 2015, J CLIN ENDOCR METAB, V100, P2123, DOI 10.1210/jc.2015-1208; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Scharhag-Rosenberger F, 2014, MED SCI SPORT EXER, V46, P1736, DOI 10.1249/MSS.0000000000000286; Stepto NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053080; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Tsuchiya Y, 2014, TOHOKU J EXP MED, V233, P135, DOI 10.1620/tjem.233.135; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1	48	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	SEP	2015	64	9					1042	1050		10.1016/j.metabol.2015.05.010		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CP7XJ	WOS:000360102600014		
J	Sakoh, T; Nakayama, M; Tanaka, S; Yoshitomi, R; Ura, Y; Nishimoto, H; Fukui, A; Shikuwa, Y; Tsuruya, K; Kitazono, T				Sakoh, Teppei; Nakayama, Masaru; Tanaka, Shigeru; Yoshitomi, Ryota; Ura, Yoriko; Nishimoto, Hitomi; Fukui, Akiko; Shikuwa, Yui; Tsuruya, Kazuhiko; Kitazono, Takanari			Association of serum total bilirubin with renal outcome in Japanese patients with stages 3-5 chronic kidney disease	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						Serum bilirubin; Renal outcome; Chronic kidney disease; Oxidative stress	OXIDATIVE STRESS; DIABETIC-NEPHROPATHY; IGA NEPHROPATHY; ALBUMINURIA; HYPERBILIRUBINEMIA; COMPLICATIONS; PROGRESSION; PREVALENCE; METABOLISM; PREDICTOR	Objective. Serum bilirubin has been reported to be associated with the progression of kidney disease in patients with diabetic nephropathy. Less is known, however, about the relationship between bilirubin and chronic kidney disease (CKD) of other etiologies. This study was designed to clarify whether serum total bilirubin concentration is associated with kidney disease progression in patients with CKD independent of etiology. Materials and methods. This prospective observational study enrolled 279 consecutive patients with stages 3-5 CKD. The renal endpoint was the composite of the doubling of serum creatinine or end-stage renal disease requiring dialysis. Patients were divided into three groups by their serum total bilirubin concentrations: <= 0.3 (lowest), 0.4-0.5 (middle), and >= 0.6 (highest) mg/dL. A Cox proportional hazards model was applied to determine the risk factors for poor renal outcome. Results. The median follow-up period was 21 months. One-hundred and three patients reached renal end points. After multivariable adjustment, a 0.1 mg/dL increase in serum bilirubin was associated negatively with poor renal outcome (hazard ratio [HA], 0.73; 95% confidence interval [CI], 0.60-0.87). In addition, after adjustment for confounding factors, including traditional and nontraditional cardiovascular risk factors, the middle (HR 3.14, 95% CI 1.36-8.57) and lowest (HR 4.22, 95% CI 1.81-11.59) bilirubin groups had significantly higher HRs for renal outcome than the highest bilirubin group. Conclusions. Lower serum bilirubin concentration was independently associated with adverse renal outcomes, suggesting that the measurement of serum bilirubin is useful for predicting kidney disease progression in patients with moderate to severe CKD. (C) 2015 Elsevier Inc. All rights reserved.	[Sakoh, Teppei; Nakayama, Masaru; Ura, Yoriko; Nishimoto, Hitomi; Fukui, Akiko; Shikuwa, Yui] Natl Kyushu Med Ctr Hosp, Dept Internal Med, Div Nephrol, Chuo Ku, Fukuoka 8108563, Japan; [Sakoh, Teppei; Nakayama, Masaru; Ura, Yoriko; Nishimoto, Hitomi; Fukui, Akiko; Shikuwa, Yui] Natl Kyushu Med Ctr Hosp, Dept Internal Med, Clin Res Inst, Chuo Ku, Fukuoka 8108563, Japan; [Tanaka, Shigeru; Yoshitomi, Ryota; Tsuruya, Kazuhiko; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, Fukuoka 8128582, Japan	Nakayama, M (reprint author), Natl Kyushu Med Ctr Hosp, Dept Internal Med, Div Nephrol, Chuo Ku, 1-8-1 Jigyohama, Fukuoka 8108563, Japan.	mnaka@kyumed.jp			Canadian Institutes of Health Research (MOP) [102626]; Fonds de recherche du Quebec Sante (FRQS)	This study was funded by a grant from the Canadian Institutes of Health Research (MOP#102626) to SSD. SSD is a Chercheur-Boursier Clinicien supported by a Fonds de recherche du Quebec Sante (FRQS) salary award.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Tanaka M, 2014, ATHEROSCLEROSIS, V234, P421, DOI 10.1016/j.atherosclerosis.2014.03.015; Descamps-Latscha B, 2004, KIDNEY INT, V66, P1606, DOI 10.1111/j.1523-1755.2004.00926.x; Fujii M, 2010, KIDNEY INT, V78, P905, DOI 10.1038/ki.2010.265; Jung CH, 2014, METABOLISM, V63, P87, DOI 10.1016/j.metabol.2013.09.011; Inoguchi T, 2007, JAMA-J AM MED ASSOC, V298, P1398, DOI 10.1001/jama.298.12.1398-b; Nishikawa T, 2003, DIABETES CARE, V26, P1507, DOI 10.2337/diacare.26.5.1507; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; Kumar A, 2007, J TROP PEDIATRICS, V53, P69, DOI 10.1093/tropej/fml060; Terawaki H, 2004, KIDNEY INT, V66, P1988, DOI 10.1111/j.1523-1755.2004.00969.x; Hinokio Y, 2002, DIABETOLOGIA, V45, P877, DOI 10.1007/s00125-002-0831-8; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Okada H, 2014, METABOLISM, V63, P409, DOI 10.1016/j.metabol.2013.11.011; Riphagen IJ, 2014, DIABETES, V63, P2845, DOI 10.2337/db13-1652; Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465; Targher G, 2009, KIDNEY INT, V75, P863, DOI 10.1038/ki.2008.677; Kao MPC, 2010, J HUM HYPERTENS, V24, P1, DOI 10.1038/jhh.2009.70; Chin HJ, 2009, J KOREAN MED SCI, V24, pS22, DOI 10.3346/jkms.2009.24.S1.S22; Kawamoto R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115294; Kuo HT, 2005, EUR J CLIN INVEST, V35, P245, DOI 10.1111/j.1365-2362.2005.01488.x; Markan S, 2008, MOL CELL BIOCHEM, V311, P105, DOI 10.1007/s11010-008-9701-0; Ohnaka K, 2010, DIABETES RES CLIN PR, V88, P103, DOI 10.1016/j.diabres.2009.12.022; PASTERNACK A, 1976, CLIN CHIM ACTA, V67, P85, DOI 10.1016/0009-8981(76)90220-5; Ryu S, 2014, PLOS ONE, V9, pe7517; Shin HS, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-29; Tanaka M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-39; Targher G, 2009, CLIN CHEM LAB MED, V47, P1055, DOI 10.1515/CCLM.2009.244; Vera T, 2010, AM J PHYSIOL-REG I, V299, pR1044, DOI 10.1152/ajpregu.00316.2010; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055	33	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	SEP	2015	64	9					1096	1102		10.1016/j.metabol.2015.06.006		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CP7XJ	WOS:000360102600020		
J	Kadota, Y; Toyoda, T; Hayashi-Kato, M; Kitaura, Y; Shimomura, Y				Kadota, Yoshihiro; Toyoda, Takanari; Hayashi-Kato, Mayumi; Kitaura, Yasuyuki; Shimomura, Yoshiharu			Octanoic acid promotes branched-chain amino acid catabolisms via the inhibition of hepatic branched-chain alpha-keto acid dehydrogenase kinase in rats	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						Branched-chain amino acid; Branched-chain alpha-ketoacid dehydrogenase complex; Branched-chain alpha-ketoacid dehydrogenase kinase; Medium-chain fatty acids; Trioctanoin	SKELETAL-MUSCLE; LIVER; METABOLISM; COMPLEX; STATE; OXIDATION; PURIFICATION; MECHANISMS; HEART; DIET	Objective. It has been reported that administration of octanoic acid, one of medium-chain fatty acids (MCFAs), promoted leucine oxidation in vitro and in vivo, but it remained unclear how octanoic acid stimulated leucine oxidation. Therefore, the aim of this study was to elucidate the mechanism that octanoic acid facilitates branched-chain amino acid (BCAA) catabolism. Materials/Methods. In in vivo experiments, male rats were orally administered MCFAs as free fatty acids or triacylglycerol (trioctanoin), and then activities of hepatic branched-chain a-ketoacid dehydrogenase (BCKDH) complex (BCKDq and BCKDH kinase (BDK) and alterations in the concentration of blood components were analyzed. In in vitro experiments, purified BCKDC associated with BDK (BCKDH-BDK complex) was reacted with various concentrations of hexanoic, octanoic, and decanoic acids. Results. Oral administration of trioctanoin in rats activated hepatic BCKDC via downregulation of BDK activity in association with a decrease in plasma BCAA concentration and an increase in serum ketone body concentration. In vitro experiments using purified BCKDH-BDK complex showed that MCFAs (hexanoic, octanoic, and decanoic acids) inhibited BDK activity and that this inhibition was higher in hexanoic and octanoic acids than in decanoic acid. Oral administration of octanoic acid, but not decanoic acid, in rats activated hepatic BCKDC via downregulation of BDK activity by decreasing the amount of BDK bound to the complex. The serum ketone body level was elevated by both administration of octanoic acid and decanoic acid. Conclusion. These results suggest that octanoic acid promotes BCAA catabolism in vivo by activation of BCKDC via decreasing the bound form of BDK. (C) 2015 Elsevier Inc. All rights reserved.	[Kadota, Yoshihiro; Toyoda, Takanari; Hayashi-Kato, Mayumi; Kitaura, Yasuyuki; Shimomura, Yoshiharu] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan	Shimomura, Y (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan.	shimo@agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20300216, 26292068]; Japanese Council for Science, Technology and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP Project) [14533567]	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20300216 and 26292068 to Y.S.) and the Japanese Council for Science, Technology and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP Project ID 14533567 to Y.S.).	SHIMOMURA Y, 1990, ARCH BIOCHEM BIOPHYS, V283, P293, DOI 10.1016/0003-9861(90)90645-F; Kadota Y, 2013, OBES RES CLIN PRACT, V7, pE439, DOI 10.1016/j.orcp.2013.07.003; Kadota Y, 2012, JPEN-PARENTER ENTER, V36, P337, DOI 10.1177/0148607111414578; PAUL HS, 1992, J BIOL CHEM, V267, P11208; Obayashi M, 2001, FEBS LETT, V491, P50, DOI 10.1016/S0014-5793(01)02149-4; Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Hartman AL, 2007, EPILEPSIA, V48, P31, DOI 10.1111/j.1528-1167.2007.00914.x; Doisaki M, 2010, BIOCHEM BIOPH RES CO, V393, P303, DOI 10.1016/j.bbrc.2010.02.004; PARKER PJ, 1978, BIOCHEM J, V171, P751; BABAYAN VK, 1987, LIPIDS, V22, P417, DOI 10.1007/BF02537271; BANAUCH D, 1975, Z KLIN CHEM KLIN BIO, V13, P101; CORKEY BE, 1982, J BIOL CHEM, V257, P9668; Fujimura Y, 2009, BIOSCI BIOTECH BIOCH, V73, P766, DOI 10.1271/bbb.80744; GOODWIN GW, 1987, ANAL BIOCHEM, V162, P536, DOI 10.1016/0003-2697(87)90430-1; HARRIS RA, 1982, J BIOL CHEM, V257, P3915; Hidaka H, 1999, Nihon Rinsho, V57 Suppl, P639; HU HY, 1992, ARCH BIOCHEM BIOPHYS, V299, P57, DOI 10.1016/0003-9861(92)90243-P; Ishiguro H, 2006, LIFE SCI, V79, P737, DOI 10.1016/j.lfs.2006.02.037; Kobayashi R, 2002, ARCH BIOCHEM BIOPHYS, V407, P231, DOI 10.1016/S0003-9861(02)00472-1; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; MAY RC, 1987, AM J PHYSIOL, V252, pE712; Nakai N, 2000, METHOD ENZYMOL, V324, P48; PARKER PJ, 1978, FEBS LETT, V95, P153, DOI 10.1016/0014-5793(78)80072-6; PAXTON R, 1984, ARCH BIOCHEM BIOPHYS, V231, P48, DOI 10.1016/0003-9861(84)90361-8; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; SPYDEVOLD O, 1981, BIOCHIM BIOPHYS ACTA, V676, P279, DOI 10.1016/0304-4165(81)90161-6; SUGO S, 1990, CLIN CHEM, V36, P163; Tso SC, 2013, P NATL ACAD SCI USA, V110, P9728, DOI 10.1073/pnas.1303220110; WAGENMAKERS AJM, 1984, INT J BIOCHEM, V16, P977, DOI 10.1016/0020-711X(84)90114-9; WILLIAMSON JR, 1979, J BIOL CHEM, V254, P1511	31	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	SEP	2015	64	9					1157	1164		10.1016/j.metabol.2015.05.014		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CP7XJ	WOS:000360102600026		
J	Nakatani, K; Watabe, T; Masuda, D; Imaizumi, M; Shimosegawa, E; Kobayashi, T; Sairyo, M; Zhu, YH; Okada, T; Kawase, R; Nakaoka, H; Naito, A; Ohama, T; Koseki, M; Oka, T; Akazawa, H; Nishida, M; Komuro, I; Sakata, Y; Hatazawa, J; Yamashita, S				Nakatani, Kazuhiro; Watabe, Tadashi; Masuda, Daisaku; Imaizumi, Masao; Shimosegawa, Eku; Kobayashi, Takuya; Sairyo, Masami; Zhu, Yinghong; Okada, Takeshi; Kawase, Ryota; Nakaoka, Hajime; Naito, Atsuhiko; Ohama, Tohru; Koseki, Masahiro; Oka, Toru; Akazawa, Hiroshi; Nishida, Makoto; Komuro, Issei; Sakata, Yasushi; Hatazawa, Jun; Yamashita, Shizuya			Myocardial energy provision is preserved by increased utilization of glucose and ketone bodies in CD36 knockout mice	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						CD36; cardiac energy metabolism; PET; glucose; ketone body	FATTY-ACID TRANSPORT; INSULIN-RESISTANCE; BINDING PROTEIN; CD36-NULL MICE; DEFICIENCY; HEART; METABOLISM; CARDIOMYOPATHY; ISCHEMIA; MUSCLE	Aims. CD36 is an important transporter of long-chain fatty acids (LCFAs) in the myocardium. As we have reported previously, CD36-deficient patients demonstrate a marked reduction in myocardial uptake of I-123-15-(p-iodophenyl)-(R, S)-methyl pentadecanoic acid (BMIPP), which is an analog of LCFAs, while myocardial 18 F-fiuorodeoxy-glucose (FOG) uptake is increased. However, it has not been clarified whether energy provision is preserved in patients with CD36 deficiency. The aims of the current study were to investigate the myocardial uptake of glucose and alterations in myocardial metabolites in wild-type (WT) and CD36 knockout (KO) mice. Methods and results. High-resolution positron emission tomography (PET) demonstrated markedly enhanced glucose uptake in KO mouse hearts compared with those of WT mice in real-time. The myocardial protein expression of glucose transporter protein 1 (GLUT1) was significantly enhanced in KO mice compared to WT mice, whereas that of GLUT4 was not altered. While the myocardial expression of genes involved in fatty acid metabolism did not increase in KO mice, that of genes related to glucose utilization compensatorily increased in KO mice. The metabolomic analysis of cardiac tissues revealed that the myocardial concentrations of ATP and phosphocreatine were maintained, even in KO mice. The concentration of 3-hydroxybutyric acid and mRNA expression of hydroxybutyrate dehydrogenase in the heart were significantly higher in KO than in WT mice. Conclusion. These data suggest that high-energy phosphate might be preserved by the increased utilization of glucose and ketone bodies in CD36KO mouse hearts under conditions of deficient LCFA uptake. (C) 2015 Elsevier Inc. All rights reserved.	[Nakatani, Kazuhiro; Masuda, Daisaku; Kobayashi, Takuya; Sairyo, Masami; Zhu, Yinghong; Okada, Takeshi; Kawase, Ryota; Nakaoka, Hajime; Naito, Atsuhiko; Ohama, Tohru; Koseki, Masahiro; Oka, Toru; Akazawa, Hiroshi; Nishida, Makoto; Sakata, Yasushi; Yamashita, Shizuya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Watabe, Tadashi] Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Suita, Osaka 5650871, Japan; [Imaizumi, Masao] Hanwa Intelligent Med Ctr, Naka Ku, Sakai, Osaka 5998271, Japan; [Shimosegawa, Eku; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka 5650871, Japan; [Naito, Atsuhiko; Akazawa, Hiroshi; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ohama, Tohru; Nishida, Makoto] Osaka Univ, Hlth Care Ctr, Toyonaka, Osaka 5600043, Japan; [Yamashita, Shizuya] Osaka Univ, Grad Sch Med, Dept Community Med, Suita, Osaka 5650871, Japan	Masuda, D (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.			Masuda, Daisaku/0000-0002-0954-4042	Ministry of Education, Science, Sports and Culture in Japan [10671070, 12835005, 13557093, 13277050]; Mitsui Life Social Welfare Foundation; Takeda Medical Research Foundation; Sumitomo Heavy Industries in Japan	This work was supported by grants from the Ministry of Education, Science, Sports and Culture in Japan [nos. 10671070, 12835005, and 13557093 to S.Y. and no. 13277050 to K.N.], Mitsui Life Social Welfare Foundation [to S.Y.], Takeda Medical Research Foundation [to S.Y.], and a joint research grant from Sumitomo Heavy Industries in Japan [to J.H.].	Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Iso T, 2013, ARTERIOSCL THROM VAS, V33, P2549, DOI 10.1161/ATVBAHA.113.301588; Wang LJ, 2014, J NUTR BIOCHEM, V25, P329, DOI 10.1016/j.jnutbio.2013.11.007; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI 10.1172/JCI200214596; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI14006; Naito AT, 2010, CIRC RES, V106, P1692, DOI 10.1161/CIRCRESAHA.109.214346; Sansbury BE, 2014, CIRC-HEART FAIL, V7, P634, DOI 10.1161/CIRCHEARTFAILURE.114.001151; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Irie H, 2003, P NATL ACAD SCI USA, V100, P6819, DOI 10.1073/pnas.1132094100; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Huang Y, 2012, P NATL ACAD SCI USA, V109, P17478, DOI 10.1073/pnas.1209281109; Kao YS, 2011, CELL SIGNAL, V23, P901, DOI 10.1016/j.cellsig.2011.01.016; Pryor PR, 2000, BIOCHEM J, V348, P83, DOI 10.1042/0264-6021:3480083; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Augustus AS, 2006, J BIOL CHEM, V281, P8716, DOI 10.1074/jbc.M509890200; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Kuang M, 2004, CIRCULATION, V109, P1550, DOI 10.1161/01.CIR.0000121730.41801.12; Yoshizumi T, 2000, J NUCL MED, V41, P1134; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Schaap FG, 1999, CIRC RES, V85, P329; Binas B, 1999, FASEB J, V13, P805; Fukuchi K, 1999, J NUCL MED, V40, P239; KELLY DP, 1994, NEW ENGL J MED, V330, P913; KUSAKA Y, 1995, J MOL CELL CARDIOL, V27, P1605, DOI 10.1016/S0022-2828(95)90524-3; Kuwasako T, 2003, DIABETES CARE, V26, P1647, DOI 10.2337/diacare.26.5.1647-a; Lopaschuk Gary D, 2002, Heart Fail Rev, V7, P149, DOI 10.1023/A:1015328625394; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Nozaki S, 1999, MOL CELL BIOCHEM, V192, P129, DOI 10.1023/A:1006816702425; PAULSON DJ, 1982, AM J PHYSIOL, V242, P1084; Stegger L, 2005, J NUCL MED, V46, P1516; Tanaka T, 1997, J MOL CELL CARDIOL, V29, P121, DOI 10.1006/jmcc.1996.0257; Varatharajalu R, 2010, ALCOHOL CLIN EXP RES, V34, P424, DOI 10.1111/j.1530-0277.2009.01107.x; YAMAMOTO N, 1994, BLOOD, V83, P392; Yamamoto S, 2010, ANN NUCL MED, V24, P89, DOI 10.1007/s12149-009-0333-6	39	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	SEP	2015	64	9					1165	1174		10.1016/j.metabol.2015.05.017		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CP7XJ	WOS:000360102600027		
J	Hirata, T; Fujita, M; Nakamura, S; Gotoh, K; Motooka, D; Murakami, Y; Maeda, Y; Kinoshita, T				Hirata, Tetsuya; Fujita, Morihisa; Nakamura, Shota; Gotoh, Kazuyoshi; Motooka, Daisuke; Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh			Post-Golgi anterograde transport requires GARP-dependent endosome-to-TGN retrograde transport	MOLECULAR BIOLOGY OF THE CELL			English	Article							GPI-ANCHORED PROTEINS; MOTOR-NEURON DISEASE; WOBBLER MOUSE; EARLY/RECYCLING ENDOSOMES; ENDOPLASMIC-RETICULUM; TETHERING COMPLEX; MEMBRANE-PROTEIN; RETROMER COMPLEX; WNT SECRETION; HUMAN-CELLS	The importance of endosome-to-trans-Golgi network (TGN) retrograde transport in the anterograde transport of proteins is unclear. In this study, genome-wide screening of the factors necessary for efficient anterograde protein transport in human haploid cells identified subunits of the Golgi-associated retrograde protein (GARP) complex, a tethering factor involved in endosome-to-TGN transport. Knockout (KO) of each of the four GARP subunits, VPS51-VPS54, in HEK293 cells caused severely defective anterograde transport of both glycosylphosphatidylinositol (GPI)-anchored and transmembrane proteins from the TGN. Overexpression of VAMP4, v-SNARE, in VPS54-KO cells partially restored not only endosome-to-TGN retrograde transport, but also anterograde transport of both GPI-anchored and transmembrane proteins. Further screening for genes whose overexpression normalized the VPS54-KO phenotype identified TMEM87A, encoding an uncharacterized Golgi-resident membrane protein. Overexpression of TMEM87A or its close homologue TMEM87B in VPS54-KO cells partially restored endosome-to-TGN retrograde transport and anterograde transport. Therefore GARP-and VAMP4-dependent endosome-to-TGN retrograde transport is required for recycling of molecules critical for efficient post-Golgi anterograde transport of cell-surface integral membrane proteins. In addition, TMEM87A and TMEM87B are involved in endosome-to-TGN retrograde transport.	[Hirata, Tetsuya; Nakamura, Shota; Gotoh, Kazuyoshi; Motooka, Daisuke; Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Osaka 5650871, Japan; [Hirata, Tetsuya; Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Fujita, Morihisa] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi 214122, Jiangsu, Peoples R China	Kinoshita, T (reprint author), Osaka Univ, Res Inst Microbial Dis, Osaka 5650871, Japan.	fujita@jiangnan.edu.cn; tkinoshi@biken.osaka-u.ac.jp	Nakamura, Shota/E-3033-2010; Kinoshita, Taroh/C-7353-2009	Nakamura, Shota/0000-0003-2058-5942; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; National Natural Science Foundation for Young Scientists of China [31400693]; Natural Science Foundation of Jiangsu Province [BK20140141]; Japan Society for the Promotion of Science Research Fellowship	We thank T. R. Brummelkamp and the Whitehead Institute for Biomedical Research for HAP1 cells; K. Horie for pCMT-SAhygpA-NP21; C. Schindler and J. S. Bonifacino for rabbit polyclonal anti-VPS52 and anti-VPS53 and expression plasmids of VPS51, VPS52, VPS53, and VPS54; Noriyuki Kanzawa, Romina Theiler, Gun-Hee Lee, and Jihyoun Seong for helpful discussions; Keiko Kinoshita, Yukari Onoe, and Kana Miyanagi for technical help; and Kohjiro Nakamura and Yuko Kabumoto for assistance with cell sorting. This work was supported by grant-in-aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T.K. and M.F.), the National Natural Science Foundation for Young Scientists of China (31400693), and the Natural Science Foundation of Jiangsu Province (BK20140141) (to M.F.). T.H. was supported by the Japan Society for the Promotion of Science Research Fellowship.	Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; Moser JM, 2013, MOL GENET GENOMICS, V288, P207, DOI 10.1007/s00438-013-0741-0; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Perez-Victoria FJ, 2009, MOL CELL BIOL, V29, P5251, DOI 10.1128/MCB.00495-09; Feinstein M, 2014, J MED GENET, V51, P303, DOI 10.1136/jmedgenet-2013-101823; Karlsson P, 2013, INT J MOL SCI, V14, P10908, DOI 10.3390/ijms140610908; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.E03-12-0876; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Horie K, 2011, NAT METHODS, V8, P1071, DOI [10.1038/nmeth.1739, 10.1038/NMETH.1739]; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Kal AJ, 1999, MOL BIOL CELL, V10, P1859; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Olson AL, 1997, MOL CELL BIOL, V17, P2425; Perez-Victoria FJ, 2010, P NATL ACAD SCI USA, V107, P12860, DOI 10.1073/pnas.1004756107; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Tafesse FG, 2014, J BIOL CHEM, V289, P24005, DOI 10.1074/jbc.M114.589275; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; VanRheenen SM, 1998, J CELL BIOL, V141, P1107, DOI 10.1083/jcb.141.5.1107; Bonifacino JS, 2011, TRENDS CELL BIOL, V21, P159, DOI 10.1016/j.tcb.2010.11.003; Schindler C, 2015, NAT CELL BIOL, V17, P639, DOI 10.1038/ncb3129; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Perez-Victoria FJ, 2010, MOL BIOL CELL, V21, P3386, DOI 10.1091/mbc.E10-05-0392; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Brunet S, 2014, TRAFFIC, V15, P803, DOI 10.1111/tra.12183; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Conibear E, 2000, MOL BIOL CELL, V11, P305; Siniossoglou S, 2002, J BIOL CHEM, V277, P48318, DOI 10.1074/jbc.M209428200; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Shitara A, 2013, MOL CELL BIOCHEM, V380, P11, DOI 10.1007/s11010-013-1652-4; Chia PZC, 2013, HISTOCHEM CELL BIOL, V140, P307, DOI 10.1007/s00418-013-1125-6; Perez-Victoria FJ, 2008, MOL BIOL CELL, V19, P2350, DOI 10.1091/mbc.E07-11-1189; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Hirata T, 2013, J BIOCHEM, V154, P257, DOI 10.1093/jb/mvt045; Hong W., 2013, TRENDS CELL BIOL, V24, P35; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Laufman O, 2011, J CELL BIOL, V194, P459, DOI 10.1083/jcb.201102045; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Oka T, 2004, MOL BIOL CELL, V15, P2423, DOI 10.1091/mbc.E03-09-0699; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Theiler R, 2014, J BIOL CHEM, V289, P16835, DOI 10.1074/jbc.M114.568311; Zhou GL, 2014, J CELL SCI, V127, P3916, DOI 10.1242/jcs.135269	60	1	1	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	SEP 1	2015	26	17					3071	3084		10.1091/mbc.E14-11-1568		14	Cell Biology	Cell Biology	CP8HL	WOS:000360133800010		
J	Kuninobu, Y; Ida, H; Nishi, M; Kanai, M				Kuninobu, Yoichiro; Ida, Haruka; Nishi, Mitsumi; Kanai, Motomu			A meta-selective C-H borylation directed by a secondary interaction between ligand and substrate	NATURE CHEMISTRY			English	Article							MOLECULAR RECOGNITION; ROOM-TEMPERATURE; BOND FORMATION; PD CATALYSTS; ACTIVATION; ARENES; FUNCTIONALIZATION; OLEFINATION; COMPLEXES; ARYLATION	Regioselective C-H bond transformations are potentially the most efficient method for the synthesis of organic molecules. However, the presence of many C-H bonds in organic molecules and the high activation barrier for these reactions make these transformations difficult. Directing groups in the reaction substrate are often used to control regioselectivity, which has been especially successful for the ortho-selective functionalization of aromatic substrates. Here, we describe an iridium-catalysed meta-selective C-H borylation of aromatic compounds using a newly designed catalytic system. The bipyridine-derived ligand that binds iridium contains a pendant urea moiety. A secondary interaction between this urea and a hydrogen-bond acceptor in the substrate places the iridium in close proximity to the meta-C-H bond and thus controls the regioselectivity. H-1 NMR studies and control experiments support the participation of hydrogen bonds in inducing regioselectivity. Reversible direction of the catalyst through hydrogen bonds is a versatile concept for regioselective C-H transformations.	[Kuninobu, Yoichiro; Ida, Haruka; Nishi, Mitsumi; Kanai, Motomu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kuninobu, Yoichiro; Nishi, Mitsumi; Kanai, Motomu] ERATO, Japan Sci & Technol Agcy JST, Kanai Life Sci Catalysis Project, Bunkyo Ku, Tokyo 1130033, Japan	Kuninobu, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kuninobu@mol.f.u-tokyo.ac.jp; kanai@mol.f.u-tokyo.ac.jp	Kuninobu, Yoichiro/N-5109-2015		ERATO from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported in part by ERATO from the Japan Science and Technology Agency and by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Hofmann N, 2013, J AM CHEM SOC, V135, P5877, DOI 10.1021/ja401466y; Murphy JM, 2007, J AM CHEM SOC, V129, P15434, DOI 10.1021/ja076498n; Wan L, 2013, J AM CHEM SOC, V135, P18056, DOI 10.1021/ja410760f; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Ye MC, 2011, J AM CHEM SOC, V133, P6964, DOI 10.1021/ja2021075; Tang RY, 2014, NATURE, V507, P215, DOI 10.1038/nature12963; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Cheng C, 2014, SCIENCE, V343, P853, DOI 10.1126/science.1248042; Boller TM, 2005, J AM CHEM SOC, V127, P14263, DOI 10.1021/ja053433g; Saidi O, 2011, J AM CHEM SOC, V133, P19298, DOI 10.1021/ja208286b; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; Kuninobu Y, 2011, CHEM REV, V111, P1938, DOI 10.1021/cr100241u; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Zhang XS, 2014, CHEM SCI, V5, P2146, DOI 10.1039/c3sc53115e; Zhang YH, 2009, J AM CHEM SOC, V131, P5072, DOI 10.1021/ja900327e; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Cho JY, 2000, J AM CHEM SOC, V122, P12868, DOI 10.1021/ja0013069; ETTER MC, 1990, J AM CHEM SOC, V112, P8415, DOI 10.1021/ja00179a028; Rouquet G, 2013, ANGEW CHEM INT EDIT, V52, P11726, DOI 10.1002/anie.201301451; Ye MC, 2011, J AM CHEM SOC, V133, P19090, DOI 10.1021/ja209510q; Duong HA, 2011, ANGEW CHEM INT EDIT, V50, P463, DOI 10.1002/anie.201004704; Ishiyama T, 2002, ANGEW CHEM INT EDIT, V41, P3056, DOI 10.1002/1521-3773(20020816)41:16<3056::AID-ANIE3056>3.0.CO;2-#; Hurst TE, 2010, CHEM-EUR J, V16, P8155, DOI 10.1002/chem.201000401; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; ASAKURA T, 1981, MAKROMOL CHEM, V182, P1135; Kakiuchi F, 2008, SYNTHESIS-STUTTGART, P3013, DOI 10.1055/s-2008-1067256; Lippert KM, 2012, EUR J ORG CHEM, P5919, DOI 10.1002/ejoc.201200739; Truong T, 2012, ANGEW CHEM INT EDIT, V51, P11677, DOI 10.1002/anie.201206568	30	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	SEP	2015	7	9					712	717		10.1038/NCHEM.2322		6	Chemistry, Multidisciplinary	Chemistry	CP9CR	WOS:000360191800008		
J	Matsumoto, M; Saito, Y; Park, C; Fukushima, T; Aida, T				Matsumoto, Michio; Saito, Yusuke; Park, Chiyoung; Fukushima, Takanori; Aida, Takuzo			Ultrahigh-throughput exfoliation of graphite into pristine 'single-layer' graphene using microwaves and molecularly engineered ionic liquids	NATURE CHEMISTRY			English	Article							PHASE EXFOLIATION; CARBON NANOTUBES; MOLTEN-SALTS; OXIDE; INTERCALATION; CRYSTALS; FILMS; MICA	Graphene has shown much promise as an organic electronic material but, despite recent achievements in the production of few-layer graphene, the quantitative exfoliation of graphite into pristine single-layer graphene has remained one of the main challenges in developing practical devices. Recently, reduced graphene oxide has been recognized as a non-feasible alternative to graphene owing to variable defect types and levels, and attention is turning towards reliable methods for the high-throughput exfoliation of graphite. Here we report that microwave irradiation of graphite suspended in molecularly engineered oligomeric ionic liquids allows for ultrahigh-efficiency exfoliation (93% yield) with a high selectivity (95%) towards 'single-layer' graphene (that is, with thicknesses <1 nm) in a short processing time (30 minutes). The isolated graphene sheets show negligible structural deterioration. They are also readily redispersible in oligomeric ionic liquids up to similar to 100 mg ml(-1), and form physical gels in which an anisotropic orientation of graphene sheets, once induced by a magnetic field, is maintained.	[Matsumoto, Michio; Saito, Yusuke; Park, Chiyoung; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Fukushima, Takanori] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Kanagawa 2268503, Japan; [Aida, Takuzo] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Aida, T (reprint author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	aida@macro.t.u-tokyo.ac.jp	Fukushima, Takanori/D-2474-2015	Fukushima, Takanori/0000-0001-5586-9238	Japan Society for the Promotion of Science (JSPS) [25000005]; JSPS FIRST Program for Innovative Basic Research Toward the Creation of a High-performance Battery; Ministry of Education, Culture, Sports, Science and Technology, Japan	We acknowledge the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Specially Promoted Research on the Physically Perturbed Assembly for Tailoring High-Performance Soft Materials with Controlled Macroscopic Structural Anisotropy (25000005) and the JSPS FIRST Program for Innovative Basic Research Toward the Creation of a High-performance Battery. We thank E. Silver for generous discussion. SEM, TEM and XPS were conducted at the Research Hub for Advanced Nano Characterization, The University of Tokyo, supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also acknowledge the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan).	Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Ochedowski O, 2014, SCI REP-UK, V4, DOI 10.1038/srep06003; Wick P, 2014, ANGEW CHEM INT EDIT, V53, P7714, DOI 10.1002/anie.201403335; Bianco A, 2013, CARBON, V65, P1, DOI 10.1016/j.carbon.2013.08.038; Liang YT, 2010, J AM CHEM SOC, V132, P17661, DOI 10.1021/ja107661g; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Lucchese MM, 2010, CARBON, V48, P1592, DOI 10.1016/j.carbon.2009.12.057; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Behabtu N, 2010, NAT NANOTECHNOL, V5, P406, DOI [10.1038/nnano.2010.86, 10.1038/NNANO.2010.86]; Sampath S, 2013, ADV MATER, V25, P2740, DOI 10.1002/adma.201205157; Robinson J, 2010, PHYS CHEM CHEM PHYS, V12, P4750, DOI 10.1039/b922797k; Nuvoli D, 2011, J MATER CHEM, V21, P3428, DOI 10.1039/c0jm02461a; Alzari V, 2011, J MATER CHEM, V21, P8727, DOI 10.1039/c1jm11076d; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Wu LL, 2014, ACS NANO, V8, P4640, DOI 10.1021/nn5003908; Wang C, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3555436; Fukushima T, 2003, SCIENCE, V300, P2072, DOI 10.1126/science.1082289; Wang XQ, 2010, CHEM COMMUN, V46, P4487, DOI 10.1039/c0cc00799d; Shim J, 2012, NANO LETT, V12, P648, DOI 10.1021/nl2034317; Lotya M, 2009, J AM CHEM SOC, V131, P3611, DOI 10.1021/ja807449u; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Shih CJ, 2011, NAT NANOTECHNOL, V6, P439, DOI [10.1038/nnano.2011.94, 10.1038/NNANO.2011.94]; Zhao WF, 2010, J MATER CHEM, V20, P5817, DOI 10.1039/c0jm01354d; Parvez K, 2014, J AM CHEM SOC, V136, P6083, DOI 10.1021/ja5017156; FULLER J, 1994, J CHEM SOC CHEM COMM, P299, DOI 10.1039/c39940000299; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Coleman JN, 2009, ADV FUNCT MATER, V19, P3680, DOI 10.1002/adfm.200901640; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Tang JB, 2008, MACROMOLECULES, V41, P493, DOI 10.1021/ma071762i; Paton KR, 2014, NAT MATER, V13, P624, DOI [10.1038/nmat3944, 10.1038/NMAT3944]; Jia XT, 2011, NANOSCALE, V3, P86, DOI 10.1039/c0nr00600a; Zhu YW, 2010, CARBON, V48, P2118, DOI 10.1016/j.carbon.2010.02.001; Mattevi C, 2011, J MATER CHEM, V21, P3324, DOI 10.1039/c0jm02126a; Vadahanambi S, 2013, CARBON, V53, P391, DOI 10.1016/j.carbon.2012.11.029; Fasting C, 2012, ANGEW CHEM INT EDIT, V51, P10472, DOI 10.1002/anie.201201114; Ciesielski A, 2014, CHEM SOC REV, V43, P381, DOI 10.1039/c3cs60217f; Ciesielski A, 2014, ANGEW CHEM INT EDIT, V53, P10355, DOI 10.1002/anie.201402696; Kovtyukhova NI, 2014, NAT CHEM, V6, P957, DOI [10.1038/nchem.2054, 10.1038/NCHEM.2054]; Lee J, 2011, CHEM COMMUN, V47, P6757, DOI 10.1039/c1cc00043h; MALLOUK T, 1983, J CHEM SOC CHEM COMM, P103, DOI 10.1039/c39830000103; Nicolosi V, 2013, SCIENCE, V340, P1420, DOI 10.1126/science.1226419; Qin F., 2012, J APPL PHYS, V111, P61301; Rangappa D, 2010, CHEM-EUR J, V16, P6488, DOI 10.1002/chem.201000199; RUDORFF W, 1947, Z ANORG CHEM, V253, P281, DOI 10.1002/zaac.19472530506; Stamenov P, 2005, J MAGN MAGN MATER, V290, P279, DOI 10.1016/j.jmmm.2004.11.209; Wei T., 2008, CARBON, V47, P337, DOI DOI 10.1016/J.CARBON.2008.10.013; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965	50	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	SEP	2015	7	9					730	736		10.1038/NCHEM.2315		7	Chemistry, Multidisciplinary	Chemistry	CP9CR	WOS:000360191800011		
J	Asai, T; Tsukada, K; Ise, S; Shirata, N; Hashimoto, M; Fujii, I; Gomi, K; Nakagawara, K; Kodama, EN; Oshima, Y				Asai, Teigo; Tsukada, Kento; Ise, Satomi; Shirata, Naoki; Hashimoto, Makoto; Fujii, Isao; Gomi, Katsuya; Nakagawara, Kosuke; Kodama, Eiichi N.; Oshima, Yoshiteru			Use of a biosynthetic intermediate to explore the chemical diversity of pseudo-natural fungal polyketides	NATURE CHEMISTRY			English	Article							HETEROLOGOUS EXPRESSION; COMBINATORIAL CHEMISTRY; ASPERGILLUS-NIDULANS; MOLECULAR DIVERSITY; PRODUCTS; GENERATION; SYNTHASES; SEMISYNTHESIS; LIBRARY; COMPLEX	The structural complexity and diversity of natural products make them attractive sources for potential drug discovery, with their characteristics being derived from the multi-step combination of enzymatic and non-enzymatic conversions of intermediates in each biosynthetic pathway. Intermediates that exhibit multipotent behaviour have great potential for use as starting points in diversity-oriented synthesis. Inspired by the biosynthetic pathways that form complex metabolites from simple intermediates, we developed a semi-synthetic process that combines heterologous biosynthesis and artificial diversification. The heterologous biosynthesis of fungal polyketide intermediates led to the isolation of novel oligomers and provided evidence for ortho-quinonemethide equivalency in their isochromene form. The intrinsic reactivity of the isochromene polyketide enabled us to access various new chemical entities by modifying and remodelling the polyketide core and through coupling with indole molecules. We thus succeeded in generating exceptionally diverse pseudo-natural polyketides through this process and demonstrated an advanced method of using biosynthetic intermediates.	[Asai, Teigo; Tsukada, Kento; Ise, Satomi; Shirata, Naoki; Oshima, Yoshiteru] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Hashimoto, Makoto; Fujii, Isao] Iwate Med Univ, Sch Pharm, Yahaba, Iwate, Japan; [Gomi, Katsuya] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan; [Nakagawara, Kosuke; Kodama, Eiichi N.] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Nakagawara, Kosuke; Kodama, Eiichi N.] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan	Asai, T (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 980, Japan.	tasai@m.tohoku.ac.jp; oshima@mail.pharm.tohoku.ac.jp	Kodama, Eiichi /C-4032-2009	Kodama, Eiichi /0000-0002-6622-2752	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS) [25108702, 25293022]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by JSPS KAKENHI (grant no. 25108702 to T.A. and 25293022 to Y.O.) from the Japan Society for the Promotion of Science (JSPS) and in part by the Platform for Drug Discovery, Informatics and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Altmann KH, 2011, MOL DIVERS, V15, P383, DOI 10.1007/s11030-010-9291-0; Tagami K, 2013, J AM CHEM SOC, V135, P1260, DOI 10.1021/ja3116636; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Xu ZL, 2012, ANGEW CHEM INT EDIT, V51, P10293, DOI 10.1002/anie.201204087; Boettger D, 2013, CHEMBIOCHEM, V14, P28, DOI 10.1002/cbic.201200624; Asai T, 2013, ORG LETT, V15, P4320, DOI 10.1021/ol401741z; Hansen DA, 2013, J AM CHEM SOC, V135, P11232, DOI 10.1021/ja404134f; Ortholand JY, 2004, CURR OPIN CHEM BIOL, V8, P271, DOI 10.1016/j.cbpa.2004.04.011; Steinhagen H, 1999, ANGEW CHEM INT EDIT, V38, P1928; Asai T, 2013, ORG LETT, V15, P3346, DOI 10.1021/ol401386w; Scherlach K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/b821578b; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Huigens RW, 2013, NAT CHEM, V5, P195, DOI [10.1038/nchem.1549, 10.1038/NCHEM.1549]; Kirschning A, 2012, ANGEW CHEM INT EDIT, V51, P4012, DOI 10.1002/anie.201107386; Kharwar RN, 2011, NAT PROD REP, V28, P1208, DOI 10.1039/c1np00008j; Liu T, 2011, J AM CHEM SOC, V133, P13314, DOI 10.1021/ja205780g; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Balthaser BR, 2011, NAT CHEM, V3, P969, DOI 10.1038/NCHEM.1178; Liao DH, 2012, ORG LETT, V14, P18, DOI 10.1021/ol202641y; Chiang YM, 2013, J AM CHEM SOC, V135, P7720, DOI 10.1021/ja401945a; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Dupuis SN, 2012, CHEM SCI, V3, P1640, DOI 10.1039/c2sc00663d; Yan Y, 2013, ANGEW CHEM INT EDIT, V52, P12308, DOI 10.1002/anie.201305569; Diaconu I, 2010, J GENE MED, V12, P435, DOI 10.1002/jgm.1453; Naesens L, 2005, ANTIMICROB AGENTS CH, V49, P1010, DOI 10.1128/AAC.3.1010-1016.2005; Fisch KM, 2009, J IND MICROBIOL BIOT, V36, P1199, DOI 10.1007/s10295-009-0601-4; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Hashimoto M, 2015, BIOORG MED CHEM LETT, V25, P1381, DOI 10.1016/j.bmcl.2015.02.057; Rosen J, 2009, J MED CHEM, V52, P1953, DOI 10.1021/jm801514w; Zi WW, 2012, J AM CHEM SOC, V134, P9126, DOI 10.1021/ja303602f; Xu YQ, 2014, P NATL ACAD SCI USA, V111, P12354, DOI 10.1073/pnas.1406999111; Asai T, 2012, ORG LETT, V14, P2006, DOI 10.1021/ol3005062; Butler M. S., 2005, NATURE REV, V4, P206; Eichner S, 2012, ANGEW CHEM INT EDIT, V51, P752, DOI 10.1002/anie.201106249; Goss RJM, 2012, NAT PROD REP, V29, P870, DOI 10.1039/c2np00001f; Harvey CJB, 2012, J AM CHEM SOC, V134, P12259, DOI 10.1021/ja304682q; Ignatenko VA, 2013, J ORG CHEM, V78, P410, DOI 10.1021/jo302211f; Morita H, 2013, P NATL ACAD SCI USA, V108, P13504; Newman AG, 2014, J AM CHEM SOC, V136, P7348, DOI 10.1021/ja5007299; Sandkovsky U, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0416-y; Steinmetz H, 2012, CHEMBIOCHEM, V13, P1813, DOI 10.1002/cbic.201200228	42	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	SEP	2015	7	9					737	743		10.1038/NCHEM.2308		7	Chemistry, Multidisciplinary	Chemistry	CP9CR	WOS:000360191800012		
J	Cai, WJ; Santoso, A; Wang, GJ; Yeh, SW; An, SI; Cobb, KM; Collins, M; Guilyardi, E; Jin, FF; Kug, JS; Lengaigne, M; McPhaden, MJ; Takahashi, K; Timmermann, A; Vecchi, G; Watanabe, M; Wu, LX				Cai, Wenju; Santoso, Agus; Wang, Guojian; Yeh, Sang-Wook; An, Soon-Il; Cobb, Kim M.; Collins, Mat; Guilyardi, Eric; Jin, Fei-Fei; Kug, Jong-Seong; Lengaigne, Matthieu; McPhaden, Michael J.; Takahashi, Ken; Timmermann, Axel; Vecchi, Gabriel; Watanabe, Masahiro; Wu, Lixin			ENSO and greenhouse warming	NATURE CLIMATE CHANGE			English	Article							NINO-SOUTHERN-OSCILLATION; SEA-SURFACE TEMPERATURE; INDIAN-OCEAN DIPOLE; EL-NINO; LA-NINA; WALKER CIRCULATION; TROPICAL PACIFIC; NORTH PACIFIC; INDO-PACIFIC; ATMOSPHERIC RESPONSE	The El Nino/Southern Oscillation (ENSO) is the dominant climate phenomenon affecting extreme weather conditions worldwide. Its response to greenhouse warming has challenged scientists for decades, despite model agreement on projected changes in mean state. Recent studies have provided new insights into the elusive links between changes in ENSO and in the mean state of the Pacific climate. The projected slow-down in Walker circulation is expected to weaken equatorial Pacific Ocean currents, boosting the occurrences of eastward-propagating warm surface anomalies that characterize observed extreme El Nino events. Accelerated equatorial Pacific warming, particularly in the east, is expected to induce extreme rainfall in the eastern equatorial Pacific and extreme equatorward swings of the Pacific convergence zones, both of which are features of extreme El Nino. The frequency of extreme La Nina is also expected to increase in response to more extreme El Ninos, an accelerated maritime continent warming and surface-intensified ocean warming. ENSO-related catastrophic weather events are thus likely to occur more frequently with unabated greenhouse-gas emissions. But model biases and recent observed strengthening of the Walker circulation highlight the need for further testing as new models, observations and insights become available.	[Cai, Wenju; Wang, Guojian] CSIRO Oceans & Atmosphere Flagship, Aspendale, Vic 3195, Australia; [Cai, Wenju; Wu, Lixin] Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao 266003, Peoples R China; [Santoso, Agus] Univ New S Wales, Australian Res Council, Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Santoso, Agus] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Yeh, Sang-Wook] Hanyang Univ, Dept Environm Marine Sci, Ansan 426791, South Korea; [An, Soon-Il] Yonsei Univ, Dept Atmospher Sci, Seoul 120749, South Korea; [Cobb, Kim M.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Collins, Mat] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX1 3PB, Devon, England; [Guilyardi, Eric; Lengaigne, Matthieu] IRD UPMC CNRS MNHN, Lab Oceanog & Climat Experimentat & Approches Num, Paris 05, France; [Guilyardi, Eric] Univ Reading, NCAS Climate, Reading RG6 6BB, Berks, England; [Jin, Fei-Fei] Univ Hawaii, SOEST, Dept Meteorol, Honolulu, HI 96822 USA; [Kug, Jong-Seong] Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Pohang 790784, South Korea; [McPhaden, Michael J.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Takahashi, Ken] Inst Geofis Peru, Lima 169, Peru; [Timmermann, Axel] Univ Hawaii, SOEST, Dept Oceanog, IPRC, Honolulu, HI 96822 USA; [Vecchi, Gabriel] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA; [Watanabe, Masahiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Cai, WJ (reprint author), CSIRO Oceans & Atmosphere Flagship, Aspendale, Vic 3195, Australia.	wenju.cai@csiro.au	Vecchi, Gabriel/A-2413-2008; Collins, Matthew/F-8473-2011; Timmermann, Axel /F-4977-2011; Takahashi, Ken/G-5321-2010; Guilyardi, Eric/D-4868-2011; Cai, Wenju/C-2864-2012	Vecchi, Gabriel/0000-0002-5085-224X; Collins, Matthew/0000-0003-3785-6008; Timmermann, Axel /0000-0003-0657-2969; Takahashi, Ken/0000-0003-3670-2939; 	Australian Climate Change Science Program; CSIRO Office of Chief Executive Science Leader award; Australian Research Council; NERC [NE/I022841/1]; National Research Fund of Korea - Korean Government (MEST) [NRF-2009-C1AAA001-2009-0093042]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [2014R1A2A1A11049497]	W.C. and G.W. are supported by the Australian Climate Change Science Program and a CSIRO Office of Chief Executive Science Leader award. A.S. is supported by the Australian Research Council. M.C. was supported by NERC NE/I022841/1. S.W.Y. is supported by the National Research Fund of Korea grant funded by the Korean Government (MEST) (NRF-2009-C1AAA001-2009-0093042). S.I.A. was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (No. 2014R1A2A1A11049497). This is PMEL contribution number 4038.	Xiang BQ, 2013, CLIM DYNAM, V41, P327, DOI 10.1007/s00382-012-1427-8; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Newman M, 2011, CLIM DYNAM, V37, P1823, DOI 10.1007/s00382-011-1034-0; An SI, 2012, CLIM DYNAM, V39, P1373, DOI 10.1007/s00382-011-1129-7; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Takahashi K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047364; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI 10.1038/NCLIMATE2100; HOSKINS BJ, 1981, J ATMOS SCI, V38, P1179, DOI 10.1175/1520-0469(1981)038<1179:TSLROA>2.0.CO;2; McGregor S, 2013, CLIM PAST, V9, P2269, DOI 10.5194/cp-9-2269-2013; Luo JJ, 2012, P NATL ACAD SCI USA, V109, P18701, DOI 10.1073/pnas.1210239109; Ham YG, 2013, NAT GEOSCI, V6, P112, DOI [10.1038/ngeo1686, 10.1038/NGEO1686]; Zhang WJ, 2012, J METEOROL SOC JPN, V90, P535, DOI 10.2151/jmsj.2012-407; Izumo T, 2010, NAT GEOSCI, V3, P168, DOI 10.1038/NGEO760; Johnson NC, 2010, NAT GEOSCI, V3, P842, DOI [10.1038/ngeo1008, 10.1038/NGEO1008]; An SI, 2000, J CLIMATE, V13, P2044, DOI 10.1175/1520-0442(2000)013<2044:ICOTSO>2.0.CO;2; Okumura YM, 2010, J CLIMATE, V23, P5826, DOI 10.1175/2010JCLI3592.1; Wu MC, 2004, J CLIMATE, V17, P1419, DOI 10.1175/1520-0442(2004)017<1419:IOENOE>2.0.CO;2; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; McPhaden MJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048275; L'Heureux ML, 2013, NAT CLIM CHANGE, V3, P571, DOI [10.1038/nclimate1840, 10.1038/NCLIMATE1840]; Trenberth KE, 2001, J CLIMATE, V14, P1697, DOI 10.1175/1520-0442(2001)014<1697:LIOENO>2.0.CO;2; Bove MC, 1998, B AM METEOROL SOC, V79, P2477, DOI 10.1175/1520-0477(1998)079<2477:EOENOO>2.0.CO;2; Chiodi AM, 2013, J CLIMATE, V26, P822, DOI 10.1175/JCLI-D-12-00097.1; Cai WJ, 2011, J CLIMATE, V24, P3910, DOI 10.1175/2011JCLI4129.1; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Zhou ZQ, 2014, J CLIMATE, V27, P9050, DOI 10.1175/JCLI-D-14-00254.1; Cai WJ, 2014, NATURE, V510, P254, DOI 10.1038/nature13327; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Hong LC, 2014, GEOPHYS RES LETT, V41, P2142, DOI 10.1002/2014GL059370; Timmermann A, 2010, J CLIMATE, V23, P4429, DOI 10.1175/2010JCLI3519.1; Hoerling MP, 1997, J CLIMATE, V10, P1769, DOI 10.1175/1520-0442(1997)010<1769:ENOLNA>2.0.CO;2; Chung CTY, 2014, CLIM DYNAM, V42, P1837, DOI 10.1007/s00382-013-1892-8; Timmermann A, 2003, J ATMOS SCI, V60, P152, DOI 10.1175/1520-0469(2003)060<0152:ANTFEN>2.0.CO;2; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; DiNezio PN, 2012, J CLIMATE, V25, P7399, DOI 10.1175/JCLI-D-11-00494.1; McGregor S, 2014, NAT CLIM CHANGE, V4, P888, DOI [10.1038/nclimate2330, 10.1038/NCLIMATE2330]; Frauen C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044444; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Santoso A, 2013, NATURE, V504, P126, DOI 10.1038/nature12683; Kug JS, 2010, THEOR APPL CLIMATOL, V100, P275, DOI 10.1007/s00704-009-0183-0; Bony S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023851; Solomon A, 2012, NAT CLIM CHANGE, V2, P691, DOI [10.1038/nclimate1591, 10.1038/NCLIMATE1591]; Sen Gupta A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051447; Yu JY, 2011, J CLIMATE, V24, P5423, DOI 10.1175/JCLI-D-11-00024.1; Kao HY, 2009, J CLIMATE, V22, P615, DOI 10.1175/2008JCLI2309.1; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1256/smsqj.44904; HOREL JD, 1981, MON WEATHER REV, V109, P813, DOI 10.1175/1520-0493(1981)109<0813:PSAPAW>2.0.CO;2; Kim ST, 2014, NAT CLIM CHANGE, V4, P786, DOI 10.1038/NCLIMATE2326; VALLE CA, 1987, J GEOPHYS RES-OCEANS, V92, P14437, DOI 10.1029/JC092iC13p14437; Seager R, 2012, J CLIMATE, V25, P3355, DOI 10.1175/JCLI-D-11-00363.1; Choi KY, 2013, J CLIMATE, V26, P9462, DOI 10.1175/JCLI-D-13-00045.1; Lengaigne M, 2010, CLIM DYNAM, V35, P299, DOI 10.1007/s00382-009-0562-3; Stevenson SL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052759; Meehl GA, 2007, CLIM DYNAM, V29, P779, DOI 10.1007/s00382-007-0268-3; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/nclimate2106, 10.1038/NCLIMATE2106]; Rodgers KB, 2004, J CLIMATE, V17, P3761, DOI 10.1175/1520-0442(2004)017<3761:TPDVAI>2.0.CO;2; Li G, 2014, J CLIMATE, V27, P1765, DOI 10.1175/JCLI-D-13-00337.1; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Tokinaga H, 2012, NATURE, V491, P439, DOI 10.1038/nature11576; Watanabe M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053305; Zhang T, 2014, J CLIMATE, V27, P4070, DOI 10.1175/JCLI-D-13-00454.1; An SI, 2008, J CLIMATE, V21, P3, DOI 10.1175/2007JCLI1500.1; Ohba M, 2009, J CLIMATE, V22, P177, DOI 10.1175/2008JCLI2334.1; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; KAROLY DJ, 1989, J CLIMATE, V2, P1239, DOI 10.1175/1520-0442(1989)002<1239:SHCFAW>2.0.CO;2; Cai WJ, 2012, NATURE, V488, P365, DOI 10.1038/nature11358; An SI, 2001, J CLIMATE, V14, P3421, DOI 10.1175/1520-0442(2001)014<3421:CROTAZ>2.0.CO;2; Gebbie G, 2007, J ATMOS SCI, V64, P3281, DOI 10.1175/JAS4029.1; Liu ZY, 2005, J CLIMATE, V18, P4684, DOI 10.1175/JCLI3579.1; Capotondi A, 2015, B AM METEOROL SOC, V96, P921, DOI 10.1175/BAMS-D-13-00117.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Li JB, 2013, NAT CLIM CHANGE, V3, P822, DOI 10.1038/NCLIMATE1936; Bell G. D., 1999, B AM METEOROL SOC, V80, P1040, DOI DOI 10.1175/1520-0477(1999)080<1040:CAF>2.0.C0;2; Bellenger H, 2014, CLIM DYNAM, V42, P1999, DOI 10.1007/s00382-013-1783-z; Bellucci A., 2009, J CLIMATOL, V23, P1127; Burgers G, 1999, GEOPHYS RES LETT, V26, P1027, DOI 10.1029/1999GL900161; Cai WJ, 2015, NAT CLIM CHANGE, V5, P132, DOI 10.1038/NCLIMATE2492; DiNezio PN, 2014, J CLIMATE, V27, P7335, DOI 10.1175/JCLI-D-14-00033.1; Dong BW, 2013, ADV ATMOS SCI, V30, P247, DOI 10.1007/s00376-012-2069-9; GLYNN PW, 1991, SCIENCE, V253, P69, DOI 10.1126/science.253.5015.69; Hua LJ, 2015, J CLIMATE, V28, P1362, DOI 10.1175/JCLI-D-14-00404.1; Jin FF, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015983; Kim W, 2014, CLIM DYNAM, V42, P3005, DOI 10.1007/s00382-013-1792-y; Kug JS, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034002; Lengaigne M, 2003, J CLIMATE, V16, P3330, DOI 10.1175/1520-0442(2003)016<3330:TMWWEA>2.0.CO;2; Lubbecke JF, 2014, J CLIMATE, V27, P2577, DOI 10.1175/JCLI-D-13-00438.1; McPhaden MJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038774; McPhaden MJ, 1999, NATURE, V398, P559, DOI 10.1038/19193; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Okumura YM, 2011, J CLIMATE, V24, P3822, DOI 10.1175/2011JCLI3999.1; PHILANDER SGH, 1983, NATURE, V305, P16, DOI 10.1038/305016a0; Power S. B., 2014, NATURE, V502, P541; Sun DZ, 2014, J CLIMATE, V27, P2545, DOI 10.1175/JCLI-D-13-00390.1; Sun DZ, 1997, GEOPHYS RES LETT, V24, P2031, DOI 10.1029/97GL01960; Takahashi K., 2015, CLIM DYNAM; Wittenberg AT, 2014, J CLIMATE, V27, P2667, DOI 10.1175/JCLI-D-13-00577.1	100	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-678X	1758-6798		NAT CLIM CHANGE	Nat. Clim. Chang.	SEP	2015	5	9					849	859		10.1038/NCLIMATE2743		11	Environmental Sciences; Environmental Studies; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CQ1DV	WOS:000360338400019		
J	Hyodo, R; Ohtsuki, K				Hyodo, Ryuki; Ohtsuki, Keiji			Saturn's F ring and shepherd satellites a natural outcome of satellite system formation	NATURE GEOSCIENCE			English	Article							IMAGING SCIENCE; MASSIVE RINGS; ACCRETION; COLLISIONS; MOONLETS; PLANETESIMALS; PROBABILITY; DISRUPTION; PARTICLES; PLANETS	Saturn's F ring is a narrow ring of icy particles, located 3,400 km beyond the outer edge of the main ring system. Enigmatically, the F ring is accompanied on either side by two small satellites, Prometheus and Pandora, which are called shepherd satellites(1-3). The inner regular satellites of giant planets are thought to form by the accretion of particles from an ancient massive ring and subsequent outward migration(4-7). However, the origin of a system consisting of a narrow ring and shepherd satellites remains poorly understood. Here we present N-body numerical simulations to show that a collision of two of the small satellites that are thought to accumulate near the main ring's outer edge can produce a system similar to the F ring and its shepherd satellites. We find that if the two rubble-pile satellites have denser cores, such an impact results in only partial disruption of the satellites and the formation of a narrow ring of particles between two remnant satellites. Our simulations suggest that the seemingly unusual F ring system is a natural outcome at the final stage of the formation process of the ring-satellite system of giant planets.	[Hyodo, Ryuki; Ohtsuki, Keiji] Kobe Univ, Dept Planetol, Kobe, Hyogo 6578501, Japan; [Hyodo, Ryuki] Inst Phys Globe Paris, F-75005 Paris, France	Hyodo, R (reprint author), Kobe Univ, Dept Planetol, Kobe, Hyogo 6578501, Japan.	ryukih@stu.kobe-u.ac.jp; ohtsuki@tiger.kobe-u.ac.jp			JSPS [15J02110, 15H03716]; UnivEarthS Labex program at Sorbonne Paris Cite [ANR-10-LABX-0023, ANR-11-IDEX-0005-02]; IPGP	This work was supported by JSPS Grants-in-Aid for JSPS Fellows (15J02110) and for Scientific Research (15H03716). R.H. is grateful for support from the UnivEarthS Labex program at Sorbonne Paris Cite (ANR-10-LABX-0023 and ANR-11-IDEX-0005-02) and IPGP. Part of the numerical simulations were performed using the GRAPE system at the Center for Computational Astrophysics of the National Astronomical Observatory of Japan, and visualization of simulation results was performed in part using Zindaiji 3. We thank L. W. Esposito for comments on the manuscript and H. Daisaka for support in simulations.	Charnoz S, 2011, ICARUS, V216, P535, DOI 10.1016/j.icarus.2011.09.017; Canup RM, 2006, NATURE, V441, P834, DOI 10.1038/nature04860; Canup RM, 2010, NATURE, V468, P943, DOI 10.1038/nature09661; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; SMITH BA, 1981, SCIENCE, V212, P163, DOI 10.1126/science.212.4491.163; Charnoz S, 2010, NATURE, V465, P752, DOI 10.1038/nature09096; NAKAZAWA K, 1989, ASTRON ASTROPHYS, V220, P293; Cuzzi JN, 2010, SCIENCE, V327, P1470, DOI 10.1126/science.1179118; Porco CC, 2007, SCIENCE, V318, P1602, DOI 10.1126/science.1143977; Leinhardt ZM, 2012, MON NOT R ASTRON SOC, V424, P1419, DOI 10.1111/j.1365-2966.2012.21328.x; CANUP RM, 1995, ICARUS, V113, P331, DOI 10.1006/icar.1995.1026; Crida A, 2012, SCIENCE, V338, P1196, DOI 10.1126/science.1226477; OHTSUKI K, 1993, ICARUS, V106, P228, DOI 10.1006/icar.1993.1168; Attree NO, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L27; Barbara JM, 2002, ICARUS, V160, P161, DOI 10.1006/icar.2002.6962; Beurle K, 2010, ASTROPHYS J LETT, V718, pL176, DOI 10.1088/2041-8205/718/2/L176; Bosh AS, 2002, ICARUS, V157, P57, DOI 10.1006/icar.2002.6791; Charnoz S, 2005, SCIENCE, V310, P1300, DOI 10.1126/science.1119387; CUZZI JN, 1988, ICARUS, V74, P284, DOI 10.1016/0019-1035(88)90043-7; Esposito LW, 2014, CAMB PLANET, V15, P1, DOI 10.1017/CBO9781139236966; Esposito LW, 2008, ICARUS, V194, P278, DOI 10.1016/j.icarus.2007.10.001; GEHRELS T, 1980, SCIENCE, V207, P434, DOI 10.1126/science.207.4429.434; Hyodo R, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/40; Hyodo R, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/56; Karjalainen R, 2007, ICARUS, V189, P523, DOI 10.1016/j.icarus.2007.02.009; Murray CD, 2008, NATURE, V453, P739, DOI 10.1038/nature06999; Murray CD, 1997, ICARUS, V129, P304, DOI 10.1006/icar.1997.5774; Nicholson PD, 1996, SCIENCE, V272, P509, DOI 10.1126/science.272.5261.509; Ohtsuki K, 2012, PROG THEOR PHYS SUPP, P29; Porco CC, 2005, SCIENCE, V307, P1226, DOI 10.1126/science.1108056; Poulet F, 2001, MON NOT R ASTRON SOC, V322, P343, DOI 10.1046/j.1365-8711.2001.04128.x; Quinn T, 2010, ASTRON J, V139, P803, DOI 10.1088/0004-6256/139/2/803; REIN H, 2012, ASTRON ASTROPHYS, V137, P128; SHOWALTER MR, 1992, ICARUS, V100, P394, DOI 10.1016/0019-1035(92)90107-I	34	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	SEP	2015	8	9					686	+		10.1038/NGEO2508		5	Geosciences, Multidisciplinary	Geology	CQ1WW	WOS:000360392000011		
J	Foreman, BZ; Lai, SYJ; Komatsu, Y; Paola, C				Foreman, Brady Z.; Lai, Steven Y. J.; Komatsu, Yuhei; Paola, Chris			Braiding of submarine channels controlled by aspect ratio similar to rivers	NATURE GEOSCIENCE			English	Article							TURBIDITY CURRENTS; SEA; ARCHITECTURE; EVOLUTION; MORPHOLOGY; PATTERNS; CANYONS; SYSTEMS; PLAINS; MODELS	The great majority of submarine channels formed by turbidity and density currents are meandering in planform; they consist of a single, sinuous channel that transports a turbid, dense flow of sediment from submarine canyons to ocean floor environments(1,2). Braided turbidite systems consisting of multiple, interconnected channel threads are conspicuously rare(1). Furthermore, such systems may not represent the spontaneous planform instability of true braiding, but instead result from erosive processes or bathymetric variability(3-5). In marked contrast to submarine environments, both meandering and braided planforms are common in fluvial systems(6,7). Here we present experiments of subaqueous channel formation conducted at two laboratory facilities. We find that density currents readily produce a braided planform for flow aspect ratios of depth to width that are similar to those that produce river braiding. Moreover, we find that stability model theory for river planform morphology(8) successfully describes submarine channels in both experiments and the field. On the basis of these observations, we propose that the rarity of braided submarine channels is explained by the generally greater flow depths in submarine systems, which necessitate commensurately greater widths to achieve the required aspect ratio, along with feedbacks(9,10) among flow thickness, suspended sediment concentration and channel relief that induce greater levee deposition rates and limit channel widening.	[Foreman, Brady Z.; Paola, Chris] Univ Minnesota, Dept Earth Sci, St Anthony Falls Lab, Minneapolis, MN 55414 USA; [Lai, Steven Y. J.] Natl Cheng Kung Univ, Dept Hydraul & Ocean Engn, Tainan 701, Taiwan; [Komatsu, Yuhei] Japan Oil Gas & Met Natl Corp, Technol Res, Chiba 2610025, Japan	Foreman, BZ (reprint author), Western Washington Univ, Dept Geol, Bellingham, WA 98225 USA.	brady.foreman@wwu.edu			St. Anthony Falls Laboratory Industry Consortium; Japan Oil, Gas and Metals National Corporation (JOGMEC); ConocoPhillips; Chevron; Shell; ExxonMobil; BHP Billiton; Ministry of Science and Technology from Taiwan [MOST 103-2221-E-006-215]	The authors thank the St. Anthony Falls Laboratory Industry Consortium, which includes Japan Oil, Gas and Metals National Corporation (JOGMEC), ConocoPhillips, Chevron, Shell, ExxonMobil, and BHP Billiton, as well as the Ministry of Science and Technology from Taiwan (MOST 103-2221-E-006-215) for funding of this research. S. S. C. Hung, D. Baldus, R. Rosario, A. Sorenson and B. Erickson are acknowledged for assistance in conducting experiments.	Flood RD, 2009, SEDIMENTOLOGY, V56, P807, DOI 10.1111/j.1365-3091.2008.00998.x; Covault JA, 2011, GEOSPHERE, V7, P313, DOI 10.1130/GES00610.1; SMITH DG, 1980, J SEDIMENT PETROL, V50, P157; SCHUMM SA, 1985, ANNU REV EARTH PL SC, V13, P5, DOI 10.1146/annurev.ea.13.050185.000253; HEIN FJ, 1982, SEDIMENTOLOGY, V29, P309, DOI 10.1111/j.1365-3091.1982.tb01798.x; SINHA R, 1994, SEDIMENTOLOGY, V41, P825, DOI 10.1111/j.1365-3091.1994.tb01426.x; Peakall J, 2000, J SEDIMENT RES, V70, P434, DOI 10.1306/2DC4091C-0E47-11D7-8643000102C1865D; Piper DJW, 2009, J SEDIMENT RES, V79, P347, DOI 10.2110/jsr.2009.046; Straub KM, 2009, J SEDIMENT RES, V79, P24, DOI 10.2110/jsr.2009.006; PARKER G, 1976, J FLUID MECH, V76, P457, DOI 10.1017/S0022112076000748; Straub KM, 2008, GEOL SOC AM BULL, V120, P368, DOI 10.1130/B25983.1; Wynn RB, 2007, MAR PETROL GEOL, V24, P341, DOI 10.1016/j.marpetgeo.2007.06.001; MURRAY AB, 1994, NATURE, V371, P54, DOI 10.1038/371054a0; Paola C, 2009, EARTH-SCI REV, V97, P1, DOI 10.1016/j.earscirev.2009.05.003; Deptuck ME, 2003, MAR PETROL GEOL, V20, P649, DOI 10.1016/j.marpetgeo.2003.01.004; Yu B, 2006, J SEDIMENT RES, V76, P889, DOI 10.2110/jsr.2006.069; Mohrig D, 2007, GEOLOGY, V35, P155, DOI 10.1130/G22716A.1; ASHMORE PE, 1988, EARTH SURF PROCESSES, V13, P677, DOI 10.1002/esp.3290130803; Cronin B., 1995, ATLAS DEEP WATER ENV, P84; Ercilla G, 1998, MAR GEOL, V146, P243, DOI 10.1016/S0025-3227(97)00134-5; Hesse R, 2001, AAPG BULL, V85, P1499; Hiscott RN, 1997, AAPG BULL, V81, P662; Leopold L.B., 1957, US GEOL SURV PROF  B, V282B, P39; Malverti L, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000974; Metivier F, 2005, J SEDIMENT RES, V75, P6, DOI 10.2110/jst.2005.002; Paola C., 2001, GRAVEL BED RIVERS, P11; Pirmez C., 1994, THESIS U COLUMBIA; SCHUMM SA, 1972, GEOL SOC AM BULL, V83, P1755, DOI 10.1130/0016-7606(1972)83[1755:ESOCP]2.0.CO;2; Sequeiros OE, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007201; Straub KM, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000896	30	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	SEP	2015	8	9					700	+		10.1038/NGEO2505		5	Geosciences, Multidisciplinary	Geology	CQ1WW	WOS:000360392000014		
J	Arculus, RJ; Ishizuka, O; Bogus, KA; Gurnis, M; Hickey-Vargas, R; Aljahdali, MH; Bandini-Maeder, AN; Barth, AP; Brandl, PA; Drab, L; Guerra, RD; Hamada, M; Jiang, FQ; Kanayama, K; Kender, S; Kusano, Y; Li, H; Loudin, LC; Maffione, M; Marsaglia, KM; McCarthy, A; Meffre, S; Morris, A; Neuhaus, M; Savov, IP; Sena, C; Tepley, FJ; van der Land, C; Yogodzinski, GM; Zhang, ZH				Arculus, Richard J.; Ishizuka, Osamu; Bogus, Kara A.; Gurnis, Michael; Hickey-Vargas, Rosemary; Aljahdali, Mohammed H.; Bandini-Maeder, Alexandre N.; Barth, Andrew P.; Brandl, Philipp A.; Drab, Laureen; Guerra, Rodrigo do Monte; Hamada, Morihisa; Jiang, Fuqing; Kanayama, Kyoko; Kender, Sev; Kusano, Yuki; Li, He; Loudin, Lorne C.; Maffione, Marco; Marsaglia, Kathleen M.; McCarthy, Anders; Meffre, Sebastien; Morris, Antony; Neuhaus, Martin; Savov, Ivan P.; Sena, Clara; Tepley, Frank J., III; van der Land, Cees; Yogodzinski, Gene M.; Zhang, Zhaohui			A record of spontaneous subduction initiation in the Izu-Bonin-Mariana arc	NATURE GEOSCIENCE			English	Article							WEST PHILIPPINE BASIN; CONTINENTAL-CRUST; EOCENE; SEA; ORIGIN; OCEAN; RECONSTRUCTIONS; MAGMATISM; EVOLUTION; HISTORY	The initiation of tectonic plate subduction into the mantle is poorly understood. If subduction is induced by the push of a distant mid-ocean ridge or subducted slab pull, we expect compression and uplift of the overriding plate. In contrast, spontaneous subduction initiation, driven by subsidence of dense lithosphere along faults adjacent to buoyant lithosphere, would result in extension and magmatism. The rock record of subduction initiation is typically obscured by younger deposits, so evaluating these possibilities has proved elusive. Here we analyse the geochemical characteristics of igneous basement rocks and overlying sediments, sampled from the Amami Sankaku Basin in the northwest Philippine Sea. The uppermost basement rocks are areally widespread and supplied via dykes. They are similar in composition and age-as constrained by the biostratigraphy of the overlying sediments-to the 52-48-million-year-old basalts in the adjacent Izu-Bonin-Mariana fore-arc. The geochemical characteristics of the basement lavas indicate that a component of subducted lithosphere was involved in their genesis, and the lavas were derived from mantle source rocks that were more melt-depleted than those tapped at mid-ocean ridges. We propose that the basement lavas formed during the inception of Izu-Bonin-Mariana subduction in a mode consistent with the spontaneous initiation of subduction.	[Arculus, Richard J.; Brandl, Philipp A.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Ishizuka, Osamu] Geol Survey Japan AIST, Tsukuba, Ibaraki 3058567, Japan; [Ishizuka, Osamu] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Ocean Drilling Sci, Yokosuka, Kanagawa 2370061, Japan; [Bogus, Kara A.] Texas A&M Univ, Int Ocean Discovery Program, College Stn, TX 77845 USA; [Gurnis, Michael] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Hickey-Vargas, Rosemary] Florida Int Univ, Earth & Environm Dept, Miami, FL 33199 USA; [Aljahdali, Mohammed H.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Bandini-Maeder, Alexandre N.] Univ Western Australia, Sch Earth & Environm, Ctr Energy Geosci, Perth, WA 6009, Australia; [Barth, Andrew P.] Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA; [Brandl, Philipp A.] Univ Erlangen Nurnberg, Geozentrum Nordbayern, D-91054 Erlangen, Germany; [Drab, Laureen] Columbia Univ, Lamont Doherty Earth Observ, Borehole Res Grp, Palisades, NY 10964 USA; [Guerra, Rodrigo do Monte] Univ Vale Rio dos Sinos, Technol Inst Micropaleontol, BR-93022 Sao Leopoldo, Brazil; [Hamada, Morihisa] Japan Agcy Marine Earth Sci & Technol, Dept Solid Earth Geochem, Yokosuka, Kanagawa 2370061, Japan; [Jiang, Fuqing] Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China; [Kanayama, Kyoko] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Kender, Sev] Univ Nottingham, Sch Geog, Nottingham NG7 2RD, England; [Kender, Sev] British Geol Survey, Keyworth NG12 5GG, Notts, England; [Kusano, Yuki; Li, He] Chinese Acad Sci, Guangzhou Inst Geochem, Guangzhou 510640, Guangdong, Peoples R China; [Loudin, Lorne C.] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA; [Maffione, Marco] Univ Utrecht, Inst Earth Sci, NL-3584 Utrecht, Netherlands; [Marsaglia, Kathleen M.] Calif State Univ Northridge, Dept Geol Sci, Northridge, CA 91330 USA; [McCarthy, Anders] Univ Lausanne, Inst Earth Sci, CH-1015 Lausanne, Switzerland; [Meffre, Sebastien] Univ Tasmania, Sch Earth Sci, Hobart, Tas 7001, Australia; [Morris, Antony] Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth PL4 8AA, Devon, England; [Neuhaus, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterrestr Phys, D-38106 Braunschweig, Germany; [Savov, Ivan P.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Sena, Clara] Univ Aveiro, Geosci Dept CESAM, P-3810193 Aveiro, Portugal; Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [van der Land, Cees] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Yogodzinski, Gene M.] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA; [Zhang, Zhaohui] Nanjing Univ, Earth Sci, Nanjing 210093, Jiangsu, Peoples R China	Arculus, RJ (reprint author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 2601, Australia.	richard.arculus@anu.edu.au	CESAM, UA/M-3762-2015; 	Kender, Sev/0000-0003-4216-3214	Australian Research Council; ANZIC office; Ministry of Education of Saudi Arabia; Fugro AG	This research used samples and data provided by the International Ocean Discovery Program. We thank the USIO staff and the SIEM Offshore crew for their invaluable assistance and skill during the expedition. Funding was provided by the Australian Research Council and the ANZIC office to R.J.A. Additional funding was provided to M.H.A. by the Ministry of Education of Saudi Arabia, and to A.N.B.-M. by Fugro AG. We gratefully acknowledge the initial inspiration and ongoing advice of brain Taylor and the drilling proposal proponents, whose efforts led to IODP Expedition 351. We thank Sherm Bloomer and Brian Taylor for their highly constructive comments and suggestions.	STERN RJ, 1992, GEOL SOC AM BULL, V104, P1621, DOI 10.1130/0016-7606(1992)104<1621:SZIEFT>2.3.CO;2; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; Macpherson CG, 2001, EARTH PLANET SC LETT, V186, P215, DOI 10.1016/S0012-821X(01)00248-5; Ishizuka O, 2011, EARTH PLANET SC LETT, V306, P229, DOI 10.1016/j.epsl.2011.04.006; TAYLOR SR, 1967, TECTONOPHYSICS, V4, P17, DOI 10.1016/0040-1951(67)90056-X; Bryant CJ, 1999, GEOLOGY, V27, P1119, DOI 10.1130/0091-7613(1999)027<1119:LAICPM>2.3.CO;2; Reagan MK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002871; Higuchi Y, 2007, ISL ARC, V16, P374, DOI 10.1111/j.1440-1738.2007.00588.x; Savov IP, 2006, J PETROL, V47, P277, DOI 10.1093/petrology/egi075; Whittaker JM, 2007, SCIENCE, V318, P83, DOI 10.1126/science.1143769; Hall R, 2012, TECTONOPHYSICS, V570, P1, DOI 10.1016/j.tecto.2012.04.021; Ishizuka O, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003440; Yamazaki T, 2010, EARTH PLANETS SPACE, V62, P495, DOI 10.5047/eps.2010.04.001; Ishizuka O, 2013, GEOLOGY, V41, P1011, DOI 10.1130/G34525.1; Hickey-Vargas R, 2005, ISL ARC, V14, P653, DOI 10.1111/j.1440-1738.2005.00474.x; Lee CTA, 2010, NATURE, V468, P681, DOI 10.1038/nature09617; Eakin DH, 2015, GEOCHEM GEOPHY GEOSY, V16, P380, DOI 10.1002/2014GC005548; RHODES JM, 1979, TECTONOPHYSICS, V55, P35, DOI 10.1016/0040-1951(79)90334-2; Ishizuka O, 2006, EARTH PLANET SC LETT, V250, P385, DOI 10.1016/j.epsl.2006.08.007; SCLATER JG, 1980, REV GEOPHYS, V18, P269, DOI 10.1029/RG018i001p00269; Taylor B, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020136; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Deschamps A, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001706; DeBari SM, 1999, EARTH PLANET SC LETT, V174, P183, DOI 10.1016/S0012-821X(99)00252-6; Arculus R.J., 1999, J P ROYAL SOC NEW S, V132, P83; Evans K. A., 2012, EARTH-SCI REV, V113, P1; Expedition 352 Scientists, 2015, 32 IODP; Gurnis M., 2004, GEOCHEM GEOPHY GEOSY, V5; Hall R., 1991, J SE ASIAN EARTH SCI, V6, P249, DOI 10.1016/0743-9547(91)90071-5; Jenner FE, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC004009; Kaneda K., J GEOGRAPHY IN PRESS; Keller X., 2007, J GEOPHYS RES, V113; Mallmann G, 2009, J PETROL, V50, P1765, DOI 10.1093/petrology/egp053; Mattey D. P., 1981, P DSDP INIT REP, V59, P753; McKenzie DP, 1977, M EWING SERIES, P57, DOI [10.1029/ME001, DOI 10.1029/ME001P0057]; Meijer A., 1980, INIT REP DSDP, V60, P709; Nishizawa A., 2007, EARTH PLANETS SPACE, V59, P17; SHERVAIS JW, 1982, EARTH PLANET SC LETT, V59, P101, DOI 10.1016/0012-821X(82)90120-0; SINTON JM, 1992, J GEOPHYS RES-SOL EA, V97, P197, DOI 10.1029/91JB02508; Stern R. J., 2004, EARTH PLANET SC LETT, V226, P275; Straub SM, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000357; Suyehiro K, 1996, SCIENCE, V272, P390, DOI 10.1126/science.272.5260.390; UYEDA S, 1972, NATURE-PHYS SCI, V240, P176	43	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	SEP	2015	8	9					728	733		10.1038/NGEO2515		6	Geosciences, Multidisciplinary	Geology	CQ1WW	WOS:000360392000020		
J	Manchon, A; Koo, HC; Nitta, J; Frolov, SM; Duine, RA				Manchon, A.; Koo, H. C.; Nitta, J.; Frolov, S. M.; Duine, R. A.			New perspectives for Rashba spin-orbit coupling	NATURE MATERIALS			English	Review							HGTE QUANTUM-WELLS; TOPOLOGICAL INSULATOR; MAJORANA FERMIONS; SEMICONDUCTOR NANOWIRE; VALLEY POLARIZATION; EFFECT TRANSISTOR; ELECTRIC-CURRENT; MAGNETIC-FIELD; SURFACE-STATES; GRAPHENE	In 1984, Bychkov and Rashba introduced a simple form of spin-orbit coupling to explain the peculiarities of electron spin resonance in two-dimensional semiconductors. Over the past 30 years, Rashba spin-orbit coupling has inspired a vast number of predictions, discoveries and innovative concepts far beyond semiconductors. The past decade has been particularly creative, with the realizations of manipulating spin orientation by moving electrons in space, controlling electron trajectories using spin as a steering wheel, and the discovery of new topological classes of materials. This progress has reinvigorated the interest of physicists and materials scientists in the development of inversion asymmetric structures, ranging from layered graphene-like materials to cold atoms. This Review discusses relevant recent and ongoing realizations of Rashba physics in condensed matter.	[Manchon, A.] KAUST, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Koo, H. C.] Korea Inst Sci & Technol, Ctr Spintron, Seoul 136791, South Korea; [Koo, H. C.] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul 136701, South Korea; [Nitta, J.] Tohoku Univ, Dept Mat Sci, Sendai, Miyagi 9808579, Japan; [Frolov, S. M.] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Duine, R. A.] Univ Utrecht, Inst Theoret Phys, NL-3584 CE Utrecht, Netherlands; [Duine, R. A.] Univ Utrecht, Ctr Extreme Matter & Emergent Phenomena, NL-3584 CE Utrecht, Netherlands	Manchon, A (reprint author), KAUST, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia.	aurelien.manchon@kaust.edu.sa	Manchon, Aurelien/A-9355-2010	Manchon, Aurelien/0000-0002-4768-293X	King Abdullah University of Science and Technology (KAUST); KIST Institutional Programme; KU-KIST Institutional Programme; Japan Society for the Promotion of Science (JSPS) [22226001]; ONR BRC on Majorana Fermions; National Science Foundation (NSF); Sloan Foundation; Charles E. Kaufman foundation; Nanoscience Foundation; Stichting voor Fundamenteel Onderzoek der Materie (FOM); European Research Council (ERC); D-ITP consortium; Dutch Ministry of Education, Culture and Science (OCW)	The authors thank E.I. Rashba, M.I. Dyakonov, D. Xiao, L. Fritz and A.H. MacDonald for useful discussions. A.M. was supported by the King Abdullah University of Science and Technology (KAUST). H.C.K. was supported by the KIST and KU-KIST Institutional Programmes. J.N. acknowledges support by the Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS; no. 22226001). S.M.F. acknowledges ONR BRC on Majorana Fermions, National Science Foundation (NSF), Sloan Foundation, the Charles E. Kaufman foundation and Nanoscience Foundation. R.A.D. is supported by the Stichting voor Fundamenteel Onderzoek der Materie (FOM), the European Research Council (ERC) and is part of the D-ITP consortium, a programme of the Netherlands Organisation for Scientific Research (NWO) that is funded by the Dutch Ministry of Education, Culture and Science (OCW).	Alexandradinata A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.116403; Park BG, 2011, NAT MATER, V10, P347, DOI [10.1038/nmat2983, 10.1038/NMAT2983]; Kurebayashi H, 2014, NAT NANOTECHNOL, V9, P211, DOI [10.1038/nnano.2014.15, 10.1038/NNANO.2014.15]; Cocks D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.205303; Xu XD, 2014, NAT PHYS, V10, P343, DOI 10.1038/NPHYS2942; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; Petersson KD, 2012, NATURE, V490, P380, DOI 10.1038/nature11559; LaShell S, 1996, PHYS REV LETT, V77, P3419, DOI 10.1103/PhysRevLett.77.3419; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Wunderlich J, 2009, NAT PHYS, V5, P675, DOI 10.1038/NPHYS1359; Ohe J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.041308; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; Knez I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.136603; Varykhalov A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.066804; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Wang PJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095301; Matsumoto R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.197202; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Garello K, 2013, NAT NANOTECHNOL, V8, P587, DOI [10.1038/nnano.2013.145, 10.1038/NNANO.2013.145]; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Sasaki A, 2014, NAT NANOTECHNOL, V9, P703, DOI [10.1038/nnano.2014.128, 10.1038/NNANO.2014.128]; Schliemann J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.146801; RAUCH H, 1975, PHYS LETT A, V54, P425, DOI 10.1016/0375-9601(75)90798-7; Jungwirth T, 2012, NAT MATER, V11, P382, DOI [10.1038/nmat3279, 10.1038/NMAT3279]; DYAKONOV MI, 1986, SOV PHYS SEMICOND+, V20, P110; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Witczak-Krempa W, 2014, ANNU REV CONDEN MA P, V5, P57, DOI 10.1146/annurev-conmatphys-020911-125138; Lin YJ, 2011, NATURE, V471, P83, DOI 10.1038/nature09887; Koo HC, 2009, SCIENCE, V325, P1515, DOI 10.1126/science.1173667; SLONCZEWSKI JC, 1958, PHYS REV, V109, P272, DOI 10.1103/PhysRev.109.272; Manchon A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.212405; Nitta J, 1997, PHYS REV LETT, V78, P1335, DOI 10.1103/PhysRevLett.78.1335; AHARONOV Y, 1984, PHYS REV LETT, V53, P319, DOI 10.1103/PhysRevLett.53.319; Qiao ZH, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.116404; Nadj-Perge S, 2010, NATURE, V468, P1084, DOI 10.1038/nature09682; DRESSELHAUS G, 1955, PHYS REV, V100, P580, DOI 10.1103/PhysRev.100.580; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; Wehling TO, 2014, ADV PHYS, V63, P1, DOI 10.1080/00018732.2014.927109; RASHBA EI, 1960, SOV PHYS-SOL STATE, V2, P1109; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Fabian J, 2007, ACTA PHYS SLOVACA, V57, P565, DOI 10.2478/v10155-010-0086-8; Radic J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.085303; Young AF, 2014, NATURE, V505, P528, DOI 10.1038/nature12800; Hoffmann A, 2013, IEEE T MAGN, V49, P5172, DOI 10.1109/TMAG.2013.2262947; Roth A, 2009, SCIENCE, V325, P294, DOI 10.1126/science.1174736; Fan YB, 2014, NAT MATER, V13, P699, DOI [10.1038/nmat3973, 10.1038/NMAT3973]; Ikegami H, 2013, SCIENCE, V341, P59, DOI 10.1126/science.1236509; Bernevig BA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236601; Hanson R, 2008, NATURE, V453, P1043, DOI 10.1038/nature07129; Wu SF, 2013, NAT PHYS, V9, P149; Bernevig BA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.033203; Koralek JD, 2009, NATURE, V458, P610, DOI 10.1038/nature07871; Ishizaka K, 2011, NAT MATER, V10, P521, DOI [10.1038/nmat3051, 10.1038/NMAT3051]; Abanin DA, 2011, SCIENCE, V332, P328, DOI 10.1126/science.1199595; Yang BJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.246402; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Naaman R, 2012, J PHYS CHEM LETT, V3, P2178, DOI 10.1021/jz300793y; Frolov SM, 2009, NATURE, V458, P868, DOI 10.1038/nature07873; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Xu SY, 2015, SCIENCE, V347, P294, DOI 10.1126/science.1256742; EDELSTEIN VM, 1990, SOLID STATE COMMUN, V73, P233, DOI 10.1016/0038-1098(90)90963-C; Qu CL, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.021604; Ganichev SD, 2006, J MAGN MAGN MATER, V300, P127, DOI 10.1016/j.jmmm.2005.10.048; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; IVCHENKO EL, 1978, JETP LETT+, V27, P604; Wunderlich J, 2010, SCIENCE, V330, P1801, DOI 10.1126/science.1195816; van den Berg JWG, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.066806; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Park YH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4855495; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; King PDC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.096802; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Beenakker CWJ, 2013, ANNU REV CONDEN MA P, V4, P113, DOI 10.1146/annurev-conmatphys-030212-184337; Aidelsburger M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.255301; Fu LA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.106802; Chen X, 2012, SCIENCE, V338, P1604, DOI 10.1126/science.1227224; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Chernyshov A, 2009, NAT PHYS, V5, P656, DOI 10.1038/NPHYS1362; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Nakamura H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.206601; Ji SC, 2014, NAT PHYS, V10, P314, DOI 10.1038/NPHYS2905; Xiao D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236809; Bihlmayer G, 2006, SURF SCI, V600, P3888, DOI 10.1016/j.susc.2006.01.098; Hsieh D, 2009, NATURE, V460, P1101, DOI 10.1038/nature08234; Schultz M, 1996, SEMICOND SCI TECH, V11, P1168, DOI 10.1088/0268-1242/11/8/009; Cheuk LW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095302; Rycerz A, 2007, NAT PHYS, V3, P172, DOI 10.1038/nphys547; Onose Y, 2010, SCIENCE, V329, P297, DOI 10.1126/science.1188260; Ganichev SD, 2008, INT J MOD PHYS B, V22, P1, DOI 10.1142/S0217979208046001; Miron IM, 2010, NAT MATER, V9, P230, DOI [10.1038/nmat2613, 10.1038/NMAT2613]; Streda P, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.256601; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Liu XJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046402; Zhang JY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.115301; Miron IM, 2011, NATURE, V476, P189, DOI 10.1038/nature10309; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Pesin D, 2012, NAT MATER, V11, P409, DOI [10.1038/nmat3305, 10.1038/NMAT3305]; Ast CR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.186807; Kato YK, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.176601; Vishwanath A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011016; MORIYA T, 1960, PHYS REV, V120, P91, DOI 10.1103/PhysRev.120.91; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Choy TP, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195442; Averkiev NS, 1999, PHYS REV B, V60, P15582, DOI 10.1103/PhysRevB.60.15582; Balakrishnan J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5748; Bergsten T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.196803; Bychkov Y. A., 1984, PISMA ESKP TEOR FIZ, V39, P66; Cai Z, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.061605; Cole WS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.085302; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Dyakonov M., 1971, PISMA ESKP TEOR FIZ, V13, P657; Dyakonov M. I., 1972, SOV PHYS-SOLID STATE, V13, P3023; Dzyaloshinskii I.E., 1957, SOV PHYS JETP, V5, P1259; Gorbachev RV, 2014, SCIENCE, V346, P448, DOI 10.1126/science.1254966; Han W, 2014, NAT NANOTECHNOL, V9, P794, DOI [10.1038/nnano.2014.214, 10.1038/NNANO.2014.214]; Heisenberg W, 1932, Z PHYS, V77, P1, DOI 10.1007/BF01342433; Herbert S. T., 2009, NATURE NANOTECH, V4, P759; Kohda M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2080; Konig M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076804; Manchon A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.224403; Marchenko D., 2012, NAT COMUN, V2, P1232; Mellnik AR, 2014, NATURE, V511, P449, DOI 10.1038/nature13534; Moser J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.056601; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; Rojas Sanchez JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3944; Sinova J., REV MOD PHYS; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Vas'ko F. T., 1979, Pis'ma v Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V30; Volovik G. E., 1988, Soviet Physics - JETP, V67; Wadley P., ELECT SWITCHING ANTI; Williams R. A., 2011, SCIENCE, V335, P314; Winkler R., 2003, SPIN ORBIT COUPLING; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Yuan HT, 2014, NAT NANOTECHNOL, V9, P851, DOI [10.1038/nnano.2014.183, 10.1038/NNANO.2014.183]; Zakeri K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137203; Zelezny J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.157201	150	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	SEP	2015	14	9					871	882		10.1038/NMAT4360		12	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CP9CT	WOS:000360192000018		
J	Mahato, P; Monguzzi, A; Yanai, N; Yamada, T; Kimizuka, N				Mahato, Prasenjit; Monguzzi, Angelo; Yanai, Nobuhiro; Yamada, Teppei; Kimizuka, Nobuo			Fast and long-range triplet exciton diffusion in metal-organic frameworks for photon upconversion at ultralow excitation power	NATURE MATERIALS			English	Article							ENERGY-TRANSFER; ANNIHILATION; LIGHT; POLYMERS; LUMINESCENCE; MIGRATION; CRYSTALS; SYSTEMS; PHASE; AIR	The conversion of low-energy light into photons of higher energy based on sensitized triplet-triplet annihilation upconversion (TTA-UC) has emerged as a promising wavelength-shifting methodology because it permits UC at excitation powers as low as the solar irradiance. However, its application has been significantly hampered by the slow diffusion of excited molecules in solid matrices. Here, we introduce metal-organic frameworks (MOFs) that promote TTA-UC by taking advantage of triplet exciton migration among fluorophores that are regularly aligned with spatially controlled chromophore orientations. We synthesized anthracene-containing MOFs with different molecular orientations, and the analysis of TTA-UC emission kinetics unveiled a high triplet diffusion rate with a micrometre-scale diffusion length. Surface modification of MOF nanocrystals with donor molecules and their encapsulation in glassy poly(methyl methacrylate) (PMMA) allowed the construction of molecular-diffusion-free solid-state upconverters, which lead to an unprecedented maximization of overall UC quantum yield at excitation powers comparable to or well below the solar irradiance.	[Mahato, Prasenjit; Yanai, Nobuhiro; Yamada, Teppei; Kimizuka, Nobuo] Kyushu Univ, Dept Chem & Biochem, Grad Sch Engn, CMS, Fukuoka 8190395, Japan; [Monguzzi, Angelo] Univ Milano Bicocca, Dipartimento Sci Mat, I-20135 Milan, Italy; [Yanai, Nobuhiro; Yamada, Teppei] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Yanai, N (reprint author), Kyushu Univ, Dept Chem & Biochem, Grad Sch Engn, CMS, Fukuoka 8190395, Japan.	yanai@mail.cstm.kyushu-u.ac.jp; n-kimi@mail.cstm.kyushu-u.ac.jp		Monguzzi, Angelo/0000-0001-9768-4573	Ministry of Education, Culture Sports, Science and Technology of Japan [25220805, 26810036, 26104529]; JSPS-NSF International Collaborations in Chemistry (ICC) program; Noguchi Institute; JSPS postdoctoral fellowships	This work was partly supported by a Grants-in-Aid for Scientific Research (S) (25220805), a Grants-in-Aid for Young Scientists (B) (26810036), a Grant-in-Aid for Scientific Research on Innovative Area (26104529) from the Ministry of Education, Culture Sports, Science and Technology of Japan, the JSPS-NSF International Collaborations in Chemistry (ICC) program, and a research grant from The Noguchi Institute. P.M. and A.M. acknowledge JSPS postdoctoral fellowships for foreign researchers. The authors acknowledge M.-a. Morikawa and R. Yoshida in Kyushu University for their help in TEM measurements.	Monguzzi A, 2013, ADV ENERGY MATER, V3, P680, DOI 10.1002/aenm.201200897; Simon YC, 2012, J MATER CHEM, V22, P20817, DOI 10.1039/c2jm33654e; Ferey G, 2009, CHEM SOC REV, V38, P1380, DOI 10.1039/b804302g; Zhang T, 2014, CHEM SOC REV, V43, P5982, DOI 10.1039/c4cs00103f; Deria P, 2014, CHEM SOC REV, V43, P5896, DOI 10.1039/c4cs00067f; Cheng YY, 2010, PHYS CHEM CHEM PHYS, V12, P66, DOI 10.1039/b913243k; Baluschev S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.143903; Haefele A, 2012, J PHYS CHEM LETT, V3, P299, DOI 10.1021/jz300012u; Furukawa S, 2014, CHEM SOC REV, V43, P5700, DOI 10.1039/c4cs00106k; Monguzzi A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195112; Lin JX, 2013, J PHYS CHEM C, V117, P22250, DOI 10.1021/jp401515r; Hauptvogel IM, 2011, INORG CHEM, V50, P8367, DOI 10.1021/ic200937u; Son HJ, 2013, J AM CHEM SOC, V135, P862, DOI 10.1021/ja310596a; Kent CA, 2012, J AM CHEM SOC, V134, P3991, DOI 10.1021/ja211271m; Zhang C, 2010, CHEM COMMUN, V46, P4959, DOI 10.1039/c0cc00347f; Li JR, 2012, CHEM REV, V112, P869, DOI 10.1021/cr200190s; Monguzzi A, 2012, PHYS CHEM CHEM PHYS, V14, P4322, DOI 10.1039/c2cp23900k; Liu Q, 2013, J AM CHEM SOC, V135, P5029, DOI 10.1021/ja3104268; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Kim JH, 2012, CHEM MATER, V24, P2250, DOI 10.1021/cm3012414; Kent CA, 2011, J AM CHEM SOC, V133, P12940, DOI 10.1021/ja204214t; INOKUTI M, 1965, J CHEM PHYS, V43, P1978, DOI 10.1063/1.1697063; Baluschev S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2409618; Singh-Rachford TN, 2010, COORDIN CHEM REV, V254, P2560, DOI 10.1016/j.ccr.2010.01.003; Scholes GD, 2003, ANNU REV PHYS CHEM, V54, P57, DOI 10.1146/annurev.physchem.54.011002.103746; Duan PF, 2015, J AM CHEM SOC, V137, P1887, DOI 10.1021/ja511061h; Sindoro M, 2014, ACCOUNTS CHEM RES, V47, P459, DOI 10.1021/ar400151n; Islangulov RR, 2007, J AM CHEM SOC, V129, P12652, DOI 10.1021/ja075014k; Gray V, 2014, PHYS CHEM CHEM PHYS, V16, P10345, DOI 10.1039/c4cp00744a; Duan PF, 2013, J AM CHEM SOC, V135, P19056, DOI 10.1021/ja411316s; Zhao JZ, 2011, RSC ADV, V1, P937, DOI 10.1039/c1ra00469g; Jiang Z, 2013, J AM CHEM SOC, V135, P16446, DOI 10.1021/ja406020r; ERN V, 1969, PHYS REV LETT, V22, P343, DOI 10.1103/PhysRevLett.22.343; Kim JH, 2012, J AM CHEM SOC, V134, P17478, DOI 10.1021/ja308789u; JORTNER J, 1963, PHYS REV LETT, V11, P323, DOI 10.1103/PhysRevLett.11.323; Kent CA, 2010, J AM CHEM SOC, V132, P12767, DOI 10.1021/ja102804s; Trupke T, 2002, J APPL PHYS, V92, P4117, DOI 10.1063/1.1505677; Kohler A, 2011, J MATER CHEM, V21, P4003, DOI 10.1039/c0jm02886j; Monguzzi A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155122; Wei ZW, 2014, J AM CHEM SOC, V136, P8269, DOI 10.1021/ja5006866; Furukawa H., 2013, SCIENCE, V341; Grisanti L, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035450; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kondo M, 2010, ANGEW CHEM INT EDIT, V49, P5327, DOI 10.1002/anie.201001063; Lin JDA, 2014, MATER HORIZONS, V1, P280, DOI 10.1039/c3mh00089c; Pope M., 1982, ELECT PROCESSES ORGA; Quarti C, 2011, PHYS CHEM CHEM PHYS, V13, P18615, DOI 10.1039/c1cp21246j; Yanai N, 2012, ANGEW CHEM INT EDIT, V51, P5638, DOI 10.1002/anie.201109132; ZHANG GH, 1995, J PHYS CHEM-US, V99, P11203, DOI 10.1021/j100028a023	49	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	SEP	2015	14	9					924	+		10.1038/NMAT4366		8	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CP9CT	WOS:000360192000027		
J	Adamantidis, A; Arber, S; Bains, JS; Bamberg, E; Bonci, A; Buzsaki, G; Cardin, JA; Costa, RM; Dan, Y; Goda, Y; Graybiel, AM; Hausser, M; Hegemann, P; Huguenard, JR; Insel, TR; Janak, PH; Johnston, D; Josselyn, SA; Koch, C; Kreitzer, AC; Luscher, C; Malenka, RC; Miesenbock, G; Nagel, G; Roska, B; Schnitzer, MJ; Shenoy, KV; Soltesz, I; Sternson, SM; Tsien, RW; Tsien, RY; Turrigiano, GG; Tye, KM; Wilson, RI				Adamantidis, Antoine; Arber, Silvia; Bains, Jaideep S.; Bamberg, Ernst; Bonci, Antonello; Buzsaki, Gyoergy; Cardin, Jessica A.; Costa, Rui M.; Dan, Yang; Goda, Yukiko; Graybiel, Ann M.; Haeusser, Michael; Hegemann, Peter; Huguenard, John R.; Insel, Thomas R.; Janak, Patricia H.; Johnston, Daniel; Josselyn, Sheena A.; Koch, Christof; Kreitzer, Anatol C.; Luescher, Christian; Malenka, Robert C.; Miesenboeck, Gero; Nagel, Georg; Roska, Botond; Schnitzer, Mark J.; Shenoy, Krishna V.; Soltesz, Ivan; Sternson, Scott M.; Tsien, Richard W.; Tsien, Roger Y.; Turrigiano, Gina G.; Tye, Kay M.; Wilson, Rachel I.			Optogenetics: 10 years after ChR2 in neurons-views from the community	NATURE NEUROSCIENCE			English	Editorial Material								On the anniversary of the Boyden et al. (2005) paper that introduced the use of channelrhodopsin in neurons, Nature Neuroscience asks selected members of the community to comment on the utility, impact and future of this important technique.	[Adamantidis, Antoine] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Adamantidis, Antoine] Univ Bern, Inselspital Univ Hosp, Dept Neurol, Bern, Switzerland; [Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, Basel, Switzerland; [Arber, Silvia] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Bains, Jaideep S.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Bamberg, Ernst] Max Planck Inst Biophys, Frankfurt, Germany; [Bonci, Antonello] NIDA, Intramural Res Program, Synapt Plast Sect, Baltimore, MD USA; [Bonci, Antonello] Johns Hopkins Univ, Sch Med, Solomon H Snyder Neurosci Inst, Baltimore, MD USA; [Bonci, Antonello] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Buzsaki, Gyoergy] NYU, Sch Med, Neurosci Inst, New York, NY USA; [Buzsaki, Gyoergy] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Cardin, Jessica A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Cardin, Jessica A.] Yale Univ, Kavli Inst Neurosci, New Haven, CT USA; [Costa, Rui M.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Helen Wills Neurosci Inst, Div Neurobiol,Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Goda, Yukiko] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Graybiel, Ann M.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London, England; [Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Hegemann, Peter] Humboldt Univ, Inst Biol Expt Biophys, D-10099 Berlin, Germany; [Huguenard, John R.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Insel, Thomas R.] NIMH, Bethesda, MD 20892 USA; [Janak, Patricia H.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA; [Janak, Patricia H.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Johnston, Daniel] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Johnston, Daniel] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Josselyn, Sheena A.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Josselyn, Sheena A.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Josselyn, Sheena A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Josselyn, Sheena A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Koch, Christof] Allen Inst Brain Sci, Washington, DC USA; [Kreitzer, Anatol C.] Gladstone Inst, San Francisco, CA USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Luescher, Christian] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Serv Neurol, Geneva, Switzerland; [Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Miesenboeck, Gero] Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England; [Nagel, Georg] Univ Wurzburg, Bioctr, Inst Mol Plant Physiol & Biophys, D-97070 Wurzburg, Germany; [Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Roska, Botond] Univ Basel, Dept Ophthalmol, Basel, Switzerland; [Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Stanford Neurosci Inst, Neurosci Program, Dept Elect Engn, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Stanford Neurosci Inst, Neurosci Program, Dept Bioengn, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Stanford Neurosci Inst, Neurosci Program, Dept Neurobiol, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Stanford Neurosci Inst, Bio X Program, Dept Elect Engn, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Stanford Neurosci Inst, Bio X Program, Dept Bioengn, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Stanford Neurosci Inst, Bio X Program, Dept Neurobiol, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Soltesz, Ivan] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA USA; [Tsien, Richard W.] NYU, Langone Med Ctr, Neurosci Inst, Dept Neurosci & Physiol, New York, NY USA; [Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Chem & Biochem, Dept Pharmacol, La Jolla, CA 92093 USA; [Turrigiano, Gina G.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Turrigiano, Gina G.] Brandeis Univ, Ctr Behav Genom, Waltham, MA USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Adamantidis, A (reprint author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	peter.hegemann@biologie.uni-regensburg.de; rtsien@ucsd.edu						0	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2015	18	9					1202	1212				11	Neurosciences	Neurosciences & Neurology	CQ0NI	WOS:000360292600007		
J	Hosaka, T; Nakamagoe, K; Takahashi, Y; Mamada, N; Tamaoka, A				Hosaka, Takashi; Nakamagoe, Kiyotaka; Takahashi, Yukitoshi; Mamada, Naomi; Tamaoka, Akira			Opsoclonus associated with autoantibodies to glutamate receptors delta 2	NEUROLOGICAL SCIENCES			English	Letter									[Hosaka, Takashi; Nakamagoe, Kiyotaka; Mamada, Naomi; Tamaoka, Akira] Univ Tsukuba, Fac Med, Dept Neurol, Div Clin Med, Tsukuba, Ibaraki 3058575, Japan; [Takahashi, Yukitoshi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan	Nakamagoe, K (reprint author), Univ Tsukuba, Fac Med, Dept Neurol, Div Clin Med, Tsukuba, Ibaraki 3058575, Japan.	nakamagoek@md.tsukuba.ac.jp					Jen JC, 2012, J NEUROL SCI, V320, P61, DOI 10.1016/j.jns.2012.06.017; Ramat S, 2005, EXP BRAIN RES, V160, P89, DOI 10.1007/s00221-004-1989-8; Takahashi Y, 2009, EPILEPSIA, V50, P1419, DOI 10.1111/j.1528-1167.2008.01977.x; Kambe T, 2013, JAMA NEUROL, V70, P654, DOI 10.1001/jamaneurol.2013.59; Shiihara T, 2010, EUR J PEDIATR, V169, P639, DOI 10.1007/s00431-009-1105-y; Yoshida T, 2004, J NEUROSCI, V24, P2440, DOI 10.1523/JNEUROSCI.0783-03.2004	6	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	SEP	2015	36	9					1741	1742		10.1007/s10072-015-2264-4		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CQ0NE	WOS:000360292200038		
J	Osawa, S; Iwasaki, M; Suzuki, H; Nakasato, N; Tominaga, T				Osawa, Shin-ichiro; Iwasaki, Masaki; Suzuki, Hiroyoshi; Nakasato, Nobukazu; Tominaga, Teiji			Occult dual pathology in mesial temporal lobe epilepsy	NEUROLOGICAL SCIENCES			English	Letter						Dual pathology; Temporal lobe epilepsy; Ganglioglioma; Negative magnetic resonance imaging			[Osawa, Shin-ichiro; Iwasaki, Masaki; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Suzuki, Hiroyoshi] Sendai Med Ctr, Natl Hosp Org, Dept Pathol & Lab Med, Sendai, Miyagi, Japan; [Nakasato, Nobukazu] Tohoku Univ, Grad Sch Med, Dept Epileptol, Sendai, Miyagi 9808574, Japan	Iwasaki, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, I-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	iwa@nsg.med.tohoku.ac.jp		Iwasaki, Masaki/0000-0002-4204-7144			Li LM, 1999, BRAIN, V122, P799, DOI 10.1093/brain/122.5.799; Blumcke I, 2007, ACTA NEUROPATHOL, V113, P235, DOI 10.1007/s00401-006-0187-0; Josephson CB, 2013, NEUROLOGY, V80, P1669, DOI 10.1212/WNL.0b013e3182904f82; Plowey ED, 2013, CLIN NEUROPATHOL, V32, P192, DOI 10.5414/NP300550	4	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	SEP	2015	36	9					1743	1745		10.1007/s10072-015-2268-0		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CQ0NE	WOS:000360292200039		
J	Royall, DR; Matsuoka, T; Palmer, RF; Kato, Y; Taniguchi, S; Ogawa, M; Fujimoto, H; Okamura, A; Shibata, K; Nakamura, K; Nakaaki, S; Koumi, H; Mimura, M; Fukui, K; Narumoto, J				Royall, Donald R.; Matsuoka, Teruyuki; Palmer, Raymond F.; Kato, Yuka; Taniguchi, Shogo; Ogawa, Mayu; Fujimoto, Hiroshi; Okamura, Aiko; Shibata, Keisuke; Nakamura, Kaeko; Nakaaki, Shutaro; Koumi, Hiroyuki; Mimura, Masaru; Fukui, Kenji; Narumoto, Jin			Greater Than the Sum of Its Parts: delta Improves Upon a Battery's Diagnostic Performance	NEUROPSYCHOLOGY			English	Article						CLOX; dementia; executive function; EXIT25; instrumental activities of daily living	DEFAULT-MODE NETWORK; CLOCK DRAWING TASK; ALZHEIMERS-DISEASE; EXECUTIVE INTERVIEW; DEMENTIAS BIOMARKERS; IMPAIRMENT; VALIDATION; BEDSIDE; MRI	Objective: "delta", a latent variable constructed from batteries that contain both cognitive and functional status measures, can accurately diagnose dementia relative to expert clinicians. The minimal assessment needed is unknown. Methods: We validated 2 delta homologs in a convenience sample of elderly Japanese persons with normal cognition (NC), mild cognitive impairment (MCI), and dementia (n = 176). The latent delta homolog "d" (for dementia) was constructed from Instrumental Activities of Daily Living (IADL) and Japanese translations of the Executive Clock-Drawing Task (CLOX), Frontal Assessment Battery (FAB), and Executive Interview (EXIT25). The latent delta homolog "d3" was constructed from a restricted set of d's factor loadings. Results: d and d3 were highly intercorrelated (r = .97) and strongly related to both IADL and dementia severity, as rated blindly by the Clinical Dementia Rating Scale (CDR). d was more strongly related to IADL and CDR than any of its indicators. In multivariate regression, d explained more variance in CDR scores than all of its indicators combined. d's areas under the receiver operating characteristic curve (AUC) were 0.95 for the discrimination between Alzheimer's disease (AD) vs. NC, 0.84 for AD vs. MCI and 0.81 for NC vs. MCI. d3's AUC's were statistically indiscriminable. These AUC's are higher than any of d's indicators, as reported recently by Matsuoka et al. (2014), as well as the Mini-Mental State Examination (MMSE), which had been made available by Matsuoka et al. to the CDR raters. Conclusions: Latent variables can improve upon a battery's diagnostic performance and offer the potential for accurate dementia case-finding after a minimal bedside assessment.	[Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Royall, Donald R.; Palmer, Raymond F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA; [Royall, Donald R.] GRECC, Audie L Murphy Div, South Texas Vet Hlth Syst, San Antonio, TX USA; [Matsuoka, Teruyuki; Kato, Yuka; Ogawa, Mayu; Fujimoto, Hiroshi; Nakamura, Kaeko; Fukui, Kenji; Narumoto, Jin] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Psychiat, Kyoto 602, Japan; [Taniguchi, Shogo] Reinan Hosp, Fukui, Japan; [Okamura, Aiko] Yashio Hosp, Saitama, Japan; [Shibata, Keisuke] Kawagoe Hosp, Kyoto, Japan; [Nakaaki, Shutaro; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 108, Japan; [Koumi, Hiroyuki] Hanazono Univ, Dept Clin Psychol, Fac Social Welf, Kyoto, Japan	Royall, DR (reprint author), UTHSCSA, Dept Psychiat, 7703 Floyd Curt Dr, San Antonio, TX 78299 USA.	royall@uthscsa.edu			"Redesigning Communities for Aged Society" project (Research Institute of Science and Technology for Society, Japan Science and Technology Agency: RISTEX, JST)	This research was supported by "Redesigning Communities for Aged Society" project (Research Institute of Science and Technology for Society, Japan Science and Technology Agency: RISTEX, JST). Dr. Royall is supported by the Julia and Van Buren Parr endowment for Alzheimer's-related research. D. R. Royall holds copyrights to the EXIT25 and CLOX. DRR and RFP have disclosed delta's invention to the University of Texas Health Science Center at San Antonio (UTHSCSA), which has filed patent application 2012.039.US1.HSCS and provisional patents 61/603,226 and 61/671,858 relating to the latent variable delta's construction and biomarkers. D. R. Royall invented delta, the CLOX, and EXIT25, designed the study, performed the analyses, and wrote the article. R. F. Palmer assisted in the analyses and with writing the article. J. Narumoto translated the J-EXIT25 and J-CLOX, collected data, and assisted with writing the article. All other authors collected the data, and assisted with editing the article.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Royall DR, 2012, J NEUROPSYCH CLIN N, V24, P37, DOI 10.1176/appi.neuropsych.11040078; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Royall DR, 2014, NEUROBIOL AGING, V35, P336, DOI 10.1016/j.neurobiolaging.2013.08.006; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Royall DR, 2013, J ALZHEIMERS DIS, V34, P547, DOI 10.3233/JAD-121639; ZWEIG MH, 1993, CLIN CHEM, V39, P561; Royall DR, 2012, J ALZHEIMERS DIS, V32, P467, DOI 10.3233/JAD-2012-120424; Dubois B, 2000, NEUROLOGY, V55, P1621; Matsuoka T, 2014, INT PSYCHOGERIATR, V26, P1387, DOI 10.1017/S104161021400088X; Royall DR, 2013, J ALZHEIMERS DIS, V37, P89, DOI 10.3233/JAD-130353; Royall DR, 2012, J ALZHEIMERS DIS, V30, P639, DOI 10.3233/JAD-2012-120055; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; ROYALL DR, 1993, AM J PSYCHIAT, V150, P1813; Zhou J, 2014, BIOL PSYCHIAT, V75, P565, DOI 10.1016/j.biopsych.2014.01.020; Royall DR, 2002, EXP AGING RES, V28, P143, DOI 10.1080/03610730252800166; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Royall DR, 2001, EXP AGING RES, V27, P293, DOI 10.1080/03610730109342350; LAWTON MP, 1969, GERONTOLOGIST, V9, P179; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Arbuckle J. L., 2006, AMOS VERSION 7 0 COM; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; Bollen K. A., 1993, TESTING STRUCTURAL E; Browne MW, 1993, SAGE FOCUS EDITIONS, V154, P136, DOI DOI 10.1080/10705511.2012.687671; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavett B. E., NEUROPSYCHO IN PRESS; Gottfredson L. S., 1997, INTELLIGENCE, V24, P24, DOI DOI 10.1016/S0160-2896(97)90014-3; Palmer R. F., 2013, 2013 ALZH ASS INT C; Royall D. R., 1999, J GERONTOL B-PSYCHOL, V54, P328; Royall DR, 2015, J ALZHEIMERS DIS, V43, P275, DOI 10.3233/JAD-140264; Spearman C., 1951, HUMAN ABILITY; Statistics P. A. S. W., 2009, 18 REL VERS 18 0 0; Sugishita M, 2012, MINI MENTAL STATE EX; Wheaton B., 1977, SOCIOL METHODOL, P84	40	7	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	SEP	2015	29	5					683	692		10.1037/neu0000153		10	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	CQ1UR	WOS:000360385900003		
J	Kim, SC; Okamoto, H				Kim, Sun-Chul; Okamoto, Hisashi			Unimodal patterns appearing in the Kolmogorov flows at large Reynolds numbers	NONLINEARITY			English	Article						Navier-Stokes equations; bifurcation; pattern formation	INCOMPRESSIBLE VISCOUS-FLUID; PROUDMAN-JOHNSON EQUATION; COMPUTER-ASSISTED PROOF; NAVIER-STOKES FLOW; 2-DIMENSIONAL TURBULENCE; DYNAMICS	We study stability and bifurcation of stationary and time-periodic solutions of Kolmogorov's problem for the Navier-Stokes equations in two-dimensional (2D) flat tori. Specifically we look for a unimodal solution, which is characterized by having a large, topologically simple pattern of streamlines. We present a conjecture that such simple patterns emerge in steady-states or time-periodic solutions at large Reynolds numbers, no matter what the external force may be. We confirm this conjecture by some numerical experiments. Thus the well-noted fact that a large structure appears in 2D large Reynolds number flows is reinforced in another form.	[Kim, Sun-Chul] Chung Ang Univ, Dept Math, Seoul 156756, South Korea; [Okamoto, Hisashi] Kyoto Univ, Math Sci Res Inst, Kyoto, Kyoto 6068502, Japan	Kim, SC (reprint author), Chung Ang Univ, Dept Math, 221 Heukseok Dong, Seoul 156756, South Korea.	okamoto@kurims.kyoto-u.ac.jp			Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education [NRF-2013R1A1A2004815]; JSPS [24244007]	Supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education(NRF-2013R1A1A2004815); Partially supported by JSPS Grant 24244007	LEITH CE, 1968, PHYS FLUIDS, V11, P671, DOI 10.1063/1.1691968; Kim SC, 2003, IMA J APPL MATH, V68, P119, DOI 10.1093/imamat/68.2.119; Armbruster D, 1996, PHYSICA D, V95, P81, DOI 10.1016/0167-2789(96)00006-1; Chandler GJ, 2013, J FLUID MECH, V722, P554, DOI 10.1017/jfm.2013.122; Kaneda Y, 2003, PHYS FLUIDS, V15, pL21, DOI 10.1063/1.1539855; OBUKHOV AM, 1983, RUSS MATH SURV+, V38, P113, DOI 10.1070/RM1983v038n04ABEH004207; ARNOLD VI, 1991, P ROY SOC LOND A MAT, V434, P19, DOI 10.1098/rspa.1991.0077; Batchelor G K, 1969, PHYS FLUIDS, V12, pII233; Bondarenko N F, 1979, IZV AS ATMOS OCEAN P, V15, P711; Burgess JM, 1999, PHYS REV E, V60, P715, DOI 10.1103/PhysRevE.60.715; Chen ZM, 1997, J STAT PHYS, V86, P301, DOI 10.1007/BF02180208; Chen ZM, 2005, COMMUN MATH PHYS, V256, P737, DOI 10.1007/s00220-005-1290-0; Funakoshi S, 2015, J PHYS C SE IN PRESS; Gallet B, 2013, J FLUID MECH, V715, P359, DOI 10.1017/jfm.2012.524; Govaerts W.J.F., 2000, NUMERICAL METHODS BI; Heywood J G, 1999, J MATH FLUID MECH, V1, P5, DOI 10.1007/s000210050002; Kim SC, 2010, JPN J IND APPL MATH, V27, P47, DOI 10.1007/s13160-010-0010-0; Kim SC, 2013, IMA J APPL MATH, V78, P379, DOI 10.1093/imamat/hxr054; KRAICHNA.RH, 1967, PHYS FLUIDS, V10, P1417, DOI 10.1063/1.1762301; Lucas D, 2014, J FLUID MECH, V750, P518, DOI 10.1017/jfm.2014.270; Nagatou K, 2004, J COMPUT APPL MATH, V169, P33, DOI 10.1016/j.cam.2003.10.016; Obuse K, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3407652; Kim SC, 2014, JPN J IND APPL MATH, V31, P541, DOI 10.1007/s13160-014-0146-4; Okamoto H., 1998, DOC MATH, V3, P523; Okamoto H., 1996, J DYN DIFFER EQU, V8, P203, DOI 10.1007/BF02218891; Okamoto H., 1993, JAPAN J IND APPL MAT, V10, P191; Okamoto H., 2012, P FAR FROM EQ DYN B, VB31, P93; Okamoto H, 2013, NAGARE, V32, P417; Sasaki E, 2010, RIMS KOKYUROKU, V1724, P212; SHE ZS, 1987, PHYS LETT A, V124, P161, DOI 10.1016/0375-9601(87)90244-1; Watanabe Y, 2009, J COMPUT APPL MATH, V223, P953, DOI 10.1016/j.cam.2008.03.034	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	SEP	2015	28	9					3219	3242		10.1088/0951-7715/28/9/3219		24	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CQ3KD	WOS:000360499900008		
J	Hisano, J; Kuwahara, T; Omura, Y				Hisano, Junji; Kuwahara, Takumi; Omura, Yuji			Threshold corrections to baryon number violating operators in supersymmetric SU(5) GUTs	NUCLEAR PHYSICS B			English	Article							RENORMALIZATION-GROUP EQUATIONS; GRAND UNIFIED MODELS; PROTON-DECAY; HIGGS-BOSON; HIGH-SCALE; UNIFICATION; MASS; ENHANCEMENT; BREAKING; PARTICLE	The nucleon decay is a significant phenomenon to verify grand unified theories (GUTs). For the precise prediction of the nucleon lifetime induced by the gauge bosons associated with the unified gauge group, it is important to include the renormalization effects on the Wilson coefficients of the dimension-six baryon number violating operators. In this study, we have derived the threshold corrections to these coefficients at the one-loop level in the minimal supersymmetric SU(5) GUT and the extended one with additional SU(5) vector-like pairs. As a result, it is found that the nucleon decay rate is suppressed about 5% in the minimal setup, and then the suppression could be O(10)% in the vector-like matter extensions. (C) 2015 The Authors. Published by Elsevier B.V.	[Hisano, Junji; Kuwahara, Takumi; Omura, Yuji] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan; [Hisano, Junji] Univ Tokyo, Kavli Inst Phys & Math Universe Kavli IPMU, Kashiwa, Chiba 2778568, Japan	Kuwahara, T (reprint author), Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan.	kuwahara@th.phys.nagoya-u.ac.jp			Ministry of Education, Science, Sports, and Culture (MEXT), Japan [24340047, 23104011]; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan	This work is supported by Grant-in-Aid for Scientific research from the Ministry of Education, Science, Sports, and Culture (MEXT), Japan, No. 24340047 (for J.H.) and No. 23104011 (for J.H. and Y.O.). The work of J.H. is also supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan.	Aad G., 2014, JHEP, V1405, P071; Aad G., 2014, J HIGH ENERGY PHYS, V1409, P176; Aad G., 2014, JHEP, V1411, P118; Abe K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.072005; Hisano J, 2012, PHYS LETT B, V716, P406, DOI 10.1016/j.physletb.2012.08.037; Aoki Y, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.014505; GRISARU MT, 1979, NUCL PHYS B, V159, P429, DOI 10.1016/0550-3213(79)90344-4; Khachatryan V, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.092007; NIHEI T, 1995, PROG THEOR PHYS, V93, P665, DOI 10.1143/PTP.93.665; SIEGEL W, 1979, PHYS LETT B, V84, P193, DOI 10.1016/0370-2693(79)90282-X; Martin SP, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.035004; MARTIN SP, 1994, PHYS REV D, V50, P2282, DOI 10.1103/PhysRevD.50.2282; Ibe M, 2012, PHYS LETT B, V709, P374, DOI 10.1016/j.physletb.2012.02.034; SAKAI N, 1982, NUCL PHYS B, V197, P533, DOI 10.1016/0550-3213(82)90457-6; GEORGI H, 1974, PHYS REV LETT, V32, P438, DOI 10.1103/PhysRevLett.32.438; MACHACEK ME, 1983, NUCL PHYS B, V222, P83, DOI 10.1016/0550-3213(83)90610-7; Hisano J, 2013, PHYS LETT B, V723, P324, DOI 10.1016/j.physletb.2013.05.017; WEINBERG S, 1982, PHYS REV D, V26, P287, DOI 10.1103/PhysRevD.26.287; Giudice GF, 2012, NUCL PHYS B, V858, P63, DOI 10.1016/j.nuclphysb.2012.01.001; HISANO J, 1993, NUCL PHYS B, V402, P46, DOI 10.1016/0550-3213(93)90636-4; MUNOZ C, 1986, PHYS LETT B, V177, P55, DOI 10.1016/0370-2693(86)90013-4; HISANO J, 1992, PHYS REV LETT, V69, P1014, DOI 10.1103/PhysRevLett.69.1014; Babu K., 2013, ARXIV13115285; Chatrchyan S, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2677-2; CMS Collab, 2012, JHEP; DANIEL M, 1984, NUCL PHYS B, V236, P467, DOI 10.1016/0550-3213(84)90546-7; Ghilencea D, 1998, NUCL PHYS B, V511, P3, DOI 10.1016/S0550-3213(97)00664-0; HISANO J, 1995, PHYS LETT B, V342, P138, DOI 10.1016/0370-2693(94)01342-A; Hisano J, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2013)038; Hisano J, 2013, PHYS LETT B, V724, P283, DOI 10.1016/j.physletb.2013.06.030; Ibe M, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.095011; Khachatryan V., 2014, ARXIV14124109; Khachatryan V, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-3036-7; Martin S.P., 2010, ADV SER DIRECT HIGH, V21, P1, DOI DOI 10.1142/9789814307505_; Nagata N., 2014, J HIGH ENERGY PHYS, V1403, P049; OVRUT BA, 1982, PHYS REV D, V25, P409, DOI 10.1103/PhysRevD.25.409; SAKAI N, 1981, Z PHYS C PART FIELDS, V11, P153, DOI 10.1007/BF01573998; Shiozawa M., TAUP 2013 AS CA; Aad G, 2012, PHYS LETT B, V716, P1, DOI 10.1016/j.physletb.2012.08.020; Chatrchyan S, 2012, PHYS LETT B, V716, P30, DOI 10.1016/j.physletb.2012.08.021	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	SEP	2015	898						1	29		10.1016/j.nuclphysb.2015.06.022		29	Physics, Particles & Fields	Physics	CQ2LF	WOS:000360431100001		
J	Kanemura, S; Yokoya, H; Zheng, YJ				Kanemura, Shinya; Yokoya, Hiroshi; Zheng, Ya-Juan			Searches for additional Higgs bosons in multi-top-quarks events at the LHC and the International Linear Collider	NUCLEAR PHYSICS B			English	Article							SYMMETRY-BREAKING; DOUBLET MODEL; BOUNDS; COUPLINGS; PHYSICS; SECTOR; SIGNAL	We study direct searches of additional Higgs bosons in multi-top-quarks events at the LHC Run-II, its luminosity upgraded version with 3000 fb(-1), and the International Linear Collider (ILC) with the collision energy of 1 TeV. Additional Higgs bosons are predicted in all kinds of extended Higgs sectors, and their detection at collider experiments is a clear signature of the physics beyond the standard model. We consider two Higgs doublet models with the discrete symmetry as benchmark models. If these additional Higgs bosons are heavy enough, the decay modes including top quarks can be dominant, and the searches in multi-top-quarks events become an important probe of the Higgs sector. We evaluate the discovery reach in the parameter space of the model, and find that there are parameter regions where the searches at the LHC with 3000 fb(-1) cannot survey, but the searches at the ILC 1 TeV run can. The combination of direct searches at the LHC and the ILC is useful to explore extended Higgs sectors. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license.	[Kanemura, Shinya; Yokoya, Hiroshi] Toyama Univ, Dept Phys, Toyama 9308555, Japan; [Yokoya, Hiroshi] KEK, Ctr Theory, Tsukuba, Ibaraki 3050801, Japan; [Zheng, Ya-Juan] Natl Taiwan Univ, CTS, CASTS, Taipei 10617, Taiwan; [Zheng, Ya-Juan] Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan	Yokoya, H (reprint author), Toyama Univ, Dept Phys, Toyama 9308555, Japan.	kanemu@sci.u-toyama.ac.jp; hyokoya@sci.u-toyama.ac.jp; yjzheng218@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [22244031, 23104006, 24340046]; NSC of ROC	H.Y. thanks Quantum Universe Center at KIAS for the warm hospitality. This work was supported, in part, by Grant-in-Aid for Scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, Nos. 22244031, 23104006 and 24340046, and NSC of ROC.	Aad G., PHYS REV LETT, V114; Aad G, 2013, PHYS LETT B, V726, P120, DOI 10.1016/j.physletb.2013.08.026; Aarons G., ARXIV07091893HEPPH; Aguilar-Saavedra JA, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.034021; Alwall J., 2011, JHEP, V1106, P128, DOI [DOI 10.1007/JHEP06(2011)128.ARXIV:1106.0522, DOI 10.1007/JHEP06(2011)128]; GROSSMAN Y, 1994, NUCL PHYS B, V426, P355, DOI 10.1016/0550-3213(94)90316-6; DESHPANDE NG, 1978, PHYS REV D, V18, P2574, DOI 10.1103/PhysRevD.18.2574; KANEMURA S, 1993, PHYS LETT B, V313, P155, DOI 10.1016/0370-2693(93)91205-2; Han CC, 2012, PHYS LETT B, V714, P295, DOI 10.1016/j.physletb.2012.07.021; Kanemura S, 2002, PHYS LETT B, V530, P188, DOI 10.1016/S0370-2693(02)01321-7; Nie SQ, 1999, PHYS LETT B, V449, P89, DOI 10.1016/S0370-2693(99)00019-2; BARGER V, 1990, PHYS REV D, V41, P3421, DOI 10.1103/PhysRevD.41.3421; Chen CR, 2014, PHYS LETT B, V736, P321, DOI 10.1016/j.physletb.2014.07.041; Branco GC, 2012, PHYS REP, V516, P1, DOI 10.1016/j.physrep.2012.02.002; Djouadi A, 2008, PHYS REP, V459, P1, DOI 10.1016/j.physrep.2007.10.005; Aad G, 2013, PHYS LETT B, V726, P88, DOI 10.1016/j.physletb.2013.08.010; JADACH S, 1993, COMPUT PHYS COMMUN, V76, P361, DOI 10.1016/0010-4655(93)90061-G; Borzumati F, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.115011; Kanemura S, 1999, PHYS LETT B, V471, P182, DOI 10.1016/S0370-2693(99)01351-9; Plehn T, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.014018; Chatrchyan S, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.092007; Barger V, 2010, PHYS LETT B, V687, P70, DOI 10.1016/j.physletb.2010.03.001; Aoki M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.015017; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Kanemura S, 2015, NUCL PHYS B, V896, P80, DOI 10.1016/j.nuclphysb.2015.04.015; Akeroyd AG, 2000, PHYS LETT B, V490, P119, DOI 10.1016/S0370-2693(00)00962-X; Gunion JF, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.075019; Kanemura S, 2014, NUCL PHYS B, V886, P524, DOI 10.1016/j.nuclphysb.2014.07.007; GLASHOW SL, 1977, PHYS REV D, V15, P1958, DOI 10.1103/PhysRevD.15.1958; GUNION JF, 1988, PHYS REV D, V38, P3444, DOI 10.1103/PhysRevD.38.3444; Asner D. M., ARXIV13100763HEPPH; ATLAS Collaboration, ATLPHSYCOM2008063; Battaglia M, 2010, Nuovo Cimento C, V33C, DOI 10.1393/ncc/i2010-10611-4; Beck L, 2015, PHYS LETT B, V746, P48, DOI 10.1016/j.physletb.2015.04.043; Behnke T., ARXIV13066329PHYSICS; Berger EL, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.115012; Bevilacqua G., 2012, JHEP, V1207, P111; Bicer M, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2014)164; Cacciapaglia G., 2011, JHEP, V1110, P042; Cacciari M, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-1896-2; Cao QH, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.075008; Bern Z, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.014025; CATANI S, 1991, PHYS LETT B, V269, P432, DOI 10.1016/0370-2693(91)90196-W; CHATRCHYAN S., 2014, J HIGH ENERGY PHYS, V1401, P096, DOI DOI 10.1007/JHEP01(2014)096; Chen CR, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.054002; Cheng XD, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-3081-2; Cheung K.-m., ARXIVHEPPH9507411; Craig N., 2015, J HIGH ENERGY PHYS, V1506, P137; Dawson S., ARXIV13108361HEPEX; Dev P. S. B., 2014, J HIGH ENERGY PHYS, V1412, P024; Djouadi A, 1996, PHYS LETT B, V375, P203, DOI 10.1016/0370-2693(96)00244-4; Ellis R. K., 1996, CAMBRIDGE MONOGR PAR, V8, P1; Ginzburg I. F., 2005, PHYS REV D, V72, P11501; Gregoire T, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.055024; Greiner N., 2015, J HIGH ENERGY PHYS, V1504, P029; Gunion J.F., 2000, FRONT PHYS, V80, P1; Hajer J., ARXIV150407617HEPPH; Jung S., 2010, JHEP, V1011, P001; Kanemura S, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.055010; Kanemura S, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.095001; Kanemura S, 2001, J HIGH ENERGY PHYS; Kanemura S, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.075001; Khachatryan V., 2014, J HIGH ENERGY PHYS, V1411, P154; Kiyoura S., ARXIVHEPPH0301172; Lillie B., 2008, JHEP, V0804, P087; Linssen L., ARXIV12025940PHYSICS; Mahmoudi F, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.035016; Moretti S., 2002, EUR PHYS J DIRECT C, V4, P15; Pumplin J., 2002, JHEP, V0207, P012, DOI [10.1088/1126-6708/2002/07/012, DOI 10.1088/1126-6708/2002/07/012]; Sjostrand T, 2006, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2006/05/026; Spira M, 1998, NUCL PHYS B, V523, P3, DOI 10.1016/S0550-3213(98)00107-2; The ATLAS Collaboration, ATLASCONF2013051; Yonamine R, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.014033	73	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	SEP	2015	898						286	300		10.1016/j.nuclphysb.2015.07.005		15	Physics, Particles & Fields	Physics	CQ2LF	WOS:000360431100015		
J	Kawano, T; Matsumiya, N				Kawano, Teruhiko; Matsumiya, Nariaki			5D SYM on 3D deformed spheres	NUCLEAR PHYSICS B			English	Article							SUPERGRAVITY; MODEL; YM	We reconsider the relation of superconformal indices of superconformal field theories of class S with five-dimensional N = 2 supersymmetric Yang-Mills theory compactified on the product space of a round three-sphere and a Riemann surface. We formulate the five-dimensional theory in supersymmetric backgrounds preserving N = 2 and N = 1 supersymmetries and discuss a subtle point in the previous paper concerned with the partial twisting on the Riemann surface. We further compute the partition function by localization of the five-dimensional theory on a squashed three-sphere in N = 2 and N = 1 supersymmetric backgrounds and on an ellipsoid three-sphere in an N = 1 supersymmetric background. (C) 2015 The Authors. Published by Elsevier B.V.	[Kawano, Teruhiko] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Matsumiya, Nariaki] Sumitomo Heavy Ind Ltd, Yokosuka, Kanagawa 2378555, Japan	Kawano, T (reprint author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.	kawano@hep-th.phys.s.u-tokyo.ac.jp			MEXT of Japan [23540286]	We would like to thank Fumitaka Fukui for collaborations at the early stage of this work. We are grateful to Kazuo Hosomichi, Yosuke Imamura, and Hiroki Matsuno for helpfuldiscussions. We would like to thank Yuji Tachikawa for helpful discussions on many crucial points. The work of T.K. was supported in part by a Grant-in-Aid #23540286 from the MEXT of Japan.	Bah I, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.121901; Kugo T, 2000, PROG THEOR PHYS, V104, P835, DOI 10.1143/PTP.104.835; Aganagic M, 2005, NUCL PHYS B, V715, P304, DOI 10.1016/j.nuclphysb.2005.02.035; Hosomichi K, 2012, NUCL PHYS B, V865, P376, DOI 10.1016/j.nuclphysb.2012.08.007; Imamura Y, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.025015; Kinney J, 2007, COMMUN MATH PHYS, V275, P209, DOI 10.1007/s00220-007-0258-7; Fukuda Y, 2013, NUCL PHYS B, V869, P493, DOI 10.1016/j.nuclphysb.2012.12.017; Gadde A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.241602; Bah I, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2012)005; Bah I., 2013, J HIGH ENERGY PHYS, V1307, P107; Beem C., 2014, J HIGH ENERGY PHYS, V1404, P036; Benini F., 2010, JHEP, V1001, P088; Bergshoeff E, 1999, CLASSICAL QUANT GRAV, V16, P3193, DOI 10.1088/0264-9381/16/10/311; BLAU M, 1993, NUCL PHYS B, V408, P345, DOI 10.1016/0550-3213(93)90538-Z; Blau M., ARXIVHEPTH9310144; Bytsko AG, 2006, J PHYS A-MATH GEN, V39, P12927, DOI 10.1088/0305-4470/39/41/S11; Cordova C., ARXIV13052891; Cordova C., ARXIV13052886; Festuccia G, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2011)114; Freedman DZ, 2012, SUPERGRAVITY, P1, DOI 10.1017/CBO9781139026833; Gadde A, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2010)032; Gaiotto D., 2012, JHEP, V1208, P034; Gaiotto D, ARXIV09073987; Gaiotto D., 2013, PROG THEOR EXP PHYS, V2013; Hama N, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2011)127; Hama N, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2011)014; Imamura Y., ARXIV14040210; Kawano T, 2012, PHYS LETT B, V716, P450, DOI 10.1016/j.physletb.2012.08.055; Kharchev S, 2002, COMMUN MATH PHYS, V225, P573, DOI 10.1007/s002200100592; Kugo T., 1989, QUANTUM THEORY GAUGE, V1; Lee S, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2013)035; Rastelli, ARXIV14127131; Tachikawa Y., ARXIV150401481; Tachikawa Y, 2013, PTEP, V2013; Yagi J, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2013)017; Yonekura K, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2014)142	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	SEP	2015	898						456	562		10.1016/j.nuclphysb.2015.07.018		107	Physics, Particles & Fields	Physics	CQ2LF	WOS:000360431100021		
J	Hosono, S				Hosono, Shinobu			Moduli spaces of Calabi-Yau complete intersections	NUCLEAR PHYSICS B			English	Article							MIRROR SYMMETRY; HYPERSURFACES; SYSTEMS; MAP	In this short note, based on the work [7] in 1994, we describe compactifications of moduli spaces of Calabi-Yau complete intersections in Gorenstein toric Fano varieties. (C) 2015 The Author. Published by Elsevier B.V.	Gakushuin Univ, Dept Math, Toshima Ku, Tokyo 1718588, Japan	Hosono, S (reprint author), Gakushuin Univ, Dept Math, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	hosono@math.gakushuin.ac.jp			 [C 18540014];  [S 24224001]	The author would like to sincerely thank Professor S.-T. Yau for his constant supports and encouragements since his stay at Harvard 1992-1993. This paper is dedicated to Professor S.-T. Yau on the occasion of his 65th birthday, and is supported in part by Grant-in Aid Scientific Research (C 18540014, S 24224001).	Batyrev VV, 1996, HIGHER DIMENSIONAL COMPLEX VARIETIES, P39; HOSONO S, 1995, NUCL PHYS B, V433, P501, DOI 10.1016/0550-3213(94)00440-P; ASPINWALL PS, 1993, PHYS LETT B, V303, P249, DOI 10.1016/0370-2693(93)91428-P; HOSONO S, 1995, COMMUN MATH PHYS, V167, P301, DOI 10.1007/BF02100589; Batyrev V. V., 1994, J ALGEBRAIC GEOM, V3, P493; Batyrev V.V., 1997, MIRROR SYMMETRY 2 AM, V1, P71; Gel'fand I.M., 1989, ANAL APPL, V23, p[12, 94]; Gel'fand I.M., 1994, DISCRIMINANTS RESULT; Hosono S, 1997, J AM MATH SOC, V10, P427, DOI 10.1090/S0894-0347-97-00230-0; Hosono S, 1996, COMMUN MATH PHYS, V182, P535, DOI 10.1007/BF02506417; Hosono S, 2014, J ALGEBRAIC GEOM, V23, P279; Jockers H, 2014, COMMUN MATH PHYS, V325, P1139, DOI 10.1007/s00220-013-1874-z	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	SEP	2015	898						661	666		10.1016/j.nuclphysb.2015.04.001		6	Physics, Particles & Fields	Physics	CQ2LF	WOS:000360431100027		
J	Araya, A; Shinohara, M; Kanazawa, T; Fujimoto, H; Yamada, T; Ishihara, T; Iizasa, K; Tsukioka, S				Araya, A.; Shinohara, M.; Kanazawa, T.; Fujimoto, H.; Yamada, T.; Ishihara, T.; Iizasa, K.; Tsukioka, S.			Development and demonstration of a gravity gradiometer onboard an autonomous underwater vehicle for detecting massive subseafloor deposits	OCEAN ENGINEERING			English	Article						Seafloor deposit; Hybrid gravity survey; Gravity gradiometer; Forced gimbal; AUV	GRAVIMETER	Gravity surveys are used to detect underground density structures. Hybrid survey configurations using a gravimeter and a gravity gradiometer are particularly effective in this regard. A gravity gradiometer was developed for use in hybrid gravity surveys of massive subseafloor deposits. Its performance was evaluated in an ocean-based trial using an autonomous underwater vehicle (AUV). The gradiometer consisted of two identical vertical long-period pendulums, acting as gravity sensors, with a separation of 0.44 m. The self-noise of the gradiometer was estimated to be 6 E (6 x 10(-9)/s(2)) at 2-50 mHz, with which the gravity gradient signal could be detected when the AUV was above a typical ore deposit. The gravity gradiometer was mounted on a forced gimbal vertically controlled by fiber optic gyroscopes and tiltmeters. The ocean-based trial observation performed at a depth of approximately 1300 m in Sagami Bay using the AUV Urashima (JAMSTEC) showed that the system operated steadily on a moving platform except during periods of extreme motion, such as turning and pitching. The resulting gravity gradient was highly affected by the motion of the platform and the estimated resolution was 3 x 102 E, which was mainly limited by the noise of the recording system. (C) 2015 Elsevier Ltd. All rights reserved.	[Araya, A.; Shinohara, M.; Yamada, T.; Ishihara, T.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Kanazawa, T.] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; [Fujimoto, H.] Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Iizasa, K.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Tsukioka, S.] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Araya, A (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	araya@eri.u-tokyo.ac.jp			MEXT, Japan	We thank Dr. Yoshiaki Tamura and Dr. Tsuneya Tsubokawa for their help with the measurements performed at the Esashi Earth Tides Station of the National Astronomical Observatory. We also thank Mr. Yuichi Shirasaki, Mr. Tsuyoshi Yoshiume, Mr. Shinobu Omika, and Mr. Takeo Yagi for their help during the ocean-based trial observation. This research was supported by a fund of the MEXT, Japan, for the development of an underwater gravimetry system for searching subseafloor hydrothermal mineral deposits.	DiFrancesco D, 2009, GEOPHYS PROSPECT, V57, P615, DOI 10.1111/j.1365-2478.2008.00764.x; Niebauer TM, 1995, METROLOGIA, V32, P159, DOI 10.1088/0026-1394/32/3/004; WIELANDT E, 1982, B SEISMOL SOC AM, V72, P2349; Li YG, 1998, GEOPHYSICS, V63, P109, DOI 10.1190/1.1444302; HUMPHRIS SE, 1995, NATURE, V377, P713, DOI 10.1038/377713a0; Aoki T., 2001, P OCEANS 2001 MTS IE, V1, P462; Araya A., 2011, P S UND TECHN 2011 W, P1064; Araya A., 2012, P OCEANS 2012 IEEE H, P120601; Araya A., 2007, P INT S UND TECHN IE, P245; Childers VA, 1999, GEOPHYSICS, V64, P61, DOI 10.1190/1.1444530; Fujimoto H., 2009, J GEOD SOC JAPAN, V55, P325; Fujimoto H., 2011, P S UND TECHN 2011 W, V1111; Jousset M., 1995, METROLOGIA SEVRES, V32, P231; Kanazawa T., 2011, P 22 OC ENG S TOK; LONGUETHIGGINS MS, 1950, PHILOS TR R SOC S-A, V243, P1, DOI 10.1098/rsta.1950.0012; Moody MV, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3632114; Sasagawa GS, 2003, GEOPHYSICS, V68, P544, DOI 10.1190/1.1567223; Segawa J, 2005, EARTH PLANETS SPACE, V57, P243; Tsukioka S, 2005, MAR TECHNOL SOC J, V39, P56; Zumberge M, 2008, GEOPHYSICS, V73, pWA133, DOI 10.1190/1.2976777	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0029-8018			OCEAN ENG	Ocean Eng.	SEP 1	2015	105						64	71		10.1016/j.oceaneng.2015.06.008		8	Engineering, Marine; Engineering, Civil; Engineering, Ocean; Oceanography	Engineering; Oceanography	CQ2GI	WOS:000360417700007		
J	Hayakawa, K; Kimura, F				Hayakawa, Kazunobu; Kimura, Fukunari			How Much Do Free Trade Agreements Reduce Impediments to Trade?	OPEN ECONOMIES REVIEW			English	Article						Tariff rates; Non-tariff barriers; Free Trade Agreement; World Trade Organization; Simulation	BILATERAL TRADE; WTO; MEMBERS	This paper empirically investigates how far free trade agreements (FTAs) successfully lower tariff rates and non-tariff barriers (NTBs) for manufacturing industries by employing the bilateral tariff and NTB data in time series for countries in the world. We find that FTAs under GATT Article XXIV and the Enabling Clause are associated with the 2.0 and 1.5 % lower tariff rates, respectively. In the case of NTBs, on the other hand, their respective effects are 2.1 and 2.4 %. Also, compared with these effects of FTAs, WTO membership does not have large effects on tariff rates but does have them on NTBs. These results provide important implication for the literature on the numerical assessment of FTAs.	[Hayakawa, Kazunobu] Bangkok Res Ctr, Inst Developing Econ, Bangkok 10330, Thailand; [Kimura, Fukunari] Keio Univ, Fac Econ, Minato Ku, Tokyo 1088345, Japan	Hayakawa, K (reprint author), Bangkok Res Ctr, Inst Developing Econ, 16th Floor,Nantawan Bldg, Bangkok 10330, Thailand.	kazunobu_hayakawa@ide-jetro.org; fkimura@econ.keio.ac.jp					Anderson JE, 2004, J ECON LIT, V42, P691, DOI 10.1257/0022051042177649; Subramanian A, 2007, J INT ECON, V72, P151, DOI 10.1016/j.jinteco.2006.07.007; Rose AK, 2004, AM ECON REV, V94, P98, DOI 10.1257/000282804322970724; Rose AK, 2004, J INT ECON, V63, P209, DOI 10.1016/S0022-1996(03)00071-0; Bagwell K, 2011, AM ECON REV, V101, P1238, DOI 10.1257/aer.101.4.1238; Baier SL, 2007, J INT ECON, V71, P72, DOI 10.1016/j.jinteco.2006.02.005; Kee HL, 2009, ECON J, V119, P172; Winchester N, 2009, J POLICY MODEL, V31, P819, DOI 10.1016/j.jpolmod.2009.08.004; Baldwin Richard E., 2010, Journal of Economic Integration, V25, P276; Caporale GM, 2009, REV WORLD ECON, V145, P189, DOI 10.1007/s10290-009-0011-8; Chang PL, 2007, J INT ECON, V85, P53; Demidova S, 2008, ECON LETT, V98, P122, DOI 10.1016/j.econlet.2007.04.020; Engelbrecht HJ, 2007, APPL ECON, V39, P1573, DOI 10.1080/00036840600592874; Estevadeordal A, 2008, Q J ECON, V123, P1531, DOI 10.1162/qjec.2008.123.4.1531; Felbermayr GJ, 2011, OPEN ECON REV, V22, P93, DOI 10.1007/s11079-009-9114-z; Hayakawa K, 2013, J JPN INT ECON, V27, P81, DOI 10.1016/j.jjie.2013.01.002; Medvedev D, 2010, REV WORLD ECON, V146, P199, DOI 10.1007/s10290-010-0054-x; Petri AP, 2011, E W CTR WORKING PAPE, V119; Plummer M, 2006, ECON INTEGRATION, V107, P59; Rose AK, 2005, OPEN ECON REV, V16, P7, DOI 10.1007/s11079-005-5329-9; Roy J, 2010, REV INT ECON, V18, P663, DOI 10.1111/j.1467-9396.2010.00904.x; Vicard V, 2009, REV WORLD ECON, V145, P167, DOI 10.1007/s10290-009-0010-9	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-7992	1573-708X		OPEN ECON REV	Open Econ. Rev.	SEP	2015	26	4					711	729		10.1007/s11079-014-9332-x		19	Economics	Business & Economics	CQ1WJ	WOS:000360390600005		
J	Verkicharla, PK; Ohno-Matsui, K; Saw, SM				Verkicharla, Pavan Kumar; Ohno-Matsui, Kyoko; Saw, Seang Mei			Current and predicted demographics of high myopia and an update of its associated pathological changes	OPHTHALMIC AND PHYSIOLOGICAL OPTICS			English	Review						choroidal thickness; eye shape; pathologic myopia; prevalence; scleral thickness	OPTICAL COHERENCE TOMOGRAPHY; SUBFOVEAL CHOROIDAL THICKNESS; CHINESE ADULT-POPULATION; VISUAL IMPAIRMENT; BEIJING EYE; LOW-VISION; RISK-FACTORS; ELDERLY CHINESE; SHIHPAI EYE; HANDAN-EYE	PurposeExcessive axial elongation of the eye in high myopia can cause biomechanical stretching leading to various ocular complications. The purpose of this review is to provide an update on various pathologic changes, especially in the chorio-retina and sclera that have been reported recently using advanced ophthalmic bio-imaging modalities such as optical coherence tomography, magnetic resonance imaging and fundus photography. Recent findingsThe prevalence rates of pathologic myopia (myopic retinopathy and maculopathy) mirror the prevalence rates of high myopia as the risks of pathologic myopia increase with high myopia. Peripapillary and sub-foveal choroidal thinning, scleral thinning, and deformed/irregular eye shapes were found to be strongly associated with various pathologic myopic lesions, especially with posterior staphyloma and chorio-retinal atrophy. Considering the increasing prevalence rate of myopia and pathologic myopia, these degenerative changes are likely to increase dramatically over the next few decades due to the rapid growth in the number of individuals with high myopia and the ageing population. SummaryThe current prevalence rates of pathologic myopia in older adults might have significantly underestimated the future prevalence rates and warrants age of onset of myopia being considered a major risk factor for pathologic myopia. Using advanced technology, identification of novel quantifiable chorio-retinal and scleral parameters in pathologic myopia would help to identify people at risk of developing pathologic myopia and potentially may revolutionise the management of myopia especially in risk prognostication and monitoring of disease progression.	[Verkicharla, Pavan Kumar; Saw, Seang Mei] The Acad, Myopia Res Grp, Singapore Eye Res Inst, Singapore, Singapore; [Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Clin Res Ctr, Tokyo, Japan; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	Saw, SM (reprint author), The Acad, Myopia Res Grp, Singapore Eye Res Inst, Singapore, Singapore.	seang_mei_saw@nuhs.edu.sg					Nishida Y, 2012, RETINA-J RET VIT DIS, V32, P1229, DOI 10.1097/IAE.0b013e318242b990; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Buch H, 2001, OPHTHALMOLOGY, V108, P2347, DOI 10.1016/S0161-6420(01)00823-5; Moriyama M, 2012, INVEST OPHTH VIS SCI, V53, P4510, DOI 10.1167/iovs.12-9426; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Imamura Y, 2011, AM J OPHTHALMOL, V151, P297, DOI 10.1016/j.ajo.2010.08.014; Cedrone C, 2006, EYE, V20, P661, DOI 10.1038/sj.eye.6701934; Saw SM, 2006, BRIT J OPHTHALMOL, V90, P525, DOI 10.1136/bjo.2005.087999; Wong TY, 2014, AM J OPHTHALMOL, V157, P9, DOI 10.1016/j.ajo.2013.08.010; Moriyama M, 2011, OPHTHALMOLOGY, V118, P1626, DOI 10.1016/j.ophtha.2011.01.018; Ohno-Matsui K, 2012, INVEST OPHTH VIS SCI, V53, P6046, DOI 10.1167/iovs.12-10161; Kobayashi K, 2005, JPN J OPHTHALMOL, V49, P306, DOI 10.1007/S10384-004-0204-6; Samarawickrama C, 2011, OPHTHALMOLOGY, V118, P2050, DOI 10.1016/j.ophtha.2011.02.040; Asakuma T, 2012, OPHTHALMOLOGY, V119, P1760, DOI 10.1016/j.ophtha.2012.02.034; Hsu WM, 2004, OPHTHALMOLOGY, V111, P62, DOI 10.1016/j.ophtha.2003.05.011; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Zheng YF, 2013, INVEST OPHTH VIS SCI, V54, P7532, DOI 10.1167/iovs.13-12795; Liang YB, 2008, OPHTHALMOLOGY, V115, P1965, DOI 10.1016/j.ophtha.2008.05.030; Gao LQ, 2011, ARCH OPHTHALMOL-CHIC, V129, P1199, DOI 10.1001/archophthalmol.2011.230; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Verkicharla PK, 2012, OPHTHAL PHYSL OPT, V32, P184, DOI 10.1111/j.1475-1313.2012.00906.x; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Chang L, 2013, AM J OPHTHALMOL, V155, P991, DOI 10.1016/j.ajo.2013.01.016; Chebil A, 2014, J FR OPHTALMOL, V37, P138, DOI 10.1016/j.jfo.2013.11.001; Chen SJ, 2012, INVEST OPHTH VIS SCI, V53, P4868, DOI 10.1167/iovs.12-9919; Chen WH, 2014, J CO2 UTIL, V5, P1, DOI 10.1016/j.jcou.2013.11.001; Cruciani F, 2011, CLIN TER, V162, pE35; Ellabban Abdallah A, 2012, Clin Ophthalmol, V6, P837, DOI 10.2147/OPTH.S30907; Fledelius HC, 2010, ACTA OPHTHALMOL, V88, P521, DOI 10.1111/j.1755-3768.2009.01550.x; Flores-Moreno I, 2013, BRIT J OPHTHALMOL, V97, P1010, DOI 10.1136/bjophthalmol-2012-302836; Gupta P, 2014, ACTA OPHTHA IN PRESS, DOI [10.1111/aos.12631, DOI 10.1111/AOS.12631]; Gupta P, 2015, INVEST OPHTH VIS SCI, V56, P1475, DOI 10.1167/iovs.14-15742; Hayashi M, 2013, EYE, V27, P410, DOI 10.1038/eye.2012.289; Healey PR, 2007, INVEST OPHTH VIS SCI, V48, P2529, DOI 10.1167/iovs.06-0714; Henaine-Berra A, 2013, OPHTHAL SURG LAS IM, V44, P140, DOI 10.3928/23258160-20130219-01; Koh VTC, 2013, ANN ACAD MED SINGAP, V42, P216; Maruko I, 2012, INVEST OPHTH VIS SCI, V53, P3834, DOI 10.1167/iovs.12-9811; Miyake M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107923; Mo Y, 2010, INT J OPHTHALMOL-CHI, V3, P80, DOI 10.3980/j.issn.2222-3959.2010.01.19; Ohno-Matsui K, 2015, AM J OPHTHALMOL, V159, P877, DOI 10.1016/j.ajo.2015.01.022; Pan CW, 2015, OPTOMETRY VISION SCI, V92, P258, DOI 10.1097/OPX.0000000000000516; Parravano M, 2014, OPHTHALMIC RES, V52, P97, DOI 10.1159/000362880; Shao L, 2014, AM J OPHTHALMOL, V158, P702, DOI 10.1016/j.ajo.2014.05.023; Wang NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053660; Wang SM, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0059-2	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-5408	1475-1313		OPHTHAL PHYSL OPT	Ophthalmic Physiol. Opt.	SEP	2015	35	5					465	475		10.1111/opo.12238		11	Ophthalmology	Ophthalmology	CP9NC	WOS:000360220100002		
J	Yamamoto, A; Okada, AA; Kano, M; Koizumi, H; Saito, M; Maruko, I; Sekiryu, T; Iida, T				Yamamoto, Akiko; Okada, Annabelle A.; Kano, Mariko; Koizumi, Hideki; Saito, Masaaki; Maruko, Ichiro; Sekiryu, Tetsuju; Iida, Tomohiro			One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy	OPHTHALMOLOGY			English	Article							SHORT-TERM EFFICACY; VEGF TRAP-EYE; PHOTODYNAMIC THERAPY; MACULAR DEGENERATION; JAPANESE PATIENTS; RANIBIZUMAB INJECTIONS; CLINICAL CHARACTERISTICS; VISUAL-ACUITY; VERTEPORFIN; BEVACIZUMAB	Purpose: To investigate 1-year outcomes of intravitreal aflibercept for polypoidal choroidal vasculopathy (PCV). Design: Retrospective, multicenter, consecutive case series. Participants: A total of 90 eyes of 87 patients with treatment-naive PCV followed at 3 tertiary centers. Methods: Clinical records were reviewed and imaging studies were analyzed of eyes with PCV that underwent 3 consecutive monthly aflibercept injections followed by injections every 2 months. Additional (rescue) injections were performed for worsening. Main Outcome Measures: Best-corrected visual acuity (BCVA), optical coherence tomography (OCT), and angiographic findings at 1 year. Results: The mean BCVA (logarithm of the minimum angle of resolution units) of the 90 eyes improved from 0.31 at baseline to 0.17 at 12 months (P < 0.001). The mean central retinal thickness decreased from 315 mm at baseline to 204 mm at 12 months (P < 0.001). At 12 months, 64 eyes (71.1%) achieved a dry macula, defined as absence of intraretinal or subretinal fluid on OCT. Of 83 eyes that underwent indocyanine green angiography at both baseline and 12 months, 46 (55.4%) showed complete and 27 (32.5%) showed partial resolution of polypoidal lesions. Eleven of 82 eyes (13.4%) showed decreased size of branching choroidal vascular networks. Conclusions: Intravitreal aflibercept administered over 1 year improved both visual acuity and macular morphology in a large number of treatment-naive eyes with PCV. (C) 2015 by the American Academy of Ophthalmology.	[Yamamoto, Akiko; Okada, Annabelle A.] Kyorin Univ, Sch Med, Dept Ophthalmol, Mitaka, Tokyo 1818611, Japan; [Kano, Mariko; Saito, Masaaki; Sekiryu, Tetsuju] Fukushima Med Univ, Dept Ophthalmol, Fukushima, Japan; [Koizumi, Hideki; Maruko, Ichiro; Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo, Japan	Okada, AA (reprint author), Kyorin Univ, Sch Med, Dept Ophthalmol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	aokada@eye-center.org			Novartis Pharma K.K. (Japan); Bayer Yakuhin, Ltd. (Japan); Santen Pharmaceutical Co., Ltd. (Japan); Pfizer Japan, Inc.; Novartis AG; Bayer Healthcare AG; Mitsubishi Tanabe Pharma Corporation (Japan)	The author(s) have made the following disclosure(s): A.Y.: Personal fees - Novartis Pharma K.K. (Japan), Bayer Yakuhin, Ltd. (Japan), Santen Pharmaceutical Co., Ltd. (Japan), outside the submitted work.; A.A.O.: Personal fees - Novartis Pharma K.K. (Japan), Bayer Yakuhin, Ltd. (Japan); Pfizer Japan, Inc., Santen Pharmaceutical Co., Ltd. (Japan), Novartis AG, Bayer Healthcare AG; Grants and personal fees - Mitsubishi Tanabe Pharma Corporation (Japan), outside the submitted work.; T.I.: Personal fees - Bayer Yakuhin, Ltd. (Japan); Grants and personal fees - Novartis Pharma K.K. (Japan), Santen Pharmaceutical Co., Ltd. (Japan), outside the submitted work.	Hirami Y, 2007, RETINA-J RET VIT DIS, V27, P335, DOI 10.1097/01.iae.0000233647.78726.46; Mori R, 2013, JPN J OPHTHALMOL, V57, P365, DOI 10.1007/s10384-013-0245-9; Hikichi T, 2012, AM J OPHTHALMOL, V154, P117, DOI 10.1016/j.ajo.2011.12.019; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Stewart MW, 2012, BRIT J OPHTHALMOL, V96, P1157, DOI 10.1136/bjophthalmol-2011-300654; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Tsuchiya D, 2009, RETINA-J RET VIT DIS, V29, P960, DOI 10.1097/IAE.0b013e3181a3b7c5; Obata R, 2006, JPN J OPHTHALMOL, V50, P354, DOI 10.1007/s10384-005-0337-2; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Kurashige Y, 2008, AM J OPHTHALMOL, V146, P513, DOI 10.1016/j.ajo.2008.05.025; Browning DJ, 2012, AM J OPHTHALMOL, V154, P222, DOI 10.1016/j.ajo.2012.04.020; Kokame GT, 2010, BRIT J OPHTHALMOL, V94, P297, DOI 10.1136/bjo.2008.150029; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Chan WM, 2004, OPHTHALMOLOGY, V111, P1576, DOI 10.1016/j.ophta.2003.12.056; Gomi F, 2008, OPHTHALMOLOGY, V115, P141, DOI 10.1016/j.ophtha.2007.02.031; Spaide RF, 2002, RETINA-J RET VIT DIS, V22, P529, DOI 10.1097/00006982-200210000-00001; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Koizumi H, 2011, BRIT J OPHTHALMOL, V95, P1555, DOI 10.1136/bjophthalmol-2011-300285; Inoue M, 2013, EYE, V27, P1013, DOI 10.1038/eye.2013.179; Akaza E, 2008, RETINA-J RET VIT DIS, V28, P717, DOI 10.1097/IAE.0b013e31816577cb; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Marcus DM, 2013, RETINA-J RET VIT DIS, V33, P35, DOI 10.1097/IAE.0b013e3182618be0; Ikuno Y, 2011, INVEST OPHTH VIS SCI, V52, P5536, DOI 10.1167/iovs.10-6811; Cho HJ, 2012, EYE, V26, P426, DOI 10.1038/eye.2011.324; Lai TYY, 2011, RETINA-J RET VIT DIS, V31, P1581, DOI 10.1097/IAE.0b013e31820d3f3f; Cheng CK, 2011, RETINA-J RET VIT DIS, V31, P846, DOI 10.1097/IAE.0b013e3181f84fdf; Gregori NZ, 2010, RETINA-J RET VIT DIS, V30, P1046, DOI 10.1097/IAE.0b013e3181d87e04; Ijiri S, 2015, GRAEF ARCH CLIN EXP, V253, P351, DOI 10.1007/s00417-014-2707-2; Inoue M, 2014, RETINA-J RET VIT DIS, V34, P2178, DOI 10.1097/IAE.0000000000000229; Kang HM, 2013, AM J OPHTHALMOL, V156, P652, DOI 10.1016/j.ajo.2013.05.038; Koizumi H, 2015, BR J OPHTHALMOL; Kokame GT, 2014, OPHTHALMOLOGICA, V231, P94, DOI 10.1159/000354072; Kokame Gregg T, 2014, Trans Am Ophthalmol Soc, V112, P74; Miura Masahiro, 2013, Clin Ophthalmol, V7, P1591, DOI 10.2147/OPTH.S50634; Saito M, 2008, BRIT J OPHTHALMOL, V92, P1642, DOI 10.1136/bjo.2007.137075; Saito M, 2014, RETINA-J RET VIT DIS, V34, P2192, DOI 10.1097/IAE.0000000000000236; Sayanagi K, 2007, GRAEF ARCH CLIN EXP, V245, P1569, DOI 10.1007/s00417-007-0582-9; Tano Y, 2008, OPHTHALMOLOGY, V115, P585, DOI 10.1016/j.ophtha.2007.10.018; Yamamoto Akiko, 2013, Clin Ophthalmol, V7, P757, DOI 10.2147/OPTH.S42189; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	44	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	SEP	2015	122	9					1866	1872		10.1016/j.ophtha.2015.05.024		7	Ophthalmology	Ophthalmology	CP8BU	WOS:000360116900028		
J	Suzuki-Okamura, E; Higashihori, N; Kawamoto, T; Moriyama, K				Suzuki-Okamura, Erika; Higashihori, Norihisa; Kawamoto, Tatsuo; Moriyama, Keiji			Three-dimensional analysis of hard and soft tissue changes in patients with facial asymmetry undergoing 2-jaw surgery	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							ORTHOGNATHIC SURGERY; COMPUTED-TOMOGRAPHY; SURGICAL-CORRECTION; DEFORMITY; STABILITY; CT	Objective. We studied 3-dimensionally how hard and soft tissues of patients with facial asymmetry were changed by 2-jaw surgery. Study design. Nine patients diagnosed with mandibular prognathism and facial asymmetry who underwent 2-jaw surgery were enrolled. Three-dimensional (3-D) computed tomographic images taken before and after surgery were superimposed by 3-D imaging software. Linear and angular measurements of hard and soft tissues were performed and compared before and after surgery. Results. Along with improved roll rotations of the hard and soft tissues of the facial structures by surgery, both hard and soft tissue mentons were moved toward the nonshifted side. Only the hard tissue mentons, however, were important for improving the roll rotation of the mandible. Variations in the wing of the nose and lip were significant for shaping the maxilla. Conclusions. The 3-D analysis in this study enabled us to understand hard and soft tissues quantitatively, thereby providing helpful information for treatment planning.	[Suzuki-Okamura, Erika; Higashihori, Norihisa; Kawamoto, Tatsuo; Moriyama, Keiji] Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Neck Reconstruct, Sect Maxillofacial Orthognath, Tokyo 1138549, Japan; [Kawamoto, Tatsuo] Kyushu Dent Univ, Fac Dent, Dept Hlth Improvement, Div Orofacial Funct & Orthodont, Kitakyushu, Fukuoka, Japan	Higashihori, N (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Neck Reconstruct, Sect Maxillofacial Orthognath, 1-5-45 Yushima, Tokyo 1138549, Japan.	n-higashihori.mort@tmd.ac.jp					Almukhtar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093402; Yanez-Vico RM, 2011, CLIN ORAL INVEST, V15, P729, DOI 10.1007/s00784-010-0441-7; Xia JJ, 2009, J ORAL MAXIL SURG, V67, P2093, DOI 10.1016/j.joms.2009.04.057; Cevidanes LHS, 2005, DENTOMAXILLOFAC RAD, V34, P369, DOI 10.1259/dmfr/17102411; Baek SH, 2007, ORAL SURG ORAL MED O, V104, P628, DOI 10.1016/j.tripleo.2007.03.002; Kim SJ, 2012, ANGLE ORTHOD, V82, P1092, DOI 10.2319/011512-36.1; Haraguchi S, 2002, ANGLE ORTHOD, V72, P28; Jung YJ, 2009, ORAL SURG ORAL MED O, V107, P763, DOI 10.1016/j.tripleo.2008.12.026; Shimomatsu K, 2012, J CRANIO MAXILL SURG, V40, P559, DOI 10.1016/j.jcms.2011.10.009; Ko EWC, 2009, J ORAL MAXIL SURG, V67, P2201, DOI 10.1016/j.joms.2009.04.039; Fujita Tadashi, 2013, J Orthod, V40, P313, DOI 10.1179/1465313313Y.0000000056; Hwang HS, 2009, AM J ORTHOD DENTOFAC, V136, P564, DOI 10.1016/j.ajodo.2007.10.060; Hwang HS, 2007, AM J ORTHOD DENTOFAC, V132, pe271; Kitahara T, 2009, ANGLE ORTHOD, V79, P158, DOI 10.2319/122707-604.1; Klinke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031766; Maeda M, 2007, ORAL RADIOL, V23, P10, DOI 10.1007/s11282-007-0058-y; Orhan H, 2014, EUR J DENT, V8, P132; Park WS, 2007, P ANN INT IEEE EMBS, P3496, DOI 10.1109/IEMBS.2007.4353084; Proffit W, 2007, CONT ORTHODONTICS, V4th, P689; Sekiya T, 2010, AM J ORTHOD DENTOFAC, V137, P552, DOI 10.1016/j.ajodo.2007.10.064; Sforza C, 2007, J PLAST RECONSTR AES, V60, P130, DOI 10.1016/j.bjps.2006.06.003; Verze L, 2012, J CRANIOFAC SURG, V23, P1448, DOI 10.1097/SCS.0b013e31824e25fc; WELCH TB, 1989, J ORAL MAXIL SURG, V47, P1142, DOI 10.1016/0278-2391(89)90003-7; Yamada D, 2012, JAPAN J JAW DEFORMIT, V22, P12	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	SEP	2015	120	3					299	306		10.1016/j.oooo.2015.05.020		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ0RG	WOS:000360303900005		
J	Miyamoto, H; Kanayama, T; Horii, K; Kawai, T; Tsuchimochi, T; Shigetomi, T; Shibamoto, Y; Shibuya, Y				Miyamoto, Hironori; Kanayama, Takeo; Horii, Koichiro; Kawai, Tatsuya; Tsuchimochi, Tsukasa; Shigetomi, Toshio; Shibamoto, Yuta; Shibuya, Yasuyuki			The relationship between the severity of radiation-induced oral mucositis and the myeloperoxidase levels in rats	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							RADIOTHERAPY; INJURY; RECOVERY; DAMAGE; HEAD	Objective. Oral mucositis is a common adverse reaction to radiotherapy for head and neck cancer, and there are concerns regarding a decreased quality of life in patients receiving radiotherapy. The purpose of this study was to investigate the relationship between the severity of radiation-induced oral mucositis and the myeloperoxidase (MPO) levels in irradiated tissues. Study Design. Ninety-six F344 rats were divided into the following 4 groups: 10-Gy, 18-Gy, and 30-Gy irradiation groups, and a nonirradiation group. Oral mucositis was induced by the administration of single doses of radiation via exposure. After irradiation, the rats were evaluated on the basis of weight measurements, macroscopic findings according to a grading scale (Oral Mucositis Index [OMI]), and the results of tissue MPO assays. Results. Weights decreased whereas the OMI scores and MPO levels increased, depending on the dose of exposure. The Spearman rank correlation test showed a significant correlation between the OMI scores and the MPO levels in the tissues with a correlation coefficient of 0.824 (P < .01). Conclusions. In this study, the MPO levels in the irradiated tissue were increased in the cases involving severe radiation-induced oral mucositis evaluated in rats using a grading scale.	[Miyamoto, Hironori; Kanayama, Takeo; Horii, Koichiro; Tsuchimochi, Tsukasa; Shigetomi, Toshio; Shibuya, Yasuyuki] Nagoya City Univ, Sch Med Sci, Dept Oral & Maxillofacial Surg, Nagoya, Aichi, Japan; [Kawai, Tatsuya; Shibamoto, Yuta] Nagoya City Univ, Sch Med Sci, Dept Radiol, Nagoya, Aichi, Japan	Miyamoto, H (reprint author), 1 Kawasumi,Mizuho Cho,Mizuho Ku, Nagoya, Aichi 4678601, Japan.	Miya0331@me.com			Research in Nagoya City University in Japan	This work was supported by a Grant-in-Aid for Research in Nagoya City University in Japan.	Shibamoto Y, 2004, INT J RADIAT ONCOL, V59, P1484, DOI 10.1016/j.ijrobp.2004.04.039; Sonis ST, 2004, CANCER, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2010, ORAL DIS, V16, P597, DOI 10.1111/j.1601-0825.2010.01681.x; Sciubba JJ, 2006, LANCET ONCOL, V7, P175, DOI 10.1016/S1470-2045(06)70580-0; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Scully C, 2006, ORAL DIS, V12, P229, DOI 10.1111/j.1601-0825.02006.01258.x; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199; Jung YY, 2013, KOREAN J PHYSIOL PHA, V17, P209, DOI 10.4196/kjpp.2013.17.3.209; Bowen JM, 2013, SUPPORT CARE CANCER, V21, P303, DOI 10.1007/s00520-012-1592-7; DORR W, 1990, RADIOTHER ONCOL, V17, P249, DOI 10.1016/0167-8140(90)90209-F; Ikeda Y, 2000, J RADIAT RES, V41, P279, DOI 10.1269/jrr.41.279; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Lee SW, 2007, INT J RADIAT ONCOL, V67, P1172, DOI 10.1016/j.ijrobp.2006.10.038; Li CY, 2011, MED ORAL PATOL ORAL, V16, pE711, DOI 10.4317/medoral.17057; Mashtoub S, 2013, EXP BIOL MED, V238, P1305, DOI 10.1177/1535370213493718; Nagler RM, 2002, ORAL DIS, V8, P141, DOI 10.1034/j.1601-0825.2002.02838.x; PARKINS C S, 1983, Radiotherapy and Oncology, V1, P159, DOI 10.1016/S0167-8140(83)80018-8; Reznani M, 2004, INT J RADIAT BIOL, V80, P177; REZVANI M, 1991, BRIT J RADIOL, V64, P1122; Sonis Stephen T, 2004, J Support Oncol, V2, P21; Sonis Stephen T, 2007, J Support Oncol, V5, P3; Wang JR, 2002, AM J PATHOL, V160, P2063, DOI 10.1016/S0002-9440(10)61156-X; Watanabe S, 2013, J PHARMACOL SCI, V121, P110, DOI 10.1254/jphs.12181FP	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	SEP	2015	120	3					329	336		10.1016/j.oooo.2015.04.012		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ0RG	WOS:000360303900009		
J	Al-Bahrani, R; Nagamori, S; Leng, R; Petryk, A; Sergi, C				Al-Bahrani, Redha; Nagamori, Seishi; Leng, Roger; Petryk, Anna; Sergi, Consolato			Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma	PATHOLOGY & ONCOLOGY RESEARCH			English	Article						Hepatocellular carcinoma; Cholangiocarcinoma; Sonic hedgehog; Bone morphogenetic protein 4; Immunohistochemistry	RISK-FACTORS; TGF-BETA; MUTATIONS; CANCER; ACTIVATION; DROSOPHILA; MOLECULES; SYSTEM; TUMOR	Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (CCA) are the two most common primary liver malignancies in adult patients. The molecular mechanisms underlying the pathogenesis of HCC and CCA are still poorly understood. Sonic hedgehog (SHH) signaling plays an essential role during mammalian development, i.e., promoting organ growth, tissue differentiation, and cell polarity. The upregulation of SHH has been observed during carcinogenesis, including colorectal carcinoma. Our aim was to investigate the expression pattern of SHH in HCC and CCA. We investigated 40 malignant tumors of the liver, including 21 HCC and 19 of intrahepatic CCA cases by immunohistochemistry (IHC) using a polyclonal antibody against SHH and Avidin-Biotin Complex method. We also investigated the co-localization of SHH and Bone morphogenetic protein 4 (BMP4) in CCA using indirect double IHC. Moreover, we examined whether SHH is expressed in two HCC cell lines HepG2 and HuH-7 and three CCA cell lines OZ, HuCCT1 and HuH28. We found that SHH was expressed in 15 out of 21 cases (71.4 %) of HCC and 100 % of CCA cases by immunohistochemistry. SHH expression showed a positive trend in liver tumors (HCC, CCA) with high grade (G2-G3). SHH localized to the epithelial cells, while BMP4 was expressed in the stromal cells in CCA by double IHC. However, both HCC and CCA cell lines showed SHH expression by Western blot analysis. In conclusion, SHH seems to be an interesting marker of de-differentiation in liver tumors and the simultaneous epithelial-mesenchymal expression may be an intriguing prompt to investigate cross-talks between SHH and BMP4.	[Al-Bahrani, Redha; Leng, Roger; Sergi, Consolato] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2B7, Canada; [Nagamori, Seishi] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Petryk, Anna] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Petryk, Anna] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Sergi, Consolato] Univ Alberta, Stollery Children Hosp, Edmonton, AB, Canada	Sergi, C (reprint author), Univ Alberta, Dept Lab Med & Pathol, 8440-112 St, Edmonton, AB T6G 2B7, Canada.	sergi@ualberta.ca		Sergi, Consolato/0000-0002-2779-7879	University of Alberta (Canada); Saudi Cultural Bureau, Ottawa, ON, Canada	We are grateful to the following funding agencies and institutions: University of Alberta Internal Funds (Canada) and the Saudi Cultural Bureau, Ottawa, ON, Canada, supported RA-B (MSc Lab Med & Pathology graduate student). The sponsors had no role in study design, data collection, data analysis, and data interpretation or in writing of the report. CS is the B105 lab director and principal investigator, designed the project and was responsible for the interpretation of data, obtaining sponsorship funding, and coordination of the study. RA-B wrote the first draft of the manuscript. RA-B was responsible for data gathering and interpretation. All authors reviewed the final draft of the manuscript.	Abuetabh Y, 2011, ANN CLIN LAB SCI, V41, P217; Alarmo EL, 2013, MODERN PATHOL, V26, P10, DOI 10.1038/modpathol.2012.128; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; Jensen ED, 2010, J CELL BIOCHEM, V109, P672, DOI 10.1002/jcb.22462; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; de Martel C, 2010, GASTROEN CLIN BIOL, V34, P173, DOI 10.1016/j.gcb.2010.01.008; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Blonski W, 2010, WORLD J GASTROENTERO, V16, P3603, DOI 10.3748/wjg.v16.i29.3603; Wang DH, 2010, GASTROENTEROLOGY, V138, P1810, DOI 10.1053/j.gastro.2010.01.048; Regateiro FS, 2011, CURR OPIN IMMUNOL, V23, P660, DOI 10.1016/j.coi.2011.07.003; Reifenberger J, 1998, CANCER RES, V58, P1798; Litingtung Y, 1998, NAT GENET, V20, P58; Al-Bahrani R, 2013, ANN CLIN LAB SCI, V43, P195; Eiró Noemí, 2014, Hepatobiliary Surg Nutr, V3, P98, DOI 10.3978/j.issn.2304-3881.2014.02.12; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Gekas Jean, 2012, J Prenat Med, V6, P36; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Huang SH, 2011, ACTA HISTOCHEM, V113, P564, DOI 10.1016/j.acthis.2010.06.003; Johnston J, 2012, J CLIN PATHOL, V65, P945, DOI 10.1136/jclinpath-2011-200577; Kawai S, 2001, BONE, V29, P54, DOI 10.1016/S8756-3282(01)00470-7; Ma XL, 2006, WORLD J GASTROENTERO, V12, P3965; Motola-Kuba Daniel, 2006, Ann Hepatol, V5, P16; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Omenetti A, 2008, AM J PHYSIOL-GASTR L, V294, pG595, DOI 10.1152/ajpgi.00543.2007; Pereira TD, 2010, LAB INVEST, V90, P1690, DOI 10.1038/labinvest.2010.147; Sergi C, 2000, AM J PATHOL, V156, P1589, DOI 10.1016/S0002-9440(10)65031-6; Shahi MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-614; Virchow R, 1863, KRANKHAFTEN GESCHWUL; Yoshikawa K, 2009, J GASTROENTEROL, V44, P1113, DOI 10.1007/s00535-009-0110-2	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1219-4956	1532-2807		PATHOL ONCOL RES	Pathol. Oncol. Res.	SEP	2015	21	4					901	908		10.1007/s12253-015-9918-7		8	Oncology; Pathology	Oncology; Pathology	CQ1UM	WOS:000360385400007		
J	Oshikawa, G; Yoshioka, K; Takahashi, Y; Shingai, N; Ikegawa, S; Kobayashil, T; Doki, N; Kakihana, K; Ohashi, K; Sakamaki, H				Oshikawa, Gaku; Yoshioka, Kousuke; Takahashi, Yukie; Shingai, Naoki; Ikegawa, Shuntaro; Kobayashil, Takeshi; Doki, Noriko; Kakihana, Kazuhiko; Ohashi, Kazuteru; Sakamaki, Hisashi			Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndrome	PATHOLOGY & ONCOLOGY RESEARCH			English	Article						Myelodysplastic syndrome; Allogeneic hematopoietic stem cell transplantation; Azacitidine	STEM-CELL TRANSPLANTATION; LEUKEMIA; MDS	To clarify the clinical impact of prior use of azacitidine (AZA) on outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for myelodysplastic syndrome (MDS), we retrospectively reviewed the clinical outcomes of 15 MDS patients who were treated with AZA before allo-HSCT (AZA group). We compared the outcomes of these 15 patients with 52 MDS patients who were solely given the best supportive care (BSC) before allo-HSCT (BSC group). Although patients in the AZA group were older with higher International Prognostic Scoring System (IPSS) scores compared to patients in the BSC group, no significant differences were found between the two groups in overall survival (OS), disease-free survival (DFS), cumulative incidence of relapse (CIR) or non-relapse mortality. However, in patients with a higher IPSS score (Int-2/High), pre-transplant AZA may provide better OS and DFS and lower CIR. Acute graft-versus-host disease rates were similar between the two groups. These results should be reassuring to patients with high-risk MDS receiving AZA before allo-HSCT.	[Oshikawa, Gaku; Yoshioka, Kousuke; Takahashi, Yukie; Shingai, Naoki; Ikegawa, Shuntaro; Kobayashil, Takeshi; Doki, Noriko; Kakihana, Kazuhiko; Ohashi, Kazuteru; Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Bunkyo Ku, Tokyo 1138677, Japan	Oshikawa, G (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	gaku.oshikawa@gmail.com					BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Field T, 2010, BONE MARROW TRANSPL, V45, P255, DOI 10.1038/bmt.2009.134; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Kim DY, 2012, BONE MARROW TRANSPL, V47, P374, DOI 10.1038/bmt.2011.86; Gyurkocza B, 2012, BLOOD REV, V26, P247, DOI 10.1016/j.blre.2012.08.002; Sanchez-Abarca LI, 2010, BLOOD, V115, P107, DOI 10.1182/blood-2009-03-210393; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Greenberg P, 1997, BLOOD, V89, P2079; Damaj G, 2012, J CLIN ONCOL, V30, P4533, DOI 10.1200/JCO.2012.44.3499; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Cogle Christopher R, 2010, Clin Adv Hematol Oncol, V8, P40; Damaj G, 2013, LEUKEMIA RES, V37, pS14; Gerds AT, 2012, BIOL BLOOD MARROW TR, V18, P1211, DOI 10.1016/j.bbmt.2012.01.009; Giralt S, 2005, HEMATOL-AM SOC HEMAT, V2005, P384, DOI DOI 10.1182/ASHEDUCATION-2005.1.384; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; National Comprehensive Cancer Network [NCCN], 2012, CLIN PRACT GUID ONC; Yahng SA, 2013, EUR J HAEMATOL, V90, P111, DOI 10.1111/ejh.12038	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1219-4956	1532-2807		PATHOL ONCOL RES	Pathol. Oncol. Res.	SEP	2015	21	4					1037	1043		10.1007/s12253-015-9933-8		7	Oncology; Pathology	Oncology; Pathology	CQ1UM	WOS:000360385400024		
J	Nikkuni, O; Kaira, K; Toyoda, M; Shino, M; Sakakura, K; Takahashi, K; Tominaga, H; Oriuchi, N; Suzuki, M; Iijima, M; Asao, T; Nishiyama, M; Nagamori, S; Kanai, Y; Oyama, T; Chikamatsu, K				Nikkuni, Osamu; Kaira, Kyoichi; Toyoda, Minoru; Shino, Masato; Sakakura, Koichi; Takahashi, Katsumasa; Tominaga, Hideyuki; Oriuchi, Noboru; Suzuki, Masami; Iijima, Misa; Asao, Takayuki; Nishiyama, Masahiko; Nagamori, Shushi; Kanai, Yoshikatsu; Oyama, Tetsunari; Chikamatsu, Kazuaki			Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma	PATHOLOGY & ONCOLOGY RESEARCH			English	Article						Larynx; LAT1; CD98; Imunohistochemistry; ASCT2; Prognostic factor	LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; CD98 EXPRESSION; HEAVY-CHAIN; INHIBITION; PROSTATE; SURVIVAL; CLONING; TARGET; GROWTH	The aim of this study is to evaluate the clinicopathological significance of L-type amino acid transporter 1 (LAT1) expression in patients with advanced laryngeal squamous cell carcinoma (LSCC). A total of 73 patients with advanced LSCC were retrospectively reviewed. Tumor sections were stained by immunohistochemistry for LAT1, 4F2hc, system ASC amino acid transporter-2 (ASCT2), cell proliferation by Ki-67, microvessel density (MVD) determined by CD34 and p53. A positive LAT1, 4F2hc and ASCT2 expression (staining more than a quarter) in the primary sites were recognized in 85, 80 and 45 %, respectively, and a high LAT1, 4F2hc and ASCT2 expression (staining more than a half) yielded 48, 31 and 18 %, respectively. High expression of LAT1 was significantly associated with lymph node metastasis, 4F2hc, ASCT2, Ki-67 and p53. The expression of LAT1 was significantly correlated with ASCT2, 4F2hc, cell proliferation, and MVD. By univariate analysis, there was no statistically significant relationship between LAT1 expression and prognosis in advanced LSCC. LAT1, 4F2hc and ASCT2 were highly expressed in patients with advanced laryngeal cancer. Our study suggests that the expression of LAT1 plays a crucial role in the metastasis and tumor progression in advanced LSCC.	[Nikkuni, Osamu; Toyoda, Minoru; Shino, Masato; Sakakura, Koichi; Takahashi, Katsumasa; Chikamatsu, Kazuaki] Gunma Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Maebashi, Gumma 3718511, Japan; [Kaira, Kyoichi; Asao, Takayuki] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gumma 3718511, Japan; [Oyama, Tetsunari] Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Maebashi, Gumma 3718511, Japan; [Oriuchi, Noboru] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gumma 3718511, Japan; [Tominaga, Hideyuki] Fukushima Med Univ, Adv Clin Res Ctr, Fukushima, Japan; [Nikkuni, Osamu; Suzuki, Masami] Gunma Prefectural Canc Ctr, Dept Head & Neck Surg, Otaru, Hokkaido, Japan; [Iijima, Misa] Gunma Prefectural Canc Ctr, Dept Pathol & Clin Labs, Ota, Japan; [Nishiyama, Masahiko] Gunma Univ, Grad Sch Med, Dept Mol Pharmacol & Oncol, Maebashi, Gumma 3718511, Japan; [Nagamori, Shushi; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Div Biosyst Pharmacol, Osaka, Japan	Kaira, K (reprint author), Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gumma 3718511, Japan.	nikkuni@gunma-u.ac.jp; kkaira1970@yahoo.co.jp; toyodami@gmail.com; mshino@gunma-u.ac.jp; koichisakakura@yahoo.co.jp; takamasa@gunma-u.ac.jp; htomi@fmu.ac.jp; oriuchi1@gmail.com; suzuoto@gunma-cc.jp; iimisajima@gunma-cc.jp; asaot@med.gunma-u.ac.jp; m.nishiyama@gunma-u.ac.jp; nagamori@pharma1.med.osaka-u.ac.jp; ykanai@pharma1.med.osaka-u.ac.jp; oyama@gunma-u.ac.jp; tikamatu@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23591750, 23592523]; National Hospital Organization Policy Based Medical Services	This work was supported in part by Grant 23591750 (K. K) and Grant 23592523 (K. C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and National Hospital Organization Policy Based Medical Services. We thank Ms. Chizuko Tomioka for their technical assistance of immunohistochemical analysis.	Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Kaira K, 2009, ANN SURG ONCOL, V16, P3473, DOI 10.1245/s10434-009-0685-0; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kaira K, 2011, AM J TRANSL RES, V3, P468; Ichinoe M, 2011, PATHOL INT, V61, P281, DOI 10.1111/j.1440-1827.2011.02650.x; Shimizu K, 2014, BRIT J CANCER, V110, P2030, DOI 10.1038/bjc.2014.88; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; Li RL, 2003, ANTICANCER RES, V23, P3413; Imai H, 2010, ANTICANCER RES, V30, P4819; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Kekuda R, 1996, J BIOL CHEM, V271, P18657; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Kaira K, 2009, LUNG CANCER, V66, P120, DOI 10.1016/j.lungcan.2008.12.015; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43; Nakanishi K, 2007, VIRCHOWS ARCH, V451, P681, DOI 10.1007/s00428-007-0457-9; Kaira K, 2012, BRIT J CANCER, V107, P632, DOI 10.1038/bjc.2012.310; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Ragin CCR, 2007, J DENT RES, V86, P104; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fuchs BC, 2007, AM J PHYSIOL-CELL PH, V293, pC55, DOI 10.1152/ajpcell.00330.2006; Toyoda M, 2014, BRIT J CANCER, V110, P2506, DOI 10.1038/bjc.2014.178; Kim CS, 2010, BIOL PHARM BULL, V33, P1117; Kim CS, 2008, BIOL PHARM BULL, V31, P1096, DOI 10.1248/bpb.31.1096; Namikawa M, 2014, HEPATOL RES IN PRESS; Thephamongkhol K, 2004, CHEMOTHERAPY RADIOTH, V5-7; Whitte D, 2002, ANTICANCER RES, V22, P2555	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1219-4956	1532-2807		PATHOL ONCOL RES	Pathol. Oncol. Res.	SEP	2015	21	4					1175	1181		10.1007/s12253-015-9954-3		7	Oncology; Pathology	Oncology; Pathology	CQ1UM	WOS:000360385400041		
J	Miura, H; Kawamura, Y; Ozeki, E; Ihira, M; Ohashi, M; Yoshikawa, T				Miura, Hiroki; Kawamura, Yoshiki; Ozeki, Erina; Ihira, Masaru; Ohashi, Masahiro; Yoshikawa, Tetsushi			Pathogenesis of Severe Neutropenia in Patients With Primary Human Herpesvirus 6B Infection	PEDIATRIC INFECTIOUS DISEASE JOURNAL			English	Article							STEM-CELL TRANSPLANTATION; BETA-CHEMOKINE RECEPTOR; EXANTHEM-SUBITUM; BONE-MARROW; THROMBOCYTOPENIC PURPURA; HEMOPHAGOCYTIC SYNDROME; ROSEOLA INFANTUM; COLONY FORMATION; HHV-6 INFECTION; IN-VITRO	Background: Although myelosuppression caused by human herpesvirus 6B (HHV-6B) reactivation in transplant recipients has been extensively investigated, the pathophysiological mechanisms of severe neutropenia in primary HHV-6B infection remain unclear. Procedure: Fifty-four patients with primary HHV-6B infection were evaluated. Hematological examinations and blood sampling were conducted on days 1-4 (pre) and 5-10 (post) after the onset of illness. Severe neutropenia was defined as a neutrophil count less than 500 cells/mu L. Patient characteristics, clinical data, and cytokines and chemokines levels were compared between the patients with (n = 16) and without (n = 38) severe neutropenia. Results: Severe neutropenia was detected in samples that were collected between days 5 and 10 after illness. Significantly lower platelet counts (pre, P = 0.048; post, P = 0.032) and regulated on activation, normal T cell expressed and secreted levels (post, P = 0.007) were detected in the patients with neutropenia. Aspartate aminotransferase levels (P = 0.008), and interferon gamma-inducible protein-10 (P < 0.0001), monocyte chemoattractant protein-1 (P = 0.005), and monokine induced by interferon gamma (P = 0.011) levels were significantly higher in post samples collected from the patients with neutropenia. No differences were observed in any patient characteristics and serum cytokines levels. No bacterial infections were detected during the observation period. Conclusions: Chemokines may play an important role in the pathogenesis of severe neutropenia in patients with primary HHV-6B infection.	[Miura, Hiroki; Kawamura, Yoshiki; Ozeki, Erina; Yoshikawa, Tetsushi] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 4701192, Japan; [Ihira, Masaru] Fujita Hlth Univ, Sch Hlth Sci, Fac Clin Engn, Toyoake, Aichi 4701192, Japan; [Ohashi, Masahiro] Toyokawa Municipal Hosp, Dept Pediat, Toyokawa, Aichi, Japan	Yoshikawa, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 4701192, Japan.	tetsushi@fujita-hu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25461610]; Japan Society for the Promotion of Science [H25-Jisedai-003]	This work was supported, in part, by a Grant-in-Aid for Scientific Research (No. 25461610) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from Japan Society for the Promotion of Science (H25-Jisedai-003). The authors have no funding or conflicts of interest to disclose.	SAIJO M, 1995, PEDIATR INFECT DIS J, V14, P405, DOI 10.1097/00006454-199505000-00022; Husain EH, 2012, PEDIATR INFECT DIS J, V31, P575, DOI 10.1097/INF.0b013e318250084a; Suga S, 2000, ARCH DIS CHILD, V82, P62, DOI 10.1136/adc.82.1.62; YOSHIKAWA T, 1992, PEDIATRICS, V89, P888; CARRIGAN DR, 1994, BLOOD, V84, P3307; ASANO Y, 1989, J PEDIATR-US, V114, P535, DOI 10.1016/S0022-3476(89)80689-4; ASANO Y, 1994, PEDIATRICS, V93, P104; YOSHIKAWA T, 1993, PEDIATR INFECT DIS J, V12, P409, DOI 10.1097/00006454-199305000-00014; Freifeld AG, 2011, CLIN INFECT DIS, V52, P427, DOI 10.1093/cid/ciq147; YAMANISHI K, 1988, LANCET, V1, P1065; HUANG LM, 1990, LANCET, V336, P60, DOI 10.1016/0140-6736(90)91580-4; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; DROBYSKI WR, 1993, J INFECT DIS, V167, P735; Vlacha V, 2007, ANN HEMATOL, V86, P865, DOI 10.1007/s00277-007-0346-y; Melendez E, 2010, ACAD EMERG MED, V17, P163, DOI 10.1111/j.1553-2712.2009.00649.x; Radonic A, 2005, BRIT J HAEMATOL, V131, P480, DOI 10.1111/j.1365-2141.2005.05788.x; SUGA S, 1993, ANN NEUROL, V33, P597, DOI 10.1002/ana.410330607; Hashimoto H, 2002, J PEDIAT HEMATOL ONC, V24, P211, DOI 10.1097/00043426-200203000-00010; BURD EM, 1993, BLOOD, V81, P1645; Grivel JC, 2003, J VIROL, V77, P8280, DOI 10.1128/JVI.77.15.8280-8289.2003; Isegawa Y, 1998, J VIROL, V72, P6104; Isomura H, 2000, J GEN VIROL, V81, P663; Isomura H, 1997, J MED VIROL, V52, P406, DOI 10.1002/(SICI)1096-9071(199708)52:4<406::AID-JMV11>3.0.CO;2-E; KNOX KK, 1992, J INFECT DIS, V165, P925; Maeda Y, 2000, LEUKEMIA LYMPHOMA, V39, P229, DOI 10.3109/10428190009065823; Milne RSB, 2000, J IMMUNOL, V164, P2396; Sheen JM, 2009, PEDIATR BLOOD CANCER, V53, P1284, DOI 10.1002/pbc.22247; Takagi M, 1996, PEDIATR HEMAT ONCOL, V13, P451, DOI 10.3109/08880019609030857; Takemoto M, 2009, VIROLOGY, V385, P294, DOI 10.1016/j.virol.2008.11.049; YOSHIKAWA T, 1989, PEDIATRICS, V84, P675	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0891-3668	1532-0987		PEDIATR INFECT DIS J	Pediatr. Infect. Dis. J.	SEP	2015	34	9					1003	1007		10.1097/INF.0000000000000777		5	Immunology; Infectious Diseases; Pediatrics	Immunology; Infectious Diseases; Pediatrics	CQ1ZH	WOS:000360398600018		
J	Ozawa, D; Yano, H; Endo, S; Hidaka, H; Kakuta, R; Okitsu, N; Kanamori, H; Ogawa, M; Ichimura, S; Shimojima, M; Inomata, S; Kaku, M; Katori, Y				Ozawa, Daiki; Yano, Hisakazu; Endo, Shiro; Hidaka, Hiroshi; Kakuta, Risako; Okitsu, Naohiro; Kanamori, Hajime; Ogawa, Miho; Ichimura, Sadahiro; Shimojima, Masahiro; Inomata, Shinya; Kaku, Mitsuo; Katori, Yukio			Impact of the Seven-valent Pneumococcal Conjugate Vaccine on Acute Otitis Media in Japanese Children Emergence of Serotype 15A Multidrug-resistant Streptococcus pneumoniae in Middle Ear Fluid Isolates	PEDIATRIC INFECTIOUS DISEASE JOURNAL			English	Article							MANAGEMENT; DIAGNOSIS; EFFICACY; FIELD; LIFE	Background: Streptococcus pneumoniae is one of the most common bacteria causing acute otitis media (AOM). In Japan, a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced for voluntary vaccination of children in 2010, and it became a recommended vaccination in April 2013. We surveyed the serotypes and antimicrobial susceptibility profile of S. pneumoniae isolates obtained from the middle ear fluid of Japanese children with AOM. Methods: Between April and September 2013, a total of 176 S. pneumoniae isolates were obtained from the middle ear fluid of children aged 0-3 years with AOM. Isolates were collected from various regions of Japan. Minimum inhibitory concentrations were measured by the broth microdilution method. Serotyping was performed by observing the Quellung reaction. Results: Although 45.5% of the strains were susceptible to penicillin G, 42.6% were penicillin-intermediate strains and 11.9% were penicillin-resistant strains. Serotype 19A (27.3%), serotype 15A (14.2%) and serotype 3 (11.9%) showed a high frequency. Although PCV7 types only accounted for 4.5% of all strains, 44.9% were PCV13 types and 55.1% were non-PCV types. Serotype 15A strains were 100% nonsusceptible to penicillin G and all of these strains showed multidrug resistance. Serotype 15A was frequent in children up to 1 year old. Conclusion: After this research was completed, PCV7 was switched to a PCV13 that also contained serotype 3 and serotype 19A. We need to consider the possibility that serotype 15A, which is not included in PCV13, may increase and cause intractable AOM in the future.	[Ozawa, Daiki; Hidaka, Hiroshi; Kakuta, Risako; Okitsu, Naohiro; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 9808575, Japan; [Ozawa, Daiki; Yano, Hisakazu; Endo, Shiro; Kakuta, Risako; Kanamori, Hajime; Inomata, Shinya; Kaku, Mitsuo] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Internal Med, Sendai, Miyagi 9808575, Japan; [Yano, Hisakazu] Nara Med Univ, Dept Microbiol & Infect Dis, Kashihara, Nara 634, Japan; [Ogawa, Miho; Ichimura, Sadahiro; Shimojima, Masahiro] BML Inc, Dept Bacteriol, Kawagoe, Saitama, Japan	Ozawa, D (reprint author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808575, Japan.	daiki-oz@med.tohoku.ac.jp			Japan Society for the Promotion of Science KAKENHI [26462546]	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 26462546.	ALHO OP, 1991, INT J PEDIATR OTORHI, V21, P7, DOI 10.1016/0165-5876(91)90054-F; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Faden H, 1997, J INFECT DIS, V175, P1440; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Palmu AAI, 2004, PEDIATR INFECT DIS J, V23, P732, DOI 10.1097/01.inf.0000133049.30299.5d; Taylor S, 2012, CLIN INFECT DIS, V54, P1765, DOI 10.1093/cid/cis292; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Gene A, 2013, PEDIATR INFECT DIS J, V32, pE128, DOI 10.1097/INF.0b013e31827c54dc; Clinical and laboratory standard institute, 2006, METH DIL ANT SUSC TE; Dupont D, 2010, DIAGN MICR INFEC DIS, V68, P89, DOI 10.1016/j.diagmicrobio.2010.04.012; Kitamura K, 2015, AURIS NASUS LARYNX, V42, P99, DOI 10.1016/j.anl.2014.09.006; Martin JM, 2014, PEDIATR INFECT DIS J, V33, pE286, DOI 10.1097/INF.0000000000000445; Ozawa D, 2014, J INFECT CHEMOTHER, V20, P702, DOI 10.1016/j.jiac.2014.07.014; PRELLNER K, 1984, INT J PEDIATR OTORHI, V7, P39, DOI 10.1016/S0165-5876(84)80052-X; Sluijter M, 1998, J CLIN MICROBIOL, V36, P2248; Stamboulidis K, 2011, PEDIATR INFECT DIS J, V30, P551, DOI 10.1097/INF.0b013e31821038d9; Suetake M, 2000, OTOL JPN, V10, P89; Sunakawa Keisuke, 2007, Ann Clin Microbiol Antimicrob, V6, P7, DOI 10.1186/1476-0711-6-7; Tajima T, 2013, J INFECT CHEMOTHER, V19, P510, DOI 10.1007/s10156-013-0593-x; Yano H, 2013, J CLIN MICROBIOL, V51, P3542, DOI 10.1128/JCM.01108-13; Yano H, 2000, J CLIN MICROBIOL, V38, P625	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0891-3668	1532-0987		PEDIATR INFECT DIS J	Pediatr. Infect. Dis. J.	SEP	2015	34	9					E217	E221		10.1097/INF.0000000000000776		5	Immunology; Infectious Diseases; Pediatrics	Immunology; Infectious Diseases; Pediatrics	CQ1ZN	WOS:000360399200003		
J	Nakagawa, M; Ozawa, Y; Sakurai, K; Shimohira, M; Ohashi, K; Asano, M; Yamaguchi, S; Shibamoto, Y				Nakagawa, Motoo; Ozawa, Yoshiyuki; Sakurai, Keita; Shimohira, Masashi; Ohashi, Kazuya; Asano, Miki; Yamaguchi, Sachiko; Shibamoto, Yuta			Image quality at low tube voltage (70 kV) and sinogram-affirmed iterative reconstruction for computed tomography in infants with congenital heart disease	PEDIATRIC RADIOLOGY			English	Article						Congenital heart disease; Dual-source CT; Sinogram-affirmed iterative reconstruction; Infant	FILTERED BACK-PROJECTION; CT ANGIOGRAPHY; RADIATION; REDUCTION; CHILDREN; PHANTOM	Lower tube voltage has advantages for CT angiography, such as improved contrast To evaluate the image quality of low-voltage (70 kV) CT for congenital heart disease and the ability of sinogram-affirmed iterative reconstruction to improve image quality. Forty-six children with congenital heart disease (median age: 109 days) were examined using dual-source CT. Scans were performed at 80 kV and 70 kV in 21 and 25 children, respectively. A nonionic iodinated contrast medium (300 mg I/ml) was used for the 80-kV protocol. The contrast medium was diluted to 75% (225 mgI/mL) with saline for the 70-kV protocol. Image noise was measured in the two protocols for each group by extracting the standard deviations of a region of interest placed on the descending aorta. We then determined whether sinogram-affirmed iterative reconstruction reduced the image noise at 70 kV. There was more noise at 70 kV than at 80 kV (29 +/- 12 vs 20 +/- 4.8; P < 0.01). Sinogram-affirmed iterative reconstruction with grade 4 strength settings improved the noise (20 +/- 5.9; P < 0.01) for the 70-kV group. Sinogram-affirmed iterative reconstruction improved the image quality of CT in congenital heart disease.	[Nakagawa, Motoo; Ozawa, Yoshiyuki; Sakurai, Keita; Shimohira, Masashi; Shibamoto, Yuta] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, Nagoya, Aichi, Japan; [Ohashi, Kazuya] Nagoya City Univ Hosp, Div Cent Radiol, Nagoya, Aichi, Japan; [Asano, Miki] Nagoya City Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Nagoya, Aichi, Japan; [Yamaguchi, Sachiko] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan	Nakagawa, M (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi, Japan.	lmloltlolol@gmail.com		Sakurai, Keita/0000-0002-8849-7335			Pache G, 2011, EUR J RADIOL, V80, pE440, DOI 10.1016/j.ejrad.2011.01.032; Tsai IC, 2007, PEDIATR RADIOL, V37, P818, DOI 10.1007/s00247-007-0512-3; Watson DJ, 2010, PEDIATR RADIOL, V40, P693, DOI 10.1007/s00247-009-1469-1; Moscariello A, 2011, EUR RADIOL, V21, P2130, DOI 10.1007/s00330-011-2164-9; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leschka S, 2008, EUR RADIOL, V18, P1809, DOI 10.1007/s00330-008-0966-1; Castaner E, 2009, RADIOGRAPHICS, V29, P31, DOI 10.1148/rg.291085061; Yang WJ, 2013, J COMPUT ASSIST TOMO, V37, P301, DOI 10.1097/RCT.0b013e31827b8c66; Asano M, 2005, PEDIATR CARDIOL, V26, P710, DOI 10.1007/s00246-005-0898-3; Boone JM, 2011, SIZE SPECIFIC DOSE E; Nakayama Yoshiharu, 2006, AJR Am J Roentgenol, V187, pW490, DOI 10.2214/AJR.05.0471; Gao Y, 2012, EUR J RADIOL, V81, pE789, DOI 10.1016/j.ejrad.2012.03.023; Hamaguchi Naoko, 2010, Nihon Hoshasen Gijutsu Gakkai Zasshi, V66, P313; Itatani R, 2013, CLIN RADIOL, V68, pE128, DOI 10.1016/j.crad.2012.10.014; Nakagawa M, 2011, JPN J RADIOL, V29, P540, DOI 10.1007/s11604-011-0594-6; Nakagawa M, 2009, PEDIATR RADIOL, V39, P933, DOI 10.1007/s00247-009-1302-x; Niboshi Ayumi, 2006, Indian Journal of Pediatrics, V73, P49, DOI 10.1007/BF02758260; Oda S, 2011, J COMPUT ASSIST TOMO, V35, P631, DOI 10.1097/RCT.0b013e31822a563d; Tricarico F, 2013, EUR RADIOL, V23, P1306, DOI 10.1007/s00330-012-2734-5; Wang R, 2012, EUR J RADIOL, V81, P3141, DOI 10.1016/j.ejrad.2012.04.012	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	SEP	2015	45	10					1472	1479		10.1007/s00247-015-3372-2		8	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	CQ2NU	WOS:000360438800006		
J	Mizuguchi, K; Miyazaki, O; Nishimura, G; Ishigro, A				Mizuguchi, Koichi; Miyazaki, Osamu; Nishimura, Gen; Ishigro, Akira			Craniovertebral junction stenosis in Lenz-Majewski syndrome	PEDIATRIC RADIOLOGY			English	Article						Lenz-Majewski syndrome; Craniovertebral junction stenosis; Hyperostosis; Child; Computed tomography; Magnetic resonance imaging; Radiography; Skeletal dysplasia	HYPEROSTOTIC DWARFISM	We report a girl with Lenz-Majewski syndrome associated with craniovertebral junction stenosis that led to communicating hydrocephalus and cervical myelopathy. The life-threatening complication was related to progressive craniovertebral hyperostosis that rapidly exacerbated during early childhood. Despite initial success of surgical intervention at 2 years of age, she developed apneic spells and died suddenly at age 5 years. Close monitoring for craniovertebral junction stenosis is essential to reduce morbidity and mortality in children with Lenz-Majewski syndrome.	[Mizuguchi, Koichi; Ishigro, Akira] Natl Ctr Child Hlth & Dev, Dept Gen Pediat & Interdisciplinary Med, Setagaya Ku, Tokyo 1578535, Japan; [Miyazaki, Osamu] Natl Ctr Child Hlth & Dev, Dept Radiol, Tokyo 1578535, Japan; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Tokyo, Japan	Mizuguchi, K (reprint author), Natl Ctr Child Hlth & Dev, Dept Gen Pediat & Interdisciplinary Med, Setagaya Ku, 10-1,Okura 2-Chome, Tokyo 1578535, Japan.	mizuguchi-k@ncchd.go.jp					Majewski F, 2000, AM J MED GENET, V93, P335, DOI 10.1002/1096-8628(20000814)93:4<335::AID-AJMG14>3.0.CO;2-5; Bagley CA, 2006, J NEUROSURG, V104, P166, DOI 10.3171/ped.2006.104.3.166; Lachman RS, 1997, PEDIATR RADIOL, V27, P402, DOI 10.1007/s002470050156; LENZ W D, 1974, Birth Defects Original Article Series, V10, P133; Marden FA, 2004, PEDIATR RADIOL, V34, P167, DOI 10.1007/s00247-003-1037-z; Saraiva JM, 2000, AM J MED GENET, V91, P198, DOI 10.1002/(SICI)1096-8628(20000320)91:3<198::AID-AJMG8>3.0.CO;2-4; Sausa SB, 2014, NAT GENET, V46, P70; Wattanasirichaigoon D, 2004, CLIN DYSMORPHOL, V13, P137, DOI 10.1097/01.mcd.0000127468.11641.b7	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	SEP	2015	45	10					1567	1570		10.1007/s00247-015-3329-5		4	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	CQ2NU	WOS:000360438800017		
J	Miyazaki, O				Miyazaki, Osamu			Has pediatric CT practice in Japan changed since the Fukushima nuclear disaster?	PEDIATRIC RADIOLOGY			English	Letter							CHILDHOOD; SCANS; RISK		Natl Ctr Child Hlth & Dev, Dept Radiol, Setagaya Ku, Tokyo 1578535, Japan	Miyazaki, O (reprint author), Natl Ctr Child Hlth & Dev, Dept Radiol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	osamu-m@rc4.so-net.ne.jp					Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Casey B, 2014, REPORT CT PROCEDURE; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Townsend BA, 2009, AM J ROENTGENOL, V194, P1194; Wikipedia, 2012, FUK DAIICH NUCL DIS	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	SEP	2015	45	10					1571	1574		10.1007/s00247-015-3295-y		4	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	CQ2NU	WOS:000360438800018		
J	Bussolotti, F; Yang, JP; Hiramoto, M; Kaji, T; Kera, S; Ueno, N				Bussolotti, Fabio; Yang, Janpeng; Hiramoto, Masahiro; Kaji, Toshihiko; Kera, Satoshi; Ueno, Nobuo			Direct detection of density of gap states in C-60 single crystals by photoemission spectroscopy	PHYSICAL REVIEW B			English	Article							FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; CHARGE-TRANSPORT; SOLID C-60; MOBILITY; BAND; C60	We report on the direct and quantitative evaluation of density of gap states (DOGS) in large-size C-60 single crystals by using ultralow-background, high-sensitivity ultraviolet photoemission spectroscopy. The charging of the crystals during photoionization was overcome using photoconduction induced by simultaneous laser irradiation. By comparison with the spectra of as-deposited and gas exposed C-60 thin films the following results were found: (i) The DOGS near the highest occupied molecular orbital edge in the C-60 single crystals (10(19) - 10(21) states eV(-1) cm(-3)) mainly originates from the exposure to inert and ambient gas atmosphere during the sample preparation, storage, and transfer; (ii) the contribution of other sources of gap states such as structural imperfections at grain boundaries is negligible (<10(18) states eV(-1) cm(-3)).	[Bussolotti, Fabio; Yang, Janpeng; Kera, Satoshi; Ueno, Nobuo] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanomat Sci, Chiba 2638522, Japan; [Yang, Janpeng] Yangzhou Univ, Coll Phys Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Hiramoto, Masahiro; Kaji, Toshihiko; Kera, Satoshi] Inst Mol Sci, Okazaki, Aichi 4448585, Japan	Bussolotti, F (reprint author), Inst Mol Sci, Okazaki, Aichi 4448585, Japan.	fabio@ims.ac.jp; uenon@faculty.chiba-u.jp	Ueno, Nobuo/F-4358-2014	Ueno, Nobuo/0000-0003-2051-1492	G-COE program at Chiba University (MEXT) [G-03]; KAKENHI (JSPS) [24245034, 23360005]; JSPS KAKENHI [26248062]	The authors acknowledge the support from the G-COE program at Chiba University (G-03, MEXT) and KAKENHI (JSPS Grants No. 24245034 and No. 23360005). This work was partly supported by JSPS KAKENHI Grant No. 26248062.	Yogev S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.036803; Xin Q, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.226401; Elschner C, 2011, J APPL CRYSTALLOGR, V44, P983, DOI 10.1107/S002188981103531X; Mao HY, 2011, ORG ELECTRON, V12, P534, DOI 10.1016/j.orgel.2011.01.003; HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0; Kalb WL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035334; Kang JH, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1900944; Li HY, 2012, J AM CHEM SOC, V134, P2760, DOI 10.1021/ja210430b; Yoshida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235205; Seah MP, 1999, SURF SCI, V420, P285, DOI 10.1016/S0039-6028(98)00852-8; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; RAO AM, 1993, SCIENCE, V259, P955; Tal O, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.256405; Bussolotti F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.155120; Sueyoshi T, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3258351; Hwang J, 2007, J PHYS CHEM C, V111, P1378, DOI 10.1021/jp067004w; HEINEY PA, 1991, PHYS REV LETT, V66, P2911, DOI 10.1103/PhysRevLett.66.2911; Hasegawa T, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/2/024314; DEBOER JL, 1994, CHEM PHYS LETT, V219, P469, DOI 10.1016/0009-2614(94)00110-3; Hwang J, 2009, MAT SCI ENG R, V64, P1, DOI 10.1016/j.mser.2008.12.001; HADDON RC, 1995, APPL PHYS LETT, V67, P121, DOI 10.1063/1.115503; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Ciuchi S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256401; Hosokai T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195310; Kalb WL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155315; Yang JP, 2014, ORG ELECTRON, V15, P2749, DOI 10.1016/j.orgel.2014.07.010; Bussolotti F, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.115319; Bussolotti F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.267602; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245310; GENSTERBLUM G, 1993, PHYS REV B, V48, P14756, DOI 10.1103/PhysRevB.48.14756; Hinderhofer A., 2012, J PHYS CHEM C, V117, P1053; Lang DV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086802; Hiramoto Masahiro, 2014, Electronics, V3, DOI 10.3390/electronics3020351; Seah M. P., 1979, SURF INTERFACE ANAL, V1, P1; So WY, 2007, SOLID STATE COMMUN, V142, P483, DOI 10.1016/j.ssc.2007.03.040; Ueno N., 2015, SPRINGER SERIES MAT, P1; Ueno N, 2008, APPL PHYS A-MATER, V92, P495, DOI 10.1007/s00339-008-4553-8; Ueno N., 2015, SPRINGER SERIES MAT, P51; Ueno N, 2012, PROG SURF SCI, V87, P291, DOI 10.1016/j.progsurf.2012.10.002; Yang J., 2014, P SOC PHOTO-OPT INS, V9165; Yogev S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.081409	41	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	SEP 1	2015	92	11							115102	10.1103/PhysRevB.92.115102		7	Physics, Condensed Matter	Physics	CQ1BC	WOS:000360331300002		
J	Liu, L; Mikami, T; Ishida, S; Koshiishi, K; Okazaki, K; Yoshida, T; Suzuki, H; Horio, M; Ambolode, LCC; Xu, J; Kumigashira, H; Ono, K; Nakajima, M; Kihou, K; Lee, CH; Iyo, A; Eisaki, H; Kakeshita, T; Uchida, S; Fujimori, A				Liu, L.; Mikami, T.; Ishida, S.; Koshiishi, K.; Okazaki, K.; Yoshida, T.; Suzuki, H.; Horio, M.; Ambolode, L. C. C., II; Xu, J.; Kumigashira, H.; Ono, K.; Nakajima, M.; Kihou, K.; Lee, C. H.; Iyo, A.; Eisaki, H.; Kakeshita, T.; Uchida, S.; Fujimori, A.			In-plane electronic anisotropy in the antiferromagnetic orthorhombic phase of isovalent-substituted Ba(Fe1-xRux)(2)As-2	PHYSICAL REVIEW B			English	Article							RESISTIVITY ANISOTROPY; BAFE2AS2	We have studied the anisotropy in the in-plane resistivity and the electronic structure of isovalent Ru-substituted BaFe2As2 in the antiferromagnetic-orthorhombic phase using well-annealed crystals. The anisotropy in the residual resistivity component increases in proportion to the Ru dopant concentration, as in the case of Co-doped compounds. On the other hand, both the residual resistivity and the resistivity anisotropy induced by isovalent Ru substitution are found to be 1 order of magnitude smaller than those induced by heterovalent Co substitution. Combined with angle-resolved photoemission spectroscopy results, which show almost the same anisotropic band structure for both the parent and the Ru-substituted compounds, we confirm the scenario that the anisotropy in the residual resistivity arises from anisotropic impurity scattering in the magnetostructurally ordered phase rather than directly from the anisotropic band structure of that phase.	[Liu, L.; Mikami, T.; Koshiishi, K.; Okazaki, K.; Suzuki, H.; Horio, M.; Ambolode, L. C. C., II; Xu, J.; Kakeshita, T.; Uchida, S.; Fujimori, A.] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Ishida, S.; Nakajima, M.; Iyo, A.; Eisaki, H.] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Yoshida, T.] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068502, Japan; [Kumigashira, H.; Ono, K.] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; [Kihou, K.; Lee, C. H.] Natl Inst Adv Ind Sci & Technol, Res Inst Energy Conservat, Tsukuba, Ibaraki 3058568, Japan	Liu, L (reprint author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.		Ono, Kanta/I-3226-2014	Ono, Kanta/0000-0002-3285-9093	Japan-China-Korea A3 Foresight Program from the Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Scholarship Program of Japan; China Scholarship Council (CSC)	We thank D. Hirai for his help in the transport measurement. Transport measurement was also performed using facilities at the Cryogenic Research Center, University of Tokyo. This work was supported by the Japan-China-Korea A3 Foresight Program from the Japan Society for the Promotion of Science (JSPS). The experiment at the Photon Factory was approved by the Photon Factory Program Advisory Committee (Proposals No. 2012S2-001 and No. 2012G075). L.L. thanks the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Scholarship Program of Japan and the China Scholarship Council (CSC) for financial support.	Ishida S, 2013, J AM CHEM SOC, V135, P3158, DOI 10.1021/ja311174e; Kuo HH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054540; Wang LM, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.037001; Nakajima M, 2011, P NATL ACAD SCI USA, V108, P12238, DOI 10.1073/pnas.1100102108; Yi M, 2011, P NATL ACAD SCI USA, V108, P6878, DOI 10.1073/pnas.1015572108; Thaler A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.014534; Fernandes RM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.217002; Paglione J, 2010, NAT PHYS, V6, P645, DOI 10.1038/NPHYS1759; Fisher IR, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124506; Allan MP, 2013, NAT PHYS, V9, P220, DOI [10.1038/nphys2544, 10.1038/NPHYS2544]; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Blomberg EC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2933; Chen CC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.100504; Chu JH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014506; Ishida S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.184514; Ishida S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.207001; Kim Y, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064509; Liang T, 2011, J PHYS CHEM SOLIDS, V72, P418, DOI 10.1016/j.jpcs.2010.10.080; MONTGOME.HC, 1971, J APPL PHYS, V42, P2971, DOI 10.1063/1.1660656; Nakajima M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.217003; Xu N, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.064505; Yi M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.174510	22	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	SEP 1	2015	92	9							094503	10.1103/PhysRevB.92.094503		5	Physics, Condensed Matter	Physics	CQ1AT	WOS:000360330400008		
J	Morimoto, T; Furusaki, A; Mudry, C				Morimoto, Takahiro; Furusaki, Akira; Mudry, Christopher			Breakdown of the topological classification Z for gapped phases of noninteracting fermions by quartic interactions	PHYSICAL REVIEW B			English	Article							HALL CONDUCTANCE; 2 DIMENSIONS; INSULATORS; SUPERCONDUCTORS	The conditions for both the stability and the breakdown of the topological classification of gapped ground states of noninteracting fermions, the tenfold way, in the presence of quartic fermion-fermion interactions are given for any dimension of space. This is achieved by encoding the effects of interactions on the boundary gapless modes in terms of boundary dynamical masses. Breakdown of the noninteracting topological classification occurs when the quantum nonlinear sigma models for the boundary dynamical masses favor quantum disordered phases. For the tenfold way, we find that (i) the noninteracting topological classification Z(2) is always stable, (ii) the noninteracting topological classification Z in even dimensions is always stable, and (iii) the noninteracting topological classification Z in odd dimensions is unstable and reduces to Z(N) that can be identified explicitly for any dimension and any defining symmetries. We also apply our method to the three-dimensional topological crystalline insulator SnTe from the symmetry class AII + R, for which we establish the reduction Z -> Z(8) of the noninteracting topological classification.	[Morimoto, Takahiro; Furusaki, Akira] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Furusaki, Akira] RIKEN, Condensed Matter Theory Lab, Wako, Saitama 3510198, Japan; [Mudry, Christopher] Paul Scherrer Inst, Condensed Matter Theory Grp, CH-5232 Villigen, Switzerland	Morimoto, T (reprint author), RIKEN, CEMS, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Furusaki, Akira/B-3204-2008	Furusaki, Akira/0000-0001-8394-0003	JSPS [15K05141]; RIKEN iTHES Project	This work was supported in part by JSPS KAKENHI Grant Number 15K05141 and by the RIKEN iTHES Project.	Fidkowski L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.134509; Witczak-Krempa W, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165122; Chen X, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035107; Kane CL, 2002, PHYS REV LETT, V88, DOI [10.1103/PhysRevLett.88.036401, 10.1103/PhysRevB.88.036401]; Mong RSK, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011036; Neupert T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165107; Cho GY, 2011, ANN PHYS-NEW YORK, V326, P1515, DOI 10.1016/j.aop.2010.12.011; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; Gu ZC, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.201113; Kitaev A, 2009, AIP CONF PROC, V1134, P22, DOI 10.1063/1.3149495; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Chiu CK, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075142; Fidkowski L, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041016; Morimoto T, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125129; Levin M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235145; Swingle B, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195139; Wang C, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.195124; NIU Q, 1985, PHYS REV B, V31, P3372, DOI 10.1103/PhysRevB.31.3372; Senthil T, 2015, ANNU REV CONDEN MA P, V6, P299, DOI 10.1146/annurev-conmatphys-031214-014740; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Turner AM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075102; Fidkowski L, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075103; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Maciejko J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246809; Qi XL, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/065002; Lu YM, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125119; Chen X, 2012, SCIENCE, V338, P1604, DOI 10.1126/science.1227224; von Keyserlingk CW, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045107; Mesaros A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155115; Maciejko J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235128; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; LAUGHLIN RB, 1981, PHYS REV B, V23, P5632, DOI 10.1103/PhysRevB.23.5632; Abanov AG, 2000, NUCL PHYS B, V570, P685, DOI 10.1016/S0550-3213(99)00820-2; Ryu S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065010; Morimoto T, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.235111; Tang E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.096403; Chen X, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155114; Vishwanath A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011016; Levin M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.196803; Hastings MB, 2015, COMMUN MATH PHYS, V334, P433, DOI 10.1007/s00220-014-2167-x; Hsieh TH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1969; Hung LY, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075121; Isobe H, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.081304; Jian CM, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041043; Kapustin A., 2014, ARXIV14046659; Kapustin A., 2014, ARXIV14067329; Kapustin A., 2014, ARXIV14031467; Kapustin A., 2013, ARXIV13082926; Koma T., 2015, ARXIV150401243; Metlitski M. A., 2014, ARXIV14063032; Neupert T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.205101; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Ryu S, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245132; Shiozaki K, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.165114; Teo JCY, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.085101; Walker K, 2012, FRONT PHYS-BEIJING, V7, P150, DOI 10.1007/s11467-011-0194-z; Wang C, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235122; Yao H, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.064507; Ye P, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045127; Yoshida T, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.085114; You Y.-Z., 2014, ARXIV14024151; You YZ, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.245120	63	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	SEP 1	2015	92	12							125104	10.1103/PhysRevB.92.125104		27	Physics, Condensed Matter	Physics	CQ1BF	WOS:000360331600005		
J	Ono, S				Ono, Shota			Linear response theory for electron-hole pair kinetics: Exciton formation	PHYSICAL REVIEW B			English	Article							TRANSIENT EXCITONS; EXCITATIONS; PARTICLE; METALS	A linear response theory for electron-hole pair density is developed, which constitutes a theoretical method, and a definition of exciton density in a first-principles context is derived by considering both the electron-hole attractive interaction and the screening effect. This allows the exciton time evolution to be examined. This formulation is applied to a jellium model in order to prove the existence of a transient exciton, and to observe crossover from a transient to a stable exciton in response to decreased electron density. The exciton formation mechanism is also revealed.	[Ono, Shota] Yokohama Natl Univ, Grad Sch Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan; [Ono, Shota] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Ono, S (reprint author), Yokohama Natl Univ, Grad Sch Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan.	shota-o@ynu.ac.jp			Computational Materials Research Initiative [High Performance Computing Infrastructure (HPCI), Ministry of Education, Culture, Sports, Science, and Technology (MEXT)] program for Young Researcher Overseas Visits; MEXT [25104713]	The author acknowledges S. G. Louie, M. Bernadi, J. Mustafa, and K. Ohno for their contributions to fruitful discussions. This research was supported by the Computational Materials Research Initiative [High Performance Computing Infrastructure (HPCI), Ministry of Education, Culture, Sports, Science, and Technology (MEXT)] program for Young Researcher Overseas Visits and a grant-in-aid for Scientific Research in Innovative Areas (Grant No. 25104713) from MEXT.	Schone WD, 2003, INT J MOD PHYS B, V17, P5655, DOI 10.1142/S0217979203023367; Cudazzo P, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.195152; ROGERS FJ, 1970, PHYS REV A-GEN PHYS, V1, P1577, DOI 10.1103/PhysRevA.1.1577; Onida G, 2002, REV MOD PHYS, V74, P601, DOI 10.1103/RevModPhys.74.601; Cui XF, 2014, NAT PHYS, V10, P505, DOI 10.1038/NPHYS2981; STRINATI G, 1988, RIV NUOVO CIMENTO, V11, P1, DOI 10.1007/BF02725962; Rohlfing M, 2000, PHYS REV B, V62, P4927, DOI 10.1103/PhysRevB.62.4927; SHAM LJ, 1966, PHYS REV, V144, P708, DOI 10.1103/PhysRev.144.708; ELLIOTT RJ, 1957, PHYS REV, V108, P1384, DOI 10.1103/PhysRev.108.1384; Gumhalter B, 2010, PHYS STATUS SOLIDI B, V247, P1907, DOI 10.1002/pssb.200983944; Schone WD, 2000, PHYS REV B, V62, P13464, DOI 10.1103/PhysRevB.62.13464; Attaccalite C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245110; CANRIGHT GS, 1988, PHYS REV B, V38, P1647, DOI 10.1103/PhysRevB.38.1647; Cudazzo P, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/11/113204; Fetter A. L., 2003, QUANTUM THEORY MANY; ICHIMARU S, 1981, PHYS REV B, V24, P7385, DOI 10.1103/PhysRevB.24.7385; Schone WD, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.113112	17	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	SEP 1	2015	92	12							125101	10.1103/PhysRevB.92.125101		11	Physics, Condensed Matter	Physics	CQ1BF	WOS:000360331600002		
J	Tada, Y				Tada, Yasuhiro			Equilibrium surface current and role of U(1) symmetry: Sum rule and surface perturbations	PHYSICAL REVIEW B			English	Article							DENSITY-FUNCTIONAL THEORY; LUTTINGERS THEOREM; SUPERFLUID HE-3-A; TOPOLOGICAL INSULATORS; ORBITAL MAGNETISM; ANGULAR-MOMENTUM; FERMI-SURFACE; MASS CURRENT; 2 DIMENSIONS; ELECTRONS	We discuss effects of surface perturbations on equilibrium surface currents which contribute to orbital magnetization and orbital angular momentum in systems without time-reversal symmetry. We show that, in a U(1) particle-number-conserving system, disorder and other perturbations at a surface do not affect the equilibrium surface current and corresponding orbital magnetization, due to a sum rule which is analogous to Luttinger's theorem. On the other hand, for a superfluid, the sum rule is no longer applicable and hence the surface mass current and corresponding orbital angular momentum can depend on details of a surface.	Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Tada, Y (reprint author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.				JSPS/MEXT [26800177, 25103706];  [R2604]	We thank M. Oshikawa, H. Akai, S. Fujimoto, Y. Yanase, T. Osada, S. Sugiura, Y. Nishida, M. Sigrist, and A. H. MacDonald for valuable discussions. This work was partly supported by JSPS/MEXT Grant-in-Aid for Scientific Research (Grants No. 26800177 and No. 25103706) and by a Grant-in-Aid for Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (Grant No. R2604) "TopoNet."	Abrikosov A.A., 1988, FUNDAMENTALS THEORY; Bradlyn B, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245309; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Shi J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.197202; Huang W, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.094507; Peierls R, 1933, Z PHYS, V80, P763, DOI 10.1007/BF01342591; Resta R, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/12/123201; Xiao D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137204; Stone M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.184511; Yamanaka M, 1997, PHYS REV LETT, V79, P1110, DOI 10.1103/PhysRevLett.79.1110; Matsumoto R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.197202; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Maeno Y, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011009; Oshikawa M, 2000, PHYS REV LETT, V84, P3370, DOI 10.1103/PhysRevLett.84.3370; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; Hoyos C, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174507; LUTTINGER JM, 1960, PHYS REV, V118, P1417, DOI 10.1103/PhysRev.118.1417; Landau L, 1930, Z PHYS, V64, P629, DOI 10.1007/BF01397213; Ceresoli D, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.024408; Thonhauser T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137205; Ohashi Y, 1996, J PHYS SOC JPN, V65, P3254, DOI 10.1143/JPSJ.65.3254; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; EAGLES DM, 1969, PHYS REV, V186, P456, DOI 10.1103/PhysRev.186.456; FUKUYAMA H, 1971, PROG THEOR PHYS, V45, P704, DOI 10.1143/PTP.45.704; Ishikawa Y, 1999, J PHYS SOC JPN, V68, P2405, DOI 10.1143/JPSJ.68.2405; VIGNALE G, 1987, PHYS REV LETT, V59, P2360, DOI 10.1103/PhysRevLett.59.2360; Kaur RP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137002; Sauls JA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214509; KUBO R, 1964, J PHYS SOC JPN, V19, P2127, DOI 10.1143/JPSJ.19.2127; Dave KB, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.090403; LUTTINGER JM, 1960, PHYS REV, V119, P1153, DOI 10.1103/PhysRev.119.1153; Ashby PEC, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224509; BOHM D, 1949, PHYS REV, V75, P502, DOI 10.1103/PhysRev.75.502; Bouhon A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.220511; CARRUTHE.P, 1968, REV MOD PHYS, V40, P411, DOI 10.1103/RevModPhys.40.411; Chen KT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195111; Chen KT, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205137; Dzyaloshinskii I, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.085113; Emch G. G., 1972, PHASE TRANSITIONS CR, V1; ESCHRIG H, 1985, SOLID STATE COMMUN, V56, P777, DOI 10.1016/0038-1098(85)90307-2; Furusaki A, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.054514; Gat O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.186801; Gat O, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/344; Goryo J, 1998, PHYS LETT A, V246, P549, DOI 10.1016/S0375-9601(98)00438-1; Higuchi M, 1997, J PHYS SOC JPN, V66, P149, DOI 10.1143/JPSJ.66.149; Huang W, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.224519; ISHIKAWA M, 1980, PROG THEOR PHYS, V63, P1083, DOI 10.1143/PTP.63.1083; Kita T, 1998, J PHYS SOC JPN, V67, P216, DOI 10.1143/JPSJ.67.216; Kusama Y, 1999, J PHYS SOC JPN, V68, P987, DOI 10.1143/JPSJ.68.987; Lederer S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.134521; Leggett A. J., 1980, MODERN TRENDS THEORY; Leggett A. J., 2006, QUANTUM LIQUIDS BOSE; LIEB E, 1961, ANN PHYS-NEW YORK, V16, P407, DOI 10.1016/0003-4916(61)90115-4; MacDonald A. H., 1995, MES QUANT PHYS HOUCH; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; Martin R. M., 2004, ELECT STRUCTURE BASI; Massignan P, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.031607; MERMIN ND, 1980, PHYS REV B, V21, P980, DOI 10.1103/PhysRevB.21.980; Mizushima T., ARXIV150800787; Mizushima T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.150409; Nagato Y, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.113706; NEE TW, 1968, PHYS REV, V174, P758, DOI 10.1103/PhysRev.174.758; OHTAKA K, 1973, J PHYS SOC JPN, V34, P1203, DOI 10.1143/JPSJ.34.1203; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Rosch A, 2007, EUR PHYS J B, V59, P495, DOI 10.1140/epjb/e2007-00312-3; Shitade A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.134510; STREDA P, 1982, J PHYS C SOLID STATE, V15, pL717, DOI 10.1088/0022-3719/15/22/005; Tada Y, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.195301; Thonhauser T, 2011, INT J MOD PHYS B, V25, P1429, DOI 10.1142/S0217979211058912; Tsuruta A., UNPUB; Tsutsumi Y, 2014, J LOW TEMP PHYS, V175, P51, DOI 10.1007/s10909-013-0968-5; VIGNALE G, 1995, PHYS REV B, V51, P2612, DOI 10.1103/PhysRevB.51.2612; Vollhart D., 1990, SUPERFLUID PHASE HEL, V3; Volovik G. E., 2003, UNIVERSE HELIUM DROP; Volovik GE, 2015, JETP LETT+, V100, P742, DOI 10.1134/S0021364014230155; Wen X. G., 2004, QUANTUM FIELD THEORY; Yip SK, 2005, J LOW TEMP PHYS, V140, P67, DOI 10.1007/s10909-005-6012-7	78	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	SEP 1	2015	92	10							104502	10.1103/PhysRevB.92.104502		15	Physics, Condensed Matter	Physics	CQ1AY	WOS:000360330900007		
J	Kim, A; Lee, NH; Han, MH; Yoo, JS; Hahn, KI; Yamaguchi, H; Binh, DN; Hashimoto, T; Hayakawa, S; Kahl, D; Kawabata, T; Kurihara, Y; Wakabayashi, Y; Kubono, S; Choi, S; Kwon, YK; Moon, JY; Jung, HS; Lee, CS; Teranishi, T; Kato, S; Komatsubara, T; Guo, B; Liu, WP; Wang, B; Wang, Y				Kim, A.; Lee, N. H.; Han, M. H.; Yoo, J. S.; Hahn, K. I.; Yamaguchi, H.; Binh, D. N.; Hashimoto, T.; Hayakawa, S.; Kahl, D.; Kawabata, T.; Kurihara, Y.; Wakabayashi, Y.; Kubono, S.; Choi, S.; Kwon, Y. K.; Moon, J. Y.; Jung, H. S.; Lee, C. S.; Teranishi, T.; Kato, S.; Komatsubara, T.; Guo, B.; Liu, W. P.; Wang, B.; Wang, Y.			Measurement of the O-14(alpha, p)F-17 cross section at E-c.m. approximate to 2.1-5.3 MeV	PHYSICAL REVIEW C			English	Article							SHORT-LIVED NUCLEI; STELLAR REACTIONS; NE-18; ALPHA)O-14; F-17(P; STATES; SHELL; O-14; CRIB	Background: The O-14(alpha, p)F-17 reaction plays an important role as the trigger reaction for the x-ray burst. Purpose: The direct measurement of O-14(alpha, p)F-17 was made for studying the resonant states in Ne-18 and determining the reaction rate of O-14(alpha, p)F-17 at astrophysical temperatures. Methods: The differential cross section of the O-14(alpha, p)F-17 reaction was measured using a 2.5-MeV/u O-14 radioactive beam and the thick target method in inverse kinematics. Three sets of Delta E-E Si telescopes were installed and coincidence measurements were performed. We analyzed single-proton decay events using the time-of-flight (TOF) information of the recoiling protons. Results: The excitation function of O-14(alpha, p)F-17 was acquired for excitation energies between 7.2 and 10.4 MeV in Ne-18 by considering the two channels which decay to the ground state and first excited state of F-17. Several new, as well as previously known, states in Ne-18 were observed and their resonance parameters were extracted from R-matrix analysis. The contributions of four resonances over the excitation energy range, 7 < E-x < 8.2 MeV, to the O-14(alpha, p)F-17 reaction rate were calculated. Conclusions: We observed very strong single-proton decay events, but did not observe strong double-proton decay events as in a previous study by Fu et al. The reaction rates contributed by the 7.35-, 7.58-, and 7.72-MeV states were estimated to be dominant at temperatures T-9 > 2. Among these three states, the 7.35-MeV state was found to enhance the reaction rate by a factor of 10 greater than the other two resonance states.	[Kim, A.; Lee, N. H.; Hahn, K. I.] Ewha Womans Univ, Dept Phys, Seoul 120750, South Korea; [Han, M. H.; Yoo, J. S.; Hahn, K. I.] Ewha Womans Univ, Dept Sci Educ, Seoul 120750, South Korea; [Yamaguchi, H.; Binh, D. N.; Hashimoto, T.; Hayakawa, S.; Kahl, D.; Kawabata, T.; Kurihara, Y.; Wakabayashi, Y.] Univ Tokyo, RIKEN Branch, Ctr Nucl Study, Tokyo 1138654, Japan; [Kubono, S.] RIKEN Nishina Ctr, Wako, Saitama 3510198, Japan; [Kubono, S.] Inst Modern Phys, Lanzhou, Peoples R China; [Choi, S.] Seoul Natl Univ, Dept Phys & Astron, Seoul 151742, South Korea; [Kwon, Y. K.; Moon, J. Y.] Inst for Basic Sci Korea, Taejon 305811, South Korea; [Jung, H. S.; Lee, C. S.] Chung Ang Univ, Dept Phys, Seoul 156756, South Korea; [Teranishi, T.] Kyushu Univ, Fukuoka 8128581, Japan; [Kato, S.] Yamagata Univ, Yamagata 9908560, Japan; [Komatsubara, T.] Univ Tsukuba, Tsukuba, Ibaraki 3058577, Japan; [Guo, B.; Liu, W. P.; Wang, B.; Wang, Y.] China Inst Atom Energy, Beijing, Peoples R China	Kim, A (reprint author), Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea.	ishahn@ewha.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2010-0027136, NRF-2012R1A1A3007962, NRF-2014R1A1A2A16052632]; JSPS KAKENHI [21340053, 25800125]; National Research Foundation - Korean Government [NRF-2009-0093817, NRF-2013R1A1A2063017]	The authors thank RIKEN and CNS staffs for their operation of the AVF cyclotron. This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education (Grants No. NRF-2010-0027136, No. NRF-2012R1A1A3007962, and No. NRF-2014R1A1A2A16052632) and by JSPS KAKENHI (Grants No. 21340053 and No. 25800125). C.S.L. was supported by the National Research Foundation grant funded by the Korean Government (Grants No. NRF-2009-0093817 and No. NRF-2013R1A1A2063017).	Almaraz-Calderon S, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.025801; WARBURTON EK, 1992, PHYS REV C, V46, P923, DOI 10.1103/PhysRevC.46.923; Kumagai H, 2001, NUCL INSTRUM METH A, V470, P562, DOI 10.1016/S0168-9002(01)00804-X; LANE AM, 1958, REV MOD PHYS, V30, P257, DOI 10.1103/RevModPhys.30.257; Bardayan DW, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.065805; Bardayan DW, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.065802; Blackmon J. C., 2003, NUCL PHYS A, V718, P127, DOI 10.1016/S0375-9474(03)00689-4; Brown B. A., 2007, MSU NCSL REPOR UNPUB; Buchmann L, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.012804; COBERN ME, 1981, PHYS REV C, V23, P2387, DOI 10.1103/PhysRevC.23.2387; del Campo JG, 2001, PHYS REV LETT, V86, P43; FALK WR, 1970, NUCL PHYS A, VA157, P241, DOI 10.1016/0375-9474(70)90111-9; Fortune HT, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.047301; Fortune HT, 2000, PHYS REV LETT, V84, P1635, DOI 10.1103/PhysRevLett.84.1635; Fu C, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.021603; Fu CB, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.064314; Goldberg VZ, 2005, PHYS ATOM NUCL+, V68, P1079, DOI 10.1134/1.1992561; Grigorenko LV, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.044612; Hahn KI, 1996, PHYS REV C, V54, P1999, DOI 10.1103/PhysRevC.54.1999; Harss B, 1999, PHYS REV LETT, V82, P3964, DOI 10.1103/PhysRevLett.82.3964; Harss B, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.035803; He JJ, 2011, EUR PHYS J A, V47, DOI 10.1140/epja/i2011-11067-6; Hu J, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.025803; Johnson ED, 2009, EUR PHYS J A, V42, P135, DOI 10.1140/epja/i2009-10887-1; Kim A, 2010, J KOREAN PHYS SOC, V57, P40, DOI 10.3938/jkps.57.40; Larson N. M., 2000, ORNLTM9179R5; NERO AV, 1981, PHYS REV C, V24, P1864, DOI 10.1103/PhysRevC.24.1864; Notani M, 2004, NUCL PHYS A, V746, p113C, DOI 10.1016/j.nuclphysa.2004.09.019; PADDOCK RA, 1972, PHYS REV C, V5, P485, DOI 10.1103/PhysRevC.5.485; Raciti G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.192503; von Oertzen W, 2010, EUR PHYS J A, V43, P17, DOI 10.1140/epja/i2009-10894-2; WALLACE RK, 1981, ASTROPHYS J SUPPL S, V45, P389, DOI 10.1086/190717; WIESCHER M, 1988, ASTROPHYS J, V316, P162; Yamaguchi H, 2008, NUCL INSTRUM METH A, V589, P150, DOI 10.1016/j.nima.2008.02.013; Yanagisawa Y, 2005, NUCL INSTRUM METH A, V539, P74, DOI 10.1016/j.nima.2004.09.041	35	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2813	1089-490X		PHYS REV C	Phys. Rev. C	SEP 1	2015	92	3							035801	10.1103/PhysRevC.92.035801		7	Physics, Nuclear	Physics	CQ1BN	WOS:000360332400003		
J	Tanimura, Y; Lacroix, D; Scamps, G				Tanimura, Yusuke; Lacroix, Denis; Scamps, Guillaume			Collective aspects deduced from time-dependent microscopic mean-field with pairing: Application to the fission process	PHYSICAL REVIEW C			English	Article							REPRESENTATION; RPA	Given a set of collective variables, a method is proposed to obtain the associated conjugated collective momenta and masses starting from a microscopic time-dependent mean-field theory. The construction of pairs of conjugated variables is the first step to bridge microscopic and macroscopic approaches. The method is versatile and can be applied to study a large class of nuclear processes. An illustration is given here with the fission of Fm-258. Using the quadrupole moment and eventually higher-order multipole moments, the associated collective masses are estimated along the microscopic mean-field evolution. When more than one collective variable is considered, it is shown that the off-diagonal matrix elements of the inertia play a crucial role. Using the information on the quadrupole moment and associated momentum, the collective evolution is studied. It is shown that dynamical effects beyond the adiabatic limit are important. Nuclei formed after fission tend to stick together for a longer time leading to a dynamical scission point at a larger distance between nuclei compared to the one anticipated from the adiabatic energy landscape. The effective nucleus-nucleus potential felt by the emitted nuclei is finally extracted.	[Tanimura, Yusuke; Lacroix, Denis] Univ Paris 11, Inst Phys Nucl, CNRS, IN2P3, F-91406 Orsay, France; [Scamps, Guillaume] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Tanimura, Y (reprint author), Univ Paris 11, Inst Phys Nucl, CNRS, IN2P3, F-91406 Orsay, France.	tanimura@ipno.in2p3.fr; lacroix@ipno.in2p3.fr; scamps@nucl.phys.tohoku.ac.jp		Scamps, Guillaume/0000-0002-8102-9758	Japan Society for the Promotion of Science for the JSPS postdoctoral fellowship;  [14F04769]	We would like to thank G. Adamian, N. Antonenko, S. Ayik, and K. Hagino for useful discussions on collective observables. G. S. acknowledges the Japan Society for the Promotion of Science for the JSPS postdoctoral fellowship for foreign researchers. This work was supported by Grant-in-Aid for JSPS Fellows No. 14F04769.	ADAMIAN GG, 1995, NUCL PHYS A, V584, P205, DOI 10.1016/0375-9474(94)00505-H; Washiyama K, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.024610; Ebata S, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.034306; Nakatsukasa T, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.024301; Bonche P, 2005, COMPUT PHYS COMMUN, V171, P49, DOI 10.1016/j.cpc.2005.05.001; Scamps G, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.034328; Kim KH, 1997, J PHYS G NUCL PARTIC, V23, P1267, DOI 10.1088/0954-3899/23/10/014; Scamps G, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.011602; Scamps G, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014605; Simenel C, 2001, PHYS REV LETT, V86, P2971, DOI 10.1103/PhysRevLett.86.2971; REINHARD PG, 1980, Z PHYS A-HADRON NUCL, V295, P45, DOI 10.1007/BF01414297; Goutte H, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.024316; Umar AS, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.034314; Avez B, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.044318; Stetcu I, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.051309; Scamps G, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.034314; Bertsch GF, 1997, PHYS REV C, V56, P839, DOI 10.1103/PhysRevC.56.839; Goddard P. M., ARXIV150400919; Goddard P. M., 2014, THESIS U SURREY; Hashimoto Y., 2012, EUR PHYS J A, V48, P1; NEGELE JW, 1989, NUCL PHYS A, V502, pC371; REINHARD PG, 1990, PHYS REV A, V41, P5568, DOI 10.1103/PhysRevA.41.5568; REINHARD PG, 1992, ANN PHYS-BERLIN, V1, P598; Scamps G, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.044310; Simenel C, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.031601; Simenel C., 2010, QUANTUM MANY BODY DY	26	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2813	1089-490X		PHYS REV C	Phys. Rev. C	SEP 1	2015	92	3							034601	10.1103/PhysRevC.92.034601		11	Physics, Nuclear	Physics	CQ1BN	WOS:000360332400002		
J	Hisano, J; Nagata, N; Omura, Y				Hisano, Junji; Nagata, Natsumi; Omura, Yuji			Interpretations of the ATLAS diboson resonances	PHYSICAL REVIEW D			English	Article							PROTON-PROTON COLLISIONS; LEFT-RIGHT SYMMETRY; NEUTRAL CURRENTS; HEAVY NEUTRINOS; LEPTOPHOBIC Z'; GAUGE BOSONS; W-BOSONS; SEARCH; SCALE; MODEL	The ATLAS Collaboration has reported excesses in searches for resonant diboson production decaying into hadronic final states. This deviation from the standard model prediction may be a signature of an extra bosonic particle having a mass of around 2 TeV with a fairly narrow width, which implies the presence of a new perturbative theory at the TeV scale. In this paper, we study interpretations of the signal and its implication to physics beyond the standard model. We find that the resonance could be regarded as a leptophobic vector particle, which could explain a part of the observed excesses without conflict with the present constraints from other direct searches for heavy vector bosons at the LHC as well as the electroweak precision measurements.	[Hisano, Junji; Omura, Yuji] Nagoya Univ, Kobayashi Maskawa Inst Origin Particles & Univers, Nagoya, Aichi 4648602, Japan; [Hisano, Junji] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan; [Hisano, Junji; Nagata, Natsumi] Univ Tokyo, Kavli IPMU WPI, UTIAS, Kashiwa, Chiba 2778583, Japan; [Nagata, Natsumi] Univ Minnesota, Sch Phys & Astron, William I Fine Theoret Phys Inst, Minneapolis, MN 55455 USA	Hisano, J (reprint author), Nagoya Univ, Kobayashi Maskawa Inst Origin Particles & Univers, Nagoya, Aichi 4648602, Japan.				Ministry of Education, Science, Sports, and Culture (MEXT), Japan [23104011]; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists	This work is supported by Grant-in-Aid for Scientific research from the Ministry of Education, Science, Sports, and Culture (MEXT), Japan, Grant No. 23104011 (for J. H. and Y. O.). The work of J. H. is also supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan. The work of N. N. is supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.	Aad G, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.052005; Aad G., ARXIV150600962 ATLAS; Aad G, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2014)037; Leike A., 1999, Physics Reports, V317, DOI 10.1016/S0370-1573(98)00133-1; Aguilar-Saavedra JA, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.115010; Gluza J, 2015, PHYS LETT B, V748, P125, DOI 10.1016/j.physletb.2015.06.077; Aad G, 2015, PHYS LETT B, V743, P235, DOI 10.1016/j.physletb.2015.02.051; Rizzo TG, 1999, PHYS REV D, V59; King SF, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.035009; Heikinheimo M, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-3107-9; Babu KS, 1996, PHYS REV D, V54, P4635, DOI 10.1103/PhysRevD.54.4635; Khachatryan V, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2014)173; Leroux K, 2002, PHYS LETT B, V526, P97, DOI 10.1016/S0370-2693(01)01489-7; Buckley MR, 2011, PHYS LETT B, V703, P343, DOI 10.1016/j.physletb.2011.08.014; Chatrchyan S, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.114015; Aad G, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.191803; PESKIN ME, 1992, PHYS REV D, V46, P381, DOI 10.1103/PhysRevD.46.381; Bertolini S, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.095028; Guadagnoli D, 2011, PHYS LETT B, V694, P386, DOI 10.1016/j.physletb.2010.10.027; Zhang Y, 2008, NUCL PHYS B, V802, P247, DOI 10.1016/j.nuclphysb.2008.05.019; BARGER V, 1980, PHYS REV D, V22, P727, DOI 10.1103/PhysRevD.22.727; MOHAPATRA RN, 1975, PHYS REV D, V11, P2558, DOI 10.1103/PhysRevD.11.2558; Vignaroli N, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.095027; Langacker P, 2009, REV MOD PHYS, V81, P1199, DOI 10.1103/RevModPhys.81.1199; Aad G, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.052007; Barger V, 1996, PHYS LETT B, V381, P226, DOI 10.1016/0370-2693(96)00554-0; Barger V, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.115010; Chiang CW, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2014)106; Khachatryan V, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2015)025; CMS Collaboration (CMS Collaboration), CMSPASEXO14010; del Aguila F, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2010)033; DELAGUILA F, 1987, NUCL PHYS B, V283, P50, DOI 10.1016/0550-3213(87)90261-6; Deppisch FF, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.053014; Erler J, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/08/017; Fukano H.S., ARXIV150603751; Grojean C, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2011)002; Khachatryan V., PHYS REV D IN PRESS; Khachatryan V, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-3149-z; Khachatryan V, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2014)174; Khachatryan V, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.092005; Khachatryan V., ARXIV150601443 CMS C; Khachatryan V, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.052009; Ko P, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2015)034; Maiezza A, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.055022; Maltoni F., 2003, JHEP, V0302, P027, DOI DOI 10.1088/1126-6708/2003/02/027; Pappadopulo D, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2014)060; Rizzo TG, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.055010; Rosner JL, 1996, PHYS LETT B, V387, P113, DOI 10.1016/0370-2693(96)01022-2; The ATLAS Collaboration, 2015, ATLASCONF2015009; Umeda Y, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.115008	50	15	15	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	SEP 1	2015	92	5							055001	10.1103/PhysRevD.92.055001		9	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CQ1BU	WOS:000360333100001		
J	Egami, Y; Iwase, S; Tsukamoto, S; Ono, T; Hirose, K				Egami, Yoshiyuki; Iwase, Shigeru; Tsukamoto, Shigeru; Ono, Tomoya; Hirose, Kikuji			First-principles calculation method for electron transport based on the grid Lippmann-Schwinger equation	PHYSICAL REVIEW E			English	Article							DIFFERENCE-PSEUDOPOTENTIAL METHOD; ATOMIC WIRES; DEPENDENCE; INTERFACES; RESISTANCE; NANOWIRES; AL	We develop a first-principles electron-transport simulator based on the Lippmann-Schwinger (LS) equation within the framework of the real-space finite-difference scheme. In our fully real-space-based LS (grid LS) method, the ratio expression technique for the scattering wave functions and the Green's function elements of the reference system is employed to avoid numerical collapse. Furthermore, we present analytical expressions and/ or prominent calculation procedures for the retarded Green's function, which are utilized in the grid LS approach. In order to demonstrate the performance of the grid LS method, we simulate the electron-transport properties of the semiconductor-oxide interfaces sandwiched between semi-infinite jellium electrodes. The results confirm that the leakage current through the (001) Si-SiO2 model becomes much larger when the dangling-bond state is induced by a defect in the oxygen layer, while that through the (001) Ge-GeO2 model is insensitive to the dangling bond state.	[Egami, Yoshiyuki] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Iwase, Shigeru] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Tsukamoto, Shigeru] Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany; [Tsukamoto, Shigeru] Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany; [Tsukamoto, Shigeru] JARA, D-52425 Julich, Germany; [Ono, Tomoya] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan; [Ono, Tomoya] JST PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hirose, Kikuji] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Egami, Y (reprint author), Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan.	y_egami@eng.hokudai.ac.jp	Ono, Tomoya/C-5077-2013		Ministry of Education, Culture, Sports, Science and Technology [24710152]	This research was supported by Grant-in-Aid for Young Scientists (B) No. 24710152 from the Ministry of Education, Culture, Sports, Science and Technology. The numerical calculation was carried out using the computer facilities at the Institute for Solid State Physics at the University of Tokyo, Information Synergy Center at Tohoku University.	Ono T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205115; Tsetseris L, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3280385; Ono T, 1999, PHYS REV LETT, V82, P5016, DOI 10.1103/PhysRevLett.82.5016; CHELIKOWSKY JR, 1994, PHYS REV B, V50, P11355, DOI 10.1103/PhysRevB.50.11355; Lang ND, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125323; Ono T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026804; Saito S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.021503; Havu P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075401; Nara J, 2004, J CHEM PHYS, V121, P6485, DOI 10.1063/1.1783251; Kobayashi N, 2000, PHYS REV B, V62, P8430, DOI 10.1103/PhysRevB.62.8430; BUTTIKER M, 1985, PHYS REV B, V31, P6207, DOI 10.1103/PhysRevB.31.6207; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Broqvist P, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3116612; Houssa M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3006320; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; LANG ND, 1995, PHYS REV B, V52, P5335, DOI 10.1103/PhysRevB.52.5335; Lang ND, 1997, PHYS REV LETT, V79, P1357, DOI 10.1103/PhysRevLett.79.1357; Yang M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3115824; Houssa M, 2009, MRS BULL, V34, P504, DOI 10.1557/mrs2009.138; Kageshima H, 1998, PHYS REV LETT, V81, P5936, DOI 10.1103/PhysRevLett.81.5936; Ono T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.206806; Binder JF, 2009, MICROELECTRON ENG, V86, P1760, DOI 10.1016/j.mee.2009.03.101; CHELIKOWSKY JR, 1994, PHYS REV LETT, V72, P1240, DOI 10.1103/PhysRevLett.72.1240; Egami Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056706; Egami Y, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/36/365201; Fujimoto Y, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.195315; Furuya S, 2006, JPN J APPL PHYS 1, V45, P8991, DOI 10.1143/JJAP.45.8991; HANEMAN D, 1961, PHYS REV, V121, P1093, DOI 10.1103/PhysRev.121.1093; Hasegawa Y., 2011, P 2011 INT C HIGH PE; Hirose K., 2005, 1 PRINCIPLES CALCULA; Hirose K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.085105; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Okamoto M, 2001, PHYS REV B, V64; Ono T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.021303; Ono T, 2009, J PHYS CHEM C, V113, P6256, DOI 10.1021/jp811214k; Ono T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085105; Ono T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195326; Ono T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195406; Ono T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085115; Otani M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121408; Saito S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085319; Sasaki T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056704; Tsukamoto S, 2002, JPN J APPL PHYS 1, V41, P7491, DOI 10.1143/JJAP.41.7491; Tsukamoto S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115443; Tsukamoto S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.161402	45	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1539-3755	1550-2376		PHYS REV E	Phys. Rev. E	SEP 1	2015	92	3							033301	10.1103/PhysRevE.92.033301		16	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	CQ1CF	WOS:000360334200006		
J	Matsubara, H; Tamii, A; Nakada, H; Adachi, T; Carter, J; Dozono, M; Fujita, H; Fujita, K; Fujita, Y; Hatanaka, K; Horiuchi, W; Itoh, M; Kawabata, T; Kuroita, S; Maeda, Y; Navratil, P; von Neumann-Cosel, P; Neveling, R; Okamura, H; Popescu, L; Poltoratska, I; Richter, A; Rubio, B; Sakaguchi, H; Sakaguchi, S; Sakemi, Y; Sasamoto, Y; Shimbara, Y; Shimizu, Y; Smit, FD; Suda, K; Tameshige, Y; Tokieda, H; Yamada, Y; Yosoi, M; Zenihiro, J				Matsubara, H.; Tamii, A.; Nakada, H.; Adachi, T.; Carter, J.; Dozono, M.; Fujita, H.; Fujita, K.; Fujita, Y.; Hatanaka, K.; Horiuchi, W.; Itoh, M.; Kawabata, T.; Kuroita, S.; Maeda, Y.; Navratil, P.; von Neumann-Cosel, P.; Neveling, R.; Okamura, H.; Popescu, L.; Poltoratska, I.; Richter, A.; Rubio, B.; Sakaguchi, H.; Sakaguchi, S.; Sakemi, Y.; Sasamoto, Y.; Shimbara, Y.; Shimizu, Y.; Smit, F. D.; Suda, K.; Tameshige, Y.; Tokieda, H.; Yamada, Y.; Yosoi, M.; Zenihiro, J.			Nonquenched Isoscalar Spin-M1 Excitations in sd-Shell Nuclei	PHYSICAL REVIEW LETTERS			English	Article							INELASTIC PROTON-SCATTERING; GAMOW-TELLER STRENGTH; MATRIX-ELEMENTS; MAGNETIC SPECTROMETER; ELECTRON-SCATTERING; M1 TRANSITIONS; GRAND-RAIDEN; P,N REACTION; BEAM LINE; ISOVECTOR	Differential cross sections of isoscalar and isovector spin-M1 (0(+) -> 1(+)) transitions are measured using high-energy-resolution proton inelastic scattering at E-p = 295 MeV on Mg-24, Si-28, S-32, and Ar-36 at 0 degrees-14 degrees. The squared spin-M1 nuclear transition matrix elements are deduced from the measured differential cross sections by applying empirically determined unit cross sections based on the assumption of isospin symmetry. The ratios of the squared nuclear matrix elements accumulated up to E-x = 16 MeV compared to a shell-model prediction are 1.01(9) for isoscalar and 0.61(6) for isovector spin-M1 transitions, respectively. Thus, no quenching is observed for isoscalar spin-M1 transitions, while the matrix elements for isovector spin-M1 transitions are quenched by an amount comparable with the analogous GamowTeller transitions on those target nuclei.	[Matsubara, H.; Tamii, A.; Adachi, T.; Fujita, H.; Fujita, K.; Fujita, Y.; Hatanaka, K.; Okamura, H.; Sakaguchi, H.; Suda, K.; Tameshige, Y.; Yosoi, M.] Osaka Univ, RCNP, Ibaraki, Osaka 5670047, Japan; [Nakada, H.] Chiba Univ, Dept Phys, Inage Ku, Chiba 2638522, Japan; [Carter, J.] Univ Witwatersrand, Sch Phys, ZA-2050 Johannesburg, South Africa; [Kawabata, T.; Sakaguchi, S.; Sasamoto, Y.; Shimizu, Y.; Tokieda, H.] Univ Tokyo, Ctr Nucl Study CNS, Bunkyo Ku, Tokyo 1130033, Japan; [Dozono, M.; Kuroita, S.; Yamada, Y.] Kyushu Univ, Dept Phys, Fukuoka 8128581, Japan; [Horiuchi, W.] Hokkaido Univ, Dept Phys, Sapporo, Hokkaido 0600810, Japan; [Itoh, M.; Sakemi, Y.] Tohoku Univ, Cyclotron & Radioisotope Ctr CYRIC, Sendai, Miyagi 9808578, Japan; [Zenihiro, J.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Maeda, Y.] Miyazaki Univ, Dept Appl Phys, Miyazaki 8892192, Japan; [Navratil, P.] TRIUMF, Vancouver, BC V6T 2A3, Canada; [von Neumann-Cosel, P.; Poltoratska, I.; Richter, A.] Tech Univ Darmstadt, Inst Kernphys, D-64289 Darmstadt, Germany; [Neveling, R.; Smit, F. D.] Natl Res Fdn, iThemba LABS, ZA-7129 Somerset West, South Africa; [Popescu, L.] Univ Ghent, Vakgrp Subatomaire & Stralingsfys, B-9000 Ghent, Belgium; [Rubio, B.] Univ Valencia, CSIC, Inst Fis Corpuscular, E-46071 Valencia, Spain; [Shimbara, Y.] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502102, Japan	Matsubara, H (reprint author), Natl Inst Radiol Sci, Chiba, Japan.	mats.hiroaki@gmail.com			JSPS International Training Program (ITP); JSPS [14740154, 24654066, 25105509]; MICIN-Spain [FPA2011-24553]; JSPS-CSIC collaboration program; DFG [SFB 634, NE 679/3-1]	We would like to thank M. Ichimura, H. Toki, Y. Ogawa, T. Myo, I. Tanihata, and B. A. Brown for valuable discussions. We are indebted to the RCNP cyclotron staff for providing us the excellent beam. This work was supported by the JSPS International Training Program (ITP) and was partially supported by JSPS (Grants No. 14740154, No. 24654066, No. and 25105509), by MICIN-Spain (Grant No. FPA2011-24553), by the JSPS-CSIC collaboration program, and by the DFG under Contracts No. SFB 634 and No. NE 679/3-1.	ANANTARAMAN N, 1984, PHYS REV LETT, V52, P1409, DOI 10.1103/PhysRevLett.52.1409; ANDERSON BD, 1991, PHYS REV C, V43, P50, DOI 10.1103/PhysRevC.43.50; Suzuki T, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.044302; Burrows A, 1998, PHYS REV C, V58, P554, DOI 10.1103/PhysRevC.58.554; Fujita Y, 2011, PROG PART NUCL PHYS, V66, P549, DOI 10.1016/j.ppnp.2011.01.056; Brown BA, 2006, PHYS REV C, V74, DOI [10.1103/PhysRevC.74.061303, 10.1103/PhyRevC.74.034315]; Cederwall B, 2011, NATURE, V469, P68, DOI 10.1038/nature09644; Subedi R, 2008, SCIENCE, V320, P1476, DOI 10.1126/science.1156675; Reddy S, 1999, PHYS REV C, V59, P2888, DOI 10.1103/PhysRevC.59.2888; ARIMA A, 1987, ADV NUCL PHYS, V18, P1; BERTSCH GF, 1982, PHYS REV C, V26, P1323, DOI 10.1103/PhysRevC.26.1323; TOWNER IS, 1987, PHYS REP, V155, P263, DOI 10.1016/0370-1573(87)90138-4; Brown BA, 2014, NUCL DATA SHEETS, V120, P115, DOI 10.1016/j.nds.2014.07.022; Langanke K, 2003, REV MOD PHYS, V75, P819, DOI 10.1103/RevModPhys.75.819; Ichimura M, 2006, PROG PART NUCL PHYS, V56, P446, DOI 10.1016/j.ppnp.2005.09.001; Langanke K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.202501; FRANEY MA, 1985, PHYS REV C, V31, P488, DOI 10.1103/PhysRevC.31.488; BROWN BA, 1987, NUCL PHYS A, V474, P290, DOI 10.1016/0375-9474(87)90619-1; Fantoni S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.181101; TADDEUCCI TN, 1987, NUCL PHYS A, V469, P125, DOI 10.1016/0375-9474(87)90089-3; von Neumann-Cosel P, 1998, PHYS LETT B, V443, P1, DOI 10.1016/S0370-2693(98)01298-2; Pudliner BS, 1997, PHYS REV C, V56, P1720, DOI 10.1103/PhysRevC.56.1720; Heyde K, 2010, REV MOD PHYS, V82, P2365, DOI 10.1103/RevModPhys.82.2365; Tamii A, 2009, NUCL INSTRUM METH A, V605, P326, DOI 10.1016/j.nima.2009.03.248; OSTERFELD F, 1992, REV MOD PHYS, V64, P491, DOI 10.1103/RevModPhys.64.491; Suzuki Y, 2008, FEW-BODY SYST, V42, P33, DOI 10.1007/s00601-008-0200-3; Barrett BR, 2013, PROG PART NUCL PHYS, V69, P131, DOI 10.1016/j.ppnp.2012.10.003; BENDEL WL, 1971, PHYS REV C, V3, P1821, DOI 10.1103/PhysRevC.3.1821; BERG UEP, 1984, PHYS LETT B, V140, P191, DOI 10.1016/0370-2693(84)90918-3; BROWN BA, 1983, PHYS REV C, V28, P2397, DOI 10.1103/PhysRevC.28.2397; CRAWLEY GM, 1989, PHYS REV C, V39, P311, DOI 10.1103/PhysRevC.39.311; Entem DR, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.041001; Firestone R.B., 1996, TABLE ISOTOPES; FOLTZ CW, 1994, PHYS REV C, V49, P1359, DOI 10.1103/PhysRevC.49.1359; Frauendorf S, 2014, PROG PART NUCL PHYS, V78, P24, DOI 10.1016/j.ppnp.2014.07.001; Fujita H, 2002, NUCL INSTRUM METH A, V484, P17, DOI 10.1016/S0168-9002(01)01970-2; Fujita Y, 1997, NUCL INSTRUM METH B, V126, P274, DOI 10.1016/S0168-583X(96)01008-7; Fujiwara M, 1999, NUCL INSTRUM METH A, V422, P484, DOI 10.1016/S0168-9002(98)01009-2; Hofmann F, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.024311; Kawabata T, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.034318; Kirson MW, 2007, NUCL PHYS A, V781, P350, DOI 10.1016/j.nuclphysa.2006.10.077; Luttge C, 1996, PHYS REV C, V53, P127, DOI 10.1103/PhysRevC.53.127; Matsubara H., 2010, THESIS OSAKA U; Matsubara H, 2009, NUCL INSTRUM METH B, V267, P3682, DOI 10.1016/j.nimb.2009.09.002; Matsubara H, 2012, NUCL INSTRUM METH A, V678, P122, DOI 10.1016/j.nima.2012.03.005; Petrovitch F., 1981, NUCL PHYS A, VA354, p499c, DOI 10.1016/0375-9474(81)90613-8; Rabhi A, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.045803; Raynal J., NEA1209008; RICHTER A, 1990, PHYS REV LETT, V65, P2519, DOI 10.1103/PhysRevLett.65.2519; RICHTER A, 1982, NUCL PHYS A, V374, pC177; ROTH R, COMMUNICATION; Sasano M, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.024602; Shen G, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.025802; TAMAGAKI R, 1968, PROG THEOR PHYS, V39, P91, DOI 10.1143/PTP.39.91; Thompson R., 1977, NUCL PHYS A, VA286, P53; TOWNER IS, 1983, NUCL PHYS A, V399, P334, DOI 10.1016/0375-9474(83)90252-X; von Neumann-Cosel P, 2000, NUCL PHYS A, V669, P3, DOI 10.1016/S0375-9474(99)00564-3; Wakasa T, 2002, NUCL INSTRUM METH A, V482, P79, DOI 10.1016/S0168-9002(01)01686-2	58	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007	1079-7114		PHYS REV LETT	Phys. Rev. Lett.	SEP 1	2015	115	10							102501	10.1103/PhysRevLett.115.102501		6	Physics, Multidisciplinary	Physics	CQ1CW	WOS:000360335900004		
J	Wang, ZT; Kamiya, Y; Nevidomskyy, AH; Batista, CD				Wang, Zhentao; Kamiya, Yoshitomo; Nevidomskyy, Andriy H.; Batista, Cristian D.			Three-Dimensional Crystallization of Vortex Strings in Frustrated Quantum Magnets	PHYSICAL REVIEW LETTERS			English	Article							BOSE-EINSTEIN CONDENSATION; WEAK FERROMAGNETISM; ANTIFERROMAGNETS; SUPERCONDUCTORS; SKYRMIONS; LATTICE; FIELD; MODEL; GAS; NMR	We demonstrate that frustrated exchange interactions can produce exotic 3D crystals of vortex strings near the saturation field (H = H-sat) of body- and face-centered cubic Mott insulators. The combination of cubic symmetry and frustration leads to a magnon spectrum of the fully polarized spin state (H > H-sat) with degenerate minima at multiple noncoplanar Q vectors. This spectrum becomes gapless at the quantum critical point H = H-sat and the magnetic ordering below Hsat can be formally described as a condensate of a dilute gas of bosons. By expanding in the lattice gas parameter, we find that different vortex crystals span sizable regions of the phase diagrams for isotropic exchange and are further stabilized by symmetric exchange anisotropy.	[Wang, Zhentao; Nevidomskyy, Andriy H.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Kamiya, Yoshitomo] RIKEN, iTHES Res Grp, Wako, Saitama 3510198, Japan; [Kamiya, Yoshitomo] RIKEN, Condensed Matter Theory Lab, Wako, Saitama 3510198, Japan; [Batista, Cristian D.] Los Alamos Natl Lab, Theoret Div, T & CNLS 4, Los Alamos, NM 87545 USA	Wang, ZT (reprint author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.		Kamiya, Yoshitomo/B-6307-2012	Kamiya, Yoshitomo/0000-0002-0758-0234	Welch Foundation [C-1818]; NSF [DMR-1350237, 1066293]; CNLS summer student program; Research Corporation for Science Advancement (RCSA) [22799]; U.S. DOE [DE-AC52-06NA25396]; RIKEN iTHES project	We would like to thank T. Momoi and N. Shannon for helpful discussions. Z. W. and A. H. N. were supported by Welch Foundation Grant No. C-1818 and the NSF CAREER Award No. DMR-1350237. Z. W. acknowledges support from the CNLS summer student program under which part of the work was performed. A. H. N. was supported by the Cottrell Award from the Research Corporation for Science Advancement (RCSA Grant No. 22799). Work at LANL was performed under the auspices of the U.S. DOE, Contract No. DE-AC52-06NA25396, through the LDRD program. Y. K. acknowledges financial supports from the RIKEN iTHES project. A. H. N. and C. D. B. thank the Aspen Center for Physics (supported by NSF Grant No. 1066293) for hospitality during the initial stage of this work.	Ueda HT, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014417; DZYALOSHINSKY I, 1958, J PHYS CHEM SOLIDS, V4, P241, DOI 10.1016/0022-3697(58)90076-3; Takabayashi Y, 2009, SCIENCE, V323, P1585, DOI 10.1126/science.1169163; FELDMAN EB, 1991, PHYS LETT A, V153, P60, DOI 10.1016/0375-9601(91)90362-C; FELDMAN EB, 1990, ZH EKSP TEOR FIZ+, V98, P967; Adams T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237204; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; MATSUBARA T, 1956, PROG THEOR PHYS, V16, P569, DOI 10.1143/PTP.16.569; Giamarchi T, 1999, PHYS REV B, V59, P11398, DOI 10.1103/PhysRevB.59.11398; Ganin AY, 2010, NATURE, V466, P221, DOI 10.1038/nature09120; Zapf V, 2014, REV MOD PHYS, V86, P563, DOI 10.1103/RevModPhys.86.563; Kamiya Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.067204; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; Munzer W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041203; Nikuni T, 2000, PHYS REV LETT, V84, P5868, DOI 10.1103/PhysRevLett.84.5868; ESSMANN U, 1967, PHYS LETT A, VA 24, P526, DOI 10.1016/0375-9601(67)90819-5; Kotov VN, 1998, PHYS REV LETT, V80, P5790, DOI 10.1103/PhysRevLett.80.5790; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; SELKE W, 1988, PHYS REP, V170, P213, DOI 10.1016/0370-1573(88)90140-8; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; ROGER M, 1983, REV MOD PHYS, V55, P1, DOI 10.1103/RevModPhys.55.1; NELSON DR, 1988, PHYS REV LETT, V60, P1973, DOI 10.1103/PhysRevLett.60.1973; ABRIKOSOV AA, 1957, J PHYS CHEM SOLIDS, V2, P199, DOI 10.1016/0022-3697(57)90083-5; MORIYA T, 1960, PHYS REV, V120, P91, DOI 10.1103/PhysRev.120.91; BELIAEV ST, 1958, SOV PHYS JETP-USSR, V7, P299; Candido L, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.094413; Goodenough J. B., 1963, MAGNETISM CHEM BOND; Kamiya Y, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011023; Marmorini G, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.134425; Nelson D. R., 2002, DEFECTS GEOMETRY CON; NIKUNI T, 1995, J PHYS SOC JPN, V64, P3471, DOI 10.1143/JPSJ.64.3471; Okubo T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.017206; Rousochatzakis I., ARXIV12095895; Tanigaki T., ARXIV150303945; Ueda HT, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.144417	36	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007	1079-7114		PHYS REV LETT	Phys. Rev. Lett.	SEP 1	2015	115	10							107201	10.1103/PhysRevLett.115.107201		5	Physics, Multidisciplinary	Physics	CQ1CW	WOS:000360335900014		
J	Vorburger, A; Wurz, P; Barabash, S; Wieser, M; Futaana, Y; Bhardwaj, A; Asamura, K				Vorburger, A.; Wurz, P.; Barabash, S.; Wieser, M.; Futaana, Y.; Bhardwaj, A.; Asamura, K.			Imaging the South Pole-Aitken basin in backscattered neutral hydrogen atoms	PLANETARY AND SPACE SCIENCE			English	Article						Moon; South Pole-Aitken basin; Energetic neutral atoms; Backscattering	PROSPECTOR GAMMA-RAY; LUNAR-PROSPECTOR; SOLAR-WIND; CHANDRAYAAN-1 MISSION; MAGNETIC-FIELDS; MOON; SURFACE; SIMULATIONS; INSTRUMENT	The lunar surface is very efficient in reflecting impinging solar wind ions as energetic neutral atoms (ENAs). A global analysis of lunar hydrogen ENAs showed that on average 16% of the solar wind protons are reflected, and that the reflected fraction can range from less than 8% to more than 24%, depending on location. It is established that magnetic anomalies reduce the flux of backscattered hydrogen ENAs by screening-off a fraction of the impinging solar wind. The effects of the surface properties, such as porosity, roughness, chemical composition, and extent of weathering, were not known. In this paper, we conduct an in-depth analysis of ENA observations of the South Pole-Aitken basin to determine which of the surface properties might be responsible for the observed variation in the integral ENA flux. The South Pole-Aitken basin with its highly variable surface properties is an ideal object for such studies. It is very deep, possesses strikingly elevated concentrations in iron and thorium, has a low albedo and coincides with a cluster of strong magnetic anomalies located on the northern rim of the basin. Our analysis shows that whereas, as expected, the magnetic anomalies can account well for the observed ENA depletion at the South Pole-Aitken basin, none of the other surface properties seem to influence the ENA reflection efficiency. Therefore, the integral flux of backscattered hydrogen ENAs is mainly determined by the impinging plasma flux and ENA imaging of backscattered hydrogen captures the electrodynamics of the plasma at the surface. We cannot exclude minor effects by surface features. (C) 2015 Elsevier Ltd. All rights reserved.	[Vorburger, A.] Amer Museum Nat Hist, Div Phys Sci, New York, NY 10024 USA; [Wurz, P.] Univ Bern, Phys Inst, CH-3012 Bern, Switzerland; [Barabash, S.; Wieser, M.; Futaana, Y.] Swedish Inst Space Phys, SE-98128 Kiruna, Sweden; [Bhardwaj, A.] Vikram Sarabhai Space Ctr, Space Phys Lab, Trivandrum 695022, Kerala, India; [Asamura, K.] Inst Space & Astronaut Sci, Sagamihara, Kanagawa 229, Japan	Vorburger, A (reprint author), Amer Museum Nat Hist, Div Phys Sci, New York, NY 10024 USA.	avorburger@amnh.org	Futaana, Yoshifumi/P-5899-2014; Bhardwaj, Anil/B-4579-2011; 	Futaana, Yoshifumi/0000-0002-7056-3517; Bhardwaj, Anil/0000-0003-1693-453X; Vorburger, Audrey/0000-0002-7400-9142	Swiss National Science Foundation	P. Wurz gratefully acknowledges financial support by the Swiss National Science Foundation.	Wieczorek MA, 2012, SCIENCE, V335, P1212, DOI 10.1126/science.1214773; Futaana Y, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009366; Kallio E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017842; NIEHUS H, 1993, SURF SCI REP, V17, P213, DOI 10.1016/0167-5729(93)90024-J; Lawrence DJ, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001530; Goswami JN, 2009, CURR SCI INDIA, V96, P486; Futaana Y, 2013, GEOPHYS RES LETT, V40, P262, DOI 10.1002/grl.50135; Mitchell DL, 2008, ICARUS, V194, P401, DOI 10.1016/j.icarus.2007.10.027; Feldman WC, 2000, J GEOPHYS RES-PLANET, V105, P4175, DOI 10.1029/1999JE001129; Benkhoff J, 2010, PLANET SPACE SCI, V58, P2, DOI 10.1016/j.pss.2009.09.020; Kallio E, 2012, PLANET SPACE SCI, V74, P146, DOI 10.1016/j.pss.2012.09.012; Orsini S, 2010, PLANET SPACE SCI, V58, P166, DOI 10.1016/j.pss.2008.09.012; Lin RP, 1998, SCIENCE, V281, P1480, DOI 10.1126/science.281.5382.1480; Richmond NC, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002933; Barabash S, 2009, CURR SCI INDIA, V96, P526; Bhardwaj A, 2005, J EARTH SYST SCI, V114, P749, DOI 10.1007/BF02715960; Crider DH, 2002, ADV SPACE RES, V30, P1869, DOI 10.1016/S0273-1177(02)00493-3; Garrick-Bethell I, 2009, ICARUS, V204, P399, DOI 10.1016/j.icarus.2009.05.032; Halekas JS, 2013, GEOPHYS RES LETT, V40, P4544, DOI 10.1002/grl.50892; Hood LL, 2013, J GEOPHYS RES-PLANET, V118, P1265, DOI 10.1002/jgre.20078; Kazama Y, 2007, PLANET SPACE SCI, V55, P1518, DOI 10.1016/j.pss.2006.11.027; Lawrence DJ, 1998, SCIENCE, V281, P1484, DOI 10.1126/science.281.5382.1484; Lee E.M., 2009, LUN PLAN SCI C, P2445; Lue C., 2011, GEOPHYS RES LETT, V38, P3202; McComas D., 2009, GEOPHYS RES LETT, V36, P12104; McFadden L., 2007, ENCY SOLAR SYSTEM; Purucker M.E., 2006, 37 ANN LUN PLAN SCI; Saito Y., 2008, GEOPHYS RES LETT, V35, P24205; Saito Y, 2010, PLANET SPACE SCI, V58, P182, DOI 10.1016/j.pss.2008.06.003; Vorburger A., 2012, J GEOPHYS RES, V117, P7208; Vorburger A, 2014, J GEOPHYS RES-SPACE, V119, P709, DOI 10.1002/2013JA019207; Vorburger A, 2013, J GEOPHYS RES-SPACE, V118, P3937, DOI 10.1002/jgra.50337; Wang X. J., 2010, J INEQUAL APPL, V2010, P1, DOI DOI 10.1155/2010/372390; Wieser M, 2009, PLANET SPACE SCI, V57, P2132, DOI 10.1016/j.pss.2009.09.012; Wieser M., 2010, GEOPHYS RES LETT, V37, P5103; Zhang W., 2013, EUR PLAN SCI C 2013, V8, P374	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	SEP	2015	115				SI		57	63		10.1016/j.pss.2015.02.007		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CQ3OP	WOS:000360512300008		
J	Luo, C; Misaka, T; Obayashi, S; Goto, T; Yamawaki, R				Luo, Chang; Misaka, Takashi; Obayashi, Shigeru; Goto, Takashi; Yamawaki, Ruriko			Computational study of compound angle film cooling flow field and aerodynamic losses using a parallel hybrid mesh Navier-Stokes code	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART A-JOURNAL OF POWER AND ENERGY			English	Article						Film cooling; compound angle; aerodynamic losses; hybrid mesh; SLAU scheme	MACH NUMBER LIMIT; TURBULENCE MODELS; HEAT-TRANSFER; UNSTRUCTURED GRIDS; DETAILED ANALYSIS; HOLES; INJECTION; BEHAVIOR; ORIENTATIONS; DISSIPATION	Flow characteristics and aerodynamic losses of film cooling injection with compound angles of 30 degrees, 60 degrees, and 90 degrees for velocity ratios of 0.5, 1.0, and 2.0 are numerically investigated using the high-quality hybrid meshes comprising tetrahedrons, prisms, and pyramids. The solutions are obtained by solving the compressible Reynolds-averaged Navier-Stokes equations, and the cell-vertex finite volume method is used to discretize these equations. The predicted results are firstly validated against the experimental data. It has been found that the variation tendency of mass average net total pressure loss coefficient with compound angles is reasonably predicted and in many cases well predicted. The analyses based on net total pressure losses show that the aerodynamic losses tend to increase with the increasing of compound angle regardless of the velocity ratio, and the tendency becomes more obvious when the velocity ratio is large. On the other hand, some typical cases are additionally calculated with different turbulence models and flux computation schemes for the comparisons. A latest proposed numerical flux computation method, simple low-dissipative AUSM (SLAU) scheme, is adopted in the predictions. The results indicate that SLAU scheme is slightly superior to Harten-Lax-van Leer-Einfeldt-Wada scheme in the prediction of compound angle film cooling injection.	[Luo, Chang; Misaka, Takashi; Obayashi, Shigeru] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan; [Goto, Takashi; Yamawaki, Ruriko] IHI Corp, Tokyo, Japan	Luo, C (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	luochang33@163.com					WILCOX DC, 1988, AIAA J, V26, P1299, DOI 10.2514/3.10041; JONES WP, 1972, INT J HEAT MASS TRAN, V15, P301, DOI 10.1016/0017-9310(72)90076-2; McGovern KT, 2000, J TURBOMACH, V122, P113, DOI 10.1115/1.555434; Pirzadeh S, 1996, AIAA J, V34, P43, DOI 10.2514/3.13019; OBAYASHI S, 1995, AIAA J, V33, P1134, DOI 10.2514/3.12533; Kallinderis Y, 2005, J COMPUT PHYS, V210, P75, DOI 10.1016/j.jcp.2005.04.002; JOHNSON DA, 1985, AIAA J, V23, P1684, DOI 10.2514/3.9152; Aga V, 2011, J TURBOMACH, V133, DOI 10.1115/1.4002420; Zhang LP, 2004, COMPUT FLUIDS, V33, P891, DOI 10.1016/j.compfluid.2003.10.004; Sharov D, 1998, AIAA J, V36, P484, DOI 10.2514/2.392; Rumsey CL, 2007, INT J HEAT FLUID FL, V28, P1460, DOI 10.1016/j.ijheatfluidflow.2007.04.003; Rieper F, 2011, J COMPUT PHYS, V230, P5263, DOI 10.1016/j.jcp.2011.03.025; LOHNER R, 1988, INT J NUMER METH FL, V8, P1135, DOI 10.1002/fld.1650081003; Ekkad SV, 1997, J TURBOMACH, V119, P580; Guillard H, 1999, COMPUT FLUIDS, V28, P63, DOI 10.1016/S0045-7930(98)00017-6; Ito Y, 2002, AIAA J, V40, P490, DOI 10.2514/2.1672; Hyams DG, 2000, J TURBOMACH, V122, P122, DOI 10.1115/1.555435; Sargison JE, 2005, EXP FLUIDS, V38, P304, DOI 10.1007/s00348-004-0892-1; Coirier WJ, 1996, AIAA 34 AER SCI M EX; GOLDSTEI.RJ, 1974, INT J HEAT MASS TRAN, V17, P595, DOI 10.1016/0017-9310(74)90007-6; Jayakumar JS, 2010, PHYS SCRIPTA, VT142, DOI 10.1088/0031-8949/2010/T142/014060; Karniadakis GE, 1999, FLUID DYN RES, V24, P343, DOI 10.1016/S0169-5983(99)00004-0; Shima E, 2011, AIAA J, V49, P1693, DOI 10.2514/1.J050905; Lee JH, 1998, KSME INT J, V12, P963; Lee JS, 2002, INT J HEAT MASS TRAN, V45, P113, DOI 10.1016/S0017-9310(01)00133-8; Lee SW, 1997, J TURBOMACH, V119, P310; Walters DK, 2000, J TURBOMACH, V122, P537, DOI 10.1115/1.1303818; LIGRANI PM, 1994, J TURBOMACH, V116, P80, DOI 10.1115/1.2928281; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Murrone A, 2008, COMPUT FLUIDS, V37, P1209, DOI 10.1016/j.compfluid.2006.12.010; Perron S, 2004, COMPUT FLUIDS, V33, P1305, DOI 10.1016/j.compfluid.2003.10.006; Sen B., 1996, ASME, V118, P800; Sharov D, 1998, AIAA J, V36, P157, DOI 10.2514/2.7497; Silieti M, 2009, INT J THERM SCI, V48, P2237, DOI 10.1016/j.ijthermalsci.2009.04.007; Spalart P. R., 1992, AIAA 30 AER SCI M EX	35	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0957-6509	2041-2967		P I MECH ENG A-J POW	Proc. Inst. Mech. Eng. Part A-J. Power Energy	SEP	2015	229	6					597	612		10.1177/0957650915590907		16	Engineering, Mechanical	Engineering	CQ2CY	WOS:000360408200003		
J	Berezovsky, IN; Zheng, ZJ; Kurotani, A; Tokmakov, AA; Kurochkin, IV				Berezovsky, Igor N.; Zheng, Zejun; Kurotani, Atsushi; Tokmakov, Alexander A.; Kurochkin, Igor V.			Organization of the multiaminoacyl-tRNA synthetase complex and the cotranslational protein folding	PROTEIN SCIENCE			English	Article						multiaminoacyl-tRNA synthetase complex (MARS); predictor of alpha-helicity; cotranslational folding; side-chain rotamers; amphiphilic alpha-helices	AMINOACYL-TRANSFER-RNA; GLOBULAR-PROTEINS; ALPHA-HELICES; BETA-SHEET; SECONDARY STRUCTURES; ACID PROPENSITIES; FAST EVENTS; HOT-SPOTS; IN-VIVO; TRANSLATION	Aminoacyl-tRNA synthetases (ARSs) play an essential role in the protein synthesis by catalyzing an attachment of their cognate amino acids to tRNAs. Unlike their prokaryotic counterparts, ARSs in higher eukaryotes form a multiaminoacyl-tRNA synthetase complex (MARS), consisting of the subset of ARS polypeptides and three auxiliary proteins. The intriguing feature of MARS complex is the presence of only nine out of twenty ARSs, specific for Arg, Asp, Gln, Glu, Ile, Leu, Lys, Met, and Pro, regardless of the organism, cell, or tissue types. Although existence of MARSs complex in higher eukaryotes has been already known for more than four decades, its functional significance remains elusive. We found that seven of the nine corresponding amino acids (Arg, Gln, Glu, Ile, Leu, Lys, and Met) together with Ala form a predictor of the protein alpha-helicity. Remarkably, all amino acids (besides Ala) in the predictor have the highest possible number of side-chain rotamers. Therefore, compositional bias of a typical alpha-helix can contribute to the helix's stability by increasing the entropy of the folded state. It also appears that position-specific alpha-helical propensity, specifically periodic alternation of charged and hydrophobic residues in the helices, may well be provided by the structural organization of the complex. Considering characteristics of MARS complex from the perspective of the alpha-helicity, we hypothesize that specific composition and structure of the complex represents a functional mechanism for coordination of translation with the fast and correct folding of amphiphilic alpha-helices.	[Berezovsky, Igor N.; Zheng, Zejun; Kurochkin, Igor V.] ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore; [Berezovsky, Igor N.] Natl Univ Singapore, DBS, Singapore 117579, Singapore; [Kurotani, Atsushi] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Tokmakov, Alexander A.] Kobe Univ, Res Ctr Environm Genom, Kobe, Hyogo 657, Japan	Berezovsky, IN (reprint author), ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore.	igorb@bii.a-star.edu.sg; igork@bii.a-star.edu.sg					CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Aurora R, 1998, PROTEIN SCI, V7, P21; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; Choi SI, 2013, CURR PROTEIN PEPT SC, V14, P721; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1424/jcs.01342; Garbuzynskiy SO, 2013, P NATL ACAD SCI USA, V110, P147, DOI 10.1073/pnas.1210180110; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; EISENHABER F, 1995, CRIT REV BIOCHEM MOL, V30, P1, DOI 10.3109/10409239509085139; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Kumar S, 1998, PROTEINS, V31, P460, DOI 10.1002/(SICI)1097-0134(19980601)31:4<460::AID-PROT12>3.0.CO;2-D; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Gilmanshin R, 1997, P NATL ACAD SCI USA, V94, P3709, DOI 10.1073/pnas.94.8.3709; Munoz V, 1998, P NATL ACAD SCI USA, V95, P5872, DOI 10.1073/pnas.95.11.5872; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; Berezovsky IN, 2002, J BIOMOL STRUCT DYN, V20, P5; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Havrylenko S, 2015, INT J MOL SCI, V16, P6571, DOI 10.3390/ijms16036571; DOIG AJ, 1995, PROTEIN SCI, V4, P1325; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Berezovsky IN, 2000, FEBS LETT, V466, P283, DOI 10.1016/S0014-5793(00)01091-7; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; BANDYOPA.AK, 1971, J MOL BIOL, V60, P113, DOI 10.1016/0022-2836(71)90451-7; Berezovsky IN, 2001, J MOL BIOL, V307, P1419, DOI 10.1006/jmbi.2001.4554; Berezovsky IN, 2005, PLOS COMPUT BIOL, V1, P322, DOI 10.1371/journal.pcbi.0010047; Berezovsky IN, 2001, PROTEINS, V45, P346, DOI 10.1002/prot.1155; CERINI C, 1991, EMBO J, V10, P4267; D'Aniello A, 2005, NEUROSCI LETT, V388, P49, DOI 10.1016/j.neulet.2005.06.030; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Engel DE, 2004, J MOL BIOL, V337, P1195, DOI 10.1016/j.jmb.2004.02.004; Eswarappa SM, 2013, TRENDS BIOCHEM SCI, V38, P222, DOI 10.1016/j.tibs.2013.01.005; Fujiwara K, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-18; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goncearenco A, 2014, BIOL DIRECT, V9, DOI 10.1186/s13062-014-0029-2; HARTMAN R, 1974, J MOL BIOL, V90, P415, DOI 10.1016/0022-2836(74)90225-3; Havrylenko S, 2011, J BIOL CHEM, V286, P28476, DOI 10.1074/jbc.M111.254037; HORNE DS, 1988, BIOPOLYMERS, V27, P451, DOI 10.1002/bip.360270308; ITTAH V, 1995, BIOCHEMISTRY-US, V34, P4493, DOI 10.1021/bi00013a042; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; KANEHISA MI, 1980, BIOPOLYMERS, V19, P1617, DOI 10.1002/bip.1980.360190906; LACEY JM, 1990, NUTR REV, V48, P297; Levinthal C., 1969, MOSSBAUER SPECTROSCO, P22; LIM VI, 1978, FEBS LETT, V89, P10, DOI 10.1016/0014-5793(78)80511-0; Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0; MIRANDE M, 1983, EUR J BIOCHEM, V131, P163, DOI 10.1111/j.1432-1033.1983.tb07244.x; Moreira IS, 2013, BBA-PROTEINS PROTEOM, V1834, P404, DOI 10.1016/j.bbapap.2012.07.005; Norcum MT, 1998, PROTEIN SCI, V7, P79; REYES VE, 1989, J BIOL CHEM, V264, P12854; SCHWARZ G, 1965, J MOL BIOL, V11, P64; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Williams S, 1996, BIOCHEMISTRY-US, V35, P691, DOI 10.1021/bi952217p; Wolfe CL, 2005, J BIOL CHEM, V280, P38870, DOI 10.1074/jbc.M502759200; Wolfson A, 2005, FEBS LETT, V579, P3467, DOI 10.1016/j.febslet.2005.05.038; WUILMART C, 1984, EUR J BIOCHEM, V139, P35, DOI 10.1111/j.1432-1033.1984.tb07972.x	74	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	SEP	2015	24	9					1475	1485		10.1002/pro.2735		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CQ1SX	WOS:000360380400013		
J	Fuseda, K; Nagano, Y; Kobayashi, T				Fuseda, Kohei; Nagano, Yuichiro; Kobayashi, Takefumi			EFFECTS OF ATTRACTIVENESS OF OPPOSITE SEX PICTURES ON PHYSIOLOGICAL RESPONSES	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		autonomic activity; attractiveness; picture			[Fuseda, Kohei] Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan; [Nagano, Yuichiro; Kobayashi, Takefumi] Bunkyo Gakuin Univ, Bunkyo, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	4-51	S113	S113				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100483		
J	Hirao, T; Murphy, TI; Masaki, H				Hirao, Takahiro; Murphy, Timothy I.; Masaki, Hiroaki			AN EVENT-RELATED POTENTIAL STUDY OF IMPLICIT LEARNING USING THE MONTY HALL DILEMMA TASK	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		Monty Hall Dilemma; stimulus-preceding negativity			[Hirao, Takahiro; Masaki, Hiroaki] Waseda Univ, Tokyo, Japan; [Murphy, Timothy I.] Brock Univ, St Catharines, ON L2S 3A1, Canada								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	2-22	S54	S54				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100235		
J	Kamijo, K; Masaki, H				Kamijo, Keita; Masaki, Hiroaki			THE ASSOCIATION OF AEROBIC FITNESS WITH PROACTIVE AND REACTIVE COGNITIVE CONTROL IN PREADOLESCENT CHILDREN	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res					[Kamijo, Keita; Masaki, Hiroaki] Waseda Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI		S20	S20				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100096		
J	Kimura, T; Katayama, J				Kimura, Tsukasa; Katayama, Jun'ichi			THE SPATIAL EXPECTATION IS MODULATED BY CONGRUENCY BETWEEN APPROACH OF VISUAL STIMULI AND LOCATION OF SUBSEQUENT SOMATOSENSORY STIMULI	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		multimodal interaction; expectation; P300			[Kimura, Tsukasa; Katayama, Jun'ichi] Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	3-84	S95	S95				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100406		
J	Kotani, Y; Ohgami, Y; Arai, J; Kiryu, S; Inoue, Y				Kotani, Yasunori; Ohgami, Yoshimi; Arai, Jun-ichiro; Kiryu, Shigeru; Inoue, Yusuke			NEURAL SUBSTRATES OF EARLY AND LATE STIMULUS-PRECEDING NEGATIVITY: FMRI-CONSTRAINED ERP SOURCE ANALYSIS	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		stimulus-preceding negativity; source analysis; fMRI			[Kotani, Yasunori; Ohgami, Yoshimi] Tokyo Inst Technol, Tokyo, Japan; [Arai, Jun-ichiro] Daikin Ind, Osaka, Japan; [Kiryu, Shigeru] Univ Tokyo, Tokyo 1138654, Japan; [Inoue, Yusuke] Kitasato Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	2-95	S72	S72				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100308		
J	Masaki, H; Takasawa, N; Soga, K; Sommer, W				Masaki, Hiroaki; Takasawa, Noriyoshi; Soga, Keishi; Sommer, Werner			MOTOR POTENTIAL IS MODULATED BY PERCEIVED CORRECTNESS IN A TARGET FORCE PRODUCTION TASK	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		performance monitoring; motor potential; target-force production			[Masaki, Hiroaki; Soga, Keishi] Waseda Univ, Tokyo, Japan; [Takasawa, Noriyoshi] Edogawa Univ, Nagareyama, Chiba, Japan; [Sommer, Werner] Humboldt Univ, Berlin, Germany			Sommer, Werner/H-4672-2011	Sommer, Werner/0000-0001-5266-3445				0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	2-20	S54	S54				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100233		
J	Matsuda, I				Matsuda, Izumi			THE INTENTION TO CONCEAL RECRUITS THE RIGHT PREFRONTAL CORTEX ACTIVITY IN THE CONCEALED INFORMATION TEST	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res					[Matsuda, Izumi] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI		S21	S21				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100098		
J	Naka, S; Katayama, J				Naka, Sanae; Katayama, Jun'ichi			THE PRESENTATION TIMING OF TASK-IRRELEVANT STIMULI AND THE DISTRACTION EFFECT	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		distraction effect; P300; multimodal			[Naka, Sanae; Katayama, Jun'ichi] Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	3-83	S94	S94				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100405		
J	Ohgami, Y; Kotani, Y; Arai, J; Kiryu, S; Inoue, Y				Ohgami, Yoshimi; Kotani, Yasunori; Arai, Jun-ichiro; Kiryu, Shigeru; Inoue, Yusuke			EFFECT OF UNILATERAL STIMULUS PRESENTATION ON COMPONENTS OF STIMULUS-PRECEDING NEGATIVITY	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		stimulus-preceding negativity; perception; laterality			[Ohgami, Yoshimi; Kotani, Yasunori] Tokyo Inst Technol, Tokyo, Japan; [Arai, Jun-ichiro] Daikin Ind, Osaka, Japan; [Kiryu, Shigeru] Univ Tokyo, Tokyo 1138654, Japan; [Inoue, Yusuke] Kitasato Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	2-96	S72	S72				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100309		
J	Omori, S; Otake, K; Katayama, J				Omori, Shunya; Otake, Keiko; Katayama, Jun'ichi			EFFECTS OF POSITIVE EMOTION ON PHYSIOLOGICAL RESPONSES AND THOUGHT-ACTION REPERTORIES REGARDING HELPFUL BEHAVIOR	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		heart rate; positive emotion; broaden-and-build theory			[Omori, Shunya; Otake, Keiko; Katayama, Jun'ichi] Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	4-50	S112	S112				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100482		
J	Soga, K; Kamijo, K; Masaki, H				Soga, Keishi; Kamijo, Keita; Masaki, Hiroaki			EFFECTS OF SIMULTANEOUS EXERCISE AND ENCODING ON BRAIN ACTIVITY DURING MEMORY RETRIEVAL	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		acute exercise; memory; encode			[Soga, Keishi; Kamijo, Keita; Masaki, Hiroaki] Waseda Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	2-21	S54	S54				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100234		
J	Sugimoto, F; Katayama, J				Sugimoto, Fumie; Katayama, Jun'ichi			DIFFICULTY OF VISUAL ODDBALL TASK MODULATES AMPLITUDE OF P3 ELICITED BY TASK-IRRELEVANT AUDITORY DISTRACTORS	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res					[Sugimoto, Fumie] Kyushu Univ, Fukuoka 812, Japan; [Katayama, Jun'ichi] Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI		S21	S21				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100100		
J	Tezuka, Y				Tezuka, Yosuke			THE USEFULNESS OF SILENT READING TECHNIQUE AT BASELINE MEASUREMENT ON CARDIOVASCULAR RESPONSE	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		baseline; cardiovascular			[Tezuka, Yosuke] Osaka Univ Hlth & Sport Sci, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	3-107	S100	S100				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100429		
J	Yoshimori, E; Nittono, H				Yoshimori, Erika; Nittono, Hiroshi			EVENT-RELATED POTENTIALS ELICITED BY THE MISMATCH BETWEEN FASHION ITEMS	PSYCHOPHYSIOLOGY			English	Meeting Abstract	55th Annual Meeting of the Society-for-Psychophysiological-Research	SEP 30-OCT 04, 2015	Seattle, WA	Soc Psychophysiol Res		mismatch; fashion coordinate; N400			[Yoshimori, Erika; Nittono, Hiroshi] Hiroshima Univ, Hiroshima 730, Japan			Nittono, Hiroshi/C-4043-2009	Nittono, Hiroshi/0000-0001-5671-609X				0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	SEP	2015	52			1	SI	4-77	S119	S119				1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CQ2PS	WOS:000360444100509		
J	Miyagishima, K				Miyagishima, Kaname			Implementability and equity in production economies with unequal skills	REVIEW OF ECONOMIC DESIGN			English	Article						Equity; Implementability; Equal income Walrasian solution; Proportional solution	COOPERATIVE PRODUCTION; OWNERSHIP; COMPENSATION; ALLOCATION; MECHANISMS; FAIRNESS; PRIVATE	In this paper, we study the problem of fair allocation in production economies where agents have different preferences and unequal production skills. We characterize the equal income Walrasian solution and the proportional solution using axioms of equity and a certain form of implementability developed by Yamada and Yoshihara (Int J Game Theory 36:85-106, 2007).	Waseda Univ, Tokyo, Japan	Miyagishima, K (reprint author), Waseda Univ, Tokyo, Japan.	Kaname1128@gmail.com			Japan Society for the Promotion of Science	The author is especially grateful to Naoki Yoshihara for helpful comments and suggestions. The author also thanks Benoit Decerf, Marc Fleurbaey, Haruo Imai, Chiaki Hara, Kazumi Hori, Ryoichi Nagahisa, Takashi Kunimoto, Z. Emel Ozturk, Marcus Pivato, Clements Puppe, Koji Takamiya, Takuma Wakayama, and audiences at Hitotsubashi University, Kyoto University, Niigata University, and New Directions in Welfare III at OECD Paris. Financial support from the Japan Society for the Promotion of Science is gratefully acknowledged.	Thomson W, 2011, HBK ECON, V2, P393, DOI 10.1016/S0169-7218(10)00021-3; Maskin E, 1999, REV ECON STUD, V66, P83, DOI 10.1111/1467-937X.00079; JACKSON MO, 1994, GAME ECON BEHAV, V6, P474, DOI 10.1006/game.1994.1028; Fleurbaey M, 1999, SOC CHOICE WELFARE, V16, P569, DOI 10.1007/s003550050161; Fleurbaey M, 2011, HBK ECON, V2, P507, DOI 10.1016/S0169-7218(10)00022-5; Fleurbaey M, 1996, MATH SOC SCI, V32, P71, DOI 10.1016/0165-4896(96)00811-6; Foley D.K., 1967, YALE ECON ESSAYS, V7, P45; Gaspart F, 1998, SOC CHOICE WELFARE, V15, P95; Hurwicz L, 1960, MATH METHODS SOCIAL, P27; MOULIN H, 1990, REV ECON STUD, V57, P439, DOI 10.2307/2298023; NAGAHISA R, 1995, SOC CHOICE WELFARE, V12, P335; PAZNER EA, 1974, REV ECON STUD, V41, P441, DOI 10.2307/2296762; ROEMER JE, 1993, J ECON THEORY, V59, P426, DOI 10.1006/jeth.1993.1027; Saijo T, 1996, INT ECON REV, V37, P949, DOI 10.2307/2527318; Sakai T, 2007, J MATH ECON, V43, P549, DOI 10.1016/j.jmateco.2006.07.006; THOMSON W, 1983, J ECON THEORY, V29, P217, DOI 10.1016/0022-0531(83)90046-7; Yamada A, 2007, INT J GAME THEORY, V36, P85, DOI 10.1007/s00182-007-0072-7; Yamada A, 2010, NASH IMPLEMENT UNPUB; Yoshihara N, 1998, MATH SOC SCI, V35, P165, DOI 10.1016/S0165-4896(97)00040-1	19	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1434-4742	1434-4750		REV ECON DES	Rev. Econ. Des.	SEP	2015	19	3					247	257		10.1007/s10058-015-0175-8		11	Economics	Business & Economics	CP9DI	WOS:000360193500004		
J	Martirosyan, NS; Litasov, KD; Shatskiy, AF; Ohtani, E				Martirosyan, N. S.; Litasov, K. D.; Shatskiy, A. F.; Ohtani, E.			Reactions of iron with calcium carbonate at 6 GPa and 1273-1873 K: implications for carbonate reduction in the deep mantle	RUSSIAN GEOLOGY AND GEOPHYSICS			English	Article						mantle; carbonate; subduction; iron; redox state; melting; experiment; high pressures	O-H FLUID; HIGH-PRESSURE; EARTHS MANTLE; DIAMOND FORMATION; PHASE-RELATIONS; SULFIDE INCLUSIONS; HIGH-TEMPERATURE; MELTS; CACO3; CRYSTALLIZATION	Experimental data on Fe-CaCO3 interaction at 6 GPa and 1273-1873 K are presented. The system models the hypothetical redox interaction in subducting slabs at the contact with the reduced mantle and a putative process at the core-mantle boundary. The reaction is accompanied by carbonatite melt formation. It also produces Fe3C and calcium wustite, which form solid or liquid phases depending on experimental conditions. In iron-containing systems at 6 GPa, calcium carbonate melts in the range 1473-1573 K, which is consistent with aragonite disappearance from complex carbonate systems. The composition of calcium carbonate liquid is not influenced by metallic Fe. It corresponds to nearly pure CaCO3. Along the mantle adiabat or at slightly higher temperatures, nearly pure CaCO3 coexists with metallic iron or calcium wustite. This hypothesis explains the coexistence of metallic iron and carbonate inclusions in lithospheric and superdeep diamonds. (C) 2015, V.S. Sobolev IGM, Siberian Branch of the RAS. Published by Elsevier B.V. All rights reserved.	[Martirosyan, N. S.; Litasov, K. D.; Shatskiy, A. F.; Ohtani, E.] Russian Acad Sci, VS Sobolev Inst Geol & Mineral, Siberian Branch, Novosibirsk 630090, Russia; [Litasov, K. D.; Shatskiy, A. F.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Ohtani, E.] Tohoku Univ, Grad Sch Sci, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan	Martirosyan, NS (reprint author), Russian Acad Sci, VS Sobolev Inst Geol & Mineral, Siberian Branch, Pr Akad Koptyuga 3, Novosibirsk 630090, Russia.	martirosyanns@gmail.com	Shatskiy, Anton/F-8731-2010; Litasov, Konstantin/A-5366-2014	Shatskiy, Anton/0000-0003-4554-9550; 	Russian Science Foundation [14-17-00601]; Ministry of Education and Science of the Russian Federation [14.B25.31.0032]	This work was supported by the Russian Science Foundation grant No. 14-17-00601 and performed under the program of Ministry of Education and Science of the Russian Federation, project 14.B25.31.0032. The authors are grateful to reviewers for valuable remarks.	Chepurov AI, 1998, GEOL GEOFIZ, V39, P234; Litasov KD, 2013, J GEOPHYS RES-SOL EA, V118, P5274, DOI 10.1002/2013JB010270; Dasgupta R, 2013, REV MINERAL GEOCHEM, V75, P183, DOI 10.2138/rmg.2013.75.7; Boulard E, 2011, P NATL ACAD SCI USA, V108, P5184, DOI 10.1073/pnas.1016934108; Grassi D, 2011, J PETROL, V52, P765, DOI 10.1093/petrology/egr002; Shirasaka M, 2002, AM MINERAL, V87, P922; Dobretsov NL, 2012, RUSS GEOL GEOPHYS+, V53, P1117, DOI 10.1016/j.rgg.2012.09.001; Safonova Inna, 2015, Geoscience Frontiers, V6, DOI 10.1016/j.gsf.2014.11.004; Foley SF, 2011, J PETROL, V52, P1363, DOI 10.1093/petrology/egq061; Nakajima Y, 2009, PHYS EARTH PLANET IN, V174, P202, DOI 10.1016/j.pepi.2008.05.014; Gudfinnsson GH, 2005, J PETROL, V46, P1645, DOI 10.1093/petrology/egi029; IRVING AJ, 1975, GEOCHIM COSMOCHIM AC, V39, P35, DOI 10.1016/0016-7037(75)90183-0; Kaminsky F, 2012, EARTH-SCI REV, V110, P127, DOI 10.1016/j.earscirev.2011.10.005; Wood BJ, 2013, REV MINERAL GEOCHEM, V75, P231, DOI 10.2138/rmg.2013.75.8; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Litasov KD, 2014, EARTH PLANET SC LETT, V391, P87, DOI 10.1016/j.epsl.2014.01.033; Rohrbach A, 2011, NATURE, V472, P209, DOI 10.1038/nature09899; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Suito K, 2001, AM MINERAL, V86, P997; Shatskiy A, 2013, AM MINERAL, V98, P1593, DOI 10.2138/am.2013.4407; BOSE K, 1995, AM MINERAL, V80, P231; KENNEDY CS, 1976, J GEOPHYS RES, V81, P2467, DOI 10.1029/JB081i014p02467; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Palyanov YN, 2013, P NATL ACAD SCI USA, V110, P20408, DOI 10.1073/pnas.1313340110; Kiseeva ES, 2012, J PETROL, V53, P727, DOI 10.1093/petrology/egr078; Lord OT, 2009, EARTH PLANET SC LETT, V284, P157, DOI 10.1016/j.epsl.2009.04.017; Richardson SH, 2001, EARTH PLANET SC LETT, V191, P257, DOI 10.1016/S0012-821X(01)00419-8; Litasov KD, 2011, RUSS GEOL GEOPHYS+, V52, P475, DOI 10.1016/j.rgg.2011.04.001; Oganov AR, 2008, EARTH PLANET SC LETT, V273, P38, DOI 10.1016/j.epsl.2008.06.005; Pal'yanov YN, 2002, LITHOS, V60, P145; Litasov KD, 2013, GEOLOGY, V41, P79, DOI 10.1130/G33488.1; Oganov AR, 2006, EARTH PLANET SC LETT, V241, P95, DOI 10.1016/j.epsl.2005.10.014; Logvinova AM, 2011, RUSS GEOL GEOPHYS+, V52, P1286, DOI 10.1016/j.rgg.2011.10.002; Sokol AG, 2001, DIAM RELAT MATER, V10, P2131, DOI 10.1016/S0925-9635(01)00491-5; Scott HP, 2004, P NATL ACAD SCI USA, V101, P14023, DOI 10.1073/pnas.0405930101; Syracuse EM, 2010, PHYS EARTH PLANET IN, V183, P73, DOI 10.1016/j.pepi.2010.02.004; Ono S, 2010, PHYS EARTH PLANET IN, V180, P1, DOI 10.1016/j.pepi.2010.03.008; Taylor LA, 2009, RUSS GEOL GEOPHYS+, V50, P1201, DOI 10.1016/j.rgg.2009.11.018; Logvinova AM, 2008, EUR J MINERAL, V20, P317, DOI 10.1127/0935-1221/2008/0020-1815; Takahashi S, 2013, PHYS CHEM MINER, V40, P647, DOI 10.1007/s00269-013-0600-x; Kiseeva ES, 2013, J PETROL, V54, P1555, DOI 10.1093/petrology/egt023; Pal'yanov YN, 1999, NATURE, V400, P417, DOI 10.1038/22678; Scott HP, 2001, GEOPHYS RES LETT, V28, P1875, DOI 10.1029/2000GL012606; Stagno V, 2010, EARTH PLANET SC LETT, V300, P72, DOI 10.1016/j.epsl.2010.09.038; Ono S, 2005, AM MINERAL, V90, P667, DOI 10.2138/am.2005.1610; Sokolova TS, 2013, RUSS GEOL GEOPHYS+, V54, P181, DOI 10.1016/j.rgg.2013.01.005; Hayman PC, 2005, CONTRIB MINERAL PETR, V149, P430, DOI 10.1007/s00410-005-0657-8; Chepurov AI, 2011, DOKL EARTH SCI, V441, P1738, DOI 10.1134/S1028334X11120233; BALLHAUS C, 1994, GEOCHIM COSMOCHIM AC, V58, P4931, DOI 10.1016/0016-7037(94)90222-4; Boulard E, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008733; Chepurov AI, 2009, DOKL EARTH SCI, V428, P1139, DOI 10.1134/S1028334X09070228; DEINES P, 1995, GEOCHIM COSMOCHIM AC, V59, P3173, DOI 10.1016/0016-7037(95)00205-E; Fedorov II, 2005, GEOCHEM INT+, V43, P1235; Kaminsky FV, 2011, CAN MINERAL, V49, P555, DOI 10.3749/canmin.49.2.555; Komabayashi T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006442; Martirosyan NS, 2015, J MINER PETROL SCI, V110, P49, DOI 10.2465/jmps.141003a; Ono S, 2011, PHYS CHEM MINER, V38, P735, DOI 10.1007/s00269-011-0446-z; Pokhilenko NP, 2015, RUSS GEOL GEOPHYS+, V56, P280, DOI 10.1016/j.rgg.2015.01.020; Ragozin AL, 2014, RUSS GEOL GEOPHYS+, V55, P428, DOI 10.1016/j.rgg.2014.03.002; Shatskiy A, 2011, PHYS EARTH PLANET IN, V189, P92, DOI 10.1016/j.pepi.2011.08.001; Shatskiy A, 2010, HIGH PRESSURE RES, V30, P443, DOI 10.1080/08957959.2010.515079; Shatskii AF, 2002, GEOL GEOFIZ, V43, P940; Shirasaka M., 2003, 8 INT KIMB C LONG AB, P1; Sobolev N.V., 1981, SOVIET GEOL GEOPHYS, V22, P18; Sobolev NV, 2015, RUSS GEOL GEOPHYS+, V56, P1, DOI 10.1016/j.rgg.201.0.001; Stagno V, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049560; Staudigel H., 2014, TREATISE GEOCHEMISTR, V4, P583; Zhimulev EI, 2012, GEOCHEM INT+, V50, P205, DOI 10.1134/S0016702912030111	68	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1068-7971	1878-030X		RUSS GEOL GEOPHYS+	Russ. Geol. Geophys.	SEP	2015	56	9					1322	1331		10.1016/j.rgg.2015.08.008		10	Geosciences, Multidisciplinary	Geology	CQ0KL	WOS:000360284000008		
J	Abe, M; Maruyama, N; Oikawa, O; Maruyama, T; Okada, K; Soma, M				Abe, Masanori; Maruyama, Noriaki; Oikawa, Osamu; Maruyama, Takashi; Okada, Kazuyoshi; Soma, Masayoshi			Urinary ACE2 is associated with urinary L-FABP and albuminuria in patients with chronic kidney disease	SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION			English	Article						Albuminuria; angiotensin-converting enzyme 2; chronic kidney disease; urinary liver-type fatty acid binding protein	ANGIOTENSIN-CONVERTING ENZYME; EARLY DIABETIC-NEPHROPATHY; ACID-BINDING PROTEIN; MAS; EXPRESSION; PREVENTION; BLOCKADE; TUBULES; MICE	Aim. Angiotensin-converting enzyme 2 (ACE2) is expressed in the kidney and may be a renoprotective enzyme since it converts angiotensin (Ang) II to Ang-(1-7). In addition, ACE2 has been detected in urine from patients with chronic kidney disease (CKD). The aim of this study was to determine the urinary ACE2 levels in patients with various stages of CKD and to identify the factors associated with the presence of ACE2. Methods. We assessed 152 patients with CKD stage G1-G4. The patients were classified according to the presence or absence of diabetes mellitus (DM) (DM group, n = 72; non-DM group, n = 80) and according to the estimated glomerular filtration rate (CKD stage G1/2 group, n = 40; CKD stage G3 group, n = 74; and CKD stage G4 group, n = 38). Parameters were urinary ACE2, urinary albumin/creatinine ratio (UACR), urinary liver-type fatty acid binding protein (L-FABP), estimated glomerular filtration rate, and other factors determined to be associated with elevated urinary ACE2. Results. Urinary ACE2 was significantly higher in patients with diabetes (p = 0.01) and in patients with CKD stage G4 compared with stages G1-G3 (p < 0.0001). Multivariable regression analysis revealed that urinary L-FABP and UACR were significantly associated with urinary ACE2 levels, indicating that urinary ACE2 is increased in patients with diabetes and advanced stage CKD. Conclusion. ACE2 might continuously protect from both glomerular and tubulointerstitial injury during CKD progression. Taken together, urinary ACE2 might be a marker of kidney renin-angiotensin system activation in such patients.	[Abe, Masanori; Maruyama, Noriaki; Oikawa, Osamu; Maruyama, Takashi; Okada, Kazuyoshi; Soma, Masayoshi] Nihon Univ, Sch Med, Dept Internal Med, Div Nephrol Hypertens & Endocrinol, Tokyo 1738610, Japan; [Soma, Masayoshi] Nihon Univ, Sch Med, Dept Internal Med, Div Gen Med, Tokyo 1738610, Japan	Abe, M (reprint author), Nihon Univ, Sch Med, Dept Internal Med, Div Nephrol Hypertens & Endocrinol,Itabashi Ku, 30-1 Oyaguchi Kami Chou, Tokyo 1738610, Japan.	abe.masanori@nihon-u.ac.jp					Abe M, 2011, J ATHEROSCLER THROMB, V18, P1018; Abe M, 2015, J RENIN-ANGIO-ALDO S, V16, P159, DOI 10.1177/1470320314551443; Agata J, 2006, HYPERTENS RES, V29, P865, DOI 10.1291/hypres.29.865; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Alenina N, 2008, EXP PHYSIOL, V93, P528, DOI 10.1113/expphysiol.2007.040345; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369; Burgelova M, 2005, KIDNEY INT, V67, P1453, DOI 10.1111/j.1523-1755.2005.00222.x; Thomas MC, 2005, ADV CHRONIC KIDNEY D, V12, P177, DOI 10.1053/j.ackd.2005.01.008; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Iwai M, 2012, HYPERTENSION, V60, P137, DOI 10.1161/HYPERTENSIONAHA.112.191452; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Shiota A, 2010, HYPERTENS RES, V33, P298, DOI 10.1038/hr.2009.231; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Ye MH, 2004, HYPERTENSION, V43, P1120, DOI 10.1161/01.HYP.0000126192.27644.76; Burgelova M, 2002, KIDNEY BLOOD PRESS R, V25, P202, DOI 10.1159/000066340; Ferrario CM, 2010, AM J PHYSIOL-RENAL, V298, pF1297, DOI 10.1152/ajprenal.00110.2010; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mizuiri S, 2011, NEPHROLOGY, V16, P567, DOI 10.1111/j.1440-1797.2011.01467.x; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Wolf G, 1997, AM J KIDNEY DIS, V29, P153, DOI 10.1016/S0272-6386(97)90023-8; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Brownlee M, 2001, NATURE, V414, P818; Donoghue M, 2000, CIRC RES, V87, P1; Goodarzi M T, 2010, J CLIN LAB ANAL, V24, P71; Japanese Society of Hypertension, 2009, HYPERTENS RES, V32, P4; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Li N, 2005, AM J PHYSIOL-RENAL, V288, P353; Nakamura T, 2005, DIABETES CARE, V28, P2728, DOI 10.2337/diacare.28.11.2728; Schalekamp MADH, 2006, KIDNEY INT, V69, P1543, DOI 10.1038/sj.ki.5000303; Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, pF82, DOI 10.1152/ajprenal.00139.2006; Xiao FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037649	37	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0036-5513	1502-7686		SCAND J CLIN LAB INV	Scand. J. Clin. Lab. Invest.	SEP	2015	75	5					421	427		10.3109/00365513.2015.1054871		7	Medicine, Research & Experimental	Research & Experimental Medicine	CP8XF	WOS:000360177600011		
J	Kolobov, AV; Fons, P; Tominaga, J				Kolobov, A. V.; Fons, P.; Tominaga, J.			Understanding Phase-Change Memory Alloys from a Chemical Perspective	SCIENTIFIC REPORTS			English	Article							INDUCED STRUCTURAL-CHANGE; AMORPHOUS SELENIUM; CHALCOGENIDE GLASSES; VALENCE-ALTERNATION; THIN-FILMS; CRYSTALLIZATION; SILICON; STATES; SEMICONDUCTORS; MODEL	Phase-change memories (PCM) are associated with reversible ultra-fast low-energy crystal-to-amorphous switching in GeTe-based alloys co-existing with the high stability of the two phases at ambient temperature, a unique property that has been recently explained by the high fragility of the glass-forming liquid phase, where the activation barrier for crystallisation drastically increases as the temperature decreases from the glass-transition to room temperature. At the same time the atomistic dynamics of the phase-change process and the associated changes in the nature of bonding have remained unknown. In this work we demonstrate that key to this behavior is the formation of transient three-center bonds in the excited state that is enabled due to the presence of lone-pair electrons. Our findings additionally reveal previously ignored fundamental similarities between the mechanisms of reversible photoinduced structural changes in chalcogenide glasses and phase-change alloys and offer new insights into the development of efficient PCM materials.	[Kolobov, A. V.; Fons, P.; Tominaga, J.] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058562, Japan	Kolobov, AV (reprint author), Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	a.kolobov@aist.go.jp			IMPULSE, AIST	This work has been partially supported by IMPULSE, AIST.	SHIMAKAWA K, 1992, PHYS REV B, V46, P10062, DOI 10.1103/PhysRevB.46.10062; DONOVAN EP, 1983, APPL PHYS LETT, V42, P698, DOI 10.1063/1.94077; Pirovano A, 2004, IEEE T ELECTRON DEV, V51, P452, DOI 10.1109/TED.2003.823243; Li J, 2000, PHYS REV LETT, V85, P2785, DOI 10.1103/PhysRevLett.85.2785; Dong JJ, 1998, PHYS REV LETT, V80, P1928, DOI 10.1103/PhysRevLett.80.1928; Kolobov AV, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165206; Kolobov AV, 1997, PHYS REV B, V55, P726, DOI 10.1103/PhysRevB.55.726; Yannopoulos SN, 2009, PHYS STATUS SOLIDI B, V246, P1773, DOI 10.1002/pssb.200982005; KASTNER M, 1972, PHYS REV LETT, V28, P355, DOI 10.1103/PhysRevLett.28.355; Kolobov AV, 2011, NAT CHEM, V3, P311, DOI [10.1038/nchem.1007, 10.1038/NCHEM.1007]; Caravati S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801626; Kalb J, 2003, J APPL PHYS, V93, P2389, DOI 10.1063/1.1540227; BIEGELSEN DK, 1980, PHYS REV LETT, V44, P803, DOI 10.1103/PhysRevLett.44.803; Krbal M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054203; Akola J, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.235201; THOMPSON MO, 1984, PHYS REV LETT, V52, P2360, DOI 10.1103/PhysRevLett.52.2360; Raoux S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3212732; HAUTALA J, 1988, PHYS REV B, V38, P11048, DOI 10.1103/PhysRevB.38.11048; Silvestrelli PL, 1998, SOLID STATE COMMUN, V107, P7, DOI 10.1016/S0038-1098(98)00175-6; Orava J, 2012, NAT MATER, V11, P279, DOI [10.1038/nmat3275, 10.1038/NMAT3275]; Skoug EJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.235901; ANDERSON PW, 1975, PHYS REV LETT, V34, P953, DOI 10.1103/PhysRevLett.34.953; Choi Y, 2009, ELECTROCHEM SOLID ST, V12, pF17, DOI 10.1149/1.3129137; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; Hegedus J, 2008, NAT MATER, V7, P399, DOI 10.1038/nmat2157; Burr GW, 2010, J VAC SCI TECHNOL B, V28, P223, DOI 10.1116/1.3301579; Li XB, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.015501; HISAKUNI H, 1995, SCIENCE, V270, P974, DOI 10.1126/science.270.5238.974; Simpson RE, 2011, NAT NANOTECHNOL, V6, P501, DOI [10.1038/nnano.2011.96, 10.1038/NNANO.2011.96]; Fons P, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.041203; Kolobov AV, 2004, NAT MATER, V3, P703, DOI 10.1038/nmat1215; Baker DA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255501; Brodsky M. H., 1983, RAMAN SCATTERING AMO, P205; Dembovsky S. A., 1990, GLASS FORMATION; DEMBOVSKY SA, 1981, MATER RES BULL, V16, P1331, DOI 10.1016/0025-5408(81)90105-7; Deringer V. L., 2014, ANG CHEM INT ED; Fons P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.094305; Fritzsche H., 2008, OVSHINSKY SCI TECHNO; FRUMAR M, 1984, PHILOS MAG B, V50, P463, DOI 10.1080/13642818408238871; Jovari P, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035202; KASTNER M, 1976, PHYS REV LETT, V37, P1504, DOI 10.1103/PhysRevLett.37.1504; Kolobov A., 1997, PHYS REV B, V56, P485; Kolobov AV, 2014, PHYS STATUS SOLIDI B, V251, P1297, DOI 10.1002/pssb.201350146; Kolobov AV, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155204; Micoulaut M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.094207; Mott N.F., 1979, ELECT PROCESSES NONC; OVSHINSK.SR, 1968, PHYS REV LETT, V21, P1450, DOI 10.1103/PhysRevLett.21.1450; Raty JY, 2010, SOLID STATE SCI, V12, P193, DOI 10.1016/j.solidstatesciences.2009.06.018; Robertson J., 2013, CAN J PHYS, V92, P671; Savin A., 1997, ANGEW CHEM INT EDIT, V36, P1808, DOI DOI 10.1002/ANIE.199718081; Stern EA, 1996, J PHYS CHEM SOLIDS, V57, P1449, DOI 10.1016/0022-3697(96)00012-1; Tanaka K, 2011, AMORPHOUS CHALCOGENIDE SEMICONDUCTORS AND RELATED MATERIALS, P1, DOI 10.1007/978-1-4419-9510-0; VANDERBILT D, 1979, PHYS REV LETT, V42, P1012, DOI 10.1103/PhysRevLett.42.1012; Waldecker L., 2014, ARXIV14120901; Xu M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.195502; Zhang XD, 1998, J NON-CRYST SOLIDS, V241, P195, DOI 10.1016/S0022-3093(98)00807-2; Zhang XD, 1999, PHYS REV LETT, V83, P5042, DOI 10.1103/PhysRevLett.83.5042; Zhu M., 2014, NAT COMMUN, V5	58	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 1	2015	5								13698	10.1038/srep13698		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1RL	WOS:000360376200001		
J	Lupberger, J; Casanova, C; Fischer, B; Weiss, A; Fofana, I; Fontaine, N; Fujiwara, T; Renaud, M; Kopp, A; Schuster, C; Brino, L; Baumert, TF; Thoma, C				Lupberger, Joachim; Casanova, Claudia; Fischer, Benoit; Weiss, Amelie; Fofana, Isabel; Fontaine, Nelly; Fujiwara, Toshinobu; Renaud, Mickael; Kopp, Arnaud; Schuster, Catherine; Brino, Laurent; Baumert, Thomas F.; Thoma, Christian			PI4K-beta and MKNK1 are regulators of hepatitis C virus IRES-dependent translation	SCIENTIFIC REPORTS			English	Article							CAP-INDEPENDENT TRANSLATION; RIBOSOME ENTRY SEGMENT; MYC PROTEIN-SYNTHESIS; MESSENGER-RNA; MEDIATED TRANSLATION; INHIBITS TRANSLATION; POLY(A) TAIL; HOST FACTORS; KINASE MNK1; CELL ENTRY	Cellular translation is down-regulated by host antiviral responses. Picornaviridae and Flaviviridae including hepatitis C virus (HCV) evade this process using internal ribosomal entry sequences (IRESs). Although HCV IRES translation is a prerequisite for HCV replication, only few host factors critical for IRES activity are known and the global regulator network remains largely unknown. Since signal transduction is an import regulator of viral infections and the host antiviral response we combined a functional RNAi screen targeting the human signaling network with a HCV IRES-specific reporter mRNA assay. We demonstrate that the HCV host cell cofactors PI4K and MKNK1 are positive regulators of HCV IRES translation representing a novel pathway with a functional relevance for the HCV life cycle and IRES-mediated translation of viral RNA.	[Lupberger, Joachim; Fofana, Isabel; Fontaine, Nelly; Schuster, Catherine; Baumert, Thomas F.] INSERM, Inst Rech Malad Virales & Hepat, U1110, Strasbourg, France; [Lupberger, Joachim; Fofana, Isabel; Fontaine, Nelly; Schuster, Catherine; Baumert, Thomas F.] Univ Strasbourg, Strasbourg, France; [Casanova, Claudia; Thoma, Christian] Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany; [Fischer, Benoit; Weiss, Amelie; Renaud, Mickael; Kopp, Arnaud; Brino, Laurent] IGBMC, CNRS, High Throughput Screening Platform, UMR7104,UdS,INSERM,U964, Illkirch Graffenstaden, France; [Fujiwara, Toshinobu] Nagoya City Univ, Grad Sch Pharmaceut Sci, Lab Hyg Chem, Nagoya, Aichi, Japan; [Baumert, Thomas F.] Inst Hosp Univ, Nouvel Hop Civil, Pole Hepatodigestif, Strasbourg, France	Baumert, TF (reprint author), INSERM, Inst Rech Malad Virales & Hepat, U1110, Strasbourg, France.	Thomas.Baumert@unistra.fr; thoma.christian@gmx.net			Wilhelm Sander-Stiftung (Forderantrag) [2010.023.1]; European Union (INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net, EU FP7 HEPAMAB) [ERC-2008-AdG-233130-HEPCENT]; ANRS [2013/108]; ARC TheraHCC (TheraHCC IHUARC) [IHU201301187]; Laboratoire d'excellence LabEx HEPSYS (Investissement d'Avenir) [ANR-10-LAB-28]; Deutsche Forschungsgemeinschaft [TH788/2-1, TH788/2-2]; French ANR; University of Strasbourg (IDEX)	We thank Petra Binninger for excellent technical assistance. This work was supported by a grant from the Wilhelm Sander-Stiftung to C.T. and T.F.B. (Forderantrag 2010.023.1), the European Union (ERC-2008-AdG-233130-HEPCENT, INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2012, EU FP7 HEPAMAB; all T. F. B), ANRS 2013/108 to T.F.B, ARC TheraHCC (TheraHCC IHUARC IHU201301187 to T.F.B.), and Laboratoire d'excellence LabEx HEPSYS (Investissement d'Avenir; ANR-10-LAB-28). C.T. was a recipient of a Heisenberg-Fellowship from the Deutsche Forschungsgemeinschaft (TH788/2-1 and TH788/2-2). J.L. is a recipient of a grant from the French ANR and the University of Strasbourg (IDEX, Projet Attractivite 2014).	Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; Majzoub K, 2014, CELL, V159, P1086, DOI 10.1016/j.cell.2014.10.041; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Preiss T, 1998, NATURE, V392, P516; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021; Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322; Niepmann M, 2009, CELL CYCLE, V8, P1473; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Kim S, 2013, J VIROL, V87, P4214, DOI 10.1128/JVI.00954-12; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Zhang XD, 2007, J BIOMOL SCREEN, V12, P497, DOI 10.1177/1087057107300646; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Kim JH, 2003, MOL CELL BIOL, V23, P708, DOI 10.1128/MCB.23.2.708-720.2003; Subkhankulova T, 2001, BIOCHEM J, V359, P183, DOI 10.1042/0264-6021:3590183; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Reiss S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003359; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Hellen CUT, 2009, BBA-GENE REGUL MECH, V1789, P558, DOI 10.1016/j.bbagrm.2009.06.001; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Cuesta R, 2000, GENE DEV, V14, P1460; Casanova CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045943; Goktug AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049386; Richards AL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003262; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Worch J, 2004, ONCOGENE, V23, P9162, DOI 10.1038/sj.onc.1208164	39	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 1	2015	5								13344	10.1038/srep13344		5	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1MB	WOS:000360360700001		
J	Masai, H; Yamada, Y; Okumura, S; Yanagida, T; Fujimoto, Y; Kanemitsu, Y; Ina, T				Masai, Hirokazu; Yamada, Yasuhiro; Okumura, Shun; Yanagida, Takayuki; Fujimoto, Yutaka; Kanemitsu, Yoshihiko; Ina, Toshiaki			Photoluminescence of monovalent indium centres in phosphate glass	SCIENTIFIC REPORTS			English	Article							ALKALI-HALIDE CRYSTALS; DOPED IN2O3 FILMS; OPTICAL-PROPERTIES; LUMINESCENCE PROPERTIES; SNO-ZNO-P2O5 GLASS; SINGLE-CRYSTALS; COLOR-CENTERS; BORATE GLASS; IONS; TIN	Valence control of polyvalent cations is important for functionalization of various kinds of materials. Indium oxides have been used in various applications, such as indium tin oxide in transparent electrical conduction films. However, although metastable In+ (5 s(2) configuration) species exhibit photoluminescence (PL), they have attracted little attention. Valence control of In+ cations in these materials will be important for further functionalization. Here, we describe In+ species using PL and X-ray absorption fine structure (XAFS) analysis. Three absorption bands in the UV region are attributed to the In+ centre: two weak forbidden bands (S-1(0) -> P-3(1), S-1(0) -> P-3(2)) and a strong allowed band (S-1(0) -> P-1(1)). The strongest PL excitation band cannot be attributed to the conventional allowed transition to the singlet excited state. Emission decay of the order of microseconds suggests that radiative relaxation occurs from the triplet excitation state. The XAFS analysis suggests that these In+ species have shorter In-O distances with lower coordination numbers than in In2O3. These results clearly demonstrate that In+ exists in a metastable amorphous network, which is the origin of the observed luminescent properties.	[Masai, Hirokazu; Yamada, Yasuhiro; Okumura, Shun; Kanemitsu, Yoshihiko] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Yanagida, Takayuki] Nara Inst Sci & Technol, Nara 6300192, Japan; [Fujimoto, Yutaka] Tohoku Univ, Dept Appl Chem, Sendai, Miyagi 9808579, Japan; [Ina, Toshiaki] Japan Synchrotron Radiat Res Inst JASRI SPring 8, Sayo, Hyogo 6795198, Japan	Masai, H (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	masai_h@scl.kyoto-u.ac.jp	Kanemitsu, Yoshihiko/D-2006-2014		Kyoto Technoscience Center; ICR Grants for Young Scientists; Collaborative Research Program of the Institute for Chemical Research, Kyoto University [2013-62, 2014-31]; Sumitomo Electric Industries Group CSR Foundation;  [26709048]	This work was partially supported by a Grant-in-Aid for Young Scientists (A) (Grant #26709048) and The Kyoto Technoscience Center. The work was also supported by ICR Grants for Young Scientists, the Collaborative Research Program of the Institute for Chemical Research, Kyoto University (Grant #2013-62 and #2014-31), and the Sumitomo Electric Industries Group CSR Foundation (to Y.Y. and Y.K.). XAFS measurements were performed with the approval of SPring-8 (No. 2014A1128). The authors wish to thank Dr. Y. Tokuda (I.C.R., Kyoto Univ.) and Dr. K. Teramura (Kyoto Univ.) for their advice and discussion.	REISFELD R, 1975, J SOLID STATE CHEM, V15, P140, DOI 10.1016/0022-4596(75)90237-6; Seitz F, 1938, J CHEM PHYS, V6, P150, DOI 10.1063/1.1750216; KANG JG, 1994, J PHYS-CONDENS MAT, V6, P2101, DOI 10.1088/0953-8984/6/10/028; MAREZIO M, 1966, ACTA CRYSTALLOGR, V20, P723, DOI 10.1107/S0365110X66001749; Masai H, 2012, J NON-CRYST SOLIDS, V358, P265, DOI 10.1016/j.jnoncrysol.2011.09.025; Masai H, 2012, J AM CERAM SOC, V95, P862, DOI 10.1111/j.1551-2916.2011.05055.x; ROPP RC, 1960, J ELECTROCHEM SOC, V107, P15, DOI 10.1149/1.2427594; RANFAGNI A, 1983, ADV PHYS, V32, P823, DOI 10.1080/00018738300101621; Masai H, 2011, OPT LETT, V36, P2868, DOI 10.1364/OL.36.002868; Hong NH, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.132404; Masai H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766340; Masai H, 2013, OPT LETT, V38, P3780, DOI 10.1364/OL.38.003780; Li C, 2003, APPL PHYS LETT, V82, P1613, DOI 10.1063/1.1559438; Masai H, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.082102; Masai H, 2014, J MATER CHEM C, V2, P2137, DOI 10.1039/c3tc32259a; KOSTLIN H, 1975, PHYS STATUS SOLIDI A, V29, P87, DOI 10.1002/pssa.2210290110; Masai H, 2012, OPT EXPRESS, V20, P27319, DOI 10.1364/OE.20.027319; Hosono H, 2006, J NON-CRYST SOLIDS, V352, P851, DOI 10.1016/j.jnoncrysol.2006.01.073; WACHTEL A, 1966, J ELECTROCHEM SOC, V113, P128, DOI 10.1149/1.2423884; Zhang DH, 2004, NANO LETT, V4, P1919, DOI 10.1021/nl0489283; Granqvist CG, 2002, THIN SOLID FILMS, V411, P1, DOI 10.1016/S0040-6090(02)00163-3; CLAPP RH, 1947, J OPT SOC AM, V37, P355, DOI 10.1364/JOSA.37.000355; TOYOZAWA Y, 1966, J PHYS SOC JPN, V21, P1663, DOI 10.1143/JPSJ.21.1663; OHHATA Y, 1979, THIN SOLID FILMS, V59, P255, DOI 10.1016/0040-6090(79)90298-0; BLASSE G, 1988, PROG SOLID STATE CH, V18, P79, DOI 10.1016/0079-6786(88)90004-0; Bunuel MA, 1999, J APPL PHYS, V86, P5045, DOI 10.1063/1.371477; BUTLER KH, 1950, J ELECTROCHEM SOC, V97, P265, DOI 10.1149/1.2778007; CASALBONI M, 1979, PHYS STATUS SOLIDI B, V93, P755, DOI 10.1002/pssb.2220930233; CHOI KO, 1991, J CHEM PHYS, V94, P6420, DOI 10.1063/1.460271; Davis T. S., 1971, Journal of Luminescence, V4, DOI 10.1016/0022-2313(71)90008-1; Ehrt D, 2001, PHYS CHEM GLASSES, V42, P231; Ehrt D, 2002, CR CHIM, V5, P679, DOI 10.1016/S1631-0748(02)01432-7; FUKUDA A, 1967, J PHYS CHEM SOLIDS, V28, P1763, DOI 10.1016/0022-3697(67)90152-7; FUKUDA A, 1970, PHYS REV B, V1, P4161, DOI 10.1103/PhysRevB.1.4161; HAMBERG I, 1986, J APPL PHYS, V60, pR123, DOI 10.1063/1.337534; Hayakawa T, 2006, JPN J APPL PHYS 1, V45, P5078, DOI 10.1143/JJAP.45.5078; Hilsch R., 1927, Zeitschrift fur Physik, V44, DOI 10.1007/BF01390859; JACOBS PWM, 1991, J PHYS CHEM SOLIDS, V52, P35, DOI 10.1016/0022-3697(91)90059-9; JACOBS PWM, 1975, J PHYS C SOLID STATE, V8, P851, DOI 10.1088/0022-3719/8/6/016; Jaek I, 1997, J LUMIN, V72-4, P681, DOI 10.1016/S0022-2313(96)00264-5; Jimenez J.A, 2008, J LUMIN, V129, P1546; KOSKENTALO T, 1985, MATER RES BULL, V20, P265, DOI 10.1016/0025-5408(85)90182-5; LESKELA M, 1985, J SOLID STATE CHEM, V59, P272, DOI 10.1016/0022-4596(85)90294-4; Masai H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03541; Polak K, 2010, OPT MATER, V32, P1280, DOI 10.1016/j.optmat.2010.05.006; SKUJA L, 1992, J NON-CRYST SOLIDS, V149, P77, DOI 10.1016/0022-3093(92)90056-P; Sundaresan A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161306; Taguchi T, 2005, PHYS SCRIPTA, VT115, P205; Tanimizu S, 2007, PHOSPHOR HDB, P155; TRINKLER MF, 1977, PHYS STATUS SOLIDI B, V79, P49, DOI 10.1002/pssb.2220790103	50	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 1	2015	5								13646	10.1038/srep13646		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1MT	WOS:000360362500001		
J	Mizukawa, Y; Miyashita, Y; Satoh, M; Shiraiwa, Y; Iwasaka, M				Mizukawa, Yuri; Miyashita, Yuito; Satoh, Manami; Shiraiwa, Yoshihiro; Iwasaka, Masakazu			Light intensity modulation by coccoliths of Emiliania huxleyi as a micro-photo-regulator	SCIENTIFIC REPORTS			English	Article							BIOMINERALIZATION; CALCIFICATION; PRYMNESIOPHYCEAE; DIFFRACTION; CHEMISTRY; MECHANISM; GROWTH; ALGAE; CELLS; PART	In this study, we present experimental evidence showing that coccoliths have light-scattering anisotropy that contributes to a possible control of solar light exposure in the ocean. Changing the angle between the incident light and an applied magnetic field causes differences in the light-scattering intensities of a suspension of coccoliths isolated from Emiliania huxleyi. The magnetic field effect is induced by the diamagnetic torque force directing the coccolith radial plane perpendicular to the applied magnetic fields at 400 to 500 mT. The developed technique reveals the light-scattering anisotropies in the 3-mu m-diameter floating coccoliths by orienting themselves in response to the magnetic fields. The detached coccolith scatters radially the light incident to its radial plane. The experimental results on magnetically oriented coccoliths show that an individual coccolith has a specific direction of light scattering, although the possible physiological effect of the coccolith remains for further study, focusing on the light-scattering anisotropies of coccoliths on living cells.	[Mizukawa, Yuri; Miyashita, Yuito; Iwasaka, Masakazu] Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima 7398527, Japan; [Mizukawa, Yuri; Miyashita, Yuito; Iwasaka, Masakazu] Hiroshima Univ, Res Inst Nanodevice & Bio Syst, Hiroshima 7398527, Japan; [Satoh, Manami; Shiraiwa, Yoshihiro] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Satoh, Manami; Shiraiwa, Yoshihiro] Japan Sci & Technol Agcy JST, CREST, Tsukuba, Ibaraki 3058572, Japan; [Iwasaka, Masakazu] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Iwasaka, M (reprint author), Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima 7398527, Japan.	iwasaka@hiroshima-u.ac.jp			JST, CREST/PRESTO "Creation of Basic Technology for Improved Bioenergy Production through Functional Analysis and Regulation of Algae and Other Aquatic Microorganisms"	This study was supported by JST, CREST/PRESTO "Creation of Basic Technology for Improved Bioenergy Production through Functional Analysis and Regulation of Algae and Other Aquatic Microorganisms."	Aizenberg J, 2010, MRS BULL, V35, P323, DOI 10.1557/mrs2010.555; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Bolton CT, 2013, NATURE, V500, P558, DOI 10.1038/nature12448; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; LaRiviere JP, 2012, NATURE, V486, P97, DOI 10.1038/nature11200; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; MANN S, 1988, PROC R SOC SER B-BIO, V234, P441, DOI 10.1098/rspb.1988.0057; YOUNG JR, 1992, NATURE, V356, P516, DOI 10.1038/356516a0; WESTBROEK P, 1984, PHILOS T ROY SOC B, V304, P435, DOI 10.1098/rstb.1984.0037; Nanninga HJ, 1996, MAR ECOL PROG SER, V136, P195, DOI 10.3354/meps136195; Marsh ME, 2003, COMP BIOCHEM PHYS B, V136, P743, DOI 10.1016/S1096-4959(03)00180-5; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Young JR, 1999, J STRUCT BIOL, V126, P195, DOI 10.1006/jsbi.1999.4132; Danbara A, 1999, PLANT CELL PHYSIOL, V40, P762; Rickaby REM, 2007, EARTH PLANET SC LETT, V253, P83, DOI 10.1016/j.epsl.2006.10.016; Young JR, 2003, REV MINERAL GEOCHEM, V54, P189, DOI 10.2113/0540189; Balch WM, 1999, J GEOPHYS RES-OCEANS, V104, P1541, DOI 10.1029/1998JC900035; FICHTINGERSCHEPMAN AM, 1981, CARBOHYD RES, V93, P105, DOI 10.1016/S0008-6215(00)80756-9; Kayano K, 2011, MAR BIOTECHNOL, V13, P83, DOI 10.1007/s10126-010-9272-4; Kayano K, 2009, PLANT CELL PHYSIOL, V50, P1522, DOI 10.1093/pcp/pcp097; Krishnan KS, 1933, PHILOS T R SOC LOND, V231, P235, DOI 10.1098/rsta.1933.0007; Iwasaka M, 2014, J APPL PHYS, V115, DOI 10.1063/1.4861556; Okamoto N., 2005, PLANT BIOTECHNOL, V22, P505, DOI 10.5511/plantbiotechnology.22.505; PAASCHE E, 1962, NATURE, V193, P1094, DOI 10.1038/1931094b0; PAASCHE E, 1970, ARCH MIKROBIOL, V73, P143; Paasche E., 1964, Physiologia Plantarum Suppl, V3, P1; Quintero-Torres R, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.032901; Saruwatari K, 2006, AM MINERAL, V91, P1937, DOI 10.2138/am.2006.2391; Satoh M, 2009, MAR BIOTECHNOL, V11, P327, DOI 10.1007/s10126-008-9147-0; Voss KJ, 1998, LIMNOL OCEANOGR, V43, P870; WESTBROEK P, 1989, J PROTOZOOL, V36, P368, DOI 10.1111/j.1550-7408.1989.tb05528.x; Young J.R., 1987, Abhandlungen der Geologischen Bundesanstalt (Vienna), V39, P305; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 1	2015	5								13577	10.1038/srep13577		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1NY	WOS:000360365600001		
J	Moritomo, Y; Yonezawa, K; Yasuda, T				Moritomo, Yutaka; Yonezawa, Kouhei; Yasuda, Takeshi			Carrier density effect on recombination in PTB7-based solar cell	SCIENTIFIC REPORTS			English	Article							PHOTOVOLTAIC CELLS; POLYMER; PERFORMANCE; MORPHOLOGY; DYNAMICS	Organic solar cells (OSCs) are promising alternatives to the conventional inorganic solar cells due to their low-cost processing and compatibility with flexible substrates. The development of low bandgap polymer, e.g., poly-[[4,8-bis[(2-ethylhexyl) oxy] benzo[1,2-b: 4,5-b'] dithiophene-2,6-diyl] [3-fluoro-2-[( 2-ethylhexyl) carbonyl] thieno[3] thiophenediyl]] (PTB7), increases the power conversion efficiency (PCE) in the last decade. Here, we investigated the interrelation between the instantaneous carrier density (n) per donor (D)/acceptor (A) interface area and the carrier density (n(collected)) collected as photocurrent in PTB7/C-70 heterojunction (HJ) device. By means of the time-resolved spectroscopy, we confirmed that the exciton-to-carrier conversion process takes place within similar to 1 ps at the D/A interface of the PTB7/C-70 HJ device. We further determined the absolute magnitude of n by combination of the time-resolved and electrochemical spectroscopies. We found that the carrier recombination becomes dominant if n exceeds a critical concentration (n(c) = 0.003 carriers/nm(-2)). We confirmed that a similar behaviors is observed in the PTB7/[6,6]-phenyl C-71-butyric acid methyl ester (PC71BM) bulk heterojunction (BHJ) device. Our quantitative investigation based on the HJ device demonstrates that the fast carrier escape from the D/A interface region is indispensable for high PCE, because the carrier accumulation nonlinearly accelerates the carrier recombination process.	[Moritomo, Yutaka; Yonezawa, Kouhei] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Moritomo, Yutaka] Univ Tsukuba, CiRfSE, Tsukuba, Ibaraki 3058571, Japan; [Yasuda, Takeshi] Natl Inst Mat Sci, Photovolta Mat Unit, Tsukuba, Ibaraki 3050047, Japan	Moritomo, Y (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.	moritomo.yutaka.gf@u.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23684022]	This work was partially supported by a Grant-in-Aid (No. 23684022) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Marsh RA, 2010, NANO LETT, V10, P923, DOI 10.1021/nl9038289; Gregg BA, 2003, J APPL PHYS, V93, P3605, DOI 10.1063/1.1544413; He ZC, 2011, ADV MATER, V23, P4636, DOI 10.1002/adma.201103006; Nguyen TL, 2014, ENERG ENVIRON SCI, V7, P3040, DOI 10.1039/c4ee01529k; Rolczynski BS, 2012, J AM CHEM SOC, V134, P4142, DOI 10.1021/ja209003y; Guo JC, 2010, J PHYS CHEM B, V114, P742, DOI 10.1021/jp909135k; Kesava SV, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201400116; Guo X, 2014, ADV MATER, V26, P4043, DOI 10.1002/adma.201400411; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI 10.1038/NPHOTON.2012.190; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Szarko JM, 2011, J MATER CHEM, V21, P7849, DOI 10.1039/c0jm04433d; Moritomo Y, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892611; HIRAMOTO M, 1991, APPL PHYS LETT, V58, P1062, DOI 10.1063/1.104423; Hedley GJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3867; Yonezawa K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.042302; Yonezawa K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.062405	16	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 1	2015	5								13648	10.1038/srep13648		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1QZ	WOS:000360374900001		
J	Sumida, K; Ohno, Y; Ohtake, J; Kaneumi, S; Kishikawa, T; Takahashi, N; Taketomi, A; Kitamura, H				Sumida, Kentaro; Ohno, Yosuke; Ohtake, Junya; Kaneumi, Shun; Kishikawa, Takuto; Takahashi, Norihiko; Taketomi, Akinobu; Kitamura, Hidemitsu			IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway	SCIENTIFIC REPORTS			English	Article							TUMOR-BEARING MICE; CARCINOMA CELLS; FAMILY CYTOKINE; BREAST-CANCER; GROWTH-FACTOR; INTERLEUKIN-11; EXPRESSION; MICROENVIRONMENT; INFLAMMATION; RESPONSES	Myeloid-derived suppressor cells (MDSCs) are immune negative regulators in the tumour microenvironment. Interleukin (IL)-11, a member of IL-6 family cytokines, functions through the unique receptor IL-11 receptor alpha coupled with the common signal transducer gp130. IL-11-gp130 signalling causes activation of the JAK/STAT3 pathway. IL-11 is highly upregulated in many types of cancers and one of the most important cytokines during tumourigenesis and metastasis. However, the precise effect of IL-11 on differentiation into MDSCs is still unknown. Here, we found that CD11b(+) CD14(+) monocytic MDSCs were generated from peripheral blood mononuclear cells (PBMCs) of healthy donors in the presence of IL-11. IL-11-conditioned PBMCs induced higher expression of immunosuppressive molecules such as arginase-1. A reduction of T-cell proliferation was observed when MDSCs generated in the presence of IL-11 were co-cultured with CD3/CD28-stimulated, autologous T cells of healthy donors. Culture of normal PBMCs with IL-11 led to STAT3 phosphorylation and differentiation into MDSCs via STAT3 activation. We confirmed expressions of both IL-11 and phosphorylated STAT3 in tumour tissues of colorectal cancer patients. These findings suggest that monocytic MDSCs may be induced by IL-11 in the tumour microenvironment. Thus, IL-11-mediated regulation in functional differentiation of MDSCs may serve as a possible target for cancer immunotherapy.	[Sumida, Kentaro; Ohno, Yosuke; Ohtake, Junya; Kaneumi, Shun; Kishikawa, Takuto; Kitamura, Hidemitsu] Hokkaido Univ, Inst Med Genet, Div Funct Immunol, Sect Dis Control, Sapporo, Hokkaido 060815, Japan; [Ohno, Yosuke; Takahashi, Norihiko; Taketomi, Akinobu] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Sapporo, Hokkaido 0608638, Japan	Kitamura, H (reprint author), Hokkaido Univ, Inst Med Genet, Div Funct Immunol, Sect Dis Control, Sapporo, Hokkaido 060815, Japan.	kitamura@igm.hokudai.ac.jp			Grant for Joint Research Program of the Institute for Genetic Medicine, Hokkaido University; apanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25460584]; Research Fellowship for Young Scientists [13J01464]; MEXT	We thank Dr. H. Kobayashi for thoughtful advice on IHC. This work was supported in part by a Grant for Joint Research Program of the Institute for Genetic Medicine, Hokkaido University, a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (H.K., 25460584), Research Fellowship for Young Scientists (K.S., 13J01464), and a Grant in aid for Translational Research Network Program from MEXT.	Chamoto K, 2010, CANCER SCI, V101, P855, DOI 10.1111/j.1349-7006.2009.01469.x; Necula LG, 2012, J GASTROINTEST LIVER, V21, P23; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Li HQ, 2009, J IMMUNOL, V182, P240; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Xiang ZL, 2012, MOL BIOL REP, V39, P6001, DOI 10.1007/s11033-011-1413-y; Haverkamp JM, 2011, EUR J IMMUNOL, V41, P749, DOI 10.1002/eji.201041069; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Nakayama T, 2007, INT J ONCOL, V30, P825; Lu TY, 2012, CLIN CANCER RES, V18, P4877, DOI 10.1158/1078-0432.CCR-11-2939; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Youn JI, 2008, J IMMUNOL, V181, P5791; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Gros A, 2012, CLIN CANCER RES, V18, P5212, DOI 10.1158/1078-0432.CCR-12-1108; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Mace TA, 2013, CANCER RES, V73, P3007, DOI 10.1158/0008-5472.CAN-12-4601; Narita Y, 2013, J IMMUNOL, V190, P812, DOI 10.4049/jimmunol.1103797; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Sumida K, 2012, EUR J IMMUNOL, V42, P2060, DOI 10.1002/eji.201142335; Bellone G, 2006, CANCER IMMUNOL IMMUN, V55, P684, DOI 10.1007/s00262-005-0047-0; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Alizadeh D, 2014, CANCER RES, V74, P2663, DOI 10.1158/0008-5472.CAN-14-0301; Campbell CL, 2001, GYNECOL ONCOL, V80, P121, DOI 10.1006/gyno.2000.6064; Chua ACG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078850; Ernst M, 2014, CLIN CANCER RES, V20, P5579, DOI 10.1158/1078-0432.CCR-13-2492; Gao YB, 2013, J CANCER RES CLIN, V139, P669, DOI 10.1007/s00432-012-1370-4; Mccoy EM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-16; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Ren L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0634-4; Sinha P, 2008, J IMMUNOL, V181, P4666; TERAMURA M, 1992, BLOOD, V79, P327; Zhang Y, 2007, INT IMMUNOL, V19, P151, DOI 10.1093/intimm/dxl132	42	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 1	2015	5								13650	10.1038/srep13650		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1QZ	WOS:000360374900003		
J	Wakatsuki, R; Ezawa, M; Nagaosa, N				Wakatsuki, Ryohei; Ezawa, Motohiko; Nagaosa, Naoto			Domain wall of a ferromagnet on a three-dimensional topological insulator	SCIENTIFIC REPORTS			English	Article							DIRAC-FERMION; SURFACE; REALIZATION; STATE	Topological insulators (TIs) show rich phenomena and functions which can never be realized in ordinary insulators. Most of them come from the peculiar surface or edge states. Especially, the quantized anomalous Hall effect (QAHE) without an external magnetic field is realized in the two-dimensional ferromagnet on a three-dimensional TI which supports the dissipationless edge current. Here we demonstrate theoretically that the domain wall of this ferromagnet, which carries edge current, is charged and can be controlled by the external electric field. The chirality and relative stability of the Neel wall and Bloch wall depend on the position of the Fermi energy as well as the form of the coupling between the magnetic moments and orbital of the host TI. These findings will pave a path to utilize the magnets on TI for the spintronics applications.	[Wakatsuki, Ryohei; Ezawa, Motohiko; Nagaosa, Naoto] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Nagaosa, Naoto] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Wakatsuki, R (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	wakatsuki@appi.t.u-tokyo.ac.jp	Nagaosa, Naoto/G-7057-2012		Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24224009, 25400317, 15H05853]	The authors are grateful for insightful discussions with M. Kawasaki and Y. Tokura. R. W. and M. E. are grateful for helpful conversations with R. Takahashi and H. Isobe. R. W. was supported by Grant-in-Aid for JSPS Fellows. This work was supported by Grant-in-Aids for Scientific Research (Nos. 24224009, 25400317, and 15H05853) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Chen YL, 2010, SCIENCE, V329, P659, DOI 10.1126/science.1189924; Ryu KS, 2013, NAT NANOTECHNOL, V8, P527, DOI [10.1038/nnano.2013.102, 10.1038/NNANO.2013.102]; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485; Onoda M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.206601; Linder J, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.041412; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; JACKIW R, 1976, PHYS REV D, V13, P3398, DOI 10.1103/PhysRevD.13.3398; Liu CX, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045122; Checkelsky JG, 2012, NAT PHYS, V8, P729, DOI [10.1038/nphys2388, 10.1038/NPHYS2388]; Shan WY, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043048; Nomura K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.166802; Chang CZ, 2015, NAT MATER, V14, P473, DOI [10.1038/nmat4204, 10.1038/NMAT4204]; Bestwick AJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.187201; Abanin DA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136802; Zhang JS, 2013, SCIENCE, V339, P1582, DOI 10.1126/science.1230905; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Tserkovnyak Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.187201; Nomura K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.161401; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Garate I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.146802; Baum Y, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195116; Checkelsky JG, 2014, NAT PHYS, V10, P731, DOI [10.1038/nphys3053, 10.1038/NPHYS3053]; Ferreiros Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024413; Figueroa AI, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.134402; He HT, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.166805; Henk J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.076801; Hurst HM, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.060401; Kou XF, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.137201; Kurebayashi D, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.063709; Mendler B, 2015, PHYS REV B, V91; Ni Y, 2015, J APPL PHYS, V117, DOI 10.1063/1.4918560; Pinczuk A, 1997, PERSPECTIVES QUANTUM; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Rojas Sanchez JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3944; Yokoyama T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.241410; Yoshimi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7627	38	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 1	2015	5								13638	10.1038/srep13638		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1MH	WOS:000360361300002		
J	Nonogaki, M; Sekine, T; Nonogaki, H				Nonogaki, Mariko; Sekine, Taira; Nonogaki, Hiroyuki			Chemically inducible gene expression in seeds before testa rupture	SEED SCIENCE RESEARCH			English	Article						germination recovery; inducible gene expression; preharvest sprouting; testa rupture	ARABIDOPSIS-THALIANA; CELL FATE; GERMINATION; DORMANCY; PROMOTER; PLANTS; METHOXYFENOZIDE; REGULATOR; PROTEIN; TOBACCO	Impermeability of the testa hinders efficient penetration of some small chemicals, such as transcriptional inhibitors, through the endosperm and the embryo during seed experiments. In Arabidopsis seeds, 5-bromo-4-chloro-3-indolyl -d-glucuronic acid, a substrate for -glucuronidase, did not permeate through the endosperm and embryo efficiently at the stages before testa rupture. The Arabidopsis testa also limited efficient entry of methoxyfenozide, a chemical ligand that was used for inducible gene expression experiments, into seeds. While the detection of a reporter gene at the early imbibitional stages could be replaced by reverse transcription-polymerase chain reaction (RT-PCR), the interference of entry of the chemical ligand into seeds by the testa was still problematic to gene induction experiments. To develop an efficient inducible expression system for gene function analysis in seeds, an inducible expression system with nitrate, which is a testa-permeable ligand, was examined. The vector containing the 2.1-kb upstream sequence of NITRITE REDUCTASE 1 was able to cause expression of a test gene (long non-coding RNA) in imbibed seeds at the stage before testa rupture in a nitrate-dependent manner. This system can be used not only for characterization of genes associated with seed dormancy and germination in basic research, but also for the development of germination recovery or enhancement technologies for agricultural applications.	[Nonogaki, Mariko; Nonogaki, Hiroyuki] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Sekine, Taira] Snow Brand Seed Co Ltd, Atsubetsu ku, Sapporo, Hokkaido, Japan	Nonogaki, H (reprint author), Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA.	hiro.nonogaki@oregonstate.edu			Integrative Seed Biology fund of the Oregon State University Foundation	This work was partially supported by the Integrative Seed Biology fund of the Oregon State University Foundation.	Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Konishi M, 2010, PLANT J, V63, P269, DOI 10.1111/j.1365-313X.2010.04239.x; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Nonogaki M, 2014, PLANT J, V78, P527, DOI 10.1111/tpj.12472; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Padidam M, 2003, CURR OPIN PLANT BIOL, V6, P169, DOI 10.1016/S1369-5266(03)00005-0; Caddick MX, 1998, NAT BIOTECHNOL, V16, P177, DOI 10.1038/nbt0298-177; Martinez-Andujar C, 2011, P NATL ACAD SCI USA, V108, P17225, DOI 10.1073/pnas.1112151108; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; AOYAMA T, 1995, PLANT CELL, V7, P1773, DOI 10.1105/tpc.7.11.1773; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Bruce W, 2000, PLANT CELL, V12, P65, DOI 10.1105/tpc.12.1.65; Mosallanejad H, 2010, J INSECT PHYSIOL, V56, P1973, DOI 10.1016/j.jinsphys.2010.08.022; Liu PP, 2005, PLANT J, V41, P936, DOI 10.1111/j.1365-313X.2005.02347.x; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Bohner S, 1999, PLANT J, V19, P87, DOI 10.1046/j.1365-313X.1999.00503.x; De Veylder L, 2000, J EXP BOT, V51, P1647, DOI 10.1093/jexbot/51.351.1647; Gatz C, 1997, ANNU REV PLANT PHYS, V48, P89, DOI 10.1146/annurev.arplant.48.1.89; Koo JC, 2004, PLANT J, V37, P439, DOI 10.1111/j.1365-313X.2004.01869.x; Liu PP, 2005, PLANT J, V44, P960, DOI 10.1111/j.1365-131X.2005.02588.x; Love J, 2000, PLANT J, V21, P579, DOI 10.1046/j.1365-313x.2000.00706.x; Matakiadis T, 2009, PLANT PHYSIOL, V149, P949, DOI 10.1104/pp.108.126938; Nonogaki H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00233; Tavva VS, 2006, PLANT J, V45, P457, DOI 10.1111/j.1365-313X.2005.02628.x	25	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0960-2585	1475-2735		SEED SCI RES	Seed Sci. Res.	SEP	2015	25	3					345	352		10.1017/S0960258515000240		8	Plant Sciences	Plant Sciences	CQ2SQ	WOS:000360451800010		
J	Kasai, K; Chou, MY; Yamaguchi, M				Kasai, Kazutaka; Chou, Michelle Yuching; Yamaguchi, Masaru			Molecular effects of low-energy laser irradiation during orthodontic tooth movement	SEMINARS IN ORTHODONTICS			English	Article							LOW-LEVEL LASER; BONE REGENERATION; IN-VITRO; SIGNALING PATHWAY; REDUCING PAIN; THERAPY; RATS; EXPRESSION; VELOCITY; CELLS	Since orthodontic treatments usually take around 2-3 years, it can be a great burden for both patients and providers. Therefore, shortening the duration of treatment is both desirable and beneficial to the orthodontists as long treatment duration is associated with increased risks of gingival inflammation, decalcification, dental caries, and root resorption. Several novel modalities have been reported to accelerate orthodontic tooth movement including low-level laser therapy, pulsed electromagnetic fields, electrical currents, corticotomy, distraction osteogenesis, and mechanical vibration. Low-level laser therapy (LLLT) is an effective method to prompt wound healing, bone repair, and modeling after surgery. These biostimulatory effects of LLLT have been related to increased fibroblast and osteoblast activities. Similarly, LLLT has been suggested to play a role in accelerated tooth movement. In vivo rat studies have demonstrated that low-level laser irradiation (LLLI) increases osteoclastogenesis on the compression side via stimulation of the receptor activator of nuclear factor-kappa B (RANK)/RANK ligand (RANKL) and the c-fms/macrophage colony-stimulating factor (M-CSF) during experimental tooth movement. On the tension side, LLLI stimulates bone formation and has been associated with increased expression of type I collagen (COL1), fibronectin (FN), and osteopontin (OPN). Furthermore, In vivo studies have shown that LLLI induces differentiation and activation of osteoblasts and osteoclasts. Therefore, LLLI facilitates the turnover of connective tissues and accelerates the bone remodeling process by stimulating osteoblast and osteoclast proliferation and function during orthodontic tooth movement. This article reviews the current knowledge of the biological effects of laser irradiation and its molecular effect on orthodontic tooth movement. (C) 2015 Elsevier Inc. All rights reserved.	[Yamaguchi, Masaru] Nihon Univ, Sch Dent Matsudo, Dept Orthodont, Matsudo, Chiba 2718587, Japan; Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	Yamaguchi, M (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Orthodont, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	yamaguchi.masaru@nihon-u.ac.jp			Japan Society for the Promotion of Science, Japan [24890261, 25463200]	This rescarch was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan (24890261 and 25463200).	Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9; Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169; Fujiyama K, 2008, ANGLE ORTHOD, V78, P299, DOI 10.2319/033007-153.1; Walsh LJ, 1997, AUST DENT J, V42, P247, DOI 10.1111/j.1834-7819.1997.tb00129.x; Youssef M, 2008, LASER MED SCI, V23, P27, DOI 10.1007/s10103-007-0449-7; Yamaguchi M, 2009, ORTHOD CRANIOFAC RES, V12, P113, DOI 10.1111/j.1601-6343.2009.01444.x; Karu TI, 2004, PHOTOCH PHOTOBIO SCI, V3, P211, DOI 10.1039/b306126d; Hopkins JT, 2004, J ATHL TRAINING, V39, P223; Aihara N, 2006, LASER MED SCI, V21, P24, DOI 10.1007/s10103-005-0368-4; Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161; Hirata S, 2010, J CELL BIOCHEM, V111, P1445, DOI 10.1002/jcb.22872; Doshi-Mehta G, 2012, AM J ORTHOD DENTOFAC, V141, P289, DOI 10.1016/j.ajodo.2011.09.009; Sousa MVD, 2011, PHOTOMED LASER SURG, V29, P191, DOI 10.1089/pho.2009.2652; Renno ACM, 2007, PHOTOMED LASER SURG, V25, P275, DOI 10.1089/pho.2007.2055; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107; Kim YD, 2010, LASER MED SCI, V25, P25, DOI 10.1007/s10103-008-0585-8; TAKANOYAMAMOTO T, 1992, J DENT RES, V71, P53, DOI 10.1177/00220345920710010901; Soma S, 1999, J BONE MINER RES, V14, P546, DOI 10.1359/jbmr.1999.14.4.546; Yamaguchi M, 2010, EUR J ORTHODONT, V32, P131, DOI 10.1093/ejo/cjp078; Fujita S, 2008, ORTHOD CRANIOFAC RES, V11, P143, DOI 10.1111/j.1601-6343.2008.00423.x; Bicakci AA, 2012, PHOTOMED LASER SURG, V30, P460, DOI 10.1089/pho.2012.3245; Seifi M, 2007, LASER MED SCI, V22, P261, DOI 10.1007/s10103-007-0447-9; Omasa S, 2012, PHOTOMED LASER SURG, V30, P255, DOI 10.1089/pho.2011.3157; Yoshida T, 2009, ORTHOD CRANIOFAC RES, V12, P289, DOI 10.1111/j.1601-6343.2009.01464.x; Fujimoto K, 2010, LASER SURG MED, V42, P519, DOI 10.1002/lsm.20880; YAMASAKI K, 1982, J DENT RES, V61, P1444, DOI 10.1177/00220345820610121401; Kiyosaki T, 2010, PHOTOMED LASER SURG, V28, pS167, DOI 10.1089/pho.2009.2693; Cruz DR, 2004, LASER SURG MED, V35, P117, DOI 10.1002/lsm.20076; Walsh LJ, 2003, AUST DENT J, V48, P146, DOI 10.1111/j.1834-7819.2003.tb00025.x; Lim HM, 1995, AM J ORTHOD DENTOFAC, V108, P614, DOI 10.1016/S0889-5406(95)70007-2; Mohammed IFR, 2007, PHOTOMED LASER SURG, V25, P107, DOI 10.1089/pho.2006.1090; Altan BA, 2012, LASER MED SCI, V27, P131, DOI 10.1007/s10103-010-0853-2; Dang YY, 2011, LASER MED SCI, V26, P837, DOI 10.1007/s10103-011-0985-z; Saito S, 1997, AM J ORTHOD DENTOFAC, V111, P525, DOI 10.1016/S0889-5406(97)70152-5; Basso FG, INT J DENT; Cepera F, 2012, AM J ORTHOD DENTOFAC, V141, P444, DOI 10.1016/j.ajodo.2011.10.023; Coombe AR, 2001, CLIN ORTHOD RES, V4, P3, DOI DOI 10.1034/J.1600-0544.2001.040102.X; de Paula EC, 2010, LASER MED SCI, V25, P781, DOI [10.1007/s10103-010-0812-y, DOI 10.1007/S10103-010-0812-Y]; De Souza Thaís Oricchio Fedri, 2010, Photomed Laser Surg, V28 Suppl 2, pS85, DOI 10.1089/pho.2009.2661; Dominguez A, 2015, LASER MED SCI, V30, P415; Duan JH, 2012, PHOTOMED LASER SURG, V30, P663, DOI 10.1089/pho.2012.3220; Hamajima S, 2003, LASER MED SCI, V18, P78, DOI 10.1007/s10103-003-0255-9; Heravi Farzin, 2014, Oral Health Dent Manag, V13, P183; Kapila YL, 1998, J PERIODONTOL, V69, P1008; Kawasaki K, 2006, Orthod Craniofac Res, V9, P137, DOI 10.1111/j.1601-6343.2006.00368.x; Kim JY, 2012, ANGLE ORTHOD, V82, P107, DOI 10.2319/030911-173.1; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129, P1; Limpanichkul W, 2006, Orthod Craniofac Res, V9, P38, DOI 10.1111/j.1601-6343.2006.00338.x; Litscher G, 2004, ACUPUNCT MED, V16, P24; Maiya GA, 2005, PHOTOMED LASER SURG, V23, P187, DOI 10.1089/pho.2005.23.187; Marquezan M, 2010, PHOTOMED LASER SURG, V28, P757, DOI 10.1089/pho.2009.2694; Merli LAD, 2005, PHOTOMED LASER SURG, V23, P212, DOI 10.1089/pho.2005.23.212; Nishijima Y, 2006, Orthod Craniofac Res, V9, P63, DOI 10.1111/j.1601-6343.2006.00340.x; Obradovic RR, 2009, LASER MED SCI, V24, P447, DOI 10.1007/s10103-008-0573-z; Ohashi M, 2013, J ORAL TISSUE ENG, V11, P67; Pita ru S, 1987, J PERIODONTAL RES, V22, P64; Pongsri B, 1991, EUR J ORHTOD, V13, P255; Shirazi M, 2015, LASER MED SCI, V30, P713, DOI 10.1007/s10103-013-1407-1; Smith LP, 2010, AUST DENT J, V55, P219, DOI 10.1111/j.1834-7819.2010.01225.x; Yamaguchi M., 2007, ORTHOD WAVES, V66, P139, DOI 10.1016/j.odw.2007.09.002; Yu HS, 2003, J INVEST DERMATOL, V120, P56, DOI 10.1046/j.1523-1747.2003.12011.x	63	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1073-8746	1558-4631		SEMIN ORTHOD	Semin. Orthod.	SEP	2015	21	3					203	209		10.1053/j.sodo.2015.06.007		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ2OY	WOS:000360442000008		
J	Omori, R; Chemaitelly, H; Abu-Raddad, LJ				Omori, Ryosuke; Chemaitelly, Hiam; Abu-Raddad, Laith J.			Dynamics of non-cohabiting sex partnering in sub-Saharan Africa: a modelling study with implications for HIV transmission	SEXUALLY TRANSMITTED INFECTIONS			English	Article							SEXUALLY-TRANSMITTED DISEASES; NETWORK FORMATION; BEHAVIOR; EPIDEMIC; DISCORDANCY; CONTEXT	Objective To develop an analytical understanding of non-cohabiting sex partnering in sub-Saharan Africa (SSA) using nationally representative sexual behaviour data. Method A non-homogenous Poisson stochastic process model was used to describe the dynamics of non-cohabiting sex. The model was applied to 25 countries in SSA and was fitted to Demographic and Health Survey data. The country-specific mean values and variances of the distributions of number of non-cohabiting partners were estimated. Results The model yielded overall robust fits to the empirical distributions stratified by marital status and sex. The median across all country-specific mean values was highest for unmarried men at 0.574 non-cohabiting partners over the last 12 months, followed by that of unmarried women at 0.337, married men at 0.192 and married women at 0.038. The median of variances was highest for unmarried men at 0.127, followed by married men at 0.057, unmarried women at 0.003 and married women at 0.000. The largest variability in mean values across countries was for unmarried men (0.103-1.206), and the largest variability in variances was among unmarried women (0.000-1.994). Conclusions Non-cohabiting sex appears to be a random 'opportunistic' phenomenon linked to situations that may facilitate it. The mean values and variances of number of partners in SSA show wide variation by country, marital status and sex. Unmarried individuals have larger mean values than their married counterparts, and men have larger mean values than women. Unmarried individuals appear to play a disproportionate role in driving heterogeneity in sexual networks and possibly epidemiology of sexually transmitted infections.	[Omori, Ryosuke] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Omori, Ryosuke; Chemaitelly, Hiam; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn Educ City, Infect Dis Epidemiol Grp, Weill Cornell Med Coll Qatar, Doha, Qatar; [Omori, Ryosuke; Abu-Raddad, Laith J.] Cornell Univ, Dept Healthcare Policy & Res, Weill Cornell Med Coll, New York, NY 10021 USA; [Abu-Raddad, Laith J.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	Omori, R (reprint author), Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Kita Ku, North 20,West 10, Sapporo, Hokkaido 0010020, Japan.	omori@czc.hokudai.ac.jp		Chemaitelly, Hiam/0000-0002-8756-6968	Biostatistics, Epidemiology and Biomathematics Research Core at the Weill Cornell Medical College in Qatar	This paper was made possible by NPRP 5-752-3-177 from the Qatar National Research Fund (a member of Qatar Foundation). Additional support was provided by the Biostatistics, Epidemiology and Biomathematics Research Core at the Weill Cornell Medical College in Qatar. The statements made herein are solely the responsibility of the authors.	Abu-Raddad LJ, 2014, AIDS, V28, P1243, DOI 10.1097/QAD.0000000000000217; Abu-Raddad LJ, 2010, EPIDEMICS-NETH, V2, P173, DOI 10.1016/j.epidem.2010.08.003; ANDERSON R M, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P229; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Chemaitelly H, 2013, AIDS, V27, P251, DOI 10.1097/QAD.0b013e32835ad459; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Guthrie BL, 2007, CURR HIV RES, V5, P416; Bellis MA, 2005, J EPIDEMIOL COMMUN H, V59, P749, DOI 10.1136/jech.2005.036517; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; BRUNHAM RC, 1990, MED CLIN N AM, V74, P1339; Hamilton DT, 2008, SEX TRANSM DIS, V35, P30, DOI 10.1097/OLQ.0b013e3181453a84; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003; Boily MC, 1997, CAN J PUBLIC HEALTH, V88, P255; Chemaitelly H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18765; Gallo MF, 2006, SEX TRANSM DIS, V33, P476, DOI 10.1097/01.olq.0000231960.92850.75; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Hallett TB, 2008, PLOS MED, V5, pe80; Holmes K, 2008, SEXUALLY TRANSMITTED; Hrdy SB, 2000, ANN NY ACAD SCI, V907, P75; Jones JH, 2003, P ROY SOC B-BIOL SCI, V270, P1123, DOI 10.1098/rspb.2003.2369; Karlin S., 2010, INTRO STOCHASTIC MOD; MATLAB&REG;, 2013, LANG TECHN COMP 8 1; MEASURE DHS, 2012, DEM HLTH SURV; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Monasch R, 2006, WHO TECH REP SER, V938, P317; Monasch R, 2006, WHO TECH REP SER, V938, P15; Morris M, 1997, AIDS, V11, pS209; Traeen B, 1998, J COMMUNITY APPL SOC, V8, P41, DOI 10.1002/(SICI)1099-1298(199801/02)8:1<41::AID-CASP440>3.0.CO;2-3	31	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1368-4973	1472-3263		SEX TRANSM INFECT	Sex. Transm. Infect.	SEP	2015	91	6					451	457		10.1136/sextrans-2014-051925		7	Infectious Diseases	Infectious Diseases	CP9BZ	WOS:000360190000016		
J	Yamamura, E; Tsutsui, Y; Yamane, C; Yamane, S; Powdthavee, N				Yamamura, Eiji; Tsutsui, Yoshiro; Yamane, Chisako; Yamane, Shoko; Powdthavee, Nattavudh			Trust and Happiness: Comparative Study Before and After the Great East Japan Earthquake	SOCIAL INDICATORS RESEARCH			English	Article						Trust; Happiness; Disaster; Great East Japan Earthquake	AWAJI KOBE EARTHQUAKE; NATURAL DISASTERS; LIFE SATISFACTION; INCOME; INCREASE; TSUNAMI	The positive relationship between trust and happiness has been demonstrated by the literature. However, it is not clear how much this relationship depends on environmental conditions. The Great East Japan Earthquake of 2011 is considered one of the most catastrophic events in human history. This disaster caused not only physical damage for Japanese people, but also perceived damage. Using individual-level panel data from Japan covering the period 2009-2012, this paper attempts to probe how the relationship between trust and happiness was influenced by the Great East Japan Earthquake by comparing the same individuals before and after the earthquake. A fixed-effects estimation showed that there is a statistically well-determined positive relationship between trust and happiness and this relationship was strengthened by disaster, especially for residents in the damaged area. We argue that social trust is a substitute for formal institutions and markets, which mitigates the effect of disaster-related shock on psychological conditions such as happiness. Therefore, a trustful society is invulnerable to a gigantic disaster.	[Yamamura, Eiji] Seinan Gakuin Univ, Sawara Ku, Fukuoka 8148511, Japan; [Tsutsui, Yoshiro] Konan Univ, Fac Econ, Higashinada Ku, Kobe, Hyogo 6588501, Japan; [Yamane, Chisako] Okayama Shoka Univ, Kita Ku, Okayama 7008601, Japan; [Yamane, Shoko] Kindai Univ, Osaka 5778502, Japan; [Powdthavee, Nattavudh] London Sch Econ, CEP, London WC2A 2AE, England; [Powdthavee, Nattavudh] Univ Melbourne, MIAESR, Melbourne, Vic, Australia	Yamamura, E (reprint author), Seinan Gakuin Univ, Sawara Ku, 6-2-92 Nishijin, Fukuoka 8148511, Japan.	yamaei@seinan-gu.ac.jp; tsutsui@center.konan-u.ac.jp; Yamane@po.osu.ac.jp; syamane@kindai.ac.jp; N.Powdthavee@lse.ac.uk			Japan Center for Economic Research; Japanese Society for the Promotion of Science [20368971]; Kikawada Foundation	This research uses microdata from the Preference Parameters Study of Osaka University's twenty-first Century GCOE program, Behavioral Macrodynamics based on Surveys and Experiments, and its GCOE project, Human Behavior and Socioeconomic Dynamics. We acknowledge the contribution from the program and project contributors: Yoshiro Tsutsui, Fumio Ohtake, and Shinsuke Ikeda. The first author gratefully acknowledges financial support in the form of research grants from the Japan Center for Economic Research as well as the Japanese Society for the Promotion of Science (Foundation C 20368971). The first author also wishes to acknowledge the financial support of the Kikawada Foundation.	Aldrich D. P., 2012, BUILDING RESILIENCE; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Blanchflower DG, 2004, J PUBLIC ECON, V88, P1359, DOI 10.1016/S0047-2727(02)00168-8; Matsubayashi T, 2013, SOC SCI MED, V82, P126, DOI 10.1016/j.socscimed.2012.12.021; [Anonymous], 2011, DAILY YOMIURI   0314; Frijters P, 2011, SCAND J ECON, V113, P190, DOI 10.1111/j.1467-9442.2010.01638.x; Yamamura E, 2010, REG STUD, V44, P1019, DOI 10.1080/00343400903365144; Clark AE, 2008, ECON J, V118, pF222, DOI 10.1111/j.1468-0297.2008.02150.x; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Sawada Y, 2011, REV ECON HOUSEHOLD, V9, P429, DOI 10.1007/s11150-011-9124-7; Bjornskov C, 2003, KYKLOS, V56, P3, DOI 10.1111/1467-6435.00207; [Anonymous], 2011, DAILY YOMIURI   0319; Luechinger S, 2009, J PUBLIC ECON, V93, P620, DOI 10.1016/j.jpubeco.2008.10.003; Uchida Y, 2014, J HAPPINESS STUD, V15, P207, DOI 10.1007/s10902-013-9463-6; Helliwell JF, 2006, ECON J, V116, pC34, DOI 10.1111/j.1468-0297.2006.01074.x; Anbarci N, 2005, J PUBLIC ECON, V89, P1907, DOI 10.1016/j.jpubeco.2004.08.002; Tanikawa H, 2014, J IND ECOL, V18, P421, DOI 10.1111/jiec.12126; Carroll N, 2009, J POPUL ECON, V22, P445, DOI 10.1007/s00148-007-0174-3; Skidmore M, 2002, ECON INQ, V40, P664, DOI 10.1093/ei/40.4.664; Kellenberg DK, 2008, J URBAN ECON, V63, P788, DOI 10.1016/j.jue.2007.05.003; Helliwell JF, 2003, ECON MODEL, V20, P331, DOI 10.1016/S0264-9993(02)00057-3; Becchetti L, 2010, J DEV STUD, V46, P211, DOI 10.1080/00220380903002947; Becchetti L., 2012, 239 CEIS TOR VERG U; Bjornskov Christian, 2006, EUROPEAN J POLITICAL, V22, P22, DOI DOI 10.1016/J.EJPOLECO.2005.05.006; Carter H, 2013, INT J EMERGENCY SERV, V2, P29; Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7; Deshmukh Y., 2009, HIKMAH PEACE PWI IMP; Drury J., 2013, RESILIENCE INT POLIC, V1, P18; Drury J, 2013, J APPL SOC PSYCHOL, V43, P2259, DOI 10.1111/jasp.12176; Eisensee T, 2007, Q J ECON, V122, P693, DOI 10.1162/qjec.122.2.693; Goebel J., 2013, IZA DISCUSSION PAPER; Hammer J, 2011, NEWSWEEK, P28; Hanaoka C., 2014, DO RISK PREFERENCES; Helliwell JF, 2007, SOC INDIC RES, V81, P455, DOI 10.1007/s11205-006-0022-y; Helliwell J. F., 2011, INT J WELLBEING, V1, P42; Helliwell J. F., 2011, NEW DIRECTIONS INTEL, P283; Helliwell JF, 2014, J HAPPINESS STUD, V15, P145, DOI 10.1007/s10902-013-9441-z; Ishino T., 2011, KEIO KYOTO GLOBAL CO, VDP2011-38v; Kawachi I., 2007, SOCIAL CAPITAL HLTH; Kawachi I., 2013, CAN WE REDUCE DISPAR; Kuroki M, 2011, JPN ECON REV, V62, P444, DOI 10.1111/j.1468-5876.2011.00533.x; Kusago T, 2011, COMMUN QUAL LIFE IND, V3, P97, DOI 10.1007/978-94-007-0535-7_5; Matsutani M., 2011, JAPAN TIMES; Metcalfe R, 2011, ECON J, V121, pF81, DOI 10.1111/j.1468-0297.2010.02416.x; National Police Agency, 2014, DAM GREAT E JAP EART; Novelli D., 2013, PLOS ONE, V8, P1; Ono H., 2012, KEIZAI SEMINAR, V2-3, P75; Oswald AJ, 2008, J LEGAL STUD, V37, pS217; Powdthavee N., 2010, HAPPINESS EQUATION S; Powdthavee Nattavudh, 2008, J SOCIO-ECON, V37, P1459, DOI DOI 10.1016/J.SOCEC.2007.04.004; Putnam R., 2000, BOWLING ALONE COLLAP; Putnam RD, 1993, MAKING DEMOCRACY WOR; Ram R., 2009, J HAPPINESS STUD, V11, P409; Sawada Y, 2008, J MONEY CREDIT BANK, V40, P463, DOI 10.1111/j.1538-4616.2008.00122.x; Sawada Y, 2007, APPL ECON LETT, V14, P303, DOI 10.1080/13504850500447364; Skidmore M., 2012, CESIFO WORKING PAPER, V3905; Yamamura E., 2014, PAPERS REGI IN PRESS	57	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0303-8300	1573-0921		SOC INDIC RES	Soc. Indic. Res.	SEP	2015	123	3					919	935		10.1007/s11205-014-0767-7		17	Social Sciences, Interdisciplinary; Sociology	Social Sciences - Other Topics; Sociology	CP7OX	WOS:000360078700015		
J	Yamamura, E				Yamamura, Eiji			Comparison of Social Trust's effect on suicide ideation between urban and non-urban areas: The Case of Japanese Adults in 2006	SOCIAL SCIENCE & MEDICINE			English	Article						Social capital; Suicide ideation; Urban	INCOME INEQUALITY; SOCIOECONOMIC DETERMINANTS; PANEL-DATA; UNEMPLOYMENT; COUNTRIES; MORTALITY; HEALTH; DEPRESSION	An increasing number of studies have addressed the determinants of suicide. Social capital is a key factor in preventing suicide. However, little is known about the experience of suicide ideation using subjective values. From the viewpoint of suicide prevention, it is worth examining how people think of suicide. This paper attempts to examine the effect of social capital on suicide ideation. Furthermore, the paper compares the effect of social capital between urban and non-urban areas. In this paper, urban areas are equivalent to mega-cities with populations over one million. Non-urban areas are cities with populations of less than one million, towns and villages. Individual-level data from the Japanese General Social Surveys (JGSSs) are used. The survey, which was conducted in 2006, provides information about the subjective value of suicide ideation. The survey was answered by 1413 subjects with a mean age of 54.5. Of the subjects, 49% were male. Social trust is used to measure the degree of social capital, and the outcome of interest is suicide ideation within the past 5 years. After controlling for various factors, the major findings are that both individual-level social trust and social trust accumulated in one's residential administrative district reduce the probability that one will consider suicide. After dividing the sample into urban and non-urban residents, particularized trust plays a role in deterring suicide ideation in urban areas, while generalized trust plays a role in deterring suicide ideation in non-urban areas. The effect of each type of trust depends on its scarcity in residential areas. (C) 2015 Elsevier Ltd. All rights reserved.	Seinan Gakuin Univ, Dept Econ, Fukuoka 8148511, Japan	Yamamura, E (reprint author), Seinan Gakuin Univ, Dept Econ, 6-2-92 Sawaraku Fukuoka, Fukuoka 8148511, Japan.	yamaei@seinan-gu.ac.jp					ANDREWS JA, 1992, J AM ACAD CHILD PSY, V31, P655, DOI 10.1097/00004583-199207000-00012; Forsman AK, 2012, AGING MENT HEALTH, V16, P771, DOI 10.1080/13607863.2012.667784; Koo J, 2008, CONTEMP ECON POLICY, V26, P162, DOI 10.1111/j.1465-7287.2007.00042; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; Moscicki EK, 2001, CLIN NEUROSCI RES, V1, P310, DOI 10.1016/S1566-2772(01)00032-9; Leigh A, 2006, ECON REC, V82, P268, DOI 10.1111/j.1475-4932.2006.00339.x; Mohnen SM, 2011, SOC SCI MED, V72, P660, DOI 10.1016/j.socscimed.2010.12.004; Leigh A, 2007, J HEALTH ECON, V26, P1, DOI 10.1016/j.jhealeco.2006.07.003; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Fiorillo D, 2015, ECON HUM BIOL, V17, P129, DOI 10.1016/j.ehb.2015.02.004; Andres AR, 2005, APPL ECON, V37, P439, DOI 10.1080/0003684042000295304; Breuer C, 2015, HEALTH ECON, V24, P936, DOI 10.1002/hec.3073; Cao WM, 2015, AGING MENT HEALTH, V19, P418, DOI 10.1080/13607863.2014.948805; Chen J, 2009, JPN WORLD ECON, V21, P140, DOI 10.1016/j.japwor.2008.06.001; Durkheim E., 1951, SUICIDE STUDY SOCIOL; GARRISON CZ, 1993, AM J PUBLIC HEALTH, V83, P179, DOI 10.2105/AJPH.83.2.179; Andres AR, 2011, J SOCIO-ECON, V40, P723, DOI 10.1016/j.socec.2011.08.002; Henriksson M M, 1995, Int Psychogeriatr, V7, P275, DOI 10.1017/S1041610295002031; Hojo M., 2009, JAPANESE EC, V36, P3; Inagaki K, 2010, J APPL ECON, V13, P113; Japan Broadcasting Corporation, 1997, DAT BOOK SURV CONSC; Kunce M, 2002, URBAN STUD, V39, P155, DOI 10.1080/00420980220099131; Kuroki M., 2010, J SOCIO-ECON, V39, P683; Kuroki M, 2014, HEALTH ECON, V23, P1502, DOI 10.1002/hec.2988; Kuroki M, 2011, JPN ECON REV, V62, P444, DOI 10.1111/j.1468-5876.2011.00533.x; Leigh A, 2006, ECON LETT, V93, P121, DOI 10.1016/j.econlet.2006.04.003; Minoiu C., 2008, J SOCIO-ECON, V37, P237, DOI 10.1016/j.socec.2006.09.001; MOSCICKI EK, 1988, YALE J BIOL MED, V61, P259; Neumayer E., 2003, URBAN STUD, V40, P276; OECD, 2013, HLTHE GLANC 2013 IND; Okamoto M, 2013, ENVIRON HEALTH PREV, V18, P306, DOI 10.1007/s12199-012-0321-7; PLATT S, 1984, SOC SCI MED, V19, P93, DOI 10.1016/0277-9536(84)90276-4; Putnam R., 2000, BOWLING ALONE COLLAP; RICH CL, 1988, AM J PSYCHIAT, V145, P718; RICH CL, 1986, ARCH GEN PSYCHIAT, V43, P577; Okada K, 2013, J SOCIO-ECON, V45, P78, DOI 10.1016/j.socec.2013.04.009; Smith NDL, 2014, SOC SCI MED, V120, P269, DOI 10.1016/j.socscimed.2014.09.007; Sugano S, 2014, APPL ECON LETT, V21, P723, DOI 10.1080/13504851.2014.881960; Suzuki E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051717; Suzuki E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063443; Suzuki E, 2014, EUR J PUBLIC HEALTH, V24, P949, DOI 10.1093/eurpub/cku023; Uslaner E., 2002, MORAL FDN TRUST; Yamamura E, 2010, APPL ECON LETT, V17, P1009, DOI 10.1080/13504850802676199; Yamamura E, 2011, J SOCIO-ECON, V40, P475, DOI 10.1016/j.socec.2010.10.009; Yang B., 1992, J SOCIO-ECON, V21, P39, DOI 10.1016/1053-5357(92)90024-2; YANG BJ, 1995, APPL ECON LETT, V2, P278	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	SEP	2015	140						118	126		10.1016/j.socscimed.2015.07.001		9	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Biomedical Social Sciences	CP9ZE	WOS:000360253600013		
J	Al-Khudairi, N; Kobayashi, S; Meir, A				Al-Khudairi, Naji; Kobayashi, Shigeru; Meir, Adam			A case of symptomatic cervical spine calcinosis in systemic sclerosis	SPINE JOURNAL			English	Editorial Material									[Al-Khudairi, Naji; Meir, Adam] UCL, Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, London WC1N 3BG, England; [Kobayashi, Shigeru] Univ Fukui, Dept Spine Surg, Eiheiji, Fukui, Japan	Al-Khudairi, N (reprint author), UCL, Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Queen Sq, London WC1N 3BG, England.						Ogawa T, 2009, ANN RHEUM DIS, V68, P1655, DOI 10.1136/ard.2008.104216; Smucker JD, 2006, SPINE, V31, P2002, DOI 10.1097/01.brs.0000229260.67357.53	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	SEP 1	2015	15	9					2099	2100		10.1016/j.spinee.2015.04.042		2	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CP7RX	WOS:000360086800027		
J	Wakeling, C				Wakeling, Corey			"Only Her Mouth Could Move" Sensory Deprivation and the Billie Whitelaw Plays	TDR-THE DRAMA REVIEW-THE JOURNAL OF PERFORMANCE STUDIES			English	Article							BECKETT,SAMUEL; BODY		Kobe Coll, Drama, Kobe, Hyogo, Japan	Wakeling, C (reprint author), Kobe Coll, Drama, Kobe, Hyogo, Japan.	wakeling@mail.kobe-c.ac.jp					Ackerley Chris J., 2004, GROVE COMPANION S BE; Artaud Antonin, 1985, THEATRE ITS DOUBLE; Badiou Alain, 2003, ON BECKETT; Beckett Samuel, 1965, 3 NOVELS MOLLOY MALO; Beckett Samuel, 2006, COMPLETE DRAMATIC WO; Beckett Samuel, 1999, THEATRICAL NOTEBOOKS, VIV; Campbell J, 2001, SAM BECKETT TODAY, V11, P454; Cioran E.M., 1979, S BECKETT CRITICAL H, P334; Connor Steven, 1988, S BECKETT REPETITION; Deleuze Gilles, 1995, SUBSTANCE, VXXIV.3, P3, DOI 10.2307/3685005; Dwan Lisa, 2013, BBC NEWS; Esslin Martin, 1980, MEDIATIONS ESSAYS BR; GARNER SB, 1993, THEATRE J, V45, P443, DOI 10.2307/3209015; Gontarski S.E., 1999, THEATRICAL NOTEBOOKS, VIV, pxv; Gontarski SE, 2001, SAM BECKETT TODAY, V11, P169; Graver Lawrence, 1979, S BECKETT CRITICAL H; Harmon Maurice, 1998, AUTHOR BETTER SERVED; KLAVER E, 1991, CONTEMP LITERATURE, V32, P366, DOI 10.2307/1208562; Knowlson Elizabeth, 2006, BECKETT REMEMBERING; Lehmann H. T., 2006, POSTDRAMATIC THEATRE; Massumi Brian, 2002, PARABLES VIRTUAL; Maude Ulrika, 2002, BECKETT PHILOS, P108; McMullan Anna, 2010, PERFORMING EMBODIMEN; Phelan P, 2004, PMLA, V119, P1279, DOI 10.1632/003081204X17842; Ranciere J., 2013, AISTHESIS SCENES AES; Uhlmann Anthony, 2006, BECKETT BECKETT, P79; Whitelaw Billie, 1995, B WHITELAW WHO HE; Worth Katharine, 1978, IRISH DRAMA EUROPE Y; Worth Katharine, 1999, S BECKETT LIFE JOURN; Zilliacus Clas, 1976, BECKETT BROADCASTING; Zoe Ingalls, 1992, CHRON HIGHER EDUC, V38, pB5	31	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	1054-2043	1531-4715		TDR-DRAMA REV-J PERF	TDR-Drama Rev.-J. Perform. Stud.	FAL	2015	59	3					91	107				17	Theater	Theater	CQ0VJ	WOS:000360315500008		
J	Kato, H; Marcelo, CL; Washington, JB; Bingham, EL; Feinberg, SE				Kato, Hiroko; Marcelo, Cynthia L.; Washington, James B.; Bingham, Eve L.; Feinberg, Stephen E.			Fabrication of Large Size Ex Vivo-Produced Oral Mucosal Equivalents for Clinical Application	TISSUE ENGINEERING PART C-METHODS			English	Article							ORGANOTYPIC CULTURE; PORE-SIZE; KERATINOCYTES; SKIN; DIFFERENTIATION; CONJUNCTIVA	The soft tissue reconstruction of significant avulsed and/or surgically created tissue defects requires the ability to manufacture substantial soft tissue constructs for repair of the resulting wounds. In this study, we detail the issues that need to be addressed in upsizing the manufacture of larger tissue-engineered devices (ex vivo-produced oral mucosa equivalent [EVPOME]) in vitro from a methodology previously used for smaller constructs. The larger-sized EVPOME, consisting of autologous human oral keratinocytes and a dermal substitute, AlloDerm((R)), was fabricated for the purpose of reconstructing large clinical defects. Regulated as an autologous somatic cell therapy product, the fabrication process abided by current Good Manufacturing Practices and current Good Tissue Practices as required by the Center for Biologics Evaluation and Research (CBER) of the United States Food and Drug Administration (FDA). Successful fabrication of large EVPOMEs utilized a higher cell seeding density (5.3x10(5) cells/cm(2)) with a relatively thinner AlloDerm, ranging from 356.6 to 508.0 mu m in thickness. During the air-liquid interface culture, the thickness of the scaffold affected the medium diffusion rate, which, in turn, resulted in changes of epithelial stratification. Histologically, keratinocyte progenitor (p63), proliferation (Ki-67), and late differentiation marker (filaggrin) expression showed differences correlating with the expression of glucose transporter-1 (GLUT1) in the EVPOMEs from the thickest (550-1020 mu m) to the thinnest (228.6-330.2 mu m) AlloDerm scaffold. Glucose consumption and 2-deoxyglucose (2DG) uptake showed direct correlation with scaffold thickness. The scaffold size and thickness have an impact on the cellular phenotype and epithelial maturation in the manufacturing process of the EVPOME due to the glucose accessibility influenced by the diffusion rate. These outcomes provide basic strategies to manufacture a large-sized, healthy EVPOME graft for reconstructing large mucosa defects.	[Kato, Hiroko; Marcelo, Cynthia L.; Washington, James B.; Bingham, Eve L.; Feinberg, Stephen E.] Univ Michigan Hlth Syst, Dept Oral & Maxillofacial Surg, Ann Arbor, MI 48109 USA; [Kato, Hiroko] Niigata Univ, Postgrad Sch Med & Dent Sci, Dept Biomimet, Course Oral Life Sci, Niigata, Japan	Feinberg, SE (reprint author), Univ Michigan Hlth Syst, Dept Oral & Maxillofacial Surg, Towsley Ctr Rm G1114,1515 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	sefein@med.umich.edu			Department of Defense [W81XWH-08-2-0034]	The authors thank Dr. Shiuhyang Kuo for his technical assistance and critical comments and the Department of Defense for providing the funding for this investigation through a subcontract to the University of Michigan from Rutgers, The State University of New Jersey: AFIRM I Contract No. W81XWH-08-2-0034.	Yoshizawa M, 2004, J ORAL MAXIL SURG, V62, P980, DOI 10.1016/j.joms.2004.02.010; Izumi K, 2003, INT J ORAL MAX SURG, V32, P188, DOI 10.1054/ijom.2002.0365; Kato H, 2013, HISTOCHEM CELL BIOL, V139, P847, DOI 10.1007/s00418-012-1064-7; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Moharamzadeh K, 2012, J DENT RES, V91, P642, DOI 10.1177/0022034511435702; Spravchikov N, 2001, DIABETES, V50, P1627, DOI 10.2337/diabetes.50.7.1627; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Izumi K, 2004, CELLS TISSUES ORGANS, V176, P134, DOI 10.1159/000075034; Moharamzadeh K, 2007, J DENT RES, V86, P115; Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.TEB.2012.0437, 10.1089/ten.teb.2012.0437]; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Xu Q, 2009, J ORAL MAXIL SURG, V67, P1256, DOI 10.1016/j.joms.2009.02.003; Sahota PS, 2003, WOUND REPAIR REGEN, V11, P275, DOI 10.1046/j.1524-475X.2003.11407.x; Eiselt P, 1998, BIOTECHNOL PROGR, V14, P134, DOI 10.1021/bp970135h; Freinkel R. K., 1991, BIOCH PHYSL SKIN, V2nd, P452; GHERZI R, 1991, EXP CELL RES, V195, P230, DOI 10.1016/0014-4827(91)90522-V; Hillerup S., 1993, ORAL MAXILLOFAC SURG, V5, P557; Izumi K., 2014, STEM CELL BIOL TISSU, P721; Izumi K, 2013, INT J ORAL MAX IMPL, V28, pE295, DOI 10.11607/jomi.te11; Izumi K, 1999, J ORAL MAXIL SURG, V57, P571, DOI 10.1016/S0278-2391(99)90077-0; Kinney MA, 2014, ANN BIOMED ENG, V42, P352, DOI 10.1007/s10439-013-0953-9; Kuroki S., 2009, KOBE J MED SCI, V5, pE5; Pappinen S, 2007, EUR J PHARM SCI, V30, P240, DOI 10.1016/j.ejps.2006.11.013; POGREL MA, 1985, ORAL SURG ORAL MED O, V60, P598, DOI 10.1016/0030-4220(85)90358-5; Terashi Hiroto, 2005, Int Wound J, V2, P298, DOI 10.1111/j.1742-4801.2005.00148.x; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809	29	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	SEP 1	2015	21	9					872	880		10.1089/ten.tec.2014.0600		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CQ1VB	WOS:000360387200002		
J	Kamo, M; Yokomizo, H				Kamo, Masashi; Yokomizo, Hiroyuki			Explanation of non-additive effects in mixtures of similar mode of action chemicals	TOXICOLOGY			English	Article						Risk assessment; Chemical mixture; Synergism; Antagonism; Mode of action	BIOTIC LIGAND MODEL; RISK-ASSESSMENT; TOXICITY; COMBINATION; TOXICOLOGY; SYNERGY; ANTAGONISM; GUIDELINES; FRAMEWORK; POLICY	Many models have been developed to predict the combined effect of drugs and chemicals. Most models are classified into two additive models: independent action (IA) and concentration addition (CA). It is generally considered if the modes of action of chemicals are similar then the combined effect obeys CA; however, many empirical studies report nonlinear effects deviating from the predictions by CA. Such deviations are termed synergism and antagonism. Synergism, which leads to a stronger toxicity, requires more careful management, and hence it is important to understand how and which combinations of chemicals lead to synergism. In this paper, three types of chemical reactions are mathematically modeled and the cause of the nonlinear effects among chemicals with similar modes of action was investigated. Our results show that combined effects obey CA only when the modes of action are exactly the same. Contrary to existing knowledge, combined effects are generally nonlinear even if the modes of action of the chemicals are similar. Our results further show that the nonlinear effects vanish out when the chemical concentrations are low, suggesting that the current management procedure of assuming CA is rarely inappropriate because environmental concentrations of chemicals are generally low. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kamo, Masashi] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki 3058569, Japan; [Yokomizo, Hiroyuki] Natl Inst Environm Studies, Ctr Environm Risk Res, Tsukuba, Ibaraki 3058506, Japan	Kamo, M (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	masashi-kamo@aist.go.jp	Kamo, Masashi/C-6049-2015; Yokomizo, Hiroyuki/A-4276-2011	Kamo, Masashi/0000-0002-6972-3333; Yokomizo, Hiroyuki/0000-0001-9814-8465			BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Feron VJ, 2002, FOOD CHEM TOXICOL, V40, P825, DOI 10.1016/S0278-6915(02)00021-2; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Meyer JS, 1999, ENVIRON SCI TECHNOL, V33, P913, DOI 10.1021/es980715q; Meek ME, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2011.03.010; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Boobis A, 2011, CRIT REV TOXICOL, V41, P369, DOI 10.3109/10408444.2010.543655; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Silva E, 2002, ENVIRON SCI TECHNOL, V36, P1751, DOI 10.1021/es0101227; BERENBAUM MC, 1977, CLIN EXP IMMUNOL, V28, P1; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; McCarty LS, 2006, REGUL TOXICOL PHARM, V45, P119, DOI 10.1016/j.yrtph.2006.03.004; Jonker DM, 2005, PHARMACOL THERAPEUT, V106, P1, DOI 10.1016/j.pharmthera.2004.10.014; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Paquin PR, 2002, COMP BIOCHEM PHYS C, V133, P3, DOI 10.1016/S1532-0456(02)00112-6; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Teuschler LK, 1995, TOXICOLOGY, V105, P137, DOI 10.1016/0300-483X(95)03207-V; [Anonymous], 2011, INT WORKSH RISK ASS, P10; Feron VJ, 1995, TOXICOLOGY, V105, P415, DOI 10.1016/0300-483X(95)03239-C; BERENBAUM MC, 1985, J THEOR BIOL, V114, P413, DOI 10.1016/S0022-5193(85)80176-4; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Cedergreen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096580; den Berg M.V., 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.2307/3434121; European Commission, 2012, TOX ASS CHEM MIXT; Farley KJ, 2015, ENVIRON TOXICOL CHEM, V34, P741, DOI 10.1002/etc.2820; GRECO WR, 1995, PHARMACOL REV, V47, P331; Groten JP, 2001, TRENDS PHARMACOL SCI, V22, P316, DOI 10.1016/S0165-6147(00)01720-X; Iwasaki Y, 2015, TOXICOLOGY, V34, P754; Kamo M., 2008, ENVIRON TOXICOL CHEM, V27, P1487; Kim J, 2014, HUM ECOL RISK ASSESS, V20, P174, DOI 10.1080/10807039.2012.754312; KODELL RL, 1991, RISK ANAL, V11, P483, DOI 10.1111/j.1539-6924.1991.tb00633.x; Konemann WH, 1996, FOOD CHEM TOXICOL, V34, P1025, DOI 10.1016/S0278-6915(97)00070-7; Kortenkamp A., 2009, STATE ART REPORT MIX; Meyer JS, 2015, TOXICOLOGY, V34, P799; OECD, 2012, ADV OUTC PATHW MOL S; Plackett R.L., 1952, J ROYAL STAT SOC B, V14, P143; Safe SH, 1998, ENVIRON HEALTH PERSP, V106, P1051, DOI 10.2307/3434151; Tian DY, 2012, CHEMOSPHERE, V88, P994, DOI 10.1016/j.chemosphere.2012.03.043; USEPA, 2002, GUID CUM RISK ASS PE; USEPA, 2003, FRAM CUM RISK ASS	41	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-483X			TOXICOLOGY	Toxicology	SEP 1	2015	335						20	26		10.1016/j.tox.2015.06.008		7	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CQ3QM	WOS:000360517600003		
J	Furuya, M; Funasaki, M; Tani, H; Sasai, K				Furuya, M.; Funasaki, M.; Tani, H.; Sasai, K.			Identification of novel tumour-associated antigens in canine mammary gland tumour	VETERINARY AND COMPARATIVE ONCOLOGY			English	Article						canine; immunoscreening; mammary gland tumour; serology; tumour-associated antigen	RENAL-CELL CARCINOMA; MALIGNANT-MELANOMA; LEUKOCYTE ANTIGEN; BREAST-CANCER; DOGS; EXPRESSION; RECEPTOR; RECOGNITION; VACCINATION; PROGNOSIS	Canine mammary gland tumour (MGT) is the most common neoplasm in female dogs and has similar biological characteristics to human MGT. Spontaneous canine MGT is a more attractive clinical model in oncological research than that of the murine experimental model. Tumour-associated antigens (TAAs), which are produced in tumour cells, are applied as tumour markers, tumour vaccine antigens and molecular targets of therapeutic drugs. In this study, we have primarily identified 13 different TAAs of canine MGT by serological immunoscreening of cDNA expression library. The results of serological mini-arrays of identified antigens showed that CCDC41 antigen specially reacted with 35% of sera from MGT-dogs and did not react with control sera. We also found that HSPH1 mRNA expression levels increased significantly in MGT tissues. These findings will contribute to the development of diagnostic technologies and translational target therapies for dogs. Clinical relevance: HSPH1, which is strongly expressed in the tumour tissue, will be a possible vaccine antigen of canine MGT.	[Furuya, M.; Funasaki, M.; Tani, H.; Sasai, K.] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Dept Vet Internal Med, Izumisano, Osaka 5988531, Japan	Furuya, M (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Dept Vet Internal Med, 1-58 Rinku Ourai Kita, Izumisano, Osaka 5988531, Japan.	furuya@vet.osakafu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (to K. S.). We also thank the efforts of veterinarians who provided serum and tissue samples (Hirano Animal Hospital, Matsuoka Animal Hospital, Tani Animal Hospital).	Alexander AN, 2006, CANCER IMMUNOL IMMUN, V55, P433, DOI 10.1007/s00262-005-0025-6; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; Keshaviah A, 2007, ANN ONCOL, V18, P701, DOI 10.1093/annonc/mdl492; Bergman PJ, 2003, CLIN CANCER RES, V9, P1284; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Winiarczyk S, 2002, J MOL MED-JMM, V80, P610, DOI 10.1007/s00109-002-0356-0; Yamshchikov GV, 2005, J IMMUNOL, V174, P6863; Scanlan MJ, 2002, CANCER RES, V62, P4041; Gobar GM, 1998, J AM VET MED ASSOC, V213, P251; London CA, 2003, CLIN CANCER RES, V9, P2755; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Kai M, 2003, ONCOL REP, V10, P1777; Visonneau S, 1999, ONCOL REP, V6, P1181; Facoetti A, 2005, CLIN CANCER RES, V11, P8304, DOI 10.1158/1078-0432.CCR-04-2588; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; Moravcikova E, 2012, INT J ONCOL, V40, P2111, DOI 10.3892/ijo.2012.1397; Maeurer MJ, 1996, J CLIN INVEST, V98, P1633, DOI 10.1172/JCI118958; Tureci O, 1998, P NATL ACAD SCI USA, V95, P5211, DOI 10.1073/pnas.95.9.5211; Lagarkova MA, 2003, IMMUNOL LETT, V85, P71, DOI 10.1016/S0165-2478(02)00209-2; Zappasodi R, 2011, BLOOD, V118, P4421, DOI 10.1182/blood-2011-06-364570; BRONSON RT, 1982, AM J VET RES, V43, P2057; Gyorffy S, 2005, J VET INTERN MED, V19, P56, DOI 10.1892/0891-6640(2005)19<56:BMDCVO>2.0.CO;2; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Yamagishi N, 2008, FEBS J, V275, P4558, DOI 10.1111/j.1742-4658.2008.06598.x; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Ayyoub M, 2002, J IMMUNOL, V168, P1717; Brody RS, 1985, J AM ANIM HOSP ASSOC, V19, P61; Devitt G, 2006, INT J CANCER, V118, P2210, DOI 10.1002/ijc.21626; Ding WQ, 2002, CANCER RES, V62, P947; Domae S, 2009, INT J CANCER, V124, P2347, DOI 10.1002/ijc.24220; Hogge GS, 2001, SMALL ANIMAL CLIN ON, V3rd, P138; Ishihara K, 2003, J BIOL CHEM, V278, P25143, DOI 10.1074/jbc.M302975200; IWASE H, 1995, BREAST CANCER RES TR, V33, P83, DOI 10.1007/BF00666074; Misdorp W, 2003, TUMORS DOMESTIC ANIM, V4th, P575; Nakatsura T, 2001, BIOCH BIOPHYSICAL RE, V2001, P281; Philibert JC, 2003, J VET INTERN MED, V17, P102, DOI 10.1892/0891-6640(2003)017<0102:IOHFOS>2.3.CO;2; Rutteman GR, 2000, SMALL ANIMAL CLIN ON, P450; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.3.CO;2-X; Smith HA, 2010, CLIN DEV IMMUNOL, V2010; Stefan E, 2001, P NATL ACAD SCI USA, V98, P629; Yamada K, 2001, BIOCHEM BIOPH RES CO, V280, P1169, DOI 10.1006/bbrc.2001.4189; Yamagami T, 1996, J VET MED SCI, V58, P1079; YASUDA K, 1995, J BIOL CHEM, V270, P29718	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1476-5810	1476-5829		VET COMP ONCOL	Vet. Comp. Oncol.	SEP	2015	13	3					194	202		10.1111/vco.12034		9	Veterinary Sciences	Veterinary Sciences	CP9KP	WOS:000360213300005		
J	Abou Asa, S; Mori, T; Maruo, K; Khater, A; El-sawak, A; el-Aziz, EA; Yanai, T; Sakai, H				Abou Asa, S.; Mori, T.; Maruo, K.; Khater, A.; El-sawak, A.; el-Aziz, E. Abd; Yanai, T.; Sakai, H.			Analysis of genomic mutation and immunohistochemistry of platelet-derived growth factor receptors in canine vascular tumours	VETERINARY AND COMPARATIVE ONCOLOGY			English	Article						dog; hemangioma; hemangiosarcoma; immunohistochemistry; mutation; PDGFR	GASTROINTESTINAL STROMAL TUMORS; C-KIT; IMATINIB MESYLATE; TYROSINE KINASE; ACTIVATING MUTATIONS; PDGF RECEPTORS; OVARIAN-CANCER; CELL-LINE; EXPRESSION; CARCINOMA	We examined whether mutation of the platelet-derived growth factor receptor protein tyrosine kinase (PDGFR)- and PDGFR- genes contributes to their overexpression in canine vascular tumours. Genomic sequences of trans- or juxtamembrane regions of PDGFR- and PDGFR- were analysed with immunohistochemical staining and polymerase chain reaction-direct sequencing using DNA from paraffin-embedded neoplastic tissues of 27 hemangiosarcomas (HSAs) and 20 hemangiomas (HAs). Immunohistochemically, 75% of the HA cases were positive for PDGFR- and almost most of the HA cases were negative for PDGFR-. Of the HSA cases, 55.6% were negative for PDGFR- and 63% were strongly positive for PDGFR-. Among the HA cases, 1 missense mutation was detected in PDGFR- exon 18 and 1 in PDGFR- exon 17. Two HSA cases had missense mutations in exon 14 and 1 in exon 17 of PDGFR-. Thus, genomic mutation of trans- or juxtamembrane regions of PDGFRs was not the main mechanism driving the activation of receptors in HSA and HA.	[Abou Asa, S.; El-sawak, A.; Sakai, H.] Gifu Univ, Dept Vet Med, Lab Vet Pathol, Gifu 5011193, Japan; [Mori, T.; Maruo, K.] Gifu Univ, Dept Vet Med, Lab Clin Oncol, Gifu 5011193, Japan; [Mori, T.; Maruo, K.; Sakai, H.] Gifu Univ, Fac Appl Biol Sci, Comparat Canc Ctr, Gifu 5011193, Japan; [Abou Asa, S.; Khater, A.; el-Aziz, E. Abd] Fac Vet Med, Dept Vet Pathol, Kafr Al Sheikh, Egypt	Sakai, H (reprint author), Gifu Univ, Fac Appl Biol Sci, Dept Vet Med, Lab Vet Pathol, 1-1 Yanagido, Gifu 5011193, Japan.	shiroki@gifu-u.ac.jp			Japan Society for the Promotion of Science [23580439]	We appreciate Dr. Atsuko Murai and Dr. Mami Murakami for their suggestions and support with some experiments. This study was supported by Grants-in-Aid for Scientific Research (C) Grant No. 23580439 from the Japan Society for the Promotion of Science.	Abou Asa S, 2012, HISTOL HISTOPATHOL, V27, P601; Mao X, 2000, CANCER GENET CYTOGEN, V122, P87, DOI 10.1016/S0165-4608(00)00278-8; Rossi G, 2005, J CLIN ONCOL, V23, P8774, DOI 10.1200/JCO.2005.02.8233; HENRIKSEN R, 1993, CANCER RES, V53, P4550; Longley BJ, 2001, LEUKEMIA RES, V25, P571, DOI 10.1016/S0145-2126(01)00028-5; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; Kindler T, 2004, BLOOD, V103, P3644, DOI 10.1182/blood-2003-06-2071; Heldin CH, 1999, PHYSIOL REV, V79, P1283; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Pietras K, 2004, SEMIN ONCOL, V31, P18, DOI 10.1053/j.seminoncol.2004.03.036; Cohen SM, 2009, TOXICOL SCI, V111, P4, DOI 10.1093/toxsci/kfp131; COLTRERA MD, 1995, CANCER RES, V55, P2703; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Kubo T, 2008, CANCER, V112, P2119, DOI 10.1002/cncr.23437; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S001-5085(03)01046-1; Tamborini E, 2006, CLIN CANCER RES, V12, P6920, DOI 10.1158/1078-0432.CCR-06-1584; Yonemori K, 2011, ANN SURG ONCOL, V18, P2841, DOI 10.1245/s10434-011-1640-4; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Apte SM, 2004, GYNECOL ONCOL, V93, P78, DOI 10.1016/j.ygyno.2003.12.041; BETSHOLTZ C, 1984, CELL, V39, P447, DOI 10.1016/0092-8674(84)90452-5; Black P, 1996, PEDIATR NEUROSURG, V24, P74, DOI 10.1159/000121020; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Grone A, 1999, J VET MED B, V46, P301, DOI 10.1046/j.1439-0442.1999.00219.x; Lasota J, 1999, AM J PATHOL, V154, P53, DOI 10.1016/S0002-9440(10)65250-9; Liegl B, 2006, HISTOPATHOLOGY, V49, P576, DOI 10.1111/j.1365-2559.2006.02562.x; Matei D, 2004, CLIN CANCER RES, V10, P681, DOI 10.1158/1078-0432.CCR-0754-03; Mayer TJ, 2000, IN VITRO CELL DEV-AN, V36, P667; Oda Yoshinao, 1995, General and Diagnostic Pathology, V141, P97; Schmandt RE, 2003, CANCER, V98, P758, DOI 10.1002/cncr.11561; Sihto H, 2005, J CLIN ONCOL, V23, P49, DOI 10.1200/JCO.2005.02.093; Taja-Chayeb L, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-22; Weiss SW, 2008, ENZINGER WEISSS SOFT, V5th, P703; Yang SY, 2001, J CLIN NEUROSCI, V8, P49, DOI 10.1054/jocn.2001.0877	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1476-5810	1476-5829		VET COMP ONCOL	Vet. Comp. Oncol.	SEP	2015	13	3					237	245		10.1111/vco.12035		9	Veterinary Sciences	Veterinary Sciences	CP9KP	WOS:000360213300009		
J	Yamazaki, H; Takagi, S; Hosoya, K; Okumura, M				Yamazaki, Hiroki; Takagi, Satoshi; Hosoya, Kenji; Okumura, Masahiro			Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells	VETERINARY JOURNAL			English	Article						Chemoresistance; Dog; Histiocytic sarcoma; Survivin; YM155	SMALL-MOLECULE SUPPRESSOR; PHASE-II; MULTIDRUG-RESISTANCE; CANCER CELLS; LUNG-CANCER; EXPRESSION; DOGS; OVEREXPRESSION; TRANSCRIPTION; OSTEOSARCOMA	Histiocytic sarcoma (HS) in dogs exhibits aggressive biological behaviors and currently few effective treatments are available. Survivin could serve as a potential therapeutic target in several cancers. Sepantronium bromide (YM155) is a potential novel survivin-targeting agent and in this study the influence of survivin expression on clinical outcomes and the effects of YM155 on biological activities in HS cells were investigated. Specimens of HS dogs (n = 30) and four canine HS cell lines were used. The correlation between survivin expression and clinical outcome in the HS dogs was retrospectively assessed using quantitative PCR. Following YM155 treatment of cell lines, apoptosis, cell viability, and drug transporter activities were evaluated using annexin V staining, methylthiazole tetrazolium assays, and Hoechst-33342 staining, respectively. Elevated survivin expression in the HS dogs corresponded with reduced disease-free intervals and survival time, and increased chemoresistance, which led to poor clinical outcomes. Furthermore, YM155 treatment suppressed cell-growth and resistance to lomustine in HS cells by inhibiting the activity of ATP-binding cassette transporters. The evidence presented here supports favorable preclinical evaluation and indicates that survivin-targeted therapies might be effective against HS dogs. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamazaki, Hiroki; Hosoya, Kenji; Okumura, Masahiro] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Surg,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Yamazaki, Hiroki] Kagoshima Univ, Joint Fac Vet Med, Vet Teaching Hosp, Kagoshima, Kagoshima 8900065, Japan; [Takagi, Satoshi] Hokkaido Univ, Grad Sch Vet Med, Vet Teaching Hosp, Kita Ku, Sapporo, Hokkaido 0600818, Japan	Takagi, S (reprint author), Hokkaido Univ, Grad Sch Vet Med, Vet Teaching Hosp, Kita Ku, N18 W9, Sapporo, Hokkaido 0600818, Japan.	staka@vetmed.hokudai.ac.jp					Iwai M, 2011, DRUG METAB DISPOS, V39, P2314, DOI 10.1124/dmd.111.040733; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Osaka E, 2006, ACTA HISTOCHEM CYTOC, V39, P95, DOI 10.1267/ahc.06005; Shoeneman JK, 2012, CANCER RES, V72, P249, DOI 10.1158/0008-5472.CAN-11-2315; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Nakagawa Y, 2006, AM J HEMATOL, V81, P824, DOI 10.1002/ajh.20656; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Liu F, 2010, ONCOL REP, V23, P1469, DOI 10.3892/or_00000786; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Rodel F, 2012, CURR MED CHEM, V19, P3679; Ke SZ, 2013, INT J ONCOL, V42, P1289, DOI 10.3892/ijo.2013.1805; Endoh T, 2005, EXP CELL RES, V305, P300, DOI 10.1016/j.yexcr.2004.12.014; Klahn SL, 2011, JAVMA-J AM VET MED A, V239, P90, DOI 10.2460/javma.239.1.90; Li J., 2013, EURASIP J ADV SIG PR, V2013, P1; Rassnick KM, 2010, J VET INTERN MED, V24, P1528, DOI 10.1111/j.1939-1676.2010.0588.x; Sela B, 2002, Harefuah, V141, P103; Wang Z., 2008, CANC THERAPY, V6, P603; Yamazaki H, 2014, J VET INTERN MED, V28, P204, DOI 10.1111/jvim.12244; Yamazaki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079810	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	SEP	2015	205	3					375	380		10.1016/j.tvjl.2015.05.003		6	Veterinary Sciences	Veterinary Sciences	CP9YN	WOS:000360251900010		
J	Vijai, D; Sakai, M; Sakurai, Y				Vijai, Dharmamony; Sakai, Mitsuo; Sakurai, Yasunori			Embryonic and paralarval development following artificial fertilization in the neon flying squid Ommastrephes bartramii	ZOOMORPHOLOGY			English	Article						Embryonic development; Paralarval development; Ommastrephids; Chorion expansion; Parthenogenesis; Oviducal gland	TODARODES PACIFICUS; LOLIGO-PEALEI; BLASTODISC FORMATION; ILLEX-ARGENTINUS; DOSIDICUS-GIGAS; OCEANIC SQUIDS; CEPHALOPODA; MICROTUBULES; TEMPERATURE; HATCHLINGS	Ommastrephidae are the most important commercial fishery group among cephalopods. However, little is known about their embryonic development. This article provides details of embryonic development observed in three ommastrephids: Ommastrephes bartramii, Sthenoteuthis oualaniensis, and Eucleoteuthis luminosa. All embryos were obtained through artificial fertilization conducted onboard the research vessel Kaiyo Maru during a cruise around the Hawaiian Islands in December 2013. The embryonic and paralarval stages of O. bartramii are explained in detail. The hatchling stages were compared between all three species, as well as with information on Illex argentinus hatchlings from the literature. The species-specific effects of the oviducal gland powder on chorion expansion were analyzed. The results indicated that the overall chemical nature of the oviducal gland was species specific, although the inducer of chorion expansion was the same across species. In addition, treatment with oviducal gland jelly induced partial parthenogenesis in the early stages of embryonic development through the expansion of the perivitelline space and blastodisc formation.	[Vijai, Dharmamony; Sakurai, Yasunori] Hokkaido Univ, Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Sakai, Mitsuo] Tohoku Natl Fisheries Res Inst, Hachinohe, Aomori 0310841, Japan	Vijai, D (reprint author), Hokkaido Univ, Sch Fisheries Sci, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	vijai@ec.hokudai.ac.jp			Hokkaido University; Fisheries Research Agency, Japan	We are grateful to the captain and crew of RV Kaiyo Maru, as well as to all cruise participants. We thank T. Wakabayashi and H.-K. Yoo for help with identifying embryonic organs. We offer our sincere thanks to Y. Kato, T. Wakabayashi, M. Naya, B. Nishizawa, and F. Tomonori for helping us with collecting mature female squids by hand jigging and for providing assistance with on-board experiments. The manuscript was greatly improved thanks to comments by Puneeta Pandey and John Bower of Hokkaido University. Special thanks go to Puneeta Pandey and Wendy Amaral for help with the drawings. This study was funded by Hokkaido University and the Fisheries Research Agency, Japan. We would like to thank two anonymous reviewers for their very useful comments and suggestions, which helped us improve the quality of our paper.	YAMAMOTO M, 1988, ZOOL SCI, V5, P989; Sakurai Y, 1996, AM MALACOL BULL, V13, P89; Vijai D, 2015, MAR ECOL PROG SER, V529, P145, DOI 10.3354/meps11286; Yatsu A, 1999, FISHERIES SCI, V65, P904; Staaf DJ, 2011, MAR ECOL PROG SER, V441, P165, DOI 10.3354/meps09389; SAKURAI Y, 1995, VELIGER, V38, P185; Watanabe K, 1996, AM MALACOL BULL, V13, P73; Sakai M, 1998, S AFR J MARINE SCI, V20, P255; Staaf DJ, 2008, J MAR BIOL ASSOC UK, V88, P759, DOI 10.1017/S0025315408001422; Arnold J.M., 1990, P77; ARNOLD JM, 1965, BIOL BULL, V128, P24, DOI 10.2307/1539386; Boletzky S. V., 1987, CEPHALOPOD LIFE CYCL, VII, P5; Boletzky SV, 2003, ADV MAR BIOL, V44, P143, DOI 10.1016/S0065-2881(03)44003-0; BOLETZKY SV, 1994, ANTARCT SCI, V6, P139; Boletsky S.v., 1989, Advances in Marine Biology, V25, P85, DOI 10.1016/S0065-2881(08)60188-1; Boletzky SV, 1998, OCEANOGR MAR BIOL AN, P341; Bonnaud-Ponticelli L, 2014, OA BIOL, V18, P6; Brooks WK, 1880, ANNIV MEM BOSTON SOC, P1; Crawford K, 2000, BIOL BULL, V199, P207, DOI 10.2307/1542901; CRAWFORD K, 1985, BIOL BULL, V169, P540; IKEDA Y, 1995, J MAR BIOL ASSOC UK, V75, P495; KAO KR, 1985, BIOL BULL, V169, P541; Laptikhovsky V, 1991, BIOL NAUKI, V3, P37; LEMAIRE J, 1970, Bulletin de la Societe Zoologique de France, V95, P773; Mangold K., 1983, CEPHALOPOD LIFE CYCL, VI, P335; Naef A, 1928, FAUNA FLORA GOLF NEA, V35, P1; O'DOR R K, 1982, Journal of Northwest Atlantic Fishery Science, V3, P41; O'Dor RK, 1982, N ATL FISH ORG SCI C, V82, P1; Roper C. F. E., 2010, FAO SPECIES CATALOGU, V2, P269; Saito Hiroaki, 1993, P457; Sakai M, 2011, JARQ-JPN AGR RES Q, V45, P301; Vijai D, 2014, SCI MAR, V78, P511, DOI 10.3989/scimar.04112.27B; Villanueva R, 2012, AQUACULTURE, V342, P125, DOI 10.1016/j.aquaculture.2012.02.025; Wakabayashi Toshie, 2002, Venus (Tokyo), V60, P237; Wakabayashi T, 2006, FISHERIES SCI, V72, P494, DOI 10.1111/j.1444-2906.2006.01177.x; YOUNG R E, 1990, Pacific Science, V44, P71; YOUNG RE, 1988, MALACOLOGIA, V29, P201	37	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0720-213X	1432-234X		ZOOMORPHOLOGY	Zoomorphology	SEP	2015	134	3					417	430		10.1007/s00435-015-0267-6		14	Anatomy & Morphology; Zoology	Anatomy & Morphology; Zoology	CQ3NN	WOS:000360509200005		
J	Matsunaga, K; Kubota, T; Toyoura, K; Nakamura, A				Matsunaga, Katsuyuki; Kubota, Tomonori; Toyoura, Kazuaki; Nakamura, Atsutomo			First-principles calculations of divalent substitution of Ca2+ in tricalcium phosphates	ACTA BIOMATERIALIA			English	Article						Electronic structure calculation; Thermodynamic stability; Calcium phosphate; Dopant	TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; CRYSTAL-STRUCTURE; POWDER DIFFRACTION; MG; SOLUBILITY; ZINC; REFINEMENT; ZN	First-principles calculations were carried out to reveal local atomic arrangements and thermodynamic stability of substitutional divalent cations of Mg2+, Zn2+, Sr2+ and Ba2+ in tricalcium phosphates (TCPs). There are two modifications of alpha-TCP and beta-TCP, and a number of inequivalent Ca sites are present in the crystal structures. It was found that each divalent cation has energetically preferential Ca sites for substitution. For instance, Mg2+ and Zn2+ favor the substitution at the Ca-5 site of beta-TCP while Sr2+ and Ba2+ tend to occupy Ca-3 and Ca-4 in the beta-type crystal structure. The calculated site preference of these cations was in reasonable agreement with available experimental data. Moreover, it was found that these cations have negative formation energies at specific Ca sites especially in beta-TCP, indicating the stabilization of the beta phase. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Matsunaga, Katsuyuki; Kubota, Tomonori; Toyoura, Kazuaki; Nakamura, Atsutomo] Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Matsunaga, Katsuyuki] Japan Fine Ceram Ctr, Nanostruct Res Lab, Atsuta Ku, Nagoya, Aichi 4568587, Japan	Matsunaga, K (reprint author), Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.				Japan Society for the Promotion of Science	This study was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science.	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; DICKENS B, 1974, J SOLID STATE CHEM, V10, P232, DOI 10.1016/0022-4596(74)90030-9; Kannan S, 2008, J AM CERAM SOC, V91, P1, DOI 10.1111/j.1551-2916.2007.02117.x; CALVO C, 1975, AM MINERAL, V60, P120; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; NORD AG, 1968, ACTA CHEM SCAND, V22, P1466, DOI 10.3891/acta.chem.scand.22-1466; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Ito A, 2002, J BIOMED MATER RES, V60, P224, DOI 10.1002/jbm.10068; Bigi A, 1997, J INORG BIOCHEM, V66, P259, DOI 10.1016/S0162-0134(96)00219-X; Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5; MATHEW M, 1977, ACTA CRYSTALLOGR B, V33, P1325, DOI 10.1107/S0567740877006037; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Liang L, 2010, ACTA BIOMATER, V6, P3763, DOI 10.1016/j.actbio.2010.03.033; Tardei C, 2006, J OPTOELECTRON ADV M, V8, P568; Li X, 2009, ACTA BIOMATER, V5, P508, DOI 10.1016/j.actbio.2008.06.010; Xue WC, 2008, J MATER SCI-MATER M, V19, P2669, DOI 10.1007/s10856-008-3395-4; Yashima M, 2003, J SOLID STATE CHEM, V175, P272, DOI 10.1016/S0022-4596(03)00279-2; Momma K, 2008, J APPL CRYSTALLOGR, V41, P653, DOI 10.1107/S0021889808012016; Yin XL, 2002, BIOMATERIALS, V23, P4155, DOI 10.1016/S0142-9612(02)00199-0; BIGI A, 1988, J INORG BIOCHEM, V34, P75, DOI 10.1016/0162-0134(88)85019-0; Bigi A, 1996, Z KRISTALLOGR, V211, P13, DOI 10.1524/zkri.1996.211.1.13; STEPHENS JS, 1967, CAN J CHEMISTRY, V45, P2303, DOI 10.1139/v67-404; Chase M.W., 1998, NIST JANAF THERMOCHE; CunetTas A., 2007, MAT SCI ENG C, V27, P394, DOI 10.1016/j.msec.2006.05.051; Drozhkin S. V., 2007, J MATER SCI, V42, P1061; Elliott J. C., 1994, STRUCTURE CHEM APATI; Endrele R., 2005, BIOMATERIALS, V26, P3379; Matsunaga K, 2010, J AM CERAM SOC, V93, P1, DOI 10.1111/j.1551-2916.2009.03485.x; Matsunaga K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094101; Matsunaga K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014102; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sugiyama K, 1990, MINERAL J, V15, P141, DOI 10.2465/minerj.15.141; Yashima M, 2007, CHEM MATER, V19, P3973, DOI 10.1021/cm070963y; Yin XL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1829995; Yin XL, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.205205; ZACHARIASEN WH, 1948, ACTA CRYSTALLOGR, V1, P263, DOI 10.1107/S0365110X48000697	36	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	SEP 1	2015	23						329	337		10.1016/j.actbio.2015.05.014		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CP5ZL	WOS:000359964000030		
J	Nagm, A; Horiuchi, T; Ichinose, S; Hongo, K				Nagm, Alhusain; Horiuchi, Tetsuyoshi; Ichinose, Shunsuke; Hongo, Kazuhiro			Unique double recurrence of cerebral arteriovenous malformation	ACTA NEUROCHIRURGICA			English	Article						Arteriovenous malformation; Recurrence; Adult; De novo AVM	OF-THE-LITERATURE; SURGICAL EXCISION; CLINICAL ARTICLE; CHILDREN; BRAIN; ADULT; EXPERIENCE; RESECTION; SURGERY	Surgically treated patients with arteriovenous malformations (AVMs) are considered cured when the postoperative angiogram proves complete resection. However, despite no residual nidus or early draining vein on postoperative angiogram, rare instances of AVM recurrence have been reported in adults. In this paper, the authors present a case of a 24-year-old woman with asymptomatic double recurrence of her cerebral AVM after angiographically proven complete resection. To the authors' knowledge, this patient represents the first case with double de novo asymptomatic recurrence of Spetzler-Martin grade I AVM. Also, she represents the first case with unique AVM criteria in each recurrence.	[Nagm, Alhusain; Horiuchi, Tetsuyoshi; Ichinose, Shunsuke; Hongo, Kazuhiro] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 3908621, Japan; [Nagm, Alhusain] Al Azhar Univ, Fac Med Nasr City, Dept Neurosurg, Cairo, Egypt	Nagm, A (reprint author), Shinshu Univ, Sch Med, Dept Neurosurg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	nagm@shinshu-u.ac.jp					Akimoto H, 2003, NEUROSURGERY, V52, P228, DOI 10.1227/NEU.0000039352.37132.0D; Andaluz N, 2004, SURG NEUROL, V62, P324, DOI 10.1016/j.surneu.2003.11.030; Klimo P, 2007, CHILD NERV SYST, V23, P31, DOI 10.1007/s00381-006-0245-x; Morgan MK, 2012, J NEUROSURG, V117, P934, DOI 10.3171/2012.8.JNS12351; HERNESNIEMI J, 1990, SURG NEUROL, V33, P384, DOI 10.1016/0090-3019(90)90149-J; Kader A, 1996, J NEUROSURG, V85, P14, DOI 10.3171/jns.1996.85.1.0014; Alvarez H, 2012, J NEUROSURG-PEDIATR, V9, P327, DOI 10.3171/2011.12.PEDS11312; Ali MJ, 2003, PEDIATR NEUROSURG, V39, P32, DOI 10.1159/000070878; HLADKY JP, 1994, CHILD NERV SYST, V10, P328, DOI 10.1007/BF00335172; Freudenstein D, 2001, CEREBROVASC DIS, V11, P59, DOI 10.1159/000047612; Bradac O, 2010, CENT EUR NEUROSURG, V71, P92, DOI 10.1055/s-0029-1220937; Bristol RE, 2006, J NEUROSURG, V105, P88, DOI 10.3171/ped.2006.105.2.88; Codd PJ, 2008, J NEUROSURG, V109, P486, DOI 10.3171/JNS/2008/109/9/0486; Davidson AS, 2010, NEUROSURGERY, V66, P498, DOI 10.1227/01.NEU.0000365518.47684.98; FUWA I, 1988, Neurological Surgery, V16, P887; Gabriel EM, 1996, J NEUROSURG, V84, P879, DOI 10.3171/jns.1996.84.5.0879; Hashimoto N, 1999, CRIT REV NEUROSURG, V9, P141, DOI 10.1007/s003290050123; Hino A, 1999, SURG NEUROL, V52, P156, DOI 10.1016/S0090-3019(99)00060-9; Hoh BL, 2000, NEUROSURGERY, V47, P346, DOI 10.1097/00006123-200008000-00015; KONDZIOLKA D, 1992, CAN J NEUROL SCI, V19, P40; Lasjaunias P, 1997, Interv Neuroradiol, V3, P275; Maher CO, 2009, J NEUROS-PEDIATR, V4, P12, DOI 10.3171/2009.1.PEDS08329; Musluman AM, 2011, TURK NEUROSURG, V21, P674, DOI [10.5137/1019-5149.JTN .3059-10.2, 10.5137/1019-5149.JTN.3059-10.2]; Neil Jayson A, 2014, Surg Neurol Int, V5, P148, DOI 10.4103/2152-7806.142796; Park YS, 2009, J KOREAN NEUROSURG S, V45, P401, DOI 10.3340/jkns.2009.45.6.401; Pellettieri L, 1997, ACTA RADIOL, V38, P2; Rodriguez AC, 2000, CHILD NERV SYST, V16, P363; Santoro A, 2000, J NEUROSURG, V93, P1082, DOI 10.3171/jns.2000.93.6.1082; Sure Ulrich, 2001, Journal of Neurosurgery, V94, P972, DOI 10.3171/jns.2001.94.6.0972; Takagi Y, 2010, WORLD NEUROSURG, V73, P100, DOI 10.1016/j.surneu.2009.07.008; Weil Alexander G, 2011, Surg Neurol Int, V2, P175, DOI 10.4103/2152-7806.90692; Wostrack M, 2011, ACTA NEUROCHIR, V153, P1821, DOI 10.1007/s00701-011-1083-5; Yasargil MG, 1988, MICRONEUROSURGERY B, VIIIB, P376	33	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2015	157	9					1461	1466		10.1007/s00701-015-2461-1		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP4OS	WOS:000359862500003		
J	Fukuda, M; Takao, T; Hiraishi, T; Fujii, Y				Fukuda, Masafumi; Takao, Tetsuro; Hiraishi, Tetsuya; Fujii, Yukihiko			Free-running EMG monitoring during microvascular decompression for hemifacial spasm	ACTA NEUROCHIRURGICA			English	Article						Abnormal muscle response; Facial motor evoked potential; Free-running EMG; Hemifacial spasm; Microvascular decompression	ABNORMAL MUSCLE RESPONSE; LATERAL SPREAD RESPONSE; PROGNOSTIC VALUE; ELECTROMYOGRAPHIC ACTIVITY; CRANIAL NERVES; SURGERY; COMPRESSION; OPERATIONS; RESECTION	The aim of this work is to determine if free-running electromyography (frEMG) can detect activity before and after microvascular decompression (MVD) treatment for hemifacial spasm (HFS), and to evaluate correlations of frEMG findings with abnormal muscle responses (AMRs) or facial motor-evoked potentials (FMEPs). To elicit nerve responses while carrying out frEMG recording before and after MVD, saline, a lactic solution, or artificial cerebrospinal fluid was injected onto the root exit zone of the facial nerve. Significantly higher frEMG activity was observed following saline injection than for the other solutions (p < 0.01). For frEMG activity ratios of a parts per thousand yenaEuro parts per thousand 50 %, there was a trend towards a greater likelihood of persistent AMRs. When frEMG activity decreased after MVD in the mentalis muscles, FMEP amplitude ratios were significantly smaller than when it did not (65 vs. 94 %, p < 0.05). Changes in intraoperative frEMG, AMRs, and FMEPs likely reflect a component of the normalization of hyper-excitability of the facial nerve by MVD for HFS.	[Fukuda, Masafumi; Takao, Tetsuro; Hiraishi, Tetsuya; Fujii, Yukihiko] Niigata Univ, Brain Res Inst, Dept Neurosurg, Chuo Ku, Niigata 9518585, Japan	Fukuda, M (reprint author), Niigata Univ, Brain Res Inst, Dept Neurosurg, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518585, Japan.	mfuku529@bri.niigata-u.ac.jp					Alfieri A, 2012, CLIN ANAT, V25, P882, DOI 10.1002/ca.22025; Alfieri A, 2014, ACTA NEUROCHIR, V156, P403, DOI 10.1007/s00701-013-1952-1; Alfieri A, 2012, ACTA NEUROCHIR, V154, P1263, DOI 10.1007/s00701-012-1359-4; Grabb PA, 1997, J NEUROSURG, V86, P1, DOI 10.3171/jns.1997.86.1.0001; Romstock J, 2000, J NEUROSURG, V93, P586, DOI 10.3171/jns.2000.93.4.0586; Wilkinson MF, 2005, J NEUROSURG, V103, P64, DOI 10.3171/jns.2005.103.1.0064; Hatem J, 2001, BRIT J NEUROSURG, V15, P496, DOI 10.1080/02688690120105101; Prell J, 2007, J NEUROSURG, V106, P826, DOI 10.3171/jns.2007.106.5.826; MOLLER AR, 1987, J NEUROSURG, V66, P681, DOI 10.3171/jns.1987.66.5.0681; Kong DS, 2007, J NEUROSURG, V106, P384, DOI 10.3171/jns.2007.106.3.384; Sun H, 2014, ACTA NEUROCHIR, V156, P1155, DOI 10.1007/s00701-014-2055-3; MOLLER AR, 1985, NEUROSURGERY, V16, P612; ESTEBAN A, 1986, J NEUROL NEUROSUR PS, V49, P58, DOI 10.1136/jnnp.49.1.58; Fan N, 2011, J NEUROPHYSIOL, V106, P3067, DOI 10.1152/jn.00752.2011; Fukuda Masafumi, 1997, Neurologia Medico-Chirurgica, V37, P771, DOI 10.2176/nmc.37.771; Fukuda M, 2006, NEUROL SURG TOKYO, V34, P583; Fukuda M, 2009, J NEUROL NEUROSUR PS, V81, P519; Fukuda Masafumi, 2010, No Shinkei Geka, V38, P531; Fukuda Masafumi, 2012, Surg Neurol Int, V3, P118, DOI 10.4103/2152-7806.102328; Joo WI, 2008, J CLIN NEUROSCI, V15, P1335, DOI 10.1016/j.jocn.2007.08.008; Kim Chang-Hyun, 2010, Neurosurgery, V67, P1581, DOI 10.1227/NEU.0b013e3181f74120; KUROKI A, 1994, ACTA NEUROCHIR, V126, P149, DOI 10.1007/BF01476426; MOLLER AR, 1986, EXP NEUROL, V93, P584, DOI 10.1016/0014-4886(86)90178-0; MOLLER AR, 1991, J NEUROL SCI, V101, P114, DOI 10.1016/0022-510X(91)90025-3; Sindou MP, 2005, ACTA NEUROCHIR, V147, P1019, DOI 10.1007/s00701-005-0583-6; PRASS RL, 1986, NEUROSURGERY, V19, P392; Prell J, 2015, CLIN NEUROPHYSIOL, V126, P1833, DOI 10.1016/j.clinph.2014.11.028; Prell J, 2008, J CLIN NEUROPHYSIOL, V25, P225, DOI 10.1097/WNP.0b013e31817f368f; Sekula Jr RF, 2009, NEUROSURG FOCUS, V27, pE10; Yamashita S, 2002, MUSCLE NERVE, V25, P845, DOI 10.1002/mus.10123; Yamashita S, 2005, ACTA NEUROCHIR, V147, P933, DOI 10.1007/s00701-005-0571-x	31	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2015	157	9					1505	1512		10.1007/s00701-015-2492-7		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP4OS	WOS:000359862500010		
J	Geisenberger, C; Mock, A; Warta, R; Rapp, C; Schwager, C; Korshunov, A; Nied, AK; Capper, D; Brors, B; Jungk, C; Jones, D; Collins, VP; Ichimura, K; Backlund, LM; Schnabel, E; Mittelbron, M; Lahrmann, B; Zheng, SY; Verhaak, RGW; Grabe, N; Pfister, SM; Hartmann, C; von Deimling, A; Debus, J; Unterberg, A; Abdollahi, A; Herold-Mende, C				Geisenberger, Christoph; Mock, Andreas; Warta, Rolf; Rapp, Carmen; Schwager, Christian; Korshunov, Andrey; Nied, Ann-Katrin; Capper, David; Brors, Benedikt; Jungk, Christine; Jones, David; Collins, V. Peter; Ichimura, Koichi; Backlund, L. Magnus; Schnabel, Elena; Mittelbron, Michel; Lahrmann, Bernd; Zheng, Siyuan; Verhaak, Roel G. W.; Grabe, Niels; Pfister, Stefan M.; Hartmann, Christian; von Deimling, Andreas; Debus, Juergen; Unterberg, Andreas; Abdollahi, Amir; Herold-Mende, Christel			Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain	ACTA NEUROPATHOLOGICA			English	Article						Glioblastoma; Molecular profiling; Microglia; Long-term survival; Short-term survival	COMPARATIVE GENOMIC HYBRIDIZATION; GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; BRAIN-TUMORS; ADJUVANT TEMOZOLOMIDE; CELL INFILTRATION; TYPICAL SURVIVORS; IDH2 MUTATIONS; HUMAN GLIOMAS; DNA-SEQUENCE	Glioblastoma (GBM) is a devastating tumor and few patients survive beyond 3 years. Defining the molecular determinants underlying long-term survival is essential for insights into tumor biology and biomarker identification. We therefore investigated homogeneously treated, IDH (wt) long-term (LTS, n = 10) and short-term survivors (STS, n = 6) by microarray transcription profiling. While there was no association of clinical parameters and molecular subtypes with long-term survival, STS tumors were characterized by differential polarization of infiltrating microglia with predominance of the M2 phenotype detectable both on the mRNA and protein level. Furthermore, transcriptional signatures of LTS and STS predicted patient outcome in a large, IDH (wt) cohort (n = 468). Interrogation of overlapping genomic alterations identified concurrent gain of chromosomes 19 and 20 as a favorable prognostic marker. The strong association of this co-gain with survival was validated by aCGH in a second, independent cohort (n = 124). Finally, FISH and gene expression data revealed gains to constitute low-amplitude, clonal events with a strong impact on transcription. In conclusion, these findings provide important insights into the manipulation of the innate immune system by particularly aggressive GBM tumors. Furthermore, we genomically characterize a previously unknown, clinically relevant subgroup of glioblastoma, which can easily be identified through modern neuropathological workup.	[Geisenberger, Christoph; Mock, Andreas; Warta, Rolf; Rapp, Carmen; Nied, Ann-Katrin; Jungk, Christine; Unterberg, Andreas; Herold-Mende, Christel] Univ Heidelberg Hosp, Dept Neurosurg, Div Expt Neurosurg, D-69120 Heidelberg, Germany; [Mock, Andreas; Schwager, Christian; Schnabel, Elena; Abdollahi, Amir] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Mol & Translat Radiat Oncol, D-69120 Heidelberg, Germany; [Schwager, Christian; Schnabel, Elena; Debus, Juergen; Abdollahi, Amir] Heidelberg Univ, HIRO, Heidelberg Ion Beam Therapy Ctr HIT, Dept Radiat Oncol,Natl Ctr Radiat Res Oncol NCRO, D-69120 Heidelberg, Germany; [Korshunov, Andrey; Capper, David; von Deimling, Andreas] Univ Heidelberg Hosp, Inst Pathol, German Canc Res Ctr DKFZ, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Korshunov, Andrey; Capper, David; von Deimling, Andreas] Univ Heidelberg Hosp, Inst Pathol, Dept Neuropathol, D-69120 Heidelberg, Germany; [Brors, Benedikt] Univ Heidelberg Hosp, Natl Ctr Tumor Dis NCT, Med Oncol, D-69120 Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, Div Appl Bioinformat, D-69120 Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, Div Biostat, Computat Oncol, D-69120 Heidelberg, Germany; [Brors, Benedikt; Schnabel, Elena; Abdollahi, Amir] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, D-69120 Heidelberg, Germany; [Jones, David; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Collins, V. Peter] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 0QQ, England; [Ichimura, Koichi] Natl Canc Ctr, Div Brain Tumor Translat Res, Chuo Ku, Tokyo 1040045, Japan; [Backlund, L. Magnus] Karolinska Inst, Canc Ctr Karolinska & Radiumhemmet, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Backlund, L. Magnus] Univ Hosp, S-17176 Stockholm, Sweden; [Mittelbron, Michel] Goethe Univ Frankfurt, Neurol Inst, Edinger Inst, D-60528 Frankfurt, Germany; [Lahrmann, Bernd; Grabe, Niels] Heidelberg Univ, BIOQUANT, Hamamatsu Tissue Imaging & Anal Ctr TIGA, D-69120 Heidelberg, Germany; [Zheng, Siyuan; Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Hartmann, Christian] Hannover Med Sch, Dept Neuropathol, Inst Pathol, D-30625 Hannover, Germany	Herold-Mende, C (reprint author), Univ Heidelberg Hosp, Dept Neurosurg, Div Expt Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	H.Mende@med.uni-heidelberg.de	von Deimling, Andreas/F-7774-2013; Capper, David/I-8500-2014; Pfister, Stefan/F-6860-2013	Pfister, Stefan/0000-0002-5447-5322	Anni Hofmann Stiftung; German Federal Ministry of Research and Education (BMBF) [01GS0883]	We thank Steffen Dettling and Saskia Rosch for proofreading of the manuscript as well as Anja Metzner and Daniela Zito for review of patient data. Furthermore, we thank Farzaneh Kashfi, Hildegard Goltzer, Ilka Hearn and Melanie Greibich as well as Barbara Schwager and Claudia Rittmuller for their excellent technical assistance. This study has been funded in part by a grant from the Anni Hofmann Stiftung to CHM and the German Federal Ministry of Research and Education (BMBF) to BB (01GS0883).	Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Nishie A, 1999, CLIN CANCER RES, V5, P1107; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Glass R, 2014, ACTA NEUROPATHOL, V128, P347, DOI 10.1007/s00401-014-1274-2; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI [10.1016/j.ajpath.2012.01.040, 10.1016/j.ajpath.2012.07.040]; Prosniak M, 2013, CLIN CANCER RES, V19, P3776, DOI 10.1158/1078-0432.CCR-12-1940; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Donson AM, 2012, J IMMUNOL, V189, P1920, DOI 10.4049/jimmunol.1103373; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Martinez FO, 2006, J IMMUNOL, V177, P7303; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Lohr J, 2011, CLIN CANCER RES, V17, P4296, DOI 10.1158/1078-0432.CCR-10-2557; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Hartmann C, 2013, CLIN CANCER RES, V19, P5146, DOI 10.1158/1078-0432.CCR-13-0017; Shinawi T, 2013, EPIGENETICS-US, V8, P149, DOI 10.4161/epi.23398; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; McLendon RE, 2003, CANCER, V98, P1745, DOI 10.1002/cncr.11666; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Kim YW, 2013, NEURO-ONCOLOGY, V15, P829, DOI 10.1093/neuonc/not024; Houillier C, 2006, CANCER, V106, P2218, DOI 10.1002/cncr.21819; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Shinojima N, 2003, CANCER RES, V63, P6962; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Burton EC, 2002, CANCER RES, V62, P6205; Li B, 2012, CLIN CANCER RES, V18, P5595, DOI 10.1158/1078-0432.CCR-12-1427; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Yamanaka R, 2006, ONCOGENE, V25, P5994, DOI 10.1038/sj.onc.1209585; McCabe MG, 2006, J NEUROPATH EXP NEUR, V65, P549; Petalidis LP, 2008, MOL CANCER THER, V7, P1013, DOI 10.1158/1535-7163.MCT-07-0177; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Reifenberger G, 2014, INT J CANCER, V135, P1822, DOI 10.1002/ijc.28836; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Alvarez S, 2001, GENE CHROMOSOME CANC, V32, P285, DOI 10.1002/gcc.1192; Jones DTW, 2006, J NEUROPATH EXP NEUR, V65, P1049, DOI 10.1097/01.jnen.0000240465.33628.87; Burton EC, 2002, CLIN CANCER RES, V8, P180; da Fonseca ACC, 2012, NEUROSCIENCE, V200, P130, DOI 10.1016/j.neuroscience.2011.10.025; Davis Sean, 2007, Bioinformatics, V23, P1846, DOI 10.1093/bioinformatics/btm254; Debus J, 2014, AM SOC CLIN ONCOL ED, V34, P95; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Gerber NK, 2014, NEURO-ONCOLOGY, V16, P1186, DOI 10.1093/neuonc/nou043; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kees T, 2012, NEURO-ONCOLOGY, V14, P64, DOI 10.1093/neuonc/nor182; LICHTER P, 1995, METHOD ENZYMOL, V254, P334; Marko NF, 2008, GENOMICS, V91, P395, DOI 10.1016/j.ygeno.2008.01.002; R Development Core Team, 2008, R LANG ENV STAT COMP; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655	59	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	SEP	2015	130	3					419	434		10.1007/s00401-015-1427-y		16	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CP6JF	WOS:000359992000008		
J	Srisuka, W; Takaoka, H; Otsuka, Y; Fukuda, M; Thongsahuan, S; Taai, K; Choochote, W; Saeung, A				Srisuka, Wichai; Takaoka, Hiroyuki; Otsuka, Yasushi; Fukuda, Masako; Thongsahuan, Sorawat; Taai, Kritsana; Choochote, Wej; Saeung, Atiporn			Seasonal biodiversity of black flies (Diptera: Simuliidae) and evaluation of ecological factors influencing species distribution at Doi Pha Hom Pok National Park, Thailand	ACTA TROPICA			English	Article						Black fly; Simuliidae; Simulium; Doi Pha Ham Pok National Park; Ecological factor; Shannon diversity index	FLY DIPTERA; NORTHERN THAILAND; TROPICAL STREAMS; LAND-USE; ASSEMBLAGES; NEVERMANNIA; DIVERSITY; RICHNESS; BRAZIL; AMAZONIA	This is the first study on the seasonal biodiversity of black flies and evaluation of ecological factors influencing their distribution at Doi Pha Horn Pok National Park, northern Thailand. Larvae were collected from six fixed-stream sites in relation to altitude gradients from May 2011 to April 2013. The water temperature, water pH, conductivity, total dissolved solids (TDS), salt, water velocity, stream width and depth, streambed particle sizes, riparian vegetation, and canopy cover were recorded from each site. Monthly collections from the six sites yielded 5475 last-instar larvae, belonging to 29 black fly species. The most frequently found species from all sites were Simulium asakoae (100%) followed by Simulium yuphae (83.3%), and Simulium chiangdaoense, Simulium gombakense, Simulium phahompokense, Simulium fruticosum, Simulium maeaiense and Simulium fenestratum (66.6%). Of the 5475 last-instar larvae, S. maeaiense (19.3%), S. chiangdaoense (15.8%) and S. asakoae (14.8%), were the three most abundant species. The Shannon diversity index (H) at the six sites with different altitudes of 2100 m, 2000 m, 1500 m, 1400 m, 700 m, and 500 m above mean sea level, were 2.042, 1.832, 2.158, 2.123, 1.821 and 1.822, respectively. The Shannon index and number of taxa in the cold season were higher than those in the rainy and hot seasons. Principal component analysis (PCA) indicated that at least three principal components have eigen values >1.0 and accounted for 93.5% of the total variability of ecological factors among sampling sites. The Canonical correspondence analyses (CCA) showed that most species had a trend towards altitude, canopy cover, riparian vegetation and water velocity. (C) 2015 The Authors. Published by Elsevier B.V.	[Srisuka, Wichai] Queen Sirikit Bot Garden, Entomol Sect, Chiang Mai 50180, Thailand; [Srisuka, Wichai; Taai, Kritsana; Choochote, Wej; Saeung, Atiporn] Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai 50200, Thailand; [Takaoka, Hiroyuki] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia; [Otsuka, Yasushi] Kagoshima Univ, Res Ctr Pacific Isl, Kagoshima 8908580, Japan; [Fukuda, Masako] Oita Univ, Dept Infect Dis Control, Fac Med, Oita 8795593, Japan; [Fukuda, Masako] Oita Univ, Res Promot Inst, Oita 8795593, Japan; [Thongsahuan, Sorawat] Prince Songkla Univ, Fac Vet Sci, Establishment Project, Hat Yai 90110, Thailand	Saeung, A (reprint author), Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai 50200, Thailand.	wsrisuka@gmail.com; takaoka@oita-u.ac.jp; yotsuka@cpi.kagoshima-u.ac.jp; mfukuda@oita-u.ac.jp; sorawat_ton@hotmail.com; kritsana_taai@hotmail.com; wchoocho@mail.med.cmu.ac.th; atisaeung.noi@gmail.com			Thailand Research Fund (TRF Senior Research Scholar) [RTA5480006]; Faculty of Medicine Research Fund and Diamond Research Grant of the Faculty of Medicine, Chiang Mai University; Chiang Mai University (CMU); University of Malaya [RP003A-13SUS]	We are grateful to Dr. Suyanee Vessabutr, Director of Queen Sirikit Botanic Garden, Chiang Mai Thailand, for her interest and support in this study. Thanks go to Mr. Sumitr Suriya, Mr. Raewat Saokod, Ms. Sunantha Pilakantha and Ms. Chayanit Surin for their kind help in the field surveys and preparation of specimens in the laboratory. This work was supported by The Thailand Research Fund to W. Choochote (TRF Senior Research Scholar: RTA5480006), the Faculty of Medicine Research Fund and Diamond Research Grant of the Faculty of Medicine, Chiang Mai University to A. Saeung, and the Chiang Mai University (CMU) through the research administration office provided budget to our Excellence Center in Insect Vector Study, as well as a research grant from the University of Malaya (RP003A-13SUS) to H. Takaoka.	Adler P. H., 2014, WORLD BLACKFLIES DIP; Pramual P, 2010, ENTOMOL SCI, V13, P17, DOI 10.1111/j.1479-8298.2009.00354.x; Ishii Y, 2008, PARASITE, V15, P121; Hamada N, 1999, HYDROBIOLOGIA, V397, P71, DOI 10.1023/A:1003642430681; Hamada N, 2002, FRESHWATER BIOL, V47, P31, DOI 10.1046/j.1365-2427.2002.00778.x; Pramual P, 2009, HYDROBIOLOGIA, V625, P173, DOI 10.1007/s10750-009-9706-z; Landeiro VL, 2009, NEOTROP ENTOMOL, V38, P332, DOI 10.1590/S1519-566X2009000300006; Figueiro R, 2012, MEM I OSWALDO CRUZ, V107, P362, DOI 10.1590/S0074-02762012000300011; Illesova D, 2010, BIOLOGIA, V65, P892, DOI 10.2478/s11756-010-0096-5; Choochote Wej, 2005, Medical Entomology and Zoology, V56, P335; Edwards F. W., 1934, ARCH HYDROBIOL S, V13, P92; Hammer O, 2013, PAST PALEONTOLOGICAL; Jani H., 2009, FRESHWATER REV, V2, P1; McCreadie J. W., 2006, Acta Entomologica Serbica, P89; McCreadie JW, 2012, AQUAT INSECT, V34, P143, DOI 10.1080/01650424.2012.718085; Pachon RT, 2011, J VECTOR ECOL, V36, P187, DOI 10.1111/j.1948-7134.2011.00156.x; Rabha B, 2013, J VECTOR DIS, V50, P18; Ramos WR, 2014, ACTA TROP, V139, P44, DOI 10.1016/j.actatropica.2014.06.017; Takaokai Hiroyuki, 2006, Medical Entomology and Zoology, V57, P83; Takaoka Hiroyuki, 2005, Medical Entomology and Zoology, V56, P99; Takaoka Hiroyuki, 2010, Medical Entomology and Zoology, V61, P273; Takaoka Hiroyuki, 2010, Medical Entomology and Zoology, V61, P265; Takaoka Hiroyuki, 2005, Medical Entomology and Zoology, V56, P319; Takaoka Hiroyuki, 2005, Medical Entomology and Zoology, V56, P21; Takaoka Hiroyuki, 2009, Medical Entomology and Zoology, V60, P269; Takaoka Hiroyuki, 2004, Tropical Medicine and Health, V32, P189, DOI 10.2149/tmh.32.189; Takaoka H., 1995, BLACK FILES DIPTERA; Takaoka Hiroyuki, 2010, Medical Entomology and Zoology, V61, P261; Takaoka H, 2012, TROP BIOMED, V29, P381; Takaoka Hiroyuki, 2005, Medical Entomology and Zoology, V56, P43; Takaoka H, 2014, J MED ENTOMOL, V51, P725, DOI 10.1603/ME13241; Takaoka Hiroyuki, 2005, Medical Entomology and Zoology, V56, P33; Takaoka H., 1984, Japanese Journal of Sanitary Zoology, V35, P7; TAKAOKA H, 1979, PAC INSECTS, V20, P365	34	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	SEP	2015	149						212	219		10.1016/j.actatropica.2015.05.024		8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CP5XA	WOS:000359957500028		
J	Yamada, K; Ishikawa, T; Kakiichi, T				Yamada, Kentaro; Ishikawa, Toshiyuki; Kakiichi, Takumi			REHABILITATION AND IMPROVEMENT OF FATIGUE LIFE OF WELDED JOINTS BY ICR TREATMENT	ADVANCED STEEL CONSTRUCTION			English	Article						Fatigue test; Welded joint; Crack; Rehabilitation; Improvement		Over 150,000 highway bridges exist in Japan and about 47 percent of the bridges will be over 50 years old in 2026. The Ministry of Land, Infrastructure, Transport and Tourism (MLIT) launched nation-wide projects to inspect and to establish maintenance plans. About one half of the highway bridges were steel bridges with concrete slabs. Due to heavy truck traffics being operated in or between industrial cities, some of which were illegally overloaded, severe deteriorations to concrete slabs and fatigue cracks in steel girders have been observed. Fatigue cracks in orthotropic steel decks were also found. It is urgent to tackle such fatigue cracks observed in welded joints of steel bridges. Various attempts have been made in Japan to repair and rehabilitate such fatigue cracked members. One is to improve fatigue strength of welded joints in existing bridges, and the other is to repair and rehabilitate cracked members. The latter were, for example, re-welding cracked joints, strengthening by using high strength bolted splices, adding glue to cracks, rehabilitating by gluing CFRP. The authors developed a technique, so-called ICR Treatment, or Impact Crack Closure Retrofit treatment, where fatigue cracks was closed by giving plastic yielding at plate surface near fatigue cracks. Since fatigue cracks do not open due to applied stress ranges, the cracks either do not propagate, or propagate much slower, to prolong remaining fatigue life of the bridges. Fatigue tests were carried out on various welded joints to show how fatigue life was improved by applying the ICR treatment to the cracked welded joints.	[Yamada, Kentaro] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Yamada, Kentaro] Cent Nippon Highway Engn Nagoya Co Ltd, Nagoya, Aichi, Japan; [Ishikawa, Toshiyuki] Kyoto Univ, Dept Urban Management, Kyoto 6068501, Japan	Yamada, K (reprint author), Nagoya Univ, Nagoya, Aichi 4648601, Japan.	k.yamada.e@c-nexco-hen.jp			Nagoya Expressway Authority	The authors acknowledge all former graduate students of Nagoya University to contribute the fatigue tests of welded joints. Fatigue testing machines used in this experiment were developed by the first author with Drs. Satoshi Yamada and Tatsuya Ojio, and their contribution is also greatly acknowledged. The fatigue testing machine enabled us to carry out fatigue tests very fast. Without them the fatigue tests would have taken several years. The experimental works were financially supported by Nagoya Expressway Authority.	Anami K, 2000, JSCE, V647, P67; Branco CM, 2004, FATIGUE FRACT ENG M, V27, P785, DOI 10.1111/j.1460-2695.2004.00777.x; Roy S, 2003, INT J FATIGUE, V25, P1239, DOI 10.1016/S0142-1123(03)00151-8; Haagensen P. J., 2007, IIW RECOMMENDATIONS; Japan Society of Steel Constructions (JSSC), 1993, FAT DES REC STEEL ST; Japanese Society of Steel Construction (JSSC), 1995, FAT DES REC STEEL ST; Pedersen M. M., 2009, XIII227209 IIW; Tominaga T., 2007, STEEL CONSTRUCTION E, V14, P47; Yamada K., 2007, XIII216107 IIW; Yamada K., 2007, STEEL CONSTRUCTION E, V14, P1; Yamada K., 2009, FATIGUE DESIGN 2009; Yamada K., 2009, XIII2289R109 IIW; Yamada K., 2008, ORTH BRIDG C SACR US, P531	13	0	0	HONG KONG INST STEEL CONSTRUCTION	HUNGHOM KOWLOON	HONG KONG POLYTECHNIC UNIV, DEPT CIVIL & STRUCTURAL ENGNG, HUNGHOM KOWLOON, HONG KONG 00000, PEOPLES R CHINA	1816-112X			ADV STEEL CONSTR	Adv. Steel Constr.	SEP	2015	11	3			SI		294	304				11	Construction & Building Technology; Engineering, Civil; Materials Science, Characterization & Testing	Construction & Building Technology; Engineering; Materials Science	CP5VP	WOS:000359953400004		
J	Sato, M; Aono, H; Yakeno, A; Nonomura, T; Fujii, K; Okada, K; Asada, K				Sato, Makoto; Aono, Hikaru; Yakeno, Aiko; Nonomura, Taku; Fujii, Kozo; Okada, Koichi; Asada, Kengo			Multifactorial Effects of Operating Conditions of Dielectric-Barrier-Discharge Plasma Actuator on Laminar-Separated-Flow Control	AIAA JOURNAL			English	Article							LARGE-EDDY SIMULATION; TRANSITIONAL BOUNDARY-LAYER; PRESSURE TURBINE-BLADES; REYNOLDS-NUMBERS; SYNTHETIC JETS; AIRFOIL; BUBBLE; SCHEME	A substantial number of large-eddy simulations are conducted on separated flow controlled by a dielectric barrier discharge plasma actuator at a Reynolds number of 63,000. In the present paper, the separated flow over a NACA 0015 airfoil at an angle of attack of 12deg, which is just poststall, is used as the base flow for separation control. The effects of the location and operating conditions of the plasma actuator on the separation control are investigated by a parametric study. The control effect is evaluated based on the improvement of not only the lift coefficient but also the drag coefficient over an airfoil. The most effective location of the plasma actuator for both lift and drag improvement is precisely confirmed to be upstream of the natural separation point. Even a low burst ratio is found to be sufficient to obtain the same improvements as the cases with a high burst ratio. The effective nondimensional burst frequency F+ is observed at 4F+6 for the improvement in the lift coefficient and at 6F+20 for that in the drag coefficient. The lift/drag ratio shows a clear peak at 6F+10. To clarify the mechanism of the laminar-separation control, the effect of a turbulent transition is investigated. There is a clear relationship between the separation control effect and the turbulent transition at the shear layer. An earlier and smoother transition case shows greater improvements in the lift and drag coefficients. Flow analyses show that the cases with early and smooth turbulent transition can attach the separated flow further upstream, resulting in a higher suction peak of the pressure coefficient. In addition, another mechanism of the separation control is observed in which the lift coefficient is improved, not by the reattachment through the turbulent transition but by the large-scale vortex shedding induced by the actuation. It is possible to separate these two dominant mechanisms based on the effect of the turbulent transition on the separation control.	[Sato, Makoto; Aono, Hikaru; Yakeno, Aiko; Nonomura, Taku; Fujii, Kozo] Japan Aerosp Explorat Agcy, Dept Space Flight Syst, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Okada, Koichi] Ryoyu Syst Co Ltd, Engn Solut Div, Nagoya, Aichi 4550024, Japan; [Asada, Kengo] Univ Tokyo, Dept Aeronaut & Astronaut, Sagamihara, Kanagawa 2525210, Japan	Sato, M (reprint author), Japan Aerosp Explorat Agcy, Dept Space Flight Syst, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan.	sato@flab.isas.jaxa.jp; aono@flab.isas.jaxa.jp; yakeno@flab.isas.jaxa.jp; nonomura@flab.isas.jaxa.jp; fujii@flab.isas.jaxa.jp; okada@flab.isas.jaxa.jp; asada@flab.isas.jaxa.jp			Strategic Programs for Innovative Research of the High Performance Computing Initiative [hp120296, hp130001, hp140207]	This research is mainly supported by Strategic Programs for Innovative Research of the High Performance Computing Initiative (project identifications hp120296, hp130001, and hp140207). The computations in this study were performed by the K supercomputer at Riken's Advanced Institute of Computational Science and by the Fujitsu FX10 in the Information Technology Center at the University of Tokyo. The present authors are grateful for their fruitful discussions with Soshi Kawai of the Japan Aerospace Exploration Agency and Associate Professor Susumu Teramoto of the University of Tokyo.	Abe Y., 2013, 5 EUR C AER SPAC SCI; Jones LE, 2010, J FLUID MECH, V648, P257, DOI 10.1017/S0022112009993089; SATO H, 1975, J FLUID MECH, V67, P539, DOI 10.1017/S0022112075000456; Nishida H, 2009, J COMPUT PHYS, V228, P3182, DOI 10.1016/j.jcp.2009.01.032; Enloe CL, 2004, AIAA J, V42, P595, DOI 10.2514/1.3884; Kawai S, 2008, AIAA J, V46, P690, DOI 10.2514/1.32239; Kotsonis M, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/4/045204; Teramoto S, 2005, AIAA J, V43, P2354, DOI 10.2514/1.16140; Huang JH, 2006, AIAA J, V44, P1477, DOI 10.2514/1.19243; Post ML, 2006, AIAA J, V44, P3125, DOI 10.2514/1.22716; Enloe CL, 2006, AIAA J, V44, P1127, DOI 10.2514/1.16297; Mabe JH, 2009, J AIRCRAFT, V46, P847, DOI 10.2514/1.37638; Greenblatt D, 2014, AIAA J, V52, P456, DOI 10.2514/1.J052776; Nishida H, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870384; Rizzetta DP, 2009, AIAA J, V47, P717, DOI 10.2514/1.39168; Kriegseis J, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/5/055202; Huang JH, 2006, AIAA J, V44, P51, DOI 10.2514/1.2903; Greenblatt D, 2008, AIAA J, V46, P1528, DOI 10.2514/1.33388; Glezer A, 2002, ANNU REV FLUID MECH, V34, P503, DOI 10.1146/annurev.fluid.34.090501.094913; Post ML, 2004, AIAA J, V42, P2177, DOI 10.2514/1.2929; Jukes TN, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3237151; Hain R, 2009, J FLUID MECH, V630, P129, DOI 10.1017/S0022112009006661; Greenblatt D, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4733399; Corke TC, 2010, ANNU REV FLUID MECH, V42, P505, DOI 10.1146/annurev-fluid-121108-145550; Vorobiev A, 2013, J AIRCRAFT, V50, P12, DOI 10.2514/1.C031249; Gaitonde DV, 2000, AIAA J, V38, P2103, DOI 10.2514/2.872; Marxen O, 2013, J FLUID MECH, V728, P58, DOI 10.1017/jfm.2013.222; You D, 2008, J FLUID STRUCT, V24, P1349, DOI 10.1016/j.jfluidstructs.2008.06.017; Amitay M, 2002, INT J HEAT FLUID FL, V23, P690, DOI 10.1016/S0142-727X(02)00165-0; Li YH, 2010, EXP FLUIDS, V48, P1015, DOI 10.1007/s00348-009-0787-2; LELE SK, 1992, J COMPUT PHYS, V103, P16, DOI 10.1016/0021-9991(92)90324-R; Little J, 2010, EXP FLUIDS, V48, P521, DOI 10.1007/s00348-009-0755-x; Mueller TJ, 2003, ANNU REV FLUID MECH, V35, P89, DOI 10.1146/annurev.fluid.35.101101.161102; Sosa R, 2011, EXP FLUIDS, V51, P853, DOI 10.1007/s00348-011-1108-0; Van Ness DK, 2012, J PROPUL POWER, V28, P504, DOI 10.2514/1.B34310; Patel MP, 2008, J AIRCRAFT, V45, P223, DOI 10.2514/1.31830; Rizzetta DP, 2011, AIAA J, V49, P411, DOI 10.2514/1.J050755; Font GI, 2010, AIAA J, V48, P1869, DOI 10.2514/1.J050003; Benard N, 2009, J ELECTROSTAT, V67, P133, DOI 10.1016/j.elstat.2009.01.008; Aono H., MECH ENG J IN PRESS; Aono H., 2013, CFD LETT, V5, P143; Asada K., 2014, THESIS U TOKYO TOKYO; Asada K., 2012, 20123054 AIAA; Asada K., 2009, 20090531 AIAA; Bernad N., 2013, J PHYS D, V46, DOI [10.1088/0022-3727/46/24/245201, DOI 10.1088/0022-3727/46/24/245201]; Dovgal A., 1994, PROG AEROSPACE SCI, V30, P61, DOI [10.1016/0376-0421(94)90003-5, DOI 10.1016/0376-0421(94)90003-5]; FUJII K, 1995, J COMPUT PHYS, V118, P92, DOI 10.1006/jcph.1995.1082; Fujii K., 1998, P INT CFD WORKSH SUP, P20; Fujii K., 1990, HIGH PERFORMANCE COM, P139; Goksel B., 2006, 20063686 AIAA; Greenblatt D, 2000, PROG AEROSP SCI, V36, P487, DOI 10.1016/S0376-0421(00)00008-7; HO CM, 1984, ANNU REV FLUID MECH, V16, P365, DOI 10.1146/annurev.fl.16.010184.002053; Jolibois J, 2008, J ELECTROSTAT, V66, P496, DOI 10.1016/j.elstat.2008.03.008; Jukes TN, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3194307; Li Y, 2010, EXP FLUIDS, V49, P367, DOI 10.1007/s00348-009-0806-3; Nonomura T., 2013, 20130853 AIAA; Riherd M, 2013, J APPL PHYS, V114, DOI 10.1063/1.4818622; Rizzetta D. P., 2011, 20113252 AIAA; Sato M., 2013, 20132750 AIAA; Sato M., 2014, 20142663 AIAA; Sekimoto S., 2011, 20113989 AIAA; Sekimoto S., 2012, 20121137 AIAA; Shang JS, 2014, PROG AEROSP SCI, V67, P29, DOI 10.1016/j.paerosci.2014.01.001; Sidorenko A. A., 2007, 20070941 AIAA; Suzen Y, 2005, 20054633 AIAA; Suzen Y. B., 2006, 20060877 AIAA; Tsubakino D., 2007, 2007474 AIAA; Visbal M. R., 1999, 19993706 AIAA; Visbal M. R., 2006, 20063230 AIAA; Visbal M. R., 2002, 20020288 AIAA; Vorobiev Alexander N, 2008, Journal of Aircraft, V45, DOI 10.2514/1.34659	71	1	1	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	SEP	2015	53	9					2544	2559		10.2514/1.J053700		16	Engineering, Aerospace	Engineering	CP6GK	WOS:000359983400010		
J	Sasoh, A; Imaizumi, T; Toyoda, A; Ooyama, T				Sasoh, Akihiro; Imaizumi, Takahiro; Toyoda, Atsushi; Ooyama, Takeshi			In-Tube Catapult Launch from Rectangular-Bore Aeroballistic Range	AIAA JOURNAL			English	Article									[Sasoh, Akihiro; Imaizumi, Takahiro; Toyoda, Atsushi; Ooyama, Takeshi] Nagoya Univ, Dept Aerosp Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Sasoh, A (reprint author), Nagoya Univ, Dept Aerosp Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.				Japan Society for Promotion of Science [22226014, 25220914]	This research was supported by the Japan Society for Promotion of Science as Grant-in-Aid for Scientific Research (S), 22226014 and 25220914. The authors would like to thank A. Saito, K. Yamamoto, and N. Shiraki of the Technical Division, Nagoya University, for their valuable technical assistance.	Canning T. N., 1970, AGARDOGRAPH, V138; Cliff S. E., 2014, 20140560 AIAA; DRYSDALE WH, 1988, PROGR ASTRONAUT AERO, V109, P133; HERTZBERG A, 1988, AIAA J, V26, P195, DOI 10.2514/3.9872; Sasoh A., 2010, INT J AEROSPACE INNO, V2, P147, DOI [10.1260/1757-2258.2.3.147, DOI 10.1260/1757-2258.2.3.147]; Sasoh A, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2360766; SCHMIDT EM, 1978, J SPACECRAFT ROCKETS, V15, P162, DOI 10.2514/3.57301	7	1	1	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	SEP	2015	53	9					2781	U23		10.2514/1.J053540		4	Engineering, Aerospace	Engineering	CP6GK	WOS:000359983400028		
J	Xue, XP; Nishiyama, Y; Nakamura, Y; Mori, K; Wen, CY				Xue, Xiao-Peng; Nishiyama, Yusuke; Nakamura, Yoshiaki; Mori, Koichi; Wen, Chih-Yung			Parametric Study on Aerodynamic Interaction of Supersonic Parachute System	AIAA JOURNAL			English	Article							FLOWS		[Xue, Xiao-Peng; Nishiyama, Yusuke; Nakamura, Yoshiaki; Mori, Koichi] Nagoya Univ, Dept Aerosp Engn, Nagoya, Aichi 4648603, Japan; [Wen, Chih-Yung] Hong Kong Polytech Univ, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China	Wen, CY (reprint author), Cent S Univ, Sch Aeronaut & Astronaut, Changsha 410083, Peoples R China.	cywen@polyu.edu.hk	Wen, Chih-yung/M-1763-2015	Wen, Chih-yung/0000-0002-1181-8786			ANDERSON WK, 1986, AIAA J, V24, P1453, DOI 10.2514/3.9465; SHU CW, 1988, J COMPUT PHYS, V77, P439, DOI 10.1016/0021-9991(88)90177-5; VANLEER B, 1977, J COMPUT PHYS, V23, P276, DOI 10.1016/0021-9991(77)90095-X; Drayna T., 2007, 20072529 AIAA; Feszty D, 2004, AIAA J, V42, P95, DOI 10.2514/1.9034; Gidzak V., 2008, 20086910 AIAA; Gidzak V., 2009, 20092971 AIAA; Lingard J., 2005, 20051607 AIAA; Lingard J., 2007, 20072507 AIAA; Nishiyama Y., 2013, THESIS NAGOYA U NAGO; Panaras AG, 2009, J FLUID MECH, V632, P69, DOI 10.1017/S0022112009006235; Sengupta A., 2009, 20092900 AIAA; Shima E., 1997, P 14 NAL S AIRCR COM, P7; Xue X., 2013, T JSASS AEROSPACE TE, V11, P99; Xue X., J FLUIDS ST IN PRESS; Xue X., 2013, T JSASS AEROSPACE TE, V11, P33; Xue XP, 2015, AEROSP SCI TECHNOL, V43, P63, DOI 10.1016/j.ast.2015.02.014	17	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	SEP	2015	53	9					2796	U24		10.2514/1.J053824		6	Engineering, Aerospace	Engineering	CP6GK	WOS:000359983400030		
J	Ashida, K; Sakurai, Y; Nishimura, A; Kudou, K; Hiramatsu, N; Umegaki, E; Iwakiri, K; Chiba, T				Ashida, K.; Sakurai, Y.; Nishimura, A.; Kudou, K.; Hiramatsu, N.; Umegaki, E.; Iwakiri, K.; Chiba, T.			Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Article							PROTON-PUMP INHIBITORS; GASTROESOPHAGEAL-REFLUX DISEASE; LONG-TERM USE; MONOFUMARATE TAK-438; ESOMEPRAZOLE; SAFETY; PHARMACOKINETICS; PHARMACODYNAMICS; TOLERABILITY; SUPPRESSION	BackgroundThe potassium-competitive acid blocker vonoprazan (VPZ) has potent acid-inhibitory effects and may offer clinical advantages over conventional therapy for acid-related disorders. AimTo investigate the efficacy and safety of VPZ in patients with erosive oesophagitis (EO). MethodsIn this multicentre, randomised, double-blind, parallel-group, dose-ranging study, patients 20years with endoscopically confirmed EO [Los Angeles (LA) grades A-D] received VPZ 5, 10, 20 or 40mg, or lansoprazole (LPZ) 30mg once daily for 8weeks. The primary endpoint was the proportion of healed EO subjects as shown by endoscopy at week 4. ResultsA total of 732 subjects received VPZ or LPZ. The proportion of healed EO subjects at week 4 was 92.3%, 92.5%, 94.4%, 97.0% and 93.2%, respectively, with VPZ 5, 10, 20 and 40mg and LPZ 30mg. All VPZ doses were non-inferior to LPZ when adjusted for baseline LA grades A/B and C/D. Among those with LA grades C/D, the proportions of healed EO subjects were 87.3%, 86.4%, 100%, 96.0% and 87.0%, respectively, with VPZ 5, 10, 20 and 40mg and LPZ 30mg. The incidence of adverse events was similar across the groups. ConclusionsVonoprazan was effective and non-inferior to LPZ in healing EO. VPZ 20mg or higher was highly efficacious for severe EO (LA grades C/D). VPZ was associated with no safety concern during this 8-week study, while there was a dose-dependent increase in serum gastrin. Once-daily VPZ 20mg is the recommended clinical dose for treating EO.	[Ashida, K.] Rakuwakai Otowa Hosp, Kyoto 6078062, Japan; [Sakurai, Y.; Nishimura, A.; Kudou, K.] Takeda Pharmaceut Co Ltd, Osaka, Japan; [Hiramatsu, N.] Osaka Univ, Grad Sch Med, Osaka, Japan; [Umegaki, E.] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan; [Iwakiri, K.] Nippon Med Sch Grad, Sch Med, Tokyo, Japan; [Chiba, T.] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Chiba, T.] Kyoto Univ, Fac Med, Kyoto, Japan	Ashida, K (reprint author), Rakuwakai Otowa Hosp, Yamashina Ku, 2 Otowachinji Cho, Kyoto 6078062, Japan.	rakuwadr1185@rakuwadr.com			Takeda Pharmaceutical Company Ltd. [TAK-438/CCT-001]; Takeda Pharmaceutical Company Ltd, Japan	Declaration of funding interests: This study (TAK-438/CCT-001) was funded in full by Takeda Pharmaceutical Company Ltd. Writing support was provided by Hiroaki Itoh of Interface, Kanagawa, Japan, and was funded by Takeda Pharmaceutical Company Ltd, Japan. The authors thank Richard Jenkins, Nigel Brayshaw and Goran Hasselgren from Takeda Development Centre, Europe, and Caterina Hatzifoti on behalf of Takeda Pharmaceuticals International GmbH for reviewing the manuscript.	Agreus L, 2009, SCAND J GASTROENTERO, V44, P564, DOI 10.1080/00365520902745062; Andersson K, 2005, PHARMACOL THERAPEUT, V108, P294, DOI 10.1016/j.pharmthera.2005.05.005; Kahrilas PJ, 2007, CLIN GASTROENTEROL H, V5, P1385, DOI 10.1016/j.cgh.2007.08.014; Bordi C, 2014, ENDOCR PATHOL, V25, P171, DOI 10.1007/s12022-014-9315-x; Higuchi K, 2013, INTERNAL MED, V52, P1447, DOI 10.2169/internalmedicine.52.0349; Chiba N, 1997, GASTROENTEROLOGY, V112, P1798, DOI 10.1053/gast.1997.v112.pm9178669; Katz PO, 2004, ALIMENT PHARM THERAP, V20, P399, DOI 10.1111/j.1365-2036.2004.02079.x; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Armstrong D, 1996, GASTROENTEROLOGY, V111, P85, DOI 10.1053/gast.1996.v111.pm8698230; Fennerty MB, 2005, ALIMENT PHARM THERAP, V21, P455, DOI 10.1111/j.1365-2036.2005.02339.x; BELL NJV, 1992, DIGESTION, V51, P59; Dent J, 2008, AM J GASTROENTEROL, V103, P20, DOI 10.1111/j.1572-0241.2007.01544.x; Edwards SJ, 2009, ALIMENT PHARM THER, V30, P547, DOI 10.1111/j.1365-2036.2009.04077.x; Arikawa Y, 2012, J MED CHEM, V55, P4446, DOI 10.1021/jm300318t; Jenkins H, 2015, ALIMENT PHARM THER, V41, P636, DOI 10.1111/apt.13121; Thomson ABR, 2010, WORLD J GASTROENTERO, V16, P2323, DOI 10.3748/wjg.v16.i19.2323; Hori Y, 2010, J PHARMACOL EXP THER, V335, P231, DOI 10.1124/jpet.110.170274; Shin JM, 2011, J PHARMACOL EXP THER, V339, P412, DOI 10.1124/jpet.111.185314; CEDERBERG C, 1992, DIGESTION, V53, P171; Chong E, 2003, PHARMACOTHERAPY, V23, P460, DOI 10.1592/phco.23.4.460.32128; Dammann HG, 1999, EUR J GASTROEN HEPAT, V11, P1277, DOI 10.1097/00042737-199911000-00016; Furuta Takahisa, 2005, Drug Metab Pharmacokinet, V20, P153, DOI 10.2133/dmpk.20.153; Hori Y, 2011, J PHARMACOL EXP THER, V337, P797, DOI 10.1124/jpet.111.179556; Jianu CS, 2012, ALIMENT PHARM THER, V36, P644, DOI 10.1111/apt.12012; Johnson DA, 2008, REV GASTROENTEROL DI, V8, P98; Kalaitzakis Evangelos, 2007, Ther Clin Risk Manag, V3, P653; Matsukawa J, 2011, BIOCHEM PHARMACOL, V81, P1145, DOI 10.1016/j.bcp.2011.02.009; Sachs George, 2010, Curr Gastroenterol Rep, V12, P437, DOI 10.1007/s11894-010-0149-5; Sakurai Y, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.18; Vakil NB, 2001, ALIMENT PHARM THERAP, V15, P927, DOI 10.1046/j.1365-2036.2001.01024.x; vansPinxteren B, 2003, J GEN INTERN MED, V18, P755; YANAGAWA T, 1994, BIOMETRICS, V50, P859, DOI 10.2307/2532800; Yu KS, 2004, J CLIN PHARMACOL, V44, P73, DOI 10.1177/0091270003261321	33	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	SEP	2015	42	6					685	695		10.1111/apt.13331		11	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	CP4MJ	WOS:000359855900004		
J	Sakurai, Y; Mori, Y; Okamoto, H; Nishimura, A; Komura, E; Araki, T; Shiramoto, M				Sakurai, Y.; Mori, Y.; Okamoto, H.; Nishimura, A.; Komura, E.; Araki, T.; Shiramoto, M.			Acid-inhibitory effects of vonoprazan 20mg compared with esomeprazole 20mg or rabeprazole 10mg in healthy adult male subjects - a randomised open-label cross-over study	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Article							PROTON PUMP INHIBITORS; HELICOBACTER-PYLORI ERADICATION; GASTROESOPHAGEAL-REFLUX DISEASE; GASTRIC-ACID; EXTENSIVE METABOLIZERS; MONOFUMARATE TAK-438; CYTOCHROME P4502C19; INTRAGASTRIC PH; LANSOPRAZOLE; OMEPRAZOLE	BackgroundProton pump inhibitors (PPIs) are widely used for the treatment of acid-related diseases. Vonoprazan is a member of a new class of acid suppressants; potassium-competitive acid blockers. Vonoprazan may thus be an alternative to PPIs. AimTo evaluate efficacy, rapidity and duration of acid-inhibitory effects of vonoprazan vs. two control PPIs, esomeprazole and rabeprazole, in 20 healthy Japanese adult male volunteers with CYP2C19 extensive metaboliser genotype. MethodsIn this randomised, open-label, two-period cross-over study, vonoprazan 20mg and esomeprazole 20mg (Study V vs. E) or rabeprazole 10mg (Study V vs. R) were orally administered daily for 7days. Primary pharmacodynamic endpoint was gastric pH over 24h measured as percentage of time pH 3, 4 and 5 (pH holding time ratios; HTRs) and mean gastric pH. ResultsAcid-inhibitory effect (pH4 HTR) of vonoprazan was significantly greater than that of esomeprazole or rabeprazole on both Days 1 and 7; Day 7 difference in pH4 HTR for vonoprazan vs. esomeprazole was 24.6% [95% confidence interval (CI): 16.2-33.1] and for vonoprazan vs. rabeprazole 28.8% [95% CI: 17.2-40.4]. The Day 1 to Day 7 ratio of 24-h pH4 HTRs was >0.8 for vonoprazan, compared with 0.370 for esomeprazole and 0.393 for rabeprazole. Vonoprazan was generally well tolerated. One vonoprazan subject withdrew due to a rash which resolved after discontinuation. ConclusionsThis study demonstrated a more rapid and sustained acid-inhibitory effect of vonoprazan 20mg vs. esomeprazole 20mg or rabeprazole 10mg. Therefore, vonoprazan may be a potentially new treatment for acid-related diseases.	[Sakurai, Y.; Mori, Y.; Okamoto, H.; Nishimura, A.; Komura, E.; Araki, T.] Takeda Pharmaceut Co Ltd, Osaka 5408645, Japan; [Shiramoto, M.] Med Co LTA, Hakata Clin, Fukuoka, Japan	Sakurai, Y (reprint author), Takeda Pharmaceut Co Ltd, Chuo Ku, 1-1 Doshomachi 4 Chome, Osaka 5408645, Japan.	yuuichi.sakurai@takeda.com			Takeda Pharmaceutical Company Ltd. [TAK-438/CPH-010]	Declaration of funding interests: The study (TAK-438/CPH-010) was funded in full by Takeda Pharmaceutical Company Ltd. Writing assistance was provided by Kerry Dechant of Content Ed Net, as well as Elise Jackson, PhD and Tania Dickson, PhD of ProScribe - part of Envision Pharma Group with funding from Takeda Pharmaceutical Company Ltd.	Adachi K, 2000, ALIMENT PHARM THERAP, V14, P1259, DOI 10.1046/j.1365-2036.2000.00840.x; Andersson K, 2005, PHARMACOL THERAPEUT, V108, P294, DOI 10.1016/j.pharmthera.2005.05.005; Fass R, 2005, ALIMENT PHARM THERAP, V22, P79, DOI 10.1111/j.1365-2036.2005.02531.x; Robinson M, 2005, INT J CLIN PRACT, V59, P709, DOI 10.1111/j.1368-5031.2005.00517.x; Ashida K, 2015, ALIMENT PHARM THER, V42, P685, DOI 10.1111/apt.13331; Wedemeyer RS, 2014, DRUG SAFETY, V37, P201, DOI 10.1007/s40264-014-0144-0; Jenkins H, 2015, ALIMENT PHARM THER, V41, P636, DOI 10.1111/apt.13121; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Sachs G, 2000, ALIMENT PHARM THERAP, V14, P1383, DOI 10.1046/j.1365-2036.2000.00837.x; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Saitoh T, 2002, ALIMENT PHARM THERAP, V16, P1811, DOI 10.1046/j.0269-2813.2002.01348.x; Hori Y, 2010, J PHARMACOL EXP THER, V335, P231, DOI 10.1124/jpet.110.170274; Furuta T, 2007, PHARMACOGENOMICS, V8, P1199, DOI 10.2217/14622416.8.9.1199; Frelinger AL, 2012, J AM COLL CARDIOL, V59, P1304, DOI 10.1016/j.jacc.2011.12.024; Shin JM, 2011, J PHARMACOL EXP THER, V339, P412, DOI 10.1124/jpet.111.185314; Frazzoni M, 2003, ALIMENT PHARM THERAP, V17, P235, DOI 10.1046/j.1365-2036.2003.01405.x; Furuta Takahisa, 2005, Drug Metab Pharmacokinet, V20, P153, DOI 10.2133/dmpk.20.153; Graham DY, 2002, HELICOBACTER, V7, P1, DOI 10.1046/j.1523-5378.2002.00048.x; Hayato S, 2012, EUR J CLIN PHARMACOL, V68, P579, DOI 10.1007/s00228-011-1164-7; Hori Y, 2011, J PHARMACOL EXP THER, V337, P797, DOI 10.1124/jpet.111.179556; Kraft WK, 2009, EXPERT REV CLIN PHAR, V2, P295, DOI 10.1586/ecp.09.8; Malfertheiner P, 2003, ALIMENT PHARM THERAP, V18, P615, DOI 10.1046/j.1365-2036.2003.01695.x; Matsukawa J, 2011, BIOCHEM PHARMACOL, V81, P1145, DOI 10.1016/j.bcp.2011.02.009; Nagashima H., 2011, J CLIN THERAP MED, V27, P735; Peghini PL, 1998, AM J GASTROENTEROL, V93, P763; Sakurai Y, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.18; Shimatani T, 2006, CLIN PHARMACOL THER, V79, P144, DOI 10.1016/j.clpt.2005.09.012	27	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	SEP	2015	42	6					719	730		10.1111/apt.13325		12	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	CP4MJ	WOS:000359855900007		
J	Kuroda, Y; Ohashi, I; Enomoto, Y; Naruto, T; Baba, N; Tanaka, Y; Aida, N; Okamoto, N; Niihori, T; Aoki, Y; Kurosawa, K				Kuroda, Yukiko; Ohashi, Ikuko; Enomoto, Yumi; Naruto, Takuya; Baba, Naoko; Tanaka, Yukichi; Aida, Noriko; Okamoto, Nobuhiko; Niihori, Tetsuya; Aoki, Yoko; Kurosawa, Kenji			A Postzygotic NRAS Mutation in a Patient with Schimmelpenning Syndrome	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Letter							CONGENITAL MELANOCYTIC NEVI; APLASIA-CUTIS-CONGENITA; NEUROCUTANEOUS MELANOSIS; MALFORMATIONS; HRAS		[Kuroda, Yukiko; Ohashi, Ikuko; Enomoto, Yumi; Naruto, Takuya; Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa 2328555, Japan; [Baba, Naoko] Kanagawa Childrens Med Ctr, Div Dermatol, Yokohama, Kanagawa 2328555, Japan; [Tanaka, Yukichi] Kanagawa Childrens Med Ctr, Dept Pathol, Yokohama, Kanagawa 2328555, Japan; [Aida, Noriko] Kanagawa Childrens Med Ctr, Dept Radiol, Yokohama, Kanagawa 2328555, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Izumi, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Izumi, Japan; [Niihori, Tetsuya; Aoki, Yoko] Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 980, Japan	Kuroda, Y (reprint author), Univ Tokyo, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ykodama-hok@umin.ac.jp; kkurosawa@kcmc.jp					Moody MN, 2012, PEDIATR DERMATOL, V29, P15, DOI 10.1111/j.1525-1470.2011.01562.x; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Groesser L, 2012, NAT GENET, V44, P783, DOI 10.1038/ng.2316; Kinsler VA, 2013, J INVEST DERMATOL, V133, P2229, DOI 10.1038/jid.2013.70; Eskandarpour M, 2005, INT J CANCER, V115, P65, DOI 10.1002/ijc.20873; Charbel C, 2014, J INVEST DERMATOL, V134, P1067, DOI 10.1038/jid.2013.429; Davies Derek, 2002, Australas J Dermatol, V43, P20, DOI 10.1046/j.1440-0960.2002.00546.x; Hsieh CW, 2012, PEDIATR DERMATOL, V29, P365, DOI 10.1111/j.1525-1470.2011.01639.x; Lam J, 2008, J AM ACAD DERMATOL, V58, P884, DOI 10.1016/j.jaad.2007.09.029; Mimouni F, 1986, Pediatr Dermatol, V3, P219, DOI 10.1111/j.1525-1470.1986.tb00517.x	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	SEP	2015	167	9					2223	2225		10.1002/ajmg.a.37135		3	Genetics & Heredity	Genetics & Heredity	CP7HB	WOS:000360056700037		
J	Ishida, T; Shinohara, K; Tanaka, Y; Moriyama, M; Morohoshi, K; Shimada, N; Yoshida, T; Ohno-Matsui, K				Ishida, Tomoka; Shinohara, Kosei; Tanaka, Yuichiro; Moriyama, Muka; Morohoshi, Kei; Shimada, Noriaki; Yoshida, Takeshi; Ohno-Matsui, Kyoko			Chorioretinal Folds in Eyes With Myopic Staphyloma	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							TILTED DISC SYNDROME; OPTICAL COHERENCE TOMOGRAPHY; INFERIOR STAPHYLOMA; PATHOLOGICAL MYOPIA; SHAPE	PURPOSE: To determine the frequency and clinical characteristics of chorioretinal folds emanating from the edge of a staphyloma in highly myopic patients. DESIGN: Observational case series. METHODS: Eight hundred and eighty-three eyes of 463 patients with an axial length >= 26.5 mm in at least 1 eye were studied. The fellow eyes of patients with unilateral high myopia were also included. Wide-field fundus images and fundus autofluorescence images were used to detect chorioretinal folds emanating from the staphyloma edge. In 100 patients, the eye shape was analyzed by 3-dimensional magnetic resonance imaging (3D MRI). RESULTS: A posterior staphyloma was found in 459 of the 883 eyes (52.0%). Choroidal folds radiating from the staphyloma edge were found in 6 of the 459 eyes (1.3%) with a posterior staphyloma in wide-field autofluorescent images. The axial length varied greatly from 24.3 mm to 32.5 mm. Regardless of the axial length, all of the 6 eyes had a wide, macular type of staphyloma. Chorioretinal folds emanated from the upper or upper-temporal staphyloma edge. 3D MRI images showed the presence of a notch along the upper or temporal edge of the outpouching, and the eye curvature became flatter toward the steep edge of the outpouching. CONCLUSIONS: Chorioretinal folds can emanate from the staphyloma edge in highly myopic patients even though the edge was away from the macula. Some directional force toward the steeper edge of the staphyloma might be related to the development of chorioretinal folds. (C) 2015 by Elsevier Inc. All rights reserved.	[Ishida, Tomoka; Shinohara, Kosei; Tanaka, Yuichiro; Moriyama, Muka; Morohoshi, Kei; Shimada, Noriaki; Yoshida, Takeshi; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo 1138510, Japan	Ohno-Matsui, K (reprint author), Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	k.ohno.oph@tmd.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [25670727]	ALL AUTHORS HAVE COMPLETED AND SUBMITTED THE ICMJE FORM FOR DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST and none were reported. Supported in part by research grant 25670727 from the Japan Society for the Promotion of Science, Tokyo, Japan. All authors attest that they meet the current ICMJE requirements to qualify as authors.	Moriyama M, 2012, INVEST OPHTH VIS SCI, V53, P4510, DOI 10.1167/iovs.12-9426; Ohno-Matsui K, 2014, OPHTHALMOLOGY, V121, P1798, DOI 10.1016/j.ophtha.2014.03.035; Steidl SM, 1997, AM J OPHTHALMOL, V123, P181; Olsen TW, 2014, AM J OPHTHALMOL, V157, P1038, DOI 10.1016/j.ajo.2014.02.021; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; Moriyama M, 2011, OPHTHALMOLOGY, V118, P1626, DOI 10.1016/j.ophtha.2011.01.018; Ohno-Matsui K, 2012, INVEST OPHTH VIS SCI, V53, P6046, DOI 10.1167/iovs.12-10161; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Cohen SY, 2009, EUR J OPHTHALMOL, V19, P876; Cohen SY, 2006, GRAEF ARCH CLIN EXP, V244, P1536, DOI 10.1007/s00417-006-0302-x; Fine Howard F, 2009, Retin Cases Brief Rep, V3, P137, DOI 10.1097/ICB.0b013e3181679f91; Ishida T, 2014, OPHTHALMOLOGY, V122, P215; Ohno-Matsui K, 2011, JPN J OPHTHALMOL, V55, P171, DOI 10.1007/s10384-010-0920-z; Pruett R C, 1998, Curr Opin Ophthalmol, V9, P16, DOI 10.1097/00055735-199806000-00004; Shinohara K, 2013, EYE, V27, P1234, DOI 10.1038/eye.2013.202	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	SEP	2015	160	3					608	613		10.1016/j.ajo.2015.05.028		6	Ophthalmology	Ophthalmology	CP6AG	WOS:000359966100027		
J	Kurihara, Y; Hanya, G				Kurihara, Yosuke; Hanya, Goro			Comparison of Feeding Behavior between Two Different-Sized Groups of Japanese Macaques (Macaca fuscata yakui)	AMERICAN JOURNAL OF PRIMATOLOGY			English	Article						feeding competition; ecological constraints model; patch use; group size; Macaca fuscata yakui	GROUP CONTEST COMPETITION; WHITE COLOBUS MONKEYS; LONG-TAILED MACAQUES; REPRODUCTIVE SUCCESS; FOOD COMPETITION; CAPUCHIN MONKEYS; INTERGROUP COMPETITION; SOCIAL RELATIONSHIPS; FORAGING SUCCESS; YAKUSHIMA	Group-living animals face intragroup scramble and intergroup contest competitions. Many studies have shown that larger groups bear the costs of intragroup scramble competition, which negatively affects the reproductive success of females. Unlike most primate species, Japanese macaques in the Yakushima coastal forest show increased reproductive success with group size. However, it remains unclear how group size affects the behavior of macaques. The present study examined the effects of group size on the feeding behavior of Japanese macaques in the Yakushima coastal forest. We investigated 9-13 adult females from two different-sized groups via focal animal sampling during October 2012-August 2013. We compared the feeding behavior, including patch use, between the two groups. The larger group had a larger home range and spent more time feeding, especially on mature leaves. This suggests that intragroup feeding competition should be more intense in the larger group than in the smaller group. The feeding of mature leaves might enable the larger group to increase the number of co-feeding individuals. Contrary to the predictions that the larger group travels longer distances and spends more time moving, the smaller group traveled longer distances, and spent more time moving, although the number of visited patches did not differ between the two groups. The immediate consequences of the loss of inter-group encounters could accumulate as daily travel costs, considering that group size is associated with inter-group dominance and that intergroup aggressive encounters occur frequently in the Yakushima coastal forest. This suggests that the smaller group has increased travel costs as a result of intergroup contest competition, which leads to decline in reproductive success. (C) 2015 Wiley Periodicals, Inc.	[Kurihara, Yosuke; Hanya, Goro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan	Kurihara, Y (reprint author), Kyoto Univ, Primate Res Inst, Kanrin 41-2, Inuyama, Aichi 4848506, Japan.	kurihara.yosuke.35s@st.kyoto-u.ac.jp			Cooperation Research Program of Wildlife Research Center [23370099]	Contract grant sponsor: Cooperation Research Program of Wildlife Research Center; contract grant number: 23370099.	AGETSUMA N, 1995, INT J PRIMATOL, V16, P595; Kazahari N, 2014, PRIMATES, V55, P179, DOI 10.1007/s10329-014-0410-x; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; Sugiura H, 2000, INT J PRIMATOL, V21, P519, DOI 10.1023/A:1005448120967; Harris TR, 2006, BEHAV ECOL SOCIOBIOL, V61, P317, DOI 10.1007/s00265-006-0261-6; Potts KB, 2011, INT J PRIMATOL, V32, P669, DOI 10.1007/s10764-011-9494-y; Takahata Y, 2006, PRIMATES, V47, P383, DOI 10.1007/s10329-006-0185-9; Borries C, 2008, BEHAV ECOL, V19, P1186, DOI 10.1093/beheco/arn088; Scarry CJ, 2013, ANIM BEHAV, V85, P931, DOI 10.1016/j.anbehav.2013.02.013; Yamagiwa J, 1998, PRIMATES, V39, P257, DOI 10.1007/BF02573076; Koenig A, 2000, BEHAV ECOL SOCIOBIOL, V48, P93, DOI 10.1007/s002650000198; CHENEY DL, 1987, BEHAV ECOL SOCIOBIOL, V21, P375, DOI 10.1007/BF00299932; Gogarten JF, 2014, INT J PRIMATOL, V35, P590, DOI 10.1007/s10764-014-9770-8; JANSON CH, 1988, BEHAVIOUR, V105, P165, DOI 10.1163/156853988X00502; Dunn JC, 2013, INT J PRIMATOL, V34, P246, DOI 10.1007/s10764-013-9657-0; Hill DA, 1997, AM J PRIMATOL, V43, P305; Dunn JC, 2012, BIOTROPICA, V44, P705, DOI 10.1111/j.1744-7429.2012.00856.x; Koenig A, 2002, INT J PRIMATOL, V23, P759, DOI 10.1023/A:1015524931226; Majolo B, 2008, ANIM BEHAV, V76, P1235, DOI 10.1016/j.anbehav.2008.06.008; Steenbeek R, 2001, BEHAV ECOL SOCIOBIOL, V49, P100, DOI 10.1007/s002650000286; TUCKER VA, 1970, COMP BIOCHEM PHYSIOL, V34, P841, DOI 10.1016/0010-406X(70)91006-6; Thompson ME, 2012, BEHAV ECOL, V23, P1234, DOI 10.1093/beheco/ars107; Crofoot MC, 2013, AM J PHYS ANTHROPOL, V152, P79, DOI 10.1002/ajpa.22330; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; Chapman Colin A., 2012, P149; Chapman CA, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P24; Cords Marina, 2012, P289; Crofoot MC, 2007, BEHAVIOUR, V144, P1473, DOI 10.1163/156853907782512119; Hanya G, 2009, INT J PRIMATOL, V30, P569, DOI 10.1007/s10764-009-9361-2; Hanya G, 2008, PRIMATES, V49, P116, DOI 10.1007/s10329-007-0073-y; Harris TR, 2007, PRIMATES, V48, P208, DOI 10.1007/s10329-006-0036-8; Hirsch BT, 2013, ANIM BEHAV, V86, P331; Isbell LA, 2012, BEHAVIOUR, V149, P493, DOI 10.1163/156853912X641748; IWAMOTO T, 1982, Primates, V23, P153, DOI 10.1007/BF02381158; JANSON CH, 1988, BEHAVIOUR, V105, P53, DOI 10.1163/156853988X00449; Kazahari N, 2008, BEHAVIOUR, V145, P843, DOI 10.1163/156853908783929188; Kazahari N, 2010, BEHAVIOUR, V147, P1481, DOI 10.1163/000579510X521573; Kazahari N, 2013, BEHAVIOUR, V150, P175, DOI 10.1163/1568539X-00003044; Majolo B, 2009, BEHAVIOUR, V146, P113, DOI 10.1163/156853908X390959; Maruhashi T, 1998, PRIMATES, V39, P291, DOI 10.1007/BF02573078; Matsubara M, 2004, INT J PRIMATOL, V25, P901, DOI 10.1023/B:IJOP.0000029128.00559.91; McCabe GM, 2013, AM J PRIMATOL, V75, P1196, DOI 10.1002/ajp.22182; ROBINSON JG, 1988, BEHAV ECOL SOCIOBIOL, V23, P187, DOI 10.1007/BF00300353; Saito C, 1998, PRIMATES, V39, P303, DOI 10.1007/BF02573079; Sanderson CE, 2014, POPUL ECOL, V56, P417, DOI 10.1007/s10144-013-0410-5; Srikosamatara S, 1987, THESIS U FLORIDA GAI, P126; Suzuki S, 1998, PRIMATES, V39, P313; Takahata Y, 1998, PRIMATES, V39, P339, DOI 10.1007/BF02573082; Tombak KJ, 2012, PRIMATES, V53, P57, DOI 10.1007/s10329-011-0274-2; Tsujino R, 2007, J PLANT RES, V120, P687, DOI 10.1007/s10265-007-0111-2; VANSCHAIK CP, 1983, BEHAV ECOL SOCIOBIOL, V13, P173; YAMAGIWA J, 1985, Primates, V26, P105, DOI 10.1007/BF02382011; Yoshihiro S, 1999, PRIMATES, V40, P409, DOI 10.1007/BF02557562; Zhao DP, 2011, FOLIA PRIMATOL, V82, P1, DOI 10.1159/000326058	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-2565	1098-2345		AM J PRIMATOL	Am. J. Primatol.	SEP	2015	77	9					986	1000		10.1002/ajp.22429		15	Zoology	Zoology	CP7MK	WOS:000360072000006		
J	Basabose, AK; Inoue, E; Kamungu, S; Murhabale, B; Akomo-Okoue, EF; Yamagiwa, J				Basabose, Augustin K.; Inoue, Eiji; Kamungu, Sebulimbwa; Murhabale, Bertin; Akomo-Okoue, Etienne-Francois; Yamagiwa, Juichi			Estimation of Chimpanzee Community Size and Genetic Diversity in Kahuzi-Biega National Park, Democratic Republic of Congo	AMERICAN JOURNAL OF PRIMATOLOGY			English	Article						chimpanzee; genetic mark-recapture; genetic diversity; community size; conservation	PAN-TROGLODYTES-SCHWEINFURTHII; MONTANE FOREST; WILD CHIMPANZEES; POPULATION-SIZE; Y-CHROMOSOME; NONINVASIVE SAMPLES; NATURAL-POPULATIONS; GRAUERS GORILLAS; DNA; IDENTIFICATION	A small chimpanzee habitat in the montane forest of Kahuzi-Biega National Park, Democratic Republic of Congo, is connected with the lowland forest of this park through a corridor, which is affected by human encroachment. To assess the conservation status of the chimpanzee population in this small habitat, we estimated the size of the community and evaluated its genetic diversity by using 279 fecal samples collected in the montane forest of Kahuzi. Using autosomal microsatellite (or short tandem repeat, STR) loci, we identified 32 individuals, comprising 19 females and 13 males. Samples from 24 individuals were collected at least twice and a genetic mark-recapture analysis estimated that the community size was 36 (range: 32-42). Data on nest site sharing confirmed that all the samples belonged to the same community. Nest site sharing information may be useful in population studies of unhabituated chimpanzees. The genetic structure and diversity of the 32 genotyped individuals was assessed using Y-chromosomal short tandem repeat (Y-STR) loci and mitochondrial D-loops. One dominant Y-STR haplotype was found, whereas there was no dominant haplotype in the mitochondrial region, reflecting a female-biased dispersal pattern, which is typical of chimpanzees. The genetic diversity for three markers in Kahuzi chimpanzees was comparable to that in other eastern chimpanzee populations. A relatively high heterozygosity and negative inbreeding coefficient (FIS) for STR loci suggests that the study community belongs to an outbreeding chimpanzee population. These findings suggest that individuals of the study community may have reproductive contact with other chimpanzee individuals from neighboring communities in Kahuzi-Biega National Park, at least in the recent past. (C) 2015 Wiley Periodicals, Inc.	[Basabose, Augustin K.; Kamungu, Sebulimbwa; Murhabale, Bertin] Ctr Rech & Sci Naturelles Lwiro, Lab Primatol, Lwiro, Congo; [Inoue, Eiji; Akomo-Okoue, Etienne-Francois; Yamagiwa, Juichi] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan	Inoue, E (reprint author), Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan.	inoue@jinrui.zool.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [162550080, 19107007, 2425501, 23770281]	Contract grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology, Japan; contract grant numbers: 162550080, 19107007. contract grant numbers: 2425501, 23770281.	Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; Hayaishi S, 2006, PRIMATES, V47, P158, DOI 10.1007/s10329-005-0169-1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Arandjelovic M, 2010, BIOL CONSERV, V143, P1780, DOI 10.1016/j.biocon.2010.04.030; TUTIN CEG, 1984, AM J PRIMATOL, V6, P313, DOI 10.1002/ajp.1350060403; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Basabose AK, 2004, PRIMATES, V45, P211, DOI 10.1007/s10329-004-0087-7; Gray M, 2013, BIOL CONSERV, V158, P230, DOI 10.1016/j.biocon.2012.09.018; Inoue E, 2007, PRIMATES, V48, P156, DOI 10.1007/s10329-006-0017-y; Plumptre AJ, 2006, PRIMATES, V47, P65, DOI 10.1007/s10329-005-0146-8; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Bradley BJ, 2001, CONSERV GENET, V2, P179, DOI 10.1023/A:1011847528045; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Basabose AK, 2002, AM J PRIMATOL, V58, P1, DOI 10.1002/ajp.10049; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Arandjelovic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014761; Basabose AK, 2005, INT J PRIMATOL, V26, P33, DOI 10.1007/s10764-005-0722-1; Basabose AK, 2002, INT J PRIMATOL, V23, P262; Basabose K, 1997, PRIMATES, V38, P45, DOI 10.1007/BF02385921; Boesch C, 2000, CHIMPANZEES TAI FORE, P328; Borgatti S. P., 2002, UCINET 6 WINDOWS SOF; Bradley Brenda J., 2000, Conservation Genetics, V1, P289, DOI 10.1023/A:1011514007741; Chancellor RL, 2012, INT J PRIMATOL, V33, P479, DOI 10.1007/s10764-012-9591-6; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Erler A, 2004, MOL ECOL, V13, P2921, DOI 10.1111/j.1365-294X.2004.02304.x; Goodall J, 1986, CHIMPANZEES GOMBE PA, P673; Gusmao L, 2002, AM J PRIMATOL, V57, P21, DOI 10.1002/ajp.1084; Hall JS, 1998, INT J PRIMATOL, V19, P207, DOI 10.1023/A:1020375430965; Hollestelle M, 2012, ELEPHANTS FIGHT IT I; Inoue Eiji, 2013, Primate Conservation, V26, P67; Inoue E, MAHALE CHIM IN PRESS; Inoue E, 2008, AM J PHYS ANTHROPOL, V137, P256, DOI 10.1002/ajpa.20865; Inskipp Tim, 2005, P53; Janecka JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089384; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Langergraber KE, 2014, J HUM EVOL, V69, P1, DOI 10.1016/j.jhevol.2013.12.005; Langergraber KE, 2014, AM J PRIMATOL, V76, P640, DOI 10.1002/ajp.22258; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Mckechnie S, 2007, J WILDLIFE MANAGE, V71, P1325, DOI 10.2193/2006-018; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Moore DL, 2014, AM J PRIMATOL, V77, P335; Moore DL, 2014, CONSERV GENET, V15, P495, DOI 10.1007/s10592-013-0556-x; Nei M., 1987, MOL EVOLUTIONARY GEN, P512; NISHIDA T, 1985, Z TIERPSYCHOL, V67, P284; Nishida T., 1972, Kyoto Univ Afr Stud, V7, P131; Nishida T, 1990, CHIMPANZEES MAHALE M; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; Pusey AE, 1979, GREAT APES, P465; Refisch J, 1991, PRESENCE GRANDS MAMM; Rivera-Ortiz FA, 2015, ANIM CONSERV, V18, P249, DOI 10.1111/acv.12165; Saltonstall K, 1998, J HERED, V89, P129, DOI 10.1093/jhered/89.2.129; Shimada MK, 2009, FOLIA PRIMATOL, V80, P19, DOI 10.1159/000181187; Takahata H, 1989, AFR STUDY MONOGR, V9, P209; van Schaik CP, 1995, THE NEGLECTED APE, P129; Wrangham RW, 1979, GREAT APES, P481; Yamagiwa J., 2003, Journal of Sustainable Forestry, V16, P115, DOI 10.1300/J091v16n03_06; Yamagiwa Juichi, 2012, P385; Yamagiwa Juichi, 1992, African Study Monographs, V13, P217	70	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-2565	1098-2345		AM J PRIMATOL	Am. J. Primatol.	SEP	2015	77	9					1015	1025		10.1002/ajp.22435		11	Zoology	Zoology	CP7MK	WOS:000360072000008		
J	Kawasaki, T; Fujii, K; Akahane, K				Kawasaki, Toshio; Fujii, Keisuke; Akahane, Keiichi			Estimation of Organ and Effective Doses for Neonate and Infant Diagnostic Cardiac Catheterizations	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						anthropomorphic phantoms; diagnostic cardiac catheterization; effective dose; organ dose; pediatrics	RADIATION EXPOSURE; PEDIATRIC-PATIENT; ANGIOCARDIOGRAPHY	OBJECTIVE. Radiation exposure to neonates and infants during cardiac catheterizations is an important issue. Smaller patient size and higher heart rate in these patients result in a greater need for magnification modes and higher frame rates, all of which contribute to a significant increase in radiation doses. The aims of our study were to evaluate organ and effective doses for neonates and infants during diagnostic cardiac catheterizations on the basis of in-phantom dosimetry and conversion factors from dose-area product (DAP) to the effective dose. MATERIALS AND METHODS. Organ doses for 0- and 1-year-old children during diagnostic cardiac catheterizations were measured by radiophotoluminescence glass dosimeters implanted in neonate and infant anthropomorphic phantoms. The effective doses were evaluated according to recommendations of the International Commission on Radiologic Protection (ICRP) publication 103. RESULTS. The mean effective doses evaluated according to ICRP 103 were 7.7 mSv (range, 0.1-18.4 mSv) for a neonate and 7.3 mSv (range, 1.9-18.6 mSv) for an infant. Conversion factors from DAP to the effective dose were 2.2 and 4.0 in posteroanterior and lateral cine angiography, respectively, for a neonate and 1.4 and 2.7 in posteroanterior and lateral cine angiography, respectively, for an infant. CONCLUSION. The dose data and conversion factors evaluated in this study could be useful for the estimation of radiation exposure in neonates and infants during diagnostic cardiac catheterization.	[Kawasaki, Toshio] Kanagawa Childrens Med Ctr, Dept Radiol Technol, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Fujii, Keisuke] Nagoya Univ, Sch Hlth Sci, Nagoya, Aichi 4648601, Japan; [Akahane, Keiichi] Natl Inst Radiol Sci, Med Exposure Res Promot Sect, Chiba 260, Japan	Kawasaki, T (reprint author), Kanagawa Childrens Med Ctr, Dept Radiol Technol, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	kawasakipencil@yahoo.co.jp					Betsou S, 1998, BRIT J RADIOL, V71, P634; Bacher K, 2005, CIRCULATION, V111, P83, DOI 10.1161/01.CIR.0000151098.52656.3A; Justino H, 2006, PEDIATR RADIOL, V36, P146, DOI 10.1007/s00247-006-0194-2; [Anonymous], 2007, ANN ICRP, V37, P1, DOI 10.1016/j.icrp.2007.09.001; Boothroyd A, 1997, BRIT J RADIOL, V70, P180; Fujii K, 2011, RADIAT PROT DOSIM, V147, P151, DOI 10.1093/rpd/ncr289; International Commission on Radiological Protection, 1991, ANN ICRP, V21, P1; International Commission on Radiological Protection, 1996, ICRP PUBL, V70; Jones NF, 2001, BRIT J RADIOL, V74, P920; Karambatsakidou A, 2009, BRIT J RADIOL, V82, P748, DOI 10.1259/bjr/57217783; Li LB, 2001, RADIAT PROT DOSIM, V94, P323; MARTIN EC, 1980, BRIT J RADIOL, V53, P100; MARTIN EC, 1981, CIRCULATION, V64, P153; Neshandar Asli I, 2005, IRAN J RADIOL, V3, P35; Nishizawa K, 2003, RADIAT PROT DOSIM, V107, P247; Schultz FW, 2003, BRIT J RADIOL, V76, P638, DOI 10.1259/bjr/21647806; Valentin J, 2000, Ann ICRP, V30, P7, DOI 10.1016/S0146-6453(01)00004-5; WALDMAN JD, 1981, CIRCULATION, V64, P158	18	0	0	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	SEP	2015	205	3					599	603		10.2214/AJR.14.13852		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP6KW	WOS:000359997100042		
J	Itou, C; Koizumi, J; Hashimoto, T; Myojin, K; Kagawa, T; Mine, T; Imai, Y				Itou, Chihiro; Koizumi, Jun; Hashimoto, Takeshi; Myojin, Kazunori; Kagawa, Tatehiro; Mine, Tetsuya; Imai, Yutaka			Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						balloon-occluded retrograde transvenous obliteration; ethanolamine oleate; gastric varices; hemolysis; polidocanol foam	FUNDAL VARICES; SCLEROTHERAPY; COMPLICATIONS; EXPERIENCE; SHUNTS; IMPACT; VEINS; BRTO	OBJECTIVE. The purpose of this study was to evaluate the clinical results of the management of gastric varices by balloon-occluded retrograde transvenous obliteration with polidocanol foam versus ethanolamine oleate. MATERIALS AND METHODS. Twenty patients treated with ethanolamine oleate and 21 patients treated with polidocanol foam were enrolled in this study. Early therapeutic effects were assessed mainly by dynamic contrast-enhanced CT. Subjective symptoms, objective findings associated with the procedures, and changes in laboratory data during the obliteration process were evaluated. Rebleeding from gastric varices was assessed after the procedures. RESULTS. Complete obliteration was confirmed in all but one case of early recanalization after treatment with polidocanol foam. One patient died of acute respiratory distress syndrome after treatment with ethanolamine oleate. The total sclerosant volume was significantly lower for 3% polidocanol foam (13.5 +/- 6.8 mL) than for 5% ethanolamine oleate (30.6 +/- 15.6 mL) (p < 0.01). Polidocanol foam caused fewer severe reactions, including pain, during and after injection. High body temperature, hemoglobinuria, and reactive pleural effusion were not observed with polidocanol foam. The variance in laboratory data values associated with hemolysis was significantly greater with ethanolamine oleate. No postprocedural rebleeding from the gastric varices was observed during a median follow-up time of 39.5 months after procedures with ethanolamine oleate and 34 months after procedures with polidocanol foam. CONCLUSION. Polidocanol foam can achieve obliteration of gastric varices comparable to that of ethanolamine oleate but with a significantly lower sclerosant dose and reduced risk of hemolysis-induced complications and harmful reactions, including pain and fever.	[Itou, Chihiro; Koizumi, Jun; Imai, Yutaka] Tokai Univ, Sch Med, Dept Diagnost Radiol, Isehara, Kanagawa 2591193, Japan; [Myojin, Kazunori] Tokai Univ, Oiso Hosp, Dept Diagnost Radiol, Isehara, Kanagawa 2591193, Japan; [Kagawa, Tatehiro; Mine, Tetsuya] Tokai Univ, Sch Med, Dept Gastroenterol & Hepatol, Isehara, Kanagawa 2591193, Japan	Itou, C (reprint author), Tokai Univ, Sch Med, Dept Diagnost Radiol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	qq4d52gf9@sirius.ocn.ne.jp					Akahoshi T, 2008, J GASTROEN HEPATOL, V23, P1702, DOI 10.1111/j.1440-1746.2008.05549.x; Akahoshi T, 2012, HEPATOL RES, V42, P385, DOI 10.1111/j.1872-034X.2011.00939.x; Smith PC, 2009, PHLEBOLOGY, V24, P260, DOI 10.1258/phleb.2009.009050; Kanagawa H, 1996, J GASTROEN HEPATOL, V11, P51, DOI 10.1111/j.1440-1746.1996.tb00010.x; Ninoi T, 2005, AM J ROENTGENOL, V184, P1340; Guex JJ, 2005, DERMATOL SURG, V31, P123; Cho SK, 2007, AM J ROENTGENOL, V189, pW365, DOI 10.2214/AJR.07.2266; Koito K, 1996, AM J ROENTGENOL, V167, P1317; Arai H, 2005, J GASTROENTEROL, V40, P964, DOI 10.1007/s00535-005-1654-4; Shimoda R, 2005, ABDOM IMAGING, V30, P306, DOI 10.1007/s00261-004-0270-8; Tessari L, 2001, DERMATOL SURG, V27, P58, DOI 10.1111/j.1524-4725.2001.00192.x; Sabri SS, 2011, J VASC INTERV RADIOL, V22, P309, DOI 10.1016/j.jvir.2010.11.022; Kitamoto M, 2002, AM J ROENTGENOL, V178, P1167; Choi SY, 2011, EUR RADIOL, V21, P122, DOI 10.1007/s00330-010-1895-3; Forlee MV, 2006, J VASC SURG, V43, P162, DOI 10.1016/j.jvs.2005.09.032; Fukuda T, 2001, J VASC INTERV RADIOL, V12, P327, DOI 10.1016/S1051-0443(07)61912-5; Hirota S, 1999, RADIOLOGY, V211, P349; Darwish WM, 2014, AM J ROENTGENOL, V203, P439, DOI 10.2214/AJR.12.8543; Demagny A., 2002, Phlebologie, V55, P133; GOLDMAN PM, 1989, J DERMATOL SURG ONC, V15, P204; Hiraga N, 2007, J GASTROENTEROL, V42, P663, DOI 10.1007/s00535-007-2077-1; Koizumi J, 2012, J VASC INTERV RADIOL, V23, P1453, DOI 10.1016/j.jvir.2012.08.004; Koizumi J, 2012, AM J ROENTGENOL, V199, P200, DOI 10.2214/AJR.11.7002; LEE H, 1992, CRIT CARE MED, V20, P1555, DOI 10.1097/00003246-199211000-00013; Marrocco-Trischitta MM, 2002, DERMATOL SURG, V28, P153, DOI 10.1046/j.1524-4725.2002.00344.x; McAree B, 2012, EUR J VASC ENDOVASC, V43, P721, DOI 10.1016/j.ejvs.2012.02.026; Saad Wael E A, 2012, Tech Vasc Interv Radiol, V15, P160, DOI 10.1053/j.tvir.2012.07.002; Saad Wael E A, 2012, Semin Intervent Radiol, V29, P118, DOI 10.1055/s-0032-1312573; Saad Wael E A, 2011, Semin Intervent Radiol, V28, P283, DOI 10.1055/s-0031-1284454; Saad Wael E A, 2011, Semin Intervent Radiol, V28, P339, DOI 10.1055/s-0031-1284461; Saad Wael E, 2013, Tech Vasc Interv Radiol, V16, P152, DOI 10.1053/j.tvir.2013.02.006; Sonomura T, 1998, CARDIOVASC INTER RAD, V21, P27, DOI 10.1007/s002709900206	32	0	0	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	SEP	2015	205	3					659	666		10.2214/AJR.14.13389		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP6KW	WOS:000359997100049		
J	Nakamura, T; Nakao, T; Yoshimura, N; Ashihara, E				Nakamura, T.; Nakao, T.; Yoshimura, N.; Ashihara, E.			Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						Animal models: murine; basic (laboratory) research; science; cellular biology; heart (allograft) function; dysfunction; heart transplantation; cardiology; immune regulation; immunosuppression; immune modulation; immunosuppressant; mechanistic target of rapamycin:sirolimus; translational research; science	COLONY-STIMULATING FACTOR; TUMOR-BEARING MICE; DENDRITIC CELLS; T-CELLS; NITRIC-OXIDE; GM-CSF; ACTIVATION; EXPANSION; PATHWAYS; INHIBITION	Mammalian target of rapamycin (mTOR) inhibitors are the main immunosuppressive drugs for organ transplant recipients. Nevertheless, the mechanisms by which mTOR inhibitors induce immunosuppression is not fully understood. Myeloid-derived suppressor cells (MDSCs) maintain host immunity; however, the relationship between mTOR inhibitors and MDSCs is unclear. Here, the results from a murine cardiac transplantation model revealed that rapamycin treatment (3mg/kg, intraperitoneally on postoperative days 0, 2, 4, and 6) led to the recruitment of MDSCs and increased their expression of inducible nitric oxide synthase (iNOS). Immunohistochemical analysis revealed that rapamycin induced the migration of iNOS-expressing MDSCs into the subintimal space within the allograft vessels, resulting in a significant prolongation of graft survival compared with that in the untreated group (67 days vs. 7 days, respectively). These effects were counterbalanced by the administration of an anti-Gr-1, which reduced allograft survival to 21 days. Moreover, adoptive transcoronary arterial transfer of MDSCs from rapamycin-treated recipients prolonged allograft survival; this increase was reversed by the anti-Gr-1 antibody. Finally, co-administration of rapamycin and a mitogen-activated protein kinase kinase (MEK) inhibitor trametinib reversed rapamycin-mediated MDSC recruitment. Thus, the mTOR and Raf/MEK/extracellular signal regulated kinase (ERK) signaling pathways appear to play an important role in MDSC expansion.	[Nakamura, T.; Nakao, T.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Transplantat & Regenerat Surg, Grad Sch Med Sci, Kamigyo Ku, Kyoto, Kyoto 602, Japan; [Nakamura, T.; Nakao, T.; Ashihara, E.] Kyoto Pharmaceut Univ, Dept Clin & Translat Physiol, Yamashina Ku, Kyoto 607, Japan	Ashihara, E (reprint author), Kyoto Pharmaceut Univ, Dept Clin & Translat Physiol, Yamashina Ku, Kyoto 607, Japan.	ash@mb.kyoto-phu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan	We thank Dr. Ushigome (Department of Organ Transplantation and General Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan), Dr. Uchiyama, Dr. Jin and Dr. Niimi (Department of Surgery, Teikyo University, Tokyo, Japan) for special advice regarding CTx. We also thank Dr. Fujii (Department of Inflammation and Immunology, Kyoto Prefectural University of Medicine) for technical assistance. This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan.	Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Raber PL, 2014, INT J CANCER, V134, P2853, DOI 10.1002/ijc.28622; Dugast AS, 2008, J IMMUNOL, V180, P7898; Valentino JD, 2014, CLIN CANCER RES, V20, P1212, DOI 10.1158/1078-0432.CCR-13-1897; Watt KDS, 2010, AM J TRANSPLANT, V10, P1420, DOI 10.1111/j.1600-6143.2010.03126.x; Menetrier-Caux C, 1998, BLOOD, V92, P4778; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Chen HW, 2013, J IMMUNOL, V190, P5065, DOI 10.4049/jimmunol.1202775; Eisen HJ, 2013, AM J TRANSPLANT, V13, P1203, DOI 10.1111/ajt.12181; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/JCI34739, 10.1172/jCI34739]; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Watson AL, 2014, ONCOTARGET, V5, P1502; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Garcia MR, 2010, J CLIN INVEST, V120, P2486, DOI 10.1172/JCI41628; Opelz G, 2013, AM J TRANSPLANT, V13, P2096, DOI 10.1111/ajt.12313; Horibe EK, 2008, TRANSPL IMMUNOL, V18, P307, DOI 10.1016/j.trim.2007.10.007; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Arakawa Y, 2014, TRANSPLANTATION, V97, P740, DOI 10.1097/01.TP.0000442504.23885.f7; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Taner T, 2005, AM J TRANSPLANT, V5, P228, DOI 10.1046/j.1600-6143.2004.00673.x; Turnquist HR, 2007, J IMMUNOL, V178, P7018; Couper KN, 2009, J IMMUNOL, V182, P3985, DOI 10.4049/jimmunol.0803053; Wang XR, 2008, CANCER BIOL THER, V7, P1952, DOI 10.4161/cbt.7.12.6944; Fujii W, 2013, J IMMUNOL, V191, P1073, DOI 10.4049/jimmunol.1203535; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Luan Y, 2013, AM J TRANSPLANT, V13, P3123, DOI 10.1111/ajt.12461; HESTDAL K, 1991, J IMMUNOL, V147, P22; Dai Z, 2014, AM J TRANSPLANT, V1, P39; Faber AC, 2009, P NATL ACAD SCI USA, V46, P19503; Garcia AJ, 2014, MOL CELL BIOL, V34, P2017, DOI 10.1128/MCB.00090-14; Grazia TJ, 2010, TRANSPLANTATION, V89, P33, DOI 10.1097/TP.0b013e3181be6bc7; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Hongo D, 2014, AM J TRANSPLANT, V14, P2467, DOI 10.1111/ajt.12914; Liao JB, 2014, J LEUKOCYTE BIOL, V96, P675, DOI 10.1189/jlb.2HI1113-611RR; Makki K, 2014, PLOS ONE, V4; Rosborough BR, 2012, J LEUKOCYTE BIOL, V91, P701, DOI 10.1189/jlb.0311119; Taylor JR, 2011, ONCOTARGET, V2, P610; Yuan HQ, 2014, BIOMED PHARMACOTHER, V68, P751, DOI 10.1016/j.biopha.2014.07.002; Zhang Y, 2014, J LEUKOCYTE BIOL, V6, P961	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	SEP	2015	15	9					2364	2377		10.1111/ajt.13276		14	Surgery; Transplantation	Surgery; Transplantation	CP7JD	WOS:000360062300011		
J	Nanto, K; Iida, O; Takahara, M; Soga, Y; Suzuki, K; Hirano, K; Kawasaki, D; Shintani, Y; Suematsu, N; Yamaoka, T; Uematsu, M				Nanto, Kiyonori; Iida, Osamu; Takahara, Mitsuyoshi; Soga, Yoshimitsu; Suzuki, Kenji; Hirano, Keisuke; Kawasaki, Daizo; Shintani, Yoshiaki; Suematsu, Nobuhiro; Yamaoka, Terutoshi; Uematsu, Masaaki			Effect of Cilostazol Following Endovascular Intervention for Peripheral Artery Disease	ANGIOLOGY			English	Article						peripheral artery disease; cilostazol; restenosis	SUPERFICIAL FEMORAL-ARTERY; FEMOROPOPLITEAL LESIONS; STENT IMPLANTATION; BALLOON ANGIOPLASTY; RANDOMIZED-TRIAL; RESTENOSIS; THERAPY; EFFICACY; CLAUDICATION; SOCIETY	Efficacy of endovascular therapy (EVT) with nitinol stents for femoropopliteal (FP) lesions is limited by restenosis. Oral cilostazol reduces angiographic restenosis rate; however, treatment duration remains unclear. In a retrospective analysis of a multicenter database of 3471 consecutive limbs in 2737 patients (mean age: 72 +/- 9 years; 61% diabetic; and 26% on regular dialysis) undergoing EVT for FP lesions between January 2004 and December 2011, we compared Kaplan-Meier estimated primary patency after EVT followed or not by cilostazol treatment. We used Cox hazard regression analysis to assess temporal association between cilostazol treatment and post-EVT restenosis. Five-year primary patency was higher in the cilostazol group than in the noncilostazol group (57% vs 47%, P < .0001). Cilostazol treatment was inversely associated with restenosis for the first 2 years following EVT (P < .05); however, no significant association was observed thereafter. Cilostazol use therefore appears efficacious in preventing restenosis up to 2 years after EVT for FP lesions.	[Nanto, Kiyonori; Iida, Osamu; Uematsu, Masaaki] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo 6608511, Japan; [Takahara, Mitsuyoshi] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan; [Soga, Yoshimitsu] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Japan; [Suzuki, Kenji] Sendai Kosei Hosp, Dept Cardiol, Sendai, Miyagi, Japan; [Hirano, Keisuke] Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Kawasaki, Daizo] Morinomiya Hosp, Dept Cardiol, Osaka, Japan; [Shintani, Yoshiaki] Shin Koga Hosp, Dept Cardiol, Kurume, Fukuoka, Japan; [Suematsu, Nobuhiro] Fukuoka Red Cross Hosp, Dept Cardiol, Fukuoka, Japan; [Yamaoka, Terutoshi] Matsuyama Red Cross Hosp, Dept Vasc Surg, Matsuyama, Ehime, Japan	Nanto, K (reprint author), Kansai Rosai Hosp, Ctr Cardiovasc, 3-1-69 Inabaso, Amagasaki, Hyogo 6608511, Japan.	kiyonori.nanto@gmail.com					Iida O, 2013, CIRCULATION, V127, P2307, DOI 10.1161/CIRCULATIONAHA.112.000711; Tsuchikane E, 1999, CIRCULATION, V100, P21; Laird JR, 2010, CIRC-CARDIOVASC INTE, V3, P267, DOI 10.1161/CIRCINTERVENTIONS.109.903468; PAN XL, 1994, BIOCHEM PHARMACOL, V48, P827, DOI 10.1016/0006-2952(94)90062-0; Soga Y, 2009, J AM COLL CARDIOL, V53, P48, DOI 10.1016/j.jacc.2008.09.020; Douglas JS, 2005, CIRCULATION, V112, P2826, DOI 10.1161/CIRCULATIONAHA.104.530097; Jang JS, 2012, CARDIOLOGY, V122, P133, DOI 10.1159/000339238; Suh JW, 2011, J AM COLL CARDIOL, V57, P280, DOI 10.1016/j.jacc.2010.08.631; Soga Y, 2010, J VASC SURG, V52, P608, DOI 10.1016/j.jvs.2010.03.050; Rowe VL, 2009, J VASC SURG, V49, P910, DOI 10.1016/j.jvs.2008.11.054; Iida O, 2008, J VASC SURG, V48, P144, DOI 10.1016/j.jvs.2008.02.062; Dake MD, 2013, J AM COLL CARDIOL, V61, P2417, DOI 10.1016/j.jacc.2013.03.034; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; CAPEK P, 1991, CIRCULATION, V83, P70; Hagenaars T, 2000, AM J CARDIOL, V86, P774, DOI 10.1016/S0002-9149(00)01079-1; Jeffrey L, 2013, CIRCULATION, V127, P1425; Morris-Stiff G, 2011, ANN ROY COLL SURG, V93, P306, DOI 10.1308/003588411X571999; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Regensteiner JG, 2006, NAT CLIN PRACT CARD, V3, P604, DOI 10.1038/ncpcardio0660; Schillinger M, 2012, CIRCULATION, V126, P2433, DOI 10.1161/CIRCULATIONAHA.111.036574; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Warner CJ, 2014, J VASC SURG, V59, P1607, DOI 10.1016/j.jvs.2013.11.096	22	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	SEP	2015	66	8					774	778		10.1177/0003319714551361		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP5KF	WOS:000359919700013		
J	Sato, N; Tan, L; Tate, K; Okada, M				Sato, Nobuya; Tan, Ling; Tate, Kazushi; Okada, Maya			Rats demonstrate helping behavior toward a soaked conspecific	ANIMAL COGNITION			English	Article						Prosocial behavior; Helping behavior; Empathy; Rats	HUMAN ALTRUISM; EMPATHY; CHIMPANZEES; OTHERS; PAIN; MICE	Helping behavior is a prosocial behavior whereby an individual helps another irrespective of disadvantages to him or herself. In the present study, we examined whether rats would help distressed, conspecific rats that had been soaked with water. In Experiment 1, rats quickly learned to liberate a soaked cagemate from the water area by opening the door to allow the trapped rat into a safe area. Additional tests showed that the presentation of a distressed cagemate was necessary to induce rapid door-opening behavior. In addition, it was shown that rats dislike soaking and that rats that had previously experienced a soaking were quicker to learn how to help a cagemate than those that had never been soaked. In Experiment 2, the results indicated that rats did not open the door to a cagemate that was not distressed. In Experiment 3, we tested behavior when rats were forced to choose between opening the door to help a distressed cagemate and opening a different door to obtain a food reward. Irrespective of how they learned to open the door, in most test trials, rats chose to help the cagemate before obtaining a food reward, suggesting that the relative value of helping others is greater than the value of a food reward. These results suggest that rats can behave prosocially and that helper rats may be motivated by empathy-like feelings toward their distressed cagemate.	[Sato, Nobuya; Tan, Ling; Tate, Kazushi; Okada, Maya] Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan	Sato, N (reprint author), Kwansei Gakuin Univ, Dept Psychol Sci, 1-1-155 Uegahara, Nishinomiya, Hyogo 6628501, Japan.	nsato@kwansei.ac.jp			JSPS KAKENHI [26118514, 24500481]	This work was supported by JSPS KAKENHI Grant Number 26118514 and 24500481.	Akyazi I, 2014, PHYSIOL BEHAV, V123, P114, DOI 10.1016/j.physbeh.2013.10.006; Shamay-Tsoory Simone G, 2011, Neuroscientist, V17, P18, DOI 10.1177/1073858410379268; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Barraza JA, 2009, ANN NY ACAD SCI, V1167, P182, DOI 10.1111/j.1749-6632.2009.04504.x; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126; Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Warneken F, 2009, BRIT J PSYCHOL, V100, P455, DOI 10.1348/000712608X379061; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Silberberg A, 2014, ANIM COGN, V17, P609, DOI 10.1007/s10071-013-0692-1; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; Atsak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021855; Bartal IB, 2014, ELIFE, V3, DOI 10.7554/eLife.01385; Bischof-Kohler D., 1991, INFANT DEV PERSPECTI, P245; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; Clay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055206; Decety J, 2011, DEV COGN NEUROSCI, V2, P1; HEYES CM, 1990, Q J EXP PSYCHOL-B, V42, P59; Hoffman M. L., 2000, EMPATHY MORAL DEV IM; Killcross S, 1996, J EXP PSYCHOL ANIM B, V22, P32; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Mogil JS, 2012, TRENDS COGN SCI, V16, P143, DOI 10.1016/j.tics.2011.12.012; RICE GE, 1962, J COMP PHYSIOL PSYCH, V55, P123, DOI 10.1037/h0042276; Viana DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008483; Yamamoto S, 2012, P NATL ACAD SCI USA, V109, P3588, DOI 10.1073/pnas.1108517109; ZENTALL TR, 1972, SCIENCE, V178, P1220, DOI 10.1126/science.178.4066.1220	35	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-9448	1435-9456		ANIM COGN	Anim. Cogn.	SEP	2015	18	5					1039	1047		10.1007/s10071-015-0872-2		9	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CP6JJ	WOS:000359992500005		
J	Sato, N; Tan, L; Tate, K; Okada, M				Sato, Nobuya; Tan, Ling; Tate, Kazushi; Okada, Maya			Rats demonstrate helping behavior toward a soaked conspecific (vol 18, pg 1039, 2015)	ANIMAL COGNITION			English	Correction									[Sato, Nobuya; Tan, Ling; Tate, Kazushi; Okada, Maya] Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan	Sato, N (reprint author), Kwansei Gakuin Univ, Dept Psychol Sci, 1-1-155 Uegahara, Nishinomiya, Hyogo 6628501, Japan.	nsato@kwansei.ac.jp					Sato N, 2015, ANIM COGN, V18, P1039, DOI 10.1007/s10071-015-0872-2	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-9448	1435-9456		ANIM COGN	Anim. Cogn.	SEP	2015	18	5					1049	1049		10.1007/s10071-015-0906-9		1	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CP6JJ	WOS:000359992500006		
J	Yamamoto, E; Goto, K; Watanabe, S				Yamamoto, Eriko; Goto, Kazuhiro; Watanabe, Shigeru			Pigeons (Columba livia) fail to connect dots in learning biological motion	ANIMAL COGNITION			English	Article						Motion discrimination; Point-light displays; Biological motion; Pigeons	PERCEPTION; DISCRIMINATIONS; CONSPECIFICS; INDIVIDUALS; CATEGORIES; IMAGES; CUES	Biological motion point-light displays provide a powerful method for studying motion perception. Nonhuman animals are capable of discriminating point-light displays, but it remains unknown how they perceive biological motion in these displays. We trained two groups of pigeons to discriminate video stimuli using two different classification rules. The motion-congruent group was trained to discriminate full-detail and corresponding point-light displays of pigeons from full-detail and point-light displays of humans. The motion-incongruent group was trained to discriminate full-detail pigeons and point-light humans from the other displays. Both groups acquired the discrimination. When tested with novel displays, pigeons showed good transfer of learning. Transfer was poorest with the point-light displays in the motion-congruent group. The results indicate that the pigeons failed to make the connection between the full-detail displays and their point-light counterparts even when the common motion was available as a cue.	[Yamamoto, Eriko] Univ Tokyo, Tokyo, Japan; [Goto, Kazuhiro] Sagami Womens Univ, Kanagawa, Japan; [Watanabe, Shigeru] Keio Univ, Tokyo, Japan	Yamamoto, E (reprint author), Univ Tokyo, Tokyo, Japan.	eyamamoto@ardbeg.c.u-tokyo.ac.jp			Global Center of Excellence program [D09]; JSPS KAKENHI [15J09751]; KAKENHI [22700271, 25730100]	The present research was supported by a grant from the Global Center of Excellence program to Keio University (D09), JSPS KAKENHI (15J09751), and KAKENHI (22700271, 25730100).	Qadri MAJ, 2015, COMP COGN BEHAV REV, V10, P73, DOI 10.3819/ccbr.2015.100004; WASSERMAN EA, 1988, J EXP PSYCHOL ANIM B, V14, P235, DOI 10.1037//0097-7403.14.3.235; Troje NF, 2013, VISION RES, V79, P47, DOI 10.1016/j.visres.2013.01.002; Brown J, 2010, ANIM COGN, V13, P555, DOI 10.1007/s10071-009-0306-0; RYAN CME, 1994, BEHAV PROCESS, V33, P155, DOI 10.1016/0376-6357(94)90064-7; BLAKE R, 1993, PSYCHOL SCI, V4, P54, DOI 10.1111/j.1467-9280.1993.tb00557.x; Cook RG, 2007, J EXP PSYCHOL ANIM B, V33, P287, DOI 10.1037/0097-7403.33.3.287; Cook RG, 1999, J EXP PSYCHOL ANIM B, V25, P194, DOI 10.1037//0097-7403.25.2.194; Dittrich WH, 1998, J EXP ANAL BEHAV, V70, P281, DOI 10.1901/jeab.1998.70-281; DITTRICH WH, 1993, J EXP ANAL BEHAV, V59, P115, DOI 10.1901/jeab.1993.59-115; Jitsumori M, 1999, ANIM LEARN BEHAV, V27, P303, DOI 10.3758/BF03199729; JOHANSSO.G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; MacKinnon LM, 2010, EXP BRAIN RES, V205, P571, DOI 10.1007/s00221-010-2378-0; Nakayasu T, 2014, ANIM COGN, V17, P559, DOI 10.1007/s10071-013-0687-y; Parron C, 2007, J EXP PSYCHOL ANIM B, V33, P381, DOI 10.1037/0097-7403.33.4.381; Qadri MAJ, 2014, J VISION, V14, DOI 10.1167/14.5.16; Regolin L., 2000, ANIMAL COGNITION, V3, P53, DOI DOI 10.1007/S100710050050; Tomonaga M, 2001, PSYCHOLOGIA, V44, P46; WATANABE S, 1993, BEHAV PROCESS, V30, P225, DOI 10.1016/0376-6357(93)90134-D; WATANABE S, 1991, BIRD BEHAV, V9, P20; Yamamoto E, 2007, COMP SOCIAL COGNITIO, P61	21	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-9448	1435-9456		ANIM COGN	Anim. Cogn.	SEP	2015	18	5					1187	1191		10.1007/s10071-015-0880-2		5	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CP6JJ	WOS:000359992500020		
J	Li, Y; Cagirici, HB; Horpaopan, S; Ott, J; Imai, A; Majewski, J; Lathrop, M				Li, Yi; Cagirici, Halise Busra; Horpaopan, Sukanya; Ott, Jurg; Imai, Atsuko; Majewski, Jacek; Lathrop, Mark			Leveling the Playing Field in Homozygosity Mapping Using Map Distances	ANNALS OF HUMAN GENETICS			English	Article						Homozygosity mapping; linkage disequilibrium; recombination	HUMAN GENOME; LINKAGE DISEQUILIBRIUM; MUTATIONS; POPULATIONS; RUNS	Studies of linkage disequilibrium (LD) and its variation in the genome are of central importance for understanding evolutionary history, population structure, and selective sweeps. Extreme forms of the latter may result in runs of homozygosity (ROH). In human gene mapping, long ROHs are the basis for homozygosity mapping (HM) with length measured in terms of Mb (10(6) base pairs physical distance). LD varies greatly over the human genome so that long ROHs tend to occur preferentially in regions of high LD and ROHs of the same length in different regions are not strictly comparable. Thus, in human gene mapping, LD appears as a confounder that needs to be taken into account in the interpretation of ROHs. The effect of varying LD can be mitigated by working on a scale of centimorgans (cM, genetic distance) instead of Mb. We demonstrate this effect for HapMap 3 data on chromosome 19 and show examples with different ROH lengths depending on whether physical or genetic lengths are used. These results suggest that HM should preferably be done on genetic rather than physical distances.	[Li, Yi] Shanxi Univ Finance & Econ, Sch Stat, Taiyuan, Shanxi, Peoples R China; [Cagirici, Halise Busra] Koc Univ, Dept Biomed Sci & Engn, Istanbul, Turkey; [Horpaopan, Sukanya] Naresuan Univ, Fac Med Sci, Dept Anat, Phitsanulok 65000, Thailand; [Ott, Jurg] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Ott, Jurg] Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; [Imai, Atsuko] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan; [Majewski, Jacek; Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Majewski, Jacek; Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	Ott, J (reprint author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	ottjurg@psych.ac.cn			NSFC [3147 0070]; Osaka University Scholarship for Short-term Overseas Research Activities; Canada Research Chairs Programme; Shanxi Scholarship Council of China [2013-072]; Natural Science Foundation of Shanxi [2014011030-4]	We would like to thank the Forge Canada Consortium and Dr. Frank Rauch for allowing us to use their data. This work was supported by China NSFC grant 3147 0070 (JO) and by the Osaka University Scholarship for Short-term Overseas Research Activities 2013 (AI). Dr. Majewski is supported by the Canada Research Chairs Programme. This work was also supported by the Shanxi Scholarship Council of China 2013-072 (YL) and by the Natural Science Foundation of Shanxi 2014011030-4 (YL). The authors declare no conflict of interest. As mentioned in the original publications reporting on the patients, studies were approved by the Institutional Review Board of McGill University and informed consent was provided by study participants.	Kalay E, 2012, AM J HUM GENET, V90, P76, DOI 10.1016/j.ajhg.2011.11.014; Laberge AM, 2005, CLIN GENET, V68, P287, DOI 10.1111/j.1399-0004.2005.00497.x; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; McVean G, 2007, GENETICS, V175, P1395, DOI 10.1534/genetics.106.062828; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Samuels ME, 2013, J MED GENET, V50, P324, DOI 10.1136/jmedgenet-2012-101483; Basel-Vanagaite L, 2012, AM J HUM GENET, V90, P49, DOI 10.1016/j.ajhg.2011.11.028; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Bloch-Zupan A, 2011, AM J HUM GENET, V89, P773, DOI 10.1016/j.ajhg.2011.11.002; Burns R, 2014, NEUROLOGY, V83, P2175, DOI 10.1212/WNL.0000000000001053; Clemente FJ, 2014, AM J HUM GENET, V95, P584, DOI 10.1016/j.ajhg.2014.09.016; Fahiminiya S., 2014, HUM MOL GENET, V24, P516; Genin E, 1998, ANN HUM GENET, V62, P419, DOI 10.1046/j.1469-1809.1998.6250419.x; Haghighi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112747; Huppke P, 2012, AM J HUM GENET, V90, P61, DOI 10.1016/j.ajhg.2011.11.030; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Ott J., 1999, ANAL HUMAN GENETIC L; Pippucci T, 2014, HUM HERED, V77, P63, DOI 10.1159/000362412; SMITH CAB, 1953, J ROY STAT SOC B, V15, P153; Steele LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123066; Tapper W, 2005, P NATL ACAD SCI USA, V102, P11835, DOI 10.1073/pnas.0505262102; Zhang L, 2011, HUM MUTAT, V32, P345, DOI 10.1002/humu.21432	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-4800	1469-1809		ANN HUM GENET	Ann. Hum. Genet.	SEP	2015	79	5					366	372		10.1111/ahg.12125		7	Genetics & Heredity	Genetics & Heredity	CP7UC	WOS:000360092800007		
J	Rahman, NHA; Islam, MT; Yamada, Y; Michishita, N				Rahman, Nurul H. Abd; Islam, Mohammad T.; Yamada, Yoshihide; Michishita, Naobumi			Design of Shaped-Beam Parabolic Reflector Antenna for Peninsular Malaysia Beam Coverage and its Overlapping Feed Issues	APPLIED COMPUTATIONAL ELECTROMAGNETICS SOCIETY JOURNAL			English	Article						Antenna feeds; arrays; caustic model; ray tracing; reflector; satellite antenna	SYSTEM	Design and performance of a shaped beam 12.2 GHz array-fed reflector antenna for broadcasting satellite is presented in this paper. Initial design, employing a cluster of feed horns illuminating a parabolic reflector is initially proposed for multi beam antenna (MBA) system to produce a contoured beam for Peninsular Malaysia. The precise feed positions are determined through a newly developed ray tracing program. Due to the small size of the coverage area, an issue with regards to physical constructability of the feed horns is raised. The MBA is modified by utilizing 18-element microstrip array as the feed, where each element positions are calculated by using the same caustic model. In this case, the preceding issue is solved, and high gain shaped beam coverage with uniform aperture is generated. This paper shows the results of the contoured beam antenna that have been achieved for beam scanned over a coverage size of approximately 0.9 degrees long and 0.5 degrees wide. Small variation of radiation level, which is less than 3dB within the edge of coverage (EOC), is also demonstrated in the performance analysis.	[Rahman, Nurul H. Abd] Univ Teknol MARA, Antenna Res Grp, Microwave Technol Ctr, Fac Elect Engn, Shah Alam 40450, Selangor, Malaysia; [Islam, Mohammad T.] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Ukm Bangi 43600, Selangor, Malaysia; [Yamada, Yoshihide] Univ Teknol Malaysia Kuala Lumpur, Malaysia Japan Int Inst Technol, Kuala Lumpur 54100, Malaysia; [Michishita, Naobumi] Natl Def Acad, Dept Elect & Elect Engn, Yokosuka, Kanagawa 239, Japan	Rahman, NHA (reprint author), Univ Teknol MARA, Antenna Res Grp, Microwave Technol Ctr, Fac Elect Engn, Shah Alam 40450, Selangor, Malaysia.	nurulhuda0340@salam.uitm.edu.my; titareq@yahoo.com; ndayamada@yahoo.co.jp; naobumi@nda.ac.jp					Fonseca NJG, 2012, IEEE ANTENN PROPAG M, V54, P88, DOI 10.1109/MAP.2012.6230720; [Anonymous], 2008, SAT IND DEV; Balanis C. A., 2005, ANTENNA THEORY ANAL; Boudriau E. R., 1995, 951 DREO; Chen C. C., 1980, 154364 NASA LANGL RE; Collin R., 1969, ANTENNA THEORY 2; Garcia-Pino A, 2012, IEEE T ANTENN PROPAG, V60, P4119, DOI 10.1109/TAP.2012.2207064; Howell A., 1991, IEE C SAT ANT TECHN, p4/1; Jorgensen R., 1985, IEEE T ANTENN PROPAG, VAP-33, P1304; Lo Y.T., 1960, Institute of Radio Engineers Transactions on Antennas and Propagation, VAP-8, DOI 10.1109/TAP.1960.1144854; Mahajan M, 2013, IEEE T ANTENN PROPAG, V61, P5297, DOI 10.1109/TAP.2013.2271492; Naderi M., 1988, AAIA 12 INT COMM SAT, P204; Rahman N. H. Abd, 2012, INT S ANT PROP ISAP, P1385; Rahrnan N. H. Abd, 2013, INT C SIGN PROC COMM, P1; Rusch W. V. T., 1973, IEEE T ANTENN PROPAG, VAP-21, P141; Schneider Michael, 2011, CEAS Space Journal, V2, DOI 10.1007/s12567-011-0012-z; Silver S., 1986, MICROWAVE ANTENNA TH; Sletten C. J., 1988, REFLECTOR LENS ANTEN; Stutzman W. L., 1988, ANTENNA THEORY DESIG, V2<SUP>nd</SUP>; Wertz J. R., 1992, SPACE MISSION ANAL D, V3<SUP>rd</SUP>	20	0	0	APPLIED COMPUTATIONAL ELECTROMAGNETICS SOC	UNIVERSITY	UNIV MISSISSIPPI, DEPT ELECTRICAL ENGINEERING, UNIVERSITY, MS 38677 USA	1054-4887	1943-5711		APPL COMPUT ELECTROM	Appl. Comput. Electromagn. Soc. J.	SEP	2015	30	9					952	958				7	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CP8ZR	WOS:000360184000002		
J	Watanabe, J; Uehara, K; Mogi, Y				Watanabe, Jun; Uehara, Kenji; Mogi, Yoshinobu			Both BAT1 and ARO8 are responsible for unpleasant odor generation in halo-tolerant yeast Zygosaccharomyces rouxii	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Zygosaccharomyces rouxii; Flor; FLO11; Aminotransferase; Soy sauce; Off-flavor	AMINO-ACID AMINOTRANSFERASE; FUSEL ALCOHOL PRODUCTION; SACCHAROMYCES-CEREVISIAE; AROMATIC AMINOTRANSFERASES; 2-OXO-ACID DECARBOXYLASES; SUBSTRATE-SPECIFICITY; MOLECULAR EVIDENCE; BREWING YEAST; CHAIN; COMPLEX	Soy sauce yeast Zygosaccharomyces rouxii plays a central role in the production of flavor compounds in soy sauce, while the flor-forming strain spoils its quality by producing 2-methylpropanoic acid, 2-methylbutanoic acid, and 3-methylbutanoic acid, which have an unpleasant odor. To investigate the relationship between flor formation and unpleasant odor, we measured the volatile compounds that accumulated under various growth conditions. As a result, marked amounts of 2-methylpropanoic acid, 2-methylbutanoic acid, or 3-methylbutanoic acid accumulated in synthetic medium containing valine, isoleucine, or leucine, respectively, under aerobic growth conditions. These results implied that the unpleasant compounds were produced from their corresponding branched chain amino acid (BCAA) when the cell was placed under aerobic condition through flor formation. The first step in BCAA catabolism and the last step in BCAA anabolism are both catalyzed by a BCAA transaminase. A mutant lacking the BCAA transaminase gene, BAT1, resulted in valine and isoleucine auxotrophy, while a mutant lacking both BAT1 and the alpha-aminoadipate aminotransferase gene, ARO8, resulted in valine, isoleucine, and leucine auxotrophy. Although the bat1a dagger aro8a dagger double mutant formed flor similarly to the wild-type strain, the mutant exhibited less unpleasant odor generation. These results suggest that the interconversion between 4-methyl-2-oxopentanoate and leucine is catalyzed by both Bat1p and Aro8p in Z. rouxii. Taken together, these results indicate that flor formation is not seemed to be directly linked to unpleasant odor generation. These findings encourage us to breed flor-forming yeasts without an unpleasant odor.	[Watanabe, Jun; Uehara, Kenji; Mogi, Yoshinobu] Yamasa Corp, Mfg Div, Choshi, Chiba 2880056, Japan	Watanabe, J (reprint author), Yamasa Corp, Mfg Div, 2-10-1 Araoicho, Choshi, Chiba 2880056, Japan.	j_watanabe@yamasa.com			Yamasa Corporation	The authors have the following competing interest. The study was supported by Yamasa Corporation, and all of the authors are employed by Yamasa Corporation.	Tanaka Y, 2012, FOOD MICROBIOL, V31, P100, DOI 10.1016/j.fm.2012.02.005; Kobayashi M, 2008, J BIOSCI BIOENG, V106, P317, DOI 10.1263/jbb.106.317; Eden A, 1998, YEAST, V14, P189, DOI 10.1002/(SICI)1097-0061(19980130)14:2<189::AID-YEA210>3.0.CO;2-V; KRADOLFER P, 1982, ARCH MICROBIOL, V133, P242, DOI 10.1007/BF00415010; Romagnoli G, 2012, APPL ENVIRON MICROB, V78, P7538, DOI 10.1128/AEM.01675-12; Solieri L, 2013, INT J SYST EVOL MICR, V63, P364, DOI 10.1099/ijs.0.043323-0; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; Eden A, 1996, J BIOL CHEM, V271, P20242; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Pires EJ, 2014, APPL MICROBIOL BIOT, V98, P1937, DOI 10.1007/s00253-013-5470-0; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Bolat I, 2013, FEMS YEAST RES, V13, P505, DOI 10.1111/1567-1364.12051; Vuralhan Z, 2003, APPL ENVIRON MICROB, V69, P4534, DOI 10.1128/AEM.69.8.4534-4541.2003; Urrestarazu A, 1998, MOL GEN GENET, V257, P230; Iraqui I, 1998, MOL GEN GENET, V257, P238; Karsten WE, 2011, ARCH BIOCHEM BIOPHYS, V516, P67, DOI 10.1016/j.abb.2011.09.008; [Anonymous], 2010, STANDARD TABLES OF F; Voordeckers K, 2012, MOL MICROBIOL, V86, P225, DOI 10.1111/j.1365-2958.2012.08192.x; Gordon JL, 2008, YEAST, V25, P449, DOI 10.1002/yea.1598; Styger G, 2013, APPL MICROBIOL BIOT, V97, P4429, DOI 10.1007/s00253-012-4522-1; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Kispal G, 1996, J BIOL CHEM, V271, P24458; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lilly M, 2006, FEMS YEAST RES, V6, P726, DOI 10.1111/j.1567-1364.2006.00057.x; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Watanabe J, 2013, GENETICS, V195, P393, DOI 10.1534/genetics.113.154690; Pribylova L, 2007, FEMS YEAST RES, V7, P1285, DOI 10.1111/j.1567-1364.2007.00308.x; Dickinson JR, 2003, J BIOL CHEM, V278, P8028, DOI 10.1074/jbc.M211914200; Chen E. C. H., 1978, J AM SOC BREW CHEM, V36, P39; Colon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016099; Dickinson JR, 1997, J BIOL CHEM, V272, P26871, DOI 10.1074/jbc.272.43.26871; DICKINSON JR, 1993, FEBS LETT, V326, P29, DOI 10.1016/0014-5793(93)81754-N; James SA, 2005, FEMS YEAST RES, V5, P747, DOI 10.1016/j.femsyr.2005.02.004; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Schoondermark-Stolk SA, 2005, FEMS YEAST RES, V5, P757, DOI 10.1016/j.femsyr.2005.02.005; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Solieri L, 2013, FEMS YEAST RES, V13, P245, DOI 10.1111/1567-1364.12027; Tomita M., 1997, J BREWING SOC JAPAN, V92, P853; Watanabe J, 2010, BIOSCI BIOTECH BIOCH, V74, P1092, DOI 10.1271/bbb.90865; Watanabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062121	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	SEP	2015	99	18					7685	7697		10.1007/s00253-015-6673-3		13	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CP7SI	WOS:000360087900024		
J	Muttaqin; Nakamura, T; Sato, S				Muttaqin; Nakamura, Takahiro; Sato, Shunichi			Synthesis of gold nanoparticle colloids by highly intense laser irradiation of aqueous solution by flow system	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							ALLOY NANOPARTICLES; ABLATION; FABRICATION; REDUCTION; WATER; AU	Highly intense femtosecond laser irradiation of a metallic ion solution is a potential technique to produce nanoparticles of noble metals and their alloys without any reducing agents. In addition, all-proportional solid-solution alloy nanoparticles of noble metals even with immiscible nature in a multimetallic system can be easily formed in the mixed ion solution. The method has many advantages compared to conventional chemical and/or physical methods with regard to not only the simplicity of the method itself but also the purity and the controllability of alloy composition of fabricated nanoparticles. However, the productivity of a stationary production system has been limited by the volume of a glass cuvette containing ion solution. In the present study, larger-scale production by applying a flow system of ion solution was demonstrated for improving the productivity. The influence of irradiation time and repetition rate of the femtosecond laser, and flow rate of the solution on the efficiency of nanoparticles formation was studied. The flow system showed similar results with the stationary system with respect to the mechanism for the nanoparticles formation. In addition, the pulse repetition rate was effective to increase the productivity by more than 200 % compared to the stationary system.	[Muttaqin; Nakamura, Takahiro; Sato, Shunichi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Muttaqin (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	muttaqin@mail.tagen.tohoku.ac.jp					Simakin AV, 2001, CHEM PHYS LETT, V348, P182, DOI 10.1016/S0009-2614(01)01136-8; Barcikowski S, 2013, PHYS CHEM CHEM PHYS, V15, P3022, DOI 10.1039/c2cp90132c; Barcikowski S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773937; Kabashin AV, 2003, J APPL PHYS, V94, P7941, DOI 10.1063/1.1626793; Sibbald MS, 1996, J PHYS CHEM-US, V100, P4672, DOI 10.1021/jp953248x; Sylvestre JP, 2004, J PHYS CHEM B, V108, P16864, DOI 10.1021/jp047134+; Lazarus LL, 2010, LAB CHIP, V10, P3377, DOI [10.1039/c0lc00297f, 10.1039/c01c00297f]; Nakamura T, 2009, APPL SURF SCI, V255, P9630, DOI 10.1016/j.apsusc.2009.04.092; Herbani Y, 2011, J PHYS CHEM C, V115, P21592, DOI 10.1021/jp205547t; Mafune F, 2000, J PHYS CHEM B, V104, P9111, DOI 10.1021/jp001336y; Hahn A, 2008, J LASER MICRO NANOEN, V3, P73; Muto H, 2007, J PHYS CHEM C, V111, P17221, DOI 10.1021/jp075582m; Roduner E, 2006, CHEM SOC REV, V35, P583, DOI 10.1039/b502142c; Prochazka M, 1997, ANAL CHEM, V69, P5103, DOI 10.1021/ac970683+; Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651; Link S, 2003, ANNU REV PHYS CHEM, V54, P331, DOI 10.1146/annurev.physchem.54.011002.103759; Petersen S, 2009, ADV FUNCT MATER, V19, P1167, DOI 10.1002/adfm.200801526; Chau JLH, 2011, MATER LETT, V65, P804, DOI 10.1016/j.matlet.2010.10.088; Dziko G., 2011, J NANOPART RES, V13, P2533; Herbani Y, 2012, J COLLOID INTERF SCI, V375, P78, DOI 10.1016/j.jcis.2012.02.030; Liu B, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2434168; Nakamura T, 2011, APPL PHYS A-MATER, V104, P1021, DOI 10.1007/s00339-011-6499-5; Nakamura T, 2013, AIP ADV, V3, DOI 10.1063/1.4817827; Nakamura T, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0785-9; Nakamura T., 2007, J MATER RES, V23, P968; NEDDERSEN J, 1993, APPL SPECTROSC, V47, P1959, DOI 10.1366/0003702934066460; Pommeret S, 2001, J PHYS CHEM A, V105, P11400, DOI 10.1021/jp0123381; Sarker MSI, 2013, APPL PHYS A-MATER, V110, P145, DOI 10.1007/s00339-012-7467-4; Takami A, 1996, JPN J APPL PHYS 2, V35, pL781, DOI 10.1143/JJAP.35.L781	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	SEP	2015	120	3					881	888		10.1007/s00339-015-9314-x		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CO8QS	WOS:000359435900012		
J	Shirai, H; Yanase, Y				Shirai, Hiroshi; Yanase, Yoshihata			Measurements of phosphorus and boron concentrations in Czochralski silicon wafer-thick samples by p-polarized Brewster incidence far-infrared transmission	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							OXYGEN CONCENTRATION; SPECTROSCOPY	Determination of phosphorus and boron concentrations in Czochralski-grown silicon wafer-thick samples has been examined by means of low-temperature high-resolution far-infrared transmission measurements with p-polarized light incident at Brewster angle. The measurements were taken at about 8.7 K with a spectral resolution of 0.5 cm(-1) under halogen light illumination. Linear correlations are clearly obtained between the absorption coefficients of several phosphorus and boron transitions and their concentrations, which are approximately in the range of 7.7 x 10(13)-1.6 x 10(15) atoms cm(-3) for phosphorus and of 2.5 x 10(14)-7.6 x 10(14) atoms cm(-3) for boron. The correlations are obtained regardless of the surface processing conditions of the samples. These are because interference fringes due to internal multiple reflections in wafer-thick silicon samples are almost suppressed using this incidence. The detection limit of phosphorus is about 1.2 x 10(13) atoms cm(-3) and that of boron is about 4.2 x 10(13) atoms cm(-3). P-polarized Brewster angle incidence has made it possible to determine phosphorus and boron concentrations in wafer-thick samples.	[Shirai, Hiroshi; Yanase, Yoshihata] Covalent Mat Corp, Technol Dev Ctr, Hadano, Kanagawa 2578566, Japan	Shirai, H (reprint author), Covalent Mat Corp, Technol Dev Ctr, 30 Soya, Hadano, Kanagawa 2578566, Japan.	shirai@covalent.co.jp					Alt HC, 1998, AIP CONF PROC, V449, P201; [Anonymous], 2003, ANN BOOK ASTM STAND; [Anonymous], 1984, 50438 DIN 3; RAMDAS AK, 1981, REP PROG PHYS, V44, P1297, DOI 10.1088/0034-4885/44/12/002; BAGHDADI A, 1989, J ELECTROCHEM SOC, V136, P2015, DOI 10.1149/1.2097135; ASTM American Society for Testing and Materials, 1996, ANN BOOK ASTM STAND; KOLBESEN BO, 1975, APPL PHYS LETT, V27, P353, DOI 10.1063/1.88474; Porrini M, 2005, APPL PHYS A-MATER, V81, P1187, DOI 10.1007/s00339-004-3032-0; SAITO H, 1995, JPN J APPL PHYS 2, V34, pL1097; SHIRAI H, 1995, JPN J APPL PHYS 1, V34, P484, DOI 10.1143/JJAP.34.484; SHIRAI H, 1991, J ELECTROCHEM SOC, V138, P1784, DOI 10.1149/1.2085873; SHIRAI H, 1992, J ELECTROCHEM SOC, V139, P3272, DOI 10.1149/1.2069066; WHITE JJ, 1967, CAN J PHYS, V45, P2695	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	SEP	2015	120	3					927	931		10.1007/s00339-015-9257-2		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CO8QS	WOS:000359435900017		
J	Moriyama, M; Fujimoto, Y; Rikimaru, S; Ushikai, M; Kuroda, E; Kawabe, K; Takano, K; Asakawa, A; Inui, A; Eto, K; Kadowaki, T; Sinasac, DS; Okano, Y; Yazaki, M; Ikeda, S; Zhang, CH; Song, YZ; Sakamoto, O; Kure, S; Mitsubuchi, H; Endo, F; Horiuchi, M; Nakamura, Y; Yamamura, K; Saheki, T				Moriyama, Mitsuaki; Fujimoto, Yuki; Rikimaru, Shizuka; Ushikai, Miharu; Kuroda, Eishi; Kawabe, Kenji; Takano, Katsura; Asakawa, Akihiro; Inui, Akio; Eto, Kazuhiro; Kadowaki, Takashi; Sinasac, David S.; Okano, Yoshiyuki; Yazaki, Masahide; Ikeda, Shu-ichi; Zhang, Chunhua; Song, Yuan-Zong; Sakamoto, Osamu; Kure, Shigeo; Mitsubuchi, Hiroshi; Endo, Fumio; Horiuchi, Masahisa; Nakamura, Yoichi; Yamamura, Ken-ichi; Saheki, Takeyori			Mechanism for increased hepatic glycerol synthesis in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse: Urine glycerol and glycerol 3-phosphate as potential diagnostic markers of human citrin deficiency	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Citrin deficiency; Glycerol; Glycerol 3-phosphate; Mitochondrial aspartate-glutamate carrier; Redox state; Pyruvate	II CITRULLINEMIA; SODIUM PYRUVATE; MICE; FRUCTOSE; IDENTIFICATION; TRANSPORTERS; METABOLISM; FEATURES; DISEASES; ARGININE	The mitochondrial aspartate-glutamate carrier isoform 2 (citrin) and mitochondrial glycerol-3-phosphate dehydrogenase (mGPD) double-knockout mouse has been a useful model of human citrin deficiency. One of the most prominent findings has been markedly increased hepatic glycerol 3-phosphate (G3P) following oral administration of a sucrose solution. We aimed to investigate whether this change is detectable outside of the liver, and to explore the mechanism underlying the increased hepatic G3P in these mice. We measured G3P and its metabolite glycerol in plasma and urine of the mice under various conditions. Glycerol synthesis from fructose was also studied using the liver perfusion system. The citrin/mGPD double-knockout mice showed increased urine G3P and glycerol under normal, fed conditions. We also found increased plasma glycerol under fasted conditions, while oral administration of different carbohydrates or ethanol led to substantially increased plasma glycerol. Fructose infusion to the perfused liver of the double-knockout mice augmented hepatic glycerol synthesis, and was accompanied by a concomitant increase in the lactate/pyruvate (LIP) ratio. Co-infusion of either pyruvate or phenazine methosulfate, a cytosolic oxidant, with fructose corrected the high L/P ratio, leading to reduced glycerol synthesis. Overall, these findings suggest that hepatic glycerol synthesis is cytosolic NADH/NAD(+) ratio-dependent and reveal a likely regulatory mechanism for hepatic glycerol synthesis following a high carbohydrate load in citrin-deficient patients. Therefore, urine G3P and glycerol may represent potential diagnostic markers for human citrin deficiency. (C) 2015 Elsevier B.V. All rights reserved.	[Moriyama, Mitsuaki; Kawabe, Kenji; Takano, Katsura; Nakamura, Yoichi] Osaka Prefecture Univ, Lab Integrat Physiol Vet Sci, Izumisano, Japan; [Fujimoto, Yuki; Yamamura, Ken-ichi; Saheki, Takeyori] Kumamoto Univ, Inst Resource Dev & Anal, Lab Yamamura Project, Kumamoto 8600811, Japan; [Fujimoto, Yuki; Rikimaru, Shizuka; Saheki, Takeyori] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima, Japan; [Ushikai, Miharu; Kuroda, Eishi; Asakawa, Akihiro; Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan; [Ushikai, Miharu; Horiuchi, Masahisa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Hyg & Hlth Promot Med, Kagoshima 890, Japan; [Eto, Kazuhiro] Teikyo Univ, Dept Internal Med, Tokyo 173, Japan; [Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Sinasac, David S.] Univ Calgary, Cumming Sch Med, Dept Med Genet, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 1N4, Canada; [Okano, Yoshiyuki] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo 6638501, Japan; [Okano, Yoshiyuki] Okano Childrens Clin, Izumi, Japan; [Yazaki, Masahide; Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 390, Japan; [Yazaki, Masahide; Ikeda, Shu-ichi] Shinshu Univ, Inst Biomed Sci, Matsumoto, Nagano 390, Japan; [Zhang, Chunhua] MILS Int, Res Dev Dept, Kanazawa, Ishikawa, Japan; [Song, Yuan-Zong] Jinan Univ, Affiliated Hosp 1, Dept Pediat, Guangzhou, Guangdong, Peoples R China; [Sakamoto, Osamu; Kure, Shigeo] Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan; [Mitsubuchi, Hiroshi] Kumamoto Univ Hosp, Dept Neonatol, Kumamoto, Japan; [Endo, Fumio] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat, Kumamoto 8600811, Japan	Saheki, T (reprint author), Kumamoto Univ, Inst Resource Dev & Anal, Lab Yamamura Project, 2-2-1 Honjo, Kumamoto 8600811, Japan.				JSPS KAKENHI [21591337, 2459156, 23580408, 26450447]; Ministry of Health, Labor and Welfare	This work was supported by the JSPS KAKENHI grant number 21591337 (TS), 2459156 (TS), 23580408 (MM) and 26450447 (MM), and Research grants from the Ministry of Health, Labor and Welfare.	Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Husek P, 1998, J CHROMATOGR B, V717, P57, DOI 10.1016/S0378-4347(98)00136-4; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; HALLFRISCH J, 1990, FASEB J, V4, P2652; Sinasac DS, 2004, MOL CELL BIOL, V24, P527, DOI 10.1128/MCB.24.2.527-536.2004; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Asipu A, 2003, DIABETES, V52, P2426, DOI 10.2337/diabetes.52.9.2426; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Burlina A., 1985, METHOD ENZYMAT AN, VVII, P20; Gutmann I., 1974, METHOD ENZYMAT AN, V3, P1464; HOLDSWORTH C. D., 1965, PROC SOC EXP BIOL MED, V118, P142; Kobayashi K., 2005, GENEREVIEWS; Lamprecht W., 1984, METHOD ENZYMAT AN, VVI, P570; Lang G., 1984, METHOD ENZYMAT AN, VVI, P525; Michal G., 1984, METHOD ENZYMAT AN, VVI, P342; Mollerring H., 1985, METHOD ENZYMAT AN, VVII, P2; Moriyama M, 2006, J HEPATOL, V44, P930, DOI 10.1016/j.jhep.2005.09.018; Mutoh K, 2008, J INHERIT METAB DIS, V31, pS343, DOI 10.1007/s10545-008-0914-x; Nagasaka H, 2009, MOL GENET METAB, V97, P21, DOI 10.1016/j.ymgme.2009.01.009; Ohura T, 2001, HUM GENET, V108, P87, DOI 10.1007/s004390000448; Okano Y, 2013, MOL GENET METAB, V109, P9, DOI 10.1016/j.ymgme.2013.01.020; Petkova I, 2000, Acta Physiol Pharmacol Bulg, V25, P103; ROGNSTAD R, 1981, BIOCHIM BIOPHYS ACTA, V676, P270, DOI 10.1016/0304-4165(81)90196-3; ROGNSTAD R, 1974, ARCH BIOCHEM BIOPHYS, V161, P638, DOI 10.1016/0003-9861(74)90348-8; Saheki T, 2007, J BIOL CHEM, V282, P25041, DOI 10.1074/jbc.M702031200; Saheki T, 2011, MOL GENET METAB, V104, P492, DOI 10.1016/j.ymgme.2011.08.015; Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046; Saheki T, 2012, MOL GENET METAB, V107, P322, DOI 10.1016/j.ymgme.2012.07.021; Song YZ, 2011, INT J MOL MED, V28, P33, DOI 10.3892/ijmm.2011.653; Tazawa Y, 2001, J PEDIATR-US, V138, P735, DOI 10.1067/mpd.2001.113264; Tokuhara D, 2007, MOL GENET METAB, V90, P30, DOI 10.1016/j.ymgme.2006.09.009; Tomomasa T, 2001, J PEDIATR-US, V138, P741, DOI 10.1067/mpd.2001.113361; TOPPING DL, 1971, NUTR METAB, V13, P331; Van den Berghe G, 1986, Prog Biochem Pharmacol, V21, P1; Wieland O.H., 1984, METHOD ENZYMAT AN, VVI, P504; Yamaguchi N, 2002, HUM MUTAT, V19, P122, DOI 10.1002/humu.10022; Yazaki M, 2013, CLIN NEUROL NEUROSUR, V115, P1542, DOI 10.1016/j.clineuro.2012.12.027	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	SEP	2015	1852	9					1787	1795		10.1016/j.bbadis.2015.04.023		9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CP5XQ	WOS:000359959100010		
J	Taniguchi, K; Sugito, N; Kumazaki, M; Shinohara, H; Yamada, N; Matsuhashi, N; Futamura, M; Ito, Y; Otsuki, Y; Yoshida, K; Uchiyama, K; Akao, Y				Taniguchi, Kohei; Sugito, Nobuhiko; Kumazaki, Minami; Shinohara, Haruka; Yamada, Nami; Matsuhashi, Nobuhisa; Futamura, Manabu; Ito, Yuko; Otsuki, Yoshinori; Yoshida, Kazuhiro; Uchiyama, Kazuhisa; Akao, Yukihiro			Positive feedback of DDX6/c-Myc/PTB1 regulated by miR-124 contributes to maintenance of the Warburg effect in colon cancer cells	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						DDX6; MiR-124; Warburg effect; PKM; PTBP1; c-Myc	DEAD-BOX PROTEIN; HUMAN COLORECTAL TUMORS; KINASE MESSENGER-RNA; PYRUVATE-KINASE; T(11-19) TRANSLOCATIONS; GASTRIC-CANCER; IN-VITRO; EXPRESSION; RCK/P54; GENE	The human DEAD/H-box RNA helicase gene DDX6 is a target of the t(11;14)(q23;q32) chromosomal translocation observed in human B-cell lymphoma, and the overexpression of its protein has been shown to cause malignant transformation. DDX6 has a variety of functions such as translation initiation, pre-mRNA splicing, ribosome assembly, and more. However, details of the regulatory mechanism of DDX6 and functions of DDX6 in cancer cells are largely unknown. On the other hand, the Warburg effect is a well-known feature of cancer cells. Pyruvate kinase in muscle (PKM), which is a rate-limiting glycolytic enzyme, has 2 isoforms, PKM1 and PKM2. It has been frequently reported that PKM2 is a tumor-specific isoform and promotes the Warburg effect. However, the functions of the PKM1 gene have been hardly mentioned. Here, we showed that DDX6 was overexpressed in colorectal cancer specimens and regulated by microRNA (miR)-124 in colon cancer cells. Also, a DDX6/c-Myc/PTB1 positive feedback circuit regulated by miR-124 was shown to be established and to contribute to maintenance of the Warburg effect. Moreover, we showed that knockdown of DDX6 induced mainly apoptosis through an imbalance of PKM gene expression, especially causing down-regulation of PKM1 in colon cancer cells. These results suggest that miR-124 is a fine tuner of the Warburg effect and that DDX6 is one of the key molecules in Warburg effect-related miR-124 targeting various genes. (C) 2015 Elsevier B.V. All rights reserved.	[Taniguchi, Kohei; Sugito, Nobuhiko; Kumazaki, Minami; Shinohara, Haruka; Yamada, Nami; Akao, Yukihiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan; [Taniguchi, Kohei; Uchiyama, Kazuhisa] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka 5698686, Japan; [Matsuhashi, Nobuhisa; Futamura, Manabu; Yoshida, Kazuhiro] Gifu Univ, Sch Med, Dept Surg Oncol, Gifu 5011193, Japan; [Ito, Yuko; Otsuki, Yoshinori] Osaka Med Coll, Dept Anat & Cell Biol, Div Life Sci, Takatsuki, Osaka 5698686, Japan	Taniguchi, K (reprint author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, 1-1 Yanagido, Gifu 5011193, Japan.	sur144@poh.osaka-med.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [YA-24659157]	The work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (YA-24659157).	AKAO Y, 1991, CANCER RES, V51, P6708; Akao Y, 2003, GENES CELLS, V8, P671, DOI 10.1046/j.1365-2443.2003.00665.x; Akao Y., 2009, CURR DRUG THER, V4, P29; AKAO Y, 1995, CANCER RES, V55, P3444; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Nakagawa Y, 2015, INT J MOL SCI, V16, P1526, DOI 10.3390/ijms16011526; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Nakagawa Y, 1999, BRIT J CANCER, V80, P914, DOI 10.1038/sj.bjc.6690441; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; AKAO Y, 1992, CANCER RES, V52, P6083; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lin F, 2008, CANCER BIOL THER, V7, P1669; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Maiorano NA, 2010, RNA BIOL, V7, P528; Akao Y, 2006, INT J ONCOL, V29, P41; Iio A, 2013, BBA-GENE REGUL MECH, V1829, P1102, DOI 10.1016/j.bbagrm.2013.07.010; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Chen M, 2010, CANCER RES, V70, P8977, DOI 10.1158/0008-5472.CAN-10-2513; Hashimoto K, 2001, CARCINOGENESIS, V22, P1965, DOI 10.1093/carcin/22.12.1965; Kamatani A, 2013, MED MOL MORPHOL, V46, P166, DOI 10.1007/s00795-013-0020-5; Matsui T, 2006, GENES CELLS, V11, P439, DOI 10.1111/j.1365-2443.2006.00951.x; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Shinohara H, 2015, CANCER LETT, V360, P28, DOI 10.1016/j.canlet.2015.01.039; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Taniguchi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08647; Taniguchi K, 2015, CANCER LETT, V363, P17, DOI 10.1016/j.canlet.2015.03.026	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	SEP	2015	1852	9					1971	1980		10.1016/j.bbadis.2015.06.022		10	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CP5XQ	WOS:000359959100028		
J	Tanji, K; Odagiri, S; Miki, Y; Maruyama, A; Nikaido, Y; Mimura, J; Mori, F; Warabi, E; Yanagawa, T; Ueno, S; Itoh, K; Wakabayashi, K				Tanji, Kunikazu; Odagiri, Saori; Miki, Yasuo; Maruyama, Atsushi; Nikaido, Yoshikazu; Mimura, Junsei; Mori, Fumiaki; Warabi, Eiji; Yanagawa, Toru; Ueno, Shinya; Itoh, Ken; Wakabayashi, Koichi			p62 Deficiency Enhances alpha-Synuclein Pathology in Mice	BRAIN PATHOLOGY			English	Article						alpha -synuclein; Lewy body disease; p62/Sequestsome 1/SQSTM1; Parkinson's disease; proteolysis; stress	TRANSCRIPTION FACTOR NRF2; INCLUSION-BODY FORMATION; PARKINSONS-DISEASE; TRANSGENIC MICE; SELECTIVE AUTOPHAGY; CAUSES NEURODEGENERATION; SEQUESTOSOME 1/P62; LEWY BODIES; IN-VIVO; DEGRADATION	In Lewy body disease (LBD) such as dementia with LBs and Parkinson's disease, several lines of evidence show that disrupted proteolysis occurs. p62/SQSTM1 (p62) is highly involved with intracellular proteolysis and is a component of ubiquitin-positive inclusions in various neurodegenerative disorders. However, it is not clear whether p62 deficiency affects inclusion formation and abnormal protein accumulation. To answer this question, we used a mouse model of LBD that lacks p62, and found that LB-like inclusions were observed in transgenic mice that overexpressed alpha-synuclein (Tg mice) with or without the p62 protein. p62 deficiency enhanced alpha-synuclein pathology with regard to the number of inclusions and staining intensity compared with Tg mice that expressed p62. To further investigate the molecular mechanisms associated with the loss of p62 in Tg mice, we assessed the mRNA and protein levels of several molecules, and found that the neighbor of the brca1 gene (NBr1), which is functionally and structurally similar to p62, is increased in Tg mice without p62 compared with control Tg mice. These findings suggest that p62 and NBR1 affect the pathogenesis of neurodegenerative diseases through the cooperative modulation of alpha-synuclein aggregation.	[Tanji, Kunikazu; Miki, Yasuo; Mori, Fumiaki; Wakabayashi, Koichi] Hirosaki Univ, Grad Sch Med, Dept Neuropathol, Hirosaki, Aomori 0368562, Japan; [Maruyama, Atsushi; Mimura, Junsei; Itoh, Ken] Hirosaki Univ, Grad Sch Med, Dept Stress Response Sci, Hirosaki, Aomori 0368562, Japan; [Nikaido, Yoshikazu; Ueno, Shinya] Hirosaki Univ, Grad Sch Med, Dept Neurophysiol, Hirosaki, Aomori 0368562, Japan; [Odagiri, Saori] Univ Tsukuba, Dept Neuroanat Cell Biol & Histol, Tsukuba, Ibaraki, Japan; [Warabi, Eiji; Yanagawa, Toru] Univ Tsukuba, Majors Med Sci, Tsukuba, Ibaraki, Japan	Tanji, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Neuropathol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	kunikazu@cc.hirosaki-u.ac.jp			JSPS KAKENHI [26430050, 26860655, 26430049, 24300131]; Priority Research Grant for Young Scientists; Hirosaki University Institutional Research Grant; Research Committee for Ataxic Disease from the Ministry of Health, Labor and Welfare, Japan; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [(24-5)]	This work was supported by JSPS KAKENHI grant numbers 26430050 (K.T.), 26860655 (Y.M.), 26430049 (F.M.), 24300131 (K.W.); Priority Research Grant for Young Scientists designated by the president of Hirosaki University (K.T., J.M.); Hirosaki University Institutional Research Grant (K.I., K.W.); grants-in-aid from the Research Committee for Ataxic Disease from the Ministry of Health, Labor and Welfare, Japan (K.W.); and an Intramural Research Grant (24-5) for Neurological and Psychiatric Disorders of NCNP (K.W.). The authors wish to express their gratitude to K. Saruta, T. Kon, M. Nakata and A. Ono for their technical assistance.	Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Braak H, 2011, J NEURAL TRANSM, V118, P809, DOI 10.1007/s00702-010-0508-2; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Graham DR, 2010, J NEUROSCI RES, V88, P1777, DOI 10.1002/jnr.22331; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Kahle PJ, 2008, ACTA NEUROPATHOL, V115, P87, DOI 10.1007/s00401-007-0302-x; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.2055-8068; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Unger EL, 2006, NEUROBIOL DIS, V21, P431, DOI 10.1016/j.nbd.2005.08.005; Odagiri S, 2012, ACTA NEUROPATHOL, V124, P173, DOI 10.1007/s00401-012-0975-7; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Doi H, 2013, J NEUROSCI, V33, P7710, DOI 10.1523/JNEUROSCI.3021-12.2013; Coupe B, 2012, CELL METAB, V15, P247, DOI 10.1016/j.cmet.2011.12.016; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; van der Putten H, 2000, J NEUROSCI, V20, P6021; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Quan W, 2012, ENDOCRINOLOGY, V153, P1817, DOI 10.1210/en.2011-1882; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Tanji K, 2010, ACTA NEUROPATHOL, V120, P145, DOI 10.1007/s00401-010-0676-z; Harada H, 2013, J NEUROSCI, V33, P14767, DOI 10.1523/JNEUROSCI.2954-12.2013; Kim OJ, 2008, J NEUROCHEM, V106, P83, DOI 10.1111/j.1471-4159.2008.05348.x; Okada K, 2009, HEPATOL RES, V39, P490, DOI 10.1111/j.1872-034X.2008.00478.x; Paumier KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070274; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Tanji K, 2012, J NEUROSCI RES, V90, P2034, DOI 10.1002/jnr.23081; Winder-Rhodes SE, 2012, MOVEMENT DISORD, V27, P312, DOI 10.1002/mds.24029	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	SEP	2015	25	5					552	564		10.1111/bpa.12214		13	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CP3VO	WOS:000359810900004		
J	Tanboon, J; Viravan, S; Hayashi, YK; Nishino, I; Sangruchi, T				Tanboon, Jantima; Viravan, Sorawit; Hayashi, Yukiko K.; Nishino, Ichizo; Sangruchi, Tumtip			2 Month-Old Male with Hypotonia Severe X-linked myotubular myopathy (XLMTM)	BRAIN PATHOLOGY			English	Editorial Material							AUTOPHAGY		[Tanboon, Jantima; Sangruchi, Tumtip] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pathol, Bangkok 10700, Thailand; [Viravan, Sorawit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pediat,Div Neurol, Bangkok 10700, Thailand; [Hayashi, Yukiko K.; Nishino, Ichizo] Natl Inst Neurosci, NCNP, Dept Neuromuscular Res, Kodaira, Tokyo 187, Japan; [Hayashi, Yukiko K.] Tokyo Med Univ, Dept Neurophysiol, Shinjuku Ku, Tokyo 1608402, Japan	Tanboon, J (reprint author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pathol, Bangkok 10700, Thailand.						Al-Qusairi L, 2013, FASEB J, V27, P3384, DOI 10.1096/fj.12-220947; Fetalvero KM, 2013, MOL CELL BIOL, V33, P98, DOI 10.1128/MCB.01075-12; Goebel HH, 2013, MUSCLE DISEASE: PATHOLOGY AND GENETICS, 2ND EDITION, P1, DOI 10.1002/9781118635469; Jungbluth H, 2013, NEUROMUSCULAR DISORD, V23, P1033, DOI 10.1016/j.nmd.2013.08.006	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	SEP	2015	25	5					651	652		10.1111/bpa.12284		2	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CP3VO	WOS:000359810900014		
J	Kuwada, K				Kuwada, Kazumasa			Space-time Wasserstein controls and Bakry-Ledoux type gradient estimates	CALCULUS OF VARIATIONS AND PARTIAL DIFFERENTIAL EQUATIONS			English	Article							METRIC-MEASURE-SPACES; HAMILTON-JACOBI EQUATIONS; RICCI CURVATURE; INEQUALITIES; TRANSPORT; MANIFOLDS; GEOMETRY	The duality in Bakry-A parts per thousand mery's gradient estimates and Wasserstein controls for heat distributions is extended to that in refined estimates in a high generality. As a result, we find an equivalent condition to Bakry-Ledoux's refined gradient estimate involving an upper dimension bound. This new condition is described as a -Wasserstein control for heat distributions at different times. The -version of those estimates are studied on Riemannian manifolds via coupling method.	Tokyo Inst Technol, Grad Sch Sci, Meguro Ku, Tokyo 1528551, Japan	Kuwada, K (reprint author), Tokyo Inst Technol, Grad Sch Sci, Meguro Ku, Ookayama 2-12-1, Tokyo 1528551, Japan.	kuwada@math.titech.ac.jp			Japan Society for the Promotion of Science [22740083]	The author would like to tell his gratitude to the anonymous referee. His/Her comments help the author to improve the quality of the paper. Especially, Proposition 4.4 and Remark 4.6 are essentially due to the comment. This work is partially supported by the Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) 22740083.	Ambrosio L, 2008, LECT MATH, P1; Ambrosio L., 2012, T AM MATH S IN PRESS; Ambrosio L, 2014, INVENT MATH, V195, P289, DOI 10.1007/s00222-013-0456-1; Ambrosio L., ARXIV12095786; Kuwada K, 2011, J FUNCT ANAL, V260, P2742, DOI 10.1016/j.jfa.2011.01.017; Sturm KT, 2006, ACTA MATH-DJURSHOLM, V196, P133, DOI 10.1007/s11511-006-0003-7; Kuwada K, 2010, J FUNCT ANAL, V258, P3758, DOI 10.1016/j.jfa.2010.01.010; Sturm KT, 2006, ACTA MATH-DJURSHOLM, V196, P65, DOI 10.1007/s11511-006-0002-8; Ambrosio L, 2013, REV MAT IBEROAM, V29, P969, DOI 10.4171/RMI/746; Lott J, 2009, ANN MATH, V169, P903; Savare G, 2014, DISCRETE CONT DYN-A, V34, P1641, DOI 10.3934/dcds.2014.34.1641; Bakry D, 2006, REV MAT IBEROAM, V22, P683; Lisini S, 2007, CALC VAR PARTIAL DIF, V28, P85, DOI 10.1007/s00526-006-0032-2; Bacher K, 2010, J FUNCT ANAL, V259, P28, DOI 10.1016/j.jfa.2010.03.024; Balogh ZM, 2012, POTENTIAL ANAL, V36, P317, DOI 10.1007/s11118-011-9232-2; Wang FY, 2011, B SCI MATH, V135, P803, DOI 10.1016/j.bulsci.2011.07.005; Gozlan N, 2014, REV MAT IBEROAM, V30, P133, DOI 10.4171/RmI/772; Ambrosio L, 2014, DUKE MATH J, V163, P1405, DOI 10.1215/00127094-2681605; Bakry D., 2014, GRUNDLEHREN MATH WIS, V348; Bakry D., 1985, SPRINGER LECT NOTES, V1123, P177, DOI DOI 10.1007/BFB0075847; Bakry D., ANN SC NORM IN PRESS; Bakry D., 2006, FUNCTIONAL INEQUALIT, P91; Bogachev V.I., 2007, MEASURE THEORY 1 2; Bolley F., J LOND MATH IN PRESS; CRANSTON M, 1991, J FUNCT ANAL, V99, P110, DOI 10.1016/0022-1236(91)90054-9; Erbar M., ARXIV13034382; Hsu E. P., 2002, GRADUATE STUDIES MAT, V38; Kendall W. S., 1986, Stochastics, V19, DOI 10.1080/17442508608833419; Kuwada K., 2013, RIMS KOKYUROKU BES B, VB43, P61; Kuwada K, 2010, ADV STU P M, V57, P273; Kuwada K, 2012, ANN PROBAB, V40, P1945, DOI 10.1214/11-AOP676; Kuwada K, 2013, POTENTIAL ANAL, V39, P231, DOI 10.1007/s11118-012-9327-4; Kuwada K, 2013, MATH NACHR, V286, P374, DOI 10.1002/mana.201100330; Ledoux M., 2000, Annales de la Faculte des Sciences de Toulouse, Mathematiques, V9; Ledoux M., 2006, DUKE MATH J, V85, P253; Popescu I., ARXIV12094150; Qian ZM, 1996, ANN PROBAB, V24, P280; Rajala T, 2012, J FUNCT ANAL, V263, P896, DOI 10.1016/j.jfa.2012.05.006; Sobolev, 1994, WORLD SCI PUBL RIVER, V1997, P43; Topping P, 2009, J REINE ANGEW MATH, V636, P93, DOI 10.1515/CRELLE.2009.083; Villani C., 2008, GRUNDLEHREN MATH WIS, V338; von Renesse MK, 2004, ELECTRON J PROBAB, V9, P411; Wang F.-Y., 2005, MATH MONOGRAPH SERIE, V4; Wang F.-Y., 2014, ANAL DIFFUSION PROCE	44	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-2669	1432-0835		CALC VAR PARTIAL DIF	Calc. Var. Partial Differ. Equ.	SEP	2015	54	1					127	161		10.1007/s00526-014-0781-2		35	Mathematics, Applied; Mathematics	Mathematics	CP5RI	WOS:000359941200006		
J	Barles, G; Koike, S; Ley, O; Topp, E				Barles, Guy; Koike, Shigeaki; Ley, Olivier; Topp, Erwin			Regularity results and large time behavior for integro-differential equations with coercive Hamiltonians	CALCULUS OF VARIATIONS AND PARTIAL DIFFERENTIAL EQUATIONS			English	Article							REGIONAL FRACTIONAL LAPLACIAN; STRONG MAXIMUM PRINCIPLE; VISCOSITY SOLUTIONS; STABLE PROCESSES; DIRICHLET PROBLEM; JACOBI EQUATIONS; GUIDE; SPACE	In this paper we obtain regularity results for elliptic integro-differential equations driven by the stronger effect of coercive gradient terms. This feature allows us to construct suitable strict supersolutions from which we conclude Holder estimates for bounded subsolutions. In many interesting situations, this gives way to a priori estimates for subsolutions. We apply this regularity results to obtain the ergodic asymptotic behavior of the associated evolution problem in the case of superlinear equations. One of the surprising features in our proof is that it avoids the key ingredient which are usually necessary to use the strong maximum principle: linearization based on the Lipschitz regularity of the solution of the ergodic problem. The proof entirely relies on the Holder regularity.	[Barles, Guy; Topp, Erwin] Univ Francois Rabelais Tours, Federat Denis Poisson FR CNRS 2964, Lab Math & Phys Theor, UMR CNRS 7350, F-37200 Tours, France; [Koike, Shigeaki] Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan; [Ley, Olivier] INSA Rennes, IRMAR, F-35708 Rennes, France; [Topp, Erwin] Univ Chile, Dept Ingn Matemat, UMI CNRS 2807, Santiago, Chile	Topp, E (reprint author), Univ Chile, Dept Ingn Matemat, UMI CNRS 2807, Casilla 170,Correo 3, Santiago, Chile.	olivier.ley@insa-rennes.fr; etopp@dim.uchile.cl			ANR (Agence Nationale de la Recherche) through ANR WKBHJ [ANR-12-BS01-0020]; Japan Society for the Promotion of Science [23340028]; CONICYT; Grants Capital Humano Avanzado; Cotutela en el Extranjero; Ayuda Realizacion Tesis Doctoral	G.B. and O.L. are partially supported by the ANR (Agence Nationale de la Recherche) through ANR WKBHJ (ANR-12-BS01-0020). S.K. is supported by Grant-in-Aid for Scientific Research (No. 23340028) of Japan Society for the Promotion of Science. E.T. was partially supported by CONICYT, Grants Capital Humano Avanzado, Cotutela en el Extranjero and Ayuda Realizacion Tesis Doctoral.	Di Nezza E, 2012, B SCI MATH, V136, P521, DOI 10.1016/j.bulsci.2011.12.004; Tchamba TT, 2010, ASYMPTOTIC ANAL, V66, P161, DOI 10.3233/ASY-2009-0965; Bardi M, 1999, ARCH MATH, V73, P276, DOI 10.1007/s000130050399; Barles G, 2010, NONLINEAR ANAL-THEOR, V73, P31, DOI 10.1016/j.na.2010.02.009; Alvarez O, 1996, ANN I H POINCARE-AN, V13, P293; Barles G, 2008, INDIANA U MATH J, V57, P213, DOI 10.1512/iumj.2008.57.3315; Barles G, 2001, SIAM J MATH ANAL, V32, P1311, DOI 10.1137/S0036141000369344; Ishii H, 2010, CALC VAR PARTIAL DIF, V37, P485, DOI 10.1007/s00526-009-0274-x; Barles G, 2014, CALC VAR PARTIAL DIF, V50, P283, DOI 10.1007/s00526-013-0636-2; Ciomaga A, 2012, ADV DIFFERENTIAL EQU, V17, P635; Guan QY, 2006, PROBAB THEORY REL, V134, P649, DOI 10.1007/s00440-005-0438-3; Chasseigne E, 2007, DIFFER INTEGRAL EQU, V20, P1389; Bogdan K, 2003, PROBAB THEORY REL, V127, P89, DOI 10.1007/s00440-003-0275-1; Cardaliaguet P, 2011, SIAM J CONTROL OPTIM, V49, P555, DOI 10.1137/100784400; Topp E, 2014, COMMUN PART DIFF EQ, V39, P1523, DOI 10.1080/03605302.2014.900567; Barles G, 2014, T AM MATH SOC, V366, P4873; Barles G, 2012, J DIFFER EQUATIONS, V252, P6012, DOI 10.1016/j.jde.2012.02.013; Barles G., 2008, ANN I H POINCARE-AN, V25, P567, DOI 10.1016/j.anihpc.2007.02.007; Barles G., 1994, MATH APPL; Caffarelli L, 2009, COMMUN PUR APPL MATH, V62, P597; Capuzzo-Dolcetta I., 2010, T AM MATH SOC, V362, P4511; Cardaliaguet P., 2010, CPAM, V63, P590; Coville J., 2007, ELECTRON J DIFFER EQ, V2007, P1; Coville J., 2008, ELECT J DIFFERENTIAL, V66, P1; CRANDALL MG, 1992, B AM MATH SOC, V27, P1, DOI 10.1090/S0273-0979-1992-00266-5; Da Lio F, 2002, COMMUN PART DIFF EQ, V27, P283; Fukushima M., 1994, DEGRUETER STUD MATH, V19; Guan QY, 2006, COMMUN MATH PHYS, V266, P289, DOI 10.1007/s00220-006-0054-9; ISHII H., 1986, FUNKC EKVACIOJ-SER I, V29, P167; Jacob N., 2005, MARKOV PROCESS APPL, VIII; Kim P, 2006, STOCH PROC APPL, V116, P1792, DOI 10.1016/j.spa.2006.04.006; Koike S., 2004, MSJ MEMOIRS, V13; SAYAH A., 1991, COMMUN PART DIFF EQ, V16, P1057; Sayah A., 1991, COMMUN PART DIFF EQ, V16, P1075	34	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-2669	1432-0835		CALC VAR PARTIAL DIF	Calc. Var. Partial Differ. Equ.	SEP	2015	54	1					539	572		10.1007/s00526-014-0794-x		34	Mathematics, Applied; Mathematics	Mathematics	CP5RI	WOS:000359941200019		
J	Seguin, B; Fried, E				Seguin, Brian; Fried, Eliot			Stable and unstable helices: soap films in cylindrical tubes	CALCULUS OF VARIATIONS AND PARTIAL DIFFERENTIAL EQUATIONS			English	Article								Cox and Jones recently devised and studied an interesting variant of the classical Plateau problem, a variant in which a helical soap film is confined to a cylindrical tube with circular cross-section. Through experiments, numerics, and some analysis, they found that the length and (inner) radius of the tube strongly influence the equilibrium shape of the confined soap film. In this paper, an area minimization problem associated with determining the shape of the film is formulated and analyzed to determine which surfaces are local minima. The connection between a functional inequality and the associated eigenvalue problem plays an important role in the analysis. For helical films, a more detailed analysis is carried out and stability conditions consistent with the experimental and numerical results of Cox and Jones are obtained.	[Seguin, Brian] Univ Dundee, Div Math, Dundee DD1 4HN, Scotland; [Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Ona, Okinawa 9040495, Japan	Fried, E (reprint author), Okinawa Inst Sci & Technol, Math Soft Matter Unit, Ona, Okinawa 9040495, Japan.	rationalmech@gmail.com; eliot.fried@oist.jp					Weaire D, 2007, SOFT MATTER, V3, P47, DOI 10.1039/b608466b; Brand L., 1947, VECTOR TENSOR CALCUL; COURANT R., 1950, DIRICHLETS PRINCIPLE; Cox SJ, 2014, J ENG MATH, V86, P1, DOI 10.1007/s10665-013-9657-2; Douglas J., 1931, J MATH PHYS, V10, P315; Goldschmidt B., 1831, DETERMINATIO SUPERFI; Plateau J.A.F., 1873, STATIQUE EXPT THEORI; Rado T, 1930, MATH Z, V32, P763, DOI 10.1007/BF01194665; SIMON L., 1983, P CTR MATH ANAL, V3	9	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-2669	1432-0835		CALC VAR PARTIAL DIF	Calc. Var. Partial Differ. Equ.	SEP	2015	54	1					969	988		10.1007/s00526-014-0813-y		20	Mathematics, Applied; Mathematics	Mathematics	CP5RI	WOS:000359941200038		
J	Fukudome, K; Suzuki, T				Fukudome, Kenta; Suzuki, Toshimitsu			Highly Selective Oxidative Dehydrogenation of Propane to Propylene over VOx-SiO2 Catalysts	CATALYSIS SURVEYS FROM ASIA			English	Review						Lattice oxygen; Vanadium oxide; Isolated vanadate; Alkoxy-exchange reaction; Sol-gel process; Polyethylene glycol	SUPPORTED VANADIUM-OXIDE; MG-O CATALYSTS; MESOPOROUS SILICA; FLAME PYROLYSIS; REDOX BEHAVIORS; SURFACE-AREA; N-BUTANE; ETHANE; PROPENE; ADDITIVES	To avoid combustion of propane and/or propylene and to obtain high propylene selectivity, oxidative dehydrogenation of propane (ODHP) was carried out using the lattice oxygen of metal oxides in the absence of gas-phase oxygen. This paper summarized the results of our recent attempts to develop new concept and effective catalysts for ODHP. As metal oxides V2O5 was active for ODHP, especially isolated VO4 (3-) species were active and selective catalysts. The isolated VO4 (3-) species loaded on a moderate surface area SiO2 and the isolated VO4 (3-) species into SiO2 framework catalyst exhibited very high propylene selectivities in ODHP. Also, the mechanism of the formation of the isolated VOx species into SiO2 framework catalyst was studied by instrumental analyses. To obtain isolated VO4 (3-) species in the silica framework, alkoxy-exchange rates between (Si(OC2H5)(4) and V(Ot-Bu)(3)O with PEG is of crucial importance. Isolated VO4 (3-) was dispersed in the silica framework of catalysts, when the catalysts were prepared with the higher degree of polymerization (over 10) of PEG and the lower vanadium contents (below 1.0 mmol/g-SiO2). During ODHP, lattice oxygen of isolated VO4 (3-) species was consumed to give propylene and water, was reduced to isolated V3+ species. Therefore regeneration of reduced isolated V3+ species with air is indispensable, and the performance was maintained for at least ten repeated cycles, suggesting that VOx-SiO2 would be a promising catalyst for ODHP.	[Fukudome, Kenta; Suzuki, Toshimitsu] Kansai Univ, Dept Chem Energy & Environm Engn, Suita, Osaka 5648680, Japan; [Fukudome, Kenta; Suzuki, Toshimitsu] Kansai Univ, High Technol Res Ctr, Suita, Osaka 5648680, Japan	Fukudome, K (reprint author), Kagoshima Univ, Dept Chem Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	bobwpan@gmail.com; v902360@kansai-u.ac.jp			"High-Tech Research Center (HRC) Project" by MEXT	A part of this work was financially supported by the "High-Tech Research Center (HRC) Project" (2007-2011) by MEXT. KF expresses his thanks for a research assistantship from the HRC project. Discussion with professors T. Mikeya and N. Ikenaga of Kansai University was greatly appreciated.	Setnicka M, 2013, TOP CATAL, V56, P662, DOI 10.1007/s11244-013-0018-1; Botella P, 2004, J CATAL, V225, P428, DOI 10.1016/j.jcat.2004.04.024; Gao XT, 1998, J PHYS CHEM B, V102, P10842, DOI 10.1021/jp9826367; Harlin ME, 2000, J CATAL, V195, P67, DOI 10.1006/jcat.2000.2969; CAVANI F, 1995, CATAL TODAY, V24, P307, DOI 10.1016/0920-5861(95)00051-G; Xie SB, 2000, LANGMUIR, V16, P7162, DOI 10.1021/la0003342; Hess C, 2007, J PHYS CHEM C, V111, P9471, DOI 10.1021/jp0713920; Liu YM, 2004, J CATAL, V224, P417, DOI 10.1016/j.jcat.2004.03.010; Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1; VANDERWEIJ FW, 1980, MAKROMOL CHEM, V181, P2541; Buyevskaya OV, 2001, CATAL TODAY, V67, P369, DOI 10.1016/S0920-5861(01)00329-7; Klisinska A, 2006, APPL CATAL A-GEN, V309, P17, DOI 10.1016/j.apcata.2006.04.040; Blasco T, 1997, APPL CATAL A-GEN, V157, P117, DOI 10.1016/S0926-860X(97)00029-X; CORMA A, 1993, J CATAL, V144, P425, DOI 10.1006/jcat.1993.1343; Cavani F, 2007, CATAL TODAY, V127, P113, DOI 10.1016/j.cattod.2007.05.009; Solsona B, 2001, J CATAL, V203, P443, DOI 10.1006/jcat.2001.3326; Pena ML, 2001, APPL CATAL A-GEN, V209, P155, DOI 10.1016/S0926-860X(00)00761-4; Rossetti I, 2008, J CATAL, V256, P45, DOI 10.1016/j.jcat.2008.02.028; Hoj M, 2013, APPL CATAL A-GEN, V451, P207, DOI 10.1016/j.apcata.2012.09.037; Carrero CA, 2013, DALTON T, V42, P12644, DOI 10.1039/c3dt50611h; CHAAR MA, 1988, J CATAL, V109, P463, DOI 10.1016/0021-9517(88)90226-6; Banares MA, 2000, CATAL TODAY, V61, P295, DOI 10.1016/S0920-5861(00)00388-6; Morishige K, 2007, J PHYS CHEM C, V111, P280, DOI [10.1021/jp064946s, 10.1021/jp065956s]; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Pak C, 2002, J CATAL, V206, P49, DOI 10.1006/jcat.2001.3473; Ballarini N, 2003, CORNARO U, V213, P95; Bulanek R, 2012, APPL CATAL A-GEN, V415, P29, DOI 10.1016/j.apcata.2011.11.033; Burrows A, 1999, CATAL LETT, V57, P121, DOI 10.1023/A:1019035229609; Chao ZS, 2004, CATAL LETT, V94, P217, DOI 10.1023/B:CATL.0000020576.75053.96; Fukudome K, 2015, J JPN PETROL INST, V58, P153, DOI 10.1627/jpi.58.153; Fukudome K, 2011, CATAL SCI TECHNOL, V1, P987, DOI 10.1039/c1cy00115a; Fukudome K, 2013, CATAL TODAY, V203, P10, DOI 10.1016/j.cattod.2012.04.042; Gao XT, 1999, J CATAL, V188, P325, DOI 10.1006/jcat.1999.2647; Gucbilmez Y, 2005, CATAL TODAY, V100, P473, DOI 10.1016/j.cattod.2004.10.032; Karakoulia SA, 2009, CATAL TODAY, V141, P245, DOI 10.1016/j.cattod.2008.05.024; Klisinska A, 2006, APPL CATAL A-GEN, V309, P10, DOI 10.1016/j.apcata.2006.04.028; Kucherov AV, 2003, CATAL TODAY, V81, P297, DOI 10.1016/S0920-5861(03)00121-4; MaGregor J, 2009, CATAL TODAY, V142, P143; Morishige K, 2010, J PHYS CHEM C, V114, P10910, DOI 10.1021/jp102727x; Ovejero G, 1996, CATAL LETT, V41, P69, DOI 10.1007/BF00811715; Ovsitser O, 2010, CHEM COMMUN, V46, P4974, DOI 10.1039/c0cc00847h; Ovsitser O, 2012, CATAL TODAY, V192, P16, DOI 10.1016/j.cattod.2012.01.034; Pieck CL, 2004, J CATAL, V224, P1, DOI 10.1016/j.jcat.2004.02.024; Rossetti I, 2009, CATAL TODAY, V141, P271, DOI 10.1016/j.cattod.2008.05.020; Routray K, 2004, APPL CATAL A-GEN, V265, P103, DOI 10.1016/j.apcata.2004.01.006; SAM DSH, 1990, J CATAL, V123, P417; Sasikala R, 2008, APPL CATAL A-GEN, V350, P252, DOI 10.1016/j.apcata.2008.08.023; Singh RP, 2005, J CATAL, V233, P388, DOI 10.1016/j.jcat.2005.05.010; Soenen V, 1996, J CATAL, V159, P410, DOI 10.1006/jcat.1996.0104; Stelzer JB, 2005, CATAL COMMUN, V6, P1, DOI 10.1016/j.catcom.2004.10.001; Sugiyama S, 2004, APPL CATAL A-GEN, V270, P253, DOI 10.1016/j.apcata.2004.05.018; Sugiyama S, 2001, CATAL LETT, V73, P137, DOI 10.1023/A:1016633506257; Sugiyama S, 2003, CATAL LETT, V89, P229, DOI 10.1023/A:1025758614040; Mitra B, 2006, J CATAL, V240, P151, DOI 10.1016/j.jcat.2006.03.015; Wang Y, 2001, CATAL LETT, V72, P215, DOI 10.1023/A:1009001707280; Yang YH, 2004, MICROPOR MESOPOR MAT, V67, P245, DOI 10.1016/j.micromeso.2003.11.010	56	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1571-1013	1574-9266		CATAL SURV ASIA	Catal. Surv. Asia	SEP	2015	19	3					172	187		10.1007/s10563-015-9192-4		16	Chemistry, Physical	Chemistry	CP5RU	WOS:000359942500004		
J	Sugi, Y; Vinu, A				Sugi, Yoshihiro; Vinu, Ajayan			Alkylation of Biphenyl over Zeolites: Shape-Selective Catalysis in Zeolite Channels	CATALYSIS SURVEYS FROM ASIA			English	Review						Alkylation; Biphenyl; Zeolite; H-mordenite; Shape-selective catalysis; 4,4 '-Dialkylbiphenyl	EXTERNAL ACID SITES; LARGE-PORE ZEOLITES; DEALUMINATED MORDENITE; H-MORDENITE; POLYNUCLEAR AROMATICS; MOLECULAR-SIEVES; TERT-BUTYLATION; AFI TOPOLOGY; ISOPROPYLATION; 4,4'-DIISOPROPYLBIPHENYL	Steric interaction of reactants, products, and transition state intermediates with zeolites with 12- and 14-membered ring pore entrances is discussed in the alkylation of biphenyl (BP) by propene, 1-butene, and 2-methylpropene as alkylating agents. The selectivities for the least bulky 4,4'-dialkylbiphenyl (4,4'-DAB) depended on the types of zeolite and alkylating agent. The zeolites are classified as two types: Category I: mordenite (MOR), SSZ-24 (AFI), SSZ-31 (STO), CIT-5 (CFI), MCM-68 (MSE), and ZSM-12 (MTW) with straight (or slightly corrugated) channels with 12-MR or 14-MR pore entrances. Category II: SSZ-42 (IFR), SSZ-55 (ATS), SSZ-60 (SSY), Y (FAU), beta (BEA), CIT-1 (CON), UTD-1 (DON), and SSZ-53 (SFH) with large channels. Category I zeolites have shape-selective natures in their channels in the isopropylation. Among them, MOR supported the highest selectivities around 85 % for 4,4'-diisopropylbipneyl (4,4'-DIPB) at moderate temperatures as 250 C-o. The selectivities of 4,4'-DIPB are: MOR > AFI, MSE > MTW, CFI, STO: the differences are due to the recognition of 4,4'- and 3,4'-DIPB by the channels. Category II zeolites allow the accommodation and the formation of bulky DIPB isomers in their channels, resulting in non-shape selective catalysis under kinetic and/or thermodynamic controls. Bulky alkylating agents, 1-butene and 2-methylpropene, enhance selective formation of the least bulky 4,4'-DAB: 4,4'-di-sec-butylbiphenyl (4,4'-DSSB) and 4,4'-di-tert-butylbiphenyl (4,4'-DTBB), respectively, even over Category II zeolites. The bulky moieties enhance the exclusion of bulky isomers by their interaction with zeolite channels. The selectivities for 4,4'-DSSB were increased remarkably to higher than 80 % for Category I zeolites and to 70 % for ATS in Category II zeolites in the sec-butylation. However, kinetic and thermodynamic controls still worked with the formation of bulky isomers over Category II zeolites: IFR, FAU, BEA, CON, DON, and SFH in the sec-butylation. The high selectivities for 4,4'-DTTB higher than 80 % were observed for the zeolites, except FAU in the tert-butylation. These results indicate that the selectivities for 4,4'-DAB are controlled primarily by space and shape of zeolite channels for active sites, and not always by the size of pore entrances.	[Sugi, Yoshihiro] Gifu Univ, Fac Engn, Dept Mat Sci & Technol, Gifu 5011193, Japan; [Sugi, Yoshihiro; Vinu, Ajayan] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia	Sugi, Y (reprint author), Gifu Univ, Fac Engn, Dept Mat Sci & Technol, Gifu 5011193, Japan.	ysugi@gifu-u.ac.jp; a.vinu@uq.edu.au					Ahedi RK, 2003, J MOL CATAL A-CHEM, V197, P133, DOI 10.1016/S1381-1169(02)00627-1; Anand C, 2013, J MOL CATAL A-CHEM, V367, P23; Anand C, 2013, KOREAN J CHEM ENG, V30, P1043, DOI 10.1007/s11814-013-0011-1; Anand R, 2004, J MOL CATAL A-CHEM, V218, P241, DOI 10.1016/j.molcata.2004.04.017; Horniakova J, 2001, APPL CATAL A-GEN, V215, P235, DOI 10.1016/S0926-860X(01)00538-5; CSICSERY SM, 1984, ZEOLITES, V4, P202, DOI 10.1016/0144-2449(84)90024-1; Sugi Y, 1999, APPL CATAL A-GEN, V189, P251, DOI 10.1016/S0926-860X(99)00282-3; Sugi Y, 2007, B CHEM SOC JPN, V80, P1418, DOI 10.1246/bcsj.80.1418; Sugi Y, 2008, CATAL TODAY, V131, P413, DOI 10.1016/j.cattod.2007.10.060; Sugi Y, 2009, J MOL CATAL A-CHEM, V304, P22, DOI 10.1016/j.molcata.2009.01.018; Maekawa H, 2008, J MOL CATAL A-CHEM, V279, P27, DOI 10.1016/j.molcata.2007.09.020; LEE GS, 1989, CATAL LETT, V2, P243, DOI 10.1007/BF00766213; VENUTO PB, 1994, MICROPOROUS MATER, V2, P297, DOI 10.1016/0927-6513(94)00002-6; Sugi Y, 2007, B CHEM SOC JPN, V80, P2232, DOI 10.1246/bcsj.80.2232; SAWA M, 1989, APPL CATAL, V53, P169, DOI 10.1016/S0166-9834(00)80019-6; Tawada S, 2000, CATAL TODAY, V60, P243, DOI 10.1016/S0920-5861(00)00341-2; Naiki H, 2011, MICROPOR MESOPOR MAT, V143, P383, DOI 10.1016/j.micromeso.2011.03.023; KARGE HG, 1986, CHEM-ING-TECH, V58, P946, DOI 10.1002/cite.330581206; GUISNET M, 1989, APPL CATAL, V54, P1, DOI 10.1016/S0166-9834(00)82350-7; Anand C, 2012, IND ENG CHEM RES, V51, P12214, DOI 10.1021/ie301362e; Bandyopadhyay M, 2002, APPL CATAL A-GEN, V225, P51, DOI 10.1016/S0926-860X(01)00738-4; Bhatia S., 1989, CATAL REV SCI ENG, V31, P31; Chen NY, 1996, SHAPE SELECTIVE CATA, V2nd; Horniakova J, 2001, CATAL LETT, V75, P163, DOI 10.1023/A:1016715308821; Horniakova J, 2000, APPL CATAL A-GEN, V203, P47, DOI 10.1016/S0926-860X(00)00466-X; Kawagoe H, 2011, J MOL CATAL A-CHEM, V350, P1, DOI 10.1016/j.molcata.2011.08.027; Maekawa H, 2007, J MOL CATAL A-CHEM, V263, P238, DOI 10.1016/j.molcata.2006.08.078; Ito A, 2007, B CHEM SOC JPN, V80, P215, DOI 10.1246/bcsj.80.215; Maekawa H, 2007, J MOL CATAL A-CHEM, V274, P24, DOI 10.1016/j.molcata.2007.04.014; MATSUDA T, 1994, STUD SURF SCI CATAL, V83, P295; Matsuzaki T., 1989, CHEM EXPRESS, V4, P413; Olah G. A., 1973, FRIEDEL CRAFTS CHEM; Pendyala VRR, 2013, APPL CATAL A-GEN, V453, P195, DOI 10.1016/j.apcata.2012.12.011; Saha SK, 2005, MATER TRANS, V46, P2659, DOI 10.2320/matertrans.46.2659; Shibata T, 2008, MICROPOR MESOPOR MAT, V116, P226; Sugi Y, 2008, J MOL CATAL A-CHEM, V285, P101, DOI 10.1016/j.molcata.2007.12.031; Sugi Y, 1996, CATAL TODAY, V31, P3, DOI 10.1016/0920-5861(96)00039-9; Sugi Y, 1997, CATALYSIS, P55, DOI 10.1039/9781847553256-00055; Takeuchi G, 1998, CATAL SURV JPN, V2, P77, DOI 10.1023/A:1019014005522; Takeuchi G, 1991, J JPN PETROL INST, V34, P242; Vergani D, 1997, APPL CATAL A-GEN, V163, P71, DOI 10.1016/S0926-860X(97)00118-X; Zhang H-X, ISOPROPYLATION UNPUB	42	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1571-1013	1574-9266		CATAL SURV ASIA	Catal. Surv. Asia	SEP	2015	19	3					188	200		10.1007/s10563-015-9193-3		13	Chemistry, Physical	Chemistry	CP5RU	WOS:000359942500005		
J	Ishihara, S; Tabata, S; Inoue, T				Ishihara, Shozo; Tabata, Shiro; Inoue, Takehiro			A novel method to bail out coronary perforation: Micro-catheter distal perfusion technique	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						percutaneous coronary intervention; coronary perforation; complication; hemostasis	POLYTETRAFLUOROETHYLENE-COVERED STENT; SAPHENOUS-VEIN GRAFTS; ARTERY PERFORATION; INTERVENTION; MANAGEMENT; OUTCOMES; TRIAL; ERA	Coronary perforation is a rare, but life-threatening complication during percutaneous coronary intervention. Prolonged balloon inflation is one option for achieving hemostasis, but it often causes ST elevation, chest pain, decreased blood pressure, or fatal arrhythmia due to ischemia. We present the case of a 73-year-old woman who suffered severe coronary perforation after stent implantation and post-dilatation. To allow prolonged balloon inflation without ischemia, we perfused the distal area with the patient's own arterial blood injected via micro-catheter. With this method, we could prolong balloon inflation for 20 min, successfully achieving hemostasis. This novel technique, which we named the distal perfusion technique, is useful to minimize ischemia during prolonged balloon inflation. (c) 2015 Wiley Periodicals, Inc.	[Ishihara, Shozo; Tabata, Shiro; Inoue, Takehiro] Mimihara Gen Hosp, Dept Cardiol, Sakai, Osaka 5908505, Japan	Ishihara, S (reprint author), Mimihara Gen Hosp, Dept Cardiol, 4-465 Sakai Ku, Sakai, Osaka 5908505, Japan.	ishihara718mac@gmail.com					GORGE G, 1994, EUR HEART J, V15, P908; ELLIS SG, 1994, CIRCULATION, V90, P2725; Shimony A, 2009, AM J CARDIOL, V104, P1674, DOI 10.1016/j.amjcard.2009.07.048; Schachinger V, 2003, J AM COLL CARDIOL, V42, P1360, DOI 10.1016/S0735-1097(03)01038-6; Fukutomi T, 2002, CIRC J, V66, P349, DOI 10.1253/circj.66.349; Stankovic G, 2003, CIRCULATION, V108, P37, DOI 10.1161/01.CIR.0000079106.71097.1C; Fasseas P, 2004, AM HEART J, V147, P140, DOI 10.1016/S0002-8703(03)00505-2; Lansky AJ, 2006, AM J CARDIOL, V98, P370, DOI 10.1016/j.amjcard.2006.02.041; Eggebrecht H, 2004, Z KARDIOL, V93, P791, DOI 10.1007/s00392-004-0123-z; Gorge G, 1996, EUR HEART J, V17, P151; Gunning MG, 2002, HEART, V88, P495, DOI 10.1136/heart.88.5.495; Meguro K, 2013, J CARDIOL, V61, P206, DOI 10.1016/j.jjcc.2012.11.007; Ramana Ravi K, 2005, J Invasive Cardiol, V17, P603; Roy P, 2009, AM J CARDIOL, V103, P950, DOI 10.1016/j.amjcard.2008.12.025; Shirakabe A, 2007, INT HEART J, V48, P1, DOI 10.1536/ihj.48.1	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	SEP 1	2015	86	3					417	421		10.1002/ccd.26018		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP3VU	WOS:000359811600019		
J	Briguori, C; Visconti, G; Donahue, M; Focaccio, A; Mitomo, S; Kawamoto, H; Nakamura, S				Briguori, Carlo; Visconti, Gabriella; Donahue, Michael; Focaccio, Amelia; Mitomo, Satoru; Kawamoto, Hiroyoshi; Nakamura, Sunao			The STENTYS (R) paclitaxel-eluting stent in the treatment of unprotected distal left main	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						coronary artery disease; bifurcation lesion; left main; stent	PERCUTANEOUS CORONARY INTERVENTION; EUROPEAN BIFURCATION CLUB; INTRAVASCULAR ULTRASOUND; CONSENSUS DOCUMENT; TASK-FORCE; CARDIOLOGY; DISEASE; REVASCULARIZATION; SOCIETY; LESIONS	BackgroundVessel tapering represents an important limitation of the balloon-expandable drug-eluting stent (DES) in the treatment of distal unprotected left main coronary artery (ULMCA) lesions. In this study, we assessed the suitability of the STENTYS DES(P), a self-apposing nitinol paclitaxel-eluting stent, for use in the treatment of distal ULMCA lesions. Methods and ResultsFrom February 2012 to September 2013, 75 consecutive patients with tapered (that is a >1 mm difference in the diameter from the proximal to the distal main vessel) distal ULMCA lesions were treated with the STENTYS DES(P) (STENTYS-DES group) at the Clinica Mediterranea (Naples, Italy). A matched-group of 75 patients treated with second-generation DES in the same period (Control group) was selected from the database of New Tokyo Hospital (Chiba, Japan). The result was assessed by both quantitative coronary angiography and intravascular ultrasound (IVUS). Although the final balloon diameter was larger in the Control group (4.510.51 vs. 3.62 +/- 0.49 mm; P<0.001), the IVUS analysis showed a larger final minimal lumen area in the STENTYS-DES group than in the Control group (left main: 17.45 +/- 3.45 vs. 14.84 +/- 3.45 mm(2); P<0.001; polygon of confluence: 15.74 +/- 3.28 vs. 12.55 +/- 5.45 mm(2); P<0.002; ostial left anterior descending artery: 11.73 +/- 1.97 vs. 8.56 +/- 1.80 mm(2); P<0.001). At 12 +/- 5 months, major adverse cardiac events (including death, myocardial infarction, and repeat revascularization) occurred in seven patients in both groups. ConclusionsThis pilot study suggests that the self-apposing properties of the STENTYS DES(P) offer a valid alternative for the treatment of the distal ULMCA lesions. (c) 2015 Wiley Periodicals, Inc.	[Briguori, Carlo; Visconti, Gabriella; Donahue, Michael; Focaccio, Amelia] Clin Mediterranea, Lab Intervent Cardiol, Dept Cardiol, I-80121 Naples, Italy; [Mitomo, Satoru; Kawamoto, Hiroyoshi; Nakamura, Sunao] New Tokyo Hosp, Intervent Cardiol Unit, Chiba, Japan	Briguori, C (reprint author), Clin Mediterranea, Lab Intervent Cardiol, Via Orazio 2, I-80121 Naples, Italy.	carlobriguori@clinicamediterranea.it					SAREMBOCK IJ, 1989, CIRCULATION, V80, P1029; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Lefevre T, 2010, EUROINTERVENTION, V6, pJ123, DOI 10.4244/EIJV6SUPJA20; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Foin N, 2013, EUROINTERVENTION, V8, P1315, DOI 10.4244/EIJV8I11A200; Louvard Y, 2004, HEART, V90, P713, DOI 10.1136/hrt.2002.007682; Valgimigli M, 2006, J AM COLL CARDIOL, V47, P1530, DOI 10.1016/j.jacc.2005.11.066; Ozaki Y, 2010, EUR HEART J, V31, P1470, DOI 10.1093/eurheartj/ehq066; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Steigen TK, 2006, CIRCULATION, V114, P1955, DOI 10.1161/CIRCULATIONAHA.106.664920; Ormiston JA, 2004, CATHETER CARDIO INTE, V63, P332, DOI 10.1002/ccd.20120; Pan M, 2002, CATHETER CARDIO INTE, V55, P50, DOI 10.1002/ccd.10057; Gastaldi D, 2010, BIOMECH MODEL MECHAN, V9, P551, DOI 10.1007/s10237-010-0196-8; Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P562, DOI 10.1161/CIRCINTERVENTIONS.111.964643; Kandzari DE, 2009, J AM COLL CARDIOL, V54, P1576, DOI 10.1016/j.jacc.2009.07.021; Stankovic G, 2013, EUROINTERVENTION, V9, P36, DOI 10.4244/EIJV9I1A7; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Stankovic G, 2009, EUROINTERVENTION, V5, P39; Arnett DK, 2012, CIRCULATION, V125, P2554, DOI 10.1161/CIRCULATIONAHA.112.107813; Basalus MWZ, 2010, EUROINTERVENTION, V6, P141, DOI 10.4244/; Chen SL, 2010, JACC-CARDIOVASC INTE, V3, P632, DOI 10.1016/j.jcin.2010.04.006; Chieffo A, 2005, CIRCULATION, V111, P791, DOI 10.1161/01.CIR.0000155256.88940.F8; Frobert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056348; Giustino G, 2014, MINERVA CARDIOANGIOL; Laborde Jean-Claude, 2007, EuroIntervention, V3, P162; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Onuma Y, 2014, EUROINTERVENTION; Palmerini T, 2008, AM J CARDIOL, V102, P1463, DOI 10.1016/j.amjcard.2008.07.030; Ramcharitar Steve, 2008, EuroIntervention, V3, P553, DOI 10.4244/EIJV3I5A100; Sianos Georgios, 2005, EuroIntervention, V1, P219; Tamburino C, 2009, EUROINTERVENTION, V5, P432, DOI 10.4244/EIJV5I4A68; Verheye S, 2009, EUROINTERVENTION, V4, P566; Windecker S, 2014, EUR HEART J, V35, P2541, DOI 10.1093/eurheartj/ehu278	34	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	SEP 1	2015	86	3					E131	E139		10.1002/ccd.25874		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP3VU	WOS:000359811600002		
J	Muramatsu, T; Grundeken, MJ; Ishibashi, Y; Nakatani, S; Girasis, C; Campos, CM; Morel, MA; Jonker, H; de Winter, RJ; Wykrzykowska, JJ; Garcia-Garcia, HM; Leon, MB; Serruys, PW; Onuma, Y				Muramatsu, Takashi; Grundeken, Maik J.; Ishibashi, Yuki; Nakatani, Shimpei; Girasis, Chrysafios; Campos, Carlos M.; Morel, Marie-Angele; Jonker, Hans; de Winter, Robbert J.; Wykrzykowska, Joanna J.; Garcia-Garcia, Hector M.; Leon, Martin B.; Serruys, Patrick W.; Onuma, Yoshinobu		Tryton Pivotal IDE Coronary	Comparison between two- and three-dimensional quantitative coronary angiography bifurcation analyses for the assessment of bifurcation lesions: A subanalysis of the TRYTON pivotal IDE coronary bifurcation trial	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						coronary bifurcation; three-dimensional; quantitative coronary angiography	IN-VITRO VALIDATION; INTEROBSERVER VARIABILITY; CARDIAC-SURGERY; ARTERY-DISEASE; INTERVENTION; METHODOLOGY; DIAMETER; PHANTOMS; SYNERGY; STENTS	BackgroundThree-dimensional (3D) quantitative coronary angiography (QCA) provides more accurate measurements by minimizing inherent limitations of two-dimensional (2D) QCA. The aim of this study was to compare the measurements between 2D and 3D QCA analyses in bifurcation lesions. Methods and ResultsA total of 114 cases with non-left main bifurcation lesions in the TRYTON pivotal IDE Coronary Bifurcation Trial (: NCT01258972) were analyzed using a validated bifurcation QCA software (CAAS 5.10, Pie Medical Imaging, Maastricht, the Netherlands). All cases were analyzed in matched projections between pre- and post-procedure. The 2D analysis was performed using one of two angiographic images used for 3D reconstruction showing a larger distal bifurcation angle. In the treated segments (stent and balloon), there were no differences in minimal luminal diameter (MLD) between 2D and 3D, while diameter stenosis (DS) was significantly higher in 2D compared to 3D both pre-procedure and post-procedure (53.9% for 2D vs. 52.1% for 3D pre-procedure, P<0.01; 23.2% for 2D vs. 20.9% for 3D post-procedure, P=0.01). In the sub-segment level analysis, lengths of proximal main branch, distal main branch, and side branch were consistently shorter in 2D compared to 3D both pre-procedure and post-procedure. Using 3D QCA, the anatomic location of the smallest MLD or the highest DS was relocated to a different bifurcation sub-segment in a considerable proportion of the patients compared to when 2D-QCA was used (kappa values: 0.50 for MLD, 0.55 for DS). ConclusionsOur data showed differences in addressing anatomical severity and location of coronary bifurcation lesions between in vivo 2D and 3D QCA analyses. More studies are needed to investigate potential clinical benefits in using 3D approach over 2D QCA for the assessment of bifurcation lesions. (c) 2015 Wiley Periodicals, Inc.	[Muramatsu, Takashi; Ishibashi, Yuki; Nakatani, Shimpei; Girasis, Chrysafios; Campos, Carlos M.; Garcia-Garcia, Hector M.; Onuma, Yoshinobu] Erasmus MC, Thoraxctr, Rotterdam, Netherlands; [Muramatsu, Takashi] Fujita Hlth Univ Hosp, Dept Cardiol, Toyoake, Aichi, Japan; [Grundeken, Maik J.; de Winter, Robbert J.; Wykrzykowska, Joanna J.] Univ Amsterdam, Acad Med Ctr, Amsterdam Heart Ctr, NL-1105 AZ Amsterdam, Netherlands; [Girasis, Chrysafios] Onassis Cardiac Surg Ctr, Dept Cardiol 1, Athens, Greece; [Campos, Carlos M.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Dept Intervent Cardiol, Sao Paulo, Brazil; [Morel, Marie-Angele; Jonker, Hans; Garcia-Garcia, Hector M.] Cardialysis BV, Rotterdam, Netherlands; [Leon, Martin B.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Cardiovasc Res Fdn, New York, NY USA; [Serruys, Patrick W.] Univ London Imperial Coll Sci Technol & Med, NHLI, Int Ctr Circulatory Hlth, London, England	Serruys, PW (reprint author), Univ London Imperial Coll Sci Technol & Med, NHLI, Int Ctr Circulatory Hlth, London, England.	patrick.w.j.c.serruys@gmail.com		Campos, Carlos M./0000-0003-1734-6924	Tryton Medical, Inc.; Tryton Medical	The TRYTON IDE trial have been sponsored and funded by Tryton Medical, Inc. Drs. Grundeken, Wykrzykowska, and de Winter declare the funding from Tryton Medical for the TRYTON Pivotal IDE Coronary Bifurcation Trial received by their institution (Academic Medical Center, Amsterdam, The Netherlands). The rest of authors have reported that they have	Ramcharitar S, 2008, CATHETER CARDIO INTE, V71, P44, DOI 10.1002/ccd.21418; Grundeken MJ, 2013, EUROINTERVENTION, V9, P195, DOI 10.4244/EIJV9I2A34; Onuma Y, 2011, EUROINTERVENTION, V7, P629, DOI 10.4244/EIJV7I5A100; Girasis C, 2013, JACC-CARDIOVASC INTE, V6, P1250, DOI 10.1016/j.jcin.2013.08.009; Rathore S, 2009, EUROINTERVENTION, V5, P349, DOI 10.4244/V5I3A55; SERRUYS PW, 1984, AM J CARDIOL, V54, P482, DOI 10.1016/0002-9149(84)90235-2; ZIR LM, 1976, CIRCULATION, V53, P627; Grundeken MJ, 2013, EXPERT REV MED DEVIC, V10, P707, DOI 10.1586/17434440.2013.848165; Lansky A, 2009, CATHETER CARDIO INTE, V73, P258, DOI 10.1002/ccd.21814; Yong ASC, 2011, EUR HEART J, V32, P345, DOI 10.1093/eurheartj/ehq259; Girasis C, 2010, JACC-CARDIOVASC INTE, V3, P41, DOI 10.1016/j.jcin.2009.10.019; REIBER JHC, 1985, CIRCULATION, V71, P280; Girasis C, 2013, EUROINTERVENTION, V8, P1451, DOI 10.4244/EIJV8I12A219; Bruining Nico, 2008, EuroIntervention, V4, P285, DOI 10.4244/EIJV4I2A49; desFeyter PJ, 1995, EUR HEART J SUPPL, V16, P26; Dvir Danny, 2010, Cardiovasc Revasc Med, V11, P236, DOI 10.1016/j.carrev.2009.10.001; Finet Gérard, 2008, EuroIntervention, V3, P490, DOI 10.4244/EIJV3I4A87; Galassi AR, 2010, J INTERV CARDIOL, V23, P46, DOI 10.1111/j.1540-8183.2009.00512.x; GALBRAITH JE, 1978, JAMA-J AM MED ASSOC, V240, P2053, DOI 10.1001/jama.240.19.2053; Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007; Genereux P, 2015, J AM COLL CARDIOL, V65, P533, DOI 10.1016/j.jacc.2014.11.031; Girasis C, 2011, CATHETER CARDIO INTE, V77, P830, DOI 10.1002/ccd.22844; Girasis C, 2012, EUROINTERVENTION, V7, P1326, DOI 10.4244/EIJV7I11A208; Ishibashi Y, 2015, CATHETER CARDIO INTE, V85, P554, DOI 10.1002/ccd.25618; LICHTLEN PR, 1990, LANCET, V335, P1109, DOI 10.1016/0140-6736(90)91121-P; Meerkin D, 2010, J INTERV CARDIOL, V23, P152, DOI 10.1111/j.1540-8183.2010.00533.x; Ramcharitar Steve, 2008, EuroIntervention, V3, P553, DOI 10.4244/EIJV3I5A100; Sarno G, 2010, CATHETER CARDIO INTE, V76, P817, DOI 10.1002/ccd.22672; Tsuchida Keiichi, 2007, EuroIntervention, V3, P100; vansWerkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI DOI 10.1016/J.JACC.2008.12.055]	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	SEP 1	2015	86	3					E140	E149		10.1002/ccd.25925		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP3VU	WOS:000359811600003		
J	Tamatsu, Y; Tsukahara, K; Sugawara, Y; Shimada, K				Tamatsu, Yuichi; Tsukahara, Kazue; Sugawara, Yasushi; Shimada, Kazuyuki			New finding that might explain why the skin wrinkles more on various parts of the face	CLINICAL ANATOMY			English	Article						anatomy; cadaver; skin aging; dermis; sebaceous glands; forehead; eyelids	CASTRATED MALE RAT; SEBACEOUS GLANDS; TESTOSTERONE; FOREHEAD; DEPTH	The mechanism of formation of facial wrinkles has not been fully clarified due to the existence of many distinct influential factors. To clarify the relationship between facial wrinkles and structures in the skin, especially sebaceous glands, image analysis was performed on the forehead and lateral canthus regions of cadaveric skin specimens; 58 male and female donated cadavers (age range at death 20s - 90s) were included in the study. Specimens were obtained from forehead and lateral canthus region after measuring wrinkle depth. Then tissue slices were prepared to observe the sebaceous gland and its density was measured and analyzed in relation to wrinkle depth, retinacula cutis density, dermal thickness, and solar elastosis degree. A correlation was found between sebaceous gland density and wrinkle depth in forehead specimens with a lower retinacula cutis density. Wrinkles were shallower in specimens with a higher sebaceous gland density. However, no such correlation was found in lateral canthus wrinkles, presumably due to the lack of sebaceous glands in that region. In addition, specimens with a higher sebaceous gland density tended to have a thicker dermis and/or less solar elastosis. Sebaceous gland density seems to be one of the multiple factors that prevent wrinkle deepening, and that is why wrinkles are deeper in the lateral canthus area than in the forehead. Functional studies will elucidate the mechanism of wrinkle formation in the future. Clin. Anat. 28:745-752, 2015. (c) 2015 Wiley Periodicals, Inc.	[Tamatsu, Yuichi; Tsukahara, Kazue; Shimada, Kazuyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Gross Anat, Kagoshima 8908544, Japan; [Sugawara, Yasushi] Jichi Med Univ, Dept Plast Surg, Shimotsuke, Tochigi, Japan	Tamatsu, Y (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Gross Anat, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	tamatsu@dent.kagoshima-u.ac.jp					Paes EC, 2009, AESTHET SURG J, V29, P467, DOI 10.1016/j.asj.2009.08.018; KLIGMAN AM, 1985, BRIT J DERMATOL, V113, P37, DOI 10.1111/j.1365-2133.1985.tb02042.x; Nash LG, 2004, CLIN ANAT, V17, P287, DOI 10.1002/ca.10203; EBLING FJ, 1973, J INVEST DERMATOL, V60, P183, DOI 10.1111/1523-1747.ep12724451; EBLING FJ, 1971, J ENDOCRINOL, V51, P181, DOI 10.1677/joe.0.0510181; Ikeda K, 1991, HIFUKA GAKKAI ZASSHI, V101, P421; Imokawa G, 1993, COSMET TOILETRIES, V108, P65; KUMAGAI K, 2011, IEEE ENG MED BIOL, P7199; Mashiko T, 1988, JPN J DERMATOL, V98, P443; Moore KL, 2006, CLIN ORIENTED ANATOM, V5th, P14; Shimizu H, 2003, SHIMIZUS TXB DERMATO, V23, P23; Takema Y, 1997, SKIN RES TECHNOL, V3, P95, DOI 10.1111/j.1600-0846.1997.tb00169.x; THODY AJ, 1976, J ENDOCRINOL, V71, P279, DOI 10.1677/joe.0.0710279; TSUJI T, 1986, BRIT J DERMATOL, V114, P329, DOI 10.1111/j.1365-2133.1986.tb02824.x; Tsukahara K, 2011, ARCH DERMATOL, V147, P822, DOI 10.1001/archdermatol.2011.158; Tsukahara K, 2012, ARCH DERMATOL, V148, P39, DOI 10.1001/archdermatol.2011.727; Tsukahara K, 2012, ARCH DERMATOL, V148, P913, DOI 10.1001/archdermatol.2012.157; Young AL, 2009, CLIN EXP DERMATOL, V35, P392; Zimbler M S, 2001, Facial Plast Surg Clin North Am, V9, P179	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	SEP	2015	28	6					745	752		10.1002/ca.22571		8	Anatomy & Morphology	Anatomy & Morphology	CO7ZJ	WOS:000359382800010		
J	Li, YX; Cheng, KC; Asakawa, A; Amitani, H; Takimoto, Y; Runtuwene, J; Inui, A				Li, Yingxiao; Cheng, Kai-Chun; Asakawa, Akihiro; Amitani, Haruka; Takimoto, Yoshiyuki; Runtuwene, Joshua; Inui, Akio			Activation of imidazoline-I3 receptors ameliorates pancreatic damage	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						agmatine; apoptosis; beta cell; imidazoline-I3 receptors	BETA-CELL APOPTOSIS; BINDING-SITES; K+ CHANNELS; AGMATINE; STREPTOZOTOCIN; DEATH; MECHANISMS; NEURONS; KINASE	Agmatine, an endogenous ligand of imidazoline receptors, is reported to exhibit anti-hyperglycaemic and many other effects. It has been established that the imidazoline I3 receptor is involved in insulin secretion. The current study characterizes the role of the imidazoline I3 receptor in the protection of pancreatic islets. The activity effect of agmatine against on streptozotocin (STZ)-induced (5mmol/L) rat cell apoptosis was examined by using ApoTox-Glo triplex assay, live/dead cell double staining assay, flow cytometric analysis, and western blot. Imidazoline I3 receptors antagonist KU14R and the phospholipase C inhibitor named U73122 were treated in cells to investigate the potential signalling pathways. The serum glucose and recovery of insulin secretion were measured in STZ-treated rats after continuously injected agmatine. The apoptosis in rat cells was reduced by agmatine in a dose-dependent manner, cell viability was improved after treatment with agmatine and these effects were suppressed after the blockade of KU14R and U73122. Western blot analysis confirmed that agmatine could decrease caspase-3 expression and increase the p-BAD levels. In STZ-treated rats, injection of agmatine for 4weeks may significantly lower the serum glucose and recovery of insulin secretion. This improvement of pancreatic islets induced by agmatine was deleted by KU14R invivo. Agmatine can activate the imidazoline I3 receptor linked with the phospholipase C pathway to induce cell protection against apoptosis induced by a low dose of STZ. This finding provides new insight into the prevention of early stage pancreatic islet damage.	[Li, Yingxiao; Cheng, Kai-Chun; Asakawa, Akihiro; Amitani, Haruka; Runtuwene, Joshua] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima, Japan; [Takimoto, Yoshiyuki; Inui, Akio] Univ Tokyo, Grad Sch Med, Dept Stress Sci & Psychosomat Med, Tokyo, Japan	Inui, A (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, 8-35-1 Sakuragaoka, Kagoshima, Japan.	inui@m.kufm.kagoshima-u.ac.jp					Thomas AP, 1996, FASEB J, V10, P1505; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Elsner M, 2000, DIABETOLOGIA, V43, P1528, DOI 10.1007/s001250051564; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.210015200; Jin ZY, 2005, CANCER BIOL THER, V4, P139; Roivainen M, 2000, J CLIN ENDOCR METAB, V85, P432, DOI 10.1210/jc.85.1.432; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; Piletz JE, 2013, DRUG DISCOV TODAY, V18, P880, DOI 10.1016/j.drudis.2013.05.017; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Molderings GJ, 2012, PHARMACOL THERAPEUT, V133, P351, DOI 10.1016/j.pharmthera.2011.12.005; Koh PO, 2007, LIFE SCI, V81, P1079, DOI 10.1016/j.lfs.2007.08.017; Raasch W, 2001, BRIT J PHARMACOL, V133, P755, DOI 10.1038/sj.bjp.0704153; Bavec A, 2014, LIFE SCI, V99, P7, DOI 10.1016/j.lfs.2013.12.210; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chang CH, 2009, NEUROSCI LETT, V468, P297; Cheng KC, 2012, J ENDOCRINOL, V215, P43, DOI 10.1530/JOE-12-0176; Cnop M, 2005, DIABETES, V54, P97, DOI [10.2337/diabetes.54.suppl_2.S97, DOI 10.2337/DIABETES.54.SUPPL_]; Greene JM, 2013, REPROD BIOL ENDOCRIN, V26, P11; Head G. A., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P17, DOI 10.2174/187152506775268758; Iwatsubo K, 2007, AM J PHYSIOL-CELL PH, V293, P1498; Kim JH, 2004, EXP NEUROL, V189, P122, DOI 10.1016/j.expneurol.2004.05.029; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Laybutt R, 2001, DIABETES, V1, P180; Lee W.K., 2006, AM J PHYSIOL-RENAL, V291, P823, DOI DOI 10.1152/AJPRENAL.00276.2005; Liu H, 2013, INVEST OPHTH VIS SCI, V54, P5236, DOI 10.1167/iovs.13-11664; Luo JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093516; Mandrup-Poulsen T., 2001, DIABETES, V1, P58; Mellado-Gil JM, 2004, J ENDOCRINOL, V183, P155, DOI 10.1677/joe.1.05542; Mohapatra S, 2009, INT J BIOCHEM CELL B, V41, P595, DOI [10.1016/j.biocel.2008.07.013, 10.1016/j.bioce1.2008.07.013]; Morgan NG, 2003, ANN NY ACAD SCI, V1009, P167, DOI 10.1196/annals.1304.019; MORGAN NG, 1994, BIOSCIENCE REP, V14, P243, DOI 10.1007/BF01209729; PLANT TD, 1990, BRIT J PHARMACOL, V101, P115; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Reid J L, 1995, Ann N Y Acad Sci, V763, P673, DOI 10.1111/j.1749-6632.1995.tb32461.x; Saini KS, 1996, BIOCHEM MOL BIOL INT, V39, P1229; Shewade YM, 1999, TRANSPLANT P, V31, P1721, DOI 10.1016/S0041-1345(99)00077-9; TESSON F, 1995, J BIOL CHEM, V270, P9856; Zhu MY, 2003, CELL MOL NEUROBIOL, V23, P865, DOI 10.1023/A:1025069407173	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	SEP	2015	42	9					964	971		10.1111/1440-1681.12441		8	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CP7WE	WOS:000360099000011		
J	Yonekura, Y; Fujii, H; Nakai, K; Kono, K; Goto, S; Shinohara, M; Nishi, S				Yonekura, Yuriko; Fujii, Hideki; Nakai, Kentaro; Kono, Keiji; Goto, Shunsuke; Shinohara, Masami; Nishi, Shinichi			Anti-oxidative effect of the -blocker carvedilol on diabetic nephropathy in non-obese type 2 diabetic rats	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						carvedilol; diabetic nephropathy; oxidative stress	CHRONIC HEART-FAILURE; OXIDATIVE STRESS; NONDIABETIC INDIVIDUALS; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISMS; BETA-BLOCKERS; VITAMIN-E; ALBUMINURIA; CARDIOMYOCYTES; GENERATION	Oxidative stress plays an important role in the pathogenesis of diabetic nephropathy. The -blocker carvedilol has been proven to have an anti-oxidant property. The aim of the present study was to elucidate the effects of carvedilol on diabetic nephropathy. At 20weeks of age, male Spontaneously Diabetic Torii (SDT) rats were divided into three groups based on treatment: (i) an INS group (administered insulin); (ii) a CAR group (administered 10mg/kg per day, p.o., carvedilol); and (iii) a diabetic (DM) group (administered vehicle). Rats were treated for a period of 10weeks and were killed at 30weeks of age. Urinary albumin excretion, renal histomorphology, and oxidative stress were evaluated. Urinary albumin excretion was significantly lower in the CAR than DM group (42.82 +/- 3.94 vs 76.62 +/- 13.74mg/day respectively; P<0.05). The mesangial index was lower in the CAR group than in the DM group. Urinary excretion of 8-hydroxydeoxyguanosine (8-OHdG), the number of 8-OHdG-positive cells in glomeruli, and the mRNA expression of NADPH oxidase p22(phox) and p47(phox) were also lower in the CAR than DM group. However, haemoglobin A1c (HbA1c) and blood pressure levels were comparable between the two groups. The results suggest that carvedilol could prevent the progression of diabetic nephropathy by suppressing oxidative stress.	[Yonekura, Yuriko; Fujii, Hideki; Nakai, Kentaro; Kono, Keiji; Goto, Shunsuke; Nishi, Shinichi] Kobe Univ, Grad Sch Med, Div Nephrol, Kobe, Hyogo 6500017, Japan; [Yonekura, Yuriko; Fujii, Hideki; Nakai, Kentaro; Kono, Keiji; Goto, Shunsuke; Nishi, Shinichi] Kobe Univ, Grad Sch Med, Kidney Ctr, Kobe, Hyogo 6500017, Japan; [Shinohara, Masami] CLEA Japan Inc, Planning & Dev Sect, Tokyo, Japan	Fujii, H (reprint author), Kobe Univ, Grad Sch Med, Div Nephrol, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	fhideki@med.kobe-u.ac.jp					Abdel-Raheem MH, 2015, HORM METAB RES, V47, P97, DOI 10.1055/s-0034-1385855; Sharma K, 2005, AM J PHYSIOL-RENAL, V288, pF1069, DOI 10.1152/ajprenal.00345.2004; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Nakamura K, 2002, CIRCULATION, V105, P2867, DOI 10.1161/01.CIR.0000018605.14470.DD; DiNicolantonio JJ, 2013, AM J CARDIOL, V111, P765, DOI 10.1016/j.amjcard.2012.11.031; Gnudi L, 2012, NEPHROL DIAL TRANSPL, V27, P2642, DOI 10.1093/ndt/gfs121; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Spallarossa P, 2004, J MOL CELL CARDIOL, V37, P837, DOI 10.1016/j.yjmcc.2004.05.024; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Kawai K, 2004, AM J PHYSIOL-HEART C, V287, pH1003, DOI 10.1152/ajpheart.00797.2003; RUDBERG S, 1992, KIDNEY INT, V41, P822, DOI 10.1038/ki.1992.126; Kobori H, 2003, HYPERTENSION, V41, P42, DOI 10.1161/01.HYP.0000050102.90932.CF; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Rodrigues MAC, 2011, CHEM-BIOL INTERACT, V189, P45, DOI 10.1016/j.cbi.2010.10.014; Arozal W, 2010, TOXICOLOGY, V274, P18, DOI 10.1016/j.tox.2010.05.003; Dandona P, 2007, J HYPERTENS, V25, P731, DOI 10.1097/HJH.0b013e3280127948; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Dandona P, 2000, CIRCULATION, V101, P122; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Tadolini B, 1998, FREE RADICAL RES, V29, P377, DOI 10.1080/10715769800300421; Huang H, 2007, DIABETES RES CLIN PR, V75, P7, DOI 10.1016/j.diabres.2006.04.016; Karalliedde J, 2004, AM J HYPERTENS, V17, P986, DOI 10.1016/j.amjhyper.2004.08.010; Bakris GL, 2006, KIDNEY INT, V70, P1905, DOI 10.1038/sj.ki.5001835; DACHS S, 1964, AM J PATHOL, V44, P155; Fujii H, 2010, AM J NEPHROL, V31, P342, DOI 10.1159/000297290; Gomes GN, 2005, BRAZ J MED BIOL RES, V38, P1043, DOI 10.1590/S0100-879X2005000700007; Goto S, 2011, AM J NEPHROL, V34, P281, DOI 10.1159/000330853; Hayashi T, 2010, INT J UROL, V17, P989, DOI 10.1111/j.1442-2042.2010.02644.x; Ichinose K, 2005, DIABETES, V54, P2891, DOI 10.2337/diabetes.54.10.2891; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT S, V2, P337; Kim SS, 2000, LIPIDS, V35, P1225, DOI 10.1007/s11745-000-0639-2; Morgensen CE, 1999, DIABTEOLOGIA, V42, P263; Morsy MA, 2014, BIOMED RES INT, DOI 10.1155/2014/105214; Okamoto H, 2013, INT J CARDIOL, V164, P238, DOI 10.1016/j.ijcard.2012.11.051; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Shinohara M, 2000, Int J Exp Diabetes Res, V1, P89, DOI 10.1155/EDR.2000.89; Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055852; Singh A, 2011, AM J PHYSIOL-RENAL, V300, pF40, DOI 10.1152/ajprenal.00103.2010; Tavafi Majid, 2013, J Nephropathol, V2, P20, DOI 10.5812/nephropathol.9093; Wang RJ, 2006, J PHARMACOL EXP THER, V318, P45, DOI 10.1124/jpet.105.099903	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	SEP	2015	42	9					972	978		10.1111/1440-1681.12447		7	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CP7WE	WOS:000360099000012		
J	Sasaki, S				Sasaki, Shoichi			Sporadic lower motor neuron disease with a snake eyes appearance on the cervical anterior horns by MRI	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Amyotrophic lateral sclerosis; Motor neuron disease; Lower motor neuron disease; Snake eyes appearance; MRI	AMYOTROPHIC-LATERAL-SCLEROSIS; JUVENILE MUSCULAR-ATROPHY; SPINAL-CORD; UPPER EXTREMITY; SPONDYLOTIC MYELOPATHY; ANTI-GM1 ANTIBODIES; SPECTRUM; NEUROPATHY	Objective: Lower motor neuron disease (LMND) is the term generally used to describe diseases in which only lower motor neuron signs are detected. A snake eyes appearance on magnetic resonance imaging (MRI) is associated with a wide spectrum of neurological conditions including LMND. The author reports on three unique LMND patients with upper limb muscle weakness and atrophy who show a snake eyes appearance by MRI. Patients and methods: The patients were aged 18, 40 and 52 years, respectively, at the onset of the disease and had a longstanding clinical course (more than 10 years for two patients and 8 years for one patient). They were followed up for more than 6 years. Results: Clinical manifestations were characterized by (1) longstanding slow progression or delayed spontaneous arrest of asymmetric lower motor neuron signs localized exclusively in the upper extremities with unilateral predominance and distal or proximal preponderance; (2) the absence of upper motor neuron signs, bulbar signs, sensory disturbances and respiratory involvement; (3) a snake eyes appearance on the anterior horns of the cervical cord over more than 3 vertebrae by axial T2-weighted MRI and a longitudinal linear-shaped T2-signal hyperintensity by sagittal MRI; (4) neurogenic change with fasciculation and denervation potentials (fibrillation and a positive sharp wave) confined to the affected muscles by needle electromyogram; and (5) normal cerebrospinal fluid and a normal creatine kinase level. These cases did not fall into any existing category of LMND, such as progressive muscular atrophy, flail arm syndrome or Hirayama disease. Conclusions: These patients should be classified as sporadic LMND with snake eyes on MRI with a relatively benign prognosis. (C) 2015 Elsevier B.V. All rights reserved.	[Sasaki, Shoichi] Tokyo Womens Med Univ, Dept Neurol, Tokyo 1628666, Japan	Sasaki, S (reprint author), Tokyo Womens Med Univ, Dept Neurol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	sasaki.shoichi@twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [22590965]	This study was supported by a Grant-in-Aid for General Scientific Research (C) from The Ministry of Education, Culture, Sports, Science and Technology (22590965).	Mallio CA, 2013, SPINE J, V13, P830, DOI 10.1016/j.spinee.2013.02.044; Lebouteux MV, 2014, EUR J NEUROL, V21, P1233, DOI 10.1111/ene.12465; LAWYER T, 1953, AMA ARCH NEUROL PSY, V69, P171; WADA E, 1995, SPINE, V20, P2226, DOI 10.1097/00007632-199510001-00009; Sasaki S, 1999, J NEUROL NEUROSUR PS, V66, P581, DOI 10.1136/jnnp.66.5.581; HIRAYAMA K, 1963, NEUROLOGY, V13, P373; Hu MTM, 1998, J NEUROL NEUROSUR PS, V65, P950, DOI 10.1136/jnnp.65.6.950; Hirayama K, 2000, NEUROLOGY, V54, P1922; Katz JS, 1999, NEUROLOGY, V53, P1071; Flanagan EP, 2014, ANN NEUROL, V76, P54, DOI 10.1002/ana.24184; Mizuno J, 2003, J NEUROSURG, V99, P162, DOI 10.3171/spi.2003.99.2.0162; Forsyth PA, 1997, ANN NEUROL, V41, P722, DOI 10.1002/ana.410410608; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; HOPKINS IJ, 1974, AUST PAEDIATR J, V10, P273; OSULLIVAN DJ, 1978, J NEUROL NEUROSUR PS, V41, P653, DOI 10.1136/jnnp.41.7.653; Bowen J, 1996, BRAIN, V119, P1429, DOI 10.1093/brain/119.5.1429; CACCAMO DV, 1992, ANN NEUROL, V32, P580, DOI 10.1002/ana.410320416; Cassinotto C, 2009, J NEURORADIOLOGY, V36, P199, DOI 10.1016/j.neurad.2008.12.008; Fukutake T., 2006, SPINAL CORD, V19, P734; GOURIEDEVI M, 1984, ARCH NEUROL-CHICAGO, V41, P388; KAESER HE, 1983, EUR NEUROL, V22, P70, DOI 10.1159/000115539; Kira J, 2002, INTERNAL MED, V41, P169, DOI 10.2169/internalmedicine.41.169; Kuwabara S, 1994, Rinsho Shinkeigaku, V34, P1111; LAMB NL, 1991, MUSCLE NERVE, V14, P1021, DOI 10.1002/mus.880141014; Ghosh PS, 2012, ARCH NEUROL-CHICAGO, V69, P407, DOI 10.1001/archneurol.2011.1132; NOBILEORAZIO E, 1990, NEUROLOGY, V40, P1747; Norris F, 1991, HDB CLIN NEUROLOGY D, V59, P13; Oishi M., 2012, CLIN NEUROL, V52, P744; PEIRIS JB, 1989, J NEUROL NEUROSUR PS, V52, P314, DOI 10.1136/jnnp.52.3.314; Li Yuebing, 2012, J Clin Neuromuscul Dis, V13, P234, DOI 10.1097/CND.0b013e3182461afc; Ropper AH, 2003, ARCH NEUROL-CHICAGO, V60, P1791, DOI 10.1001/archneur.60.12.1791; SADIQ SA, 1990, NEUROLOGY, V40, P1067; Sharma S, 2013, NEUROLOGY, V81, pE29, DOI 10.1212/WNL.0b013e31829d85ae; te Lintelo Merijn P, 2012, Clin Neurol Neurosurg, V114, P159, DOI 10.1016/j.clineuro.2011.09.008; Turk HM, 2009, MED PRIN PRACT, V18, P73, DOI 10.1159/000163053; Van den Berg-Vos RM, 2003, J NEUROL, V250, P1279, DOI 10.1007/s00415-003-0235-9; Van den Berg-Vos RM, 2003, BRAIN, V126, P1036, DOI 10.1093/brain/awg117; Vlam L, 2012, NAT REV NEUROL, V8, P48, DOI 10.1038/nrneurol.2011.175; WAKAMOTO H, 1992, PEDIATR RADIOL, V22, P533, DOI 10.1007/BF02013004	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2015	136						122	131		10.1016/j.clineuro.2015.06.006		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP4XV	WOS:000359886800025		
J	Ando, M; Tamaki, T; Yoshida, M; Kawakami, M; Kubota, S; Nakagawa, Y; Iwasaki, H; Tsutsui, S; Yamada, H				Ando, Muneharu; Tamaki, Tetsuya; Yoshida, Munehito; Kawakami, Mamoru; Kubota, Seij; Nakagawa, Yukihiro; Iwasaki, Hiroshi; Tsutsui, Shunji; Yamada, Hiroshi			Intraoperative spinal cord monitoring using combined motor and sensory evoked potentials recorded from the spinal cord during surgery for intramedullary spinal cord tumor (vol 133, pg 18, 2015)	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Correction						Intramedullary spinal cord tumor; Spinal cord monitoring; Spinal cord evoked potential; Multimodal monitoring		Objectives: The risk of postoperative neurological impairment mandates the use of intraoperative spinal cord monitoring (IOM) during intramedullary spinal cord tumor (IMSCT) surgery. We have used spinal cord evoked potential after electrical stimulation of the cord (Sp-SCEP) to monitor the sensory tract, and SCEP after electrical stimulation to the brain (Br-SCEP) to monitor the motor tract. Both Sp-SCEP and Br-SCEP are stable under general anesthesia. We assessed the clinical utility of these multimodal spinal cord monitoring methods in a retrospective study of a cohort of patients undergoing IMSCT surgery. Methods: Thirteen patients with IMSCTs underwent tumor resection using Sp-SCEP and/or Br-SCEP. Results: Four patients underwent surgery using only Sp-SCEP monitoring, resulting in two false negatives. Nine patients underwent surgery monitored by Br-SCEP and Sp-SCEP. In three of the nine cases, Br-SCEP amplitude fell by 50% from control levels, despite there being no change in Sp-SCEP. In one of the nine cases, Sp-SCEP amplitude fell to 50% of control levels, but Br-SCEP amplitude was stable. Conclusions: During IMSCT surgery, localized regions of the cord may be damaged. Multimodal monitoring should be used to monitor. Combining Sp-SCEP and Br-SCEP is a useful means of monitoring the sensory and motor tracts.	[Ando, Muneharu; Tamaki, Tetsuya] Wakayama Rosai Hosp, Dept Orthoped Surg, Wakayama 6408505, Japan; [Yoshida, Munehito; Nakagawa, Yukihiro; Iwasaki, Hiroshi; Tsutsui, Shunji; Yamada, Hiroshi] Wakayama Med Univ, Dept Orthoped Surg, Wakayama, Japan; [Kawakami, Mamoru] Wakayama Med Univ Kihoku Hosp, Dept Orthoped Surg, Wakayama, Japan; [Kubota, Seij] Naga Hosp, Dept Orthoped Surg, Wakayama, Japan	Ando, M (reprint author), Wakayama Rosai Hosp, Dept Orthoped Surg, 93-1 Kinomoto, Wakayama 6408505, Japan.	mando@gaia.eonet.ne.jp					Ando M, 2015, CLIN NEUROL NEUROSUR, V133, P18, DOI 10.1016/j.clineuro.2015.03.004	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2015	136						148	148		10.1016/j.clineuro.2015.07.011		1	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP4XV	WOS:000359886800029		
J	Motomura, G; Yamamoto, T; Karasuyama, K; Iwamoto, Y				Motomura, Goro; Yamamoto, Takuaki; Karasuyama, Kazuyuki; Iwamoto, Yukihide			Bone SPECT/CT of Femoral Head Subchondral Insufficiency Fracture	CLINICAL NUCLEAR MEDICINE			English	Editorial Material						subchondral insufficiency fracture; SPECT; CT; osteonecrosis	OSTEONECROSIS; MRI	Subchondral insufficiency fracture of the femoral head may be confused with osteonecrosis, mainly because of radiological overlap. SPECT/CT with Tc-99 m hydroxymethylene diphosphonate images in 7 patients with subchondral insufficiency fracture were retrospectively reviewed and compared with those from 11 patients with symptomatic early osteonecrosis. In all of the hips with subchondral insufficiency fracture, SPECT/CT showed increased uptake at the subchondral lesions of the femoral head. On the other hand, in all of the hips with osteonecrosis, absence of uptake was confirmed at the subchondral lesions. SPECT/CT may assist in differentiating subchondral insufficiency fracture from osteonecrosis.	[Motomura, Goro; Yamamoto, Takuaki; Karasuyama, Kazuyuki; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 8128582, Japan	Motomura, G (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	goromoto@ortho.med.kyushu-u.ac.jp					Yamamoto T, 1999, ARTHRITIS RHEUM, V42, P2719, DOI 10.1002/1529-0131(199912)42:12<2719::AID-ANR31>3.0.CO;2-X; Kubo T, 1997, MAGN RESON IMAGING, V15, P1017, DOI 10.1016/S0730-725X(97)00159-8; Yamamoto T, 2001, SKELETAL RADIOL, V30, P247; Brenner AI, 2012, SEMIN NUCL MED, V42, P11, DOI 10.1053/j.semnuclmed.2011.07.005; Ikemura S, 2010, AM J ROENTGENOL, V195, pW63, DOI 10.2214/AJR.09.3271; MIKI T, 1987, ACTA ORTHOP SCAND, V58, P375; Motomura G, 2014, NUCL MED COMMUN, V35, P1047, DOI 10.1097/MNM.0000000000000166; Vande Berg B C, 2001, Semin Musculoskelet Radiol, V5, P57, DOI 10.1055/s-2001-12924	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	SEP	2015	40	9					752	754		10.1097/RLU.0000000000000886		3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP1WR	WOS:000359668600018		
J	Kawase, T; Naka, G; Kubota, K; Sakashita, B; Takeda, Y				Kawase, Takatsugu; Naka, Go; Kubota, Kazuo; Sakashita, Baku; Takeda, Yuichiro			NUT Midline Carcinoma in Elderly Patients Usefulness of F-18-FDG PET/CT for Treatment Assessment	CLINICAL NUCLEAR MEDICINE			English	Editorial Material						NUT midline carcinoma; F-18-FDG PET; elderly; chemotherapy; radiotherapy		Nuclear protein in testis (NUT) midline carcinoma is a rare disease that generally arises in adolescents and young adults. However, we encountered a rare NUT midline carcinoma case in an elderly patient. F-18-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography (PET/CT) studies were performed before and during the treatment course. In this case, the initial PET/CT study revealed locoregional hypermetabolism in the mediastinal lesion. After then, the interim PET/CT study indicated a clear diminishing response to the initial treatment, whereas the residual masses were morphologically observable. Nuclear imaging may allow visualization of the therapeutic effect of antineoplastic therapies in both young and elderly patients.	[Kawase, Takatsugu; Sakashita, Baku] Natl Ctr Global Hlth & Med, Dept Radiat Oncol, Shinjuku Ku, Tokyo, Japan; [Naka, Go; Takeda, Yuichiro] Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan; [Kubota, Kazuo] Natl Ctr Global Hlth & Med, Div Nucl Med, Dept Radiol, Tokyo, Japan	Kawase, T (reprint author), Natl Ctr Global Hlth & Med, Dept Radiat Oncol, Shinjuku Ku, 1-21-1Toyama, Tokyo, Japan.	tkawase@hosp.ncgm.go.jp					Rosenbaum DG, 2012, PEDIATR RADIOL, V42, P249, DOI 10.1007/s00247-011-2288-8; Parikh SA, 2013, J THORAC ONCOL, V8, P1335, DOI 10.1097/JTO.0b013e3182a00f41; Tanaka M, 2012, AM J SURG PATHOL, V36, P381, DOI 10.1097/PAS.0b013e31824230a8; Polsani A, 2012, PEDIATR RADIOL, V42, P205, DOI 10.1007/s00247-011-2272-3; Teo M, 2011, J CLIN ONCOL, V29, pE336, DOI 10.1200/JCO.2010.32.7486; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; Niederkohr RD, 2011, CLIN NUCL MED, V36, pE124, DOI 10.1097/RLU.0b013e31821c9a23; Rutt AL, 2011, ANN OTO RHINOL LARYN, V120, P546; Watanabe S, 2015, ANTICANCER RES, V35, P1607	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	SEP	2015	40	9					764	765		10.1097/RLU.0000000000000795		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP1WR	WOS:000359668600023		
J	Matsutani, S; Previato, E				Matsutani, Shigeki; Previato, Emma			The function of a cyclic trigonal curve of genus three	COLLECTANEA MATHEMATICA			English	Article							HYPERELLIPTIC SOLUTIONS; DIFFERENTIAL-EQUATIONS; ABELIAN FUNCTIONS; JACOBI INVERSION; FORMULAS; VARIETIES; STRATA; SYSTEM; FLOWS; Y(R)	A cyclic trigonal curve of genus three is a Galois cover of , therefore can be written as a smooth plane curve with equation . Following Weierstrass for the hyperelliptic case, we define an "" function for this curve and , , for each one of three particular covers of the Jacobian of the curve, and for a finite branchpoint . This generalization of the Jacobi , , functions satisfies the relation: Sigma(4)(r=1) Pi(2)(c=0) al(r)((c)) (u)/f'(b(r)) = 1 which generalizes . We also show that this can be viewed as a special case of the Frobenius theta identity.	[Matsutani, Shigeki] Natl Inst Technol, Div Ind Math, Sasebo Coll, Nagasaki 8571193, Japan; [Previato, Emma] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Previato, E (reprint author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.	rxb01142@nifty.com; ep@bu.edu					ADAMS MR, 1988, COMMUN MATH PHYS, V117, P451, DOI 10.1007/BF01223376; CORNALBA M, 1987, ANN MAT PUR APPL, V149, P135, DOI 10.1007/BF01773930; Arbarello E., 1984, GEOMETRY ALGEBRAIC C, VI; Baker HF, 1995, ABELIAN FUNCTIONS AB; Baker H.F., 1898, AM J MATH, VXX, P301, DOI DOI 10.2307/2369512; Baker HF, 1903, ACTA MATH-DJURSHOLM, V27, P135, DOI 10.1007/BF02421301; Buchstaber VM, 2000, FUNCT ANAL APPL+, V34, P159, DOI 10.1007/BF02482405; Buchstaber VM, 1997, REV MATH MATH PHYSIC, V10, P1; Eilbeck JC, 2008, J REINE ANGEW MATH, V619, P37, DOI 10.1515/CRELLE.2008.039; Eilbeck JC, 2000, CRM P LECT NOTES, V25, P121; Eilbeck J.C., 2008, INT MATH RES NOTICES; Eilbeck J.C., 2007, SIGMA, V3, P17; Fay J.D, 1973, THETA FUNCTIONS RIEM; Gibbons J, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/17/175203; Klein F, 1886, MATH ANN, V27, P431, DOI 10.1007/BF01445285; Komeda J., 2013, INT J MATH, V24, P58; Konigsberger L., 1865, J REINE ANGEW MATH, V64, P17; Krazer A., 1970, LEHRBUCH THETAFUNCTI; Lindqvist P, 2001, AM MATH MON, V108, P403, DOI 10.2307/2695794; Matsutani S, 2014, J MATH SOC JPN, V66, P647, DOI 10.2969/jmsj/06620647; Matsutani S, 2001, J PHYS A-MATH GEN, V34, P4721, DOI 10.1088/0305-4470/34/22/312; Matsutani S, 2004, HYPERELLIPTIC AL FUN, P177; Matsutani S, 2002, J PHYS A-MATH GEN, V35, P4321, DOI 10.1088/0305-4470/35/19/312; Matsutani S, 2002, INT J APPL MATH, V11, P295; Matsutani S, 2008, J MATH SOC JPN, V60, P1009, DOI 10.2969/jmsj/06041009; Matsutani S, 2008, SURV MATH APPL, V3, P13; Mumford D., 1984, TATA LECT THETA, VII; Mumford D., 1981, TATA LECT THETA, VI; Onishi Y, 2011, COMPUT METH FUNCT TH, V11, P547; Onishi Y, 2009, INT J MATH, V20, P427; Onishi Y, 2010, ICMS 11 15 OCT; PREVIATO E, 1987, COMMENT MATH HELV, V62, P292, DOI 10.1007/BF02564449; SCHILLING RJ, 1989, COMMUN PUR APPL MATH, V42, P409, DOI 10.1002/cpa.3160420404; Schilling R.J, 1987, COMMUN PURE APPL MAT, V1992, P775; Schilling R.J, 1989, COMMUN PURE APPL MAT, VXL, P455; Weber H., 1878, MATH ANN, V14, P173, DOI 10.1007/BF02174679; Weierstrass K, 1854, J REINE ANGEW MATH, V47, P289; Wellstein J., 1898, MATH ANN, V52, P440	38	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	0010-0757	2038-4815		COLLECT MATH	Collect. Math.	SEP	2015	66	3					311	349		10.1007/s13348-015-0138-y		39	Mathematics, Applied; Mathematics	Mathematics	CP3WL	WOS:000359813400001		
J	Murai, S				Murai, Satoshi			Tight combinatorial manifolds and graded Betti numbers	COLLECTANEA MATHEMATICA			English	Article							LOWER-BOUND CONJECTURE; STACKED POLYTOPES; HILBERT FUNCTION; MONOMIAL IDEALS; PSEUDOMANIFOLDS; TRIANGULATIONS; CRITERION; VERTICES; MODULES; SPHERES	In this paper, we study the conjecture of Kuhnel and Lutz, who state that a combinatorial triangulation of the product of two spheres with is tight if and only if it has exactly vertices. To approach this conjecture, we use graded Betti numbers of Stanley-Reisner rings. By using recent results on graded Betti numbers, we prove that the only if part of the conjecture holds when and that the if part of the conjecture holds for triangulations all whose vertex links are simplicial polytopes. We also apply this algebraic approach to obtain lower bounds on the numbers of vertices and edges of triangulations of manifolds and pseudomanifolds.	Osaka Univ, Grad Sch Informat Sci & Technol, Dept Pure & Appl Math, Toyonaka, Osaka 5600043, Japan	Murai, S (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Pure & Appl Math, Toyonaka, Osaka 5600043, Japan.	s-murai@ist.osaka-u.ac.jp			JSPS KAKENHI [25400043]	We would like to thank Isabella Novik for helpful comments on an earlier version of this paper. The author was partially supported by JSPS KAKENHI 25400043.	Macaulay FS, 1927, P LOND MATH SOC, V26, P531; BREHM U, 1987, TOPOLOGY, V26, P465, DOI 10.1016/0040-9383(87)90042-5; Novik I, 2009, ADV MATH, V222, P2059, DOI 10.1016/j.aim.2009.07.001; Datta B, 2013, J COMB THEORY A, V120, P2148, DOI 10.1016/j.jcta.2013.08.005; Novik I, 2009, DISCRETE COMPUT GEOM, V42, P261, DOI 10.1007/s00454-009-9187-x; Effenberger F, 2011, J COMB THEORY A, V118, P1843, DOI 10.1016/j.jcta.2011.03.003; BARNETTE DW, 1971, ISRAEL J MATH, V10, P121, DOI 10.1007/BF02771522; [Anonymous], 1981, ALGEBRAIC TOPOLOGY; Murai S, 2014, J ALGEBR COMB, V39, P373, DOI 10.1007/s10801-013-0451-z; Pardue K, 1996, ILLINOIS J MATH, V40, P564; BARNETTE D, 1973, PAC J MATH, V46, P349; Bagchi B, 2014, EUR J COMBIN, V36, P294, DOI 10.1016/j.ejc.2013.07.018; Avramov LL, 2015, MATH ANN, V361, P511, DOI 10.1007/s00208-014-1060-4; Bagchi B, 2015, EUR J COMBIN, V46, P10, DOI 10.1016/j.ejc.2014.11.002; Bagchi B, ARXIV14055675; BIGATTI AM, 1993, COMMUN ALGEBRA, V21, P2317, DOI 10.1080/00927879308824679; Bruns W., 1993, COHEN MACAULAY RINGS; Burton B.A., ARXIV14035862; Datta B., ARXIV14076767; ELIAHOU S, 1990, J ALGEBRA, V129, P1, DOI 10.1016/0021-8693(90)90237-I; Fernandez-Ramos O, 2014, J ALGEBR COMB, V39, P919, DOI 10.1007/s10801-013-0473-6; Flores A., 1933, ERGEB MATH K, V6, P4; Fogelsanger A., 1988, THESIS CORNELL U; Herzog J., MSRI P IN PRESS; Herzog J, 2011, GRAD TEXTS MATH, V260, P3, DOI 10.1007/978-0-85729-106-6; HULETT HA, 1993, COMMUN ALGEBRA, V21, P2335, DOI 10.1080/00927879308824680; KALAI G, 1987, INVENT MATH, V88, P125, DOI 10.1007/BF01405094; Kuhnel W., 1999, PERIOD MATH HUNG, V39, P161; Kuhnel W., 1995, LECT NOTES MATH, V1612; Lutz F. H., 2009, ELECTRON J COMB, V16, P33; Lutz F.H., ARXIVMATH0506372; Migliore J, 2003, ADV MATH, V180, P1, DOI 10.1016/S0001-8708(02)00079-8; Murai S, 2013, ACTA MATH-DJURSHOLM, V210, P185, DOI 10.1007/s11511-013-0093-y; Novik I, 2012, MATH SCAND, V110, P198; Spreer J., ARXIV14055962; Stanley R. P., 1996, COMBINATORICS COMMUT; Swartz E., ARXIV14110987; TAY TS, 1995, DISCRETE COMPUT GEOM, V13, P203, DOI 10.1007/BF02574038; Terai N, 1997, MANUSCRIPTA MATH, V92, P447, DOI 10.1007/BF02678204; van Kampen E.R, 1933, ABH MATH SEM HAMBURG, V9, P152; Ziegler G.M., 2007, GRADUATE TEXTS MATH, V152	41	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	0010-0757	2038-4815		COLLECT MATH	Collect. Math.	SEP	2015	66	3					367	386		10.1007/s13348-015-0137-z		20	Mathematics, Applied; Mathematics	Mathematics	CP3WL	WOS:000359813400003		
J	Sueda, S; Miyoshi, T; Sasaki, Y; Sakaue, T; Habara, H; Kohno, H				Sueda, Shozo; Miyoshi, Toru; Sasaki, Yasuhiro; Sakaue, Tomoki; Habara, Hirokazu; Kohno, Hiroaki			Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests	CORONARY ARTERY DISEASE			English	Article						acetylcholine; adding acetylcholine after ergonovine; coronary spasm; ergonovine	CORONARY-ARTERY SPASM; INTRACORONARY INJECTION; VARIANT ANGINA; ACETYLCHOLINE; ERGONOVINE; INDUCTION; ARTERIOGRAPHY; SENSITIVITY; FREQUENCY; MECHANISM	ObjectiveWe examined the clinical usefulness of sequential spasm provocation tests as follows: first, acetylcholine (ACh) test, second, ergonovine (ER) test, and finally, the ACh test following the ER test.Patients and methodsWe performed the ACh and ER tests in 461 patients (294 men, 64.411.3 years of age) during a 23-year period. In addition, we administered an intracoronary injection of ACh after the ER tests in 240 patients. First, ACh [right coronary artery (RCA): 20/50/(80)g, left coronary artery (LCA): 20/50/100/(200)g] was administered incrementally over 20s. Second, ER (RCA: 40g, LCA: 64g) was administered over 2-4min. If a provoked spasm did not occur, we administered an intracoronary injection of ACh (50/80g into the RCA and 100/200g into the LCA) just after the ER tests. A positive spasm was defined as more than 99% transient luminal narrowing.ResultsA positive spasm was observed in 221 (47.9%) patients including 181 ACh-positive (39.3%) and 119 ER-positive (25.8%) patients by the ACh or ER tests. In the 240 patients with a negative spasm in the ACh and ER tests, 48 (10.4%) patients developed provoked spasms on adding ACh after the ER test. The distributions of various cardiac disorders and provoked spasm vessels were similar among the three positive groups. Focal spasm was frequently observed in the ER-positive group, whereas diffuse spasm was frequently obtained in the ACh-positive group and by adding ACh after ER in the positive group. No major complications were recognized during the sequential spasm provocation tests.ConclusionSequential spasm provocation tests might overcome a limitation of standard spasm provocation tests.	[Sueda, Shozo; Miyoshi, Toru; Sasaki, Yasuhiro; Sakaue, Tomoki; Habara, Hirokazu; Kohno, Hiroaki] Ehime Prefectural Niihama Hosp, Dept Cardiol, Niihama, Japan	Sueda, S (reprint author), Ehime Niihama Prefectural Hosp, Dept Cardiol, Hongou 3 Choume 1-1, Niihama, Ehime 7920042, Japan.	ezf03146@nifty.com					OKUMURA K, 1988, CIRCULATION, V77, P535; OKUMURA K, 1988, J AM COLL CARDIOL, V12, P883; Sueda S, 1999, AM J CARDIOL, V83, P1186, DOI 10.1016/S0002-9149(99)00057-0; Sueda S, 2004, CORONARY ARTERY DIS, V15, P491, DOI 10.1097/00019501-200412000-00006; Sueda S, 2001, AM J CARDIOL, V88, P570, DOI 10.1016/S0002-9149(01)01744-1; Sueda S, 2000, AM J CARDIOL, V85, P391, DOI 10.1016/S0002-9149(99)00754-7; YASUE H, 1986, CIRCULATION, V74, P955; Seo SM, 2013, HEART VESSELS, V28, P301, DOI 10.1007/s00380-012-0249-2; Sueda S, 2003, CORONARY ARTERY DIS, V14, P451, DOI 10.1097/01.mca.0000085706.34267.39; Nishino M, 2014, HEART VESSELS, V29, P186, DOI 10.1007/s00380-013-0346-x; CURRY RC, 1979, CIRCULATION, V59, P307; Austen W G, 1975, Circulation, V51, P5; Goto A, 1999, J Cardiol, V34, P309; HACKETT D, 1987, CIRCULATION, V75, P577; HARDING MB, 1992, J AM COLL CARDIOL, V20, P107; HENRY PD, 1980, J CLIN INVEST, V66, P306, DOI 10.1172/JCI109858; Sueda S, 2007, JPN J INTERV CARDIOL, V22, P510; Sueda S, 2003, CHEST, V123, P380, DOI 10.1378/chest.123.2.380; Sueda S, 2004, ANGIOLOGY, V55, P403, DOI 10.1177/000331970405500407; Sueda S, 2014, HEART VESSELS; Sueda S, 2000, JPN CIRC J, V64, P559, DOI 10.1253/jcj.64.559; WHO Expert Committee on Diabetes Mellitus, 1980, WHO TECH REP SER, V646; World Health Organization Expert Committee, 1978, ART HYP REP SER, V628, P7	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	SEP	2015	26	6					490	494		10.1097/MCA.0000000000000267		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP4LS	WOS:000359853900006		
J	Watanabe, Y; Takagi, K; Nakamura, S				Watanabe, Yusuke; Takagi, Kensuke; Nakamura, Sunao			Acute and chronic total occlusion of the left circumflex artery following unprotected left main stenting: two contrasting cases	CORONARY ARTERY DISEASE			English	Editorial Material							PREDICTORS		[Watanabe, Yusuke; Takagi, Kensuke; Nakamura, Sunao] New Tokyo Hosp, Intervent Cardiol Unit, Matsudo, Chiba 2702232, Japan	Nakamura, S (reprint author), New Tokyo Hosp, Intervent Cardiol Unit, 1271 Wanagaya, Matsudo, Chiba 2702232, Japan.	boss0606@pluto.plala.or.jp					Hahn JY, 2013, J AM COLL CARDIOL, V62, P1654, DOI 10.1016/j.jacc.2013.07.041; Fujino Y, 2014, INT J CARDIOL, V176, P1056, DOI 10.1016/j.ijcard.2014.07.143; Takagi K, 2012, CIRC-CARDIOVASC INTE, V5, P491, DOI 10.1161/CIRCINTERVENTIONS.111.964874	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	SEP	2015	26	6					548	550		10.1097/MCA.0000000000000238		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP4LS	WOS:000359853900015		
J	Li, YP; Xu, XD; Hou, YH; Zhang, C; Wang, FL; Omura, K; Koizumi, Y; Chiba, A				Li, Yunping; Xu, Xiandong; Hou, Yuhang; Zhang, Chen; Wang, Fenglin; Omura, Kazuyo; Koizumi, Yuichiro; Chiba, Akihiko			Regulating the passive film of NiCoCrMo alloy in hydrofluoric acid solution by small addition of Cu	CORROSION SCIENCE			English	Article						Interfaces; Alloys; Acid solutions; Acid corrosion; Cobalt; Nickel	SULFURIC-ACID; CORROSION-RESISTANCE; STAINLESS-STEELS; DISSOLUTION BEHAVIOR; HYDROGEN ABSORPTION; COPPER ADDITION; NI-16CR-15MO; CHROMIUM; IRON	The effect of 2 wt.% Cu addition on the corrosion resistance of Ni-30Co-16Cr-15Mo-6Fe alloy in hydrofluoric acid was investigated by immersion testing at 100 degrees C. Microstructural observations of the passive film of samples after immersion testing via various methods revealed that the small addition of Cu yielded a tremendous improvement in corrosion resistance, even after cold forging. In addition, the passivation of Ni-30Co-16Cr-15Mo-6Fe alloy by a Mo-oxide-dominated passive film was completely changed to passivation by a Cu-dominated one in Ni-30Co-16Cr-15Mo-6Fe-2Cu alloy during immersion in hydrofluoric acid solution because the segregation behaviour of Cu was much stronger compared to that of Mo. Crown Copyright (C) 2015 Published by Elsevier Ltd. All rights reserved.	[Li, Yunping] Cent S Univ, Dept Mat Sci & Engn, Changsha 410083, Peoples R China; [Li, Yunping; Wang, Fenglin; Omura, Kazuyo; Koizumi, Yuichiro; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Xu, Xiandong; Hou, Yuhang; Zhang, Chen] Tohoku Univ, Sch Engn, Mat Syst Engn, Sendai, Miyagi 9808577, Japan	Li, YP (reprint author), Cent S Univ, Dept Mat Sci & Engn, Changsha 410083, Peoples R China.	lyping@csu.edu.cn			Ministry of Education, Culture, Sports, Science and Technology of Japan	This research was primarily supported by the Regional Innovation Cluster Program 2010 of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aigueperse J., 2000, FLUORINE COMPOUNDS I; Kawamura T, 2006, J POWER SOURCES, V156, P547, DOI 10.1016/j.jpowsour.2005.05.084; Zhang C, 2014, CORROS SCI, V89, P81, DOI 10.1016/j.corsci.2014.08.010; Ye HZ, 2008, J MATER PROCESS TECH, V200, P12, DOI 10.1016/j.jmatprotec.2007.10.066; Ujiro T, 2001, CORROS SCI, V43, P2185, DOI 10.1016/S0010-938X(01)00008-7; Hou YH, 2015, CORROS SCI, V90, P133, DOI 10.1016/j.corsci.2014.10.003; [Anonymous], 1968, INCO CORROSION ENG B; Liu SJ, 2007, POLYM TEST, V26, P232, DOI 10.1016/j.polymertesting.2006.10.008; PAWEL SJ, 1994, CORROSION, V50, P963; Drews T, 2006, INORG CHEM, V45, P3782, DOI 10.1021/ic052029f; Jeon SH, 2011, CORROS SCI, V53, P1408, DOI 10.1016/j.corsci.2011.01.005; Kim ST, 2007, CORROSION, V63, P114, DOI 10.5006/1.3278336; Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005; POSTRACH B, 1994, WERKST KORROS, V45, P508; HERMAS AA, 1995, CORROSION, V51, P3; Dieudonne T, 2014, CORROS SCI, V83, P234, DOI 10.1016/j.corsci.2014.02.018; Li YP, 2014, CORROS SCI, V78, P101, DOI 10.1016/j.corsci.2013.09.004; Critchlow GW, 2006, INT J ADHES ADHES, V26, P577, DOI 10.1016/j.ijadhadh.2005.09.003; HULTQUIST G, 1987, CORROS SCI, V27, P937, DOI 10.1016/0010-938X(87)90060-6; Chase Jr M.W., 1998, J PHYS CHEM REF DATA, V9, P1; Crook P., 2005, CORROSION NICKEL NIC; DEWULF DW, 1985, J ELECTROCHEM SOC, V132, P2965, DOI 10.1149/1.2113702; Dieudonne T., 2012, THESIS U EVRY VAL ES; Fedrizzi L., 1991, British Corrosion Journal, V26; Jiangnan Y., 1992, CORROS SCI, V33, P851, DOI 10.1016/0010-938X(92)90049-9; Joseph Davis R., 2001, COPPER COPPER ALLOYS; KATO C, 1984, CORROS SCI, V24, P591, DOI 10.1016/0010-938X(84)90077-5; Lide DR, 2003, CRC HDB CHEM PHYS; Moulder J. F., 1995, HDB XRAY PHOTOELECTR; Raton B., 2009, CRC HDB CHEM PHYS, P4; RUDD DW, 1961, J PHYS CHEM-US, V65, P1018, DOI 10.1021/j100824a032; SEO M, 1986, CORROS SCI, V26, P949, DOI 10.1016/0010-938X(86)90085-5; Toyoda S, 2011, ISIJ INT, V51, P456, DOI 10.2355/isijinternational.51.456; Yamamoto A., 1986, BOSHOKU GIJUTSU, V35, P448	34	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	SEP	2015	98						119	127		10.1016/j.corsci.2015.05.024		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CO9OH	WOS:000359504600013		
J	Tomio, A; Sagara, M; Doi, T; Amaya, H; Otsuka, N; Kudo, T				Tomio, Akiko; Sagara, Masayuki; Doi, Takashi; Amaya, Hisashi; Otsuka, Nobuo; Kudo, Takeo			Role of alloyed molybdenum on corrosion resistance of austenitic Ni-Cr-Mo-Fe alloys in H2S-Cl- environments	CORROSION SCIENCE			English	Article						Nickel-based alloy; Polarization; Stress corrosion; Pitting corrosion; Pourbaix diagram	STAINLESS-STEEL; CHLORIDE SOLUTIONS; PITTING CORROSION; HIGH-TEMPERATURE; BIPOLAR MODEL; INHIBITION; PASSIVITY; MOLYBDATE; BEHAVIOR; KINETICS	Corrosion test and surface analysis were conducted in the H2S-Cl- environments to elucidate the role of alloyed molybdenum on the corrosion resistance of Ni-Cr-Mo-Fe alloys. The alloyed molybdenum improves the localized corrosion resistance. The surface film is of double layers which comprise sulfide including molybdenum and chromium oxide. However, the Ni-Mo-Fe alloy also shows good corrosion resistance in the H2S-Cl- environment. This good corrosion resistance is considered to be due to the cation selectivity of molybdenum sulfide, which can form in such environments. The role of alloyed molybdenum on the corrosion resistance of Ni-Cr-Mo-Fe alloys in H2S-Cl- environments is proposed. (C) 2015 Elsevier Ltd. All rights reserved.	[Tomio, Akiko; Sagara, Masayuki; Doi, Takashi] Nippon Steel & Sumitomo Met Corp, Tech Res & Dev Bur, Amagasaki, Hyogo 6600891, Japan; [Amaya, Hisashi] Nippon Steel & Sumitomo Met Corp, Wakayama Works, Wakayama, Wakayama 6408555, Japan; [Otsuka, Nobuo] Nippon Steel & Sumikin Technol Co Ltd, Amagasaki, Hyogo 6600891, Japan; [Kudo, Takeo] Univ Hyogo, Former Grad Sch Engn, Himeji, Hyogo 6712201, Japan	Tomio, A (reprint author), 1-8 Fuso Cho, Amagasaki, Hyogo 6600891, Japan.	tomio.7ae.akiko@jp.nssmc.com					Aberle B., 2008, 08085 NACE; LECKIE HP, 1966, J ELECTROCHEM SOC, V113, P1262, DOI 10.1149/1.2423801; [Anonymous], 2004, TM01982004 NACE; Ilevbare GO, 2003, CORROS SCI, V45, P1545, DOI 10.1016/S0010-938X(02)00229-9; Park JO, 2002, J ELECTROCHEM SOC, V149, pB34, DOI 10.1149/1.1430415; Davenport AJ, 2011, J ELECTROCHEM SOC, V158, pC111, DOI 10.1149/1.3559457; FRANKEL GS, 1987, CORROSION, V43, P429; Williams DE, 2010, CORROS SCI, V52, P3702, DOI 10.1016/j.corsci.2010.07.021; Rhode S, 2013, MATER CHARACT, V77, P109, DOI 10.1016/j.matchar.2013.01.006; KUO HC, 1978, J ELECTROCHEM SOC, V125, P853, DOI 10.1149/1.2131567; CLAYTON CR, 1986, J ELECTROCHEM SOC, V133, P2465, DOI 10.1149/1.2108451; He W, 2009, CORROS SCI, V51, P2811, DOI 10.1016/j.corsci.2009.08.010; AZUMA S, 1991, CORROSION, V47, P458; Davoodi A, 2011, CORROS SCI, V53, P399, DOI 10.1016/j.corsci.2010.09.050; Taveira LV, 2010, CORROS SCI, V52, P2813, DOI 10.1016/j.corsci.2010.04.021; Bale CW, 2009, CALPHAD, V33, P295, DOI 10.1016/j.calphad.2008.09.009; Ilevbare GO, 2001, CORROS SCI, V43, P485, DOI 10.1016/S0010-938X(00)00086-X; MARSHALL PI, 1984, CORROS SCI, V24, P463, DOI 10.1016/0010-938X(84)90071-4; SUGIMOTO K, 1976, CORROSION, V32, P347; WILLIAMS DE, 1994, CORROS SCI, V36, P1213, DOI 10.1016/0010-938X(94)90145-7; Laycock NJ, 1997, CORROS SCI, V39, P1771, DOI 10.1016/S0010-938X(97)00049-8; Tomio A, 2014, CORROS SCI, V81, P144, DOI 10.1016/j.corsci.2013.12.013; BOUCHERIT N, 1992, CORROSION, V48, P569; BURSTEIN GT, 1993, CORROS SCI, V35, P57, DOI 10.1016/0010-938X(93)90133-2; Chaung H. E., 1985, 227 NACE; Denpo K, 1997, CORROSION, V53, P718; Ding JH, 2013, J MATER SCI, V48, P3708, DOI 10.1007/s10853-013-7168-1; Hibner E. L., 2003, 03125 NACE; Ikeda A., 1984, 206 NACE; Ikeda A., 1989, 47 NACE; Juhlin A., 2007, 07101 NACE; Lee L.B., 1981, CORROSION, V37, P467; LU YC, 1989, CORROS SCI, V29, P863, DOI 10.1016/0010-938X(89)90058-9; Matsushima I., 1985, 233 NACE; Miyuki H., 1998, CORROSION ENG, V47, P186; Miyuki H., 1984, 209 NACE; Moyer J. M., 166 NACE; MURAYAMA J, 1988, J JPN I MET, V52, P1127; Muto Izumi, 2009, Journal of the Electrochemical Society, V156, DOI 10.1149/1.3033498; OGAWA H, 1978, CORROSION, V34, P52; Persson K. B., 2010, 10317 NACE; Place M. C., 1991, 1 NACE; Rhodes P. R., 1985, 322 NACE; Sagara M., 2011, 11109 NACE; SAKASHITA M, 1977, CORROS SCI, V17, P473, DOI 10.1016/0010-938X(77)90003-8; Sato N., 1990, BOSHOKU GIJUTSU, V39, P495; Sridhar N., 1989, 12 NACE; Ueda M., 1994, 69 NACE; Uesugi Y., 1985, 230 NACE; Wang HT, 2013, ELECTROCHIM ACTA, V90, P128, DOI 10.1016/j.electacta.2012.11.056; Wilhelm S. M., 1988, 77 NACE; YAMAUCHI A, 1991, DESALINATION, V80, P61, DOI 10.1016/0011-9164(91)80005-G; Yashiro H, 1997, CORROSION, V53, P290	53	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	SEP	2015	98						391	398		10.1016/j.corsci.2015.05.053		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CO9OH	WOS:000359504600040		
J	Ootsuka, S; Fujita, S; Tada, E; Nishikata, A; Tsuru, T				Ootsuka, Shinji; Fujita, Sakae; Tada, Eiji; Nishikata, Atsushi; Tsuru, Tooru			Evaluation of hydrogen absorption into steel in automobile moving environments	CORROSION SCIENCE			English	Article						Steel; Hydrogen permeation; Atmospheric corrosion; Hydrogen absorption	HIGH-STRENGTH STEEL; ATMOSPHERIC CORROSION; DELAYED FRACTURE; PRESTRESSED CONCRETE; WEATHERING STEEL; PERMEATION; ENTRY; EMBRITTLEMENT; DIFFUSION; BEHAVIOR	Hydrogen absorption behaviors into steel in automobile moving environments were investigated with a temperature-compensating hydrogen absorption monitoring system. On-vehicle monitoring tests of hydrogen absorption into steel revealed that the amounts of the absorbed hydrogen into steel increases remarkably with increasing corrosion mass loss of steel and the hydrogen absorption into steel is enhanced when the vehicle travels on a wet road and when chloride loading on the steel is increased. These results described that hydrogen absorption into steel in automobile moving environments can be influenced by moving states of a vehicle in addition to road surface conditions. (C) 2015 Elsevier Ltd. All rights reserved.	[Ootsuka, Shinji] JFE Steel Corp, Steel Res Lab, Fukuyama, Hiroshima 7218510, Japan; [Fujita, Sakae] JFE Techno Res Corp, Fukuyama, Hiroshima 7210931, Japan; [Tada, Eiji; Nishikata, Atsushi] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528552, Japan; [Tsuru, Tooru] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan	Ootsuka, S (reprint author), JFE Steel Corp, Steel Res Lab, 1 Kokan Cho, Fukuyama, Hiroshima 7218510, Japan.	s-ootsuka@jfe-steel.co.jp					Hao L, 2012, CORROS SCI, V59, P270, DOI 10.1016/j.corsci.2012.03.010; Huang WD, 2011, SENSOR ACTUAT A-PHYS, V169, P1, DOI 10.1016/j.sna.2011.05.016; Tsuru T, 2005, CORROS SCI, V47, P2431, DOI 10.1016/j.corsci.2004.10.006; Omura T, 2006, MATER TRANS, V47, P2956, DOI 10.2320/matertrans.47.2956; Ha HM, 2014, CORROSION-US, V70, P166, DOI 10.5006/0990; Komazaki S, 2005, CORROS SCI, V47, P2450, DOI 10.1016/j.corsci.2004.10.008; Nishimura R, 2004, CORROS SCI, V46, P225, DOI 10.1016/S0010-938X(03)00141-0; Akiyama E, 2011, ELECTROCHIM ACTA, V56, P1799, DOI 10.1016/j.electacta.2010.09.043; Akiyama E, 2010, CORROS SCI, V52, P2758, DOI 10.1016/j.corsci.2009.11.046; [Anonymous], 1991, ISO84071991E; HIRTH JP, 1976, CORROSION, V32, P3; Sato K, 2013, INT J IMPACT ENG, V54, P1, DOI 10.1016/j.ijimpeng.2012.10.012; Mizuno D, 2014, CORROS SCI, V83, P217, DOI 10.1016/j.corsci.2014.02.020; DEVANATHAN MAV, 1962, PROC R SOC LON SER-A, V270, P90, DOI 10.1098/rspa.1962.0205; Enos DG, 1997, CORROSION, V53, P891; Fujita T., 1971, NACE, V5, P736; Hagihara Y, 2008, TETSU TO HAGANE, V94, P215; Huang YL, 2005, CORROS SCI, V47, P1545, DOI 10.1016/j.corsci.2004.07.044; Kittel J., 2008, P NACE INT C HOUST T; Krupitzer R.P., 2004, P GALV 04 CHIC US, P31; Kushida T, 1996, TETSU TO HAGANE, V82, P297; Kuziak R., 2008, ARCH CIV MECH ENG, V2, P103; Li YX, 2003, MATER DESIGN, V24, P177, DOI 10.1016/S0261-3069(03)00021-9; Motoda S., 2001, P 121 FUSH BOUSH S J, P1; MURALIDHARAN S, 1995, CORROS SCI, V37, P1739, DOI 10.1016/0010-938X(95)00068-U; Nishikata A, 2014, CORROS SCI, V87, P80, DOI 10.1016/j.corsci.2014.06.007; Omura T., 2005, ZAIRYO TO KANKYO, V54, P61; Shibata T., 2011, ZAIRYO TO KANKYO, V60, P374; Suzuki S., 2007, GALVATECH 07; Tada E., 2012, CAMP ISIJ, V25, P509; TAKAI K, 1995, TETSU TO HAGANE, V81, P1025; Takebe M, 2010, CORROS SCI, V52, P2928, DOI 10.1016/j.corsci.2010.05.004; The Incorporated Administrative Agency Public Works Research Institute (IAA-PWRI), 1993, REP APPL WEATH STEEL; Troiano A, 1960, T AM SOC MET, V52, P54; Zhou CS, 2014, CORROS SCI, V89, P30, DOI 10.1016/j.corsci.2014.07.061	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	SEP	2015	98						430	437		10.1016/j.corsci.2015.05.049		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CO9OH	WOS:000359504600044		
J	Arrighi, PA; Le Masson, P; Weil, B				Arrighi, Pierre-Antoine; Le Masson, Pascal; Weil, Benoit			Managing Radical Innovation as an Innovative Design Process: Generative Constraints and Cumulative Sets of Rules	CREATIVITY AND INNOVATION MANAGEMENT			English	Article							PRODUCT DEVELOPMENT PROCESS; PERSPECTIVE; FLEXIBILITY; MANAGEMENT; STRATEGY; ISSUES	This paper focuses on the organization of design processes and the difficulty of simultaneously achieving control and exploration while aiming to achieve radical innovation. After a first generation of works that tended to oppose new product development (NPD) processes (with controlled convergence and very limited exploration) to innovation processes (with poorly controlled convergence and random (uncontrolled) exploration), the new generation of works proposed ways to combine control and convergence either through concept shift or through stable architectures. Relying on a generic analytical framework (design space/value management), it appears that each model makes restrictive hypotheses (respectively smart leadership or stable architecture) to address two critical questions: How can one increase the efficiency of exploration? How can one ensure forms of cumulative convergence? Relying on the same analytical framework, we analyse two cases that explore the unknown in a controlled way and still do not correspond two either of the two models. We show that these two anomalies and the two models actually have two critical features in common: a focus on generative constraint and a logic of cumulative design rules. As a consequence, these two features might lead to several processes where teams have to explore the unknown and still have to keep a rigorous control of exploration and convergence.	[Arrighi, Pierre-Antoine] Tokyo Inst Technol, Tokyo Tech, Tokyo, Japan; [Le Masson, Pascal] MINES ParisTech, Design Innovat & Management, Paris, France; [Weil, Benoit] MINES ParisTech, Engn Design & Management Curricula, Paris, France; [Weil, Benoit] MINES ParisTech, Ctr Management Sci, Paris, France	Arrighi, PA (reprint author), Tokyo Inst Technol, Tokyo Tech, Tokyo, Japan.	arrighi.p.aa@m.titech.ac.jp; pascal.le_masson@mines-paristech.fr; benoit.weil@mines-paristech.fr					Agogue M, 2014, J CREATIVE BEHAV, V48, P1, DOI 10.1002/jocb.37; GARUD R, 1993, STRATEGIC MANAGE J, V14, P351, DOI 10.1002/smj.4250140504; UTTERBACK JM, 1975, OMEGA-INT J MANAGE S, V3, P639, DOI 10.1016/0305-0483(75)90068-7; Sommer SC, 2004, MANAGE SCI, V50, P1334, DOI 10.1287/mnsc.1040.0274; Christiansen JK, 2009, J PROD INNOVAT MANAG, V26, P502; Kroll E, 2013, RES ENG DES, V24, P165, DOI 10.1007/s00163-012-0149-6; Seidel VP, 2007, J PROD INNOVAT MANAG, V24, P522, DOI 10.1111/j.1540-5885.2007.00269.x; McDermott CM, 2002, J PROD INNOVAT MANAG, V19, P424, DOI 10.1016/S0737-6782(02)00174-1; COOPER RG, 1993, J PROD INNOVAT MANAG, V10, P90, DOI 10.1016/0737-6782(93)90002-8; Thomke S, 2000, J PROD INNOVAT MANAG, V17, P128, DOI 10.1016/S0737-6782(99)00031-4; Cheng YT, 1996, ORGAN SCI, V7, P593, DOI 10.1287/orsc.7.6.593; Harmancioglu N, 2007, R&D MANAGE, V37, P399, DOI 10.1111/j.1467-9310.2007.00486.x; Ozer M, 2007, RES POLICY, V36, P1372, DOI 10.1016/j.respol.2007.06.001; Sanchez R, 1996, STRATEGIC MANAGE J, V17, P63; Khurana A, 1998, J PROD INNOVAT MANAG, V15, P57, DOI 10.1111/1540-5885.1510057; Cropley A, 2006, CREATIVITY RES J, V18, P391, DOI 10.1207/s15326934crj1803_13; Veryzer RW, 1998, J PROD INNOVAT MANAG, V15, P304, DOI 10.1016/S0737-6782(97)00105-7; Archer L. B, 1965, SYSTEMATIC METHOD DE; Arrighi PA, 2015, CREAT INNOV MANAG, V24, P247, DOI 10.1111/caim.12082; Badke-Schaub P, 2010, CREAT INNOV MANAG, V19, P119, DOI 10.1111/j.1467-8691.2010.00553.x; Baldwin C. Y., 2008, 90034 HARV BUS SCH; Bonnardel N., 2004, CREATIVITY INNOVATIO, V13, P176, DOI 10.1111/j.0963-1690.2004.00307.x; Christiansen J. K., 2005, CREATIVITY INNOVATIO, V14, P384, DOI 10.1111/j.1467-8691.2005.00358.x; Clark K.B., 1991, PRODUCT DEV PERFORMA; COOPER RG, 1994, J PROD INNOVAT MANAG, V11, P3, DOI 10.1016/0737-6782(94)90115-5; Gawer A, 2009, PLATFORMS MARKETS IN; Hatchuel A., 2005, CREATIVITY INNOVATIO, V14, P345, DOI 10.1111/j.1467-8691.2005.00354.x; Jansson D., 1991, DESIGN STUDIES, V12, P3, DOI 10.1016/0142-694X(91)90003-F; Le Masson P, 2011, CREAT INNOV MANAG, V20, P217, DOI 10.1111/j.1467-8691.2011.00613.x; MacCormack A, 2001, MANAGE SCI, V47, P133, DOI 10.1287/mnsc.47.1.133.10663; Pahl G., 2006, ENG DESIGN SYSTEMATI, V3rd; SANCHEZ R, 1995, STRATEGIC MANAGE J, V16, P135, DOI 10.1002/smj.4250160921; Ulrich K.T., 2008, PRODUCT DESIGN DEV; Van De Ven A. H., 1999, INNOVATION JOURNEY; Yin R., 2003, CASE STUDY RES DESIG	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0963-1690	1467-8691		CREAT INNOV MANAG	Creat. Innov. Manag.	SEP	2015	24	3					373	390		10.1111/caim.12135		18	Management	Business & Economics	CP4QA	WOS:000359866100003		
J	Kawakami, T; Parry, ME				Kawakami, Tomoko; Parry, Mark E.			The Adoption of Electronic Innovations with Indirect Network Externalities that Compete with Standalone Physical Products	CREATIVITY AND INNOVATION MANAGEMENT			English	Article							WORD-OF-MOUTH; TECHNOLOGY ACCEPTANCE MODEL; STRUCTURAL EQUATION MODELS; VIDEO GAME INDUSTRY; PERCEIVED USEFULNESS; INFORMATION TECHNOLOGY; MICROCOMPUTER SOFTWARE; INDIVIDUAL-DIFFERENCES; HAPTIC INFORMATION; USER ACCEPTANCE	The authors consider how a change in product form impacts the adoption decision for an innovative product based on digital technology. Examples of changes in product form often arise in products that feature indirect network externalities, such as MP3 players, PDAs and e-readers. Existing research suggests that, for innovations with indirect network externalities, the consumer's hardware adoption decision is influenced by the availability of complementary products. However, these studies of complementary products tend to focus on products that exist only as complementary products, such as DVDs, CDs, and video games. This research focuses on the case of an innovative hardware product that uses digital complementary products that compete with standalone versions of the same products. The authors argue that high levels of experience with a standalone product that competes with an innovative hardware/software bundle should increase the consumer's appreciation of (1) the utilitarian benefits of the hardware/software bundle and (2) the hedonic benefits of the standalone product, some of which may not be transferable to the electronic hardware. An analysis of data collected from 549 potential adopters of e-readers in Japan support these hypotheses. The findings have important implications for the design and marketing of digital innovations that involve a change in product form.	[Kawakami, Tomoko] Waseda Univ, Sch Business, Mkt, Shinjuku Ku, Tokyo, Japan; [Kawakami, Tomoko] Nanyang Technol Univ, Inst Asian Consumer Insight, Singapore 639798, Singapore; [Parry, Mark E.] Univ Missouri Kansas City, Bloch Sch, Mkt, Kansas City, MO USA	Kawakami, T (reprint author), Waseda Univ, Sch Business, Mkt, Shinjuku Ku, Tokyo, Japan.	ktomoko@waseda.jp; parryma@umkc.edu					Lu J, 2005, J STRATEGIC INF SYST, V14, P245, DOI 10.1016/j.jsis.2005.07.003; Cheong JH, 2005, INTERNET RES, V15, P125, DOI 10.1108/10662240510590324; Trusov M, 2009, J MARKETING, V73, P90; KATZ ML, 1985, AM ECON REV, V75, P424; BUCHANAN JM, 1962, ECONOMICA, V29, P371, DOI 10.2307/2551386; Zhu F, 2012, STRATEGIC MANAGE J, V33, P88, DOI 10.1002/smj.941; WRIGHT AA, 1995, J CONSUM RES, V21, P708, DOI 10.1086/209429; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Davis FD, 1996, INT J HUM-COMPUT ST, V45, P19, DOI 10.1006/ijhc.1996.0040; Walther E, 2002, J PERS SOC PSYCHOL, V82, P919, DOI 10.1037//0022-3514.82.6.919; Bloch PH, 2003, J CONSUM RES, V29, P551, DOI 10.1086/346250; Ratner RK, 2002, J CONSUM RES, V29, P246, DOI 10.1086/341574; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Steinfield C, 2008, J APPL DEV PSYCHOL, V29, P434, DOI 10.1016/j.appdev.2008.07.002; Brown SA, 2005, MIS QUART, V29, P399; Boyd TC, 1999, J ACAD MARKET SCI, V27, P306, DOI 10.1177/0092070399273002; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; Shankar V, 2003, STRATEGIC MANAGE J, V24, P375, DOI 10.1002/smj.296; Clements MT, 2004, INT J IND ORGAN, V22, P633, DOI 10.1016/j.ijindorg.2004.01.003; Hennig-Thurau T, 2004, J INTERACT MARK, V18, P38, DOI 10.1002/dir.10073; Wu JH, 2005, INFORM MANAGE-AMSTER, V42, P719, DOI 10.1016/j.im.2007.07.001; HIRSCHMAN EC, 1982, J MARKETING, V46, P92, DOI 10.2307/1251707; Corts KS, 2009, INT J IND ORGAN, V27, P121, DOI 10.1016/j.ijindorg.2008.08.002; Nysveen H, 2005, J ACAD MARKET SCI, V33, P330, DOI 10.1177/0092070305276149; Dhar R, 2000, J MARKETING RES, V37, P60, DOI 10.1509/jmkr.37.1.60.18718; HOLBROOK MB, 1982, J CONSUM RES, V9, P132, DOI 10.1086/208906; Botti S, 2011, J CONSUM RES, V37, P1065, DOI 10.1086/656570; Creusen MEH, 2005, J PROD INNOVAT MANAG, V22, P63, DOI 10.1111/j.0737-6782.2005.00103.x; Stremersch S, 2007, J MARKETING, V71, P52, DOI 10.1509/jmkg.71.3.52; BABIN BJ, 1994, J CONSUM RES, V20, P644, DOI 10.1086/209376; Novak TP, 2000, MARKET SCI, V19, P22, DOI 10.1287/mksc.19.1.22.15184; ZEITHAML VA, 1988, J MARKETING, V52, P2, DOI 10.2307/1251446; ADAMS DA, 1992, MIS QUART, V16, P227, DOI 10.2307/249577; Kozinets RV, 2010, J MARKETING, V74, P71; KATZ ML, 1994, J ECON PERSPECT, V8, P93; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; HENDRICKSON AR, 1993, MIS QUART, V17, P227, DOI 10.2307/249803; Voss KE, 2003, J MARKETING RES, V40, P310, DOI 10.1509/jmkr.40.3.310.19238; Peck J, 2003, J MARKETING, V67, P35, DOI 10.1509/jmkg.67.2.35.18612; Venkatesh V, 2001, MIS QUART, V25, P71, DOI 10.2307/3250959; Peck J, 2003, J CONSUM RES, V30, P430, DOI 10.1086/378619; Yoo Y, 2012, ORGAN SCI, V23, P1398, DOI 10.1287/orsc.1120.0771; ARNDT J, 1967, J MARKETING RES, V4, P291, DOI 10.2307/3149462; Basu A, 2003, MARKET SCI, V22, P209, DOI 10.1287/mksc.22.2.209.16037; Batra R., 1991, MARKET LETT, V2, P159, DOI DOI 10.1007/BF00436035; Bickart B., 2001, J INTERACT MARK, V15, P31, DOI DOI 10.1002/DIR.1014; Binken JLG, 2009, J MARKETING, V73, P88; BRUNER GC, 1990, J MARKETING, V54, P94; CELSI RL, 1988, J CONSUM RES, V15, P210, DOI 10.1086/209158; Childers TL, 2001, J RETAILING, V77, P511, DOI 10.1016/S0022-4359(01)00056-2; Cottrell T, 1998, J ENG TECHNOL MANAGE, V15, P309, DOI 10.1016/S0923-4748(98)00021-6; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; Day G. S., 1990, MARKETING DRIVEN STR; Dichter E, 1966, HARVARD BUS REV, V16, P31; Dillman D., 1978, MAIL TELEPHONE SURVE; Douglas S. P., 1983, INT MARKETING RES; Dube JPH, 2010, MARKET SCI, V29, P216, DOI 10.1287/mksc.1090.0541; Duhan DF, 1997, J ACAD MARKET SCI, V25, P283, DOI 10.1177/0092070397254001; Ellen PS, 1998, J ADVERTISING, V27, P29; Gandal N, 2000, RAND J ECON, V31, P43, DOI 10.2307/2601028; GANDAL N, 1994, RAND J ECON, V25, P160, DOI 10.2307/2555859; Graham J, 2007, J ADVERTISING RES, V47, P427, DOI 10.2501/S0021849907070444; GREENWALD AG, 1984, J CONSUM RES, V11, P581, DOI 10.1086/208994; Gretz RT, 2010, J ECON BEHAV ORGAN, V76, P168, DOI 10.1016/j.jebo.2010.07.007; Gupta S, 1999, MARKET SCI, V18, P396, DOI 10.1287/mksc.18.3.396; Inceoglu F, 2011, APPL ECON, V43, P4803, DOI 10.1080/00036846.2010.498358; Kawakami T, 2013, J PROD INNOVAT MANAG, V30, P1112, DOI 10.1111/jpim.12049; Kawakami T, 2013, J PROD INNOVAT MANAG, V30, P17, DOI 10.1111/j.1540-5885.2012.00983.x; Brynjolfsson E, 1996, MANAGE SCI, V42, P1627, DOI 10.1287/mnsc.42.12.1627; Khan U., 2005, INSIDE CONSUMPTION F, P144; Kim JH, 2014, INT J IND ORGAN, V37, P99, DOI 10.1016/j.ijindorg.2014.08.005; Livingston JA, 2013, APPL ECON LETT, V20, P76, DOI 10.1080/13504851.2012.681018; Morrin M, 2003, J MARKETING RES, V40, P10, DOI 10.1509/jmkr.40.1.10.19128; Ohashi H, 2003, J ECON MANAGE STRAT, V12, P447, DOI 10.1162/105864003322538929; Parry M. E., 2011, MARKETING J, V31, P34; Parry M. E., 2013, DETERMINANTS ENCROAC; Parry ME, 2012, J PROD INNOVAT MANAG, V29, P952, DOI 10.1111/j.1540-5885.2012.00972.x; PETTY RE, 1983, J CONSUM RES, V10, P135, DOI 10.1086/208954; Prieger J., 2006, 0625 NET I; Raynor M. E., 2003, INNOVATORS SOLUTION; REDMOND WH, 1991, J PROD INNOVAT MANAG, V8, P170, DOI 10.1016/0737-6782(91)90024-S; Rogers E., 2003, DIFFUSION INNOVATION; Slama M., 1999, J MARKETING, V63, P135, DOI 10.2307/1251979; Song M, 2009, J PROD INNOVAT MANAG, V26, P291; Steinfield Charles, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Todd S., 2009, AUSTRALASIAN MARKETI, V17, P16; Walther E, 2004, PSYCHOL MARKET, V21, P755, DOI 10.1002/mar.20028; ZAICHKOWSKY JL, 1985, J CONSUM RES, V12, P341, DOI 10.1086/208520	90	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0963-1690	1467-8691		CREAT INNOV MANAG	Creat. Innov. Manag.	SEP	2015	24	3					430	448		10.1111/caim.12140		19	Management	Business & Economics	CP4QA	WOS:000359866100006		
J	Sharma, AM; Gupta, A; Kumar, PK; Rajan, J; Saba, L; Nobutaka, I; Laird, JR; Nicolades, A; Suri, JS				Sharma, Aditya M.; Gupta, Ajay; Kumar, P. Krishna; Rajan, Jeny; Saba, Luca; Nobutaka, Ikeda; Laird, John R.; Nicolades, Andrew; Suri, Jasjit S.			A Review on Carotid Ultrasound Atherosclerotic Tissue Characterization and Stroke Risk Stratification in Machine Learning Framework	CURRENT ATHEROSCLEROSIS REPORTS			English	Review						Vascular atherosclerosis; Carotid artery disease; Cardiovascular disease; Plaque morphology; Tissue characterization; Ultrasonic features; Machine learning; Computer-aided diagnosis	INTIMA-MEDIA THICKNESS; HISTOLOGY INTRAVASCULAR ULTRASOUND; B-MODE ULTRASOUND; ARTERY STENOSIS; PLAQUE CHARACTERIZATION; VULNERABLE PLAQUE; CARDIOVASCULAR EVENTS; DIABETIC-PATIENTS; IMT MEASUREMENT; VASA VASORUM	Cardiovascular diseases (including stroke and heart attack) are identified as the leading cause of death in today's world. However, very little is understood about the arterial mechanics of plaque buildup, arterial fibrous cap rupture, and the role of abnormalities of the vasa vasorum. Recently, ultrasonic echogenicity characteristics and morphological characterization of carotid plaque types have been shown to have clinical utility in classification of stroke risks. Furthermore, this characterization supports aggressive and intensive medical therapy as well as procedures, including endarterectomy and stenting. This is the first state-of-the-art review to provide a comprehensive understanding of the field of ultrasonic vascular morphology tissue characterization. This paper presents fundamental and advanced ultrasonic tissue characterization and feature extraction methods for analyzing plaque. Additionally, the paper shows how the risk stratification is achieved using machine learning paradigms. More advanced methods need to be developed which can segment the carotid artery walls into multiple regions such as the bulb region and areas both proximal and distal to the bulb. Furthermore, multimodality imaging is needed for validation of such advanced methods for stroke and cardiovascular risk stratification.	[Sharma, Aditya M.] Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA USA; [Gupta, Ajay] Weill Cornell Med Coll, Brain & Mind Res Inst, Dept Radiol, New York, NY USA; [Kumar, P. Krishna; Rajan, Jeny] Natl Inst Technol Karnataka, Dept Comp Sci & Engn, Surathkal, India; [Saba, Luca] Univ Cagliari, Dept Radiol, Cagliari, Italy; [Nobutaka, Ikeda] Natl Ctr Global Hlth & Med, Cardiovasc Med, Tokyo, Japan; [Laird, John R.] Univ Calif Davis, UC Davis Vasc Ctr, Davis, CA 95616 USA; [Nicolades, Andrew] Vasc Screening & Diagnost Ctr, London, England; [Nicolades, Andrew] Univ Cyprus, Vasc Diagnost Ctr, Nicosia, Cyprus; [Suri, Jasjit S.] AtheroPoint TM, Monitoring & Diagnost Div, Roseville, CA USA; [Suri, Jasjit S.] Global Biomed Technol Inc, Point Care Devices, Roseville, CA USA; [Suri, Jasjit S.] Univ Idaho, Dept Elect Engn, Moscow, ID 83843 USA	Suri, JS (reprint author), AtheroPoint TM, Monitoring & Diagnost Div, Roseville, CA USA.	jasjit.suri@atheropoint.com			Foundation of the American Society of Neuroradiology Grant	A Gupta has received research support from Foundation of the American Society of Neuroradiology Grant.	Abd-Allah F, 2012, PERSPECTIVES MED, V1, P167; AbuRahma AF, 2002, J VASC SURG, V36, P437, DOI 10.1067/mva.2002.126545; Acharya R., 2007, ADV CARDIAC SIGNAL P; Acharya U.R., 2012, J MED SYST, V3, P1861; Acharya UR, 2014, J CLIN ULTRASOUND, V42, P302; Christodoulou CI, 2003, IEEE T MED IMAGING, V22, P902, DOI 10.1109/TMI.2003.815066; Molinari F, 2010, IEEE T ULTRASON FERR, V57, P1112, DOI 10.1109/TUFFC.2010.1522; Shah F, 2007, VASC MED, V12, P291, DOI 10.1177/135886307083363; Randoux B, 2001, RADIOLOGY, V220, P179; Dunmore BJ, 2007, J VASC SURG, V45, P155, DOI 10.1016/j.jvs.2006.08.072; Xiong L, 2009, RADIOLOGY, V251, P583, DOI 10.1148/radiol.2512081829; McCarthy MJ, 1999, J VASC SURG, V30, P261, DOI 10.1016/S0741-5214(99)70136-9; Polak JF, 1998, RADIOLOGY, V208, P649; Lal BK, 2002, J VASC SURG, V35, P1210, DOI 10.1067/mva.2002.122888; Diethrich EB, 2007, J ENDOVASC THER, V14, P676, DOI 10.1583/1545-1550(2007)14[676:VHIUAO]2.0.CO;2; Kyriacou EC, 2012, IEEE T INF TECHNOL B, V16, P966, DOI 10.1109/TITB.2012.2192446; AbuRahma AF, 2002, STROKE, V33, P1772, DOI 10.1161/01.STR.0000019127.11189.B5; Loizou CP, 2014, IEEE T ULTRASON FERR, V61, P86, DOI [10.1109/TUFFC.2014.6689778, 10.1109/TUFFC.2014.2881]; Gupta A, 2014, STROKE, V45, P740, DOI 10.1161/STROKEAHA.113.003882; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; WAGNER RF, 1983, IEEE T SON ULTRASON, V30, P156, DOI 10.1109/T-SU.1983.31404; Carr S, 1996, J VASC SURG, V23, P755, DOI 10.1016/S0741-5214(96)70237-9; Irshad K, 2007, J ENDOVASC THER, V14, P198, DOI 10.1583/1545-1550(2007)14[198:VHIUIC]2.0.CO;2; FOGEL I, 1989, BIOL CYBERN, V61, P103; Molinari F, 2010, COMPUT METH PROG BIO, V100, P201, DOI 10.1016/j.cmpb.2010.04.007; Wyman RA, 2006, VASC MED, V11, P123, DOI 10.1191/1358863x06vm666ra; Gonzalez A, 2012, J ENDOVASC THER, V19, P764, DOI 10.1583/JEVT-12-3914MR2.1; Saba L, 2010, CARDIOVASC INTER RAD, V33, P681, DOI 10.1007/s00270-010-9828-8; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Schneider PA, 2010, EUR J VASC ENDOVASC, V40, P274, DOI 10.1016/j.ejvs.2010.05.004; Shrivastava VK, 2015, EXPERT SYST APPL, V42, P6184, DOI 10.1016/j.eswa.2015.03.014; Portanova A, 2013, RADIOLOGY, V267, P667, DOI 10.1148/radiol.13112310; Das M, 2009, EUR J VASC ENDOVASC, V38, P14, DOI 10.1016/j.ejvs.2009.03.013; ElBarghouty N, 1996, EUR J VASC ENDOVASC, V11, P470, DOI 10.1016/S1078-5884(96)80184-5; Tsiaparas NN, 2011, IEEE T INF TECHNOL B, V15, P130, DOI 10.1109/TITB.2010.2091511; [Anonymous], 2010, CARD DIS REP; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Reiter M, 2007, AM J NEURORADIOL, V28, P122; Saba L, 2014, CARDIOVASC INTER RAD, V37, P572, DOI 10.1007/s00270-013-0711-2; Molinari F, 2012, COMPUT METH PROG BIO, V108, P946, DOI 10.1016/j.cmpb.2012.05.008; Acharya UR, 2013, MED BIOL ENG COMPUT, V51, P513, DOI 10.1007/s11517-012-1019-0; Acharya UR, 2013, IEEE T INSTRUM MEAS, V62, P392, DOI 10.1109/TIM.2012.2217651; Acharya UR, 2012, ULTRASOUND MED BIOL, V38, P899, DOI 10.1016/j.ultrasmedbio.2012.01.015; Granada JF, 2008, NAT CLIN PRACT CARD, V5, pS18, DOI 10.1038/ncpcardio1157; Bots ML, 1997, CIRCULATION, V96, P1432; Pedro LM, 2014, ECHOCARDIOGR-J CARD, V31, P353, DOI 10.1111/echo.12348; Madani A, 2011, NEUROLOGY, V77, P744, DOI 10.1212/WNL.0b013e31822b0090; Hitchner E, 2014, J VASC SURG, V59, P774, DOI 10.1016/j.jvs.2013.09.028; Feinstein SB, 2004, AM J PHYSIOL-HEART C, V287, pH450, DOI 10.1152/ajpheart.00134.2004; Zacharatos H, 2010, AM J NEURORADIOL, V31, P586, DOI 10.3174/ajnr.A1810; Katakami N, 2012, DIABETES CARE, V35, P2640, DOI 10.2337/dc12-0331; Acharya UR, 2012, IEEE T INSTRUM MEAS, V61, P1045, DOI 10.1109/TIM.2011.2174897; Guan FD, 2014, SCI CHINA TECHNOL SC, V57, P607, DOI 10.1007/s11431-014-5483-7; Dumont TM, 2012, J NEUROSURG, V116, P1251, DOI 10.3171/2012.3.JNS111320; Spagnoli LG, 2007, J NUCL MED, V48, P1800, DOI 10.2967/jnumed.107.038661; WU CM, 1992, IEEE T MED IMAGING, V11, P141, DOI 10.1109/42.141636; Kyriacou E, 2009, APPL INTELL, V30, P3, DOI 10.1007/s10489-007-0072-0; Acharya UR, 2013, COMPUT METH PROG BIO, V110, P66, DOI 10.1016/j.cmpb.2012.09.008; Asvestas P, 2002, ULTRASOUND MED BIOL, V28, P1129, DOI 10.1016/S0301-5629(02)00550-1; Chiu B, 2012, J ULTRAS MED, V31, P1567; Christodoulou CI, 2010, OPEN CARDIOVASCULAR, V2, P18, DOI 10.2174/1876538601002010018; Deans SR, 2007, RADON TRANSFORM SOME; El-Baz A., 2013, INT J BIOMEDICAL IMA, V2013, P1; ERIKSON KR, 1974, IEEE T SON ULTRASON, VSU21, P144; SILLESEN H, 1995, EUR J VASC ENDOVASC, V10, P23; Ferrero GVS, 2014, IEEE T ULTRASON FERR, V61, P44; Flach P., 2004, ICML TUT 2004; Fletcher RH, 2012, CLIN EPIDEMIOLOGY ES; Friera F, 2014, REV J CARDIOVASC TRA, V7, P623; Giannoukos G, 2014, MATH METHOD APPL SCI, V37, P711, DOI 10.1002/mma.2829; Gupta A, 2014, AM J NEURORADIOL, V36, P1; GUPTA L, 1987, PATTERN RECOGN, V20, P267, DOI 10.1016/0031-3203(87)90001-X; Hurtut T, 2008, COMPUT VIS IMAGE UND, V112, P101, DOI 10.1016/j.cviu.2007.12.006; Irie Y, 2014, J DIABETES COMPLICAT, V28, P523, DOI 10.1016/j.jdiacomp.2014.03.009; Joshi FR, 2012, EUR HEART J-CARD IMG, V13, P205, DOI [10.1093/ehjci/jer319, 10.1093/ejechocard/jer319]; Kakkos SK, 2007, EUR J VASC ENDOVASC, V33, P422, DOI 10.1016/j.ejvs.2006.10.018; Keenan NG, 2009, LANCET, V374, P1703, DOI 10.1016/S0140-6736(09)60291-9; Kohavi R, 1995, ARTIF INTELL, V14, P1137; Lindenmaier TJ, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-39; MAGNIN PA, 1982, ULTRASONIC IMAGING, V4, P267, DOI 10.1016/0161-7346(82)90011-6; Maseri A, 2003, CIRCULATION, V107, P2068, DOI 10.1161/01.CIR.0000070585.48035.D1; Mirmehdi M., 2009, HDB TEXTURE ANAL; Mougiakakou SG, 2007, ULTRASOUND MED BIOL, V33, P26, DOI 10.1016/j.ultrasmedbio.2006.07.032; Mughal Majid M, 2011, Expert Rev Cardiovasc Ther, V9, P1315, DOI 10.1586/erc.11.120; Naqvi TZ, 2014, JACC-CARDIOVASC IMAG, V7, P1025, DOI 10.1016/j.jcmg.2013.11.014; Nicolaides AN, 2010, J VASC SURG, V52, P1486, DOI 10.1016/j.jvs.2010.07.021; Niu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076880; Saba Luca, 2012, Cardiovasc Diagn Ther, V2, P10, DOI 10.3978/j.issn.2223-3652.2011.11.01; Saba L, 2012, ECHOCARDIOGR-J CARD, V29, P1111, DOI 10.1111/j.1540-8175.2012.01763.x; Sanches JM, 2012, ULTRASOUND IMAGING: ADVANCES AND APPLICATIONS, P1, DOI 10.1007/978-1-4614-1180-2; Scholkopft B., 1999, NEURAL NETWORKS SIGN, VIX; Schuster L, 2010, RADIOLOGE, V50, P597, DOI 10.1007/s00117-009-1932-x; Steinl DC, 2015, INT J MOL SCI, V16, P9749, DOI 10.3390/ijms16059749; Suri JS, 2011, ATHEROSCLEROSIS DISEASE MANAGEMENT, P1, DOI 10.1007/978-1-4419-7222-4; Tsiaparas NN, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/11/114004; Virmani Renu, 2006, Neurosurgery, V59, pS219; Virmani Renu, 2003, J Interv Cardiol, V16, P267, DOI 10.1034/j.1600-0854.2003.8042.x; Wilhjelm JE, 1998, IEEE T MED IMAGING, V17, P910, DOI 10.1109/42.746624; Wold H, 1985, ENCY STAT SCI; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wu TH, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-98; Yoshida K, 2008, AM J NEURORADIOL, V29, P868, DOI 10.3174/ajnr.A1015	102	0	0	CURRENT MEDICINE GROUP	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1523-3804	1534-6242		CURR ATHEROSCLER REP	Curr. Atheroscleros. Rep.	SEP	2015	17	9							55	10.1007/s11883-015-0529-2		13	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP6QA	WOS:000360011600002		
J	Kita, Y; Tanaka, K; Murakami, F				Kita, Yoshiaki; Tanaka, Kazuto; Murakami, Fujio			Specific labeling of climbing fibers shows early synaptic interactions with immature Purkinje cells in the prenatal cerebellum	DEVELOPMENTAL NEUROBIOLOGY			English	Article						climbing fiber; Purkinje cell; in utero electroporation; synaptic contact; cerebellum	OLIVOCEREBELLAR PROJECTION; POSTNATAL MATURATION; MOUSE CEREBELLUM; WAITING PERIOD; AXONS; RAT; NEURONS; HISTOGENESIS; HINDBRAIN; INTERNEURONS	During development, growing axons must locate target cells to form synapses. This is not easy, since target cells are also growing and even actively migrating. In some brain regions, such axons have been reported to wait for the timing when target cells become mature, without invading their target region. However, in the cerebellum climbing fibers (CFs), major afferent axons, arrive near their target neurons, Purkinje cells, when the neurons are still actively migrating. We, therefore, examined whether synaptic contacts are established at such early stages. To specifically label CFs, we introduced by in utero electroporation a mixture of genes encoding for Ptf1a-enhancer-driven Cre recombinase and Cre-dependent fluorescent protein into the mouse hindbrain at embryonic day (E) 10.5 and observed them during development. The earliest stages at which labeled CFs were observed in the cerebellar primordium were E15.5-E16.5. These fibers were fasciculated in the dorsal region and entered the cerebellar primordium. Some fibers defasciculated and reached the caudal region. At E17.5 and E18.5, fasciculated fibers were also found in the mantle region, and some grew toward the surface of the primordium to penetrate a mass of Purkinje cells. Interestingly, as early as E16.5, labeled fibers were found to run in close apposition to Purkinje cell dendrites and to express a presynaptic marker. These observations suggest that CFs form synapses with Purkinje cells as soon as the fibers enter the cerebellum. (c) 2014 Wiley Periodicals, Inc. Develop Neurobiol 75: 927-934, 2015	[Kita, Yoshiaki; Tanaka, Kazuto; Murakami, Fujio] Osaka Univ, Grad Sch Frontier Biosciences, Neurosci Lab, Suita, Osaka 5650871, Japan	Murakami, F (reprint author), Osaka Univ, Grad Sch Frontier Biosciences, Neurosci Lab, Suita, Osaka 5650871, Japan.	kita-y@brain.riken.jp; murakami@fbs.osaka-u.ac.jp			Scientific Research on Priority from Ministry of Education, Science, Sports and Culture of Japan [MEXT KAKENHI 22200045002]	Contract grant sponsor: Scientific Research on Priority from the Ministry of Education, Science, Sports and Culture of Japan; contract grant number: MEXT KAKENHI 22200045002, http://www.mext.go.jp/english/.	Hirata T, 1999, J NEUROBIOL, V38, P93; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Ako R, 2011, MOL CELL NEUROSCI, V48, P246, DOI 10.1016/j.mcn.2011.08.005; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Morara S, 2001, NEUROSCIENCE, V108, P655, DOI 10.1016/S0306-4522(01)00433-X; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; MASON CA, 1984, J NEUROSCI, V4, P1715; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Kohl A, 2012, J NEUROSCI, V32, P5757, DOI 10.1523/JNEUROSCI.4231-11.2012; Hatanaka Y, 2013, CEREB CORTEX, V23, P105, DOI 10.1093/cercor/bhr383; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; Watanabe M, 2011, EUR J NEUROSCI, V34, P1697, DOI 10.1111/j.1460-9568.2011.07894.x; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; CHEDOTAL A, 1992, EUR J NEUROSCI, V4, P1159, DOI 10.1111/j.1460-9568.1992.tb00142.x; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Yamada M, 2007, J NEUROSCI, V27, P10924, DOI 10.1523/JNEUROSCI.1423-07.2007; BERRY M, 1964, NATURE, V203, P591, DOI 10.1038/203591b0; BRUCKNER G, 1976, J COMP NEUROL, V166, P245, DOI 10.1002/cne.901660208; Kalinovsky A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001013; MASON CA, 1985, J NEUROSCI RES, V13, P55, DOI 10.1002/jnr.490130105; Miyata T, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-23; Nishida K, 2011, MOL CELL NEUROSCI, V46, P662, DOI 10.1016/j.mcn.2011.01.007; PARADIES MA, 1993, DEV DYNAM, V197, P125; Shinohara M, 2013, J COMP NEUROL, V521, P3340, DOI 10.1002/cne.23353; Simmons DD, 1996, J COMP NEUROL, V370, P551, DOI 10.1002/(SICI)1096-9861(19960708)370:4<551::AID-CNE10>3.0.CO;2-M; TAKEDA T, 1989, NEUROSCIENCE, V32, P99, DOI 10.1016/0306-4522(89)90110-3; Tashiro Y, 2000, J COMP NEUROL, V417, P491, DOI 10.1002/(SICI)1096-9861(20000221)417:4<491::AID-CNE7>3.0.CO;2-1; UZMAN LL, 1960, J COMP NEUROL, V114, P137; Wang GY, 2000, J NEUROSCI, V20, P5358; WASSEF M, 1992, J COMP NEUROL, V323, P519, DOI 10.1002/cne.903230405; YAMAKUNI T, 1984, NEUROSCI LETT, V45, P235, DOI 10.1016/0304-3940(84)90232-5; YAMANO M, 1993, DEV BRAIN RES, V72, P107, DOI 10.1016/0165-3806(93)90164-6	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	SEP	2015	75	9					927	934		10.1002/dneu.22259		8	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CP2KD	WOS:000359705000003		
J	Iida, A; Iwagawa, T; Baba, Y; Satoh, S; Mochizuki, Y; Nakauchi, H; Furukawa, T; Koseki, H; Murakami, A; Watanabe, S				Iida, Atsumi; Iwagawa, Toshiro; Baba, Yukihiro; Satoh, Shinya; Mochizuki, Yujin; Nakauchi, Hiromitsu; Furukawa, Takahisa; Koseki, Haruhiko; Murakami, Akira; Watanabe, Sumiko			Roles of histone H3K27 trimethylase Ezh2 in retinal proliferation and differentiation	DEVELOPMENTAL NEUROBIOLOGY			English	Article						retina; histone methylation; differentiation; proliferation	DEMETHYLASE JMJD3; STEM-CELLS; MEDIATED REPRESSION; XENOPUS RETINA; HOMEOBOX GENE; SELF-RENEWAL; MOUSE RETINA; BIPOLAR; METHYLTRANSFERASE; LOCUS	The histone modification H3K27me3 regulates transcription negatively, and Jmjd3 and Ezh2 demethylate and methylate H3K27me3 and H3K27, respectively. We demonstrated previously that Jmjd3 plays pivotal roles in the differentiation of subsets of bipolar (BP) cells by regulating H3K27me3 levels at the Bhlhb4 and Vsx1 loci, both of which are transcription factors essential for the maturation of BP cell subsets. In this study, we examined the role of Ezh2 in retinal development using retina-specific Ezh2 conditional knockout mice (Ezh2-CKO). The eyes of the Ezh2-CKO mice were microphthalemic, and the proliferation of retinal cells was diminished postnatally in Ezh2-CKO. Differentiation of all examined retinal subsets was observed with higher proportion of BP cell subsets, which was determined by immunostaining using specific retinal markers. The onsets of Muller glia and rod photoreceptor differentiation were accelerated. The expression of Bhlhb4 was increased in postnatal retinas, which was accompanied by the loss of H3K27me3 modifications at these genetic loci. Decreased expression of proneural genes in postnatal stage was observed. As reported previously in other Ezh2-KO tissues, increased expression of Arf/Ink4a was observed in the Ezh2-CKO retinas. The ectopic expression of Arf or Ink4a in the retina suppressed proliferation and increased apoptosis. In addition, earlier onset of Muller glia differentiation was observed in Ink4a-expressing cells. These results support an important role for histone H3K27me3 modification in regulating the proliferation and maturation of certain subsets of interneurons in the retina. (c) 2015 Wiley Periodicals, Inc. Develop Neurobiol 75: 947-960, 2015	[Iida, Atsumi; Iwagawa, Toshiro; Baba, Yukihiro; Satoh, Shinya; Mochizuki, Yujin; Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan; [Mochizuki, Yujin; Murakami, Akira] Juntendo Univ, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo, Japan; [Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Osaka, Japan; [Koseki, Haruhiko] RIKEN, Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa, Japan	Watanabe, S (reprint author), Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan.	sumiko@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Contract grant sponsor: the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aldiri I, 2013, DEVELOPMENT, V140, P2867, DOI 10.1242/dev.088096; Yoo KH, 2012, INT J BIOL SCI, V8, P59, DOI 10.7150/ijbs.8.59; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Chatoo W, 2010, STEM CELLS, V28, P1412, DOI 10.1002/stem.462; Testa G, 2011, BIOESSAYS, V33, P519, DOI 10.1002/bies.201100021; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Usui A, 2013, DEVELOPMENT, V140, P740, DOI 10.1242/dev.090274; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Iida A, 2014, P NATL ACAD SCI USA, V111, P3751, DOI 10.1073/pnas.1311480111; Jacobs JJL, 1999, NATURE, V397, P164; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Sato S, 2007, GENESIS, V45, P502, DOI 10.1002/dvg.20318; Bramblett DE, 2004, NEURON, V43, P779, DOI 10.1016/j.neuron.2004.08.032; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chen YH, 2014, AM J TRANSL RES, V4, P364; Helin K, 2012, NAT REV MOL CELL BIO, V13, P305; Hojo M, 2000, DEVELOPMENT, V127, P2515; Iida A, 2011, INVEST OPHTH VIS SCI, V52, P3008, DOI 10.1167/iovs.10-6428; Marqueron R, 2009, NATURE, V461, P762; Nagao M, 2008, J CELL BIOL, V183, P1243, DOI 10.1083/jcb.200807130; Tabata Y, 2004, MOL CELL BIOL, V24, P4513, DOI 10.1128/MCB.24.10.4513-4512.2004; Xu F, 2012, EXPERT REV HEMATOL, V5, P177, DOI [10.1586/ehm.12.5, 10.1586/EHM.12.5]	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	SEP	2015	75	9					947	960		10.1002/dneu.22261		14	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CP2KD	WOS:000359705000005		
J	Hashimoto, Y; Tanaka, M; Senmaru, T; Okada, H; Hamaguchi, M; Asano, M; Yamazaki, M; Oda, Y; Hasegawa, G; Nakamura, N; Fukui, M				Hashimoto, Y.; Tanaka, M.; Senmaru, T.; Okada, H.; Hamaguchi, M.; Asano, M.; Yamazaki, M.; Oda, Y.; Hasegawa, G.; Nakamura, N.; Fukui, M.			Heart rate-corrected QT interval is a novel risk marker for the progression of albuminuria in people with Type2 diabetes	DIABETIC MEDICINE			English	Article							CARDIOVASCULAR MORTALITY; ENDOTHELIAL DYSFUNCTION; HYPERTENSION; INFLAMMATION; POPULATION; CARDIOLOGY; GUIDELINE; MELLITUS; FAILURE; DISEASE	AimsA close association between heart rate-corrected QT interval (QTc) and albuminuria in people with Type2 diabetes has been reported in cross sectional studies. The aim of this study was to evaluate the relationship between QTc and change in urine albumin excretion (UAE) or progression of albuminuria in people with Type2 diabetes. MethodsWe measured QTc in 251 consecutive people at baseline. We performed a 5-year follow-up cohort study to assess the relationship between QTc and change in UAE, defined as an increase of UAE/follow-up duration (year), or progression of albuminuria, defined as an increase in the category of diabetic nephropathy. ResultsDuring follow-up, 23 of 151 people with normoalbuminuria and 13 of 73 people with microalbuminuria at baseline had progression of albuminuria. Multiple regression analysis demonstrated that QTc was independently associated with change in UAE (=0.176, P=0.0104). Logistic regression analyses showed that QTc was a risk marker for progression of albuminuria [odds ratio per 0.01-s increase in QTc 1.35, 95% confidence interval (CI) 1.11-1.66, P=0.0024] after adjusting for confounders. According to the receiver operator characteristic (ROC) analysis, the optimal cut-off point of QTc for progression of albuminuria was 0.418s [area under the ROC curve 0.75 (95% CI 0.66-0.82), sensitivity=0.86, specificity=0.56, P<0.0001]. ConclusionsHeart rate-corrected QT interval could be a novel risk marker for progression of albuminuria in people with Type2 diabetes.	[Hashimoto, Y.; Tanaka, M.; Senmaru, T.; Hamaguchi, M.; Asano, M.; Yamazaki, M.; Oda, Y.; Nakamura, N.; Fukui, M.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan; [Okada, H.; Hasegawa, G.] Japanese Red Cross Kyoto Daini Hosp, Div Metab Nephrol & Rheumatol, Kyoto, Japan	Fukui, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan.	sayarinapm@hotmail.com					Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Goldenberg I, 2006, J CARDIOVASC ELECTR, V17, P333, DOI 10.1111/j.1540-8167.2006.00408.x; Okada H, 2013, DIABETES CARE, V36, P1908, DOI 10.2337/dc12-2087; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Shenkman HJ, 2002, CHEST, V122, P528, DOI 10.1378/chest.122.2.528; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Drury PL, 2011, DIABETOLOGIA, V54, P32, DOI 10.1007/s00125-010-1854-1; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516; Li X, 2012, EXP DIABETES RES, DOI 10.1155/2012/234084; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1717, DOI 10.1681/ASN.2012030252; Mant J, 2011, ANN INTERN MED, V155, P252, DOI [10.7326/0003-4819-155-4-201108160-00009, 10.1059/0003-4819-155-4-201108160-00009]; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Cox AJ, 2014, DIABETES CARE, V37, P1454, DOI 10.2337/dc13-1257; Toshima S, 2000, ARTERIOSCL THROM VAS, V20, P2243; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Cappellin E, 2013, J CARDIOVASC MED, V14, P308, DOI 10.2459/JCM.0b013e3283536517; Carella MJ, 1996, INT J OBESITY, V20, P938; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Fiorentini A, 2010, AUTON NEUROSCI-BASIC, V154, P94, DOI 10.1016/j.autneu.2009.11.006; Hashimoto Y, 2013, J DIABETES METAB, V4, P8; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2003.08.030; Meier M, 2000, J DIABETES COMPLICAT, V14, P90, DOI 10.1016/S1056-8727(00)00055-6; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; SCHMITZ A, 1994, DIABETOLOGIA, V37, P1251, DOI 10.1007/BF00399799; Tomassoni Gery, 1998, Journal of Electrocardiology, V30, P187, DOI 10.1016/S0022-0736(98)80073-3; Watabe D, 2006, AM J HYPERTENS, V19, P1199, DOI 10.1016/j.amjhyper.2006.05.001; Wu AYT, 2009, SINGAP MED J, V50, P976; Yokoyama H, 2004, KIDNEY INT, V66, P448, DOI 10.1111/j.1523-1755.2004.00752.x	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3071	1464-5491		DIABETIC MED	Diabetic Med.	SEP	2015	32	9					1221	1226		10.1111/dme.12728		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CP4LK	WOS:000359853000015		
J	Miyake, K; Akimoto, T; Hanada, Y; Nagoya, H; Kodaka, Y; Ueki, N; Kusunoki, M; Kawagoe, T; Futagami, S; Takahashi, Y; Takano, H; Sakamoto, C				Miyake, Kazumasa; Akimoto, Teppei; Hanada, Yuriko; Nagoya, Hiroyuki; Kodaka, Yasuhiro; Ueki, Nobue; Kusunoki, Masafumi; Kawagoe, Tetsuro; Futagami, Seiji; Takahashi, Yasuhiro; Takano, Hitoshi; Sakamoto, Choitsu			Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease	DIGESTIVE AND LIVER DISEASE			English	Article						Gastrointestinal bleeding; Histamine-2 receptor antagonists; Low-dose aspirin; Oroton pump inhibitors	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ABCG2 DYSFUNCTION INCREASES; COA REDUCTASE INHIBITORS; ACUTE CORONARY SYNDROMES; ANTIPLATELET THERAPY; HEMOGLOBIN CONCENTRATION; MYOCARDIAL-INFARCTION; CLINICAL-IMPLICATIONS; PLATELET-AGGREGATION; OLDER-ADULTS	Background: Impact of acid suppressants on lower gastrointestinal bleeding remains unclear in low-dose aspirin users; we aimed to investigate this relationship. Methods: Retrospective cohort study of low-dose aspirin users who underwent coronary angiography for ischaemic heart disease in our institution between October 2005 and December 2006; patients were evaluated for upper or lower gastrointestinal bleedings within 3 years post-angiography. Results: 538 patients were enrolled (males, 74.4%; mean age 67.4 +/- 10.6 years). Risk for upper gastrointestinal bleeding decreased with concomitant use of statins (HR, 0.37; 95% CI, 0.15-0.89), calcium channel blockers (HR, 0.29; 95% CI, 0.10-0.85), and histamine-2 receptor antagonists (HR, 0.26; 95% CI, 0.08-0.89). Concomitant use of proton pump inhibitors tended to decrease risk of upper gastrointestinal bleeding (HR, 0.27; 95% CI, 0.06-1.18). Risk for lower gastrointestinal bleeding increased with both concomitant use of warfarin (HR, 15.68; 95% CI, 4.43-55.53) and proton pump inhibitors (HR, 6.55; 95% CI, 2.01-21.32), but not with histamine-2 receptor antagonists. Hyperuricemia lowered risk for lower gastrointestinal bleeding (HR, 0.12; 95% CI, 0.02-0.88). Conclusions: In low-dose aspirin users, concomitant use of proton pump inhibitors increased lower gastrointestinal bleeding risk, independent from effects on upper gastrointestinal bleeding. (C) 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Miyake, Kazumasa; Akimoto, Teppei; Hanada, Yuriko; Nagoya, Hiroyuki; Kodaka, Yasuhiro; Ueki, Nobue; Kusunoki, Masafumi; Kawagoe, Tetsuro; Futagami, Seiji; Sakamoto, Choitsu] Nippon Med Sch, Dept Gastroenterol, Tokyo 1138603, Japan; [Takahashi, Yasuhiro; Takano, Hitoshi] Nippon Med Sch, Dept Cardiol, Tokyo 1138603, Japan	Miyake, K (reprint author), Nippon Med Sch, Dept Gastroenterol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	km366@nms.ac.jp					TOPOL E, 1993, NEW ENGL J MED, V329, P673; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Werner N, 2002, BASIC RES CARDIOL, V97, P105, DOI 10.1007/s003950200000; Wallace JL, 2013, WORLD J GASTROENTERO, V19, P1861, DOI 10.3748/wjg.v19.i12.1861; Serrano P, 2002, ALIMENT PHARM THERAP, V16, P1945, DOI 10.1046/j.0269-2813.2002.01355.x; Nikolsky E, 2009, J AM COLL CARDIOL, V54, P1293, DOI 10.1016/j.jacc.2009.07.019; Thorens J, 1996, GUT, V39, P54, DOI 10.1136/gut.39.1.54; Sostres C, 2011, NAT REV GASTRO HEPAT, V8, P385, DOI 10.1038/nrgastro.2011.97; Chaves PHM, 2004, J AM GERIATR SOC, V52, P1811, DOI 10.1111/j.1532-5415.2004.52502.x; Patel KV, 2007, BLOOD, V109, P4663, DOI 10.1182/blood-2006-10-055384; Lanas A, 2015, CLIN GASTROENTEROL H, V13, P906, DOI 10.1016/j.cgh.2014.11.007; ALLISON MC, 1992, NEW ENGL J MED, V327, P749, DOI 10.1056/NEJM199209103271101; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832; Weisman SM, 2002, ARCH INTERN MED, V162, P2197, DOI 10.1001/archinte.162.19.2197; Fortun PJ, 2005, CURR OPIN GASTROEN, V21, P169, DOI 10.1097/01.mog.0000153314.51198.58; Arroyo RC, 2012, HEART, V98, P718, DOI 10.1136/heartjnl-2012-301632; Matsuo H, 2014, NUCLEOS NUCLEOT NUCL, V33, P266, DOI 10.1080/15257770.2013.866679; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Heeba GH, 2009, EUR J PHARMACOL, V607, P188, DOI 10.1016/j.ejphar.2009.02.008; LANGMAN MJS, 1985, BRIT MED J, V290, P347; Takada T, 2014, NUCLEOS NUCLEOT NUCL, V33, P275, DOI 10.1080/15257770.2013.854902; Dalen JE, 2006, AM J MED, V119, P198, DOI 10.1016/j.amjmed.2005.11.013; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P719, DOI 10.1111/j.1532-5415.2004.52208.x; Culleton BF, 2006, BLOOD, V107, P3841, DOI 10.1182/blood-2005-10-4308; Diomede L, 2001, ARTERIOSCL THROM VAS, V21, P1327, DOI 10.1161/hq0801.094222; Lanas A, 1997, GASTROENTEROLOGY, V112, P683, DOI 10.1053/gast.1997.v112.pm9041228; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; LANAS A, 1992, GASTROENTEROLOGY, V103, P862; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Abraham NS, 2010, AM J GASTROENTEROL, V105, P2533, DOI 10.1038/ajg.2010.445; Atar S, 2006, AM HEART J, V151; BERKELS R, 1994, THROMB HAEMOSTASIS, V72, P309; BLACHE D, 1992, PHARMACOLOGY, V45, P250, DOI 10.1159/000139008; Chen JC, 2004, EXP CELL RES, V301, P305, DOI 10.1016/j.yexcr.2004.05.039; Cohen M, 2009, MAYO CLIN PROC, V84, P149, DOI 10.1016/S0025-6196(11)60823-9; Coskun T, 1996, PHARMACOLOGY, V52, P199, DOI 10.1159/000139384; Davies NM, 1999, J PHARM PHARM SCI, V2, P5; Endo H, 2012, DIGEST LIVER DIS, V44, P833, DOI 10.1016/j.dld.2012.05.016; Hung CR, 2007, CHINESE J PHYSIOL, V50, P315; Kaplan RC, 2000, ARCH INTERN MED, V160, P1849, DOI 10.1001/archinte.160.12.1849; Lanas Angel, 2007, Curr Med Res Opin, V23, P163, DOI 10.1185/030079907X162656; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Matsuo H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03755; Nakayama A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05227; ODAWARA A, 1994, THROMB RES, V75, P109, DOI 10.1016/0049-3848(94)90060-4; Pahor M, 1996, LANCET, V347, P1061, DOI 10.1016/S0140-6736(96)90276-7; Rostom A, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002296; Semba RD, 2004, HAEMATOLOGICA, V89, P357; Serebrulany VL, 2007, AM J CARDIOL, V99, P288, DOI 10.1016/j.amjcard.2006.07.091; Suzuki Y, 1998, JPN J PHARMACOL, V78, P435, DOI 10.1254/jjp.78.435; WALLEN NH, 1995, AM J CARDIOL, V75, P1, DOI 10.1016/S0002-9149(99)80516-5; Yamato M, 2007, DIGEST DIS SCI, V52, P2833, DOI 10.1007/s10620-006-9638-7	55	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	SEP	2015	47	9					757	762		10.1016/j.dld.2015.05.020		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6DY	WOS:000359975700007		
J	Overby, A; Zhao, CM; Matsui, H; Takahashi, T; Chen, D; Nakamura, M				Overby, Anders; Zhao, Chun-Mei; Matsui, Hidenori; Takahashi, Tetsufumi; Chen, Duan; Nakamura, Masahiko			Phytochemical Isothiocyanate Prevention of Helicobacter heilmannii-Induced Gastric Malt Lymphoma and Resulting Tumors in Mice	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Overby, Anders; Zhao, Chun-Mei; Chen, Duan] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Overby, Anders; Matsui, Hidenori; Takahashi, Tetsufumi; Nakamura, Masahiko] Kitasato Univ, Tokyo, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2545	2546				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700003		
J	Yanaka, A; Suzuki, H				Yanaka, Akinori; Suzuki, Hideo			Acid Inhibitors Do Not Mitigate, But Exacerbate H. pylori-Induced Gastritis Both In Vitro and In Vivo	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Yanaka, Akinori] Hitachi Med Educ & Res Ctr, Hitachi, Ibaraki, Japan; [Suzuki, Hideo] Univ Tsukuba, Div GI Endoscopy, Tsukuba, Ibaraki, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2545	2545				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700002		
J	Takeuchi, K; Kita, K; Takahashi, K; Aihara, E; Hayashi, S				Takeuchi, Koji; Kita, Kazutomo; Takahashi, Kento; Aihara, Eitaro; Hayashi, Shusaku			Muscarinic Acetylcholine Receptor Subtype 4 Is Essential for Cholinergic Stimulation of Duodenal Bicarbonate Secretion: Relationship to D Cell/Somatostatin	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Takeuchi, Koji; Kita, Kazutomo; Takahashi, Kento; Aihara, Eitaro; Hayashi, Shusaku] Kyoto Pharmaceut Univ, Kyoto 607, Japan; [Takeuchi, Koji] Kyoto Res Ctr Gastrointestinal Dis, Gen Inc Assoc, Kyoto, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2554	2555				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700027		
J	Tanaka, M; Takagi, T; Uchiyama, K; Hotta, Y; Mizushima, K; Higashimura, Y; Okayama, T; Katada, K; Kamada, K; Handa, O; Ishikawa, T; Naito, Y; Itoh, Y				Tanaka, Makoto; Takagi, Tomohisa; Uchiyama, Kazuhiko; Hotta, Yuma; Mizushima, Katsura; Higashimura, Yasuki; Okayama, Tetsuya; Katada, Kazuhiro; Kamada, Kazuhiro; Handa, Osamu; Ishikawa, Takeshi; Naito, Yuji; Itoh, Yoshito			The Role of Secreted Protein Acidic and Rich in Cysteine (SPARC) on Trinitrobenzene Sulfonic Acid-Induced Colitis in Mice	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Tanaka, Makoto; Takagi, Tomohisa; Uchiyama, Kazuhiko; Hotta, Yuma; Mizushima, Katsura; Higashimura, Yasuki; Okayama, Tetsuya; Katada, Kazuhiro; Kamada, Kazuhiro; Handa, Osamu; Ishikawa, Takeshi; Naito, Yuji; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Grad Sch Med Sci, Kyoto, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2556	2556				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700031		
J	Nakamura, M; Overby, A; Takahashi, T; Matsui, H				Nakamura, Masahiko; Overby, Anders; Takahashi, Tetsufumi; Matsui, Hidenori			Angiogenesis and Malt Lymphoma in Stomach, Liver and Lacrimal Gland: Interaction with VASH2 as well as VEGF	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Nakamura, Masahiko; Overby, Anders; Takahashi, Tetsufumi; Matsui, Hidenori] Kitasato Univ, Tokyo, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2557	2557				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700033		
J	Horie, S; Tashima, K				Horie, Syunji; Tashima, Kimihito			Protective Role of TRPA1 on TRPV1-Expessing Nerve Fibers Against Gastric Mucosal Barrier Break Induced by Allyl-isothiocyanate in Rats	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Horie, Syunji; Tashima, Kimihito] Josai Int Univ, Togane, Chiba, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2561	2562				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700047		
J	Arakawa, T; Watanabe, T; Tanigawa, T				Arakawa, Tetsuo; Watanabe, Toshio; Tanigawa, Tetsuya			Small Bowel Injury Caused by NSAIDs/Aspirin: From Bases to Clinical Site	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Arakawa, Tetsuo; Watanabe, Toshio; Tanigawa, Tetsuya] Osaka City Univ, Osaka 558, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2562	2562				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700048		
J	Tanigawa, T; Watanabe, T; Takeda, S; Higashimori, A; Shimada, S; Nadatani, Y; Otani, K; Tanaka, F; Kamata, N; Nagami, Y; Yamagami, H; Shiba, M; Tominaga, K; Fujiwara, Y; Arakawa, T				Tanigawa, Tetsuya; Watanabe, Toshio; Takeda, Shogo; Higashimori, Akira; Shimada, Sunao; Nadatani, Yuji; Otani, Koji; Tanaka, Fumio; Kamata, Noriko; Nagami, Yasuaki; Yamagami, Hirokazu; Shiba, Masatsugu; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo			Inhibitory Effect of Rebamipide on Indomethacin-Induced Experimental Small Intestinal Injury and Exacerbation of the Injury Induced by Proton Pump Inhibitor: Possible Involvement of Modulation of Intestinal Microbiota by Rebamipide	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Tanigawa, Tetsuya; Watanabe, Toshio; Takeda, Shogo; Higashimori, Akira; Shimada, Sunao; Nadatani, Yuji; Otani, Koji; Tanaka, Fumio; Kamata, Noriko; Nagami, Yasuaki; Yamagami, Hirokazu; Shiba, Masatsugu; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2562	2562				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700049		
J	Watanabe, T; Higashimori, A; Nadatani, Y; Tanigawa, T; Tominaga, K; Fujiwara, Y; Arakawa, T				Watanabe, Toshio; Higashimori, Akira; Nadatani, Yuji; Tanigawa, Tetsuya; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo			Mechanisms of Activation of the NLRP3 Inflammasome and Its Role in NSAID-Induced Small Intestinal Damage	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Watanabe, Toshio; Higashimori, Akira; Nadatani, Yuji; Tanigawa, Tetsuya; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2563	2563				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700051		
J	Horii, Y; Uchiyama, K; Yasukawa, Z; Tokunaga, M; Okubo, T; Mizushima, K; Hotta, Y; Tanaka, M; Katada, K; Kamada, K; Handa, O; Takagi, T; Naito, Y				Horii, Yusuke; Uchiyama, Kazuhiko; Yasukawa, Zenta; Tokunaga, Makoto; Okubo, Tsutomu; Mizushima, Katsura; Hotta, Yuma; Tanaka, Makoto; Katada, Kazuhiro; Kamada, Kazuhiro; Handa, Osamu; Takagi, Tomohisa; Naito, Yuji			Dietary Fiber Enhances Intestinal Epithelial Wound Healing Via Activation of ERK and Rho Kinase	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Horii, Yusuke; Uchiyama, Kazuhiko; Yasukawa, Zenta; Tokunaga, Makoto; Okubo, Tsutomu; Mizushima, Katsura; Hotta, Yuma; Tanaka, Makoto; Katada, Kazuhiro; Kamada, Kazuhiro; Handa, Osamu; Takagi, Tomohisa; Naito, Yuji] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2564	2564				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700055		
J	Watanabe, Y; Murata, T; Amakawa, M; Miyake, Y; Handa, T; Konishi, K; Matsumura, Y; Tanaka, T; Takeuchi, K				Watanabe, Yusuke; Murata, Takahiko; Amakawa, Masahiro; Miyake, Yoshihide; Handa, Tango; Konishi, Katsuhiko; Matsumura, Yasushi; Tanaka, Takuji; Takeuchi, Koji			Preventive Effects of a Novel Orally-Active EP4-Selective Agonist, KAG-308, in Gastrointestinal Mucosal Injuries	DIGESTIVE DISEASES AND SCIENCES			English	Meeting Abstract									[Watanabe, Yusuke; Murata, Takahiko; Amakawa, Masahiro; Miyake, Yoshihide; Handa, Tango] Kaken Pharmaceut Co Ltd, Kyoto, Japan; [Konishi, Katsuhiko; Matsumura, Yasushi] Asahi Glass Co Ltd, Chiba, Japan; [Tanaka, Takuji] Gifu Municipal Hosp, Gifu, Japan; [Takeuchi, Koji] Kyoto Pharmaceut Univ, Kyoto 607, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2565	2565				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700056		
J	Kohata, Y; Nakahara, K; Tanigawa, T; Yamagami, H; Shiba, M; Watanabe, T; Tominaga, K; Fujiwara, Y; Arakawa, T				Kohata, Yukie; Nakahara, Kenichi; Tanigawa, Tetsuya; Yamagami, Hirokazu; Shiba, Masatsugu; Watanabe, Toshio; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo			Rebamipide Alters the Esophageal Microbiome and Reduces the Incidence of Barrett's Esophagus in a Rat Model	DIGESTIVE DISEASES AND SCIENCES			English	Article						Barrett's esophagus; Esophageal microbiome; Rebamipide; Terminal-restriction fragment length polymorphism	GASTROESOPHAGEAL-REFLUX; INTESTINAL MICROBIOTA; DISTAL ESOPHAGUS; RIBOSOMAL-RNA; METAPLASIA; ADENOCARCINOMA; INFLAMMATION; POPULATIONS; INVOLVEMENT; CARCINOMA	Barrett's esophagus (BE) is characterized by a distinct Th2-predominant cytokine profile. However, antigens that shift the immune response toward the Th2 profile are unknown. We examined the effects of rebamipide on the esophageal microbiome and BE development in a rat model. BE was induced by esophagojejunostomy in 8-week-old male Wistar rats. Rats were divided into control and rebamipide-treated group receiving either a normal or a 0.225 % rebamipide-containing diet, respectively, and killed 8, 16, 24, and 32 weeks after the operation. PCR-amplified 16S rDNAs extracted from esophageal samples were examined by terminal-restriction fragment length polymorphism (T-RFLP) analysis to assess microbiome composition. The dynamics of four bacterial genera (Lactobacillus, Clostridium, Streptococcus, and Enterococcus) were analyzed by real-time PCR. The incidences of BE in the control and rebamipide group at 24 and 32 weeks were 80 and 100, and 20 and 33 %, respectively. T-RFLP analysis of normal esophagus revealed that the proportion of Clostridium was 8.3 %, while that of Lactobacillales was 71.8 %. The proportions of Clostridium increased and that of Lactobacillales decreased at 8 weeks in both groups. Such changes were consistently observed in the control but not in the rebamipide group. Clostridium and Lactobacillus expression was lower and higher, respectively, in the rebamipide group than in the control group. Rebamipide reduced BE development and altered the esophageal microbiome composition, which might play a role in BE development.	[Kohata, Yukie; Nakahara, Kenichi; Tanigawa, Tetsuya; Yamagami, Hirokazu; Shiba, Masatsugu; Watanabe, Toshio; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Abeno Ku, Osaka 5458585, Japan	Fujiwara, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Abeno Ku, 1-4-7 Asahimachi, Osaka 5458585, Japan.	yuki1215@med.osaka-cu.ac.jp; kenichi.caesar1@gmail.com; ttanigawa@med.osaka-cu.ac.jp; yamagami@med.osaka-cu.ac.jp; shiba@med.osaka-cu.ac.jp; watanabet@med.osaka-cu.ac.jp; tomy@med.osaka-cu.ac.jp; yasu@med.osaka-cu.ac.jp; arakawat@med.osaka-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [24590925, 23590924]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (Nos. 24590925, 23590924).	Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Jankowski JA, 1999, AM J PATHOL, V154, P965, DOI 10.1016/S0002-9440(10)65346-1; Dvorakova K, 2004, CLIN CANCER RES, V10, P2020, DOI 10.1158/1078-0432.CCR-0437-03; Fitzgerald RC, 2002, GUT, V50, P451, DOI 10.1136/gut.50.4.451; Yang LY, 2014, CANCER J, V20, P207, DOI 10.1097/PPO.0000000000000044; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Poehlmann A, 2012, PATHOL RES PRACT, V208, P269, DOI 10.1016/j.prp.2012.03.007; Moons LMG, 2005, J PATHOL, V207, P269, DOI 10.1002/path.1847; Kohata Y, 2011, J GASTROENTEROL, V46, P883, DOI 10.1007/s00535-011-0405-y; PERA M, 1989, CANCER RES, V49, P6803; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008; Seery JP, 2002, J CELL SCI, V115, P1783; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Arakawa T, 2005, DIGEST DIS SCI, V50, pS3, DOI 10.1007/s10620-005-2800-9; Blackett KL, 2013, ALIMENT PHARM THER, V37, P1084, DOI 10.1111/apt.12317; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046; Imaeda H, 2012, DIGESTION, V86, P250, DOI 10.1159/000341508; Kauppila JH, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00200; LEVRAT M, 1962, AM J DIG DIS, V7, P564, DOI 10.1007/BF02236137; Lind A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106261; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; Pera M, 2000, CARCINOGENESIS, V21, P1587, DOI 10.1093/carcin/21.8.1587; Pera Manuel, 2002, Chest Surg Clin N Am, V12, P25, DOI 10.1016/S1052-3359(03)00063-2; Sarosi G, 2008, DIS ESOPHAGUS, V21, P43, DOI 10.1111/j.1442-2050.2007.00744.x; Songjinda P, 2007, BIOSCI BIOTECH BIOCH, V71, P2338, DOI 10.1271/bbb.70154; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Tanigawa T, 2013, EUR J PHARMACOL, V704, P64, DOI 10.1016/j.ejphar.2013.02.010; Wang ZK, 2013, WORLD J GASTROENTERO, V19, P1541, DOI 10.3748/wjg.v19.i10.1541; Yang LY, 2012, CLIN CANCER RES, V18, P2138, DOI 10.1158/1078-0432.CCR-11-0934	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2654	2661		10.1007/s10620-015-3662-4		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700073		
J	Luo, FQ; Ishigami, M; Achiwa, K; Ishizu, Y; Kuzuya, T; Honda, T; Hayashi, K; Ishikawa, T; Katano, Y; Goto, H				Luo, Fangqiong; Ishigami, Masatoshi; Achiwa, Koichi; Ishizu, Yoji; Kuzuya, Teiji; Honda, Takashi; Hayashi, Kazuhiko; Ishikawa, Tetsuya; Katano, Yoshiaki; Goto, Hidemi			Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice	DIGESTIVE DISEASES AND SCIENCES			English	Article						Nonalcoholic steatohepatitis; Raloxifene; Ovariectomy; Estrogen	ESTROGEN-RECEPTOR-ALPHA; HEPATIC STELLATE CELLS; OXIDATIVE STRESS; KUPFFER CELLS; DISEASE; RATS; WOMEN; REQUIREMENTS; ESTRADIOL; MENOPAUSE	Background and Aim The prevalence of nonalcoholic fatty liver disease (NAFLD) is higher in men than in women, but according to some epidemiological studies, this gender difference disappears after menopause. Estrogen therapy protects against NAFLD and nonalcoholic steatohepatitis (NASH) after menopause. We investigated the therapeutic effect of raloxifene, a second-generation selective estrogen-receptor modulator, on NASH induced by a choline-deficient high-fat (CDHF) diet in female ovariectomized (OVX) mice. Methods Seven-week-old female C57BL/6J mice were divided into three experimental groups as follows: (1) sham operation (SHAM group), (2) ovariectomy (OVX group), and (3) ovariectomy + raloxifene (intraperitoneal injection, 3 mg/kg body weight/day; OVX + RLX group). These three groups of mice were fed a CDHF diet for 8 weeks; choline-sufficient high-fat (CSHF) diet was used as control diet. Serum biochemical indicators of hepatic function and liver histological changes were evaluated. Results Compared with CSHF diet, ovariectomy enhances liver injury and fibrosis in CDHF diet-fed mice. Serum alanine aminotransferase (ALT) levels were significantly lower in the OVX + RLX group than in the OVX group. The OVX group developed extensive steatosis with inflammation and fibrosis. Lobular inflammatory scores and fibrosis staging in the OVX + RLX group were significantly lower than in the OVX group. Furthermore, the OVX + RLX group exhibited significantly higher expression of hepatic estrogen receptor-alpha, which was significantly lower in the OVX group than in the SHAM group. Conclusions Raloxifene may ameliorate progression of liver fibrosis of NASH induced by CDHF diet in ovariectomized female mice, and up-regulation of estrogen receptor-alpha may play an important role in the beneficial effects of raloxifene on NASH.	[Luo, Fangqiong; Ishigami, Masatoshi; Achiwa, Koichi; Ishizu, Yoji; Kuzuya, Teiji; Honda, Takashi; Hayashi, Kazuhiko; Ishikawa, Tetsuya; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Katano, Yoshiaki] Fujita Hlth Univ, Banbuntane Hotokukai Hosp, Sch Med, Dept Internal Med, Nagoya, Aichi, Japan	Ishigami, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	luo_fangqiong@hotmail.com; masaishi@med.nagoya-u.ac.jp; kachiwa@med.nagoya-u.ac.jp; y-ishizu@med.nagoya-u.ac.jp; tkuzuya@med.nagoya-u.ac.jp; honda@med.nagoya-u.ac.jp; kazuh@med.nagoya-u.ac.jp; ishikawa@met.nagoya-u.ac.jp; ykatano@fujita-hu.ac.jp; hgoto@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26460998]	This work was supported in part by a Grant-in-Aid for Scientific Research (26460998) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Kamada Y, 2011, AM J PHYSIOL-GASTR L, V301, pG1031, DOI 10.1152/ajpgi.00211.2011; Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278; Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307; McKenzie J, 2006, CLIN ENDOCRINOL, V65, P40, DOI 10.1111/j.1365-2265.2006.02543.x; Fischer LM, 2010, AM J CLIN NUTR, V92, P1113, DOI [10.3945/ajcn.2010.30064, 10.3945/ajen.2010.30064]; Hildebrand F, 2006, AM J PATHOL, V169, P784, DOI 10.2353/ajpath.2006.060010; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Chow JDY, 2011, J ENDOCRINOL, V210, P323, DOI 10.1530/JOE-10-0462; Zelber-Sagi S, 2006, LIVER INT, V26, P856, DOI 10.1111/j.1478-3231.2006.01311.x; Pearce ST, 2004, CRIT REV ONCOL HEMAT, V50, P3, DOI 10.1016/j.critrevonc.2003.09.003; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Yatsuji S, 2007, HEPATOL RES, V37, P1034, DOI 10.1111/j.1872-034X.2007.00156.x; Takayama F, 2010, J OLEO SCI, V59, P407, DOI 10.5650/jos.59.407; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Weston SR, 2005, HEPATOLOGY, V41, P372, DOI 10.1002/hep.20554; AHMEDSOROUR H, 1981, ANN NUTR METAB, V25, P208, DOI 10.1159/000176496; Vickers AEM, 1996, CARCINOGENESIS, V17, P1235, DOI 10.1093/carcin/17.6.1235; LEY CJ, 1992, AM J CLIN NUTR, V55, P950; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUCHSYOUNG R, 1995, ANN NY ACAD SCI, V761, P355, DOI 10.1111/j.1749-6632.1995.tb31392.x; Furusyo N, 2012, J HEPATOL, V57, P1186, DOI 10.1016/j.jhep.2012.08.003; Prestes J, 2012, INT J SPORTS MED, V33, P550, DOI 10.1055/s-0032-1304646; Shimizu I, 2007, HEPATOL RES, V37, P239, DOI 10.1111/j.1872-034X.2007.00032.x; SHUPNIK MA, 1989, MOL ENDOCRINOL, V3, P660; Wong CM, 2008, BRIT J PHARMACOL, V155, P326, DOI 10.1038/bjp.2008.262; Wu G., 2012, J OBES, V2012; Xu JW, 2004, WORLD J GASTROENTERO, V10, P250; Zhou Y, 2001, BIOCHEM BIOPH RES CO, V286, P1059, DOI 10.1006/bbrc.2001.5479	36	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2015	60	9					2730	2739		10.1007/s10620-015-3660-6		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LC	WOS:000359997700081		
J	Ohtake, Y; Takahashi, A; Watanabe, K				Ohtake, Yoshihisa; Takahashi, Ayaka; Watanabe, Kentaro			Using an Animated Cartoon Hero in Video Instruction to Improve Bathroom-Related Skills of a Student with Autism Spectrum Disorder	EDUCATION AND TRAINING IN AUTISM AND DEVELOPMENTAL DISABILITIES			English	Article								The present study investigated the effectiveness of video hero modeling (VHM) for building four bathroom-related behaviors of an elementary-aged student with autism spectrum disorder. In the VHM intervention, the participant watched a video immediately before going to the bathroom he typically used. In the video, an animated face of a cartoon hero with which the participant was preoccupied and an adult who pretended he was the hero appeared in the bathroom. While the adult (whose head was not shown in the film) engaged in the target behavior, the animated cartoon hero explained that the adult was hero and showed how the student had to behave. A multiple baseline across behaviors demonstrated that VHM interventions contributed to improving the four target behaviors. However, for one target behavior, the video hero praising (VHF) intervention seemed necessary to evoke a correct response in a stable manner.	[Ohtake, Yoshihisa; Takahashi, Ayaka] Okayama Univ, Okayama, Okayama 7008530, Japan; [Watanabe, Kentaro] Okayama Univ, Fac Educ, Special Sch, Okayama, Okayama 7008530, Japan	Ohtake, Y (reprint author), Okayama Univ, Div Dev Studies & Support, Kita Ku, 3-1-1 Tsushima Naka, Okayama, Okayama 7008530, Japan.	ohtake@cc.okayama-u.ac.jp					Alberto P. A., 2013, APPL BEHAV ANAL TEAC; Laraway S, 2003, J APPL BEHAV ANAL, V36, P407, DOI 10.1901/jaba.2003.36-407; McLaughlin DM, 2005, J POSIT BEHAV INTERV, V7, P68; Winter-Messiers MA, 2007, REM SPEC EDUC, V28, P140, DOI 10.1177/07419325070280030301; Cooper J. O., 2007, APPL BEHAV ANAL; Farlow L. J., 2000, INSTRUCTION STUDENTS, P331; Gagnon E, 2001, POWER CARDS USING SP; Geiger Kaneen B, 2010, Behav Anal Pract, V3, P22; Ikusawa M., 2002, SHINPAN K SHIKI HATT; O'Neill R. E., 1997, FUNCTIONAL ASSESSMEN; Ohtake Y, 2014, EDUC TRAIN AUTISM DE, V49, P32; Ohtake Y, 2015, INT J DISABIL DEV ED, V62, P363, DOI 10.1080/1034912X.2015.1027179; Uechi H., 2011, JAPANESE J PHYS ED H, V56, P215	13	0	0	COUNCIL EXCEPTIONAL CHILDREN	ARLINGTON	1110 N GLEBE RD, ARLINGTON, VA 22201-5704 USA	2154-1647			EDUC TRAIN AUTISM DE	Educ. Train. Autism Dev. Disabil.	SEP	2015	50	3					343	355				13	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	CP5YS	WOS:000359962100008		
J	Tanaka, S; Martling, A; Lindholm, J; Holm, T; Palmer, G				Tanaka, S.; Martling, A.; Lindholm, J.; Holm, T.; Palmer, G.			Remaining cancer cells within the fibrosis after neoadjuvant treatment for locally advanced rectal cancer	EJSO			English	Article						Locally advanced rectal cancer; Preoperative chemoradiotherapy (CRT); Fibrosis; Mesorectal fascia (MRF); Local recurrence	PREOPERATIVE CHEMORADIOTHERAPY; MULTIMODALITY TREATMENT; MESORECTAL EXCISION; TUMOR-REGRESSION; CHEMORADIATION; RADIOTHERAPY; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN; RECURRENCE	Aim: To analyse the incidence and distribution of remaining cancer cells within the fibrosis induced by preoperative chemo-radiotherapy (CRT) for locally advanced rectal cancer. Methods: The histopathological specimens from 46 patients operated on with extensive surgery for locally advanced rectal cancer after CRT were examined. The extension of fibrosis in relation to the mesorectal fascia (MRF) and the distribution of cancer cells within the fibrosis was examined using routine haematoxylin-eosin staining. In addition, immunohistochemical staining with CK20 was done to examine if cancer cells were missed by routine pathological work up. Results: All specimens showed CRT induced fibrosis. Two specimens showed complete response without viable cancer cells (ypT0). The fibrosis was limited inside the MRF in three cases, adherent to or involved the MRF in ten cases and in 33 cases the fibrosis was obvious outside as well as inside the fascia. Twenty-one cases showed fibrosis on the surgical resection margin, and in 9 of these cancer cells were found on the surgical margin (R1, R2-resection). 37 patients had R0 resections and among those 24 showed fibrosis beyond the MFR and 13 had scattered cancer cells in the fibrosis along or outside the MRF. Conclusions: The rate of remaining cancer cells within the fibrosis was high in patients with locally advanced rectal cancer treated with CRT. Frequently cancer cells were detected near the border of the fibrosis. A complete resection of the fibrosis is therefore recommended to achieve an R0 resection after neo-adjuvant treatment. (C) 2015 Elsevier Ltd. All rights reserved.	[Tanaka, S.; Martling, A.; Holm, T.; Palmer, G.] Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Lindholm, J.] Karolinska Univ Hosp, Dept Pathol, S-17176 Stockholm, Sweden; [Lindholm, J.] Karolinska Inst, S-17176 Stockholm, Sweden; [Tanaka, S.] Matsuda Coloproctol Ctr, Dept Surg, Hamamatsu, Shizuoka 4328061, Japan	Palmer, G (reprint author), Karolinska Univ Hosp, Dept Digest Dis, P9 03, S-17176 Stockholm, Sweden.	gabriella.jansson-palmer@karolinska.se			Stockholm Community Council; Karolinska Institutet; Swedish Cancer Society; Stockholm Cancer Society; Bengt Ihre Foundation	Financial support was provided through the Regional Agreement on Medical Training and Clinical Research (ALF) between the Stockholm Community Council and Karolinska Institutet. Financial support was also provided by the Swedish Cancer Society, the Stockholm Cancer Society and the Bengt Ihre Foundation.	MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Maas M, 2011, J CLIN ONCOL, V29, P4633, DOI 10.1200/JCO.2011.37.7176; MINSKY BD, 1992, J CLIN ONCOL, V10, P79; Hartley A, 2005, BRIT J RADIOL, V78, P934, DOI 10.1259/bjr/86650067; Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Martling AL, 2000, LANCET, V356, P93, DOI 10.1016/S0140-6736(00)02469-7; Brown G, 2003, BRIT J SURG, V90, P355, DOI 10.1002/bjs.4034; Braendengen M, 2008, J CLIN ONCOL, V26, P3687, DOI 10.1200/JCO.2007.15.3858; Habr-Gama A, 2005, J GASTROINTEST SURG, V9, P90, DOI 10.1016/j.gassur.2004.10.010; Nagtegaal ID, 2002, AM J SURG PATHOL, V26, P350, DOI 10.1097/00000478-200203000-00009; Patel UB, 2012, AM J ROENTGENOL, V199, pW486, DOI 10.2214/AJR.11.8210; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Ryan R, 2005, HISTOPATHOLOGY, V47, P141, DOI 10.1111/j.1365-2559.2005.02176.x; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Mannaerts GHH, 2002, INT J RADIAT ONCOL, V54, P1082, DOI 10.1016/S0360-3016(02)03012-2; Tot T, 2002, EUR J CANCER, V38, P758, DOI 10.1016/S0959-8049(02)00008-4; MACFARLANE JK, 1993, LANCET, V341, P457; Sloothaak DAM, 2013, BRIT J SURG, V100, P933, DOI 10.1002/bjs.9112; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Glimelius Bengt, 2014, Front Oncol, V4, P50, DOI 10.3389/fonc.2014.00050; Habr-Gama A, 2014, INT J RADIAT ONCOL, V88, P822, DOI 10.1016/j.ijrobp.2013.12.012; Habr-Gama A, 2004, HEPATO-GASTROENTEROL, V51, P1703; Habr-Gama A, 2005, J GASTROINTEST SURG, V9, P9; Morgan MJ, 2002, COLORECTAL DIS, V4, P177, DOI 10.1046/j.1463-1318.2002.00330.x; Palmer G, 2005, EJSO, V31, P727, DOI 10.1016/j.ejso.2005.04.009; Wheeler JMD, 2002, DIS COLON RECTUM, V45, P1051, DOI 10.1097/01.DCR.0000019489.72676.50	27	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	SEP	2015	41	9					1204	1209		10.1016/j.ejso.2015.05.019		6	Oncology; Surgery	Oncology; Surgery	CP4TL	WOS:000359875400012		
J	Watanabe, S; Yamamori, S; Otsuka, S; Saito, M; Suzuki, E; Kataoka, M; Miyaoka, H; Takahashi, M				Watanabe, Shigeru; Yamamori, Saori; Otsuka, Shintaro; Saito, Masanori; Suzuki, Eiji; Kataoka, Masakazu; Miyaoka, Hitoshi; Takahashi, Masami			Epileptogenesis and epileptic maturation in phosphorylation site-specific SNAP-25 mutant mice	EPILEPSY RESEARCH			English	Article						Antiepileptic drug; Anxiety-like behavior; Epileptogenesis; Epileptic maturation; Mutant mouse; SNARE protein	TEMPORAL-LOBE EPILEPSY; SPONTANEOUS RECURRENT SEIZURES; MOUSE PILOCARPINE MODEL; GATED CALCIUM-CHANNELS; RAT MODEL; NEUROTRANSMITTER RELEASE; ANIMAL-MODELS; ACQUIRED EPILEPSY; ABSENCE EPILEPSY; STIMULATION	Snap25(S187A/S187A) mouse is a knock-in mouse with a single amino acid substitution at a protein kinase C-dependent phosphorylation site of the synaptosomal-associated protein of 25 kDa (SNAP-25), which is a target-soluble NSF attachment protein receptor (t-SNARE) protein essential for neurotransmitter release. Snap25(S187A/S187A) mice exhibit several distinct phenotypes, including reductions in dopamine and serotonin release in the brain, anxiety-like behavior, and cognitive dysfunctions. Homozygous mice show spontaneous epileptic convulsions, and about 15% of the mice die around three weeks after birth. The remaining mice survive for almost two years and exhibit spontaneous recurrent seizures throughout their lifetime. Here, we conducted long-term continuous video electroencephalogram recording of the mice and analyzed the process of epileptogenesis and epileptic maturation in detail. Spikes and slow-wave discharges (SWDs) were observed in the cerebral cortex and thalamus before epileptic convulsions began. SWDs showed several properties similar to those observed in absence seizures including (1) lack of in the hippocampus, (2) movement arrest during SWDs, and (3) inhibition by ethosuximide. Multiple generalized seizures occurred in all homozygous mice around three weeks after birth. However, seizure generation stopped within several days, and a seizure-free latent period began. Following a spike-free quiet period, the number of spikes increased gradually, and epileptic seizures reappeared. Subsequently, spontaneous seizures occurred cyclically throughout the life of the mice, and several progressive changes in seizure frequency, seizure duration, seizure cycle interval, seizure waveform, and the number and waveform of epileptic discharges during slow-wave sleep occurred with different time courses over 10 weeks. Anxiety-related behaviors appeared suddenly within three days after epileptic seizures began and were delayed markedly by oral administration of valproic acid. These results showed that Snap25(S187A/S187A) mice exhibited a variety of epilepsy-related phenomena, and thus, they will be useful for understanding the mechanisms of epileptogenesis, epileptic maturation, and the actions of antiepileptic drugs. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Watanabe, Shigeru; Saito, Masanori; Miyaoka, Hitoshi] Kitasato Univ, Sch Med, Dept Psychiat, Minami Ku, Sagamihara, Kanagawa 2520380, Japan; [Yamamori, Saori; Takahashi, Masami] Kitasato Univ, Sch Med, Dept Biochem, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Otsuka, Shintaro] Kitasato Univ, Grad Sch Med Sci, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Suzuki, Eiji] Int Univ Hlth & Welf, Atami Hosp, Dept Psychiat, Atami, Shizuoka 4130012, Japan; [Kataoka, Masakazu] Shinshu Univ, Dept Environm Sci & Technol Engn, Nagano, Nagano 3808553, Japan	Takahashi, M (reprint author), Kitasato Univ, Sch Med, Dept Biochem, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	nabesige@kitasato-u.ac.jp; yamamori@med.kitasato-u.ac.jp; otsuka@z6.keio.jp; 7n2ecx@mtf.biglobe.ne.jp; e-suzuki@iuhw.ac.jp; mars@shinshu-u.ac.jp; miyaoka@med.kitasato-u.ac.jp; masami@med.kitasato-u.ac.jp			Japan Science and Technology Agency [24240055, 18300127, 21300141, 40344171]	This work was supported by: Grants-in-Aid 24240055 for Scientific Research (A), Grants-in-Aid 18300127 and 21300141 for Scientific Research (B), and a Grant-in-Aid for Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency (40344171).	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; BERTRAM EH, 1994, BRAIN RES, V661, P157, DOI 10.1016/0006-8993(94)91192-4; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Coulter DA, 2002, BRAIN PATHOL, V12, P240; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Mazzuferi M, 2012, EXP NEUROL, V238, P156, DOI 10.1016/j.expneurol.2012.08.022; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Bumanglag AV, 2008, J COMP NEUROL, V510, P561, DOI 10.1002/cne.21801; BERTRAM EH, 1993, BRAIN RES, V625, P295, DOI 10.1016/0006-8993(93)91071-Y; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; Blume WT, 2006, EPILEPSIA, V47, P71, DOI 10.1111/j.1528-1167.2006.00665.x; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Scharfman HE, 2000, J NEUROSCI, V20, P6144; Bortel A, 2010, NEUROBIOL DIS, V40, P478, DOI 10.1016/j.nbd.2010.07.015; Sloviter RS, 2013, NEUROPHARMACOLOGY, V69, P3, DOI 10.1016/j.neuropharm.2012.01.022; Baraban SC, 2007, CURR OPIN NEUROL, V20, P164, DOI 10.1097/WCO.0b013e328042bae0; Gorter JA, 2001, EUR J NEUROSCI, V13, P657, DOI 10.1046/j.1460-9568.2001.01428.x; Jarvis SE, 2007, CURR OPIN CELL BIOL, V19, P474, DOI 10.1016/j.ceb.2007.04.020; Raol YH, 2006, J NEUROSCI, V26, P11342, DOI 10.1523/JNEUROSCI.3329-06.2006; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Kadam SD, 2007, J COMP NEUROL, V505, P716, DOI 10.1002/cne.21533; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Kalynchuk LE, 2000, NEUROSCI BIOBEHAV R, V24, P691, DOI 10.1016/S0149-7634(00)00031-2; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Zhu G, 2008, J NEUROSCI, V28, P12465, DOI 10.1523/JNEUROSCI.2961-08.2008; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Corradini I, 2014, CEREB CORTEX, V24, P364, DOI 10.1093/cercor/bhs316; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Dudek FE, 2011, NEUROSCI LETT, V497, P240, DOI 10.1016/j.neulet.2011.03.071; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Chen Yucai, 2014, Front Neurol, V5, P45, DOI 10.3389/fneur.2014.00045; Dudek FE, 2011, EPILEPSY RES, V97, P324, DOI 10.1016/j.eplepsyres.2011.10.017; Iwasaki S, 2000, J BIOCHEM-TOKYO, V128, P407; Johansson JU, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000278; Kanner AM, 2004, EPILEPSIA, V45, P22, DOI 10.1111/j.0013-9580.2004.452004.x; Kataoka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025158; Meisler MH, 2001, ANNU REV GENET, V35, P567, DOI 10.1146/annurev.genet.35.102401.091142; Ohira K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-12; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; REYNOLDS EH, 1995, BRIT MED J, V310, P176; Rohena L, 2013, RARE DIS, V1, DOI [10.4161/rdis.26314, DOI 10.4161/RDIS.26314]; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Steinlein OK, 2000, CURR OPIN GENET DEV, V10, P286, DOI 10.1016/S0959-437X(00)00079-4; Upton N, 2003, CURR OPIN PHARMACOL, V3, P19, DOI 10.1016/S1471-4892(02)00010-3; Williams P.A., 2004, EPILEPSIA, V45, P1208; Zhang Y, 2004, J NEUROSCI, V24, P5239, DOI 10.1523/JNEUROSCI.0992-04.2004	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	SEP	2015	115						30	44		10.1016/j.eplepsyres.2015.05.004		15	Clinical Neurology	Neurosciences & Neurology	CP5XH	WOS:000359958200004		
J	Kanemura, H; Sano, F; Ohyama, T; Mizorogi, S; Sugita, K; Aihara, M				Kanemura, Hideaki; Sano, Fumikazu; Ohyama, Tetsuo; Mizorogi, Sonoko; Sugita, Kanji; Aihara, Masao			EEG characteristics predict subsequent epilepsy in children with their first unprovoked seizure	EPILEPSY RESEARCH			English	Article						First unprovoked seizure; Electroencephalogram (EEG); Paroxysmal abnormality; Frontal; Recurrence; Risk factor	MULTIPLE SEIZURES; FOLLOW-UP; RECURRENCE; RISK; ELECTROENCEPHALOGRAM; CHILDHOOD; IMPACT; TIME	One of the most important risk factors for seizure recurrence is the electroencephalogram (EEG) characteristics of children with a first unprovoked seizure. However, the nature of the relationship between the risk factors for subsequent epilepsy and EEG characteristics, especially the localization of EEG paroxysmal abnormalities (PAs), remains unclear. The importance of EEG characteristics, especially the localizations of PAs, as predictors for subsequent epilepsy in children with a first unprovoked seizure was investigated. The participants were recruited from University of Yamanashi Hospital between July 1, 1997 and June 30, 2010 and followed until December 31, 2014. Eligible candidates were children between 1 month and 15 years old who presented with their first unprovoked non-febrile seizure. Awake and sleep EEGs were performed on a 12- or 16-channel machine 7-20 days after a first unprovoked seizure. Agreement regarding the presence of a PA was required for inclusion of the patient in the study. EEG PAs were classified based on the presence of spikes, sharp waves, or spike-wave complexes, whether focal or generalized, that were considered abnormal for age and state. All subjects were followed for more than 4 years. Of 87 subjects, 48(55.2%) experienced recurrence. On the other hand, of 87 subjects, 52(59.8%) showed an EEG PA. Of 18 patients with paroxysms in the frontal region, 17 (94.4%) developed epilepsy. Patients with frontal EEG paroxysms had a significantly higher risk of developing epilepsy than those with focal paroxysms in other regions of EEG foci (p < 0.05). Moreover, compared with generalized EEG foci, the odds ratios for patients with frontal, RD, occipital, and mid-temporal EEG foci were 85.0 (95% Cl: 4.5-1617.1), 9.3(0.9-96.0), 2.5 (0.1-62.6), and 7.5 (0.5-122.7), respectively. Children with a first unprovoked seizure presenting with frontal paroxysmal EEG abnormalities may be at risk for the development of epilepsy later in life. (C) 2015 Elsevier B.V. All rights reserved.	[Kanemura, Hideaki; Sano, Fumikazu; Ohyama, Tetsuo; Mizorogi, Sonoko; Sugita, Kanji] Univ Yamanashi, Fac Med, Dept Pediat, Yamanashi 4093898, Japan; [Aihara, Masao] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Yamanashi 4093898, Japan	Kanemura, H (reprint author), Univ Yamanashi, Fac Med, Dept Pediat, 1110 Shimokato, Yamanashi 4093898, Japan.	ykimu@yamanashi.ac.jp; fsano@yamanashi.ac.jp; tohyama@yamanashi.ac.jp; sonokoh@yamanashi.ac.jp; ksugita@yamanashi.ac.jp; maihara@yamanashi.ac.jp			Japan Epilepsy Research Foundation; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [25-6];  [22591123]	This research was supported in part by The Japan Epilepsy Research Foundation, a Grant-in-Aid for Scientific Research (22591123), and an Intramural Research Grant (25-6) for Neurological and Psychiatric Disorders of NCNP. The funding sources had no involvement in the design of the study, the collection, analysis and interpretation of data, the writing of the report, or the decision to submit the article for publication.	Pohlmann-Eden B, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01445.x; JACOBY A, 1995, EPILEPSY RES, V21, P125, DOI 10.1016/0920-1211(95)00013-Z; Lizana JR, 2000, EPILEPSIA, V41, P1005, DOI 10.1111/j.1528-1157.2000.tb00286.x; Schreiner A, 2003, CLIN ELECTROENCEPHAL, V34, P140; Shinnar S, 2000, ANN NEUROL, V48, P140, DOI 10.1002/1531-8249(200008)48:2<140::AID-ANA2>3.0.CO;2-Y; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Fountain NB, 2006, EPILEPSIA, V47, P23, DOI 10.1111/j.1528-1167.2006.00655.x; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)07383-0; Shinnar S, 1996, PEDIATRICS, V98, P216; Hirtz D, 2000, NEUROLOGY, V55, P616; BERG AT, 1991, NEUROLOGY, V41, P965; Kho LK, 2006, NEUROLOGY, V67, P1047, DOI 10.1212/01.wnl.0000237555.12146.66; Fisher RS, 2000, EPILEPSY RES, V41, P39, DOI 10.1016/S0920-1211(00)00126-1; Winckler MIB, 2004, PEDIATR NEUROL, V30, P201, DOI 10.1016/j.pediatrneurol.2003.08.002; Beghi E, 2008, EPILEPSIA, V49, P1, DOI 10.1111/j.1528-1167.2008.01441.x; Chadwick DW, 2008, EPILEPSIA, V49, P26, DOI 10.1111/j.1528-1167.2008.01446.x; Commission on Epidemiology and Prognosis of the International League Against Epilepsy, 1993, EPILEPSIA, V34, P592; Haut S.R., 2007, PROGR EPILEPTIC DISO, P37; HOPKINS A, 1988, LANCET, V1, P721; IASEMIDIS LD, 1994, EPILEPSY RES, V17, P81, DOI 10.1016/0920-1211(94)90081-7; BANCAUD J, 1981, EPILEPSIA, V22, P489; Mizorogi S., 2015, PEDIAT INT IN PRESS; Neufeld MY, 2000, EPILEPSY RES, V42, P197, DOI 10.1016/S0920-1211(00)00183-2; Perucca E, 2008, EPILEPSIA, V49, P29, DOI 10.1111/j.1528-1167.2008.01447.x; VANDONSELAAR CA, 1992, ARCH NEUROL-CHICAGO, V49, P231	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	SEP	2015	115						58	62		10.1016/j.eplepsyres.2015.05.011		5	Clinical Neurology	Neurosciences & Neurology	CP5XH	WOS:000359958200007		
J	Kawanai, T; Taruta, A; Inoue, A; Watanabe, R; Ago, Y; Hashimoto, H; Hasebe, S; Ooi, Y; Takuma, K; Matsuda, T				Kawanai, Takuya; Taruta, Atsuki; Inoue, Aya; Watanabe, Ryo; Ago, Yukio; Hashimoto, Hitoshi; Hasebe, Shigeru; Ooi, Yasuhiro; Takuma, Kazuhiro; Matsuda, Toshio			Decreased expression of hippocampal Na+/Ca2+ exchanger isoform-1 by pentylenetetrazole kindling in mice	EPILEPSY RESEARCH			English	Article						Pentylenetetrazole; Kindling; Na+/Ca2+ exchanger isoforms; Hippocampus	CALCIUM HOMEOSTATIC MECHANISMS; NITRIC-OXIDE; PILOCARPINE MODEL; SEIZURES; RATS; INVOLVEMENT; INDUCTION; EPILEPSY	Previous studies have shown that inhibitors of the Na+/Ca2+-exchanger (NCX) attenuate seizure activity in drug-induced epilepsy models, but the role of NCX in epilepsy is not fully understood. The present study examined the effects of pentylenetetrazole (PTZ)-induced kindling on the mRNA expression of NCX isoforms (NCX1, NCX2 and NCX3) in mouse brain. Chronic administration of PTZ at 40 mg/kg resulted in kindling seizure development. It caused decreases in the mRNA levels of NCX1 and NCX2, but not NCX3, in the hippocampus. Changes in NCX isoform expression levels were not observed in the prefrontal cortex or striatum. Acute PTZ at 40 mg/kg, which caused little seizure activity, also decreased NCX2, but not NCX1 mRNA levels in the hippocampus. These results suggest that down-regulation of hippocampal NCX1 expression is associated with PTZ-induced kindling seizure development. (C) 2015 Elsevier B.V. All rights reserved.	[Kawanai, Takuya; Taruta, Atsuki; Inoue, Aya; Watanabe, Ryo; Ago, Yukio; Hasebe, Shigeru; Takuma, Kazuhiro; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuroharmacol, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Osaka Univ, United Grad Sch Child Dev, Suita, Osaka 565871, Japan; [Hasebe, Shigeru; Ooi, Yasuhiro; Takuma, Kazuhiro] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Suita, Osaka 5650871, Japan	Matsuda, T (reprint author), 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	matsuda@phs.osaka-u.ac.jp			KAKENHI [25460099, 26293020, 26670122]; Takeda Science Foundation (Japan); Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers	This study was supported in part by KAKENHI (25460099 (YA), 26293020 (HH) and 26670122 (HH)), Takeda Science Foundation (Japan) (YA) and Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (HH).	Ago Y, 2011, NEUROPHARMACOLOGY, V61, P1441, DOI 10.1016/j.neuropharm.2011.08.041; Zhu LJ, 2004, NEUROSCI LETT, V356, P53, DOI 10.1016/j.neulet.2003.11.029; Kita Y, 2013, PSYCHOPHARMACOLOGY, V225, P543, DOI 10.1007/s00213-012-2841-7; Itoh K, 2004, NEUROSCIENCE, V129, P757, DOI 10.1016/j.neuroscience.2004.09.025; Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Kumar A, 2013, EPILEPSY BEHAV, V29, P103, DOI 10.1016/j.yebeh.2013.06.007; Martinez Y, 2010, BRAIN RES, V1366, P211, DOI 10.1016/j.brainres.2010.09.100; Banach M, 2011, CNS NEUROL DISORD-DR, V10, P808; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; ASANO S, 1995, J NEUROCHEM, V64, P2437; Han D, 2000, J NEUROCHEM, V74, P792, DOI 10.1046/j.1471-4159.2000.740792.x; Morimoto N, 2012, BIOCHEM BIOPH RES CO, V429, P186, DOI 10.1016/j.bbrc.2012.10.114; N'Gouemo P, 2013, BRAIN RES BULL, V90, P52, DOI 10.1016/j.brainresbull.2012.09.007; Pal S, 2000, CELL CALCIUM, V28, P181, DOI 10.1054/ceca.2000.0146; Pannaccione A, 2012, J NEUROSCI, V32, P10609, DOI 10.1523/JNEUROSCI.6429-11.2012; Park DK, 2011, BMB REP, V44, P306, DOI 10.5483/BMBRep.2011.44.5.306; Parsons JT, 2000, J NEUROCHEM, V75, P1209, DOI 10.1046/j.1471-4159.2000.0751209.x; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; Saito R, 2009, BIOL PHARM BULL, V32, P1928; Takuma K, 2013, CURR PROTEIN PEPT SC, V14, P43	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	SEP	2015	115						109	112		10.1016/j.eplepsyres.2015.06.002		4	Clinical Neurology	Neurosciences & Neurology	CP5XH	WOS:000359958200016		
J	Korosue, K; Endo, Y; Murase, H; Ishimaru, M; Nambo, Y; Sato, F				Korosue, K.; Endo, Y.; Murase, H.; Ishimaru, M.; Nambo, Y.; Sato, F.			The cross-sectional area changes in digital flexor tendons and suspensory ligament in foals by ultrasonographic examination	EQUINE VETERINARY JOURNAL			English	Article						horse; foal; distal limb; conformation change; radiographic evaluation	FRACTURES; EXERCISE; HORSE	Reasons for performing studyFlexural deformities are common conditions of growing horses and are suggested to have a relationship with the contraction of musculotendinous units. However, limited studies have documented the changes in each tendon and ligament in the metacarpal region with age. ObjectivesTo investigate the changes in the cross-sectional area (CSA) of each tendon and ligament in the metacarpal region with age by ultrasonographic examination. Study designLongitudinal study of foals from Day 1 to age 24 months. MethodsThe CSA of the superficial digital flexor tendon, deep digital flexor tendon, accessory ligament of the deep digital flexor tendon and suspensory ligament was measured by ultrasonographic examination at monthly intervals from Day 1 to age 24 months in 7 Thoroughbred foals. ResultsChanges in superficial digital flexor CSA in all regions were larger than those of other structures from 10 months to 15 months. The suspensory ligament CSA was significantly larger than those of other structures on Day 1 in both the region of suspensory origin (RSO) and region of suspensory body (RSBO). This condition continued until 2 months in the RSO and until 5 months in the RSBO. The changes in deep digital flexor CSA were larger than those of other structures from 2 to 5 months in both the RSO and RSBO. ConclusionsThe rate of change in each structure varies with age. Thus, the functional adaptation with age that takes place may differ among structures because the primary function of each structure differs.	[Korosue, K.; Endo, Y.; Murase, H.; Ishimaru, M.; Nambo, Y.; Sato, F.] Japan Racing Assoc, Hidaka Training & Res Ctr, Sapporo, Hokkaido, Japan	Korosue, K (reprint author), Japan Racing Assoc, Hidaka Training & Res Ctr, Sapporo, Hokkaido, Japan.	kenji_korosue@jra.go.jp					Bhatnagar AS, 2010, J EQUINE VET SCI, V30, P349, DOI 10.1016/j.jevs.2010.05.004; HENNEKE DR, 1983, EQUINE VET J, V15, P371; Zauscher JM, 2013, EQUINE VET J, V45, P164, DOI 10.1111/j.2042-3306.2012.00597.x; Kidd JA, 2002, EQUINE VET EDUC, V14, P311; Firth EC, 2006, J ANAT, V208, P513, DOI 10.1111/j.1469-7580.2006.00547.x; Auer J. A., 2006, EQUINE SURG, V3rd, P1150; Baxter G. M., 2011, Adams and Stashak's lameness in horses, P1123; Birch H. L., 1999, EQUINE VET J S, V30, P222; Birch HL, 1998, EQUINE VET J, V30, P534; Bischofberger AS, 2006, EQUINE VET J, V38, P508, DOI 10.2746/042516406X156109; Bramlage L., 2009, P AM ASS EQUINE PRAC, V55, P96; Cherdchutham W, 2001, AM J VET RES, V62, P1859, DOI 10.2460/ajvr.2001.62.1859; ELLIS DR, 1979, EQUINE VET J, V11, P48; Hunt R. J., 1998, CURRENT TECHNIQUES E, P323; Kasashima Y., 2002, EQUINE VET J S, V34, P264; McIlwraith C. W., 2002, ADAMS LAMENESS HORSE, V5th, P459; RIEMERSMA DJ, 1986, RES VET SCI, V41, P7; WAGNER PC, 1985, J AM VET MED ASSOC, V187, P915	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0425-1644	2042-3306		EQUINE VET J	Equine Vet. J.	SEP	2015	47	5					548	552		10.1111/evj.12330		5	Veterinary Sciences	Veterinary Sciences	CP5DS	WOS:000359902100010		
J	Yamada, K; Aono, H; Hosomi, Y; Okamoto, H; Kato, T; Komase, Y; Nishikawa, M; Azuma, K; Takeoka, H; Okuma, Y; Nakahara, Y; Sato, A; Oba, MS; Morita, S; Kunitoh, H; Watanabe, K				Yamada, Kazuhiko; Aono, Hiromi; Hosomi, Yukio; Okamoto, Hiroaki; Kato, Terufumi; Komase, Yuko; Nishikawa, Masanori; Azuma, Koichi; Takeoka, Hiroaki; Okuma, Yusuke; Nakahara, Yoshiro; Sato, Akira; Oba, Mari S.; Morita, Satoshi; Kunitoh, Hideo; Watanabe, Koshiro			A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911	EUROPEAN JOURNAL OF CANCER			English	Article						Low-dose; Erlotinib; Non-small cell lung cancer; EGFR mutation	GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; JAPANESE PATIENTS; OPEN-LABEL; 1ST-LINE TREATMENT; CLINICAL-TRIALS; GEFITINIB; DOCETAXEL; SURVIVAL; THERAPY	Background: Low-dose erlotinib may be as effective as gefitinib or erlotinib at full dose in non-small cell lung cancer (NSCLC) patients with activating mutations of the epidermal growth factor receptor (EGFR) gene. Methods: Patients with chemotherapy pretreated NSCLC harbouring EGFR mutations received erlotinib at 50 mg/d until disease progression or unacceptable toxicities. The dose was escalated to 150 mg/d in patients showing no response (i.e. without major tumour shrinkage according to Response Evaluation Criteria in Solid Tumours (RECIST)) to the initial dose during the first 4 weeks. The primary end-point was the objective response rate at the dose of 50 mg/d. Results: Thirty-four patients from seven institutes were enrolled. The study was closed early when no response was confirmed in 15 patients, excluding the possibility that the primary end-point would be met. The objective response and disease control rates at the dose of 50 mg/d as determined by an independent review committee were 54.5% and 84.8%, respectively. Four additional patients achieved partial response with increased 150 mg/d dose. Progression-free survival and median survival times during the entire period of the study were 9.5 and 28.5 months, respectively. Treatment-related toxicities were generally mild, the most common being skin disorders and diarrhoea. Only one case experienced grade 3 toxicity, which was transient increase of hepatic enzymes. Conclusion: The primary end-point was not met; low-dose erlotinib is not recommended for fit patients with NSCLC harbouring EGFR mutations. However, it may merit further evaluation for elderly or frail patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamada, Kazuhiko; Azuma, Koichi; Takeoka, Hiroaki] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 8300011, Japan; [Aono, Hiromi; Kunitoh, Hideo] Mitsui Mem Hosp, Resp Med, Tokyo 101, Japan; [Hosomi, Yukio; Okuma, Yusuke; Nakahara, Yoshiro] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Tokyo, Japan; [Okamoto, Hiroaki; Sato, Akira] Yokohama Municipal Citizens Hosp, Dept Resp Med & Med Oncol, Yokohama, Kanagawa, Japan; [Kato, Terufumi] Kanagawa Cardiovasc & Resp Ctr, Div Resp Med, Kawasaki, Kanagawa, Japan; [Komase, Yuko] St Marianna Univ, Sch Med, Yokohama City Seibu Hosp, Dept Resp Internal Med, Kawasaki, Kanagawa, Japan; [Nishikawa, Masanori] Fujisawa City Hosp, Dept Resp Med, Fujisawa, Kanagawa, Japan; [Oba, Mari S.] Yokohama City Univ, Med Ctr, Dept Biostat, Yokohama, Kanagawa, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Watanabe, Koshiro] Thorac Oncol Res Grp, Yokohama, Kanagawa, Japan; [Kunitoh, Hideo] Japanese Red Cross Med Ctr, Dept Med Oncol, Tokyo, Japan; [Nakahara, Yoshiro] Kitasato Univ, Sch Med, Dept Resp Med, Kitasato, Kanagawa, Japan	Yamada, K (reprint author), Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	kayamada@med.kurume-u.ac.jp					Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; GREEN SJ, 1992, STAT MED, V11, P853, DOI 10.1002/sim.4780110703; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Goto K, 2013, LUNG CANCER, V82, P109, DOI 10.1016/j.lungcan.2013.07.003; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Wu JY, 2008, AM J RESP CRIT CARE, V178, P847, DOI 10.1164/rccm.200803-389OC; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Yeo WL, 2010, J THORAC ONCOL, V5, P1048, DOI 10.1097/JTO.0b013e3181dd1386; Endo K, 2005, LUNG CANCER-J IASLC, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Hamada A, 2012, PHARMACOGENOMICS, V13, P615, DOI [10.2217/pgs.11.176, 10.2217/PGS.11.176]; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Yamada K, 2013, JPN J CLIN ONCOL, V43, P629, DOI 10.1093/jjco/hyt056; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Gandhi J, 2009, PLOS ONE, V4; Mast Andrea, 2006, V335, P173; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Nomoto K, 2006, AM J CLIN PATHOL, V126, P608, DOI 10.1309/N5PQNGW2QKMX09X7; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208	27	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	SEP	2015	51	14					1904	1910		10.1016/j.ejca.2015.06.120		7	Oncology	Oncology	CP7PW	WOS:000360081300007		
J	Shiota, M; Fujimoto, N; Yokomizo, A; Takeuchi, A; Itsumi, M; Inokuchi, J; Tatsugami, K; Uchiumi, T; Naito, S				Shiota, Masaki; Fujimoto, Naohiro; Yokomizo, Akira; Takeuchi, Ario; Itsumi, Momoe; Inokuchi, Junichi; Tatsugami, Katsunori; Uchiumi, Takeshi; Naito, Seiji			SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy	EUROPEAN JOURNAL OF CANCER			English	Article						Androgen-deprivation therapy; Castration-resistant prostate cancer; Prostate cancer; SNP; SRD5A	5-ALPHA-REDUCTASE TYPE-II; RISK-ASSESSMENT; HORMONE-LEVELS; DOUBLE-BLIND; DUTASTERIDE; RECEPTOR; TRIAL; ENZALUTAMIDE; TESTOSTERONE; PROGRESSION	Aim: De novo androgen synthesis is thought to be involved in the progression to castration-resistant prostate cancer (CRPC) during androgen-deprivation therapy (ADT). During androgen synthesis, 5a-reductase encoded by SRD5A catalyses testosterone into more active dihydrotestosterone and may be involved in the progression to CRPC. Then, this study aimed to reveal the association between genetic variations in SRD5A and the prognosis in metastatic prostate cancer. Methods: We studied the polymorphisms rs518673 and rs166050 in SRD5A1, and rs12470143, rs523349, rs676033 and rs2208532 in SRD5A2 as well as the time to CRPC progression and overall survival in 104 patients with metastatic prostate cancer that had undergone primary ADT. The association between the polymorphisms and the progression to CRPC as well as overall survival was examined. Results: Patients carrying the more active GG genotype in SRD5A2 rs523349 exhibited a higher risk of the progression (hazard ration [95% confidence interval], 1.93 [1.14-3.14], p = 0.016) and death (hazard ration [95% confidence interval], 2.14 [1.16-3.76], p = 0.016), compared with less active GC/CC genotypes in SRD5A2 rs523349. Conclusions: High 5 alpha-reductase activity due to the polymorphism in SRD5A2 may contribute to resistance to ADT. Furthermore, SRD5A2 rs523349 polymorphism may be a promising biomarker for metastatic prostate cancer patients treated with primary ADT and a molecular target for advanced prostate cancer. (C) 2015 Elsevier Ltd. All rights reserved.	[Shiota, Masaki; Yokomizo, Akira; Takeuchi, Ario; Itsumi, Momoe; Inokuchi, Junichi; Tatsugami, Katsunori; Naito, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 8128582, Japan; [Fujimoto, Naohiro] Univ Occupat & Environm Hlth, Sch Med, Dept Urol, Kitakyushu, Fukuoka 8078556, Japan; [Uchiumi, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 8128582, Japan	Yokomizo, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yokoa@uro.med.kyushu-u.ac.jp					Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Morote J, 2007, J UROLOGY, V178, P1290, DOI 10.1016/j.juro.2007.05.129; Sadar MD, 2011, CANCER RES, V71, P1208, DOI [10.1158/0008-5472.CAN_10-3398, 10.1158/0008-5472.CAN-10-3398]; Levesque E, 2014, CLIN CANCER RES, V20, P576, DOI 10.1158/1078-0432.CCR-13-1100; Akaza H, 2009, CANCER, V115, P3437, DOI 10.1002/cncr.24395; Fleshner NE, 2012, LANCET, V379, P1103, DOI 10.1016/S0140-6736(11)61619-X; Fujimoto N, 2013, PROSTATE CANCER P D, V16, P336, DOI 10.1038/pcan.2013.23; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Shiota M, 2011, CURR CANCER DRUG TAR, V11, P870; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Audet-Walsh E, 2011, EUR UROL, V60, P1226, DOI 10.1016/j.eururo.2011.06.020; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Nacusi LP, 2011, NAT REV UROL, V8, P378, DOI 10.1038/nrurol.2011.67; Makridakis N, 1997, CANCER RES, V57, P1020; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Fukagai T, 2006, BJU INT, V97, P1190, DOI 10.1111/j.1464-410X.2006.06201.x; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Makridakis NM, 2000, PHARMACOGENETICS, V10, P407, DOI 10.1097/00008571-200007000-00004; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Cooperberg MR, 2009, J CLIN ONCOL, V27, P4306, DOI 10.1200/JCO.2008.21.5228; Titus MA, 2005, CLIN CANCER RES, V11, P4365, DOI 10.1158/1078-0432.CCR-04-0738; Attard G, 2014, EUR UROL, V66, P799, DOI 10.1016/j.eururo.2014.05.038; Boger-Megiddo I, 2008, CANCER EPIDEM BIOMAR, V17, P286, DOI [10.1158/1055-9965.EPI-07-0238, 10.1158/1055-9963.EPI-07-0238]; Cooperberg MR, 2014, BJU INT; Cussenot O, 2007, EUR UROL, V52, P1082, DOI 10.1016/j.eururo.2007.04.008; Giwercman YL, 2005, EUR UROL, V48, P679, DOI 10.1016/j.eururo.2005.06.011; Hamid ARAH, 2015, J UROLOGY, V193, P1023, DOI 10.1016/j.juro.2014.09.021; Hayes VM, 2007, INT J CANCER, V120, P776, DOI 10.1002/ijc.22408; Holmes L, 2009, CANCER CONTROL, V16, P176; Kakinuma H, 2004, PROSTATE CANCER P D, V7, P333, DOI 10.1038/sj.pcan.4500753; Klotz L, 2015, J CLIN ONCOL, V33, P1151, DOI 10.1200/JCO.2014.58.2973; Kosaka T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01268; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; Shibata A, 2002, PROSTATE, V52, P269, DOI 10.1002/pros.10119; Shiota M, 2011, J MOL ENDOCRINOL, V47, pR25, DOI 10.1530/JME-11-0018; Shiota M, 2015, J CANCER RES CLIN, V141, P495, DOI 10.1007/s00432-014-1828-7; Shiota M, 2013, CURR CANCER DRUG TAR, V13, P444; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sobin LH, 1997, TNM CLASSIFICATION M, P170; Sweeney C, 2014, J CLIN ONCOL S, V32; Titus MA, 2014, PROSTATE, V74, P235, DOI 10.1002/pros.22745; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184	42	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	SEP	2015	51	14					1962	1969		10.1016/j.ejca.2015.06.122		8	Oncology	Oncology	CP7PW	WOS:000360081300014		
J	Matsuo, K; Hasegawa, K; Yoshino, K; Murakami, R; Hisamatsu, T; Stone, RL; Previs, RA; Hansen, JM; Ikeda, Y; Miyara, A; Hiramatsu, K; Enomoto, T; Fujiwara, K; Matsumura, N; Konishi, I; Roman, LD; Gabra, H; Fotopoulou, C; Sood, AK				Matsuo, Koji; Hasegawa, Kosei; Yoshino, Kiyoshi; Murakami, Ryusuke; Hisamatsu, Takeshi; Stone, Rebecca L.; Previs, Rebecca A.; Hansen, Jean M.; Ikeda, Yuji; Miyara, Akiko; Hiramatsu, Kosuke; Enomoto, Takayuki; Fujiwara, Keiichi; Matsumura, Noriomi; Konishi, Ikuo; Roman, Lynda D.; Gabra, Hani; Fotopoulou, Christina; Sood, Anil K.			Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma	EUROPEAN JOURNAL OF CANCER			English	Article						Ovarian cancer; Clear cell carcinoma; Venous thromboembolism; IL-6; Survival outcome	EPITHELIAL OVARIAN; 2-TIER SYSTEM; CANCER; CYTOKINE; EXPRESSION; MICROENVIRONMENT; THROMBOSIS; IL-6	Background: We compared survival outcomes and risk of venous thromboembolism (VTE) among patients with advanced and early-stage ovarian clear cell carcinoma (OCCC) and serous ovarian carcinoma (SOC), as well as potential links with interleukin-6 (IL-6) levels. Methods: A multicenter case-control study was conducted in 370 patients with OCCC and 938 with SOC. In a subset of 200 cases, pretreatment plasma IL-6 levels were examined. Findings: Patients with advanced OCCC had the highest 2-year cumulative VTE rates (advanced OCCC 43.1%, advanced SOC 16.2%, early-stage OCCC 11.9% and early-stage SOC 6.4%, P < 0.0001) and the highest median levels of IL-6 (advanced OCCC 17.8 pg/mL, advanced SOC 9.0 pg/mL, early-stage OCCC 4.2 pg/mL and early-stage SOC 5.0 pg/mL, P = 0.006). Advanced OCCC (hazard ratio [HR] 3.38, P < 0.0001), thrombocytosis (HR 1.42, P = 0.032) and elevated IL-6 (HR 8.90, P = 0.046) were independent predictors of VTE. In multivariate analysis, patients with advanced OCCC had significantly poorer 5-year progression-free and overall survival rates than those with advanced SOC (P < 0.01), and thrombocytosis was an independent predictor of decreased survival outcomes (P < 0.01). Elevated IL-6 levels led to poorer 2-year progression-free survival rates in patients with OCCC (50% versus 87.5%, HR 4.89, P = 0.016) than in those with SOC (24.9% versus 40.8%, HR 1.40, P = 0.07). Interpretation: Advanced OCCC is associated with an increased incidence of VTE and decreased survival outcomes, which has major implications for clinical management of OCCC. (C) 2015 Elsevier Ltd. All rights reserved.	[Matsuo, Koji; Roman, Lynda D.] Univ So Calif, Dept Obstet & Gynecol, Los Angeles, CA 90089 USA; [Matsuo, Koji; Roman, Lynda D.] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Hasegawa, Kosei; Ikeda, Yuji; Miyara, Akiko; Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Saitama, Japan; [Yoshino, Kiyoshi; Hisamatsu, Takeshi; Hiramatsu, Kosuke] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka, Japan; [Murakami, Ryusuke; Matsumura, Noriomi; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto, Japan; [Hisamatsu, Takeshi; Previs, Rebecca A.; Hansen, Jean M.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Stone, Rebecca L.] Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD USA; [Ikeda, Yuji] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Enomoto, Takayuki] Niigata Univ, Grad Sch Med, Dept Obstet & Gynecol, Niigata, Japan; [Gabra, Hani; Fotopoulou, Christina] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Ovarian Canc Act Res Ctr, London, England; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA	Matsuo, K (reprint author), Univ So Calif, Dept Obstet & Gynecol, Div Gynecol Oncol, 2020 Zonal Ave,IRD520, Los Angeles, CA 90089 USA.	koji.matsuo@med.usc.edu					Zhang L, 2012, BLOOD, V120, P3783, DOI 10.1182/blood-2012-04-424630; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; Kerr R, 2001, BRIT J HAEMATOL, V115, P3, DOI 10.1046/j.1365-2141.2001.03061.x; Gunderson CC, 2014, GYNECOL ONCOL, V134, P73, DOI 10.1016/j.ygyno.2014.04.046; Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Rodriguez AL, 2012, J THROMB THROMBOLYS, V33, P371, DOI 10.1007/s11239-012-0687-9; Diaz ES, 2013, GYNECOL ONCOL, V131, P541, DOI 10.1016/j.ygyno.2013.09.005; Braicu EI, 2011, BRIT J CANCER, V105, P1818, DOI 10.1038/bjc.2011.455; Hutti JE, 2012, CANCER RES, V72, P3260, DOI 10.1158/0008-5472.CAN-11-4141; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Bodurka DC, 2012, CANCER-AM CANCER SOC, V118, P3087, DOI 10.1002/cncr.26618; Prat J, 2014, INT J GYNECOL OBSTET, V124, P1, DOI 10.1016/j.ijgo.2013.10.001; Yamamoto S, 1997, BRIT J CANCER, V76, P1221, DOI 10.1038/bjc.1997.537; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Reitter EM, 2014, CLIN EXP IMMUNOL, V177, P253, DOI 10.1111/cei.12308; Matsuura Y, 2007, GYNECOL ONCOL, V104, P406, DOI 10.1016/j.ygyno.2006.08.026; Chandler RL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7118; Connolly GC, 2014, SEMIN ONCOL, V41, P302, DOI 10.1053/j.seminoncol.2014.04.009; Coward JI, 2011, CYTOKINE GROWTH F R, V23, P333; Davis AN, 2014, SEMIN ONCOL, V41, P378, DOI 10.1053/j.seminoncol.2014.04.004; Duska LR, 2009, GYNECOL ONCOL, V116, P374; Fadare Oluwole, 2014, Womens Health (Lond Engl), V10, P479, DOI 10.2217/whe.14.42; Farley JH, 2013, J CLIN ONCOL, V31; Fotopoulou C, 2008, J CLIN ONCOL, V26, P2683, DOI 10.1200/JCO.2008.16.1109; Glasspool RM, 2013, CURR ONCOL REP, V15, P566, DOI 10.1007/s11912-013-0346-0; Matsuo K, 2012, GYNECOL ONCOL, V128, P544; Okamoto A, 2014, INT J GYNECOL CANCER, V24, pS20, DOI 10.1097/IGC.0000000000000289; Rosean TR, 2015, LEUKEMIA, V29, P233, DOI 10.1038/leu.2014.260; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Yanaihara N, 2012, INT J ONCOL, V41, P1094, DOI 10.3892/ijo.2012.1533	36	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	SEP	2015	51	14					1978	1988		10.1016/j.ejca.2015.07.012		11	Oncology	Oncology	CP7PW	WOS:000360081300016		
J	Ito, H; Hozawa, A; Yamashita, H; Kubota, I; Nemoto, K; Yoshioka, T; Kayama, T; Murakami, M				Ito, H.; Hozawa, A.; Yamashita, H.; Kubota, I.; Nemoto, K.; Yoshioka, T.; Kayama, T.; Murakami, M.			Employment status among non-retired cancer survivors in Japan	EUROPEAN JOURNAL OF CANCER CARE			English	Article						cancer stage; employment status; return to work	BREAST-CANCER; WORK; DIAGNOSIS; COHORT	Employed cancer patients confront some challenges as they attempt to return to work after treatment. We aimed to identify correlates of return to work for cancer survivors in Japan, with an emphasis on employment status. Participants were 260 patients (aged <65years) who had received a cancer diagnosis 1year previously and who were employed at the time of diagnosis. Participants completed questionnaires at consultations at any Regional Cancer Center Hospitals in Yamagata, Japan between 28 November 2011 and 9 December 2011. Logistic regression analysis was used to identify correlates of return to work. Data cross-tabulation was used to evaluate relationships to workplace and income-changes by employment status. A high proportion of patients (75.8%) had returned to work. Non-regularly employed survivors were less likely to return to work (odds ratio=5.03; 95% confidence interval, 1.18-21.35). Individuals with poor health, advanced-stage tumours, of advanced age and women were significantly less likely to return to work. Only 52.8% of non-regular employees continued to be employed, and their income decreased by as much as 61.1%. Social and financial support policies should be organised based on more intensive study of employment circumstances.	[Ito, H.; Murakami, M.] Yamagata Univ, Grad Sch Med Sci, Dept Hlth Policy Sci, Yamagata 9909585, Japan; [Hozawa, A.] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 980, Japan; [Yamashita, H.] Yamagata Univ, Fac Med, Dept Ophthalmol, Yamagata 9909585, Japan; [Kubota, I.] Yamagata Univ, Fac Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 9909585, Japan; [Nemoto, K.] Yamagata Univ, Fac Med, Dept Radiat Oncol, Yamagata 9909585, Japan; [Yoshioka, T.] Yamagata Univ, Fac Med, Dept Clin Oncol, Yamagata 9909585, Japan; [Kayama, T.] Yamagata Univ, Grad Sch Med Sci, Dept Neurosurg, Yamagata 9909585, Japan	Ito, H (reprint author), Yamagata Univ, Grad Sch Med Sci, Dept Hlth Policy Sci, 2-2-2 Iidanishi, Yamagata 9909585, Japan.	h-itoh@med.id.yamagata-u.ac.jp					Abegglen James C., 2006, 21 CENTURY JAPANESE; Ahn E., 2008, BREAST CANC RES TREA, V116, P609; Amir Ziv, 2007, J Cancer Surviv, V1, P129, DOI 10.1007/s11764-007-0021-2; Choi KS, 2007, PSYCHO-ONCOL, V16, P205, DOI 10.1002/pon.1054; Taskila T, 2007, ACTA ONCOL, V46, P446, DOI 10.1080/02841860701355048; Bradley CJ, 2002, PSYCHO-ONCOL, V11, P188, DOI 10.1002/pon.544; Peteet JR, 2000, GEN HOSP PSYCHIAT, V22, P200, DOI 10.1016/S0163-8343(00)00076-1; Hansen JA, 2008, J OCCUP ENVIRON MED, V50, P777, DOI 10.1097/JOM.0b013e318165159e; Lauzier S, 2008, J NATL CANCER I, V100, P321, DOI 10.1093/jnci/djn028; Bieri S, 2008, BONE MARROW TRANSPL, V42, P819, DOI 10.1038/bmt.2008.253; Mehnert A, 2011, CRIT REV ONCOL HEMAT, V77, P109, DOI 10.1016/j.critrevonc.2010.01.004; Bouknight RR, 2006, J CLIN ONCOL, V24, P345, DOI 10.1200/JCO.2004.00.4929; Bednarek HL, 2005, RES NURS HEALTH, V28, P126, DOI 10.1002/nur.20062; Carlsen K, 2008, SCAND J PUBLIC HEALT, V36, P117, DOI 10.1177/1403494807085192; desBoer A. G., 2008, BRIT J CANCER, V98, P1342; Drolet M, 2005, J CLIN ONCOL, V23, P8305, DOI 10.1200/JCO.2005.09.500; Gudbergsson S. B., 2008, J CANC SURVIV, V2, P159, DOI DOI 10.1007/S11764-008-0059-9; Gudbergsson SB, 2008, SUPPORT CARE CANCER, V16, P1163, DOI 10.1007/s00520-008-0407-3; Gudbergsson SB, 2007, ACTA ONCOL, V46, P534, DOI 10.1080/02841860601156132; Koinuma N., 2011, STUDY CANC PATIENTS; Ministry of Health Labour and Welfare, 2013, EMPL STAT SURV; Ministry of Health Labour andWelfare, 2012, BAS PLAN PROM CANC C; Ohguri T, 2009, J OCCUP HEALTH, V51, P267; Syse Astri, 2008, J Cancer Surviv, V2, P149, DOI 10.1007/s11764-008-0053-2; vansMuijen P., 2013, EUROPEAN J CANC CARE, V22, P144; Yamaguchi K., 2004, REPORT TROUBLES BURD	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-5423	1365-2354		EUR J CANCER CARE	Eur. J. Cancer Care	SEP	2015	24	5					718	723		10.1111/ecc.12304		6	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	CP7VV	WOS:000360098100012		
J	Noda, H; Ogasawara, N; Izawa, S; Ozeki, T; Yanamoto, K; Okaniwa, N; Tanabe, A; Sasaki, M; Kasugai, K				Noda, Hisatsugu; Ogasawara, Naotaka; Izawa, Shinya; Ozeki, Tomonori; Yanamoto, Kenichiro; Okaniwa, Noriko; Tanabe, Atsushi; Sasaki, Makoto; Kasugai, Kunio			Risk factors for bleeding evaluated using the Forrest classification in Japanese patients after endoscopic submucosal dissection for early gastric neoplasm	EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY			English	Article						early gastric neoplasm; endoscopic submucosal dissection; Forrest classification; recurrent bleeding; second-look endoscopy	PROSPECTIVE RANDOMIZED-TRIAL; MUCOSAL RESECTION; 2ND-LOOK ENDOSCOPY; CLINICAL-OUTCOMES; ELECTROSURGICAL KNIFE; PLATELET DYSFUNCTION; SODIUM HYALURONATE; PEPTIC-ULCER; CANCER; TUMORS	Background/aimsBleeding remains a serious complication after endoscopic submucosal dissection (ESD). Second-look endoscopy for hemostasis helps prevent post-ESD bleeding. We investigated the relationships between patient characteristics, tumor characteristics, and the Forrest classification for exposed vessels on artificial ulcers after ESD and evaluated whether hemostasis during second-look endoscopy was useful for preventing post-ESD bleeding.Patients and methodsWe analyzed 250 patients (265 lesions) who underwent ESD for gastric neoplasms. Vessels classified by Forrest classifications during scheduled second-look endoscopy were analyzed for associations with patient characteristics, tumor characteristics, and recurrent bleeding.ResultsTwo of 250 patients (0.8%) underwent emergency hemostatic endoscopy before scheduled second-look endoscopy. The remaining 248 patients (99.2%) underwent scheduled second-look endoscopy on the day after ESD. Patients with Forrest classification Ia, Ib, or IIa vessels had a significantly higher risk for recurrent bleeding after scheduled second-look endoscopy compared with patients with IIb or III vessels according to univariate analysis (P<0.05) and multivariate logistic regression analysis (odds ratio: 3.45; 95% confidence interval: 1.04-11.41; P=0.042). Univariate analysis indicated that hemodialysis correlated significantly with the presence of Ia, Ib, or IIa vessels compared with that of IIb or III vessels found during second-look endoscopy (P<0.05). Multivariate analysis indicated a significant relationship between hemodialysis and recurrent bleeding after second-look endoscopy (odds ratio: 10.05; 95% confidence interval: 1.97-51.26; P=0.006).ConclusionHemodialysis is a risk factor for post-ESD bleeding. Proper classification of exposed vessels within post-ESD ulcers according to the Forrest classification using second-look endoscopy might help predict or prevent recurrent bleeding.	[Noda, Hisatsugu; Ogasawara, Naotaka; Izawa, Shinya; Ozeki, Tomonori; Yanamoto, Kenichiro; Okaniwa, Noriko; Tanabe, Atsushi; Sasaki, Makoto; Kasugai, Kunio] Aichi Med Univ, Sch Med, Dept Gastroenterol, Nagakute, Aichi 4801195, Japan	Ogasawara, N (reprint author), Aichi Med Univ, Sch Med, Dept Gastroenterol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	nogasa@aichi-med-u.ac.jp					Higashiyama M, 2011, DIGEST ENDOSC, V23, P290, DOI 10.1111/j.1443-1661.2011.01151.x; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; NORIS M, 1993, KIDNEY INT, V44, P445, DOI 10.1038/ki.1993.264; Saeed ZA, 1996, ENDOSCOPY, V28, P288, DOI 10.1055/s-2007-1005455; Goto O, 2009, DIGEST LIVER DIS, V41, P26, DOI 10.1016/j.dld.2008.02.023; Yamamoto H, 2002, GASTROINTEST ENDOSC, V56, P507, DOI 10.1067/mge.2002.128108; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Chiu PWY, 2003, GUT, V52, P1403, DOI 10.1136/gut.52.10.1403; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Soetikno RM, 2003, GASTROINTEST ENDOSC, V57, P567, DOI 10.1067/mge.2003.130; Galbusera M, 2009, SEMIN DIALYSIS, V22, P279, DOI 10.1111/j.1525-139X.2008.00556.x; Mannen K, 2010, J GASTROENTEROL, V45, P30, DOI 10.1007/s00535-009-0137-4; Yamamoto H, 2003, ENDOSCOPY, V35, P690; Kang HY, 2010, SURG ENDOSC, V24, P509, DOI 10.1007/s00464-009-0614-0; Kim HH, 2012, GUT LIVER, V6, P316, DOI 10.5009/gnl.2012.6.3.316; Miyamoto S, 2002, GASTROINTEST ENDOSC, V55, P576, DOI 10.1067/mge.2002.122579; Guglielmi A, 2002, ENDOSCOPY, V34, P778, DOI 10.1055/s-2002-34261; Ell C, 2000, GASTROENTEROLOGY, V118, P670, DOI 10.1016/S0016-5085(00)70136-3; Tsuji Y, 2010, WORLD J GASTROENTERO, V16, P2913, DOI 10.3748/wjg.v16.i23.2913; Goto O, 2010, GASTROINTEST ENDOSC, V71, P241, DOI 10.1016/j.gie.2009.08.030; NAKAMURA K, 1992, CANCER, V70, P1030, DOI 10.1002/1097-0142(19920901)70:5<1030::AID-CNCR2820700504>3.0.CO;2-C; VILLANUEVA C, 1994, GASTROINTEST ENDOSC, V40, P34; Choi CW, 2014, SURG ENDOSC, V28, P2213, DOI 10.1007/s00464-014-3457-2; Watanabe K, 2006, GASTROINTEST ENDOSC, V63, P776, DOI 10.1016/j.gie.2005.08.049; Kaw D, 2006, SEMIN DIALYSIS, V19, P317; Chung IK, 2001, ENDOSCOPY, V33, P969, DOI 10.1055/s-2001-17951; FORREST JAH, 1974, LANCET, V2, P394; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Gotoda T, 1999, GASTROINTEST ENDOSC, V50, P560, DOI 10.1016/S0016-5107(99)70084-2; HIRAO M, 1988, GASTROINTEST ENDOSC, V34, P264, DOI 10.1016/S0016-5107(88)71327-9; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; SHIMIZU S, 1995, ENDOSCOPY, V27, P27, DOI 10.1055/s-2007-1005628; Imagawa A, 2006, ENDOSCOPY, V38, P987, DOI 10.1055/s-2006-944716; Takizawa K, 2008, ENDOSCOPY, V40, P179, DOI 10.1055/s-2007-995530; Cheung J, 2010, GASTROINTEST ENDOSC, V71, P44, DOI 10.1016/j.gie.2009.04.014; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Hamanaka H, 2005, DIGEST ENDOSC, V17, P275, DOI 10.1111/j.1443-1661.2005.00545.x; HERBELIN A, 1990, KIDNEY INT, V37, P116, DOI 10.1038/ki.1990.16; Hijikata Y, 2012, HEPATO-GASTROENTEROL, V59, P353, DOI 10.5754/hge11458; Ikeda Y, 1998, J CLIN GASTROENTEROL, V27, P60, DOI 10.1097/00004836-199807000-00012; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Mukai S, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/875323; Oda Ichiro, 2006, Gastric Cancer, V9, P262, DOI 10.1007/s10120-006-0389-0; Oda I, 2005, DIGEST ENDOSC, V17, P54, DOI 10.1111/j.1443-1661.2005.00459.x; Ogasawara Naotaka, 2014, Clin Endosc, V47, P162, DOI 10.5946/ce.2014.47.2.162; Onozato Y, 2006, ENDOSCOPY, V38, P980, DOI 10.1055/s-2006-944809; Sloand JA, 1997, J AM SOC NEPHROL, V8, P799; Takeuchi T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-136; Tanabe S, 2002, GASTROINTEST ENDOSC, V56, P708, DOI 10.1067/mge.2002.129085; Tjiri H, 2004, DIGEST ENDOSC, V16, pS134	50	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-691X	1473-5687		EUR J GASTROEN HEPAT	Eur. J. Gastroenterol. Hepatol.	SEP	2015	27	9					1022	1029		10.1097/MEG.0000000000000419		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP4OI	WOS:000359861300006		
J	Ishitani, H; Suzuki, H; Saito, Y; Yamashita, Y; Kobayashi, S				Ishitani, Haruro; Suzuki, Hirotsugu; Saito, Yuki; Yamashita, Yasuhiro; Kobayashi, Shu			Hafnium Trifluoromethanesulfonate [Hf(OTf)(4)] as a Unique Lewis Acid in Organic Synthesis	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Review						Synthetic methods; Acylation; Mannich reaction; Hafnium; Lewis acids	FRIEDEL-CRAFTS ACYLATION; ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; ATOM ECONOMIC NITRATION; C-ARYL GLYCOSIDES; CARBOXYLIC-ACIDS; EFFICIENT CATALYST; CONJUGATE-ADDITION; MANNICH-TYPE; DI-2-THIENYL CARBONATE; NAPHTHOL DERIVATIVES	This microreview summarizes examples of Hf(OTf)(4)-mediated or -catalyzed organic reactions. Hafnium triflate possesses four strongly electron-withdrawing OTf groups, together with an ionic radius of intermediate range (Al < Ti < Hf, Zr < Sc < Ln), and has an oxophilic hard character typical of group IV metals. This Lewis acid shows outstanding performance in catalytic Friedel-Crafts acylation reactions and Mannich-type reactions of imines, hydrazones, and N,O-acetals. Several natural products have also been synthesized by use of Hf(OTf)(4)-mediated or -catalyzed reactions. Moreover, Hf(OTf)(4) has a number of potent features in carbohydrate syntheses. Hf(OTf)(4) possesses many unique characteristics that distinguish it from other Lewis acids. The unique characteristics of Hf(OTf)(4) should make this compound a major candidate for selection as a Lewis acid in the future.	[Ishitani, Haruro; Kobayashi, Shu] Univ Tokyo, Sch Sci, Green & Sustainable Chem Social Cooperat Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Suzuki, Hirotsugu; Saito, Yuki; Yamashita, Yasuhiro; Kobayashi, Shu] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Kobayashi, S (reprint author), Univ Tokyo, Sch Sci, Green & Sustainable Chem Social Cooperat Lab, Bunkyo Ku, Tokyo 1130033, Japan.	shu_kobayashi@chem.s.u-tokyo.ac.jp	Kobayashi, Shu/E-9214-2012		Japan Society for the Promotion of Science (JSPS); Global COE Program; University of Tokyo; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Science and Technology Agency (JST)	This work was partially supported by a Grant-in-Aid for Science Research from the Japan Society for the Promotion of Science (JSPS), Global COE Program, The University of Tokyo (grants to H. S. and Y. S., MERIT program), Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Japan Science and Technology Agency (JST).	Abe AMM, 2007, J ORG CHEM, V72, P5411, DOI 10.1021/jo070492z; Aburatani S, 2008, HETEROCYCLES, V75, P1407; Alcaide B, 2002, EUR J ORG CHEM, P1595; Kobayashi S, 2011, CHEM REV, V111, P2626, DOI 10.1021/cr100204f; Parsons AT, 2009, J AM CHEM SOC, V131, P14202, DOI 10.1021/ja906755e; Noji M, 2003, J ORG CHEM, V68, P9340, DOI 10.1021/jo034255h; Calloway NO, 1935, CHEM REV, V17, P327, DOI 10.1021/cr60058a002; Bandini M, 2004, ANGEW CHEM INT EDIT, V43, P550, DOI 10.1002/anie.200301679; Qiu RH, 2012, CHEM-EUR J, V18, P6172, DOI 10.1002/chem.201103874; Goossen L, 2003, ADV SYNTH CATAL, V345, P943, DOI 10.1002/adsc.200303040; Ji Y, 2013, J ORG CHEM, V78, P11606, DOI 10.1021/jo401941v; Ollevier T, 2007, ORG BIOMOL CHEM, V5, P3126, DOI 10.1039/b710794c; Shibasaki M, 2002, CHEM REV, V102, P2187, DOI 10.1021/cr010297z; Yoon MY, 2007, ADV SYNTH CATAL, V349, P1725, DOI 10.1002/adsc.200700039; Li Z, 2014, J AM CHEM SOC, V136, P104, DOI 10.1021/ja411546r; Das B, 2007, HELV CHIM ACTA, V90, P105, DOI 10.1002/hlca.200790001; Qin HB, 2007, CHEM-ASIAN J, V2, P150, DOI 10.1002/asia.200600284; MATSUMOTO T, 1988, TETRAHEDRON LETT, V29, P6935, DOI 10.1016/S0040-4039(00)88479-8; Kawatsura M, 2007, TETRAHEDRON, V63, P4172, DOI 10.1016/j.tet.2007.02.091; Geiseler O, 2013, TETRAHEDRON, V69, P3683, DOI 10.1016/j.tet.2013.03.013; Yamamoto A, 2012, J AM CHEM SOC, V134, P893, DOI 10.1021/ja2108307; Noji M, 2007, J ORG CHEM, V72, P5161, DOI 10.1021/jo0705216; Sibi MP, 2000, TETRAHEDRON, V56, P8033; Boyer N, 2012, CHEM SCI, V3, P1798, DOI 10.1039/c2sc20270k; MATSUMOTO T, 1990, TETRAHEDRON LETT, V31, P4629, DOI 10.1016/S0040-4039(00)97693-7; Arrayas RG, 2009, CHEM SOC REV, V38, P1940, DOI 10.1039/b820303b; Song CE, 2004, ANGEW CHEM INT EDIT, V43, P6183, DOI 10.1002/anie.200460292; Azumaya I, 2004, SYNLETT, P959, DOI 10.1055/s-2004-822885; Bandini M., 2004, ANGEW CHEM, V116, P560, DOI 10.1002/ange.200301679; Barrett AGM, 2000, SYNLETT, P57; Bradley D. C., 1973, COMPREHENSIVE INORGA, V3, P419; Buzin P, 2008, MACROMOLECULES, V41, P8491, DOI 10.1021/ma8017662; Cardin D. J., 1982, COMPREHENSIVE ORGANO, V3, P559; de Leseleuc M, 2015, ACS CATAL, V5, P1462, DOI 10.1021/acscatal.5b00082; Effenberger F., 1972, ANGEW CHEM, V84, P295, DOI 10.1002/ange.19720840711; EFFENBER.F, 1972, ANGEW CHEM INT EDIT, V11, P300, DOI 10.1002/anie.197203001; Gualtierotti JB, 2014, ANGEW CHEM INT EDIT, V53, P9926, DOI 10.1002/anie.201405842; HACHIYA I, 1995, TETRAHEDRON LETT, V36, P409, DOI 10.1016/0040-4039(94)02221-V; HACHIYA I, 1995, B CHEM SOC JPN, V68, P2053, DOI 10.1246/bcsj.68.2053; Hao XH, 2006, CHEM LETT, V35, P1102, DOI 10.1246/cl.2006.1102; HARADA T, 1991, SYNTHESIS-STUTTGART, P1216; Isobe Y, 2001, J POLYM SCI POL CHEM, V39, P1463, DOI 10.1002/pola.1123; Kawamura M, 2006, TETRAHEDRON, V62, P9201, DOI 10.1016/j.tet.2006.07.031; Kawatsura M, 2005, SYNLETT, P2492, DOI 10.1055/s-2005-872694; Kobayashi S, 1996, TETRAHEDRON LETT, V37, P2053, DOI 10.1016/0040-4039(96)00216-X; Kobayashi S, 1997, SYNLETT, P1099; Kobayashi S, 2003, TETRAHEDRON LETT, V44, P3351, DOI 10.1016/S0040-4039(03)00606-3; Kobayashi S, 1996, TETRAHEDRON LETT, V37, P4183, DOI 10.1016/0040-4039(96)00790-3; Kobayashi S, 2001, SYNLETT, P983; Konishi S, 2010, POLYM BULL, V64, P435, DOI 10.1007/s00289-009-0148-6; Kricheldorf HR, 2012, MACROMOL CHEM PHYS, V213, P1482, DOI 10.1002/macp.201200061; Manabe K, 1999, J ORG CHEM, V64, P8054, DOI 10.1021/jo991009q; Manabe S, 2013, TETRAHEDRON LETT, V54, P6838, DOI 10.1016/j.tetlet.2013.10.011; Manabe S, 2013, J ORG CHEM, V78, P4568, DOI 10.1021/jo400282x; Marques M. M. B., 2006, ANGEW CHEM, V118, P356, DOI 10.1002/ange.200502630; Marques MMB, 2006, ANGEW CHEM INT EDIT, V45, P348, DOI 10.1002/anie.200502630; MATSUMOTO T, 1991, J AM CHEM SOC, V113, P6982, DOI 10.1021/ja00018a041; MATSUMOTO T, 1991, SYNLETT, P709; MATSUMOTO T, 1988, TETRAHEDRON LETT, V29, P3567, DOI 10.1016/0040-4039(88)85294-8; MATSUMOTO T, 1989, TETRAHEDRON LETT, V30, P6185, DOI 10.1016/S0040-4039(01)93337-4; MUKAIYAMA T, 1991, CHEM LETT, P1059, DOI 10.1246/cl.1991.1059; Nakajima M, 2003, TETRAHEDRON, V59, P7307, DOI 10.1016/S0040-4020(03)01139-6; Nakamura M, 2009, TETRAHEDRON LETT, V50, P6462, DOI 10.1016/j.tetlet.2009.08.120; Oohashi Y, 2005, CHEM LETT, V34, P190, DOI 10.1246/cl.2005.190; Oohashi Y, 2005, CHEM LETT, V34, P710, DOI 10.1246/cl.2005.710; Perin G, 2010, TETRAHEDRON LETT, V51, P4354, DOI 10.1016/j.tetlet.2010.06.049; Sakai N, 2009, SYNLETT, P1449, DOI 10.1055/s-0029-1216743; Sakai N, 2010, J ORG CHEM, V75, P3923, DOI [10.1021/jo1006043, 10.1021/jo.1006043]; Sakai N, 2007, SYNLETT, P2675, DOI 10.1055/s-2007-991060; Sakai N, 2008, TETRAHEDRON, V64, P9208, DOI 10.1016/j.tet.2008.07.052; Sakai N, 2003, J ORG CHEM, V68, P483, DOI 10.1021/jo026465k; Sartori G, 2006, CHEM REV, V106, P1077, DOI 10.1021/cr040695c; Sasada T, 2011, SYNLETT, P2029, DOI 10.1055/s-0030-1260978; Shiina I, 2002, TETRAHEDRON LETT, V43, P6395, DOI 10.1016/S0040-4039(02)01374-6; Song C.E., 2004, ANGEW CHEM, V116, P6309, DOI 10.1002/200460292; SUZUKI K, 1988, TETRAHEDRON LETT, V29, P3571, DOI 10.1016/0040-4039(88)85295-X; Suzuki K., 2000, LEWIS ACIDS ORGANIC, P849, DOI 10.1002/9783527618309.ch17; SUZUKI K, 1993, B CHEM SOC JPN, V66, P3729, DOI 10.1246/bcsj.66.3729; Tran PH, 2015, TETRAHEDRON LETT, V56, P612, DOI 10.1016/j.tetlet.2014.12.038; Waller FJ, 1998, TETRAHEDRON LETT, V39, P1641, DOI 10.1016/S0040-4039(97)10861-9; Weidner SM, 2013, MACROMOL CHEM PHYS, V214, P2043, DOI 10.1002/macp.201300279; Wu YC, 2011, ADV SYNTH CATAL, V353, P907, DOI 10.1002/adsc.201000930; Wu YC, 2008, J ORG CHEM, V73, P9522, DOI 10.1021/jo8021988; Wu YC, 2008, J AM CHEM SOC, V130, P7148, DOI 10.1021/ja800662q; Wu YC, 2009, J ORG CHEM, V74, P2046, DOI 10.1021/jo8027449; Yashiro T, 2010, MACROMOL CHEM PHYS, V211, P1311, DOI 10.1002/macp.200900662; Yoshimatsu M, 2010, TETRAHEDRON, V66, P7975, DOI 10.1016/j.tet.2010.08.015	87	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	SEP	2015		25					5485	5499		10.1002/ejoc.201500423		15	Chemistry, Organic	Chemistry	CP7JY	WOS:000360064500001		
J	Nakamoto, A; Kim, T; Hori, M; Onishi, H; Tsuboyama, T; Sakane, M; Tatsumi, M; Tomiyama, N				Nakamoto, Atsushi; Kim, Tonsok; Hori, Masatoshi; Onishi, Hiromitsu; Tsuboyama, Takahiro; Sakane, Makoto; Tatsumi, Mitsuaki; Tomiyama, Noriyuki			Clinical evaluation of image quality and radiation dose reduction in upper abdominal computed tomography using model-based iterative reconstruction; comparison with filtered back projection and adaptive statistical iterative reconstruction	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Computed tomography; Model-based iterative reconstruction; Dose reduction; Liver	LOW-TUBE-VOLTAGE; CT; ABDOMEN; DETECTABILITY; EXPOSURE; HYBRID; PURE; MBIR	Purpose: To evaluate the image quality of upper abdominal CT images reconstructed with model-based iterative reconstruction (MBIR) in comparison with filtered back projection (FBP) and adaptive statistical iterative reconstruction (ASIR) on scans acquired with various radiation exposure dose protocols. Materials and methods: This prospective study was approved by our institutional review board, and informed consent was obtained from all 90 patients who underwent both control-dose (CD) and reduceddose (RD) CT of the upper abdomen (unenhanced: n = 45, contrast-enhanced: n = 45). The RD scan protocol was randomly selected from three protocols; Protocol A: 12.5% dose, Protocol B: 25% dose, Protocol C: 50% dose. Objective image noise, signal-to-noise (SNR) ratio for the liver parenchyma, visual image score and lesion conspicuity were compared among CD images of FBP and RD images of FBP, ASIR and MBIR. Results: RD images of MBIR yielded significantly lower objective image noise and higher SNR compared with RD images of FBP and ASIR for all protocols (P < .01) and CD images of FBP for Protocol C (P < .05). Although the subjective image quality of RD images of MBIR was almost acceptable for Protocol C, it was inferior to that of CD images of FBP for Protocols A and B (P < .0083). The conspicuity of the small lesions in RD images of MBIR tended to be superior to that in RD images of FBP and ASIR and inferior to that in CD images for Protocols A and B, although the differences were not significant (P > .0083). Conclusion: Although 12.5%-dose MBIR images (mean size-specific dose estimates [SSDE] of 1.13 mGy) yielded objective image noise and SNR comparable to CD-FBP images, at least a 50% dose (mean SSDE of 4.63 mGy) would be needed to maintain the subjective image quality and the lesion conspicuity. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nakamoto, Atsushi; Kim, Tonsok; Hori, Masatoshi; Onishi, Hiromitsu; Tsuboyama, Takahiro; Sakane, Makoto; Tatsumi, Mitsuaki; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka 5650871, Japan	Nakamoto, A (reprint author), Osaka Univ, Grad Sch Med, Dept Radiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	a-nakamoto@radiol.med.osaka-u.ac.jp; kim@radiol.med.osaka-u.ac.jp; mhori@radiol.med.osaka-u.ac.jp; h-onishi@radiol.med.osaka-u.ac.jp; t-tsuboyama@radiol.med.osaka-u.ac.jp; m-sakane@radiol.med.osaka-u.ac.jp; m-tatsumi@radiol.med.osaka-u.ac.jp; tomiyama@radiol.med.osaka-u.ac.jp					AAPM Task Group 204 of Computer Tomography Subcommittee, 2011, SIZ SPEC DOS EST SSD; Mitsumori LM, 2012, EUR RADIOL, V22, P138, DOI 10.1007/s00330-011-2186-3; Deak Z, 2013, RADIOLOGY, V266, P197, DOI 10.1148/radiol.12112707; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Singh S, 2012, J COMPUT ASSIST TOMO, V36, P347, DOI 10.1097/RCT.0b013e31824e639e; Katsura M, 2013, EUR J RADIOL, V82, P356, DOI 10.1016/j.ejrad.2012.11.004; Katsura M, 2013, INVEST RADIOL, V48, P206, DOI 10.1097/RLI.0b013e31827efc3a; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI [10.1097/RLI.ob013e3181dzfeec, 10.1097/RLI.0b013e3181dzfeec]; Chang W, 2013, INVEST RADIOL, V48, P598, DOI 10.1097/RLI.0b013e3182899104; Lee S, 2011, ACTA RADIOL, V52, P1101, DOI 10.1258/ar.2011.100295; Funama Y, 2005, RADIOLOGY, V237, P905, DOI 10.1148/radiol.2373041643; Kalra MK, 2003, RADIOLOGY, V228, P251, DOI 10.1148/radiol.2281020693; Christner JA, 2012, RADIOLOGY, V265, P841, DOI 10.1148/radiol.12112365; Pickhardt PJ, 2012, AM J ROENTGENOL, V199, P1266, DOI 10.2214/AJR.12.9382; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Kalra MK, 2004, RADIOLOGY, V232; Kanal KM, 2007, AM J ROENTGENOL, V189, P219, DOI 10.2214/AJR.06.1524; Onishi H, 2006, RADIOLOGY, V239, P131, DOI 10.1148/radiol.2383041825; Volders David, 2013, Radiology, V269, P469, DOI 10.1148/radiol.13130002	23	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	SEP	2015	84	9					1715	1723		10.1016/j.ejrad.2015.05.027		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP1EI	WOS:000359618700013		
J	Jiang, BH; Takashima, S; Hakucho, T; Hodaka, N; Yasuhiko, T; Masahiko, H				Jiang, Binghu; Takashima, Shodayu; Hakucho, Tomoaki; Hodaka, Numasaki; Yasuhiko, Tomita; Masahiko, Higashiyama			Adenocarcinoma of the lung with scattered consolidation: Radiological-pathological correlation and prognosis (Retraction of vol 82, pg e623, 2013)	EUROPEAN JOURNAL OF RADIOLOGY			English	Correction									[Jiang, Binghu] Nanjing Med Univ, Thorac Med Ctr, Nanjing 210019, Jiangsu, Peoples R China; [Jiang, Binghu] Nanjing Med Univ, BenQ Hosp, Dept Radiol, Nanjing 210019, Jiangsu, Peoples R China; [Jiang, Binghu; Takashima, Shodayu; Hakucho, Tomoaki; Hodaka, Numasaki] Osaka Univ, Grad Sch Med, Dept Diagnost Radiol Imaging, Div Allied Hlth Sci, Suita, Osaka 5650871, Japan; [Yasuhiko, Tomita; Masahiko, Higashiyama] Osaka Med Ctr Canc & Cardiovasc Dis, Higashinari Ku, Osaka 5370025, Japan	Jiang, BH (reprint author), Osaka Univ, Grad Sch Med, Dept Diagnost Radiol Imaging, Div Allied Hlth Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	mbhh@live.cn					Jiang BH, 2013, EUR J RADIOL, V82, pE623, DOI 10.1016/j.ejrad.2013.06.010	1	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	SEP	2015	84	9					1828	1828		10.1016/j.ejrad.2015.06.007		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP1EI	WOS:000359618700029		
J	Shingyochi, Y; Orbay, H; Mizunot, H				Shingyochi, Yoshiaki; Orbay, Hakan; Mizunot, Hiroshi			Adipose-derived stem cells for wound repair and regeneration	EXPERT OPINION ON BIOLOGICAL THERAPY			English	Review						adipose-derived stem cells; clinical trials; growth factors; regeneration; wound healing	HUMAN DERMAL FIBROBLASTS; STROMAL CELLS; POSTNATAL NEOVASCULARIZATION; CLINICAL-TRIAL; LIMB ISCHEMIA; IN-VIVO; TISSUE; MODEL; TRANSPLANTATION; THERAPY	Introduction: The use of undifferentiated cells for cell-based tissue repair and regeneration strategies represents a promising approach for chronic wound healing. Multipotent adult stem cells isolated from adipose tissue, termed adipose-derived stem cells (ASCs), appear to be an ideal population of stem cells because they are autologous, non-immunogenic, plentiful, and easily obtained. Both preclinical and clinical studies have revealed that ASCs have potential for wound healing due to the mechanisms described below. Areas covered: Both in vitro and in vivo studies demonstrated that ASCs not only differentiate into keratinocytes, fibroblasts, and endothelial cells, as evidenced by their morphology, expression of cell surface markers, and gene expression, but also secrete several soluble factors, which positively contribute to wound healing in a paracrine manner. Clinical trials have been conducted using autologous ASCs with great success. Expert opinion: There remain many concerns regarding the use of ASCs, including how these cells act as precursors of keratinocytes, fibroblasts, and endothelial cells, or as a secretion vehicle of soluble factors. Further studies are necessary to establish the optimal strategy for the treatment of chronic wounds in patients with different disease backgrounds.	[Shingyochi, Yoshiaki] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138421, Japan; [Orbay, Hakan] Univ Calif Davis, Med Ctr, Div Plast & Reconstruct Surg, Sacramento, CA 95817 USA; [Mizunot, Hiroshi] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138421, Japan	Mizunot, H (reprint author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hmizuno@juntendo.ac.jp					Akita S, 2010, STEM CELLS INT, V2010; Akita S, 2012, RADIAT PROT DOSIM, V151, P656, DOI 10.1093/rpd/ncs176; Mert T, 2015, INFLAMMATION, V38, P1302, DOI 10.1007/s10753-014-0101-1; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Takami T, 2012, CURR OPIN GASTROEN, V28, P203, DOI 10.1097/MOG.0b013e3283521d6a; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Kim EK, 2011, PLAST RECONSTR SURG, V128, P387, DOI 10.1097/PRS.0b013e31821e6de2; Zhao JJ, 2013, BIOMED RES INT, DOI 10.1155/2013/578479; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Honmou O, 2012, TRENDS MOL MED, V18, P292, DOI 10.1016/j.molmed.2012.02.003; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Bura A, 2014, CYTOTHERAPY, V16, P245, DOI 10.1016/j.jcyt.2013.11.011; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Altman AM, 2008, BIOMATERIALS, V29, P1431, DOI 10.1016/j.biomaterials.2007.11.026; Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Yamamoto T, 2010, INT J UROL, V17, P75, DOI 10.1111/j.1442-2042.2009.02429.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Yoshimura K, 2008, TRANSPLANTATION, V85, P1868, DOI 10.1097/TP.0b013e3181775136; Collawn SS, 2012, ANN PLAS SURG, V68, P501, DOI 10.1097/SAP.0b013e31823b69fc; Atalay S, 2014, BURNS, V40, P1375, DOI 10.1016/j.burns.2014.01.023; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Kakudo N, 2008, PLAST RECONSTR SURG, V122, P1352, DOI 10.1097/PRS.0b013e3181882046; Garcia-Olmo D, 2009, INT J COLORECTAL DIS, V24, P27, DOI 10.1007/s00384-008-0559-0; Nambu M, 2009, ANN PLAS SURG, V62, P317, DOI 10.1097/SAP.0b013e31817f01b6; Badillo AT, 2007, CELL TISSUE RES, V329, P301, DOI 10.1007/s00441-007-0417-3; Blanton MW, 2009, PLAST RECONSTR SURG, V23, P56, DOI DOI 10.1097/PRS; Diez-Tejedor E, 2014, J STROKE CEREBROVASC, V23, P2694, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.011; Garcia-Olmo D, 2010, CASE REPORT MED, V2010, DOI DOI 10.1155/2010/961758; Hasegawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118402; Hassan Waqar Ul, 2014, Wound Repair Regen, V22, P313, DOI 10.1111/wrr.12173; Heo SC, 2011, J INVEST DERMATOL, V131, P1559, DOI 10.1038/jid.2011.64; Hu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092676; Huang SP, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-51; Ichioka S, 2009, WOUND REPAIR REGEN, V17, P492, DOI 10.1111/j.1524-475X.2009.00508.x; Jeong JH, 2010, CURR STEM CELL RES T, V5, P137; Ko SH, 2011, PLAST RECONSTR SURG, V127, P10; Kouraba S, 2006, J JPN PLAST RECONSTR, V26, P825; Mizuno H, 2006, J JPN PLAST RECONSTR, V26, P726; Perin EC, 2014, AM HEART J, V168, P88; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1423; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Sivan Unnikrishnan, 2014, Biores Open Access, V3, P339, DOI 10.1089/biores.2014.0036; Sumi M, 2007, LIFE SCI, V80, P559, DOI 10.1016/j.lfs.2006.10.020; Uysal CA, 2014, ADV WOUND CARE NEW R, V3, P405; Zheng GP, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-39	58	2	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1471-2598	1744-7682		EXPERT OPIN BIOL TH	Expert Opin. Biol. Ther.	SEP	2015	15	9					1285	1292		10.1517/14712598.2015.1053867		8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CP4UT	WOS:000359878800004		
J	Kadoya, H; Satoh, M; Sasaki, T; Taniguchi, S; Takahashi, M; Kashihara, N				Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Taniguchi, Shun'ichiro; Takahashi, Masafumi; Kashihara, Naoki			Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice	FASEB JOURNAL			English	Article						chronic inflammation; kidney; mineralocorticoid receptor; mitochondria; reactive oxygen species	CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; OXIDATIVE STRESS; ANGIOTENSIN-II; INJURY; DEFICIENCY; PROMOTES; PROTEIN; ASC; NLRP3-INFLAMMASOME	High levels of aldosterone impair renal function by activating proinflammatory and profibrotic pathways. However, the molecular mechanism underlying aldosterone-induced inflammation and fibrosis is unknown. Inflammasome activation contributes to chronic kidney disease. We hypothesized that aldosterone induces renal tubulointerstitial inflammation and fibrosis by activating the inflammasome. Infusing wild-type mice with aldosterone (0.25 mg/kg/d) caused tubulointerstitial damage, increased expression of inflammasome components, caspase 1 activation, and overproduction of IL-1 beta and IL-18. These changes were suppressed by eplerenone treatment (100 mg/kg/d) in wild-type mice or in mice deficient in apoptosis-associated speck-like protein with a caspase-recruitment domain (ASC). Caspase 1-positive and F4/80-positive cells colocalized in the interstitium. Bone marrow transplantation using ASC-deficient mice indicated that inflammasome activation in macrophages mediated aldosterone-induced renal fibrosis. IL-18 was detected in culture supernatants of macrophages treated with aldosterone, and mitochondria-derived reactive oxygen species activated the inflammasome in these macrophages. Our results indicate that exposure of macrophages to high levels of aldosterone resulted in the activation of inflammasomes via the mitochondria-derived reactive oxygen species. Thus, inflammasome activation in macrophages may serve as a new therapeutic target for chronic kidney disease.	[Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Kashihara, Naoki] Kawasaki Med Univ, Dept Hypertens & Nephrol, Kurashiki, Okayama 7010192, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Matsumoto, Nagano 390, Japan; [Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan	Satoh, M (reprint author), Kawasaki Med Univ, Dept Hypertens & Nephrol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	msatoh@med.kawasaki-m.ac.jp			Japan Society for the Promotion of Science [24390218, 24591220]	The authors thank E. Yorimasa and M. Yokohata for animal care, S. Hanada and K. Satoh (Kawasaki Medical School) for their help with in vitro assays, and M. Takahashi (Jichi Medical University) for invaluable research advice. This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24390218 to N.K. and 24591220 to M.S.).	Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Dooley R, 2012, MOL CELL ENDOCRINOL, V350, P223, DOI 10.1016/j.mce.2011.07.019; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Nakamura T, 2009, HYPERTENSION, V54, P544, DOI 10.1161/HYPERTENSIONAHA.109.135392; Irita J, 2011, AM J PHYSIOL-RENAL, V301, pF833, DOI 10.1152/ajprenal.00557.2010; Schjoedt KJ, 2004, DIABETOLOGIA, V47, P1936, DOI 10.1007/s00125-004-1542-0; McCurley A, 2012, NAT MED, V18, P1429, DOI 10.1038/nm.2891; Wuhl E, 2011, NAT REV NEPHROL, V7, P434, DOI 10.1038/nrneph.2011.73; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Han SY, 2006, J AM SOC NEPHROL, V17, P1362, DOI 10.1681/ASN.2005111196; Bomback AS, 2007, NAT CLIN PRACT NEPHR, V3, P486, DOI 10.1038/ncpneph0575; Yoneda T, 2007, AM J HYPERTENS, V20, P1329, DOI 10.1016/j.amjhyper.2007.09.001; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Luther JM, 2012, KIDNEY INT, V82, P643, DOI 10.1038/ki.2012.170; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Luo P, 2013, DIABETOLOGIA, V56, P901, DOI 10.1007/s00125-012-2814-8; Lee SH, 2009, AM J PHYSIOL-RENAL, V297, pF1381, DOI 10.1152/ajprenal.00101.2009; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D; Quinn S, 2014, STEROIDS, V81, P43, DOI 10.1016/j.steroids.2013.11.005; Kuwabara A, 2010, DIABETOLOGIA, V53, P2056, DOI 10.1007/s00125-010-1810-0; Jiang YG, 2012, BIOCHEM BIOPH RES CO, V425, P121, DOI 10.1016/j.bbrc.2012.07.011; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Guney I, 2009, RENAL FAILURE, V31, P779, DOI 10.3109/08860220903150312; Hagiwara H, 2006, FEBS LETT, V580, P4463, DOI 10.1016/j.febslet.2006.07.015; Luheshi NM, 2012, EUR J IMMUNOL, V42, P716, DOI 10.1002/eji.201142079; Nagasu H, 2012, AM J PHYSIOL-RENAL, V302, pF1402, DOI 10.1152/ajprenal.00459.2011; Nolly MB, 2014, J MOL CELL CARDIOL, V67, P60, DOI 10.1016/j.yjmcc.2013.12.004; Ptinopoulou AG, 2013, HYPERTENS RES, V36, P91, DOI 10.1038/hr.2012.157; Remuzzi G, 2008, J AM SOC NEPHROL, V19, P1459, DOI 10.1681/ASN.2007101079; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Tokuyama H, 2012, INT J OBESITY, V36, P1062, DOI 10.1038/ijo.2011.232; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688	43	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3899	3910		10.1096/fj.15-271734		12	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	WOS:000359915600025		
J	Bhat, HB; Ishitsuka, R; Inaba, T; Murate, M; Abe, M; Makino, A; Kohyama-Koganeya, A; Nagao, K; Kurahashi, A; Kishimoto, T; Tahara, M; Yamano, A; Nagamune, K; Hirabayashi, Y; Juni, N; Umeda, M; Fujimori, F; Nishibori, K; Yamaji-Hasegawa, A; Greimel, P; Kobayashi, T				Bhat, Hema Balakrishna; Ishitsuka, Reiko; Inaba, Takehiko; Murate, Motohide; Abe, Mitsuhiro; Makino, Asami; Kohyama-Koganeya, Ayako; Nagao, Kohjiro; Kurahashi, Atsushi; Kishimoto, Takuma; Tahara, Michiru; Yamano, Akinori; Nagamune, Kisaburo; Hirabayashi, Yoshio; Juni, Naoto; Umeda, Masato; Fujimori, Fumihiro; Nishibori, Kozo; Yamaji-Hasegawa, Akiko; Greimel, Peter; Kobayashi, Toshihide			Evaluation of aegerolysins as novel tools to detect and visualize ceramide phosphoethanolamine, a major sphingolipid in invertebrates	FASEB JOURNAL			English	Article						lipid binding protein; membrane lipids; poreforming toxins	RICH MEMBRANE DOMAINS; LIPID DOMAINS; PLEUROTUS-ERYNGII; EDIBLE MUSHROOM; SPHINGOMYELIN; CHOLESTEROL; BINDING; DROSOPHILA; REVEALS; PROTEIN	Ceramide phosphoethanolamine (CPE), a sphingomyelin analog, is a major sphingolipid in invertebrates and parasites, whereas only trace amounts are present in mammalian cells. In this study, mushroom-derived proteins of the aegerolysin family-pleurotolysin A2 (PlyA2; K-D = 12 nM), ostreolysin (Oly; K-D = 1.3 nM), and erylysin A (EryA; K-D = 1.3 nM)-strongly associated with CPE/cholesterol (Chol)-containing membranes, whereas their low affinity to sphingomyelin/Chol precluded establishment of the binding kinetics. Binding specificity was determined by multilamellar liposome binding assays, supported bilayer assays, and solid-phase studies against a series of neutral and negatively charged lipid classes mixed 1:1 with Chol or phosphatidylcholine. No cross-reactivity was detected with phosphatidylethanolamine. Only PlyA2 also associated with CPE, independent of Chol content (K-D = 41 mu M), rendering it a suitable tool for visualizing CPE in lipid-blotting experiments and biologic samples from sterol auxotrophic organisms. Visualization of CPE enrichment in the CNS of Drosophila larvae (by PlyA2) and in the bloodstream form of the parasite Trypanosoma brucei (by EryA) by fluorescence imaging demonstrated the versatility of aegerolysin family proteins as efficient tools for detecting and visualizing CPE.	[Bhat, Hema Balakrishna; Ishitsuka, Reiko; Inaba, Takehiko; Murate, Motohide; Abe, Mitsuhiro; Makino, Asami; Kishimoto, Takuma; Yamaji-Hasegawa, Akiko; Greimel, Peter; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Kohyama-Koganeya, Ayako; Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama 3510198, Japan; [Nagao, Kohjiro; Juni, Naoto; Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Kurahashi, Atsushi; Nishibori, Kozo] Yukiguni Maitake Co Ltd, Niigata, Japan; [Tahara, Michiru; Nagamune, Kisaburo] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan; [Yamano, Akinori; Nagamune, Kisaburo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Nagamune, Kisaburo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Fujimori, Fumihiro] Tokyo Kasei Univ, Fac Human Life Sci, Dept Environm Sci & Educ, Tokyo, Japan; [Kobayashi, Toshihide] Univ Lyon 1, INSERM, U1060, F-69622 Villeurbanne, France	Kobayashi, T (reprint author), RIKEN, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kobayasi@riken.jp			Integrated Lipidology Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan [24790104, 23590251, 23790115, 24770135, 22390018, 25293015]; Naito Foundation	This work was supported by the Integrated Lipidology Program of RIKEN; and by Grants in Aid for Scientific Research 24790104 (to R.I.), 23590251 (to M.M.), 23790115 (to A.M.), 24770135 (to T.Ki.), and 22390018 and 25293015 (to T.Ko.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by the Naito Foundation.	Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Abeytunga DTU, 2004, J LIPID RES, V45, P1221, DOI 10.1194/jlr.M300392-JLR200; Kraut R, 2011, J NEUROCHEM, V116, P764, DOI 10.1111/j.1471-4159.2010.07022.x; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Kellermann MY, 2012, ORG GEOCHEM, V43, P112, DOI 10.1016/j.orggeochem.2011.10.005; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; Weber DK, 2015, BIOPHYS J, V108, P1987, DOI 10.1016/j.bpj.2015.03.024; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Lebars I, 2008, NUCLEIC ACIDS RES, V36, P7146, DOI 10.1093/nar/gkn831; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; Murate M, 2015, J CELL SCI, V128, P1627, DOI 10.1242/jcs.163105; Sepcic K, 2004, FEBS LETT, V575, P81, DOI 10.1016/j.febslet.2004.07.093; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Ghosh A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003980; HORI T, 1967, J BIOCHEM-TOKYO, V62, P67; Hursey B. S., 1995, World Animal Review, P67; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; KUZOE FAS, 1993, ACTA TROP, V54, P153, DOI 10.1016/0001-706X(93)90089-T; Lukoyanova N, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002049; Makino A, 2015, FASEB J, V29, P477, DOI 10.1096/fj.13-247585; Murate M, 2010, BIOCHEMISTRY-US, V49, P4732, DOI 10.1021/bi100007u; O'Connor J. D, 1970, Biochim. biophys. Acta, V202, P195, DOI 10.1016/0005-2760(70)90234-1; Shibata T, 2010, TOXICON, V56, P1436, DOI 10.1016/j.toxicon.2010.08.010; Skocaj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092783; Terova B, 2005, BIOPHYS J, V88, P2661, DOI 10.1529/biophysj.104.058149; Vacaru AM, 2013, J BIOL CHEM, V288, P11520, DOI 10.1074/jbc.M113.460972; WHITE DC, 1969, BIOCHIM BIOPHYS ACTA, V187, P527, DOI 10.1016/0005-2760(69)90050-2; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; YANG TK, 1974, LIPIDS, V9, P1009, DOI 10.1007/BF02533827	40	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3920	3934		10.1096/fj.15-272112		15	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	WOS:000359915600027		
J	Hirota, S; Takahama, U				Hirota, Sachiko; Takahama, Umeo			Reactions of polyphenols in masticated apple fruit with nitrite under stomach simulating conditions: Formation of nitroso compounds and thiocyanate conjugates	FOOD RESEARCH INTERNATIONAL			English	Article						Nitrite; Nitrosation of catechins; Polyphenols; Stomach; Thiocyanate conjugate of chlorogenic acid	ACIDIC CONDITIONS; ETHYL NITRITE; CAFFEIC ACID; HUMAN SALIVA; OXIDE; PROCYANIDINS; MIXTURE; IDENTIFICATION; (+)-CATECHIN; DERIVATIVES	By the ingestion of fresh apple fruit, it is masticated squeezing apple juice into the oral cavity and the juice is mixed with saliva. The mixture of saliva and apple juice is swallowed into the stomach where the pH is around 2. This paper deals with the reactions of polyphenols in the juice obtained by mastication of apple fruit with salivary nitrite under acidic conditions. The concentrations of catechins, procyanidins, and chlorogenic acid in the apple juice were approximately 55, 55, and 170 mu M, respectively, and the polyphenols were oxidized by salivary nitrite under conditions of the stomach. Rates of the oxidation increased in order chlorogenic acid < catechins < procyanidins. The oxidation of catechins and procyanidins resulted in the formation of the nitroso compounds, and the oxidation of chlorogenic acid resulted in the formation of the thiocyanate conjugate. The production of dinitroso compounds is proposed to be due to the addition of nitric oxide (NO) to radicals of catechins and procyanidins. As the mechanism of thiocyanate conjugate formation, reaction of o-quinone of chlorogenic add with a salivary component thiocyanate is proposed, and the formation of the thiocyanate conjugate is discussed from the point of detoxification of chlorogenic acid quinone. (C) 2015 Elsevier Ltd. All rights reserved.	[Hirota, Sachiko; Takahama, Umeo] Univ E Asia, Fac Appl Hlth Sci, Dept Hlth & Nutr Care, Shimonoseki, Yamaguchi 7518503, Japan; [Takahama, Umeo] Kyushu Dent Univ, Dept Biosci, Kitakyushu, Fukuoka 8038580, Japan	Takahama, U (reprint author), Univ E Asia, Fac Appl Hlth Sci, Dept Hlth & Nutr Care, Shimonoseki, Yamaguchi 7518503, Japan.	takahama@toua-u.ac.jp			Ministry of Education and Science in Japan [22500790, 23500986]	A part of this study was supported by Grants-in-Aid for Scientific Research (22500790 and 23500986) from the Ministry of Education and Science in Japan.	Degen LP, 1996, GUT, V39, P299, DOI 10.1136/gut.39.2.299; CAMILLERI M, 1989, AM J PHYSIOL, V257, pG284; Foo LY, 1999, FOOD CHEM, V64, P511; Tsuge K, 2000, J HEALTH SCI, V46, P343; Rocha BS, 2014, FOOD FUNCT, V5, P1646, DOI [10.1039/c4fo00124a, 10.1039/C4FO00124A]; Lee SYH, 2006, FREE RADICAL BIO MED, V40, P323, DOI 10.1016/j.freeadbiomed.2005.08.031; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, P156, DOI 10.1038/nrd2466; Takahama U, 2014, FREE RADICAL RES, V48, P956, DOI 10.3109/10715762.2014.929121; Hirota S, 2014, FOOD SCI TECHNOL RES, V20, P439, DOI 10.3136/fstr.20.439; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7; Peri L, 2005, FREE RADICAL BIO MED, V39, P668, DOI 10.1016/j.freeradbiomed.2005.04.021; Shoji T, 2003, J AGR FOOD CHEM, V51, P3806, DOI 10.1021/jf0300184; Panzella L, 2005, CHEM RES TOXICOL, V18, P722, DOI 10.1021/tx0496486; Egert S, 2011, ADV NUTR, V2, P8, DOI [10.3945/an.110.000026., 10.3945/an.110.000026]; Pannala AS, 2003, FREE RADICAL BIO MED, V34, P576, DOI 10.1016/S0891-5849(02)01353-9; Takahama U, 2010, FREE RADICAL RES, V44, P293, DOI 10.3109/10715760903486057; Muselik J, 2007, INT J MOL SCI, V8, P797, DOI 10.3390/i8080797; Morina F, 2015, FOOD FUNCT, V6, P219, DOI 10.1039/c4fo00695j; Takahama U, 2007, J AGR FOOD CHEM, V55, P4169, DOI 10.1021/jf0634606; Cotelle P, 2001, TETRAHEDRON LETT, V42, P3303, DOI 10.1016/S0040-4039(01)00441-5; Gago B, 2008, FREE RADICAL BIO MED, V45, P404, DOI 10.1016/j.freeradbiomed.2008.04.027; Hirota S, 2005, J AGR FOOD CHEM, V53, P3265, DOI 10.1021/jf0404389; Kochar NI, 2011, INT J PHARMACOL, V7, P31, DOI 10.3923/ijp.2011.31.39; Veljovic-Jovanovic S, 2014, J AGR FOOD CHEM, V62, P4951, DOI 10.1021/jf500860s; Takahama U, 2009, FOOD CHEM, V116, P214, DOI 10.1016/j.foodchem.2009.02.036; Takahama U, 2003, FEBS LETT, V550, P64, DOI 10.1016/S0014-5793(03)00820-2; Takahama U, 2007, FREE RADICAL RES, V41, P627, DOI 10.1080/10715760701218566; Xiao JS, 2008, J AGR FOOD CHEM, V56, P2096, DOI 10.1021/jf072679x	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0963-9969	1873-7145		FOOD RES INT	Food Res. Int.	SEP	2015	75						20	26		10.1016/j.foodres.2015.05.018		7	Food Science & Technology	Food Science & Technology	CP5YP	WOS:000359961800004		
J	Jarunglumlert, T; Nakagawa, K; Adachi, S				Jarunglumlert, Teeraya; Nakagawa, Kyuya; Adachi, Shuji			Digestibility and structural parameters of spray-dried casein clusters under simulated gastric conditions	FOOD RESEARCH INTERNATIONAL			English	Article						Encapsulation; Casein; Sodium caseinate; Digestion; Small-angle X-ray scattering; Ultra-small-angle X-ray scattering	IN-VITRO DIGESTION; SURFACE HYDROPHOBICITY; BETA-LACTOGLOBULIN; STABILIZED EMULSIONS; WHEY-PROTEIN; BOVINE; RELEASE; ENCAPSULATION; MICELLE; TEMPERATURE	The digestibility of casein clusters prepared from sodium caseinate solution (plain or pH-adjusted (pH = 6.0)) was studied. The prepared solutions were spray-dried at different inlet air temperatures (150 degrees C and 180 degrees C), and the properties (i.e. encapsulation efficiency, surface hydrophobicity, and digestibility) of the resultant powders were investigated. The specimens obtained from the pH-adjusted solution had higher encapsulation efficiencies than the specimens obtained from the plain solution. A higher spray-drying temperature resulted in lower encapsulation efficiencies and higher surface hydrophobicities. Simulated gastric digestion tests were carried out to study the digestibility of the obtained casein clusters, which was analyzed in terms of reaction kinetics and structural changes during digestion. The effects of drying temperature and pH on the amount of casein digested were not significant; that is, approximately 30% of casein was digested in 120 min for all specimens. Small-angle and ultra-small-angle X-ray scattering measurements were used to analyze the structure of the obtained clusters and their changes during digestion. The results suggested that all the obtained casein clusters, with an average size of approximately 428 nm, had a rough, fractal-structured surface with many dense primary clusters. These structures changed during digestion; specifically, the cluster size increased both in the overall diameter and on the primary structure scale. The fractal characteristics changed from surface to mass fractals, and simultaneously, the cluster density decreased. The drying temperature affected the cluster size during digestion, and the trends were different in the specimens obtained from the plain and pH-adjusted solutions. These results could be useful in the design of protein-based encapsulation systems with desirable digestibility and bioavailability. (C) 2015 Elsevier Ltd. All rights reserved.	[Jarunglumlert, Teeraya] Univ Hyogo, Dept Mech & Syst Engn, Himeji, Hyogo 6712280, Japan; [Jarunglumlert, Teeraya; Nakagawa, Kyuya; Adachi, Shuji] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan	Nakagawa, K (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan.	kyuya@kais.kyoto-u.ac.jp					Agudelo RA, 2004, J SCI FOOD AGR, V84, P325, DOI 10.1002/jsfa.1662; Yazdi SR, 2012, FOOD CHEM, V132, P1143, DOI 10.1016/j.foodchem.2011.11.019; Fox PF, 2008, INT DAIRY J, V18, P677, DOI 10.1016/j.idairyj.2008.03.002; Farrell HM, 2002, J PROTEIN CHEM, V21, P307; Sava N, 2005, J DAIRY SCI, V88, P1646; Quek SY, 2007, CHEM ENG PROCESS, V46, P386, DOI 10.1016/j.cep.2006.06.020; Roccia P, 2014, POWDER TECHNOL, V254, P307, DOI 10.1016/j.powtec.2014.01.044; Zhang F, 2010, POLYM REV, V50, P59, DOI 10.1080/15583720903503486; Alizadeh-Pasdar N, 2000, J AGR FOOD CHEM, V48, P328, DOI 10.1021/jf990393p; Heidebach T, 2009, INT DAIRY J, V19, P77, DOI 10.1016/j.idairyj.2008.08.003; Marchin S, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2409933; Zhang S, 2014, FOOD FUNCT, V5, P102, DOI 10.1039/c3fo60331h; Pan K, 2013, J AGR FOOD CHEM, V61, P6036, DOI 10.1021/jf400752a; Flores FP, 2015, FOOD CHEM, V168, P225, DOI 10.1016/j.foodchem.2014.07.059; McClements DJ, 2010, FOOD FUNCT, V1, P32, DOI 10.1039/c0fo00111b; Nag A, 2011, INT DAIRY J, V21, P247, DOI 10.1016/j.idairyj.2010.11.002; Walstra P, 1999, INT DAIRY J, V9, P189, DOI 10.1016/S0958-6946(99)00059-X; VOUTSINAS LP, 1983, J FOOD SCI, V48, P26, DOI 10.1111/j.1365-2621.1983.tb14781.x; Liu WL, 2015, FOOD CHEM, V175, P16, DOI 10.1016/j.foodchem.2014.11.108; WATANABE A, 1994, CHEM PHARM BULL, V42, P1642; Risso PH, 2008, COLLOID POLYM SCI, V286, P1369, DOI 10.1007/s00396-008-1906-y; Burgain J, 2013, INNOV FOOD SCI EMERG, V19, P233, DOI 10.1016/j.ifset.2013.04.012; FRELTOFT T, 1986, PHYS REV B, V33, P269, DOI 10.1103/PhysRevB.33.269; Mackie A, 2010, CURR OPIN COLLOID IN, V15, P102, DOI 10.1016/j.cocis.2009.11.005; Dupont D, 2010, MOL NUTR FOOD RES, V54, P1677, DOI 10.1002/mnfr.200900582; Pignon F, 2004, J CHEM PHYS, V121, P8138, DOI 10.1063/1.1800931; SORENSEN CM, 1992, LANGMUIR, V8, P2064, DOI 10.1021/la00044a029; Elzoghby AO, 2011, J CONTROL RELEASE, V153, P206, DOI 10.1016/j.jconrel.2011.02.010; Holt C, 2013, J DAIRY SCI, V96, P6127, DOI 10.3168/jds.2013-6831; Sauer A, 2012, J DAIRY SCI, V95, P6339, DOI 10.3168/jds.2012-5706; Mandalari G, 2009, REGUL TOXICOL PHARM, V55, P372, DOI 10.1016/j.yrtph.2009.08.010; Ao J, 2013, FOOD RES INT, V52, P334, DOI 10.1016/j.foodres.2013.03.036; Livney YD, 2010, CURR OPIN COLLOID IN, V15, P73, DOI 10.1016/j.cocis.2009.11.002; Li J, 2012, FOOD FUNCT, V3, P320, DOI 10.1039/c2fo10242k; Qi PX, 2004, PROTEIN J, V23, P389, DOI 10.1023/B:JOPC.0000039553.66233.3f; Shu B, 2006, J FOOD ENG, V76, P664, DOI 10.1016/j.jfoodeng.2005.05.062; Singh H, 2013, CURR OPIN COLLOID IN, V18, P360, DOI 10.1016/j.cocis.2013.04.006; Augustin MA, 2014, FOOD FUNCT, V5, P2905, DOI 10.1039/c4fo00743c; Elzoghby AO, 2013, INT J NANOMED, V8, P1721, DOI 10.2147/IJN.S40674; Euston SR, 2007, FOOD HYDROCOLLOID, V21, P1081, DOI 10.1016/j.foodhyd.2006.07.018; EYNARD L, 1992, J AGR FOOD CHEM, V40, P1731, DOI 10.1021/jf00022a002; Fox P. F., 2003, ADV DAIRY CHEM; Goula AM, 2005, LWT-FOOD SCI TECHNOL, V38, P479, DOI 10.1016/j.lwt.2004.07.020; Guri A., 2014, Food Digestion, V5, P8; HAYAKAWA S, 1985, CAN I FOOD SC TECH J, V18, P290; Inglingstad RA, 2010, DAIRY SCI TECHNOL, V90, P549, DOI 10.1051/dst/2010018; Ixtaina V.Y., 2015, POWDER TECHNOL, V27, P126; Jarunglumlert T, 2013, DRY TECHNOL, V31, P1459, DOI 10.1080/07373937.2013.800548; LATHA MS, 1995, J CONTROL RELEASE, V34, P1, DOI 10.1016/0168-3659(94)00088-C; McMahon DJ, 1998, J DAIRY SCI, V81, P2985; Menendez-Aguirre O., 2011, HIGH PRESSURE RES, V31, P265; MILLAR FC, 1993, INT J PHARM, V92, P97, DOI 10.1016/0378-5173(93)90268-K; Nakagawa K., 2014, JAPAN J FOOD ENG, V15, P51; NAKAI S, 1983, J AGR FOOD CHEM, V31, P676, DOI 10.1021/jf00118a001; Pai DA, 2015, J FOOD ENG, V161, P68, DOI 10.1016/j.jfoodeng.2015.03.037; Qi W, 2007, J DAIRY SCI, V90, P5004, DOI 10.3168/jds.2007-0230; Shanmugam VP, 2015, INT DAIRY J, V42, P1, DOI 10.1016/j.idairyj.2014.11.001; Shapira A, 2012, EUR J PHARM BIOPHARM, V80, P298, DOI 10.1016/j.ejpb.2011.10.022; SHIMIZU M, 1985, AGR BIOL CHEM TOKYO, V49, P189; TAKAHASHI S, 1978, J BIOCHEM-TOKYO, V83, P57; Tuyen C. K., 2010, J FOOD ENG, V98, P385; Yuksel Z, 2005, J FOOD ENG, V67, P301, DOI 10.1016/j.jfoodeng.2004.04.032	62	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0963-9969	1873-7145		FOOD RES INT	Food Res. Int.	SEP	2015	75						166	173		10.1016/j.foodres.2015.05.049		8	Food Science & Technology	Food Science & Technology	CP5YP	WOS:000359961800021		
J	Rahim, ATMA; Takahashi, Y; Yamaki, K				Rahim, Abu Torab M. A.; Takahashi, Yoko; Yamaki, Kohji			Mode of pancreatic lipase inhibition activity in vitro by some flavonoids and non-flavonoid polyphenols	FOOD RESEARCH INTERNATIONAL			English	Article						Lipase; IC50 value; Double-reciprocal plot; Inhibition mode; Ki	TEA POLYPHENOLS; PLANT-EXTRACTS; GREEN TEA; ABSORPTION; ANTHOCYANINS; PROCYANIDINS	Numerous reports have shown plant metabolites as potential inhibitors of pancreatic lipase (PL). The most notable group is plant polyphenols. However, a limited number of reports diagnosed their mode of inhibition delineating conflicting results. To elucidate the kinetic mode of PL inhibition, some selected flavonoid and nonflavonoid polyphenol standards were first screened for their lipase inhibition potency by their half maximal inhibitory concentration (IC50) followed by inhibition kinetic analysis. Of the phenolics tested, only gallic acid (GA) and galloyl moiety containing epicatechin, viz., epigallocatechin (EGC) and epigallocatechin gallate (EGCG) showed, comparative to others, higher PL inhibitions (IC50, 387.2, 2373, and 391.2 mu M respectively). Analysis of enzyme inhibition modalities at various substrate concentrations revealed a dose-dependent inhibition of reaction velocity. Inhibitory rates decreased by the order of EGCG> EGC> GA (Ki, 13.29 > 35.0 > 44.61 mu M respectively). The results, when verified by visual inspection of Lineweaver-Burk as well as Dixon plots, showed inhibitions of PL by GA, EGC, and EGCG that were best fit to competitive inhibitions. A role of the galloyl moiety in enzyme-inhibitor binding has been evident from their structural resemblance. Depicting it further, ethyl gallate (EG), showed a similar competitive inhibition, therefore, indicating a galloyl moiety driven competitive inhibition of PL. (C) 2015 Elsevier Ltd. All rights reserved.	[Rahim, Abu Torab M. A.; Takahashi, Yoko; Yamaki, Kohji] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Rahim, Abu Torab M. A.] Univ Dhaka, Inst Nutr & Food Sci, Dhaka 1000, Bangladesh	Yamaki, K (reprint author), 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	kyamaki@affrc.go.jp			Kirin Holdings Co., Ltd. Tokyo, Japan under UNU-Kirin Fellowship Programme	This research work was supported by Kirin Holdings Co., Ltd. Tokyo, Japan under UNU-Kirin Fellowship Programme during 2014 to 2015. KY conceived, designed, and supervised the study. ATMAR designed and conducted experiments, analyzed the data, and drafted the manuscript YT facilitated the study.	Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139; Wu XL, 2013, J AGR FOOD CHEM, V61, P8829, DOI 10.1021/jf401779z; Lunagariya NA, 2014, EXCLI J, V13, P897; McDougall GJ, 2009, FOOD CHEM, V115, P193, DOI 10.1016/j.foodchem.2008.11.093; Slanc P, 2009, PHYTOTHER RES, V23, P874, DOI 10.1002/ptr.2718; Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Sugiyama H, 2007, J AGR FOOD CHEM, V55, P4604, DOI 10.1021/jf070569k; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1016/jf047814+; Sergent T, 2012, FOOD CHEM, V135, P68, DOI 10.1016/j.foodchem.2012.04.074; de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924; You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v; Cai SB, 2012, J AGR FOOD CHEM, V60, P7245, DOI 10.1021/jf3009958; Moreno DA, 2003, NUTRITION, V19, P876, DOI 10.1016/S0899-9007(03)00167-9; Gu YY, 2011, J AGR FOOD CHEM, V59, P5305, DOI 10.1021/jf200180n; Brooks H.B., 2012, BASICS ENZYMATIC ASS; Copeland RA, 2000, ENZYMES PRACTICAL IN, V2nd, P273; Sreerama N.Y., 2012, J FOOD SCI, V77, pC927; Yao SL, 2013, FOOD FUNCT, V4, P1602, DOI 10.1039/c3fo60196j; Yuda N, 2012, J FOOD SCI, V77, pH254, DOI 10.1111/j.1750-3841.2012.02967.x	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0963-9969	1873-7145		FOOD RES INT	Food Res. Int.	SEP	2015	75						289	294		10.1016/j.foodres.2015.05.017		6	Food Science & Technology	Food Science & Technology	CP5YP	WOS:000359961800034		
J	Murakami, M; Nishi, Y; Seto, K; Kamashita, Y; Nagaoka, E				Murakami, Mamoru; Nishi, Yasuhiro; Seto, Katsura; Kamashita, Yuji; Nagaoka, Eiichi			Dry mouth and denture plaque microflora in complete denture and palatal obturator prosthesis wearers	GERODONTOLOGY			English	Article						denture bases; biofilms; palatal obturators	SJOGRENS-SYNDROME; SALIVARY FLOW; XEROSTOMIA; COMPLAINTS; BIOFILM	Objective and backgroundThe purpose of this study was to investigate the association of dry mouth with denture plaque microflora in patients with palatal obturator prostheses from the viewpoint of infection control. MethodsThirty palatal obturator prosthesis wearers were compared with 30 healthy maxillary complete denture wearers. Dry mouth was examined using a moisture-checking device and was diagnosed by the measured moisture levels. Denture plaque was collected by rubbing the mucosal surface of the denture with a swab; collected microorganisms were cultured and identified using culture-dependent methods. The number of colonising microorganisms and prevalence of microorganisms were examined according to the type of prostheses and presence of dry mouth using nonparametric tests and frequency analysis (=0.05). ResultsThe prevalence of Candida spp. and Staphylococcus spp. in palatal obturator prostheses was significantly higher than that in complete dentures. In palatal obturator prostheses, the total number of colonising microorganisms showed no significant differences between the groups with and without dry mouth on each side of the prostheses. However, the prevalence of Candida spp. and Staphylococcus spp. in the group with dry mouth was significantly higher than that in the group without dry mouth. The number of microorganisms and moisture levels of palatal obturator prosthesis wearers showed a significantly negative correlation with Candida spp. and Staphylococcus spp., but a positive correlation with Neisseria spp. ConclusionIt was concluded that palatal obturator prosthesis wearers with a dry mouth have greater colonisation by Candida spp. and Staphylococcus spp. than do complete denture wearers.	[Murakami, Mamoru; Nishi, Yasuhiro; Seto, Katsura] Kagoshima Univ, Dept Oral & Maxillofacial Prosthodont, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; [Kamashita, Yuji] Kagoshima Univ, Denture Prosthodont Restorat, Adv Dent Ctr, Med & Dent Hosp, Kagoshima, Japan; [Nagaoka, Eiichi] Kagoshima Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med & Dent Sci, Field Oral & Maxillofacial Rehabil,Course Adv The, Kagoshima 8908544, Japan	Murakami, M (reprint author), Kagoshima Univ, Dept Oral & Maxillofacial Prosthodont, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	kaku@dent.kagoshima-u.ac.jp					Ryu M, 2010, J ORAL REHABIL, V37, P194, DOI 10.1111/j.1365-2842.2009.02042.x; Almstahl A, 2003, ORAL MICROBIOL IMMUN, V18, P1, DOI 10.1034/j.1399-302X.2003.180101.x; Torres SR, 2002, ORAL SURG ORAL MED O, V93, P149, DOI 10.1067/moe.2002.119738; Nikawa H, 1998, J DENT, V26, P299, DOI 10.1016/S0300-5712(97)00026-2; ARENDORF TM, 1980, ARCH ORAL BIOL, V25, P1, DOI 10.1016/0003-9969(80)90147-8; Smith AJ, 2001, J MED MICROBIOL, V50, P940; ARAMANY MA, 1978, J PROSTHET DENT, V40, P554, DOI 10.1016/0022-3913(78)90092-6; Bergdahl M, 2000, COMMUNITY DENT ORAL, V28, P59, DOI 10.1034/j.1600-0528.2000.280108.x; BRUCE SK, 1981, J CLIN MICROBIOL, V13, P1114; Diaz-Arnold AM, 2002, J PROSTHET DENT, V88, P337, DOI 10.1067/mpr.2002.128176; Hashiguchi M, 2009, DENT MATER J, V28, P307; Kashiwabara T, 2007, PROSTHODONT RES PRAC, V6, P153, DOI 10.2186/prp.6.153; MACFARLA.TW, 1974, J CLIN PATHOL, V27, P416, DOI 10.1136/jcp.27.5.416; MARSH PD, 1992, J DENT RES, V71, P1374, DOI 10.1177/00220345920710070501; Mattos Beatriz Silva Câmara, 2009, Braz Dent J, V20, P336, DOI 10.1590/S0103-64402009000400013; Murakami Mamoru, 2010, J Prosthodont Res, V54, P65, DOI 10.1016/j.jpor.2009.11.002; Murakami M, 2014, GERODONTOLOGY, V31, P83, DOI 10.1111/ger.12008; Murakami Mamoru, 2009, J Prosthodont Res, V53, P67, DOI 10.1016/j.jpor.2008.08.010; Murray P. R., 1999, MANUAL CLIN MICROBIO; Nishi Y, 2012, GERODONTOLOGY, V29, pE259, DOI 10.1111/j.1741-2358.2011.00461.x; Nishi Y, 2014, GERODONTOLOGY, V31, P202, DOI 10.1111/ger.12027; Paranhos HDO, 2007, GERODONTOLOGY, V24, P162, DOI 10.1111/j.1741-2358.2007.00177.x; Paranhos HFO, 2007, J ORAL REHABIL, V34, P606, DOI 10.1111/j.1365-2842.2007.01753.x; Radfar L, 2003, ORAL SURG ORAL MED O, V96, P283, DOI 10.1016/S1079-2104(03)00224-5; Rammelkamp CH, 1950, J EXP MED, V28, P295; SCHIAVONE E L, 1964, Rev Sanid Milit Argent, V63, P85; Sumi Yasunori, 2003, Gerodontology, V20, P84, DOI 10.1111/j.1741-2358.2003.00084.x; Sumi Y, 2002, Gerodontology, V19, P25, DOI 10.1111/j.1741-2358.2002.00025.x; Takahashi F, 2006, PROSTHODONT RES PRAC, V5, P26, DOI 10.2186/prp.5.26; Takahashi F, 2008, PROSTHODONT RES PRAC, V7, P78, DOI 10.2186/prp.7.78; van der Reijden WA, 1999, ANN RHEUM DIS, V58, P465, DOI 10.1136/ard.58.8.465	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	SEP	2015	32	3					188	194		10.1111/ger.12073		7	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	CP7DM	WOS:000360047400005		
J	Asahi, Y; Omichi, S; Ono, T				Asahi, Yoshinao; Omichi, Shiro; Ono, Takahiro			Orodental status and medical problems of stroke inpatients undergoing rehabilitation at a rehabilitation hospital in Japan	GERODONTOLOGY			English	Article						dental treatment; stroke; hospitalisation; rehabilitation	MANAGEMENT; RISK	Background and objectiveMany stroke patients may have oral problems and systemic diseases, but clinical information on treatment provided to stroke patients for dental problems during inpatient rehabilitation is rare. The objective of this study was to research stroke inpatients' requirements for dental treatment and the accompanying risks. MethodsWe included 165 stroke patients undergoing inpatient rehabilitation at Morinomiya Hospital during the year 2010 and researched the causes of stroke and the patients' orodental status, underlying diseases, antithrombotic drugs prescribed and special considerations or difficulties in the treatment. ResultsCerebral infarction was the most common causes of stroke. Many patients had hypertension, heart disease or diabetes mellitus, and 54.5% had been prescribed antithrombotic drugs. Dentists diagnosed 57.0% patients with untreated dental cavities. Approximately 30% did not use dentures despite having a requirement. In total, 142 patients underwent dental treatment including periodontal treatment, prosthetic treatment and tooth extraction under management of circulation and haemostasis such as monitoring vital signs and surgical splints in cases of the difficult extraction. ConclusionThe current study revealed a high requirement for dental treatment among stroke patients and demonstrated the effectiveness of performing dental treatment during inpatient rehabilitation of these patients.	[Asahi, Yoshinao; Omichi, Shiro] Morinomiya Hosp, Dept Dent, Osaka, Osaka 5360025, Japan; [Asahi, Yoshinao; Omichi, Shiro] Bobath Mem Hosp, Dept Dent, Osaka, Osaka, Japan; [Ono, Takahiro] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka, Japan	Asahi, Y (reprint author), Morinomiya Hosp, Dept Dent, Joto Ku, 2-1-88 Morinomiya, Osaka, Osaka 5360025, Japan.	asahi@omichikai.or.jp					Cui RZ, 2011, STROKE, V42, P2611, DOI 10.1161/STROKEAHA.111.614313; Schimmel M, 2011, J DENT RES, V90, P230, DOI 10.1177/0022034510383860; Schimmel M, 2011, GERODONTOLOGY, V28, P3, DOI 10.1111/j.1741-2358.2009.00330.x; EICHNER K, 1990, Stomatologie der DDR, V40, P321; Elad S, 2010, ORAL SURG ORAL MED O, V110, P145, DOI 10.1016/j.tripleo.2010.03.023; McNally L, 1999, Gerodontology, V16, P81, DOI 10.1111/j.1741-2358.1999.00081.x; Skolarus LE, 2011, CIRC-CARDIOVASC QUAL, V4, P206, DOI 10.1161/CIRCOUTCOMES.110.959551; Tran Phuong, 2009, Spec Care Dentist, V29, P218, DOI 10.1111/j.1754-4505.2009.00096.x; Wang DR, 2011, CLIN NEUROL NEUROSUR, V113, P442, DOI 10.1016/j.clineuro.2011.01.005	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	SEP	2015	32	3					237	240		10.1111/ger.12059		4	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	CP7DM	WOS:000360047400012		
J	Shimpo, M; Akamatsu, R				Shimpo, Misa; Akamatsu, Rie			The development of an Aftermath of Dietary Lapses Coping Questionnaire for weight control	HEALTH EDUCATION JOURNAL			English	Article						Adults; coping skills; dietary lapse; Japan; weight control	LOSS MAINTENANCE; RELAPSE CRISES; LIFE-STYLE; OBESITY; OVERWEIGHT; RESTRAINT; PROGRAM; WOMEN	Objective: This study was designed to develop the Aftermath of Dietary Lapses Coping Questionnaire (ADLCQ) for evaluating how people cope with the aftermath of dietary lapses during weight control. Method: Between June-July 2012, dieticians working in public health centres and city offices in Sizuoka, Japan, recruited 466 participants. They were asked to complete a 20-item self-report questionnaire pertaining to coping strategies in the aftermath of dietary lapses. The questionnaire included items regarding the stage (readiness) of weight control, the experience of weight loss and demographic characteristics. We examined the questionnaire's construct validity by conducting confirmatory and exploratory factor analyses and investigated reliability by examining internal consistency and correlations of factors with readiness for weight control and the experience of weight loss. Results: Data from 411 participants were analysed. Five factors (i.e. self-reflective thoughts, compensation by healthy eating, compensation by exercising, self-monitoring and positive thoughts), collectively consisting of 17 items, reached nearly acceptable levels of validity (adjusted goodness-of-fit index [AGFI]=.919, goodness-of-fit index [GFI]=.943, comparative fit index [CFI]=.832, root mean square error of approximation [RMSEA]=.045). Cronbach's alpha coefficients ranged from .61 to .87. Scores for coping differed with the readiness for weight control and the experience of weight loss. Conclusion: We developed the 17-item ADLCQ to evaluate coping with the aftermath of dietary lapses and confirmed the validity and the reliability of the questionnaire.	[Shimpo, Misa; Akamatsu, Rie] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan	Akamatsu, R (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	akamatsu.rie@ocha.ac.jp			JSPS [26.12145]	This study was supported by JSPS Grant-in-Aid for JSPS Fellows Numbers 26.12145.	Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427; Reyes NR, 2012, J ACAD NUTR DIET, V112, P499, DOI 10.1016/j.jand.2011.11.014; Stubbs J, 2011, OBES REV, V12, P688, DOI 10.1111/j.1467-789X.2011.00883.x; Barte JCM, 2010, OBES REV, V11, P899, DOI 10.1111/j.1467-789X.2010.00740.x; Chambers JA, 2012, BRIT J HEALTH PSYCH, V17, P223, DOI 10.1111/j.2044-8287.2011.02030.x; Westenhoefer J, 1999, INT J EAT DISORDER, V26, P53, DOI 10.1002/(SICI)1098-108X(199907)26:1<53::AID-EAT7>3.0.CO;2-N; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037//0278-6133.19.Suppl1.5; Carels R A, 2001, Eat Behav, V2, P307, DOI 10.1016/S1471-0153(01)00037-X; Cleanthous X, 2007, OBES RES CLIN PRACT, V1, P195, DOI 10.1016/j.orcp.2007.07.002; Dohm FA, 2001, J CLIN PSYCHOL, V57, P105, DOI 10.1002/1097-4679(200101)57:1<105::AID-JCLP11>3.0.CO;2-I; DRAPKIN RG, 1995, HEALTH PSYCHOL, V14, P427, DOI 10.1037//0278-6133.14.5.427; Flegal K. M., 2010, JAMA-J AM MED ASSOC, V307, P491, DOI DOI 10.1001/JAMA.2012.39; GRILO CM, 1993, ADDICT BEHAV, V18, P89, DOI 10.1016/0306-4603(93)90012-X; GRILO CM, 1989, J CONSULT CLIN PSYCH, V57, P488, DOI 10.1037//0022-006X.57.4.488; Marlatt G. A., 1985, RELAPSE PREVENTION M, P3; Ministry of Health Labour and Welfare, 2011, RES NAT NUTR SURV JA; Miwa S, 2007, MULTIVARIATE ANAL SP, P223; Murohashi H, 2007, COVARIANCE STRUCTURE, P235; Nakade M, 2012, J OBESITY, DOI 10.1155/2012/202037; Tamaura Y., 2010, Japanese Journal of Nutrition and Dietetics, V68, P87, DOI 10.5264/eiyogakuzashi.68.87; Theim KR, 2012, J YOUTH ADOLESCENCE, V41, P86, DOI 10.1007/s10964-011-9728-5; Tsushima E, 2008, MULTIVARIATE MED DAT, P167; Wills T. A., 1985, COPING SUBSTANCE USE, P3; Wing RR, 2005, AM J CLIN NUTR S, V82, p222S; Zyriax BC, 2012, PUBLIC HEALTH NUTR, V15, P860, DOI 10.1017/S1368980011002370	28	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0017-8969	1748-8176		HEALTH EDUC J	Health Educ. J.	SEP	2015	74	5					616	626		10.1177/0017896914550169		11	Education & Educational Research; Public, Environmental & Occupational Health	Education & Educational Research; Public, Environmental & Occupational Health	CP7PN	WOS:000360080300010		
J	Kaneda, M; Kano, H; Suga, K				Kaneda, Masayuki; Kano, Hironori; Suga, Kazuhiko			Development of magneto-thermal lattice Boltzmann heat and fluid flow simulation	HEAT AND MASS TRANSFER			English	Article							3-DIMENSIONAL POROUS STRUCTURE; NATURAL-CONVECTION; MAGNETIC-FIELD; MEDIA; MODEL; AIR	In this study, magneto-thermal lattice Boltzmann model is developed and heat transfer enhancement is investigated for a porous media heat exchanger. First, two models of thermal LBM are discussed in terms of its precision and applicability to magneto-thermal LBM including tolerance range of computational parameter. The implemented magneto-thermal LBM is then validated by convection in a cubic enclosure comparing with finite difference computation. The incompressibility limit of magneto-thermal LBM is additionally discussed. Finally, the effect of magnetic field on a flow through heated porous media is numerically investigated. It is found that, the magneto-thermal force is effective at the stagnant region inside the porous media to enhance the heat transfer. In a macroscopic view, the heat transfer enhancement is found in overall region. The effect becomes remarkable at low Reynolds number flow. Since its effect is aligned on a curve of Nusselt-Reynolds relation, the magnetic effect obviously found to assist the main flow.	[Kaneda, Masayuki; Kano, Hironori; Suga, Kazuhiko] Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Kaneda, M (reprint author), Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, 1-1 Gakuencho, Sakai, Osaka 5998531, Japan.	mkaneda@me.osakafu-u.ac.jp			MEXT [24760139]	This study is partially supported by MEXT, Grant-in-aid for Young Scientists (B) No. 24760139.	Chen HD, 2003, SCIENCE, V301, P633, DOI 10.1126/science.1085048; Ikezoe Y, 1998, NATURE, V393, P749, DOI 10.1038/31619; Uetake H, 2000, J APPL PHYS, V87, P6310, DOI 10.1063/1.372689; Ashorynejad HR, 2013, INT J THERM SCI, V64, P240, DOI 10.1016/j.ijthermalsci.2012.08.006; WAKAYAMA NI, 1991, J APPL PHYS, V69, P2734, DOI 10.1063/1.348629; SHAN XW, 1993, PHYS REV E, V47, P1815, DOI 10.1103/PhysRevE.47.1815; BRAITHWAITE D, 1991, NATURE, V354, P134, DOI 10.1038/354134a0; Niu XD, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036711; He X, 1998, J COMPUT PHYS, V146, P282, DOI 10.1006/jcph.1998.6057; Kaneda M, 2002, J HEAT TRANS-T ASME, V124, P17, DOI 10.1115/1.1418369; Peng Y, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026701; Suga K, 2009, PROG COMPUT FLUID DY, V9, P201, DOI 10.1504/PCFD.2009.024820; Mohamad AA, 2010, INT J HEAT MASS TRAN, V53, P990, DOI 10.1016/j.ijheatmasstransfer.2009.11.014; Inamuro T, 2002, J COMPUT PHYS, V179, P201, DOI 10.1006/jcph.2002.7051; Bai B, 1999, AIAA J, V37, P1538, DOI 10.2514/2.652; FUSEGI T, 1991, INT J HEAT MASS TRAN, V34, P1543, DOI 10.1016/0017-9310(91)90295-P; Inamuro T, 1999, INT J NUMER METH FL, V29, P737, DOI 10.1002/(SICI)1097-0363(19990415)29:7<737::AID-FLD813>3.0.CO;2-H; Niu XD, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046713; Ozoe H, 2005, MAGNETIC CONVECTION, P1, DOI 10.1142/9781860947124; Peng Y., 2003, J COMPUT PHYS, V193, P260, DOI DOI 10.1016/J.JCP.2003.08.008); Roussellet V, 2011, ADV APPL MATH MECH, V3, P121, DOI 10.4208/aamm.10-m1036; Servati V. A. A., 2014, ADV POWDER TECHNOL, V25, P666; Yoshino M, 2003, INT J NUMER METH FL, V43, P183, DOI 10.1002/fld.607	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-7411	1432-1181		HEAT MASS TRANSFER	Heat Mass Transf.	SEP	2015	51	9					1263	1275		10.1007/s00231-015-1498-2		13	Thermodynamics; Mechanics	Thermodynamics; Mechanics	CO9XK	WOS:000359529800006		
J	Nabeshima, S; Morikawa, A				Nabeshima, Syuta; Morikawa, Atsushi			Synthesis and properties of polyimides having a hexaphenylbenzene unit	HIGH PERFORMANCE POLYMERS			English	Article						Aromatic polyimide; hexaphenylbenzene unit; 1,4-bis[4-(4-aminophenoxy)phenyl]-2, 3, 5, 6-tetraphenylbenzene; structure-property relationship	AROMATIC TETRACARBOXYLIC DIANHYDRIDES; HIGH THERMOOXIDATIVE STABILITY; THERMO-PROCESSABLE POLYIMIDES; FLUORINATED POLYIMIDES; WAVE-GUIDES; BIPHENYL; ABSORPTION; DIAMINE; POLYMER	Aromatic polyimides (PIs) with a hexaphenylbenzene unit were synthesized from 1,4-bis[4-(4-aminophenoxy)phenyl]-2,3,5,6-tetraphenylbenzene (1) and various tetracarboxylic dianhydrides by a conventional two-step procedure that included ring-opening polymerization in N-methyl-2-pyrrolidone and subsequent thermal cyclic dehydration. The PIs were characterized by X-ray diffraction, differential scanning calorimetry, thermogravimetry, and dynamic mechanical analysis. The PIs had glass transition temperatures in the range of 289-352 degrees C, and all the polymers were amorphous. The structure-property relationships of these PIs were examined and compared with those of the previously prepared analogous PIs from 4,4-bis(4-aminophenoxy)biphenyl (2) and 4,4-bis(4-amino-2-phenylphenoxy)biphenyl (3). Water absorption and dielectric constants of the PIs were also compared and discussed on the basis of imide content per repeating unit.	[Nabeshima, Syuta; Morikawa, Atsushi] Ibaraki Univ, Dept Biomol Funct Engn, Hitachi, Ibaraki 3168511, Japan	Morikawa, A (reprint author), Ibaraki Univ, Dept Biomol Funct Engn, Hitachi, Ibaraki 3168511, Japan.	morikawa@mx.ibaraki.ac.jp					HOUGHAM G, 1994, MACROMOLECULES, V27, P5964, DOI 10.1021/ma00099a006; Harris FW, 1997, HIGH PERFORM POLYM, V9, P251, DOI 10.1088/0954-0083/9/3/005; Matsumoto T, 1999, MACROMOLECULES, V32, P4933, DOI 10.1021/ma9903862; Ebisawa S, 2010, EUR POLYM J, V46, P283, DOI 10.1016/j.eurpolymj.2009.10.015; Hasegawa M, 2006, HIGH PERFORM POLYM, V18, P697, DOI 10.1177/0954008306068231; Simpson JO, 1997, THIN SOLID FILMS, V308, P480, DOI 10.1016/S0040-6090(97)00481-1; MATSUURA T, 1994, MACROMOLECULES, V27, P6665, DOI 10.1021/ma00100a061; Ando S, 1997, POLYM J, V29, P69, DOI 10.1295/polymj.29.69; Ishii J, 2010, EUR POLYM J, V46, P69, DOI 10.1016/j.eurpolymj.2009.09.002; ANDO S, 1992, MACROMOLECULES, V25, P5858, DOI 10.1021/ma00047a045; Hasegawa M, 1999, MACROMOLECULES, V32, P387, DOI 10.1021/ma9808629; Han K, 2000, J APPL POLYM SCI, V77, P2172, DOI 10.1002/1097-4628(20000906)77:10<2172::AID-APP10>3.0.CO;2-9; AUMAN BC, 1995, POLYMER, V36, P651, DOI 10.1016/0032-3861(95)91576-S; CHEN CL, 1994, MACROMOLECULES, V27, P2087, DOI 10.1021/ma00086a017; COAN SB, 1955, J AM CHEM SOC, V77, P60, DOI 10.1021/ja01606a018; De Abajo J, 1999, ADV POLYM SCI, V140, P25; Feger C, 1996, POLYIMIDES FUNDAMENT, P759; Fukuka K, 2008, POLYM J, V40, P281, DOI 10.1295/polymj.PJ2007178; Goto K., 2001, Journal of Photopolymer Science and Technology, V14, DOI 10.2494/photopolymer.14.33; Goto K., 2000, Journal of Photopolymer Science and Technology, V13, DOI 10.2494/photopolymer.13.313; Han K, 1999, J APPL POLYM SCI, V74, P107, DOI 10.1002/(SICI)1097-4628(19991003)74:1<107::AID-APP12>3.3.CO;2-V; Harris FW, 1989, HIGH PERFORM POLYM, V1, P3; Hasegawa M, 2001, HIGH PERFORM POLYM, V13, P355, DOI 10.1088/0954-0083/13/4/312; Hsiao S-H, 1995, J POLYM RES, V2, P1, DOI 10.1007/BF01493428; Imai Y., 1995, HIGH PERFORM POLYM, V7, P337, DOI 10.1088/0954-0083/7/3/010; Jonson John R, 1943, ORG SYNTH, V3, P806; Morikawa A, 2011, HIGH PERFORM POLYM, P205; Morikawa A, 2000, POLYM J, V32, P275, DOI 10.1295/polymj.32.275; Morikawa A, 1999, POLYM J, V31, P76, DOI 10.1295/polymj.31.76; Morikawa A, 2006, HIGH PERFORM POLYM, V18, P593, DOI 10.1177/0954008306068121; Morikawa A, 2012, HIGH PERFORM POLYM, V24, P783, DOI 10.1177/0954008312453062; NEWMAN MS, 1976, J AM CHEM SOC, V98, P3237, DOI 10.1021/ja00427a031; Satoh A, 2010, HIGH PERFORM POLYM, V22, P412, DOI 10.1177/0954008309336324; Shi ZM, 2000, HIGH PERFORM POLYM, V12, P377, DOI 10.1088/0954-0083/12/3/302; Spiliopoulos IK, 1998, MACROMOLECULES, V31, P515, DOI 10.1021/ma970490o	35	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-0083	1361-6412		HIGH PERFORM POLYM	High Perform. Polym.	SEP	2015	27	6					772	781		10.1177/0954008314561244		10	Polymer Science	Polymer Science	CP5JR	WOS:000359918000010		
J	Son, ES; Kyung, SY; Lee, SP; Jeong, SH; Shin, JY; Ohba, M; Yeo, EJ; Park, JW				Son, E. S.; Kyung, S. Y.; Lee, S. P.; Jeong, S. H.; Shin, J. Y.; Ohba, M.; Yeo, E. J.; Park, J. W.			Role of protein kinase C- in cigarette smoke extract-induced apoptosis in MRC-5-cells	HUMAN & EXPERIMENTAL TOXICOLOGY			English	Article						Apoptosis; chronic obstructive pulmonary disease; cigarette smoke; protein kinase C	OBSTRUCTIVE PULMONARY-DISEASE; DNA-DAMAGE; CELL-DEATH; LUNG; ETA; INDUCTION; FORM	Cigarette smoke (CS) is a major risk factor for emphysema, which causes cell death in structural cells of the lung by mechanisms that are still not completely understood. We demonstrated previously that CS extract (CSE) induces caspase activation in MRC-5 human lung fibroblasts, activated protein kinase C- (PKC-), and translocated PKC- from the cytosol to the membrane. The objective of this study was to investigate the involvement of PKC- activation in a CSE-induced extrinsic apoptotic pathway. We determined that CSE increases expression of caspase 3 and 8 cleavage in MRC-5 cells and overexpression of PKC- significantly increased expression of caspase 3 and 8 cleavage compared with control LacZ-infected cells. In contrast, dominant negative (dn) PKC- inhibited apoptosis in MRC-5 cells exposed to CSE and decreased expression of caspase 3 and 8 compared with control cells. Exposure to 10% CSE for >8 h significantly increased lactate dehydrogenase release in PKC--infected cells compared with LacZ-infected cells. Additionally, PKC--infected cells had an increased number of Hoechst 33342 stained nuclei compared with LacZ-infected cells, while dn PKC--infected cells exhibited fewer morphological changes than LacZ-infected cells under phase-contrast microscopy. In conclusion, PKC- activation plays a pro-apoptotic role in CSE-induced extrinsic apoptotic pathway in MRC-5 cells. These results suggest that modulation of PKC- may be a useful tool for regulating the extrinsic apoptosis of MRC-5 cells by CSE and may have therapeutic potential in the treatment of CS-induced lung injury.	[Son, E. S.; Kyung, S. Y.; Lee, S. P.; Jeong, S. H.; Shin, J. Y.; Park, J. W.] Gachon Univ, Gil Med Ctr, Dept Allergy Pulm & Crit Care Med, Inchon 405760, South Korea; [Ohba, M.] Showa Univ, Inst Mol Oncol, Shinagawa Ku, Tokyo, Japan; [Yeo, E. J.] Gachon Univ, Sch Med, Dept Biochem, Inchon 405760, South Korea	Park, JW (reprint author), Gachon Univ, Gil Med Ctr, Dept Allergy Pulm & Crit Care Med, 774 Beon Gil, Inchon 405760, South Korea.	jwpark@gilhospital.com			Gachon University Gil Medical Center	This work was supported by Research Grants funded by Gachon University Gil Medical Center in 2011 to JW Park.	Abu-Ghanem S, 2007, CANCER BIOL THER, V6, P1375; Kuo WH, 2005, CHEM-BIOL INTERACT, V155, P31, DOI 10.1016/j.cbi.2005.04.008; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Mizumura K, 2012, CHEST, V142, P1289, DOI 10.1378/chest.12-0809; Barnes PJ, 2013, NAT REV DRUG DISCOV, V12, P543, DOI 10.1038/nrd4025; KISCHKEL FC, 1995, EMBO J, V14, P5579; Kim HP, 2008, AUTOPHAGY, V4, P887; Ohba M, 1998, MOL CELL BIOL, V18, P5199; Kim HJ, 2004, AM J RESP CELL MOL, V31, P483, DOI 10.1165/rcmb.2002-0300OC; Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL1392; Liu XD, 2005, AM J RESP CELL MOL, V33, P121, DOI 10.1165/rcmb.2003-0341OC; Maher P, 2001, J NEUROSCI, V21, P2929; Park JW, 2008, J IMMUNOL, V180, P4668; Reshef A, 2000, NEUROSCI LETT, V287, P223, DOI 10.1016/S0304-3940(00)01190-3; Rotem-Dai N, 2009, EXP CELL RES, V315, P2616, DOI 10.1016/j.yexcr.2009.06.004; Sakao S, 2003, CHEST, V124, P323, DOI 10.1378/chest.124.1.323; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; Shizukuda Y, 2001, J MOL CELL CARDIOL, V33, P1791, DOI 10.1006/jmcc.2001.1442; Sugano N, 2000, IMMUNOL LETT, V72, P163, DOI 10.1016/S0165-2478(00)00181-4; Wang J, 2001, MOL GENET METAB, V72, P82, DOI 10.1006/mgme.2000.3115; Wu CH, 2006, ARCH TOXICOL, V80, P328, DOI 10.1007/s00204-005-0050-4	21	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0960-3271	1477-0903		HUM EXP TOXICOL	Hum. Exp. Toxicol.	SEP	2015	34	9					869	877		10.1177/0960327114561343		9	Toxicology	Toxicology	CP7TF	WOS:000360090300002		
J	Gu, X; Chung, FL; Ishibuchi, H; Wang, ST				Gu, Xin; Chung, Fu-Lai; Ishibuchi, Hisao; Wang, Shitong			Multitask Coupled Logistic Regression and Its Fast Implementation for Large Multitask Datasets	IEEE TRANSACTIONS ON CYBERNETICS			English	Article						Dual coordinate descent method (CDdual); logistic regression (LR); multitask classification learning (MTC); posterior probability	MULTIPLE TASKS	When facing multitask-learning problems, it is desirable that the learning method could find the correct input-output features and share the commonality among multiple domains and also scale-up for large multitask datasets. We introduce the multitask coupled logistic regression (LR) framework called LR-based multitask classification learning algorithm (MTC-LR), which is a new method for generating each classifier for each task, capable of sharing the commonality among multitask domains. The basic idea of MTC-LR is to use all individual LR based classifiers, each one appropriate for each task domain, but in contrast to other support vector machine (SVM)-based proposals, learning all the parameter vectors of all individual classifiers by using the conjugate gradient method, in a global way and without the use of kernel trick, and being easily extended into its scaled version. We theoretically show that the addition of a new term in the cost function of the set of LRs (that penalizes the diversity among multiple tasks) produces a coupling of multiple tasks that allows MTC-LR to improve the learning performance in a LR way. This finding can make us easily integrate it with a state-of-the-art fast LR algorithm called dual coordinate descent method (CDdual) to develop its fast version MTC-LR-CDdual for large multitask datasets. The proposed algorithm MTC-LR-CDdual is also theoretically analyzed. Our experimental results on artificial and real-datasets indicate the effectiveness of the proposed algorithm MTC-LR-CDdual in classification accuracy, speed, and robustness.	[Gu, Xin; Wang, Shitong] Jiangnan Univ, Sch Digital Media, Wuxi 214122, Peoples R China; [Chung, Fu-Lai] Hong Kong Polytech Univ, Dept Comp, Hong Kong, Hong Kong, Peoples R China; [Ishibuchi, Hisao] Osaka Prefecture Univ, Dept Comp Sci, Osaka 5998531, Japan	Gu, X (reprint author), Jiangnan Univ, Sch Digital Media, Wuxi 214122, Peoples R China.	wxwangst@aliyun.com			Japan Society for the Promotion of Science; Hong Kong Polytechnic University [G-UA68]; National Natural Science Foundation of China [61170122, 61272210]; Natural Science Foundation of Jiangsu Province [BK2011417, BK2011003]; Jiangsu 333 expert engineering [BRA2011142]; Postgraduate Student's Creative Research Funds of Jiangsu Province; Fundamental Funds for the Central Universities [JUSRP51321B]	This work was supported in part by the Japan Society for the Promotion of Science, in part by Hong Kong Polytechnic University under Grant G-UA68, in part by the National Natural Science Foundation of China under Grant 61170122 and Grant 61272210, in part by the Natural Science Foundation of Jiangsu Province under Grant BK2011417 and Grant BK2011003, in part by Jiangsu 333 expert engineering under Grant BRA2011142, in part by the 2012 and 2013 Postgraduate Student's Creative Research Funds of Jiangsu Province, and in part by Fundamental Funds for the Central Universities under Grant JUSRP51321B. This paper was recommended by Associate Editor P. P. Angelov.	Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Gauvain JL, 1994, IEEE T SPEECH AUDI P, V2, P291, DOI 10.1109/89.279278; Baxter J, 2000, J ARTIF INTELL RES, V12, P149; Ando RK, 2005, J MACH LEARN RES, V6, P1817; Yu HF, 2011, MACH LEARN, V85, P41, DOI 10.1007/s10994-010-5221-8; Zhu XQ, 2011, IEEE T SYST MAN CY B, V41, P1627, DOI 10.1109/TSMCB.2011.2157999; Lin CJ, 2008, J MACH LEARN RES, V9, P627; Evgeniou T, 2005, J MACH LEARN RES, V6, P615; Pang YW, 2014, IEEE T CYBERNETICS, V44, P2122, DOI 10.1109/TCYB.2014.2301453; Xue Y, 2007, J MACH LEARN RES, V8, P35; Bian W, 2012, IEEE T SYST MAN CY B, V42, P298, DOI 10.1109/TSMCB.2011.2166761; Cali D., 2011, PROCEDIA COMPUT SCI, V21, P920; Chapelle O., 2006, P 23 INT C MACH LEAR, P185, DOI 10.1145/1143844.1143868; Collobert P., 2006, J MACH LEARN RES, V7, P1687; Deng W. B., 1996, NUMER MATH, V5, P71; Evgeniou T., 2004, P 10 ACM SIGKDD INT, P109, DOI 10.1145/1014052.1014067; Hosmer DW, 2001, APPL LOGISTIC REGRES; Jalali A., 2010, ADV NEURAL INFORM PR, V23, P964; Joachims T., 1999, ADV KERNEL METHODS S, V1999, P169; Lapedriza A, 2007, LECT NOTES COMPUT SC, V4478, P258; Lawrence N. D., P 21 INT C MACH LEAR, P65; Lozeno A. C., 2012, P 29 INT C MACH LEAR, P361; Minka T. P., 2003, COMP NUMERICAL OPTIM; Mitov V., 2013, ARXIV13127750; Moreno, 2012, P 21 ACM INT C INF K, P425; Ruszczynsk A., 2006, NONLINEAR OPTIMIZATI; Seah CW, 2013, IEEE T CYBERNETICS, V43, P1153, DOI 10.1109/TSMCB.2012.2225102; Shi XX, 2013, IEEE T KNOWL DATA EN, V25, P906, DOI 10.1109/TKDE.2011.252; Thrun S., 1997, LEARNING LEARN; Vapnik V. N., 1995, NATURE STAT LEARNING; Yu K., 2005, P 22 INT C MACH LEAR, P1012, DOI 10.1145/1102351.1102479; Zhang K, 2010, BIOINFORMATICS, V26, pi97, DOI 10.1093/bioinformatics/btq181; Zhang L., 2001, THESIS TSINGHUA U BE	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2267	2168-2275		IEEE T CYBERNETICS	IEEE T. Cybern.	SEP	2015	45	9					1953	1966		10.1109/TCYB.2014.2362771		14	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	CP6SR	WOS:000360019000020		
J	Tyagi, H; Watanabe, S				Tyagi, Himanshu; Watanabe, Shun			Converses For Secret Key Agreement and Secure Computing	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Hypothesis testing; secret key agreement; secure two-party computation; single-shot converse	OBLIVIOUS-TRANSFER; PRIVACY AMPLIFICATION; COMMON INFORMATION; ENTANGLEMENT; CAPACITY; DISTILLATION; RANDOMNESS; CHANNELS; BOUNDS	We consider information theoretic secret key (SK) agreement and secure function computation by multiple parties observing correlated data, with access to an interactive public communication channel. Our main result is an upper bound on the SK length, which is derived using a reduction of binary hypothesis testing to multiparty SK agreement. Building on this basic result, we derive new converses for multiparty SK agreement. Furthermore, we derive converse results for the oblivious transfer problem and the bit commitment problem by relating them to SK agreement. Finally, we derive a necessary condition for the feasibility of secure computation by trusted parties that seek to compute a function of their collective data, using an interactive public communication that by itself does not give away the value of the function. In many cases, we strengthen and improve upon previously known converse bounds. Our results are single-shot and use only the given joint distribution of the correlated observations. For the case when the correlated observations consist of independent and identically distributed (in time) sequences, we derive strong versions of previously known converses.	[Tyagi, Himanshu] Indian Inst Sci, Dept Elect Commun Engn, Bangalore 560012, Karnataka, India; [Watanabe, Shun] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Tokyo 1848588, Japan	Tyagi, H (reprint author), Indian Inst Sci, Dept Elect Commun Engn, Bangalore 560012, Karnataka, India.	htyagi@ece.iisc.ernet.in; shunwata@cc.tuat.ac.jp			U.S. National Science Foundation [CCF1117546]; Japan Society for the Promotion of Science	H. Tyagi was supported, in part, by the U.S. National Science Foundation under Grant CCF1117546. S. Watanabe was supported by the Japan Society for the Promotion of Science Post-Doctoral Fellowships for Research Abroad. This paper was presented at the Proceedings of EUROCRYPT 2014 and the IEEE International Symposium on Information Theory in 2015.	Ahlswede Rudolf, 2013, Information Theory, Combinatorics, and Search Theory. In Memory of Rudolf Ahlswede, DOI 10.1007/978-3-642-36899-8_6; AHLSWEDE R, 1993, IEEE T INFORM THEORY, V39, P1121, DOI 10.1109/18.243431; Gohari AA, 2010, IEEE T INFORM THEORY, V57, P3973, DOI 10.1109/TIT.2010.2050832; Hayashi M, 2014, IEEE INT SYMP INFO, P1136, DOI 10.1109/ISIT.2014.6875010; Renner R, 2003, LECT NOTES COMPUT SC, V2656, P562; Devetak I, 2005, P ROY SOC A-MATH PHY, V461, P207, DOI 10.1098/rspa.2004.1372; Beaver D, 1995, LECT NOTES COMPUT SC, V963, P97; Hayashi M, 2003, IEEE T INFORM THEORY, V49, P1753, DOI 10.1109/TIT.2003.813556; Bennett CH, 1995, IEEE T INFORM THEORY, V41, P1915, DOI 10.1109/18.476316; Tyagi H, 2013, IEEE T INFORM THEORY, V59, P5363, DOI 10.1109/TIT.2013.2262496; Watanabe S, 2013, IEEE INT SYMP INFO, P2715, DOI 10.1109/ISIT.2013.6620720; Vedral V, 1998, PHYS REV A, V57, P1619, DOI 10.1103/PhysRevA.57.1619; Nascimento ACA, 2008, IEEE T INFORM THEORY, V54, P2572, DOI 10.1109/TIT.2008.921856; Konig R, 2009, IEEE T INFORM THEORY, V55, P4337, DOI 10.1109/TIT.2009.2025545; Datta N, 2009, IEEE T INFORM THEORY, V55, P2816, DOI 10.1109/TIT.2009.2018325; Ibinson B, 2008, COMMUN MATH PHYS, V277, P289, DOI 10.1007/s00220-007-0362-8; Tyagi H, 2013, IEEE T INFORM THEORY, V59, P5627, DOI 10.1109/TIT.2013.2264355; Bennett CH, 1996, PHYS REV A, V54, P3824, DOI 10.1103/PhysRevA.54.3824; Maurer UM, 2000, IEEE T INFORM THEORY, V46, P1350, DOI 10.1109/18.850674; [Anonymous], 1990, LECT NOTES COMPUT SC; Canetti R, 2001, ANN IEEE SYMP FOUND, P136; Renner R, 2005, LECT NOTES COMPUT SC, V3788, P199; Konig R, 2012, IEEE T INFORM THEORY, V58, P1962, DOI 10.1109/TIT.2011.2177772; Winter A, 2003, LECT NOTES COMPUT SC, V2898, P35; Polyanskiy Y, 2010, IEEE T INFORM THEORY, V56, P2307, DOI 10.1109/TIT.2010.2043769; Wolf S, 2006, LECT NOTES COMPUT SC, V4004, P222; MAURER UM, 1993, IEEE T INFORM THEORY, V39, P733, DOI 10.1109/18.256484; Wehner S, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.052336; Dodis Y, 2008, SIAM J COMPUT, V38, P97, DOI 10.1137/060651380; Maurer UM, 1999, IEEE T INFORM THEORY, V45, P499, DOI 10.1109/18.748999; Tomamichel M, 2013, IEEE T INFORM THEORY, V59, P7041, DOI 10.1109/TIT.2013.2276077; Beimel A., 2014, P 11 TCC, P317; Blum M., 1983, SIGACT News, V15; Cerf N. J., 2002, Physical Review A (Atomic, Molecular, and Optical Physics), V66, DOI 10.1103/PhysRevA.66.042309; Chang CS, 2010, PROCEEDINGS OF THE ASME MICRO/NANOSCALE HEAT AND MASS TRANSFER INTERNATIONAL CONFERENCE, VOL 3, P1; Christandl M, 2007, LECT NOTES COMPUT SC, V4392, P456; Csiszar I., 1996, PROBLEMS INFORMATION, V32, P48; Csiszar I, 2004, IEEE T INFORM THEORY, V50, P3047, DOI 10.1109/TIT.2004.838380; Csiszar I, 2008, IEEE T INFORM THEORY, V54, P2437, DOI 10.1109/TIT.2008.921705; EVEN S, 1985, COMMUN ACM, V28, P637, DOI 10.1145/3812.3818; Feller W., 1971, INTRO PROBABILITY TH, V2; Fitzi M, 2004, LECT NOTES COMPUT SC, V3152, P562; Fumy W., 1997, LECT NOTES COMPUTER, V1233, P306; Gertner Y, 2000, ANN IEEE SYMP FOUND, P325, DOI 10.1109/SFCS.2000.892121; Hayashi M., 2014, SECRET KEY AGREEMENT; Hayashi M., 2014, P C COMM CONTR COMP, P148; Hayashi Masahito, 2006, QUANTUM INFORM INTRO; Imai H., 2006, P IEEE ISIT SEATTL U, P1432; Impagliazzo R., 1989, P 30 ANN IEEE S FDN, P248; Impagliazzo R., 1989, Proceedings of the Twenty First Annual ACM Symposium on Theory of Computing, DOI 10.1145/73007.73009; Iwamoto M, 2014, LECT NOTES COMPUT SC, V8317, P103, DOI 10.1007/978-3-319-04268-8_7; Kamath S., 2010, P 48 ALL C COMM CONT, P1340; Katz J., 2007, INTRO MODERN CRYPTOG; Kilian J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, DOI 10.1145/335305.335342; Kilian J., 1988, Proceedings of the Twentieth Annual ACM Symposium on Theory of Computing, DOI 10.1145/62212.62215; Korner J., 2011, INFORM THEORY CODING; Gacs P., 1973, Problems of Control and Information Theory, V2; Kullback S., 1968, INFORM THEORY STAT; Narayan P., 2015, P IEEE INT S INF THE, P949; Ogawa T, 2000, IEEE T INFORM THEORY, V46, P2428, DOI 10.1109/18.887855; Orlitsky A., 1984, P 16 ANN ACM S THEOR, P217, DOI 10.1145/800057.808684; Pappu R. S., 2001, THESIS MIT MA; Polyanskiy Y., 2010, P 48 ANN ALL C COMM, P1327; Prabhakaran VM, 2014, IEEE T INFORM THEORY, V60, P3413, DOI 10.1109/TIT.2014.2316011; Rabin M. O., 2005, TR81 HARV U AIK COMP; Ranellucci S, 2011, LECT NOTES COMPUT SC, V7073, P520, DOI 10.1007/978-3-642-25385-0_28; Rao K. S., 2014, P IEEE INF THEOR WOR, P35; Renner R., 2005, THESIS ETZ ZURICH ZU; Renyi A., 1961, P 4 BERK S MATH STAT, V1, P547; SHANNON CE, 1949, AT&T TECH J, V28, P656; Tomamichel M., 2012, FRAMEWORK NONASYMPTO; Topsoe F., 1967, STUDIA SCIENTIARUM M, V2, P291; Tuyls P., 2007, SECURITY NOISY DATA; Tyagi H., 2015, INFORM COMPLEXITY DE; Tyagi H, 2014, LECT NOTES COMPUT SC, V8441, P369, DOI 10.1007/978-3-642-55220-5_21; Tyagi H, 2013, 2013 51ST ANNUAL ALLERTON CONFERENCE ON COMMUNICATION, CONTROL, AND COMPUTING (ALLERTON), P1, DOI 10.1109/Allerton.2013.6736497; Tyagi H., 1806, P IEEE INT S INF THE; Tyagi H, 2011, IEEE T INFORM THEORY, V57, P6337, DOI 10.1109/TIT.2011.2165807; Wang LG, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.200501; Watanabe S., 2014, FINITE LENGTH ANAL T; Winkler S, 2014, IEEE T INFORM THEORY, V60, P3123, DOI 10.1109/TIT.2014.2314467; Wolf Stefan, 2008, IEEE Transactions on Information Theory, V54, DOI 10.1109/TIT.2008.921674; Yao A. C. C., 1982, FOCS, V82, P160, DOI DOI 10.1109/SFCS.1982.88	83	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	SEP	2015	61	9					4809	4827		10.1109/TIT.2015.2457926		19	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CP6RO	WOS:000360015900017		
J	Kuzuoka, S; Watanabe, S				Kuzuoka, Shigeaki; Watanabe, Shun			A Dichotomy of Functions in Distributed Coding: An Information Spectral Approach	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Distributed computing; information-spectrum method; Slepian-Wolf coding	CORRELATED SOURCES	The problem of distributed data compression for function computation is considered, where: 1) the function to be computed is not necessarily symbolwise function and 2) the information source has memory and may not be stationary nor ergodic. We introduce the class of smooth sources and give a sufficient condition on functions so that the achievable rate region for computing coincides with the Slepian-Wolf region (i.e., the rate region for reproducing the entire source) for any smooth sources. Moreover, for symbolwise functions, the necessary and sufficient condition for the coincidence is established. Our result for the full side-information case is a generalization of the result by Ahlswede and Csiszar to sources with memory; our dichotomy theorem is different from Han and Kobayashi's dichotomy theorem, which reveals an effect of memory in distributed function computation. All results are given not only for fixed-length coding but also for variable-length coding in a unified manner. Furthermore, for the full side-information case, the error probability in the moderate deviation regime is also investigated.	[Kuzuoka, Shigeaki] Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan; [Watanabe, Shun] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Tokyo 1848588, Japan	Kuzuoka, S (reprint author), Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan.	kuzuoka@ieee.org; shunwata@cc.tuat.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [26820145]; JSPS	S. Kuzuoka was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI under Grant 26820145. S. Watanabe was supported by the JSPS Post-Doctoral Fellowships for Research Abroad. This paper was presented at 2015 IEEE International Symposium on Information Theory.	AHLSWEDE R, 1981, IEEE T INFORM THEORY, V27, P398, DOI 10.1109/TIT.1981.1056381; KORNER J, 1979, IEEE T INFORM THEORY, V25, P219, DOI 10.1109/TIT.1979.1056022; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; HAN TS, 1993, IEEE T INFORM THEORY, V39, P752, DOI 10.1109/18.256486; ELIAS P, 1975, IEEE T INFORM THEORY, V21, P194, DOI 10.1109/TIT.1975.1055349; Altug Y, 2014, IEEE T INFORM THEORY, V60, P4417, DOI 10.1109/TIT.2014.2323418; Billingsley P., 1995, PROBABILITY MEASURE; Cover T. M., 2006, ELEMENTS INFORM THEO; Gamal A. E., 1983, IEEE T INFORM THEORY, V29, P931, DOI 10.1109/TIT.1983.1056742; Gamal A. E., 2011, NETWORK INFORM THEOR; Han T. S., 2002, INFORM SPECTRUM METH; HAN TS, 1987, IEEE T INFORM THEORY, V33, P69; He DK, 2009, IEEE T INFORM THEORY, V55, P5607, DOI 10.1109/TIT.2009.2032803; Korner J., 2011, INFORM THEORY CODING; Kuzuoka S, 2015, IEEE T INFORM THEORY, V61, P3559, DOI 10.1109/TIT.2015.2424406; MIYAKE S, 1995, IEICE T FUND ELECTR, VE78A, P1063; Orlitsky A, 2001, IEEE T INFORM THEORY, V47, P903, DOI 10.1109/18.915643; YAMAMOTO H, 1982, IEEE T INFORM THEORY, V28, P803, DOI 10.1109/TIT.1982.1056560	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	SEP	2015	61	9					5028	5041		10.1109/TIT.2015.2458871		14	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CP6RO	WOS:000360015900034		
J	Manesh, A; Murthy, CR; Annavajjala, R				Manesh, A.; Murthy, Chandra R.; Annavajjala, Ramesh			Physical Layer Data Fusion Via Distributed Co-Phasing With General Signal Constellations	IEEE TRANSACTIONS ON SIGNAL PROCESSING			English	Article						Distributed co-phasing; K-means algorithm; sensor networks; data fusion; mutual information; Nakagami-m fading	WIRELESS NETWORKS; SENSOR NETWORKS; CHANNELS; SYNCHRONIZATION; FEEDBACK; RECEIVER; MIMO	This paper studies a pilot-assisted physical layer data fusion technique known as Distributed Co-Phasing (DCP). In this two-phase scheme, the sensors first estimate the channel to the fusion center (FC) using pilots sent by the latter; and then they simultaneously transmit their common data by pre-rotating them by the estimated channel phase, thereby achieving physical layer data fusion. First, by analyzing the symmetric mutual information of the system, it is shown that the use of higher order constellations (HOC) can improve the throughput of DCP compared to the binary signaling considered heretofore. Using an HOC in the DCP setting requires the estimation of the composite DCP channel at the FC for data decoding. To this end, two blind algorithms are proposed: 1) power method, and 2) modified K-means algorithm. The latter algorithm is shown to be computationally efficient and converges significantly faster than the conventional K-means algorithm. Analytical expressions for the probability of error are derived, and it is found that even at moderate to low SNRs, the modified K-means algorithm achieves a probability of error comparable to that achievable with a perfect channel estimate at the FC, while requiring no pilot symbols to be transmitted from the sensor nodes. Also, the problem of signal corruption due to imperfect DCP is investigated, and constellation shaping to minimize the probability of signal corruption is proposed and analyzed. The analysis is validated, and the promising performance of DCP for energy-efficient physical layer data fusion is illustrated, using Monte Carlo simulations.	[Manesh, A.] Indian Inst Sci, Dept Elect Commun Engn ECE, Bangalore 560012, Karnataka, India; [Murthy, Chandra R.] IISc Bangalore, Dept Elect Commun Engn, Bangalore 560012, Karnataka, India; [Annavajjala, Ramesh] Charles Stark Draper Lab Inc, Cambridge, MA 02139 USA	Manesh, A (reprint author), Def Res & Dev Org, Naval Phys & Oceanog Lab, Kochi 682012, Japan.	a.manesh@gmail.com; cmurthy@ece.iisc.ernet.in; ramesh.annavajjala@gmail.com					LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Beaulieu NC, 2005, IEEE T VEH TECHNOL, V54, P413, DOI 10.1109/TVT.2004.841555; HOLTZMAN JM, 1992, IEEE T COMMUN, V40, P461, DOI 10.1109/26.135712; Mudumbai R, 2007, IEEE T WIREL COMMUN, V6, P1754, DOI 10.1109/TWC.2007.05610; SELIM SZ, 1984, IEEE T PATTERN ANAL, V6, P81; Mudumbai R, 2009, IEEE COMMUN MAG, V47, P102, DOI 10.1109/MCOM.2009.4785387; Ochiai H, 2005, IEEE T SIGNAL PROCES, V53, P4110, DOI 10.1109/TSP.2005.857028; Chamberland JF, 2007, IEEE SIGNAL PROC MAG, V24, P16, DOI 10.1109/MSP.2007.361598; Rogalin R, 2014, IEEE T WIREL COMMUN, V13, P1815, DOI 10.1109/TWC.2014.030314.130474; Ahmed MFA, 2009, IEEE T WIREL COMMUN, V8, P638, DOI 10.1109/TWC.2009.071339; Beukers F, 2007, PROG MATH, V260, P23; Bishop C. M., 2006, PATTERN RECOGNITION; Brown I., 2008, IEEE T SIGNAL PROCES, V56, P5630; Chaythanya KVK, 2011, IEEE T SIGNAL PROCES, V59, P3722, DOI 10.1109/TSP.2011.2145374; Cover T., 1991, ELEMENTS INFORM THEO; Dong L, 2008, IEEE T SIGNAL PROCES, V56, P2981, DOI 10.1109/TSP.2008.917352; Dong L, 2009, IEEE T SIGNAL PROCES, V57, P3240, DOI 10.1109/TSP.2009.2020048; Ekbal A, 2005, IEEE ICC, P2690; Kumar A, 2013, 2013 3RD AUSTRALIAN CONTROL CONFERENCE (AUCC), P207, DOI 10.1109/AUCC.2013.6697274; Ma XQ, 2002, IEEE WCNC, P228; Manesh A., 2012, THESIS INDIAN I SCI; Manesh A., 2013, P ICC, P1; Mudumbai R, 2010, IEEE T INFORM THEORY, V56, P411, DOI 10.1109/TIT.2009.2034786; Zamiri-Jafarian H, 1999, IEEE T COMMUN, V47, P1297, DOI 10.1109/26.789663; Proakis J.G., 1987, DIGITAL COMMUNICATIO; Quirk KJ, 2002, IEEE T INFORM THEORY, V48, P669, DOI 10.1109/18.985999; Quitin F, 2012, GLOB TELECOMM CONF, P4787, DOI 10.1109/GLOCOM.2012.6503876; Rahman M., 2011, P IFAC WORLD C, P10038; Ryzhik I. M., 1980, TABLE INTEGRALS SERI; Schwartz M, 1966, COMMUNICATION SYSTEM; Shin H, 2004, IEEE T COMMUN, V52, P536, DOI 10.1109/TCOMM.2004.826373; Simon M. K., 2000, DIGITAL COMMUNICATIO; Thibault I., 2010, P 5 ADV SAT MULT SYS, P221; Thibault I, 2011, INT WIREL COMMUN, P77, DOI 10.1109/IWCMC.2011.5982510; Tu YS, 2002, IEEE VTS VEH TECHNOL, P130; Zhao T, 2006, IEEE T COMMUN, V54, P1492, DOI 10.1109/TCOMM.2006.878840; Zhou SL, 2004, IEEE T WIREL COMMUN, V3, P1285, DOI 10.1109/twc.2004.830842	37	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1053-587X	1941-0476		IEEE T SIGNAL PROCES	IEEE Trans. Signal Process.	SEP 1	2015	63	17					4660	4672		10.1109/TSP.2015.2442954		13	Engineering, Electrical & Electronic	Engineering	CP7KA	WOS:000360064700017		
J	Kasahara, M; Sutoh, Y				Kasahara, Masanori; Sutoh, Yoichi			Comparative genomics of the NKG2D ligand gene family	IMMUNOLOGICAL REVIEWS			English	Review						MIC; MILL; NKG2D ligand; ULBP	MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I GENES; CYTOMEGALOVIRUS GLYCOPROTEIN UL16; CELL-SURFACE PROTEINS; INDUCIBLE CDNA-CLONES; NATURAL-KILLER-CELLS; MIC GENES; NK CELLS; RHESUS MACAQUES; CD1 GENES	NKG2D ligands (NKG2DLs) are a group of stress-inducible major histocompatibility complex (MHC) class I-like molecules that act as a danger signal alerting the immune system to the presence of abnormal cells. In mammals, two families of NKG2DL genes have been identified: the MIC gene family encoded in the MHC region and the ULBP gene family encoded outside the MHC region in most species. Some mammals have a third family of NKG2DL-like class I genes which we named MILL (MHC class I-like located near the leukocyte receptor complex). Despite the fact that MILL genes are more closely related to MIC genes than ULBP genes are to MIC genes, MILL molecules do not function as NKG2DLs, and their function remains unknown. With the progress of mammalian genome projects, information on the MIC, ULBP, and MILL gene families became available in many mammalian species. Here, we summarize such information and discuss the origin and evolution of the NKG2DL gene family from the viewpoint of host-pathogen coevolution.	[Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan; [Sutoh, Yoichi] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Sutoh, Yoichi] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Kasahara, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Pathol, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	mkasaha@med.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare no conflicts of interest.	Aida K, 2002, IMMUNOGENETICS, V54, P439, DOI 10.1007/s00251-002-0485-1; HASHIMOTO K, 1995, SCIENCE, V269, P693, DOI 10.1126/science.7624800; Klein J, 1998, CYTOGENET CELL GENET, V80, P123, DOI 10.1159/000014967; Salomonsen J, 2005, P NATL ACAD SCI USA, V102, P8668, DOI 10.1073/pnas.0409213102; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079; LEELAYUWAT C, 1994, IMMUNOGENETICS, V40, P339, DOI 10.1007/BF01246675; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Hamerman JA, 2004, J IMMUNOL, V172, P2001; Choy MK, 2010, TRENDS MOL MED, V16, P97, DOI 10.1016/j.molmed.2010.01.002; Takada A, 2008, J IMMUNOL, V180, P1678; Arapovic J, 2009, J VIROL, V83, P8198, DOI 10.1128/JVI.02549-08; Wong ESW, 2009, IMMUNOGENETICS, V61, P565, DOI 10.1007/s00251-009-0386-7; Whelan S, 2001, MOL BIOL EVOL, V18, P691; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Malarkannan S, 1998, J IMMUNOL, V161, P3501; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; Yoshida S, 2012, J IMMUNOL, V188, P3972, DOI 10.4049/jimmunol.1102886; Kasahara M, 2012, IMMUNOGENETICS, V64, P855, DOI 10.1007/s00251-012-0638-9; Snyder MR, 2004, TRENDS IMMUNOL, V25, P25, DOI 10.1016/j.it.2003.10.011; Shiina T, 2011, IMMUNOGENETICS, V63, P485, DOI 10.1007/s00251-011-0526-8; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Zhang H, 2011, MOL IMMUNOL, V48, P539, DOI 10.1016/j.molimm.2010.10.015; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Antoun A, 2010, HUM IMMUNOL, V71, P610, DOI 10.1016/j.humimm.2010.02.018; Bahram S, 2005, CURR OPIN IMMUNOL, V17, P505, DOI 10.1016/j.coi.2005.07.016; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Sutherland CL, 2002, J IMMUNOL, V168, P671; Diefenbach A, 2003, EUR J IMMUNOL, V33, P381, DOI 10.1002/immu.200310012; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Welte SA, 2003, EUR J IMMUNOL, V33, P194, DOI 10.1002/immu.200390022; Bennett NJ, 2010, J IMMUNOL, V185, P1093, DOI 10.4049/jimmunol.1000789; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Romphruk AV, 2009, IMMUNOGENETICS, V61, P611, DOI 10.1007/s00251-009-0394-7; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; KLEIN J, 1990, IMMUNOGENETICS, V31, P217; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Miller MM, 2005, P NATL ACAD SCI USA, V102, P8674, DOI 10.1073/pnas.0500105102; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Bacon L, 2004, J IMMUNOL, V173, P1078; Oganesyan V, 2002, J BIOL CHEM, V277, P24851, DOI 10.1074/jbc.C200163200; Birch J, 2008, IMMUNOGENETICS, V60, P477, DOI 10.1007/s00251-008-0306-2; Kasahara M, 2014, ADV IMMUNOL, V122, P59, DOI 10.1016/B978-0-12-800267-4.00002-X; Anzai T, 2003, P NATL ACAD SCI USA, V100, P7708, DOI 10.1073/pnas.1230533100; ARAKI T, 1988, P NATL ACAD SCI USA, V85, P679, DOI 10.1073/pnas.85.3.679; Averdam A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000688; Averdam A, 2007, IMMUNOGENETICS, V59, P247, DOI 10.1007/s00251-006-0187-1; Bahram S, 2000, Adv Immunol, V76, P1; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; Chardon P, 2001, TISSUE ANTIGENS, V57, P55, DOI 10.1034/j.1399-0039.2001.057001055.x; Chen D, 2014, CARCINOGENESIS, V35, P2633, DOI 10.1093/carcin/bgu215; desGroot NG, 2005, MOL BIOL EVOL, V22, P1375; Doxiadis GGM, 2007, TISSUE ANTIGENS, V69, P212, DOI 10.1111/j.1399-0039.2006.00791.x; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Fukami-Kobayashi K, 2005, P NATL ACAD SCI USA, V102, P9230, DOI 10.1073/pnas.0500770102; Jonjic S, 2008, EUR J IMMUNOL, V38, P2952, DOI 10.1002/eji.200838823; Kajikawa M, 2006, J IMMUNOL, V177, P3108; KARRE K, 1995, SCIENCE, V267, P978, DOI 10.1126/science.7863341; Kasahara M, 1996, RES IMMUNOL, V147, P278, DOI 10.1016/0923-2494(96)89640-4; Kasahara M, 2002, P NATL ACAD SCI USA, V99, P13687, DOI 10.1073/pnas.212375299; Komatsu-Wakui M, 2001, TISSUE ANTIGENS, V57, P1, DOI 10.1034/j.1399-0039.2001.057001001.x; Kondo M, 2010, IMMUNOGENETICS, V62, P441, DOI 10.1007/s00251-010-0438-z; Kubin M, 2001, EUR J IMMUNOL, V31, P1428, DOI 10.1002/1521-4141(200105)31:5<1428::AID-IMMU1428>3.0.CO;2-4; Larson JH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-227; Maruoka T, 2005, IMMUNOGENETICS, V57, P590, DOI 10.1007/s00251-005-0016-y; Meyer A, 2014, IMMUNOGENETICS, V66, P581, DOI 10.1007/s00251-014-0791-4; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Naruse TK, 2011, IMMUNOGENETICS, V63, P501, DOI 10.1007/s00251-011-0531-y; Ojcius DM, 2002, FASEB J, V16, P202, DOI 10.1096/fj.01-0758com; Ota M, 2000, TISSUE ANTIGENS, V56, P268, DOI 10.1034/j.1399-0039.2000.560309.x; Rabinovich B, 2006, IMMUNOGENETICS, V58, P81, DOI 10.1007/s00251-005-0078-x; Rabinovich BA, 2008, IMMUNOL CELL BIOL, V86, P489, DOI 10.1038/icb.2008.41; Radosavljevic M, 2003, IMMUNOGENETICS, V55, P1, DOI 10.1007/s00251-003-0546-0; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Samarakoon A, 2009, MOL IMMUNOL, V46, P1011, DOI 10.1016/j.molimm.2008.09.035; Seo JW, 1999, IMMUNOGENETICS, V50, P358, DOI 10.1007/s002510050614; Seo JW, 2001, TISSUE ANTIGENS, V58, P159, DOI 10.1034/j.1399-0039.2001.580303.x; Watanabe Y, 2004, EUR J IMMUNOL, V34, P1597, DOI 10.1002/eji.200424919; Wilming LG, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat011; Yang Z, 2015, IMMUNOGENETICS, V67, P337, DOI 10.1007/s00251-015-0837-2; Yoder JA, 2011, IMMUNOGENETICS, V63, P123, DOI 10.1007/s00251-010-0506-4; Yuhki N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002674; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	113	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-2896	1600-065X		IMMUNOL REV	Immunol. Rev.	SEP	2015	267	1			SI		72	87		10.1111/imr.12320		16	Immunology	Immunology	CP7QD	WOS:000360082000006		
J	Tokunaga, T; Szeliga, D; Matsuura, K; Ohno, M; Pietrzyk, M				Tokunaga, Toko; Szeliga, Danuta; Matsuura, Kiyotaka; Ohno, Munekazu; Pietrzyk, Maciej			Sensitivity analysis for thickness uniformity of Al coating layer in extrusion of Mg/Al clad bar	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						Plastic deformation; Extrusion; Coating; Cladding; Corrosion resistance	MAGNESIUM; ALLOYS; BEHAVIOR	Although Mg alloys possess many attractive properties, the use of Mg alloys has been limited due to their extremely poor corrosion resistance. In the authors' previous study, they have developed a new process for Mg/Al cladding by hot extrusion with a convex die. In the extrusion process, it was found that the thickness uniformity of the Al coating layer can be controlled by changing the die angle. However, the optimal condition of the extrusion and the influences of extrusion parameters on the coating thickness uniformity remain unclear. In this study, therefore, the sensitivity analysis has been performed in order to evaluate the influences of extrusion parameters on the coating thickness uniformity. The sensitivities of the following five parameters were evaluated: (1) initial thickness of the coating material plate, (2) extrusion temperature, (3) ram speed, (4) die angle, and (5) ratio of simulated flow stress to the experimental one for pure Al. In order to perform the sensitivity analysis, the process for Mg/Al cladding was modeled. The results from the extrusion model fairly agree with the experimental results. Thus, it can be said that the present model of Mg/Al cladding process is reliable. From the sensitivity analysis, it was found that the initial thickness of the coating material plate and die angle influence on the uniformity most. The extrusion temperature, ram speed, and flow stress ratio do not have significant influences.	[Tokunaga, Toko] Hokkaido Univ, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Szeliga, Danuta; Pietrzyk, Maciej] AGH Univ Sci & Technol, PL-30059 Krakow, Poland; [Matsuura, Kiyotaka; Ohno, Munekazu] Fac Engn, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Tokunaga, T (reprint author), Hokkaido Univ, Grad Sch Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	ue145460@frontier.hokudai.ac.jp	Ohno, Munekazu/A-5222-2012	Ohno, Munekazu/0000-0001-5383-412X	JSPS KAKENHI grant [25.1024]	The financial support by JSPS KAKENHI grant numbers 25.1024 is gratefully acknowledged.	Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0; Kulekci MK, 2008, INT J ADV MANUF TECH, V39, P851, DOI 10.1007/s00170-007-1279-2; Ambat R, 2000, CORROS SCI, V42, P1433, DOI 10.1016/S0010-938X(99)00143-2; El Mehtedi M, 2014, MATER DESIGN, V54, P869, DOI 10.1016/j.matdes.2013.09.013; Chenot JL, 1992, NUMERICAL MODELLING, P179; FUNAHASHI T, 1992, KAWASAKI STEEL GIHO, V24, P135; SALTELLI A, 1992, COMPUT STAT DATA AN, V13, P73, DOI 10.1016/0167-9473(92)90155-9; Saltelli A., 2000, SENSITIVITY ANAL; Tokunaga T, 2012, MATER TRANS, V53, P1034, DOI [10.2320/matertrans.M20120261, 10.2320/matertrans.M2012026]; Tokunaga T, 2014, COMPUT METHODS MAT S, V14, P147; Zhang Q, 2009, J MATER PROCESS TECH, V209, P5720, DOI 10.1016/j.jmatprotec.2009.06.002	11	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	SEP	2015	80	1-4					507	513		10.1007/s00170-015-7019-0		7	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	CP4EO	WOS:000359835000039		
J	Murayama, T; Nakamura, K; Tsuchida, T				Murayama, Takayuki; Nakamura, Koichiro; Tsuchida, Tetsuya			Eosinophilic pustular folliculitis with extensive distribution: correlation of serum TARC levels and peripheral blood eosinophil numbers	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Editorial Material							ACTIVATION-REGULATED CHEMOKINE; OFUJIS-DISEASE; THYMUS		[Murayama, Takayuki; Nakamura, Koichiro; Tsuchida, Tetsuya] Saitama Med Univ, Dept Dermatol, Moroyama, Saitama 3500495, Japan	Nakamura, K (reprint author), Saitama Med Univ, Dept Dermatol, 38 Morohogo, Moroyama, Saitama 3500495, Japan.	nakamu@saitama-med.ac.jp					Amerio Paolo, 2003, Current Drug Targets - Inflammation and Allergy, V2, P81, DOI 10.2174/1568010033344480; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Kakinuma T, 2003, BRIT J DERMATOL, V148, P203, DOI 10.1046/j.1365-2133.2003.05066.x; Razera F, 2011, AN BRAS DERMATOL, V86, P195, DOI 10.1590/S0365-05962011000200001; AOYAMA H, 1992, DERMATOLOGY, V185, P276; Ishiguro N, 2002, J AM ACAD DERMATOL, V46, P827, DOI 10.1067/mjd.2002.120533; Keida T, 2004, J DERMATOL, V31, P21; Kimoto M, 2005, DERMATOLOGY, V210, P239, DOI 10.1159/000083518; Maejima H, 2002, ACTA DERM-VENEREOL, V82, P316, DOI 10.1080/000155502320323397; Nervi SJ, 2006, J AM ACAD DERMATOL, V55, P285, DOI 10.1016/j.jaad.2006.02.034; OFUJI S, 1970, ACTA DERM-VENEREOL, V50, P195; Wong TW, 2004, J DERMATOL, V31, P727	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	SEP	2015	54	9					1071	1074		10.1111/ijd.12281		4	Dermatology	Dermatology	CP7DG	WOS:000360046800031		
J	Korekawa, A; Kaneko, T; Nakajima, K; Rokunohe, D; Akasaka, E; Nakano, H; Fukui, T; Takiyoshi, N; Kitamura, H; Harada, K; Sawamura, D				Korekawa, Ayumi; Kaneko, Takahide; Nakajima, Koji; Rokunohe, Daiki; Akasaka, Eijiro; Nakano, Hajime; Fukui, Tomohisa; Takiyoshi, Noriko; Kitamura, Hideo; Harada, Ken; Sawamura, Daisuke			Mycosis fungoides bullosa associated with bullous pemphigoid	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter									[Korekawa, Ayumi; Kaneko, Takahide; Nakajima, Koji; Rokunohe, Daiki; Akasaka, Eijiro; Nakano, Hajime] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan; [Fukui, Tomohisa; Takiyoshi, Noriko; Kitamura, Hideo; Harada, Ken; Sawamura, Daisuke] Aomori Prefectural Cent Hosp, Dept Dermatol, Aomori, Japan	Korekawa, A (reprint author), Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan.	smartdai@cc.hirosaki-u.ac.jp					Bermardini ML, 2009, J EUR ACAD DERMATOL, V23, P839; Gantcheva Mary, 2005, J Dtsch Dermatol Ges, V3, P898, DOI 10.1111/j.1610-0387.2005.05739.x; Gardner JM, 2009, ARCH DERMATOL, V145, P985, DOI 10.1001/archdermatol.2009.229; Kamran Balighi, 2008, Dermatol Online J, V14, P11; Kaposi M, 1887, WIEN MED WSCHR, V19, P22; OGAWA H, 1995, J DERMATOL SCI, V9, P136, DOI 10.1016/0923-1811(94)00371-K; PATTERSON JW, 1985, INT J DERMATOL, V24, P173, DOI 10.1111/j.1365-4362.1985.tb05751.x; PREESMAN AH, 1990, CLIN EXP DERMATOL, V15, P363, DOI 10.1111/j.1365-2230.1990.tb02115.x; Ueda C, 2011, BRIT J DERMATOL, V165, P213, DOI 10.1111/j.1365-2133.2011.10323.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	SEP	2015	54	9					E366	E368		10.1111/ijd.12821		3	Dermatology	Dermatology	CP7DG	WOS:000360046800011		
J	ElMasry, G; Nakauchi, S				ElMasry, Gamal; Nakauchi, Shigeki			Noninvasive sensing of thermal treatments of Japanese seafood products using imaging spectroscopy	INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY			English	Article						Imaging spectroscopy; Japanese Kamaboko; multivariate analysis; seafood; temperature; thermal treatment	NEAR-INFRARED SPECTROSCOPY; END-POINT TEMPERATURE; HEAT-TREATED BEEF; REFLECTANCE SPECTROSCOPY; HYPERSPECTRAL REFLECTANCE; MULTIVARIATE CALIBRATION; CHICKEN PATTIES; SYSTEM; KAMABOKO; SURIMI	The potential of imaging spectroscopy for noncontact sensing of thermal treatments experienced on Japanese kamaboko was investigated. Samples were thermally treated at 100, 120, 140, 160, 180 and 200 degrees C to core temperatures of 45, 50, 55, 60, 65, 70, 75 and 80 degrees C and then promptly cooled and imaged in the short-wave near infrared spectral range of 900-2500nm. Partial least square (PLS) regression models were developed using the whole spectral range as well as using the most important wavelengths to predict the core temperature (T-C) and thermal history (TH) yielding a reasonable level of accuracy of (R-P(2) = 0.83 and RMSEP=0.29min), respectively. Moreover, a stepwise linear discriminant analysis (LDA) model was developed for identifying samples whose core temperatures reached a threshold of 65 degrees C. The LDA model yielded overall classification accuracy of 93.75% in both calibration and validation sets. The resulting discrimination function was then applied in a pixel-wise manner to produce understandable classification maps to exhibit the difference among samples with high accuracy.	[ElMasry, Gamal; Nakauchi, Shigeki] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi 4418580, Japan; [ElMasry, Gamal] Suez Canal Univ, Fac Agr, Dept Agr Engn, Ismailia, Egypt	ElMasry, G (reprint author), Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi 4418580, Japan.	g.elmasry@vpac.cs.tut.ac.jp			Japan Society for the Promotion of Science (JSPS)	The authors would like to acknowledge the financial support and research grant provided by the Japan Society for the Promotion of Science (JSPS).	ElMasry G, 2008, J AGR FOOD CHEM, V56, P7672, DOI 10.1021/jf801074s; Elmasry G, 2012, CRIT REV FOOD SCI, V52, P689, DOI 10.1080/10408398.2010.507908; Park B, 2006, J FOOD ENG, V75, P340, DOI 10.1016/j.jfoodeng.2005.03.060; Sivertsen AH, 2012, J FOOD ENG, V111, P675, DOI 10.1016/j.jfoodeng.2012.02.036; Kandpal LM, 2013, SENSORS-BASEL, V13, P13289, DOI 10.3390/s131013289; Damez JL, 2013, MEAT SCI, V95, P879, DOI 10.1016/j.meatsci.2013.04.037; Liu Y, 2000, J AGR FOOD CHEM, V48, P901, DOI 10.1021/jf990662b; Everard CD, 2014, J FOOD ENG, V143, P139, DOI 10.1016/j.jfoodeng.2014.06.042; Sone I, 2012, J FOOD ENG, V109, P482, DOI 10.1016/j.jfoodeng.2011.11.001; Chen H, 1997, J FOOD SCI, V62, P753, DOI 10.1111/j.1365-2621.1997.tb15450.x; Chen H, 1998, J FOOD SCI, V63, P279; Chen T, 2007, J CHEMOMETR, V21, P198, DOI 10.1002/cem.1041; ELLEKJAER MR, 1992, J SCI FOOD AGR, V59, P335, DOI 10.1002/jsfa.2740590310; ElMasry G., 2010, HYPERSPECTRAL IMAGIN, P175, DOI DOI 10.1016/B978-0-12-374753-2.10006-1; Guerrero C, 2007, SOIL SCI SOC AM J, V71, P1029, DOI 10.2136/sssaj2006.0187; Hageman JA, 2005, J NEAR INFRARED SPEC, V13, P53; Kakuta N, 2011, LAB CHIP, V11, P3479, DOI 10.1039/c1lc20261h; Kamruzamman M, 2015, WOODHEAD PUBL FOOD S, P425, DOI 10.1016/B978-0-85709-801-6.00018-6; Mao WJ, 2005, J FOOD ENG, V71, P187, DOI 10.1016/j.jfoodeng.2004.10.045; Morita K., 2011, HDB SEAFOOD QUALITY, P39; O'Farrell M, 2011, APPL SPECTROSC, V65, P1372, DOI 10.1366/11-06277; Ooizumi T., 2013, SURIMI SURIMI SEAFOO, P271; ozogul F., 2011, HDB SEAFOOD QUALITY, P206; Park J. W., 2013, SURIMI SURIMI SEAFOO, P206; Peinado AC, 2006, CHEMOMETR INTELL LAB, V83, P75, DOI 10.1016/j.chemolab.2006.01.006; Khojastehnazhand M, 2014, FOOD RES INT, V56, P25, DOI 10.1016/j.foodres.2013.12.018; Sakai N, 2005, J FOOD ENG, V66, P525, DOI 10.1016/j.jfoodeng.2004.04.025; Skara T, 2014, J FOOD ENG, V120, P75, DOI 10.1016/j.jfoodeng.2013.07.022; Stormo SK, 2012, FOOD CONTROL, V26, P92, DOI 10.1016/j.foodcont.2011.07.035; Suzuki T., 2013, SURIMI SURIMI SEAFOO, P603; Swierenga H, 2000, ANAL CHIM ACTA, V411, P121, DOI 10.1016/S0003-2670(00)00718-2; Thyholt K, 1998, MEAT SCI, V48, P49, DOI 10.1016/S0309-1740(97)00075-2; Uddin M, 2002, J SCI FOOD AGR, V82, P286, DOI 10.1002/jsfa.1032; Uddin M, 2005, LWT-FOOD SCI TECHNOL, V38, P809, DOI 10.1016/j.lwt.2004.10.008; Williams P. C., 2001, NEAR INFRARED TECHNO; Wulfert F, 2000, CHEMOMETR INTELL LAB, V51, P189, DOI 10.1016/S0169-7439(00)00069-1; Yao Y, 2013, J FOOD ENG, V119, P22, DOI 10.1016/j.jfoodeng.2013.04.033; Zardetto S, 2005, FOOD CONTROL, V16, P249, DOI 10.1016/j.foodcont.2004.03.002; Zhang XD, 2010, INFRARED PHYS TECHN, V53, P177, DOI 10.1016/j.infrared.2009.11.003	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-5423	1365-2621		INT J FOOD SCI TECH	Int. J. Food Sci. Technol.	SEP	2015	50	9					1960	1971		10.1111/ijfs.12863		12	Food Science & Technology	Food Science & Technology	CP4NP	WOS:000359859300003		
J	Kittiphattanabawon, P; Benjakul, S; Sinthusamran, S; Kishimura, H				Kittiphattanabawon, Phanat; Benjakul, Soottawat; Sinthusamran, Sittichoke; Kishimura, Hideki			Characteristics of collagen from the skin of clown featherback (Chitala ornata)	INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY			English	Article						Acid soluble collagen; Chitala ornata; clown featherback; collagen; pepsin solubilise collagen; type I collagen	SNAPPER PRIACANTHUS-TAYENUS; PEPSIN-SOLUBLE COLLAGENS; BIGEYE SNAPPER; SWIM BLADDERS; ACID; EXTRACTION; GELATIN; BONE; SPECTROSCOPY	Acid soluble collagen (ASC) and pepsin soluble collagen (PSC) from the skin of clown featherback (Chitala ornata) were isolated and characterised. Yields of ASC and PSC were 27.64 and 44.63% (dry weight basis) with total collagen recovery of 82.08%. Both collagens contained glycine as the major amino acid with relatively high content of proline, hydroxyproline and glutamic acid/glutamine. Nevertheless, they had the low content of cysteine, histidine and tryrosine. The collagen was characterised as type I, comprising (1)(2)2-heterotrimer. Pepsin-aided process did not affect triple-helical structure of PSC as determined by FTIR spectra. Thermal transition temperature of ASC (36.28 degrees C) was slightly higher than that of PSC (35.23 degrees C). However, no differences in isoelectric point (5.54-5.68) between ASC and PSC were observed. Therefore, collagen from the skin of clown featherback could be successfully extracted for further applications.	[Kittiphattanabawon, Phanat] Thaksin Univ, Fac Technol & Community Dev, Dept Food Sci & Technol, Phatthalung 93110, Thailand; [Kittiphattanabawon, Phanat] King Mongkuts Univ Technol North Bangkok, Fac Agroind, Dept Agroind Technol & Management, Bangkok 25230, Prachinburi, Thailand; [Benjakul, Soottawat; Sinthusamran, Sittichoke] Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand; [Kishimura, Hideki] Hokkaido Univ, Res Fac Fisheries Sci, Lab Marine Prod & Food Sci, Hakodate, Hokkaido 0418611, Japan	Kittiphattanabawon, P (reprint author), Thaksin Univ, Fac Technol & Community Dev, Dept Food Sci & Technol, Phatthalung Campus, Phatthalung 93110, Thailand.	kphanat@gmail.com		Kittiphattanabawon, Phanat/0000-0001-8860-1350	Thailand Research Fund; Thaksin University [TRG5780036]; TRF	We would like to thank Department of Food Technology, Faculty of Agro-industry, Prince of Songkla University, Songkhla, Thailand for the instrument support. This work was supported by The Thailand Research Fund and Thaksin University for contract No. TRG5780036 to Dr. Phanat Kittiphattanabawon. The TRF Distinguished Research Professor Grant was also acknowledged.	Nalinanon S, 2007, FOOD CHEM, V104, P593, DOI 10.1016/j.foodchem.2006.12.035; Zeng SK, 2012, FOOD CHEM, V135, P1975, DOI 10.1016/j.foodchem.2012.06.086; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Aewsiri T, 2009, FOOD CHEM, V115, P243, DOI 10.1015/j.foodchem.2008.12.012; Wang L, 2014, FOOD HYDROCOLLOID, V38, P104, DOI 10.1016/j.foodhyd.2013.12.002; DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505; Benjakul S, 2010, J SCI FOOD AGR, V90, P132, DOI 10.1002/jsfa.3795; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Singh P, 2011, FOOD CHEM, V124, P97, DOI 10.1016/j.foodchem.2010.05.111; Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020; Nalinanon S, 2011, FOOD CHEM, V125, P500, DOI 10.1016/j.foodchem.2010.09.040; PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105; Plepis AMD, 1996, POLYM ENG SCI, V36, P2932; Li ZR, 2013, FOOD HYDROCOLLOID, V31, P103, DOI 10.1016/j.foodhyd.2012.10.001; Liu DS, 2012, FOOD CHEM, V133, P1441, DOI 10.1016/j.foodchem.2012.02.032; Sinthusamran S, 2013, FOOD CHEM, V138, P2435, DOI 10.1016/j.foodchem.2012.11.136; Jia YJ, 2012, FOOD SCI BIOTECHNOL, V21, P1585, DOI 10.1007/s10068-012-0211-1; AOAC, 2000, OFFICIAL METHODS ANA; Belitz H. D., 2009, FOOD CHEM; Benjakul S., 2012, FOOD BIOCH FOOD PROC, P365; Chen Y, 2015, INT J FOOD SCI TECH, V50, P186, DOI 10.1111/ijfs.12675; Foegeding E.A., 1996, FOOD CHEM, V3, P879; JOHNSTONBANKS FA, 1990, FOOD GELS, P233; Jongiareonrak A, 2006, FOOD HYDROCOLLOID, V20, P1216, DOI 10.1016/j.foodhyd.2006.01.006; Kaewdang O, 2014, FOOD CHEM, V155, P264, DOI 10.1016/j.foodchem.2014.01.076; Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042; Kittiphattanabawon P, 2010, LWT-FOOD SCI TECHNOL, V43, P792, DOI 10.1016/j.lwt.2010.01.006; Kittiphattanabawon P, 2010, FOOD CHEM, V119, P1519, DOI 10.1016/j.foodchem.2009.09.037; Kittiphattanabawon P, 2010, EUR FOOD RES TECHNOL, V230, P475, DOI 10.1007/s00217-009-1191-0; Nagai T., 2014, J FOOD SCI TECHNOLOG, V52, P2344; Nalinanon S, 2008, J FOOD SCI, V73, pC413, DOI 10.1111/j.1750-3841.2008.00777.x; Regenstein JM, 2007, MAXIMIS VAL MARINE P, V1, P279; Steel R.G., 1980, PRINCIPLES PROCEDURE; Wong DW, 1989, MECH THEORY FOOD CHE	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-5423	1365-2621		INT J FOOD SCI TECH	Int. J. Food Sci. Technol.	SEP	2015	50	9					1972	1978		10.1111/ijfs.12864		7	Food Science & Technology	Food Science & Technology	CP4NP	WOS:000359859300004		
J	Li, Q; Kobayashi, M; Kawada, T				Li, Qing; Kobayashi, Maiko; Kawada, Tomoyuki			Effect of carbamate pesticides on perforin, granzymes A-B-3/K, and granulysin in human natural killer cells	INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY			English	Article						carbaryl; granulysin; granzyme; maneb; NK cells; perforin; thiram	DDVP MARKEDLY DECREASES; HUMAN NK CELLS; ANTICANCER PROTEINS; CYTOTOXIC FUNCTION; EXPRESSION; APOPTOSIS; FOREST; ZIRAM; TRIP; LINE	We previously found that ziram, a carbamate pesticide, significantly reduced perforin, granzyme A (GrA), granzyme B (GrB), granzyme 3/K (Gr3/K), and granulysin (GRN) levels in NK-92MI cells, a human natural killer (NK) cell line. To investigate whether other carbamate pesticides also show similar toxicity on human NK cells, we conducted further experiments with NK-92CI cells, a human NK cell line, using a more sensitive assay. We previously confirmed that NK-92CI cells express CD56, perforin, GrA, GrB, Gr3/K, and GRN and are highly cytotoxic to K562 cells in a chromium release assay, which are more sensitive to organophosphorus pesticides and ziram than the NK-92MI cell line. NK-92CI cells were treated with ziram, thiram, maneb, or carbaryl at various concentrations for 4-24 h at 37 degrees C in vitro. Thereafter, intracellular levels of perforin, GrA, GrB, Gr3/K, and GRN were determined by flow cytometry. It was found that all carbamate pesticides significantly reduced the intracellular levels of perforin, GrA, GrB, Gr3/K, and GRN in NK-92CI cells in a dose-dependent manner. However, the strength of the effect differed among the pesticides, and the order was thiram > ziram > maneb > carbaryl. In addition, it was also found that the degree of the reductions differed among the five proteins, with perforin more sensitive to pesticides than GRN, GrA, GrB, and Gr3/K, and the order was perforin > GRN > Gr3/K ? GrA ? GrB.	[Li, Qing; Kobayashi, Maiko; Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Li, Q (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	qing-li@nms.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Li Q, 2007, TOXICOLOGY, V239, P89, DOI 10.1016/j.tox.2007.06.100; Li Q, 2008, INT J IMMUNOPATH PH, V21, P117; McDuffie HH, 2001, CANCER EPIDEM BIOMAR, V10, P1155; Li Q, 2009, INT J IMMUNOPATH PH, V22, P951; Tam YK, 1999, HUM GENE THER, V10, P1359, DOI 10.1089/10430349950018030; GONG JH, 1994, LEUKEMIA, V8, P652; Li Q, 2006, IMMUNOPHARM IMMUNOT, V28, P319, DOI 10.1080/08923970600809439; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Li Q, 2008, J BIOL REG HOMEOS AG, V22, P45; Okada S, 2003, J IMMUNOL, V171, P2556; Clayberger C, 2003, CURR OPIN IMMUNOL, V15, P560, DOI 10.1016/S0952-7915(03)00097-9; Li Q, 2008, TOXICOLOGY, V243, P294, DOI 10.1016/j.tox.2007.10.018; Li Q, 2005, TOXICOLOGY, V213, P107, DOI 10.1016/j.tox.2005.05.018; Li Q, 2014, J BIOL REG HOMEOS AG, V28, P23; Li Q, 2010, J BIOL REG HOMEOS AG, V24, P157; Li Q, 2012, ARCH TOXICOL, V86, P475, DOI 10.1007/s00204-011-0771-5; Li Q, 2007, Int J Immunopathol Pharmacol, V20, P3; Li Q, 2012, P 19 ANN M JAP SOC I, P77; Richardson ML, 1993, DICT SUBSTANCES THEI, V2, P99; Richardson ML, 1993, DICT SUBSTANCES THEI, V7, P437; Richardson ML, 1993, DICT SUBSTANCES THEI, V5, P323; SMYTH MJ, 1995, IMMUNOL TODAY, V16, P202, DOI 10.1016/0167-5699(95)80122-7; Taylor TR, 2005, ENVIRON TOXICOL, V20, P418, DOI 10.1002/tox.20127; Taylor TR, 2009, CELL BIOL TOXICOL, V25, P447, DOI 10.1007/s10565-008-9098-2; VANDEKAR M, 1971, B WORLD HEALTH ORGAN, V44, P241; Whalen MM, 2003, CHEM-BIOL INTERACT, V145, P311, DOI 10.1016/S0009-2797(03)00027-9; Wilson S, 2004, ENVIRON TOXICOL, V19, P554, DOI 10.1002/tox.20061	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0394-6320			INT J IMMUNOPATH PH	Int. J. Immunopathol. Pharmacol.	SEP	2015	28	3					403	410		10.1177/0394632015582334		8	Immunology; Pathology; Pharmacology & Pharmacy	Immunology; Pathology; Pharmacology & Pharmacy	CP7SA	WOS:000360087100013		
J	Iuchi, T; Hatano, K; Uchino, Y; Itami, M; Hasegawa, Y; Kawasaki, K; Sakaida, T; Hara, R				Iuchi, Toshihiko; Hatano, Kazuo; Uchino, Yoshio; Itami, Makiko; Hasegawa, Yuzo; Kawasaki, Koichiro; Sakaida, Tsukasa; Hara, Ryusuke			Methionine Uptake and Required Radiation Dose to Control Glioblastoma	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NEWLY-DIAGNOSED GLIOBLASTOMA; RADIOBIOLOGICAL PARAMETERS; ADJUVANT TEMOZOLOMIDE; BRAIN-TUMOR; GLIOMA; PROLIFERATION; RADIOTHERAPY; MGMT; PET	Purpose: The purpose of this study was to retrospectively assess the feasibility of radiation therapy planning for glioblastoma multiforme (GBM) based on the use of methionine (MET) positron emission tomography (PET), and the correlation among MET uptake, radiation dose, and tumor control. Methods and Materials: Twenty-two patients with GBM who underwent MET-PET prior to radiation therapy were enrolled. MET uptake in 30 regions of interest (ROIs) from 22 GBMs, biologically effective doses (BEDs) for the ROIs and their ratios (MET uptake: BED) were compared in terms of whether the ROIs were controlled for >12 months. Results: MET uptake was significantly correlated with tumor control (odds ratio [OR], 10.0; PZ. 005); however, there was a higher level of correlation between MET uptake: BED ratio and tumor control (OR, 40.0; P<.0001). These data indicated that the required BEDs for controlling the ROIs could be predicted in terms of MET uptake; BED could be calculated as [34.0 x MET uptake] Gy from the optimal threshold of the MET uptake: BED ratio for tumor control. Conclusions: Target delineation based on MET-PET was demonstrated to be feasible for radiation therapy treatment planning. MET-PET could not only provide precise visualization of infiltrating tumor cells but also predict the required radiation doses to control target regions. (C) 2015 Elsevier Inc. All rights reserved.	[Iuchi, Toshihiko; Hasegawa, Yuzo; Kawasaki, Koichiro; Sakaida, Tsukasa] Chiba Canc Ctr, Div Neurol Surg, Chiba 2608717, Japan; [Hatano, Kazuo] Tokyo Bay Adv Imaging & Radiat Oncol Clin, Div Radiat Oncol, Chiba, Japan; [Uchino, Yoshio] Chiba Ryogo Ctr, Div Nucl Med, Chiba, Japan; [Itami, Makiko] Chiba Canc Ctr, Div Surg Pathol, Chiba 2608717, Japan; [Hara, Ryusuke] Chiba Canc Ctr, Div Radiat Oncol, Chiba 2608717, Japan	Iuchi, T (reprint author), Chiba Canc Ctr, Div Neurol Surg, Chuo Ku, 666-2 Nitona Cho, Chiba 2608717, Japan.	tiuchi@chiba-cc.jp					Ullrich R, 2008, CLIN CANCER RES, V14, P2049, DOI 10.1158/1078-0432.CCR-07-1553; Iuchi T, 2006, INT J RADIAT ONCOL, V64, P1317, DOI 10.1016/j.ijrobp.2005.12.005; Pirotte B, 2004, J NUCL MED, V45, P1293; Kracht LW, 2004, CLIN CANCER RES, V10, P7163, DOI 10.1158/1078-0432.CCR-04-0262; Jacobs AH, 2005, J NUCL MED, V46, P1948; Goldman S, 1997, J NUCL MED, V38, P1459; Qi XS, 2006, INT J RADIAT ONCOL, V64, P1570, DOI 10.1016/j.ijrobp.2005.12.022; Tsien CI, 2012, CLIN CANCER RES, V18, P273, DOI 10.1158/1078-0432.CCR-11-2073; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Jones B, 2007, INT J RADIAT ONCOL, V68, P441, DOI 10.1016/j.ijrobp.2006.12.025; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; BURGER PC, 1988, J NEUROSURG, V68, P698, DOI 10.3171/jns.1988.68.5.0698; MOSSKIN M, 1989, ACTA RADIOL, V30, P225; Arita H, 2012, CANCER-AM CANCER SOC, V118, P1619, DOI 10.1002/cncr.26445; Carlson BL, 2009, INT J RADIAT ONCOL, V75, P21; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; FOWLER JF, 1989, BRIT J RADIOL, V62, P679; Grosu AL, 2011, INT J RADIAT ONCOL, V81, P1049, DOI 10.1016/j.ijrobp.2010.07.002; Iuchi T, 2014, INT J RADIAT ONCOL, V88, P793, DOI 10.1016/j.ijrobp.2013.12.011; Kinoshita M, 2009, NEUROIMAGE, V45, P312, DOI 10.1016/j.neuroimage.2008.11.034; Langen KJ, 2000, J NUCL MED, V41, P1250; Nagashima G, 1999, SURG NEUROL, V51, P292, DOI 10.1016/S0090-3019(98)00056-1; Okubo S, 2010, J NEURO-ONCOL, V99, P217, DOI 10.1007/s11060-010-0117-9; Van Nifterik KA, 2007, INT J RADIAT ONCOL, V69, P1246, DOI 10.1016/j.ijrobp.2007.07.2366; Viel T, 2013, EUR J NUCL MED MOL I, V40, P1595, DOI 10.1007/s00259-013-2464-1	26	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	SEP 1	2015	93	1					133	140		10.1016/j.ijrobp.2015.04.044		8	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CP3AV	WOS:000359750100020		
J	Ohashi, T; Yorozu, A; Saito, S; Tanaka, N; Katayama, N; Kojima, S; Maruo, S; Kikuchi, T; Dokiya, T; Fukushima, M; Yamanaka, H				Ohashi, Toshio; Yorozu, Atsunori; Saito, Shiro; Tanaka, Nobumichi; Katayama, Norihisa; Kojima, Shinsuke; Maruo, Shinichiro; Kikuchi, Takashi; Dokiya, Takushi; Fukushima, Masanori; Yamanaka, Hidetoshi			Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							EXTERNAL-BEAM RADIATION; RISK PROSTATE-CANCER; CLINICALLY LOCALIZED ADENOCARCINOMA; VOLUME HISTOGRAM ANALYSIS; PHASE-II TRIAL; INTERMEDIATE-RISK; SEED IMPLANTATION; GASTROINTESTINAL TOXICITY; PREDICTIVE FACTORS; THERAPY	Purpose: To assess, in a nationwide multi-institutional cohort study begun in 2005 and in which 6927 subjects were enrolled by 2010, the urinary and rectal toxicity profiles of subjects who enrolled during the first 2 years, and evaluate the toxicity profiles for permanent seed implantation (PI) and a combination therapy with PI and external beam radiation therapy (EBRT). Methods and Materials: Baseline data for 2339 subjects out of 2354 patients were available for the analyses. Toxicities were evaluated using the National Cancer Institute's Common Terminology Criteria for Adverse Events, and the International Prostate Symptom Scores were recorded prospectively until 36 months after radiation therapy. Results: Grade 2+ acute urinary toxicities developed in 7.36% (172 of 2337) and grade 2+ acute rectal toxicities developed in 1.03% (24 of 2336) of the patients. Grade 2+ late urinary and rectal toxicities developed in 5.75% (133 of 2312) and 1.86% (43 of 2312) of the patients, respectively. A higher incidence of grade 2+ acute urinary toxicity occurred in the PI group than in the EBRT group (8.49% vs 3.66%; P<.01). Acute rectal toxicity outcomes were similar between the treatment groups. The 3-year cumulative incidence rates for grade 2+ late urinary toxicities were 6.04% versus 4.82% for the PI and the EBRT groups, respectively, with no significant differences between the treatment groups. The 3-year cumulative incidence rates for grade 2+ late rectal toxicities were 0.90% versus 5.01% (P<.01) for the PI and the EBRT groups, respectively. The mean of the postimplant International Prostate Symptom Score peaked at 3 months, but it decreased to a range that was within 2 points of the baseline score, which was observed in 1625 subjects (69.47%) at the 1-year follow-up assessment. Conclusions: The acute urinary toxicities observed were acceptable given the frequency and retention, and the late rectal toxicities were more favorable than those of other studies. (C) 2015 Elsevier Inc. All rights reserved.	[Ohashi, Toshio] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Yorozu, Atsunori; Saito, Shiro] Natl Hosp Org, Tokyo Med Ctr, Tokyo, Japan; [Tanaka, Nobumichi] Nara Med Univ, Sch Med, Nara, Japan; [Katayama, Norihisa] Okayama Univ, Sch Med, Okayama 700, Japan; [Kojima, Shinsuke; Maruo, Shinichiro; Kikuchi, Takashi; Fukushima, Masanori] Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Dokiya, Takushi] Kyoundo Hosp, Tokyo, Japan; [Yamanaka, Hidetoshi] Kurosawa Hosp, Inst Prevent Med, Gunma, Japan	Ohashi, T (reprint author), Keio Univ, Sch Med, Dept Radiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ohashi@rad.med.keio.ac.jp					Albert M, 2003, CANCER, V98, P949, DOI 10.1002/cncr.11595; Keyes M, 2009, INT J RADIAT ONCOL, V73, P1023, DOI 10.1016/j.ijrobp.2008.05.022; Sylvester JE, 2011, INT J RADIAT ONCOL, V81, P376, DOI 10.1016/j.ijrobp.2010.05.042; Gelblum DY, 2000, INT J RADIAT ONCOL, V48, P119, DOI 10.1016/S0360-3016(00)00632-5; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P327, DOI 10.1016/j.ijrobp.2006.08.056; Williams SG, 2004, RADIOTHER ONCOL, V73, P33, DOI 10.1016/j.radonc.2004.07.026; Stone NN, 2012, J UROLOGY, V187, P117, DOI 10.1016/j.juro.2011.09.045; Hurwitz MD, 2011, CANCER-AM CANCER SOC, V117, P5579, DOI 10.1002/cncr.26203; Zelefsky MJ, 2008, BRACHYTHERAPY, V7, P1, DOI 10.1016/j.brachy.2007.12.002; Morris WJ, 2013, CANCER-AM CANCER SOC, V119, P1537, DOI 10.1002/cncr.27911; Zelefsky MJ, 2011, UROLOGY, V77, P986, DOI 10.1016/j.urology.2010.07.539; Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3; Lee WR, 2007, CANCER, V109, P1506, DOI 10.1002/cncr.22560; Kang SK, 2002, INT J RADIAT ONCOL, V53, P99, DOI 10.1016/S0360-3016(01)02811-5; Crook J, 2008, J UROLOGY, V179, P141, DOI 10.1016/j.juro.2007.08.136; Price JG, 2013, INT J RADIAT ONCOL, V86, P842, DOI 10.1016/j.ijrobp.2013.04.033; Grimm P, 2012, BJU INT, V109, P22, DOI 10.1111/j.1464-410X.2011.10827.x; Di Maio M, 2015, J CLIN ONCOL, V33, P910, DOI 10.1200/JCO.2014.57.9334; Crook J, 2011, INT J RADIAT ONCOL, V80, P1323, DOI 10.1016/j.ijrobp.2010.04.038; Ghaly M, 2003, INT J RADIAT ONCOL, V55, P1288, DOI 10.1016/S0360-3016(02)04527-3; Hurwitz MD, 2008, INT J RADIAT ONCOL, V72, P814, DOI 10.1016/j.ijrobp.2008.01.010; Kalakota K, 2010, BRACHYTHERAPY, V9, P131, DOI 10.1016/j.brachy.2009.08.012; Keyes M, 2014, INT J RADIAT ONCOL, V90, P570, DOI 10.1016/j.ijrobp.2014.06.037; Lawton CA, 2011, INT J RADIAT ONCOL, V81, P1, DOI 10.1016/j.ijrobp.2010.05.056; Lawton CA, 2012, INT J RADIAT ONCOL, V82, pE795, DOI 10.1016/j.ijrobp.2011.11.040; Lee WR, 2006, INT J RADIAT ONCOL, V64, P804, DOI 10.1016/j.ijrobp.2005.09.002; Marshall RA, 2014, UROL ONCOL, V32; Ohashi T, 2007, JPN J CLIN ONCOL, V37, P121, DOI 10.1093/jjco/hyl133; Saito S, 2015, INT J CLIN ONCOL, V20, P375, DOI 10.1007/s10147-014-0704-4; Sarosdy MF, 2004, CANCER, V101, P754, DOI 10.1002/cncr.20446; Shiraishi Y, 2011, INT J RADIAT ONCOL, V81, pE127, DOI 10.1016/j.ijrobp.2011.01.012; Snyder KM, 2001, INT J RADIAT ONCOL, V50, P335, DOI 10.1016/S0360-3016(01)01442-0; Wust P, 2004, RADIOTHER ONCOL, V73, P39, DOI 10.1016/j.radonc.2004.08.003; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P65, DOI 10.1016/j.ijrobp.2006.08.030	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	SEP 1	2015	93	1					141	149		10.1016/j.ijrobp.2015.05.014		9	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CP3AV	WOS:000359750100021		
J	Fujita, M; Imadome, K; Shoji, Y; Isozaki, T; Endo, S; Yamada, S; Imai, T				Fujita, Mayumi; Imadome, Kaori; Shoji, Yoshimi; Isozaki, Tetsurou; Endo, Satoshi; Yamada, Shigeru; Imai, Takashi			Carbon-Ion Irradiation Suppresses Migration and Invasiveness of Human Pancreatic Carcinoma Cells MIAPaCa-2 via Rac1 and RhoA Degradation	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							NF-KAPPA-B; UBIQUITIN LIGASES; INDUCED APOPTOSIS; OXIDATIVE STRESS; CANCER; EXPRESSION; ACTIVATION; PROTEIN; RADIOTHERAPY; RHOGDIS	Purpose: To investigate the mechanisms underlying the inhibition of cancer cell migration and invasion by carbon (C)-ion irradiation. Methods and Materials: Human pancreatic cancer cells MIAPaCa-2, AsPC-1, and BxPC-3 were treated by x-ray (4 Gy) or C-ion (0.5, 1, 2, or 4 Gy) irradiation, and their migration and invasion were assessed 2 days later. The levels of guanosine triphosphate (GTP)-bound Rac1 and RhoA were determined by the active GTPase pull-down assay with or without a proteasome inhibitor, and the binding of E3 ubiquitin ligase to GTP-bound Rac1 was examined by immunoprecipitation. Results: Carbon-ion irradiation reduced the levels of GTP-bound Rac1 and RhoA, 2 major regulators of cell motility, in MIAPaCa-2 cells and GTP-bound Rac1 in AsPC-1 and BxPC-3 cells. Proteasome inhibition reversed the effect, indicating that C-ion irradiation induced Rac1 and RhoA degradation via the ubiquitin (Ub)-proteasome pathway. E3 Ub ligase X-linked inhibitor of apoptosis protein (XIAP), which directly targets Rac1, was selectively induced in C-ioneirradiated MIAPaCa-2 cells and co-precipitated with GTP-bound Rac1 in C-ioneirradiated cells, which was associated with Rac1 ubiquitination. Cell migration and invasion reduced by C-ion radiation were restored by short interfering RNA-mediated XIAP knockdown, indicating that XIAP is involved in C-ion-induced inhibition of cell motility. Conclusion: In contrast to x-ray irradiation, C-ion treatment inhibited the activity of Rac1 and RhoA in MIAPaCa-2 cells and Rac1 in AsPC-1 and BxPC-3 cells via Ub-mediated proteasomal degradation, thereby blocking the motility of these pancreatic cancer cells. (C) 2015 The Authors. Published by Elsevier Inc.	[Fujita, Mayumi; Imadome, Kaori; Shoji, Yoshimi; Imai, Takashi] Natl Inst Radiol Sci, Adv Radiat Biol Res Program, Res Ctr Charged Particle Therapy, Chiba 2638555, Japan; [Isozaki, Tetsurou; Endo, Satoshi; Yamada, Shigeru] Natl Inst Radiol Sci, Res Ctr Hosp Charged Particle Therapy, Chiba 2638555, Japan	Imai, T (reprint author), Natl Inst Radiol Sci, Adv Radiat Biol Res Program, Res Ctr Charged Particle Therapy, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	imait@nirs.go.jp			Japan Society for the Promotion of Science [22591394, 25461934, 23791467]	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (grant nos. 22591394 and 25461934 to T.I.) and for Young Scientists (B) (grant no. 23791467 to M.F.) from the Japan Society for the Promotion of Science. This work was performed as a Research Project with Heavy Ions at the National Institute of Radiological Sciences-Heavy Ion Medical Accelerator in Chiba.	Nikjoo H, 1998, INT J RADIAT BIOL, V73, P355, DOI 10.1080/095530098142176; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Mitra AK, 2004, J ENVIRON PATHOL TOX, V23, P53, DOI 10.1615/JEnvPathToxOncol.v23.i1.50; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Fokas E, 2009, BBA-REV CANCER, V1796, P216, DOI 10.1016/j.bbcan.2009.07.005; Shishodia S, 2004, J BIOL CHEM, V279, P47148, DOI 10.1074/jbc.M408093200; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Cabal-Hierro L, 2014, CELL SIGNAL, V26, P2658, DOI 10.1016/j.cellsig.2014.08.011; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Yin SL, 2011, MOL PHARMACOL, V79, P1072, DOI 10.1124/mol.110.068528; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Kastle M, 2011, CURR PHARM DESIGN, V17, P4007; Fujita M, 2011, CANCER SCI, V102, P792, DOI 10.1111/j.1349-7006.2011.01852.x; Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124; Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Fujita M, 2012, CANCER SCI, V103, P677, DOI 10.1111/j.1349-7006.2011.02190.x; Fujita M, 2014, FEBS LETT, V588, P3240, DOI 10.1016/j.febslet.2014.07.006; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Mitra AK, 2005, MOL CELL BIOCHEM, V276, P169, DOI 10.1007/s11010-005-3903-5; Hellweg CE, 2011, INT J RADIAT BIOL, V87, P954, DOI 10.3109/09553002.2011.584942; Shinoto M, 2013, CANCER-AM CANCER SOC, V119, P45, DOI 10.1002/cncr.27723; DeNicola G, 2005, CANCER BIOL THER, V4, P509; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Fratini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019242; Sangsliwan T, 2008, RADIAT RES, V170, P776, DOI 10.1667/RR1399.1; Kamada T, 2015, LANCET ONCOL, V16, pE93, DOI 10.1016/S1470-2045(14)70412-7; Matsumoto K, 2015, CHEM PHARM BULL, V63, P195, DOI 10.1248/cpb.c14-00736; Nikjoo H, 1994, INT J RADIAT BIOL, V65, P7; Oberoi-Khanuja TK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.311; Sadok A, 2014, SMALL GTPASES, V5; Yen HC, 2009, SCIENCE, V322, P923	34	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	SEP 1	2015	93	1					173	180		10.1016/j.ijrobp.2015.05.009		8	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CP3AV	WOS:000359750100025		
J	Takahashi, A; Abe, K; Usami, K; Imaizumi, H; Hayashi, M; Okai, K; Kanno, Y; Tanji, N; Watanabe, H; Ohira, H				Takahashi, A.; Abe, K.; Usami, K.; Imaizumi, H.; Hayashi, M.; Okai, K.; Kanno, Y.; Tanji, N.; Watanabe, H.; Ohira, H.			Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						push-ups; squats; NAFLD	WEIGHT-LOSS; HEPATIC STEATOSIS; PHYSICAL-ACTIVITY; CONTROLLED-TRIAL; SKELETAL-MUSCLE; STEATOHEPATITIS; OBESE; MEN; ULTRASONOGRAPHY; METAANALYSIS	To date, only limited evidence has supported the notion that resistance exercise positively impacts non-alcoholic fatty liver disease. We evaluated the effects of resistance exercise on the metabolic parameters of non-alcoholic fatty liver disease (NAFLD) in 53 patients who were assigned to either a group that performed push-ups and squats 3 times weekly for 12 weeks (exercise group; n=31) or a group that did not (control; n=22). Patients in the control group proceeded with regular physical activities under a restricted diet throughout the study. The effects of the exercise were compared between the 2 groups after 12 weeks. Fat-free mass and muscle mass significantly increased, whereas hepatic steatosis grade, mean insulin and ferritin levels, and the homeostasis model assessment-estimated insulin resistance index were significantly decreased in the exercise group. Compliance with the resistance exercise program did not significantly correlate with patient background characteristics such as age, sex, BMI and metabolic complications. These findings show that resistance exercise comprising squats and push-ups helps to improve the characteristics of metabolic syndrome in patients with non-alcoholic fatty liver disease.	[Takahashi, A.; Abe, K.; Imaizumi, H.; Hayashi, M.; Okai, K.; Kanno, Y.; Watanabe, H.; Ohira, H.] Fukushima Med Univ, Sch Med, Gastroenterol & Rheumatol, Fukushima 9601295, Japan; [Usami, K.] Usami Med Clin, Internal Med, Koriyama, Fukushima, Japan; [Tanji, N.] Watari Hosp, Gastroenterol, Fukushima, Japan	Takahashi, A (reprint author), Fukushima Med Univ, Sch Med, Gastroenterol & Rheumatol, 1 HikarigaokaFukushima, Fukushima 9601295, Japan.	junior@fmu.ac.jp			Fukushima Medical University	This study was supported by a fellowship from Fukushima Medical University.	American Gastroenterological Association, 2002, GASTROENTEROLOGY, V123, P1702; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Johnson NA, 2010, HEPATOLOGY, V52, P370, DOI 10.1002/hep.23711; Zelber-Sagi S, 2008, HEPATOLOGY, V48, P1791, DOI 10.1002/hep.22525; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; McGuigan MR, 2009, J STRENGTH COND RES, V23, P80, DOI 10.1519/JSC.0b013e3181876a56; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Oza N, 2009, J GASTROENTEROL, V44, P1203, DOI 10.1007/s00535-009-0115-x; Lee S, 2012, DIABETES, V61, P2787, DOI 10.2337/db12-0214; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073; Kawaguchi T, 2011, J GASTROENTEROL, V46, P746, DOI 10.1007/s00535-011-0378-x; Keating SE, 2012, J HEPATOL, V57, P157, DOI 10.1016/j.jhep.2012.02.023; Bacchi E, 2013, HEPATOLOGY, V58, P1287, DOI 10.1002/hep.26393; Ueno T, 1997, J HEPATOL, V27, P103, DOI 10.1016/S0168-8278(97)80287-5; Ferrara CM, 2006, J GERONTOL A-BIOL, V61, P480; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Finelli C, 2012, WORLD J GASTROENTERO, V18, P6790, DOI 10.3748/wjg.v18.i46.6790; CELLE G, 1988, DIGEST DIS SCI, V33, P467, DOI 10.1007/BF01536033; Devries MC, 2008, OBESITY, V16, P2281, DOI 10.1038/oby.2008.358; DURAK EP, 1990, DIABETES CARE, V13, P1039, DOI 10.2337/diacare.13.10.1039; Frith J, 2010, J HEPATOL, V52, P112, DOI 10.1016/j.jhep.2009.10.010; Gordon BA, 2009, DIABETES RES CLIN PR, V83, P157, DOI 10.1016/j.diabres.2008.11.024; Johnson NA, 2012, SEMIN LIVER DIS, V32, P65, DOI 10.1055/s-0032-1306427; Kraemer WJ, 2001, MED SCI SPORT EXER, V33, P1011, DOI 10.1097/00005768-200106000-00022; Larose J, 2012, MED SCI SPORTS EXERC, V42, P1439; Tsochatzis EA, 2009, MEDIAT INFLAMM, DOI 10.1155/2009/831670	35	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	SEP	2015	36	10					848	852		10.1055/s-0035-1549853		5	Sport Sciences	Sport Sciences	CP7UW	WOS:000360095200012		
J	Hiroi, T; Omori, S				Hiroi, Taeko; Omori, Sawa			Policy change and coups: The role of income inequality and asset specificity	INTERNATIONAL POLITICAL SCIENCE REVIEW			English	Article						Coup; regime change; inequality; fixed assets; political instability; event history analysis	US FOREIGN-POLICY; POLITICAL-ECONOMY; CIVIL-WAR; AFRICA; DEMOCRACY; MODELS; AID; DATABASE; WORLD; POWER	Building on the models developed by Boix, Acemoglu, and Robinson on the relationship between economic structures and regime change, we develop a theory that emphasises structural characteristics of societies and the effects of policy change in such circumstances. We posit that significant policy change in an unequal or asset-specific society induces coups against the incumbent political leader by the losing faction of the elites seeking to prevent or cut losses associated with the policy shifts. Our empirical analysis indicates that the risk of a coup rises considerably during a period of a significant policy change in a society with a skewed distribution of income and one dominated by asset-specific production, such as oil, mining, and agriculture.	[Hiroi, Taeko] Univ Texas El Paso, Polit Sci, El Paso, TX 79968 USA; [Omori, Sawa] Int Christian Univ, Dept Polit & Int Studies, Mitaka, Tokyo 181, Japan	Hiroi, T (reprint author), Univ Texas El Paso, Dept Polit Sci, 500 W Univ Ave, El Paso, TX 79968 USA.	thiroi@utep.edu					Belkin A, 2003, J CONFLICT RESOLUT, V47, P594, DOI 10.1177/0022002703258197; LONDREGAN JB, 1990, WORLD POLIT, V42, P151, DOI 10.2307/2010462; Hegre H, 2001, AM POLIT SCI REV, V95, P33; Collier P, 2002, J CONFLICT RESOLUT, V46, P13, DOI 10.1177/0022002702046001002; Meernik J, 1998, J POLIT, V60, P63, DOI 10.2307/2648001; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; OKANE RHT, 1993, J PEACE RES, V30, P251, DOI 10.1177/0022343393030003002; Djankov S, 2008, J ECON GROWTH, V13, P169, DOI 10.1007/s10887-008-9032-8; Freeman JR, 2012, AM POLIT SCI REV, V106, P58, DOI 10.1017/S0003055411000505; Stone RW, 2004, AM POLIT SCI REV, V98, P577; Beck T, 2001, WORLD BANK ECON REV, V15, P165, DOI 10.1093/wber/15.1.165; Jones BS, 2005, STATE POLIT POLICY Q, V5, P420, DOI 10.1177/153244000500500406; Solt F, 2009, SOC SCI QUART, V90, P231, DOI 10.1111/j.1540-6237.2009.00614.x; Quinn D, 2011, IMF ECON REV, V59, P488, DOI 10.1057/imfer.2011.18; Ross ML, 2001, WORLD POLIT, V53, P325, DOI 10.1353/wp.2001.0011; Banks Arthur S, 2011, CROSS NATL TIME SERI; Beblawi Hazem, 1987, RENTIER STATE; Box-Steffensmeier Janet M, 2004, EVENT HIST MODELING; Carles Boix, 2003, DEMOCRACY REDISTRIBU; Chinn Menzie, 2008, J COMP POLICY ANAL, V10, P309, DOI DOI 10.1080/13876980802231123; Daron Acemoglu, 2006, EC ORIGINS DICTATORS; GASIOROWSKI MJ, 1987, INT J MIDDLE E STUD, V19, P261; Genna Gaspare M, 2013, 54 INT STUD ASS ANN; Genna GM, 2007, LAT AM PERSPECT, V34, P43, DOI 10.1177/0094582XO7306237; Huntington P., 1991, 3 WAVE DEMOCRATIZATI; Huntington Samuel P, 1957, SOLDIER STATE THEORY; Huntington Samuel P, 1968, POLITICAL ORDER CHAN; Jackman Robert W, 1978, AM POLIT SCI REV, V72, P1262; Jenkins Craig J, 1992, INT STUDIES Q, V36, P271; Larrain Felipe, 1991, MACROECONOMICS POPUL, P175; Lehoucq Fabrice, 2013, COMP POLIT STUD, DOI [10.1177/0010414013488561, DOI 10.1177/0010414013488561]; Licht AA, 2011, POLIT ANAL, V19, P227, DOI 10.1093/pan/mpq039; Lindberg SI, 2008, DEMOCRATIZATION, V15, P86, DOI 10.1080/13510340701768182; Luttwak Edward, 1969, COUP ETAT PRACTICAL; Marshall Monty G, 2010, COUP ETAT EVENTS 194; Marshall Monty G, 2010, POLITY 4 PROJECT POL; Mokhtari F, 2008, MIDDLE EAST J, V62, P457, DOI 10.3751/62.3.15; MULLER EN, 1985, INT STUD QUART, V29, P445, DOI 10.2307/2600381; Omori S., 2013, POLITICS POLICY, V41, P39; Russett Bruce M, 1993, GRASPING DEMOCRATIC; Sen Amartya, 1999, J DEMOCR, V10, P3; Siverson RM, 1992, AM POLIT SCI REV, V86, P638; Svolik Milan W, 2012, POLITICS AUTHORITARI; THOMPSON WR, 1980, COMP POLIT STUD, V12, P485; Thyne CL, 2010, J PEACE RES, V47, P449, DOI 10.1177/0022343310368350	45	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0192-5121	1460-373X		INT POLIT SCI REV	Int. Polit. Sci. Rev.	SEP	2015	36	4					441	456		10.1177/0192512113518568		16	Political Science	Government & Law	CP5JT	WOS:000359918300006		
J	Erbar, M; Kuwada, K; Sturm, KT				Erbar, Matthias; Kuwada, Kazumasa; Sturm, Karl-Theodor			On the equivalence of the entropic curvature-dimension condition and Bochner's inequality on metric measure spaces	INVENTIONES MATHEMATICAE			English	Article							RICCI CURVATURE; ALEXANDROV SPACES; LI-YAU; WASSERSTEIN DISTANCE; EULERIAN CALCULUS; HEAT-FLOW; CONTRACTION; GEOMETRY; BOUNDS	We prove the equivalence of the curvature-dimension bounds of Lott-Sturm-Villani (via entropy and optimal transport) and of Bakry-A parts per thousand mery (via energy and -calculus) in complete generality for infinitesimally Hilbertian metric measure spaces. In particular, we establish the full Bochner inequality on such metric measure spaces. Moreover, we deduce new contraction bounds for the heat flow on Riemannian manifolds and on mms in terms of the -Wasserstein distance.	[Erbar, Matthias; Sturm, Karl-Theodor] Univ Bonn, Inst Appl Math, D-53115 Bonn, Germany; [Kuwada, Kazumasa] Tokyo Inst Technol, Grad Sch Sci, Meguro Ku, Tokyo 1528551, Japan	Sturm, KT (reprint author), Univ Bonn, Inst Appl Math, Endenicher Allee 60, D-53115 Bonn, Germany.	erbar@iam.uni-bonn.de; kuwada@math.titech.ac.jp; sturm@uni-bonn.de					Ambrosio L., T AM MATH SOC; Ambrosio L., NONLINEAR DIFFUSION; Ambrosio L., 2013, INVENT MATH, V195, P289; Ambrosio L., 2012, CIME LECT NOTES MATH; Ambrosio L, 2008, LECT MATH ETH ZURICH; Ambrosio L., 2014, J GEOM ANAL; Ambrsio L, 2015, ANN PROBAB, V43, P339, DOI 10.1214/14-AOP907; Bolley F, 2014, J LOND MATH SOC, V90, P309, DOI 10.1112/jlms/jdu027; Koskela P, 2012, ADV MATH, V231, P2755, DOI 10.1016/j.aim.2012.08.004; Otto F, 2000, J FUNCT ANAL, V173, P361, DOI 10.1006/jfan.1999.3557; Kuwada K, 2010, J FUNCT ANAL, V258, P3758, DOI 10.1016/j.jfa.2010.01.010; Sturm KT, 2006, ACTA MATH-DJURSHOLM, V196, P65, DOI 10.1007/s11511-006-0002-8; Otto F, 2005, SIAM J MATH ANAL, V37, P1227, DOI 10.1137/050622420; Lott J, 2009, ANN MATH, V169, P903; Ohta S, 2009, CALC VAR PARTIAL DIF, V36, P211, DOI 10.1007/s00526-009-0227-4; Gigli N, 2013, COMMUN PUR APPL MATH, V66, P307, DOI 10.1002/cpa.21431; Rajala T, 2012, CALC VAR PARTIAL DIF, V44, P477, DOI 10.1007/s00526-011-0442-7; Daneri S, 2008, SIAM J MATH ANAL, V40, P1104, DOI 10.1137/08071346X; Bakry D, 2006, REV MAT IBEROAM, V22, P683; Villani C, 2000, IEEE T INFORM THEORY, V46, P1695, DOI 10.1109/18.850718; DEMBO A, 1991, IEEE T INFORM THEORY, V37, P1501, DOI 10.1109/18.104312; Jordan R, 1998, SIAM J MATH ANAL, V29, P1, DOI 10.1137/S0036141096303359; Ohta S, 2014, ADV MATH, V252, P429, DOI 10.1016/j.aim.2013.10.018; Rajala T, 2014, CALC VAR PARTIAL DIF, V50, P831, DOI 10.1007/s00526-013-0657-x; Bacher K, 2010, J FUNCT ANAL, V259, P28, DOI 10.1016/j.jfa.2010.03.024; Wang FY, 2011, B SCI MATH, V135, P803, DOI 10.1016/j.bulsci.2011.07.005; Ambrosio L, 2014, DUKE MATH J, V163, P1405, DOI 10.1215/00127094-2681605; Zhang HC, 2012, J DIFFER GEOM, V91, P445; Bacher K., 2014, SINGULAR PHENOMENA S, P3; Bakry D., 1985, LECT NOTES MATH, V1123, P177, DOI DOI 10.1007/BFB0075847.MR889476; Bakry D., 1994, LECT NOTES MATH, V1581, P1, DOI 10.1007/BFb0073872; Burago D., 2001, GRADUATE STUDIES MAT, V33; Cavalletti F, 2012, J FUNCT ANAL, V262, P5110, DOI 10.1016/j.jfa.2012.02.015; Davies E.B., 1990, CAMBRIDGE TRACTS MAT, V92; Garofalo N, 2014, NONLINEAR ANAL-THEOR, V95, P721, DOI 10.1016/j.na.2013.10.002; Gigli N, 2010, CALC VAR PARTIAL DIF, V39, P101, DOI 10.1007/s00526-009-0303-9; Gigli N., PREPRINT; HAJLASZ P., 2000, MEM AM MATH SOC, V145; Ketterer C, 2013, J FUNCT ANAL, V265, P266, DOI 10.1016/j.jfa.2013.05.008; Kuwada K., 2014, CALC VAR PARTIAL DIF; LI P, 1986, ACTA MATH-DJURSHOLM, V156, P153, DOI 10.1007/BF02399203; Naber A., PREPRINT; Petrunin A., 2011, MUNSTER J MATH, V4, P53; Profeta A., PREPRINT; Simon B., 2011, CAMBRIDGE TRACTS MAT, V187; Villani C, 2009, GRUNDLEHR MATH WISS, V338, P5; Zhang HC, 2010, COMMUN ANAL GEOM, V18, P503	47	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-9910	1432-1297		INVENT MATH	Invent. Math.	SEP	2015	201	3					993	1071		10.1007/s00222-014-0563-7		79	Mathematics	Mathematics	CP6LN	WOS:000359998900005		
J	Hathwar, VR; Sist, M; Jorgensen, MRV; Mamakhel, AH; Wang, XP; Hoffmann, CM; Sugimoto, K; Overgaard, J; Iversen, BB				Hathwar, Venkatesha R.; Sist, Mattia; Jorgensen, Mads R. V.; Mamakhel, Aref H.; Wang, Xiaoping; Hoffmann, Christina M.; Sugimoto, Kunihisa; Overgaard, Jacob; Iversen, Bo Brummerstedt			Quantitative analysis of intermolecular interactions in orthorhombic rubrene	IUCRJ			English	Article						electron density; rubrene; organic semiconductor; interaction energy	FIELD-EFFECT TRANSISTORS; EXPERIMENTAL ELECTRON-DENSITY; THEORETICAL CHARGE-DENSITY; PI-PI INTERACTIONS; ORGANIC SEMICONDUCTORS; SINGLE-CRYSTALS; NEUTRON-DIFFRACTION; MOLECULAR-CRYSTALS; INTERACTION ENERGIES; NONCOVALENT INTERACTIONS	Rubrene is one of the most studied organic semiconductors to date due to its high charge carrier mobility which makes it a potentially applicable compound in modern electronic devices. Previous electronic device characterizations and first principles theoretical calculations assigned the semiconducting properties of rubrene to the presence of a large overlap of the extended pi-conjugated core between molecules. We present here the electron density distribution in rubrene at 20 K and at 100 K obtained using a combination of high-resolution X-ray and neutron diffraction data. The topology of the electron density and energies of intermolecular interactions are studied quantitatively. Specifically, the presence of C-pi center dot center dot center dot C-pi interactions between neighbouring tetracene backbones of the rubrene molecules is experimentally confirmed from a topological analysis of the electron density, Non-Covalent Interaction (NCI) analysis and the calculated interaction energy of molecular dimers. A significant contribution to the lattice energy of the crystal is provided by H-H interactions. The electron density features of H-H bonding, and the interaction energy of molecular dimers connected by H-H interaction clearly demonstrate an importance of these weak interactions in the stabilization of the crystal structure. The quantitative nature of the intermolecular interactions is virtually unchanged between 20 K and 100 K suggesting that any changes in carrier transport at these low temperatures would have a different origin. The obtained experimental results are further supported by theoretical calculations.	[Hathwar, Venkatesha R.; Sist, Mattia; Jorgensen, Mads R. V.; Mamakhel, Aref H.; Overgaard, Jacob; Iversen, Bo Brummerstedt] Aarhus Univ, Dept Chem, Ctr Mat Crystallog, DK-8000 Aarhus C, Denmark; [Hathwar, Venkatesha R.; Sist, Mattia; Jorgensen, Mads R. V.; Mamakhel, Aref H.; Overgaard, Jacob; Iversen, Bo Brummerstedt] Aarhus Univ, iNANO, DK-8000 Aarhus C, Denmark; [Wang, Xiaoping; Hoffmann, Christina M.] Oak Ridge Natl Lab, Neutron Sci Directorate, Chem & Engn Mat Div, Oak Ridge, TN 37831 USA; [Sugimoto, Kunihisa] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Overgaard, J (reprint author), Aarhus Univ, Dept Chem, Ctr Mat Crystallog, Langelandsgade 140, DK-8000 Aarhus C, Denmark.	jacobo@chem.au.dk; bo@chem.au.dk	Wang, Xiaoping/E-8050-2012	Wang, Xiaoping/0000-0001-7143-8112	Danish National Research Foundation [DNRF93]; Danish Council for Nature and Universe (DanScatt); Scientific User Facilities Division, Office of Basic Energy Sciences, US Department of Energy	This work was supported by the Danish National Research Foundation (DNRF93) and the Danish Council for Nature and Universe (DanScatt). Research conducted at the Spallation Neutron Source, Oak Ridge National Laboratory was sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, US Department of Energy. The synchrotron radiation experiment at BL02B1/SPring8, Japan, was conducted with the approval of the Japan Synchrotron Radiation Research Institute (Proposal No: 2014A0078).	Reese C, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70016-0; Gavezzotti A, 2011, NEW J CHEM, V35, P1360, DOI 10.1039/c0nj00982b; HANSEN NK, 1978, ACTA CRYSTALLOGR A, V34, P909, DOI 10.1107/S0567739478001886; Sovago I, 2014, CRYST GROWTH DES, V14, P1227, DOI 10.1021/cg401757z; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/nmat2834, 10.1038/NMAT2834]; Hulea IN, 2006, NAT MATER, V5, P982, DOI 10.1038/nmat1774; SCHULTZ AJ, 1984, J AM CHEM SOC, V106, P999, DOI 10.1021/ja00316a031; Wu SM, 2008, NAT NANOTECHNOL, V3, P569, DOI 10.1038/nnano.2008.237; Wolstenholme DJ, 2006, J PHYS CHEM A, V110, P8970, DOI 10.1021/jp061205i; Hubschle CB, 2006, J APPL CRYSTALLOGR, V39, P901, DOI 10.1107/S0021889806041859; Jiang H, 2013, MRS BULL, V38, P28, DOI 10.1557/mrs.2012.308; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Murphy AR, 2007, CHEM REV, V107, P1066, DOI 10.1021/cr0501386; Dovesi R, 2014, INT J QUANTUM CHEM, V114, P1287, DOI 10.1002/qua.24658; Madsen AO, 2006, J APPL CRYSTALLOGR, V39, P757, DOI 10.1107/S0021889806026379; da Silva DA, 2005, ADV MATER, V17, P1072, DOI 10.1002/adma.200401866; Schultz AJ, 2014, J APPL CRYSTALLOGR, V47, P915, DOI 10.1107/S1600576714006372; Saleh G, 2013, J APPL CRYSTALLOGR, V46, P1513, DOI 10.1107/S0021889813020098; Wen SH, 2009, J PHYS CHEM B, V113, P8813, DOI 10.1021/jp900512s; Grabowski SJ, 2007, CHEM PHYS, V337, P68, DOI 10.1016/j.chemphys.2007.06.042; Gavezzotti A, 2008, MOL PHYS, V106, P1473, DOI 10.1080/00268970802060674; Saleh G, 2012, CHEM-EUR J, V18, P15523, DOI 10.1002/chem.201201290; Paul A, 2011, ACTA CRYSTALLOGR B, V67, P365, DOI 10.1107/S0108768111022683; Nguyen TH, 2012, J PHYS CHEM A, V116, P3420, DOI 10.1021/jp2108076; Su ZW, 1998, ACTA CRYSTALLOGR A, V54, P646, DOI 10.1107/S0108767398003390; Dong HL, 2010, CHEM COMMUN, V46, P5211, DOI 10.1039/c0cc00947d; Li HY, 2012, J AM CHEM SOC, V134, P2760, DOI 10.1021/ja210430b; Podzorov V, 2013, MRS BULL, V38, P15, DOI 10.1557/mrs.2012.306; STRICKLER SJ, 1962, J CHEM PHYS, V37, P814, DOI 10.1063/1.1733166; Subramanian V, 2005, IEEE T COMPON PACK T, V28, P742, DOI 10.1109/TCAPT.2005.859672; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Jurchescu OD, 2007, ADV MATER, V19, P688, DOI 10.1002/adma.200600929; GATTI C, 1994, J CHEM PHYS, V101, P10686, DOI 10.1063/1.467882; BIEGLERKONIG FW, 1982, J COMPUT CHEM, V3, P317, DOI 10.1002/jcc.540030306; Espinosa E, 2002, J CHEM PHYS, V117, P5529, DOI 10.1063/1.1501133; Wolstenholme DJ, 2007, J PHYS CHEM A, V111, P8803, DOI 10.1021/jp071002+; Scherer W, 2006, NEW J CHEM, V30, P309, DOI 10.1039/b515171f; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Echeverria J, 2011, NAT CHEM, V3, P323, DOI [10.1038/nchem.1004, 10.1038/NCHEM.1004]; Matta CF, 2003, CHEM-EUR J, V9, P1940, DOI 10.1002/chem.200204626; Johnson ER, 2010, J AM CHEM SOC, V132, P6498, DOI 10.1021/ja100936w; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; Delgado MCR, 2009, J AM CHEM SOC, V131, P1502, DOI 10.1021/ja807528w; Lane JR, 2013, J CHEM THEORY COMPUT, V9, P3263, DOI 10.1021/ct400420r; Shishkina AV, 2013, CRYST GROWTH DES, V13, P816, DOI 10.1021/cg3015223; Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242; Mishra A, 2012, ANGEW CHEM INT EDIT, V51, P2020, DOI 10.1002/anie.201102326; Sinnokrot MO, 2002, J AM CHEM SOC, V124, P10887, DOI 10.1021/ja025896h; Dunitz JD, 2012, CRYST GROWTH DES, V12, P5873, DOI 10.1021/cg301293r; Facchetti A, 2007, MATER TODAY, V10, P28, DOI 10.1016/S1369-7021(07)70017-2; Reineke S, 2013, REV MOD PHYS, V85, P1245, DOI 10.1103/RevModPhys.85.1245; Lezama IG, 2013, MRS BULL, V38, P51, DOI 10.1557/mrs.2012.311; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Macchi P, 2001, ACTA CRYSTALLOGR A, V57, P656, DOI 10.1107/S0108767301010182; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Volkov A, 2004, CHEM PHYS LETT, V391, P170, DOI 10.1016/j.cplett.2004.04.097; Macchi P, 1998, J AM CHEM SOC, V120, P1447, DOI 10.1021/ja972558l; Maschio L, 2011, J PHYS CHEM A, V115, P11179, DOI 10.1021/jp203132k; Bader R F W, 1990, ATOMS MOL QUANTUM TH; Bergantin S, 2012, CRYST GROWTH DES, V12, P6035, DOI 10.1021/cg301130n; Braun DE, 2013, CRYST GROWTH DES, V13, P4071, DOI 10.1021/cg4009015; COPPENS P, 1967, SCIENCE, V158, P1577, DOI 10.1126/science.158.3808.1577; Farrugia LJ, 2012, J APPL CRYSTALLOGR, V45, P849, DOI 10.1107/S0021889812029111; FIGGIS BN, 1993, ACTA CRYSTALLOGR B, V49, P794, DOI 10.1107/S0108768193002812; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fumagalli E, 2011, CHEM MATER, V23, P3246, DOI 10.1021/cm201230j; Hasegawa T., 2009, SCI TECHNOL ADV MAT, P10; HIRSHFELD FL, 1976, ACTA CRYSTALLOGR A, V32, P239, DOI 10.1107/S0567739476000533; Hunter CA, 2001, J CHEM SOC PERK T 2, P651, DOI 10.1039/b008495f; Iversen B. B., 1997, DALTON T, V13, P2227; Jorgensen MRV, 2014, ACTA CRYSTALLOGR A, V70, P679, DOI 10.1107/S2053273314015599; Jurchescu OD, 2006, ACTA CRYSTALLOGR B, V62, P330, DOI 10.1107/S0108768106003053; Kobayashi H., 2013, J CHEM PHYS, P139; Larson A. C., 1994, 86748 LAUR LOS AL NA; Lu YX, 2007, CHEM PHYS, V334, P1, DOI 10.1016/j.chemphys.2006.12.011; Mastrogiovanni DDT, 2014, SCI REP-UK, V4, DOI 10.1038/srep04753; McGarry KA, 2013, CHEM MATER, V25, P2254, DOI 10.1021/cm400736s; Morgenroth W, 2008, J APPL CRYSTALLOGR, V41, P846, DOI 10.1107/S0021889808024643; Overgaard J, 2001, CHEM-EUR J, V7, P3756, DOI 10.1002/1521-3765(20010903)7:17<3756::AID-CHEM3756>3.0.CO;2-Q; Podzorov V., 2004, PHYS REV LETT, P93; Reyes-Martinez MA, 2012, ADV MATER, V24, P5548, DOI 10.1002/adma.201201749; Seferos DS, 2005, P NATL ACAD SCI USA, V102, P8821, DOI 10.1073/pnas.0500002102; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stehr V., 2011, PHYS REV B, P83; Takahashi T., 2006, APPL PHYS LETT, P88; Taylor J., 2012, B AM PHYS SOC, P57; Volkov A., 2006, XD2006 COMPUTER PROG; WILLIAMS DE, 1984, ACTA CRYSTALLOGR B, V40, P404, DOI 10.1107/S010876818400238X; Yamashita Y, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/2/024313; Yassar A, 2014, POLYM SCI SER C+, V56, P4, DOI 10.1134/S1811238214010111; Zhurova EA, 2006, J AM CHEM SOC, V128, P8849, DOI 10.1021/ja061080v	91	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2052-2525			IUCRJ	IUCrJ	SEP	2015	2		5				563	574		10.1107/S2052252515012130		12	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CP7KV	WOS:000360067300012		
J	Bruner, E; Amano, H; de la Cuetara, JM; Ogihara, N				Bruner, Emiliano; Amano, Hideki; de la Cuetara, Jose Manuel; Ogihara, Naomichi			The brain and the braincase: a spatial analysis on themidsagittal profile in adult humans	JOURNAL OF ANATOMY			English	Article						geometric morphometrics; neuroanatomy; paleoneurology; parietal lobes; precuneus; vault	GENUS HOMO; GEOMETRIC MORPHOMETRICS; SHAPE VARIATION; SKULL VAULT; INTEGRATION; EVOLUTION; MRI; CRANIOSYNOSTOSIS; MODULARITY; ALLOMETRY	The spatial relationships between brain and braincase represent a major topic in surgery and evolutionary neuroanatomy. In paleoneurology, neurocranial landmarks are often used as references for brain areas. In this study, we analyze the variation and covariation of midsagittal brain and skull coordinates in a sample of adult modern humans in order to demonstrate spatial associations between hard and soft tissues. The correlation between parietal lobe size and parietal bone size is very low, and there is a marked individual variation. The distances between lobes and bones are partially influenced by the dimensions of the parietal lobes. The main pattern of morphological variability among individuals, associated with the size of the precuneus, apparently does not influence the position of the neurocranial sutures. Therefore, variations in precuneal size modify the distance between the paracentral lobule and bregma, and between the parietal lobe and lambda. Hence, the relative position of the cranial and cerebral landmarks can change as a function of the parietal dimensions. The slight correlation and covariation among these elements suggests a limited degree of spatial integration between soft and hard tissues. Therefore, although the brain influences the cranial size and shape during morphogenesis, the specific position of the cerebral components is sensitive to multiple effects and local factors, without a strict correspondence with the bone landmarks. This absence of correspondent change between brain and skull boundaries suggests caution when making inferences about the brain areas from the position of the cranial sutures. The fact that spatial relationships between cranial and brain areas may vary according to brain proportions must be considered in paleoneurology, when brain anatomy is inferred from cranial evidence.	[Bruner, Emiliano] Ctr Nacl Invest Evoluc Humana, Burgos 09002, Spain; [Amano, Hideki; Ogihara, Naomichi] Keio Univ, Yokohama, Kanagawa 223, Japan; [de la Cuetara, Jose Manuel] Univ Autonoma Madrid, Madrid, Spain	Bruner, E (reprint author), Ctr Nacl Invest Evoluc Humana, Paseo Sierra Atapuerca 3, Burgos 09002, Spain.	emiliano.bruner@cenieh.es			Japanese Ministry of Education, Culture, Sports, Science, and Technology [22101006]; Ministerio de Economia y Competitividad, Spain [CGL2012-38434-C03-02]; Italian Institute of Anthropology (Isita); NIH [P50AG05681, P01AG03991, P20MH071616, RR14075, RR16594, BIRN002]	This study is funded by a Grant-in-Aid for Scientific Research on Innovative Areas 'Replacement of Neanderthals by Modern Humans: Testing Evolutionary Models of Learning' from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#22101006). Emiliano Bruner and Jose Manuel de la Cuetara are funded by the Ministerio de Economia y Competitividad, Spain (CGL2012-38434-C03-02) and by the Italian Institute of Anthropology (Isita). Two anonymous referees provided very useful notes improving the structure of the manuscript and the interpretation of the results. We thank Gizeh Rangel and Sofia Pedro for their comments, and Simon Neubauer for the images in Fig. 4. The OASIS project is founded by NIH grants P50AG05681, P01AG03991, P20MH071616, RR14075, RR16594, BIRN002, the Alzheimer's Association, the James S. McDonnell Foundation, the Mental Illness and Neuroscience Discovery Institute, and the Howard Hughes Medical Institute. The authors declare no conflict of interest.	Aldridge K, 2002, J ANAT, V201, P31, DOI 10.1046/j.1469-7580.2002.00074.x; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Manzi G, 1996, J HUM EVOL, V30, P511, DOI 10.1006/jhev.1996.0040; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Morriss-Kay GM, 2005, J ANAT, V207, P637; Richtsmeier JT, 2006, J EXP ZOOL PART B, V306B, P360, DOI 10.1002/jez.b.21092; Rohlf FJ, 2000, SYST BIOL, V49, P740; Cheverud JM, 1996, AM ZOOL, V36, P44; Bastir M, 2006, J ANAT, V209, P637, DOI 10.1111/j.1469-7580.2006.00644.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; Bruner E, 2004, J HUM EVOL, V47, P279, DOI 10.1016/j.jhevol.2004.03.009; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Gunz P, 2007, J HUM EVOL, V52, P262, DOI 10.1016/j.jhevo1.2006.08.010; Ribas GC, 2006, NEUROSURGERY, V59, P177, DOI 10.1227/01.NEU.0000240682.28616.b2; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; MOSS ML, 1960, AM J PHYS ANTHROPOL, V18, P281, DOI 10.1002/ajpa.1330180406; Barberini F, 2008, SURG RADIOL ANAT, V30, P683, DOI 10.1007/s00276-008-0371-0; Bookstein F., 1991, MORPHOMETRIC TOOLS L; Bruner E, 2004, COLLEGIUM ANTROPOL, V28, P99; Bruner E, 2008, AM J PHYS ANTHROPOL, V137, P30, DOI 10.1002/ajpa.20837; Bruner E, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00019; Bruner E, 2010, J ANAT, V216, P589, DOI 10.1111/j.1469-7580.2010.01221.x; Bruner E, 2015, HUMAN PALEONEUROLOGY, P57; Bruner E, 2015, NEUROSCIENCE, V286, P345, DOI 10.1016/j.neuroscience.2014.11.063; Bruner E, 2014, J ANAT, V224, P367, DOI 10.1111/joa.12155; Bruner E., 2014, DYNAMICS LEARNING NE, V2, P121, DOI DOI 10.1007/978-4-431-54553-8_13; Bruner E, 2011, ANAT REC, V294, P1548, DOI 10.1002/ar.21450; CHEVERUD JM, 1982, AM J PHYS ANTHROPOL, V59, P139, DOI 10.1002/ajpa.1330590204; Cotton F, 2005, SURG RADIOL ANAT, V27, P64, DOI 10.1007/s00276-004-0283-6; Enlow DH, 1990, FACIAL GROWTH; Gomez-Robles A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5469; Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025; Hilgetag CC, 2005, ANAT EMBRYOL, V210, P411, DOI 10.1007/s00429-005-0041-5; Holloway RL, 2004, HUMAN FOSSIL RECORD, VThree; Kobayashi Y, 2014, DYNAMICS LEARNING NE, V2, P139; Kobayashi Y., 2014, DYNAMICS LEARNING NE, V2, P131; MARTIN RD, 1989, FOLIA PRIMATOL, V53, P65, DOI 10.1159/000156409; Neubauer S, 2014, BRAIN BEHAV EVOLUT, V84, P117, DOI 10.1159/000365276; Ogihara N, 2015, ANTHROPOL SCI, V123, P57, DOI 10.1537/ase.141109; VansEssen DC, 1997, NATURE, V385, P313; WAGNER GP, 1984, J MATH BIOL, V21, P77; Zelditch M, 2004, GEOMETRIC SHAPE ANAL	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	SEP	2015	227	3					268	276		10.1111/joa.12355		9	Anatomy & Morphology	Anatomy & Morphology	CP4RD	WOS:000359869300002		
J	Tsutsumi, S; Ogino, I; Miyajima, M; Ito, M; Arai, H; Yasumoto, Y				Tsutsumi, Satoshi; Ogino, Ikuko; Miyajima, Masakazu; Ito, Masanori; Arai, Hajime; Yasumoto, Yukimasa			Cerebrospinal fluid drainage through the diploic and spinal epidural veins	JOURNAL OF ANATOMY			English	Article						biomarkers; CSF drainage; diploic veins; spinal epidural venous plexus	PROSTAGLANDIN D SYNTHASE; ARACHNOID GRANULATIONS; MR VENOGRAPHY; ABSORPTION; METRIZAMIDE; CHANNELS; OUTFLOW; SINUSES; BLOOD; MODEL	The aim of this study was to quantitatively evaluate the function of the cranial diploic and spinal epidural veins as cerebrospinal fluid (CSF) drainage pathways by measuring lipocalin-type prostaglandin D synthase (PGDS) and cystatin C (CysC) dissolved in the blood of these veins. This was a prospective study involving 51 consecutive patients, 31 males and 20 females, who underwent 41 cranial and 10 spinal surgeries. Intraoperatively, peripheral venous blood and diploic venous blood, or peripheral venous blood and spinal epidural venous blood samples were simultaneously collected and immediately centrifuged. For all samples, dissolved albumin (for reference), PGDS and CysC were measured using an enzyme-linked immunosorbent assay. The diploic vein/peripheral vein ratios in five cranial locations and epidural vein/peripheral vein ratios were calculated and statistically evaluated for the three biomarkers. For PGDS, the diploic vein/peripheral vein ratio was significantly increased in the frontal (P = 0.011), temporal (P = 0.028), parietal (P = 0.046) and skull base (P = 0.039), while it did not reach statistical significance for CysC. For patients older than 45 years, the diploic vein/peripheral vein ratio for PGDS was significantly decreased in the frontal region (P = 0.028), and theepidural vein/peripheral vein ratio for CysC was significantly decreased (P = 0.014). These results show that the diploic veins constitute CSF drainage pathways with heterogeneous functional intensity at different cranial locations. Compared with the diploic veins, spinal epidural veins seem to drain less CSF. The cranial diploic and spinal epidural veins may jointly function as an alternative, age-related trans-dural CSF drainage system.	[Tsutsumi, Satoshi; Ito, Masanori; Yasumoto, Yukimasa] Juntendo Univ, Urayasu Hosp, Dept Neurol Surg, Urayasu, Chiba 2790021, Japan; [Ogino, Ikuko; Miyajima, Masakazu; Arai, Hajime] Juntendo Univ, Sch Med, Dept Neurol Surg, Tokyo 113, Japan	Tsutsumi, S (reprint author), Juntendo Univ, Urayasu Hosp, Dept Neurol Surg, 2-1-1 Tomioka, Urayasu, Chiba 2790021, Japan.	shotaro@juntendo-urayasu.jp					Huang YC, 2009, J NEUROIMMUNOL, V206, P100, DOI 10.1016/j.jneuroim.2008.10.011; Yamashima T, 1997, J NEUROSCI, V17, P2376; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Roche J, 1996, AM J NEURORADIOL, V17, P677; Carrette O, 2005, PROTEOMICS, V5, P3060, DOI 10.1002/pmic.200402039; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Groen RJM, 1997, ANAT REC, V249, P285, DOI 10.1002/(SICI)1097-0185(199710)249:2<285::AID-AR16>3.0.CO;2-K; Kapoor KG, 2008, BRAIN RES BULL, V77, P327, DOI 10.1016/j.brainresbull.2008.08.009; KIDO DK, 1976, NEURORADIOLOGY, V11, P221; Chen F, 2011, SURG RADIOL ANAT, V33, P215, DOI 10.1007/s00276-010-0733-2; ELDEVIK OP, 1983, AM J NEURORADIOL, V4, P585; Farb RI, 2007, NEURORADIOLOGY, V49, P727, DOI 10.1007/s00234-007-0250-0; Glimcher SA, 2008, INVEST OPHTH VIS SCI, V49, P4721, DOI 10.1167/iovs.08-2238; GOLMAN K, 1975, J PHARM SCI, V64, P405, DOI 10.1002/jps.2600640310; Griessenauer CJ, 2015, CLIN ANAT, V28, P75, DOI 10.1002/ca.22354; Haybaeck J, 2008, SURG RADIOL ANAT, V30, P417, DOI 10.1007/s00276-008-0345-2; Johnston KD, 2007, J NEUROSURG, V107, P841, DOI 10.3171/JNS-07/10/0841; Koh Lena, 2005, Cerebrospinal Fluid Res, V2, P6, DOI 10.1186/1743-8454-2-6; Leach JL, 2008, AM J NEURORADIOL, V29, P1335, DOI 10.3174/ajnr.A1093; PARTAIN CL, 1978, RADIOLOGY, V127, P705; Pollay Michael, 2010, Cerebrospinal Fluid Res, V7, P9, DOI 10.1186/1743-8454-7-9; Seyfert S, 2003, J NEUROL SCI, V206, P85, DOI 10.1016/S0022-510X(02)00340-4; Tobinick Edward, 2006, MedGenMed, V8, P53; Tsutsumi S, 2013, SURG RADIOL ANAT, V35, P935, DOI 10.1007/s00276-013-1123-3; Tsutsumi S, 2014, AM J NEURORADIOL, V35, P1735, DOI 10.3174/ajnr.A4007; Tubbs RS, 2007, J NEUROSURG-SPINE, V7, P328, DOI 10.3171/SPI-07/09/328; Yew M, 2011, OTOL NEUROTOL, V32, P602, DOI 10.1097/MAO.0b013e3182129026	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	SEP	2015	227	3					297	301		10.1111/joa.12349		5	Anatomy & Morphology	Anatomy & Morphology	CP4RD	WOS:000359869300005		
J	Hara, ES; Ono, M; Pham, HT; Sonoyama, W; Kubota, S; Takigawa, M; Matsumoto, T; Young, MF; Olsen, BR; Kuboki, T				Hara, Emilio Satoshi; Ono, Mitsuaki; Hai Thanh Pham; Sonoyama, Wataru; Kubota, Satoshi; Takigawa, Masaharu; Matsumoto, Takuya; Young, Marian F.; Olsen, Bjorn R.; Kuboki, Takuo			Fluocinolone Acetonide Is a Potent Synergistic Factor of TGF-beta 3-Associated Chondrogenesis of Bone Marrow-Derived Mesenchymal Stem Cells for Articular Surface Regeneration	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						BMP; TGF-beta; GLUCOCORTICOIDS; FLUOCINOLONE ACETONIDE; CHONDROGENESIS; STEM CELLS; CARTILAGE REGENERATION	RANDOMIZED CONTROLLED-TRIALS; HYDROGEL SCAFFOLDS; CARTILAGE REPAIR; DIFFERENTIATION; GROWTH; MEDICINE; MODULATION; ACTIVATION; EXPRESSION; DELIVERY	Articular cartilage repair remains a challenging problem. Based on a high-throughput screening and functional analysis, we found that fluocinolone acetonide (FA) in combination with transforming growth factor beta 3 (TGF-3) strongly potentiated chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs). In an in vivo cartilage defect model in knee joints of immunocompromised mice, transplantation of FA/TGF-3-treated hBMSCs could completely repair the articular surface. Analysis of the intracellular pathways revealed that FA enhanced TGF-3-induced phosphorylation of Smad2 and Smad3. Additionally, we performed a pathway array and found that FA activates the mTORC1/AKT pathway. Chemical inhibition of mTORC1 with rapamycin substantially suppressed FA effect, and inhibition of AKT completely repressed chondrogenesis of hBMSCs. Inhibition of glucocorticoid receptor with mifepristone also suppressed FA effect, suggesting that FA involves binding to the glucocorticoid receptor. Comparative analysis with other glucocorticoids (triamcinolone acetonide [TA] and dexamethasone [DEX]) revealed the unique ability of FA to repair articular cartilage surgical defects. Analysis of intracellular pathways showed that the mTORC1/AKT pathway and the glucocorticoid receptor was highly activated with FA and TA, but to a lesser extent with DEX. Collectively, these results show a unique ability of FA to enhance TGF-3-associated chondrogenesis, and suggest that the FA/TGF-3 combination may be used as major inducer of chondrogenesis in vitro. Additionally, FA/TGF-3 could be potentially applied in a clinical setting to increase the efficiency of regenerative approaches based on chondrogenic differentiation of stem cells. (c) 2015 American Society for Bone and Mineral Research.	[Hara, Emilio Satoshi; Ono, Mitsuaki; Hai Thanh Pham; Sonoyama, Wataru; Kuboki, Takuo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama, Okayama 7008525, Japan; [Hara, Emilio Satoshi; Matsumoto, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Okayama, Okayama 7008525, Japan; [Kubota, Satoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama, Okayama 7008525, Japan; [Takigawa, Masaharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Adv Res Ctr Oral & Craniofacial Sci, Okayama, Okayama 7008525, Japan; [Young, Marian F.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	Kuboki, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008525, Japan.	kuboki@md.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [26253088, 22249064, 19109008]	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (#26253088, #22249064, and #19109008; all to TK). The plasmid encoding the Col2a1 promoter used in the luciferase assay was received from Yoshihiko Yamada, NIDCR, NIH. The authors also thank Yumiko Morishita at research joint facility of Okayama University for part of the histological sectioning.	Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x; Merceron C, 2012, STEM CELLS, V30, P471, DOI 10.1002/stem.1686; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Ringe J, 2012, NAT REV RHEUMATOL, V8, P493, DOI 10.1038/nrrheum.2012.98; Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026; Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Gaujoux-Viala C, 2009, ANN RHEUM DIS, V68, P1843, DOI 10.1136/ard.2008.099572; Phornphutkul C, 2008, DEV DYNAM, V237, P702, DOI 10.1002/dvdy.21464; Liu ZN, 2013, BRIT J PHARMACOL, V170, P1262, DOI 10.1111/bph.12404; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Olivotto E, 2008, ARTHRITIS RHEUM-US, V58, P227, DOI 10.1002/art.23211; Farkas B, 2010, CLIN ORTHOP RELAT R, V468, P3112, DOI 10.1007/s11999-010-1443-0; Kiernan DF, 2012, EXPERT OPIN PHARMACO, V13, P1679, DOI 10.1517/14656566.2012.690736; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Gat-Yablonski G, 2004, ENDOCRINOLOGY, V145, P343, DOI 10.1210/en.2003-0910; Phornphutkul C, 2009, J ORTHOP RES, V27, P1157, DOI 10.1002/jor.20894; Kim K, 2013, J CONTROL RELEASE, V168, P166, DOI 10.1016/j.jconrel.2013.03.013; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Kita K, 2008, GENES CELLS, V13, P839, DOI 10.1111/j.1365-2443.2008.01209.x; Hara ES, 2013, BIOCHIMIE, V95, P374, DOI 10.1016/j.biochi.2012.10.016; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Fujita T, 2004, J CELL BIOCHEM, V93, P374, DOI 10.1002/jcb.20192; Arden NK, 2008, OSTEOARTHR CARTILAGE, V16, P733, DOI 10.1016/j.joca.2007.10.011; Hara ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083545; He CX, 2012, BIOTECHNOL APPL BIOC, V59, P163, DOI 10.1002/bab.1001; Jin EJ, 2007, J CELL BIOCHEM, V102, P252, DOI 10.1002/jcb.21430; Jutley GS, 2014, J AM ACAD DERMATOL, V70, P369, DOI 10.1016/j.jaad.2013.07.044; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Phornphutkul C, 2006, MOL CELL ENDOCRINOL, V249, P107, DOI 10.1016/j.mce.2006.02.002	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	SEP	2015	30	9					1585	1596		10.1002/jbmr.2502		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CP4QG	WOS:000359866800006		
J	Notomi, T; Kuno, M; Hiyama, A; Ohura, K; Noda, M; Skerry, TM				Notomi, Takuya; Kuno, Miyuki; Hiyama, Akiko; Ohura, Kiyoshi; Noda, Masaki; Skerry, Timothy M.			Zinc-Induced Effects on Osteoclastogenesis Involves Activation of Hyperpolarization-Activated Cyclic Nucleotide Modulated Channels via Changes in Membrane Potential	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						OSTEOCLAST; ION CHANNEL; HYPERPOLARIZATION	VACUOLAR H+-ATPASE; AVIAN OSTEOCLAST; SINOATRIAL NODE; DIFFERENTIATION; CELLS; PROSTAGLANDIN-E-2; IDENTIFICATION; DEFICIENCY; EXPRESSION; PATHWAYS	Zinc is a trace element in the mammalian body, and increasing evidence shows its critical role in bone development and osteoclastogenesis. The relationships between zinc and voltage-gated ion channels have been reported; however, the effects of zinc on membrane potential and the related ion channels remain unknown. In this study, we found that zinc-induced hyperpolarization in RAW264.7 cells (RAW) was promoted by inhibition of hyperpolarization-activated cyclic nucleotide modulated channels (HCNs). In electrophysiological experiments with RAW-derived osteoclasts, HCNs were functional and generated hyperpolarization-activated inward currents (Ih) with properties similar to the Ih recorded in excitable cells such as neurons and cardiomyocytes. Quantitative PCR of HCN subunits HCN1 and HCN4 in RAW cells showed detectable levels of HCN1 mRNA and HCN4 expression was the highest of all four subunits. HCN4 knockdown decreased osteoclastic Ih and promoted osteoclastogenesis in the presence of zinc, but not in the absence of zinc. To determine the effect of membrane hyperpolarization on osteoclastogenesis, we developed a light-controllable membrane potential system in RAW cells by stably expressing the light-driven outward proton pump, Archaerhodopsin3 (Arch). Arch activation by yellow-green light hyperpolarizes the cell membrane. Light-induced hyperpolarization accelerated osteoclast differentiation in the presence of receptor activator of nuclear factor kappa-B ligand (RANKL). Thus, HCN activation reduced the hyperpolarization-related promotion of osteoclast differentiation in the presence of zinc. This study revealed the novel role of HCN and membrane potential in non-excitable osteoclasts. (c) 2015 American Society for Bone and Mineral Research.	[Notomi, Takuya; Skerry, Timothy M.] Univ Sheffield, Mellanby Ctr Bone Res, Dept Human Metab, Sheffield, S Yorkshire, England; [Notomi, Takuya; Kuno, Miyuki] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan; [Notomi, Takuya; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Tokyo, Japan; [Notomi, Takuya; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence, Program Mol Sci Tooth & Bone Dis, Tokyo, Japan; [Notomi, Takuya; Hiyama, Akiko; Ohura, Kiyoshi] Osaka Dent Univ, Dept Pharmacol, Hirakata, Osaka 5731121, Japan	Notomi, T (reprint author), Osaka Dent Univ, Dept Pharmacol, 8-1 Kuzuhahanazono Cho, Hirakata, Osaka 5731121, Japan.	notomi@cc.osaka-dent.ac.jp			Uehara Memorial Foundation; Nakatomi Foundation; Mochida Memorial Foundation; Biotechnology and Biological Sciences Research Council (BBSRC)	This work was supported in part by grants from Uehara Memorial Foundation, Nakatomi Foundation, Mochida Memorial Foundation, a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows, and Biotechnology and Biological Sciences Research Council (BBSRC).	Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Fukada T, 2013, J BONE MINER METAB, V31, P129, DOI 10.1007/s00774-012-0409-6; Ludwig A, 1998, NATURE, V393, P587; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Hie M, 2011, BONE, V49, P1152, DOI 10.1016/j.bone.2011.08.019; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Sakai H, 2010, AM J PHYSIOL-CELL PH, V299, pC570, DOI 10.1152/ajpcell.00486.2009; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; BLAIR HC, 1991, AM J PHYSIOL, V260, pC1315; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Notomi T, 2012, J BIOL CHEM, V287, P35057, DOI 10.1074/jbc.M111.328930; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Harzheim D, 2008, EMBO J, V27, P692, DOI 10.1038/emboj.2008.3; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; DiFrancesco D, 2006, PROG BIOPHYS MOL BIO, V90, P13, DOI 10.1016/j.pbiomolbio.2005.05.001; Herrmann S, 2011, J MOL CELL CARDIOL, V51, P997, DOI 10.1016/j.yjmcc.2011.09.005; Eberle J, 1999, J TRACE ELEM MED BIO, V13, P21; Elmstahl S, 1998, OSTEOPOROSIS INT, V8, P333, DOI 10.1007/s001980050072; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Gupta A, 1996, BONE, V18, P87, DOI 10.1016/8756-3282(95)00455-6; Kaneko H, 2007, PROSTAG LEUKOTR ESS, V77, P181, DOI 10.1016/j.plefa.2007.09.002; Karieb S, 2012, BRIT J NUTR, V108, P1736, DOI 10.1017/S0007114511007355; Kobayashi Y, 2005, J BIOL CHEM, V280, P11395, DOI 10.1074/jbc.M411189200; Kotake S, 2013, CELL BIOL INT, V37, P65, DOI 10.1002/cbin.10013; Mori H, 2003, J BONE MINER RES, V18, P2069, DOI 10.1359/jbmr.2003.18.11.2069; Park KH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-74; Protas L, 1999, AM J PHYSIOL-HEART C, V277, pH940; Rico H, 2000, CALCIFIED TISSUE INT, V67, P422, DOI 10.1007/s002230001138; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Yamasaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039654	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	SEP	2015	30	9					1618	1626		10.1002/jbmr.2507		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CP4QG	WOS:000359866800009		
J	de Molon, RS; Shimamoto, H; Bezouglaia, O; Pirih, FQ; Dry, SM; Kostenuik, P; Boyce, RW; Dwyer, D; Aghaloo, TL; Tetradis, S				de Molon, Rafael Scaf; Shimamoto, Hiroaki; Bezouglaia, Olga; Pirih, Flavia Q.; Dry, Sarah M.; Kostenuik, Paul; Boyce, Rogely W.; Dwyer, Denise; Aghaloo, Tara L.; Tetradis, Sotirios			OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						OSTEONECROSIS OF THE JAW (ONJ); ANTIRESORPTIVES; BISPHOSPHONATES; ZOLEDRONIC ACID; DENOSUMAB; ALVEOLAR BONE; OSTEOCLASTS	BISPHOSPHONATE-RELATED OSTEONECROSIS; KAPPA-B LIGAND; NITROGEN-CONTAINING BISPHOSPHONATES; BONE-RESORPTION; POSTMENOPAUSAL OSTEOPOROSIS; INDUCE OSTEONECROSIS; CANCER-PATIENTS; RISK-FACTORS; EXPERIMENTAL PERIODONTITIS; CLINICAL-APPLICATIONS	Osteonecrosis of the jaws (ONJ) is a significant complication of antiresorptive medications, such as bisphosphonates and denosumab. Antiresorptive discontinuation to promote healing of ONJ lesions remains highly controversial and understudied. Here, we investigated whether antiresorptive discontinuation alters ONJ features in mice, employing the potent bisphosphonate zoledronic acid (ZA) or the receptor activator of NF-B ligand (RANKL) inhibitor OPG-Fc, utilizing previously published ONJ animal models. Mice were treated with vehicle (veh), ZA, or OPG-Fc for 11 weeks to induce ONJ, and antiresorptives were discontinued for 6 or 10 weeks. Maxillae and mandibles were examined by CT imaging and histologically. ONJ features in ZA and OPG-Fc groups included periosteal bone deposition, empty osteocyte lacunae, osteonecrotic areas, and bone exposure, each of which substantially resolved 10 weeks after discontinuing OPG-Fc but not ZA. Full recovery of tartrate-resistant acid phosphatase-positive (TRAP+) osteoclast numbers occurred after discontinuing OPG-Fc but not ZA. Our data provide the first experimental evidence demonstrating that discontinuation of a RANKL inhibitor, but not a bisphosphonate, reverses features of osteonecrosis in mice. It remains unclear whether antiresorptive discontinuation increases the risk of skeletal-related events in patients with bone metastases or fracture risk in osteoporosis patients, but these preclinical data may nonetheless help to inform discussions on the rationale for a drug holiday in managing the ONJ patient. (c) 2015 American Society for Bone and Mineral Research.	[de Molon, Rafael Scaf; Bezouglaia, Olga; Aghaloo, Tara L.; Tetradis, Sotirios] Univ Calif Los Angeles, Sch Dent, Div Diagnost & Surg Sci, Los Angeles, CA 90095 USA; [de Molon, Rafael Scaf] Sao Paulo State Univ, Sch Dent Araraquara, Dept Diag & Surg, Araraquara, Brazil; [Shimamoto, Hiroaki] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Radiol, Osaka, Japan; [Pirih, Flavia Q.] Univ Calif Los Angeles, Sch Dent, Div Associated Specialties, Los Angeles, CA 90095 USA; [Dry, Sarah M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Kostenuik, Paul] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Boyce, Rogely W.; Dwyer, Denise] Amgen Inc, Dept Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA; [Tetradis, Sotirios] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	Tetradis, S (reprint author), Univ Calif Los Angeles, Sch Dent, 10833 Le Conte Ave,CHS Room 53-068, Los Angeles, CA 90095 USA.	taghaloo@dentistry.ucla.edu; stetradis@dentistry.ucla.edu	de Molon, Rafael Scaf/D-6633-2012	de Molon, Rafael Scaf/0000-0003-1110-6233	Amgen Inc.; NIH/NIDCR [R01 DE019465]; State of Sao Paulo Research Foundation (FAPESP) [2012/09968-5]; Coordination for the Improvement of Higher Level or Education Personnel (CAPES) [11575/13-1]; Lemann Foundation	ST has served as a paid consultant for and has received grant support from Amgen Inc. PK, RB, and DD are full-time employees and/or shareholders of Amgen Inc. All other authors state that they do not have any conflicts of interest.; This work was supported by grants from Amgen Inc, and by NIH/NIDCR R01 DE019465. RSM was supported by fellowships from the State of Sao Paulo Research Foundation (FAPESP) #2012/09968-5, the Coordination for the Improvement of Higher Level or Education Personnel (CAPES) #11575/13-1, and Lemann Foundation.	Abtahi J, 2012, J ORAL PATHOL MED, V41, P494, DOI 10.1111/j.1600-0714.2011.01125.x; Ali-Erdem Mehmet, 2011, Med Oral Patol Oral Cir Bucal, V16, pe879; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Marx RE, 2007, J ORAL MAXIL SURG, V65, P2397, DOI 10.1016/j.joms.2007.08.003; Lin JH, 1996, BONE, V18, P75, DOI 10.1016/8756-3282(95)00445-9; Allen MR, 2014, INT J ORAL MAX IMPL, V29, pE45, DOI 10.11607/jomi.te41; Allen MR, 2009, J ORAL MAXIL SURG, V67, P61, DOI 10.1016/j.joms.2009.01.007; Bone HG, 2011, J CLIN ENDOCR METAB, V96, P972, DOI [10.1210/jc.2010-1502, 10.1210/jc.2010]; Tella SH, 2014, J STEROID BIOCHEM, V142, P155, DOI 10.1016/j.jsbmb.2013.09.008; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Bi YM, 2010, AM J PATHOL, V177, P280, DOI 10.2353/ajpath.2010.090592; GOTCHER JE, 1981, J PERIODONTAL RES, V16, P441, DOI 10.1111/j.1600-0765.1981.tb00995.x; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Kimmel DB, 2007, J DENT RES, V86, P1022; Malan J, 2012, OR SURG OR MED OR PA, V114, P671, DOI 10.1016/j.oooo.2012.08.439; Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; Kikuiri T, 2010, J BONE MINER RES, V25, P1668, DOI 10.1002/jbmr.37; Watts NB, 2008, OSTEOPOROSIS INT, V19, P365, DOI 10.1007/s00198-007-0460-7; Brown JP, 2014, J BONE MINER RES, V29, P2051, DOI 10.1002/jbmr.2236; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Sasaki H, 2000, J IMMUNOL, V165, P3626; Lopez-Jornet P, 2010, J ORAL PATHOL MED, V39, P697, DOI 10.1111/j.1600-0714.2010.00927.x; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Sonis ST, 2009, ORAL ONCOL, V45, P164, DOI 10.1016/j.oraloncology.2008.04.013; Lewiecki EM, 2009, CURR OPIN RHEUMATOL, V21, P369, DOI 10.1097/BOR.0b013e32832ca41c; Jin QM, 2007, J PERIODONTOL, V78, P1300, DOI 10.1902/jop.2007.070073; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Lewin J, 2013, DRUG TODAY, V49, P693, DOI 10.1358/dot.2013.49.11.2064725; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Xiong H, 2010, INT ENDOD J, V43, P485, DOI 10.1111/j.1365-2591.2010.01703.x; Damm Douglas D., 2013, General Dentistry, V61, P33; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Aghaloo TL, 2014, J BONE MINER RES, V29, P843, DOI 10.1002/jbmr.2097; Aguirre JI, 2012, J BONE MINER RES, V27, P2130, DOI 10.1002/jbmr.1669; Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Kostenuik PJ, 2011, BONE, V49, P151, DOI 10.1016/j.bone.2011.03.769; Woo SB, 2006, ANN INTERN MED, V144, P753; Allen MR, 2009, CELLS TISSUES ORGANS, V189, P289, DOI 10.1159/000151371; Coxon FP, 2000, J BONE MINER RES, V15, P1467, DOI 10.1359/jbmr.2000.15.8.1467; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Pautke C, 2012, BONE, V51, P592, DOI 10.1016/j.bone.2012.04.020; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Saad F, 2012, ANN ONCOL, V23, P1341, DOI 10.1093/annonc/mdr435; Hellstein JW, 2011, J AM DENT ASSOC, V142, P1243; Reid IR, 2010, J BONE MINER RES, V25, P2256, DOI 10.1002/jbmr.149; Kang B, 2013, J BONE MINER RES, V28, P1631, DOI 10.1002/jbmr.1894; Allen MR, 2013, J ORAL MAXIL SURG, V71, P1017, DOI 10.1016/j.joms.2012.11.016; Geusens P, 2009, CLIN INTERV AGING, V4, P241; Brown JP, 2011, J BONE MINER RES, V26, P2737, DOI 10.1002/jbmr.448; CLARKE MC, 1978, LAB ANIM, V12, P121, DOI 10.1258/002367778780936296; de Molon RS, 2014, BONE, V68, P11, DOI 10.1016/j.bone.2014.07.027; Food and Drug Administration, 2011, M ADV COMM REPR HLTH; Grant N, 2002, LAB ANIMAL, V31, P25; Han XZ, 2013, INFECT IMMUN, V81, P1502, DOI 10.1128/IAI.00043-13; Iranikhah Maryam, 2014, Cancer Manag Res, V6, P217, DOI 10.2147/CMAR.S40151; Khosla S, 2008, J ORAL MAXIL SURG, V66, P1320, DOI 10.1016/j.jams.2008.01.054; Khosla S, 2008, J ORAL MAXILLOFAC SU, V66, P1321; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Lawson GW, 2010, COMPARATIVE MED, V60, P200; Lewiecki E Michael, 2008, Biologics, V2, P645; Morgans AK, 2012, UROL CLIN N AM, V39, P533, DOI 10.1016/j.ucl.2012.07.009; Ominsky MS, 2008, J BONE MINER RES, V23, P672, DOI [10.1359/jbmr.080109, 10.1359/JBMR.080109]; Roelofs A. J., 2006, CLIN CANCER RES, V12, p6222s, DOI DOI 10.1158/1078-0432.CCR-06-0843; Romas E, 2009, INTERN MED J, V39, P110, DOI 10.1111/j.1445-5994.2008.01732.x; Ruggiero SL, 2014, MEDICATION RELATED O; Silva I, 2012, ACTA REUMATOL PORT, V37, P302; Tolia M, 2014, ANTICANCER RES, V34, P23; WANG CY, 1991, J DENT RES, V70, P1362, DOI 10.1177/00220345910700100901; Williams DW, 2014, AM J PATHOL, V184, P3084, DOI 10.1016/j.ajpath.2014.07.010; Yamashita Junro, 2012, J Evid Based Dent Pract, V12, P233, DOI 10.1016/S1532-3382(12)70046-5; Yuan HP, 2011, J CLIN PERIODONTOL, V38, P1029, DOI 10.1111/j.1600-051X.2011.01780.x	72	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	SEP	2015	30	9					1627	1640		10.1002/jbmr.2490		14	Endocrinology & Metabolism	Endocrinology & Metabolism	CP4QG	WOS:000359866800010		
J	Recknor, CP; Recker, RR; Benson, CT; Robins, DA; Chiang, AY; Alam, J; Hu, LJ; Matsumoto, T; Sowa, H; Sloan, JH; Konrad, RJ; Mitlak, BH; Sipos, AA				Recknor, Christopher P.; Recker, Robert R.; Benson, Charles T.; Robins, Deborah A.; Chiang, Alan Y.; Alam, Jahangir; Hu, Leijun; Matsumoto, Toshio; Sowa, Hideaki; Sloan, John H.; Konrad, Robert J.; Mitlak, Bruce H.; Sipos, Adrien A.			The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						BLOSOZUMAB; SCLEROSTIN ANTIBODY; ANABOLICS; DXA; OSTEOPOROSIS	SCLEROSTIN ANTIBODY; MONOCLONAL-ANTIBODY; FRACTURES; OSTEOPOROSIS; IMPACT; SERUM; MODEL; RISK; MASS; BMD	Administration of blosozumab, a humanized monoclonal antibody that binds sclerostin, increases bone formation and bone mineral density (BMD) in postmenopausal women with low BMD. To evaluate the effect of discontinuing blosozumab, we studied women enrolled in a 1-year randomized, placebo-controlled phase 2 trial for an additional year after they completed treatment. Of the 120 women initially enrolled in the study, 106 women completed treatment and continued into follow-up; 88 women completed 1 year of follow-up. At the beginning of follow-up, groups remained balanced for age, race, and body mass index, but lumbar spine and total hip BMD were increased in prior blosozumab groups, reflecting an anabolic treatment effect. At the end of follow-up, 1 year after discontinuing treatment, lumbar spine BMD remained significantly greater than placebo in women initially treated with blosozumab 270mg every 2 weeks (Q2W) and blosozumab 180mg Q2W (6.9% and 3.6% above baseline, respectively). Total hip BMD also declined after discontinuation of treatment but at 1 year after treatment remained significantly greater than placebo in women initially treated with blosozumab 270mg Q2W and blosozumab 180mg Q2W (3.9% and 2.6% above baseline, respectively). During follow-up, median serum P1NP was not consistently different between the prior blosozumab groups and placebo. A similar pattern was apparent for median serum C-terminal telopeptide of type 1 collagen (CTx) levels, with more variability. Mean serum total sclerostin concentration increased with blosozumab, indicating target engagement, and declined to baseline after discontinuation. There were no adverse events considered related to prior treatment with blosozumab. Anti-drug antibodies generally declined in patients who had detectable levels during prior treatment. These findings support the continued study of blosozumab as an anabolic therapy for treatment of osteoporosis. (c) 2015 American Society for Bone and Mineral Research.	[Recknor, Christopher P.] United Osteoporosis Ctr, Gainesville, GA 30502 USA; [Recker, Robert R.] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68178 USA; [Benson, Charles T.; Robins, Deborah A.; Chiang, Alan Y.; Alam, Jahangir; Hu, Leijun; Sloan, John H.; Konrad, Robert J.; Mitlak, Bruce H.; Sipos, Adrien A.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Matsumoto, Toshio] Univ Tokushima, Fuji Mem Inst Med Sci, Tokushima 770, Japan; [Sowa, Hideaki] Lilly Res Labs Japan, Kobe, Hyogo, Japan	Recknor, CP (reprint author), United Osteoporosis Ctr, 2350 Limestone Pkwy NE, Gainesville, GA 30502 USA.	crecknor@uochs.org					Bliuc D, 2014, J CLIN ENDOCR METAB, V99, P415, DOI 10.1210/jc.2013-3461; Cauley JA, 2013, J GERONTOL A-BIOL, V68, P1243, DOI 10.1093/gerona/glt093; McColm J, 2014, J BONE MINER RES, V29, P935, DOI 10.1002/jbmr.2092; Sapir-Koren R, 2014, OSTEOPOROSIS INT, V25, P2685, DOI 10.1007/s00198-014-2808-0; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Mallinckrodt CH, 2008, DRUG INF J, V42, P303; Miller PD, 2008, BONE, V43, P222, DOI 10.1016/j.bone.2008.04.007; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Gerdhem P, 2013, BEST PRACT RES CL RH, V27, P743, DOI 10.1016/j.berh.2014.01.002; Davda JP, 2010, MABS-AUSTIN, V2, P576, DOI 10.4161/mabs.2.5.12833; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Slavin RG, 2009, J ALLERGY CLIN IMMUN, V123, P107, DOI 10.1016/j.jaci.2008.09.050; Qvist P, 2002, BONE, V31, P57, DOI 10.1016/S8756-3282(02)00791-3; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Davis RA, 2008, J PHARMACEUT BIOMED, V48, P897, DOI 10.1016/j.jpba.2008.07.012; Food and Drug Administration, 2009, GUID IND ASS DEV IMM; Lewiecki E Michael, 2014, Ther Adv Musculoskelet Dis, V6, P48, DOI 10.1177/1759720X13510479; Li XD, 2014, ENDOCRINOLOGY, V155, P4785, DOI 10.1210/en.2013-1905; Ma YF, 2013, J BONE MINER RES, V28; Martin T John, 2014, J Bone Metab, V21, P8, DOI 10.11005/jbm.2014.21.1.8; Pajevic Paola Divieti, 2013, Endocrinology and Metabolism, V28, P255; Recker RR, 2015, J BONE MINER RES, V30, P216, DOI 10.1002/jbmr.2351; Sanchez-Riera L, 2014, ANN RHEUM DIS, V73, P1635, DOI 10.1136/annrheumdis-2013-204320; Tang CY, 2011, PHARM RES-DORDR, V28, P2447, DOI 10.1007/s11095-011-0471-0; van Bezooijen Rutger L, 2005, Cytokine Growth Factor Rev, V16, P319; Wichers M, 1999, CLIN CHEM, V45, P1858; World Medical Association, WMA DECL HELS ETH PR	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	SEP	2015	30	9					1717	1725		10.1002/jbmr.2489		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CP4QG	WOS:000359866800020		
J	Cundy, T; Michigami, T; Tachikawa, K; Dray, M; Collins, JF; Paschalis, EP; Gamsjaeger, S; Roschger, A; Fratzl-Zelman, N; Roschger, P; Klaushofer, K				Cundy, Tim; Michigami, Toshimi; Tachikawa, Kanako; Dray, Michael; Collins, John F.; Paschalis, Eleftherios P.; Gamsjaeger, Sonja; Roschger, Andreas; Fratzl-Zelman, Nadja; Roschger, Paul; Klaushofer, Klaus			Reversible Deterioration in Hypophosphatasia Caused by Renal Failure With Bisphosphonate Treatment	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						HYPOPHOSPHATASIA; RENAL FAILURE; BISPHOSPHONATES; OSTEOMALACIA; GENOTYPE-PHENOTYPE	MINERALIZATION DENSITY DISTRIBUTION; ATYPICAL FEMORAL FRACTURES; ALKALINE-PHOSPHATASE; ADULT HYPOPHOSPHATASIA; BONE; TERIPARATIDE; FORMS; PYROPHOSPHATE; LOCALIZATION; CHILDHOOD	Hypophosphatasia is an inborn error of metabolism caused by mutations in the ALPL gene. It is characterized by low serum alkaline phosphatase (ALP) activity and defective mineralization of bone, but the phenotype varies greatly in severity depending on the degree of residual enzyme activity. We describe a man with compound heterozygous mutations in ALPL, but no previous bone disease, who suffered numerous disabling fractures after he developed progressive renal failure (for which he eventually needed dialysis treatment) and was prescribed alendronate treatment. A bone biopsy showed marked osteomalacia with low osteoblast numbers and greatly elevated pyrophosphate concentrations at mineralizing surfaces. In vitro testing showed that one mutation, T117H, produced an ALP protein with almost no enzyme activity; the second, G438S, produced a protein with normal activity, but its activity was inhibited by raising the media phosphate concentration, suggesting that phosphate retention (attributable to uremia) could have contributed to the phenotypic change, although a pathogenic effect of bisphosphonate treatment is also likely. Alendronate treatment was discontinued and, while a suitable kidney donor was sought, the patient was treated for 6 months with teriparatide, which significantly reduced the osteomalacia. Eighteen months after successful renal transplantation, the patient was free of symptoms and the scintigraphic bone lesions had resolved. A third bone biopsy showed marked hyperosteoidosis but with plentiful new bone formation and a normal bone formation rate. This case illustrates how pharmacological (bisphosphonate treatment) and physiologic (renal failure) changes in the environment can dramatically affect the phenotype of a genetic disorder. (c) 2015 American Society for Bone and Mineral Research. (c) 2015 American Society for Bone and Mineral Research.	[Cundy, Tim] Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland 1142, New Zealand; [Michigami, Toshimi; Tachikawa, Kanako] Osaka Med Ctr Maternal & Child Hlth, Dept Bone & Mineral Res, Osaka, Japan; [Dray, Michael] Middlemore Hosp, Dept Pathol, Auckland 6, New Zealand; [Collins, John F.] Auckland City Hosp, Dept Renal Med, Auckland, New Zealand; [Paschalis, Eleftherios P.; Gamsjaeger, Sonja; Roschger, Andreas; Fratzl-Zelman, Nadja; Roschger, Paul; Klaushofer, Klaus] Hanusch Hosp, WGKK & AUVA Trauma Ctr Meidling, Dept Med 1, Ludwig Boltzmann Inst Osteol, Vienna, Austria	Cundy, T (reprint author), Univ Auckland, Fac Med & Hlth Sci, Dept Med, Private Bag 92019, Auckland 1142, New Zealand.	t.cundy@auckland.ac.nz			Ministry of Health, Labour, and Welfare of Japan; AUVA (Austrian Social Insurance for Occupational Risk); WGKK (Social Health Insurance Vienna)	We wish to acknowledge the great support and commitment of our patient and his family in completing this study. The work was supported in part by grants-in-aid for Scientific Research from Ministry of Health, Labour, and Welfare of Japan (to TM) and by the AUVA (Austrian Social Insurance for Occupational Risk) and the WGKK (Social Health Insurance Vienna). We thank D Gabriel, P Messmer, S Lueger, and P Keplinger for careful sample preparation and qBEI measurements at the Bone Material Laboratory of the Ludwig Boltzmann Institute of Osteology, Vienna, Austria.	Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Vaisman DN, 2005, BIOL TRACE ELEM RES, V104, P131, DOI 10.1385/BTER:104:2:131; Berkseth KE, 2013, BONE, V54, P21, DOI 10.1016/j.bone.2013.01.024; Miller PD, 2011, BONE, V49, P77, DOI 10.1016/j.bone.2010.12.024; Mornet E, 2011, ANN HUM GENET, V75, P439, DOI 10.1111/j.1469-1809.2011.00642.x; FALLON MD, 1984, MEDICINE, V63, P12; Mornet E, 2008, BEST PRACT RES CL RH, V22, P113, DOI 10.1016/j.berh.2007.11.003; Nielson CM, 2012, J BONE MINER RES, V27, P93, DOI 10.1002/jbmr.527; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Whyte MP, 2009, J BONE MINER RES, V24, P1132, DOI [10.1359/jbmr.081253, 10.1359/JBMR.081253]; Chen KH, 2009, INT J EXP PATHOL, V90, P74, DOI 10.1111/j.1365-2613.2008.00614.x; Gagnon C, 2010, J CLIN ENDOCR METAB, V95, P1007, DOI 10.1210/jc.2009-1965; Schalin-Jantti C, 2010, J CLIN ENDOCR METAB, V95, P5174, DOI 10.1210/jc.2010-1168; Zurutuza L, 1999, HUM MOL GENET, V8, P1039, DOI 10.1093/hmg/8.6.1039; Whyte MP, 2007, J CLIN ENDOCR METAB, V92, P1203, DOI 10.1210/jc.2006-1902; WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x; Cai GM, 1998, J CLIN ENDOCR METAB, V83, P3936, DOI 10.1210/jc.83.11.3936; Wenkert D, 2002, J BONE MINER RES, V17, pS384; Laroche M, 2012, CALCIFIED TISSUE INT, V90, P250, DOI 10.1007/s00223-011-9562-5; Barvencik F, 2011, OSTEOPOROSIS INT, V22, P2667, DOI 10.1007/s00198-011-1528-y; Sutton RAL, 2012, J BONE MINER RES, V27, P987, DOI 10.1002/jbmr.1565; Coburn SP, 1998, J CLIN ENDOCR METAB, V83, P3951, DOI 10.1210/jc.83.11.3951; Camacho Pauline M, 2008, Endocr Pract, V14, P204; COURNOTWITMER G, 1981, KIDNEY INT, V20, P375, DOI 10.1038/ki.1981.149; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Draguet C, 2004, ARCH PEDIATRIE, V11, P440, DOI 10.1016/j.arcped.2004.02.018; Fauvert D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-51; Fuerst M, 2010, RHEUMATOL INT, V30, P623, DOI 10.1007/s00296-009-1032-2; Hassler N, 2014, J BONE MINER RES, V29, P2144, DOI 10.1002/jbmr.2259; Kang DH, 1998, PERITON DIALYSIS INT, V18, P294; McKiernan FE, 2014, J BONE MINER RES, V29, P1651, DOI 10.1002/jbmr.2178; MELSEN F, 1978, ACTA PATH MICRO IM A, V86, P70; Miller PD, 2008, CLIN J AM SOC NEPHRO, V3, pS140, DOI 10.2215/CJN.02430508; Mimoun E, 2012, B GROUP INT RECH SCI, V51, pe41; Mornet E, 2014, TISSUE NONSPECIFIC A; Mumm S, 2002, MOL GENET METAB, V75, P143, DOI 10.1006/mgme.2001.3283; Pautke P, 2010, J ANAT, V217, P76; Roschger P, 2003, BONE, V32, P316, DOI 10.1016/S8756-3282(02)00973-0; RUSSELL RGG, 1969, ARCH INTERN MED, V124, P571, DOI 10.1001/archinte.124.5.571; Shabestari M, 2013, BONE ABSTRACTS, V1, P417, DOI [10.1530/boneabs.1.PP417, DOI 10.1530/BONEABS.1]; Whyte MP, 2012, J CLIN ENDOCR METAB, V98, P4606; Whyte MP, 1995, J CLIN INVEST, V95, P1140	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	SEP	2015	30	9					1726	1737		10.1002/jbmr.2495		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CP4QG	WOS:000359866800021		
J	Fujino, H; Saito, T; Matsumura, T; Shibata, S; Iwata, Y; Fujimura, H; Shinno, S; Imura, O				Fujino, Haruo; Saito, Toshio; Matsumura, Tsuyoshi; Shibata, Saki; Iwata, Yuko; Fujimura, Harutoshi; Shinno, Susumu; Imura, Osamu			How Physicians Support Mothers of Children with Duchenne Muscular Dystrophy	JOURNAL OF CHILD NEUROLOGY			English	Article						Duchenne muscular dystrophy; physicians; mothers; communication; qualitative study	FAMILY COMMUNICATION; YOUNG-PEOPLE; GENETIC RISK; PARENTS; CANCER; EXPERIENCES; IMPACT; PERSPECTIVES; INTERVIEWS; DIAGNOSIS	Communicating about Duchenne muscular dystrophy and its prognosis can be difficult for affected children and their family. We focused on how physicians provide support to the mothers of children with Duchenne muscular dystrophy who have difficulty communicating about the condition with their child. The eligible participants were certified child neurologists of the Japanese Society of Child Neurology. Participants responded to questionnaires consisting of free descriptions of a vignette of a child with Duchenne muscular dystrophy and a mother. We analyzed 263 responses of the participants. We found 4 themes on advising mothers, involving encouraging communication, family autonomy, supporting family, and considering the child's concerns. These results provide a better understanding of the communication between physicians and family members who need help sharing information with a child with Duchenne muscular dystrophy. These findings will assist clinical practitioners in supporting families and the affected children throughout the course of their illness.	[Fujino, Haruo; Shibata, Saki; Iwata, Yuko; Imura, Osamu] Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan; [Saito, Toshio] Natl Hosp Org, Toneyama Natl Hosp, Div Child Neurol, Toyonaka, Osaka, Japan; [Saito, Toshio; Matsumura, Tsuyoshi; Fujimura, Harutoshi; Shinno, Susumu] Natl Hosp Org, Toneyama Natl Hosp, Dept Neurol, Toyonaka, Osaka, Japan; [Shinno, Susumu] Shinno Clin, Nara, Japan	Imura, O (reprint author), Osaka Univ, Grad Sch Human Sci, 1-2 Yamadaoka, Suita, Osaka, Japan.	osamui@hus.osaka-u.ac.jp			Japanese Ministry of Health, Labour and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [22530738]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported in part by research grants from the Japanese Ministry of Health, Labour and Welfare and the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [22530738-Grant-in-Aid for Scientific Research (C)]. The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Parsons SK, 2007, PSYCHO-ONCOL, V16, P60, DOI 10.1002/pon.1048; Mack JW, 2014, PEDIATRICS, V133, pS24, DOI 10.1542/peds.2013-3608E; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Moxley RT, 2005, NEUROLOGY, V64, P13; Nereo NE, 2003, J PEDIATR PSYCHOL, V28, P473, DOI 10.1093/jpepsy/jsg038; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Hodges L, 2010, J HEALTH PSYCHOL, V15, P483, DOI 10.1177/1359105309355491; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Ishikawa Y, 2011, NEUROMUSCULAR DISORD, V21, P47, DOI 10.1016/j.nmd.2010.09.006; Patterson JM, 2004, PSYCHO-ONCOL, V13, P390, DOI 10.1002/pon.761; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Daack-Hirsch S, 2013, AM J MED GENET A, V161A, P687, DOI 10.1002/ajmg.a.35810; FALLOWFIELD L, 1995, PSYCHO-ONCOLOGY, V4, P197, DOI 10.1002/pon.2960040305; Fee RJ, 2011, J DEV BEHAV PEDIATR, V32, P644, DOI 10.1097/DBP.0b013e318235d614; FIRTH MA, 1983, BRIT MED J, V286, P700; Fujino Haruo, 2013, No To Hattatsu, V45, P11; Erby Lori Hamby, 2006, Semin Pediatr Neurol, V13, P132, DOI 10.1016/j.spen.2006.06.009; Magliano L, 2014, J NEUROL, V261, P188, DOI 10.1007/s00415-013-7176-8; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Metcalfe A, 2011, EUR J HUM GENET, V19, P640, DOI 10.1038/ejhg.2010.258; Metcalfe A, 2008, EUR J HUM GENET, V16, P1193, DOI 10.1038/ejhg.2008.84; Miller JR, 1991, LOSS GRIEF CARE, V4, P31; Mizuno T, 2012, BRAIN DEV-JPN, V34, P756, DOI 10.1016/j.braindev.2011.11.012; Murray SA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2581; Plumridge G, 2010, AM J MED GENET A, V152A, P1225, DOI 10.1002/ajmg.a.33364; Poysky J, 2009, NEUROMUSCULAR DISORD, V19, P733; Read J, 2011, EUR J PAEDIATR NEURO, V15, P21, DOI 10.1016/j.ejpn.2010.07.006; Sato Y, 2014, PEDIATR NEUROL, V50, P31, DOI 10.1016/j.pediatrneurol.2013.07.022; Schrans DGM, 2013, NEUROMUSCULAR DISORD, V23, P283, DOI 10.1016/j.nmd.2012.08.009; Ulph F, 2010, EUR J HUM GENET, V18, P1090, DOI 10.1038/ejhg.2010.86; Webb CL, 2005, CHILD CARE HLTH DEV, V31, P385, DOI 10.1111/j.1365-2214.2005.00518.x	32	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	SEP	2015	30	10					1287	1294		10.1177/0883073814558334		8	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CP5JJ	WOS:000359917100006		
J	Kobuchi, S; Ito, Y; Yano, K; Sakaeda, T				Kobuchi, Shinji; Ito, Yukako; Yano, Kyoka; Sakaeda, Toshiyuki			A quantitative LC-MS/MS method for determining ipragliflozin, a sodium-glucose co-transporter 2 (SGLT-2) inhibitor, and its application to a pharmacokinetic study in rats	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						SGLT2; Ipragliflozin; Empagliflozin; Liquid chromatography-tandem mass spectrometry	TYPE-2 DIABETES-MELLITUS; SELECTIVE INHIBITOR; ASP1941	Ipragliflozin is a highly potent and selective sodium-dependent glucose co-transporter-2 (SGLT2) inhibitor, a novel class of hypoglycemic agents. The aim of the present study was to establish a new highly sensitive and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantitative analysis of ipragliflozin in rat plasma and apply this method to a pharmacokinetic study in rats. Empagliflozin was used as an internal standard (I.S.) and liquid-liquid extraction was conducted using tert-butyl methyl ether. Chromatographic separation was accomplished on a Quicksorb ODS (2.1 mm i.d. x 150 mm, 5 mu m in size) with acetonitrile/0.1% formic acid (90:10, v/v) at a flow rate of 0.2 mL/min. An API 3200 triple quadrupole mass spectrometer operating in the positive electrospray ionization mode with multiple reaction monitoring was used to detect ipragliflozin and I.S. transitions: m/z 422.0 [M+NH4](+) --> 151.0 for ipragliflozin and m/z 451.2 [M + H](+) --> 71.0 for I.S. Inter- and intra-day accuracies and precisions were within +/-15%. This validated method was successfully applied to a pharmacokinetic study of ipragliflozin in rats. This assay method mar contribute to assessment of novel SGLT2 inhibitors using the rat as an animal model. (C) 2015 Elsevier B.V. All rights reserved.	[Kobuchi, Shinji; Ito, Yukako; Yano, Kyoka; Sakaeda, Toshiyuki] Kyoto Pharmaceut Univ, Dept Pharmacokinet, Kyoto 6078414, Japan	Sakaeda, T (reprint author), Kyoto Pharmaceut Univ, Dept Pharmacokinet, Kyoto 6078414, Japan.	sakaedat@mb.kyoto-phu.ac.jp					Abad-Garcia B., 2008, MASS SPECTROM, V22, P1834; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Schwartz SL, 2011, DIABETES TECHNOL THE, V13, P1219, DOI 10.1089/dia.2011.0012; Tahara A, 2012, N-S ARCH PHARMACOL, V385, P423, DOI 10.1007/s00210-011-0713-z; Imamura M, 2012, BIOORGAN MED CHEM, V20, P3263, DOI 10.1016/j.bmc.2012.03.051; Veltkamp SA, 2011, CLIN DRUG INVEST, V31, P839, DOI 10.2165/11594330-000000000-00000; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Aubry AF, 2010, BIOANALYSIS, V2, P2001, DOI [10.4155/bio.10.139, 10.4155/BIO.10.139]; FDA, GUID IND BIOAN METH; Kadokura T, 2014, DIABETES RES CLIN PR, V106, P50, DOI 10.1016/j.diabres.2014.07.020; Kadokura T, 2011, DIABETOL INT, V2, P172, DOI DOI 10.1007/S13340-011-0037-8; Kadokura T, 2014, CLIN PHARMACOKINET, V53, P975, DOI 10.1007/s40262-014-0180-z	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	SEP 1	2015	1000						22	28		10.1016/j.jchromb.2015.07.013		7	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CP4TE	WOS:000359874700003		
J	Yamamoto, Y; Ishizaki, A; Kataoka, H				Yamamoto, Yusuke; Ishizaki, Atsushi; Kataoka, Hiroyuki			Biomonitoring method for the determination of polycyclic aromatic hydrocarbons in hair by online in-tube solid-phase microextraction coupled with high performance liquid chromatography and fluorescence detection	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Polycyclic aromatic hydrocarbons; Hair; Exposure biomarkers; In-tube solid-phase microextraction; High-performance liquid chromatography-fluorescence detection	ORGANIC POLLUTANTS; MASS-SPECTROMETRY; EXPOSURE; METABOLITES; SMOKERS; PAHS	Polycyclic aromatic hydrocarbons (PAHs) are formed from the incomplete combustion or pyrolysis of organic matter during industrial processing and various human activities, but human exposure to PAHs has not yet been elucidated in detail. To assess long-term exposure to PAHs, we developed a simple and sensitive method for measuring PAHs in hair by online in-tube solid-phase microextraction using a CP-Sil 19CB capillary column as an extraction device, followed by high-performance liquid chromatography using a Zorbax Eclipse PAH column and fluorescence detection. Seventeen PAHs could be analyzed simultaneously, with good linearity from 20 to 1000 pg/mL each as determined using stable isotope-labeled PAH internal standards. The detection limits of PAHs were 0.5-20.4 pg/mL. PAHs in human hair samples were extracted by ultrasonication in 50 mM NaOH in methanol, and successfully analyzed without any interference peaks, with good recovery rates above 70% in spiked hair samples. Using this method, we evaluated the suitability of using hair PAHs as biomarkers for long-term exposure. (C) 2015 Elsevier B.V. All rights reserved.	[Yamamoto, Yusuke; Ishizaki, Atsushi; Kataoka, Hiroyuki] Shujitsu Univ, Sch Pharm, Okayama 7038516, Japan	Kataoka, H (reprint author), Shujitsu Univ, Sch Pharm, Okayama 7038516, Japan.	hkataoka@shujitsu.ac.jp			National Cancer Center Research and Development Fund	This work was supported by the National Cancer Center Research and Development Fund.	Ishizaki A, 2010, J CHROMATOGR A, V1217, P5555, DOI 10.1016/j.chroma.2010.06.068; Jarvis IWH, 2014, TOXICOLOGY, V321, P27, DOI 10.1016/j.tox.2014.03.012; Appenzeller BMR, 2012, TOXICOL LETT, V210, P119, DOI 10.1016/j.toxlet.2011.10.021; Ishizaki A, 2011, ANAL METHODS-UK, V3, P299, DOI 10.1039/c0ay00423e; Kataoka H, 2002, ANAL BIOANAL CHEM, V373, P31, DOI 10.1007/s00216-002-1269-z; Diggs DL, 2011, J ENVIRON SCI HEAL C, V29, P324, DOI 10.1080/10590501.2011.629974; St Helen G, 2012, CHEM RES TOXICOL, V25, P952, DOI 10.1021/tx300043k; Schramm KW, 2008, CHEMOSPHERE, V72, P1103, DOI 10.1016/j.chemosphere.2008.04.017; Kataoka H, 2009, ANAL CHIM ACTA, V655, P8, DOI 10.1016/j.aca.2009.09.032; Bandeira G.C., 2013, HDB POLYCYCLIC AROMA; Grova N, 2013, ANAL BIOANAL CHEM, V405, P8897, DOI 10.1007/s00216-013-7317-z; Hagedorn HW, 2009, J ANAL TOXICOL, V33, P301; Schummer C, 2009, J CHROMATOGR A, V1216, P6012, DOI 10.1016/j.chroma.2009.05.068; Toriba A, 2003, BIOMED CHROMATOGR, V17, P126, DOI 10.1002/bmc.222	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	SEP 1	2015	1000						187	191		10.1016/j.jchromb.2015.07.033		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CP4TE	WOS:000359874700023		
J	Altay, A; Aydin, M; Matsumoto, T; Yahiro, T; Dalgic, B; Bozdayi, G				Altay, Aylin; Aydin, Merve; Matsumoto, Takashi; Yahiro, Takaaki; Dalgic, Buket; Bozdayi, Gulendam			Emergence of rotavirus G9 as the dominant genotype in Turkish children with diarrhea	JOURNAL OF CLINICAL VIROLOGY			English	Meeting Abstract									[Altay, Aylin; Bozdayi, Gulendam] Gazi Univ, Fac Med, Dept Med Microbiol, Ankara, Turkey; [Aydin, Merve] Erzincan Univ, Fac Med, Dept Med Microbiol, Erzincan, Turkey; [Matsumoto, Takashi; Yahiro, Takaaki] Oita Univ, Dept Microbiol, Fac Med, Res Promot Inst, Oita, Japan; [Dalgic, Buket] Gazi Univ, Fac Med, Dept Pediat Gastroenterol, Ankara, Turkey								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	SEP	2015	70			1		1450	S22	S23		10.1016/j.jcv.2015.07.058		3	Virology	Virology	CP7QI	WOS:000360082500049		
J	Tang, XH; Luo, HN; Bai, Y; Tang, H; Nakamura, T; Yatani, H				Tang, Xuehua; Luo, Huinan; Bai, Yang; Tang, Hui; Nakamura, Takashi; Yatani, Hirofumi			Influences of multiple firings and aging on surface roughness, strength and hardness of veneering ceramics for zirconia frameworks	JOURNAL OF DENTISTRY			English	Article						Veneering ceramics; Multiple firings; Accelerated aging; Surface roughness; Flexural strength; Vickers hardness	CHEMICAL DURABILITY; GLASS-CERAMICS; CE-TZP/AL2O3 NANOCOMPOSITE; CRYSTALLIZATION BEHAVIOR; MECHANICAL-PROPERTIES; STABILIZED ZIRCONIA; FRACTURE-TOUGHNESS; PORCELAIN STRENGTH; DENTAL CERAMICS; MARGINAL FIT	Objectives: To evaluate the effects of multiple firings and aging on surface roughness, strength, and hardness of veneering ceramics for zirconia frameworks. Methods: Five different veneering ceramics for zirconia frameworks were used: Vintage ZR (ZR), Cerabien ZR (CZR), VitaVM9 (VM9), Cercon ceram KISS (KISS), and IPS e.max ceram (e.max). Specimens were fired 2 or 10 times in order to accelerate aging. Surface roughness was evaluated using laser profilometry. Flexural strength and Vickers hardness were also measured. Surface topography was observed using scanning electron microscopy. Results: After accelerated aging, the surface roughness of all specimens fired 10 times was significantly lower than that of the same specimens fired 2 times (P = 0.000). Except for VM9, the flexural strength of all specimens fired 10 times was greater than that of the same specimens fired 2 times, and the differences were significant for ZR and CZR (P < 0.01). The flexural strength of VM9 fired 10 times was significantly lower than that of VM9 fired 2 times (P = 0.034). The Vickers hardness of ZR and VM9 fired 10 times was significantly higher than that of the same specimens fired 2 times (P < 0.05), but that of KISS fired 10 times was significantly lower than that of KISS fired 2 times (P = 0.000). Conclusions: Multiple firings had a positive effect on the surface roughness of all aged veneering ceramics used for zirconia restorations and on the strength and hardness of many aged veneering ceramics used for zirconia restorations. (C) 2015 Elsevier Ltd. All rights reserved.	[Tang, Xuehua] Nanjing Med Univ, Affiliated Hosp 1, Dept Stomatol, Nanjing 210029, Jiangsu, Peoples R China; [Tang, Xuehua; Nakamura, Takashi; Yatani, Hirofumi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka 5650871, Japan; [Luo, Huinan] Nanjing Univ, Sch Med, Jinling Hosp, Dept Stomatol, Nanjing 210002, Jiangsu, Peoples R China; [Bai, Yang] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Dept Oral Med, Nanjing 210008, Jiangsu, Peoples R China; [Tang, Hui] Nanjing Med Univ, Inst Stomatol, Nanjing 210029, Jiangsu, Peoples R China	Tang, XH (reprint author), 300 Guang Zhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	t-xuehua2008@hotmail.com			Japanese Ministry of Education, Culture, Sports, Science and Technology [205922620]	This study was supported in part by a Grant-in-Aid for Scientific Research (No. 205922620) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, for which we express our thanks. The authors also would like to thank Mr. Yoshimoto, Mr. Takahashi and Mr. Watanabe of Shofu Inc., and Mr. Ishida of Dental Studio Laboratory for their technical assistance in this study.	Preis V, 2011, DENT MATER, V27, P796, DOI 10.1016/j.dental.2011.04.001; Gherlone E, 2014, J DENT, V42, P1151, DOI 10.1016/j.jdent.2014.06.002; Tang XH, 2012, J DENT, V40, P372, DOI 10.1016/j.jdent.2012.01.014; Schmitter M, 2012, J DENT, V40, P154, DOI 10.1016/j.jdent.2011.12.007; Geisler T, 2010, J NON-CRYST SOLIDS, V356, P1458, DOI 10.1016/j.jnoncrysol.2010.04.033; Barbieri L, 2008, J NON-CRYST SOLIDS, V354, P521, DOI 10.1016/j.jnoncrysol.2007.07.080; Tang XH, 2012, J DENT, V40, P913, DOI 10.1016/j.jdent.2012.07.009; Lynch ME, 2007, J NON-CRYST SOLIDS, V353, P2667, DOI 10.1016/j.jnoncrysol.2007.05.012; Gregson KS, 2012, CLIN ORAL INVEST, V16, P1095, DOI 10.1007/s00784-011-0613-0; Nakamura Y, 2010, DENT MATER J, V29, P30; Inokoshi M, 2013, J DENT, V41, P170, DOI 10.1016/j.jdent.2012.10.017; Kim JW, 2010, J DENT RES, V89, P91, DOI 10.1177/0022034509354193; de Jager N, 2000, DENT MATER, V16, P381, DOI 10.1016/S0109-5641(00)00030-0; Milleding P, 2003, J MATER SCI-MATER M, V14, P557, DOI 10.1023/A:1023416232222; Lorenzoni FC, 2010, J DENT, V38, P626, DOI 10.1016/j.jdent.2010.04.011; Esquivel-Upshaw JF, 2013, J DENT RES, V92, P467, DOI 10.1177/0022034513484332; BUNKER BC, 1994, J NON-CRYST SOLIDS, V179, P300, DOI 10.1016/0022-3093(94)90708-0; Anami LC, 2012, J DENT, V40, P742, DOI 10.1016/j.jdent.2012.05.005; Benzaid R, 2008, BIOMATERIALS, V29, P3636, DOI 10.1016/j.biomaterials.2008.05.021; Fischer H, 2003, J DENT RES, V82, P972; Guess PC, 2012, CLIN IMPLANT DENT R, V14, P633, DOI 10.1111/j.1708-8208.2010.00317.x; Takano T, 2012, J DENT RES, V91, P800, DOI 10.1177/0022034512452277; Hahnel S, 2009, DENT MATER, V25, P969, DOI 10.1016/j.dental.2009.02.003; [Anonymous], 2008, 13356 INT STAND ORG; Ban S, 2008, J BIOMED MATER RES B, V87B, P492, DOI 10.1002/jbm.b.31131; Buchi DL, 2014, QUINTESSENCE INT, V45, P837, DOI 10.3290/j.qi.a32565; Cesar PF, 2007, J BIOMED MATER RES B, V83B, P538, DOI 10.1002/jbm.b.30826; Chavan NM, 2011, SURF COAT TECH, V205, P4798, DOI 10.1016/j.surfcoat.2011.04.063; Deng W, 2012, J NON-CRYST SOLIDS, V358, P2847, DOI 10.1016/j.jnoncrysol.2012.07.003; Egilmez F, 2014, J MECH BEHAV BIOMED, V37, P78, DOI 10.1016/j.jmbbm.2014.05.013; Field J, 2010, J DENT, V38, P182, DOI 10.1016/j.jdent.2010.01.002; Flinn BD, 2014, J PROSTHET DENT, V112, P1377, DOI 10.1016/j.prosdent.2014.07.015; Guo XZ, 2014, J NON-CRYST SOLIDS, V405, P63, DOI 10.1016/j.jnoncrysol.2014.08.048; Hubsch C, 2015, ACTA BIOMATER, V11, P488, DOI 10.1016/j.actbio.2014.09.042; International Organization For Standardization, 2008, 6872 ISO; Kamio S., 2014, CLIN ORAL IMPLANTS R; Keuper M, 2014, ACTA BIOMATER, V10, P951, DOI 10.1016/j.actbio.2013.09.033; Mackert JR, 1996, J DENT RES, V75, P1484; Margha FH, 2009, CERAM INT, V35, P1133, DOI 10.1016/j.ceramint.2008.05.009; Nakamura T, 2011, DENT MATER J, V30, P330, DOI 10.4012/dmj.2010-142; Quinn GD, 2015, DENT MATER, V31, P26, DOI 10.1016/j.dental.2014.08.378; Rinke S, 2012, DENT MATER J, V31, P601, DOI 10.4012/dmj.2012-017; Rozenstrauha I, 2013, CERAM INT, V39, P8007, DOI 10.1016/j.ceramint.2013.03.069; Saadaldin SA, 2014, DENT MATER, V30, P364, DOI 10.1016/j.dental.2013.12.007; Shemtov-Yona K, 2014, CLIN ORAL IMPLAN RES, V25, pE166, DOI 10.1111/clr.12084; Sui T, 2014, J MECH BEHAV BIOMED, V32, P113, DOI 10.1016/j.jmbbm.2013.12.014; Swain MV, 2014, DENT MATER, V30, P33, DOI 10.1016/j.dental.2013.08.199; Wang GQ, 2014, J MECH BEHAV BIOMED, V39, P119, DOI 10.1016/j.jmbbm.2014.07.019; Yeh ST, 2011, DENT MATER, V27, P187, DOI 10.1016/j.dental.2010.10.013; Zaghloul HH, 2013, J ORAL IMPLANTOL, V39, P417, DOI 10.1563/AAID-JOI-D-11-00103; Zhao BH, 2013, COMPOS PART B-ENG, V54, P265, DOI 10.1016/j.compositesb.2013.05.045; Zinelis S, 2005, DENT MATER, V21, P890, DOI 10.1016/j.dental.2005.03.007	52	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	SEP	2015	43	9					1148	1153		10.1016/j.jdent.2015.06.006		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP7NU	WOS:000360075700014		
J	Eddy, C; Sase, E				Eddy, Christopher; Sase, Eriko			The 2014 Dallas, Texas, Ebola Incident: Global Implications to All-Hazards Preparedness and Health Care Worker Protection	JOURNAL OF ENVIRONMENTAL HEALTH			English	Editorial Material							ENVIRONMENTAL-HEALTH; HEMORRHAGIC-FEVER; VIRUS		[Eddy, Christopher] Grand Canyon Univ, Coll Sci Engn & Technol, Phoenix, AZ 85017 USA; [Sase, Eriko] Univ Tokyo, Grad Sch Med, Tokyo 1138654, Japan	Eddy, C (reprint author), Grand Canyon Univ, Coll Sci Engn & Technol, Adjunct Fac, 3300 West Camelback Rd, Phoenix, AZ 85017 USA.	chris.eddy@my.gcu.edu					Kortepeter MG, 2008, EMERG INFECT DIS, V14, P881, DOI 10.3201/eid1406.071489; Gostin LO, 2014, LANCET, V384, P1323, DOI 10.1016/S0140-6736(14)61791-8; Mardani M, 2009, AM J TROP MED HYG, V81, P675, DOI 10.4269/ajtmh.2009.09-0051; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Association of State and Territorial Health Officials, 2014, ASS RESP PERS PROT E; ASTM, 2004, STAND GUID HOSP PREP, VE 2413-04 E54.02; Austin E., 2013, DISASTER EMERGENCY P; Brosseau L. M., 2014, HLTH WORKERS NEED OP; Burd EM, 2015, J CLIN MICROBIOL, V53, P4, DOI 10.1128/JCM.03115-14; Campbell P, 2011, PUBLIC HEALTH REP, V126, P290; Centers for Disease Control and Prevention, 2015, CONS SEL PROT CLOTH; Centers for Disease Control and Prevention, 2013, CAT BIOT AG 1 HOURS; CNN, 2014, HOSP DROPP BALL EB P; Conger NG, 2015, EMERG INFECT DIS, V21, P23, DOI 10.3201/eid2101.141413; Eddy C., 2010, GEORGETOWN PUBLIC PO, V15, P63; Eddy C, 2013, J ENVIRON HEALTH, V76, P46; Eddy C, 2015, J ENVIRON HEALTH, V78, P26; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Gillman T. J., 2014, DALLAS MORNING NEWS; Henderson D. A., 2002, BIOTERRORISM GUIDELI; House Energy and Commerce Committee Subcommittee on Oversight and Investigations, 2014, TEST D VARG EX US PU; Institute of Medicine, 2009, MICR EV COAD TRIB LI; Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677; Liverman C. T., 2015, USE EFFECTIVENESS PO; Locsin R C, 2003, Int Nurs Rev, V50, P156, DOI 10.1046/j.1466-7657.2003.00194.x; McCarty C. L., 2014, MMWR-MORBID MORTAL W, V63, P1; Occupational Safety and Health Administration, 2005, OSHA BEST PRACT HOSP; Osterholm MT, 2015, MBIO, V6, DOI 10.1126/mBio.00137-15; Parra JM, 2014, NEW ENGL J MED, V371, P2439, DOI 10.1056/NEJMc1412662; Sack K., 2014, NY TIMES; Smith CL, 2015, MMWR-MORBID MORTAL W, V64, P121; Texas Health Resources, 2014, LETT OUR COMM; The InterAgency Board, 2014, REC SEL US PERS PROT; U. S. Army Medical Research Institute of Infectious Diseases, 2011, USAMRIIDS MED MAN BI; U. S. Department of Health and Human Services, 2014, PPE IM GALL RESP PRO; U. S. Department of Homeland Security, 2014, NAT RESP PLAN DEC 20; U.S. Department of Homeland Security, 2008, NAT RESP FRAM; Washkuch E, 2014, BURSON HIRED DALLAS	38	0	0	NATL ENVIRON HEALTH ASSOC	DENVER	720 S COLORADO BLVD SUITE 970, SOUTH TOWER, DENVER, CO 80246 USA	0022-0892			J ENVIRON HEALTH	J. Environ. Health	SEP	2015	78	2					28	32				5	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CP5BB	WOS:000359895200005		
J	Nishioka, Y; Shindoh, J; Yoshioka, R; Gonoi, W; Abe, H; Okura, N; Yoshida, S; Oba, M; Hashimoto, M; Watanabe, G; Hasegawa, K; Kokudo, N				Nishioka, Yujiro; Shindoh, Junichi; Yoshioka, Ryuji; Gonoi, Wataru; Abe, Hiroyuki; Okura, Naoki; Yoshida, Shuntaro; Oba, Masaru; Hashimoto, Masaji; Watanabe, Goro; Hasegawa, Kiyoshi; Kokudo, Norihiro			Radiological Morphology of Colorectal Liver Metastases after Preoperative Chemotherapy Predicts Tumor Viability and Postoperative Outcomes	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Colorectal liver metastases; Chemotherapy; RECIST; Morphologic response; Pathologic response	NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL RESPONSE; SURVIVAL; RESECTION; BEVACIZUMAB; SURGERY; THICKNESS; INTERFACE; NECROSIS; CRITERIA	The computed tomography (CT) morphology after chemotherapy is reportedly correlated with the histopathologic response to chemotherapy and a better surgical outcome in patients with colorectal liver metastases (CLM). However, the true prognostic advantage of CT morphology remains uncertain. The prognostic advantage of CT morphology was validated in 86 patients who underwent surgical resection for CLM after undergoing a 5-fluorouracil-based chemotherapy regimen with or without bevacizumab. An optimal morphologic response was observed in 18 (22.8 %) patients, and a strong correlation between the CT morphology and tumor viability was confirmed (P < 0.001). A multivariate analysis revealed that bevacizumab (odds ratio [OR], 6.8; P = 0.03) and chemotherapy cycles a parts per thousand yen6 (OR, 3.6; P = 0.04) were associated with an optimal morphologic response. Overall survival (OS) and recurrence-free survival (RFS) were also predicted by CT morphology with a higher sensitivity. Particularly, a group 1 morphology was associated with a higher OS rate (3-year OS 100 %) and RFS rate (3-year RFS, 57.0 %), and a multivariate analysis confirmed that group 2 and group 3 tumor morphology was a significant predictive factor for tumor recurrence (hazard ratio [HR], 2.5; P = 0.03 and HR, 3.2; P < 0.01, respectively). The CT morphology of CLM predicts tumor viability and long-term surgical outcomes after chemotherapy.	[Nishioka, Yujiro; Shindoh, Junichi; Yoshioka, Ryuji; Oba, Masaru; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Shindoh, Junichi; Hashimoto, Masaji; Watanabe, Goro] Toranomon Gen Hosp, Dept Digest Surg, Hepatobiliary Pancreat Surg Div, Minato Ku, Tokyo 1058470, Japan; [Gonoi, Wataru; Okura, Naoki] Univ Tokyo, Dept Radiol, Grad Sch Med, Tokyo, Japan; [Abe, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Yoshida, Shuntaro] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan	Shindoh, J (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan.	shindou-tky@umin.ac.jp			JSPS KAKENHI [26861063]	This study was supported by JSPS KAKENHI Grant No. 26861063.	Blazer DG, 2008, J CLIN ONCOL, V26, P5344, DOI 10.1200/JCO.2008.17.5299; Poultsides GA, 2012, ANN SURG ONCOL, V19, P2797, DOI 10.1245/s10434-012-2335-1; Chun YS, 2009, JAMA-J AM MED ASSOC, V302, P2338, DOI 10.1001/jama.2009.1755; Maru DM, 2010, AM J SURG PATHOL, V34, P1287, DOI 10.1097/PAS.0b013e3181eb2f7b; Sathornsumetee S, 2008, J CLIN ONCOL, V26, P271, DOI 10.1200/JCO.2007.13.3652; Allen PJ, 2003, J GASTROINTEST SURG, V7, P109, DOI 10.1016/S1091-255X(02)00121-X; Brouquet A, 2013, CANCER-AM CANCER SOC, V119, P2778, DOI 10.1002/cncr.28097; Chang HHL, 2012, AM J SURG PATHOL, V36, P570, DOI 10.1097/PAS.0b013e31824057e7; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; Grothey A, 2008, J CLIN ONCOL, V26, P183, DOI 10.1200/JCO.2007.13.8099; Adam R, 2004, ANN SURG, V240, P1052, DOI 10.1097/01.sla.0000145964.08365.01; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Shindoh J, 2012, J CLIN ONCOL, V30, P4566, DOI 10.1200/JCO.2012.45.2854; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Rubbia-Brandt L, 2007, ANN ONCOL, V18, P299, DOI 10.1093/annonc/mdl386; Parikh AA, 2003, J GASTROINTEST SURG, V7, P1082, DOI 10.1016/j.gassur.2003.08.005; Yoshita H, 2014, DIGESTION, V89, P43, DOI 10.1159/000356218	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	SEP	2015	19	9					1653	1661		10.1007/s11605-015-2836-x		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CP5OY	WOS:000359934200011		
J	Sakamoto, K; Tamesa, T; Tokuhisa, Y; Matsukuma, S; Tokumitsu, Y; Maeda, Y; Takeda, S; Ueno, T; Yamamoto, S; Yoshino, S; Hazama, S; Nagano, H; Oka, M				Sakamoto, Kazuhiko; Tamesa, Takao; Tokuhisa, Yoshihiro; Matsukuma, Satoshi; Tokumitsu, Yukio; Maeda, Yoshinari; Takeda, Shigeru; Ueno, Tomio; Yamamoto, Shigeru; Yoshino, Shigefumi; Hazama, Shoichi; Nagano, Hiroaki; Oka, Masaaki			Perioperative Microbiologic Monitoring of Sputum on Postoperative Day One as a Predictor of Pneumonia After Hepatectomy	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Postoperative pneumonia; Hepatectomy	UPPER ABDOMINAL-SURGERY; COLLEGE-OF-PHYSICIANS; PULMONARY COMPLICATIONS; RISK-FACTORS; NONCARDIOTHORACIC SURGERY; HEPATIC RESECTION; LIVER RESECTION; SMOKING; INTERVENTION; STRATEGIES	The purpose of this study was to retrospectively evaluate microbial examination of sputum on postoperative day one (POD1) and to determine risk factors for postoperative pneumonia (POP) after hepatectomy. Two hundred ninety-four patients who expectorated sputum on POD1 after hepatectomy between 2003 and 2014 were investigated. Sputum samples were submitted for microbial examination. Risk factors for POP were identified using multivariable analysis. One hundred fifty-eight (53.7 %) of 294 patients had bacteria in their sputum on POD1. POP was observed in 24 (8.2 %) patients, with increased mortality in the patients with POP (0.74 vs 12.5 %, p < 0.01). Multivariate analysis demonstrated that a Brinkman index of > 400 and bacteria in sputum on POD1 were independent risk factors for POP. Bacterial homology in sputum obtained on POD1 and onset day of POP was found in 13 of the 24 (54.2 %) patients with POP. In particular, in 13 patients with POP caused by methicillin-resistant Staphylococcus aureus or Pseudomonas aeruginosa, homology was confirmed in 9 patients (69.2 %). A Brinkman index a parts per thousand yen400 and bacteria in sputum on POD1 increased the risk of POP. Presence of bacteria in sputum on POD1 may be useful in determining early treatment against POP after hepatectomy.	[Sakamoto, Kazuhiko; Tamesa, Takao; Tokuhisa, Yoshihiro; Matsukuma, Satoshi; Tokumitsu, Yukio; Maeda, Yoshinari; Takeda, Shigeru; Ueno, Tomio; Yamamoto, Shigeru; Yoshino, Shigefumi; Hazama, Shoichi; Nagano, Hiroaki; Oka, Masaaki] Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol, Ube, Yamaguchi 7558505, Japan	Sakamoto, K (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	kazusaka@yamaguchi-u.ac.jp					Qaseem A, 2006, ANN INTERN MED, V144, P575; BRINKMAN GL, 1963, AM REV RESPIR DIS, V87, P684; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Schroeder RA, 2006, ANN SURG, V243, P373, DOI 10.1097/01.sla.0000201483.95911.08; Mathur AK, 2010, J GASTROINTEST SURG, V14, P849, DOI 10.1007/s11605-010-1163-5; Lindstrom D, 2008, ANN SURG, V248, P739, DOI 10.1097/SLA.0b013e3181889d0d; Itoh S, 2012, SURG TODAY, V42, P1176, DOI 10.1007/s00595-012-0306-6; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; Bluman LG, 1998, CHEST, V113, P883, DOI 10.1378/chest.113.4.883; Lawrence VA, 2006, ANN INTERN MED, V144, P596; McAlister FA, 2005, AM J RESP CRIT CARE, V171, P514, DOI 10.1164/rccm.200408-1069OC; Nobili C, 2012, ANN SURG, V255, P540, DOI 10.1097/SLA.0b013e3182485857; Kanat F, 2007, ANZ J SURG, V77, P135, DOI 10.1111/j.1445-2197.2006.03993.x; Barisione G, 1997, EUR RESPIR J, V10, P1301, DOI 10.1183/09031936.97.10061301; Carrel TP, 2001, ANN THORAC SURG, V72, P143, DOI 10.1016/S0003-4975(01)02669-8; Hirokawa F, 2011, SURGERY, V149, P438, DOI 10.1016/j.surg.2009.11.015; Kojima S, 2007, J EPIDEMIOL, V17, P54, DOI 10.2188/jea.17.54; Pessaux P, 2013, J GASTROINTEST SURG, V17, P1907, DOI 10.1007/s11605-013-2226-1; Smetana GW, 1999, NEW ENGL J MED, V340, P937, DOI 10.1056/NEJM199903253401207; Smetana GW., 2009, CLEV CLIN J MED, V76, P60; Smetana Gerald W, 2006, Cleve Clin J Med, V73 Suppl 1, pS36; Takao T, 1999, EUR SURG RES, V31, P173, DOI 10.1159/000008636	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	SEP	2015	19	9					1662	1667		10.1007/s11605-015-2869-1		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CP5OY	WOS:000359934200012		
J	Chian, SC; Tokimatsu, K; Madabhushi, SPG				Chian, Siau Chen; Tokimatsu, Kohji; Madabhushi, Santana Phani Gopal			Closure to "Soil Liquefaction-Induced Uplift of Underground Structures: Physical and Numerical Modeling" by Siau Chen Chian, Kohji Tokimatsu, and Santana Phani Gopal Madabhushi	JOURNAL OF GEOTECHNICAL AND GEOENVIRONMENTAL ENGINEERING			English	Editorial Material									[Chian, Siau Chen] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117576, Singapore; [Tokimatsu, Kohji] Tokyo Inst Technol, Dept Architecture & Bldg Engn, Tokyo 1528550, Japan; [Madabhushi, Santana Phani Gopal] Univ Cambridge, Schofield Ctr, Dept Engn, Cambridge CB3 0EL, England	Chian, SC (reprint author), Natl Univ Singapore, Dept Civil & Environm Engn, 1 Engn Dr 2,E1A-07-03, Singapore 117576, Singapore.	sc.chian@nus.edu.sg; kohji@o.cc.titech.ac.jp; mspg1@eng.cam.ac.uk					Zeng X, 1996, GEOTECHNIQUE, V46, P83; Chou JC, 2011, J GEOTECH GEOENVIRON, V137, P754, DOI 10.1061/(ASCE)GT.1943-5606.0000489; Cilingir U, 2011, SOIL DYN EARTHQ ENG, V31, P452, DOI 10.1016/j.soildyn.2010.10.004; DAFALIAS YF, 1977, NUCL ENG DES, V41, P293, DOI 10.1016/0029-5493(77)90117-0; JRA (Japan Road Association), 1986, DES MAN COMM UT DUCT, P58; Koseki J, 1997, SOILS FOUND, V37, P97; Ling HI, 2003, J GEOTECH GEOENVIRON, V129, P1092, DOI 10.1061/(ASCE)1090-0241(2003)129:12(1092); Tobita T, 2011, SOILS FOUND, V51, P1091, DOI 10.3208/sandf.51.1091; Wang ZL, 2006, SOIL DYN EARTHQ ENG, V26, P231, DOI 10.1016/j.soildyn.2004.11.032; WANG ZL, 1990, J ENG MECH-ASCE, V116, P983, DOI 10.1061/(ASCE)0733-9399(1990)116:5(983)	10	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1090-0241	1943-5606		J GEOTECH GEOENVIRON	J. Geotech. Geoenviron. Eng.	SEP	2015	141	9							07015020	10.1061/(ASCE)GT.1943-5606.0001324		2	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CP5TC	WOS:000359946400003		
J	Kayen, R; Moss, RES; Thompson, EM; Seed, RB; Cetin, KO; Kiureghian, AD; Tanaka, Y; Tokimatsu, K				Kayen, R.; Moss, R. E. S.; Thompson, E. M.; Seed, R. B.; Cetin, K. O.; Kiureghian, A. Der; Tanaka, Y.; Tokimatsu, K.			Shear-Wave Velocity-Based Probabilistic and Deterministic Assessment of Seismic Soil Liquefaction Potential (vol 139, pg 407, 2013)	JOURNAL OF GEOTECHNICAL AND GEOENVIRONMENTAL ENGINEERING			English	Correction									[Kayen, R.] US Geol Survey, Menlo Pk, CA 94025 USA; [Kayen, R.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Moss, R. E. S.] Calif Polytech State Univ San Luis Obispo, Dept Civil & Environm Engn, San Luis Obispo, CA 93407 USA; [Thompson, E. M.] US Geol Survey, Golden, CO USA; [Seed, R. B.; Kiureghian, A. Der] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Cetin, K. O.] Middle Eastern Tech Univ, Ankara, Turkey; [Tanaka, Y.] UTAR, Dept Civil Engn, Kuala Lumpur, Malaysia; [Tokimatsu, K.] Tokyo Inst Technol, Dept Civil & Architectural Engn, Tokyo 152, Japan	Kayen, R (reprint author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	rkayen@ucla.edu					Kayen R, 2013, J GEOTECH GEOENVIRON, V139, P407, DOI 10.1061/(ASCE)GT.1943-5606.0000743	1	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1090-0241	1943-5606		J GEOTECH GEOENVIRON	J. Geotech. Geoenviron. Eng.	SEP	2015	141	9							08215002	10.1061/(ASCE)GT.1943-5606.0001390		1	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CP5TC	WOS:000359946400013		
J	Meissner, L; Kauffmann, K; Wengeler, T; Mitsunaga, H; Fukusaki, E; Buchs, J				Meissner, Lena; Kauffmann, Kira; Wengeler, Timo; Mitsunaga, Hitoshi; Fukusaki, Eiichiro; Buechs, Jochen			Influence of nitrogen source and pH value on undesired poly(gamma-glutamic acid) formation of a protease producing Bacillus licheniformis strain	JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Protease and amylase production; Bacillus licheniformis; Poly(gamma-glutamic acid); Ammonium; Nitrate	SHAKE FLASKS; NASB OPERON; SUBTILIS; ASSIMILATION; GLUTAMATE; BIOSYNTHESIS; PURIFICATION; SUBSTRATE; CULTURES	Bacillus spp. are used for the production of industrial enzymes but are also known to be capable of producing biopolymers such as poly(gamma-glutamic acid). Biopolymers increase the viscosity of the fermentation broth, thereby impairing mixing, gas/liquid mass and heat transfer in any bioreactor system. Undesired biopolymer formation has a significant impact on the fermentation and downstream processing performance. This study shows how undesirable poly(gamma-glutamic acid) formation of an industrial protease producing Bacillus licheniformis strain was prevented by switching the nitrogen source from ammonium to nitrate. The viscosity was reduced from 32 to 2.5 mPa s. A constant or changing pH value did not influence the poly(gamma-glutamic acid) production. Protease production was not affected: protease activities of 38 and 46 U mL(-1) were obtained for ammonium and nitrate, respectively. With the presented results, protease production with industrial Bacillus strains is now possible without the negative impact on fermentation and downstream processing by undesired poly(gamma-glutamic acid) formation.	[Meissner, Lena; Kauffmann, Kira; Wengeler, Timo; Buechs, Jochen] Rhein Westfal TH Aachen, AVT Biochem Engn, D-52074 Aachen, Germany; [Mitsunaga, Hitoshi; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan	Buchs, J (reprint author), Rhein Westfal TH Aachen, AVT Biochem Engn, Worringer Weg 1, D-52074 Aachen, Germany.	lena.meissner@avt.rwth-aachen.de; kira.kauffmann@rwth-aachen.de; timo.wengeler@rwth-aachen.de; hitoshi_mitsunaga@bio.eng.osaka-u.ac.jp; fukusaki@bio.eng.osaka-u.ac.jp; jochen.buechs@avt.rwth-aachen.de			Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [0313917D]; Henkel AG & Co. KGaA (Dusseldorf, Germany) [0313917D]	The Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) and Henkel AG & Co. KGaA (Dusseldorf, Germany) are kindly acknowledged for partly funding this work through the joint research project "Industrieinitiative GenoMik Design" (Support Code 0313917D). Henkel AG & Co. KGaA (Dusseldorf, Germany) is also kindly acknowledged for providing the used Bacillus licheniformis strain.	Abe K, 1997, BIOSCI BIOTECH BIOCH, V61, P1621; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Wilming A, 2013, BIOCHEM ENG J, V73, P29, DOI 10.1016/j.bej.2013.01.008; Bajaj I, 2011, BIORESOURCE TECHNOL, V102, P5551, DOI 10.1016/j.biortech.2011.02.047; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Buchs J, 2001, BIOCHEM ENG J, V7, P135, DOI 10.1016/S1369-703X(00)00113-3; Klockner W, 2012, TRENDS BIOTECHNOL, V30, P307, DOI 10.1016/j.tibtech.2012.03.001; Maier B, 2001, FOOD BIOPROD PROCESS, V79, P107, DOI 10.1205/096030801750286267; Anderlei T, 2004, BIOCHEM ENG J, V17, P187, DOI 10.1016/S1369-703X(03)00181-5; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Anderlei T, 2001, BIOCHEM ENG J, V7, P157, DOI 10.1016/S1369-703X(00)00116-9; Giese H, 2014, BIOTECHNOL BIOENG, V111, P295, DOI 10.1002/bit.25015; Maurer KH, 2004, CURR OPIN BIOTECH, V15, P330, DOI 10.1016/j.copbio.2004.06.005; Giese H, 2014, CHEM ENG SCI, V118, P102, DOI 10.1016/j.ces.2014.07.037; HARWOOD CR, 1992, TRENDS BIOTECHNOL, V10, P247, DOI 10.1016/0167-7799(92)90233-L; Kambourova M, 2001, APPL ENVIRON MICROB, V67, P1004, DOI 10.1128/AEM.67.2.1004-1007.2001; Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458; Kumar P, 2013, BIOTECHNOL ADV, V31, P1543, DOI 10.1016/j.biotechadv.2013.08.007; ASALI EC, 1992, J BIOTECHNOL, V23, P83, DOI 10.1016/0168-1656(92)90101-E; Ashiuchi M, 2003, J MOL CATAL B-ENZYM, V23, P249, DOI 10.1016/S1381-1177(03)00087-0; Bedingfield J, 2012, NOVOZYMES REPORT 201; BERNLOHR RW, 1984, CURR TOP CELL REGUL, V24, P145; BULTHUIS BA, 1988, A VAN LEEUW J MICROB, V54, P95, DOI 10.1007/BF00419198; GIESECKE UE, 1991, APPL MICROBIOL BIOT, V35, P720; HARRISON DE, 1970, APPL MICROBIOL, V19, P446; Herrmann HA, 1997, ENZYMES DETERGENCY, P251; KEMBLOWSKI Z, 1986, BIOTECHNOL BIOENG, V28, P1474, DOI 10.1002/bit.260281005; Li X, 2014, ARCH MICROBIOL, V196, P791, DOI 10.1007/s00203-014-1014-y; MEERS JL, 1972, J GEN MICROBIOL, V70, P277; NAKANO MM, 1995, J BACTERIOL, V177, P573; OGAWA KI, 1995, J BACTERIOL, V177, P1409; Schreier Harold J., 1993, P281	32	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1367-5435	1476-5535		J IND MICROBIOL BIOT	J. Ind. Microbiol. Biotechnol.	SEP	2015	42	9					1203	1215		10.1007/s10295-015-1640-7		13	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CP3KJ	WOS:000359777500001		
J	MaruYama, T				MaruYama, Takashi			Memorial: Tatsushi Muta, 1963-2013	JOURNAL OF LEUKOCYTE BIOLOGY			English	Biographical-Item							HEMOCYTES		Gifu Univ, Sch Med, Gifu 5011194, Japan	MaruYama, T (reprint author), Gifu Univ, Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.	ta-maru@umin.ac.jp					MaruYama T, 2015, J LEUKOCYTE BIOL, V98, P385, DOI 10.1189/jlb.2A0814-384R; MUTA T, 1994, NATURE          0526, P369; MUTA T, 1990, ADV EXP MED BIOL, V256, P273; MUTA T, 1990, J BIOCHEM-TOKYO, V108, P261; MUTA T, 1990, J BIOL CHEM, V265, P22426; MUTA T, PUBLICATION LIST; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016	7	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	SEP	2015	98	3					295	295		10.1189/jlb.2LT0515-222		1	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	CP7KS	WOS:000360066900001		
J	MaruYama, T; Kobayashi, S; Ogasawara, K; Yoshimura, A; Chen, WJ; Muta, T				MaruYama, Takashi; Kobayashi, Shuhei; Ogasawara, Kouetsu; Yoshimura, Akihiko; Chen, WanJun; Muta, Tatsushi			Control of IFN-gamma production and regulatory function by the inducible nuclear protein I kappa B-zeta in T cells	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						T lymphocyte; cytokine; transcriptional regulator	TRANSCRIPTION FACTOR FOXP3; MEDIATED REGULATION; GENE-EXPRESSION; RECEPTOR; DNA; DIFFERENTIATION; INFLAMMATION; DISRUPTION; ACTIVATION; INDUCTION	The transcriptional regulator I kappa B-zeta is important for the control of apoptosis in keratinocytes. Thus, I kappa B-zeta-deficient mice develop autoimmune diseases, such as Sjogren's syndrome. However, T cells also play a pivotal role in Sjogren's syndrome. To study the role of I kappa B-zeta in T cells, we generated T cell-specific, I kappa B-zeta-deficient mice. We observed increased numbers of peripheral effector/memory CD4(+) cells and IFN-gamma-producing CD4(+) cells in 3-week-old mice. We found that I kappa B-zeta can be up-regulated by TGF-beta 1 in naive CD4(+) T cells and that it negatively regulates IFN-gamma expression. In addition, we generated T-reg-specific, I kappa B-zeta deficient mice and found that I kappa B-zeta is dispensable for the plasticity and stability of T-regs. However, T-regs from T cell-specific, I kappa B-zeta-deficient mice have reduced immunoregulatory function. Thus, our data reveal a previously unappreciated role for I kappa B-zeta in IFN-gamma production in T cells and the immunoregulatory function of T-regs.	[MaruYama, Takashi; Kobayashi, Shuhei; Muta, Tatsushi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 980, Japan; [Ogasawara, Kouetsu] Tohoku Univ, Dept Immunobiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [MaruYama, Takashi] Gifu Univ, Sch Med, Gifu 5011194, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Chen, WanJun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	MaruYama, T (reprint author), Gifu Univ, Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.	ta-maru@umin.ac.jp			Ministry of Education [25118702]; Takeda Science Foundation [24790458, 26670019]; Uehara Memorial Foundation; Novartis Foundation; Sumitomo Foundation; Cooperative Research Project Program of the Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas 25118702 from the Ministry of Education (to Tak.Y.); a Grant-in-Aid for Young Scientists B (Grant 24790458); Grant-in-Aid for Challenging Exploratory Research 26670019 from the Japan Society for the Promotion of Science (to Tak.Y.); and grants from the Takeda Science Foundation, Uehara Memorial Foundation, Novartis Foundation, and Sumitomo Foundation (to Tak.Y.). This work was partly supported by the Cooperative Research Project Program of the Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University. The authors are grateful to Dr. Alexander Y. Rudensky (Memorial Sloan-Kettering Cancer Center) for providing the Foxp3<SUP>YFP-cre</SUP> mice. The authors also thank Drs. Ono Masao, Atsushi Okuma (Tohoku University), and Maekawa Yoichi (Gifu University) for discussion.	Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Lin JT, 2005, J IMMUNOL, V174, P5950; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; CHEN C, 1987, MOL CELL BIOL, V7, P2745; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Gad M, 2003, CLIN EXP IMMUNOL, V131, P34, DOI 10.1046/j.1365-2249.2003.02049.x; Lai W, 2011, J IMMUNOL, V187, P133, DOI 10.4049/jimmunol.1002742; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Mottet C, 2003, J IMMUNOL, V170, P3939; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B	34	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	SEP	2015	98	3					385	393		10.1189/jlb.2A0814-384R		9	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	CP7KS	WOS:000360066900012		
J	Watanabe, K; Kataoka, M; Yano, K; Nishio, S; Umehana, M; Kido, A; Togashi, K				Watanabe, Koichi; Kataoka, Masako; Yano, Kojiro; Nishio, Shuro; Umehana, Masaki; Kido, Aki; Togashi, Kaori			Automated detection and measurement of uterine peristalsis in cine MR images	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						MRI; uterus; peristalsis; cine mode; automated detection		PurposeTo evaluate the ability of automated software to quantify uterine peristalsis on cine magnetic resonance imaging (MRI). Materials and MethodsAt 1.5T, half-Fourier acquisition single-shot turbo spin echo (HASTE) techniques were used to obtain 60 serial images over 3 minutes (TR/TE 3000/80 msec) in a midsagittal plane of the uterus. Thirty-two cine MR datasets, obtained from 16 healthy females, were analyzed. Uterine peristalsis was defined as the traveling waves of decreasing signal intensity on the endometrium-junctional zone border. The software detected traveling waves by identifying the neighboring areas showing similar patterns of signal intensity decrease in a different timing. Quantification of uterine peristaltic wave using the fully automated software was compared to qualitative visual evaluation by two readers. ResultsThe mean number (and standard deviation) of peristaltic waves detected by the fully automated software and visual evaluations (readers 1 and 2) were 5.4 (3.0), 4.7 (3.1), and 4.5 (3.1) per 3 minutes, respectively. Quantification by fully automated software demonstrated excellent agreement with repeated measurement (weighted kappa 0.99) and with qualitative visual evaluations (range 0.89-0.95), comparable to interreader agreement by visual evaluations (range 0.89-0.93). ConclusionThe fully automated software can be used to quantify uterine peristalsis comparable to visual evaluation. J. Magn. Reson. Imaging 2015;42:644-650.	[Watanabe, Koichi; Kataoka, Masako; Nishio, Shuro; Umehana, Masaki; Kido, Aki; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Yano, Kojiro] Osaka Inst Technol, Fac Informat Sci & Technol, Osaka 535, Japan	Kataoka, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.	makok@kuhp.kyoto-u.ac.jp					Kido A, 2005, J MAGN RESON IMAGING, V22, P265, DOI 10.1002/jmri.20384; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Nakai A, 2003, J MAGN RESON IMAGING, V18, P726, DOI 10.1002/jmri.10415; Kido A, 2005, J MAGN RESON IMAGING, V21, P249, DOI 10.1002/h=jmri.20258; Kido A, 2008, MAGN RESON IMAGING, V26, P54, DOI 10.1016/j.mri.2007-06.001; Kido A, 2007, EUR RADIOL, V17, P1813, DOI 10.1007/s00330-006-0494-9; Yoshino O, 2012, J MINIM INVAS GYN, V19, P63, DOI 10.1016/j.jmig.2011.09.010; Fujiwara Toshitaka, 2004, Radiographics, V24, pe19, DOI 10.1148/rg.e19; Kass M., 1988, INT J COMPUT VISION, V1, P321, DOI DOI 10.1007/BF00133570; Weickert J., 1998, ANISOTROPIC DIFFUSIO	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	SEP	2015	42	3					644	650		10.1002/jmri.24817		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP5CN	WOS:000359899000010		
J	Tomiyama, Y; Manabe, O; Oyama-Manabe, N; Naya, M; Sugimori, H; Hirata, K; Mori, Y; Tsutsui, H; Kudo, K; Tamaki, N; Katoh, C				Tomiyama, Yuuki; Manabe, Osamu; Oyama-Manabe, Noriko; Naya, Masanao; Sugimori, Hiroyuki; Hirata, Kenji; Mori, Yuki; Tsutsui, Hiroyuki; Kudo, Kohsuke; Tamaki, Nagara; Katoh, Chietsugu			Quantification of myocardial blood flow with dynamic perfusion 3.0 Tesla MRI: Validation with (15)o-water PET	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						myocardial blood flow; dynamic magnetic resonance imaging; O-15-water positron emission tomography; perfusion	CORONARY-ARTERY-DISEASE; POSITRON-EMISSION-TOMOGRAPHY; MAGNETIC-RESONANCE; KAWASAKI-DISEASE; HEALTHY HUMANS; GD-DTPA; RESERVE; O-15-WATER; STENOSIS; MODEL	BackgroundTo develop and validate a method for quantifying myocardial blood flow (MBF) using dynamic perfusion magnetic resonance imaging (MBFMRI) at 3.0 Tesla (T) and compare the findings with those of O-15-water positron emission tomography (MBFPET). MethodsTwenty healthy male volunteers underwent magnetic resonance imaging (MRI) and O-15-water positron emission tomography (PET) at rest and during adenosine triphosphate infusion. The single-tissue compartment model was used to estimate the inflow rate constant (K1). We estimated the extraction fraction of Gd-DTPA using K1 and MBF values obtained from O-15-water PET for the first 10 subjects. For validation, we calculated MBFMRI values for the remaining 10 subjects and compared them with the MBFPET values(.) In addition, we compared MBFMRI values of 10 patients with coronary artery disease with those of healthy subjects. ResultsThe mean resting and stress MBFMRI values were 0.760.10 and 3.04 +/- 0.82 mL/min/g, respectively, and showed excellent correlation with the mean MBFPET values (r=0.96, P<0.01). The mean stress MBFMRI value was significantly lower for the patients (1.92 +/- 0.37) than for the healthy subjects (P<0.001). ConclusionThe use of dynamic perfusion MRI at 3T is useful for estimating MBF and can be applied for patients with coronary artery disease. J. Magn. Reson. Imaging 2015;42:754-762.	[Tomiyama, Yuuki; Manabe, Osamu; Hirata, Kenji; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan; [Oyama-Manabe, Noriko; Sugimori, Hiroyuki; Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido 0608638, Japan; [Naya, Masanao; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Mori, Yuki; Katoh, Chietsugu] Hokkaido Univ, Fac Hlth Sci, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan	Oyama-Manabe, N (reprint author), Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Kita Ku, Kita15 Nishi7, Sapporo, Hokkaido 0608638, Japan.	norikooyama@med.hokudai.ac.jp			Ministry of Education, Science and Culture Japan [40443957, 10292012]	Contract grant sponsor: the Ministry of Education, Science and Culture Japan; Contract grant number: 40443957; Contract grant number: 10292012.	Fritz-Hansen T, 2008, J MAGN RESON IMAGING, V27, P818, DOI 10.1002/jmri.21306; Cheng ASH, 2007, J AM COLL CARDIOL, V49, P2440, DOI 10.1016/j.jacc.2007.03.028; Klein R, 2010, J NUCL CARDIOL, V17, P555, DOI 10.1007/s12350-010-9256-9; Naya M, 2011, J AM COLL CARDIOL, V58, P1807, DOI 10.1016/j.jacc.2011.06.051; HERRERO P, 1992, CIRC RES, V70, P496; Mueller A, 2012, RADIOLOGY, V263, P77, DOI 10.1148/radiol.11110347; Ichihara T, 2009, MAGN RESON MED, V62, P373, DOI 10.1002/mrm.22018; George RT, 2007, INVEST RADIOL, V42, P815; Manabe O, 2009, J NUCL MED, V50, P68, DOI 10.2967/jnumed.108.055673; Morton G, 2012, J AM COLL CARDIOL, V60, P1546, DOI 10.1016/j.jacc.2012.05.052; Ishida M, 2011, MAGN RESON MED, V66, P1391, DOI 10.1002/mrm.22936; Hsu LY, 2006, J MAGN RESON IMAGING, V23, P315, DOI 10.1002/jmri.20502; Schwitter J, 2001, CIRCULATION, V103, P2230; So A, 2011, J CARDIOVASC COMPUT, V5, P467, DOI 10.1016/j.jcct.2011.11.002; Furuyama H, 2002, CIRCULATION, V105, P2878, DOI 10.1161/01.CIR.0000018652.59840.57; Furuyama H, 2003, J PEDIATR-US, V142, P149, DOI 10.1067/mpd.2003.46; GOLDSTEIN RA, 1987, J CLIN INVEST, V79, P1473, DOI 10.1172/JCI112976; Jerosch-Herold M, 2008, CURR OPIN CARDIOL, V23, P599, DOI 10.1097/HCO.0b013e328312c2f5; Katoh C, 2012, J NUCL CARDIOL, V19, P763, DOI 10.1007/s12350-012-9558-1; Katoh C, 2004, J NUCL MED, V45, P1908; Kikuchi Y, 2014, EUR RADIOL, V24, P1547, DOI 10.1007/s00330-014-3164-3; Morita K, 2006, J NUCL MED, V47, P1914; Naya M, 2010, Q J NUCL MED MOL IM, V54, P145; Parkka JP, 2006, MAGN RESON MED, V55, P772, DOI 10.1002/mrm.20833; Reichenbach JR, 1997, EUR RADIOL, V7, P264, DOI 10.1007/s003300050149; Sasaki Makoto, 2005, Magn Reson Med Sci, V4, P145, DOI 10.2463/mrms.4.145; Tsukamoto T, 2006, EUR J NUCL MED MOL I, V33, P1150, DOI 10.1007/s00259-006-0082-x; WHITE CW, 1984, NEW ENGL J MED, V310, P819, DOI 10.1056/NEJM198403293101304; Wong KK, 2005, P ANN INT IEEE EMBS, P453, DOI 10.1109/IEMBS.2005.1616444; Yoshinaga K, 2003, J NUCL CARDIOL, V10, P275, DOI 10.1016/S1071-3581(02)43243-6	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	SEP	2015	42	3					754	762		10.1002/jmri.24834		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP5CN	WOS:000359899000023		
J	Yamaguchi, K; Schacht, D; Nakazono, T; Irie, H; Abe, H				Yamaguchi, Ken; Schacht, David; Nakazono, Takahiko; Irie, Hiroyuki; Abe, Hiroyuki			Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						breast cancer; diffusion weighted image; apparent diffusion coefficient; axillary lymph node; lymph node metastasis	CONTRAST-ENHANCED MRI; MAGNETIC-RESONANCE; CLINICAL-EXPERIENCE; BIOPSY; DISSECTION; ACCURACY; WOMEN; TRIAL; METAANALYSIS; COEFFICIENT	BackgroundTo investigate the ability of diffusion weighted images (DWI) to differentiate between metastatic and nonmetastatic axillary lymph nodes (LNs) in patients with newly diagnosed breast cancer. MethodsFrom January 2010 to February 2012, DWI was performed at b values of 0 and 800 for 16 metastatic LNs from 16 patients with breast cancer, and 20 nonmetastatic LNs from 20 women without breast cancer. The metastatic LNs were proven by ultrasound (US) guided core biopsy and the same LNs were identified on MRI by comparing the US images with MR images. Nonmetastatic LNs were verified by the stability in size and shape for at least 2 years on MRI. The apparent diffusion coefficient (ADC) value of the metastatic and nonmetastatic axillary LNs was compared. Receiver-operating-characteristics (ROC) analysis was performed to evaluate the diagnostic performance of the ADC value in differentiating between metastatic and nonmetastatic axillary LNs. ResultsThe mean ADC value was 0.746 x 10(-3) for metastatic LNs and 1.033 x 10(-3) for nonmetastatic LNs (P<0.001). The area under the ROC curve was 0.884. The sensitivity and specificity for differentiating metastatic from nonmetastatic axillary LNs using a cutoff ADC value of 0.852 were 85% and 81%, respectively. ConclusionThere is a statistically significant difference between the ADC values of pathologically proven metastatic LNs and nonmetastatic LNs. DWI and ADC values are a useful tool for differentiating metastatic from nonmetastatic axillary LNs. J. Magn. Reson. Imaging 2015;42:771-778.	[Yamaguchi, Ken; Nakazono, Takahiko; Irie, Hiroyuki] Saga Univ, Dept Radiol, Fac Med, Saga 8498501, Japan; [Yamaguchi, Ken; Schacht, David; Abe, Hiroyuki] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Yamaguchi, K (reprint author), Saga Univ, Dept Radiol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	yamaguk@cc.saga-u.ac.jp					Marini C, 2007, EUR RADIOL, V17, P2646, DOI 10.1007/s00330-007-0621-2; Scaranelo AM, 2012, RADIOLOGY, V262, P425, DOI 10.1148/radiol.11110639; Abe H, 2009, RADIOLOGY, V250, P41, DOI 10.1148/radiol.2493071483; Alvarez S, 2006, AM J ROENTGENOL, V186, P1342, DOI 10.1021/2214/AJR.05.0936; Abe H, 2013, ACAD RADIOL, V20, P1399, DOI 10.1016/j.acra.2013.08.003; Woodhams R, 2011, RADIOGRAPHICS, V31, P1059, DOI 10.1148/rg.314105160; Ecanow JS, 2013, RADIOGRAPHICS, V33, P1589, DOI 10.1148/rg.336125060; Yuen S, 2009, J MAGN RESON IMAGING, V29, P1080, DOI 10.1002/jmri.21743; Rubesova E, 2006, J MAGN RESON IMAGING, V24, P319, DOI 10.1002/jmri.20643; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Harnan SE, 2011, EJSO-EUR J SURG ONC, V37, P928, DOI 10.1016/j.ejso.2011.07.007; Valente SA, 2012, ANN SURG ONCOL, V19, P1825, DOI 10.1245/s10434-011-2200-7; Crane-Okada R, 2008, ANN SURG ONCOL, V15, P1996, DOI 10.1245/s10434-008-9909-y; FISHER B, 1983, CANCER, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Swenson KK, 2002, ANN SURG ONCOL, V9, P745, DOI 10.1245/ASO.2002.02.007; Kvistad KA, 2000, EUR RADIOL, V10, P1464, DOI 10.1007/s003300000370; Janka R, 2014, ROFO-FORTSCHR RONTG, V186, P130, DOI 10.1055/s-0033-1350298; Nakai G, 2011, J MAGN RESON IMAGING, V34, P557, DOI 10.1002/jmri.22651; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Bedi DG, 2008, AM J ROENTGENOL, V191, P646, DOI 10.2214/AJR.07.2460; Partridge SC, 2009, AM J ROENTGENOL, V193, P1716, DOI 10.2214/AJR.08.2139; Memarsadeghi M, 2006, RADIOLOGY, V241, P367, DOI 10.1148/radiol.2412050693; Kim JK, 2008, J MAGN RESON IMAGING, V28, P714, DOI 10.1002/jmri.21480; Woodhams R, 2005, J COMPUT ASSIST TOMO, V29, P644, DOI 10.1097/01.rct.0000171913.74086.1b; Purushotham AD, 2005, J CLIN ONCOL, V23, P4312, DOI 10.1200/JCO.2005.03.228; Chen G, 2005, MAGN RESON IMAGING, V23, P685, DOI 10.1016/j.mri.2005.02.015; Baltzer PAT, 2011, AM J ROENTGENOL, V196, pW641, DOI 10.2214/AJR.10.4889; Banerjee M, 2004, J CLIN ONCOL, V22, P2567, DOI 10.1200/JCO.2004.11.141; Dorrius MD, 2014, EUR RADIOL, V24, P2835, DOI 10.1007/s00330-014-3338-z; Fitzek C, 2003, NEURORADIOLOGY, V45, P592, DOI 10.1007/s00234-003-0965-5; Fornasa F, 2012, J MAGN RESON IMAGING, V36, P858, DOI 10.1002/jmri.23706; He N, 2012, EUR J RADIOL, V81, P2602, DOI 10.1016/j.ejrad.2012.03.019; Kamitani T, 2013, CLIN IMAG, V37, P56, DOI [10.1016/j.clinimag.2012.02.014, 10.1016/j.clinitmag.2012.02.014]; Kuroki Yoshifumi, 2004, Magn Reson Med Sci, V3, P79, DOI 10.2463/mrms.3.79; Kwee TC, 2010, EUR J RADIOL, V75, P215, DOI 10.1016/j.ejrad.2009.03.026; Mortellaro VE, 2009, J MAGN RESON IMAGING, V30, P309, DOI 10.1002/jmri.21802; Murray AD, 2002, BRIT J RADIOL, V75, P220; Ochi M, 2013, BREAST CANCER-TOKYO, V20, P137, DOI 10.1007/s12282-011-0319-9; Ogura A, 2008, ACAD RADIOL, V15, P867, DOI 10.1016/j.acra.2007.12.020; Podkrajsek M, 2005, EUR RADIOL, V15, P1044, DOI 10.1007/s00330-004-2545-4; Sumi M, 2006, AM J ROENTGENOL, V186, P749, DOI 10.2214/AJR.04.1832; Vandecaveye V, 2008, CANCER IMAGING, V8, P173, DOI 10.1102/1470-7330.2008.0025	44	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	SEP	2015	42	3					771	778		10.1002/jmri.24829		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP5CN	WOS:000359899000025		
J	Shimizu, A; Kobayashi, A; Motoyama, H; Sakai, H; Yamada, A; Yoshizawa, A; Momose, M; Kadoya, M; Miyagawa, S				Shimizu, Akira; Kobayashi, Akira; Motoyama, Hiroaki; Sakai, Hiroshi; Yamada, Akira; Yoshizawa, Akihiko; Momose, Masanobu; Kadoya, Masumi; Miyagawa, Shin-ichi			Features of acute liver congestion on gadoxetate disodium-enhanced MRI in a rat model: Role of organic anion-transporting polypeptide 1A1	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						Gd-EOB-DTPA-enhanced MR imaging; partial liver congestion; rat; Oatp1a1	GD-EOB-DTPA; HEPATIC VENOUS CONGESTION; PRIMARY BILIARY-CIRRHOSIS; CONTRAST AGENT; TRANSPLANTATION; EXPRESSION; GRAFT; CT; DYSFUNCTION; HEPATOCYTE	PurposeTo evaluate the features of hepatic congestion on gadoxetate disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and the mechanisms responsible for the radiological findings in a rat model of partial liver congestion. Materials and MethodsA conventional T-1-weighted spin-echo sequence of the liver was performed using a 1.5T magnetic resonance imager with an 80-mm magnetic aperture for animal studies. We induced regional congestion using partial left lateral hepatic vein ligation (n = 5) and evaluated the following in both congestive liver (CL) and noncongestive liver (non-CL): 1) chronological changes in the relative enhancement (RE) up to 60 minutes after Gd-EOB-DTPA administration, and 2) mRNA and protein expression of rat organic anion transporting protein 1a1 (Oatp1a1). ResultsThe RE in the CL reached a small peak (18%) at 5 minutes, corresponding to approximately half of the value observed in the non-CL, then slowly decreased in a linear manner thereafter. The degree of RE in the CL was significantly lower than that in the non-CL for up to 30 minutes (P < 0.05). An immunohistological examination showed that Oatp1a1 protein expression was downregulated in the CL. The mRNA level of Oatp1a1 in the CL was significantly upregulated, compared with that in control rat liver (P = 0.046), whereas no significant difference was observed between the CL and the non-CL (P = 0.698). ConclusionThe reduced signal intensity in the CL on Gd-EOB-DTPA-enhanced MRI could be explained by the decreased uptake of Gd-EOB-DTPA via Oatp1a1 protein in the congestive area. J. Magn. Reson. Imaging 2015;42:828-836.	[Shimizu, Akira; Kobayashi, Akira; Motoyama, Hiroaki; Sakai, Hiroshi; Miyagawa, Shin-ichi] Shinshu Univ, Sch Med, Dept Surg 1, Matsumoto, Nagano 3908621, Japan; [Yamada, Akira; Kadoya, Masumi] Shinshu Univ, Sch Med, Dept Radiol, Matsumoto, Nagano 3908621, Japan; [Yoshizawa, Akihiko; Momose, Masanobu] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan	Kobayashi, A (reprint author), Shinshu Univ, Sch Med, Dept Surg 1, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	kbys@shinshu-u.ac.jp					Leonhardt M, 2010, DRUG METAB DISPOS, V38, P1024, DOI 10.1124/dmd.110.032862; Hashimoto T, 2008, LIVER TRANSPLANT, V14, P872, DOI 10.1002/lt.21460; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200; Nilsson H, 2010, HPB, V12, P567, DOI 10.1111/j.1477-2574.2010.00223.x; Ogasawara K, 2010, DRUG METAB PHARMACOK, V25, P190; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646; Lee S, 2001, TRANSPLANTATION, V71, P812, DOI 10.1097/00007890-200103270-00021; Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f; Pascolo L, 2001, BIOCHEM BIOPH RES CO, V282, P60, DOI 10.1006/bbrc.2001.4318; Verloh N, 2014, EUR RADIOL, V24, P1013, DOI 10.1007/s00330-014-3108-y; Pascolo L, 1999, BIOCHEM BIOPH RES CO, V257, P746, DOI 10.1006/bbrc.1999.0454; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; Schmitz SA, 1996, INVEST RADIOL, V31, P154, DOI 10.1097/00004424-199603000-00006; Sano K, 2002, ANN SURG, V236, P241, DOI 10.1097/01.SLA.0000021845.89475.00; Gotoh K, 2009, AUTOPHAGY, V5, P351; CLEMENT O, 1992, INVEST RADIOL, V27, P612; Zollner G, 2003, J HEPATOL, V38, P717, DOI 10.1016/S0168-8278(03)00096-5; WEINMANN HJ, 1991, MAGNET RESON MED, V22, P233, DOI 10.1002/mrm.1910220214; Yamada A, 2011, RADIOLOGY, V260, P727, DOI 10.1148/radiol.11100586; Bastati N, 2014, RADIOLOGY, V271, P739, DOI 10.1148/radiol.14131890; BOWERS BA, 1987, J SURG RES, V42, P565, DOI 10.1016/0022-4804(87)90033-3; COUINAUD C, 1958, Acta Anat (Basel), V34, P84; HUI AM, 1994, HEPATOLOGY, V20, P1287, DOI 10.1002/hep.1840200528; KAMIIKE W, 1985, TRANSPLANTATION, V39, P50, DOI 10.1097/00007890-198501000-00005; Kato N, 2002, INVEST RADIOL, V37, P680, DOI 10.1097/01.RLI.0000035235.50306.30; Kim BS, 2004, RADIOLOGY, V232, P173, DOI 10.1148/radiol.2321030482; Kim T, 1997, JMRI-J MAGN RESON IM, V7, P683, DOI 10.1002/jmri.1880070413; Kitajima K, 2011, MAGN RESON IMAGING, V29, P579, DOI 10.1016/j.mri.2010.10.013; Kuwatsuru R, 1997, RADIOLOGY, V202, P131; Lorusso V, 2002, BIOCHEM BIOPH RES CO, V293, P100, DOI 10.1016/S0006-291X(02)00182-1; Miyagawa Y, 2002, LIVER TRANSPLANT, V8, P370, DOI 10.1053/jlts.2002.32281; Moseley RH, 1996, AM J PHYSIOL-GASTR L, V271, pG137; MURATA S, 1995, RADIOLOGY, V197, P351; NI YC, 1994, RADIOLOGY, V190, P753; Park EA, 2007, J COMPUT ASSIST TOMO, V31, P181, DOI 10.1097/01.rct.0000236420.28137.aa; SchuhmannGiampieri G, 1997, J CLIN PHARMACOL, V37, P587; vansMontfoort JE, 1999, J PHARMACOL EXP THER, V290, P153; vansMontfoort JE, 1999, J PHARMACOL EXP THER, V291, P147; Yamamoto H, 2003, TRANSPLANTATION, V76, P164, DOI 10.1097/01.TP.0000072340.87482.17	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	SEP	2015	42	3					828	836		10.1002/jmri.24839		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP5CN	WOS:000359899000031		
J	Takahashi, K; Iwanaka, K; Osada, T; Koike, H				Takahashi, Koji; Iwanaka, Kae; Osada, Toshio; Koike, Hitonobu			Increase in Strength of Partially Stabilized Zirconia After Shot Peening	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						bending strength; partially stabilized zirconia; residual stress; shot peening	CERAMICS; RELIABILITY; STEEL	The effects of shot peening (SP) on the strength of partially stabilized zirconia (PSZ) were studied. The compressive residual stress, apparent fracture toughness (K (C)), and bending strength values of specimens subjected to SP were investigated. Results of x-ray diffraction analyses showed that SP introduced large compressive residual stress in specimens. As a result, the K (C) and bending strength values of specimens having semi-elliptical pre-cracks on their surfaces increased significantly. Shot-peened specimens having surface pre-cracks with lengths less than 140 A mu m exhibited strength comparable to that of smooth specimens and fractured outside the pre-crack zone, indicating that the pre-cracks were rendered harmless by SP. Thus, the introduction of a compressive residual stress by SP is an effective technique for increasing the strength of PSZ.	[Takahashi, Koji; Iwanaka, Kae; Koike, Hitonobu] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2408501, Japan; [Osada, Toshio] Natl Inst Mat Sci, Tsukuba 3050047, Japan	Takahashi, K (reprint author), Yokohama Natl Univ, Fac Engn, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	ktaka@ynu.ac.jp	Koike, Hitonobu/G-3699-2011	Koike, Hitonobu/0000-0002-1307-7045			Pfeiffer W, 2006, J EUR CERAM SOC, V26, P2639, DOI 10.1016/j.jeurceramsoc.2005.06.036; Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6; GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0; Takahashi K, 2010, J EUR CERAM SOC, V30, P3047, DOI 10.1016/j.jeurceramsoc.2010.07.030; [Anonymous], 1995, R1607 JAP IND; Fernandez-Pariente I, 2013, ENG FRACT MECH, V103, P2, DOI 10.1016/j.engfracmech.2012.09.014; Itou Y., 2003, J CERAM SOC JPN, V111, P776; Moon WJ, 2004, MAT SCI ENG A-STRUCT, V387, P837, DOI 10.1016/j.msea.2004.01.133; Oki T., 2013, J POWDER TECHNOL, V2013; Sakamoto J., 2014, ENG FRACT MECH, V133, P99; Suresh S., 1991, FATIGUE MAT, P134; Takahashi Koji, 2011, International Journal of Structural Integrity, V2, DOI 10.1108/17579861111162888; Tanaka K., 1989, T JAPAN SOC MECH E A, V55, P318; Yamamoto H., 2013, T JPN SOC MECH ENG A, V79, P740	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	SEP	2015	24	9					3573	3578		10.1007/s11665-015-1623-x		6	Materials Science, Multidisciplinary	Materials Science	CP6QW	WOS:000360014000038		
J	Laghfour, Z; Ajjammouri, T; Aazou, S; Refki, S; Nesterenko, DV; Rahmouni, A; Abd-Lefdil, M; Ulyashin, A; Slaoui, A; Sekkat, Z				Laghfour, Z.; Ajjammouri, T.; Aazou, S.; Refki, S.; Nesterenko, D. V.; Rahmouni, A.; Abd-Lefdil, M.; Ulyashin, A.; Slaoui, A.; Sekkat, Z.			Structural and opto-electrical properties of Al doped ZnO sputtered thin films	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							ZINC-OXIDE FILMS; OPTICAL-PROPERTIES; SOLAR-CELLS; ITO FILMS; THICKNESS; TEMPERATURE; DEPOSITION	Transparent and conductive aluminum-doped zinc oxide (AZO) thin films with high preferential c-axis orientation have been deposited on glass substrates by radio frequency magnetron sputtering method of ZnO and DC magnetron sputtering of Al. Structural, surface morphology, optical and electrical properties of ZnO thin films were studied by X-ray diffraction, scanning electron microscope, ultraviolet-visible spectrophotometer, surface plasmon spectroscopy and Hall effect measurements. The results show that AZO films are polycrystalline and exhibit the hexagonal wurzite crystal structure with a preferred orientation along (002) direction. When DC sputtering power supplied to Al target increases, the crystallinity decreases while the electrical resistivity increases. The average measured transmittance exceeded 75 % in the visible range for all AZO thin films. The band gap values increase with decreasing the Al concentrations.	[Laghfour, Z.; Ajjammouri, T.; Aazou, S.; Refki, S.; Nesterenko, D. V.; Rahmouni, A.; Sekkat, Z.] Moroccan Fdn Adv Sci Innovat & Res MAScIR, Opt & Photon Ctr, Rabat, Morocco; [Laghfour, Z.; Ajjammouri, T.; Refki, S.; Abd-Lefdil, M.; Sekkat, Z.] Univ Mohammed 5, Fac Sci, Rabat, Morocco; [Ulyashin, A.] SINTEF Mat & Chem, Oslo, Norway; [Slaoui, A.] Univ Strasbourg, ICube Lab, Strasbourg, France; [Slaoui, A.] CNRS, Strasbourg, France; [Sekkat, Z.] Osaka Univ, Dept Appl Phys, Grad Sch Engn, Suita, Osaka 5850871, Japan	Sekkat, Z (reprint author), Moroccan Fdn Adv Sci Innovat & Res MAScIR, Opt & Photon Ctr, Rabat, Morocco.	z.sekkat@mascir.com					Choi YJ, 2013, APPL SURF SCI, V269, P92, DOI 10.1016/j.apsusc.2012.09.159; Wang ZA, 2009, SOLID STATE ELECTRON, V53, P1149, DOI 10.1016/j.sse.2009.07.006; Zhu BL, 2012, PHYS STATUS SOLIDI A, V209, P1251, DOI 10.1002/pssa.201228014; Kim KK, 2011, ELECTRON MATER LETT, V7, P145, DOI 10.1007/s13391-011-0610-0; Nouneh K, 2015, MATER LETT, V139, P26, DOI 10.1016/j.matlet.2014.09.141; Zhou HM, 2007, THIN SOLID FILMS, V515, P6909, DOI 10.1016/j.tsf.2007.01.041; Soderstrom T, 2009, PROG PHOTOVOLTAICS, V17, P165, DOI 10.1002/pip.869; Oh BY, 2005, J CRYST GROWTH, V274, P453, DOI 10.1016/j.jcrysgro.2004.10.026; Chang JF, 2001, APPL SURF SCI, V183, P18, DOI 10.1016/S0169-4332(01)00541-4; Caglar M., 2008, J MATER SCI-MATER EL, V19, P8; Huafu Z., 2009, J SEMICOND, V30, DOI [10.1088/1674-4926/30/11/113002, DOI 10.1088/1674-4926/30/11/113002]; Jong-Wook Kim, 2011, Journal of the Korean Physical Society, V59, DOI 10.3938/jkps.59.2349; Ma Z. Q., TCO SI BASED HETEROJ; Park SH, 2009, J KOREAN PHYS SOC, V54, P1344; Ravichandran K, 2013, SUPERLATTICE MICROST, V64, P185, DOI 10.1016/j.spmi.2013.09.029; Rehman SU, 2014, PLASMONICS, V9, P381, DOI 10.1007/s11468-013-9635-6; Sekkat Z, 1996, LANGMUIR, V12, P2976, DOI 10.1021/la9515581; T-Thienprasert J., 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.055502; Zhang MY, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3702460; Zhang ZY, 2011, SUPERLATTICE MICROST, V49, P644, DOI 10.1016/j.spmi.2011.04.002	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	SEP	2015	26	9					6730	6735		10.1007/s10854-015-3277-8		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CO8XC	WOS:000359454500054		
J	Ma, JS; Yang, CY; Sung, JC; Minemoto, T; Lu, CH				Ma, Jeng-Shin; Yang, Che-Yuan; Sung, Jen-Cheng; Minemoto, Takashi; Lu, Chung-Hsin			Effects of CBD-derived CdS film thickness on the photovoltaic properties of Cu(In,Ga)Se-2 solar cells	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							BATH DEPOSITION PROCESS; THIN-FILMS; BUFFER LAYERS; EFFICIENCY; RECOMBINATION; DEVICE; ROUTE; CU(IN; GAP	This study investigates the effects of the thickness of CdS buffer layers on the photovoltaic properties of Cu(In,Ga)Se-2 solar cells. Continuous and dense CdS films were formed with a thickness of 103.7 nm. Increasing the film thickness caused cracks in the prepared films. The illuminated current-voltage characteristics of the cells revealed that V-oc and FF firstly increased and then decreased as CdS film thickness increased over 103.7 nm. The conversion efficiency of Cu(In,Ga)Se-2 solar cell increased with the thickness of CdS films. The proper CdS film thickness yielded a maximum conversion efficiency of 11.9 %. Complete coverage of the Cu(In,Ga)Se-2 layers by CdS films without cracking reduced the diode factor of the prepared Cu(In,Ga)Se-2 solar cells. The UV-Vis spectra and external quantum efficiency indicated that the absorption loss at short wavelengths decreased as the thickness of CdS films increased. This study found that a CdS film thickness was required to ensure the complete coverage by CdS films to optimize the photovoltaic properties of Cu(In,Ga)Se-2 solar cells.	[Ma, Jeng-Shin; Yang, Che-Yuan; Sung, Jen-Cheng; Lu, Chung-Hsin] Natl Taiwan Univ, Dept Chem Engn, Taipei 10764, Taiwan; [Minemoto, Takashi] Ritsumeikan Univ, Coll Sci & Engn, Kusatsu, Shiga 5258577, Japan	Lu, CH (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10764, Taiwan.	chlu@ntu.edu.tw	Minemoto, Takashi/F-9342-2011		Ministry of Science and Technology, Taiwan, Republic of China [MOST 103-3113-E-002-011]	The authors would like to thank the Ministry of Science and Technology, Taiwan, the Republic of China, for partial financially supporting this research under Contract No. MOST 103-3113-E-002-011.	Alagappan SA, 2005, MAT SCI ENG B-SOLID, V116, P293, DOI 10.1016/j.mseb.2004.05.048; Contreras MA, 2002, THIN SOLID FILMS, V403, P204, DOI 10.1016/S0040-6090(01)01538-3; Metin H, 2003, SEMICOND SCI TECH, V18, P647, DOI 10.1088/0268-1242/18/7/308; Shirakata S, 2007, THIN SOLID FILMS, V515, P6151, DOI 10.1016/j.tsf.2006.12.040; Nakada T, 1999, APPL PHYS LETT, V74, P2444, DOI 10.1063/1.123875; Shafarman WN, 1996, J APPL PHYS, V79, P7324, DOI 10.1063/1.361431; Zhong ZY, 2012, MATER CHEM PHYS, V135, P287, DOI 10.1016/j.matchemphys.2012.03.090; Oliveira L, 2009, THIN SOLID FILMS, V517, P2272, DOI 10.1016/j.tsf.2008.10.104; Turcu M, 2002, APPL PHYS LETT, V80, P2598, DOI 10.1063/1.1467621; Klenk R, 2001, THIN SOLID FILMS, V387, P135, DOI 10.1016/S0040-6090(00)01736-3; Chen FS, 2014, SOL ENERG MAT SOL C, V124, P166, DOI 10.1016/j.solmat.2013.12.023; Negami T, 2001, SOL ENERG MAT SOL C, V67, P331, DOI 10.1016/S0927-0248(00)00300-7; Naghavi N, 2003, PROG PHOTOVOLTAICS, V11, P437, DOI 10.1002/pip.508; Cheng HY, 2012, J ALLOY COMPD, V543, P84, DOI 10.1016/j.jallcom.2012.07.004; Dullweber T, 2000, IEEE T ELECTRON DEV, V47, P2249, DOI 10.1109/16.887004; Naghavi N, 2010, PROG PHOTOVOLTAICS, V18, P411, DOI 10.1002/pip.955; Nakada T, 2000, THIN SOLID FILMS, V361, P346, DOI 10.1016/S0040-6090(99)00767-1; Nakada T, 1999, IEEE T ELECTRON DEV, V46, P2093, DOI 10.1109/16.792002; Okamoto C, 2005, JPN J APPL PHYS 1, V44, P7372, DOI 10.1143/JJAP.44.7372; Phillips JE, 1996, PHYS STATUS SOLIDI B, V194, P31, DOI 10.1002/pssb.2221940105; Repins I, 2008, PROG PHOTOVOLTAICS, V16, P235, DOI 10.1002/pip.822; Su YW, 2013, THIN SOLID FILMS, V532, P16, DOI 10.1016/j.tsf.2012.12.040; Wada T, 1997, SOL ENERG MAT SOL C, V49, P249, DOI 10.1016/S0927-0248(97)00201-8; Witte W, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4788717; Wu CH, 2013, CERAM INT, V39, P3393, DOI 10.1016/j.ceramint.2012.08.082	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	SEP	2015	26	9					6736	6743		10.1007/s10854-015-3278-7		8	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CO8XC	WOS:000359454500055		
J	Fuks-Janczarek, I; Miedzinski, R; Chrunik, M; Majchrowski, A; Kobayashi, K; Chen, XM; Oyama, M; Jaroszewicz, LR; Pepczynska, M; Wojciechowski, A				Fuks-Janczarek, I.; Miedzinski, R.; Chrunik, M.; Majchrowski, A.; Kobayashi, K.; Chen, X. M.; Oyama, M.; Jaroszewicz, L. R.; Pepczynska, M.; Wojciechowski, A.			delta-BiB3O6:Pr3+: polymer nanocomposites deposited on substrates with silver nanoparticles for nonlinear optics	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							THIN-FILMS; DOPED BATIO3; PHOTOPOLYMERS; NANOCRYSTALS; COMPOSITES; ABSORPTION	Composites containing nanocrystallites of novel rare earth doped borate delta-BiB3O6 and polyvinyl alcohol (PVA) polymer are reported. Experimental studies of the third-order nonlinear refractive index n(2), absorption coefficient beta and second-order nonlinearity for delta-BiB3O6:Pr3+(7.5 at.%) large-size nanocrystallites embedded into PVA polymer matrices and deposited on gallium-doped zinc oxide substrates modified with silver nanoparticles (Ag-NPs) using Z-scan technique and second harmonic generation (SHG) method were performed. The complex SHG and Z-scan measurements for different sizes of Ag-NPs were done. It was shown that the polymer composite of PVA containing particles of orthorhombic bismuth triborate doped with praseodymium (7.5 at.%) reveals optically nonlinear response. It was shown that the studied composites possess both coherent and non-coherent component of nonlinear optics. The Z-scan measurements were done with use of 5 ns Nd:YAG laser and the second harmonic generation was measured using the 25 ns Nd:YAG laser with frequency repetition about 10 Hz. The measurements showed that both second as well as third-order susceptibilities are sensitive to the sizes of the Ag-NPs. The obtained results confirm a principal role of the Ag-NPs in influencing the output susceptibilities.	[Fuks-Janczarek, I.; Miedzinski, R.] J Dlugosz Univ, Inst Phys, Czestochowa, Poland; [Chrunik, M.; Majchrowski, A.; Jaroszewicz, L. R.; Pepczynska, M.] Mil Univ Technol, Inst Appl Phys, PL-00908 Warsaw, Poland; [Kobayashi, K.] Kyoto Univ, Hakubi Ctr Adv Res, Nishikyo Ku, Kyoto 6158520, Japan; [Kobayashi, K.] Kyoto Univ, Grad Sch Engn, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158520, Japan; [Chen, X. M.] Jimei Univ, Coll Food & Bioengn, Xiamen 361021, Peoples R China; [Oyama, M.] Kyoto Univ, Dept Chem Mat, Grad Sch Engn, Nishikyo Ku, Kyoto 6158520, Japan; [Wojciechowski, A.] Czestochowa Technol Univ, Dept Elect Engn, Czestochowa, Poland	Miedzinski, R (reprint author), J Dlugosz Univ, Inst Phys, Al Armii Krajowej 13-15, Czestochowa, Poland.	rmied@wp.pl			Polish Ministry of Sciences and Higher Education [POIG. 01.03.01-14-016/08]	This work was partially supported by the Polish Ministry of Sciences and Higher Education, Key Project POIG. 01.03.01-14-016/08 "New Photonic Materials and their Advanced Applications".	Kityk IV, 1997, POLYMER, V38, P4803, DOI 10.1016/S0032-3861(96)01084-1; Koscien E, 2004, OPT COMMUN, V242, P401, DOI 10.1016/j.optcom.2004.09.012; Tsuchiya K, 2008, OPT EXPRESS, V16, P5362, DOI 10.1364/OE.16.005362; Fuks-Janczarek I, 2014, PHYSICA E, V64, P1, DOI 10.1016/j.physe.2014.06.015; Chen LM, 2013, MATER CHARACT, V85, P48, DOI 10.1016/j.matchar.2013.09.001; Kityk IV, 2004, J PHYS-CONDENS MAT, V16, P231, DOI 10.1088/0953-8984/16/3/004; Ebothe J, 2006, OPT COMMUN, V268, P269, DOI 10.1016/j.optcom.2006.07.017; Chang JY, 1998, OPT COMMUN, V153, P106, DOI 10.1016/S0030-4018(98)00213-2; Chen KS, 2009, J ALLOY COMPD, V476, P635, DOI 10.1016/j.jallcom.2008.09.093; Fasasi AY, 2008, THIN SOLID FILMS, V516, P6233, DOI 10.1016/j.tsf.2007.11.125; Kacperski M., 2002, POLIMERY, V47, P11; KITYK IV, 1994, J PHYS-CONDENS MAT, V6, P4119, DOI 10.1088/0953-8984/6/22/011; KITYK IV, 1995, J MATER SCI LETT, V14, P1292, DOI 10.1007/BF01262271; Li JT, 2008, DYES PIGMENTS, V78, P219, DOI 10.1016/j.dyepig.2007.12.005; Liu NN, 2000, OPT COMMUN, V176, P239, DOI 10.1016/S0030-4018(00)00501-0; Majchrowski A, 2013, J MATER SCI-MATER EL, V24, P1485, DOI 10.1007/s10854-012-0959-3; Majchrowski A, 2014, J MATER SCI-MATER EL, V25, P2426, DOI 10.1007/s10854-014-1884-4; Pechini M. P., 1967, U. S. Pat., Patent No. [3330697, 3 330 697]; Pielichowski K., 2009, CZAS TECH, V95, P95; Plucinski KJ, 1999, MAT SCI ENG B-SOLID, V64, P88, DOI 10.1016/S0921-5107(99)00106-3; Polloni R, 2003, J NON-CRYST SOLIDS, V322, P300, DOI 10.1016/S0022-3093(03)00219-9; Wang WT, 2007, APPL SURF SCI, V253, P4673, DOI 10.1016/j.apsusc.2006.10.033; Yan B, 2011, J MATER SCI-MATER EL, V22, P905, DOI 10.1007/s10854-010-0234-4; Yang G, 2007, THIN SOLID FILMS, V515, P7926, DOI 10.1016/j.tsf.2007.03.027; Zhang LM, 2012, J MATER SCI-MATER EL, V23, P1031, DOI 10.1007/s10854-011-0542-3; Zhang T, 2008, OPT COMMUN, V281, P439, DOI 10.1016/j.optcom.2007.09.052; Zhang WF, 2000, APPL PHYS LETT, V76, P1003, DOI 10.1063/1.125920; Zhang Y, 2003, J PHYS CHEM SOLIDS, V64, P927, DOI 10.1016/S0022-3697(02)00448-1	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	SEP	2015	26	9					7134	7139		10.1007/s10854-015-3336-1		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CO8XC	WOS:000359454500109		
J	Jiu, JT; Zhang, H; Koga, S; Nagao, S; Izumi, Y; Suganuma, K				Jiu, Jinting; Zhang, Hao; Koga, Shunsuke; Nagao, Shijo; Izumi, Yasuha; Suganuma, Katsuaki			Simultaneous synthesis of nano and micro-Ag particles and their application as a die-attachment material	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							POLYOL PROCESS; NANOPARTICLES; PASTE; NUCLEATION; NANOWIRES; GROWTH	A simple and large-scale two-steps polyol process was used to simultaneously synthesize nano and micro Ag particle pastes, which were used to joint Ag-plated Cu sheets. It is found the optimized size distribution of the Ag particles and less organics remainder highly improved the shear strength and conductivity of the sintered Ag paste. After sintering at 200 A degrees C, a shear strength of over 40 MPa and a resistivity of 5.1 mu I (c) cm were achieved by using a paste composed by nano-Ag particles (AgNPs) with the diameter below 800 nm and micro-Ag particles (AgMPs) with the diameter of 1.5-4.2 mu m under a small sintering pressure of 0.4 MPa. In contrast, the Ag paste including particles with unsatisfied size distribution resulted in low shear strengths due to inhomogeneous sintering and the presence of large voids. These results are superior to those obtained with only AgNP pastes and suggested that the Ag paste composed of both the AgNPs and AgMPs with suitable ratio and size distribution will be an excellent die-attachment material in microelectronic packaging.	[Jiu, Jinting; Zhang, Hao; Koga, Shunsuke; Nagao, Shijo; Izumi, Yasuha; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Zhang, Hao; Koga, Shunsuke] Osaka Univ, Grad Sch Engn, Ibaraki, Osaka 5670047, Japan	Jiu, JT (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	jiujinting@hotmail.com			Japan Society for the Promotion of Science [24226017]	The work is partly supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (Grant No. 24226017). The authors would like to thank Jun Wang and Tsukasa Takahashi for their help and support in experimental work.	Skrabalak SE, 2007, NAT PROTOC, V2, P2182, DOI 10.1038/nprot.2007.326; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; Wang S, 2013, SCRIPTA MATER, V69, P789, DOI 10.1016/j.scriptamat.2013.08.031; Suganuma K, 2012, MICROELECTRON RELIAB, V52, P375, DOI 10.1016/j.microrel.2011.07.088; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Zhang J, 2010, NANOSCALE, V2, P18, DOI 10.1039/b9nr00047j; Yan JF, 2012, J PHYS CONF SER, V379, DOI 10.1088/1742-6596/379/1/012024; Yan JF, 2012, SCRIPTA MATER, V66, P582, DOI 10.1016/j.scriptamat.2012.01.007; Wang T, 2007, J ELECTRON MATER, V36, P1333, DOI 10.1007/s11664-007-0230-5; Johnson RW, 2007, IEEE T ELECTRON PACK, V30, P182, DOI [10.1109/TEPM.2007.899158, 10.1109/TEMP.2007.899158]; Ung D, 2005, ADV MATER, V17, P338, DOI 10.1002/adma.200400915; Lim PY, 2006, CHEM PHYS LETT, V420, P304, DOI 10.1016/j.cplett.2005.12.075; Ide E, 2005, ACTA MATER, V53, P2385, DOI 10.1016/j.actamat.2005.01.047; Maruyama M, 2008, APPL PHYS A-MATER, V93, P467, DOI 10.1007/s00339-008-4807-5; Moon KS, 2005, J ELECTRON MATER, V34, P168, DOI 10.1007/s11664-005-0229-8; Jin RC, 2003, NATURE, V425, P487, DOI 10.1038/nature02020; Jiu JT, 2009, MATER CHEM PHYS, V114, P333, DOI 10.1016/j.matchemphys.2008.09.028; Dong H, 2004, J ELECTRON MATER, V33, P1326, DOI 10.1007/s11664-004-0161-3; Fruh C., 2010, P 2010 EL SYST INT T, P1; Jiang XC, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9780-1; Kim S. S., 2014, J ELECT MAT, V43, P947; Mohamed MB, 1999, J PHYS CHEM A, V103, P10255, DOI 10.1021/jp9919720; Oestreicher A, 2013, APPL SURF SCI, V265, P239, DOI 10.1016/j.apsusc.2012.10.186; Oh C, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4872320; Palmer M. J., 2006, P INT HIGH TEMP EL C, P118	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	SEP	2015	26	9					7183	7191		10.1007/s10854-015-3343-2		9	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CO8XC	WOS:000359454500116		
J	Park, S; Nagao, S; Sugahara, T; Suganuma, K				Park, Semin; Nagao, Shijo; Sugahara, Tohru; Suganuma, Katsuaki			Heel crack propagation mechanism of cold-rolled Cu/Al clad ribbon bonding in harsh environment	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							ELECTRON BACKSCATTER DIFFRACTION; POLYCRYSTALLINE FCC METALS; GRAIN-SIZE MEASUREMENT; DYNAMIC RECRYSTALLIZATION; ROLLING TEXTURES; ALUMINUM-ALLOY; SHEET METALS; POWER MODULES; DEFORMATION; EBSD	A cold-rolled Cu/Al clad ribbon was bonded on an electroless nickel immersion gold (ENIG)-finished Cu substrate by ultrasonic bonding. The bonding samples were subjected to harsh conditions such as thermal exposure at 200 A degrees C and thermal shock at -40/250 A degrees C. The microstructural evolution and textural transitions in the Cu/Al clad ribbons were analyzed using electron backscatter diffraction to understand the heel crack propagation mechanism. The heel cracks were initiated at the edge of the Al layer between the bonded and non-bonded zones and were propagated along the coarsened grain boundaries deep into the cladded Cu layer. The continuous dynamic recrystallization (CDRX) transition phenomena around the heel cracks were scrutinized by electron backscatter pattern analysis to reveal the different microstructural and textural evolutions as a function of the ultrasonic bonding process at the bonded part and of lift-up at the non-bonded part. The heel cracks were occurred by grain coarsening due to CDRX within the Al layer during the environmental tests. The region of coarsened grains by CDRX was extended with increasing test periods. Especially in the thermal shock tests at -40/250 A degrees C, severe grain coarsening was found involving significant transformation of sub-grains into grains by rapid CDRX development. Thus, heel crack propagation accelerated more during thermal shock cycles than during high-temperature storage.	[Park, Semin] Osaka Univ, Dept Adapt Machine Syst, Ibaraki, Osaka 5670047, Japan; [Nagao, Shijo; Sugahara, Tohru; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Park, S (reprint author), Osaka Univ, Dept Adapt Machine Syst, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	seminpark@eco.sanken.osaka-u.ac.jp			Japan Society for the Promotion of Science [24226017]	The present work was partially supported by a Grant-in-Aid for Scientific Research (S) from the Japan Society for the Promotion of Science Grant Number 24226017. The authors thank Mr. Osami Iizuka at Technoalpha Co., Ltd. for his assistance with the ribbon bonding.	KUNZE K, 1993, TEXTURE MICROSTRUCT, V20, P41, DOI 10.1155/TSM.20.41; Gourdet S, 2003, ACTA MATER, V51, P2685, DOI 10.1016/S1359-6454(03)00078-8; HIRSCH J, 1988, ACTA METALL MATER, V36, P2883, DOI 10.1016/0001-6160(88)90173-3; YAMAGATA H, 1995, ACTA METALL MATER, V43, P723, DOI 10.1016/0956-7151(94)00267-L; Saito Y, 1998, SCRIPTA MATER, V39, P1221, DOI 10.1016/S1359-6462(98)00302-9; Gunduz IE, 2005, SCRIPTA MATER, V52, P939, DOI 10.1016/j.scriptamat.2004.12.015; Medjahed H, 2012, MICROELECTRON RELIAB, V52, P1099, DOI 10.1016/j.microrel.2012.01.013; Wheeler J, 2001, CONTRIB MINERAL PETR, V141, P109; Gourdet S, 2000, MAT SCI ENG A-STRUCT, V283, P274, DOI 10.1016/S0921-5093(00)00733-4; Li MY, 2006, ULTRASONICS, V45, P61, DOI 10.1016/j.ultras.2006.06.058; Zaefferer S, 2008, J MICROSC-OXFORD, V230, P499, DOI 10.1111/j.1365-2818.2008.02010.x; Alvi MH, 2008, ACTA MATER, V56, P3098, DOI 10.1016/j.actamat.2008.02.037; Wright SI, 2011, MICROSC MICROANAL, V17, P316, DOI 10.1017/S1431927611000055; Choi CH, 1997, ACTA MATER, V45, P5119, DOI 10.1016/S1359-6454(97)00169-9; ZHOU Y, 1992, ACTA METALL MATER, V40, P3179, DOI 10.1016/0956-7151(92)90481-S; Jamaati R, 2012, MATER SCI TECH-LOND, V28, P406, DOI 10.1179/1743284711Y.0000000073; Su LH, 2014, J ALLOY COMPD, V594, P12, DOI 10.1016/j.jallcom.2014.01.125; Hurley PJ, 2003, ACTA MATER, V51, P1087, DOI 10.1016/S1359-6454(02)00513-X; Doherty RD, 1997, MAT SCI ENG A-STRUCT, V238, P219, DOI 10.1016/S0921-5093(97)00424-3; Mingard KP, 2009, INT J REFRACT MET H, V27, P213, DOI 10.1016/j.ijrmhm.2008.06.009; Astashev VK, 1998, ULTRASONICS, V36, P89, DOI 10.1016/S0041-624X(97)00101-7; Choi SH, 1999, METALL MATER TRANS A, V30, P377, DOI 10.1007/s11661-999-0327-y; BECKER R, 1991, METALL TRANS A, V22, P45; Celnikier Y, 2011, MICROELECTRON RELIAB, V51, P965, DOI 10.1016/j.microrel.2011.01.001; Choi SH, 2000, INT J MECH SCI, V42, P1571, DOI 10.1016/S0020-7403(99)00091-0; Chun EJ, 2013, MATER CHEM PHYS, V140, P307, DOI 10.1016/j.matchemphys.2013.03.041; Ciappa M, 2002, MICROELECTRON RELIAB, V42, P653, DOI 10.1016/S0026-2714(02)00042-2; HIRSCH J, 1988, ACTA METALL MATER, V36, P2863, DOI 10.1016/0001-6160(88)90172-1; HIRSCH JR, 1994, MATER SCI FORUM, V157-, P1979; Humphreys F. J., 2004, RECRYSTALLIZATION RE; Humphreys FJ, 2001, J MATER SCI, V36, P3833, DOI 10.1023/A:1017973432592; Kuroda M, 2005, AIP CONF PROC, V778, P445; Lu G. Q., 2000, INT MICROELECTRON PA, V23, P407; Mariani E, 2009, ACTA MATER, V57, P1886, DOI 10.1016/j.actamat.2008.12.029; McQueen HJ, 2004, MAT SCI ENG A-STRUCT, V387, P203, DOI 10.1016/j.msea.2004.01.064; Mingard KP, 2007, J MICROSC-OXFORD, V227, P298, DOI 10.1111/j.1365-2818.2007.01814.x; Montheillet F, 2002, PHYS STATUS SOLIDI A, V189, P51, DOI 10.1002/1521-396X(200201)189:1<51::AID-PSSA51>3.0.CO;2-M; NEALE KW, 1990, INT J PLASTICITY, V6, P45, DOI 10.1016/0749-6419(90)90029-E; TOTH LS, 1990, INT J PLASTICITY, V6, P83, DOI 10.1016/0749-6419(90)90031-9; Yamada Y, 2007, MICROELECTRON RELIAB, V47, P2147, DOI 10.1016/j.microrel.2007.07.102; YAMAGATA H, 1992, SCRIPTA METALL MATER, V27, P201, DOI 10.1016/0956-716X(92)90113-S; Zhou Y, 1996, ACTA MATER, V44, P607, DOI 10.1016/1359-6454(95)00181-6	42	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	SEP	2015	26	9					7277	7289		10.1007/s10854-015-3355-y		13	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CO8XC	WOS:000359454500128		
J	Sakata, J; Kawatsu, K; Iwasaki, T; Kumeda, Y				Sakata, Junko; Kawatsu, Kentaro; Iwasaki, Tadashi; Kumeda, Yuko			Development of a rapid and simple immunochromatographic assay to identify Vibrio parahaemolyticus	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Epitope mapping; Identification; Immunochromatographic assay; Vibrio parahaemolyticus	MONOCLONAL-ANTIBODY; CAMPYLOBACTER-JEJUNI; STOOL SPECIMENS; IDENTIFICATION; CULTURES; STRAINS; EPITOPE; SEAFOOD; GENE	To rapidly and simply determine whether or not bacterial colonies growing on agar were Vibrio parahaemolyticus, we developed an immunochromatographic assay (VP-ICA) using two different monoclonal antibodies (designated mAb-VP34 and mAb-VP109) against the delta subunit of V. parahaemolyticus-F0F1 ATP synthase. The epitopes recognized by mAb-VP34 and mAb-VP109 were mapped to sequences of eight ((47)LLTSSFSA(54)) and six amino acid residues ((16)FDFAVD(21)), respectively. An amino acid sequence similarity search of the NCBI database using BLASTP showed that both epitopic amino acid sequences were present together only in V. parahaemolyticus. When 124 V. parahaemolyticus strains and 94 strains of 27 other Vibrio species or 35 non-Vibrio species were tested using the VP-ICA, the VP-ICA identified V. parahaemolyticus with 100% accuracy. The VP-ICA rapidly and simply identified the pathogen directly from a single agar colony within 30 min, indicating that VP-ICA will greatly reduce labor and time required to identify V. parahaemolyticus compared with conventional biochemical tests. (C) 2015 Elsevier B.V. All rights reserved.	[Sakata, Junko; Kawatsu, Kentaro; Kumeda, Yuko] Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Osaka 5370025, Japan; [Iwasaki, Tadashi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Osaka, Japan	Sakata, J (reprint author), Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Higashinari Ku, 1-3-69 Nakamichi, Osaka 5370025, Japan.	sakata@iph.pref.osaka.jp			JSPS KAKENHI [24780206]	We are grateful to the staff of the Kansai Airport Quarantine Station for providing the Vibrio strains. This work was supported by JSPS KAKENHI Grant Number 24780206.	Sakata J, 2012, J MICROBIOL METH, V88, P77, DOI 10.1016/j.mimet.2011.10.014; Thompson CC, 2007, INT J SYST EVOL MICR, V57, P2480, DOI 10.1099/ijs.0.65223-0; Pongsunk S, 1999, J CLIN MICROBIOL, V37, P3662; Kawatsu K, 1997, JPN J MED SCI BIOL, V50, P133; Kim YB, 1999, J CLIN MICROBIOL, V37, P1173; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Kawatsu K, 2008, J CLIN MICROBIOL, V46, P1226, DOI 10.1128/JCM.02170-07; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Hara-Kudo Y, 2001, APPL ENVIRON MICROB, V67, P5819, DOI 10.1128/AEM.67.12.5819-5823.2001; Kawatsu K, 2006, J CLIN MICROBIOL, V44, P1821, DOI 10.1128/JCM.44.5.1821-1827.2006; Bautista DA, 2002, J VET DIAGN INVEST, V14, P427; Croci L, 2007, J AOAC INT, V90, P1588; Farmer III JJ, 2005, BERGEYS MANUAL SYSTE, V2, P494; Galfrè G, 1981, Methods Enzymol, V73, P3; Gomez-Gil B, 2006, BIOLOGY OF VIBRIOS, P15; Kaysner C.A., 2004, VIBRIO; Marot-Leblond A, 2006, J CLIN MICROBIOL, V44, P138, DOI 10.1128/JCM.44.1.138-142.2006; Ministry of Health Labor and Welfare, 2004, STAND METH AN FOOD S, V2004, P201; NICOLAISENSTROUSS K, 1987, J VIROL, V61, P3410; Park CH, 2003, J CLIN MICROBIOL, V41, P2650, DOI 10.1128/JCM.41.6.2650-2653.2003; Qian HL, 2008, APPL ENVIRON MICROB, V74, P833, DOI 10.1128/AEM.01559-07; SAKAI Y, 1990, BIOCHIM BIOPHYS ACTA, V1018, P18, DOI 10.1016/0005-2728(90)90104-C; Shima Tomoko, 2011, Japanese Journal of Food Microbiology, V28; Su YC, 2005, J FOOD PROTECT, V68, P1454; Thompson FL, 2006, BIOLOGY OF VIBRIOS, P29; Yeung M., 2004, FOODBORNE PATHOG DIS, V1, P74	26	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	SEP	2015	116						23	29		10.1016/j.mimet.2015.06.009		7	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CP5ZH	WOS:000359963600004		
J	Tsuzukibashi, O; Uchibori, S; Kobayashi, T; Saito, M; Umezawa, K; Ohta, M; Shinozaki-Kuwahara, N				Tsuzukibashi, Osamu; Uchibori, Satoshi; Kobayashi, Taira; Saito, Masanori; Umezawa, Koji; Ohta, Mitsuhiro; Shinozaki-Kuwahara, Noriko			A selective medium for the isolation of Microbacterium species in oral cavities	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Genus Microbacterium; Selective medium; Oral cavity	SP-NOV; COMB. NOV; BACTEREMIA; RECLASSIFICATION; SUSCEPTIBILITY; PATIENT; CELL	The genus Microbacterium has been isolated from the environment, dairy goods, and human clinical specimens. Although, in our previous studies, some Micro bacterium species were infrequently detected in oral samples collected from humans, there is currently no report that these organisms, which are capable of causing serious systemic infections, were isolated from the human oral cavity. The aim of the present study was to develop a selective medium to isolate the representative Micro bacterium species most frequently detected in human clinical specimens, and reveal the distribution of individual Micro bacterium species in the oral cavity. The growth recoveries of representative Microbacterium species on the selective medium, designated as MSM, were sufficient. Moreover, the growth of other representative oral bacteria was markedly inhibited on the selective medium. The proportion of Microbacterium species in the saliva samples of 60 subjects, 20 of whom were removable denture wearers, was then examined. The proportion of these organisms was also examined in environmental samples obtained by swabbing 20 washstands. PCR primers were designed for representative Microbacterium species. The genus Microbacterium was detected in 45% of the saliva and denture plaque samples collected from the twenty removable denture wearers, but was absent in the saliva of the forty non-denture wearers. On the other hand, these organisms were detected in all environmental samples. The genus Microbacterium accounted for 0.00003%, 0.0001%, and 12.6% of the total cultivable bacteria number on the BHI medium in the saliva and denture plaque samples of removable denture wearers and in the environmental samples, respectively. The most predominant Microbacterium species in all positive samples was Microbacterium oxydans. These results indicated that the genus Micro bacterium was not a part of the normal flora in the human oral cavity, except for subjects wearing dentures that were contaminated by the environment, and the selective medium, designated as MSM, was useful for isolating Microbacterium species, which are frequently encountered in human clinical specimens, from the various samples. (C) 2015 Elsevier B.V. All rights reserved.	[Tsuzukibashi, Osamu; Saito, Masanori; Shinozaki-Kuwahara, Noriko] Nihon Univ, Dept Microbiol & Immunol, Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan; [Uchibori, Satoshi; Kobayashi, Taira] Nihon Univ, Dept Crown Bridge Prosthodont, Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan; [Umezawa, Koji] Nihon Univ, Dept Special Needs Dent, Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan; [Ohta, Mitsuhiro] Nihon Univ, Dept Oral Diagnost, Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan	Tsuzukibashi, O (reprint author), Nihon Univ, Dept Microbiol & Immunol, Sch Dent Matsudo, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	tsudukibashi.osamu@nihon-u.ac.jp					Alonso-Echanove J, 2001, J INFECT DIS, V184, P754, DOI 10.1086/323080; Giammanco GM, 2006, J MED MICROBIOL, V55, P335, DOI 10.1099/jmm.0.46219-0; Schumann P, 1999, INT J SYST BACTERIOL, V49, P175; Lau SKP, 2002, J CLIN MICROBIOL, V40, P2681, DOI 10.1128/JCM.40.7.2681-2685.2002; Tang YW, 2000, J CLIN MICROBIOL, V38, P1676; Adderson EE, 2008, PEDIATR INFECT DIS J, V27, P136, DOI [10.1097/INF.0b013e31814fab12, 10.1097/INF.0b0113e31814fab12]; Behrendt U, 2001, INT J SYST EVOL MICR, V51, P1267; Funke G, 1998, FEMS MICROBIOL LETT, V158, P89, DOI 10.1111/j.1574-6968.1998.tb12805.x; Gneiding K, 2008, J CLIN MICROBIOL, V46, P3646, DOI 10.1128/JCM.01202-08; Hirasawa M, 2002, CARIES RES, V36, P155, DOI 10.1159/000059329; Hirji Z, 2003, CLIN INFECT DIS, V36, pE115, DOI 10.1086/374051; Ko KS, 2007, DIAGN MICR INFEC DIS, V57, P393, DOI 10.1016/j.diagmicrobio.2006.10.010; Laffineur K, 2003, J CLIN MICROBIOL, V41, P2242, DOI 10.1128/JCM.41.5.2242-2246.2003; Magar D.L., 2003, J CLIN PERIODONTOL, V30, P644	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	SEP	2015	116						60	65		10.1016/j.mimet.2015.06.016		6	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CP5ZH	WOS:000359963600010		
J	Maeda, K; Miki, T; Itoh, K; Arafune, K; Yamamoto, T; Fukui, K				Maeda, Kouji; Miki, Takumi; Itoh, Kazuhiro; Arafune, Koji; Yamamoto, Takuji; Fukui, Keisuke			Anti-solvent crystallization of a ternary Lennard-Jones mixture performed by molecular dynamics	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Molecular dynamics; Anti-solvent crystallization; Lennard-Jones potential; Local composition	PHASE-TRANSITION; SIMULATIONS	Anti-solvent crystallization from a ternary mixture was examined by an NpT ensemble molecular dynamics simulation. The co-solvent and anti-solvent effects were represented by the Lennard-Jones interaction energy parameter, epsilon(ij). The homogeneous binary solution of the solute and solvent was achieved at a constant temperature and pressure. Anti-solvent crystallization was introduced by changing some co-solvent molecules to anti-solvent molecules, immediately. The configuration of solute molecules was investigated by using the radial distribution function, g(r), and the local composition, X-L. The value of epsilon(ij) affected the configuration of the solute molecules significantly; the decrease in epsilon(ij) provided the localization and crystallization of the solute molecules. The composition of the anti-solvent molecules in the solution also affected the configuration of the solute molecules; the increase in the anti-solvent composition produced the crystal structure of the solute molecules more rapidly. These qualitative results corresponded well to anti-solvent crystallization. The radial distribution function represented the crystal structure for solute molecules, and the local composition of the solute was increased from the bulk composition as the effect of the anti-solvent increased. We proposed that the time variation of the local composition of the solute represents the temporal development of the crystal structure and the time to crystallization well. (c) 2015 Elsevier B.V. All rights reserved.	[Maeda, Kouji; Miki, Takumi; Itoh, Kazuhiro; Arafune, Koji; Yamamoto, Takuji; Fukui, Keisuke] Univ Hyogo, Dept Chem Engn, Himeji, Hyogo 6712201, Japan	Maeda, K (reprint author), Univ Hyogo, Dept Chem Engn, 2167 Shosha, Himeji, Hyogo 6712201, Japan.	maeda@eng.u-hyogo.ac.jp					ALDER BJ, 1962, PHYS REV, V127, P359, DOI 10.1103/PhysRev.127.359; Allen M. P., 1987, COMPUTER SIMULATION; ALDER BJ, 1957, J CHEM PHYS, V27, P1208, DOI 10.1063/1.1743957; Maeda K, 2003, J MOL LIQ, V102, P1, DOI 10.1016/S0167-7322(02)00055-7; Anwar J, 1998, J AM CHEM SOC, V120, P9600, DOI 10.1021/ja972750n; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; Lamm M. C., 2001, AICHE J, V47, P1664; Maeda K, 2005, J MOL LIQ, V122, P43, DOI 10.1016/j.molliq.2005.01.008; Maeda K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2825601; Mullin J.W., 1993, CRYSTALLIZATION; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	SEP	2015	209						1	5		10.1016/j.molliq.2015.05.019		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CP5XK	WOS:000359958500001		
J	Louzguine-Luzgin, DV; Georgarakis, K; Tsarkov, A; Solonin, A; Honkimaki, V; Hennet, L; Yavari, AR				Louzguine-Luzgin, Dmitri V.; Georgarakis, Konstantinos; Tsarkov, Andrey; Solonin, Alexey; Honkimaki, Veijo; Hennet, Louis; Yavari, Alain R.			Structural changes in liquid Fe and Fe-B alloy on cooling	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Undercooling; Metallic liquids; Atomic structure; Synchrotron radiation X-ray diffractometry	BULK METALLIC-GLASS; X-RAY-DIFFRACTION; PHASE-TRANSITION; ELECTRON-DIFFRACTION; MOLECULAR-DYNAMICS; AMORPHOUS-ALLOYS; FE80B20 GLASS; RANGE ORDER; FREE-VOLUME; SYNCHROTRON	The existence of liquid-liquid phase transitions has been suggested for liquid Fe and some of its alloys. In order to shed light on this phenomenon in-situ cooling of the Fe80B20 and Fe melts was performed under a synchrotron beam radiation. It allowed for the continuous acquisition of X-ray diffraction spectra in the supercooled liquid region below the liquidus temperature. The procedure allowed monitoring of the structural changes in the supercooled liquid state using real-space atomic pair PDF(R) and radial RDF(R) distribution functions. The results are discussed in comparison with those of molecular dynamics simulation for liquid Fe. (C) 2015 Elsevier B.V. All rights reserved.	[Louzguine-Luzgin, Dmitri V.; Georgarakis, Konstantinos; Yavari, Alain R.] Tohoku Univ, WPI Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Georgarakis, Konstantinos; Yavari, Alain R.] Inst Natl Polytech Grenoble, CNRS, SIMAP, F-38402 St Martin Dheres, France; [Tsarkov, Andrey; Solonin, Alexey] Natl Univ Sci & Technol MISIS, Moscow 119049, Russia; [Honkimaki, Veijo; Yavari, Alain R.] European Synchrotron Radiat Facil, F-38042 Grenoble, France; [Hennet, Louis] Univ Orleans, CNRS, CEMHTI, F-45071 Orleans 02, France	Louzguine-Luzgin, DV (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.	dml@wpi-aimr.tohoku.ac.jp	Georgarakis, Konstantinos/K-1939-2015; Georgarakis, Konstantinos/E-6390-2010; LOUZGUINE, Dmitri/D-2492-2010; Solonin, Alexey/H-9930-2014; Tsarkov, Andrey/H-1523-2015	LOUZGUINE, Dmitri/0000-0001-5716-4987; Solonin, Alexey/0000-0002-6520-7964; Tsarkov, Andrey/0000-0002-9179-1201	European Network on bulk metallic glasses VitriMetTech [607080]; French national ANR project [ANR-12-EMMA-0054]; ESRF [HD-592]; World Premier International Research Center Initiative (WPI), MEXT, Japan; Ministry of Education and Science of the Russian Federation [K2-2014-013]	Support from the European Network on bulk metallic glasses VitriMetTech Nr 607080 and the French national ANR project ANR-12-EMMA-0054 and an ESRF long-term project HD-592 coordinated by A.R.Y. is gratefully acknowledged. This work was supported by World Premier International Research Center Initiative (WPI), MEXT, Japan and by the Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST "MISiS" (No K2-2014-013). One of the authors AT sincerely thanks Masamichi Miyama for his kind help with MD modeling.	Hirata A, 2005, MATER TRANS, V46, P2781, DOI 10.2320/matertrans.46.2781; Wessels V, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.094116; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; Greaves GN, 2008, SCIENCE, V322, P566, DOI 10.1126/science.1160766; Johnson WL, 1999, MRS BULL, V24, P42; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Katayama Y, 2000, NATURE, V403, P170, DOI 10.1038/35003143; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; INOUE A, 1995, MATER T JIM, V36, P866; Zhou XW, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144113; Lou HB, 2013, P NATL ACAD SCI USA, V110, P10068, DOI 10.1073/pnas.1307967110; Yavari AR, 2006, NATURE, V439, P405, DOI 10.1038/439405a; Egami T, 2002, MATER TRANS, V43, P510, DOI 10.2320/matertrans.43.510; NOSE S, 1984, J CHEM PHYS, V81, P511; Yavari AR, 2005, ACTA MATER, V53, P1611, DOI 10.1016/j.actamat.2004.12.011; Evteev AV, 2004, J EXP THEOR PHYS+, V99, P522, DOI 10.1134/1.1809680; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; Hennet L, 2011, EUR PHYS J-SPEC TOP, V196, P151, DOI 10.1140/epjst/e2011-01425-0; Mattern N, 2013, INTERMETALLICS, V32, P51, DOI 10.1016/j.intermet.2012.08.024; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Hirata A, 2006, INTERMETALLICS, V14, P903, DOI 10.1016/j.intermet.2006.01.007; Belousov O.K., 2009, RUSS METALL METALLY, V6, P6488; Cheng YQ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014207; Cromer D.T., 1969, FREE ATOMS J CHEM PH, V47, P4857; Dahlborg U, 2000, EUR PHYS J B, V14, P639, DOI 10.1007/s100510051073; DAVIS LA, 1976, SCRIPTA METALL MATER, V10, P541, DOI 10.1016/0036-9748(76)90257-X; EGAMI T, 1978, J MATER SCI, V13, P2587, DOI 10.1007/BF00552688; Franzese G, 2001, NATURE, V409, P692, DOI 10.1038/35055514; Gale W.F., 2004, SMITHELLS METALS REF, V8-th; Gale W.F., 2004, SMITHELLS METALS REF, Veight, P4; Georgarakis K., 2011, ACTA MAT, V59, P2708; Glosli J.N., 1998, PHYS REV LETT, V82; GREER AL, 1982, ACTA METALL MATER, V30, P171, DOI 10.1016/0001-6160(82)90056-6; Haruyama O, 2007, J NON-CRYST SOLIDS, V353, P3053, DOI 10.1016/j.jnoncrysol.2007.05.071; Hoover W. G., 1985, PHYS REV A, V31, P1965; Ibers J.A., 1974, INT TABLES XRAY CRYS, P41; Jiang QK, 2010, METALL MATER TRANS A, V41A, P1634, DOI 10.1007/s11661-009-0041-9; KIM YW, 1989, ACTA METALL MATER, V37, P247, DOI 10.1016/0001-6160(89)90283-6; Krishnan S., 2000, J PHYS CONDENS MATT, V12, P145; Li MY, 2015, J MOL LIQ, V204, P27, DOI 10.1016/j.molliq.2015.01.005; Louzguine DV, 2005, J NON-CRYST SOLIDS, V351, P1639, DOI [10.1016/j.jnoncrysol.2005.04.054, 10.1016/j.jnonsrysol.2005.04.054]; Louzguine-Luzgin DV, 2014, MATER CHARACT, V96, P6, DOI 10.1016/j.matchar.2014.07.014; Louzguine-Luzgin D.V., 2009, J MATER RES, V24, P24274; Louzguine-Luzgin D.V., 2014, J ALLOY COMPD, V586, P2, DOI DOI 10.1016/J.JALLC0M.2012.09.057; Louzguine-Luzgin D.V., 2008, J APPL PHYS, V104; Louzguine-Luzgin DV, 2011, J APPL PHYS, V110, DOI 10.1063/1.3624745; Mattern N, 2003, APPL PHYS LETT, V82, P2589, DOI 10.1063/1.1567457; Mauro NA, 2013, J NON-CRYST SOLIDS, V362, P237, DOI 10.1016/j.jnoncrysol.2012.11.022; Miracle D.B., 2004, NAT MATER, V3, P3697; Mirzoev AA, 2011, EPJ WEB CONF, V15, DOI 10.1051/epjconf/20111501012; Novakovic R, 2014, J MOL LIQ, V200, P153, DOI 10.1016/j.molliq.2014.09.053; Sastry S., 2003, NAT MATER, V2, P2739; Stoica M, 2010, JOM-US, V62, P76, DOI 10.1007/s11837-010-0037-3; Sugie K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.11RD04; Suzuki K., 1982, P 4 INT C RAP QUENCH, V1, P309; TAMURA K, 1969, PHYS LETT A, VA 29, P52, DOI 10.1016/0375-9601(69)91025-1; Tanaka H, 2000, PHYS REV E, V62, P6968, DOI 10.1103/PhysRevE.62.6968; WAGNER CNJ, 1965, Z NATURFORSCH PT A, VA 20, P325; Wagner C.N.J., 1978, J NONCRYST SOLIDS, V31, P311; Waseda Y., 1980, STRUCTURE NONCRYSTAL; WASEDA Y, 1978, PHYS STATUS SOLIDI A, V49, P387, DOI 10.1002/pssa.2210490149; Yavari AR, 2004, MAT SCI ENG A-STRUCT, V375, P709, DOI [10.1016/j.msea.2003.10.224, 10.1016/j.msca.2003.10.224]; Yavari AR, 1999, MATER RES SOC SYMP P, V554, P21	64	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	SEP	2015	209						233	238		10.1016/j.molliq.2015.05.062		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CP5XK	WOS:000359958500030		
J	Umecky, T; Suga, K; Masaki, E; Takamuku, T; Makino, T; Kanakubo, M				Umecky, Tatsuya; Suga, Kenta; Masaki, Eiji; Takamuku, Toshiyuki; Makino, Takashi; Kanakubo, Mitsuhiro			Solvation structure and dynamics of Li+ in Lewis-basic ionic liquid of 1-octy1-4-aza-l-azoniabicyclo[2.2.2]octane bis(trifluoromethanesulfonyl)amide	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Ionic liquid; NMR chemical shift; Relaxation time; Self-diffusion coefficient; 1-Octyl-4-aza-1-azoniabicyclo[2.2.2]octane	LITHIUM ION; DIFFUSION-COEFFICIENTS; TRANSPORT-PROPERTIES; ELECTROLYTES; TEMPERATURE; SPECTROSCOPY; IMIDAZOLIUM; DENSITIES; MIXTURES; CATIONS	H-1, C-13, L, N-15, and F-19 NMR spectra of 1-octy1-4-aza-1-azoniabicyclo[2.2.2]octane bis(trifluoromethanesulfonyl) amide ([C(8)dabco][TFSA]) solutions with and without LiTFSA (lithium mole fractions of x(Li); = 0 and 0.1) were measured at 3132 K. The chemical shift measured for each nucleus was corrected for volume magnetic susceptibility of the solution. For comparison, those NMR spectra of 1-methyl-3-octylimidazolium bis(trifluoromethanesulfonyl) amide ([C(8)mim][TFSAD solutions were recorded under the same condition. The peak shifts for the nuclei induced by the dissolution of Li+ showed that Li+ interacts with not only TFSA(-) but also Caciabco+ in [C(8)dabco][TFSA] solution. Self-diffusion coefficients of the cation, anion, and Li+ in the ionic liquid solutions were determined by a pulsed field gradient NMR technique. Correlation times for jump motion of Li+ were estimated from Li-7 longitudinal relaxation times with two different magnetic fields. The diffusion and jump motions of Li+ in [C(8)dabco][TFSA] and IConim][TFSA] solutions are discussed in terms of interionic interactions. (C) 2015 Elsevier B.V. All rights reserved.	[Umecky, Tatsuya; Suga, Kenta; Masaki, Eiji; Takamuku, Toshiyuki] Saga Univ, Grad Sch Sci & Engn, Saga 8408502, Japan; [Makino, Takashi; Kanakubo, Mitsuhiro] Natl Inst Adv Ind Sci & Technol, Miyagino Ku, Sendai, Miyagi 9838551, Japan	Umecky, T (reprint author), Saga Univ, Grad Sch Sci & Engn, Honjo Machi, Saga 8408502, Japan.	umecky@cc.saga-u.ac.jp			Japan Society for the Promotion of Science [24750019]; Saga University	This work was supported partly by Grant-in-Aid for Young Scientists (B) (No. 24750019) from the Japan Society for the Promotion of Science and Dean's Grant for Progressive Research Projects from Saga University. The NMR experiments using the Agilent 400 MHz NMR spectrometer and fluorescence X-ray analysis were conducted at the Analytical Research Center for Experimental Sciences of Saga University.	Abragam A., 1989, PRINCIPLES NUCL MAGN, P313; Holz M, 2000, PHYS CHEM CHEM PHYS, V2, P4740, DOI 10.1039/b005319h; Tariq M, 2009, J CHEM THERMODYN, V41, P790, DOI 10.1016/j.jct.2009.01.012; Le MLP, 2010, J PHYS CHEM B, V114, P894, DOI 10.1021/jp9098842; Borodin O, 2006, J PHYS CHEM B, V110, P16879, DOI 10.1021/jp061930t; Umebayashi Y, 2007, J PHYS CHEM B, V111, P13028, DOI 10.1021/jp076869m; Li Z, 2012, J PHYS CHEM B, V116, P12801, DOI 10.1021/jp3052246; Harris KR, 2012, FARADAY DISCUSS, V154, P425, DOI 10.1039/c1fd00085c; Lassegues JC, 2009, J PHYS CHEM A, V113, P305, DOI 10.1021/jp806124w; Castiglione F, 2011, J PHYS CHEM LETT, V2, P153, DOI 10.1021/jz101516c; Fromling T, 2008, J PHYS CHEM B, V112, P12985, DOI 10.1021/jp804097j; Umebayashi Y, 2010, J PHYS CHEM B, V114, P6513, DOI 10.1021/jp100898h; Mizuno K, 2004, PURE APPL CHEM, V76, P105, DOI 10.1351/pac200476010105; Bayley PM, 2010, J PHYS CHEM C, V114, P20569, DOI 10.1021/jp104957j; Jacquemin J, 2008, J CHEM ENG DATA, V53, P716, DOI 10.1021/je700707y; MOMOKI K, 1990, ANAL CHEM, V62, P1665, DOI 10.1021/ac00214a026; Duluard S, 2008, J RAMAN SPECTROSC, V39, P627, DOI 10.1002/jrs.1896; Lassegues JC, 2006, PHYS CHEM CHEM PHYS, V8, P5629, DOI 10.1039/b615127b; Nicotera I, 2005, J PHYS CHEM B, V109, P22814, DOI 10.1021/jp053799f; Saito Y, 2007, J PHYS CHEM B, V111, P11794, DOI 10.1021/jp072998r; Shirai A, 2008, ANAL SCI, V24, P1291, DOI 10.2116/analsci.24.1291; Gardas RL, 2007, J CHEM ENG DATA, V52, P1881, DOI 10.1021/je700205n; Nockemann P, 2005, CHEM PHYS LETT, V415, P131, DOI 10.1016/j.cplett.2005.08.128; Hardwick LJ, 2007, J RAMAN SPECTROSC, V38, P110, DOI 10.1002/jrs.1632; Castiglione F, 2014, J PHYS CHEM B, V118, P13679, DOI 10.1021/jp509387r; Umebayashi Y, 2011, J PHYS CHEM B, V115, P12179, DOI 10.1021/jp2072827; Kunze M, 2011, J PHYS CHEM C, V115, P19431, DOI 10.1021/jp2055969; Haskins JB, 2014, J PHYS CHEM B, V118, P11295, DOI 10.1021/jp5061705; Appetecchi G. B., 2012, ACS SYM SER, V117, P67; Hayamizu K, 2008, J PHYS CHEM B, V112, P1189, DOI 10.1021/jp077714h; Hayamizu K., 2011, J CHEM PHYS, V135; Makino T, 2013, J CHEM ENG DATA, V58, P370, DOI 10.1021/je3010062; Umecky T, 2008, J PHYS CHEM B, V112, P3357, DOI 10.1021/jp711625r; Yoshizawa-Fujita M, 2006, ELECTROCHEM COMMUN, V8, P445, DOI 10.1016/j.elecom.2006.01.008; Yoshizawa-Fujita M, 2006, TETRAHEDRON LETT, V47, P2755, DOI 10.1016/j.tetlet.2006.02.073	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	SEP	2015	209						557	562		10.1016/j.molliq.2015.06.006		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CP5XK	WOS:000359958500071		
J	Reuss, B; Schroten, H; Ishikawa, H; Asif, AR				Reuss, B.; Schroten, H.; Ishikawa, H.; Asif, A. R.			Cross-reactivity of Antibodies Directed to the Gram-Negative Bacterium Neisseria gonorrhoeae With Heat Shock Protein 60 and ATP-Binding Protein Correlates to Reduced Mitochondrial Activity in HIBCPP Choroid Plexus Papilloma Cells	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						HIBCPP; Choroid plexus; Neisseria gonorrhoeae; Mitochondria; Hsp60; ATPB	BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID BARRIER; HEAT-SHOCK-PROTEIN; LIPID-INSOLUBLE MOLECULES; NEURONAL DIFFERENTIATION; INTERMEDIATE-FILAMENTS; MULTIPLE-SCLEROSIS; NEURITE OUTGROWTH; PRENATAL EXPOSURE; MONONUCLEAR-CELLS	Antibacterial antibodies can cause neurologic side-effects by cross-reactivity with cellular antigens. Here we investigated interactions of antibodies to Neisseria gonorrhoeae (alpha-NG) - maternal infections by which increases the offspring's risk for later psychosis-with HIBCPP cells, a cell culture model of choroid plexus epithelium. Immunocytochemistry and Western blotting with alpha-NG, revealed organelle-like intracellular staining in HIBCPP cells, and labelling of several immunoreactive bands in cellular protein. Two-dimensional Western blotting revealed several immunopositive spots, most prominent of which were identified by mass spectrometry as mitochondrially localized proteins heat shock protein 60 (Hsp60) and ATP-binding protein beta-subunit (ATPB). Similarly alpha-NG interacted with commercial samples of these proteins as revealed by Western blotting. Three alternative methods (JC-1, Janus green and MTT staining) revealed alpha-NG to cause in HIBCPP cells a significant decrease in mitochondrial activity, which could be reverted by neuroleptic drugs. Immunoreactivity of alpha-NG with choroid plexus epithelium in human post mortem samples suggests in vivo relevance of these findings. Finally, distinctly different staining patterns of antibodies against Neisseria meningitidis (alpha-NM), confirmed antibody specificity. To our knowledge this is the first report that alpha-NG cross-reactivity with Hsp60 and ATPB impairs mitochondrial activity in choroid plexus epithelial cells, pathogenetic relevance of which needs further clarification.	[Reuss, B.] UMG, Inst Neuroanat, D-37075 Gottingen, Germany; [Schroten, H.] Heidelberg Univ, Univ Childrens Hosp Mannheim, Pediat Infect Dis, Heidelberg, Germany; [Ishikawa, H.] Nippon Dent Univ Tokyo, Tokyo, Japan; [Asif, A. R.] UMG, Inst Clin Chem, D-37075 Gottingen, Germany	Reuss, B (reprint author), UMG, Inst Neuroanat, Kreuzbergring 36, D-37075 Gottingen, Germany.	breuss@gwdg.de					Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; MELTZER HY, 1976, SCHIZOPHRENIA BULL, V2, P19; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Quintana FJ, 2012, NEUROLOGY, V78, P532, DOI 10.1212/WNL.0b013e318247f9f3; Grundler T, 2013, MICROBES INFECT, V15, P291, DOI 10.1016/j.micinf.2012.12.005; Sprenger RR, 2004, ELECTROPHORESIS, V25, P156, DOI 10.1002/elps.200305675; SPECTOR R, 1989, SCI AM, V261, P68; Dale RC, 2012, J CHILD NEUROL, V27, P1470, DOI 10.1177/0883073812451327; Anglin RE, 2012, J CLIN PSYCHIAT, V73, P506, DOI 10.4088/JCP.11r07237; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Robicsek O, 2013, MOL PSYCHIATR, V18, P1067, DOI 10.1038/mp.2013.67; Babulas V, 2006, AM J PSYCHIAT, V163, P927, DOI 10.1176/appi.ajp.163.5.927; Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z; Kniesel U, 1996, DEV BRAIN RES, V96, P229, DOI 10.1016/0165-3806(96)00117-4; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; HABGOOD MD, 1993, J PHYSIOL-LONDON, V468, P73; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; HENKEL AW, 1994, ANAL BIOCHEM, V223, P329, DOI 10.1006/abio.1994.1595; Lehtinen MK, 2013, J NEUROSCI, V33, P17553, DOI 10.1523/JNEUROSCI.3258-13.2013; Contreras-Shannon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059012; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; Nord M, 2011, CNS NEUROSCI THER, V17, P97, DOI 10.1111/j.1755-5949.2010.00222.x; SAUNDERS NR, 1984, J DEV PHYSIOL, V6, P45; Nagele RG, 2011, J ALZHEIMERS DIS, V25, P605, DOI 10.3233/JAD-2011-110098; Gubert C, 2013, J PSYCHIATR RES, V47, P1396, DOI 10.1016/j.jpsychires.2013.06.018; Nicholls DG, 2002, INT J BIOCHEM CELL B, V34, P1372, DOI 10.1016/S1357-2725(02)00077-8; Zhu JH, 2001, CIRCULATION, V103, P1071; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; FERGUSON RK, 1969, EXP BRAIN RES, V7, P181; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Rosenfeld M, 2011, BIOL PSYCHIAT, V69, P980, DOI 10.1016/j.biopsych.2011.01.010; DZIEGIELEWSKA KM, 1979, J PHYSIOL-LONDON, V292, P207; Dobbs RJ, 2005, HELICOBACTER, V10, P267, DOI 10.1111/j.1523-5378.2005.00331.x; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Deitiker P, 2000, HUM IMMUNOL, V61, P255, DOI 10.1016/S0198-8859(99)00117-2; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Casademont J, 2007, J CLIN PSYCHOPHARM, V27, P284, DOI 10.1097/JCP.0b013e318054753e; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Spector R, 2007, PHARM RES, V24, P859, DOI 10.1007/s11095-006-9221-0; Westall FC, 2006, J CLIN MICROBIOL, V44, P2099, DOI 10.1128/JCM.02532-05; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Redzic ZB, 2004, ADV DRUG DELIVER REV, V56, P1695, DOI 10.1016/j,addr.2004.07.005; von Haller PD, 2001, PROTEOMICS, V1, P1010; Sorensen HJ, 2009, SCHIZOPHRENIA BULL, V35, P631, DOI 10.1093/schbul/sbn121; Spector R, 2007, J NEUROCHEM, V103, P425, DOI 10.1111/j.1471-4159.2007.04773.x; Anthony Shawn G, 2003, J Alzheimers Dis, V5, P171; Asif AR, 2010, ELECTROPHORESIS, V31, P1947, DOI 10.1002/elps.201000015; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; BERG K, 1990, APMIS, V98, P156; Bollag DM, 1994, PROTEIN METHODS; Buckman JF, 2001, J NEUROSCI, V21, P5054; Bueno D, 2014, CROAT MED J, V55, P306, DOI 10.3325/cmj.2014.55.306; Campbell GR, 2012, ACTA NEUROPATHOL, V124, P209, DOI 10.1007/s00401-012-1001-9; COOPERSTEIN SJ, 1953, EXP CELL RES, V5, P82, DOI 10.1016/0014-4827(53)90096-2; Cornford EM, 1997, EXP BRAIN RES, V116, P399, DOI 10.1007/PL00005768; Cossu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018482; Dahm L, 2010, CELL BIOL TOXICOL, V26, P579, DOI 10.1007/s10565-010-9165-3; Ek CJ, 2001, J PHYSIOL-LONDON, V536, P841, DOI 10.1111/j.1469-7793.2001.00841.x; Elfaitouri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081155; Gordon N, 2008, DEV MED CHILD NEUROL, V51, P180; Guy J, 2008, OPHTHAL RES, V40, P212, DOI 10.1159/000119879; Hornig M, 2013, CURR OPIN RHEUMATOL, V25, P488, DOI 10.1097/BOR.0b013e32836208de; Ishiwata Isamu, 2005, Hum Cell, V18, P67; Johansson PA, 2014, FRONT NEUROSCI, V8, pe340; KILIDIREAS K, 1992, LANCET, V340, P569, DOI 10.1016/0140-6736(92)92105-O; Kung Lili, 1999, Synapse (New York), V31, P67, DOI 10.1002/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-#; Li Xi-Yuan, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P596; Marinescu I, 2013, ROM J MORPHOL EMBRYO, V54, P365; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; Michaelis L, 1900, ARCH MIKRO ANAT ENTW, V55, P558; Modica-Napolitano JS, 2003, ARCH PHARM RES, V26, P951, DOI 10.1007/BF02980205; MOLLGARD K, 1979, J NEUROCYTOL, V8, P139, DOI 10.1007/BF01175557; Morowoka T, 1921, Proc R Soc Med, V14, P23; MUNEYUKI E, 1993, BIOCHIM BIOPHYS ACTA, V1144, P62, DOI 10.1016/0005-2728(93)90031-A; Nann D, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-152; Ozawa Y, 1996, J AUTOIMMUN, V9, P517, DOI 10.1006/jaut.1996.0069; Preuss B, 2012, LIVER INT, V32, P249, DOI 10.1111/j.1478-3231.2011.02630.x; Reuss B, 2014, J MOL NEUROSCI, V52, P353, DOI 10.1007/s12031-013-0156-8; Reuss B, 2014, J MOL NEUROSCI, V54, P125, DOI 10.1007/s12031-014-0258-y; RUDIN DO, 1979, SCHIZOPHRENIA BULL, V5, P623; Schwarz MJ, 1998, EUR ARCH PSY CLIN N, V248, P282, DOI 10.1007/s004060050051; Schwerk C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030069; Soltys BJ, 2000, INT REV CYTOL, V194, P133; Strazielle N, 1999, J NEUROSCI, V19, P6275; TAUC M, 1984, TISSUE CELL, V16, P65, DOI 10.1016/0040-8166(84)90019-3; Tenenbaum Tobias, 2013, Fluids Barriers CNS, V10, P1, DOI 10.1186/2045-8118-10-1; VANEDEN W, 1991, IMMUNOL REV, V121, P5; Wang WJ, 2013, J CELL BIOCHEM, V114, P1695, DOI 10.1002/jcb.24511; Wax MB, 2001, OPHTHALMOLOGY, V108, P296, DOI 10.1016/S0161-6420(00)00525-X; Wei ZL, 2003, J NEUROSCI RES, V74, P942, DOI 10.1002/jnr.10832; Yokota S, 2000, CELL STRESS CHAPERON, V5, P337, DOI 10.1379/1466-1268(2000)005<0337:AACCIH>2.0.CO;2	96	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2015	57	1					123	138		10.1007/s12031-015-0585-7		16	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP7MW	WOS:000360073300014		
J	Sentoku, A; Ishibashi, M; Masumoto, S; Ohno, R; Tomiyama, T; Machiyama, H; Tadai, O; Ezaki, Y				Sentoku, Asuka; Ishibashi, Masatsugu; Masumoto, Shinji; Ohno, Rie; Tomiyama, Takayuki; Machiyama, Hideaki; Tadai, Osamu; Ezaki, Yoichi			Regular budding modes in a zooxanthellate dendrophylliid Turbinaria peltata (Scleractinia) revealed by X-ray CT imaging and three-dimensional reconstruction	JOURNAL OF MORPHOLOGY			English	Article						colony; growth structure; plasticity; regularity; reproduction	RESULTANT GROWTH-MORPHOLOGY; PLASTICITY; CORALS	The zooxanthellate dendrophylliid coral, Turbinaria peltata (Scleractinia), exhibit various growth forms that increase the photoreception area through the development of coenosteum skeletons. Because it is difficult to make detailed observations of the internal structures, we visualized inner skeletal structures using nondestructive microfocus X-ray computed tomography (CT) imaging. After removal of the coenosteum skeletons from the X-ray CT images, three-dimensional 3D-models were reconstructed for individual corallites. Regular budding was observed from the 3D-model and cross-sectional images as follows: 1) lateral corallites occurred only near the two primary septa on one side, apart from a directive primary septum with distinct polarity; 2) the budding occurred upward at acute angles; and 3) these regular structures and polarity were repeated throughout growth with every generation. Even in zooxanthellate dendrophylliids, the same budding modes as observed in azooxanthellate equivalents control the colonial growth. These characteristics provide clues for understanding the mechanisms that regulate the shapes of modular marine organisms. J. Morphol. 276:1100-1108, 2015. (c) 2015 Wiley Periodicals, Inc.	[Sentoku, Asuka] Kyoto Univ, JSPS, Seto Marine Biol Lab, Field Sci Educ & Res Ctr, Wakayama 6492211, Japan; [Ishibashi, Masatsugu; Masumoto, Shinji; Ohno, Rie; Ezaki, Yoichi] Osaka City Univ, Dept Geosci, Fac Sci, Sumiyoshi Ku, Osaka 5588585, Japan; [Tomiyama, Takayuki; Machiyama, Hideaki] Japan Agcy Marine Earth Sci & Technol, Kochi Core Ctr, Yokosuka, Kanagawa 2370061, Japan; [Tadai, Osamu] Marin Works Japan Ltd, Yokosuka, Kanagawa 2370063, Japan	Sentoku, A (reprint author), Kyoto Univ, JSPS, Seto Marine Biol Lab, Field Sci Educ & Res Ctr, Wakayama 6492211, Japan.	a.sentoku@gmail.com			Japan Society for the Promotion of Science [24340130, 25610151, 15H03744];  [25.866]	Grant-in-Aid for JSPS Fellows (25.866); Contract grant sponsor: Scientific Research Fund of the Japan Society for the Promotion of Science; Grant numbers: 24340130, 25610151 and 15H03744.	Lasker HR, 2003, BIOL BULL-US, V205, P319, DOI 10.2307/1543295; Veal CJ, 2010, LIMNOL OCEANOGR-METH, V8, P241, DOI 10.4319/lom.2010.8.241; LOGAN A, 1991, B MAR SCI, V49, P847; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.1890/0012-9658(1997)078[2177:CVFPPI]2.0.CO;2; Roche RC, 2010, J EXP MAR BIOL ECOL, V396, P1, DOI 10.1016/j.jembe.2010.10.006; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Cairns Stephen D., 2001, Smithsonian Contributions to Zoology, V615, P1; Chindapol N, 2013, PLOS ONE, V8; DAUGET JM, 1991, MAR BIOL, V111, P157, DOI 10.1007/BF01986357; Gateno D, 2003, MAR BIOL, V142, P971, DOI 10.1007/s00227-003-1009-8; Graus RR, 1982, SMITHSONIAN CONTRIBU, V12, P441; Jackson JBC, 1979, BIOL SYSTEMATICS COL, P499; Kaandorp JA, 2001, ALGORITHMIC BEAUTY S, P194; Muko S, 2000, B MAR SCI, V66, P225; Nowinski A., 1976, Palaeontologia Polonica, VNo. 35, P1; Rinkevich B, 2002, ISRAEL J ZOOL, V48, P71, DOI 10.1560/BCPA-UM3A-MKBP-HGL2; Sentoku A, 2012, CORAL REEFS, V31, P67, DOI 10.1007/s00338-011-0808-5; Sentoku A, 2012, LETHAIA, V45, P62, DOI 10.1111/j.1502-3931.2011.00293.x; Sentoku A, 2013, PLOS ONE, V8; Sentoku A, 2012, PALEONTOL RES, V16, P252, DOI 10.2517/1342-8144-16.3.252; Sentoku A, 2012, LETHAIA, V45, P586, DOI 10.1111/j.1502-3931.2012.00321.x; Stasinska A., 1969, Acta Palaeontologica Polonica, V14, P553; Zapalski MK, 2013, LETHAIA, V46, P223, DOI 10.1111/let.12005	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0362-2525	1097-4687		J MORPHOL	J. Morphol.	SEP	2015	276	9					1100	1108		10.1002/jmor.20402		9	Anatomy & Morphology	Anatomy & Morphology	CP7LS	WOS:000360070000008		
J	Enomoto, H; Terao, Y; Kadowaki, S; Nakamura, K; Moriya, A; Nakatani-Enomoto, S; Kobayashi, S; Yoshihara, A; Hanajima, R; Ugawa, Y				Enomoto, Hiroyuki; Terao, Yasuo; Kadowaki, Suguru; Nakamura, Koichiro; Moriya, Arata; Nakatani-Enomoto, Setsu; Kobayashi, Shunsuke; Yoshihara, Akioh; Hanajima, Ritsuko; Ugawa, Yoshikazu			Effects of L-Dopa and pramipexole on plasticity induced by QPS in human motor cortex	JOURNAL OF NEURAL TRANSMISSION			English	Article						Quadripulse stimulation (QPS); L-Dopa; Pramipexole; Motor cortical plasticity	THETA-BURST-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; PAIRED ASSOCIATIVE STIMULATION; D1 RECEPTOR ACTIVATION; PARKINSONS-DISEASE; SYNAPTIC PLASTICITY; CORTICAL PLASTICITY; INDUCED NEUROPLASTICITY; INDUCED DYSKINESIA; LEVODOPA	Abnormal plasticity has been reported in the brain of patients with Parkinson's disease (PD), especially in the striatum. Although both l-Dopa and dopamine agonist remain to be the mainstay of the treatment in PD, their differential effects on cortical plasticity are unclear. We applied quadripulse stimulation (QPS) over the primary motor cortex (M1) in ten normal subjects to induce bidirectional long-term motor cortical plasticity. A long-term potentiation (LTP)-like effect was induced in the primary motor cortex (M1) by high-frequency QPS5 (interpulse interval of 5 ms) over M1, whereas a long-term depression (LTD)-like effect was induced by low-frequency QPS50 (interpulse interval of 50 ms), and the effects lasted up to 90 min after the stimulation pulses have ceased. In a double-blind randomized placebo-controlled crossover design, l-Dopa carbidopa 100 mg, pramipexole 1.5 mg [150 mg LED (l-Dopa equivalent dose)], or placebo was administered to the subjects 30 min before applying QPS. l-Dopa enhanced both LTP- and LTD-like plasticity as compared to placebo. In contrast, neither an LTP-like effect nor an LTD-like effect was modulated by pramipexole. The lack of LTP enhancement by pramipexole is compatible with the finding that D1 activation strengthens LTP because pramipexole is almost purely a D2 agonist. The lack of LTD enhancement by pramipexole is also consistent with the finding that both D1 and D2 coactivation is required for LTD. This is the first report to show that dopamine enhances LTD as well as LTP in the human brain and that coactivation of D1 and D2 is a requisite for LTD enhancement in normal humans.	[Enomoto, Hiroyuki; Kadowaki, Suguru; Nakamura, Koichiro; Moriya, Arata; Nakatani-Enomoto, Setsu; Kobayashi, Shunsuke; Yoshihara, Akioh; Ugawa, Yoshikazu] Fukushima Med Univ, Sch Med, Dept Neurol, Fukushima, Japan; [Terao, Yasuo] Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci,Bunkyo Ku, Tokyo, Japan; [Hanajima, Ritsuko] Kitasato Univ, Dept Neurol, Sagamihara, Kanagawa 228, Japan	Enomoto, H (reprint author), Fukushima Med Univ, Sch Med, Dept Neurol, 1 Hikarigaoka, Fukushima, Japan.	enomoto-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [25461322, 22590954, 23591270, 22390181, 25293206]; Catecholamine and the Neurological Disorders Symposium; Magnetic Health Science Foundation; Kato Memorial Trust for Nambyo Research, Japan; Research Committee on Degenerative Ataxia from the Ministry of Health and Welfare of Japan; Uehara Memorial Foundation; Novartis Foundation (Japan) for the Promotion of Science	This work was supported in part by grants from the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology No. 25461322 (HE), No. 22590954 (YT), No. 23591270 (RH), No. 22390181(YU), No. 25293206 (YU), a research grant from the Catecholamine and the Neurological Disorders Symposium (RH), and research funds from the Magnetic Health Science Foundation (RH, YT) and the Kato Memorial Trust for Nambyo Research, Japan (YT), and the Research Committee on Degenerative Ataxia from the Ministry of Health and Welfare of Japan; the Magnetic Health Science Foundation; the Uehara Memorial Foundation and The Novartis Foundation (Japan) for the Promotion of Science (YU).	Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; Nitsche MA, 2009, J NEUROSCI, V29, P2648, DOI 10.1523/JNEUROSCI.5366-08.2009; Huang YZ, 2010, J PHYSIOL-LONDON, V588, P3683, DOI 10.1113/jphysiol.2010.191361; Suppa A, 2011, EXP NEUROL, V227, P296, DOI 10.1016/j.expneurol.2010.11.020; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Bagnato S, 2006, MOVEMENT DISORD, V21, P639, DOI 10.1002/mds.20778; Hamada M, 2008, J PHYSIOL-LONDON, V586, P3927, DOI 10.1113/jphysiol.2008.152793; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Ueki Y, 2006, ANN NEUROL, V59, P60, DOI 10.1002/ana.20692; Sonde L, 2007, ACTA NEUROL SCAND, V115, P55, DOI 10.1111/j.1600-0404.2006.00728.x; Monte-Silva K, 2011, NEUROPSYCHOPHARMACOL, V36, P2097, DOI 10.1038/npp.2011.100; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Monte-Silva K, 2009, J NEUROSCI, V29, P6124, DOI 10.1523/JNEUROSCI.0728-09.2009; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32; Floel A, 2005, NEUROLOGY, V65, P472, DOI 10.1212/01.wnl.0000172340.56307.5e; Muller T, 2013, CLIN NEUROPHARMACOL, V36, P84, DOI 10.1097/WNF.0b013e31828f3385; Eggers C, 2010, J NEUROL, V257, P1669, DOI 10.1007/s00415-010-5597-1; Deleu D, 2002, CLIN PHARMACOKINET, V41, P261, DOI 10.2165/00003088-200241040-00003; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Hamada M, 2009, J PHYSIOL-LONDON, V587, P4845, DOI 10.1113/jphysiol.2009.179101; Huang YZ, 2011, BRAIN, V134, P2312, DOI 10.1093/brain/awr158; Kuo MF, 2008, CEREB CORTEX, V18, P648, DOI 10.1093/cercor/bhm098; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Fresnoza S, 2014, J NEUROSCI, V34, P2744, DOI 10.1523/JNEUROSCI.3655-13.2014; Schwingenschuh P, 2010, MOVEMENT DISORD, V25, P493, DOI 10.1002/mds.22936; Scheidtmann K, 2001, LANCET, V358, P787, DOI 10.1016/S0140-6736(01)05966-9; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Morgante F, 2006, BRAIN, V129, P1059, DOI 10.1093/brain/awl031; Antonini A, 2011, EXPERT OPIN DRUG MET, V7, P1307, DOI 10.1517/17425255.2011.614232; Bagetta V, 2010, BIOCHEM SOC T, V38, P493, DOI 10.1042/BST0380493; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; Chen ZX, 1996, RECEPTOR CHANNEL, V4, P1; Enomoto Hiroyuki, 2012, Rinsho Shinkeigaku, V52, P1204; Goetz CG, 1999, NEUROLOGY, V52, P1227; Hebb D., 1949, ORG BEHAV; Kawashima S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062515; Koch Giacomo, 2013, Front Neurol, V4, P180, DOI 10.3389/fneur.2013.00180; Suarez LM, 2014, NEUROPHARMACOLOGY, V79, P101, DOI 10.1016/j.neuropharm.2013.10.035; Thirugnanasambandam N, 2011, J NEUROSCI, V31, P5294, DOI 10.1523/JNEUROSCI.6258-10.2011; Udupa Kaviraja, 2013, Front Neurol, V4, P128, DOI 10.3389/fneur.2013.00128; Ueno T, 2014, NEUROBIOL DIS, V64, P142, DOI 10.1016/j.nbd.2013.12.014	48	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	SEP	2015	122	9					1253	1261		10.1007/s00702-015-1374-8		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CP5TO	WOS:000359947700005		
J	Takahashi, K; Kakuda, Y; Munemoto, S; Yamazaki, H; Nozaki, I; Yamada, M				Takahashi, Kazuya; Kakuda, Yumiko; Munemoto, Saori; Yamazaki, Hirohito; Nozaki, Ichiro; Yamada, Masahito			Differentiation of Donor-Derived Cells Into Microglia After Umbilical Cord Blood Stem Cell Transplantation	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article							MONOCYTES; BRAIN; MACROPHAGES; CONTRIBUTE	Recent studies have indicated that microglia originate from immature progenitors in the yolk sac. After birth, microglial populations are maintained under normal conditions via self-renewal without the need to recruit monocyte-derived microglial precursors. Peripheral cell invasion of the brain parenchyma can only occur with disruption of the blood-brain barrier. Here, we report an autopsy case of an umbilical cord blood transplant recipient in whom cells derived from the donor blood differentiated into ramified microglia in the recipient brain parenchyma. Although the blood-brain barrier and glia limitans seemed to prevent invasion of these donor-derived cells, most of the invading donor-derived ramified cells were maintained in the cerebral cortex. This result suggests that invasion of donor-derived cells occurs through the pial membrane.	[Takahashi, Kazuya] Natl Hosp Org Iou Hosp, Dept Neurol, Kanazawa, Ishikawa 9200192, Japan; [Takahashi, Kazuya; Kakuda, Yumiko; Nozaki, Ichiro; Yamada, Masahito] Kanazawa Univ, Dept Neurol & Neurobiol Aging, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Munemoto, Saori; Yamazaki, Hirohito] Kanazawa Univ, Dept Cellular Transplantat Biol, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Munemoto, Saori] Keijyu Kanazawa Hosp, Dept Internal Med, Kanazawa, Ishikawa, Japan	Takahashi, K (reprint author), Natl Hosp Org Iou Hosp, Dept Neurol, Ni 73-1,Iwade Machi, Kanazawa, Ishikawa 9200192, Japan.	ktakaha@ioudom.hosp.go.jp					UNGER ER, 1993, J NEUROPATH EXP NEUR, V52, P460, DOI 10.1097/00005072-199309000-00004; Prinz M, 2014, ACTA NEUROPATHOL, V128, P319, DOI 10.1007/s00401-014-1267-1; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Noto D, 2010, EUR J NEUROSCI, V31, P1155, DOI 10.1111/j.1460-9568.2010.07152.x; Noto D, 2014, NEUROPATH APPL NEURO, V40, P697, DOI 10.1111/nan.12086; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	SEP	2015	74	9					862	866		10.1097/NEN.0000000000000234		5	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CP8KP	WOS:000360142900001		
J	Serrano, GE; Intorcia, A; Carew, J; Chiarolanza, G; Hidalgo, JA; Sue, LI; Dugger, BN; Saxon-LaBelle, M; Filon, J; Scroggins, A; Pullen, J; Fornwalt, BE; Scott, S; Sabbagh, MN; Adler, CH; Akiyama, H; Beach, TG				Serrano, Geidy E.; Intorcia, Anthony; Carew, Jeremiah; Chiarolanza, Glenn; Hidalgo, Jose A.; Sue, Lucia I.; Dugger, Brittany N.; Saxon-LaBelle, Megan; Filon, Jessica; Scroggins, Alex; Pullen, Joel; Fornwalt, Brandon E.; Scott, Sarah; Sabbagh, Marwan N.; Adler, Charles H.; Akiyama, Haruhiko; Beach, Thomas G.			Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS ASSOCIATION GUIDELINES; PHOSPHORYLATED ALPHA-SYNUCLEIN; STEREOTACTIC BRAIN BIOPSY; NEUROPATHOLOGIC ASSESSMENT; NATIONAL INSTITUTE; LEWY BODIES; IMMUNOHISTOCHEMICAL METHODS; DEFICIT ACCUMULATION; OLDER PERSONS	The clinical diagnosis and classification of neurodegenerative diseases based on clinical examination or available biomarkers are currently insufficiently accurate. Although histologic examination is considered the gold standard for diagnosis, brain biopsies have been avoided because of the high risk-benefit ratio. However, brain biopsies have previously been performed with a craniotomy and excision of approximately 1 cm(3) of cerebral cortex tissue, and it is possible that needle core brain biopsies would have a lower morbidity and mortality risk. Here, we compared the ability of simulated needle core biopsy versus simulated open biopsy to detect the frontal cortex histopathology associated with common neurodegenerative diseases in the elderly using 144 autopsy-proven cases. Simulated needle core biopsy, as compared with simulated open biopsy, gave close to 90% sensitivity and specificity for identifying graded densities of beta-amyloid and neuritic plaques, neurofibrillary tangles, phosphorylated alpha-synuclein, and phosphorylated TDP-43 pathology. This study shows that the presence and densities of the most common molecular pathologies may be histopathologically assessed in simulated frontal cortex needle biopsies, with accuracy very close to that obtained by open cortical biopsy. An accurate estimation of the morbidity and mortality risk associated with cortical needle core biopsy will require specifically designed clinical trials in appropriate subjects.	[Serrano, Geidy E.; Intorcia, Anthony; Carew, Jeremiah; Chiarolanza, Glenn; Hidalgo, Jose A.; Sue, Lucia I.; Dugger, Brittany N.; Saxon-LaBelle, Megan; Filon, Jessica; Scroggins, Alex; Pullen, Joel; Fornwalt, Brandon E.; Scott, Sarah; Sabbagh, Marwan N.; Beach, Thomas G.] Banner Sun Hlth Res Inst, Sun City, AZ 85351 USA; [Adler, Charles H.] Mayo Clin Arizona, Scottsdale, AZ USA; [Akiyama, Haruhiko] Tokyo Metropolitan Inst Med Sci, Setagaya Ku, Tokyo 113, Japan	Serrano, GE (reprint author), Banner Sun Hlth Res Inst, 10515 W Santa Fe Dr,Bldg B,3rd Floor, Sun City, AZ 85351 USA.	Geidy.Serrano@bannerhealth.com			National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610, P01 AG-017586, P01 AG-032953]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research	This study was supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center, P01 AG-017586, and P01 AG-032953), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901, and 1001 to the Arizona Parkinson's Disease Consortium), and the Michael J. Fox Foundation for Parkinson's Research.	McKeith IG, 1996, NEUROLOGY, V47, P1113; Kovacs GG, 2008, DEMENT GERIATR COGN, V26, P343, DOI 10.1159/000161560; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Knopman DS, 2005, ANN NEUROL, V57, P480, DOI 10.1002/ana.20425; VALLET PG, 1992, ACTA NEUROPATHOL, V83, P170; Schott JM, 2010, ACTA NEUROPATHOL, V120, P327, DOI 10.1007/s00401-010-0721-y; Buchman AS, 2008, NEUROLOGY, V71, P499, DOI 10.1212/01.wnl.0000324864.81179.6a; MIRRA SS, 1991, NEUROLOGY, V41, P479; Paleologos TS, 2001, NEUROSURGERY, V49, P830, DOI 10.1097/00006123-200110000-00009; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Curtis C, 2015, JAMA NEUROL, V72, P287, DOI 10.1001/jamaneurol.2014.4144; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Geschwind MD, 2008, ANN NEUROL, V64, P97, DOI 10.1002/ana.21430; Nelson PT, 2010, J NEUROL, V257, P359, DOI 10.1007/s00415-009-5324-y; McGirt MJ, 2005, J NEUROSURG, V102, P897, DOI 10.3171/jns.2005.102.5.0897; Cohen RR, 2012, J AM GERIATR SOC, V60, P1609, DOI 10.1111/j.1532-5415.2012.04109.x; Sawin PD, 1998, SURG NEUROL, V49, P640, DOI 10.1016/S0090-3019(97)00435-7; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Kongkham PN, 2008, CAN J NEUROL SCI, V35, P79; WOLFKLEIN GP, 1988, J AM GERIATR SOC, V36, P219; Wang SY, 2013, ARCH GERONTOL GERIAT, V57, P16, DOI 10.1016/j.archger.2013.03.007; Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x; Beach TG, 2008, ACTA NEUROPATHOL, V116, P277, DOI 10.1007/s00401-008-0409-8; Chen CC, 2009, CLIN NEUROL NEUROSUR, V111, P835, DOI 10.1016/j.clineuro.2009.08.013; Beach TG, 2010, ACTA NEUROPATHOL, V119, P689, DOI 10.1007/s00401-010-0664-3; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Beach TG, 2009, ACTA NEUROPATHOL, V117, P613, DOI 10.1007/s00401-009-0538-8; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; BERNSTEIN M, 1994, J NEUROSURG, V81, P165, DOI 10.3171/jns.1994.81.2.0165; Beach TG, 2013, J ALZHEIMERS DIS, V33, pS219, DOI 10.3233/JAD-2012-129020; Kreth FW, 2001, ACTA NEUROCHIR, V143, P539, DOI 10.1007/s007010170058; Walker DG, 2013, EXP NEUROL, V240, P190, DOI 10.1016/j.expneurol.2012.11.020; Handforth C, 2015, ANN ONCOL, V26, P1091, DOI 10.1093/annonc/mdu540; Mielke MM, 2005, NEUROLOGY, V64, P1689, DOI 10.1212/01.WNL.0000161870.78572.A5; Czyz M, 2014, NEUROSURG REV, V37, P127, DOI 10.1007/s10143-013-0486-6; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Balasa M, 2014, NEUROPATHOL APPL NEU; Beach TG, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-3; Beach TG, 2015, NEUROPATHOLOGY; Bergmann C, 2006, NEUROL RES, V28, P595, DOI 10.1179/016164106X130498; Bucelli Robert C, 2013, Mo Med, V110, P422; Dickerman RD, 2005, ACTA NEUROCHIR, V147, P911, DOI 10.1007/s00701-005-0566-7; He HX, 2014, J NEUROPATH EXP NEUR, V73, P59, DOI [10.1097/NEN.0000000000000028, 10.1097/NEN.0000000000000026]; Elobeid A, 2015, J NEUROPATH EXP NEUR, V74, P470, DOI 10.1097/NEN.0000000000000191; Field Melvin, 2001, Journal of Neurosurgery, V94, P545, DOI 10.3171/jns.2001.94.4.0545; King Andrew, 2013, Acta Neuropathol Commun, V1, P53, DOI 10.1186/2051-5960-1-53; Koch G, 2013, CNS NEUROL DISORD-DR, V12, P507; Nishihara Masamitsu, 2011, Kobe J Med Sci, V56, pE148; Obi K, 2008, EXP NEUROL, V210, P409, DOI 10.1016/j.expneurol.2007.11.019; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rosano C, 2006, NEUROL RES, V28, P612, DOI 10.1179/016164106X130407; Sabri O, 2015, ALZHEIMERS DEMENT, V15, pS1552; The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease, 1997, NEUROBIOL AGING, V18, pS1; Venneti S, 2011, ACTA NEUROPATHOL, V122, P737, DOI 10.1007/s00401-011-0880-5; Warren JD, 2005, BRAIN, V128, P2016, DOI 10.1093/brain/awh543; Wemheuer WM, 2013, J NEUROPATH EXP NEUR, V72, P758, DOI 10.1097/NEN.0b013e31829d2799; Wong SH, 2010, EUR NEUROL, V64, P42, DOI 10.1159/000315032	59	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	SEP	2015	74	9					934	942		10.1097/NEN.0000000000000235		9	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CP8KP	WOS:000360142900008		
J	Katsuta, T; Abe, H; Miki, K; Inoue, T				Katsuta, Toshiro; Abe, Hiroshi; Miki, Koichi; Inoue, Tooru			Reversible occlusion of donor vessel caused by mouth opening after superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya patients	JOURNAL OF NEUROSURGERY			English	Article						extracranial-intracranial bypass; mouth opening; occlusion; superficial temporal artery; temporalis muscle; moyamoya disease; vascular disorders	STA-MCA ANASTOMOSIS; RANDOMIZED-TRIAL; BYPASS FUNCTION; COMPRESSION; MOVEMENT; SURGERY; DISEASE; STROKE	OBJECT The authors experienced an intriguing phenomenon in 2 adult patients with moyamoya disease. Mouth opening caused reversible occlusion of the donor superficial temporal artery (STA), and the patients exhibited transient cerebral ischemic symptoms. The aim of this study was to assess the incidence of such occlusion and the mechanism of this phenomenon. METHODS Twelve consecutive adult patients with moyamoya disease (15 affected sides) who underwent STA middle cerebral artery anastomosis were included in this study. Ultrasound examination was performed more than 3 months postoperatively to determine whether mouth opening affected blood flow of the donor STA and led to any ischemic symptoms within 1 minute. Computed tomography angiography was performed during both mouth opening and mouth closing, when blood flow changes of the donor STA were recognized. RESULTS Under wide mouth opening, steno-occlusion of the donor STA occurred in 5 of 15 sides (33.3%). On 1 side (6.7%), complete occlusion induced ischemic symptoms. Steno-occlusion occurred by at least 2 mechanisms: either the stretched temporalis muscle pushed the donor STA against the edge of the bone window, or the redundant donor STA kinked when the muscle was stretched. CONCLUSIONS Even with temporary occlusion of the donor STA, ischemic symptoms seem to rarely occur. However, to avoid the "big bite ischemic phenomenon," the authors recommend securing a sufficient distance between the donor STA and the edge of the bone window and avoiding a redundant course of the donor STA within the muscle layer.	[Katsuta, Toshiro; Abe, Hiroshi; Miki, Koichi; Inoue, Tooru] Fukuoka Univ, Fac Med, Dept Neurosurg, Fukuoka 8140180, Japan	Katsuta, T (reprint author), Fukuoka Univ, Fac Med, Dept Neurosurg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	tktktk010101@m3.dion.ne.jp					Powers WJ, 2011, JAMA-J AM MED ASSOC, V306, P1983, DOI 10.1001/jama.2011.1610; ELSENBURG PHJM, 1985, CLIN NEUROL NEUROSUR, V87, P259, DOI 10.1016/0303-8467(85)90133-7; Freyschlag CF, 2011, ACTA NEUROCHIR SUPPL, V112, P35, DOI 10.1007/978-3-7091-0661-7_7; HYODO A, 1983, Neurological Surgery, V11, P627; KARASAWA J, 1978, J NEUROSURG, V49, P679, DOI 10.3171/jns.1978.49.5.0679; KUBO N, 1986, Neurological Surgery, V14, P1547; Matsumoto K, 1983, GEKA CHIRYO, V49, P600; Murata Y, 2003, J NEUROSURG, V99, P304, DOI 10.3171/jns.2003.99.2.0304; Nakamura T, 2000, NEUROL SURG TOKYO, V28, P1057; OBWEGESER HL, 1987, ORAL SURG ORAL MED O, V63, P517, DOI 10.1016/0030-4220(87)90219-2; Park JT, 2013, J CRANIOFAC SURG, V24, pE347, DOI 10.1097/SCS.0b013e31828f2d73; BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191	12	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2015	123	3					670	675		10.3171/2014.10.JNS141805		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP6VZ	WOS:000360027600022		
J	Fukuda, H; Hayashi, K; Moriya, T; Nakashita, S; Lo, BWY; Yamagata, S				Fukuda, Hitoshi; Hayashi, Kosuke; Moriya, Takafumi; Nakashita, Satoru; Lo, Benjamin W. Y.; Yamagata, Sen			Intrasylvian hematoma caused by ruptured middle cerebral artery aneurysms predicts recovery from poor-grade subarachnoid hemorrhage	JOURNAL OF NEUROSURGERY			English	Article						intracerebral hemorrhage; intrasylvian hematoma; middle cerebral artery aneurysm; subarachnoid hemorrhage; vasospasm; favorable outcome; vascular disorders	INTRACEREBRAL HEMORRHAGE; DECOMPRESSIVE CRANIECTOMY; SURGICAL-TREATMENT; CLINICAL ARTICLE; VASOSPASM; MANAGEMENT; MILRINONE; VOLUME; BLOOD	OBJECT lntrasylvian hematoma (ISH) is a subtype of intracranial hematoma caused by aneurysmal rupture and often presents with a poor initial neurological grade; it is not well studied. The aim of this study was to elucidate outcomes of aneurysmal subarachnoid hemorrhage (SAH) with ISH. METHODS Data for 97 patients with poor-grade SAH (World Federation of Neurosurgical Societies Grade IV or V) were retrospectively analyzed from a single-center, prospective, observational cohort database. Ultra-early surgical clipping, removal of hematoma, external decompression for brain swelling, and prevention of vasospasm by cisternal irrigation with milrinone were combined as an aggressive treatment. Characteristics and clinical courses of SAH with ISH were identified. The authors also evaluated any correlations between poor admission-grade SAH and ISH with good functional outcome. RESULTS Patients with poor admission-grade SAH and with ISH were more likely to have initial cerebral edema (p < 0.001, Mann-Whitney U-test), which significantly resolved over time (p < 0.001, Mann-Whitney U-test). These patients had a better chance of functional survival (modified Rankin Scale scores of 1-3; OR 5.75; 95% CI 1.36-24.3; p = 0.017) at 6 months after hospital discharge, after adjustment for potential confounders such as younger age and better initial neurological grade by multivariable analysis. CONCLUSIONS ISH predicted good functional recovery from poor-grade aneurysmal SAH.	[Fukuda, Hitoshi; Hayashi, Kosuke; Yamagata, Sen] Kurashiki Cent Hosp, Dept Neurosurg, Kurashiki, Okayama 7100052, Japan; [Moriya, Takafumi; Nakashita, Satoru] Kurashiki Cent Hosp, Dept Radiol, Kurashiki, Okayama 7100052, Japan; [Lo, Benjamin W. Y.] Univ Toronto, Dept Clin Epidemiol & Biostat, Div Neurosurg, Hamilton, ON, Canada; [Lo, Benjamin W. Y.] Univ Toronto, Dept Clin Epidemiol & Biostat, Div Crit Care Med, Hamilton, ON, Canada; [Lo, Benjamin W. Y.] McMaster Univ, Hamilton, ON, Canada	Fukuda, H (reprint author), Kurashiki Cent Hosp, Dept Neurosurg, 1-1-1 Miwa, Kurashiki, Okayama 7100052, Japan.	fukudaharpseal@gmail.com					BRODERICK JP, 1993, STROKE, V24, P987; Shimoda M, 1997, J NEUROSURG, V87, P170, DOI 10.3171/jns.1997.87.2.0170; Mocco J, 2006, NEUROSURGERY, V59, P529, DOI 10.1227/01.NEU.0000228680.22550.A2; Reilly C, 2004, J NEUROSURG, V101, P255, DOI 10.3171/jns.2004.101.2.0255; HIJDRA A, 1990, STROKE, V21, P1156; Macdonald RL, 2006, NEUROSURG REV, V29, P179, DOI 10.1007/s10143-005-0013-5; DRAKE CG, 1988, J NEUROSURG, V68, P985; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Arakawa Y, 2004, NEUROL MED-CHIR, V44, P393, DOI 10.2176/nmc.44.393; Baskaya MK, 2001, CLIN NEUROL NEUROSUR, V103, P23, DOI 10.1016/S0303-8467(01)00104-4; Egashira Y, 2013, J NEUROSURG, V118, P1003, DOI 10.3171/2012.11.JNS12610; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; Hardemark HG, 1999, CEREBROVASC DIS, V9, P10, DOI 10.1159/000015890; HELWEGLARSEN S, 1984, STROKE, V15, P1045; Hosoda K, 1999, SURG NEUROL, V51, P81, DOI 10.1016/S0090-3019(97)00508-9; Ibrahim GM, 2011, J NEUROSURG, V115, P1191, DOI 10.3171/2011.7.JNS11725; Kumar A, 2013, NEUROSURGERY, V73, P617, DOI 10.1227/NEU.0000000000000057; Macdonald RL, 2003, J NEUROSURG, V99, P644, DOI 10.3171/jns.2003.99.4.0644; Sadamasa N, 2014, NEUROCRIT CARE, V21, P470, DOI 10.1007/s12028-014-9996-5; Saito A, 2010, NEUROL MED-CHIR, V50, P281; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1227/01.NEU.0000017192.85679.38; Su CC, 2002, ACT NEUR S, V82, P65; van Asch CJJ, 2010, STROKE, V41, P2592, DOI 10.1161/STROKEAHA.110.589291; Yoshimoto Y, 1999, BRIT J NEUROSURG, V13, P18	24	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2015	123	3					686	692		10.3171/2014.10.JNS141658		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP6VZ	WOS:000360027600024		
J	Shin, M; Kondo, K; Hanakita, S; Suzukawa, K; Kin, TC; Shojima, M; Nakagawa, D; Saito, N				Shin, Masahiro; Kondo, Kenji; Hanakita, Shunya; Suzukawa, Keigo; Kin, Taichi; Shojima, Masaaki; Nakagawa, Daichi; Saito, Nobuhito			Endoscopic transnasal approach for resection of locally aggressive tumors in the orbit	JOURNAL OF NEUROSURGERY			English	Article						chordoma; endoscopic transnasal surgery; medial orbitotomy; meningioma; orbit; orbital tumor; oncology	SKULL BASE SURGERY; ENDONASAL TRANSSPHENOIDAL SURGERY; DECOMPRESSION; MENINGIOMAS; EXPERIENCE	OBJECT In recent years, application of endoscopic transnasal surgery (ETS) has been expanded to orbital lesions, and preliminary results have started to be published for medially located soft mass lesions. However, reports on experience with endoscopic intraorbital surgery aimed at resection of invasive skull base tumors remains quite limited. This report presents the authors' experience with ETS for locally aggressive tumors involving the orbit. METHODS ETS was performed for 15 cases of aggressive tumors involving the orbit: 5 meningiomas (meningothelial, n = 3; atypical, n = 1; anaplastic, n = 1), 4 chordomas, 2 chondrosarcomas, and 4 others (metastasis from systemic myxofibrosarcoma, schwannoma, inverted papilloma, and acinic cell carcinoma, n = 1 each). Among these, 9 tumors were located outside the periorbita and 6 inside the periorbita. In 6 intraperiosteal tumors, 5 were intraconal lesions, of which 3 arose in the muscle cone (anaplastic meningioma, optic sheath meningioma, and metastatic myxofibrosarcoma), and 2 meningothelial meningioma had invaded from the sphenoid ridge or the cavernous sinus into the muscle cone through the optic canal and the superior orbital fissure. A case of schwannoma originated around the cavernous sinus and pterygopalatine fossa and extended extraconally into the periorbita. Intraoperatively, ethmoid air cells and the lamina papyracea were removed, and extraperiosteal tumors were safely approached. For intraperiosteal tumors, the periorbita was widely opened, and the tumors were approached through the surgical window between the rectus and oblique muscles. RESULTS Gross-total resection was achieved for 12 of the 15 tumors, including 2 intraconal lesions. After surgery, exophthalmos resolved in all 8 patients with this symptom, and diplopia resolved in 5 of 6 patients. Improvement of visual symptoms was reported by 4 of 5 patients with loss of visual acuity or constriction of the visual field. Postoperatively, 1 patient showed mild, transient worsening of existing facial dysesthesia, and another showed transient ptosis and mild hypesthesia of the forehead on the affected side. All those symptoms resolved within 3 months. No patients showed enophthalmos, worsening of diplopia or visual function, or impairment of olfaction after surgery. CONCLUSIONS ETS appears acceptable as a less-invasive alternative for treating aggressive tumors involving the orbit. For extraperiosteal tumors, gross-total removal can generally be achieved without neurological complications. For intraperiosteal tumors, surgical indications should be carefully discussed, considering the relationship between the tumor and normal anatomy. Wide opening of the periorbital window is advocated to create a sufficient surgical pathway between the extraocular muscles, allowing a balance between functional preservation and successful tumor resection.	[Shin, Masahiro; Hanakita, Shunya; Kin, Taichi; Shojima, Masaaki; Nakagawa, Daichi; Saito, Nobuhito] Tokyo Univ Hosp, Dept Neurosurg, Tokyo 1338655, Japan; [Kondo, Kenji; Suzukawa, Keigo] Tokyo Univ Hosp, Dept Otolaryngol, Tokyo 1338655, Japan	Shin, M (reprint author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1338655, Japan.	shin-nsu@h.u-tokyo.ac.jp					Abuzayed B, 2012, NEUROSURG REV, V35, P573, DOI 10.1007/s10143-012-0393-2; Acheson JF, 2004, EYE, V18, P1169, DOI 10.1038/sj.eye.6701559; Hayreh SS, 2006, EYE, V20, P1130, DOI 10.1038/sj.eye.6702377; Zanation AM, 2009, LARYNGOSCOPE, V119, P19, DOI 10.1002/lary.20027; McKinney KA, 2010, OTOLARYNG HEAD NECK, V143, P699, DOI 10.1016/j.otohns.2010.07.010; Stippler M, 2009, NEUROSURGERY, V64, P268, DOI 10.1227/01.NEU.0000338071.01241.E2; Castelnuovo P, 2012, EUR ARCH OTO-RHINO-L, V269, P1929, DOI 10.1007/s00405-011-1917-z; Saeki N, 2010, NEUROL MED-CHIR, V50, P756; BORRUAT FX, 1993, OPHTHALMOLOGY, V100, P562; Jho HD, 1997, J NEUROSURG, V87, P44, DOI 10.3171/jns.1997.87.1.0044; Muscatello L, 2013, HEAD NECK-J SCI SPEC, V35, pE218, DOI 10.1002/hed.23027; Murchison AP, 2011, LARYNGOSCOPE, V121, P463, DOI 10.1002/lary.21357; Benedicic M, 2011, ACTA NEUROCHIR, V153, P1919, DOI 10.1007/s00701-011-1098-y; Cappabianca P, 2004, NEUROSURGERY, V55, P933, DOI 10.1227/01.NEU.0000137330.02549.0D; Ducic Y, 2004, LARYNGOSCOPE, V114, P164, DOI 10.1097/00005537-200401000-00031; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P146, DOI 10.1227/NEU.0b013e3182438915; Fraser JF, 2010, NEUROSURGERY S, V67; Fukaya C, 2000, SKULL BASE SURG, V10, P11, DOI 10.1055/s-2000-6788; Hong NJL, 2013, ANN SURG ONCOL, V20, P80, DOI 10.1245/s10434-012-2572-3; Karaki M, 2012, J CRANIOFAC SURG, V23, P1093, DOI 10.1097/SCS.0b013e31824f6680; MAMES RN, 1991, OPHTHALMOLOGY, V98, P527; Marcus H, 2013, ACTA NEUROCHIR, V155, P981, DOI 10.1007/s00701-013-1662-8; Pletcher SD, 2006, OTOLARYNGOL CLIN N A, V39, pvi; Pletcher SD, 2006, OTOLARYNG CLIN N AM, V39, P943, DOI 10.1016/j.otc.2006.06.003; Roth Jonathan, 2011, Orbit, V30, P43, DOI 10.3109/01676830.2010.543004; Sasaki T, 2010, J NEUROSURG, V112, P273, DOI 10.3171/2008.9.JNS08451; Schlake HP, 2001, ACTA NEUROCHIR, V143, P251	27	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2015	123	3					748	759		10.3171/2014.11.JNS141921		12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP6VZ	WOS:000360027600032		
J	Ogawa, Y; Tominaga, T				Ogawa, Yoshikazu; Tominaga, Teiji			Sellar and parasellar tumor removal without discontinuing antithrombotic therapy	JOURNAL OF NEUROSURGERY			English	Article						anticoagulant; antiplatelet; antithrombotic therapy; discontinuation; operation; transsphenoidal approach; pituitary surgery	PROSTHETIC HEART-VALVES; CATARACT-SURGERY; WARFARIN THERAPY; CUTANEOUS SURGERY; PERIOPERATIVE MANAGEMENT; HEMORRHAGIC COMPLICATIONS; ANTICOAGULATED PATIENTS; ORAL ANTICOAGULANTS; NONCARDIAC SURGERY; OCULAR SURGERY	OBJECT Treatment with dual antiplatelet agents associated with coronary stenting procedures and long-term anticoagulant therapy is increasingly common, but the treatment carries risks during surgical procedures. Evidence-based recommendations have proposed discontinuation of antithrombotic treatment or introduction of bridging therapy in some procedures less invasive and with lower risk of bleeding. However, neurosurgical procedures without discontinuation of antithrombotic treatment and perioperative management have received little investigation. METHODS Between October 2008 and January 2014, 15 consecutive patients (11 males and 4 females; age range 51-75 years [mean 68.2 years]), with sellar and parasellar tumors were treated through the transsphenoidal approach without discontinuation of antithrombotic therapy. Clinical data were compared with another 15 patients, who underwent transsphenoidal surgeries without preoperative antithrombotic therapy. RESULTS Gross-total removal of the tumor or total aspiration of the content of Rathke's cleft cyst was achieved in 13 patients, and subtotal removal was achieved in 1 patient with a small remnant in the cavernous sinus. No difference was found in intraoperative bleeding between the antithrombotic agent group and the control group (mean 255 ml vs 215 ml, Mann-Whitney U-test, p = 0.547), and no patient required transfusion. No difference was found in operation time between the antithrombotic agent group and the control group (167.8 minutes vs 150.0 minutes, Mann-Whitney U-test, p = 0.262). All patients were discharged on postoperative Day 12 without neurological deficits. CONCLUSIONS The present study suggests that discontinuation of antithrombotic therapy may be unnecessary before the typical transsphenoidal surgery. Large randomized clinical trials at multiple centers are needed to confirm these findings.	[Ogawa, Yoshikazu] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi 9828523, Japan; [Tominaga, Teiji] Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi 980, Japan	Ogawa, Y (reprint author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, 4-20-1 Nagamachiminami, Sendai, Miyagi 9828523, Japan.	yogawa@kohnan-sendai.or.jp					Ah-Weng A, 2003, BRIT J DERMATOL, V149, P386, DOI 10.1046/j.1365-2133.2003.05506.x; Carter K, 1998, J CATARACT REFR SURG, V24, P1361; Palareti G, 1996, CLIN PHARMACOKINET, V30, P300, DOI 10.2165/00003088-199630040-00003; Narendran N, 2003, ACTA OPHTHALMOL SCAN, V81, P38, DOI 10.1034/j.1600-0420.2003.00020.x; Otley CC, 1996, ARCH DERMATOL, V132, P161, DOI 10.1001/archderm.132.2.161; Katz J, 2003, OPHTHALMOLOGY, V110, P1784, DOI 10.1016/S0161-6420(03)00785-1; Souto JC, 1996, J ORAL MAXIL SURG, V54, P27, DOI 10.1016/S0278-2391(96)90297-9; Alam M, 2002, DERMATOL SURG, V28, P992, DOI 10.1046/j.1524-4725.2002.02085.x; Alcalay J, 2001, DERMATOL SURG, V27, P756, DOI 10.1046/j.1524-4725.2001.01056.x; HALL DL, 1988, OPHTHALMIC SURG LAS, V19, P221; Morris A, 2000, CLIN EXP OPHTHALMOL, V28, P419, DOI 10.1046/j.1442-9071.2000.00350.x; Billingsley EM, 1997, DERMATOL SURG, V23, P381; Schanbacher CF, 2000, DERMATOL SURG, V26, P785, DOI 10.1046/j.1524-4725.2000.00079.x; Dunn AS, 2003, ARCH INTERN MED, V163, P901, DOI 10.1001/archinte.163.8.901; Shalom A, 2003, ANN PLAS SURG, V50, P296, DOI 10.1097/01.SAP.0000037275.54751.4E; Armstrong MJ, 2013, NEUROLOGY, V80, P2065, DOI 10.1212/WNL.0b013e318294b32d; Baron TH, 2013, NEW ENGL J MED, V368, P2113, DOI 10.1056/NEJMra1206531; Cannon PD, 2003, AUST DENT J, V48, P115, DOI 10.1111/j.1834-7819.2003.tb00019.x; Carrel TP, 1999, J HEART VALVE DIS, V8, P392; Custer PL, 2002, OPHTHALMIC PLAST REC, V18, P409, DOI 10.1097/01.IOP.0000031382.70088.95; Devani P, 1998, BRIT J ORAL MAX SURG, V36, P107, DOI 10.1016/S0266-4356(98)90177-2; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Evans IL, 2002, BRIT J ORAL MAX SURG, V40, P248, DOI 10.1054/bjom.2001.0773; GAINEY SP, 1989, AM J OPHTHALMOL, V108, P142; Kallio H, 2000, BRIT J ANAESTH, V85, P708, DOI 10.1093/bja/85.5.708; KATHOLI RE, 1976, AM HEART J, V92, P162, DOI 10.1016/S0002-8703(76)80251-7; Kim DJ, 2010, NEUROSURGERY, V67, P73, DOI 10.1227/01.NEU.0000370937.70207.95; Lip GYH, 2011, INT J CLIN PRACT, V65, P361, DOI 10.1111/j.1742-1241.2010.02538.x; MCCORMACK P, 1993, EYE, V7, P749; MCMAHAN LB, 1988, J CATARACT REFR SURG, V14, P569; Niemi T, 2010, CURR OPIN ANESTHESIO, V23, P558, DOI 10.1097/ACO.0b013e32833e1589; Niemi T, 2009, ACTA NEUROCHIR, V151, P1289, DOI 10.1007/s00701-009-0419-x; Ortel TL, 2012, HEMATOL-AM SOC HEMAT, P529, DOI 10.1182/asheducation-2012.1.529; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; ROBERTS CW, 1991, J CATARACT REFR SURG, V17, P309; ROBINSON GA, 1989, BRIT J OPHTHALMOL, V73, P702, DOI 10.1136/bjo.73.9.702; Rotenstreich Y, 2001, J CATARACT REFR SURG, V27, P1344, DOI 10.1016/S0886-3350(00)00887-7; Saitoh AK, 1998, OPHTHALMIC SURG LAS, V29, P909; SHULER JD, 1992, J CATARACT REFR SURG, V18, P567; Suyama Kazuhiko, 2008, Brain and Nerve (Tokyo), V60, P1115; Sweeney JM, 2013, J NEUROSURG, V118, P1009, DOI 10.3171/2013.2.JNS121114; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12180	42	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2015	123	3					794	798		10.3171/2014.9.JNS141088		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP6VZ	WOS:000360027600037		
J	Yamakami, I				Yamakami, Iwao			Save the nerve Response	JOURNAL OF NEUROSURGERY			English	Letter									Seikei Kai Chiba Med Ctr, Chiba, Japan	Yamakami, I (reprint author), Seikei Kai Chiba Med Ctr, Chiba, Japan.						Yamakami I, 2009, J NEUROL NEUROSUR PS, V80, P218, DOI 10.1136/jnnp.2008.156919	1	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2015	123	3					822	823				2	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP6VZ	WOS:000360027600042		
J	Sato, H; Terakawa, Y; Tsuyuguchi, N; Kuwae, Y; Ohsawa, M; Ohata, K				Sato, Hidetoshi; Terakawa, Yuzo; Tsuyuguchi, Naohiro; Kuwae, Yuko; Ohsawa, Masahiko; Ohata, Kenji			Embryonal tumor with abundant neuropil and true rosettes in the brainstem: case report	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						ETANTR; ETMR; embryonal tumor; brainstem; surgical treatment; oncology	CASE-BASED UPDATE	Embryonal tumor with abundant neuropil and true rosettes (ETANTR) is rarely seen in the brainstem, and there are few case reports of brainstem ETANTR in the literature. Accordingly, the characteristics and the role of surgical treatment of this rare entity remain unclear. The authors present a case of brainstem ETANTR involving a 33-month-old boy along with a review of the literature and discuss the role of surgical removal in the treatment of this entity. In the authors' case, the tumor was surgically treated with subtotal resection, which resulted in improvement of the patient's preoperative symptoms. Chemotherapy was initiated but did not appear to be effective, radiotherapy was declined, and the boy died 6 months after the operation. Based on their analysis of 10 previously reported cases and their own case, the authors conclude that, with respect to survival, surgery may be beneficial even in cases of ETANTR in the brainstem. They note, however, that further studies with a large number of cases are needed to validate the role of surgical treatment in brainstem ETANTR.	[Sato, Hidetoshi; Terakawa, Yuzo; Tsuyuguchi, Naohiro; Ohata, Kenji] Osaka City Univ, Grad Sch Med, Dept Neurosurg, Osaka 5458585, Japan; [Kuwae, Yuko; Ohsawa, Masahiko] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka 5458585, Japan	Terakawa, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Neurosurg, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	terakawa@med.osaka-cu.ac.jp					La Spina M, 2006, J NEURO-ONCOL, V78, P317, DOI 10.1007/s11060-005-9105-x; Eberhart CG, 2000, PEDIATR DEVEL PATHOL, V3, P346, DOI 10.1007/s100249910049; Fuller C, 2006, AM J CLIN PATHOL, V126, P277, DOI 10.1309/TFBX1LWQ93MXQBAW; Niguez BF, 2010, CHILD NERV SYST, V26, P1003, DOI 10.1007/s00381-010-1179-x; Korshunov A, 2010, ACTA NEUROPATHOL, V120, P253, DOI 10.1007/s00401-010-0688-8; Korshunov A, 2014, ACTA NEUROPATHOL, V128, P279, DOI 10.1007/s00401-013-1228-0; Paulus W, 2010, ACTA NEUROPATHOL, V120, P269, DOI 10.1007/s00401-010-0710-1; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Adamek D, 2013, CHILD NERV SYST, V29, P849, DOI 10.1007/s00381-013-2037-4; Korshunov A, 2012, ACTA NEUROPATHOL, V124, P875, DOI 10.1007/s00401-012-1068-3; Alexiou GA, 2013, J CHILD NEUROL, V28, P1709, DOI 10.1177/0883073812471434; Gessi M, 2009, AM J SURG PATHOL, V33, P211, DOI 10.1097/PAS.0b013e318186235b	12	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2015	16	3					291	295		10.3171/2015.3.PEDS14727		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CP6VY	WOS:000360027500008		
J	Shinojima, N; Nakamura, H; Kuratsu, J				Shinojima, Naoki; Nakamura, Hideo; Kuratsu, Jun-ichi			Temporal evolution of medulloblastoma subgroups Response	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Letter							CELL COMPETITION		[Shinojima, Naoki; Nakamura, Hideo; Kuratsu, Jun-ichi] Kumamoto Univ Hosp, Kumamoto, Japan	Shinojima, N (reprint author), Kumamoto Univ Hosp, Kumamoto, Japan.						Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281	4	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2015	16	3					350	351				2	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CP6VY	WOS:000360027500021		
J	Tamaki, Y; Sakai, T; Miyagi, R; Nakagawa, T; Shimakawa, T; Sairyo, K; Chikawa, T				Tamaki, Yasuaki; Sakai, Toshinori; Miyagi, Ryo; Nakagawa, Takefumi; Shimakawa, Tateaki; Sairyo, Koichi; Chikawa, Takashi			Intradural lumbar disc herniation after percutaneous endoscopic lumbar discectomy: case report	JOURNAL OF NEUROSURGERY-SPINE			English	Article						intradural disc herniation; percutaneous endoscopic lumbar discectomy; complications; low-back pain	COMPLICATIONS	A 64-year-old man was referred to the authors with low-back pain (LBP) and right leg pain with a history of previously diagnosed lumbar disc herniation (LDH) at L4-5. He had undergone 2 percutaneous endoscopic lumbar discectomies (PELDs) for the herniation at another institution, and according to the surgical record of the second surgery, a dural tear occurred intraoperatively but was not repaired. Postoperative conservative treatments such as an epidural block and blood patch had not relieved his persistent LBP or right leg pain. Upon referral to the authors, MRI and myelography revealed an intradural LDH. The herniated mass was removed by durotomy, and posterior lumbar interbody fusion was performed. His symptoms were partially improved after surgery. Primary suture is technically difficult when a dural tear occurs during PELD. Therefore, close attention should be paid to avoiding such tears, and surgeons should increase their awareness of intradural LDH as a possible postoperative complication of PELD.	[Tamaki, Yasuaki; Nakagawa, Takefumi; Shimakawa, Tateaki; Chikawa, Takashi] Tokushima Municipal Hosp, Dept Orthoped, Tokushima, Japan; [Sakai, Toshinori; Miyagi, Ryo; Sairyo, Koichi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthoped, Tokushima 7708503, Japan	Sakai, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthoped, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	norinori@tokushima-u.ac.jp					Ahn Y, 2011, EUR SPINE J, V20, P58, DOI 10.1007/s00586-010-1493-8; Dandy WE, 1942, J AMER MED ASSOC, V119, P474; Ducati LG, 2013, EUR SPINE J, V22, pS404, DOI 10.1007/s00586-012-2516-4; Hidalgo-Ovejero AM, 2004, SPINE, V29, pE463; Choi JY, 2007, SPINE J, V7, P111, DOI 10.1016/j.spinee.2006.02.025; Yeung AT, 2002, SPINE, V27, P722, DOI 10.1097/00007632-200204010-00009; Aydin MV, 2004, SPINAL CORD, V42, P52, DOI 10.1038/sj.sc.3101476; D'Andrea G, 2004, NEUROSURG REV, V27, P75, DOI 10.1007/s10143-003-0296-3; Floeth Frank, 2012, Eur Spine J, V21 Suppl 4, pS453, DOI 10.1007/s00586-011-2073-2	9	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	SEP	2015	23	3					336	339		10.3171/2014.12.SPINE14682		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP6VW	WOS:000360027300012		
J	Yamamoto, S; Kanaya, H; Kim, P				Yamamoto, Shinji; Kanaya, Hideaki; Kim, Phyo			Spinal intraarterial computed tomography angiography as an effective adjunct for spinal angiography	JOURNAL OF NEUROSURGERY-SPINE			English	Article						spinal angiography; CT angiography; intraarterial; spinal arteriovenous malformation; spinal arteriovenous fistula; technique	DURAL ARTERIOVENOUS-FISTULAS; CT ANGIOGRAPHY; ADAMKIEWICZ ARTERY; MR-ANGIOGRAPHY; CORD ARTERIOGRAPHY; AORTIC-ANEURYSM; ROW CT; LOCALIZATION; COMPLICATIONS; EMBOLIZATION	OBJECT Spinal digital subtraction angiography (DSA) is indispensable for the precise diagnosis of spinal vascular lesions and the assessment of blood supply to the spinal cord. However, comprehensive spinal DSA covering multiple segments requires repetition of selective catheterization into small segmental arteries, which is time consuming, sometimes difficult, and hazardous. The authors investigated the usefulness of CT angiography with intraarterial contrast injection (IA-CTA) as a preliminary study preceding spinal DSA. With the advent of multidetector CT, it is feasible to obtain images of the spinal cord vasculature instantaneously over a number of segments. METHODS A total of 56 patients with lesions involving the spinal vasculature underwent IA-CTA with 64- or 320-row detector CT in advance of comprehensive spinal DSA. Contrast material was injected via a pigtail catheter placed at the aorta in proximity to the segments of interest. Scanning was repeated twice to obtain arterial- and venous-phase images to differentiate between the arterial and venous components. The spinal arteries were identified by paging the various multiplanar reconstruction images and tracing the vessels from the aorta. Spinal DSA was subsequently performed by guiding selective catheterization to the feeding segments in reference to the IA-CTA findings. Visualization of the segmental arteries, normal spinal arteries, and abnormal vessels during IA-CTA was investigated and compared with that obtained during spinal DSA. RESULTS In all 56 patients, spinal IA-CTA successfully enabled visualization of the spinal vessels, including the radicular arteries and the anterior spinal artery. Below the aortic arch, all segmental arteries were identified clearly. The segmental arteries, radiculomedullary arteries, spinal arteries, and abnormal vessels were traced from the aorta, which would be the target of selective catheterization. In 3 (6.8%) patients, IA-CTA revealed severe aortic atherosclerosis and occlusion of some segmental arteries. The information obtained was useful for directing selective catheterization studies. The findings of IA-CTA corresponded well with those of spinal DSA. CONCLUSIONS IA-CTA is a useful adjunct to spinal DSA for surveying the vasculature surrounding the spinal cord and for orienting selective catheterization. IA-CTA can complement spinal DSA, curtail unnecessary segmental injections, and thus reduce procedural complications.	[Yamamoto, Shinji; Kanaya, Hideaki; Kim, Phyo] Dokkyo Univ, Sch Med, Dept Neurosurg, Mibu, Tochigi 3210293, Japan	Yamamoto, S (reprint author), Dokkyo Univ, Sch Med, Dept Neurosurg, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	shinjiyamamoto2-nsu@umin.ac.jp					Aadland TD, 2010, AM J NEURORADIOL, V31, P476, DOI 10.3174/ajnr.A1840; Zampakis P, 2006, NEUROSURGERY, V58, P686, DOI 10.1227/01.NEU00199163.10539.56; Yoshioka K, 2006, RADIOGRAPHICS, V26, pS63, DOI 10.1148/rg.26si065506; Guillevin R, 2005, AM J NEURORADIOL, V26, P929; Kieffer E, 2002, J VASC SURG, V35, P262, DOI 10.1067/mva.2002.120378; Uotani K, 2008, AM J NEURORADIOL, V29, P314, DOI 10.3174/ajnr.A0812; Lai PH, 2006, AM J NEURORADIOL, V27, P813; Boll DT, 2006, AM J ROENTGENOL, V187, P1054, DOI 10.2214/AJR.05.0562; Chen J, 2011, NEUROLOGY, V77, P1235, DOI 10.1212/WNL.0b013e3182302068; Yamaguchi S, 2010, J NEUROSURG-SPINE, V12, P243, DOI 10.3171/2009.9.SPINE0971; Bley TA, 2010, RADIOLOGY, V255, P873, DOI 10.1148/radiol.10091304; Cognard C, 1996, NEURORADIOLOGY, V38, P603; FORBES G, 1988, RADIOLOGY, V169, P479; Hyodoh H, 2005, RADIOLOGY, V236, P1004, DOI 10.1148/radiol.2363040911; Kawaharada N, 2004, ANN THORAC SURG, V78, P846, DOI 10.1016/j.athoracsur.2004.02.085; Kudo K, 2003, AM J NEURORADIOL, V24, P13; Nakayama Y, 2008, CLIN RADIOL, V63, P880, DOI 10.1016/j.crad.2008.01.009; Nojiri J, 2007, EUR J CARDIO-THORAC, V31, P249; Oldfield EH, 2002, J NEUROSURG, V96, P220, DOI 10.3171/spi.2002.96.2.0220; SAVADER SJ, 1993, RADIOLOGY, V189, P165; Si-jia Gao, 2009, Eur J Radiol, V71, P22, DOI 10.1016/j.ejrad.2008.04.005; Takase K, 2002, RADIOLOGY, V223, P39, DOI 10.1148/radiol.2231010513; Utsunomiya D, 2008, EUR RADIOL, V18, P2684, DOI 10.1007/s00330-008-1036-4; Yamada N, 2000, J COMPUT ASSIST TOMO, V24, P362, DOI 10.1097/00004728-200005000-00002; Yamaguchi S, 2007, NEUROSURG REV, V30, P321, DOI 10.1007/s10143-007-0088-2	25	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	SEP	2015	23	3					360	367		10.3171/2014.12.SPINE14584		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CP6VW	WOS:000360027300015		
J	Okamoto, S; Matsuura, N; Ichinohe, T				Okamoto, Sota; Matsuura, Nobuyuki; Ichinohe, Tatsuya			Effects of Volatile Anesthetics on Oral Tissue Blood Flow in Rabbits: A Comparison Among Isoflurane, Sevoflurane, and Desflurane	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							MANDIBULAR BONE-MARROW; ZEALAND WHITE-RABBITS; PROPOFOL ANESTHESIA; HEART-RATE; DOGS; REMIFENTANIL; RATS; MAC; CONSTRICTION; HYPOCAPNIA	Purpose: The aim of this study was to compare the concentration-dependent effects of isoflurane, sevoflurane, and desflurane on oral tissue blood flow. Materials and Methods: Thirty male Japan White rabbits were randomized to receive 1 of 3 volatile anesthetics: isoflurane (group Iso), sevoflurane (group Sevo), or desflurane (group Des). The end-tidal concentration of each volatile anesthetic was regulated to 0.5, 1, and 1.5 minimum alveolar concentrations (MACs). The observed variables were heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, common carotid arterial blood flow, tongue mucosal blood flow, mandibular bone marrow blood flow (BBF), masseter muscle blood flow (MBF), upper alveolar tissue blood flow, and lower alveolar tissue blood flow (LBF). Results: The blood pressure in each group tended to decrease depending on the concentration of each volatile anesthetic, with the smallest effect in group Des. BBF and MBF in group Iso were higher than those in group Des at 1 MAC, and MBF and LBF in group Iso were highest at 1.5 MAC. Conclusion: The results of this study suggest that each volatile anesthetic produced unique effects on blood flow in oral tissues and circulatory parameters. Among the 3 volatile anesthetics, desflurane produced the smallest effects on oral tissue blood flow. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Okamoto, Sota; Matsuura, Nobuyuki; Ichinohe, Tatsuya] Tokyo Dent Coll, Dept Dent Anesthesiol, Chiba, Chiba 2618502, Japan	Okamoto, S (reprint author), Tokyo Dent Coll, Dept Dent Anesthesiol, Mihama Ku, 1-2-2 Masago, Chiba, Chiba 2618502, Japan.	getaniyakimiso@mac.com			JSPS KAKENHI [25463147]	This work was supported in part by JSPS KAKENHI (grant 25463147).	RAMPIL IJ, 1988, ANESTHESIOLOGY, V69, P298, DOI 10.1097/00000542-198809000-00002; TerRiet MF, 2000, BRIT J ANAESTH, V85, P305, DOI 10.1093/bja/85.2.305; Scheeren TWL, 1999, ACTA ANAESTH SCAND, V43, P421, DOI 10.1034/j.1399-6576.1999.430410.x; DRUMMOND JC, 1985, ANESTHESIOLOGY, V62, P336, DOI 10.1097/00000542-198503000-00020; Kemmochi M, 2009, J ORAL MAXIL SURG, V67, P1245, DOI 10.1016/j.joms.2008.06.008; CONZEN PF, 1992, ANESTH ANALG, V74, P79; Dong YH, 2012, J NEUROL SCI, V322, P112, DOI 10.1016/j.jns.2012.07.034; Koshika K, 2011, J ORAL MAXIL SURG, V69, P2128, DOI 10.1016/j.joms.2010.12.056; Sazuka S, 2012, J ORAL MAXIL SURG, V70, P1808, DOI 10.1016/j.joms.2012.02.022; Rossi A, 2010, J ORAL MAXIL SURG, V68, P1007, DOI 10.1016/j.joms.2008.12.012; Ichinohe T, 1998, ORAL SURG ORAL MED O, V85, P268, DOI 10.1016/S1079-2104(98)90006-3; Blaudszun G, 2012, ANESTHESIOLOGY, V117, P1051, DOI 10.1097/ALN.0b013e31826cb20b; DOORLEY BM, 1988, ANESTHESIOLOGY, V69, P89, DOI 10.1097/00000542-198807000-00013; Handa M, 2008, J ORAL MAXIL SURG, V66, P1820, DOI 10.1016/j.joms.2007.09.010; HANSEN TD, 1989, J CEREBR BLOOD F MET, V9, P323; Holmstrom A, 2004, ACTA ANAESTH SCAND, V48, P400, DOI 10.1111/j.1399-6576.2004.00361.x; LISCHKE V, 1995, ANESTHESIOLOGY, V83, P574, DOI 10.1097/00000542-199509000-00017; Luginbuehl IA, 2003, PAEDIATR ANAESTH, V13, P496, DOI 10.1046/j.1460-9592.2003.00966.x; Marano G, 1996, J CARDIOVASC PHARM, V28, P513, DOI 10.1097/00005344-199610000-00006; Mizuta K, 2006, J DENT RES, V85, P379; Mutoh T, 2013, LIFE SCI, V92, P821, DOI 10.1016/j.lfs.2013.02.015; NAKAMURA K, 1993, CAN J ANAESTH, V40, P257; Nishizawa S, 2012, J ORAL MAXIL SURG, V70, P797, DOI 10.1016/j.joms.2011.10.012; Ogawa K, 1997, CAN J ANAESTH, V44, P426; Ozarslan NG, 2012, J CARDIOTHOR VASC AN, V26, P791, DOI 10.1053/j.jvca.2012.03.019; Park KW, 1999, ANESTHESIOLOGY, V90, P1422, DOI 10.1097/00000542-199905000-00027; Picker O, 2001, BRIT J ANAESTH, V87, P748, DOI 10.1093/bja/87.5.748; Picker O, 2003, EUR J ANAESTH, V20, P945; SCHELLER MS, 1988, CAN J ANAESTH, V35, P153; Terakawa Y, 2010, J ORAL MAXIL SURG, V68, P15, DOI 10.1016/j.joms.2009.04.040; Toader E, 2011, MINERVA ANESTESIOL, V77, P142; Van Aken H, 1991, Agressologie, V32, P303; YOUNG WL, 1992, ANESTH ANALG, V75, pS32	33	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	SEP	2015	73	9							1714.e1	10.1016/j.joms.2015.03.047		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP6SG	WOS:000360017800013		
J	Otsuka, J; Horii, E; Koh, S; Hiroishi, M				Otsuka, Junko; Horii, Emiko; Koh, Shukuki; Hiroishi, Masayuki			Unusual humeral medial condyle fracture in an adolescent because of a previous post-traumatic fishtail deformity: a case report	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						fishtail deformity; lateral humeral condyle fracture; children; medial humeral condyle fracture	DISTAL HUMERUS; CHILDREN	A fishtail deformity is a well-known complication following pediatric lateral condyle fracture of the humerus. We report a rare case of a medial humeral condyle fracture in a 12-year-old boy who had had a fishtail deformity because of a lateral condyle fracture in childhood. Radiographs showed a longitudinal fracture plane of the medial condyle extending to the articular surface, which is different from the three types of medial condyle fracture classified by Kilfoyle. We present our case and reviewed the literature to clarify the difference in the mechanism of medial humeral condyle fracture after a fishtail deformity. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Otsuka, Junko; Horii, Emiko; Koh, Shukuki; Hiroishi, Masayuki] Gen Inuyama Chuo Hosp, Dept Orthopaed Surg, Inuyama, Aichi 4848511, Japan	Otsuka, J (reprint author), Gen Inuyama Chuo Hosp, Dept Orthopaed Surg, 6 Futakozuka Goromaru, Inuyama, Aichi 4848511, Japan.	junko_otsuka_1128@yahoo.co.jp					MORRISSY RT, 1984, J BONE JOINT SURG AM, V66A, P557; Brouwer KM, 2009, J HAND SURG-AM, V34A, P439, DOI 10.1016/j.jhsa.2008.11.022; FOWLES JV, 1980, J BONE JOINT SURG AM, V62, P1159; Glotzbecker MP, 2013, J PEDIATR ORTHOPED, V33, P592, DOI 10.1097/BPO.0b013e3182933c51; Hasler CC, 2001, J PEDIATR ORTHOP B, V10, P123, DOI 10.1097/00009957-200104000-00009; Ippolito E, 1996, ACTA ORTHOP SCAND, V67, P173, DOI 10.3109/17453679608994666; JAKOB R, 1975, J BONE JOINT SURG BR, V57, P430; Kilfoyle R M, 1965, Clin Orthop Relat Res, V41, P43; Namba Jiro, 2011, Emerg Radiol, V18, P507, DOI 10.1007/s10140-011-0985-0; Ohmori M, 1997, SEIKEIGEKA, V48, P551; Patel B, 2009, PEDIATR RADIOL, V39, P226, DOI 10.1007/s00247-008-1078-4; RUTHERFORD A, 1985, J BONE JOINT SURG AM, V67A, P851; Schulte DW, 2009, ACTA ORTHOP BELG, V75, P408; Skak SV, 2001, J PEDIATR ORTHOP B, V10, P142, DOI 10.1097/00009957-200104000-00012; WADSWORTH TG, 1964, J BONE JOINT SURG BR, V46, P46; Yang ZY, 1998, J HAND SURG-AM, V23A, P165, DOI 10.1016/S0363-5023(98)80107-X	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	SEP	2015	24	5					408	411		10.1097/BPB.0000000000000185		4	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CP4JF	WOS:000359847100005		
J	Asplen, MK; Anfora, G; Biondi, A; Choi, DS; Chu, D; Daane, KM; Gibert, P; Gutierrez, AP; Hoelmer, KA; Hutchison, WD; Isaacs, R; Jiang, ZL; Karpati, Z; Kimura, MT; Pascual, M; Philips, CR; Plantamp, C; Ponti, L; Vetek, G; Vogt, H; Walton, VM; Yu, Y; Zappala, L; Desneux, N				Asplen, Mark K.; Anfora, Gianfranco; Biondi, Antonio; Choi, Deuk-Soo; Chu, Dong; Daane, Kent M.; Gibert, Patricia; Gutierrez, Andrew P.; Hoelmer, Kim A.; Hutchison, William D.; Isaacs, Rufus; Jiang, Zhi-Lin; Karpati, Zsolt; Kimura, Masahito T.; Pascual, Marta; Philips, Christopher R.; Plantamp, Christophe; Ponti, Luigi; Vetek, Gabor; Vogt, Heidrun; Walton, Vaughn M.; Yu, Yi; Zappala, Lucia; Desneux, Nicolas			Invasion biology of spotted wing Drosophila (Drosophila suzukii): a global perspective and future priorities	JOURNAL OF PEST SCIENCE			English	Review						Biological control; Drosophila; Frugivore; Integrated pest management; Invasion biology	MATSUMURA DIPTERA DROSOPHILIDAE; NORTH-AMERICA; LEPTOPILINA PARASITOIDS; INSECTICIDE RESISTANCE; BENEFICIAL ARTHROPODS; LARVAL PARASITOIDS; ASOBARA-JAPONICA; NATURAL ENEMIES; SOYBEAN APHID; UNITED-STATES	The Asian vinegar fly Drosophila suzukii (spotted wing Drosophila [SWD]) has emerged as a major invasive insect pest of small and stone fruits in both the Americas and Europe since the late 2000s. While research efforts have rapidly progressed in Asia, North America, and Europe over the past 5 years, important new insights may be gained in comparing and contrasting findings across the regions affected by SWD. In this review, we explore common themes in the invasion biology of SWD by examining (1) its biology and current pest status in endemic and recently invaded regions; (2) current efforts and future research needs for the development of predictive models for its geographic expansion; and (3) prospects for both natural and classical (=importation) biological control of SWD in invaded habitats, with emphasis on the role of hymenopteran parasitoids. We conclude that particularly fruitful areas of research should include fundamental studies of its overwintering, host-use, and dispersal capabilities; as well as applied studies of alternative, cost-effective management techniques to complement insecticide use within the integrated pest management framework. Finally, we emphasize that outreach efforts are critical to effective SWD management by highlighting successful strategies and insights gained from various geographic regions.	[Asplen, Mark K.] Metropolitan State Univ, Dept Nat Sci, St Paul, MN 55106 USA; [Anfora, Gianfranco] Fdn Edmund, Res & Innovat Ctr, Mach, San Michele All, Italy; [Biondi, Antonio; Daane, Kent M.; Gutierrez, Andrew P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Biondi, Antonio; Zappala, Lucia] Univ Catania, Dept Agr Food & Environm, I-95123 Catania, Italy; [Choi, Deuk-Soo] Anim & Plant Quarantine Agcy, Yeongnam Reg Off, Expt & Anal Div, Busan 600016, South Korea; [Chu, Dong] Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao 266109, Shandong, Peoples R China; [Gibert, Patricia; Plantamp, Christophe] Univ Lyon 1, UMR CNRS 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Gutierrez, Andrew P.; Ponti, Luigi] Ctr Anal Sustainable Agr Syst, Kensington, CA 94707 USA; [Hoelmer, Kim A.] USDA ARS, Beneficial Insects Intro Res Unit, Newark, DE 19713 USA; [Hutchison, William D.; Philips, Christopher R.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Isaacs, Rufus] Michigan State Univ, Dept Entomol, Ctr Integrated Plant Syst 202, E Lansing, MI 48824 USA; [Jiang, Zhi-Lin] Yunnan Agr Univ, Coll Plant Protect, Key Lab Agr Biodivers & Pest Management, Minist Educ China, Kunming, Yunnan, Peoples R China; [Karpati, Zsolt] Hungarian Acad Sci, Dept Zool, Agr Res Ctr, H-1525 Budapest, Hungary; [Karpati, Zsolt] Hungarian Acad Sci, Inst Plant Protect, H-1525 Budapest, Hungary; [Kimura, Masahito T.] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 060, Japan; [Pascual, Marta] Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain; [Pascual, Marta] Univ Barcelona, IrBio, E-08028 Barcelona, Spain; [Philips, Christopher R.] Univ Minnesota, Dept Entomol, NC Res & Outreach Ctr, Grand Rapids, MN 55744 USA; [Ponti, Luigi] ENEA, Ctr Ric Casaccia, Agenzia Nazl Nuove Tecnol Energia & Sviluppo Econ, I-00123 Rome, Italy; [Vetek, Gabor] Corvinus Univ Budapest, Fac Hort Sci, Dept Entomol, H-1118 Budapest, Hungary; [Vogt, Heidrun] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Plant Protect Fruit Crops & Viticulture, D-69221 Dossenheim, Germany; [Walton, Vaughn M.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Walton, Vaughn M.] Oregon State Univ, Oregon Wine Res Inst, Corvallis, OR 97331 USA; [Yu, Yi] Shandong Acad Agr Sci, Inst Plant Protect, Key Lab Plant Virol Shandong, Jinan 250100, Peoples R China; [Desneux, Nicolas] Univ Nice Sophia Antipolis, CNRS, French Natl Inst Agr Res INRA, UMR Inst Sophia Agrobiotech 1355 7254, F-06903 Sophia Antipolis, France	Asplen, MK (reprint author), Metropolitan State Univ, Dept Nat Sci, 700 East 7th St, St Paul, MN 55106 USA.	mark.asplen@metrostate.edu; nicolas.desneux@sophia.inra.fr	Pascual, Marta/M-7626-2015; BIONDI, Antonio/I-6381-2012	Pascual, Marta/0000-0002-6189-0612; BIONDI, Antonio/0000-0002-1982-7716	Rapid Agricultural Response Fund, University of Minnesota; University of Minnesota Agricultural Experiment Station; Michigan's Project GREEEN, the Michigan Department of Agriculture and Rural Development; North Central IPM Program of USDA; US Environmental Protection Agency; MBG Marketing; Italian Ministry of Education; University and Research (PRIN project GEISCA) [2010CXXHJE_004]; Hungarian Scientific Research Fund [PD 1041310]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; COST Action [TD1209]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme [318246 (ASCII), 333980]; US Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) [2010-51181-21167]; Center for the Analysis of Agricultural Systems, Kensington CA	This review was supported by the Rapid Agricultural Response Fund, University of Minnesota, the University of Minnesota Agricultural Experiment Station, Michigan's Project GREEEN, the Michigan Department of Agriculture and Rural Development, the North Central IPM Program of USDA, the US Environmental Protection Agency, MBG Marketing, the Italian Ministry of Education, University and Research (PRIN project GEISCA, 2010CXXHJE_004), the Hungarian Scientific Research Fund PD 1041310, Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, the COST Action TD1209 (European Information System for Alien Species), the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013, under REA Grant Agreement No. 318246 (ASCII) and No 333980, and the US Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) award # 2010-51181-21167. The development of the PBDM for SWD was funded by the Center for the Analysis of Agricultural Systems, Kensington CA (casasglobal.org). The authors would like to thank all the colleagues and students of the Corvinus University of Budapest who participated in the data collection on SWD distributions in the Carpathian Basin, and A. Blanton, University of Minnesota for SWD confirmations. Special thanks are due to Beata Mavracic and Akos Varga, for setting SWD traps in Serbia, and for Attila Haltrich for setting SWD traps at Rimavska Sobota, Slovakia. The authors thank the many colleagues and research technicians who have contributed their time and expertise to understanding the spread, impact, and management of SWD.	Alberta Agriculture and Rural Development, 2013, DROS SUZ ALB; Burrack HJ, 2013, PEST MANAG SCI, V69, P1173, DOI 10.1002/ps.3489; Cini A, 2012, B INSECTOL, V65, P149; Kasuya N, 2013, APPL ENTOMOL ZOOL, V48, P87, DOI 10.1007/s13355-012-0156-0; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Hamby KA, 2012, APPL ENVIRON MICROB, V78, P4869, DOI 10.1128/AEM.00841-12; Ideo S, 2008, ENTOMOL SCI, V11, P1, DOI 10.1111/j.1479-8298.2007.00244.x; Allemand R, 1999, ANN SOC ENTOMOL FR, V35, P97; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Colinet D, 2013, INSECT BIOCHEM MOLEC, V43, P601, DOI 10.1016/j.ibmb.2013.03.010; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Adrion JR, 2014, MOL BIOL EVOL, V31, P3148, DOI 10.1093/molbev/msu246; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Perry T, 2015, INSECT BIOCHEM MOLEC, V64, P106, DOI 10.1016/j.ibmb.2015.01.017; Fleury F, 2009, ADV PARASIT, V70, P3, DOI 10.1016/S0065-308X(09)70001-6; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Gabarra R, 2015, BIOCONTROL, V60, P331, DOI 10.1007/s10526-014-9646-z; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Briere JF, 1998, ENVIRON ENTOMOL, V27, P94; Cha DH, 2012, J CHEM ECOL, V38, P1419, DOI 10.1007/s10886-012-0196-5; Chiu JC, 2013, G3-GENES GENOM GENET, V3, P2257, DOI 10.1534/g3.113.008185; Mitsui H, 2010, ENTOMOL SCI, V13, P60, DOI 10.1111/j.1479-8298.2010.00372.x; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Menozzi P, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-4; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Wertheim B, 2006, ECOL ENTOMOL, V31, P216, DOI 10.1111/j.1365-2311.2006.00757.x; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Prevost G, 2005, J INSECT PHYSIOL, V51, P171, DOI 10.1016/j.jinsphys.2004.10.002; Mortelmans J, 2012, BELG J ZOOL, V142, P143; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Mazzetto F, 2015, J ASIA-PAC ENTOMOL, V18, P321, DOI 10.1016/j.aspen.2015.04.001; Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Kim SS, 2014, J ECON ENTOMOL, V107, P1292, DOI 10.1603/EC13389; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Heimpel GE, 2010, BIOL INVASIONS, V12, P2913, DOI 10.1007/s10530-010-9736-5; Poyet M, 2013, PHYSIOL ENTOMOL, V38, P45, DOI 10.1111/phen.12002; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Gilchrist GW, 2004, EVOLUTION, V58, P768; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Asplen MK, 2009, PHYSIOL ENTOMOL, V34, P350, DOI 10.1111/j.1365-3032.2009.00698.x; Baroffio C, 2011, UFAREVUE, V11, P46; Baroffio C. A., 2014, Journal of Berry Research, V4, P47; Baser N, 2015, FRUITS, V70, P1; Belien T, 2013, FRUITTEELTNIEUWS, V26, P25; Bellamy DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061227; Beppu Katsura, 2000, Memoirs of the National Science Museum (Tokyo), V36, P409; BEPPU K, 1984, Kontyu, V52, P58; Bieri M, 1983, B SOC ENTOMOL SUISSE, V56, P163; Biurrun R, 2013, NAVAR AGRAR, V197, P13; Bleyer K, 2013, M WORK GROUP CHERR V; Bogwitz MR, 2005, P NATL ACAD SCI USA, V102, P12807, DOI 10.1073/pnas.0503709102; Bolda M. P., 2010, AGR RESOUR EC UPDATE, V13, P5; Brezikova M, 2014, KLAPALEKIANA, V50, P247; Briem F., 2015, IOBC/WPRS Bulletin, V109, P233; Brown PH, 2011, PEST MANAG SCI; Burrack H. J., 2012, J INTEGR PEST MANAGE, V4, P1; Burrack HJ, 2014, SWD IMPACTS 2013; Burrack HJ, 2015, ENVIRON ENTOMOL, V44, P704, DOI 10.1093/ee/nvv022; CABI, 2014, INV SPEC COMP; Caprile J, 2013, SPOTTED WING DROSPHI; CARTON Y, 1991, OIKOS, V60, P222, DOI 10.2307/3544869; Carton Y., 1986, Genetics and Biology of Drosophila, V3e, P347; Chabert S, 2013, PHYTOMA, V660, P34; Chireceanu C, 2014, P 8 INT C BIL INV, P213; Choi DS, 2012, ANN REP RES PROJ EXP; Cini A, 2014, J PEST SCI, V87, P559, DOI 10.1007/s10340-014-0617-z; Cormier D., 2015, IOBC/WPRS Bulletin, V109, P181; Dalton DT, 2011, PEST MANAG SCI, V67, P368; Ros G. de, 2013, IOBC/WPRS Bulletin, V91, P317; Dreves AJ, 2009, NEW PEST ATTACKING; EPPO, 2012, 1 EPPO; EPPO, 2015, 012015 EPPO; Fagan WF, 2002, ECOL LETT, V5, P148, DOI 10.1046/j.1461-0248.2002.0_285.x; Franco AM, 2013, VOZ DO CAMPO, V158, P36; Gabarra R, 2012, PHYTOMA ESPANA, V240, P46; Godfray H.C.J., 1994, PARASITOIDS BEHAV EV; Grassi A., 2009, TERRA TRENTINA, V55, P19; Guo Jian-Ming, 2007, Chinese Bulletin of Entomology, V44, P743; Gutierrez A. P., 1984, Canadian Entomologist, V116, P933; Gutierrez AP, 1996, APPL POPULATION ECOL; Gutierrez AP, 2013, ENVIRON ENTOMOL, V42, P395, DOI 10.1603/EN12018; Hamby KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068472; Hamilton K, 2010, 1 REPORT SPOTTED; Helsen H., 2013, Gewasbescherming, V44, P72; Hirai Yoshiyuki, 2000, Entomological Science, V3, P273; Hui J-T, 2010, HORTICULTURE, V8, P2728; Ioriatti C, 2015, J ECON ENTOMOL, V108, P1148, DOI 10.1093/jee/tov042; Isaacs R, 2011, NEWSL ENTOMOL SOC MI, V56, P10; Jenni W, 1951, ACTA ZOOLOGICA, V32, P177; Kacsoh BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034721; Kanzawa T, 1939, STUDIES DROSOPHILA; Kawase S, 2008, B CHIBA PREFECT AGR, V7, P9; Kikkawa H., 1938, Japanese Journal of Zoology, V7, P507; Kim IS, 2013, DEV DISINFECTION; Kim YJ, 2012, P 24 INT C ENT; KIMURA M T, 1977, Kontyu, V45, P571; Kinjo H, 2014, APPL ENTOMOL ZOOL, V49, P297, DOI 10.1007/s13355-014-0249-z; Kiss B., 2013, Novenyvdelem, V49, P97; Kiss B, 2014, INTEGRALT TERMESZTES, V31, P34; Kiss B, 2015, NOVENYVEDEMIL, V61; Kiss B, 2014, NOVENYDEDELMI TUIDO, V60; Klick J, 2015, J APPL ENTOMOL, DOI [10.1111/jen.12234, DOI 10.1111/JEN.12234]; Kondo M, 2008, ENTOMOL SCI, V11, P7, DOI 10.1111/j.1479-8298.2007.00250.x; Labanowska B, 2015, TRUSKAWKA MALIN, V1, P16; Landolt PJ, 2012, J APPL ENTOMOL, V136, P148, DOI 10.1111/j.1439-0418.2011.01646.x; Lee JC, 2015, ANN ENTOMOL SOC AM, V108, P117, DOI 10.1093/aesa/sau014; Lee JC, 2013, ENVIRON ENTOMOL, V42, P1348, DOI 10.1603/EN13148; Lee JC, 2012, J ECON ENTOMOL, V105, P1350, DOI 10.1603/EC12132; Lethmayer C, 2012, BESSERES OBST, V10-11, P4; Lethmayer C, 2014, BESSERES OBST, V4, P4; Maca Jan, 2014, Drosophila Information Service, V97, P28; Milek T. M., 2011, Glasilo Biljne Zaštite, V11, P377; Momma E, 1954, J FS HOKKAIDO U 6, V13, P93; MOMMA E, 1965, JPN J GENET, V40, P275, DOI 10.1266/jjg.40.275; Nagayama S, 1940, ANN AGR EXP ST GOV, V12, P195; Nishiharu S, 1980, THESIS; Nomano F. Y., 2014, J APPL ENTOMOL, V139, P105; Nostvik E., 1954, Genet ed Entom Pavia, V2, P139; NPPO of Slovakia, 2014, SK00007 NPPO; Ontario Ministry of Agriculture and Food, 2014, REP SWD REAR COMM BU; Ostojic´ I., 2014, Radovi Poljoprivrednog Fakulteta Univerziteta u Sarajevu (Works of the Faculty of Agriculture University of Sarajevo), V59, P127; Papachristos D, 2013, 15 ENT M HELL ENT SO; Perez-Otero R., 2013, Arquivos Entomoloxicos, V9, P7; Poyet M, 2014, AGR FOREST ENTOMOL, V16, P251, DOI 10.1111/afe.12052; Price JF, 2012, PUBLICATION; [钱远槐 QIAN Yuanhuai], 2006, [湖北大学学报. 自然科学版, Journal of Hubei University. Natural Science Edition], V28, P397; Radonjic S, 2014, 7 C PLANT PROT; RIZKI MOHAMMED TAHIR MIRZA, 1957, J MORPH, V100, P437, DOI 10.1002/jmor.1051000303; Rodriguez-Saona Cesar R., 2009, P263, DOI 10.1007/978-1-4020-8992-3_11; Rohlfs M, 2004, OECOLOGIA, V140, P654, DOI 10.1007/s00442-004-1629-9; Rossi Stacconi MV, 2013, ENTOMOLOGIA, V1, pe3; Stacconi MVR, 2015, BIOL CONTROL, V84, P28, DOI 10.1016/j.biocontrol.2015.02.003; Salt G, 1970, CELLULAR DEFENCE SR; Sarto V., 2011, PHYTOMA, V234, P1; Sasaki M, 1995, ANN REPORT SOC PLANT, V46, P164; Sasaki M., 1995, ANN REP PLANT PROT N, V46, P170; Sasaki M, 1995, ANN REP SOC PLANT PR, V46, P167; Seljak G., 2011, SAD, Revija za Sadjarstvo, Vinogradništvo in Vinarstvo, V22, P3; Shimizu K, 2004, SHOKUBUTSU BOEKI, V60, P103; Steffan SA, 2013, J ECON ENTOMOL, V106, P2424, DOI 10.1603/EC13331; Tan C.C., 1949, University of Texas Publications, Vno. 4920, P196; Tosevski I, 2014, PLANT PROT, V65, P99; Van Timmeren S, 2014, CROP PROT, V54, P126; Vilela CR, 2014, REV BRAS ENTOMOL, V58, P371, DOI 10.1590/S0085-56262014000400004; Vogt H., 2012, Entomologische Nachrichten und Berichte, V56, P191; Vogt H, 2014, MITT DEUT GES ALLGEM, V19, P211; Vogt H, 2012, J KULTURPFLANZEN, V64, P68; Vogt H., 2011, OBSTBAU, V8, P452; Walsh D. B., 2011, Journal of Integrated Pest Management, V2, pG1; Walton VM, 2011, EM 9021; Wang H-X, 2003, ZHEJIANG FOR SCI, V23, P4547; Wang L-F, 2004, CITRUS SUBTROPICA, V20, P12; Wang XG, 2004, BEHAV ECOL SOCIOBIOL, V56, P513, DOI 10.1007/s00265-004-0829-y; Weydert C, 2013, INFOS CTIFL, V292, P32; Whitener A, 2015, BASELINE MORTALITY; Wiman NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106909; Wise JC, 2014, CAN ENTOMOL, V147, P109; Withers Philip, 2012, Bulletin de la Societe Entomologique de France, V117, P473; Woltz J. M., 2015, J APPL ENTOMOL, DOI [10.1111/jen.12200, DOI 10.1111/JEN.12200]; Wu S-R, 2007, J YUNNAN AGR U, V22; Xue W. Q., 1996, FLIES CHINA; Yamakawa R, 1991, TOHOKU NOGYO KENKYU, V44, P221; Yang XD, 2011, NW HORTICULT, V2, P35; Yang Y, 2011, MOL PHYLOGENET EVOL, V62, P214, DOI DOI 10.1016/J.YMPEV.2011.09.018; YUKINARI M, 1988, JPN J APPL ENTOMOL Z, V32, P146; Zhang C-L, 2011, CHINA PLANT PROT, V31, P2628; Zhang FX, 2012, YANTAI FRUIT, V119, P3	177	4	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-4758	1612-4766		J PEST SCI	J. Pest Sci.	SEP	2015	88	3					469	494		10.1007/s10340-015-0681-z		26	Entomology	Entomology	CP4CK	WOS:000359829400003		
J	Donovan, MD; Polli, JE; Langguth, P; Tamai, I; Vig, B; Yu, LX				Donovan, Maureen D.; Polli, James E.; Langguth, Peter; Tamai, Ikumi; Vig, Balvinder; Yu, Lawrence X.			Gordon L. Amidon: Very Sustained Drug Absorption	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Editorial Material						absorption; active transport; Biopharmaceutics Classification System (BCS); gastrointestinal; intestinal absorption; membrane transport; prodrugs	ACID ESTER PRODRUGS; BIOPHARMACEUTICS CLASSIFICATION-SYSTEM; INTESTINAL-MEMBRANE PERMEABILITY; BETA-LACTAM ANTIBIOTICS; ALPHA-METHYLDOPA ABSORPTION; HUMAN DIPEPTIDE TRANSPORTER; HUMAN JEJUNAL PERMEABILITY; HUMAN PEPTIDE TRANSPORTER; BOUNDARY-LAYER APPROACH; HYDROLASE-LIKE PROTEIN		[Donovan, Maureen D.] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Polli, James E.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Langguth, Peter] Johannes Gutenberg Univ Mainz, Inst Pharm, D-55122 Mainz, Germany; [Tamai, Ikumi] Kanazawa Univ, Fac Pharm, Kanazawa, Ishikawa, Japan; [Vig, Balvinder] Bristol Myers Squibb, New Brunswick, NJ USA; [Yu, Lawrence X.] US FDA, Rockville, MD 20857 USA	Polli, JE (reprint author), Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA.	jpolli@rx.umaryland.edu	TAMAI, Ikumi/D-8412-2015				AMIDON GE, 1981, J THEOR BIOL, V89, P195, DOI 10.1016/0022-5193(81)90306-4; AMIDON GL, 1988, PHARMACEUT RES, V5, P651, DOI 10.1023/A:1015927004752; AMIDON GL, 1980, J PHARM SCI, V69, P1363, DOI 10.1002/jps.2600691203; AMIDON GL, 1986, J PHARM PHARMACOL, V38, P363; Amidon GL, 1999, PHARMACEUT RES, V16, P175, DOI 10.1023/A:1011955803803; AMIDON GL, 1982, J PHARM SCI, V71, P1138, DOI 10.1002/jps.2600711015; AMIDON GL, 1985, GASTROENTEROLOGY, V88, P858; AMIDON GL, 1983, J PHARM SCI, V72, P943, DOI 10.1002/jps.2600720826; Covitz KMY, 1998, BIOCHEMISTRY-US, V37, P15214, DOI 10.1021/bi981128k; Granero GE, 2006, INT J PHARM, V317, P14, DOI 10.1016/j.ijpharm.2006.01.050; Yu LX, 2002, PHARMACEUT RES, V19, P921, DOI 10.1023/A:1016473601633; Han HK, 1998, PHARMACEUT RES, V15, P1154, DOI 10.1023/A:1011919319810; Han HK, 1999, J PHARM SCI, V88, P347, DOI 10.1021/js980132e; Amidon KS, 2011, CLIN PHARMACOL THER, V90, P467, DOI 10.1038/clpt.2011.109; MERFELD AE, 1986, J PHARM PHARMACOL, V38, P815; Yu LX, 1999, INT J PHARM, V186, P119, DOI 10.1016/S0378-5173(99)00147-7; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; TSUJI A, 1990, PHARMACEUT RES, V7, P308, DOI 10.1023/A:1015894617027; Takamatsu N, 2001, PHARMACEUT RES, V18, P742, DOI 10.1023/A:1011020025338; Lorenzi PL, 2006, DRUG METAB DISPOS, V34, P1070; Ettmayer P, 2004, J MED CHEM, V47, P2393, DOI 10.1021/jm0303812; STEHLE RG, 1967, J PHARM SCI, V56, P1367, DOI 10.1002/jps.2600561040; Yu LX, 1996, ADV DRUG DELIVER REV, V19, P359, DOI 10.1016/0169-409X(96)00009-9; Tsume Y, 2010, MOL PHARMACEUT, V7, P1235, DOI 10.1021/mp100053q; Takamatsu N, 1997, PHARMACEUT RES, V14, P1127, DOI 10.1023/A:1012134219095; JOHNSON DA, 1988, J THEOR BIOL, V131, P93, DOI 10.1016/S0022-5193(88)80123-1; Landowski CP, 2005, PHARM RES, V22, P1510, DOI 10.1007/s11095-005-6156-9; AMIDON GE, 1982, J PHARM SCI, V71, P77, DOI 10.1002/jps.2600710120; Yu LX, 1998, EUR J PHARM BIOPHARM, V45, P199, DOI 10.1016/S0939-6411(97)00088-X; Gupta D, 2009, MOL PHARMACEUT, V6, P1604, DOI 10.1021/mp900084v; Chiu YY, 2003, PHARMACEUT RES, V20, P749, DOI 10.1023/A:1023481418576; Croyle MA, 1998, PHARMACEUT RES, V15, P1348, DOI 10.1023/A:1011985101580; HIGUCHI WI, 1963, J PHARM SCI, V52, P67, DOI 10.1002/jps.2600520114; BAI JPF, 1992, PHARMACEUT RES, V9, P969, DOI 10.1023/A:1015885823793; AMIDON GL, 1980, J PHARM SCI, V69, P1369, DOI 10.1002/jps.2600691204; Lobenberg R, 2000, EUR J PHARM BIOPHARM, V50, P3, DOI 10.1016/S0939-6411(00)00091-6; SINKO PJ, 1988, PHARMACEUT RES, V5, P645, DOI 10.1023/A:1015974920682; Benet LZ, 2008, PHARM RES, V25, P483, DOI 10.1007/s11095-007-9523-x; Song XQ, 2005, J MED CHEM, V48, P1274, DOI 10.1021/jm049450i; Tsume Y, 2014, EUR J PHARM SCI, V57, P152, DOI 10.1016/j.ejps.2014.01.009; Xu H, 2013, BEILSTEIN J ORG CHEM, V9, P89, DOI 10.3762/bjoc.9.12; SINKO PJ, 1993, PHARMACEUT RES, V10, P271, DOI 10.1023/A:1018999130076; Niphakis MJ, 2014, ANNU REV BIOCHEM, V83, P341, DOI 10.1146/annurev-biochem-060713-035708; Mudie DM, 2012, BIOPHARM DRUG DISPOS, V33, P378, DOI 10.1002/bdd.1803; Tsume Y, 2012, J PHARM PHARM SCI, V15, P433; Dahan A, 2009, AM J PHYSIOL-GASTR L, V297, pG371, DOI 10.1152/ajpgi.00102.2009; Mudie DM, 2014, MOL PHARMACEUT, V11, P3039, DOI 10.1021/mp500210c; Dahan A, 2009, AAPS J, V11, P740, DOI 10.1208/s12248-009-9144-x; Gupta SV, 2011, MOL PHARMACEUT, V8, P2358, DOI 10.1021/mp200291x; OBERLE RL, 1990, GASTROENTEROLOGY, V99, P1275; Miller JM, 2010, MOL PHARMACEUT, V7, P1223, DOI 10.1021/mp100050d; Mudie DM, 2010, MOL PHARMACEUT, V7, P1388, DOI 10.1021/mp100149j; DEMIRANDA P, 1983, J ANTIMICROB CHEMOTH, V12, P29; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; HO NFH, 1972, J PHARM SCI, V61, P192, DOI 10.1002/jps.2600610210; Bird R.B., 2002, TRANSPORT PHENOMENA; Covitz KMY, 1996, PHARMACEUT RES, V13, P1631, DOI 10.1023/A:1016476220296; Dahan A, 2012, MOL PHARMACEUT, V9, P1847, DOI 10.1021/mp300140h; Dahan A, 2013, MOL PHARMACEUT, V10, P4378, DOI 10.1021/mp400485k; Dahan A, 2010, MOL PHARMACEUT, V7, P1827, DOI 10.1021/mp100175a; Dahan A, 2010, INT J PHARMACEUT, V386, P216, DOI 10.1016/j.ijpharm.2009.11.021; DRESSMAN JB, 1985, J PHARM SCI, V74, P588, DOI 10.1002/jps.2600740523; ELLIOTT RL, 1980, J THEOR BIOL, V87, P757, DOI 10.1016/0022-5193(80)90115-0; FLEISHER D, 1986, J PHARM SCI, V75, P934, DOI 10.1002/jps.2600751004; FLEISHER D, 1985, METHOD ENZYMOL, V112, P360; Foster DR, 2009, JPEN-PARENTER ENTER, V33, P520, DOI 10.1177/0148607109333002; FRIEDMAN DI, 1991, PHARMACEUT RES, V8, P93, DOI 10.1023/A:1015842609565; FRIEDMAN DI, 1989, PHARMACEUT RES, V6, P1043, DOI 10.1023/A:1015978420797; FRIEDMAN DI, 1989, J PHARM SCI, V78, P995, DOI 10.1002/jps.2600781205; Granero GE, 2005, DRUG DEV IND PHARM, V31, P917, DOI 10.1080/03639040500272108; Granero GE, 2006, PHARMAZIE, V61, P673; Han H K, 2000, AAPS PharmSci, V2, pE6; Han HK, 1998, LIFE SCI, V63, P1599, DOI 10.1016/S0024-3205(98)00429-9; Han HK, 1998, PHARMACEUT RES, V15, P1382, DOI 10.1023/A:1011945420235; Higaki K, 2008, EUR J PHARM BIOPHARM, V70, P313, DOI 10.1016/j.ejpb.2008.02.022; Higaki K, 2001, J PHARMACOKINET PHAR, V28, P109, DOI 10.1023/A:1011573831444; HIGUCHI WI, 1964, J PHARM SCI, V53, P333, DOI 10.1002/jps.2600530321; HIGUCHI WI, 1963, J PHARM SCI, V52, P162, DOI 10.1002/jps.2600520213; HIGUCHI WI, 1965, J PHARM SCI, V54, P1405, DOI 10.1002/jps.2600541003; HO NFH, 1974, J PHARM SCI, V63, P686, DOI 10.1002/jps.2600630508; HU M, 1988, J THEOR BIOL, V131, P107, DOI 10.1016/S0022-5193(88)80124-3; HU M, 1988, J PHARM SCI, V77, P1007, DOI 10.1002/jps.2600771204; HU M, 1989, PHARMACEUT RES, V6, P66, DOI 10.1023/A:1015855820488; Idkaidek NM, 1998, BIOPHARM DRUG DISPOS, V19, P169, DOI 10.1002/(SICI)1099-081X(199804)19:3<169::AID-BDD83>3.3.CO;2-3; Jakubowski H, 2000, J NUTR S, V130, P377; Jinno J, 2000, J PHARM SCI, V89, P268, DOI 10.1002/(SICI)1520-6017(200002)89:2<268::AID-JPS14>3.3.CO;2-6; JOHNSON K, 1985, J PHARM SCI, V74, P87, DOI 10.1002/jps.2600740124; Kim I, 2003, J BIOL CHEM, V278, P25348, DOI 10.1074/jbc.M302055200; Kim I, 2004, MOL PHARMACEUT, V1, P434, DOI 10.1021/mp049959; Kim I, 2004, MOL PHARMACEUT, V1, P117, DOI 10.1021/mp0499757; KIM JS, 2006, MOL PHARM, V3, P686, DOI DOI 10.1021/MP060042F; Knutson L, 1994, Lakartidningen, V91, P1941; KOU JH, 1991, PHARMACEUT RES, V8, P298, DOI 10.1023/A:1015829128646; Krieg BJ, 2014, J PHARM SCI-US, V103, P3473, DOI 10.1002/jps.24108; Lai LS, 2008, J BIOL CHEM, V283, P9318, DOI 10.1074/jbc.M709530200; Landowski Christopher P, 2004, AAPS J, V6, pe21; Landowski CP, 2005, MOL CANCER THER, V4, P659, DOI 10.1158/1535-7163.MCT-04-0290; Landowski CP, 2006, J PHARMACOL EXP THER, V316, P572, DOI 10.1124/jpet.105.092726; LANGGUTH P, 1994, PHARMACEUT RES, V11, P528, DOI 10.1023/A:1018962415287; Lee HJ, 2002, BIOPHARM DRUG DISPOS, V23, P131, DOI 10.1002/bdd.302; LENNERNAS H, 1992, PHARMACEUT RES, V9, P1243, DOI 10.1023/A:1015888813741; LEVY G, 1965, J PHARM SCI, V54, P812, DOI 10.1002/jps.2600540540; Lipka E, 1995, J PHARMACOKINET BIOP, V23, P267, DOI 10.1007/BF02354285; Lipka E, 1996, J CONTROL RELEASE, V39, P121, DOI 10.1016/0168-3659(95)00145-X; Lipka E, 1998, EUR J PHARM SCI, V6, P75, DOI 10.1016/S0928-0987(97)00070-5; Lorenzi PL, 2005, J PHARMACOL EXP THER, V314, P883, DOI 10.1124/jpet.104.082412; MARGLIN A, 1966, J AM CHEM SOC, V88, P5051; Marsillach J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110054; Martinez M, 2002, ADV DRUG DELIVER REV, V54, P825, DOI 10.1016/S0169-409X(02)00071-6; Mathews D M, 1976, Gastroenterology, V71, P151; MATTHEWS DM, 1972, P NUTR SOC, V31, P171, DOI 10.1079/PNS19720033; MATTHEWS DM, 1968, LANCET, V2, P639; Matthews D M, 1987, Beitr Infusionther Klin Ernahr, V17, P6; McCully KS, 2015, EXPERT REV CLIN PHAR, V8, P211, DOI 10.1586/17512433.2015.1010516; MERRIFIE.RB, 1965, SCIENCE, V150, P178, DOI 10.1126/science.150.3693.178; MERRIFIE.RB, 1965, ENDEAVOUR, V24, P3, DOI 10.1016/0160-9327(65)90090-6; MERRIFIELD RB, 1964, BIOCHEMISTRY-US, V3, P1385, DOI 10.1021/bi00897a032; MERRIFIE.RB, 1965, NATURE, V207, P522, DOI 10.1038/207522a0; Meyer J H, 1985, Nihon Heikatsukin Gakkai Zasshi, V21 Suppl, P99; Miller JM, 2009, J CONTROL RELEASE, V137, P31, DOI 10.1016/j.jconrel.2009.02.018; Mittal S, 2007, EUR J PHARM BIOPHARM, V67, P752, DOI 10.1016/j.ejpb.2007.03.024; Mittal S, 2007, PHARM RES, V24, P1290, DOI 10.1007/s11095-007-9249-9; NELSON E, 1965, CHEMOTHERAPY, V10, P145; NELSON EINO, 1965, LIFE SCI, V4, P949, DOI 10.1016/0024-3205(65)90195-5; NELSON E K, 1965, Hosp Top, V43, P45; Oh D M, 1999, Pharm Biotechnol, V12, P59; OH DM, 1993, J PHARM SCI, V82, P897, DOI 10.1002/jps.2600820907; OH DM, 1993, PHARMACEUT RES, V10, P264, DOI 10.1023/A:1018947113238; PARK JY, 1984, J PHARM SCI, V73, P1588, DOI 10.1002/jps.2600731126; Radwan A, 2014, EUR J PHARM SCI, V57, P273, DOI 10.1016/j.ejps.2013.08.038; Rhie JK, 1998, PHARMACEUT RES, V15, P233, DOI 10.1023/A:1011962501270; Sabit H, 2013, MOL PHARMACEUT, V10, P1417, DOI 10.1021/mp3007067; Sadee W, 1995, PHARMACEUT RES, V12, P1823, DOI 10.1023/A:1016211015926; Shin HC, 2006, BIOL PHARM BULL, V29, P247, DOI 10.1248/bpb.29.247; Silk D B, 1977, Ciba Found Symp, P15; SILK DBA, 1974, GUT, V15, P494, DOI 10.1136/gut.15.6.494; SINKO PJ, 1991, PHARMACEUT RES, V8, P979, DOI 10.1023/A:1015892621261; SINKO PJ, 1989, J PHARM SCI, V78, P723, DOI 10.1002/jps.2600780904; SIROIS PJ, 1990, AM J PHYSIOL, V258, pG65; Smith DE, 2012, PHARM RES-DORDR, V29, P2345, DOI 10.1007/s11095-012-0808-3; Song XQ, 2005, MOL PHARMACEUT, V2, P157, DOI 10.1021/mp049888e; STEWART BH, 1986, J PHARM SCI, V75, P940, DOI 10.1002/jps.2600751005; SU SF, 1995, BBA-GEN SUBJECTS, V1245, P62, DOI 10.1016/0304-4165(95)00063-H; Takamatsu N, 2002, EUR J PHARM BIOPHARM, V53, P37, DOI 10.1016/S0939-6411(01)00207-7; Taki Y, 1998, J PHARM PHARMACOL, V50, P1013; Tehler U, 2010, ANTIVIR RES, V85, P482, DOI 10.1016/j.antiviral.2009.12.003; Tsume Yasuhiro, 2014, Pharmaceuticals (Basel), V7, P169, DOI 10.3390/ph7020169; Tsume Y, 2012, MOLECULES, V17, P3672, DOI 10.3390/molecules17043672; Tsume Y, 2014, EUR J PHARM BIOPHARM, V86, P514, DOI 10.1016/j.ejpb.2013.12.009; Vig BS, 2003, PHARMACEUT RES, V20, P1381, DOI 10.1023/A:1025745824632	151	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	SEP	2015	104	9					2650	2663		10.1002/jps.24523		14	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CP4MV	WOS:000359857200002		
J	Sugano, K; Terada, K				Sugano, Kiyohiko; Terada, Katsuhide			Rate- and Extent-Limiting Factors of Oral Drug Absorption: Theory and Applications	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Review						intestinal absorption; salt selection; bioequivalence; biopharmaceutics classification system (BCS); in silico modeling; dissolution; food effects; formulation; gastrointestinal transit; oral absorption	BIOPHARMACEUTICS CLASSIFICATION-SYSTEM; IMMEDIATE-RELEASE FORMULATIONS; MINISCALE DISSOLUTION TEST; MEMBRANE PERMEATION ASSAY; PARTICLE-SIZE REDUCTION; UNSTIRRED WATER LAYER; IN-VIVO PERFORMANCE; COMPUTER-SIMULATION; INTESTINAL-ABSORPTION; BIOWAIVER EXTENSION	The oral absorption of drugs has been represented by various concepts such as the absorption potential, the maximum absorbable dose, the biopharmaceutics classification system, and in vitro-in vivo correlation. The aim of this article is to provide an overview of the theoretical relationships between these concepts. It shows how a simple analytical solution for the fraction of a dose absorbed (Fa equation) can offer a theoretical base to tie together the various concepts, and discusses how this solution relates to the rate-limiting cases of oral drug absorption. The article introduces the Fa classification system as a framework in which all the above concepts were included, and discusses its applications for food effect prediction, active pharmaceutical ingredient form selection, formulation design, and biowaiver strategy. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2777-2788, 2015	[Sugano, Kiyohiko; Terada, Katsuhide] Toho Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Funabashi, Chiba 2748510, Japan	Sugano, K (reprint author), Toho Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Funabashi, Chiba 2748510, Japan.	kiyohiko.sugano@phar.toho-u.ac.jp					Yu LX, 2002, PHARMACEUT RES, V19, P921, DOI 10.1023/A:1016473601633; WILS P, 1994, J PHARMACOL EXP THER, V269, P654; Gao P, 2003, J PHARM SCI-US, V92, P2386, DOI 10.1002/jps.10511; Chen ML, 2011, PHARM RES-DORDR, V28, P1774, DOI 10.1007/s11095-011-0438-1; Johnson KC, 1996, PHARMACEUT RES, V13, P1795, DOI 10.1023/A:1016068705255; Krishna G, 2001, INT J PHARM, V222, P77, DOI 10.1016/S0378-5173(01)00698-6; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Kortejarvi H, 2007, EUR J PHARM SCI, V30, P155, DOI 10.1016/j.ejps.2006.10.011; Wu CY, 2005, PHARM RES, V22, P11, DOI 10.1007/s11095-004-9004-4; Jinno J, 2006, J CONTROL RELEASE, V111, P56, DOI 10.1016/j.jconrel.2005.11.013; Takano R, 2006, PHARM RES, V23, P1144, DOI 10.1007/s11095-006-0162-4; Yu LX, 1996, ADV DRUG DELIVER REV, V19, P359, DOI 10.1016/0169-409X(96)00009-9; Ahmed IS, 2008, EUR J PHARM SCI, V35, P219, DOI 10.1016/j.ejps.2008.07.002; Tsume Y, 2010, MOL PHARMACEUT, V7, P1235, DOI 10.1021/mp100053q; Wohnsland F, 2001, J MED CHEM, V44, P923, DOI 10.1021/jm001020e; Norris DA, 1998, ADV DRUG DELIVER REV, V34, P135, DOI 10.1016/S0169-409X(98)00037-4; Sugano K, 2011, INT J PHARMACEUT, V405, P79, DOI 10.1016/j.ijpharm.2010.11.049; AMIDON GE, 1982, J PHARM SCI, V71, P77, DOI 10.1002/jps.2600710120; Sugano K, 2009, EXPERT OPIN DRUG MET, V5, P259, DOI [10.1517/17425250902835506 , 10.1517/17425250902835506]; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Sugano K, 2010, INT J PHARMACEUT, V387, P103, DOI 10.1016/j.ijpharm.2009.12.014; Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e; Sugano K, 2010, INT J PHARMACEUT, V398, P73, DOI 10.1016/j.ijpharm.2010.07.027; Friesen DT, 2008, MOL PHARMACEUT, V5, P1003, DOI 10.1021/mp8000793; Butler JM, 2010, J PHARM SCI-US, V99, P4940, DOI 10.1002/jps.22217; Dokoumetzidis A, 2006, INT J PHARM, V321, P1, DOI 10.1016/j.ijpharm.2006.07.011; Rodgers T, 2006, J PHARM SCI-US, V95, P1238, DOI 10.1002/jps.20502; SHEFTER E, 1963, J PHARM SCI, V52, P781, DOI 10.1002/jps.2600520815; Shiraki K, 2008, PHARM RES-DORDR, V25, P2581, DOI 10.1007/s11095-008-9676-2; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Tsume Y, 2014, EUR J PHARM SCI, V57, P152, DOI 10.1016/j.ejps.2014.01.009; Sugano K, 2001, J BIOMOL SCREEN, V6, P189, DOI 10.1177/108705710100600309; LIVERSIDGE GG, 1995, INT J PHARM, V125, P91, DOI 10.1016/0378-5173(95)00122-Y; Takano R, 2010, MOL PHARMACEUT, V7, P1431, DOI 10.1021/mp100109a; Rinaki E, 2004, PHARM RES, V21, P1567, DOI 10.1023/B:PHAM.0000041450.25106.c8; ROLAN PE, 1994, BRIT J CLIN PHARMACO, V37, P13; Anby MU, 2012, MOL PHARMACEUT, V9, P2063, DOI 10.1021/mp300164u; DAVIS SS, 1986, GUT, V27, P886, DOI 10.1136/gut.27.8.886; Sugano K, 2007, DRUG METAB PHARMACOK, V22, P225, DOI 10.2133/dmpk.22.225; Thombre AG, 2005, DRUG DISCOV TODAY, V10, P1159, DOI 10.1016/S1359-6446(05)03551-8; Kobayashi Y, 2000, INT J PHARM, V193, P137, DOI 10.1016/S0378-5173(99)00315-4; Sugano K, 2009, CHEM BIODIVERS, V6, P2014, DOI 10.1002/cbdv.200900101; Yu LX, 1999, PHARMACEUT RES, V16, P1883, DOI 10.1023/A:1018911728161; YALKOWSKY SH, 1980, J PHARM SCI, V69, P912, DOI 10.1002/jps.2600690814; Rodgers T, 2005, J PHARM SCI-US, V94, P1259, DOI 10.1002/jps.20322; Sugano K, 2010, EUR J PHARM SCI, V40, P118, DOI 10.1016/j.ejps.2010.03.011; Sugano K, 2009, INT J PHARM, V368, P116, DOI 10.1016/j.ijpharm.2008.10.001; Ramirez E, 2010, BRIT J CLIN PHARMACO, V70, P694, DOI 10.1111/j.1365-2125.2010.03757.x; Garcia-Arieta A, 2012, AAPS J, V14, P738, DOI 10.1208/s12248-012-9382-1; Yazdanian M, 2004, PHARM RES, V21, P293, DOI 10.1023/B:PHAM.0000016242.48642.71; Gardner CR, 2004, NAT REV DRUG DISCOV, V3, P926, DOI 10.1038/nrd1550; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Rege BD, 2001, J PHARM SCI, V90, P1776, DOI 10.1002/jps.1127; Atkins P, 2003, GALILEOS FINGER 10 G, P392; Bramlage Peter, 2008, BMC Pharmacology, V8, P18, DOI 10.1186/1471-2210-8-18; Brewster ME, 2007, INT J PHARM, V342, P250, DOI 10.1016/j.ijpharm.2007.04.029; Dahlgren D, 2015, J PHARM SCI; Doyle-McCullough M, 2007, INT J PHARM, V335, P79, DOI 10.1016/j.ijpharm.2006.10.043; DRESSMAN JB, 1986, J PHARM SCI, V75, P109, DOI 10.1002/jps.2600750202; DRESSMAN JB, 1985, J PHARM SCI, V74, P588, DOI 10.1002/jps.2600740523; Fiese EF, 2003, J PHARM SCI, V92, P1331, DOI 10.1002/jps.10366; Galia E, 1998, PHARMACEUT RES, V15, P698, DOI 10.1023/A:1011910801212; Hansen MB, 2002, PHYSIOL RES, V51, P541; Jantratid E, 2006, CLIN PHARMACOKINET, V45, P385, DOI 10.2165/00003088-200645040-00004; Kawai Y, 2011, DRUG METAB PHARMACOK, V26, P180, DOI 10.2133/dmpk.DMPK-10-RG-098; LENNERNAS H, 1993, PHARMACEUT RES, V10, P879, DOI 10.1023/A:1018965328626; Lennernaas H, 2014, EUR J PHARM SCI, V57, P292, DOI 10.1016/j.ejps.2013.10.012; Noyes AA, 1897, J AM CHEM SOC, V19, P930, DOI DOI 10.1021/JA02086A003; OH DM, 1993, PHARMACEUT RES, V10, P264, DOI 10.1023/A:1018947113238; Ono A, 2014, EUR J PHARM SCI, V64, P37, DOI 10.1016/j.ejps.2014.08.003; Singh BN, 2005, DRUG DEVELOP RES, V65, P55, DOI 10.1002/ddr.20008; Sugano K, 2009, CBI J, V9, P75; Sugano K., 2012, BIOPHARMACEUTICS MOD; Sunesen VH, 2005, EUR J PHARM SCI, V24, P297, DOI 10.1016/j.ejps.2004.11.005; Takano R, 2008, PHARM RES-DORDR, V25, P2334, DOI 10.1007/s11095-008-9637-9; YAMAGUCHI T, 1986, CHEM PHARM BULL, V34, P3362; Yamashita S, 2013, PHARM RES-DORDR, V30, P951, DOI 10.1007/s11095-012-0931-1; Young D, 1997, IN VITRO IN VIVO COR	78	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	SEP	2015	104	9					2777	2788		10.1002/jps.24391		12	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CP4MV	WOS:000359857200009		
J	Yano, K; Mita, S; Morimoto, K; Haraguchi, T; Arakawa, H; Yoshida, M; Yamashita, F; Uchida, T; Ogihara, T				Yano, Kentaro; Mita, Suzune; Morimoto, Kaori; Haraguchi, Tamami; Arakawa, Hiroshi; Yoshida, Miyako; Yamashita, Fumiyoshi; Uchida, Takahiro; Ogihara, Takuo			Multiple Linear Regression Analysis Indicates Association of P-Glycoprotein Substrate or Inhibitor Character with Bitterness Intensity, Measured with a Sensor	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						P-glycoprotein; substrate specificity; inhibition; bitterness intensity; Log P; Transporters; absorption; solubility; Multivariate analysis; Physicochemical properties; multiple linear regression analysis; correlation efficient	ORALLY DISINTEGRATING TABLETS; CANCER RESISTANCE PROTEIN; TASTE RECEPTORS; ATPASE ACTIVITY; TRANSPORT; CELLS; DRUG; IDENTIFICATION; EXPRESSION; INTESTINE	P-glycoprotein (P-gp) regulates absorption of many drugs in the gastrointestinal tract and their accumulation in tumor tissues, but the basis of substrate recognition by P-gp remains unclear. Bitter-tasting phenylthiocarbamide, which stimulates taste receptor 2 member 38 (T2R38), increases P-gp activity and is a substrate of P-gp. This led us to hypothesize that bitterness intensity might be a predictor of P-gp-inhibitor/substrate status. Here, we measured the bitterness intensity of a panel of P-gp substrates and nonsubstrates with various taste sensors, and used multiple linear regression analysis to examine the relationship between P-gp-inhibitor/substrate status and various physical properties, including intensity of bitter taste measured with the taste sensor. We calculated the first principal component analysis score (PC1) as the representative value of bitterness, as all taste sensor's outputs shared significant correlation. The P-gp substrates showed remarkably greater mean bitterness intensity than non-P-gp substrates. We found that K-m value of P-gp substrates were correlated with molecular weight, log P, and PC1 value, and the coefficient of determination (R-2) of the linear regression equation was 0.63. This relationship might be useful as an aid to predict P-gp substrate status at an early stage of drug discovery. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2789-2794, 2015	[Yano, Kentaro; Mita, Suzune; Arakawa, Hiroshi; Ogihara, Takuo] Takasaki Univ Hlth & Welf, Fac Pharm, Takasaki, Gumma 3700033, Japan; [Morimoto, Kaori] Tohoku Pharmaceut Univ, Dept Drug Absorpt & Pharmacokinet, Sendai, Miyagi 9818558, Japan; [Haraguchi, Tamami; Yoshida, Miyako; Uchida, Takahiro] Mukogawa Womens Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Nishinomiya, Hyogo 6638179, Japan; [Yamashita, Fumiyoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo, Kyoto 6068501, Japan	Ogihara, T (reprint author), Takasaki Univ Hlth & Welf, Fac Pharm, Takasaki, Gumma 3700033, Japan.	togihara@takasaki-u.ac.jp			 [24590667]	This work was supported by Grant-in-Aid for Scientific Research (No. 24590667).	Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Ieiri I, 2012, DRUG METAB PHARMACOK, V27, P85, DOI 10.2133/dmpk.DMPK-11-RV-098; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Didziapetris R, 2003, J DRUG TARGET, V11, P391, DOI 10.1080/10611860310001648248; Petri N, 2004, PHARM RES, V21, P1398, DOI 10.1023/B:PHAM.0000036913.90332.b1; Mottino AD, 2008, WORLD J GASTROENTERO, V14, P7068, DOI 10.3748/wjg.14.7068; Kobayashi Y, 2010, SENSORS-BASEL, V10, P3411, DOI 10.3390/s100403411; Harada T, 2010, CHEM PHARM BULL, V58, P1009; Cho HJ, 2011, J PHARM PHARMACOL, V63, P385, DOI 10.1111/j.2042-7158.2010.01221.x; Kaji I, 2009, AM J PHYSIOL-GASTR L, V296, pG971, DOI 10.1152/ajpgi.90514.2008; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Bauer B, 2003, PHARMACEUT RES, V20, P1170, DOI 10.1023/A:1025040712857; Borgnia MJ, 1996, J BIOL CHEM, V271, P3163; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; Haraguchi T, 2013, J PHARM PHARMACOL, V65, P980, DOI 10.1111/jphp.12078; Hoffmann G, 2009, ANTIMICROB AGENTS CH, V53, P4753, DOI 10.1128/AAC.01541-08; Hosomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030456; Ingels F, 2002, INT J PHARM, V232, P183, DOI 10.1016/S0378-5173(01)00897-3; Kneuer C, 2007, PFLUG ARCH EUR J PHY, V454, P587, DOI 10.1007/s00424-007-0235-1; Matsushima S, 2005, J PHARMACOL EXP THER, V314, P1059, DOI 10.1124/jpet.105.085589; Ogihara T, 2004, J PHARM PHARMACOL, V56, P79, DOI 10.1211/0022357022386; Shintaku K, 2007, DRUG METAB DISPOS, V35, P772, DOI 10.1124/dmd.106.013029; Tachibana T, 2012, PHARM RES-DORDR, V29, P651, DOI 10.1007/s11095-011-0579-2; Uchida T, 2013, J PHARM PHARMACOL, V65, P1312, DOI 10.1111/jphp.12101; Watanabe T, 2013, J PHARM SCI-US, V102, P3196, DOI 10.1002/jps.23623; Yang CP, 2013, FOOD CHEM TOXICOL, V57, P195, DOI 10.1016/j.fct.2013.03.033; Yano K, 2013, J PHARM SCI-US, V102, P2875, DOI 10.1002/jps.23637; Yano K, 2014, DRUG METAB PHARMACOK, V29, P254, DOI 10.2133/dmpk.DMPK-13-RG-072	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	SEP	2015	104	9					2789	2794		10.1002/jps.24232		6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CP4MV	WOS:000359857200010		
J	Yamada, Y; Perez, SMV; Tabata, M; Abe, J; Yasuzaki, Y; Harashima, H				Yamada, Yuma; Perez, Sandra Milena Vergara; Tabata, Mai; Abe, Jiro; Yasuzaki, Yukari; Harashima, Hideyoshi			Efficient and High-Speed Transduction of an Antibody into Living Cells Using a Multifunctional Nanocarrier System to Control Intracellular Trafficking	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						biomaterials; nanoparticles; liposomes; macromolecular drug delivery; protein delivery; multifunctional envelope-type nano device (MEND); antibody delivery; octaarginine; GALA; antibody drug	BIOLOGICALLY-ACTIVE PROTEINS; SENSITIVE FUSOGENIC PEPTIDE; ARGININE-RICH PEPTIDES; NANO DEVICE; MAMMALIAN-CELLS; DELIVERY-SYSTEM; GENE DELIVERY; CARRIER; OCTAARGININE; LIPOSOMES	The transduction of antibodies into living cells would represent a major contribution to both basic and applied biomedical fields, as currently available methods suffer from limitations such as low-uptake efficiency and endosomal entrapment. In this study, a liposome-based carrier was designed to overcome these issues. Liposomes were modified with octaarginine (R8), a cell penetrating peptide and GALA, a pH-sensitive fusogenic peptide. The presence of R8 enhanced the cellular uptake of antibodies, whereas GALA reduced endosomal entrapment, resulting in antibodies being released into the cytosol within 30 min. Moreover, compared with commercially available reagents for delivering antibodies, our system was superior in both cellular uptake and endosomal escape. In addition, specific antibodies delivered by R8-GALA liposomes were found to be associated with their epitope, confirming the preservation of functionality. This system for the efficient and high-speed cytosolic delivery of an antibody provides a valuable tool that can be useful in basic and applied research for analyzing the expression and function of intracellular molecules. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2845-2854, 2015	[Yamada, Yuma; Perez, Sandra Milena Vergara; Tabata, Mai; Abe, Jiro; Yasuzaki, Yukari; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Sapporo, Hokkaido 0600812, Japan; [Abe, Jiro] Hokkaido Univ Hosp, Dept Pediat, Sapporo, Hokkaido 0608638, Japan	Harashima, H (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Sapporo, Hokkaido 0600812, Japan.	harasima@pharm.hokudai.ac.jp			Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japanese Government (MEXT)	This work was supported, in part, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan (NIBIO), a Grant-in-Aid for Young Scientists (A) and a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology of Japanese Government (MEXT). We also thank Dr. Milton Feather for his helpful advice in writing the manuscript.	Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Nakamura Y, 2007, J CONTROL RELEASE, V119, P360, DOI 10.1016/j.jconrel.2007.03.010; Kakudo T, 2004, BIOCHEMISTRY-US, V43, P5618, DOI 10.1021/bi035802w; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Futaki S, 2006, BIOPOLYMERS, V84, P241, DOI 10.1002/hip.20421; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/nmeth.2998, 10.1038/NMETH.2998]; CHAKRABARTI R, 1989, J BIOL CHEM, V264, P15494; PLANK C, 1994, J BIOL CHEM, V269, P12918; Loudet A, 2008, ORG BIOMOL CHEM, V6, P4516, DOI 10.1039/b809006h; Futaki S, 2005, J GENE MED, V7, P1450, DOI 10.1002/jgm.796; ARNHEITER H, 1988, EMBO J, V7, P1315; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Akita H, 2010, J CONTROL RELEASE, V143, P311, DOI 10.1016/j.jconrel.2010.01.012; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Didenko VV, 2005, ANAL BIOCHEM, V344, P168, DOI 10.1016/j.ab.2005.06.011; Khalil IA, 2004, GENE THER, V11, P636, DOI 10.1038/sj.gt.3302128; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8720, DOI 10.1021/bi00489a031; Lee Y, 2010, ANGEW CHEM INT EDIT, V49, P2552, DOI 10.1002/anie.200905264; SUBBARAO NK, 1987, BIOCHEMISTRY-US, V26, P2964, DOI 10.1021/bi00385a002; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Kogure K, 2004, J CONTROL RELEASE, V98, P317, DOI 10.1016/j.jconrel.2004.04.024; LAMAZE C, 1995, CURR OPIN CELL BIOL, V7, P573, DOI 10.1016/0955-0674(95)80015-8; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Nakamura Y, 2006, J PHARM PHARMACOL, V58, P431, DOI 10.1211/jpp.58.4.0002; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Furukawa R, 2011, BIOCHEM BIOPH RES CO, V404, P796, DOI 10.1016/j.bbrc.2010.12.062; Green I, 2003, TRENDS PHARMACOL SCI, V24, P213, DOI 10.1016/S0165-6147(03)00076-2; Kondo Y, 2008, J IMMUNOL METHODS, V332, P10, DOI 10.1016/j.jim.2007.12.008; Mahlitin E, 2007, ANAL BIOCHEM, V365, P215, DOI 10.1016/j.ab.2007.03.020; Nicol F, 1999, BIOPHYS J, V76, P2121; SENIOR J, 1986, FEBS LETT, V196, P54, DOI 10.1016/0014-5793(86)80213-7; Siprashvili Z, 2004, MOL THER, V9, P721, DOI 10.1016/j.ymthe.2004.02.004; Suzuki R, 2007, BIOL PHARM BULL, V30, P758, DOI 10.1248/bpb.30.758; Weill CO, 2008, BIOTECHNIQUES, V44, P7; Yamada Y, 2014, BIOMATERIALS, V35, P6430, DOI 10.1016/j.biomaterials.2014.04.017; Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	SEP	2015	104	9					2845	2854		10.1002/jps.24310		10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CP4MV	WOS:000359857200016		
J	Kosugi, Y; Yamamoto, S; Sano, N; Furuta, A; Igari, T; Fujioka, Y; Amano, N				Kosugi, Yohei; Yamamoto, Syunsuke; Sano, Noriyasu; Furuta, Atsutoshi; Igari, Tomoko; Fujioka, Yasushi; Amano, Nobuyuki			Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						gastric pH; acid tolerance; pentagastrin; gastric acid secretion; stability; oral bioavailability; pharmacokinetics; formulation; enteric coating	CONSCIOUS BEAGLE DOGS; GASTROINTESTINAL PHYSIOLOGY; DOSAGE FORMS; VIVO EVALUATION; COATED PELLETS; RESIDENCE TIME; ERYTHROMYCIN; PH; OMEPRAZOLE; INHIBITOR	We attempted to establish animal models to evaluate the effects of drug degradation in the stomach on oral bioavailability. In addition, we assessed the utilization of animal studies in determining the need for enteric-coated formulations. In order to control the gastric pH in rats and dogs, appropriate dosing conditions were investigated using pentagastrin and rabeprazole, which stimulate and inhibit gastric acid secretion. Using animals controlled for gastric acid secretion, the area under curve (AUC) ratios (AUC with rabeprazole/AUC with pentagastrin) of all compounds unstable under acidic conditions were evaluated. The AUC ratios of omeprazole and erythromycin, which are administered orally to humans, as enteric-coated tablets, were greater than 1.9 in the rats and dogs controlled for gastric acid secretion. On the contrary, the AUC ratios of clarithromycin, azithromycin, and etoposide (commercially available as a standard immediate-release form) were less than 1.3 each. In conclusion, in vivo models using rats and dogs were optimized to evaluate the effects of gastric acid on the oral bioavailability of drugs, and demonstrated that in vivo models can lead to a better understanding of the oral bioavailability, with respect to the formulation development. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2887-2893, 2015	[Kosugi, Yohei; Yamamoto, Syunsuke; Sano, Noriyasu; Furuta, Atsutoshi; Igari, Tomoko; Fujioka, Yasushi; Amano, Nobuyuki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, Kanagawa, Japan	Kosugi, Y (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, Kanagawa, Japan.	youhei.kosugi@takeda.com					Akimoto M, 2000, EUR J PHARM BIOPHARM, V49, P99, DOI 10.1016/S0939-6411(99)00070-3; JANSSENS J, 1990, NEW ENGL J MED, V322, P1028, DOI 10.1056/NEJM199004123221502; Zvyaga T, 2012, DRUG METAB DISPOS, V40, P1698, DOI 10.1124/dmd.112.045575; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; LARSSON H, 1983, GASTROENTEROLOGY, V85, P900; SATOH H, 1989, J PHARMACOL EXP THER, V248, P806; LUI CY, 1986, J PHARM SCI, V75, P271, DOI 10.1002/jps.2600750313; NAKAGAWA Y, 1992, CHEM PHARM BULL, V40, P725; Tari A, 2002, J GASTROENTEROL, V37, P177, DOI 10.1007/s005350200018; CATNACH SM, 1992, GUT, V33, P397, DOI 10.1136/gut.33.3.397; DRESSMAN JB, 1990, PHARMACEUT RES, V7, P756, DOI 10.1023/A:1015827908309; Chiba T, 2002, NEUROGASTROENT MOTIL, V14, P535, DOI 10.1046/j.1365-2982.2002.00357.x; WALLMARK B, 1984, BIOCHIM BIOPHYS ACTA, V778, P549, DOI 10.1016/0005-2736(84)90406-1; Kalantzi L, 2006, PHARM RES-DORDR, V23, P165, DOI 10.1007/s11095-005-8476-1; BRENER W, 1983, GASTROENTEROLOGY, V85, P76; BERTACCINI G, 1982, BRIT J PHARMACOL, V77, P443; Boivin MA, 2003, PHARMACOTHERAPY, V23, P5, DOI 10.1592/phco.23.1.5.31919; CADIERE GB, 1986, DIGEST DIS SCI, V31, P418, DOI 10.1007/BF01311679; CHAUDHUR.TK, 1974, J NUCL MED, V15, P391; CHOW D, 1987, J CHROMATOGR, V396, P217, DOI 10.1016/S0021-9673(01)94059-2; COOKE AR, 1972, AM J PHYSIOL, V223, P934; Debunne A, 2004, EUR J PHARM SCI, V22, P305, DOI 10.1016/j.ejps.2004.03.017; DOZOIS RR, 1971, AM J PHYSIOL, V221, P113; DRESSMAN JB, 1986, PHARMACEUT RES, V3, P123, DOI 10.1023/A:1016353705970; EHRLEIN HJ, 1982, Q J EXP PHYSIOL CMS, V67, P419; Fancher RM, 2011, J PHARM SCI-US, V100, P2979, DOI 10.1002/jps.22486; FIESE EF, 1990, J ANTIMICROB CHEMOTH, V25, P39; GarciaLopez P, 1997, BIOPHARM DRUG DISPOS, V18, P203, DOI 10.1002/(SICI)1099-081X(199704)18:3<203::AID-BDD11>3.0.CO;2-F; GRIFFITH RS, 1964, AM J MED SCI, V247, P69, DOI 10.1097/00000441-196401000-00010; He W, 2009, CHEM PHARM BULL, V57, P122; HUNT JN, 1951, J PHYSIOL-LONDON, V113, P157; Ikegami K, 2003, BIOL PHARM BULL, V26, P1442, DOI 10.1248/bpb.26.1442; ITOH Z, 1984, AM J PHYSIOL, V247, pG688; JANG SH, 1994, J PHARM SCI, V83, P810, DOI 10.1002/jps.2600830610; KANIWA N, 1988, J PHARMACOBIO-DYNAM, V11, P563; Keto Y, 2012, NEUROGASTROENT MOTIL, V24, P147, DOI 10.1111/j.1365-2982.2011.01809.x; KNUPP CA, 1993, PHARMACEUT RES, V10, P1157, DOI 10.1023/A:1018964117665; Kristl A, 2000, DRUG DEV IND PHARM, V26, P781, DOI 10.1081/DDC-100101299; LAZAREVSKI T, 1978, J PHARM SCI, V67, P1031, DOI 10.1002/jps.2600670747; Lubach JW, 2013, MOL PHARMACEUT, V10, P3997, DOI 10.1021/mp400283j; MAERZ LL, 1994, AM J PHYSIOL-REG I, V267, pR1163; Mahar KM, 2012, J PHARM SCI-US, V101, P2439, DOI 10.1002/jps.23159; MAJUMDAR APN, 1978, MOL CELL ENDOCRINOL, V11, P137, DOI 10.1016/0303-7207(78)90002-3; Makino C, 2006, CHEM PHARM BULL, V54, P409, DOI 10.1248/cpb.54.409; MCDONALD PJ, 1977, J CLIN PHARMACOL, V17, P601, DOI 10.1177/009127007701701007; Mistiaen W, 2000, J Nucl Med Technol, V28, P165; Pilbrant A, 1985, Scand J Gastroenterol Suppl, V108, P113; Rudholm T, 2008, WORLD J GASTROENTERO, V14, P6180, DOI 10.3748/wjg.14.6180; RUSSELL TL, 1993, PHARMACEUT RES, V10, P187, DOI 10.1023/A:1018970323716; SAGARA K, 1992, CHEM PHARM BULL, V40, P3303; Sagawa K, 2009, J PHARM SCI-US, V98, P2494, DOI 10.1002/jps.21602; Shao F, 2007, BIOPHARM DRUG DISPOS, V28, P177, DOI 10.1002/bdd.543; Shimizu T, 2003, CHEM PHARM BULL, V51, P1121, DOI 10.1248/cpb.51.1121; TABATA T, 1992, DRUG DEV IND PHARM, V18, P1437, DOI 10.3109/03639049209040850; Tamaş S, 1988, Physiologie, V25, P47; Wang YJ, 2013, PHARM DEV TECHNOL, V18, P401, DOI 10.3109/10837450.2012.659254; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	SEP	2015	104	9					2887	2893		10.1002/jps.24401		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CP4MV	WOS:000359857200020		
J	Mizusako, H; Tagami, T; Hattori, K; Ozeki, T				Mizusako, Hideki; Tagami, Tatsuaki; Hattori, Kenjiro; Ozeki, Tetsuya			Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						cyclodextrin; drug resistance; folate; per-FOL-beta-CD; receptor-mediated endocytosis; drug delivery; cancer; supramolecular chemistry	LIPOSOMAL DOXORUBICIN; CANCER; RECEPTOR; DELIVERY; CARRIER; NANOPARTICLES; ENDOCYTOSIS; THERAPY; PROTEIN; SYSTEM	Active drug targeting is an effective therapeutic approach for the treatment of malignant cancers and novel types of drug carriers have been developed. In this study, we developed a cyclodextrin (CD)-based novel carrier-drug conjugate, called per-FOL--CD-ss-DOX, which has folic acid (FA) molecules at the end of primary hydroxyl groups of -CD and a pH-cleavable spacer with an anticancer drug, doxorubicin (DOX), at the end of secondary hydroxyl groups. This per-FOL--CD-ss-DOX exhibited a significant cellular uptake as compared with the free DOX solution by EMT6/P cells, which activate the expression of folate receptor (FR). Cellular uptake of per-FOL--CD-ss-DOX was significantly inhibited in the presence of FA and was also inhibited at 4 degrees C. The conjugate exhibited remarkable cytotoxic effects in EMT6/AR1 cells, which are resistant to DOX, whereas free DOX solution did not exhibit this effect. These results suggest that per-FOL--CD-ss-DOX can be taken up into cells via FR-related endocytosis and the cleaved DOX derived from it in endosomes could escape the efflux caused by P-glycoprotein, resulting in the cytotoxic effect. Therefore, the drug delivery by per-FOL--CD-ss-DOX may be a useful approach for drug delivery to FR-expressing cells such as drug-resistant malignant cancers. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2934-2940, 2015	[Mizusako, Hideki; Tagami, Tatsuaki; Ozeki, Tetsuya] Nagoya City Univ, Grad Sch Pharmaceut Sci, Drug Delivery & Nano Pharmaceut, Nagoya, Aichi 4678603, Japan; [Hattori, Kenjiro] Nano Dex Inc, R&D Lab, Kawasaki, Kanagawa 2430435, Japan	Ozeki, T (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Drug Delivery & Nano Pharmaceut, Nagoya, Aichi 4678603, Japan.	ozekit@phar.nagoya-cu.ac.jp			Japan Society for the Promotion of Science [22590040]	This research was partly funded by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (22590040).	Markman JL, 2013, ADV DRUG DELIVER REV, V65, P1866, DOI 10.1016/j.addr.2013.09.019; Loftsson T, 2007, INT J PHARM, V329, P1, DOI 10.1016/j.ijpharm.2006.10.044; Okamatsu A, 2013, BIOCONJUGATE CHEM, V24, P724, DOI 10.1021/bc400015r; Wong HL, 2006, J PHARMACOL EXP THER, V317, P1372, DOI 10.1124/jpet.106.101154; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Arima H, 2012, MOL PHARMACEUT, V9, P2591, DOI 10.1021/mp300188f; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Saul JM, 2003, J CONTROL RELEASE, V92, P49, DOI 10.1016/S0168-3659(03)00295-5; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Mohanty C, 2011, CURR DRUG DELIV, V8, P45, DOI 10.2174/156720111793663606; Geng JL, 2012, SMALL, V8, P3655, DOI 10.1002/smll.201200814; Kim D, 2008, SMALL, V4, P2043, DOI 10.1002/smll.200701275; Wu M, 1999, CANCER EPIDEM BIOMAR, V8, P775; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kobayashi T, 2007, INT J PHARM, V329, P94, DOI 10.1016/j.ijpharm.2006.08.039; Mukherjee B, 2013, CURR PHARM BIOTECHNO, V14, P1221; Gabizon A, 2004, ADV DRUG DELIVER REV, V56, P1177, DOI 10.1016/j.addr.2004.01.011; GARINCHESA P, 1993, AM J PATHOL, V142, P557; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Leamon CP, 2001, DRUG DISCOV TODAY, V6, P44, DOI 10.1016/S1359-6446(00)01594-4; Tagami T, 2014, INT J PHARMACEUT, V468, P91, DOI 10.1016/j.ijpharm.2014.04.013; Zheng XH, 2011, MOL PHARMACEUT, V8, P447, DOI 10.1021/mp100301t; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Hattori K, 2010, Google Patents. Patent, Patent No. [WO 2009/041666 A1, 2009041666]; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; TUREK JJ, 1993, J CELL SCI, V106, P423; Vhora Imran, 2014, Ther Deliv, V5, P1007, DOI 10.4155/tde.14.63; Yang J, 2006, P NATL ACAD SCI USA, V103, P13872, DOI 10.1073/pnas.0601455103; Yu H, 2006, TETRAHEDRON LETT, V47, P8837, DOI 10.1016/j.tetlet.2006.10.061	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	SEP	2015	104	9					2934	2940		10.1002/jps.24428		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CP4MV	WOS:000359857200025		
